,MIM Number,Preferred Title,symbol
0,100050,"AARSKOG SYNDROME, AUTOSOMAL DOMINANT",
1,100070,"AORTIC ANEURYSM, FAMILIAL ABDOMINAL, 1", AAA1
2,100100,PRUNE BELLY SYNDROME, PBS
3,100200,ABDUCENS PALSY,
4,100300,ADAMS-OLIVER SYNDROME 1, AOS1
5,100500,CHOREOACANTHOCYTOSIS,
6,100600,ACANTHOSIS NIGRICANS,
7,100640,"ALDEHYDE DEHYDROGENASE 1 FAMILY, MEMBER A1", ALDH1A1
8,100650,ALDEHYDE DEHYDROGENASE 2 FAMILY, ALDH2
9,100660,"ALDEHYDE DEHYDROGENASE, FAMILY 3, SUBFAMILY A, MEMBER 1", ALDH3A1
10,100670,"ALDEHYDE DEHYDROGENASE 1 FAMILY, MEMBER B1", ALDH1B1
11,100675,ACETAMINOPHEN METABOLISM,
12,100678,ACETYL-CoA ACETYLTRANSFERASE 2, ACAT2
13,100680,ACETYLCHOLINESTERASE,
14,100690,"CHOLINERGIC RECEPTOR, NICOTINIC, ALPHA POLYPEPTIDE 1", CHRNA1
15,100700,ACHARD SYNDROME,
16,100710,"CHOLINERGIC RECEPTOR, NICOTINIC, BETA POLYPEPTIDE 1", CHRNB1
17,100720,"CHOLINERGIC RECEPTOR, NICOTINIC, DELTA POLYPEPTIDE", CHRND
18,100725,"CHOLINERGIC RECEPTOR, NICOTINIC, EPSILON POLYPEPTIDE", CHRNE
19,100730,"CHOLINERGIC RECEPTOR, NICOTINIC, GAMMA POLYPEPTIDE", CHRNG
20,100735,NEUREGULIN 1,
21,100740,ACETYLCHOLINESTERASE, ACHE
22,100790,ACHAETE-SCUTE FAMILY bHLH TRANSCRIPTION FACTOR 1, ASCL1
23,100800,ACHONDROPLASIA, ACH
24,100820,ACHOO SYNDROME,
25,100850,ACONITASE 2, ACO2
26,100880,ACONITASE 1, ACO1
27,100900,ACONITASE 1,
28,101000,"SCHWANNOMATOSIS, VESTIBULAR", SWNV
29,101120,ACROCEPHALOPOLYSYNDACTYLY TYPE III,
30,101200,APERT SYNDROME,
31,101400,SAETHRE-CHOTZEN SYNDROME, SCS
32,101600,PFEIFFER SYNDROME,
33,101800,ACRODYSOSTOSIS 1 WITH OR WITHOUT HORMONE RESISTANCE, ACRDYS1
34,101805,"ACROFACIAL DYSOSTOSIS, CATANIA TYPE",
35,101840,"ACROKERATODERMA, HEREDITARY PAPULOTRANSLUCENT",
36,101850,"PALMOPLANTAR KERATODERMA, PUNCTATE TYPE III", PPKP3
37,101900,ACROKERATOSIS VERRUCIFORMIS, AKV
38,102000,"ACROLEUKOPATHY, SYMMETRIC",
39,102100,"ACROMEGALOID CHANGES, CUTIS VERTICIS GYRATA, AND CORNEAL LEUKOMA",
40,102150,ACROMEGALOID FACIAL APPEARANCE SYNDROME,
41,102200,"PITUITARY ADENOMA 1, MULTIPLE TYPES", PITA1
42,102300,"RESTLESS LEGS SYNDROME, SUSCEPTIBILITY TO, 1", RLS1
43,102350,ACROMIAL DIMPLES,
44,102370,ACROMICRIC DYSPLASIA, ACMICD
45,102400,ACROOSTEOLYSIS,
46,102480,ACROSIN, ACR
47,102490,DUANE-RADIAL RAY SYNDROME,
48,102500,HAJDU-CHENEY SYNDROME, HJCYS
49,102510,ACROPECTOROVERTEBRAL DYSPLASIA, ACRPV
50,102520,ACRORENAL SYNDROME,
51,102525,ACROSOMAL VESICLE PROTEIN 1, ACRV1
52,102530,SPERMATOGENIC FAILURE 6, SPGF6
53,102540,"ACTIN, ALPHA, CARDIAC MUSCLE", ACTC1
54,102545,"ACTIN, GAMMA-2, SMOOTH MUSCLE, ENTERIC", ACTG2
55,102550,"ACTIN, BETA",
56,102560,"ACTIN, GAMMA-1", ACTG1
57,102565,FILAMIN C, FLNC
58,102570,TITLE NOT AVAILABLE AT THIS MOMENT,
59,102573,"ACTININ, ALPHA-2", ACTN2
60,102574,"ACTININ, ALPHA-3", ACTN3
61,102575,"ACTININ, ALPHA-1", ACTN1
62,102576,"ACTIVIN A RECEPTOR, TYPE I", ACVR1
63,102577,"REPLICATION FACTOR C, SUBUNIT 4", RFC4
64,102578,"ACUTE PROMYELOCYTIC LEUKEMIA, INDUCER OF", PML
65,102579,"REPLICATION FACTOR C, SUBUNIT 1", RFC1
66,102581,"ACTIVIN A RECEPTOR, TYPE IIA", ACVR2A
67,102582,SIGNAL TRANSDUCER AND ACTIVATOR OF TRANSCRIPTION 3, STAT3
68,102590,AMINOACYLASE 3,
69,102593,ACYLOXYACYL HYDROLASE, AOAH
70,102595,"ACYLPHOSPHATASE 2, MUSCLE TYPE", ACYP2
71,102600,ADENINE PHOSPHORIBOSYLTRANSFERASE, APRT
72,102610,"ACTIN, ALPHA-1, SKELETAL MUSCLE", ACTA1
73,102620,"ACTIN, ALPHA-2, SMOOTH MUSCLE, AORTA", ACTA2
74,102630,"ACTIN, BETA", ACTB
75,102640,"ACTIN, BETA",
76,102642,STEROL O-ACYLTRANSFERASE 1, SOAT1
77,102645,ACYLAMINOACYL-PEPTIDE HYDROLASE, APEH
78,102650,"ADACTYLIA, UNILATERAL",
79,102660,ADAMANTINOMA OF LONG BONES,
80,102670,MUCOSAL VASCULAR ADDRESSIN CELL ADHESION MOLECULE 1, MADCAM1
81,102680,ADDUCIN 1, ADD1
82,102681,ADDUCIN 2, ADD2
83,102699,ADENO-ASSOCIATED VIRUS INTEGRATION SITE 1, AAVS1
84,102700,"SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-NEGATIVE, NK CELL-NEGATIVE, DUE TO ADENOSINE DEAMINASE DEFICIENCY",
85,102710,DIPEPTIDYL PEPTIDASE IV,
86,102720,DIPEPTIDYL PEPTIDASE IV, DPP4
87,102730,"ANEMIA, CONGENITAL, NONSPHEROCYTIC HEMOLYTIC, 9",
88,102750,ADENOSINE KINASE, ADK
89,102770,ADENOSINE MONOPHOSPHATE DEAMINASE 1, AMPD1
90,102771,ADENOSINE MONOPHOSPHATE DEAMINASE 2, AMPD2
91,102772,ADENOSINE MONOPHOSPHATE DEAMINASE 3, AMPD3
92,102775,ADENOSINE A1 RECEPTOR, ADORA1
93,102776,ADENOSINE A2A RECEPTOR, ADORA2A
94,102777,ADENOSINE A2B RECEPTOR,
95,102800,"ANEMIA, CONGENITAL, NONSPHEROCYTIC HEMOLYTIC, 2",
96,102900,"ADENOSINE TRIPHOSPHATE, ELEVATED, OF ERYTHROCYTES",
97,102910,"ATP SYNTHASE F1, SUBUNIT BETA", ATP5F1B
98,102920,TITLE NOT AVAILABLE AT THIS MOMENT,
99,102930,TITLE NOT AVAILABLE AT THIS MOMENT,
100,102940,TITLE NOT AVAILABLE AT THIS MOMENT,
101,102970,TITLE NOT AVAILABLE AT THIS MOMENT,
102,102980,ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE 1, ADCYAP1
103,102981,"ADCYAP RECEPTOR, TYPE I", ADCYAP1R1
104,102990,"MALIGNANT HYPERTHERMIA, SUSCEPTIBILITY TO, 1",
105,103000,ADENYLATE KINASE 1, AK1
106,103020,ADENYLATE KINASE 2, AK2
107,103030,ADENYLATE KINASE 4, AK4
108,103050,ADENYLOSUCCINASE DEFICIENCY, ADSLD
109,103060,ADENYLOSUCCINATE SYNTHETASE, ADSS
110,103070,ADENYLATE CYCLASE 8, ADCY8
111,103071,ADENYLATE CYCLASE 2, ADCY2
112,103072,ADENYLATE CYCLASE 1, ADCY1
113,103100,ADIE PUPIL,
114,103180,ADP-RIBOSYLATION FACTOR 1, ARF1
115,103188,ADP-RIBOSYLATION FACTOR 5, ARF5
116,103190,ADP-RIBOSYLATION FACTOR 3, ARF3
117,103195,PERILIPIN 2, PLIN2
118,103200,ADIPOSIS DOLOROSA,
119,103220,"SOLUTE CARRIER FAMILY 25 (MITOCHONDRIAL CARRIER, ADENINE NUCLEOTIDE TRANSLOCATOR), MEMBER 4", SLC25A4
120,103230,"ADRENOCORTICAL HYPOFUNCTION, CHRONIC PRIMARY CONGENITAL",
121,103260,FERREDOXIN 1, FDX1
122,103270,FERREDOXIN REDUCTASE, FDXR
123,103275,ADRENOMEDULLIN, ADM
124,103280,"H19, IMPRINTED MATERNALLY EXPRESSED NONCODING TRANSCRIPT", H19
125,103285,ADULT SYNDROME,
126,103300,HYPOGLOSSIA-HYPODACTYLIA,
127,103320,AGRIN, AGRN
128,103321,DYSTROGLYCAN 1,
129,103390,AHNAK NUCLEOPROTEIN, AHNAK
130,103400,AINHUM,
131,103420,"ALACRIMA, CONGENITAL, AUTOSOMAL DOMINANT",
132,103470,"WAARDENBURG SYNDROME, TYPE 2A",
133,103500,TIETZ ALBINISM-DEAFNESS SYNDROME, TADS
134,103580,"PSEUDOHYPOPARATHYROIDISM, TYPE IA", PHP1A
135,103581,"PSEUDOHYPOPARATHYROIDISM, TYPE IA",
136,103600,ALBUMIN, ALB
137,103700,"ALCOHOL DEHYDROGENASE 1A, CLASS I, ALPHA POLYPEPTIDE", ADH1A
138,103710,"ALCOHOL DEHYDROGENASE 5, CHI POLYPEPTIDE", ADH5
139,103720,"ALCOHOL DEHYDROGENASE 1B, CLASS I, BETA POLYPEPTIDE", ADH1B
140,103730,"ALCOHOL DEHYDROGENASE 1C, GAMMA POLYPEPTIDE", ADH1C
141,103735,ALCOHOL DEHYDROGENASE 6, ADH6
142,103740,ALCOHOL DEHYDROGENASE 4, ADH4
143,103780,ALCOHOL DEPENDENCE,
144,103800,"MUCOPOLYSACCHARIDOSIS, TYPE VI",
145,103830,"ALDO-KETO REDUCTASE FAMILY 1, MEMBER A1", AKR1A1
146,103850,"ALDOLASE A, FRUCTOSE-BISPHOSPHATE", ALDOA
147,103870,"ALDOLASE C, FRUCTOSE-BISPHOSPHATE", ALDOC
148,103880,"ALDO-KETO REDUCTASE FAMILY 1, MEMBER B1", AKR1B1
149,103890,"ALDO-KETO REDUCTASE FAMILY 1, MEMBER B1",
150,103900,"HYPERALDOSTERONISM, FAMILIAL, TYPE I", HALD1
151,103920,"ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS, FAMILIAL",
152,103950,ALPHA-2-MACROGLOBULIN, A2M
153,104000,ALOPECIA AREATA 1, AA1
154,104100,PALMOPLANTAR KERATODERMA AND CONGENITAL ALOPECIA 1, PPKCA1
155,104110,"ALOPECIA, FAMILIAL FOCAL", ALPF
156,104130,"ALOPECIA, PSYCHOMOTOR EPILEPSY, PYORRHEA, AND MENTAL SUBNORMALITY",
157,104145,AFAMIN, AFM
158,104150,ALPHA-FETOPROTEIN, AFP
159,104155,ZINC FINGER HOMEOBOX 3, ZFHX3
160,104160,"GLUCOSIDASE, ALPHA, NEUTRAL AB", GANAB
161,104170,N-ACETYL-ALPHA-D-GALACTOSAMINIDASE, NAGA
162,104175,"GLYCOPROTEIN, ALPHA-GALACTOSYLTRANSFERASE 1 PSEUDOGENE", GGTA1P
163,104180,"GLUCOSIDASE, ALPHA, NEUTRAL C", GANC
164,104200,"ALPORT SYNDROME 3A, AUTOSOMAL DOMINANT", ATS3A
165,104210,ALPHA-2A-ADRENERGIC RECEPTOR, ADRA2A
166,104219,ALPHA-1D-ADRENERGIC RECEPTOR, ADRA1D
167,104220,ALPHA-1B-ADRENERGIC RECEPTOR, ADRA1B
168,104221,ALPHA-1A-ADRENERGIC RECEPTOR, ADRA1A
169,104222,ALPHA-1D-ADRENERGIC RECEPTOR,
170,104225,LOW DENSITY LIPOPROTEIN RECEPTOR-RELATED PROTEIN-ASSOCIATED PROTEIN 1, LRPAP1
171,104230,FUCOSYLTRANSFERASE 4, FUT4
172,104240,"ST3 BETA-GALACTOSIDE ALPHA-2,3-SIALYLTRANSFERASE 4", ST3GAL4
173,104250,ALPHA-2C-ADRENERGIC RECEPTOR, ADRA2C
174,104260,ALPHA-2B-ADRENERGIC RECEPTOR, ADRA2B
175,104290,ALTERNATING HEMIPLEGIA OF CHILDHOOD 1, AHC1
176,104300,"ALZHEIMER DISEASE, FAMILIAL, 1", AD1
177,104310,ALZHEIMER DISEASE 2, AD2
178,104311,PRESENILIN 1, PSEN1
179,104350,"AMASTIA, BILATERAL, WITH URETERAL TRIPLICATION AND DYSMORPHISM",
180,104400,AMELIA AND TERMINAL TRANSVERSE HEMIMELIA,
181,104500,"AMELOGENESIS IMPERFECTA, TYPE IB", AI1B
182,104510,"AMELOGENESIS IMPERFECTA, TYPE IV", AI4
183,104530,"AMELOGENESIS IMPERFECTA, TYPE IA", AI1A
184,104570,AMELOONYCHOHYPOHIDROTIC SYNDROME,
185,104600,AMENORRHEA-GALACTORRHEA SYNDROME,
186,104610,"AMINE OXIDASE, COPPER-CONTAINING, 1", AOC1
187,104613,"CHAPERONIN CONTAINING T-COMPLEX POLYPEPTIDE 1, SUBUNIT 6A", CCT6A
188,104614,"SOLUTE CARRIER FAMILY 3 (CYSTINE, DIBASIC, AND NEUTRAL AMINO ACID TRANSPORTER), MEMBER 1", SLC3A1
189,104615,"SOLUTE CARRIER FAMILY 7 (CATIONIC AMINO ACID TRANSPORTER, y+ SYSTEM), MEMBER 1", SLC7A1
190,104620,AMINOACYLASE 1, ACY1
191,104640,AMPHIREGULIN, AREG
192,104650,"AMYLASE, PANCREATIC, A", AMY2A
193,104660,"AMYLASE, PANCREATIC, B", AMY2B
194,104700,"AMYLASE, SALIVARY, A", AMY1A
195,104701,"AMYLASE, SALIVARY, B", AMY1B
196,104702,"AMYLASE, SALIVARY, C", AMY1C
197,104740,"AMYLOID BETA A4 PRECURSOR PROTEIN-BINDING, FAMILY A, MEMBER 1",
198,104750,SERUM AMYLOID A1, SAA1
199,104751,SERUM AMYLOID A2, SAA2
200,104752,SERUM AMYLOID A4, SAA4
201,104760,AMYLOID BETA A4 PRECURSOR PROTEIN, APP
202,104770,"AMYLOID P COMPONENT, SERUM", APCS
203,104775,AMYLOID BETA A4 PRECURSOR-LIKE PROTEIN 1, APLP1
204,104776,AMYLOID BETA A4 PRECURSOR-LIKE PROTEIN 2, APLP2
205,105120,"AMYLOIDOSIS, FINNISH TYPE",
206,105150,"CEREBRAL AMYLOID ANGIOPATHY, CST3-RELATED",
207,105200,"AMYLOIDOSIS, HEREDITARY SYSTEMIC 2", AMYLD2
208,105210,"AMYLOIDOSIS, HEREDITARY SYSTEMIC 1", AMYLD1
209,105250,"AMYLOIDOSIS, PRIMARY LOCALIZED CUTANEOUS, 1", PLCA1
210,105300,AMYOTROPHIC DYSTONIC PARAPLEGIA,
211,105400,AMYOTROPHIC LATERAL SCLEROSIS 1, ALS1
212,105500,AMYOTROPHIC LATERAL SCLEROSIS-PARKINSONISM/DEMENTIA COMPLEX 1,
213,105550,FRONTOTEMPORAL DEMENTIA AND/OR AMYOTROPHIC LATERAL SCLEROSIS 1, FTDALS1
214,105563,ANAL SPHINCTER DYSPLASIA, ASDP
215,105565,"ANAL SPHINCTER MYOPATHY, INTERNAL",
216,105570,"ANDROSTENONE, ABILITY TO SMELL",
217,105580,ANAL CANAL CARCINOMA,
218,105590,ALK RECEPTOR TYROSINE KINASE, ALK
219,105600,"ANEMIA, CONGENITAL DYSERYTHROPOIETIC, TYPE IIIa", CDAN3A
220,105650,DIAMOND-BLACKFAN ANEMIA 1, DBA1
221,105800,"ANEURYSM, INTRACRANIAL BERRY, 1", ANIB1
222,105805,ANEURYSM OF INTERVENTRICULAR SEPTUM,
223,105830,ANGELMAN SYNDROME, AS
224,105835,ANGEL-SHAPED PHALANGOEPIPHYSEAL DYSPLASIA, ASPED
225,105850,ANGIOGENIN, ANG
226,106050,"ANGIOMA SERPIGINOSUM, AUTOSOMAL DOMINANT",
227,106070,"ANGIOMA, HEREDITARY NEUROCUTANEOUS",
228,106100,"ANGIOEDEMA, HEREDITARY, 1", HAE1
229,106150,ANGIOTENSINOGEN, AGT
230,106160,"ANGIOTENSIN II RECEPTOR, TYPE 1",
231,106165,"ANGIOTENSIN II RECEPTOR, TYPE 1", AGTR1
232,106180,ANGIOTENSIN I-CONVERTING ENZYME, ACE
233,106190,"ANHIDROSIS, ISOLATED, WITH NORMAL SWEAT GLANDS", ANHD
234,106195,"SOLUTE CARRIER FAMILY 4 (ANION EXCHANGER), MEMBER 3", SLC4A3
235,106200,ANIRIDIA 1,
236,106210,ANIRIDIA 1, AN1
237,106220,ANIRIDIA AND ABSENT PATELLA,
238,106230,"ANIRIDIA, MICROCORNEA, AND SPONTANEOUSLY REABSORBED CATARACT",
239,106240,ANISOCORIA,
240,106250,ANKYLOBLEPHARON FILIFORME ADNATUM AND CLEFT PALATE, AFA
241,106260,ANKYLOBLEPHARON-ECTODERMAL DEFECTS-CLEFT LIP/PALATE, AEC
242,106280,ANKYLOGLOSSIA WITH OR WITHOUT TOOTH ANOMALIES, ANKG
243,106300,"SPONDYLOARTHROPATHY, SUSCEPTIBILITY TO, 1", SPDA1
244,106400,ANKYLOSING VERTEBRAL HYPEROSTOSIS WITH TYLOSIS,
245,106410,ANKYRIN 2, ANK2
246,106490,ANNEXIN A3, ANXA3
247,106491,ANNEXIN A4, ANXA4
248,106500,ANNULAR ERYTHEMA,
249,106600,"TOOTH AGENESIS, SELECTIVE, 1", STHAG1
250,106700,TOTAL ANOMALOUS PULMONARY VENOUS RETURN 1, TAPVR1
251,106750,ANONYCHIA WITH FLEXURAL PIGMENTATION,
252,106900,ANONYCHIA-ECTRODACTYLY,
253,106990,ANONYCHIA-ONYCHODYSTROPHY WITH BRACHYDACTYLY TYPE B AND ECTRODACTYLY,
254,106995,ANONYCHIA-ONYCHODYSTROPHY WITH HYPOPLASIA OR ABSENCE OF DISTAL PHALANGES,
255,107000,"NAIL DISORDER, NONSYNDROMIC CONGENITAL, 6", NDNC6
256,107100,ANORECTAL ANOMALIES,
257,107200,"ANOSMIA, ISOLATED CONGENITAL", ANIC
258,107240,"CELL ADHESION MOLECULE, NEURAL, 1",
259,107250,ANTERIOR SEGMENT DYSGENESIS 1, ASGD1
260,107253,TITLE NOT AVAILABLE AT THIS MOMENT,
261,107254,ANTIGEN IDENTIFIED BY MONOCLONAL ANTIBODY 30.2A8, MIC12
262,107257,CD9 ANTIGEN,
263,107260,ANTIGEN MSK41 IDENTIFIED BY MONOCLONAL ANTIBODY E3, MSK41
264,107265,CD19 ANTIGEN, CD19
265,107266,CD22 ANTIGEN, CD22
266,107269,CD44 ANTIGEN, CD44
267,107270,CD38 ANTIGEN, CD38
268,107271,CD59 ANTIGEN, CD59
269,107272,CD72 ANTIGEN, CD72
270,107273,CD69 ANTIGEN, CD69
271,107280,"SERPIN PEPTIDASE INHIBITOR, CLADE A, MEMBER 3", SERPINA3
272,107285,SECRETORY LEUKOCYTE PROTEASE INHIBITOR, SLPI
273,107290,ANTIPYRINE METABOLISM,
274,107300,"SERPIN PEPTIDASE INHIBITOR, CLADE C (ANTITHROMBIN), MEMBER 1", SERPINC1
275,107310,"SOLUTE CARRIER FAMILY 9, MEMBER 1", SLC9A1
276,107320,"ANTIPHOSPHOLIPID SYNDROME, FAMILIAL",
277,107323,"ALDEHYDE DEHYDROGENASE 7 FAMILY, MEMBER A1", ALDH7A1
278,107325,"POLYMERASE I, RNA, SUBUNIT G", POLR1G
279,107400,"SERPIN PEPTIDASE INHIBITOR, CLADE A, MEMBER 1", SERPINA1
280,107410,"SERPIN PEPTIDASE INHIBITOR, CLADE A, MEMBER 2, PSEUDOGENE", SERPINA2P
281,107440,"ANTIVIRAL STATE REPRESSOR, REGULATOR OF", AVRR
282,107450,"INTERFERON-ALPHA, -BETA, AND -OMEGA RECEPTOR 1", IFNAR1
283,107460,"INTERFERON-ALPHA, -BETA, AND -OMEGA RECEPTOR 1",
284,107470,INTERFERON-GAMMA RECEPTOR 1, IFNGR1
285,107480,TOWNES-BROCKS SYNDROME 1, TBS1
286,107500,AORTIC ARCH ANOMALY WITH PECULIAR FACIES AND IMPAIRED INTELLECTUAL DEVELOPMENT,
287,107550,"AORTIC ARCH INTERRUPTION, FACIAL PALSY, AND RETINAL COLOBOMA",
288,107580,TRANSCRIPTION FACTOR AP2-ALPHA, TFAP2A
289,107600,"APLASIA CUTIS CONGENITA, NONSYNDROMIC", ACC
290,107601,ADAMS-OLIVER SYNDROME 1,
291,107640,"APNEA, CENTRAL SLEEP",
292,107650,"APNEA, OBSTRUCTIVE SLEEP",
293,107670,APOLIPOPROTEIN A-II, APOA2
294,107680,APOLIPOPROTEIN A-I, APOA1
295,107690,APOLIPOPROTEIN A-IV, APOA4
296,107700,"APPENDICITIS, PRONENESS TO",
297,107710,APOLIPOPROTEIN C-I, APOC1
298,107720,APOLIPOPROTEIN C-III, APOC3
299,107730,APOLIPOPROTEIN B, APOB
300,107740,APOLIPOPROTEIN D, APOD
301,107741,APOLIPOPROTEIN E, APOE
302,107748,APEX NUCLEASE 1, APEX1
303,107750,ARBITRARY RESTRICTION POLYMORPHISM 1,
304,107760,APOLIPOPROTEIN F, APOF
305,107770,LOW DENSITY LIPOPROTEIN RECEPTOR-RELATED PROTEIN 1, LRP1
306,107773,"NUCLEAR RECEPTOR SUBFAMILY 2, GROUP F, MEMBER 2", NR2F2
307,107776,AQUAPORIN 1, AQP1
308,107777,AQUAPORIN 2, AQP2
309,107800,ARCUS CORNEAE,
310,107820,ARGINYL-tRNA SYNTHETASE 1, RARS1
311,107830,ARGINASE 2, ARG2
312,107840,"CITRULLINEMIA, CLASSIC",
313,107850,ARM FOLDING PREFERENCE,
314,107900,"ARMS, MALFORMATION OF",
315,107910,"CYTOCHROME P450, FAMILY 19, SUBFAMILY A, POLYPEPTIDE 1", CYP19A1
316,107920,MALATE DEHYDROGENASE 1,
317,107930,DOPA DECARBOXYLASE, DDC
318,107940,"ARRESTIN, BETA, 1", ARRB1
319,107941,"ARRESTIN, BETA, 2", ARRB2
320,107950,"GOITER, MULTINODULAR 1, WITH OR WITHOUT SERTOLI-LEYDIG CELL TUMORS",
321,107970,"ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 1", ARVD1
322,108000,"ARTERIES, ANOMALIES OF",
323,108010,ARTERIOVENOUS MALFORMATIONS OF THE BRAIN,
324,108050,"ARTERITIS, FAMILIAL GRANULOMATOUS, WITH JUVENILE POLYARTHRITIS",
325,108100,"ARTHRITIS, SACROILIAC",
326,108110,"ARTHROGRYPOSIS, DISTAL, TYPE 1A",
327,108120,"ARTHROGRYPOSIS, DISTAL, TYPE 1A", DA1A
328,108130,"ARTHROGRYPOSIS, DISTAL, TYPE 2B1",
329,108140,"ARTHROGRYPOSIS, DISTAL, TYPE 2B1",
330,108145,"ARTHROGRYPOSIS, DISTAL, TYPE 5", DA5
331,108200,"ARTHROGRYPOSIS, DISTAL, TYPE 6", DA6
332,108300,"STICKLER SYNDROME, TYPE I", STL1
333,108320,"ARTICHOKE, MODIFICATION OF TASTE BY",
334,108330,"CYTOCHROME P450, SUBFAMILY I, POLYPEPTIDE 1", CYP1A1
335,108340,ARYL HYDROCARBON HYDROXYLASE INDUCIBILITY,
336,108345,N-ACETYLTRANSFERASE 1, NAT1
337,108355,GROWTH FACTOR RECEPTOR-BOUND PROTEIN 2, GRB2
338,108360,ASIALOGLYCOPROTEIN RECEPTOR 1, ASGR1
339,108361,ASIALOGLYCOPROTEIN RECEPTOR 2, ASGR2
340,108370,ASPARAGINE SYNTHETASE, ASNS
341,108390,"ASPARAGUS, SPECIFIC SMELL HYPERSENSITIVITY",
342,108400,TITLE NOT AVAILABLE AT THIS MOMENT,
343,108410,ASPARAGINYL-tRNA SYNTHETASE 1, NARS1
344,108420,SPERMATOGENIC FAILURE 2, SPGF2
345,108450,ASYMMETRIC SHORT STATURE SYNDROME,
346,108500,"EPISODIC ATAXIA, TYPE 2", EA2
347,108600,"SPASTIC ATAXIA 1, AUTOSOMAL DOMINANT", SPAX1
348,108650,"SPASTIC ATAXIA 7, AUTOSOMAL DOMINANT", SPAX7
349,108700,ATAXIA WITH FASCICULATIONS,
350,108720,"ATELOSTEOGENESIS, TYPE I", AO1
351,108721,"ATELOSTEOGENESIS, TYPE III", AO3
352,108725,ATHEROSCLEROSIS SUSCEPTIBILITY, ATHS
353,108728,ATP CITRATE LYASE, ACLY
354,108729,"ATP SYNTHASE F1, SUBUNIT GAMMA", ATP5F1C
355,108730,"ATPase, Ca(2+)-TRANSPORTING, FAST-TWITCH 1", ATP2A1
356,108731,"ATPase, Ca(2+)-TRANSPORTING, PLASMA MEMBRANE, 1", ATP2B1
357,108732,"ATPase, Ca(2+)-TRANSPORTING, PLASMA MEMBRANE, 4", ATP2B4
358,108733,"ATPase, Ca(2+)-TRANSPORTING, PLASMA MEMBRANE, 2", ATP2B2
359,108740,"ATPase, Ca(2+)-TRANSPORTING, SLOW-TWITCH", ATP2A2
360,108745,"ATPase, H+ TRANSPORTING, LYSOSOMAL, 16-KD, V0 SUBUNIT C", ATP6V0C
361,108746,"ATPase, H+ TRANSPORTING, LYSOSOMAL, 31-KD, V1 SUBUNIT E, ISOFORM 1", ATP6V1E1
362,108760,ATRESIA OF EXTERNAL AUDITORY CANAL AND CONDUCTIVE DEAFNESS,
363,108770,ATRIAL STANDSTILL 1, ATRST1
364,108780,NATRIURETIC PEPTIDE PRECURSOR A, NPPA
365,108800,ATRIAL SEPTAL DEFECT 1, ASD1
366,108900,ATRIAL SEPTAL DEFECT 7 WITH OR WITHOUT ATRIOVENTRICULAR CONDUCTION DEFECTS, ASD7
367,108950,ATRIAL TACHYARRHYTHMIA WITH SHORT PR INTERVAL,
368,108960,NATRIURETIC PEPTIDE RECEPTOR A/GUANYLATE CYCLASE A, NPR1
369,108961,NATRIURETIC PEPTIDE RECEPTOR 2, NPR2
370,108962,NATRIURETIC PEPTIDE RECEPTOR C, NPR3
371,108970,MEMBRANE METALLOENDOPEPTIDASE,
372,108980,"PR INTERVAL, VARIATION IN",
373,108985,SVEINSSON CHORIORETINAL ATROPHY, SCRA
374,108990,ATTACHED CELL ANTIGEN 28.3.7, MIC7
375,109000,AURICULOOSTEODYSPLASIA,
376,109050,AUROCEPHALOSYNDACTYLY,
377,109090,SMALL RNA-BINDING EXONUCLEASE PROTECTION FACTOR La, SSB
378,109091,CALRETICULIN, CALR
379,109092,TRIPARTITE MOTIF-CONTAINING PROTEIN 21, TRIM21
380,109100,AUTOIMMUNE DISEASE,
381,109110,AUTONOMOUSLY REPLICATING SEQUENCE 1,
382,109120,"AXENFELD-RIEGER ANOMALY WITH PARTIALLY ABSENT EYE MUSCLES, DISTINCTIVE FACE, HYDROCEPHALY, AND SKELETAL ABNORMALITIES",
383,109130,AXIAL OSTEOMALACIA,
384,109135,AXL RECEPTOR TYROSINE KINASE, AXL
385,109150,MACHADO-JOSEPH DISEASE, MJD
386,109160,"AZOTEMIA, FAMILIAL",
387,109170,LEUKOCYTE-SPECIFIC TRANSCRIPT 1, LST1
388,109180,BABOON M7 VIRUS INTEGRATION SITE, BEVI
389,109190,"SOLUTE CARRIER FAMILY 1 (NEUTRAL AMINO ACID TRANSPORTER), MEMBER 5", SLC1A5
390,109195,BACTERICIDAL PERMEABILITY-INCREASING PROTEIN, BPI
391,109200,"ALOPECIA, ANDROGENETIC, 1", AGA1
392,109270,"SOLUTE CARRIER FAMILY 4 (ANION EXCHANGER), MEMBER 1", SLC4A1
393,109280,"SOLUTE CARRIER FAMILY 4 (ANION EXCHANGER), MEMBER 2", SLC4A2
394,109300,BANKI SYNDROME,
395,109350,GASTROESOPHAGEAL REFLUX, GER
396,109390,BAZEX-DUPRE-CHRISTOL SYNDROME,
397,109400,BASAL CELL NEVUS SYNDROME 1, BCNS1
398,109480,BASIGIN, BSG
399,109500,"BASILAR IMPRESSION, PRIMARY",
400,109530,CD48 ANTIGEN, CD48
401,109535,CD40 ANTIGEN, CD40
402,109540,B-CELL GROWTH FACTOR, BCGF
403,109543,"LEUKEMIA, CHRONIC LYMPHOCYTIC, SUSCEPTIBILITY TO, 2",
404,109545,"TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY, MEMBER 17", TNFRSF17
405,109560,BCL3 TRANSCRIPTION COACTIVATOR, BCL3
406,109565,BCL6 TRANSCRIPTION REPRESSOR, BCL6
407,109580,B-CELL ANTIPROLIFERATION FACTOR 1, BTG1
408,109600,BEETURIA,
409,109610,"TRANSLOCATOR PROTEIN, 18-KD", TSPO
410,109630,BETA-1-ADRENERGIC RECEPTOR, ADRB1
411,109635,G PROTEIN-COUPLED RECEPTOR KINASE 2, GRK2
412,109636,BETA-ADRENERGIC RECEPTOR KINASE 2, ADRBK2
413,109640,BETA-GLYCEROL PHOSPHATASE, GPB
414,109650,BEHCET SYNDROME,
415,109660,"BETA-AMINO ACIDS, RENAL TRANSPORT OF", AABT
416,109670,"BETA-ADRENERGIC STIMULATION, RESPONSE TO", BAS
417,109675,"ST6 BETA-GALACTOSAMIDE ALPHA-2,6-SIALYLTRANSFERASE 1", ST6GAL1
418,109684,17-BETA-HYDROXYSTEROID DEHYDROGENASE I, HSD17B1
419,109685,17-BETA-HYDROXYSTEROID DEHYDROGENASE II, HSD17B2
420,109690,BETA-2-ADRENERGIC RECEPTOR, ADRB2
421,109691,BETA-3-ADRENERGIC RECEPTOR, ADRB3
422,109700,BETA-2-MICROGLOBULIN, B2M
423,109710,BETA-2-MICROGLOBULIN REGULATOR, B2MR
424,109715,3-BETA-HYDROXYSTEROID DEHYDROGENASE 1, HSD3B1
425,109720,"BILIARY CIRRHOSIS, PRIMARY, 1", PBC1
426,109730,AORTIC VALVE DISEASE 1, AOVD1
427,109740,"BIFID NOSE, AUTOSOMAL DOMINANT",
428,109750,BILIVERDIN REDUCTASE A, BLVRA
429,109760,5-HYDROXYTRYPTAMINE RECEPTOR 1A, HTR1A
430,109770,CEA CELL ADHESION MOLECULE 1, CEACAM1
431,109780,BKM DNA,
432,109800,BLADDER CANCER,
433,109820,BLADDER DIVERTICULUM,
434,109900,BLEPHAROCHALASIS AND DOUBLE LIP,
435,110000,"BLEPHAROCHALASIS, SUPERIOR",
436,110050,BLEPHARONASOFACIAL MALFORMATION SYNDROME,
437,110100,"BLEPHAROPHIMOSIS, PTOSIS, AND EPICANTHUS INVERSUS", BPES
438,110150,"BLEPHAROPTOSIS, MYOPIA, AND ECTOPIA LENTIS",
439,110250,BLOOD GROUP--ABO SUPPRESSOR,
440,110300,ABO GLYCOSYLTRANSFERASE, ABO
441,110310,"BLOOD GROUP--ABH ANTIGEN, TYPE 2",
442,110350,BLOOD GROUP--AHONEN, AN
443,110450,"BLOOD GROUP, COLTON SYSTEM", CO
444,110500,"BLOOD GROUP, DIEGO SYSTEM", DI
445,110600,ADP-RIBOSYLTRANSFERASE 4, ART4
446,110700,"BLOOD GROUP, DUFFY SYSTEM", FY
447,110720,BLOOD GROUP--En,
448,110750,GLYCOPHORIN C, GYPC
449,110800,"BLOOD GROUP, I SYSTEM", Ii
450,110900,BLOOD GROUP--KELL SYSTEM, KEL
451,111000,"BLOOD GROUP, KIDD SYSTEM", JK
452,111100,FUCOSYLTRANSFERASE 3, FUT3
453,111130,BLOOD GROUP--LKE, LKE
454,111150,BLOOD GROUP--LUTHERAN INHIBITOR, INLU
455,111200,BLOOD GROUP--LUTHERAN SYSTEM, LU
456,111250,"BLOOD GROUP SYSTEM, LANDSTEINER-WIENER", LW
457,111300,"BLOOD GROUP, MN", MN
458,111360,BLOOD GROUP--NEWFOUNDLAND, NFLD
459,111380,BLOOD GROUP--OK, OK
460,111400,"BLOOD GROUP, P1PK SYSTEM",
461,111410,"BLOOD GROUP, P1PK SYSTEM",
462,111500,BLOOD GROUP--PRIVATE SYSTEMS,
463,111600,"BLOOD GROUP, LANGEREIS SYSTEM", LAN
464,111620,RADIN BLOOD GROUP ANTIGEN, RD
465,111680,"RHESUS BLOOD GROUP, D ANTIGEN", RHD
466,111690,"BLOOD GROUP, RH SYSTEM",
467,111700,"RHESUS BLOOD GROUP, CcEe ANTIGENS", RHCE
468,111730,"BETA-1,4-N-ACETYL-GALACTOSAMINYLTRANSFERASE 2", B4GALNT2
469,111740,"BLOOD GROUP, Ss", Ss
470,111750,BLOOD GROUP--SCIANNA SYSTEM, SC
471,111800,BLOOD GROUP--STOLTZFUS SYSTEM, Sf
472,112000,BLOOD GROUP--Ul SYSTEM, UL
473,112010,BLOOD GROUP--WALDNER TYPE, WD
474,112050,BLOOD GROUP--WRIGHT ANTIGEN, WR
475,112100,YT BLOOD GROUP ANTIGEN,
476,112200,BLUE RUBBER BLEB NEVUS,
477,112203,CD80 ANTIGEN, CD80
478,112205,CD79A ANTIGEN, CD79A
479,112210,"MEMBRANE-SPANNING 4 DOMAINS, SUBFAMILY A, MEMBER 1", MS4A1
480,112240,COLE-CARPENTER SYNDROME 1, CLCRP1
481,112250,DIAPHYSEAL MEDULLARY STENOSIS WITH MALIGNANT FIBROUS HISTIOCYTOMA, DMSMFH
482,112260,"GAMMA-CARBOXYGLUTAMIC ACID PROTEIN, BONE", BGLAP
483,112261,BONE MORPHOGENETIC PROTEIN 2, BMP2
484,112262,BONE MORPHOGENETIC PROTEIN 4, BMP4
485,112263,BONE MORPHOGENETIC PROTEIN 3, BMP3
486,112264,BONE MORPHOGENETIC PROTEIN 1, BMP1
487,112265,BONE MORPHOGENETIC PROTEIN 5, BMP5
488,112266,BONE MORPHOGENETIC PROTEIN 6, BMP6
489,112267,BONE MORPHOGENETIC PROTEIN 7, BMP7
490,112270,"BONE PAIN, PERIODIC",
491,112300,BOOK SYNDROME,
492,112310,BOOMERANG DYSPLASIA, BOOMD
493,112350,WEISMANN-NETTER SYNDROME, WNS
494,112370,"BRACHMANN-DE LANGE-LIKE FACIAL CHANGES WITH MICROCEPHALY, METATARSUS ADDUCTUS, AND DEVELOPMENTAL DELAY",
495,112410,HYPERTENSION AND BRACHYDACTYLY SYNDROME, HTNB
496,112430,LONG-THUMB BRACHYDACTYLY SYNDROME,
497,112440,"BRACHYDACTYLY, COMBINED B AND E TYPES",
498,112450,"BRACHYDACTYLY, PREAXIAL, WITH HALLUX VARUS AND THUMB ABDUCTION",
499,112500,"BRACHYDACTYLY, TYPE A1", BDA1
500,112600,"BRACHYDACTYLY, TYPE A2", BDA2
501,112700,"BRACHYDACTYLY, TYPE A3", BDA3
502,112800,"BRACHYDACTYLY, TYPE A4", BDA4
503,112900,"BRACHYDACTYLY, TYPE A4",
504,112910,OSEBOLD-REMONDINI SYNDROME,
505,113000,"BRACHYDACTYLY, TYPE B1", BDB1
506,113100,"BRACHYDACTYLY, TYPE C", BDC
507,113200,"BRACHYDACTYLY, TYPE D", BDD
508,113300,"BRACHYDACTYLY, TYPE E1", BDE1
509,113301,"BRACHYDACTYLY, TYPE E, WITH ATRIAL SEPTAL DEFECT, TYPE II",
510,113310,BRACHYDACTYLY-ECTRODACTYLY WITH FIBULAR APLASIA OR HYPOPLASIA,
511,113400,BRACHYDACTYLY-NYSTAGMUS-CEREBELLAR ATAXIA,
512,113450,BRACHYDACTYLY-DISTAL SYMPHALANGISM SYNDROME,
513,113470,BRACHYMESOMELIA-RENAL SYNDROME,
514,113475,BRACHYMETATARSUS IV,
515,113477,BRACHYMORPHISM-ONYCHODYSPLASIA-DYSPHALANGISM SYNDROME,
516,113480,BRACHYTELEPHALANGY WITH CHARACTERISTIC FACIES AND KALLMANN SYNDROME,
517,113500,BRACHYOLMIA TYPE 3, BCYM3
518,113503,BRADYKININ RECEPTOR B2, BDKRB2
519,113505,BRAIN-DERIVED NEUROTROPHIC FACTOR, BDNF
520,113508,"TYROSINE 3-MONOOXYGENASE/TRYPTOPHAN 5-MONOOXYGENASE ACTIVATION PROTEIN, ETA ISOFORM", YWHAH
521,113510,BRAIN-SPECIFIC PROTEIN Pc-1,
522,113520,BRANCHED-CHAIN AMINOTRANSFERASE 1, BCAT1
523,113530,BRANCHED-CHAIN AMINOTRANSFERASE 2, BCAT2
524,113600,BRANCHIAL CLEFT ANOMALIES,
525,113610,BRANCHIAL MYOCLONUS WITH SPASTIC PARAPARESIS AND CEREBELLAR ATAXIA,
526,113620,BRANCHIOOCULOFACIAL SYNDROME, BOFS
527,113630,BCR ACTIVATOR OF RhoGEF AND GTPase,
528,113640,BCR ACTIVATOR OF RhoGEF AND GTPase,
529,113650,BRANCHIOOTORENAL SYNDROME 1, BOR1
530,113660,BCR ACTIVATOR OF RhoGEF AND GTPase,
531,113670,"HYPERTROPHY OF THE BREAST, JUVENILE", JHB
532,113700,"BREASTS AND/OR NIPPLES, APLASIA OR HYPOPLASIA OF, 1", BNAH1
533,113703,RIBOSOMAL PROTEIN L13, RPL13
534,113705,BRCA1 DNA REPAIR-ASSOCIATED PROTEIN, BRCA1
535,113710,TREFOIL FACTOR 1, TFF1
536,113720,"MUCIN 1, CELL SURFACE ASSOCIATED",
537,113721,BREAST CANCER-RELATED REGULATOR OF TP53,
538,113725,"POU DOMAIN, CLASS 4, TRANSCRIPTION FACTOR 2", POU4F2
539,113730,UNCOUPLING PROTEIN 1, UCP1
540,113750,"ALBINISM, OCULOCUTANEOUS, TYPE VI", OCA6
541,113800,EPIDERMOLYTIC HYPERKERATOSIS 1, EHK1
542,113810,DYSTONIN, DST
543,113811,"COLLAGEN, TYPE XVII, ALPHA-1", COL17A1
544,113900,"PROGRESSIVE FAMILIAL HEART BLOCK, TYPE IA", PFHB1A
545,113950,"BUNDLE BRANCH BLOCK, FAMILIAL ISOLATED COMPLETE RIGHT",
546,113955,"BUNGAROTOXIN, ALPHA, RECEPTOR FOR", BGTXR
547,113960,BUTYRYLESTERASE 1,
548,113970,BURKITT LYMPHOMA, BL
549,113995,COMPLEMENT COMPONENT 5a RECEPTOR 1, C5AR1
550,114000,CAFFEY DISEASE, CAFYD
551,114010,CARBAMOYL PHOSPHATE SYNTHETASE/ASPARTATE TRANSCARBAMYLASE/DIHYDROOROTASE, CAD
552,114019,CADHERIN 15, CDH15
553,114020,CADHERIN 2, CDH2
554,114021,CADHERIN 3, CDH3
555,114025,"CATENIN, ALPHA-2", CTNNA2
556,114030,"CAFE-AU-LAIT SPOTS, MULTIPLE",
557,114050,CALBINDIN 1, CALB1
558,114051,CALBINDIN 2, CALB2
559,114065,"CALCIFIC AORTIC DISEASE WITH IMMUNOLOGIC ABNORMALITIES, FAMILIAL",
560,114070,ANNEXIN A6, ANXA6
561,114078,CALCIUM/CALMODULIN-DEPENDENT PROTEIN KINASE II-ALPHA, CAMK2A
562,114080,CALCIUM/CALMODULIN-DEPENDENT PROTEIN KINASE IV, CAMK4
563,114085,S100 CALCIUM-BINDING PROTEIN A10, S100A10
564,114090,CALPASTATIN, CAST
565,114100,"BASAL GANGLIA CALCIFICATION, IDIOPATHIC, CHILDHOOD-ONSET",
566,114105,"PROTEIN PHOSPHATASE 3, CATALYTIC SUBUNIT, ALPHA ISOFORM", PPP3CA
567,114106,"PROTEIN PHOSPHATASE 3, CATALYTIC SUBUNIT, BETA ISOFORM", PPP3CB
568,114107,"PROTEIN PHOSPHATASE 3, CATALYTIC SUBUNIT, GAMMA ISOFORM", PPP3CC
569,114110,S100 CALCIUM-BINDING PROTEIN A6, S100A6
570,114120,"TUMORAL CALCINOSIS, HYPERPHOSPHATEMIC, FAMILIAL, 1",
571,114130,"CALCITONIN/CALCITONIN-RELATED POLYPEPTIDE, ALPHA", CALCA
572,114131,CALCITONIN RECEPTOR, CALCR
573,114140,"CALLOSITIES, HEREDITARY PAINFUL",
574,114150,CAMPTOBRACHYDACTYLY,
575,114160,"CALCITONIN-RELATED POLYPEPTIDE, BETA", CALCB
576,114170,"CALPAIN, SMALL SUBUNIT 1", CAPNS1
577,114180,CALMODULIN 1, CALM1
578,114181,CALMODULIN 1,
579,114182,CALMODULIN 2, CALM2
580,114183,CALMODULIN 3, CALM3
581,114184,CALMODULIN-LIKE 3, CALML3
582,114190,CALCITONIN RECEPTOR-LIKE RECEPTOR, CALCRL
583,114200,CAMPTODACTYLY 1, CAMPD1
584,114204,"CALCIUM CHANNEL, VOLTAGE-DEPENDENT, ALPHA-2/DELTA SUBUNIT 1", CACNA2D1
585,114205,"CALCIUM CHANNEL, VOLTAGE-DEPENDENT, L TYPE, ALPHA-1C SUBUNIT", CACNA1C
586,114206,"CALCIUM CHANNEL, VOLTAGE-DEPENDENT, L TYPE, ALPHA-1D SUBUNIT", CACNA1D
587,114207,"CALCIUM CHANNEL, VOLTAGE-DEPENDENT, BETA-1 SUBUNIT", CACNB1
588,114208,"CALCIUM CHANNEL, VOLTAGE-DEPENDENT, L TYPE, ALPHA-1S SUBUNIT", CACNA1S
589,114209,"CALCIUM CHANNEL, VOLTAGE-DEPENDENT, GAMMA-1 SUBUNIT", CACNG1
590,114210,S100 CALCIUM-BINDING PROTEIN A4, S100A4
591,114212,CALCYPHOSINE, CAPS
592,114213,CALDESMON 1, CALD1
593,114217,CALNEXIN, CANX
594,114220,CALPAIN 1, CAPN1
595,114230,CALPAIN 2, CAPN2
596,114240,CALPAIN 3, CAPN3
597,114250,CALSEQUESTRIN 1, CASQ1
598,114251,CALSEQUESTRIN 2, CASQ2
599,114260,CENTRIN 2,
600,114280,CAMPATH-1 ANTIGEN, CDW52
601,114290,CAMPOMELIC DYSPLASIA, CMPD
602,114300,"ARTHROGRYPOSIS, DISTAL, TYPE 3", DA3
603,114350,"NUCLEOPORIN, 214-KD", NUP214
604,114400,LYNCH SYNDROME 1,
605,114450,"CANCER, FAMILIAL, WITH IN VITRO RADIORESISTANCE",
606,114480,BREAST CANCER,
607,114500,COLORECTAL CANCER, CRC
608,114550,HEPATOCELLULAR CARCINOMA,
609,114580,"CANDIDIASIS, FAMILIAL, 1", CANDF1
610,114600,"CANINE TEETH, ABSENCE OF UPPER PERMANENT",
611,114610,CANNABINOID RECEPTOR 1, CNR1
612,114620,CRANIOFACIOFRONTODIGITAL SYNDROME,
613,114650,CAR FACTOR DEFICIENCY,
614,114700,CARABELLI ANOMALY OF MAXILLARY MOLAR TEETH,
615,114750,CARBONIC ANHYDRASE III, CA3
616,114760,CARBONIC ANHYDRASE IV, CA4
617,114761,CARBONIC ANHYDRASE VA, CA5A
618,114770,CARBONIC ANHYDRASE VII, CA7
619,114780,CARBONIC ANHYDRASE VI, CA6
620,114800,CARBONIC ANHYDRASE I, CA1
621,114815,CARBONIC ANHYDRASE VIII, CA8
622,114830,CARBONYL REDUCTASE 1, CBR1
623,114835,CARBOXYLESTERASE 1, CES1
624,114836,CARBOXYLESTERASE 1,
625,114840,CARBOXYL-ESTER LIPASE, CEL
626,114841,CARBOXYL-ESTER LIPASE,
627,114850,CARBOXYPEPTIDASE A1, CPA1
628,114851,"CARBOXYPEPTIDASE A3, MAST CELL", CPA3
629,114852,"CARBOXYPEPTIDASE B1, TISSUE", CPB1
630,114855,CARBOXYPEPTIDASE E, CPE
631,114860,CARBOXYPEPTIDASE M, CPM
632,114890,CEA CELL ADHESION MOLECULE 5, CEACAM5
633,114900,"CARCINOID TUMORS, INTESTINAL",
634,115000,VENTRICULAR ARRHYTHMIAS DUE TO CARDIAC RYANODINE RECEPTOR CALCIUM RELEASE DEFICIENCY SYNDROME, VACRDS
635,115080,CARDIAC CONDUCTION DEFECT,
636,115150,CARDIOFACIOCUTANEOUS SYNDROME 1, CFC1
637,115195,"CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 2", CMH2
638,115196,"CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 3", CMH3
639,115197,"CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 4", CMH4
640,115198,"CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 1",
641,115200,"CARDIOMYOPATHY, DILATED, 1A", CMD1A
642,115210,"CARDIOMYOPATHY, FAMILIAL RESTRICTIVE, 1", RCM1
643,115250,"COLLAGENOMA, FAMILIAL CUTANEOUS",
644,115300,"HYPERCAROTENEMIA AND VITAMIN A DEFICIENCY, AUTOSOMAL DOMINANT", HCVAD
645,115310,PHEOCHROMOCYTOMA/PARAGANGLIOMA SYNDROME 4, PPGL4
646,115400,CARPAL DISPLACEMENT,
647,115430,CARPAL TUNNEL SYNDROME 1, CTS1
648,115435,HYALURONAN AND PROTEOGLYCAN LINK PROTEIN 1, HAPLN1
649,115437,MATRILIN 1, MATN1
650,115440,"CASEIN KINASE II, ALPHA-1", CSNK2A1
651,115441,"CASEIN KINASE II, BETA", CSNK2B
652,115442,"CASEIN KINASE II, ALPHA-2", CSNK2A2
653,115450,"CASEIN, ALPHA", CSN1
654,115460,"CASEIN, BETA", CSN2
655,115470,CAT EYE SYNDROME, CES
656,115500,CATALASE, CAT
657,115501,TYROSINASE-RELATED PROTEIN 1, TYRP1
658,115645,"CATARACT, ABERRANT ORAL FRENULA, AND GROWTH RETARDATION",
659,115650,"CATARACT 32, MULTIPLE TYPES", CTRCT32
660,115660,CATARACT 7, CTRCT7
661,115665,"CATARACT 8, MULTIPLE TYPES", CTRCT8
662,115700,"CATARACT 4, MULTIPLE TYPES", CTRCT4
663,115800,CATARACT 29, CTRCT29
664,115900,CATARACT 42, CTRCT42
665,116100,"CATARACT 20, MULTIPLE TYPES", CTRCT20
666,116150,"CATARACT 1, MULTIPLE TYPES",
667,116200,"CATARACT 1, MULTIPLE TYPES", CTRCT1
668,116300,"CATARACT 30, MULTIPLE TYPES", CTRCT30
669,116400,CATARACT 41, CTRCT41
670,116600,"CATARACT 6, MULTIPLE TYPES", CTRCT6
671,116700,CATARACT 13 WITH ADULT i PHENOTYPE, CTRCT13
672,116790,CATECHOL-O-METHYLTRANSFERASE, COMT
673,116800,"CATARACT 5, MULTIPLE TYPES", CTRCT5
674,116805,"CATENIN, ALPHA-1", CTNNA1
675,116806,"CATENIN, BETA-1", CTNNB1
676,116810,CATHEPSIN B, CTSB
677,116820,CATHEPSIN H, CTSH
678,116830,CATHEPSIN G, CTSG
679,116831,GRANZYME H, GZMH
680,116840,CATHEPSIN D, CTSD
681,116845,CATHEPSIN S, CTSS
682,116850,CATATRICHY,
683,116860,CEREBRAL CAVERNOUS MALFORMATIONS, CCM
684,116870,CELIAC ARTERY STENOSIS FROM COMPRESSION BY MEDIAN ARCUATE LIGAMENT OF DIAPHRAGM,
685,116880,CATHEPSIN L, CTSL
686,116890,CATHEPSIN E, CTSE
687,116896,CUT-LIKE HOMEOBOX 1, CUX1
688,116897,"CCAAT/ENHANCER-BINDING PROTEIN, ALPHA", CEBPA
689,116898,"CCAAT/ENHANCER-BINDING PROTEIN, DELTA", CEBPD
690,116899,CYCLIN-DEPENDENT KINASE INHIBITOR 1A, CDKN1A
691,116900,CDC28 PROTEIN KINASE 1B, CKS1B
692,116901,CDC2-ASSOCIATED PROTEIN CKS2, CKS2
693,116920,"LEUKOCYTE ADHESION DEFICIENCY, TYPE I", LAD1
694,116930,"CELL ADHESION MOLECULE, NEURAL, 1", NCAM1
695,116935,"SPG7 MATRIX AAA PEPTIDASE SUBUNIT, PARAPLEGIN",
696,116940,CYCLIN-DEPENDENT KINASE 1, CDK1
697,116945,MINICHROMOSOME MAINTENANCE COMPLEX COMPONENT 2, MCM2
698,116946,CELL DIVISION CYCLE 27, CDC27
699,116947,CELL DIVISION CYCLE 25A, CDC25A
700,116948,"CELL DIVISION CYCLE 34, UBIQUITIN-CONJUGATING ENZYME", CDC34
701,116949,CELL DIVISION CYCLE 25B, CDC25B
702,116950,TEMPERATURE-SENSITIVE AF8 COMPLEMENT, AF8T
703,116951,CYCLIN-DEPENDENT KINASE 11A, CDK11A
704,116952,CELL DIVISION CYCLE 42, CDC42
705,116953,CYCLIN-DEPENDENT KINASE 2, CDK2
706,116954,CD46 ANTIGEN,
707,116955,CCHC-TYPE ZINC FINGER NUCLEIC ACID-BINDING PROTEIN, CNBP
708,116957,RB TRANSCRIPTIONAL COREPRESSOR-LIKE 1, RBL1
709,116960,"MORTALITY FACTOR 4, PSEUDOGENE", MORF4
710,117000,"CONGENITAL MYOPATHY 1A, AUTOSOMAL DOMINANT, WITH SUSCEPTIBILITY TO MALIGNANT HYPERTHERMIA", CMYO1A
711,117100,CENTRALOPATHIC EPILEPSY,
712,117139,CENTROMERIC PROTEIN A, CENPA
713,117140,CENTROMERIC PROTEIN B, CENPB
714,117141,CENTROMERIC PROTEIN C1, CENPC1
715,117142,CENTROMERIC PROTEIN B,
716,117143,CENTROMERIC PROTEIN E, CENPE
717,117200,TITLE NOT AVAILABLE AT THIS MOMENT,
718,117210,SPINOCEREBELLAR ATAXIA 31, SCA31
719,117300,"CEREBRAL AMYLOID ANGIOPATHY, ITM2B-RELATED, 2",
720,117340,CEREBELLAR DEGENERATION-RELATED AUTOANTIGEN 2, CDR2
721,117350,SPINOCEREBELLAR ATAXIA 2,
722,117360,SPINOCEREBELLAR ATAXIA 29, SCA29
723,117400,SPINOCEREBELLAR ATAXIA 1,
724,117550,SOTOS SYNDROME, SOTOS
725,117600,CEREBRAL SARCOMA,
726,117650,CEREBROCOSTOMANDIBULAR SYNDROME, CCMS
727,117700,CERULOPLASMIN, CP
728,117800,"APOCRINE GLAND SECRETION, VARIATION IN",
729,117850,CERVICAL HYPERTRICHOSIS WITH UNDERLYING KYPHOSCOLIOSIS,
730,117900,CERVICAL RIB,
731,118000,CERVICAL VERTEBRAL BRIDGE,
732,118005,CERVICAL VERTEBRAL DYSPLASIA,
733,118100,"KLIPPEL-FEIL SYNDROME 1, AUTOSOMAL DOMINANT", KFS1
734,118150,AQUAPORIN 1,
735,118190,HEAT-SHOCK 60-KD PROTEIN 1, HSPD1
736,118200,"CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1B", CMT1B
737,118210,"CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2A1", CMT2A1
738,118220,"CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1A", CMT1A
739,118230,"CHARCOT-MARIE-TOOTH DISEASE, GUADALAJARA NEURONAL TYPE",
740,118300,CHARCOT-MARIE-TOOTH DISEASE AND DEAFNESS,
741,118301,CHARCOT-MARIE-TOOTH DISEASE WITH PTOSIS AND PARKINSONISM,
742,118330,CHEILITIS GLANDULARIS,
743,118350,"CHEMODECTOMA, INTRAABDOMINAL, WITH CUTANEOUS ANGIOLIPOMAS",
744,118400,CHERUBISM,
745,118420,CHIARI MALFORMATION TYPE I,
746,118423,CHIMERIN 1, CHN1
747,118425,"CHLORIDE CHANNEL 1, SKELETAL MUSCLE", CLCN1
748,118430,CHLORPROPAMIDE-ALCOHOL FLUSHING, CPAF
749,118440,CHOLECYSTOKININ, CCK
750,118444,CHOLECYSTOKININ A RECEPTOR, CCKAR
751,118445,CHOLECYSTOKININ B RECEPTOR, CCKBR
752,118450,ALAGILLE SYNDROME 1, ALGS1
753,118455,"CYTOCHROME P450, SUBFAMILY VIIA, POLYPEPTIDE 1", CYP7A1
754,118457,CHOLESTEROL CRYSTALLIZATION INHIBITOR, CCI
755,118470,"CHOLESTERYL ESTER TRANSFER PROTEIN, PLASMA", CETP
756,118480,FARNESYL DIPHOSPHATE SYNTHASE,
757,118485,"CYTOCHROME P450, SUBFAMILY XIA, POLYPEPTIDE 1", CYP11A1
758,118490,CHOLINE ACETYLTRANSFERASE, CHAT
759,118491,"CHOLINE KINASE, ALPHA", CHKA
760,118493,"CHOLINERGIC RECEPTOR, MUSCARINIC, 2", CHRM2
761,118494,"CHOLINERGIC RECEPTOR, MUSCARINIC, 3", CHRM3
762,118495,"CHOLINERGIC RECEPTOR, MUSCARINIC, 4", CHRM4
763,118496,"CHOLINERGIC RECEPTOR, MUSCARINIC, 5", CHRM5
764,118502,"CHOLINERGIC RECEPTOR, NEURONAL NICOTINIC, ALPHA POLYPEPTIDE 2", CHRNA2
765,118503,"CHOLINERGIC RECEPTOR, NEURONAL NICOTINIC, ALPHA POLYPEPTIDE 3", CHRNA3
766,118504,"CHOLINERGIC RECEPTOR, NEURONAL NICOTINIC, ALPHA POLYPEPTIDE 4", CHRNA4
767,118505,"CHOLINERGIC RECEPTOR, NEURONAL NICOTINIC, ALPHA POLYPEPTIDE 5", CHRNA5
768,118507,"CHOLINERGIC RECEPTOR, NEURONAL NICOTINIC, BETA POLYPEPTIDE 2", CHRNB2
769,118508,"CHOLINERGIC RECEPTOR, NEURONAL NICOTINIC, BETA POLYPEPTIDE 3", CHRNB3
770,118509,"CHOLINERGIC RECEPTOR, NEURONAL NICOTINIC, BETA POLYPEPTIDE 4", CHRNB4
771,118510,"CHOLINERGIC RECEPTOR, MUSCARINIC, 1", CHRM1
772,118511,"CHOLINERGIC RECEPTOR, NEURONAL NICOTINIC, ALPHA POLYPEPTIDE 7", CHRNA7
773,118600,CHONDROCALCINOSIS 2, CCAL2
774,118610,CHONDROCALCINOSIS DUE TO APATITE CRYSTAL DEPOSITION,
775,118650,"CHONDRODYSPLASIA PUNCTATA, AUTOSOMAL DOMINANT",
776,118651,"CHONDRODYSPLASIA PUNCTATA, TIBIA-METACARPAL TYPE",
777,118661,VERSICAN, VCAN
778,118670,CHONDRONECTIN,
779,118700,"CHOREA, BENIGN HEREDITARY", BHC
780,118750,"CHOREOATHETOSIS, FAMILIAL INVERTED",
781,118800,PAROXYSMAL NONKINESIGENIC DYSKINESIA 1, PNKD1
782,118820,CHORIONIC SOMATOMAMMOTROPIN HORMONE 2, CSH2
783,118825,CHM-LIKE, CHML
784,118830,"CHYLOMICRONEMIA, FAMILIAL, DUE TO CIRCULATING INHIBITOR OF LIPOPROTEIN LIPASE",
785,118840,CHROMATE RESISTANCE, CHR
786,118850,"CHORIONIC GONADOTROPIN, ALPHA CHAIN", CGA
787,118860,"CHORIONIC GONADOTROPIN, BETA CHAIN", CGB
788,118865,"CHOROIDAL OSTEOMA, BILATERAL",
789,118870,"CHROMOSOMAL PROTEIN, NONHISTONE 1", NHCP1
790,118880,"CHROMOSOMAL PROTEIN, NONHISTONE 2", NHCP2
791,118888,CHYMOTRYPSIN-LIKE PROTEASE, CTRL
792,118890,CHYMOTRYPSINOGEN B1, CTRB1
793,118900,"CIRRHOSIS, FAMILIAL",
794,118910,CHROMOGRANIN A, CHGA
795,118920,CHROMOGRANIN B, CHGB
796,118930,SECRETOGRANIN II, SCG2
797,118938,CHYMASE 1, CMA1
798,118940,CHYMASE 1,
799,118943,CHYMOSIN PSEUDOGENE, CYMP
800,118945,CILIARY NEUROTROPHIC FACTOR, CNTF
801,118946,CILIARY NEUROTROPHIC FACTOR RECEPTOR, CNTFR
802,118950,CITRATE SYNTHASE, CS
803,118953,"SECRETOGLOBIN, FAMILY 1A, MEMBER 1",
804,118955,"CLATHRIN, HEAVY POLYPEPTIDE", CLTC
805,118960,"CLATHRIN, LIGHT POLYPEPTIDE A", CLTA
806,118970,"CLATHRIN, LIGHT POLYPEPTIDE B", CLTB
807,118980,"CLAVICLE, PSEUDARTHROSIS OF, CONGENITAL",
808,118990,ITPR-INTERACTING DOMAIN-CONTAINING PROTEIN 2, ITPRID2
809,119000,CLEFT CHIN,
810,119100,SPLIT-HAND/FOOT MALFORMATION WITH LONG BONE DEFICIENCY 1, SHFLD1
811,119300,VAN DER WOUDE SYNDROME 1, VWS1
812,119500,POPLITEAL PTERYGIUM SYNDROME, PPS
813,119530,OROFACIAL CLEFT 1, OFC1
814,119540,"CLEFT PALATE, ISOLATED", CPI
815,119550,SYNGNATHIA,
816,119570,CLEFT SOFT PALATE,
817,119580,BLEPHAROCHEILODONTIC SYNDROME 1, BCDS1
818,119600,CLEIDOCRANIAL DYSPLASIA 1, CLCD1
819,119650,CLEIDORHIZOMELIC SYNDROME,
820,119800,"CLUBFOOT, CONGENITAL, WITH OR WITHOUT DEFICIENCY OF LONG BONES AND/OR MIRROR-IMAGE POLYDACTYLY", CCF
821,119900,"DIGITAL CLUBBING, ISOLATED CONGENITAL", DIGC
822,119915,"CLUSTER HEADACHE, FAMILIAL",
823,120000,COARCTATION OF AORTA,
824,120040,COCHLEOSACCULAR DEGENERATION WITH PROGRESSIVE CATARACTS,
825,120050,COXSACKIEVIRUS B3 SUSCEPTIBILITY, CXB3S
826,120070,"COLLAGEN, TYPE IV, ALPHA-3", COL4A3
827,120080,COLCHICINE RESISTANCE,
828,120090,"COLLAGEN, TYPE IV, ALPHA-2", COL4A2
829,120100,FAMILIAL COLD AUTOINFLAMMATORY SYNDROME 1, FCAS1
830,120105,"COLIPASE, PANCREATIC", CLPS
831,120110,"COLLAGEN, TYPE X, ALPHA-1", COL10A1
832,120120,"COLLAGEN, TYPE VII, ALPHA-1", COL7A1
833,120130,"COLLAGEN, TYPE IV, ALPHA-1", COL4A1
834,120131,"COLLAGEN, TYPE IV, ALPHA-4", COL4A4
835,120140,"COLLAGEN, TYPE II, ALPHA-1", COL2A1
836,120150,"COLLAGEN, TYPE I, ALPHA-1", COL1A1
837,120160,"COLLAGEN, TYPE I, ALPHA-2", COL1A2
838,120165,"COLLAGEN, TYPE XIX, ALPHA-1", COL19A1
839,120170,"COLLAGEN, TYPE V, ALPHA-2",
840,120180,"COLLAGEN, TYPE III, ALPHA-1", COL3A1
841,120190,"COLLAGEN, TYPE V, ALPHA-2", COL5A2
842,120200,MICROPHTHALMIA/COLOBOMA 12, MCOPCB12
843,120210,"COLLAGEN, TYPE IX, ALPHA-1", COL9A1
844,120215,"COLLAGEN, TYPE V, ALPHA-1", COL5A1
845,120216,"COLLAGEN, TYPE V, ALPHA-3", COL5A3
846,120220,"COLLAGEN, TYPE VI, ALPHA-1", COL6A1
847,120240,"COLLAGEN, TYPE VI, ALPHA-2", COL6A2
848,120250,"COLLAGEN, TYPE VI, ALPHA-3", COL6A3
849,120251,"COLLAGEN, TYPE VIII, ALPHA-1", COL8A1
850,120252,"COLLAGEN, TYPE VIII, ALPHA-2", COL8A2
851,120260,"COLLAGEN, TYPE IX, ALPHA-2", COL9A2
852,120270,"COLLAGEN, TYPE IX, ALPHA-3", COL9A3
853,120280,"COLLAGEN, TYPE XI, ALPHA-1", COL11A1
854,120290,"COLLAGEN, TYPE XI, ALPHA-2", COL11A2
855,120300,COLOBOMA OF MACULA,
856,120310,"COLLAGEN, TYPE II, ALPHA-1",
857,120320,"COLLAGEN, TYPE XII, ALPHA-1", COL12A1
858,120321,"COLLAGEN, TYPE XII, ALPHA-1",
859,120324,"COLLAGEN, TYPE XIV, ALPHA-1", COL14A1
860,120325,"COLLAGEN, TYPE XV, ALPHA-1", COL15A1
861,120326,"COLLAGEN, TYPE XVI, ALPHA-1", COL16A1
862,120327,"COLLAGEN, TYPE XVII, ALPHA-1",
863,120328,"COLLAGEN, TYPE XVIII, ALPHA-1", COL18A1
864,120330,PAPILLORENAL SYNDROME, PAPRS
865,120340,"COLLAGEN, TYPE I, ALPHA, RECEPTOR", COL1AR
866,120350,"COLLAGEN, TYPE XIII, ALPHA-1", COL13A1
867,120353,MATRIX METALLOPROTEINASE 1, MMP1
868,120355,MATRIX METALLOPROTEINASE 8, MMP8
869,120360,MATRIX METALLOPROTEINASE 2, MMP2
870,120361,MATRIX METALLOPROTEINASE 9, MMP9
871,120400,COLOBOMA OF MACULA WITH TYPE B BRACHYDACTYLY,
872,120420,COLONY-STIMULATING FACTOR 1, CSF1
873,120430,COLOBOMA OF OPTIC NERVE,
874,120433,"COLOBOMA, OCULAR, WITH OR WITHOUT HEARING IMPAIRMENT, CLEFT LIP/PALATE, AND/OR IMPAIRED INTELLECTUAL DEVELOPMENT", COB1
875,120435,LYNCH SYNDROME 1, LYNCH1
876,120436,DNA MISMATCH REPAIR PROTEIN MLH1, MLH1
877,120440,COLONIC VARICES WITHOUT PORTAL HYPERTENSION,
878,120450,"COMEDONES, FAMILIAL DYSKERATOTIC",
879,120460,TUMOR PROTEIN p53,
880,120470,DCC NETRIN 1 RECEPTOR, DCC
881,120500,COMMISSURAL LIP PITS,
882,120502,BRANCHIOOTIC SYNDROME 2, BOS2
883,120520,MEMBRANE METALLOENDOPEPTIDASE, MME
884,120550,"COMPLEMENT COMPONENT 1, q SUBCOMPONENT, A CHAIN", C1QA
885,120560,"COMPLEMENT COMPONENT C1q, FIBROBLAST TYPE",
886,120570,"COMPLEMENT COMPONENT 1, q SUBCOMPONENT, B CHAIN", C1QB
887,120575,"COMPLEMENT COMPONENT 1, q SUBCOMPONENT, C CHAIN", C1QC
888,120577,"COMPLEMENT COMPONENT 1, q SUBCOMPONENT, RECEPTOR 1", C1QR1
889,120580,"COMPLEMENT COMPONENT 1, s SUBCOMPONENT", C1S
890,120620,COMPLEMENT COMPONENT RECEPTOR 1, CR1
891,120650,COMPLEMENT COMPONENT RECEPTOR 2, CR2
892,120700,COMPLEMENT COMPONENT 3, C3
893,120790,"COMPLEMENT COMPONENT 4, PARTIAL DEFICIENCY OF",
894,120810,COMPLEMENT COMPONENT 4A, C4A
895,120820,COMPLEMENT COMPONENT 4B, C4B
896,120830,"COMPLEMENT COMPONENT 4-BINDING PROTEIN, ALPHA", C4BPA
897,120831,"COMPLEMENT COMPONENT 4-BINDING PROTEIN, BETA CHAIN", C4BPB
898,120832,"COMPLEMENT COMPONENT 4-BINDING PROTEIN, ALPHA",
899,120900,COMPLEMENT COMPONENT 5, C5
900,120920,CD46 ANTIGEN, CD46
901,120930,"COMPLEMENT COMPONENT 8, GAMMA SUBUNIT", C8G
902,120940,COMPLEMENT COMPONENT 9, C9
903,120950,"COMPLEMENT COMPONENT 8, ALPHA SUBUNIT", C8A
904,120960,"COMPLEMENT COMPONENT 8, BETA SUBUNIT", C8B
905,120970,CONE-ROD DYSTROPHY 2, CORD2
906,120980,"INTEGRIN, ALPHA-M", ITGAM
907,121000,TITLE NOT AVAILABLE AT THIS MOMENT,
908,121009,CELLULAR COMMUNICATION NETWORK FACTOR 2, CCN2
909,121010,PRO-PLATELET BASIC PROTEIN, PPBP
910,121011,"GAP JUNCTION PROTEIN, BETA-2", GJB2
911,121012,"GAP JUNCTION PROTEIN, ALPHA-4", GJA4
912,121013,"GAP JUNCTION PROTEIN, ALPHA-5", GJA5
913,121014,"GAP JUNCTION PROTEIN, ALPHA-1", GJA1
914,121015,"GAP JUNCTION PROTEIN, ALPHA-3", GJA3
915,121020,"EPISODIC ATAXIA, TYPE 1",
916,121050,"CONTRACTURAL ARACHNODACTYLY, CONGENITAL", CCA
917,121070,"ARTHROGRYPOSIS, DISTAL, TYPE 2E",
918,121200,"SEIZURES, BENIGN FAMILIAL NEONATAL, 1", BFNS1
919,121201,"SEIZURES, BENIGN FAMILIAL NEONATAL, 2", BFNS2
920,121210,"FEBRILE SEIZURES, FAMILIAL, 1", FEB1
921,121250,DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 9,
922,121270,"COPPER DEFICIENCY, FAMILIAL BENIGN",
923,121300,"COPROPORPHYRIA, HEREDITARY", HCP
924,121350,"CORACOCLAVICULAR JOINT, ANOMALOUS",
925,121360,"CORE-BINDING FACTOR, BETA SUBUNIT", CBFB
926,121390,CORNEA GUTTATA WITH ANTERIOR POLAR CATARACTS,
927,121400,"CORNEA PLANA 1, AUTOSOMAL DOMINANT", CNA1
928,121450,"CORNEAL DEGENERATION, RIBBONLIKE, WITH DEAFNESS",
929,121700,"CORNEAL DYSTROPHY, POSTERIOR POLYMORPHOUS, 1",
930,121800,SCHNYDER CORNEAL DYSTROPHY, SCCD
931,121820,"CORNEAL DYSTROPHY, EPITHELIAL BASEMENT MEMBRANE", EBMD
932,121850,"CORNEAL DYSTROPHY, FLECK", CFD
933,121900,"CORNEAL DYSTROPHY, GROENOUW TYPE I", CDGG1
934,122000,"CORNEAL DYSTROPHY, POSTERIOR POLYMORPHOUS, 1", PPCD1
935,122100,"CORNEAL DYSTROPHY, MEESMANN, 1", MECD1
936,122200,"CORNEAL DYSTROPHY, LATTICE TYPE I", CDL1
937,122400,EPITHELIAL RECURRENT EROSION DYSTROPHY, ERED
938,122430,RAMOS-ARROYO SYNDROME,
939,122440,CORNEODERMATOOSSEOUS SYNDROME,
940,122450,"CORNEAL HYPESTHESIA, FAMILIAL",
941,122455,"CORONARY ARTERY DISSECTION, SPONTANEOUS",
942,122460,HUMAN CORONAVIRUS SENSITIVITY, HCVS
943,122470,CORNELIA DE LANGE SYNDROME 1, CDLS1
944,122480,OSTEOSCLEROSIS WITH ICHTHYOSIS AND FRACTURES,
945,122500,"SERPIN PEPTIDASE INHIBITOR, CLADE A, MEMBER 6", SERPINA6
946,122550,CORTICOSTERONE SIDE-CHAIN ISOMERASE, CSCI
947,122559,CORTICOTROPIN-RELEASING HORMONE-BINDING PROTEIN, CRHBP
948,122560,CORTICOTROPIN-RELEASING HORMONE, CRH
949,122561,CORTICOTROPIN-RELEASING HORMONE RECEPTOR 1, CRHR1
950,122580,"COSTOCORACOID LIGAMENT, CONGENITALLY SHORT",
951,122600,SPONDYLOCOSTAL DYSOSTOSIS 5, SCDO5
952,122700,COUMARIN RESISTANCE,
953,122720,"CYTOCHROME P450, SUBFAMILY IIA, POLYPEPTIDE 6", CYP2A6
954,122750,COXA VARA,
955,122780,COXOAURICULAR SYNDROME,
956,122850,CRANIOACROFACIAL SYNDROME,
957,122860,"CRANIODIAPHYSEAL DYSPLASIA, AUTOSOMAL DOMINANT", CDD
958,122880,CRANIOFACIAL-DEAFNESS-HAND SYNDROME, CDHS
959,122900,CRANIOFACIAL DYSOSTOSIS WITH DIAPHYSEAL HYPERPLASIA,
960,122920,CRANIOFRONTONASAL SYNDROME,
961,123000,"CRANIOMETAPHYSEAL DYSPLASIA, AUTOSOMAL DOMINANT", CMDD
962,123050,CRANIORHINY,
963,123100,CRANIOSYNOSTOSIS 1, CRS1
964,123101,MSH HOMEOBOX 2, MSX2
965,123150,JACKSON-WEISS SYNDROME, JWS
966,123155,"HYDROCEPHALUS, AUTOSOMAL DOMINANT", HDCPH1
967,123260,C-REACTIVE PROTEIN, CRP
968,123270,"CREATINE KINASE, BRAIN TYPE, ECTOPIC EXPRESSION OF", CKBE
969,123280,"CREATINE KINASE, BRAIN TYPE", CKB
970,123290,"CREATINE KINASE, MITOCHONDRIAL 1B", CKMT1B
971,123295,"CREATINE KINASE, MITOCHONDRIAL 2", CKMT2
972,123310,"CREATINE KINASE, MUSCLE TYPE", CKM
973,123320,"CREATINE PHOSPHOKINASE, ELEVATED SERUM",
974,123400,CREUTZFELDT-JAKOB DISEASE, CJD
975,123450,CRI-DU-CHAT SYNDROME,
976,123500,CROUZON SYNDROME,
977,123540,"CRYOFIBRINOGENEMIA, FAMILIAL PRIMARY",
978,123550,"CRYOGLOBULINEMIA, FAMILIAL MIXED",
979,123555,"DEFENSIN, ALPHA, 1",
980,123557,"CRYPTOTIA, FAMILIAL",
981,123560,CRYPTOMICROTIA-BRACHYDACTYLY SYNDROME,
982,123570,"CRYPTOPHTHALMOS, UNILATERAL OR BILATERAL, ISOLATED", CRYPTOP
983,123580,"CRYSTALLIN, ALPHA-A", CRYAA
984,123590,"CRYSTALLIN, ALPHA-B", CRYAB
985,123610,"CRYSTALLIN, BETA-A1", CRYBA1
986,123620,"CRYSTALLIN, BETA-B2", CRYBB2
987,123630,"CRYSTALLIN, BETA-B3", CRYBB3
988,123631,"CRYSTALLIN, BETA-A4", CRYBA4
989,123660,"CRYSTALLIN, GAMMA-A", CRYGA
990,123670,"CRYSTALLIN, GAMMA-B", CRYGB
991,123680,"CRYSTALLIN, GAMMA-C", CRYGC
992,123690,"CRYSTALLIN, GAMMA-D", CRYGD
993,123691,"CRYSTALLIN, ZETA", CRYZ
994,123695,"PHOSPHATE CYTIDYLYLTRANSFERASE 1, CHOLINE, ALPHA ISOFORM", PCYT1A
995,123700,"CUTIS LAXA, AUTOSOMAL DOMINANT 1", ADCL1
996,123710,"CRYSTALLIN, GAMMA-A",
997,123720,"CRYSTALLIN, GAMMA-A",
998,123730,"CRYSTALLIN, GAMMA-S", CRYGS
999,123740,"CRYSTALLIN, MU", CRYM
1000,123790,BEARE-STEVENSON CUTIS GYRATA SYNDROME, BSTVS
1001,123803,ACTIVATING TRANSCRIPTION FACTOR 1, ATF1
1002,123805,PHOSPHODIESTERASE 3A, PDE3A
1003,123810,cAMP RESPONSE ELEMENT-BINDING PROTEIN 1, CREB1
1004,123811,ACTIVATING TRANSCRIPTION FACTOR 2, ATF2
1005,123812,cAMP RESPONSE ELEMENT MODULATOR, CREM
1006,123825,"CYCLIC NUCLEOTIDE-GATED CHANNEL, ALPHA-1", CNGA1
1007,123828,CYCLIN-DEPENDENT KINASE 3, CDK3
1008,123829,CYCLIN-DEPENDENT KINASE 4, CDK4
1009,123830,CYCLIC NUCLEOTIDE PHOSPHODIESTERASE, CNP
1010,123831,CYCLIN-DEPENDENT KINASE 5, CDK5
1011,123832,CYCLIN-DEPENDENT KINASE INHIBITOR 3, CDKN3
1012,123833,CYCLIN D2, CCND2
1013,123834,CYCLIN D3, CCND3
1014,123835,CYCLIN A2, CCNA2
1015,123836,CYCLIN B1, CCNB1
1016,123837,CYCLIN E1, CCNE1
1017,123838,CYCLIN C, CCNC
1018,123839,PROSTAGLANDIN-ENDOPEROXIDE SYNTHASE 2,
1019,123840,PEPTIDYL-PROLYL ISOMERASE A, PPIA
1020,123841,PEPTIDYL-PROLYL ISOMERASE B, PPIB
1021,123842,PEPTIDYL-PROLYL ISOMERASE C, PPIC
1022,123850,"CYLINDROMATOSIS, FAMILIAL",
1023,123853,CYPRUS FACIAL NEUROMUSCULOSKELETAL SYNDROME,
1024,123855,CYSTATIN 1, CST1
1025,123856,CYSTATIN 2, CST2
1026,123857,CYSTATIN 4, CST4
1027,123858,CYSTATIN 5, CST5
1028,123859,CYSTEINYL-tRNA SYNTHETASE 1, CARS1
1029,123860,CYTIDINE 5-PRIME TRIPHOSPHATE SYNTHETASE 1, CTPS1
1030,123864,"CYTOCHROME c OXIDASE, SUBUNIT 4I1", COX4I1
1031,123866,"CYTOCHROME c OXIDASE, SUBUNIT 5B", COX5B
1032,123870,"CYTOCHROME c OXIDASE, SUBUNIT 8A", COX8A
1033,123875,CYSTEINE-RICH INTESTINAL PROTEIN 1, CRIP1
1034,123876,CYSTEINE- AND GLYCINE-RICH PROTEIN 1, CSRP1
1035,123880,"CYSTIC ANGIOMATOSIS OF BONE, DIFFUSE",
1036,123885,S100 CALCIUM-BINDING PROTEIN A8, S100A8
1037,123886,S100 CALCIUM-BINDING PROTEIN A9, S100A9
1038,123889,"INTERLEUKIN 10 RECEPTOR, BETA", IL10RB
1039,123890,CYTOTOXIC T LYMPHOCYTE-ASSOCIATED 4, CTLA4
1040,123900,EZRIN, EZR
1041,123910,GRANZYME B, GZMB
1042,123920,CYTIDINE DEAMINASE, CDA
1043,123930,"CYTOCHROME P450, SUBFAMILY IIB, POLYPEPTIDE 6", CYP2B6
1044,123940,"KERATIN 4, TYPE II", KRT4
1045,123950,METHEMOGLOBINEMIA AND AMBIGUOUS GENITALIA,
1046,123960,"CYTOCHROME P450, SUBFAMILY IIA, POLYPEPTIDE 6",
1047,123970,"CYTOCHROME C, SOMATIC", CYCS
1048,123980,CYTOCHROME C1, CYC1
1049,123995,"CYTOCHROME c OXIDASE, SUBUNIT 7A1", COX7A1
1050,123996,"CYTOCHROME c OXIDASE, SUBUNIT 7A2", COX7A2
1051,123997,"CYTOCHROME c OXIDASE, SUBUNIT 7A2, PSEUDOGENE 2", COX7A2P2
1052,124000,"MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 1", MC3DN1
1053,124010,"CYTOCHROME P450, SUBFAMILY IIIA, POLYPEPTIDE 4", CYP3A4
1054,124015,CYTOCHROME P450 OXIDOREDUCTASE, POR
1055,124020,"CYTOCHROME P450, SUBFAMILY IIC, POLYPEPTIDE 19", CYP2C19
1056,124030,"CYTOCHROME P450, SUBFAMILY IID, POLYPEPTIDE 6", CYP2D6
1057,124040,"CYTOCHROME P450, SUBFAMILY IIE", CYP2E1
1058,124050,D-AMINO ACID OXIDASE, DAO
1059,124060,"CYTOCHROME P450, SUBFAMILY I, POLYPEPTIDE 2", CYP1A2
1060,124070,"CYTOCHROME P450, SUBFAMILY IIF, POLYPEPTIDE 1", CYP2F1
1061,124075,"CYTOCHROME P450, SUBFAMILY IVB, MEMBER 1", CYP4B1
1062,124080,"CYTOCHROME P450, SUBFAMILY XIB, POLYPEPTIDE 2", CYP11B2
1063,124089,"CYTOCHROME c OXIDASE, SUBUNIT 6B1", COX6B1
1064,124090,"CYTOCHROME c OXIDASE, SUBUNIT 6C", COX6C
1065,124092,INTERLEUKIN 10, IL10
1066,124095,C-TERMINAL SRC KINASE, CSK
1067,124097,D-BOX-BINDING PAR bZIP TRANSCRIPTION FACTOR, DBP
1068,124100,DANUBIAN ENDEMIC FAMILIAL NEPHROPATHY,
1069,124200,DARIER-WHITE DISEASE, DAR
1070,124300,DARWINIAN TUBERCLE OF PINNA,
1071,124400,DARWINIAN TUBERCLE OF PINNA,
1072,124450,D-ASPARTATE OXIDASE, DDO
1073,124480,"DEAFNESS, CONGENITAL, WITH ONYCHODYSTROPHY, AUTOSOMAL DOMINANT", DDOD
1074,124490,"DEAFNESS, CONDUCTIVE STAPEDIAL, WITH EAR MALFORMATION AND FACIAL PALSY",
1075,124500,VOHWINKEL SYNDROME, VOWNKL
1076,124580,TITLE NOT AVAILABLE AT THIS MOMENT,
1077,124700,"DEAFNESS, MID-TONE NEURAL",
1078,124800,"DEAFNESS, AUTOSOMAL DOMINANT 5",
1079,124900,"DEAFNESS, AUTOSOMAL DOMINANT 1, WITH OR WITHOUT THROMBOCYTOPENIA", DFNA1
1080,124910,"DEAFNESS, AUTOSOMAL DOMINANT 1, WITH OR WITHOUT THROMBOCYTOPENIA",
1081,124950,"DEAFNESS, SENSORINEURAL, WITH PERIPHERAL NEUROPATHY AND ARTERIAL DISEASE",
1082,125000,"DEAFNESS, UNILATERAL",
1083,125050,DEAFNESS WITH ANHIDROTIC ECTODERMAL DYSPLASIA,
1084,125100,BRANCHIOOTIC SYNDROME 1,
1085,125220,"DEFENSIN, ALPHA, 1", DEFA1
1086,125230,DEAFNESS-CRANIOFACIAL SYNDROME,
1087,125240,CD55 ANTIGEN, CD55
1088,125250,"OPTIC ATROPHY WITH OR WITHOUT DEAFNESS, OPHTHALMOPLEGIA, MYOPATHY, ATAXIA, AND NEUROPATHY",
1089,125255,DECORIN, DCN
1090,125260,"DEFECTIVE INTERFERING PARTICLE INDUCTION, CONTROL OF",
1091,125263,"SULFOTRANSFERASE FAMILY 2A, DEHYDROEPIANDROSTERONE-PREFERRING, MEMBER 1", SULT2A1
1092,125264,DEK ONCOGENE, DEK
1093,125265,RECEPTOR EXPRESSION-ENHANCING PROTEIN 5, REEP5
1094,125270,DELTA-AMINOLEVULINATE DEHYDRATASE, ALAD
1095,125280,DENS EVAGINATUS,
1096,125290,DELTA-AMINOLEVULINATE SYNTHASE 1, ALAS1
1097,125300,DENS IN DENTE AND PALATAL INVAGINATIONS,
1098,125305,ERYTHROCYTE MEMBRANE PROTEIN BAND 4.9, EPB49
1099,125310,"CEREBRAL ARTERIOPATHY, AUTOSOMAL DOMINANT, WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY, TYPE 1", CADASIL1
1100,125320,DEMENTIA/PARKINSONISM WITH NON-ALZHEIMER AMYLOID PLAQUES,
1101,125350,"FAILURE OF TOOTH ERUPTION, PRIMARY", PFE
1102,125370,DENTATORUBRAL-PALLIDOLUYSIAN ATROPHY, DRPLA
1103,125400,"DENTIN DYSPLASIA, TYPE I", DTDP1
1104,125420,"DENTIN DYSPLASIA, TYPE II", DTDP2
1105,125440,DENTIN DYSPLASIA WITH SCLEROTIC BONES,
1106,125450,DEOXYCYTIDINE KINASE, DCK
1107,125460,DEOXYRIBOSE-5-PHOSPHATE ALDOLASE DEFICIENCY,
1108,125480,MAJOR AFFECTIVE DISORDER 1, MAFD1
1109,125485,DENTIN SIALOPHOSPHOPROTEIN, DSPP
1110,125490,DENTINOGENESIS IMPERFECTA 1, DGI1
1111,125500,"DENTINOGENESIS IMPERFECTA, SHIELDS TYPE III",
1112,125505,DEOXYRIBONUCLEASE I, DNASE1
1113,125510,TITLE NOT AVAILABLE AT THIS MOMENT,
1114,125520,CAYLER CARDIOFACIAL SYNDROME,
1115,125530,"DERMAL RIDGES, NELSON SYNDROME",
1116,125540,"DERMAL RIDGES, PATTERNLESS",
1117,125550,DERMAL RIDGES-OFF-THE-END, ROES
1118,125570,DERMATOGLYPHICS--ARCH ON ANY DIGIT,
1119,125580,DERMATOGLYPHICS--FINGER RIDGE COUNT,
1120,125590,DERMATOGLYPHICS--FINGERPRINT PATTERN,
1121,125595,DERMATOPATHIA PIGMENTOSA RETICULARIS, DPR
1122,125597,DERMATOPONTIN, DPT
1123,125600,DERMATOSIS PAPULOSA NIGRA,
1124,125630,VIBRATORY URTICARIA, VBU
1125,125635,"DERMOGRAPHISM, FAMILIAL",
1126,125640,DERMOODONTODYSPLASIA,
1127,125643,DESMOCOLLIN 1, DSC1
1128,125645,DESMOCOLLIN 2, DSC2
1129,125647,DESMOPLAKIN, DSP
1130,125650,24-DEHYDROCHOLESTEROL REDUCTASE,
1131,125660,DESMIN, DES
1132,125670,DESMOGLEIN 1, DSG1
1133,125671,DESMOGLEIN 2, DSG2
1134,125700,"DIABETES INSIPIDUS, NEUROHYPOPHYSEAL",
1135,125800,"DIABETES INSIPIDUS, NEPHROGENIC, 2, AUTOSOMAL", NDI2
1136,125850,"MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 1", MODY1
1137,125851,"MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 2", MODY2
1138,125852,TYPE 1 DIABETES MELLITUS 2, T1D2
1139,125853,TYPE 2 DIABETES MELLITUS, T2D
1140,125855,"DIACYLGLYCEROL KINASE, ALPHA, 80-KD", DGKA
1141,125860,"NAD(P)H DEHYDROGENASE, QUINONE 1", NQO1
1142,125870,BILIVERDIN REDUCTASE B,
1143,125880,DIAPHORASE 3, DIA3
1144,125890,"DIARRHEA, GLUCOSE-STIMULATED SECRETORY, WITH COMMON VARIABLE IMMUNODEFICIENCY",
1145,125900,"DIASTEMA, DENTAL MEDIAL",
1146,125950,DIAZEPAM BINDING INHIBITOR, DBI
1147,126050,DIGITOTALAR DYSMORPHISM,
1148,126060,DIHYDROFOLATE REDUCTASE, DHFR
1149,126061,DIHYDROFOLATE REDUCTASE,
1150,126063,DIHYDROLIPOAMIDE S-SUCCINYLTRANSFERASE, DLST
1151,126064,DIHYDROOROTATE DEHYDROGENASE, DHODH
1152,126065,"CYTOCHROME P450, FAMILY 24, SUBFAMILY A, POLYPEPTIDE 1", CYP24A1
1153,126070,"DILUTION, PIGMENTARY",
1154,126090,PTERIN-4-ALPHA-CARBINOLAMINE DEHYDRATASE 1, PCBD1
1155,126100,"DIMPLES, FACIAL",
1156,126110,ARYL HYDROCARBON RECEPTOR NUCLEAR TRANSLOCATOR, ARNT
1157,126140,DIPEPTIDYL PEPTIDASE IV,
1158,126141,DIPEPTIDYL PEPTIDASE VI, DPP6
1159,126150,HEPARIN-BINDING EGF-LIKE GROWTH FACTOR, HBEGF
1160,126180,"DISCRIMINATION, TWO-POINT, REDUCTION IN",
1161,126190,DISPROPORTIONATE SHORT STATURE WITH PTOSIS AND VALVULAR HEART LESIONS,
1162,126200,"MULTIPLE SCLEROSIS, SUSCEPTIBILITY TO", MS
1163,126250,DISTAL OSTEOSCLEROSIS,
1164,126255,DISTAL-LESS HOMEOBOX 2, DLX2
1165,126300,DISTICHIASIS,
1166,126320,DISTICHIASIS WITH CONGENITAL ANOMALIES OF THE HEART AND PERIPHERAL VASCULATURE,
1167,126330,"DNA, CYTOPLASMIC-MEMBRANE", DNCM
1168,126335,"GROWTH ARREST- AND DNA DAMAGE-INDUCIBLE GENE, ALPHA", GADD45A
1169,126337,DNA DAMAGE-INDUCIBLE TRANSCRIPT 3, DDIT3
1170,126340,"ERCC EXCISION REPAIR 2, TFIIH CORE COMPLEX HELICASE SUBUNIT", ERCC2
1171,126350,"DEOXYRIBONUCLEASE II, LYSOSOMAL", DNASE2
1172,126370,"DNA, SATELLITE, III", HS3; D1Z1
1173,126375,DNA METHYLTRANSFERASE 1, DNMT1
1174,126380,"ERCC EXCISION REPAIR 1, ENDONUCLEASE NONCATALYTIC SUBUNIT", ERCC1
1175,126390,"DNA, LOW-REPETITIVE SEQUENCES OF",
1176,126391,"LIGASE I, DNA, ATP-DEPENDENT", LIG1
1177,126410,"DNA, SATELLITE, ALPHA TYPE",
1178,126420,"TOPOISOMERASE, DNA, I", TOP1
1179,126430,"TOPOISOMERASE, DNA, II, ALPHA", TOP2A
1180,126431,"TOPOISOMERASE, DNA, II, BETA", TOP2B
1181,126440,TITLE NOT AVAILABLE AT THIS MOMENT,
1182,126448,DOPAMINE RECEPTOR D5,
1183,126449,DOPAMINE RECEPTOR D1, DRD1
1184,126450,DOPAMINE RECEPTOR D2, DRD2
1185,126451,DOPAMINE RECEPTOR D3, DRD3
1186,126452,DOPAMINE RECEPTOR D4, DRD4
1187,126453,DOPAMINE RECEPTOR D5, DRD5
1188,126455,"SOLUTE CARRIER FAMILY 6 (NEUROTRANSMITTER TRANSPORTER, DOPAMINE), MEMBER 3", SLC6A3
1189,126500,DOUBLE NAIL FOR FIFTH TOE,
1190,126550,CALVARIAL DOUGHNUT LESIONS WITH BONE FRAGILITY, CDL
1191,126600,DOYNE HONEYCOMB RETINAL DYSTROPHY, DHRD
1192,126650,"SOLUTE CARRIER FAMILY 26, MEMBER 3", SLC26A3
1193,126660,DREBRIN E, DBN1
1194,126700,BASAL LAMINAR DRUSEN,
1195,126800,DUANE RETRACTION SYNDROME 1, DURS1
1196,126830,CHAR SYNDROME,
1197,126840,DUODENAL ULCER DUE TO ANTRAL G-CELL HYPERFUNCTION,
1198,126850,"DUODENAL ULCER, HYPERPEPSINOGENEMIC I",
1199,126900,DUPUYTREN CONTRACTURE,
1200,126950,DWARFISM WITH TALL VERTEBRAE,
1201,127000,"KENNY-CAFFEY SYNDROME, TYPE 2", KCS2
1202,127100,"DWARFISM, LEVI TYPE",
1203,127200,DWARFISM WITH STIFF JOINTS AND OCULAR ABNORMALITIES,
1204,127300,LERI-WEILL DYSCHONDROSTEOSIS, LWD
1205,127350,DYSCHONDROSTEOSIS AND NEPHRITIS,
1206,127400,DYSCHROMATOSIS SYMMETRICA HEREDITARIA, DSH
1207,127500,DYSCHROMATOSIS UNIVERSALIS HEREDITARIA 1, DUH1
1208,127550,"DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 1", DKCA1
1209,127600,"DYSKERATOSIS, HEREDITARY BENIGN INTRAEPITHELIAL", HBID
1210,127700,"DYSLEXIA, SUSCEPTIBILITY TO, 1", DYX1
1211,127750,"DEMENTIA, LEWY BODY", DLB
1212,127800,DYSPLASIA EPIPHYSEALIS HEMIMELICA,
1213,127820,DYSPLASIA EPIPHYSEALIS HEMIMELICA WITH CHONDROMAS AND OSTEOCHONDROMAS,
1214,128000,DYSTELEPHALANGY,
1215,128100,"DYSTONIA 1, TORSION, AUTOSOMAL DOMINANT", DYT1
1216,128101,"DYSTONIA 4, TORSION, AUTOSOMAL DOMINANT", DYT4
1217,128200,EPISODIC KINESIGENIC DYSKINESIA 1, EKD1
1218,128230,"DYSTONIA, DOPA-RESPONSIVE", DRD
1219,128235,DYSTONIA 12, DYT12
1220,128239,DYSTROGLYCAN 1, DAG1
1221,128240,UTROPHIN, UTRN
1222,128260,SMALL NUCLEAR RIBONUCLEOPROTEIN POLYPEPTIDE E, SNRPE
1223,128290,"EAR ANTITRAGUS, TAG AT BASE OF",
1224,128300,EAR EXOSTOSES,
1225,128400,EAR FLARE,
1226,128500,EAR FOLDING,
1227,128600,EAR MALFORMATION,
1228,128700,"PREAURICULAR FISTULAE, CONGENITAL",
1229,128710,"EAR PITS, POSTERIOR HELICAL",
1230,128800,EAR WITHOUT HELIX,
1231,128900,"EARLOBE ATTACHMENT, ATTACHED VS UNATTACHED",
1232,128950,EARLOBE CREASE,
1233,128980,"EARLOBES, THICKENED, WITH CONDUCTIVE DEAFNESS FROM INCUDOSTAPEDIAL ABNORMALITIES",
1234,128990,EARLY GROWTH RESPONSE 1, EGR1
1235,128992,EARLY GROWTH RESPONSE 4, EGR4
1236,129000,"EARRING HOLES, NATURAL",
1237,129010,EARLY GROWTH RESPONSE 2, EGR2
1238,129100,"EARS, ABILITY TO MOVE",
1239,129150,ECHO VIRUS 11 SENSITIVITY, E11S
1240,129190,ECTO-5-PRIME NUCLEOTIDASE, NT5E
1241,129200,BASAN SYNDROME,
1242,129400,RAPP-HODGKIN SYNDROME, RHS
1243,129490,"ECTODERMAL DYSPLASIA 10A, HYPOHIDROTIC/HAIR/NAIL TYPE, AUTOSOMAL DOMINANT", ECTD10A
1244,129500,CLOUSTON SYNDROME,
1245,129510,"ECTODERMAL DYSPLASIA, TRICHOODONTOONYCHIAL TYPE",
1246,129540,ECTODERMAL DYSPLASIA SYNDROME WITH DISTINCTIVE FACIAL APPEARANCE AND PREAXIAL POLYDACTYLY OF FEET,
1247,129550,ECTODERMAL DYSPLASIA WITH ADRENAL CYST,
1248,129600,"ECTOPIA LENTIS 1, ISOLATED, AUTOSOMAL DOMINANT", ECTOL1
1249,129750,ECTOPIA PUPILLAE,
1250,129810,ECTRODACTYLY AND ECTODERMAL DYSPLASIA WITHOUT CLEFT LIP/PALATE,
1251,129830,ECTRODACTYLY-CLEFT PALATE SYNDROME,
1252,129840,"EDEMA, FAMILIAL IDIOPATHIC, PREPUBERTAL",
1253,129850,EDINBURGH MALFORMATION SYNDROME,
1254,129900,"ECTRODACTYLY, ECTODERMAL DYSPLASIA, AND CLEFT LIP/PALATE SYNDROME 1", EEC1
1255,129905,EGASYN,
1256,130000,"EHLERS-DANLOS SYNDROME, CLASSIC TYPE, 1", EDSCL1
1257,130010,"EHLERS-DANLOS SYNDROME, CLASSIC TYPE, 2", EDSCL2
1258,130020,"EHLERS-DANLOS SYNDROME, HYPERMOBILITY TYPE", EDSHMB
1259,130050,"EHLERS-DANLOS SYNDROME, VASCULAR TYPE", EDSVASC
1260,130060,"EHLERS-DANLOS SYNDROME, ARTHROCHALASIA TYPE, 1", EDSARTH1
1261,130070,"EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 1", EDSSPD1
1262,130080,"EHLERS-DANLOS SYNDROME, PERIODONTAL TYPE, 1", EDSPD1
1263,130090,"EHLERS-DANLOS SYNDROME, AUTOSOMAL DOMINANT, TYPE UNSPECIFIED",
1264,130100,ELASTOSIS PERFORANS SERPIGINOSA, EPS
1265,130120,"CHYMOTRYPSIN-LIKE ELASTASE FAMILY, MEMBER 1", CELA1
1266,130130,"ELASTASE, NEUTROPHIL-EXPRESSED", ELANE
1267,130135,"SERPIN PEPTIDASE INHIBITOR, CLADE B (OVALBUMIN), MEMBER 1", SERPINB1
1268,130160,ELASTIN, ELN
1269,130180,"ELECTROENCEPHALOGRAM, LOW-VOLTAGE",
1270,130190,"ELECTROENCEPHALOGRAPHIC PATTERN, BETA FREQUENCY, QUANTITATIVE TRAIT LOCUS", EEGBQTL
1271,130200,ELECTROENCEPHALOGRAPHIC PECULIARITY: 14 AND 6 PER SEC. POSITIVE SPIKE PHENOMENON,
1272,130300,ELECTROENCEPHALOGRAPHIC PECULIARITY: FRONTO-PRECENTRAL BETA WAVE GROUPS,
1273,130400,ELECTROENCEPHALOGRAPHIC PECULIARITY: OCCIPITAL SLOW BETA WAVES,
1274,130410,"ELECTRON TRANSFER FLAVOPROTEIN, BETA POLYPEPTIDE", ETFB
1275,130500,ERYTHROCYTE MEMBRANE PROTEIN BAND 4.1, EPB41
1276,130590,"EUKARYOTIC TRANSLATION ELONGATION FACTOR 1, ALPHA-1", EEF1A1
1277,130591,"EUKARYOTIC TRANSLATION ELONGATION FACTOR 1, BETA-2",
1278,130592,"EUKARYOTIC TRANSLATION ELONGATION FACTOR 1, DELTA", EEF1D
1279,130593,"EUKARYOTIC TRANSLATION ELONGATION FACTOR 1, GAMMA", EEF1G
1280,130600,ELLIPTOCYTOSIS 2, EL2
1281,130610,EUKARYOTIC TRANSLATION ELONGATION FACTOR 2, EEF2
1282,130620,RIBOSOMAL PROTEIN S14, RPS14
1283,130650,BECKWITH-WIEDEMANN SYNDROME, BWS
1284,130660,ELASTIN MICROFIBRIL INTERFACER 1, EMILIN1
1285,130700,"EMPHYSEMA, HEREDITARY PULMONARY",
1286,130710,"EMPHYSEMA, CONGENITAL LOBAR", CLE
1287,130720,LATERAL MENINGOCELE SYNDROME, LMNS
1288,130900,"AMELOGENESIS IMPERFECTA, TYPE IIIA", AI3A
1289,130950,"ENCEPHALOPATHY, RECURRENT, OF CHILDHOOD",
1290,131100,"MULTIPLE ENDOCRINE NEOPLASIA, TYPE I", MEN1
1291,131150,ENDOGENOUS RETROVIRAL SEQUENCE 1, ERV1
1292,131170,ENDOGENOUS RETROVIRAL SEQUENCE 3, ERV3
1293,131180,ENDOGENOUS RETROVIRAL POL-LIKE SEQUENCE-2, ERPL2
1294,131190,ENDOGENOUS RETROVIRAL POL-LIKE SEQUENCE-1, ERPL1
1295,131195,ENDOGLIN, ENG
1296,131200,"ENDOMETRIOSIS, SUSCEPTIBILITY TO, 1",
1297,131210,SELECTIN E, SELE
1298,131220,FIBROBLAST GROWTH FACTOR 1, FGF1
1299,131222,THYMIDINE PHOSPHORYLASE, TYMP
1300,131230,ANNEXIN A5, ANXA5
1301,131235,KDEL ENDOPLASMIC RETICULUM PROTEIN RETENTION RECEPTOR 1, KDELR1
1302,131240,ENDOTHELIN 1, EDN1
1303,131241,ENDOTHELIN 2, EDN2
1304,131242,ENDOTHELIN 3, EDN3
1305,131243,"ENDOTHELIN RECEPTOR, TYPE A", EDNRA
1306,131244,"ENDOTHELIN RECEPTOR, TYPE B", EDNRB
1307,131290,ENGRAILED 1, EN1
1308,131300,CAMURATI-ENGELMANN DISEASE, CAEND
1309,131310,ENGRAILED 2, EN2
1310,131320,GATA-BINDING PROTEIN 3, GATA3
1311,131330,PROENKEPHALIN, PENK
1312,131340,PRODYNORPHIN, PDYN
1313,131360,ENOLASE 2, ENO2
1314,131370,ENOLASE 3, ENO3
1315,131375,ENOLASE 4, ENO4
1316,131390,NIDOGEN 1, NID1
1317,131398,"RIBONUCLEASE A FAMILY, MEMBER 3", RNASE3
1318,131399,EOSINOPHIL PEROXIDASE, EPX
1319,131400,"EOSINOPHILIA, FAMILIAL",
1320,131410,"RIBONUCLEASE A FAMILY, MEMBER 2", RNASE2
1321,131430,EOSINOPHILOPENIA,
1322,131440,"MYELOPROLIFERATIVE DISORDER, CHRONIC, WITH EOSINOPHILIA",
1323,131445,GLIOMA SUSCEPTIBILITY 1,
1324,131450,EPIBLEPHARON OF LOWER LID,
1325,131460,EPIBLEPHARON OF UPPER LID,
1326,131500,EPICANTHUS,
1327,131530,EPIDERMAL GROWTH FACTOR, EGF
1328,131550,EPIDERMAL GROWTH FACTOR RECEPTOR, EGFR
1329,131560,FLOTILLIN 2, FLOT2
1330,131600,EPIDERMOID CYSTS,
1331,131705,TRANSIENT BULLOUS DERMOLYSIS OF THE NEWBORN, TBDN
1332,131750,"EPIDERMOLYSIS BULLOSA DYSTROPHICA, AUTOSOMAL DOMINANT", DDEB
1333,131760,"EPIDERMOLYSIS BULLOSA SIMPLEX 1A, GENERALIZED SEVERE", EBS1A
1334,131800,"EPIDERMOLYSIS BULLOSA SIMPLEX 1C, LOCALIZED", EBS1C
1335,131850,"EPIDERMOLYSIS BULLOSA DYSTROPHICA, PRETIBIAL",
1336,131880,EPIDERMOLYSIS BULLOSA WITH DEFICIENCY OF GALACTOSYLHYDROXYLYSYL GLUCOSYLTRANSFERASE,
1337,131900,"EPIDERMOLYSIS BULLOSA SIMPLEX 1B, GENERALIZED INTERMEDIATE", EBS1B
1338,131950,"EPIDERMOLYSIS BULLOSA SIMPLEX 5A, OGNA TYPE", EBS5A
1339,131960,"EPIDERMOLYSIS BULLOSA SIMPLEX 2F, WITH MOTTLED PIGMENTATION", EBS2F
1340,132000,EPIDERMOLYSIS BULLOSA WITH CONGENITAL LOCALIZED ABSENCE OF SKIN AND DEFORMITY OF NAILS,
1341,132090,"EPILEPSY, BENIGN OCCIPITAL", BOE
1342,132100,PHOTOPAROXYSMAL RESPONSE 1, PPR1
1343,132300,"EPILEPSY, READING",
1344,132350,SYNTAXIN 2, STX2
1345,132400,"EPIPHYSEAL DYSPLASIA, MULTIPLE, 1", EDM1
1346,132450,"EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH MYOPIA AND CONDUCTIVE DEAFNESS", EDMMD
1347,132500,"EPISTAXIS, HEREDITARY",
1348,132600,PILOMATRIXOMA,
1349,132700,"CYLINDROMATOSIS, FAMILIAL",
1350,132800,"MULTIPLE SELF-HEALING SQUAMOUS EPITHELIOMA, SUSCEPTIBILITY TO", MSSE
1351,132810,"EPOXIDE HYDROLASE 1, MICROSOMAL", EPHX1
1352,132811,"EPOXIDE HYDROLASE 2, CYTOSOLIC", EPHX2
1353,132850,EPSTEIN-BARR VIRUS INSERTION SITE 1, EBVS1
1354,132860,TITLE NOT AVAILABLE AT THIS MOMENT,
1355,132880,"NUCLEAR RECEPTOR SUBFAMILY 2, GROUP F, MEMBER 6", NR2F6
1356,132890,"NUCLEAR RECEPTOR SUBFAMILY 2, GROUP F, MEMBER 1", NR2F1
1357,132900,"AORTIC ANEURYSM, FAMILIAL THORACIC 4", AAT4
1358,132990,"ERYTHEMA NODOSUM, FAMILIAL",
1359,133000,ERYTHEMA PALMARE HEREDITARIUM,
1360,133020,"ERYTHERMALGIA, PRIMARY",
1361,133090,STOMATIN, STOM
1362,133100,"ERYTHROCYTOSIS, FAMILIAL, 1", ECYT1
1363,133170,ERYTHROPOIETIN, EPO
1364,133171,ERYTHROPOIETIN RECEPTOR, EPOR
1365,133180,"ERYTHROLEUKEMIA, FAMILIAL, SUSCEPTIBILITY TO", FERLK
1366,133190,SPINOCEREBELLAR ATAXIA 34, SCA34
1367,133200,ERYTHROKERATODERMIA VARIABILIS ET PROGRESSIVA 1, EKVP1
1368,133220,ESTERASE A4, ESA4
1369,133230,ESTERASE A-5, ESA5
1370,133239,ESOPHAGEAL CANCER,
1371,133240,"ESOPHAGEAL RING, LOWER",
1372,133250,METHYLENETETRAHYDROFOLATE DEHYDROGENASE 1,
1373,133260,ESTERASE B, ESB
1374,133270,ESTERASE C, ESC
1375,133280,ESTERASE D, ESD
1376,133290,ESTERASE B3, ESB3
1377,133300,"ESTERASE ES-2, REGULATOR FOR",
1378,133420,TREFOIL FACTOR 1,
1379,133430,ESTROGEN RECEPTOR 1, ESR1
1380,133435,"RUNT-RELATED TRANSCRIPTION FACTOR 1, TRANSLOCATED TO, 1", RUNX1T1
1381,133440,EUKARYOTIC TRANSLATION INITIATION FACTOR 4E, EIF4E
1382,133450,EWS RNA-BINDING PROTEIN 1, EWSR1
1383,133500,"EXCHONDROSIS OF PINNA, POSTERIOR",
1384,133510,"ERCC EXCISION REPAIR 3, TFIIH CORE COMPLEX HELICASE SUBUNIT", ERCC3
1385,133520,"ERCC EXCISION REPAIR 4, ENDONUCLEASE CATALYTIC SUBUNIT", ERCC4
1386,133530,"ERCC EXCISION REPAIR 5, ENDONUCLEASE", ERCC5
1387,133535,"XPC COMPLEX SUBUNIT, DNA DAMAGE RECOGNITION AND REPAIR FACTOR",
1388,133540,COCKAYNE SYNDROME B, CSB
1389,133550,"SOLUTE CARRIER FAMILY 1 (NEURONAL/EPITHELIAL HIGH AFFINITY GLUTAMATE TRANSPORTER), MEMBER 1", SLC1A1
1390,133600,EXOSTOSES OF HEEL,
1391,133690,"EXOSTOSES WITH ANETODERMIA AND BRACHYDACTYLY, TYPE E",
1392,133700,"EXOSTOSES, MULTIPLE, TYPE I", EXT1
1393,133701,"EXOSTOSES, MULTIPLE, TYPE II", EXT2
1394,133705,"EXTERNAL AUDITORY CANAL, BILATERAL ATRESIA OF, WITH CONGENITAL VERTICAL TALUS",
1395,133710,TITLE NOT AVAILABLE AT THIS MOMENT,
1396,133730,TITLE NOT AVAILABLE AT THIS MOMENT,
1397,133740,TITLE NOT AVAILABLE AT THIS MOMENT,
1398,133750,"EXTRASYSTOLES, MULTIFORM VENTRICULAR, WITH SHORT STATURE, HYPERPIGMENTATION AND MICROCEPHALY",
1399,133780,EXUDATIVE VITREORETINOPATHY 1, EVR1
1400,133800,"EYEBROW, WHORL IN",
1401,133900,HEMIFACIAL HYPERPLASIA,
1402,134000,FACIAL HYPERTRICHOSIS,
1403,134100,"FACIAL PARESIS, HEREDITARY CONGENITAL, 1",
1404,134200,"FACIAL PALSY, FAMILIAL RECURRENT PERIPHERAL",
1405,134300,FACIAL SPASM,
1406,134350,COMPLEMENT FACTOR D, CFD
1407,134370,COMPLEMENT FACTOR H, CFH
1408,134371,COMPLEMENT FACTOR H-RELATED 1, CFHR1
1409,134390,COAGULATION FACTOR III, F3
1410,134400,FACTOR V EXCESS WITH SPONTANEOUS THROMBOSIS,
1411,134430,"FACTOR VII AND FACTOR VIII, COMBINED DEFICIENCY OF",
1412,134450,COAGULATION FACTOR VII,
1413,134500,FACTOR VIII DEFICIENCY,
1414,134510,"FACTOR VIII AND FACTOR IX, COMBINED DEFICIENCY OF", F8F9D
1415,134520,"FACTORS VIII, IX AND XI, COMBINED DEFICIENCY OF",
1416,134530,FACTOR X DEFICIENCY,
1417,134540,"FACTOR IX AND FACTOR XI, COMBINED DEFICIENCY OF",
1418,134570,"FACTOR XIII, A1 SUBUNIT", F13A1
1419,134580,"FACTOR XIII, B SUBUNIT", F13B
1420,134600,FANCONI RENOTUBULAR SYNDROME 1, FRTS1
1421,134610,"FAMILIAL MEDITERRANEAN FEVER, AUTOSOMAL DOMINANT",
1422,134629,FARNESYL DIPHOSPHATE SYNTHASE, FDPS
1423,134631,FARNESYL DIPHOSPHATE SYNTHASE,
1424,134632,FARNESYL DIPHOSPHATE SYNTHASE,
1425,134633,FARNESYL DIPHOSPHATE SYNTHASE,
1426,134634,FARNESYL DIPHOSPHATE SYNTHASE,
1427,134635,"FARNESYLTRANSFERASE, CAAX BOX, ALPHA", FNTA
1428,134636,"FARNESYLTRANSFERASE, CAAX BOX, BETA", FNTB
1429,134637,FAS CELL SURFACE DEATH RECEPTOR, FAS
1430,134638,FAS LIGAND, FASLG
1431,134640,FATTY ACID-BINDING PROTEIN 2, FABP2
1432,134650,FATTY ACID-BINDING PROTEIN 1, FABP1
1433,134651,FATTY ACID-BINDING PROTEIN 3, FABP3
1434,134660,"GLUTATHIONE S-TRANSFERASE, PI", GSTP1
1435,134690,FAU UBIQUITIN-LIKE AND RIBOSOMAL PROTEIN S30 FUSION, FAU
1436,134700,"ANEMIA, CONGENITAL, NONSPHEROCYTIC HEMOLYTIC, 1",
1437,134720,"FECUNDITY GENE, BOOROOLA, OF SHEEP, HOMOLOG OF",
1438,134750,FELTY SYNDROME,
1439,134770,FERRITIN HEAVY CHAIN 1, FTH1
1440,134780,FEMORAL-FACIAL SYNDROME, FFS
1441,134790,FERRITIN LIGHT CHAIN, FTL
1442,134795,FIBRILLARIN, FBL
1443,134797,FIBRILLIN 1, FBN1
1444,134820,"FIBRINOGEN, A ALPHA POLYPEPTIDE", FGA
1445,134830,"FIBRINOGEN, B BETA POLYPEPTIDE", FGB
1446,134850,"FIBRINOGEN, G GAMMA POLYPEPTIDE", FGG
1447,134900,FIBRINOLYTIC DEFECT,
1448,134920,FIBROBLAST GROWTH FACTOR 2, FGF2
1449,134921,FIBROBLAST GROWTH FACTOR 6, FGF6
1450,134934,FIBROBLAST GROWTH FACTOR RECEPTOR 3, FGFR3
1451,134935,FIBROBLAST GROWTH FACTOR RECEPTOR 4, FGFR4
1452,135000,INTERSTITIAL LUNG DISEASE 2,
1453,135100,FIBRODYSPLASIA OSSIFICANS PROGRESSIVA, FOP
1454,135150,BIRT-HOGG-DUBE SYNDROME 1, BHD1
1455,135290,"DESMOID DISEASE, HEREDITARY", DESMD
1456,135300,"FIBROMATOSIS, GINGIVAL, 1", GINGF1
1457,135400,"HYPERTRICHOSIS, CONGENITAL GENERALIZED, 3, WITH OR WITHOUT GINGIVAL HYPERPLASIA", HTC3
1458,135500,ZIMMERMANN-LABAND SYNDROME 1, ZLS1
1459,135550,"FIBROMATOSIS, GINGIVAL, WITH PROGRESSIVE DEAFNESS",
1460,135580,"FIBROMUSCULAR DYSPLASIA, ARTERIAL", FMDA
1461,135600,FIBRONECTIN 1, FN1
1462,135610,FIBRONECTIN-LIKE 2, FNL2
1463,135620,"INTEGRIN, ALPHA-5", ITGA5
1464,135630,"INTEGRIN, BETA-1", ITGB1
1465,135631,"INTEGRIN, BETA-1",
1466,135700,"FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, 1", CFEOM1
1467,135750,LAURIN-SANDROW SYNDROME, LSS
1468,135800,"FIBULA, RECURRENT DISLOCATION OF HEAD OF",
1469,135820,FIBULIN 1, FBLN1
1470,135821,FIBULIN 2, FBLN2
1471,135900,COFFIN-SIRIS SYNDROME 1, CSS1
1472,135940,FILAGGRIN, FLG
1473,135950,"FINGER LOCKING, RECURRENT, WITH INTRAUTERINE GROWTH RETARDATION AND PROPORTIONATE SHORT STATURE",
1474,136000,ADERMATOGLYPHIA, ADERM
1475,136100,"FINGERS, RELATIVE LENGTH OF",
1476,136120,FISH-EYE DISEASE, FED
1477,136130,FLAVIN-CONTAINING DIMETHYLANILINE MONOOXYGENASE 1, FMO1
1478,136131,FLAVIN-CONTAINING DIMETHYLANILINE MONOOXYGENASE 4, FMO4
1479,136132,FLAVIN-CONTAINING DIMETHYLANILINE MONOOXYGENASE 3, FMO3
1480,136140,FLOATING-HARBOR SYNDROME, FLHS
1481,136150,FLOOD FACTOR DEFICIENCY,
1482,136200,FLUSHING OF EARS AND SOMNOLENCE,
1483,136300,FLYNN-AIRD SYNDROME,
1484,136350,FIBROBLAST GROWTH FACTOR RECEPTOR 1, FGFR1
1485,136351,FMS-RELATED TYROSINE KINASE 3, FLT3
1486,136352,FMS-LIKE TYROSINE KINASE 4, FLT4
1487,136400,FOCAL EPITHELIAL HYPERPLASIA OF THE ORAL MUCOSA,
1488,136425,"FOLATE RECEPTOR, BETA", FOLR2
1489,136430,"FOLATE RECEPTOR, ALPHA", FOLR1
1490,136435,FOLLICLE-STIMULATING HORMONE RECEPTOR, FSHR
1491,136440,3-KETODIHYDROSPHINGOSINE REDUCTASE, KDSR
1492,136470,FOLLISTATIN, FST
1493,136480,"FOURTH CRANIAL NERVE PALSY, FAMILIAL CONGENITAL",
1494,136490,"ALCOHOL DEHYDROGENASE 5, CHI POLYPEPTIDE",
1495,136500,"FOCAL FACIAL DERMAL DYSPLASIA 1, BRAUER TYPE", FFDD1
1496,136510,FOLYLPOLYGLUTAMATE SYNTHETASE, FPGS
1497,136515,"FOS-LIKE 1, AP-1 TRANSCRIPTION FACTOR SUBUNIT", FOSL1
1498,136520,FOVEAL HYPOPLASIA 1, FVH1
1499,136530,"FOLLICLE-STIMULATING HORMONE, BETA POLYPEPTIDE", FSHB
1500,136533,FORKHEAD BOX O1A, FOXO1A
1501,136535,FORMIN 1, FMN1
1502,136537,FORMYL PEPTIDE RECEPTOR 1, FPR1
1503,136538,FORMYL PEPTIDE RECEPTOR 2, FPR2
1504,136539,FORMYL PEPTIDE RECEPTOR 3, FPR3
1505,136540,FRAGILE SITE 10q23,
1506,136550,"MACULAR DYSTROPHY, RETINAL, 1, NORTH CAROLINA TYPE", MCDR1
1507,136560,TOP6B-LIKE INITIATOR OF MEIOTIC DOUBLE STRAND BREAKS,
1508,136570,"CHROMOSOME 16p12.1 DELETION SYNDROME, 520-KB",
1509,136580,"FRAGILE SITE, DISTAMYCIN A TYPE, RARE, FRA(16)(q22.1)", FRA16B
1510,136590,FRAGILE SITE 20p11,
1511,136600,"FRIEDREICH ATAXIA, SO-CALLED, WITH OPTIC ATROPHY AND SENSORINEURAL DEAFNESS",
1512,136610,ALF TRANSCRIPTION ELONGATION FACTOR 3,
1513,136620,FRAGILE SITE 10q25, FRA10B
1514,136630,"INTELLECTUAL DEVELOPMENTAL DISORDER, FRA12A TYPE",
1515,136640,FRAGILE SITE 9q32,
1516,136650,FRAGILE HISTIDINE TRIAD DIADENOSINE TRIPHOSPHATASE,
1517,136660,FRAGILE SITE 17p12,
1518,136670,TITLE NOT AVAILABLE AT THIS MOMENT,
1519,136680,FRASIER SYNDROME,
1520,136750,COLONY-STIMULATING FACTOR 1 RECEPTOR,
1521,136760,FRONTONASAL DYSPLASIA 1, FND1
1522,136770,COLONY-STIMULATING FACTOR 1 RECEPTOR,
1523,136800,"CORNEAL DYSTROPHY, FUCHS ENDOTHELIAL, 1", FECD1
1524,136820,"FUCOSIDASE, ALPHA-L, 2", FUCA2
1525,136830,FUCOSIDASE REGULATOR,
1526,136835,FUCOSYLTRANSFERASE 5, FUT5
1527,136836,FUCOSYLTRANSFERASE 6, FUT6
1528,136840,FULL-LENGTH RETROVIRAL SEQUENCE 1, FRV1
1529,136850,FUMARATE HYDRATASE, FH
1530,136870,FULL-LENGTH RETROVIRAL SEQUENCE 2, FRV2
1531,136880,FUNDUS ALBIPUNCTATUS,
1532,136890,FULL-LENGTH RETROVIRAL SEQUENCE 3, FRV3
1533,136900,SORSBY FUNDUS DYSTROPHY, SFD
1534,136950,"FURIN, PAIRED BASIC AMINO ACID CLEAVING ENZYME", FURIN
1535,137000,FUTCHER LINE,
1536,137010,F9 EMBRYONIC ANTIGEN, FEA
1537,137020,GDP-L-FUCOSE SYNTHASE, GFUS
1538,137025,"FYN PROTOONCOGENE, SRC FAMILY TYROSINE KINASE", FYN
1539,137026,G PROTEIN-COUPLED RECEPTOR KINASE 4, GRK4
1540,137028,GALACTOKINASE 2, GALK2
1541,137030,GALACTOSE MUTAROTASE, GALM
1542,137033,"LECTIN, GALACTOSIDE-BINDING, SOLUBLE, 3",
1543,137035,GALANIN, GAL
1544,137040,"GALLBLADDER, AGENESIS OF",
1545,137050,"GAMMA-A-GLOBULIN, DEFECT IN ASSEMBLY OF",
1546,137060,"BETA-1,4-GALACTOSYLTRANSFERASE 1", B4GALT1
1547,137061,"BETA-1,4-GALACTOSYLTRANSFERASE 1",
1548,137070,FUS RNA-BINDING PROTEIN, FUS
1549,137100,IMMUNOGLOBULIN A DEFICIENCY 1, IGAD1
1550,137130,GASTRIC SNEEZING,
1551,137140,"GAMMA-AMINOBUTYRIC ACID RECEPTOR, ALPHA-2", GABRA2
1552,137141,"GAMMA-AMINOBUTYRIC ACID RECEPTOR, ALPHA-4", GABRA4
1553,137142,"GAMMA-AMINOBUTYRIC ACID RECEPTOR, ALPHA-5", GABRA5
1554,137143,"GAMMA-AMINOBUTYRIC ACID RECEPTOR, ALPHA-6", GABRA6
1555,137150,4-AMINOBUTYRATE AMINOTRANSFERASE, ABAT
1556,137160,"GAMMA-AMINOBUTYRIC ACID RECEPTOR, ALPHA-1", GABRA1
1557,137161,"GAMMA-AMINOBUTYRIC ACID RECEPTOR, RHO-1", GABRR1
1558,137162,"GAMMA-AMINOBUTYRIC ACID RECEPTOR, RHO-2", GABRR2
1559,137163,"GAMMA-AMINOBUTYRIC ACID RECEPTOR, DELTA", GABRD
1560,137164,"GAMMA-AMINOBUTYRIC ACID RECEPTOR, GAMMA-2", GABRG2
1561,137165,"SOLUTE CARRIER FAMILY 6 (NEUROTRANSMITTER TRANSPORTER, GABA), MEMBER 1", SLC6A1
1562,137166,"GAMMA-AMINOBUTYRIC ACID RECEPTOR, GAMMA-1", GABRG1
1563,137167,GAMMA-GLUTAMYL CARBOXYLASE, GGCX
1564,137168,GAMMA-GLUTAMYLTRANSFERASE 5, GGT5
1565,137170,GAMMA-GLUTAMYL CYCLOTRANSFERASE, GGCT
1566,137181,GAMMA-GLUTAMYLTRANSFERASE 2, GGT2
1567,137190,"GAMMA-AMINOBUTYRIC ACID RECEPTOR, BETA-1", GABRB1
1568,137192,"GAMMA-AMINOBUTYRIC ACID RECEPTOR, BETA-3", GABRB3
1569,137200,"NEUROMYOTONIA AND AXONAL NEUROPATHY, AUTOSOMAL RECESSIVE", NMAN
1570,137207,LEUCINE-RICH REPEAT-CONTAINING PROTEIN 32, LRRC32
1571,137210,"GASTRIC VOLVULUS, INTRATHORACIC",
1572,137215,DIFFUSE GASTRIC AND LOBULAR BREAST CANCER SYNDROME, DGLBC
1573,137216,"ATPase, H+,K+ EXCHANGING, ALPHA SUBUNIT", ATP4A
1574,137217,"ATPase, H+,K+ EXCHANGING, BETA POLYPEPTIDE", ATP4B
1575,137220,GASTRIC JUICE PEPTIDES,
1576,137240,GASTRIC INHIBITORY POLYPEPTIDE, GIP
1577,137241,GASTRIC INHIBITORY POLYPEPTIDE RECEPTOR, GIPR
1578,137245,"LYMPHOMA, MUCOSA-ASSOCIATED LYMPHOID TYPE",
1579,137250,GASTRIN, GAST
1580,137260,GASTRIN-RELEASING PEPTIDE, GRP
1581,137270,GASTROCUTANEOUS SYNDROME,
1582,137280,"GASTRITIS, FAMILIAL GIANT HYPERTROPHIC",
1583,137290,TUMOR-ASSOCIATED CALCIUM SIGNAL TRANSDUCER 2, TACSTD2
1584,137295,GATA-BINDING PROTEIN 2, GATA2
1585,137350,GELSOLIN, GSN
1586,137357,"WILMS TUMOR, ANIRIDIA, GENITOURINARY ANOMALIES, AND IMPAIRED INTELLECTUAL DEVELOPMENT SYNDROME",
1587,137360,GENOCHONDROMATOSIS,
1588,137370,"GENU VALGUM, ST. HELENA FAMILIAL",
1589,137400,GEOGRAPHIC AND FISSURED TONGUE,
1590,137440,GERSTMANN-STRAUSSLER DISEASE, GSD
1591,137500,GIANT NEUTROPHIL LEUKOCYTES,
1592,137550,"MELANOCYTIC NEVUS SYNDROME, CONGENITAL", CMNS
1593,137560,MACROTHROMBOCYTOPENIA AND GRANULOCYTE INCLUSIONS WITH OR WITHOUT NEPHRITIS OR SENSORINEURAL HEARING LOSS,
1594,137570,"SOLUTE CARRIER FAMILY 20 (PHOSPHATE TRANSPORTER), MEMBER 1", SLC20A1
1595,137575,"GIGANTIFORM CEMENTOMA, FAMILIAL", FGC
1596,137580,GILLES DE LA TOURETTE SYNDROME, GTS
1597,137600,ANTERIOR SEGMENT DYSGENESIS 4, ASGD4
1598,137700,GLAUCOMA WITH ELEVATED EPISCLERAL VENOUS PRESSURE,
1599,137750,"GLAUCOMA 1, OPEN ANGLE, A", GLC1A
1600,137760,"GLAUCOMA, PRIMARY OPEN ANGLE", POAG
1601,137763,GLAUCOMA AND SLEEP APNEA,
1602,137765,WEILL-MARCHESANI SYNDROME 2,
1603,137780,GLIAL FIBRILLARY ACIDIC PROTEIN, GFAP
1604,137800,GLIOMA SUSCEPTIBILITY 1, GLM1
1605,137900,GLOBULIN ANOMALY INVOLVING BETA (2A)-GLOBULIN,
1606,137920,RENAL CYSTS AND DIABETES SYNDROME, RCAD
1607,137940,HYPOTRICHOSIS-LYMPHEDEMA-TELANGIECTASIA-RENAL DEFECT SYNDROME, HLTRS
1608,137950,GLOMERULOPATHY WITH FIBRONECTIN DEPOSITS 1, GFND1
1609,137960,MITOCHONDRIAL INNER MEMBRANE PROTEIN MPV17, MPV17
1610,138000,GLOMUVENOUS MALFORMATIONS, GVM
1611,138030,GLUCAGON, GCG
1612,138032,GLUCAGON-LIKE PEPTIDE 1 RECEPTOR, GLP1R
1613,138033,GLUCAGON RECEPTOR, GCGR
1614,138035,"GAUCHER DISEASE, TYPE I",
1615,138040,"NUCLEAR RECEPTOR SUBFAMILY 3, GROUP C, MEMBER 1", NR3C1
1616,138060,GLUCOCORTICOID RECEPTOR-LIKE 1, GRLL1
1617,138070,GLUCOGLYCINURIA,
1618,138079,GLUCOKINASE, GCK
1619,138090,HEXOSE-6-PHOSPHATE DEHYDROGENASE, H6PD
1620,138100,HEXOSE-6-PHOSPHATE DEHYDROGENASE,
1621,138110,GLUCOSE-6-PHOSPHATE DEHYDROGENASE-LIKE, G6PDL
1622,138120,HEAT-SHOCK 70-KD PROTEIN 5, HSPA5
1623,138130,GLUTAMATE DEHYDROGENASE 1, GLUD1
1624,138140,"SOLUTE CARRIER FAMILY 2 (FACILITATED GLUCOSE TRANSPORTER), MEMBER 1", SLC2A1
1625,138150,"GLUTAMATE OXALOACETATE TRANSAMINASE, MITOCHONDRIAL", GOT2
1626,138160,"SOLUTE CARRIER FAMILY 2 (FACILITATED GLUCOSE TRANSPORTER), MEMBER 2", SLC2A2
1627,138170,"SOLUTE CARRIER FAMILY 2 (FACILITATED GLUCOSE TRANSPORTER), MEMBER 3", SLC2A3
1628,138180,"GLUTAMATE OXALOACETATE TRANSAMINASE, SOLUBLE", GOT1
1629,138190,"SOLUTE CARRIER FAMILY 2 (FACILITATED GLUCOSE TRANSPORTER), MEMBER 4", SLC2A4
1630,138200,GLUTAMATE PYRUVATE TRANSAMINASE, GPT
1631,138210,GLUTAMATE PYRUVATE TRANSAMINASE 2, GPT2
1632,138220,GLUTAMATE PYRUVATE TRANSAMINASE,
1633,138230,"SOLUTE CARRIER FAMILY 2 (FACILITATED GLUCOSE/FRUCTOSE TRANSPORTER), MEMBER 5", SLC2A5
1634,138240,"SOLUTE CARRIER FAMILY 2 (FACILITATED GLUCOSE TRANSPORTER), MEMBER 3",
1635,138243,"GLUTAMATE RECEPTOR, IONOTROPIC, KAINATE 3", GRIK3
1636,138244,"GLUTAMATE RECEPTOR, IONOTROPIC, KAINATE 2", GRIK2
1637,138245,"GLUTAMATE RECEPTOR, IONOTROPIC, KAINATE 1", GRIK1
1638,138246,"GLUTAMATE RECEPTOR, IONOTROPIC, AMPA 4", GRIA4
1639,138247,"GLUTAMATE RECEPTOR, IONOTROPIC, AMPA 2", GRIA2
1640,138248,"GLUTAMATE RECEPTOR, IONOTROPIC, AMPA 1", GRIA1
1641,138249,"GLUTAMATE RECEPTOR, IONOTROPIC, N-METHYL-D-ASPARTATE, SUBUNIT 1", GRIN1
1642,138250,"ALDEHYDE DEHYDROGENASE 18 FAMILY, MEMBER A1", ALDH18A1
1643,138251,"GLUTAMATE RECEPTOR, IONOTROPIC, N-METHYL-D-ASPARTATE, ASSOCIATED PROTEIN", GRINA
1644,138252,"GLUTAMATE RECEPTOR, IONOTROPIC, N-METHYL-D-ASPARTATE, SUBUNIT 2B", GRIN2B
1645,138253,"GLUTAMATE RECEPTOR, IONOTROPIC, N-METHYL-D-ASPARTATE, SUBUNIT 2A", GRIN2A
1646,138254,"GLUTAMATE RECEPTOR, IONOTROPIC, N-METHYL-D-ASPARTATE, SUBUNIT 2C", GRIN2C
1647,138270,"GLUTATHIONE S-TRANSFERASE, MU-5",
1648,138275,GLUTAMATE DECARBOXYLASE 2, GAD2
1649,138276,GLUTAMATE DECARBOXYLASE 1,
1650,138277,"GLUTAMIC ACID DECARBOXYLASE, BRAIN, MEMBRANE FORM",
1651,138280,GLUTAMINASE, GLS
1652,138290,GLUTAMATE-AMMONIA LIGASE, GLUL
1653,138292,GLUTAMINE:FRUCTOSE-6-PHOSPHATE AMIDOTRANSFERASE 1, GFPT1
1654,138295,GLUTAMYL-PROLYL-tRNA SYNTHETASE 1, EPRS1
1655,138297,GLUTAMYL AMINOPEPTIDASE, ENPEP
1656,138300,GLUTATHIONE REDUCTASE, GSR
1657,138319,GLUTATHIONE PEROXIDASE 2, GPX2
1658,138320,GLUTATHIONE PEROXIDASE 1, GPX1
1659,138321,GLUTATHIONE PEROXIDASE 3, GPX3
1660,138322,GLUTATHIONE PEROXIDASE 4, GPX4
1661,138330,"GLUTATHIONE S-TRANSFERASE, MICROSOMAL, 1", MGST1
1662,138333,"GLUTATHIONE S-TRANSFERASE, MU-4", GSTM4
1663,138335,"GLUTATHIONE S-TRANSFERASE, PI",
1664,138340,GLUTATHIONE TRANSFERASE ACTIVITY TOWARD TRANS-STILBENE OXIDE,
1665,138350,"GLUTATHIONE S-TRANSFERASE, MU-1", GSTM1
1666,138359,"GLUTATHIONE S-TRANSFERASE, ALPHA-1", GSTA1
1667,138360,"GLUTATHIONE S-TRANSFERASE, ALPHA-2", GSTA2
1668,138370,"GLUTATHIONE S-TRANSFERASE, PI",
1669,138380,"GLUTATHIONE S-TRANSFERASE, MU-2", GSTM2
1670,138385,"GLUTATHIONE S-TRANSFERASE, MU-5", GSTM5
1671,138390,"GLUTATHIONE S-TRANSFERASE, MU-3", GSTM3
1672,138391,TITLE NOT AVAILABLE AT THIS MOMENT,
1673,138400,GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE, GAPDH
1674,138420,GLYCEROL-3-PHOSPHATE DEHYDROGENASE 1, GPD1
1675,138430,GLYCEROL-3-PHOSPHATE DEHYDROGENASE 2, GPD2
1676,138440,PHOSPHORIBOSYLGLYCINAMIDE FORMYLTRANSFERASE/PHOSPHORIBOSYLGLYCINAMIDE SYNTHETASE/PHOSPHORIBOSYLAMINOIMIDAZOLE SYNTHETASE, GART
1677,138450,"SERINE HYDROXYMETHYLTRANSFERASE, MITOCHONDRIAL", SHMT2
1678,138470,COMPLEMENT FACTOR B, CFB
1679,138480,"SOLUTE CARRIER FAMILY 25 (MITOCHONDRIAL CARRIER, FOLATE), MEMBER 32", SLC25A32
1680,138491,"GLYCINE RECEPTOR, ALPHA-1 SUBUNIT", GLRA1
1681,138492,"GLYCINE RECEPTOR, BETA SUBUNIT", GLRB
1682,138500,HYPERGLYCINURIA,
1683,138550,"GLYCOGEN PHOSPHORYLASE, BRAIN TYPE", PYGB
1684,138570,GLYCOGEN SYNTHASE 1, GYS1
1685,138571,GLYCOGEN SYNTHASE 2, GYS2
1686,138590,GLYCOPHORIN E, GYPE
1687,138600,OROSOMUCOID 1, ORM1
1688,138610,OROSOMUCOID 2, ORM2
1689,138670,ALPHA-1-B-GLYCOPROTEIN, A1BG
1690,138680,ALPHA-2-HS-GLYCOPROTEIN, AHSG
1691,138700,APOLIPOPROTEIN H, APOH
1692,138710,"GLYCOPROTEIN, RENAL",
1693,138720,"GLYCOPROTEIN Ib, PLATELET, BETA POLYPEPTIDE", GP1BB
1694,138750,GLYOXALASE I, GLO1
1695,138760,HYDROXYACYL GLUTATHIONE HYDROLASE, HAGH
1696,138770,GMS SYNDROME,
1697,138790,"GOITER, MULTINODULAR, CYSTIC RENAL DISEASE, AND DIGITAL ANOMALIES",
1698,138800,"GOITER, MULTINODULAR 1, WITH OR WITHOUT SERTOLI-LEYDIG CELL TUMORS", MNG1
1699,138850,GONADOTROPIN-RELEASING HORMONE RECEPTOR, GNRHR
1700,138890,GOOSECOID HOMEOBOX, GSC
1701,138900,"URIC ACID CONCENTRATION, SERUM, QUANTITATIVE TRAIT LOCUS 1", UAQTL1
1702,138920,GRANDDAD SYNDROME,
1703,138930,GRANT SYNDROME,
1704,138945,GRANULIN PRECURSOR, GRN
1705,138960,COLONY-STIMULATING FACTOR 2, CSF2
1706,138965,"CHEMOKINE, CXC MOTIF, LIGAND 6", CXCL6
1707,138970,COLONY-STIMULATING FACTOR 3, CSF3
1708,138971,"COLONY-STIMULATING FACTOR 3 RECEPTOR, GRANULOCYTE", CSF3R
1709,138972,"CCAAT/ENHANCER-BINDING PROTEIN, GAMMA", CEBPG
1710,138981,"GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR RECEPTOR, BETA", CSF2RB
1711,138990,"GRANULOMATOUS DISEASE, CHRONIC, X-LINKED",
1712,139000,GRANULOSIS RUBRA NASI,
1713,139080,"SOLUTE CARRIER FAMILY 25 (MITOCHONDRIAL CARRIER, GRAVES DISEASE AUTOANTIGEN), MEMBER 16", SLC25A16
1714,139090,GRAY PLATELET SYNDROME, GPS
1715,139100,"GRAYING OF HAIR, PRECOCIOUS",
1716,139110,"CHEMOKINE, CXC MOTIF, LIGAND 2", CXCL2
1717,139111,"CHEMOKINE, CXC MOTIF, LIGAND 3", CXCL3
1718,139130,"GUANINE NUCLEOTIDE-BINDING PROTEIN, BETA-3", GNB3
1719,139139,"NUCLEAR RECEPTOR SUBFAMILY 4, GROUP A, MEMBER 1", NR4A1
1720,139145,"NUCLEAR RECEPTOR SUBFAMILY 4, GROUP A, MEMBER 1",
1721,139150,RAS p21 PROTEIN ACTIVATOR 1, RASA1
1722,139160,"GUANINE NUCLEOTIDE-BINDING PROTEIN, ALPHA Z POLYPEPTIDE", GNAZ
1723,139180,"GUANINE NUCLEOTIDE-BINDING PROTEIN, ALPHA-INHIBITING, POLYPEPTIDE 2 PSEUDOGENE 1", GNAI2P1
1724,139185,GROWTH ARREST-SPECIFIC 1, GAS1
1725,139190,GROWTH HORMONE-RELEASING HORMONE, GHRH
1726,139191,GROWTH HORMONE-RELEASING HORMONE RECEPTOR, GHRHR
1727,139200,GROUP-SPECIFIC COMPONENT, GC
1728,139210,MYHRE SYNDROME, MYHRS
1729,139220,TITLE NOT AVAILABLE AT THIS MOMENT,
1730,139230,TITLE NOT AVAILABLE AT THIS MOMENT,
1731,139240,GROWTH HORMONE 2, GH2
1732,139250,GROWTH HORMONE 1, GH1
1733,139255,METALLOTHIONEIN 3, MT3
1734,139259,G1- TO S-PHASE TRANSITION 1, GSPT1
1735,139260,GUANINE DEAMINASE, GDA
1736,139265,GUANOSINE MONOPHOSPHATE REDUCTASE, GMPR
1737,139270,GUANYLATE KINASE 1, GUK1
1738,139280,GUANYLATE KINASE 2, GUK2
1739,139290,GUANYLATE KINASE 3, GUK3
1740,139300,AROMATASE EXCESS SYNDROME, AEXS
1741,139310,"GUANINE NUCLEOTIDE-BINDING PROTEIN, ALPHA-INHIBITING ACTIVITY POLYPEPTIDE 1", GNAI1
1742,139311,"GUANINE NUCLEOTIDE-BINDING PROTEIN, ALPHA-ACTIVATING ACTIVITY POLYPEPTIDE O", GNAO1
1743,139312,"GUANINE NUCLEOTIDE-BINDING PROTEIN, ALPHA-ACTIVATING ACTIVITY POLYPEPTIDE, OLFACTORY TYPE", GNAL
1744,139313,"GUANINE NUCLEOTIDE-BINDING PROTEIN, ALPHA-11", GNA11
1745,139314,"GUANINE NUCLEOTIDE-BINDING PROTEIN, ALPHA-15", GNA15
1746,139320,GNAS COMPLEX LOCUS, GNAS
1747,139330,"GUANINE NUCLEOTIDE-BINDING PROTEIN, ALPHA-TRANSDUCING ACTIVITY POLYPEPTIDE 1", GNAT1
1748,139340,"GUANINE NUCLEOTIDE-BINDING PROTEIN, ALPHA-TRANSDUCING ACTIVITY POLYPEPTIDE 2", GNAT2
1749,139350,"KERATIN 1, TYPE II", KRT1
1750,139360,"GUANINE NUCLEOTIDE-BINDING PROTEIN, ALPHA-INHIBITING ACTIVITY POLYPEPTIDE 2", GNAI2
1751,139370,"GUANINE NUCLEOTIDE-BINDING PROTEIN, ALPHA-INHIBITING ACTIVITY POLYPEPTIDE 3", GNAI3
1752,139380,"GUANINE NUCLEOTIDE-BINDING PROTEIN, BETA-1", GNB1
1753,139390,"GUANINE NUCLEOTIDE-BINDING PROTEIN, BETA-2", GNB2
1754,139391,"GUANINE NUCLEOTIDE-BINDING PROTEIN, GAMMA-TRANSDUCING ACTIVITY POLYPEPTIDE 2", GNGT2
1755,139392,GUANYLATE CYCLASE ACTIVATOR 2A, GUCA2A
1756,139393,"GUILLAIN-BARRE SYNDROME, FAMILIAL", GBS
1757,139395,"GUANINE NUCLEOTIDE-BINDING PROTEIN, ALPHA-TRANSDUCING ACTIVITY POLYPEPTIDE 3", GNAT3
1758,139396,"GUANYLATE CYCLASE, SOLUBLE, ALPHA-1", GUCY1A1
1759,139397,"GUANYLATE CYCLASE, SOLUBLE, BETA-1", GUCY1B1
1760,139400,HAIR WHORL,
1761,139450,HAIR MORPHOLOGY 2, HRM2
1762,139500,HAIRY EARS,
1763,139600,HAIRY ELBOWS,
1764,139605,HES FAMILY bHLH TRANSCRIPTION FACTOR 1, HES1
1765,139630,HAIRY NOSE TIP,
1766,139650,HAIRY PALMS AND SOLES,
1767,139750,HAND AND FOOT DEFORMITY WITH FLAT FACIES,
1768,139800,HAND CLASPING PATTERN,
1769,139900,"HAND SKILL, RELATIVE", HSR
1770,140000,HAND-FOOT-GENITAL SYNDROME, HFG
1771,140050,GRANZYME A, GZMA
1772,140090,"NUCLEAR TRANSCRIPTION FACTOR Y, ALPHA",
1773,140100,HAPTOGLOBIN, HP
1774,140210,HAPTOGLOBIN-RELATED PROTEIN, HPR
1775,140300,HASHIMOTO THYROIDITIS, HT
1776,140340,DENTATORUBRAL-PALLIDOLUYSIAN ATROPHY,
1777,140350,HAWKINSINURIA, HWKS
1778,140400,"PROGRESSIVE FAMILIAL HEART BLOCK, TYPE II", PFHB2
1779,140450,"HEART-HAND SYNDROME, SPANISH TYPE",
1780,140500,"HEART, MALFORMATION OF",
1781,140550,HEAT-SHOCK 70-KD PROTEIN 1A, HSPA1A
1782,140555,HEAT-SHOCK 70-KD PROTEIN 6, HSPA6
1783,140556,"HEAT-SHOCK PROTEIN FAMILY A (HSP70), MEMBER 7, PSEUDOGENE", HSPA7
1784,140559,HEAT-SHOCK 70-KD PROTEIN-LIKE 1, HSPA1L
1785,140560,HEAT-SHOCK 70-KD PROTEIN 2, HSPA2
1786,140570,HEAT-SHOCK 70-KD PROTEIN 1A,
1787,140571,"HEAT-SHOCK PROTEIN, 90-KD, ALPHA, CLASS A, MEMBER 1", HSP90AA1
1788,140572,"HEAT-SHOCK PROTEIN, 90-KD, ALPHA, CLASS B, MEMBER 1", HSP90AB1
1789,140573,"HEAT-SHOCK PROTEIN, 90-KD, ALPHA, CLASS A, MEMBER 1",
1790,140574,"HEAT-SHOCK PROTEIN, 90-KD, ALPHA, CLASS A, MEMBER 1",
1791,140575,"HEAT-SHOCK PROTEIN, 90-KD, ALPHA, CLASS A, MEMBER 2, PSEUDOGENE", HSP90AA2P
1792,140576,"HEAT-SHOCK PROTEIN, 90-KD, ALPHA, CLASS A, MEMBER 1",
1793,140580,HEAT-SHOCK TRANSCRIPTION FACTOR 1, HSF1
1794,140581,HEAT-SHOCK TRANSCRIPTION FACTOR 2, HSF2
1795,140600,OSTEOARTHRITIS SUSCEPTIBILITY 2, OS2
1796,140700,HEINZ BODY ANEMIAS,
1797,140750,SUPPRESSOR OF TUMORIGENICITY 5, ST5
1798,140850,"HEMANGIOMAS, CAVERNOUS, OF FACE AND SUPRAUMBILICAL MIDLINE RAPHE",
1799,140900,HEMANGIOMAS OF SMALL INTESTINE,
1800,141000,HEMANGIOMA-THROMBOCYTOPENIA SYNDROME,
1801,141180,NCK-ASSOCIATED PROTEIN 1-LIKE, NCKAP1L
1802,141200,"HEMATURIA, BENIGN FAMILIAL, 1", BFH1
1803,141250,HEME OXYGENASE 1, HMOX1
1804,141251,HEME OXYGENASE 2, HMOX2
1805,141300,"HEMIFACIAL ATROPHY, PROGRESSIVE", HFA
1806,141350,HEMIFACIAL HYPERPLASIA WITH STRABISMUS,
1807,141400,HEMIFACIAL MICROSOMIA WITH RADIAL DEFECTS,
1808,141405,"HEMIFACIAL SPASM, FAMILIAL",
1809,141500,"MIGRAINE, FAMILIAL HEMIPLEGIC, 1", FHM1
1810,141700,HEMOLYTIC POIKILOCYTIC ANEMIA DUE TO REDUCED ANKYRIN BINDING SITES,
1811,141749,FETAL HEMOGLOBIN QUANTITATIVE TRAIT LOCUS 1, HBFQTL1
1812,141750,"ALPHA-THALASSEMIA/IMPAIRED INTELLECTUAL DEVELOPMENT SYNDROME, DELETION TYPE",
1813,141800,HEMOGLOBIN--ALPHA LOCUS 1, HBA1
1814,141850,HEMOGLOBIN--ALPHA LOCUS 2, HBA2
1815,141860,HEMOGLOBIN--ALPHA LOCUS 3,
1816,141900,HEMOGLOBIN--BETA LOCUS, HBB
1817,141940,HEMOGLOBIN--BETA LOCUS,
1818,142000,HEMOGLOBIN--DELTA LOCUS, HBD
1819,142100,HEMOGLOBIN--EPSILON LOCUS, HBE1
1820,142200,"HEMOGLOBIN, GAMMA A", HBG1
1821,142210,"HISTONE GENE CLUSTER 1, H1 HISTONE FAMILY, MEMBER D", HIST1H1D
1822,142220,"HISTONE GENE CLUSTER 1, H1 HISTONE FAMILY, MEMBER E", HIST1H1E
1823,142230,CD34 ANTIGEN, CD34
1824,142240,HEMOGLOBIN--THETA-1 LOCUS, HBQ1
1825,142250,"HEMOGLOBIN, GAMMA G", HBG2
1826,142270,"HEMOGLOBIN, GAMMA A",
1827,142290,HEMOPEXIN, HPX
1828,142300,HEMOGLOBIN--ZETA LOCUS,
1829,142309,HEMOGLOBIN--VARIANTS FOR WHICH THE CHAIN CARRYING THE MUTATION IS UNKNOWN OR UNCERTAIN,
1830,142310,HEMOGLOBIN--ZETA LOCUS, HBZ
1831,142330,"HEPATIC ADENOMAS, FAMILIAL",
1832,142333,HEPATOCELLULAR CARCINOMA,
1833,142335,FETAL HEMOGLOBIN QUANTITATIVE TRAIT LOCUS 5, HBFQTL5
1834,142340,"DIAPHRAGMATIC HERNIA, CONGENITAL",
1835,142350,"HERNIA, DOUBLE INGUINAL",
1836,142360,HEPARIN COFACTOR II, HCF2
1837,142370,"HCK PROTOONCOGENE, SRC FAMILY TYROSINE KINASE", HCK
1838,142380,HEPATOCELLULAR CARCINOMA,
1839,142385,HEPATIC LEUKEMIA FACTOR, HLF
1840,142390,HEPATIC PROTEIN, HEP10
1841,142395,"HEPATITIS B VACCINE, RESPONSE TO",
1842,142400,"HERNIA, HIATUS",
1843,142408,MACROPHAGE STIMULATING 1, MST1
1844,142409,HEPATOCYTE GROWTH FACTOR, HGF
1845,142410,HNF1 HOMEOBOX A, HNF1A
1846,142420,TITLE NOT AVAILABLE AT THIS MOMENT,
1847,142440,HEPSIN, HPN
1848,142445,NEUREGULIN 1, NRG1
1849,142450,NECTIN CELL ADHESION MOLECULE 1,
1850,142460,SYNDECAN 2, SDC2
1851,142461,HEPARAN SULFATE PROTEOGLYCAN OF BASEMENT MEMBRANE, HSPG2
1852,142470,FETAL HEMOGLOBIN QUANTITATIVE TRAIT LOCUS 2, HBFQTL2
1853,142500,HETEROCHROMIA IRIDIS,
1854,142510,PERIVENTRICULAR NODULAR HETEROTOPIA 1,
1855,142550,HEXOKINASE 1,
1856,142560,DExD-BOX HELICASE 39B, DDX39B
1857,142570,HEXOKINASE 3, HK3
1858,142580,PROLINE-RICH COILED-COIL PROTEIN 2A, PRRC2A
1859,142590,BAG COCHAPERONE 6, BAG6
1860,142600,HEXOKINASE 1, HK1
1861,142610,G-PATCH DOMAIN- AND ANKYRIN REPEATS-CONTAINING PROTEIN 1, GPANK1
1862,142620,"ABHYDROLASE DOMAIN-CONTAINING PROTEIN 16A, PHOSPHOLIPASE", ABHD16A
1863,142622,HIPPOCALCIN, HPCA
1864,142623,"HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 1", HSCR1
1865,142625,"HIRSUTISM, SKELETAL DYSPLASIA, AND IMPAIRED INTELLECTUAL DEVELOPMENT",
1866,142630,"HISTIOCYTOSIS, PROGRESSIVE MUCINOUS",
1867,142640,HISTIDINE-RICH GLYCOPROTEIN, HRG
1868,142660,HEXOSAMINIDASE C, HEXC
1869,142669,BEUKES HIP DYSPLASIA, HDB
1870,142680,"PERIODIC FEVER, FAMILIAL, AUTOSOMAL DOMINANT", FPF
1871,142690,"ACNE INVERSA, FAMILIAL, 1", ACNINV1
1872,142695,HIGH DENSITY LIPOPROTEIN-BINDING PROTEIN, HDLBP
1873,142700,DEVELOPMENTAL DYSPLASIA OF THE HIP 1, DDH1
1874,142701,HISTATIN 1, HTN1
1875,142702,HISTATIN 3, HTN3
1876,142703,HISTAMINE RECEPTOR H2, HRH2
1877,142704,HISTIDINE DECARBOXYLASE, HDC
1878,142705,HISTIDINE-RICH CALCIUM-BINDING PROTEIN, HRC
1879,142708,"H1 HISTONE FAMILY, MEMBER 0", H1F0
1880,142709,"HISTONE GENE CLUSTER 1, H1 HISTONE FAMILY, MEMBER A", HIST1H1A
1881,142710,"HISTONE GENE CLUSTER 1, H1 HISTONE FAMILY, MEMBER C", HIST1H1C
1882,142711,"HISTONE GENE CLUSTER 1, H1 HISTONE FAMILY, MEMBER B", HIST1H1B
1883,142712,"HISTONE GENE CLUSTER 1, H1 HISTONE FAMILY, MEMBER T", HIST1H1T
1884,142720,"HISTONE GENE CLUSTER 2, H2A HISTONE FAMILY, MEMBER A3", HIST2H2AA3
1885,142730,HISTIOCYTIC DERMATOARTHRITIS,
1886,142750,H4 CLUSTERED HISTONE 14, H4C14
1887,142760,"HISTONE GENE CLUSTER 2, H2A HISTONE FAMILY, MEMBER A3",
1888,142763,H2A.Z VARIANT HISTONE 1, H2AZ1
1889,142765,"REGULATORY FACTOR X, 2", RFX2
1890,142770,HLA MODIFIER,
1891,142780,"HISTONE GENE CLUSTER 2, H3 HISTONE FAMILY, MEMBER C", HIST2H3C
1892,142790,CD74 ANTIGEN, CD74
1893,142795,HLA-8 HISTOCOMPATIBILITY TYPE, HLA8
1894,142800,"MAJOR HISTOCOMPATIBILITY COMPLEX, CLASS I, A", HLA-A
1895,142810,HISTIDYL-tRNA SYNTHETASE 1, HARS1
1896,142830,"MAJOR HISTOCOMPATIBILITY COMPLEX, CLASS I, B", HLA-B
1897,142840,"MAJOR HISTOCOMPATIBILITY COMPLEX, CLASS I, C", HLA-C
1898,142850,"MAJOR HISTOCOMPATIBILITY COMPLEX, CLASS II, DR ALPHA",
1899,142855,"MAJOR HISTOCOMPATIBILITY COMPLEX, CLASS II, DM ALPHA", HLA-DMA
1900,142856,"MAJOR HISTOCOMPATIBILITY COMPLEX, CLASS II, DM BETA", HLA-DMB
1901,142857,"MAJOR HISTOCOMPATIBILITY COMPLEX, CLASS II, DR BETA-1", HLA-DRB1
1902,142858,"MAJOR HISTOCOMPATIBILITY COMPLEX, CLASS II, DP BETA-1", HLA-DPB1
1903,142860,"MAJOR HISTOCOMPATIBILITY COMPLEX, CLASS II, DR ALPHA", HLA-DRA
1904,142870,TITLE NOT AVAILABLE AT THIS MOMENT,
1905,142871,"HLA-G HISTOCOMPATIBILITY ANTIGEN, CLASS I", HLA-G
1906,142880,"MAJOR HISTOCOMPATIBILITY COMPLEX, CLASS II, DP ALPHA-1", HLA-DPA1
1907,142890,HLA-MT HISTOCOMPATIBILITY TYPE, HLA-MT
1908,142900,HOLT-ORAM SYNDROME, HOS
1909,142910,3-HYDROXY-3-METHYLGLUTARYL-CoA REDUCTASE, HMGCR
1910,142920,HLA-DO HISTOCOMPATIBILITY TYPE, HLA-DO
1911,142925,"MAJOR HISTOCOMPATIBILITY COMPLEX, CLASS I, A",
1912,142930,"MAJOR HISTOCOMPATIBILITY COMPLEX, CLASS II, DN ALPHA", HLA-DNA
1913,142940,3-HYDROXY-3-METHYLGLUTARYL-CoA SYNTHASE 1, HMGCS1
1914,142945,HOLOPROSENCEPHALY 3, HPE3
1915,142946,HOLOPROSENCEPHALY 4, HPE4
1916,142950,HOMEOBOX A7, HOXA7
1917,142951,HOMEOBOX A6, HOXA6
1918,142952,HOMEOBOX A5, HOXA5
1919,142953,HOMEOBOX A4, HOXA4
1920,142954,HOMEOBOX A3, HOXA3
1921,142955,HOMEOBOX A1, HOXA1
1922,142956,HOMEOBOX A9, HOXA9
1923,142957,HOMEOBOX A10, HOXA10
1924,142958,HOMEOBOX A11, HOXA11
1925,142959,HOMEOBOX A13, HOXA13
1926,142960,HOMEOBOX B5, HOXB5
1927,142961,HOMEOBOX B6, HOXB6
1928,142962,HOMEOBOX B7, HOXB7
1929,142963,HOMEOBOX B8, HOXB8
1930,142964,HOMEOBOX B9, HOXB9
1931,142965,HOMEOBOX B4, HOXB4
1932,142966,HOMEOBOX B3, HOXB3
1933,142967,HOMEOBOX B2, HOXB2
1934,142968,HOMEOBOX B1, HOXB1
1935,142970,HOMEOBOX C8, HOXC8
1936,142971,HOMEOBOX C9, HOXC9
1937,142972,HOMEOBOX C6, HOXC6
1938,142973,HOMEOBOX C5, HOXC5
1939,142974,HOMEOBOX C4, HOXC4
1940,142975,HOMEOBOX C12, HOXC12
1941,142976,HOMEOBOX C13, HOXC13
1942,142980,HOMEOBOX D3, HOXD3
1943,142981,HOMEOBOX D4, HOXD4
1944,142982,HOMEOBOX D9, HOXD9
1945,142983,MSH HOMEOBOX 1, MSX1
1946,142984,HOMEOBOX D10, HOXD10
1947,142985,HOMEOBOX D8, HOXD8
1948,142986,HOMEOBOX D11, HOXD11
1949,142987,HOMEOBOX D1, HOXD1
1950,142988,HOMEOBOX D12, HOXD12
1951,142989,HOMEOBOX D13, HOXD13
1952,142990,HOMEOBOX D4,
1953,142991,EVEN-SKIPPED HOMEOBOX 2, EVX2
1954,142992,H6 FAMILY HOMEOBOX 1, HMX1
1955,142993,VISUAL SYSTEM HOMEOBOX 2, VSX2
1956,142994,MOTOR NEURON AND PANCREAS HOMEOBOX 1, MNX1
1957,142995,H.20-LIKE HOMEOBOX, HLX
1958,142996,EVEN-SKIPPED HOMEOBOX 1, EVX1
1959,143000,"HORNER SYNDROME, CONGENITAL",
1960,143010,"MAJOR HISTOCOMPATIBILITY COMPLEX, CLASS I, E", HLA-E
1961,143020,"HPA I RECOGNITION POLYMORPHISM, BETA-GLOBIN-RELATED", HPA1
1962,143023,"RAS ASSOCIATION DOMAIN FAMILY, MEMBER 7", RASSF7
1963,143024,GUANINE NUCLEOTIDE-BINDING PROTEIN-LIKE 1, GNL1
1964,143025,HTLV-RELATED ENDOGENOUS SEQUENCE 1, HRES1
1965,143030,CD9 ANTIGEN, CD9
1966,143040,ANTIGEN DEFINED BY MONOCLONAL ANTIBODY F10.44.2,
1967,143050,HUMERORADIAL SYNOSTOSIS,
1968,143054,HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 ENHANCER-BINDING PROTEIN 2, HIVEP2
1969,143055,CYCLIN T1, CCNT1
1970,143060,HUMAN LEUKOCYTE ANTIGEN MIC6, MIC6
1971,143065,CD59 ANTIGEN,
1972,143070,TITLE NOT AVAILABLE AT THIS MOMENT,
1973,143080,TITLE NOT AVAILABLE AT THIS MOMENT,
1974,143089,FORKHEAD BOX N2, FOXN2
1975,143090,"SOLUTE CARRIER FAMILY 2 (FACILITATED GLUCOSE TRANSPORTER), MEMBER 1",
1976,143095,SPONDYLOEPIPHYSEAL DYSPLASIA WITH CONGENITAL JOINT DISLOCATIONS, SEDCJD
1977,143100,HUNTINGTON DISEASE, HD
1978,143110,"MAJOR HISTOCOMPATIBILITY COMPLEX, CLASS I, F", HLA-F
1979,143150,LYSINE DEMETHYLASE 5D,
1980,143170,MALE-ENHANCED ANTIGEN 1, MEA1
1981,143200,WAGNER VITREORETINOPATHY, WGVRP
1982,143400,CONGENITAL ANOMALIES OF KIDNEY AND URINARY TRACT 2, CAKUT2
1983,143450,"HYDROXYACYL-CoA DEHYDROGENASE/3-KETOACYL-CoA THIOLASE/ENOYL-CoA HYDRATASE, BETA SUBUNIT", HADHB
1984,143460,5-HYDROXYTRYPTAMINE OXYGENASE REGULATOR, HTOR
1985,143465,ATTENTION DEFICIT-HYPERACTIVITY DISORDER, ADHD
1986,143470,HYPERALPHALIPOPROTEINEMIA 1, HALP1
1987,143500,GILBERT SYNDROME,
1988,143850,"ORTHOSTATIC HYPOTENSIVE DISORDER, STREETEN TYPE",
1989,143860,"HYPERCHLORHIDROSIS, ISOLATED", HYCHL
1990,143870,"HYPERCALCIURIA, ABSORPTIVE, 2", HCA2
1991,143880,"HYPERCALCEMIA, INFANTILE, 1", HCINF1
1992,143890,"HYPERCHOLESTEROLEMIA, FAMILIAL, 1", FHCL1
1993,144010,"HYPERCHOLESTEROLEMIA, FAMILIAL, 2", FHCL2
1994,144020,HYPERCHOLESTEROLEMIA SUPPRESSOR,
1995,144050,HYPERHEPARINEMIA,
1996,144100,"HYPERHIDROSIS, GUSTATORY", HYPRG
1997,144110,HYPERHIDROSIS PALMARIS ET PLANTARIS, HYPRPP
1998,144120,HYPERIMMUNOGLOBULIN G1(A1) SYNDROME,
1999,144150,HYPERKERATOSIS LENTICULARIS PERSTANS, HLP
2000,144190,HYPERKERATOSIS-HYPERPIGMENTATION SYNDROME,
2001,144200,"PALMOPLANTAR KERATODERMA, EPIDERMOLYTIC, 1", EPPK1
2002,144250,"HYPERLIPIDEMIA, FAMILIAL COMBINED, 3", FCHL3
2003,144300,"HYPERLIPOPROTEINEMIA, TYPE II, AND DEAFNESS",
2004,144400,"HYPERCHOLESTEROLEMIA, FAMILIAL, 1",
2005,144600,"HYPERLIPOPROTEINEMIA, TYPE IV",
2006,144650,"HYPERLIPOPROTEINEMIA, TYPE V",
2007,144700,"RENAL CELL CARCINOMA, NONPAPILLARY", RCC
2008,144750,"ENDOSTEAL HYPEROSTOSIS, AUTOSOMAL DOMINANT",
2009,144755,HYPEROSTOSIS CRANIALIS INTERNA, HCIN
2010,144800,HYPEROSTOSIS FRONTALIS INTERNA,
2011,145000,HYPERPARATHYROIDISM 1, HRPT1
2012,145001,HYPERPARATHYROIDISM 2 WITH JAW TUMORS, HRPT2
2013,145100,HYPERPIGMENTATION OF EYELIDS,
2014,145200,HYPERPIGMENTATION OF FULDAUER AND KUIJPERS,
2015,145250,"HYPERPIGMENTATION WITH OR WITHOUT HYPOPIGMENTATION, FAMILIAL PROGRESSIVE", FPHH
2016,145260,"PSEUDOHYPOALDOSTERONISM, TYPE IIA", PHA2A
2017,145270,HYPERPROGLUCAGONEMIA,
2018,145290,HYPERREFLEXIA, HRX
2019,145295,"HYPERSECRETION OF ADRENAL ANDROGENS, FAMILIAL",
2020,145300,"HYPERSENSITIVITY PNEUMONITIS, FAMILIAL",
2021,145350,HYPOTAURINEMIC RETINAL DEGENERATION AND CARDIOMYOPATHY, HTRDC
2022,145400,HYPERTELORISM,
2023,145410,TEEBI HYPERTELORISM SYNDROME 1,
2024,145420,TEEBI HYPERTELORISM SYNDROME 1, TBHS1
2025,145500,"HYPERTENSION, ESSENTIAL",
2026,145505,"ACYL-CoA SYNTHETASE MEDIUM CHAIN FAMILY, MEMBER 3", ACSM3
2027,145590,"HYPERTHERMIA, CUTANEOUS, WITH HEADACHES AND NAUSEA",
2028,145600,"MALIGNANT HYPERTHERMIA, SUSCEPTIBILITY TO, 1", MHS1
2029,145650,"THYROID HORMONE RESISTANCE, SELECTIVE PITUITARY", PRTH
2030,145680,"HYPERTHYROXINEMIA, DYSTRANSTHYRETINEMIC", DTTRH
2031,145700,HYPERTRICHOSIS LANUGINOSA CONGENITA,
2032,145701,"HYPERTRICHOSIS UNIVERSALIS CONGENITA, AMBRAS TYPE", HTC1
2033,145750,HYPERTRIGLYCERIDEMIA 1, HYTG1
2034,145800,HYPERTROPHIA MUSCULORUM VERA,
2035,145900,HYPERTROPHIC NEUROPATHY OF DEJERINE-SOTTAS,
2036,145980,"HYPOCALCIURIC HYPERCALCEMIA, FAMILIAL, TYPE I", HHC1
2037,145981,"HYPOCALCIURIC HYPERCALCEMIA, FAMILIAL, TYPE II", HHC2
2038,146000,HYPOCHONDROPLASIA, HCH
2039,146110,HYPOGONADOTROPIC HYPOGONADISM 7 WITH OR WITHOUT ANOSMIA, HH7
2040,146150,HYPOMELANOSIS OF ITO,
2041,146160,HYPOMELIA WITH MULLERIAN DUCT ANOMALIES,
2042,146200,"HYPOPARATHYROIDISM, FAMILIAL ISOLATED, 1", FIH1
2043,146255,"HYPOPARATHYROIDISM, SENSORINEURAL DEAFNESS, AND RENAL DYSPLASIA SYNDROME", HDRS
2044,146300,"HYPOPHOSPHATASIA, ADULT", HPPA
2045,146350,HYPOPHOSPHATEMIC BONE DISEASE, HBD
2046,146390,CHROMOSOME 18p DELETION SYNDROME,
2047,146400,"DENTIN DYSPLASIA, TYPE I",
2048,146450,"HYPOSPADIAS 3, AUTOSOMAL", HYSP3
2049,146500,"MULTIPLE SYSTEM ATROPHY 1, SUSCEPTIBILITY TO", MSA1
2050,146510,PALLISTER-HALL SYNDROME, PHS
2051,146520,HYPOTRICHOSIS 2, HYPT2
2052,146530,BAZEX-DUPRE-CHRISTOL SYNDROME,
2053,146550,HYPOTRICHOSIS 4, HYPT4
2054,146580,HYPOXANTHINE GUANINE PHOSPHORIBOSYLTRANSFERASE SUPPRESSOR,
2055,146590,"ICHTHYOSIS HYSTRIX, CURTH-MACKLIN TYPE", IHCM
2056,146600,"ICHTHYOSIS HYSTRIX, LAMBERT TYPE", IHL
2057,146630,INTERCELLULAR ADHESION MOLECULE 2, ICAM2
2058,146631,INTERCELLULAR ADHESION MOLECULE 3, ICAM3
2059,146640,"INTER-ALPHA-TRYPSIN INHIBITOR, HEAVY CHAIN 2", ITIH2
2060,146650,"INTER-ALPHA-TRYPSIN INHIBITOR, HEAVY CHAIN 3", ITIH3
2061,146660,INTERLEUKIN 7, IL7
2062,146661,INTERLEUKIN 7 RECEPTOR, IL7R
2063,146680,INSULIN-DEGRADING ENZYME, IDE
2064,146690,IMP DEHYDROGENASE 1, IMPDH1
2065,146691,IMP DEHYDROGENASE 2, IMPDH2
2066,146692,IMP DEHYDROGENASE 1,
2067,146700,ICHTHYOSIS VULGARIS,
2068,146710,"INTERLEUKIN 2 RECEPTOR, BETA", IL2RB
2069,146720,ICHTHYOSIS--CHEEK--EYEBROW SYNDROME,
2070,146730,INSULIN-LIKE GROWTH FACTOR-BINDING PROTEIN 1, IGFBP1
2071,146731,INSULIN-LIKE GROWTH FACTOR-BINDING PROTEIN 2, IGFBP2
2072,146732,INSULIN-LIKE GROWTH FACTOR-BINDING PROTEIN 3, IGFBP3
2073,146733,INSULIN-LIKE GROWTH FACTOR-BINDING PROTEIN 4, IGFBP4
2074,146734,INSULIN-LIKE GROWTH FACTOR-BINDING PROTEIN 5, IGFBP5
2075,146735,INSULIN-LIKE GROWTH FACTOR-BINDING PROTEIN 6, IGFBP6
2076,146738,INSULIN-LIKE 3, INSL3
2077,146740,Fc FRAGMENT OF IgG RECEPTOR IIIa, FCGR3A
2078,146750,"ICHTHYOSIS, LAMELLAR, AUTOSOMAL DOMINANT", ADLI
2079,146760,Fc FRAGMENT OF IgG RECEPTOR Ia, FCGR1A
2080,146770,IMMUNOGLOBULIN LAMBDA-LIKE POLYPEPTIDE 1, IGLL1
2081,146771,IMMUNOGLOBULIN LAMBDA-LIKE POLYPEPTIDE 1,
2082,146780,IMMUNOGLOBULIN KAPPA DELETING ELEMENT, IGKDEL
2083,146790,Fc GAMMA RECEPTOR IIa, FCGR2A
2084,146800,ICHTHYOSIS BULLOSA OF SIEMENS, IBS
2085,146810,IMMUNE RESPONSE TO SYNTHETIC POLYPEPTIDE--IRPHEGAL, IPHEG
2086,146820,IMMUNE RESPONSE TO SYNTHETIC POLYPEPTIDE--IRGAT, IGAT
2087,146830,"IMMUNE DEFICIENCY, FAMILIAL VARIABLE",
2088,146840,"HYPER-IgE SYNDROME 1, AUTOSOMAL DOMINANT, WITH RECURRENT INFECTIONS",
2089,146850,IMMUNE SUPPRESSION, IS
2090,146880,"MAJOR HISTOCOMPATIBILITY COMPLEX, CLASS II, DQ ALPHA-1", HLA-DQA1
2091,146900,IgA CONSTANT HEAVY CHAIN 1, IGHA1
2092,146910,IMMUNOGLOBULIN HEAVY CHAIN DIVERSITY GENE CLUSTER, IGHD@
2093,146920,"ADENOSINE DEAMINASE, RNA-SPECIFIC", ADAR
2094,146928,"CHEMOKINE, CXC MOTIF, RECEPTOR 2", CXCR2
2095,146929,"CHEMOKINE, CXC MOTIF, RECEPTOR 1", CXCR1
2096,146930,"CHEMOKINE, CXC MOTIF, LIGAND 8", CXCL8
2097,146931,INTERLEUKIN 9, IL9
2098,146932,INTERLEUKIN 9 RECEPTOR,
2099,146933,"INTERLEUKIN 10 RECEPTOR, ALPHA", IL10RA
2100,146940,IMMUNOGLOBULIN LAMBDA CONSTANT REGION 1,
2101,146950,IMMUNE RESPONSE TO SYNTHETIC POLYPEPTIDE--IRHGAL, IHG
2102,146960,IMMUNE RESPONSE TO SYNTHETIC POLYPEPTIDE--IRTGAL, ITG
2103,146970,IMMUNOGLOBULIN KAPPA LIGHT CHAIN JOINING GENE CLUSTER, IGKJ@
2104,146980,IMMUNOGLOBULIN KAPPA LIGHT CHAIN VARIABLE GENE CLUSTER, IGKV@
2105,146990,IMMUNOGLOBULIN HEAVY CHAIN DIVERSITY REGION 2, IGHDY2
2106,147000,IgA CONSTANT HEAVY CHAIN 2, IGHA2
2107,147010,IMMUNOGLOBULIN HEAVY CHAIN JOINING GENE CLUSTER, IGHJ@
2108,147020,IMMUNOGLOBULIN HEAVY CHAIN CONSTANT REGION MU, IGHM
2109,147040,INTERFERON-INDUCED PROTEIN WITH TETRATRICOPEPTIDE REPEATS 2, IFIT2
2110,147045,"Fc FRAGMENT OF IgA, RECEPTOR FOR", FCAR
2111,147050,"IgE RESPONSIVENESS, ATOPIC", IGER
2112,147060,"HYPER-IgE SYNDROME 1, AUTOSOMAL DOMINANT, WITH RECURRENT INFECTIONS", HIES1
2113,147061,"IMMUNOGLOBULIN E CONCENTRATION, SERUM", IGES
2114,147070,IMMUNOGLOBULIN HEAVY CHAIN VARIABLE GENE CLUSTER, IGHV@
2115,147080,IMMUNE RESPONSE TO SYNTHETIC POLYPEPTIDE--IRGLPHE 1, IGLP1
2116,147090,IMMUNE RESPONSE TO SYNTHETIC POLYPEPTIDE--IRGLPHE 2, IGLP2
2117,147100,IgG HEAVY CHAIN LOCUS, IGHG1
2118,147110,IMMUNOGLOBULIN HEAVY CHAIN CONSTANT REGION GAMMA-2, IGHG2
2119,147120,IMMUNOGLOBULIN Gm3, IGHG3
2120,147130,IMMUNOGLOBULIN Gm4, IGHG4
2121,147138,"MEMBRANE-SPANNING 4 DOMAINS, SUBFAMILY A, MEMBER 2", MS4A2
2122,147139,"Fc FRAGMENT OF IgE, HIGH AFFINITY I, RECEPTOR FOR, GAMMA SUBUNIT", FCER1G
2123,147140,"Fc FRAGMENT OF IgE, HIGH AFFINITY I, RECEPTOR FOR, ALPHA SUBUNIT", FCER1A
2124,147141,TRANSCRIPTION FACTOR 3, TCF3
2125,147150,MX DYNAMIN-LIKE GTPase 1, MX1
2126,147160,IMMUNOGLOBULIN: HEAVY EPSILON CHAIN,
2127,147170,IMMUNOGLOBULIN: HEAVY DELTA CHAIN, IGHD
2128,147180,IMMUNOGLOBULIN: HEAVY EPSILON CHAIN, IGHE
2129,147183,RECOMBINATION SIGNAL-BINDING PROTEIN FOR IMMUNOGLOBULIN KAPPA J REGION, RBPJ
2130,147185,IMMUNOGLOBULIN KAPPA VARIABLE 1/OR2-108, IGKV1OR2108
2131,147200,IMMUNOGLOBULIN KAPPA LIGHT CHAIN CONSTANT REGION, IGKC
2132,147210,IMMUNOGLOBULIN: HEAVY EPSILON CHAIN,
2133,147220,IMMUNOGLOBULIN LAMBDA CONSTANT REGION 1, IGLC1
2134,147230,IMMUNOGLOBULIN LAMBDA LIGHT CHAIN JOINING GENE CLUSTER, IGLJ@
2135,147240,IMMUNOGLOBULIN LAMBDA LIGHT CHAIN VARIABLE GENE CLUSTER, IGLV@
2136,147245,CD79B ANTIGEN, CD79B
2137,147250,SOLITARY MEDIAN MAXILLARY CENTRAL INCISOR, SMMCI
2138,147251,"INCISORS, FUSED MANDIBULAR",
2139,147260,IMMUNOGLOBULIN SWITCH SEQUENCES,
2140,147263,INOSITOL POLYPHOSPHATE-1-PHOSPHATASE, INPP1
2141,147264,"INOSITOL POLYPHOSPHATE-5-PHOSPHATASE, 75-KD", INPP5B
2142,147265,"INOSITOL 1,4,5-TRIPHOSPHATE RECEPTOR, TYPE 1", ITPR1
2143,147267,"INOSITOL 1,4,5-TRISPHOSPHATE RECEPTOR, TYPE 3", ITPR3
2144,147270,"INTER-ALPHA-TRYPSIN INHIBITOR, HEAVY CHAIN 1", ITIH1
2145,147280,INSULIN-LIKE GROWTH FACTOR II RECEPTOR, IGF2R
2146,147290,"INHIBIN, BETA A", INHBA
2147,147300,"INCISORS, LONG UPPER CENTRAL",
2148,147310,"CHEMOKINE, CXC MOTIF, LIGAND 10", CXCL10
2149,147320,"INSULIN RECEPTORS, FAMILIAL INCREASE IN",
2150,147330,"INCISORS, LOWER CENTRAL, ABSENCE OF",
2151,147350,"INCISORS, ROTATION OF UPPER CENTRAL",
2152,147360,INVOLUCRIN, IVL
2153,147370,INSULIN-LIKE GROWTH FACTOR I RECEPTOR, IGF1R
2154,147380,"INHIBIN, ALPHA", INHA
2155,147390,"INHIBIN, BETA B", INHBB
2156,147400,"INCISORS, SHOVEL-SHAPED",
2157,147410,TITLE NOT AVAILABLE AT THIS MOMENT,
2158,147420,"MYOPATHY, MYOFIBRILLAR, 1",
2159,147421,INCLUSION BODY MYOSITIS,
2160,147430,MARSILI SYNDROME, MARSIS
2161,147435,"INDOLEAMINE 2,3-DIOXYGENASE", IDO1
2162,147440,INSULIN-LIKE GROWTH FACTOR I, IGF1
2163,147450,SUPEROXIDE DISMUTASE 1, SOD1
2164,147460,SUPEROXIDE DISMUTASE 2, SOD2
2165,147470,INSULIN-LIKE GROWTH FACTOR II, IGF2
2166,147480,"CHOLESTASIS, INTRAHEPATIC, OF PREGNANCY, 1", ICP1
2167,147485,INTRACISTERNAL A PARTICLE-PROMOTED POLYPEPTIDE, IPP
2168,147490,TITLE NOT AVAILABLE AT THIS MOMENT,
2169,147510,INSULIN-RELATED DNA POLYMORPHISM, IRDN
2170,147520,INOSINE TRIPHOSPHATASE, ITPA
2171,147521,"INOSITOL 1,4,5-TRISPHOSPHATE 3-KINASE A", ITPKA
2172,147522,"INOSITOL 1,4,5-TRISPHOSPHATE 3-KINASE B", ITPKB
2173,147530,INSENSITIVITY TO PAIN WITH HYPERPLASTIC MYELINOPATHY,
2174,147540,"INSECT STINGS, HYPERSENSITIVITY TO",
2175,147545,INSULIN RECEPTOR SUBSTRATE 1, IRS1
2176,147553,"INTERFERON, OMEGA-1", IFNW1
2177,147554,"INTERFERON, OMEGA-1",
2178,147556,"INTEGRIN, ALPHA-6", ITGA6
2179,147557,"INTEGRIN, BETA-4", ITGB4
2180,147558,"INTEGRIN, BETA-6", ITGB6
2181,147559,"INTEGRIN, BETA-7", ITGB7
2182,147560,INTERFERON ANTIVIRAL DEPRESSOR,
2183,147561,"INTEGRIN, BETA-5", ITGB5
2184,147562,"INTERFERON, ALPHA-2", IFNA2
2185,147563,INTEGRIN-BINDING SIALOPROTEIN, IBSP
2186,147564,"INTERFERON, ALPHA-4", IFNA4
2187,147565,"INTERFERON, ALPHA-5", IFNA5
2188,147566,"INTERFERON, ALPHA-6", IFNA6
2189,147567,"INTERFERON, ALPHA-7", IFNA7
2190,147568,"INTERFERON, ALPHA-8", IFNA8
2191,147569,INTERFERON-GAMMA RECEPTOR 2, IFNGR2
2192,147570,"INTERFERON, GAMMA", IFNG
2193,147571,UBIQUITIN-LIKE MODIFIER ISG15, ISG15
2194,147572,INTERFERON-ALPHA-INDUCIBLE PROTEIN 6, IFI6
2195,147573,INTERFERON PRODUCTION REGULATOR, IFNR
2196,147574,INTERFERON REGULATORY FACTOR 9, IRF9
2197,147575,INTERFERON REGULATORY FACTOR 1, IRF1
2198,147576,INTERFERON REGULATORY FACTOR 2, IRF2
2199,147577,"INTERFERON, ALPHA-10", IFNA10
2200,147578,"INTERFERON, ALPHA-13", IFNA13
2201,147579,"INTERFERON, ALPHA-14", IFNA14
2202,147580,"INTERFERON, ALPHA-16", IFNA16
2203,147581,ACONITASE 1,
2204,147582,IRON-RESPONSIVE ELEMENT-BINDING PROTEIN 2, IREB2
2205,147583,"INTERFERON, ALPHA-17", IFNA17
2206,147584,"INTERFERON, ALPHA-21", IFNA21
2207,147585,"INTERFERON, ALPHA-1",
2208,147586,INTERFERON-GAMMA-INDUCIBLE PROTEIN 16, IFI16
2209,147590,"AXENFELD-RIEGER ANOMALY WITH PARTIALLY ABSENT EYE MUSCLES, DISTINCTIVE FACE, HYDROCEPHALY, AND SKELETAL ABNORMALITIES",
2210,147610,"IRIS PIGMENT LAYER, CLEAVAGE OF",
2211,147620,INTERLEUKIN 6, IL6
2212,147625,ISLET CELL AUTOANTIGEN 1, ICA1
2213,147630,INSULINOMATOSIS AND DIABETES MELLITUS, INSDM
2214,147640,"INTERFERON, BETA-1", IFNB1
2215,147650,"ISOCITRATE DEHYDROGENASE, NADP(+), 2", IDH2
2216,147660,"INTERFERON, ALPHA-1", IFNA1
2217,147670,INSULIN RECEPTOR, INSR
2218,147671,INSULIN RECEPTOR-RELATED RECEPTOR, INSRR
2219,147678,"CASPASE 1, APOPTOSIS-RELATED CYSTEINE PROTEASE", CASP1
2220,147679,INTERLEUKIN 1 RECEPTOR ANTAGONIST, IL1RN
2221,147680,INTERLEUKIN 2, IL2
2222,147681,INTERLEUKIN 11, IL11
2223,147683,INTERLEUKIN 13, IL13
2224,147684,TITLE NOT AVAILABLE AT THIS MOMENT,
2225,147685,FORKHEAD BOX K2, FOXK2
2226,147686,"INTERLEUKIN 13 RECEPTOR, ALPHA-1",
2227,147690,INTERFERON-INDUCED PROTEIN WITH TETRATRICOPEPTIDE REPEATS 1, IFIT1
2228,147700,"ISOCITRATE DEHYDROGENASE, NADP(+), 1", IDH1
2229,147710,INTUSSUSCEPTION,
2230,147720,INTERLEUKIN 1-BETA, IL1B
2231,147730,"INTERLEUKIN 2 RECEPTOR, ALPHA", IL2RA
2232,147740,INTERLEUKIN 3, IL3
2233,147750,IVIC SYNDROME, IVIC
2234,147760,INTERLEUKIN 1-ALPHA, IL1A
2235,147770,JOHNSON NEUROECTODERMAL SYNDROME,
2236,147780,INTERLEUKIN 4, IL4
2237,147781,INTERLEUKIN 4 RECEPTOR, IL4R
2238,147790,JOINING CHAIN OF MULTIMERIC IgA AND IgM, JCHAIN
2239,147791,JACOBSEN SYNDROME, JBS
2240,147795,JANUS KINASE 1, JAK1
2241,147796,JANUS KINASE 2, JAK2
2242,147800,AASE-SMITH SYNDROME I,
2243,147810,"INTERLEUKIN 1 RECEPTOR, TYPE I", IL1R1
2244,147811,"INTERLEUKIN 1 RECEPTOR, TYPE II", IL1R2
2245,147820,"INTERNAL CAROTID ARTERY, SPONTANEOUS DISSECTION OF",
2246,147830,T-CELL TUMOR INVASION AND METASTASIS 1, TTIM1
2247,147840,INTERCELLULAR ADHESION MOLECULE 1, ICAM1
2248,147850,INTERLEUKIN 5, IL5
2249,147851,"INTERLEUKIN 5 RECEPTOR, ALPHA", IL5RA
2250,147860,"INTERFERON, BETA-3", IFNB3
2251,147870,"WINGLESS-TYPE MMTV INTEGRATION SITE FAMILY, MEMBER 2", WNT2
2252,147880,INTERLEUKIN 6 RECEPTOR, IL6R
2253,147890,MX DYNAMIN-LIKE GTPase 2, MX2
2254,147891,ISCHIOCOXOPODOPATELLAR SYNDROME WITH OR WITHOUT PULMONARY ARTERIAL HYPERTENSION, ICPPS
2255,147892,"DEIODINASE, IODOTHYRONINE, TYPE I", DIO1
2256,147900,"JOINT LAXITY, FAMILIAL",
2257,147910,KALLIKREIN 1, KLK1
2258,147920,KABUKI SYNDROME 1, KABUK1
2259,147935,"SERPIN PEPTIDASE INHIBITOR, CLADE A, MEMBER 4", SERPINA4
2260,147940,ISLET AMYLOID POLYPEPTIDE, IAPP
2261,147950,HYPOGONADOTROPIC HYPOGONADISM 2 WITH OR WITHOUT ANOSMIA, HH2
2262,147960,KALLIKREIN-RELATED PEPTIDASE 2, KLK2
2263,148000,"KAPOSI SARCOMA, SUSCEPTIBILITY TO",
2264,148020,KERATIN 19, KRT19
2265,148021,KERATIN-ASSOCIATED PROTEIN 5-9, KRTAP5-9
2266,148022,KERATIN-ASSOCIATED PROTEIN 5-1, KRTAP5-1
2267,148030,"KERATIN 15, TYPE I", KRT15
2268,148040,"KERATIN 5, TYPE II", KRT5
2269,148041,"KERATIN 6A, TYPE II", KRT6A
2270,148042,"KERATIN 6B, TYPE II", KRT6B
2271,148043,"KERATIN 3, TYPE II", KRT3
2272,148050,KBG SYNDROME, KBGS
2273,148059,"KERATIN 7, TYPE II", KRT7
2274,148060,"KERATIN 8, TYPE II", KRT8
2275,148065,"KERATIN 13, TYPE I", KRT13
2276,148066,"KERATIN 14, TYPE I", KRT14
2277,148067,"KERATIN 16, TYPE I", KRT16
2278,148069,"KERATIN 17, TYPE I", KRT17
2279,148070,"KERATIN 18, TYPE I", KRT18
2280,148080,"KERATIN 10, TYPE I", KRT10
2281,148100,KELOID FORMATION, KLDF
2282,148180,FIBROBLAST GROWTH FACTOR 7, FGF7
2283,148181,FIBROBLAST GROWTH FACTOR RECEPTOR 2,
2284,148190,"KERATITIS, HEREDITARY",
2285,148200,KERATOENDOTHELIITIS FUGAX HEREDITARIA, KEFH
2286,148210,"KERATITIS-ICHTHYOSIS-DEAFNESS SYNDROME, AUTOSOMAL DOMINANT", KIDAD
2287,148300,KERATOCONUS 1, KTCN1
2288,148350,"KERATODERMA, PALMOPLANTAR, WITH DEAFNESS",
2289,148360,"KERATODERMA, PALMOPLANTAR, WITH NAIL DYSTROPHY AND HEREDITARY MOTOR-SENSORY NEUROPATHY",
2290,148370,KERATOLYTIC WINTER ERYTHEMA, KWE
2291,148390,"KERATOSIS, FAMILIAL ACTINIC",
2292,148500,TYLOSIS WITH ESOPHAGEAL CANCER, TOC
2293,148520,KERATOSIS PALMARIS ET PLANTARIS WITH CLINODACTYLY,
2294,148600,"PALMOPLANTAR KERATODERMA, PUNCTATE TYPE IA", PPKP1A
2295,148700,"PALMOPLANTAR KERATODERMA I, STRIATE, FOCAL, OR DIFFUSE", PPKS1
2296,148730,"KERATOSIS, FOCAL PALMOPLANTAR AND GINGIVAL",
2297,148750,KINASE-LIKE PROTEIN G7P1, G7P1
2298,148760,KINESIN FAMILY MEMBER 11, KIF11
2299,148800,KLEEBLATTSCHAEDEL,
2300,148820,"WAARDENBURG SYNDROME, TYPE 3", WS3
2301,148840,KLEINE-LEVIN HIBERNATION SYNDROME,
2302,148860,"MULLERIAN DUCT APLASIA, UNILATERAL RENAL AGENESIS, AND CERVICOTHORACIC SOMITE ANOMALIES",
2303,148870,"KLIPPEL-FEIL SYNDROME 1, AUTOSOMAL DOMINANT",
2304,148900,"KLIPPEL-FEIL SYNDROME 1, AUTOSOMAL DOMINANT",
2305,149000,KLIPPEL-TRENAUNAY-WEBER SYNDROME,
2306,149100,KNUCKLE PADS,
2307,149200,BART-PUMPHREY SYNDROME, BAPS
2308,149300,"NAIL DISORDER, NONSYNDROMIC CONGENITAL, 2", NDNC2
2309,149400,HYPEREKPLEXIA 1, HKPX1
2310,149500,KYRLE DISEASE,
2311,149600,"LABIA MINORA, INCOMPLETE ADHESION OF",
2312,149700,LACRIMAL DUCT DEFECT, LCDD
2313,149730,LACRIMOAURICULODENTODIGITAL SYNDROME 1, LADD1
2314,149750,"LACTALBUMIN, ALPHA", LALBA
2315,150000,LACTATE DEHYDROGENASE A, LDHA
2316,150100,LACTATE DEHYDROGENASE B, LDHB
2317,150150,LACTATE DEHYDROGENASE C, LDHC
2318,150160,LACTATE DEHYDROGENASE A,
2319,150170,"LACTIC ACIDOSIS, CHRONIC ADULT FORM",
2320,150200,CHORIONIC SOMATOMAMMOTROPIN HORMONE 1, CSH1
2321,150205,LACTOPEROXIDASE, LPO
2322,150210,LACTOTRANSFERRIN, LTF
2323,150220,"LACTASE DEFICIENCY, CONGENITAL",
2324,150230,"TRICHORHINOPHALANGEAL SYNDROME, TYPE II", TRPS2
2325,150240,"LAMININ, BETA-1", LAMB1
2326,150250,LARSEN SYNDROME, LRS
2327,150260,LARYNGEAL ABDUCTOR PARALYSIS,
2328,150270,LARYNGEAL ADDUCTOR PARALYSIS, LAP
2329,150280,LARYNGOMALACIA,
2330,150290,"LAMININ, GAMMA-1", LAMC1
2331,150292,"LAMININ, GAMMA-2", LAMC2
2332,150300,"LARYNX, CONGENITAL PARTIAL ATRESIA OF",
2333,150310,"LAMININ, BETA-3", LAMB3
2334,150320,"LAMININ, ALPHA-1", LAMA1
2335,150325,"LAMININ, BETA-2", LAMB2
2336,150330,LAMIN A/C, LMNA
2337,150340,LAMIN B1, LMNB1
2338,150341,LAMIN B2, LMNB2
2339,150360,"LARYNGEAL WEB, FAMILIAL",
2340,150370,RIBOSOMAL PROTEIN SA, RPSA
2341,150390,LATENT TRANSFORMING GROWTH FACTOR-BETA-BINDING PROTEIN 1, LTBP1
2342,150400,"TOOTH AGENESIS, SELECTIVE, 4", STHAG4
2343,150500,LATTICE DEGENERATION OF RETINA LEADING TO RETINAL DETACHMENT,
2344,150550,"PERIODIC FEVER, IMMUNODEFICIENCY, AND THROMBOCYTOPENIA SYNDROME", PFITS
2345,150570,"LECTIN, GALACTOSIDE-BINDING, SOLUBLE, 1", LGALS1
2346,150571,"LECTIN, GALACTOSIDE-BINDING, SOLUBLE, 2", LGALS2
2347,150590,"LEG ULCERS, FAMILIAL, OF JUVENILE ONSET",
2348,150600,LEGG-CALVE-PERTHES DISEASE, LCPD
2349,150699,"LEIOMYOMA, UTERINE", UL
2350,150700,LEIOMYOMA OF VULVA AND ESOPHAGUS,
2351,150800,HEREDITARY LEIOMYOMATOSIS AND RENAL CELL CANCER, HLRCC
2352,150900,LENTIGINES,
2353,151000,"LENTIGINOSIS, CENTROFACIAL NEURODYSRAPHIC",
2354,151001,"LENTIGINOSIS, INHERITED PATTERNED",
2355,151020,LENTIL AGGLUTININ BINDING,
2356,151050,LENZ-MAJEWSKI HYPEROSTOTIC DWARFISM, LMHD
2357,151100,LEOPARD SYNDROME 1, LPRD1
2358,151200,CHROMOSOME 8q22.1 DUPLICATION SYNDROME,
2359,151210,"PLATYSPONDYLIC LETHAL SKELETAL DYSPLASIA, TORRANCE TYPE", PLSDT
2360,151250,LETHAL ANTIGEN--A1, AL-A1
2361,151290,"BETA-1,3-GLUCURONYLTRANSFERASE 1", B3GAT1
2362,151300,LEUCYL-CYSTINYL AMINOPEPTIDASE, LNPEP
2363,151310,"LEUCINE TRANSPORT, HIGH", LEUT
2364,151350,LEUCYL-tRNA SYNTHETASE 1, LARS1
2365,151380,"LEUKEMIA, ACUTE MONOCYTIC",
2366,151385,RUNT-RELATED TRANSCRIPTION FACTOR 1, RUNX1
2367,151390,LIM DOMAIN ONLY 2,
2368,151400,"LEUKEMIA, CHRONIC LYMPHOCYTIC", CLL
2369,151410,BCR ACTIVATOR OF RhoGEF AND GTPase, BCR
2370,151430,B-CELL CLL/LYMPHOMA 2, BCL2
2371,151440,LYMPHOBLASTIC LEUKEMIA-DERIVED SEQUENCE 1, LYL1
2372,151441,"LEUKEMIA/LYMPHOMA, CHRONIC B-CELL, 5", BCL5
2373,151442,STATHMIN 1, STMN1
2374,151443,LEUKEMIA INHIBITORY FACTOR RECEPTOR, LIFR
2375,151445,"Fc FRAGMENT OF IgE, LOW AFFINITY II, RECEPTOR FOR", FCER2
2376,151450,LEUKOCYTE ANTIGEN GROUP FIVE, LAG5
2377,151460,"PROTEIN-TYROSINE PHOSPHATASE, RECEPTOR-TYPE, C", PTPRC
2378,151465,"CHEMOKINE, CXC MOTIF, RECEPTOR 4",
2379,151500,"LEUKOCYTE NUCLEAR APPENDAGES, HEREDITARY PREVALENCE OF",
2380,151510,"INTEGRIN, ALPHA-X", ITGAX
2381,151520,LEUKOCYTE TYROSINE KINASE, LTK
2382,151523,LEUKOCYTE SURFACE ANTIGEN CD37, CD37
2383,151525,LEUKOCYTE SURFACE ANTIGEN CD53, CD53
2384,151530,ALANYL AMINOPEPTIDASE, ANPEP
2385,151540,CD82 ANTIGEN,
2386,151550,TITLE NOT AVAILABLE AT THIS MOMENT,
2387,151570,LEUKOTRIENE A4 HYDROLASE, LTA4H
2388,151580,HEPARIN COFACTOR II,
2389,151590,LICHEN SCLEROSUS ET ATROPHICUS, LSA
2390,151600,"NAIL DISORDER, NONSYNDROMIC CONGENITAL, 3", NDNC3
2391,151610,OCULOMOTOR-LEVATOR SYNKINESIS, OCLEVS
2392,151620,"LICHEN PLANUS, FAMILIAL",
2393,151623,LI-FRAUMENI SYNDROME, LFS
2394,151625,LIGATIN, LGTN
2395,151626,LINE RETROTRANSPOSABLE ELEMENT 1, LRE1
2396,151627,LINKIN,
2397,151628,LINE RETROTRANSPOSABLE ELEMENT 2, LRE2
2398,151630,"LIP, MEDIAN NODULE OF UPPER",
2399,151640,"LIP, HAMARTOMATOUS",
2400,151660,"LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 2", FPLD2
2401,151670,"LIPASE, HEPATIC", LIPC
2402,151675,LIPOCALIN 1, LCN1
2403,151680,SHORT SYNDROME,
2404,151690,ANNEXIN A1, ANXA1
2405,151700,LIPOMA OF THE CONJUNCTIVA,
2406,151710,ANNEXIN A2,
2407,151720,ANNEXIN A2,
2408,151730,ANNEXIN A2,
2409,151740,ANNEXIN A2, ANXA2
2410,151750,"LIPASE, HORMONE-SENSITIVE", LIPE
2411,151800,"LIPOMATOSIS, MULTIPLE SYMMETRIC, WITH OR WITHOUT AXONAL PERIPHERAL NEUROPATHY", MSL
2412,151900,"LIPOMATOSIS, FAMILIAL MULTIPLE", FML
2413,151990,LIPOPOLYSACCHARIDE-BINDING PROTEIN, LBP
2414,152100,LIPOPROTEIN TYPES--Ld SYSTEM,
2415,152200,LIPOPROTEIN(a), LPA
2416,152300,LIPOPROTEIN TYPES--Lt SYSTEM,
2417,152310,TISSUE FACTOR PATHWAY INHIBITOR, TFPI
2418,152390,ARACHIDONATE 5-LIPOXYGENASE, ALOX5
2419,152391,ARACHIDONATE 12-OXIDOREDUCTASE, ALOX12
2420,152392,ARACHIDONATE 15-LIPOXYGENASE, ALOX15
2421,152400,"LIPOPROTEIN, VARIANT OF BETA",
2422,152420,LITHIUM TRANSPORT,
2423,152422,"LOCUS CONTROL REGION, ALPHA",
2424,152423,CADHERIN 1,
2425,152424,"LOCUS CONTROL REGION, BETA",
2426,152425,"ACYL-CoA SYNTHETASE LONG CHAIN FAMILY, MEMBER 1", ACSL1
2427,152426,"ACYL-CoA SYNTHETASE LONG CHAIN FAMILY, MEMBER 1",
2428,152427,"POTASSIUM CHANNEL, VOLTAGE-GATED, SUBFAMILY H, MEMBER 2", KCNH2
2429,152430,LONGEVITY 1,
2430,152445,LORICRIN, LOR
2431,152450,"LOW DENSITY LIPOPROTEIN, VARIATION IN MOLECULAR WEIGHT OF",
2432,152460,GLOMERULOPATHY WITH FIBRONECTIN DEPOSITS 1,
2433,152550,"LUMBAR STENOSIS, FAMILIAL",
2434,152600,LUNULAE OF FINGERNAILS,
2435,152690,X-RAY REPAIR CROSS COMPLEMENTING 6, XRCC6
2436,152700,SYSTEMIC LUPUS ERYTHEMATOSUS, SLE
2437,152760,GONADOTROPIN-RELEASING HORMONE 1, GNRH1
2438,152761,GONADOTROPIN-RELEASING HORMONE RECEPTOR,
2439,152780,"LUTEINIZING HORMONE, BETA POLYPEPTIDE", LHB
2440,152790,LUTEINIZING HORMONE/CHORIOGONADOTROPIN RECEPTOR, LHCGR
2441,152800,"LYMPHANGIECTASIA, INTESTINAL",
2442,152900,LYMPHEDEMA AND CEREBRAL ARTERIOVENOUS ANOMALY,
2443,152950,"MICROCEPHALY WITH OR WITHOUT CHORIORETINOPATHY, LYMPHEDEMA, OR IMPAIRED INTELLECTUAL DEVELOPMENT", MCLMR
2444,153000,LYMPHEDEMA-DISTICHIASIS SYNDROME,
2445,153100,LYMPHATIC MALFORMATION 1, LMPHM1
2446,153200,LYMPHATIC MALFORMATION 5, LMPHM5
2447,153240,SELECTIN L, SELL
2448,153243,"TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY, MEMBER 8", TNFRSF8
2449,153245,LYMPHOID ENHANCER-BINDING FACTOR 1, LEF1
2450,153280,"LYMPHOCYTE CYTOSOL POLYPEPTIDE, 40-KD",
2451,153290,"LYMPHOCYTE CYTOSOL POLYPEPTIDE, 49-KD",
2452,153300,YELLOW NAIL SYNDROME,
2453,153310,CHARCOT-LEYDEN CRYSTAL PROTEIN, CLC
2454,153330,LYSOSOME-ASSOCIATED MEMBRANE PROTEIN 1, LAMP1
2455,153335,"CHEMOKINE, CC MOTIF, LIGAND 4",
2456,153337,LYMPHOCYTE ACTIVATION GENE 3, LAG3
2457,153340,LYMPHOCYTE ANTIGEN CD5, CD5
2458,153360,DANON DISEASE,
2459,153370,"INTEGRIN, ALPHA-L", ITGAL
2460,153380,"LYMPHOCYTE CYTOSOL POLYPEPTIDE, 20-KD",
2461,153390,"LCK PROTOONCOGENE, SRC FAMILY TYROSINE KINASE", LCK
2462,153400,LYMPHEDEMA-DISTICHIASIS SYNDROME, LPHDST
2463,153420,CD58 ANTIGEN, CD58
2464,153430,LYMPHOCYTE CYTOSOLIC PROTEIN 1, LCP1
2465,153432,LYMPHOCYTE-SPECIFIC PROTEIN,  LSP1
2466,153435,LYMPHOKINE-ACTIVATED KILLER CELL LIGAND, LAKL
2467,153440,LYMPHOTOXIN-ALPHA, LTA
2468,153450,LYSOZYME, LYZ
2469,153454,"PROCOLLAGEN-LYSINE, 2-OXOGLUTARATE 5-DIOXYGENASE", PLOD1
2470,153455,LYSYL OXIDASE, LOX
2471,153456,LYSYL OXIDASE-LIKE 1, LOXL1
2472,153460,GLYCOGEN STORAGE DISEASE V,
2473,153470,"MACROCEPHALY, BENIGN FAMILIAL",
2474,153480,COWDEN SYNDROME 1,
2475,153550,CHROMOSOME 5q DELETION SYNDROME,
2476,153600,"MACROGLOBULINEMIA, WALDENSTROM, SUSCEPTIBILITY TO, 1", WM1
2477,153615,"CAPPING PROTEIN, GELSOLIN-LIKE", CAPG
2478,153618,"MANNOSE RECEPTOR, C-TYPE, 1", MRC1
2479,153619,"LECTIN, GALACTOSIDE-BINDING, SOLUBLE, 3", LGALS3
2480,153620,MACROPHAGE MIGRATION INHIBITORY FACTOR, MIF
2481,153622,MACROPHAGE SCAVENGER RECEPTOR, MSR1
2482,153630,MACROGLOSSIA,
2483,153634,MACROPHAGE ANTIGEN CD68, CD68
2484,153640,MACROTHROMBOCYTOPENIA AND GRANULOCYTE INCLUSIONS WITH OR WITHOUT NEPHRITIS OR SENSORINEURAL HEARING LOSS,
2485,153650,MACROTHROMBOCYTOPENIA AND GRANULOCYTE INCLUSIONS WITH OR WITHOUT NEPHRITIS OR SENSORINEURAL HEARING LOSS,
2486,153670,"BERNARD-SOULIER SYNDROME, TYPE A2, AUTOSOMAL DOMINANT", BSSA2
2487,153700,"MACULAR DYSTROPHY, VITELLIFORM, 2", VMD2
2488,153800,"MACULAR DEGENERATION, AGE-RELATED, 2", ARMD2
2489,153840,"MACULAR DYSTROPHY, VITELLIFORM, 1", VMD1
2490,153860,"MACULAR DYSTROPHY, PATTERNED, 1",
2491,153870,RETINITIS PIGMENTOSA 91, RP91
2492,153880,"MACULAR DYSTROPHY, DOMINANT CYSTOID", DCMD
2493,153890,"MACULAR DYSTROPHY, FENESTRATED SHEEN TYPE",
2494,153900,STARGARDT DISEASE 3,
2495,154000,"HYPERPIGMENTATION WITH OR WITHOUT HYPOPIGMENTATION, FAMILIAL PROGRESSIVE",
2496,154020,"HYPOMAGNESEMIA 2, RENAL", HOMG2
2497,154030,Y-BOX BINDING PROTEIN 1, YBX1
2498,154040,"NEGATIVE ELONGATION FACTOR COMPLEX, MEMBER E", NELFE
2499,154045,"LENS INTRINSIC MEMBRANE PROTEIN 2, 19-KD", LIM2
2500,154050,MAJOR INTRINSIC PROTEIN OF LENS FIBER, MIP
2501,154100,MALATE DEHYDROGENASE 2, MDH2
2502,154200,MALATE DEHYDROGENASE 1, MDH1
2503,154230,"46,XY SEX REVERSAL 4", SRXY4
2504,154235,MALE GERM CELL-ASSOCIATED KINASE, MAK
2505,154250,MALIC ENZYME 1, ME1
2506,154270,MALIC ENZYME 2, ME2
2507,154275,"MALIGNANT HYPERTHERMIA, SUSCEPTIBILITY TO, 2",
2508,154276,"MALIGNANT HYPERTHERMIA, SUSCEPTIBILITY TO, 3",
2509,154280,SUPPRESSOR OF ANCHORAGE INDEPENDENCE 1, SAI1
2510,154300,MALOCCLUSION DUE TO PROTUBERANT UPPER FRONT TEETH,
2511,154360,MALTASE-GLUCOAMYLASE, MGAM
2512,154365,"PROTEASOME 26S SUBUNIT, ATPase, 2", PSMC2
2513,154370,MAMMASTATIN,
2514,154400,"ACROFACIAL DYSOSTOSIS 1, NAGER TYPE", AFD1
2515,154500,TREACHER COLLINS SYNDROME 1, TCS1
2516,154540,"MANNOSE 6-PHOSPHATE RECEPTOR, CATION-DEPENDENT", M6PR
2517,154545,MANNOSE-BINDING LECTIN 2, MBL2
2518,154550,MANNOSEPHOSPHATE ISOMERASE, MPI
2519,154570,"MANNOSE 6-PHOSPHATE RECEPTOR RECOGNITION DEFECT, LEBANESE TYPE",
2520,154580,"MANNOSIDASE, ALPHA, CLASS 2C, MEMBER 1", MAN2C1
2521,154582,"MANNOSIDASE, ALPHA, CLASS 2A, MEMBER 1", MAN2A1
2522,154600,MARCUS GUNN PHENOMENON,
2523,154700,MARFAN SYNDROME, MFS
2524,154705,LOEYS-DIETZ SYNDROME 2,
2525,154750,MARFANOID HYPERMOBILITY SYNDROME,
2526,154780,MARSHALL SYNDROME, MRSHS
2527,154790,PROTEASE INHIBITOR 5, PI5
2528,154800,"MASTOCYTOSIS, CUTANEOUS", MASTC
2529,154850,"MASTICATORY MUSCLES, HYPERTROPHY OF",
2530,154870,MATRIX GAMMA-CARBOXYGLUTAMIC ACID, MGP
2531,154950,MAX PROTEIN, MAX
2532,155000,MAXILLOFACIAL DYSOSTOSIS,
2533,155050,"MAXILLONASAL DYSPLASIA, BINDER TYPE",
2534,155100,MACROTHROMBOCYTOPENIA AND GRANULOCYTE INCLUSIONS WITH OR WITHOUT NEPHRITIS OR SENSORINEURAL HEARING LOSS, MATINS
2535,155120,A DISINTEGRIN AND METALLOPROTEINASE DOMAIN 11, ADAM11
2536,155140,MECKEL DIVERTICULUM,
2537,155145,"CLEFT, MEDIAN, OF UPPER LIP WITH POLYPS OF FACIAL SKIN AND NASAL MUCOSA",
2538,155150,MEDIAN-ULNAR NERVE COMMUNICATIONS,
2539,155200,MEDIOSTERNAL DEPIGMENTATION LINE,
2540,155240,"THYROID CARCINOMA, FAMILIAL MEDULLARY", MTC
2541,155250,"ELASTASE, NEUTROPHIL-EXPRESSED",
2542,155255,MEDULLOBLASTOMA, MDB
2543,155310,VISCERAL MYOPATHY 1, VSCM1
2544,155350,"MEGALENCEPHALY, AUTOSOMAL DOMINANT",
2545,155500,MACRODACTYLY,
2546,155540,MELANOCORTIN 3 RECEPTOR, MC3R
2547,155541,MELANOCORTIN 4 RECEPTOR, MC4R
2548,155550,PREMELANOSOME PROTEIN, PMEL
2549,155555,MELANOCORTIN 1 RECEPTOR, MC1R
2550,155600,"MELANOMA, CUTANEOUS MALIGNANT, SUSCEPTIBILITY TO, 1", CMM1
2551,155601,"MELANOMA, CUTANEOUS MALIGNANT, SUSCEPTIBILITY TO, 2", CMM2
2552,155700,"MELANOMA, MALIGNANT FAMILIAL INTRAOCULAR",
2553,155720,"MELANOMA, UVEAL",
2554,155730,"CHEMOKINE, CXC MOTIF, LIGAND 1", CXCL1
2555,155735,MELANOMA ADHESION MOLECULE, MCAM
2556,155740,CD63 ANTIGEN, CD63
2557,155741,"MELANOMA ANTIGEN, FAMILY A, 1",
2558,155750,MELANOTRANSFERRIN, MELTF
2559,155755,MELANOMA-ASTROCYTOMA SYNDROME,
2560,155760,AGGRECAN, ACAN
2561,155770,MELANOMA TUMOR ANTIGEN GP90,
2562,155800,"HYPERPIGMENTATION WITH OR WITHOUT HYPOPIGMENTATION, FAMILIAL PROGRESSIVE",
2563,155900,MELKERSSON-ROSENTHAL SYNDROME,
2564,155950,"MELORHEOSTOSIS, ISOLATED", MEL
2565,155960,TITLE NOT AVAILABLE AT THIS MOMENT,
2566,155970,MEMBRANE GLYCOPROTEIN MRC OX-2, MOX2
2567,155975,CD79A ANTIGEN,
2568,155980,"MEMBRANOUS CRANIAL OSSIFICATION, DELAYED",
2569,156000,MENIERE DISEASE,
2570,156100,"MN1 PROTOONCOGENE, TRANSCRIPTIONAL REGULATOR", MN1
2571,156190,MENTAL AND GROWTH RETARDATION WITH AMBLYOPIA,
2572,156200,"INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 1", MRD1
2573,156220,"MERALGIA PARAESTHETICA, FAMILIAL",
2574,156225,"LAMININ, ALPHA-2", LAMA2
2575,156230,MESOMELIC DWARFISM OF HYPOPLASTIC TIBIA AND RADIUS TYPE,
2576,156232,"MESOMELIC DYSPLASIA, KANTAPUTRA TYPE", MMDK
2577,156240,"MESOTHELIOMA, MALIGNANT", MESOM
2578,156250,METACHONDROMATOSIS, METCDS
2579,156300,METACHROMASIA OF FIBROBLASTS,
2580,156310,"METACHROMATIC LEUKODYSTROPHY, ADULT-ONSET, WITH NORMAL ARYLSULFATASE A",
2581,156340,METALLOTHIONEIN 2A,
2582,156349,METALLOTHIONEIN 1B, MT1B
2583,156350,METALLOTHIONEIN 1A, MT1A
2584,156351,METALLOTHIONEIN 1E, MT1E
2585,156352,METALLOTHIONEIN 1F, MT1F
2586,156353,METALLOTHIONEIN 1G, MT1G
2587,156354,METALLOTHIONEIN 1H, MT1H
2588,156355,"METALLOTHIONEIN 1I, PSEUDOGENE", MT1IP
2589,156356,"METALLOTHIONEIN 1J, PSEUDOGENE", MT1JP
2590,156357,METALLOTHIONEIN 1K, MT1K
2591,156358,"METALLOTHIONEIN 1L, PSEUDOGENE", MT1LP
2592,156359,METALLOTHIONEIN 1X, MT1X
2593,156360,METALLOTHIONEIN 2A, MT2A
2594,156400,"METAPHYSEAL CHONDRODYSPLASIA, JANSEN TYPE", MCDJ
2595,156490,NME/NM23 NUCLEOSIDE DIPHOSPHATE KINASE 1, NME1
2596,156491,NME/NM23 NUCLEOSIDE DIPHOSPHATE KINASE 2, NME2
2597,156500,"METAPHYSEAL CHONDRODYSPLASIA, SCHMID TYPE", MCDS
2598,156510,METAPHYSEAL DYSPLASIA WITH MAXILLARY HYPOPLASIA WITH OR WITHOUT BRACHYDACTYLY, MDMHB
2599,156520,"METATARSUS VARUS, TYPE I",
2600,156530,METATROPIC DYSPLASIA, MTD
2601,156535,METHYL-CpG-BINDING DOMAIN PROTEIN 1, MBD1
2602,156536,METHYL-CpG-BINDING PROTEIN 2,
2603,156540,METHYLTHIOADENOSINE PHOSPHORYLASE, MTAP
2604,156550,KNIEST DYSPLASIA,
2605,156560,METHIONYL-tRNA SYNTHETASE 1, MARS1
2606,156565,N-METHYLPURINE DNA GLYCOSYLASE, MPG
2607,156569,METHYLGUANINE-DNA METHYLTRANSFERASE, MGMT
2608,156570,5-METHYLTETRAHYDROFOLATE-HOMOCYSTEINE S-METHYLTRANSFERASE, MTR
2609,156575,"SOLUTE CARRIER FAMILY 16 (MONOCARBOXYLIC ACID TRANSPORTER), MEMBER 1",
2610,156580,"MICROCEPHALY, AUTOSOMAL DOMINANT",
2611,156590,"MICROCEPHALY WITH OR WITHOUT CHORIORETINOPATHY, LYMPHEDEMA, OR IMPAIRED INTELLECTUAL DEVELOPMENT",
2612,156600,"MICROCORIA, CONGENITAL",
2613,156610,"SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 1", CSCSC1
2614,156620,MICROCEPHALY-DEAFNESS SYNDROME,
2615,156700,"MICROCORNEA, GLAUCOMA, AND ABSENT FRONTAL SINUSES",
2616,156790,MICROFIBRILLAR-ASSOCIATED PROTEIN 2, MFAP2
2617,156810,MICROGASTRIA-LIMB REDUCTION DEFECTS ASSOCIATION, MLRD
2618,156830,MICROMELIC BONE DYSPLASIA WITH CLOVERLEAF SKULL,
2619,156845,MICROPHTHALMIA-ASSOCIATED TRANSCRIPTION FACTOR, MITF
2620,156850,"MICROPHTHALMIA, ISOLATED, WITH CATARACT 1", MCOPCT1
2621,156900,"MICROPHTHALMIA, ISOLATED, WITH CORECTOPIA", MCOPCR
2622,157100,VITREORETINOCHOROIDOPATHY,
2623,157129,MICROTUBULE-ASSOCIATED PROTEIN 1B, MAP1B
2624,157130,MICROTUBULE-ASSOCIATED PROTEIN 2, MAP2
2625,157132,MICROTUBULE-ASSOCIATED PROTEIN 4, MAP4
2626,157140,MICROTUBULE-ASSOCIATED PROTEIN TAU, MAPT
2627,157145,"MICROSEMINOPROTEIN, BETA", MSMB
2628,157147,MICROSOMAL TRIGLYCERIDE TRANSFER PROTEIN, MTTP
2629,157150,MICROSPHEROPHAKIA WITH HERNIA,
2630,157151,MICROSPHEROPHAKIA-METAPHYSEAL DYSPLASIA,
2631,157160,MICROTUBULE-ASSOCIATED PROTEIN TAU,
2632,157170,HOLOPROSENCEPHALY 2, HPE2
2633,157200,MIDPHALANGEAL HAIR,
2634,157300,"MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 1",
2635,157400,"MILIA, MULTIPLE ERUPTIVE", MEM
2636,157500,PROGESTAGEN-ASSOCIATED ENDOMETRIAL PROTEIN,
2637,157550,"CONGENITAL MYOPATHY 1A, AUTOSOMAL DOMINANT, WITH SUSCEPTIBILITY TO MALIGNANT HYPERTHERMIA",
2638,157560,MINISATELLITE 33.6,
2639,157570,MINISATELLITE 33.15,
2640,157600,MIRROR MOVEMENTS 1, MRMV1
2641,157640,"PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 1", PEOA1
2642,157650,MITOCHONDRIAL MYOPATHY WITH DIABETES,
2643,157655,NADH-UBIQUINONE OXIDOREDUCTASE Fe-S PROTEIN 1, NDUFS1
2644,157660,"MITOCHONDRIAL RNA-PROCESSING ENDORIBONUCLEASE, RNA COMPONENT OF", RMRP
2645,157670,"TRANSCRIPTION FACTOR A, MITOCHONDRIAL",
2646,157680,CELL DIVISION CYCLE 25C, CDC25C
2647,157700,MITRAL VALVE PROLAPSE 1, MVP1
2648,157800,CARDIOSPONDYLOCARPOFACIAL SYNDROME, CSCF
2649,157860,"MAJOR HISTOCOMPATIBILITY COMPLEX, CLASS II, DR ALPHA",
2650,157900,MOEBIUS SYNDROME, MBS
2651,157910,MOEBIUS SYNDROME,
2652,157920,MOESIN,
2653,157950,"PERMANENT MOLARS, SECONDARY RETENTION OF",
2654,157960,"MOLONEY LEUKEMIA VIRUS INTEGRATION SITE 2, MOUSE, HOMOLOG OF", MLVI2
2655,157970,"PROTEASOME 26S SUBUNIT, NON-ATPase, 7", PSMD7
2656,157975,"PHOSPHOLIPASE A2, GROUP IIA",
2657,157980,MOMO SYNDROME,
2658,158000,MONILETHRIX, MNLIX
2659,158020,"SOLUTE CARRIER FAMILY 7 (CATIONIC AMINO ACID TRANSPORTER, y+ SYSTEM), MEMBER 5",
2660,158030,ANTIGEN DEFINED BY MONOCLONAL ANTIBODY AJ9,
2661,158040,ANTIGEN DEFINED BY MONOCLONAL ANTIBODY T87,
2662,158050,MONKEY RED BLOOD CELL RECEPTOR, MRBC
2663,158070,"SOLUTE CARRIER FAMILY 3 (ACTIVATOR OF DIBASIC AND NEUTRAL AMINO ACID TRANSPORT), MEMBER 2", SLC3A2
2664,158100,MONOPHALANGY OF GREAT TOE,
2665,158105,"CHEMOKINE, CC MOTIF, LIGAND 2", CCL2
2666,158106,"CHEMOKINE, CC MOTIF, LIGAND 7", CCL7
2667,158120,MONOCYTE DIFFERENTIATION ANTIGEN CD14, CD14
2668,158130,"CHEMOKINE, CC MOTIF, LIGAND 2",
2669,158150,PHOSPHOGLYCERATE MUTASE 1,
2670,158170,CHROMOSOME 9p DELETION SYNDROME,
2671,158250,NONDISJUNCTION,
2672,158270,MOTILIN, MLN
2673,158280,MOTION SICKNESS,
2674,158300,"ARTHROGRYPOSIS, DISTAL, TYPE 7", DA7
2675,158310,"MUCOEPITHELIAL DYSPLASIA, HEREDITARY", HMD
2676,158320,MUIR-TORRE SYNDROME, MRTES
2677,158330,MULLERIAN APLASIA AND HYPERANDROGENISM,
2678,158340,"MUCIN 1, CELL SURFACE ASSOCIATED", MUC1
2679,158343,"ATP-BINDING CASSETTE, SUBFAMILY C, MEMBER 1", ABCC1
2680,158345,MULTIPLE EXOSTOSES WITH SPASTIC TETRAPARESIS,
2681,158350,COWDEN SYNDROME 1, CWS1
2682,158370,"MUCIN 2, INTESTINAL", MUC2
2683,158371,"MUCIN 3A, INTESTINAL", MUC3A
2684,158372,"MUCIN 4, TRACHEOBRONCHIAL", MUC4
2685,158373,"MUCIN 5, SUBTYPES A AND C, TRACHEOBRONCHIAL", MUC5AC
2686,158374,"MUCIN 6, GASTRIC", MUC6
2687,158375,"MUCIN 7, SALIVARY", MUC7
2688,158378,"SOLUTE CARRIER FAMILY 20 (PHOSPHATE TRANSPORTER), MEMBER 2", SLC20A2
2689,158380,ECOTROPIC VIRAL INTEGRATION SITE 2A, EVI2A
2690,158381,ECOTROPIC VIRAL INTEGRATION SITE 2B, EVI2B
2691,158400,"MUSCLE CRAMPS, FAMILIAL",
2692,158500,"MUSCULAR ATROPHY, ATAXIA, RETINITIS PIGMENTOSA, AND DIABETES MELLITUS",
2693,158580,"NEURONOPATHY, DISTAL HEREDITARY MOTOR, AUTOSOMAL DOMINANT 7", HMND7
2694,158590,"NEURONOPATHY, DISTAL HEREDITARY MOTOR, AUTOSOMAL DOMINANT 2", HMND2
2695,158600,"SPINAL MUSCULAR ATROPHY, LOWER EXTREMITY-PREDOMINANT, 1, AUTOSOMAL DOMINANT", SMALED1
2696,158650,"MUSCULAR ATROPHY, MALIGNANT NEUROGENIC",
2697,158700,AMYOTROPHIC LATERAL SCLEROSIS 1,
2698,158800,"MUSCULAR DYSTROPHY, BARNES TYPE",
2699,158810,BETHLEM MYOPATHY 1A, BTHLM1A
2700,158900,FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY 1, FSHD1
2701,158901,"FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY 2, DIGENIC", FSHD2
2702,159000,"MYOPATHY, MYOFIBRILLAR, 3",
2703,159001,"EMERY-DREIFUSS MUSCULAR DYSTROPHY 2, AUTOSOMAL DOMINANT",
2704,159050,"MUSCULAR DYSTROPHY, PSEUDOHYPERTROPHIC, WITH INTERNALIZED CAPILLARIES",
2705,159100,"MUSCULAR HYPOPLASIA, CONGENITAL UNIVERSAL, OF KRABBE",
2706,159300,MUSICAL PERFECT PITCH,
2707,159350,MCC REGULATOR OF WNT SIGNALING PATHWAY, MCC
2708,159400,"MYASTHENIA, LIMB-GIRDLE, AUTOIMMUNE",
2709,159405,MYB PROTOONCOGENE LIKE 1, MYBL1
2710,159410,MYDRIATIC RESPONSE TO PHARMACOLOGIC AGENTS,
2711,159420,"MYDRIASIS, CONGENITAL",
2712,159430,MYELIN BASIC PROTEIN, MBP
2713,159440,MYELIN PROTEIN ZERO, MPZ
2714,159455,PERIPHERAL MYELIN PROTEIN 2,
2715,159460,MYELIN-ASSOCIATED GLYCOPROTEIN, MAG
2716,159465,MYELIN-OLIGODENDROCYTE GLYCOPROTEIN, MOG
2717,159500,MYELINATED OPTIC NERVE FIBERS,
2718,159530,"MPL PROTOONCOGENE, THROMBOPOIETIN RECEPTOR", MPL
2719,159540,LEUKEMIA-INHIBITORY FACTOR, LIF
2720,159550,ATAXIA-PANCYTOPENIA SYNDROME, ATXPC
2721,159552,MYELOID CELL LEUKEMIA SEQUENCE 1, MCL1
2722,159553,MYELOID CELL NUCLEAR DIFFERENTIATION ANTIGEN, MNDA
2723,159555,LYSINE-SPECIFIC METHYLTRANSFERASE 2A, KMT2A
2724,159556,MLLT1 SUPER ELONGATION COMPLEX SUBUNIT, MLLT1
2725,159557,ALF TRANSCRIPTION ELONGATION FACTOR 1, AFF1
2726,159558,MLLT3 SUPER ELONGATION COMPLEX SUBUNIT, MLLT3
2727,159559,AFADIN, AFDN
2728,159580,"MYELOPATHY, HTLV-1-ASSOCIATED", HAM
2729,159590,CD33 ANTIGEN, CD33
2730,159595,"MYELOPROLIFERATIVE SYNDROME, TRANSIENT",
2731,159600,"MYOCLONIC EPILEPSY, HARTUNG TYPE",
2732,159700,DYSSYNERGIA CEREBELLARIS MYOCLONICA OF HUNT,
2733,159800,"MYOCLONUS, CEREBELLAR ATAXIA, AND DEAFNESS",
2734,159900,"DYSTONIA 11, MYOCLONIC", DYT11
2735,159950,SPINAL MUSCULAR ATROPHY WITH PROGRESSIVE MYOCLONIC EPILEPSY, SMAPME
2736,159970,MYOGENIC DIFFERENTIATION ANTIGEN 1, MYOD1
2737,159980,MYOGENIN, MYOG
2738,159990,MYOGENIC FACTOR 5, MYF5
2739,159991,MYOGENIC FACTOR 6, MYF6
2740,160000,MYOGLOBIN, MB
2741,160010,"MYOGLOBINURIA, AUTOSOMAL DOMINANT",
2742,160100,"EPISODIC ATAXIA, TYPE 1",
2743,160120,"EPISODIC ATAXIA, TYPE 1", EA1
2744,160150,"MYOPATHY, CENTRONUCLEAR, 1", CNM1
2745,160200,"CONGENITAL MYOPATHY 2A, TYPICAL, AUTOSOMAL DOMINANT",
2746,160300,"MYOPATHY, DISTAL, INFANTILE-ONSET",
2747,160500,"MYOPATHY, DISTAL, 1", MPD1
2748,160550,"PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 1",
2749,160565,"MYOPATHY, TUBULAR AGGREGATE, 1", TAM1
2750,160570,MYOPATHY WITH STORAGE OF GLYCOPROTEINS AND GLYCOSAMINOGLYCANS,
2751,160700,"MYOPIA 2, AUTOSOMAL DOMINANT", MYP2
2752,160710,"MYOSIN, HEAVY CHAIN 6, CARDIAC MUSCLE, ALPHA", MYH6
2753,160720,"MYOSIN, HEAVY CHAIN 3, SKELETAL MUSCLE, EMBRYONIC", MYH3
2754,160730,"MYOSIN, HEAVY CHAIN 1, SKELETAL MUSCLE, ADULT", MYH1
2755,160740,"MYOSIN, HEAVY CHAIN 2, SKELETAL MUSCLE, ADULT", MYH2
2756,160741,"MYOSIN, HEAVY CHAIN 8, SKELETAL MUSCLE, PERINATAL", MYH8
2757,160742,"MYOSIN, HEAVY CHAIN 4, SKELETAL MUSCLE", MYH4
2758,160745,"MYOSIN, HEAVY CHAIN 11, SMOOTH MUSCLE", MYH11
2759,160750,MYOSITIS,
2760,160760,"MYOSIN, HEAVY CHAIN 7, CARDIAC MUSCLE, BETA", MYH7
2761,160770,"MYOSIN, LIGHT CHAIN 4, ALKALI, ATRIAL, EMBRYONIC", MYL4
2762,160775,"MYOSIN, HEAVY CHAIN 9, NONMUSCLE", MYH9
2763,160776,"MYOSIN, HEAVY CHAIN 10, NONMUSCLE", MYH10
2764,160777,MYOSIN VA, MYO5A
2765,160780,"MYOSIN, LIGHT POLYPEPTIDE 1, ALKALI, SKELETAL, FAST", MYL1
2766,160781,"MYOSIN, LIGHT CHAIN 2, REGULATORY, CARDIAC, SLOW", MYL2
2767,160782,"MYOSIN, LIGHT CHAIN 5, REGULATORY", MYL5
2768,160790,"MYOSIN, LIGHT CHAIN 3, ALKALI, VENTRICULAR, SKELETAL, SLOW", MYL3
2769,160793,"MYOSIN-BINDING PROTEIN C, FAST TYPE", MYBPC2
2770,160794,"MYOSIN-BINDING PROTEIN C, SLOW TYPE", MYBPC1
2771,160795,MYOSIN-BINDING PROTEIN H, MYBPH
2772,160800,"MYOTONIA CONGENITA, AUTOSOMAL DOMINANT",
2773,160900,MYOTONIC DYSTROPHY 1, DM1
2774,160980,"CARNEY COMPLEX, TYPE 1", CNC1
2775,160990,MYOTONIC MYOPATHY WITH CYLINDRICAL SPIRALS,
2776,160993,N-MYRISTOYLTRANSFERASE 1, NMT1
2777,160994,HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN M, HNRNPM
2778,160995,"ALPHA-1,3-MANNOSYL-GLYCOPROTEIN BETA-1,2-N-ACETYLGLUCOSAMINYLTRANSFERASE", MGAT1
2779,160998,"NAD(P)H DEHYDROGENASE, QUINONE 2", NQO2
2780,161000,NAEGELI-FRANCESCHETTI-JADASSOHN SYNDROME, NFJS
2781,161015,NADH-UBIQUINONE OXIDOREDUCTASE FLAVOPROTEIN 1, NDUFV1
2782,161050,"NAIL DISORDER, NONSYNDROMIC CONGENITAL, 1", NDNC1
2783,161070,NAIL HIGH-SULFUR PROTEIN,
2784,161080,NAIL LOW-SULFUR PROTEIN,
2785,161100,"NAILBEDS, PIGMENTATION OF",
2786,161200,NAIL-PATELLA SYNDROME, NPS
2787,161400,NARCOLEPSY 1, NRCLP1
2788,161470,"NASAL ALAR COLLAPSE, BILATERAL",
2789,161480,"NASAL BONES, ABSENCE OF",
2790,161500,"NASAL GROOVE, FAMILIAL TRANSVERSE",
2791,161530,"NASAL HYPERPIGMENTATION, FAMILIAL TRANSVERSE",
2792,161550,"NASOPHARYNGEAL CARCINOMA, SUSCEPTIBILITY TO, 2", NPCA2
2793,161555,"KILLER CELL LECTIN-LIKE RECEPTOR, SUBFAMILY C, MEMBER 1", KLRC1
2794,161560,INTERLEUKIN 12A, IL12A
2795,161561,INTERLEUKIN 12B, IL12B
2796,161565,NATURAL KILLER CELL TRIGGERING RECEPTOR, NKTR
2797,161600,"NAVICULAR BONE, ACCESSORY",
2798,161650,NEBULIN, NEB
2799,161700,"NECROTIZING ENCEPHALOMYELOPATHY, SUBACUTE, OF LEIGH, ADULT",
2800,161800,"CONGENITAL MYOPATHY 2A, TYPICAL, AUTOSOMAL DOMINANT", CMYO2A
2801,161900,"RENAL FAILURE, PROGRESSIVE, WITH HYPERTENSION", RFH1
2802,161950,"IgA NEPHROPATHY, SUSCEPTIBILITY TO, 1", IGAN1
2803,162000,"TUBULOINTERSTITIAL KIDNEY DISEASE, AUTOSOMAL DOMINANT 1", ADTKD1
2804,162010,NERVE GROWTH FACTOR RECEPTOR, NGFR
2805,162020,KALLIKREIN 1,
2806,162030,NERVE GROWTH FACTOR, NGF
2807,162040,KALLIKREIN-RELATED PEPTIDASE 2,
2808,162060,GROWTH-ASSOCIATED PROTEIN 43, GAP43
2809,162080,NEURAL RETINA LEUCINE ZIPPER, NRL
2810,162091,SCHWANNOMATOSIS 1, SWN1
2811,162095,PLEIOTROPHIN, PTN
2812,162096,MIDKINE, MDK
2813,162100,"AMYOTROPHY, HEREDITARY NEURALGIC", HNA
2814,162150,"PROPROTEIN CONVERTASE, SUBTILISIN/KEXIN-TYPE, 1", PCSK1
2815,162151,"PROPROTEIN CONVERTASE, SUBTILISIN/KEXIN-TYPE, 2", PCSK2
2816,162200,"NEUROFIBROMATOSIS, TYPE I", NF1
2817,162210,"NEUROFIBROMATOSIS, FAMILIAL SPINAL",
2818,162220,"NEUROFIBROMATOSIS, TYPE I",
2819,162230,"NEUROFILAMENT PROTEIN, HEAVY POLYPEPTIDE", NEFH
2820,162240,NEUROFIBROMATOSIS-PHEOCHROMOCYTOMA-DUODENAL CARCINOID SYNDROME,
2821,162250,"NEUROFILAMENT PROTEIN, MEDIUM POLYPEPTIDE", NEFM
2822,162260,"NEUROFIBROMATOSIS, TYPE III, MIXED CENTRAL AND PERIPHERAL", NF3A
2823,162270,"NEUROFIBROMATOSIS, TYPE IV, OF RICCARDI", NF4
2824,162280,"NEUROFILAMENT PROTEIN, LIGHT POLYPEPTIDE", NEFL
2825,162300,"MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIB", MEN2B
2826,162320,TACHYKININ 1, TAC1
2827,162321,TACHYKININ RECEPTOR 2, TACR2
2828,162323,TACHYKININ RECEPTOR 1, TACR1
2829,162330,TACHYKININ 3, TAC3
2830,162332,TACHYKININ RECEPTOR 3, TACR3
2831,162340,NEUROMEDIN B, NMB
2832,162341,NEUROMEDIN B RECEPTOR, NMBR
2833,162350,"CEROID LIPOFUSCINOSIS, NEURONAL, 4 (KUFS TYPE)", CLN4
2834,162360,NESCIENT HELIX LOOP HELIX 1, NHLH1
2835,162361,NESCIENT HELIX LOOP HELIX 2, NHLH2
2836,162370,"NEUROPATHY, CONGENITAL, WITH ARTHROGRYPOSIS MULTIPLEX",
2837,162375,"CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1B",
2838,162380,"NEUROPATHY, HEREDITARY SENSORIMOTOR, WITH UPPER MOTOR NEURON, VISUAL PATHWAY AND AUTONOMIC DISTURBANCE",
2839,162400,"NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE IA", HSAN1A
2840,162500,"NEUROPATHY, HEREDITARY, WITH LIABILITY TO PRESSURE PALSIES", HNPP
2841,162600,"NEUROPATHY, WITH PARAPROTEIN IN SERUM, CEREBROSPINAL FLUID AND URINE",
2842,162640,NEUROPEPTIDE Y, NPY
2843,162641,NEUROPEPTIDE Y RECEPTOR Y1, NPY1R
2844,162642,NEUROPEPTIDE Y RECEPTOR Y2, NPY2R
2845,162643,"CHEMOKINE, CXC MOTIF, RECEPTOR 4", CXCR4
2846,162650,NEUROTENSIN, NTS
2847,162651,NEUROTENSIN RECEPTOR 1, NTSR1
2848,162660,NEUROTROPHIN 3, NTF3
2849,162661,NEUROTROPHIN 4,
2850,162662,NEUROTROPHIN 4, NTF4
2851,162700,"NEUTROPENIA, CHRONIC FAMILIAL",
2852,162800,CYCLIC NEUTROPENIA,
2853,162815,NEUTROPHIL AZUROCIDIN, NAZC
2854,162820,"HYPER-IgE SYNDROME 1, AUTOSOMAL DOMINANT, WITH RECURRENT INFECTIONS",
2855,162830,"NEUTROPHILIA, HEREDITARY",
2856,162860,CD177 ANTIGEN, CD177
2857,162870,Fc FRAGMENT OF IgG RECEPTOR IIIa,
2858,162880,NEUTROPHIL-SPECIFIC ANTIGEN: ND1,
2859,162890,NEUTROPHIL-SPECIFIC ANTIGEN: NE1,
2860,162900,"NEVUS, EPIDERMAL",
2861,163000,"CAPILLARY MALFORMATIONS, CONGENITAL", CMC
2862,163050,NEVUS ANEMICUS,
2863,163100,NEVUS FLAMMEUS OF NAPE OF NECK,
2864,163200,SCHIMMELPENNING-FEUERSTEIN-MIMS SYNDROME, SFM
2865,163260,NUCLEAR FACTOR ERYTHROID 2-LIKE 1, NFE2L1
2866,163400,NIEVERGELT SYNDROME,
2867,163500,"NIGHT BLINDNESS, CONGENITAL STATIONARY, AUTOSOMAL DOMINANT 2", CSNBAD2
2868,163600,NIPPLES INVERTED,
2869,163700,"NIPPLES, SUPERNUMERARY",
2870,163728,NITRIC OXIDE SYNTHASE 2,
2871,163729,NITRIC OXIDE SYNTHASE 3, NOS3
2872,163730,NITRIC OXIDE SYNTHASE 2, NOS2
2873,163731,NITRIC OXIDE SYNTHASE 1, NOS1
2874,163800,SICK SINUS SYNDROME 2, SSS2
2875,163850,"NODULI CUTANEI, MULTIPLE, WITH URINARY TRACT ABNORMALITIES",
2876,163890,"SYNUCLEIN, ALPHA", SNCA
2877,163900,TITLE NOT AVAILABLE AT THIS MOMENT,
2878,163905,HIGH MOBILITY GROUP BOX 1, HMGB1
2879,163906,HIGH MOBILITY GROUP BOX 2, HMGB2
2880,163910,HIGH MOBILITY GROUP NUCLEOSOMAL BINDING PROTEIN 2, HMGN2
2881,163920,HIGH MOBILITY GROUP NUCLEOSOMAL BINDING PROTEIN 1, HMGN1
2882,163950,NOONAN SYNDROME 1, NS1
2883,163955,NOONAN SYNDROME 1,
2884,163970,"SOLUTE CARRIER FAMILY 6 (NEUROTRANSMITTER TRANSPORTER, NORADRENALINE), MEMBER 2", SLC6A2
2885,163980,CEA CELL ADHESION MOLECULE 6, CEACAM6
2886,164000,"NOSE, ANOMALOUS SHAPE OF",
2887,164005,NUCLEAR FACTOR I/X, NFIX
2888,164008,"NUCLEAR FACTOR KAPPA-B INHIBITOR, ALPHA", NFKBIA
2889,164009,NUCLEAR MITOTIC APPARATUS PROTEIN 1, NUMA1
2890,164010,CHARGED MULTIVESICULAR BODY PROTEIN 1A, CHMP1A
2891,164011,"NUCLEAR FACTOR KAPPA-B, SUBUNIT 1", NFKB1
2892,164012,"NUCLEAR FACTOR KAPPA-B, SUBUNIT 2", NFKB2
2893,164013,NUCLEAR FACTOR RELATED TO KAPPA-B BINDING PROTEIN, NFRKB
2894,164014,"RELA PROTOONCOGENE, NFKB SUBUNIT", RELA
2895,164015,MATRIN 3, MATR3
2896,164016,"NUCLEAR FACTOR OF ACTIVATED T CELLS, CYTOPLASMIC, CALCINEURIN-DEPENDENT 1",
2897,164017,HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN A1, HNRNPA1
2898,164018,HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN A2/B1,
2899,164019,HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN A2/B1,
2900,164020,HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN C, HNRNPC
2901,164021,HETEROGENEOUS NUCLEAR RIBOPROTEIN L,
2902,164022,"RNA-BINDING MOTIF PROTEIN, X CHROMOSOME",
2903,164031,NUCLEOLAR PROTEIN NOP2, NOP2
2904,164035,NUCLEOLIN, NCL
2905,164040,"NUCLEOPHOSMIN/NUCLEOPLASMIN FAMILY, MEMBER 1", NPM1
2906,164050,PURINE NUCLEOSIDE PHOSPHORYLASE, PNP
2907,164060,NUCLEOSOME ASSEMBLY PROTEIN 1-LIKE 1, NAP1L1
2908,164100,"NYSTAGMUS 2, CONGENITAL, AUTOSOMAL DOMINANT", NYS2
2909,164150,"NYSTAGMUS, HEREDITARY VERTICAL",
2910,164160,LEPTIN, LEP
2911,164170,"NYSTAGMUS, VOLUNTARY",
2912,164175,"POU DOMAIN, CLASS 2, TRANSCRIPTION FACTOR 1", POU2F1
2913,164176,"POU DOMAIN, CLASS 2, TRANSCRIPTION FACTOR 2", POU2F2
2914,164177,"POU DOMAIN, CLASS 5, TRANSCRIPTION FACTOR 1", POU5F1
2915,164180,OCULOCEREBROCUTANEOUS SYNDROME,
2916,164185,OCULAR CICATRICIAL PEMPHIGOID, OCP
2917,164190,OCULAR DOMINANCE,
2918,164200,OCULODENTODIGITAL DYSPLASIA, ODDD
2919,164210,CRANIOFACIAL MICROSOMIA 1, CFM1
2920,164220,SCHILBACH-ROTT SYNDROME, SBRS
2921,164230,OBSESSIVE-COMPULSIVE DISORDER, OCD
2922,164280,FEINGOLD SYNDROME 1, FGLDS1
2923,164300,OCULOPHARYNGEAL MUSCULAR DYSTROPHY 1, OPMD1
2924,164310,OCULOPHARYNGODISTAL MYOPATHY 1, OPDM1
2925,164320,ODORANT-BINDING PROTEIN 2A, OBP2A
2926,164330,ODONTOMA-DYSPHAGIA SYNDROME,
2927,164340,OLFACTORY MARKER PROTEIN, OMP
2928,164342,"OLFACTORY RECEPTOR, FAMILY 1, SUBFAMILY D, MEMBER 2", OR1D2
2929,164343,EARLY B-CELL FACTOR 1, EBF1
2930,164345,OLIGODENDROCYTE-MYELIN GLYCOPROTEIN, OMG
2931,164350,"2-PRIME,5-PRIME-OLIGOADENYLATE SYNTHETASE 1", OAS1
2932,164360,"ATP SYNTHASE F1, SUBUNIT ALPHA", ATP5F1A
2933,164400,SPINOCEREBELLAR ATAXIA 1, SCA1
2934,164500,SPINOCEREBELLAR ATAXIA 7, SCA7
2935,164600,SPINOCEREBELLAR ATAXIA 1,
2936,164680,"ONYCHOGRYPOSIS, PEDAL, WITH KERATOSIS PLANTARIS AND COARSE HAIR",
2937,164690,"ABL PROTOONCOGENE 2, NONRECEPTOR TYROSINE KINASE", ABL2
2938,164700,SPINOCEREBELLAR ATAXIA 17,
2939,164710,TITLE NOT AVAILABLE AT THIS MOMENT,
2940,164720,"ETS PROTOONCOGENE 1, TRANSCRIPTION FACTOR", ETS1
2941,164730,AKT SERINE/THREONINE KINASE 1, AKT1
2942,164731,AKT SERINE/THREONINE KINASE 2, AKT2
2943,164740,"ETS PROTOONCOGENE 2, TRANSCRIPTION FACTOR", ETS2
2944,164745,OMODYSPLASIA 2, OMOD2
2945,164750,"OMPHALOCELE, AUTOSOMAL",
2946,164755,VIRAL INTEGRATION SITE 1, VIS1
2947,164756,VIRAL INTEGRATION SITE 1,
2948,164757,"B-RAF PROTOONCOGENE, SERINE/THREONINE KINASE", BRAF
2949,164759,OVARIAN CANCER,
2950,164760,"RAF1 PROTOONCOGENE, SERINE/THREONINE KINASE ", RAF1
2951,164761,RET PROTOONCOGENE, RET
2952,164762,"CRK PROTOONCOGENE, ADAPTOR PROTEIN", CRK
2953,164765,CORTACTIN, CTTN
2954,164770,COLONY-STIMULATING FACTOR 1 RECEPTOR, CSF1R
2955,164772,"FOSB PROTOONCOGENE, AP1 TRANSCRIPTION FACTOR SUBUNIT", FOSB
2956,164780,SKI PROTOONCOGENE, SKI
2957,164785,MDM2 PROTOONCOGENE, MDM2
2958,164790,"NRAS PROTOONCOGENE, GTPase", NRAS
2959,164795,ONCOMODULIN, OCM
2960,164800,"NAIL DISORDER, NONSYNDROMIC CONGENITAL, 5", NDNC5
2961,164810,"FOS PROTOONCOGENE, AP1 TRANSCRIPTION FACTOR SUBUNIT", FOS
2962,164820,"WINGLESS-TYPE MMTV INTEGRATION SITE FAMILY, MEMBER 1", WNT1
2963,164830,TITLE NOT AVAILABLE AT THIS MOMENT,
2964,164831,"BMI1 PROTOONCOGENE, POLYCOMB RING FINGER", BMI1
2965,164840,"MYCN PROTOONCOGENE, bHLH TRANSCRIPTION FACTOR", MYCN
2966,164850,"MYCL PROTOONCOGENE, bHLH TRANSCRIPTION FACTOR", MYCL
2967,164860,"MET PROTOONCOGENE, RECEPTOR TYROSINE KINASE", MET
2968,164865,V-MYC AVIAN MYELOCYTOMATOSIS VIRAL ONCOGENE HOMOLOG-LIKE 1, MYCLK1
2969,164870,ERB-B2 RECEPTOR TYROSINE KINASE 2, ERBB2
2970,164873,ETS VARIANT TRANSCRIPTION FACTOR 3, ETV3
2971,164874,FORKHEAD BOX G1, FOXG1
2972,164875,VAV GUANINE NUCLEOTIDE EXCHANGE FACTOR 1, VAV1
2973,164880,V-YES-1 YAMAGUCHI SARCOMA VIRAL ONCOGENE, YES1
2974,164891,"B-RAF PROTOONCOGENE, SERINE/THREONINE KINASE",
2975,164900,OPHTHALMOMANDIBULOMELIC DYSPLASIA,
2976,164905,DEAD-BOX HELICASE 6,
2977,164910,"REL PROTOONCOGENE, NF-KAPPA-B SUBUNIT", REL
2978,164920,"KIT PROTOONCOGENE, RECEPTOR TYROSINE KINASE", KIT
2979,164940,"FGR PROTOONCOGENE, SRC FAMILY TYROSINE KINASE", FGR
2980,164950,FIBROBLAST GROWTH FACTOR 3, FGF3
2981,164951,NOTCH RECEPTOR 4, NOTCH4
2982,164953,ONCOGENE LIPOSARCOMA, LPSA
2983,164958,CELLULAR COMMUNICATION NETWORK FACTOR 3, CCN3
2984,164960,ONCOGENE PIM 1, PIM1
2985,164970,"NEUROTROPHIC TYROSINE KINASE, RECEPTOR, TYPE 1",
2986,164975,"WINGLESS-TYPE MMTV INTEGRATION SITE FAMILY, MEMBER 5A", WNT5A
2987,164980,FIBROBLAST GROWTH FACTOR 4, FGF4
2988,165000,"OPHTHALMOPLEGIA, FAMILIAL STATIC",
2989,165010,TITLE NOT AVAILABLE AT THIS MOMENT,
2990,165020,"ROS PROTOONCOGENE 1, RECEPTOR TYROSINE KINASE", ROS1
2991,165040,RAS-ASSOCIATED PROTEIN RAB8A, RAB8A
2992,165060,tRNA SELENOCYSTEINE (ANTICODON TCA) 1-1, TRU-TCA1-1
2993,165070,FMS-RELATED TYROSINE KINASE 1, FLT1
2994,165080,ETS TRANSCRIPTION FACTOR ERG, ERG
2995,165090,RELATED RAS VIRAL ONCOGENE HOMOLOG, RRAS
2996,165095,ONCOSTATIN M, OSM
2997,165098,"OPHTHALMOPLEGIA, FAMILIAL TOTAL, WITH IRIS TRANSILLUMINATION",
2998,165110,S13 AVIAN ERYTHROBLASTOSIS ONCOGENE HOMOLOG, SEA
2999,165120,"LYN PROTOONCOGENE, SRC FAMILY TYROSINE KINASE", LYN
3000,165140,ONCOGENE PVT1, PVT1
3001,165150,"OPHTHALMOPLEGIA, PROGRESSIVE, WITH SCROTAL TONGUE AND MENTAL DEFICIENCY",
3002,165160,"JUN PROTOONCOGENE, AP-1 TRANSCRIPTION FACTOR SUBUNIT", JUN
3003,165161,ONCOGENE JUN-B, JUNB
3004,165162,ONCOGENE JUN-D, JUND
3005,165170,SPI1 PROTOONCOGENE, SPI1
3006,165180,MAS1 ONCOGENE, MAS1
3007,165190,FIBROBLAST GROWTH FACTOR 5, FGF5
3008,165195,"OPIOID RECEPTOR, DELTA-1", OPRD1
3009,165196,"OPIOID RECEPTOR, KAPPA-1", OPRK1
3010,165199,"OPTIC ATROPHY, HEARING LOSS, AND PERIPHERAL NEUROPATHY, AUTOSOMAL DOMINANT",
3011,165200,OPTIC ATROPHY WITH DEMYELINATING DISEASE OF CNS,
3012,165210,ONCOGENE BMYC, BMYC
3013,165215,MDS1 AND EVI1 COMPLEX LOCUS, MECOM
3014,165220,GLI FAMILY ZINC FINGER 1, GLI1
3015,165230,GLI-KRUPPEL FAMILY MEMBER 2, GLI2
3016,165240,GLI-KRUPPEL FAMILY MEMBER 3, GLI3
3017,165250,ZINC FINGER PROTEIN 875, ZNF875
3018,165260,ZINC FINGER- AND SCAN DOMAIN-CONTAINING PROTEIN 22, ZSCAN22
3019,165270,ZINC FINGER- AND BTB DOMAIN-CONTAINING PROTEIN 48, ZBTB48
3020,165280,GLI-KRUPPEL FAMILY MEMBER 4, GLI4
3021,165290,ONCOGENE RMYC, RMYC
3022,165300,"OPTIC ATROPHY 3, AUTOSOMAL DOMINANT", OPA3
3023,165320,LIVER CANCER ONCOGENE, LCO
3024,165330,"WINGLESS-TYPE MMTV INTEGRATION SITE FAMILY, MEMBER 3", WNT3
3025,165340,SKI-LIKE, SKIL
3026,165350,"ELK1, MEMBER OF ETS ONCOGENE FAMILY",
3027,165360,CBL PROTOONCOGENE, CBL
3028,165370,"RAS HOMOLOG GENE FAMILY, MEMBER B", RHOB
3029,165380,"RAS HOMOLOG GENE FAMILY, MEMBER C", RHOC
3030,165390,"RAS HOMOLOG GENE FAMILY, MEMBER A", RHOA
3031,165490,OPTIC ATROPHY 1,
3032,165500,OPTIC ATROPHY 1, OPA1
3033,165510,OPTIC ATROPHY 13 WITH RETINAL AND FOVEAL ABNORMALITIES, OPA13
3034,165550,"OPTIC NERVE HYPOPLASIA, BILATERAL",
3035,165590,OROFACIODIGITAL SYNDROME X, OFD10
3036,165600,"ORBITAL MARGIN, HYPOPLASIA OF",
3037,165630,SCHIMMELPENNING-FEUERSTEIN-MIMS SYNDROME,
3038,165635,GYRATE ATROPHY OF CHOROID AND RETINA,
3039,165640,ORNITHINE DECARBOXYLASE 1, ODC1
3040,165650,ORNITHINE DECARBOXYLASE 1,
3041,165660,OSLAM SYNDROME,
3042,165670,OSSIFIED EAR CARTILAGES,
3043,165680,"OSSICULAR MALFORMATIONS, FAMILIAL",
3044,165700,THIEMANN DISEASE,
3045,165720,OSTEOARTHRITIS SUSCEPTIBILITY 1, OS1
3046,165800,SHORT STATURE AND ADVANCED BONE AGE WITH OR WITHOUT EARLY-ONSET OSTEOARTHRITIS AND/OR OSTEOCHONDRITIS DISSECANS, SSOAOD
3047,166000,"ENCHONDROMATOSIS, MULTIPLE, OLLIER TYPE",
3048,166200,"OSTEOGENESIS IMPERFECTA, TYPE I", OI1
3049,166210,"OSTEOGENESIS IMPERFECTA, TYPE II", OI2
3050,166220,"OSTEOGENESIS IMPERFECTA, TYPE IV", OI4
3051,166230,"OSTEOGENESIS IMPERFECTA WITH OPALESCENT TEETH, BLUE SCLERAE AND WORMIAN BONES, BUT WITHOUT FRACTURES",
3052,166240,"OSTEOGENESIS IMPERFECTA, TYPE I",
3053,166250,OSTEOGLOPHONIC DYSPLASIA, OGD
3054,166260,GNATHODIAPHYSEAL DYSPLASIA, GDD
3055,166300,MULTICENTRIC CARPOTARSAL OSTEOLYSIS SYNDROME, MCTO
3056,166350,"OSSEOUS HETEROPLASIA, PROGRESSIVE", POH
3057,166400,OSTEOMAS OF MANDIBLE,
3058,166450,OSTEOMESOPYKNOSIS,
3059,166490,SECRETED PHOSPHOPROTEIN 1, SPP1
3060,166500,OSTEOPATHIA STRIATA WITH CRANIAL SCLEROSIS,
3061,166600,"OSTEOPETROSIS, AUTOSOMAL DOMINANT 2", OPTA2
3062,166700,BUSCHKE-OLLENDORFF SYNDROME, BOS
3063,166705,OSTEOPOIKILOSIS AND DACRYOCYSTITIS,
3064,166710,OSTEOPOROSIS,
3065,166720,LATERAL MENINGOCELE SYNDROME,
3066,166740,OSTEOSCLEROSIS WITH ICHTHYOSIS AND FRACTURES,
3067,166750,OTODENTAL DYSPLASIA,
3068,166760,"OTITIS MEDIA, SUSCEPTIBILITY TO", OMS
3069,166780,OTOFACIOCERVICAL SYNDROME 1, OTFCS
3070,166800,OTOSCLEROSIS 1, OTSC1
3071,166900,"OVALOCYTOSIS, SOUTHEAST ASIAN", SAO
3072,166910,"OVALOCYTOSIS, HEREDITARY HEMOLYTIC, WITH DEFECTIVE ERYTHROPOIESIS",
3073,166945,NBR1 AUTOPHAGY CARGO RECEPTOR, NBR1
3074,166950,"TERATOMA, OVARIAN",
3075,166970,OVARIAN FIBROMATA,
3076,166990,"OSTEOCHONDRODYSPLASIA, RHIZOMELIC, WITH CALLOSAL AGENESIS, THROMBOCYTOPENIA, HYDROCEPHALUS, AND HYPERTENSION",
3077,167000,OVARIAN CANCER,
3078,167030,"NEPHROLITHIASIS, CALCIUM OXALATE, 1", CAON1
3079,167040,OXYSTEROL-BINDING PROTEIN, OSBP
3080,167050,OXYTOCIN, OXT
3081,167055,OXYTOCIN RECEPTOR, OXTR
3082,167100,"HYPERTROPHIC OSTEOARTHROPATHY, PRIMARY, AUTOSOMAL DOMINANT", PHOAD
3083,167200,PACHYONYCHIA CONGENITA 1, PC1
3084,167210,PACHYONYCHIA CONGENITA 2, PC2
3085,167220,PACMAN DYSPLASIA,
3086,167250,PAGET DISEASE OF BONE 3, PDB3
3087,167300,"PAGET DISEASE, EXTRAMAMMARY",
3088,167320,INCLUSION BODY MYOPATHY WITH EARLY-ONSET PAGET DISEASE WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA 1, IBMPFD1
3089,167400,PAROXYSMAL EXTREME PAIN DISORDER, PEXPD
3090,167405,PROPROTEIN CONVERTASE SUBTILISIN/KEXIN TYPE 6, PCSK6
3091,167409,PAIRED BOX GENE 2, PAX2
3092,167410,PAIRED BOX GENE 7, PAX7
3093,167411,PAIRED BOX GENE 1, PAX1
3094,167413,PAIRED BOX GENE 4, PAX4
3095,167414,PAIRED BOX GENE 5, PAX5
3096,167415,PAIRED BOX GENE 8, PAX8
3097,167416,PAIRED BOX GENE 9, PAX9
3098,167420,PAIRED-RELATED HOMEOBOX GENE 1, PRRX1
3099,167500,PALATOPHARYNGEAL INCOMPETENCE,
3100,167600,"PALMARIS LONGUS MUSCLE, ABSENCE OF",
3101,167700,PALMOMENTAL REFLEX,
3102,167730,NASOPALPEBRAL LIPOMA-COLOBOMA SYNDROME, NPLCS
3103,167750,"PANCREAS, ANNULAR",
3104,167755,"PANCREAS, DORSAL, AGENESIS OF",
3105,167770,REGENERATING ISLET-DERIVED 1-ALPHA, REG1A
3106,167771,REGENERATING ISLET-DERIVED 1-BETA, REG1B
3107,167780,PANCREATIC POLYPEPTIDE/PANCREATIC ICOSAPEPTIDE, PPY
3108,167790,"SERINE PROTEASE INHIBITOR, KAZAL-TYPE, 1", SPINK1
3109,167800,"PANCREATITIS, HEREDITARY", PCTT
3110,167805,REGENERATING ISLET-DERIVED 3-ALPHA, REG3A
3111,167850,PANCYTOPENIA AND OCCLUSIVE VASCULAR DISEASE,
3112,167870,PANIC DISORDER 1, PAND1
3113,167900,"PAPILLOMATOSIS, CONFLUENT AND RETICULATED", CARP
3114,167950,"PAPILLOMATOSIS, FLORID, OF NIPPLE",
3115,167959,HUMAN PAPILLOMAVIRUS TYPE 18 INTEGRATION SITE 1, HPV18I1
3116,167960,HUMAN PAPILLOMAVIRUS TYPE 18 INTEGRATION SITE 2, HPV18I2
3117,168000,PHEOCHROMOCYTOMA/PARAGANGLIOMA SYNDROME 1, PPGL1
3118,168100,"PARALYSIS AGITANS, JUVENILE, OF HUNT",
3119,168200,PARAMOLAR TUBERCLE OF BOLK,
3120,168300,PARAMYOTONIA CONGENITA, PMC
3121,168350,PARAMYOTONIA CONGENITA,
3122,168360,ELAV-LIKE RNA-BINDING PROTEIN 4, ELAVL4
3123,168400,PARASTREMMATIC DWARFISM,
3124,168440,PARATHYMOSIN, PTMS
3125,168450,PARATHYROID HORMONE, PTH
3126,168460,HYPERPARATHYROIDISM 2 WITH JAW TUMORS,
3127,168461,CYCLIN D1, CCND1
3128,168468,PARATHYROID HORMONE 1 RECEPTOR, PTH1R
3129,168470,PARATHYROID HORMONE-LIKE HORMONE, PTHLH
3130,168500,PARIETAL FORAMINA 1, PFM1
3131,168550,PARIETAL FORAMINA WITH CLEIDOCRANIAL DYSPLASIA, PFMCCD
3132,168600,"PARKINSON DISEASE, LATE-ONSET", PD
3133,168601,"PARKINSON DISEASE 1, AUTOSOMAL DOMINANT", PARK1
3134,168605,PERRY SYNDROME,
3135,168610,FRONTOTEMPORAL DEMENTIA 1,
3136,168710,PAROTID PROLINE-RICH SALIVARY PROTEIN Pc,
3137,168730,"PROLINE-RICH PROTEIN, HaeIII SUBFAMILY, 1", PRH1
3138,168790,"PROLINE-RICH PROTEIN, HaeIII SUBFAMILY, 2", PRH2
3139,168800,"PAROTIDOMEGALY, HEREDITARY BILATERAL",
3140,168810,"PROLINE-RICH PROTEIN, BstNI SUBFAMILY, 2", PRB2
3141,168820,PARAOXONASE 1, PON1
3142,168830,PASSOVOY FACTOR DEFECT,
3143,168840,"PROLINE-RICH PROTEIN, BstNI SUBFAMILY, 3", PRB3
3144,168850,ISCHIOCOXOPODOPATELLAR SYNDROME WITH OR WITHOUT PULMONARY ARTERIAL HYPERTENSION,
3145,168860,PATELLA APLASIA-HYPOPLASIA, PTLAH
3146,168885,"NEUROOCULAR SYNDROME 2, PAROXYSMAL TYPE", NOC2
3147,168890,PARVALBUMIN, PVALB
3148,168900,"PATELLA, CHONDROMALACIA OF",
3149,169000,"PATELLA, FAMILIAL RECURRENT DISLOCATION OF",
3150,169100,CHAR SYNDROME, CHAR
3151,169150,"MACULAR DYSTROPHY, PATTERNED, 1", MDPT1
3152,169170,PATTERSON PSEUDOLEPRECHAUNISM SYNDROME,
3153,169190,CYCLIN-DEPENDENT KINASE 18, CDK18
3154,169200,PECHET FACTOR DEFICIENCY,
3155,169300,PECTUS EXCAVATUM,
3156,169400,PELGER-HUET ANOMALY, PHA
3157,169500,"LEUKODYSTROPHY, DEMYELINATING, ADULT-ONSET, AUTOSOMAL DOMINANT, TYPICAL", ADLDTY
3158,169545,PELVIC LIPOMATOSIS WITH CROSSED RENAL ECTOPIA,
3159,169550,PELVIS-SHOULDER DYSPLASIA,
3160,169600,HAILEY-HAILEY DISEASE, HHD
3161,169610,"PEMPHIGUS VULGARIS, FAMILIAL",
3162,169615,DESMOGLEIN 3, DSG3
3163,169700,PEPSINOGEN, PG
3164,169710,"PEPSINOGEN 3, GROUP I", PGA3
3165,169720,"PEPSINOGEN 4, GROUP I", PGA4
3166,169730,"PEPSINOGEN 5, GROUP I", PGA5
3167,169740,PROGASTRICSIN, PGC
3168,169800,CARNOSINE DIPEPTIDASE 2, CNDP2
3169,169900,PEPTIDASE B, PEPB
3170,170000,PEPTIDASE C, PEPC
3171,170100,PROLIDASE DEFICIENCY,
3172,170200,PEPTIDASE E, PEPE
3173,170250,LEUCINE AMINOPEPTIDASE 3, LAP3
3174,170260,"TRANSPORTER, ATP-BINDING CASSETTE, MAJOR HISTOCOMPATIBILITY COMPLEX, 1", TAP1
3175,170261,"TRANSPORTER, ATP-BINDING CASSETTE, MAJOR HISTOCOMPATIBILITY COMPLEX, 2", TAP2
3176,170270,PEPTIDYLGLYCINE ALPHA-AMIDATING MONOOXYGENASE, PAM
3177,170280,PERFORIN 1, PRF1
3178,170285,"NUCLEOPORIN, 85-KD", NUP85
3179,170290,PERILIPIN 1, PLIN1
3180,170300,"PERIODIC FEVER, FAMILIAL, AUTOSOMAL DOMINANT",
3181,170390,ANDERSEN CARDIODYSRHYTHMIC PERIODIC PARALYSIS,
3182,170400,"HYPOKALEMIC PERIODIC PARALYSIS, TYPE 1", HOKPP1
3183,170500,HYPERKALEMIC PERIODIC PARALYSIS, HYPP
3184,170600,NORMOKALEMIC PERIODIC PARALYSIS,
3185,170650,"PERIODONTITIS, AGGRESSIVE, 1",
3186,170700,PERIPHERAL DYSOSTOSIS,
3187,170710,PERIPHERIN, PRPH
3188,170715,PERIPHERAL MYELIN PROTEIN 2, PMP2
3189,170900,PERNICIOUS ANEMIA,
3190,170950,TITLE NOT AVAILABLE AT THIS MOMENT,
3191,170980,"PERONEAL NERVE, ACCESSORY DEEP",
3192,170990,"PEROXIDASE, SALIVARY", SAPX
3193,170993,PEROXISOME BIOGENESIS FACTOR 2, PEX2
3194,170995,"ATP-BINDING CASSETTE, SUBFAMILY D, MEMBER 3", ABCD3
3195,170998,PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR-ALPHA, PPARA
3196,171000,PEYRONIE DISEASE,
3197,171050,"ATP-BINDING CASSETTE, SUBFAMILY B, MEMBER 1", ABCB1
3198,171060,"ATP-BINDING CASSETTE, SUBFAMILY B, MEMBER 4", ABCB4
3199,171100,"PHAGOCYTOSIS, PLASMA-RELATED DEFECT IN",
3200,171150,"SULFOTRANSFERASE FAMILY 1A, CYTOSOLIC, PHENOL-PREFERRING, MEMBER 1", SULT1A1
3201,171190,PHENYLETHANOLAMINE N-METHYLTRANSFERASE, PNMT
3202,171200,THIOUREA TASTING, THIOT
3203,171300,PHEOCHROMOCYTOMA,
3204,171350,PHEOCHROMOCYTOMA/PARAGANGLIOMA SYNDROME 4,
3205,171400,"MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIA", MEN2A
3206,171420,PHEOCHROMOCYTOMA--ISLET CELL TUMOR SYNDROME,
3207,171450,PHLEBECTASIA OF LIPS,
3208,171480,"PHOCOMELIA-ECTRODACTYLY, EAR MALFORMATION, DEAFNESS, AND SINUS ARRHYTHMIA",
3209,171490,PHOSDUCIN, PDC
3210,171500,"ACID PHOSPHATASE 1, SOLUBLE", ACP1
3211,171640,"PHOSPHATASE, ACID, TYPE 5, TARTRATE-RESISTANT", ACP5
3212,171650,"ACID PHOSPHATASE 2, LYSOSOMAL", ACP2
3213,171660,"PHOSPHATASE, ACID, OF TISSUES",
3214,171700,TITLE NOT AVAILABLE AT THIS MOMENT,
3215,171720,"ALKALINE PHOSPHATASE, PLASMA LEVEL OF, QUANTITATIVE TRAIT LOCUS 1",
3216,171740,"ALKALINE PHOSPHATASE, INTESTINAL", ALPI
3217,171750,"ALKALINE PHOSPHATASE, INTESTINAL, FETAL FORM",
3218,171760,"ALKALINE PHOSPHATASE, LIVER", ALPL
3219,171790,"PHOSPHATASE, PROSTATE-SPECIFIC ACID", ACPP
3220,171800,"ALKALINE PHOSPHATASE, PLACENTAL", ALPP
3221,171810,"ALKALINE PHOSPHATASE, PLACENTAL-LIKE 2", ALPPL2
3222,171820,"PHOSPHATASE, SALIVARY ACID, A", SACP; ACPS
3223,171830,"PHOSPHATASE, SALIVARY ACID, B",
3224,171833,"PHOSPHATIDYLINOSITOL 3-KINASE, REGULATORY SUBUNIT 1", PIK3R1
3225,171834,"PHOSPHATIDYLINOSITOL 3-KINASE, CATALYTIC, ALPHA", PIK3CA
3226,171835,"6-PHOSPHOFRUCTO-2-KINASE/FRUCTOSE-2,6-BISPHOSPHATASE 2", PFKFB2
3227,171840,"PHOSPHOFRUCTOKINASE, PLATELET TYPE", PFKP
3228,171850,"PHOSPHOFRUCTOKINASE, LIVER TYPE",
3229,171860,"PHOSPHOFRUCTOKINASE, LIVER TYPE", PFKL
3230,171880,"PHOSPHOFRUCTOKINASE, MUSCLE TYPE",
3231,171885,PHOSPHODIESTERASE 7A, PDE7A
3232,171890,PHOSPHODIESTERASE 1A, PDE1A
3233,171891,PHOSPHODIESTERASE 1B, PDE1B
3234,171900,PHOSPHOGLUCOMUTASE 1, PGM1
3235,172000,PHOSPHOGLUCOMUTASE 2, PGM2
3236,172100,PHOSPHOGLUCOMUTASE 3, PGM3
3237,172110,PHOSPHOGLUCOMUTASE 4,
3238,172150,6-PHOSPHOGLUCONOLACTONASE DEFICIENCY,
3239,172200,6-PHOSPHOGLUCONATE DEHYDROGENASE, PGD
3240,172250,PHOSPHOGLYCERATE MUTASE 1, PGAM1
3241,172270,PHOSPHOGLYCERATE KINASE 2, PGK2
3242,172280,PHOSPHOGLYCOLATE PHOSPHATASE, PGP
3243,172290,PHOSPHOGLYCOPROTEIN 1, PGP1
3244,172300,"PHOSPHOFRUCTOKINASE, LIVER TYPE",
3245,172400,GLUCOSE-6-PHOSPHATE ISOMERASE, GPI
3246,172405,PHOSPHOLAMBAN, PLN
3247,172410,"PHOSPHOLIPASE A2, GROUP IB", PLA2G1B
3248,172411,"PHOSPHOLIPASE A2, GROUP IIA", PLA2G2A
3249,172420,"PHOSPHOLIPASE C, GAMMA-1", PLCG1
3250,172425,PHOSPHOLIPID TRANSFER PROTEIN, PLTP
3251,172430,ENOLASE 1, ENO1
3252,172439,PHOSPHORIBOSYLAMINOIMIDAZOLE CARBOXYLASE, PAICS
3253,172450,PHOSPHORIBOSYLPYROPHOSPHATE AMIDOTRANSFERASE, PPAT
3254,172460,METHYLENETETRAHYDROFOLATE DEHYDROGENASE 1, MTHFD1
3255,172470,"PHOSPHORYLASE KINASE, MUSCLE, GAMMA-1", PHKG1
3256,172471,"PHOSPHORYLASE KINASE, TESTIS/LIVER, GAMMA-2", PHKG2
3257,172480,PHOSPHOSERINE PHOSPHATASE, PSPH
3258,172490,"PHOSPHORYLASE KINASE, BETA SUBUNIT", PHKB
3259,172500,"PHOTOMYOCLONUS, DIABETES MELLITUS, DEAFNESS, NEPHROPATHY, AND CEREBRAL DYSFUNCTION",
3260,172700,PICK DISEASE OF BRAIN,
3261,172800,PIEBALD TRAIT, PBT
3262,172850,PIEBALD TRAIT WITH NEUROLOGIC DEFECTS,
3263,172860,"SERPIN PEPTIDASE INHIBITOR, CLADE F, MEMBER 1", SERPINF1
3264,172870,PIGMENTED PARAVENOUS CHORIORETINAL ATROPHY, PPCRA
3265,172880,PIERRE ROBIN SYNDROME AND OLIGODACTYLY,
3266,172900,PIGMENTED PURPURIC ERUPTION,
3267,173000,PILONIDAL SINUS,
3268,173100,"ISOLATED GROWTH HORMONE DEFICIENCY, TYPE II", IGHD2
3269,173110,"POU DOMAIN, CLASS 1, TRANSCRIPTION FACTOR 1", POU1F1
3270,173120,SECRETORY GRANULE NEUROENDOCRINE PROTEIN 1, SGNE1
3271,173200,PITYRIASIS RUBRA PILARIS, PRP
3272,173310,PROGESTAGEN-ASSOCIATED ENDOMETRIAL PROTEIN, PAEP
3273,173320,RIBONUCLEASE/ANGIOGENIN INHIBITOR 1, RNH1
3274,173321,"SERPIN PEPTIDASE INHIBITOR, CLADE B (OVALBUMIN), MEMBER 6", SERPINB6
3275,173325,JUNCTION PLAKOGLOBIN, JUP
3276,173335,ECTONUCLEOTIDE PYROPHOSPHATASE/PHOSPHODIESTERASE 1, ENPP1
3277,173340,PLASMINOGEN-LIKE B1, PLGLB1
3278,173350,PLASMINOGEN, PLG
3279,173360,"SERPIN PEPTIDASE INHIBITOR, CLADE E (NEXIN, PLASMINOGEN ACTIVATOR INHIBITOR TYPE 1), MEMBER 1", SERPINE1
3280,173370,"PLASMINOGEN ACTIVATOR, TISSUE", PLAT
3281,173390,"SERPIN PEPTIDASE INHIBITOR, CLADE B (OVALBUMIN), MEMBER 2", SERPINB2
3282,173391,"PLASMINOGEN ACTIVATOR RECEPTOR, UROKINASE-TYPE", PLAUR
3283,173393,PLATELET-ACTIVATING FACTOR RECEPTOR, PTAFR
3284,173395,PLATELET ADENYLATE CYCLASE ACTIVITY,
3285,173400,"PLATELET AGGREGATION, SPONTANEOUS",
3286,173410,"PLATELET-DERIVED GROWTH FACTOR RECEPTOR, BETA", PDGFRB
3287,173420,"PLATELET DISORDER, UNDEFINED",
3288,173430,"PLATELET-DERIVED GROWTH FACTOR, ALPHA POLYPEPTIDE", PDGFA
3289,173445,PLATELET-ENDOTHELIAL CELL ADHESION MOLECULE 1, PECAM1
3290,173450,PLATELET FACTOR 3 DEFICIENCY,
3291,173460,PLATELET FACTOR 4, PF4
3292,173461,"PLATELET FACTOR 4, VARIANT 1", PF4V1
3293,173470,"INTEGRIN, BETA-3", ITGB3
3294,173490,"PLATELET-DERIVED GROWTH FACTOR RECEPTOR, ALPHA", PDGFRA
3295,173500,PLATELET GROUPS--Ko SYSTEM, HPA-2
3296,173510,CD36 ANTIGEN, CD36
3297,173511,"GLYCOPROTEIN V, PLATELET", GP5
3298,173515,"GLYCOPROTEIN IX, PLATELET", GP9
3299,173540,PLATELET GROUPS--Pl(E) SYSTEM,
3300,173560,PLATELET MEMBRANE FLUIDITY, PMF
3301,173570,PLECKSTRIN, PLEK
3302,173580,"PLATELET RESPONSIVENESS TO ADRENALINE, DEPRESSED",
3303,173590,PLATELET SIGNAL PROCESSING DEFECT,
3304,173600,"PNEUMOTHORAX, PRIMARY SPONTANEOUS", PSP
3305,173610,SELECTIN P, SELP
3306,173650,KINDLER SYNDROME, KNDLRS
3307,173700,"POIKILODERMA, HEREDITARY SCLEROSING",
3308,173750,POLAND SYNDROME,
3309,173800,POLAND SYNDROME,
3310,173850,POLIOVIRUS RECEPTOR, PVR
3311,173865,"POLYADENYLATE-BINDING PROTEIN, CYTOPLASMIC, 3",
3312,173870,POLY(ADP-RIBOSE) POLYMERASE 1, PARP1
3313,173871,POLY(ADP-RIBOSE) POLYMERASE 1,
3314,173880,POLYMERIC IMMUNOGLOBULIN RECEPTOR, PIGR
3315,173900,POLYCYSTIC KIDNEY DISEASE 1 WITH OR WITHOUT POLYCYSTIC LIVER DISEASE, PKD1
3316,173910,POLYCYSTIN 2, PKD2
3317,174000,"TUBULOINTERSTITIAL KIDNEY DISEASE, AUTOSOMAL DOMINANT 2", ADTKD2
3318,174050,POLYCYSTIC LIVER DISEASE 1 WITH OR WITHOUT KIDNEY CYSTS, PCLD1
3319,174100,VATER/VACTERL ASSOCIATION,
3320,174200,"POLYDACTYLY, POSTAXIAL, TYPE A1", PAPA1
3321,174300,OROFACIODIGITAL SYNDROME V, OFD5
3322,174310,"POLYDACTYLY, POSTAXIAL, WITH PROGRESSIVE MYOPIA",
3323,174400,"POLYDACTYLY, PREAXIAL I", PPD1
3324,174500,"POLYDACTYLY, PREAXIAL II", PPD2
3325,174600,"POLYDACTYLY, PREAXIAL III", PPD3
3326,174700,"POLYDACTYLY, PREAXIAL IV", PPD4
3327,174750,POLYKARYOCYTOSIS INDUCER, FUSE
3328,174760,"POLYMERASE, DNA, BETA", POLB
3329,174761,"POLYMERASE (DNA-DIRECTED), DELTA 1, CATALYTIC SUBUNIT", POLD1
3330,174762,"POLYMERASE, DNA, EPSILON", POLE
3331,174763,"POLYMERASE, DNA, GAMMA", POLG
3332,174770,ACTINIC PRURIGO,
3333,174800,MCCUNE-ALBRIGHT SYNDROME, MAS
3334,174810,FAMILIAL EXPANSILE OSTEOLYSIS, FEO
3335,174880,"LYMPHOCYTE CYTOSOL POLYPEPTIDE, 100-KD",
3336,174900,JUVENILE POLYPOSIS SYNDROME, JPS
3337,175000,JUVENILE POLYPOSIS SYNDROME,
3338,175020,GASTRIC ADENOCARCINOMA AND PROXIMAL POLYPOSIS OF THE STOMACH,
3339,175050,JUVENILE POLYPOSIS/HEREDITARY HEMORRHAGIC TELANGIECTASIA SYNDROME, JPHT
3340,175100,FAMILIAL ADENOMATOUS POLYPOSIS 1, FAP1
3341,175200,PEUTZ-JEGHERS SYNDROME, PJS
3342,175400,"POLYPOSIS, INTESTINAL, SCATTERED AND DISCRETE",
3343,175450,"POLYPOSIS, INTESTINAL, WITH MULTIPLE EXOSTOSES",
3344,175500,"POLYPOSIS, SKIN PIGMENTATION, ALOPECIA, AND FINGERNAIL CHANGES",
3345,175505,GASTRIC ADENOCARCINOMA AND PROXIMAL POLYPOSIS OF THE STOMACH,
3346,175510,GIST-PLUS SYNDROME, GISTPS
3347,175690,"POLYSYNDACTYLY, CROSSED",
3348,175700,GREIG CEPHALOPOLYSYNDACTYLY SYNDROME, GCPS
3349,175750,POPLITEAL CYST,
3350,175780,BRAIN SMALL VESSEL DISEASE 1 WITH OR WITHOUT OCULAR ANOMALIES, BSVD1
3351,175800,"POROKERATOSIS 1, MULTIPLE TYPES", POROK1
3352,175850,"POROKERATOSIS 2, PALMAR, PLANTAR, AND DISSEMINATED TYPE", POROK2
3353,175860,"PALMOPLANTAR KERATODERMA, PUNCTATE TYPE II", PPKP2
3354,175900,"POROKERATOSIS 3, MULTIPLE TYPES", POROK3
3355,176000,"PORPHYRIA, ACUTE INTERMITTENT", AIP
3356,176010,"PORPHYRIA, ACUTE INTERMITTENT",
3357,176090,"PORPHYRIA CUTANEA TARDA, TYPE I",
3358,176100,PORPHYRIA CUTANEA TARDA,
3359,176200,VARIEGATE PORPHYRIA, VP
3360,176240,"POSTAXIAL OLIGODACTYLY, TETRAMELIC",
3361,176250,POSTERIOR COLUMN ATAXIA,
3362,176256,"POTASSIUM CHANNEL, VOLTAGE-GATED, SHAW-RELATED SUBFAMILY, MEMBER 2", KCNC2
3363,176257,"POTASSIUM CHANNEL, VOLTAGE-GATED, SHAKER-RELATED SUBFAMILY, MEMBER 6", KCNA6
3364,176258,"POTASSIUM CHANNEL, VOLTAGE-GATED, SHAW-RELATED SUBFAMILY, MEMBER 1", KCNC1
3365,176260,"POTASSIUM CHANNEL, VOLTAGE-GATED, SHAKER-RELATED SUBFAMILY, MEMBER 1", KCNA1
3366,176261,"POTASSIUM CHANNEL, VOLTAGE-GATED, ISK-RELATED SUBFAMILY, MEMBER 1", KCNE1
3367,176262,"POTASSIUM CHANNEL, VOLTAGE-GATED, SHAKER-RELATED SUBFAMILY, MEMBER 2", KCNA2
3368,176263,"POTASSIUM CHANNEL, VOLTAGE-GATED, SHAKER-RELATED SUBFAMILY, MEMBER 3", KCNA3
3369,176264,"POTASSIUM CHANNEL, VOLTAGE-GATED, SHAW-RELATED SUBFAMILY, MEMBER 3", KCNC3
3370,176265,"POTASSIUM CHANNEL, VOLTAGE-GATED, SHAW-RELATED SUBFAMILY, MEMBER 4", KCNC4
3371,176266,"POTASSIUM CHANNEL, VOLTAGE-GATED, SHAKER-RELATED SUBFAMILY, MEMBER 4", KCNA4
3372,176267,"POTASSIUM CHANNEL, VOLTAGE-GATED, SHAKER-RELATED SUBFAMILY, MEMBER 5", KCNA5
3373,176268,"POTASSIUM CHANNEL, VOLTAGE-GATED, SHAKER-RELATED SUBFAMILY, MEMBER 7", KCNA7
3374,176269,"POTASSIUM CHANNEL, VOLTAGE-GATED, SHAKER-RELATED SUBFAMILY, MEMBER 4",
3375,176270,PRADER-WILLI SYNDROME, PWS
3376,176290,DELTA-LIKE NONCANONICAL NOTCH LIGAND 1, DLK1
3377,176300,TRANSTHYRETIN, TTR
3378,176305,"PREAXIAL DEFICIENCY, POSTAXIAL POLYDACTYLY, AND HYPOSPADIAS",
3379,176310,PRE-B-CELL LEUKEMIA TRANSCRIPTION FACTOR 1, PBX1
3380,176311,PRE-B-CELL LEUKEMIA TRANSCRIPTION FACTOR 2, PBX2
3381,176312,PRE-B-CELL LEUKEMIA TRANSCRIPTION FACTOR 3, PBX3
3382,176385,PAPPALYSIN 1, PAPPA
3383,176390,PREGNANCY-SPECIFIC BETA-1-GLYCOPROTEIN 1, PSG1
3384,176391,PREGNANCY-SPECIFIC BETA-1-GLYCOPROTEIN 2, PSG2
3385,176392,PREGNANCY-SPECIFIC BETA-1-GLYCOPROTEIN 3, PSG3
3386,176393,PREGNANCY-SPECIFIC BETA-1-GLYCOPROTEIN 4, PSG4
3387,176394,PREGNANCY-SPECIFIC BETA-1-GLYCOPROTEIN 5, PSG5
3388,176395,PREGNANCY-SPECIFIC BETA-1-GLYCOPROTEIN 6, PSG6
3389,176396,PREGNANCY-SPECIFIC BETA-1-GLYCOPROTEIN 7, PSG7
3390,176397,PREGNANCY-SPECIFIC BETA-1-GLYCOPROTEIN 8, PSG8
3391,176398,PREGNANCY-SPECIFIC BETA-1-GLYCOPROTEIN 9, PSG9
3392,176399,"PREGNANCY-SPECIFIC BETA-1-GLYCOPROTEIN 10, PSEUDOGENE", PSG10P
3393,176400,"PRECOCIOUS PUBERTY, CENTRAL, 1", CPPB1
3394,176401,PREGNANCY-SPECIFIC BETA-1-GLYCOPROTEIN 11, PSG11
3395,176410,"PRECOCIOUS PUBERTY, MALE-LIMITED",
3396,176420,PREGNANCY ZONE PROTEIN, PZP
3397,176430,PREMATURE CHROMATID SEPARATION TRAIT, PCS
3398,176440,PREMATURE OVARIAN FAILURE 1,
3399,176450,CURRARINO SYNDROME,
3400,176500,"CEREBRAL AMYLOID ANGIOPATHY, ITM2B-RELATED, 1",
3401,176590,PROFILIN 2, PFN2
3402,176600,"PRESENILE DEMENTIA, KRAEPELIN TYPE",
3403,176610,PROFILIN 1, PFN1
3404,176620,"PRIAPISM, FAMILIAL IDIOPATHIC",
3405,176630,PRIMARY RELEASE DISORDER OF PLATELETS,
3406,176635,PRIMASE POLYPEPTIDE 1, PRIM1
3407,176636,PRIMASE POLYPEPTIDE 2A, PRIM2A
3408,176640,PRION PROTEIN, PRNP
3409,176670,HUTCHINSON-GILFORD PROGERIA SYNDROME, HGPS
3410,176680,"MAJOR HISTOCOMPATIBILITY COMPLEX, CLASS II, DP ALPHA-1",
3411,176690,PROGEROID SHORT STATURE WITH PIGMENTED NEVI,
3412,176700,"PROGNATHISM, MANDIBULAR",
3413,176705,PROHIBITIN, PHB
3414,176710,"PROCOLLAGEN-PROLINE, 2-OXOGLUTARATE-4-DIOXYGENASE, ALPHA SUBUNIT, ISOFORM 1", P4HA1
3415,176720,PROLACTIN-INDUCIBLE PROTEIN, PIP
3416,176730,INSULIN, INS
3417,176740,PROLIFERATING CELL NUCLEAR ANTIGEN, PCNA
3418,176741,MARKER OF PROLIFERATION KI67, MKI67
3419,176760,PROLACTIN, PRL
3420,176761,PROLACTIN RECEPTOR, PRLR
3421,176763,PEROXIREDOXIN 1, PRDX1
3422,176770,"PROLINE-NEGATIVE AUXOTROPH OF HAMSTER, COMPLEMENTATION OF", PROA
3423,176780,"PELVIC ORGAN PROLAPSE, SUSCEPTIBILITY TO",
3424,176785,PROLYLCARBOXYPEPTIDASE, PRCP
3425,176790,"PROCOLLAGEN-PROLINE, 2-OXOGLUTARATE-4-DIOXYGENASE, BETA SUBUNIT", P4HB
3426,176793,"PRO-MELANIN-CONCENTRATING HORMONE-LIKE 1, PSEUDOGENE", PMCHL1
3427,176794,"PRO-MELANIN-CONCENTRATING HORMONE-LIKE 2, PSEUDOGENE", PMCHL2
3428,176795,PRO-MELANIN-CONCENTRATING HORMONE, PMCH
3429,176797,ZINC FINGER- AND BTB DOMAIN-CONTAINING PROTEIN 16, ZBTB16
3430,176800,"PRONATION-SUPINATION OF THE FOREARM, IMPAIRMENT OF",
3431,176801,PROSAPOSIN, PSAP
3432,176802,"PROSTAGLANDIN E RECEPTOR 1, EP1 SUBTYPE", PTGER1
3433,176803,"PROSTAGLANDIN D2 SYNTHASE, BRAIN", PTGDS
3434,176804,"PROSTAGLANDIN E RECEPTOR 2, EP2 SUBTYPE", PTGER2
3435,176805,PROSTAGLANDIN-ENDOPEROXIDE SYNTHASE 1, PTGS1
3436,176806,"PROSTAGLANDIN E RECEPTOR 3, EP3 SUBTYPE", PTGER3
3437,176807,PROSTATE CANCER,
3438,176820,KALLIKREIN-RELATED PEPTIDASE 3, KLK3
3439,176830,PROOPIOMELANOCORTIN, POMC
3440,176842,"PROTEASOME SUBUNIT, ALPHA-TYPE, 2", PSMA2
3441,176843,"PROTEASOME SUBUNIT, ALPHA-TYPE, 3", PSMA3
3442,176844,"PROTEASOME SUBUNIT, ALPHA-TYPE, 5", PSMA5
3443,176845,PROTEASOME COMPONENT 8, PSC8
3444,176846,"PROTEASOME SUBUNIT, ALPHA-TYPE, 4", PSMA4
3445,176847,"PROTEASOME 20S SUBUNIT, BETA-TYPE, 10", PSMB10
3446,176851,PROTEIN-L-ISOASPARTATE (D-ASPARTATE) O-METHYLTRANSFERASE, PCMT1
3447,176860,"THROMBOPHILIA DUE TO PROTEIN C DEFICIENCY, AUTOSOMAL DOMINANT", THPH3
3448,176870,ALPHA-1 MICROGLOBULIN/BIKUNIN PRECURSOR, AMBP
3449,176871,EUKARYOTIC TRANSLATION INITIATION FACTOR 2-ALPHA KINASE 2, EIF2AK2
3450,176872,MITOGEN-ACTIVATED PROTEIN KINASE KINASE 1, MAP2K1
3451,176873,CYCLIN-DEPENDENT KINASE 11B, CDK11B
3452,176874,S100 CALCIUM-BINDING PROTEIN A10,
3453,176875,"PROTEIN PHOSPHATASE 1, CATALYTIC SUBUNIT, ALPHA ISOFORM", PPP1CA
3454,176876,"PROTEIN-TYROSINE PHOSPHATASE, NONRECEPTOR-TYPE, 11", PTPN11
3455,176877,"PROTEIN-TYROSINE PHOSPHATASE, NONRECEPTOR-TYPE, 3", PTPN3
3456,176878,"PROTEIN-TYROSINE PHOSPHATASE, NONRECEPTOR-TYPE, 4", PTPN4
3457,176879,"PROTEIN-TYROSINE PHOSPHATASE, NONRECEPTOR-TYPE, 5", PTPN5
3458,176880,PROTEIN S, PROS1
3459,176882,"PROTEIN-TYROSINE PHOSPHATASE, RECEPTOR-TYPE, BETA", PTPRB
3460,176883,"PROTEIN-TYROSINE PHOSPHATASE, NONRECEPTOR-TYPE, 6", PTPN6
3461,176884,"PROTEIN-TYROSINE PHOSPHATASE, RECEPTOR-TYPE, ALPHA", PTPRA
3462,176885,"PROTEIN-TYROSINE PHOSPHATASE, NONRECEPTOR-TYPE, 1", PTPN1
3463,176886,"PROTEIN-TYROSINE PHOSPHATASE, RECEPTOR-TYPE, GAMMA", PTPRG
3464,176887,"PROTEIN-TYROSINE PHOSPHATASE, NONRECEPTOR-TYPE, 2", PTPN2
3465,176888,"PROTEIN-TYROSINE PHOSPHATASE, RECEPTOR-TYPE, MU", PTPRM
3466,176889,"PROTEIN-TYROSINE PHOSPHATASE, NONRECEPTOR-TYPE, 7", PTPN7
3467,176891,"PROTEIN-TYROSINE PHOSPHATASE, RECEPTOR-TYPE, ZETA-1", PTPRZ1
3468,176892,"PROTEIN KINASE, cAMP-DEPENDENT, CATALYTIC, BETA", PRKACB
3469,176893,"PROTEIN KINASE, cAMP-DEPENDENT, CATALYTIC, GAMMA", PRKACG
3470,176894,"PROTEIN KINASE, cGMP-DEPENDENT, REGULATORY, TYPE I", PRKG1
3471,176895,PROTEIN Z, PROZ
3472,176900,PROTEOLYTIC CAPACITY OF PLASMA,
3473,176910,"PROTEIN KINASE, cAMP-DEPENDENT, REGULATORY, TYPE II, ALPHA", PRKAR2A
3474,176911,"PROTEIN KINASE, cAMP-DEPENDENT, REGULATORY, TYPE I, BETA", PRKAR1B
3475,176912,"PROTEIN KINASE, cAMP-DEPENDENT, REGULATORY, TYPE II, BETA", PRKAR2B
3476,176914,"PROTEIN PHOSPHATASE 1, CATALYTIC SUBUNIT, GAMMA ISOFORM", PPP1CC
3477,176915,"PROTEIN PHOSPHATASE 2, CATALYTIC SUBUNIT, ALPHA ISOFORM", PPP2CA
3478,176916,"PROTEIN PHOSPHATASE 2, CATALYTIC SUBUNIT, BETA ISOFORM", PPP2CB
3479,176920,PROTEUS SYNDROME,
3480,176930,COAGULATION FACTOR II, F2
3481,176940,S100 CALCIUM-BINDING PROTEIN A1, S100A1
3482,176941,TYROSINE KINASE 2, TYK2
3483,176942,FPS/FES-RELATED TYROSINE KINASE, FER
3484,176943,FIBROBLAST GROWTH FACTOR RECEPTOR 2, FGFR2
3485,176944,FIBROBLAST GROWTH FACTOR RECEPTOR 4,
3486,176945,EPHRIN RECEPTOR EphA8, EPHA8
3487,176946,EPHRIN RECEPTOR EphA2, EPHA2
3488,176947,ZETA-CHAIN-ASSOCIATED PROTEIN KINASE, ZAP70
3489,176948,MITOGEN-ACTIVATED PROTEIN KINASE 1, MAPK1
3490,176949,MITOGEN-ACTIVATED PROTEIN KINASE 4, MAPK4
3491,176950,SCOTT SYNDROME,
3492,176960,"PROTEIN KINASE C, ALPHA", PRKCA
3493,176970,"PROTEIN KINASE C, BETA", PRKCB
3494,176975,"PROTEIN KINASE C, EPSILON", PRKCE
3495,176977,"PROTEIN KINASE C, DELTA", PRKCD
3496,176980,"PROTEIN KINASE C, GAMMA", PRKCG
3497,176981,"RECEPTOR FOR ACTIVATED PROTEIN KINASE C, 1", RACK1
3498,176982,"PROTEIN KINASE C, ZETA FORM", PRKCZ
3499,176990,"S100 CALCIUM-BINDING PROTEIN, BETA", S100B
3500,176991,S100 CALCIUM-BINDING PROTEIN A5, S100A5
3501,176992,S100 CALCIUM-BINDING PROTEIN A3, S100A3
3502,176993,S100 CALCIUM-BINDING PROTEIN A2, S100A2
3503,177000,"PROTOPORPHYRIA, ERYTHROPOIETIC, 1", EPP1
3504,177010,"SERPIN PEPTIDASE INHIBITOR, CLADE E (NEXIN, PLASMINOGEN ACTIVATOR INHIBITOR TYPE 1), MEMBER 2", SERPINE2
3505,177015,PROTEIN SERINE KINASE H1, PSKH1
3506,177020,PROTEINASE 3, PRTN3
3507,177030,PROTEIN S,
3508,177040,SERGLYCIN, SRGN
3509,177045,"PROTEASOME SUBUNIT, BETA-TYPE, 9", PSMB9
3510,177046,"PROTEASOME SUBUNIT, BETA-TYPE, 8", PSMB8
3511,177050,PROTRUSIO ACETABULI,
3512,177060,"PROTEIN KINASE C SUBSTRATE, 80-KD, HEAVY CHAIN", PRKCSH
3513,177061,MYRISTOYLATED ALANINE-RICH PROTEIN KINASE C SUBSTRATE, MARCKS
3514,177070,"PROTEIN 4.2, ERYTHROCYTIC", EPB42
3515,177075,MAF bZIP TRANSCRIPTION FACTOR, MAF
3516,177100,"PRURITUS, HEREDITARY LOCALIZED",
3517,177150,PSEUDOACHONDROPLASIA,
3518,177170,PSEUDOACHONDROPLASIA, PSACH
3519,177200,LIDDLE SYNDROME 1, LIDLS1
3520,177300,PSEUDOARTHROGRYPOSIS,
3521,177350,PSEUDOATROPHODERMA COLLI,
3522,177400,BUTYRYLCHOLINESTERASE, BCHE
3523,177500,BUTYRYLCHOLINESTERASE,
3524,177600,"PSEUDOCHOLINESTERASE, INCREASE IN PLASMA LEVEL OF",
3525,177650,EXFOLIATION SYNDROME, XFS
3526,177700,"GLAUCOMA 1, OPEN ANGLE, P", GLC1P
3527,177720,DEHYDRATED HEREDITARY STOMATOCYTOSIS 1 WITH OR WITHOUT PSEUDOHYPERKALEMIA AND/OR PERINATAL EDEMA,
3528,177735,"PSEUDOHYPOALDOSTERONISM, TYPE I, AUTOSOMAL DOMINANT", PHA1A
3529,177750,PSEUDOMONILETHRIX,
3530,177800,PSEUDOPAPILLEDEMA,
3531,177820,"VON WILLEBRAND DISEASE, PLATELET-TYPE", VWDP
3532,177850,"PSEUDOXANTHOMA ELASTICUM, FORME FRUSTE",
3533,177860,TITLE NOT AVAILABLE AT THIS MOMENT,
3534,177900,"PSORIASIS 1, SUSCEPTIBILITY TO", PSORS1
3535,177980,"PTERYGIA, IMPAIRED INTELLECTUAL DEVELOPMENT, AND DISTINCTIVE CRANIOFACIAL FEATURES",
3536,177990,"PTERYGIUM COLLI, ISOLATED",
3537,178000,PTERYGIUM OF CONJUNCTIVA AND CORNEA,
3538,178110,"CONTRACTURES, PTERYGIA, AND SPONDYLOCARPOTARSAL FUSION SYNDROME 1A", CPSFS1A
3539,178200,"PTERYGIUM, ANTECUBITAL",
3540,178300,"PTOSIS, HEREDITARY CONGENITAL 1", PTOS1
3541,178330,"PTOSIS, STRABISMUS, AND ECTOPIC PUPILS",
3542,178350,PUBIC BONE DYSPLASIA,
3543,178370,PULMONARY ATRESIA WITH VENTRICULAR SEPTAL DEFECT,
3544,178400,"PULMONARY EDEMA OF MOUNTAINEERS, SUSCEPTIBILITY TO",
3545,178500,INTERSTITIAL LUNG DISEASE 2, ILD2
3546,178550,PULMONARY HEMOSIDEROSIS,
3547,178600,"PULMONARY HYPERTENSION, PRIMARY, 1", PPH1
3548,178610,"PULMONARY NODULAR LYMPHOID HYPERPLASIA, FAMILIAL",
3549,178620,"SURFACTANT, PULMONARY-ASSOCIATED PROTEIN C", SFTPC
3550,178630,"SURFACTANT, PULMONARY-ASSOCIATED PROTEIN A1", SFTPA1
3551,178635,"SURFACTANT, PULMONARY-ASSOCIATED PROTEIN D", SFTPD
3552,178640,"SURFACTANT, PULMONARY-ASSOCIATED PROTEIN B", SFTPB
3553,178642,"SURFACTANT, PULMONARY-ASSOCIATED PROTEIN A2", SFTPA2
3554,178650,"PULMONIC STENOSIS, ATRIAL SEPTAL DEFECT, AND UNIQUE ELECTROCARDIOGRAPHIC ABNORMALITIES",
3555,178651,PULMONIC STENOSIS AND DEAFNESS,
3556,178800,"PUPIL, EGG-SHAPED",
3557,178900,"PUPILLARY MEMBRANE, PERSISTENCE OF",
3558,178990,MATRIX METALLOPROTEINASE 7, MMP7
3559,178995,PRURITIC URTICARIAL PAPULES AND PLAQUES OF PREGNANCY, PUPPP
3560,179000,PURPURA SIMPLEX,
3561,179010,"PYLORIC STENOSIS, INFANTILE HYPERTROPHIC, 1", IHPS1
3562,179020,PYRIDOXAL KINASE, PDXK
3563,179030,"PYROPHOSPHATASE, INORGANIC, 1", PPA1
3564,179035,PYRROLINE-5-CARBOXYLATE REDUCTASE 1, PYCR1
3565,179040,"PYRUVATE KINASE, MUSCLE",
3566,179050,"PYRUVATE KINASE, MUSCLE", PKM
3567,179060,"PYRUVATE DEHYDROGENASE E1, SUBUNIT BETA", PDHB
3568,179061,"PYRUVATE DEHYDROGENASE E1, SUBUNIT ALPHA-2", PDHA2
3569,179080,"RAB GERANYLGERANYL TRANSFERASE, BETA SUBUNIT", RABGGTB
3570,179090,AKT SERINE/THREONINE KINASE 1,
3571,179095,UBIQUITIN-CONJUGATING ENZYME E2 B, UBE2B
3572,179200,"RADIAL HEADS, POSTERIOR DISLOCATION OF",
3573,179250,"RADIAL HYPOPLASIA, TRIPHALANGEAL THUMBS, HYPOSPADIAS, AND MAXILLARY DIASTEMA",
3574,179270,RADIAL RAY HYPOPLASIA WITH CHOANAL ATRESIA,
3575,179280,RADIAL-RENAL SYNDROME,
3576,179300,"RADIOULNAR SYNOSTOSIS, NONSYNDROMIC, SUSCEPTIBILITY TO", RUS
3577,179400,"RADIUS, APLASIA OF, WITH CLEFT LIP/PALATE",
3578,179410,RADIXIN, RDX
3579,179450,RAGWEED SENSITIVITY,
3580,179490,RAS-ASSOCIATED PROTEIN RAB3A, RAB3A
3581,179500,RAINDROP HYPOPIGMENTATION,
3582,179502,"RAP1, GTPase-GDP DISSOCIATION STIMULATOR 1", RAP1GDS1
3583,179503,RRAD RAS-RELATED GLYCOLYSIS INHIBITOR AND CALCIUM CHANNEL REGULATOR, RRAD
3584,179505,"RAS HOMOLOG GENE FAMILY, MEMBER G", RHOG
3585,179508,RAS-ASSOCIATED PROTEIN RAB1, RAB1
3586,179509,RAS-ASSOCIATED PROTEIN RAB2, RAB2
3587,179510,RAS-ASSOCIATED PROTEIN RAB3B, RAB3B
3588,179511,RAS-ASSOCIATED PROTEIN RAB4A, RAB4A
3589,179512,RAS-ASSOCIATED PROTEIN RAB5A, RAB5A
3590,179513,RAS-ASSOCIATED PROTEIN RAB6A, RAB6A
3591,179514,RAS-ASSOCIATED PROTEIN RAB5B, RAB5B
3592,179520,RAS-RELATED PROTEIN 1A, RAP1A
3593,179530,RAS-RELATED PROTEIN 1B, RAP1B
3594,179540,RAS-RELATED PROTEIN 2A, RAP2A
3595,179541,RAS-RELATED PROTEIN 2B, RAP2B
3596,179550,RAS-LIKE PROTOONCOGENE A, RALA
3597,179551,RAS-LIKE PROTOONCOGENE B, RALB
3598,179555,RAS SUPPRESSOR PROTEIN 1, RSU1
3599,179590,"PROTEIN-TYROSINE PHOSPHATASE, RECEPTOR-TYPE, F", PTPRF
3600,179600,RAYNAUD DISEASE,
3601,179605,PERIPHERIN 2, PRPH2
3602,179610,EPHRIN RECEPTOR EphA1, EPHA1
3603,179611,EPHRIN RECEPTOR EphA3, EPHA3
3604,179613,RECOMBINANT CHROMOSOME 8 SYNDROME,
3605,179615,RECOMBINATION-ACTIVATING GENE 1, RAG1
3606,179616,RECOMBINATION-ACTIVATING GENE 2, RAG2
3607,179617,RAD51 RECOMBINASE, RAD51
3608,179618,RECOVERIN, RCVRN
3609,179620,RAPH BLOOD GROUP SYSTEM,
3610,179650,RED CELL PERMEABILITY DEFECT,
3611,179700,RED CELL PHOSPHOLIPID DEFECT WITH HEMOLYSIS,
3612,179710,REGULATOR OF CHROMOSOME CONDENSATION 1, RCC1
3613,179715,TITLE NOT AVAILABLE AT THIS MOMENT,
3614,179730,RELAXIN 1, RLN1
3615,179740,RELAXIN 2, RLN2
3616,179755,PROLINE-RICH MITOTIC CHECKPOINT CONTROL FACTOR, PRCC
3617,179760,"RENAL CELL CARCINOMA, NONPAPILLARY",
3618,179770,"RENAL CELL CARCINOMA, NONPAPILLARY",
3619,179780,DIPEPTIDASE 1, DPEP1
3620,179800,"RENAL TUBULAR ACIDOSIS, DISTAL, 1", DRTA1
3621,179820,RENIN, REN
3622,179830,"RENAL TUBULAR ACIDOSIS, PROXIMAL",
3623,179835,"REPLICATION PROTEIN A1, 70-KD", RPA1
3624,179836,"REPLICATION PROTEIN A2, 32-KD", RPA2
3625,179837,"REPLICATION PROTEIN A3, 14-KD", RPA3
3626,179838,CAP-GLY DOMAIN-CONTAINING LINKER PROTEIN 1, CLIP1
3627,179840,RETICULAR DYSTROPHY OF RETINAL PIGMENT EPITHELIUM,
3628,179850,DOWLING-DEGOS DISEASE 1, DDD1
3629,179900,RETINAL APLASIA,
3630,180000,"RETINAL ARTERIES, TORTUOSITY OF", RATOR
3631,180020,RETINAL CONE DYSTROPHY 1, RCD1
3632,180040,RD3 REGULATOR OF GUCY2D, RD3
3633,180050,RETINAL DETACHMENT,
3634,180060,"MICROCEPHALY WITH OR WITHOUT CHORIORETINOPATHY, LYMPHEDEMA, OR IMPAIRED INTELLECTUAL DEVELOPMENT",
3635,180069,RETINOID ISOMEROHYDROLASE RPE65, RPE65
3636,180070,"PERSISTENT HYPERPLASTIC PRIMARY VITREOUS, AUTOSOMAL RECESSIVE",
3637,180071,PHOSPHODIESTERASE 6A, PDE6A
3638,180072,PHOSPHODIESTERASE 6B, PDE6B
3639,180073,PHOSPHODIESTERASE 6G, PDE6G
3640,180080,RETINAL VENOUS BEADING,
3641,180090,RETINALDEHYDE-BINDING PROTEIN 1, RLBP1
3642,180100,RETINITIS PIGMENTOSA 1, RP1
3643,180102,RHODOPSIN,
3644,180103,RETINITIS PIGMENTOSA-DEAFNESS SYNDROME,
3645,180104,RETINITIS PIGMENTOSA 9, RP9
3646,180105,RETINITIS PIGMENTOSA 10, RP10
3647,180190,"RETINOIC ACID RECEPTOR, GAMMA", RARG
3648,180200,RETINOBLASTOMA, RB1
3649,180201,AT-RICH INTERACTION DOMAIN-CONTAINING PROTEIN 4A, ARID4A
3650,180202,LYSINE DEMETHYLASE 5A, KDM5A
3651,180203,RB TRANSCRIPTIONAL COREPRESSOR-LIKE 2, RBL2
3652,180210,"RETINOPATHY, PERICENTRAL PIGMENTARY, DOMINANT",
3653,180220,"RETINOIC ACID RECEPTOR, BETA", RARB
3654,180230,"RETINOIC ACID-BINDING PROTEIN, CELLULAR, TYPE I", CRABP1
3655,180231,"RETINOIC ACID-BINDING PROTEIN, CELLULAR, TYPE II", CRABP2
3656,180240,"RETINOIC ACID RECEPTOR, ALPHA", RARA
3657,180245,"RETINOID X RECEPTOR, ALPHA", RXRA
3658,180246,"RETINOID X RECEPTOR, BETA", RXRB
3659,180247,"RETINOID X RECEPTOR, GAMMA", RXRG
3660,180250,RETINOL-BINDING PROTEIN 4, RBP4
3661,180260,RETINOL-BINDING PROTEIN 1, RBP1
3662,180270,"RETINOSCHISIS, AUTOSOMAL DOMINANT",
3663,180280,RETINOL-BINDING PROTEIN 2, RBP2
3664,180290,RETINOL-BINDING PROTEIN 3, RBP3
3665,180295,"RHABDOMYOSARCOMA, EMBRYONAL, 2", RMSE2
3666,180297,RHESUS BLOOD GROUP-ASSOCIATED GLYCOPROTEIN, RHAG
3667,180300,RHEUMATOID ARTHRITIS, RA
3668,180330,TITLE NOT AVAILABLE AT THIS MOMENT,
3669,180350,RHEUMATOID NODULOSIS,
3670,180360,RHINY,
3671,180370,THIOSULFATE SULFURTRANSFERASE, TST
3672,180380,RHODOPSIN, RHO
3673,180381,G PROTEIN-COUPLED RECEPTOR KINASE 1, GRK1
3674,180385,LIM DOMAIN ONLY 2, LMO2
3675,180386,LIM DOMAIN ONLY 3, LMO3
3676,180390,RIBONUCLEOTIDE REDUCTASE REGULATORY SUBUNIT M2, RRM2
3677,180410,RIBONUCLEOTIDE REDUCTASE CATALYTIC SUBUNIT M1, RRM1
3678,180420,"RNA, 5S RIBOSOMAL, GENE CLUSTER 1", RN5S1@
3679,180430,RIBOSE 5-PHOSPHATE ISOMERASE A, RPIA
3680,180435,RIBONUCLEASE L, RNASEL
3681,180440,"RIBONUCLEASE A FAMILY, MEMBER 1, PANCREATIC", RNASE1
3682,180450,RIBOSOMAL RNA 1, RNR1
3683,180451,RIBOSOMAL RNA 2, RNR2
3684,180452,RIBOSOMAL RNA 3, RNR3
3685,180453,RIBOSOMAL RNA 4, RNR4
3686,180454,RIBOSOMAL RNA 5, RNR5
3687,180460,RIBOSOMAL PROTEIN S6, RPS6
3688,180461,RIBOSOMAL PROTEIN S17,
3689,180462,RIBOSOMAL PROTEIN S17,
3690,180463,RIBOSOMAL PROTEIN S20A, RPS20A
3691,180464,RIBOSOMAL PROTEIN S20B, RPS20B
3692,180465,RIBOSOMAL PROTEIN S25, RPS25
3693,180466,RIBOSOMAL PROTEIN L19, RPL19
3694,180467,RIBOSOMAL PROTEIN L30, RPL30
3695,180468,RIBOSOMAL PROTEIN L35A, RPL35A
3696,180469,RIBOSOMAL PROTEIN L36A-LIKE, RPL36AL
3697,180470,RIBOPHORIN I, RPN1
3698,180471,RIBOSOMAL PROTEIN S11, RPS11
3699,180472,RIBOSOMAL PROTEIN S17, RPS17
3700,180473,RIBOSOMAL PROTEIN S18, RPS18
3701,180474,RIBOSOMAL PROTEIN L22, RPL22
3702,180475,RIBOSOMAL PROTEIN L12, RPL12
3703,180476,RIBOSOMAL PROTEIN S13, RPS13
3704,180477,RIBOSOMAL PROTEIN S21, RPS21
3705,180478,RIBOSOMAL PROTEIN S3a, RPS3A
3706,180479,RIBOSOMAL PROTEIN L4, RPL4
3707,180480,RIBULOSE 5-PHOSPHATE 3-EPIMERASE, RPE
3708,180490,RIBOPHORIN II, RPN2
3709,180500,"AXENFELD-RIEGER SYNDROME, TYPE 1", RIEG1
3710,180510,RIBOSOMAL PROTEIN LATERAL STALK SUBUNIT P0, RPLP0
3711,180520,RIBOSOMAL PROTEIN LATERAL STALK SUBUNIT P1, RPLP1
3712,180530,RIBOSOMAL PROTEIN LATERAL STALK SUBUNIT P2, RPLP2
3713,180535,RIBOSOMAL PROTEIN S15, RPS15
3714,180540,"RIBONUCLEASE A FAMILY, MEMBER 2",
3715,180550,RING DERMOID OF CORNEA, RDC
3716,180600,RINGED HAIR,
3717,180610,REARRANGED LMYC FUSION, RLF
3718,180620,tRNA INITIATOR METHIONINE (ANTICODON CAT) 2-1, TRX-CAT2-1
3719,180621,tRNA INITIATOR METHIONINE (ANTICODON CAT) 1-2, TRX-CAT1-2
3720,180630,DEAD-BOX HELICASE 5, DDX5
3721,180640,tRNA GLUTAMIC ACID (ANTICODON TTC) 3-1, TRE-TTC3-1
3722,180645,"SMALL NUCLEOLAR RNA, H/ACA BOX, 73A", SNORA73A
3723,180646,"SMALL NUCLEOLAR RNA, H/ACA BOX, 62", SNORA62
3724,180647,"SMALL NUCLEOLAR RNA, H/ACA BOX, 63", SNORA63
3725,180660,"POLYMERASE II, RNA, SUBUNIT A", POLR2A
3726,180661,"POLYMERASE II, RNA, SUBUNIT B", POLR2B
3727,180662,"POLYMERASE II, RNA, SUBUNIT I", POLR2I
3728,180663,"POLYMERASE II, RNA, SUBUNIT C", POLR2C
3729,180664,"POLYMERASE II, RNA, SUBUNIT E", POLR2E
3730,180670,RNA POLYMERASE III TRANSCRIPTIONAL UNITS,
3731,180680,"RNA, U1A SMALL NUCLEAR", RNU1A
3732,180690,"RNA, U2 SMALL NUCLEAR, 1", RNU2-1
3733,180691,"RNA, U5A SMALL NUCLEAR 1", RNU5A-1
3734,180692,"RNA, U6 SMALL NUCLEAR, 1", RNU6-1
3735,180700,"ROBINOW SYNDROME, AUTOSOMAL DOMINANT 1", DRS1
3736,180710,"SMALL NUCLEOLAR RNA, C/D BOX, 3A", SNORD3A
3737,180720,"RNA, U1A SMALL NUCLEAR",
3738,180721,ROD OUTER SEGMENT PROTEIN 1, ROM1
3739,180730,ROMBO SYNDROME,
3740,180740,"SMALL NUCLEAR RIBONUCLEOPROTEIN, U1 SUBUNIT, 70-KD", SNRNP70
3741,180750,ROBINOW-SORAUF SYNDROME,
3742,180800,ROUSSY-LEVY HEREDITARY AREFLEXIC DYSTASIA,
3743,180840,ADP-RIBOSYLTRANSFERASE 1,
3744,180849,RUBINSTEIN-TAYBI SYNDROME 1, RSTS1
3745,180850,RUBINSTEIN-TAYBI SYNDROME 1,
3746,180860,SILVER-RUSSELL SYNDROME 1, SRS1
3747,180870,RUVALCABA SYNDROME,
3748,180900,RUTHERFURD SYNDROME,
3749,180901,RYANODINE RECEPTOR 1, RYR1
3750,180902,RYANODINE RECEPTOR 2, RYR2
3751,180903,RYANODINE RECEPTOR 3, RYR3
3752,180910,SALIVARY ESTERASE,
3753,180920,APLASIA OF LACRIMAL AND SALIVARY GLANDS, ALSG
3754,180930,TITLE NOT AVAILABLE AT THIS MOMENT,
3755,180940,TITLE NOT AVAILABLE AT THIS MOMENT,
3756,180950,"SALIVARY SUBSTANCE, CLOSTRIDIUM BOTULINUM TYPE",
3757,180960,S-ADENOSYLHOMOCYSTEINE HYDROLASE, AHCY
3758,180980,S-ADENOSYLMETHIONINE DECARBOXYLASE, AMD1
3759,180989,"PROLINE-RICH PROTEIN, BstNI SUBFAMILY, 1", PRB1
3760,180990,"PROLINE-RICH PROTEIN, BstNI SUBFAMILY, 4", PRB4
3761,181000,"SARCOIDOSIS, SUSCEPTIBILITY TO, 1", SS1
3762,181010,SALIVARY DUCT CALCULI,
3763,181030,"SALIVARY GLAND ADENOMA, PLEOMORPHIC",
3764,181031,S-ANTIGEN, SAG
3765,181035,TETRASPANIN 31, TSPAN31
3766,181180,SAY SYNDROME,
3767,181200,SC(1) TRAIT OF SALIVA,
3768,181250,SCALP DEFECTS AND POSTAXIAL POLYDACTYLY,
3769,181270,SCALP-EAR-NIPPLE SYNDROME, SENS
3770,181300,"SCAPULA, CONTOUR OF VERTEBRAL BORDER OF",
3771,181350,"EMERY-DREIFUSS MUSCULAR DYSTROPHY 2, AUTOSOMAL DOMINANT", EDMD2
3772,181400,"SCAPULOPERONEAL SYNDROME, NEUROGENIC, KAESER TYPE", SCPNK
3773,181405,SCAPULOPERONEAL SPINAL MUSCULAR ATROPHY, SPSMA
3774,181430,"CONGENITAL MYOPATHY 7A, MYOSIN STORAGE, AUTOSOMAL DOMINANT",
3775,181440,SCHEUERMANN DISEASE,
3776,181450,ULNAR-MAMMARY SYNDROME, UMS
3777,181460,"SCHISTOSOMA MANSONI INFECTION, SUSCEPTIBILITY/RESISTANCE TO",
3778,181500,SCHIZOPHRENIA, SCZD
3779,181510,SCHIZOPHRENIA 1, SCZD1
3780,181515,SCHOLTE SYNDROME,
3781,181520,AMPHIREGULIN,
3782,181590,SCL/TAL1-INTERRUPTING LOCUS, STIL
3783,181600,HURIEZ SYNDROME, HRZ
3784,181700,"SCLEROCORNEA, AUTOSOMAL DOMINANT",
3785,181750,"SCLERODERMA, FAMILIAL PROGRESSIVE",
3786,181800,"SCOLIOSIS, ISOLATED, SUSCEPTIBILITY TO, 1", IS1
3787,182000,"KERATOSIS, SEBORRHEIC",
3788,182090,SIMIAN SARCOMA-ASSOCIATED VIRUS-1/GIBBON APE LEUKEMIA VIRUS, SSAV1
3789,182098,SECRETIN RECEPTOR, SCTR
3790,182099,SECRETIN, SCT
3791,182100,FUCOSYLTRANSFERASE 2, FUT2
3792,182115,CYTOHESIN 1, CYTH1
3793,182120,"SECRETED PROTEIN, ACIDIC, CYSTEINE-RICH", SPARC
3794,182125,SEPIAPTERIN REDUCTASE, SPR
3795,182128,SERINE DEHYDRATASE, SDS
3796,182131,5-HYDROXYTRYPTAMINE RECEPTOR 1B, HTR1B
3797,182132,5-HYDROXYTRYPTAMINE RECEPTOR 1E, HTR1E
3798,182133,5-HYDROXYTRYPTAMINE RECEPTOR 1D, HTR1D
3799,182134,5-HYDROXYTRYPTAMINE RECEPTOR 1F, HTR1F
3800,182135,5-HYDROXYTRYPTAMINE RECEPTOR 2A, HTR2A
3801,182137,5-HYDROXYTRYPTAMINE RECEPTOR 7, HTR7
3802,182138,"SOLUTE CARRIER FAMILY 6 (NEUROTRANSMITTER TRANSPORTER, SEROTONIN), MEMBER 4", SLC6A4
3803,182139,5-HYDROXYTRYPTAMINE RECEPTOR 3A, HTR3A
3804,182140,SEMENOGELIN I, SEMG1
3805,182141,SEMENOGELIN II, SEMG2
3806,182143,SERGLYCIN,
3807,182144,"SERINE HYDROXYMETHYLTRANSFERASE, CYTOSOLIC", SHMT1
3808,182145,SERUM PROTEIN POLYMORPHISM M-158,
3809,182150,SIMOSA CRANIOFACIAL SYNDROME,
3810,182160,SIALOPHORIN, SPN
3811,182170,"ANEMIA, SIDEROBLASTIC, 4", SIDBA4
3812,182175,"SIGNAL RECOGNITION PARTICLE, 19-KD", SRP19
3813,182180,"SRP RECEPTOR SUBUNIT, ALPHA", SRPRA
3814,182190,SINUS NODE DISEASE AND MYOPIA,
3815,182200,"SELLA TURCICA, BRIDGED",
3816,182203,"CHEMOKINE, CXC MOTIF, RECEPTOR 4",
3817,182205,SEX HORMONE-BINDING GLOBULIN, SHBG
3818,182210,SHPRINTZEN OMPHALOCELE SYNDROME,
3819,182212,SHPRINTZEN-GOLDBERG CRANIOSYNOSTOSIS SYNDROME, SGS
3820,182220,"SISTER CHROMATID EXCHANGE, FREQUENCY OF",
3821,182230,SEPTOOPTIC DYSPLASIA,
3822,182250,SINGLETON-MERTEN SYNDROME 1, SGMRT1
3823,182255,SKELETAL DYSPLASIA WITH DELAYED EPIPHYSEAL AND CARPAL BONE OSSIFICATION,
3824,182257,PROTEINASE INHIBITOR 3, PI3
3825,182260,SLIPPED FEMORAL CAPITAL EPIPHYSES,
3826,182265,SMALL PROLINE-RICH PROTEIN 1A, SPRR1A
3827,182266,SMALL PROLINE-RICH PROTEIN 1B, SPRR1B
3828,182267,SMALL PROLINE-RICH PROTEIN 2A, SPRR2A
3829,182268,SMALL PROLINE-RICH PROTEIN 2B, SPRR2B
3830,182269,"SMALL PROLINE-RICH PROTEIN 2C, PSEUDOGENE", SPRR2C
3831,182270,"KETONE COMPOUNDS, ABILITY TO SMELL",
3832,182271,SMALL PROLINE-RICH PROTEIN 3, SPRR3
3833,182279,SMALL NUCLEAR RIBONUCLEOPROTEIN POLYPEPTIDE N, SNRPN
3834,182280,SMALL CELL CANCER OF THE LUNG,
3835,182281,"CHEMOKINE, CC MOTIF, LIGAND 1", CCL1
3836,182282,SMALL NUCLEAR RIBONUCLEOPROTEIN POLYPEPTIDES B AND B1, SNRPB
3837,182283,"CHEMOKINE, CC MOTIF, LIGAND 3", CCL3
3838,182284,"CHEMOKINE, CC MOTIF, LIGAND 4", CCL4
3839,182285,SMALL NUCLEAR RIBONUCLEOPROTEIN POLYPEPTIDE A, SNRPA
3840,182290,SMITH-MAGENIS SYNDROME, SMS
3841,182305,"SOLUTE CARRIER FAMILY 8 (SODIUM-CALCIUM EXCHANGER), MEMBER A1", SLC8A1
3842,182307,"SOLUTE CARRIER FAMILY 9, MEMBER 3", SLC9A3
3843,182308,"SOLUTE CARRIER FAMILY 17 (ORGANIC ANION COTRANSPORTER), MEMBER 1", SLC17A1
3844,182309,"SOLUTE CARRIER FAMILY 34 (TYPE II SODIUM/PHOSPHATE COTRANSPORTER), MEMBER 1", SLC34A1
3845,182310,"ATPase, Na+/K+ TRANSPORTING, ALPHA-1 POLYPEPTIDE", ATP1A1
3846,182330,"ATPase, Na+/K+ TRANSPORTING, BETA-1 POLYPEPTIDE", ATP1B1
3847,182331,"ATPase, Na+/K+ TRANSPORTING, BETA-2 POLYPEPTIDE", ATP1B2
3848,182340,"ATPase, Na+/K+ TRANSPORTING, ALPHA-2 POLYPEPTIDE", ATP1A2
3849,182350,"ATPase, Na+/K+ TRANSPORTING, ALPHA-3 POLYPEPTIDE", ATP1A3
3850,182360,"ATPase, H+/K+ TRANSPORTING, NONGASTRIC, ALPHA POLYPEPTIDE", ATP12A
3851,182370,"ATPase, Na+/K+ TRANSPORTING, BETA-1 POLYPEPTIDE",
3852,182380,"SOLUTE CARRIER FAMILY 5 (SODIUM/GLUCOSE COTRANSPORTER), MEMBER 1", SLC5A1
3853,182381,"SOLUTE CARRIER FAMILY 5 (SODIUM/GLUCOSE COTRANSPORTER), MEMBER 2", SLC5A2
3854,182389,"SODIUM VOLTAGE-GATED CHANNEL, ALPHA SUBUNIT 1", SCN1A
3855,182390,"SODIUM VOLTAGE-GATED CHANNEL, ALPHA SUBUNIT 2", SCN2A
3856,182391,"SODIUM VOLTAGE-GATED CHANNEL, ALPHA SUBUNIT 3", SCN3A
3857,182392,"SODIUM VOLTAGE-GATED CHANNEL, ALPHA SUBUNIT 7", SCN7A
3858,182396,"SOLUTE CARRIER FAMILY 10 (SODIUM/BILE ACID COTRANSPORTER FAMILY), MEMBER 1", SLC10A1
3859,182400,"SOMATOMEDIN, EMBRYONIC",
3860,182410,SNEDDON SYNDROME, SNDNS
3861,182450,SOMATOSTATIN, SST
3862,182451,SOMATOSTATIN RECEPTOR 1, SSTR1
3863,182452,SOMATOSTATIN RECEPTOR 2, SSTR2
3864,182453,SOMATOSTATIN RECEPTOR 3, SSTR3
3865,182454,SOMATOSTATIN RECEPTOR 4, SSTR4
3866,182455,SOMATOSTATIN RECEPTOR 5, SSTR5
3867,182465,SON DNA-BINDING PROTEIN, SON
3868,182500,SORBITOL DEHYDROGENASE, SORD
3869,182520,SORCIN, SRI
3870,182530,SOS RAS/RAC GUANINE NUCLEOTIDE EXCHANGE FACTOR 1, SOS1
3871,182590,TREFOIL FACTOR 2, TFF2
3872,182600,"SPASTIC PARAPLEGIA 3, AUTOSOMAL DOMINANT", SPG3A
3873,182601,"SPASTIC PARAPLEGIA 4, AUTOSOMAL DOMINANT", SPG4
3874,182610,"SPASTIC PARAPLEGIA, EPILEPSY, AND IMPAIRED INTELLECTUAL DEVELOPMENT", SPEMR
3875,182690,"SPASTIC PARAPLEGIA, SENSORINEURAL DEAFNESS, IMPAIRED INTELLECTUAL DEVELOPMENT, AND PROGRESSIVE NEPHROPATHY",
3876,182700,"SPASTIC PARAPLEGIA 17, AUTOSOMAL DOMINANT",
3877,182790,"SPECTRIN, BETA, NONERYTHROCYTIC, 1", SPTBN1
3878,182800,SPASTIC PARAPLEGIA WITH ASSOCIATED EXTRAPYRAMIDAL SIGNS,
3879,182810,"SPECTRIN, ALPHA, NONERYTHROCYTIC 1", SPTAN1
3880,182815,SPASTIC PARAPLEGIA WITH NEUROPATHY AND POIKILODERMA,
3881,182820,SPASTIC PARAPLEGIA WITH PRECOCIOUS PUBERTY,
3882,182830,"SPASTIC PARAPLEGIA, OPTIC ATROPHY, AND DEMENTIA",
3883,182860,"SPECTRIN, ALPHA, ERYTHROCYTIC 1", SPTA1
3884,182870,"SPECTRIN, BETA, ERYTHROCYTIC", SPTB
3885,182875,"SPEECH DEVELOPMENT, DELAYED, WITH FACIAL ASYMMETRY, STRABISMUS, AND TRANSVERSE EARLOBE CREASE",
3886,182878,OUTER DENSE FIBER OF SPERM TAILS 1, ODF1
3887,182879,AMYLOID BETA A4 PRECURSOR-LIKE PROTEIN 2,
3888,182880,SPERM PROTAMINE P1, PRM1
3889,182882,SPERM PROTAMINE P4, PRM4
3890,182888,ZONA PELLUCIDA GLYCOPROTEIN 2, ZP2
3891,182889,ZONA PELLUCIDA GLYCOPROTEIN 3, ZP3
3892,182890,SPERM PROTAMINE P2, PRM2
3893,182891,SPERMIDINE SYNTHASE, SRM
3894,182892,SPERMINE SYNTHASE,
3895,182900,"SPHEROCYTOSIS, TYPE 1", SPH1
3896,182920,"MYOPATHY, MYOFIBRILLAR, 3",
3897,182930,"PANCREATITIS, HEREDITARY",
3898,182940,"NEURAL TUBE DEFECTS, SUSCEPTIBILITY TO", NTD
3899,182950,SPINAL ARACHNOIDITIS,
3900,182960,"NEURONOPATHY, DISTAL HEREDITARY MOTOR, AUTOSOMAL DOMINANT 1", HMND1
3901,182970,"SPINAL MUSCULAR ATROPHY, FACIOSCAPULOHUMERAL TYPE",
3902,182980,"SPINAL MUSCULAR ATROPHY, LATE-ONSET, FINKEL TYPE", SMAFK
3903,182990,SPINAL INTRADURAL ARACHNOID CYSTS,
3904,183000,GERSTMANN-STRAUSSLER DISEASE,
3905,183020,"SPINAL MUSCULAR ATROPHY, SEGMENTAL",
3906,183050,SPINOCEREBELLAR ATAXIA WITH RIGIDITY AND PERIPHERAL NEUROPATHY,
3907,183085,MACHADO-JOSEPH DISEASE,
3908,183086,SPINOCEREBELLAR ATAXIA 6, SCA6
3909,183090,SPINOCEREBELLAR ATAXIA 2, SCA2
3910,183100,SPINOCEREBELLAR ATROPHY WITH PUPILLARY PARALYSIS,
3911,183250,TITLE NOT AVAILABLE AT THIS MOMENT,
3912,183300,SPLENOGONADAL FUSION WITH LIMB DEFECTS AND MICROGNATHIA,
3913,183350,SPLENOMEGALY SYNDROME WITH SPLENIC GERMINAL CENTER HYPOPLASIA AND REDUCED CIRCULATING T HELPER CELLS,
3914,183400,SPLIT LOWER LIP,
3915,183500,SPLIT-HAND AND SPLIT-FOOT WITH HYPODONTIA,
3916,183600,SPLIT-HAND/FOOT MALFORMATION 1, SHFM1
3917,183700,SPLIT-FOOT DEFORMITY WITH MANDIBULOFACIAL DYSOSTOSIS,
3918,183800,"SPLIT-HAND WITH CONGENITAL NYSTAGMUS, FUNDAL CHANGES, AND CATARACTS",
3919,183802,"SPLIT-HAND WITH OBSTRUCTIVE UROPATHY, SPINA BIFIDA, AND DIAPHRAGMATIC DEFECTS",
3920,183840,"SPONDYLOARTHROPATHY, SUSCEPTIBILITY TO, 2", SPDA2
3921,183849,SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH HYPOTRICHOSIS,
3922,183850,SPONDYLOEPIPHYSEAL DYSPLASIA WITH PUNCTATE CORNEAL DYSTROPHY,
3923,183900,SPONDYLOEPIPHYSEAL DYSPLASIA CONGENITA, SEDC
3924,184000,"SPONDYLOEPIPHYSEAL DYSPLASIA, MYOPIA, AND SENSORINEURAL DEAFNESS",
3925,184095,"SPONDYLOEPIPHYSEAL DYSPLASIA, MAROTEAUX TYPE",
3926,184100,"SPONDYLOEPIPHYSEAL DYSPLASIA TARDA, AUTOSOMAL DOMINANT",
3927,184200,SPONDYLOLISTHESIS,
3928,184250,"SPONDYLOEPIMETAPHYSEAL DYSPLASIA, STRUDWICK TYPE", SEMDSTWK
3929,184252,"SPONDYLOMETAPHYSEAL DYSPLASIA, KOZLOWSKI TYPE", SMDK
3930,184253,"SPONDYLOMETAPHYSEAL DYSPLASIA, ALGERIAN TYPE", SMDALG
3931,184255,"SPONDYLOMETAPHYSEAL DYSPLASIA, CORNER FRACTURE TYPE", SMDCF
3932,184260,ODONTOCHONDRODYSPLASIA 1, ODCD1
3933,184300,"SPONDYLOSIS, CERVICAL",
3934,184400,SPRENGEL DEFORMITY,
3935,184420,FARNESYLDIPHOSPHATE FARNESYLTRANSFERASE 1, FDFT1
3936,184429,SRY-BOX 2, SOX2
3937,184430,SRY-BOX 4, SOX4
3938,184450,"STUTTERING, FAMILIAL PERSISTENT, 1", STUT1
3939,184460,STAPES ANKYLOSIS WITH BROAD THUMBS AND TOES,
3940,184470,STATHERIN, STATH
3941,184500,STEATOCYSTOMA MULTIPLEX,
3942,184510,STEATOCYSTOMA MULTIPLEX WITH NATAL TEETH,
3943,184600,CYSTATIN A, CSTA
3944,184601,CYSTATIN B,
3945,184700,POLYCYSTIC OVARY SYNDROME 1, PCOS1
3946,184705,STEINFELD SYNDROME,
3947,184745,KIT LIGAND, KITLG
3948,184747,FMS-RELATED TYROSINE KINASE 3,
3949,184753,STEROID 5-ALPHA-REDUCTASE 1, SRD5A1
3950,184754,"ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 21-HYDROXYLASE DEFICIENCY",
3951,184755,STEROL CARRIER PROTEIN 2, SCP2
3952,184756,STEROL REGULATORY ELEMENT-BINDING TRANSCRIPTION FACTOR 1, SREBF1
3953,184757,"NUCLEAR RECEPTOR SUBFAMILY 5, GROUP A, MEMBER 1", NR5A1
3954,184800,"STERNUM, PREMATURE OBLITERATION OF SUTURES OF",
3955,184840,"OTOSPONDYLOMEGAEPIPHYSEAL DYSPLASIA, AUTOSOMAL DOMINANT", OSMEDA
3956,184850,STIFF-PERSON SYNDROME, SPS
3957,184900,STIFF SKIN SYNDROME, SSKS
3958,185000,OVERHYDRATED HEREDITARY STOMATOCYTOSIS, OHST
3959,185010,DEHYDRATED HEREDITARY STOMATOCYTOSIS 1 WITH OR WITHOUT PSEUDOHYPERKALEMIA AND/OR PERINATAL EDEMA,
3960,185020,CRYOHYDROCYTOSIS, CHC
3961,185050,STORAGE POOL PLATELET DISEASE,
3962,185069,STORM SYNDROME,
3963,185070,STORMORKEN SYNDROME, STRMK
3964,185100,"STRABISMUS, SUSCEPTIBILITY TO",
3965,185120,STRATTON-PARKER SYNDROME,
3966,185200,"STRIAE DISTENSAE, FAMILIAL",
3967,185250,MATRIX METALLOPROTEINASE 3, MMP3
3968,185260,MATRIX METALLOPROTEINASE 10, MMP10
3969,185261,MATRIX METALLOPROTEINASE 11, MMP11
3970,185300,STURGE-WEBER SYNDROME, SWS
3971,185400,"LARYNGEAL WEB, FAMILIAL",
3972,185430,CLUSTERIN, CLU
3973,185440,SUPPRESSOR OF TUMORIGENICITY 2, ST2
3974,185450,TITLE NOT AVAILABLE AT THIS MOMENT,
3975,185460,"SULFHEMOGLOBINEMIA, CONGENITAL",
3976,185470,"SUCCINATE DEHYDROGENASE COMPLEX, IRON-SULFUR SUBUNIT B", SDHB
3977,185480,"SUPRABULBAR PARESIS, CONGENITAL",
3978,185490,SUPEROXIDE DISMUTASE 3, SOD3
3979,185500,SUPRAVALVULAR AORTIC STENOSIS, SVAS
3980,185510,SURFACE ANTIGEN 5, S5
3981,185520,SURFACE ANTIGEN 6, S6
3982,185535,EPITHELIAL CELLULAR ADHESION MOLECULE, EPCAM
3983,185540,"SURFACE ANTIGEN, GLYCOPROTEIN 75",
3984,185560,SURFACE ANTIGEN 8, S8
3985,185570,SURFACE ANTIGEN 17, SA17
3986,185580,SURFACE ANTIGEN 22, S13
3987,185590,SURFACE ANTIGEN 21, S14
3988,185595,TITLE NOT AVAILABLE AT THIS MOMENT,
3989,185600,SYMPHALANGISM OF TOES,
3990,185605,SYNAPTOTAGMIN 1, SYT1
3991,185610,"SURFACE POLYPEPTIDES, ANONYMOUS",
3992,185620,SURFEIT 1, SURF1
3993,185630,SURFEIT 2, SURF2
3994,185640,RIBOSOMAL PROTEIN L7a, RPL7A
3995,185641,MEDIATOR COMPLEX SUBUNIT 22, MED22
3996,185642,SURFEIT 6, SURF6
3997,185650,"SYMPHALANGISM, C. S. LEWIS TYPE",
3998,185660,SURFEIT 4, SURF4
3999,185700,"SYMPHALANGISM, DISTAL",
4000,185750,SYMPHALANGISM WITH MULTIPLE ANOMALIES OF HANDS AND FEET,
4001,185800,"SYMPHALANGISM, PROXIMAL, 1A", SYM1A
4002,185860,SYNAPTIC VESICLE GLYCOPROTEIN 2A, SV2A
4003,185861,SYNAPTIC VESICLE GLYCOPROTEIN 2B, SV2B
4004,185880,VESICLE-ASSOCIATED MEMBRANE PROTEIN 1, VAMP1
4005,185881,VESICLE-ASSOCIATED MEMBRANE PROTEIN 2, VAMP2
4006,185900,CHROMOSOME 2q35 DUPLICATION SYNDROME,
4007,186000,SYNPOLYDACTYLY 1, SPD1
4008,186100,"SYNDACTYLY, TYPE III", SDTY3
4009,186200,"SYNDACTYLY, TYPE IV", SDTY4
4010,186300,"SYNDACTYLY, TYPE V", SDTY5
4011,186350,SYNDACTYLY-POLYDACTYLY-EARLOBE SYNDROME,
4012,186355,SYNDECAN 1, SDC1
4013,186357,SYNDECAN 3, SDC3
4014,186360,ANNEXIN A7, ANXA7
4015,186400,"SYNOSTOSES, TARSAL, CARPAL, AND DIGITAL",
4016,186500,MULTIPLE SYNOSTOSES SYNDROME 1, SYNS1
4017,186550,LIEBENBERG SYNDROME, LBNBG
4018,186570,TARSAL-CARPAL COALITION SYNDROME, TCC
4019,186575,"SYNOVIAL CHONDROMATOSIS, FAMILIAL, WITH DWARFISM",
4020,186580,BLAU SYNDROME, BLAUS
4021,186590,SYNTAXIN 1A, STX1A
4022,186591,SYNTAXIN 4, STX4
4023,186600,"SYRINGOMAS, MULTIPLE",
4024,186690,TITLE NOT AVAILABLE AT THIS MOMENT,
4025,186700,"SYRINGOMYELIA, NONCOMMUNICATING ISOLATED",
4026,186710,DIPEPTIDYL PEPTIDASE IV,
4027,186711,CD27 ANTIGEN, CD27
4028,186720,CD6 ANTIGEN, CD6
4029,186730,"CD8 ANTIGEN, BETA POLYPEPTIDE", CD8B
4030,186740,"CD3 ANTIGEN, GAMMA SUBUNIT", CD3G
4031,186745,TALIN 1, TLN1
4032,186750,TALONAVICULAR COALITION,
4033,186760,ANTIGEN CD28, CD28
4034,186770,"T-CELL LEUKEMIA, HOMEOBOX 1", TLX1
4035,186780,CD247 ANTIGEN, CD247
4036,186790,"CD3 ANTIGEN, DELTA SUBUNIT", CD3D
4037,186810,T-CELL RECEPTOR DELTA CHAIN CONSTANT REGION, TRDC
4038,186820,T-CELL ANTIGEN CD7, CD7
4039,186830,"CD3 ANTIGEN, EPSILON SUBUNIT", CD3E
4040,186845,CD81 ANTIGEN, CD81
4041,186850,TARSAL COALITION,
4042,186852,"PROTEASOME 26S SUBUNIT, ATPase, 3", PSMC3
4043,186854,"SOLUTE CARRIER FAMILY 6 (NEUROTRANSMITTER TRANSPORTER, TAURINE), MEMBER 6", SLC6A6
4044,186855,T-CELL ACUTE LYMPHOCYTIC LEUKEMIA 2, TAL2
4045,186860,T-CELL LEUKEMIA/LYMPHOMA 4, TCL4
4046,186880,T-CELL RECEPTOR ALPHA CHAIN CONSTANT REGION, TRAC
4047,186890,"TEAR PROTEIN, ANODAL",
4048,186910,"CD8 ANTIGEN, ALPHA POLYPEPTIDE", CD8A
4049,186920,TITLE NOT AVAILABLE AT THIS MOMENT,
4050,186921,LIM DOMAIN ONLY 1, LMO1
4051,186930,T-CELL RECEPTOR BETA CHAIN CONSTANT REGION 1, TRBC1
4052,186940,CD4 ANTIGEN, CD4
4053,186945,FK506-BINDING PROTEIN 1A, FKBP1A
4054,186946,FK506-BINDING PROTEIN 2, FKBP2
4055,186947,FK506-BINDING PROTEIN 3, FKBP3
4056,186950,"T-CELL SUBGROUPS, NON-HLA-LINKED",
4057,186960,T-CELL LEUKEMIA/LYMPHOMA 1A, TCL1A
4058,186970,T-CELL RECEPTOR GAMMA CHAIN CONSTANT REGION 1, TRGC1
4059,186973,IL2-INDUCIBLE T-CELL KINASE, ITK
4060,186975,T COMPLEX-ASSOCIATED TESTIS-EXPRESSED 1, TCTE1
4061,186977,T COMPLEX-ASSOCIATED TESTIS-EXPRESSED 3, TCTE3
4062,186980,T-COMPLEX 1, TCP1
4063,186982,T-COMPLEX PROTEIN 11, TCP11
4064,186990,T-LYMPHOCYTE SURFACE CD2 ANTIGEN, CD2
4065,187000,"TEETH, ODD SHAPES OF",
4066,187010,"CHEMOKINE, CC MOTIF, LIGAND 5",
4067,187011,"CHEMOKINE, CC MOTIF, LIGAND 5", CCL5
4068,187020,T-COMPLEX 10, TCP10
4069,187030,T-COMPLEX LOCUS TCP10B, TCP10B
4070,187040,T-CELL ACUTE LYMPHOCYTIC LEUKEMIA 1, TAL1
4071,187050,TEETH PRESENT AT BIRTH,
4072,187100,"TEETH, SUPERNUMERARY",
4073,187260,"TELANGIECTASIA, HEREDITARY BENIGN",
4074,187270,TELOMERASE REVERSE TRANSCRIPTASE, TERT
4075,187280,"POLYMERASE III, RNA, SUBUNIT D", POLR3D
4076,187290,"TEMPERATURE SENSITIVITY COMPLEMENTATION, CELL CYCLE SPECIFIC, H142", H142T
4077,187300,"TELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 1", HHT1
4078,187310,"TEMPERATURE SENSITIVITY COMPLEMENTATION, CELL CYCLE SPECIFIC, K12",
4079,187320,"TEMPERATURE SENSITIVITY COMPLEMENTATION, CELL CYCLE SPECIFIC, ts13", TS13
4080,187330,"TEMPERATURE SENSITIVITY COMPLEMENTATION, CELL CYCLE SPECIFIC, ts546", TS546
4081,187340,TEMPERATURE-SENSITIVE LETHAL MUTATION,
4082,187350,TELECANTHUS,
4083,187360,TEMPORAL ARTERITIS,
4084,187370,"ARTHROGRYPOSIS, DISTAL, TYPE 10", DA10
4085,187380,TENASCIN C, TNC
4086,187390,"TENDONS, EXTENSOR, OF FINGERS, ANOMALOUS INSERTION OF",
4087,187395,"CRIPTO, EGF-CFC FAMILY MEMBER", CRIPTO
4088,187400,TESTICULAR TORSION,
4089,187410,"DEOXYNUCLEOTIDYLTRANSFERASE, TERMINAL", DNTT
4090,187430,CYSTEINE-RICH SECRETORY PROTEIN 2, CRISP2
4091,187450,SEX HORMONE-BINDING GLOBULIN,
4092,187500,TETRALOGY OF FALLOT, TOF
4093,187501,TETRALOGY OF FALLOT AND GLAUCOMA,
4094,187510,TETRAMELIC MONODACTYLY,
4095,187520,"C-TYPE LECTIN DOMAIN FAMILY 3, MEMBER B", CLEC3B
4096,187550,"THALASSEMIA, BETA+, SILENT ALLELE",
4097,187600,"THANATOPHORIC DYSPLASIA, TYPE I", TD1
4098,187601,"THANATOPHORIC DYSPLASIA, TYPE II", TD2
4099,187650,THEOPHYLLINE BIOTRANSFORMATION,
4100,187680,THIOPURINE S-METHYLTRANSFERASE, TPMT
4101,187700,THIOREDOXIN, TXN
4102,187750,"THORACIC DYSOSTOSIS, ISOLATED",
4103,187760,THORACOLARYNGOPELVIC DYSPLASIA, TLPD
4104,187770,THORACOPELVIC DYSOSTOSIS,
4105,187790,THREONYL-tRNA SYNTHETASE 1, TARS1
4106,187800,"BLEEDING DISORDER, PLATELET-TYPE, 16", BDPLT16
4107,187900,"BLEEDING DISORDER, PLATELET-TYPE, 17", BDPLT17
4108,187930,COAGULATION FACTOR II RECEPTOR, F2R
4109,187940,THROMBOCYTE B, THB
4110,187950,THROMBOCYTHEMIA 1, THCYT1
4111,188000,THROMBOCYTOPENIA 2, THC2
4112,188020,"THROMBOCYTOPENIA, CYCLIC",
4113,188025,"THROMBOCYTOPENIA, PARIS-TROUSSEAU TYPE", TCPT
4114,188030,IMMUNE THROMBOCYTOPENIA, ITP
4115,188035,PRO-PLATELET BASIC PROTEIN-LIKE 1, PPBPL1
4116,188040,THROMBOMODULIN, THBD
4117,188050,THROMBOPHILIA DUE TO THROMBIN DEFECT, THPH1
4118,188055,THROMBOPHILIA DUE TO ACTIVATED PROTEIN C RESISTANCE, THPH2
4119,188060,THROMBOSPONDIN I, THBS1
4120,188061,THROMBOSPONDIN II, THBS2
4121,188062,THROMBOSPONDIN III, THBS3
4122,188070,"THROMBOXANE A2 RECEPTOR, PLATELET", TBXA2R
4123,188100,THUMB DEFORMITY,
4124,188150,THUMB DEFORMITY AND ALOPECIA,
4125,188200,"NAIL DISORDER, NONSYNDROMIC CONGENITAL, 6",
4126,188201,"THUMBS, STIFF, WITH BRACHYDACTYLY TYPE A1 AND DEVELOPMENTAL DELAY",
4127,188230,THY-1 T-CELL ANTIGEN, THY1
4128,188250,"THYMIDINE KINASE, MITOCHONDRIAL", TK2
4129,188300,"THYMIDINE KINASE, SOLUBLE", TK1
4130,188340,THYMOCYTE ANTIGEN CD1C, CD1C
4131,188345,DEOXYTHYMIDYLATE KINASE, DTYMK
4132,188350,THYMIDYLATE SYNTHETASE, TYMS
4133,188360,THYMOCYTE ANTIGEN CD1B, CD1B
4134,188370,THYMOCYTE ANTIGEN CD1A, CD1A
4135,188380,THYMOPOIETIN, TMPO
4136,188390,"PROTHYMOSIN, ALPHA", PTMA
4137,188395,"THYMOSIN, BETA-4, X CHROMOSOME",
4138,188399,"THYMOSIN, BETA-10", TMSB10
4139,188400,DIGEORGE SYNDROME, DGS
4140,188410,THYMOCYTE ANTIGEN CD1D, CD1D
4141,188411,THYMOCYTE ANTIGEN CD1E, CD1E
4142,188450,THYROGLOBULIN, TG
4143,188455,"THYROGLOSSAL DUCT CYST, FAMILIAL",
4144,188470,"THYROID CANCER, NONMEDULLARY, 2", NMTC2
4145,188530,"CHORIONIC GONADOTROPIN, ALPHA CHAIN",
4146,188540,"THYROID-STIMULATING HORMONE, BETA CHAIN", TSHB
4147,188545,THYROTROPIN-RELEASING HORMONE RECEPTOR, TRHR
4148,188550,"THYROID CANCER, NONMEDULLARY, 1", NMTC1
4149,188555,"PYRUVATE KINASE, MUSCLE",
4150,188560,THYROID HORMONE PLASMA MEMBRANE TRANSPORT DEFECT,
4151,188570,"THYROID HORMONE RESISTANCE, GENERALIZED, AUTOSOMAL DOMINANT", GRTHD
4152,188580,"THYROTOXIC PERIODIC PARALYSIS, SUSCEPTIBILITY TO, 1", TTPP1
4153,188590,"THYROID HORMONE RECEPTOR, ALPHA-1",
4154,188595,THYROTROPH EMBRYONIC FACTOR, TEF
4155,188600,THYROXINE-BINDING GLOBULIN OF SERUM,
4156,188700,"BLOUNT DISEASE, INFANTILE",
4157,188740,"TIBIA, HYPOPLASIA OR APLASIA OF, WITH POLYDACTYLY", THYP
4158,188770,"TIBIA, HYPOPLASIA OR APLASIA OF, WITH POLYDACTYLY",
4159,188800,"TIBIAL TORSION, BILATERAL MEDIAL",
4160,188825,TISSUE INHIBITOR OF METALLOPROTEINASE 2, TIMP2
4161,188826,TISSUE INHIBITOR OF METALLOPROTEINASE 3, TIMP3
4162,188830,"PROTEIN KINASE, cAMP-DEPENDENT, REGULATORY, TYPE I, ALPHA", PRKAR1A
4163,188840,TITIN, TTN
4164,188850,TL ANTIGEN,
4165,188855,GRANULYSIN, GNLY
4166,188860,MYELIN AND LYMPHOCYTE PROTEIN, MAL
4167,188890,"TOBACCO ADDICTION, SUSCEPTIBILITY TO",
4168,189000,"TOE, FIFTH, NUMBER OF PHALANGES IN",
4169,189100,"TOE, MISSHAPEN",
4170,189150,"TOE, ROTATED FIFTH",
4171,189200,"TOES, RELATIVE LENGTH OF FIRST AND SECOND",
4172,189230,"TOES, SPACE BETWEEN FIRST AND SECOND",
4173,189300,"TONGUE CURLING, FOLDING, OR ROLLING",
4174,189490,MALPOSITION OF TEETH WITH OR WITHOUT HYPODONTIA/OLIGODONTIA,
4175,189500,WITKOP SYNDROME,
4176,189600,TORTICOLLIS,
4177,189700,TORUS PALATINUS AND TORUS MANDIBULARIS,
4178,189800,PREECLAMPSIA/ECLAMPSIA 1, PEE1
4179,189880,tRNA ASPARAGINE (ANTICODON GTT) 2-7, TRN-GTT2-7
4180,189889,TRANSCRIPTION FACTOR CP2, TFCP2
4181,189890,TRANSFER RNA ASPARAGINE-LIKE, TRNL
4182,189901,TRANSCRIPTION FACTOR 9, TCF9
4183,189902,TRANSCRIPTION FACTOR DP1, TFDP1
4184,189903,"NUCLEAR TRANSCRIPTION FACTOR Y, ALPHA", NFYA
4185,189904,"NUCLEAR TRANSCRIPTION FACTOR Y, BETA", NFYB
4186,189905,TRANSCOBALAMIN I, TCN1
4187,189906,TRANSCRIPTION FACTOR Sp1, SP1
4188,189907,HNF1 HOMEOBOX B, HNF1B
4189,189908,TRANSCRIPTION FACTOR 7, TCF7
4190,189909,ZINC FINGER E BOX-BINDING HOMEOBOX 1, ZEB1
4191,189910,tRNA SERINE (ANTICODON AGA) 2-3, TRS-AGA2-3
4192,189911,tRNA GLYCINE (ANTICODON CCC) 1-1, TRG-CCC1-1
4193,189912,tRNA PROLINE (ANTICODON TGG) 3-1, TRP-TGG3-1
4194,189913,tRNA THREONINE (ANTICODON TGT) 6-1, TRT-TGT6-1
4195,189918,tRNA LYSINE (ANTICODON TTT) 3-5, TRK-TTT3-5
4196,189919,tRNA GLUTAMINE (ANTICODON CTG) 1-5, TRQ-CTG1-5
4197,189920,tRNA LEUCINE (ANTICODON TAG) 1-1, TRL-TAG1-1
4198,189921,tRNA VALINE (ANTICODON AAC) 1-4, TRV-AAC1-4
4199,189923,tRNA GLUTAMINE (ANTICODON TTG) 1-1, TRQ-TTG1-1
4200,189930,tRNA PROLINE (ANTICODON AGG) 2-5, TRP-AGG2-5
4201,189931,tRNA PROLINE (ANTICODON AGG) 2-6, TRP-AGG2-6
4202,189932,tRNA LEUCINE (ANTICODON AAG) 2-3, TRL-AAG2-3
4203,189933,tRNA THREONINE (ANTICODON TGT) 3-1, TRT-TGT3-1
4204,189940,TRANSLOCATED PROMOTER REGION, TPR
4205,189960,TRACHEOESOPHAGEAL FISTULA WITH OR WITHOUT ESOPHAGEAL ATRESIA,
4206,189961,TRACHEOPATHIA OSTEOPLASTICA,
4207,189962,"GENERAL TRANSCRIPTION FACTOR IIE, POLYPEPTIDE 1", GTF2E1
4208,189963,GENERAL TRANSCRIPTION FACTOR IIB, GTF2B
4209,189964,"GENERAL TRANSCRIPTION FACTOR IIE, POLYPEPTIDE 2", GTF2E2
4210,189965,"CCAAT/ENHANCER-BINDING PROTEIN, BETA", CEBPB
4211,189967,TEA DOMAIN FAMILY MEMBER 1, TEAD1
4212,189968,"GENERAL TRANSCRIPTION FACTOR IIF, POLYPEPTIDE 1, 74-KD", GTF2F1
4213,189969,"GENERAL TRANSCRIPTION FACTOR IIF, POLYPEPTIDE 2, 30-KD", GTF2F2
4214,189970,"GUANINE NUCLEOTIDE-BINDING PROTEIN, GAMMA-TRANSDUCING ACTIVITY POLYPEPTIDE 1", GNGT1
4215,189971,E2F TRANSCRIPTION FACTOR 1, E2F1
4216,189972,"GENERAL TRANSCRIPTION FACTOR IIH, POLYPEPTIDE 1", GTF2H1
4217,189973,E74-LIKE ETS TRANSCRIPTION FACTOR 1, ELF1
4218,189974,"GUANINE NUCLEOTIDE-BINDING PROTEIN, BETA-1",
4219,189980,"ABL PROTOONCOGENE 1, NONRECEPTOR TYROSINE KINASE", ABL1
4220,189990,"MYB PROTOONCOGENE, TRANSCRIPTION FACTOR", MYB
4221,190000,TRANSFERRIN, TF
4222,190010,TRANSFERRIN RECEPTOR, TFRC
4223,190020,"HRAS PROTOONCOGENE, GTPase", HRAS
4224,190030,"FES PROTOONCOGENE, TYROSINE KINASE", FES
4225,190040,"PLATELET-DERIVED GROWTH FACTOR, BETA POLYPEPTIDE", PDGFB
4226,190060,"MOS PROTOONCOGENE, SERINE/THREONINE KINASE", MOS
4227,190070,"KRAS PROTOONCOGENE, GTPase", KRAS
4228,190080,"MYC PROTOONCOGENE, bHLH TRANSCRIPTION FACTOR", MYC
4229,190090,"SRC PROTOONCOGENE, NONRECEPTOR TYROSINE KINASE", SRC
4230,190100,GENIOSPASM 1, GSM1
4231,190110,"KRAS PROTOONCOGENE, GTPase",
4232,190120,"THYROID HORMONE RECEPTOR, ALPHA-1", THRA
4233,190151,ERB-B2 RECEPTOR TYROSINE KINASE 3, ERBB3
4234,190160,"THYROID HORMONE RECEPTOR, BETA", THRB
4235,190170,"TRANSFORMING GROWTH FACTOR, ALPHA", TGFA
4236,190180,"TRANSFORMING GROWTH FACTOR, BETA-1", TGFB1
4237,190181,"TRANSFORMING GROWTH FACTOR-BETA RECEPTOR, TYPE I", TGFBR1
4238,190182,"TRANSFORMING GROWTH FACTOR-BETA RECEPTOR, TYPE II", TGFBR2
4239,190190,SUPPRESSOR OF ANCHORAGE INDEPENDENCE 1,
4240,190195,TRANSGLUTAMINASE 1, TGM1
4241,190196,TRANSGLUTAMINASE 2, TGM2
4242,190197,CONTACTIN 2, CNTN2
4243,190198,NOTCH RECEPTOR 1, NOTCH1
4244,190200,"TREMOR OF INTENTION, ATAXIA, AND LIPOFUSCINOSIS",
4245,190220,"TRANSFORMING GROWTH FACTOR, BETA-2", TGFB2
4246,190230,"TRANSFORMING GROWTH FACTOR, BETA-3", TGFB3
4247,190231,TRANSITION PROTEIN 1, TNP1
4248,190232,TRANSITION PROTEIN 2, TNP2
4249,190300,"TREMOR, HEREDITARY ESSENTIAL, 1", ETM1
4250,190310,"TREMOR, NYSTAGMUS, AND DUODENAL ULCER",
4251,190315,"SOLUTE CARRIER FAMILY 25 (MITOCHONDRIAL CARRIER, CITRATE TRANSPORTER), MEMBER 1", SLC25A1
4252,190320,TRICHODENTOOSSEOUS SYNDROME, TDO
4253,190330,TRICHOMEGALY, TCMGLY
4254,190340,"DISCOID FIBROMAS, FAMILIAL MULTIPLE", FMDF
4255,190345,"TRICHOEPITHELIOMAS, MULTIPLE DESMOPLASTIC",
4256,190350,"TRICHORHINOPHALANGEAL SYNDROME, TYPE I", TRPS1
4257,190351,"TRICHORHINOPHALANGEAL SYNDROME, TYPE III", TRPS3
4258,190360,TRICHODYSPLASIA-XERODERMA,
4259,190370,TRICHOHYALIN, TCHH
4260,190400,TRIGEMINAL NEURALGIA,
4261,190410,TRIGGER THUMB,
4262,190420,"TRIGLYCERIDE STORAGE DISEASE, TYPE I",
4263,190430,"TRIGLYCERIDE STORAGE DISEASE, TYPE II",
4264,190440,TRIGONOCEPHALY 1, TRIGNO1
4265,190445,TRIIODOTHYRONINE RECEPTOR AUXILIARY PROTEIN, TRAP
4266,190450,TRIOSEPHOSPHATE ISOMERASE 1, TPI1
4267,190470,TRIPEPTIDYL PEPTIDASE II, TPP2
4268,190500,TRIPHALANGEAL THUMB WITH DOUBLE PHALANGES,
4269,190600,"TRIPHALANGEAL THUMB, NONOPPOSABLE",
4270,190605,TRIPHALANGEAL THUMB WITH POLYSYNDACTYLY, TPTPS
4271,190650,TRIPHALANGEAL THUMBS AND DISLOCATION OF PATELLA,
4272,190680,TRIPHALANGEAL THUMBS WITH BRACHYECTRODACTYLY,
4273,190685,DOWN SYNDROME,
4274,190700,ZFP36 RING FINGER PROTEIN, ZFP36
4275,190800,TRISTICHIASIS,
4276,190900,TRITANOPIA,
4277,190920,TROPHOBLAST GLYCOPROTEIN, TPBG
4278,190930,TROPOMODULIN 1, TMOD1
4279,190940,"ENDOGENOUS RETROVIRAL SEQUENCE, TRUNCATED 1", ERVT1
4280,190950,"ENDOGENOUS RETROVIRAL SEQUENCE, TRUNCATED 2", ERVT2
4281,190960,"ENDOGENOUS RETROVIRAL SEQUENCE, TRUNCATED 3", ERVT3
4282,190970,"ENDOGENOUS RETROVIRAL SEQUENCE, TRUNCATED 4", ERVT4
4283,190980,"ENDOGENOUS RETROVIRAL SEQUENCE, TRUNCATED 5", ERVT5
4284,190990,TROPOMYOSIN 2, TPM2
4285,191000,"TROCHLEA OF THE HUMERUS, APLASIA OF",
4286,191010,TROPOMYOSIN 1, TPM1
4287,191020,CD46 ANTIGEN,
4288,191030,TROPOMYOSIN 3, TPM3
4289,191039,"TROPONIN C, FAST", TNNC2
4290,191040,"TROPONIN C, SLOW", TNNC1
4291,191041,"TROPONIN T1, SKELETAL, SLOW", TNNT1
4292,191042,"TROPONIN I, SLOW-TWITCH SKELETAL MUSCLE ISOFORM", TNNI1
4293,191043,"TROPONIN I, FAST-TWITCH SKELETAL MUSCLE ISOFORM", TNNI2
4294,191044,"TROPONIN I, CARDIAC", TNNI3
4295,191045,"TROPONIN T2, CARDIAC", TNNT2
4296,191050,TRYPTOPHANYL-tRNA SYNTHETASE 1, WARS1
4297,191060,TRYPTOPHAN HYDROXYLASE 1, TPH1
4298,191070,"TRYPTOPHAN 2,3-DIOXYGENASE", TDO2
4299,191080,"TRYPTASE, ALPHA/BETA-1", TPSAB1
4300,191081,"TRYPTASE, BETA-2", TPSB2
4301,191090,TUBEROUS SCLEROSIS 1,
4302,191091,TUBEROUS SCLEROSIS 1,
4303,191092,TSC COMPLEX SUBUNIT 2, TSC2
4304,191100,TUBEROUS SCLEROSIS 1, TSC1
4305,191110,"TUBULIN, ALPHA-4A", TUBA4A
4306,191120,"TUBULIN, ALPHA-LIKE 1", TUBAL1
4307,191130,"TUBULIN, BETA", TUBB
4308,191135,"TUBULIN, GAMMA-1", TUBG1
4309,191150,TUFTSIN DEFICIENCY,
4310,191155,"TRANSMEMBRANE 4 L6 FAMILY, MEMBER 1", TM4SF1
4311,191160,TUMOR NECROSIS FACTOR, TNF
4312,191161,TUMOR NECROSIS FACTOR-ALPHA-INDUCED PROTEIN 1, TNFAIP1
4313,191163,TUMOR NECROSIS FACTOR-ALPHA-INDUCED PROTEIN 3, TNFAIP3
4314,191164,EPHRIN A1, EFNA1
4315,191170,TUMOR PROTEIN p53, TP53
4316,191175,"HEAT-SHOCK PROTEIN, 90-KD, BETA, 1", HSP90B1
4317,191181,SUPPRESSOR OF TUMORIGENICITY 3, ST3
4318,191190,"TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY, MEMBER 1A", TNFRSF1A
4319,191191,"TUMOR NECROSIS FACTOR RECEPTOR SUBFAMILY, MEMBER 1B", TNFRSF1B
4320,191195,MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 8, MAP3K8
4321,191200,TUNE DEAFNESS,
4322,191250,TWINNING DUE TO SUPERFETATION,
4323,191270,TYROSINASE-LIKE, TYRL
4324,191275,DOPACHROME TAUTOMERASE, DCT
4325,191290,TYROSINE HYDROXYLASE, TH
4326,191305,"BLK PROTOONCOGENE, SRC FAMILY TYROSINE KINASE", BLK
4327,191306,KINASE INSERT DOMAIN RECEPTOR, KDR
4328,191309,ERB-B2 RECEPTOR TYROSINE KINASE 3,
4329,191311,"DISCOIDIN DOMAIN RECEPTOR FAMILY, MEMBER 2", DDR2
4330,191315,"NEUROTROPHIC TYROSINE KINASE, RECEPTOR, TYPE 1", NTRK1
4331,191316,"NEUROTROPHIC TYROSINE KINASE, RECEPTOR, TYPE 3", NTRK3
4332,191317,U2 SMALL NUCLEAR RNA AUXILIARY FACTOR 1, U2AF1
4333,191318,U2 SMALL NUCLEAR RNA AUXILIARY FACTOR 2, U2AF2
4334,191320,UBIQUITIN B,
4335,191321,UBIQUITIN A-52-RESIDUE RIBOSOMAL PROTEIN FUSION PRODUCT, UBA52
4336,191325,UBIQUITIN-LIKE MODIFIER ACTIVATING ENZYME 7, UBA7
4337,191327,"UBIQUINOL-CYTOCHROME c REDUCTASE, RIESKE IRON-SULFUR", UQCRFS1
4338,191328,UBIQUINOL-CYTOCHROME c REDUCTASE CORE PROTEIN I, UQCRC1
4339,191329,UBIQUINOL-CYTOCHROME c REDUCTASE CORE PROTEIN II, UQCRC2
4340,191330,UBIQUINOL-CYTOCHROME c REDUCTASE-BINDING PROTEIN, UQCRB
4341,191339,UBIQUITIN B, UBB
4342,191340,UBIQUITIN C, UBC
4343,191342,UBIQUITIN CARBOXYL-TERMINAL ESTERASE L1, UCHL1
4344,191343,RIBOSOMAL PROTEIN S27a, RPS27A
4345,191344,UBIQUITIN A-52-RESIDUE RIBOSOMAL PROTEIN FUSION PRODUCT,
4346,191350,DOLICHYL-PHOSPHATE N-ACETYLGLUCOSAMINE PHOSPHOTRANSFERASE, DPAGT1
4347,191390,INFLAMMATORY BOWEL DISEASE 11, IBD11
4348,191400,"ULNA AND FIBULA, HYPOPLASIA OF",
4349,191420,ULNA METAPHYSEAL DYSPLASIA SYNDROME,
4350,191440,ULNAR HYPOPLASIA,
4351,191480,UNCOMBABLE HAIR SYNDROME 1, UHS1
4352,191482,"UNCOMBABLE HAIR, RETINAL PIGMENTARY DYSTROPHY, DENTAL ANOMALIES, AND BRACHYDACTYLY",
4353,191500,UNDRITZ ANOMALY,
4354,191510,"COLD-SHOCK DOMAIN-CONTAINING E1, RNA-BINDING", CSDE1
4355,191520,UPINGTON DISEASE,
4356,191523,UPSTREAM TRANSCRIPTION FACTOR 1, USF1
4357,191525,URACIL-DNA GLYCOSYLASE, UNG
4358,191530,"URATE-BINDING GLOBULIN, DECREASE IN",
4359,191540,"URATE OXIDASE, PSEUDOGENE", UOX
4360,191550,"URETER, BIFID OR DOUBLE",
4361,191600,"URETER, CANCER OF",
4362,191650,URETEROCELE,
4363,191700,"UROLITHIASIS, URIC ACID, AUTOSOMAL DOMINANT",
4364,191710,"CYTIDINE MONOPHOSPHATE (UMP-CMP) KINASE 1, CYTOSOLIC", CMPK1
4365,191720,"5-PRIME,3-PRIME-NUCLEOTIDASE, CYTOSOLIC", NT5C
4366,191730,URIDINE PHOSPHORYLASE 1, UPP1
4367,191740,"UDP-GLYCOSYLTRANSFERASE 1 FAMILY, POLYPEPTIDE A1", UGT1A1
4368,191741,"UDP-GLYCOSYLTRANSFERASE 1 FAMILY, POLYPEPTIDE A1",
4369,191742,"URIDINE DIPHOSPHATE GLYCOSYLTRANSFERASE 2 FAMILY, MEMBER B4",
4370,191743,"URIDINE DIPHOSPHATE GLYCOSYLTRANSFERASE 2 FAMILY, MEMBER B4",
4371,191750,URIDYL DIPHOSPHATE GLUCOSE PYROPHOSPHORYLASE 2,
4372,191760,URIDYL DIPHOSPHATE GLUCOSE PYROPHOSPHORYLASE 2, UGP2
4373,191800,"BLADDER DYSFUNCTION, AUTONOMIC, WITH IMPAIRED PUPILLARY REFLEX AND SECONDARY CAKUT", BAIPRCK
4374,191810,EPIDERMAL GROWTH FACTOR,
4375,191830,RENAL HYPODYSPLASIA/APLASIA 1, RHDA1
4376,191840,"PLASMINOGEN ACTIVATOR, URINARY", PLAU
4377,191845,UROMODULIN, UMOD
4378,191850,"URTICARIA, AQUAGENIC",
4379,191900,MUCKLE-WELLS SYNDROME, MWS
4380,191950,"URTICARIA, FAMILIAL LOCALIZED HEAT",
4381,192000,UTERINE ANOMALIES,
4382,192020,"SECRETOGLOBIN, FAMILY 1A, MEMBER 1", SCGB1A1
4383,192050,UTERUS BICORNIS BICOLLIS WITH PARTIAL VAGINAL SEPTUM AND UNILATERAL HEMATOCOLPOS WITH IPSILATERAL RENAL AGENESIS,
4384,192070,TITLE NOT AVAILABLE AT THIS MOMENT,
4385,192090,CADHERIN 1, CDH1
4386,192100,"UVULA, BIFID",
4387,192130,"ATPase, H+ TRANSPORTING, LYSOSOMAL, V0 SUBUNIT A1", ATP6V0A1
4388,192132,"ATPase, H+ TRANSPORTING, LYSOSOMAL, 56/58-KD, V1 SUBUNIT B, ISOFORM 1", ATP6V1B1
4389,192150,VALYL-tRNA SYNTHETASE 1, VARS1
4390,192200,VARICOSE VEINS,
4391,192225,VASCULAR CELL ADHESION MOLECULE 1, VCAM1
4392,192240,VASCULAR ENDOTHELIAL GROWTH FACTOR A, VEGFA
4393,192300,VASCULAR HELIX OF UMBILICAL CORD,
4394,192310,"VASCULITIS, LYMPHOCYTIC, NODULAR",
4395,192315,"VASCULOPATHY, RETINAL, WITH CEREBRAL LEUKOENCEPHALOPATHY AND SYSTEMIC MANIFESTATIONS", RVCLS
4396,192320,VASOACTIVE INTESTINAL PEPTIDE, VIP
4397,192321,VASOACTIVE INTESTINAL PEPTIDE RECEPTOR 1, VIPR1
4398,192340,ARGININE VASOPRESSIN, AVP
4399,192350,VATER/VACTERL ASSOCIATION,
4400,192400,"VEINS, PATTERN OF, ON ANTERIOR THORAX",
4401,192430,VELOCARDIOFACIAL SYNDROME, VCFS
4402,192445,"VENTRICULAR EXTRASYSTOLES WITH SYNCOPE, PERODACTYLY, AND ROBIN SEQUENCE",
4403,192450,"VENTRICULAR FIBRILLATION, PAROXYSMAL FAMILIAL, 1",
4404,192500,LONG QT SYNDROME 1, LQT1
4405,192600,"CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 1", CMH1
4406,192605,"VENTRICULAR TACHYCARDIA, FAMILIAL",
4407,192700,"VENULAR INSUFFICIENCY, SYSTEMIC",
4408,192800,"VERTEBRAL FUSION, POSTERIOR LUMBOSACRAL, WITH BLEPHAROPTOSIS",
4409,192900,VERTEBRAL HYPOPLASIA WITH LUMBAR KYPHOSIS,
4410,192950,"VERTICAL TALUS, CONGENITAL", CVT
4411,192968,"INTEGRIN, ALPHA-1", ITGA1
4412,192972,"INTEGRIN, ALPHA-4",
4413,192974,"INTEGRIN, ALPHA-2", ITGA2
4414,192975,"INTEGRIN, ALPHA-4", ITGA4
4415,192977,VERY LOW DENSITY LIPOPROTEIN RECEPTOR, VLDLR
4416,193000,VESICOURETERAL REFLUX 1, VUR1
4417,193001,"SOLUTE CARRIER FAMILY 18 (VESICULAR MONOAMINE), MEMBER 2", SLC18A2
4418,193002,"SOLUTE CARRIER FAMILY 18 (VESICULAR MONOAMINE), MEMBER 1", SLC18A1
4419,193003,SPINOCEREBELLAR ATAXIA 27A, SCA27A
4420,193005,"VESTIBULOCOCHLEAR DYSFUNCTION, PROGRESSIVE",
4421,193007,"VERTIGO, BENIGN RECURRENT", BRV
4422,193010,BONE MORPHOGENETIC PROTEIN 6,
4423,193040,VILLIN 1, VIL1
4424,193050,VIBRATORY URTICARIA,
4425,193060,VIMENTIN, VIM
4426,193065,VINCULIN, VCL
4427,193067,"FLI1 PROTOONCOGENE, ETS TRANSCRIPTION FACTOR", FLI1
4428,193070,VIRUS RD114 RNA COMPLEMENTARITY,
4429,193090,TRANSCOBALAMIN I DEFICIENCY, TCN1D
4430,193100,"HYPOPHOSPHATEMIC RICKETS, AUTOSOMAL DOMINANT", ADHR
4431,193190,VITRONECTIN, VTN
4432,193200,VITILIGO-ASSOCIATED MULTIPLE AUTOIMMUNE DISEASE SUSCEPTIBILITY 6, VAMAS6
4433,193210,"INTEGRIN, ALPHA-V", ITGAV
4434,193220,VITREORETINOCHOROIDOPATHY, VRCP
4435,193230,"VITREORETINAL DEGENERATION, SNOWFLAKE TYPE", SVD
4436,193235,"VITREORETINOPATHY, NEOVASCULAR INFLAMMATORY", VRNI
4437,193240,VOCAL CORD PARALYSIS AND PTOSIS,
4438,193245,VOLTAGE-DEPENDENT ANION CHANNEL 2, VDAC2
4439,193250,VOLVULUS OF MIDGUT,
4440,193290,LIPOCALIN 1,
4441,193300,VON HIPPEL-LINDAU SYNDROME, VHLS
4442,193400,"VON WILLEBRAND DISEASE, TYPE 1", VWD1
4443,193450,"VULVOVAGINITIS, ALLERGIC SEMINAL",
4444,193500,"WAARDENBURG SYNDROME, TYPE 1", WS1
4445,193510,"WAARDENBURG SYNDROME, TYPE 2A", WS2A
4446,193520,WATSON SYNDROME, WTSN
4447,193525,WEE1 G2 CHECKPOINT KINASE, WEE1
4448,193530,WEYERS ACROFACIAL DYSOSTOSIS, WAD
4449,193670,WHIM SYNDROME 1, WHIMS1
4450,193675,TITLE NOT AVAILABLE AT THIS MOMENT,
4451,193680,"DYSTONIA 4, TORSION, AUTOSOMAL DOMINANT",
4452,193700,"ARTHROGRYPOSIS, DISTAL, TYPE 2A", DA2A
4453,193900,WHITE SPONGE NEVUS 1, WSN1
4454,194000,WIDOW'S PEAK,
4455,194050,WILLIAMS-BEUREN SYNDROME, WBS
4456,194070,WILMS TUMOR 1, WT1
4457,194071,WILMS TUMOR 2, WT2
4458,194072,"WILMS TUMOR, ANIRIDIA, GENITOURINARY ANOMALIES, AND IMPAIRED INTELLECTUAL DEVELOPMENT SYNDROME", WAGR
4459,194080,DENYS-DRASH SYNDROME, DDS
4460,194090,WILMS TUMOR 3, WT3
4461,194100,"TOOTH AGENESIS, SELECTIVE, 1",
4462,194190,WOLF-HIRSCHHORN SYNDROME, WHS
4463,194200,WOLFF-PARKINSON-WHITE SYNDROME, WPW
4464,194300,"WOOLLY HAIR, AUTOSOMAL DOMINANT", ADWH
4465,194320,WORONETS TRAIT,
4466,194350,WT LIMB-BLOOD SYNDROME,
4467,194355,X BOX-BINDING PROTEIN 1, XBP1
4468,194360,X-RAY REPAIR CROSS COMPLEMENTING 1, XRCC1
4469,194363,X-RAY REPAIR CROSS COMPLEMENTING 4, XRCC4
4470,194364,X-RAY REPAIR CROSS COMPLEMENTING 5, XRCC5
4471,194370,X-RAY SENSITIVITY, XRS
4472,194380,DEHYDRATED HEREDITARY STOMATOCYTOSIS 1 WITH OR WITHOUT PSEUDOHYPERKALEMIA AND/OR PERINATAL EDEMA, DHS1
4473,194400,"XERODERMA PIGMENTOSUM, AUTOSOMAL DOMINANT, MILD",
4474,194450,YEAST FACTOR,
4475,194460,"ALPHA-2-GLYCOPROTEIN, ZINC", AZGP1
4476,194470,"ZINC, ELEVATED PLASMA",
4477,194480,ZFP3 RING FINGER PROTEIN, ZFP3
4478,194490,ZINC FINGER PROTEIN 1, ZNF1
4479,194500,ZINC FINGER PROTEIN 2, ZNF2
4480,194510,ZINC FINGER PROTEIN 3, ZNF3
4481,194520,TITLE NOT AVAILABLE AT THIS MOMENT,
4482,194521,ZINC FINGER PROTEIN 33A, ZNF33A
4483,194522,ZINC FINGER PROTEIN 33B, ZNF33B
4484,194524,ZINC FINGER PROTEIN 18, ZNF18
4485,194525,ZINC FINGER PROTEIN 19, ZNF19
4486,194526,ZINC FINGER PROTEIN 34, ZNF34
4487,194527,ZINC FINGER PROTEIN 23, ZNF23
4488,194528,ZINC FINGER PROTEIN 25, ZNF25
4489,194529,ZINC FINGER PROTEIN 22, ZNF22
4490,194530,TITLE NOT AVAILABLE AT THIS MOMENT,
4491,194531,ZINC FINGER PROTEIN 7, ZNF7
4492,194532,ZINC FINGER PROTEIN 8, ZNF8
4493,194533,ZINC FINGER PROTEIN 35, ZNF35
4494,194534,ZINC FINGER PROTEIN 24, ZNF24
4495,194535,"ZINC FINGER PROTEIN 29, PSEUDOGENE", ZNF29P
4496,194536,ZINC FINGER PROTEIN 12, ZNF12
4497,194537,ZINC FINGER PROTEIN 26, ZNF26
4498,194538,ZINC FINGER PROTEIN 10, ZNF10
4499,194539,ZINC FINGER PROTEIN 32, ZNF32
4500,194540,HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 ENHANCER-BINDING PROTEIN 1, HIVEP1
4501,194541,ZINC FINGER- AND BTB DOMAIN-CONTAINING PROTEIN 25, ZBTB25
4502,194542,ZINC FINGER PROTEIN 44, ZNF44
4503,194543,ZINC FINGER PROTEIN 69, ZNF69
4504,194544,ZINC FINGER PROTEIN 70, ZNF70
4505,194545,ZINC FINGER PROTEIN 71, ZNF71
4506,194546,ZINC FINGER PROTEIN 72, ZNF72
4507,194547,ZINC FINGER PROTEIN 73, ZNF73
4508,194548,ZINC FINGER PROTEIN 74, ZNF74
4509,194549,ZINC FINGER PROTEIN 76, ZNF76
4510,194550,MYELOID ZINC FINGER 1, MZF1
4511,194551,ZINC FINGER PROTEIN 77, ZNF77
4512,194552,ZINC FINGER PROTEIN 79, ZNF79
4513,194553,ZINC FINGER PROTEIN 80, ZNF80
4514,194554,ZINC FINGER PROTEIN 45, ZNF45
4515,194555,ZINC FINGER PROTEIN 224, ZNF224
4516,194556,ZINC FINGER PROTEIN 14, ZNF14
4517,194557,ZINC FINGER PROTEIN 20, ZNF20
4518,194558,ZINC FINGER PROTEIN 83, ZNF83
4519,194624,ZINC FINGER PROTEIN 117, ZNF117
4520,194628,ZINC FINGER PROTEIN 121, ZNF121
4521,194630,"ZINC FINGER PROTEIN 123, PSEUDOGENE", ZNF123P
4522,194631,ZINC FINGER PROTEIN 124, ZNF124
4523,194632,ZINC FINGER PROTEIN 125, ZNF125
4524,194633,ZINC FINGER PROTEIN 126, ZNF126
4525,194648,ZINC FINGER PROTEIN 141, ZNF141
4526,195000,ZONA PELLUCIDA GLYCOPROTEIN 1, ZP1
4527,195002,ZONA PELLUCIDA GLYCOPROTEIN 3,
4528,200100,ABETALIPOPROTEINEMIA, ABL
4529,200110,ABLEPHARON-MACROSTOMIA SYNDROME, AMS
4530,200130,ABSENT EYEBROWS AND EYELASHES WITH IMPAIRED INTELLECTUAL DEVELOPMENT,
4531,200150,CHOREOACANTHOCYTOSIS, CHAC
4532,200170,ACANTHOSIS NIGRICANS WITH MUSCLE CRAMPS AND ACRAL ENLARGEMENT,
4533,200300,ACETOPHENETIDIN SENSITIVITY,
4534,200350,ACETYL-CoA CARBOXYLASE-ALPHA, ACACA
4535,200400,"ACHALASIA, FAMILIAL ESOPHAGEAL",
4536,200440,ACHALASIA-ADDISONIANISM-ALACRIMA SYNDROME,
4537,200450,ACHALASIA-MICROCEPHALY SYNDROME,
4538,200500,ACHEIROPODY, ACHP
4539,200600,"ACHONDROGENESIS, TYPE IA", ACG1A
4540,200610,"ACHONDROGENESIS, TYPE II", ACG2
4541,200700,ACROMESOMELIC DYSPLASIA 2A, AMD2A
4542,200710,"ACHONDROGENESIS, TYPE II",
4543,200720,"ACHONDROGENESIS, TYPE II",
4544,200900,SHORT-LIMB SKELETAL DYSPLASIA WITH SEVERE COMBINED IMMUNODEFICIENCY,
4545,200930,TITLE NOT AVAILABLE AT THIS MOMENT,
4546,200950,ACID PHOSPHATASE DEFICIENCY,
4547,200970,ACKERMAN SYNDROME,
4548,200980,ACRORENAL-MANDIBULAR SYNDROME,
4549,200990,ACROCALLOSAL SYNDROME, ACLS
4550,200995,ACROCEPHALOPOLYDACTYLOUS DYSPLASIA,
4551,201000,CARPENTER SYNDROME 1, CRPT1
4552,201020,ACROCEPHALOPOLYSYNDACTYLY TYPE IV,
4553,201050,ACROCRANIOFACIAL DYSOSTOSIS,
4554,201100,"ACRODERMATITIS ENTEROPATHICA, ZINC-DEFICIENCY TYPE", AEZ
4555,201170,ACROFACIAL DYSOSTOSIS SYNDROME OF RODRIGUEZ,
4556,201180,ACROFRONTOFACIONASAL DYSOSTOSIS 1,
4557,201181,ACROFRONTOFACIONASAL DYSOSTOSIS 2,
4558,201200,"ACROGERIA, GOTTRON TYPE",
4559,201250,ACROMESOMELIC DYSPLASIA 2C, AMD2C
4560,201300,"NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE IIA", HSAN2A
4561,201310,"ACRORENAL SYNDROME, AUTOSOMAL RECESSIVE",
4562,201400,"ACTH DEFICIENCY, ISOLATED", IAD
4563,201450,"ACYL-CoA DEHYDROGENASE, MEDIUM-CHAIN, DEFICIENCY OF", ACADMD
4564,201460,"ACYL-CoA DEHYDROGENASE, VERY LONG-CHAIN, DEFICIENCY OF",
4565,201470,"ACYL-CoA DEHYDROGENASE, SHORT-CHAIN, DEFICIENCY OF", ACADSD
4566,201475,"ACYL-CoA DEHYDROGENASE, VERY LONG-CHAIN, DEFICIENCY OF", ACADVLD
4567,201550,ADDUCTED THUMBS SYNDROME,
4568,201710,LIPOID CONGENITAL ADRENAL HYPERPLASIA, LCAH
4569,201750,ANTLEY-BIXLER SYNDROME WITH GENITAL ANOMALIES AND DISORDERED STEROIDOGENESIS, ABS1
4570,201810,"ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 3-BETA-HYDROXYSTEROID DEHYDROGENASE 2 DEFICIENCY",
4571,201910,"ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 21-HYDROXYLASE DEFICIENCY",
4572,202010,"ADRENAL HYPERPLASIA, CONGENITAL, DUE TO STEROID 11-BETA-HYDROXYLASE DEFICIENCY",
4573,202110,"ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 17-ALPHA-HYDROXYLASE DEFICIENCY",
4574,202150,"ADRENAL HYPOPLASIA, CONGENITAL, WITH ABSENT PITUITARY LUTEINIZING HORMONE",
4575,202155,"ADRENAL HYPOPLASIA, CYTOMEGALIC TYPE",
4576,202200,GLUCOCORTICOID DEFICIENCY 1, GCCD1
4577,202300,"ADRENOCORTICAL CARCINOMA, HEREDITARY", ADCC
4578,202355,ADRENOCORTICAL UNRESPONSIVENESS TO ACTH WITH POSTRECEPTOR DEFECT,
4579,202370,PEROXISOME BIOGENESIS DISORDER 2B, PBD2B
4580,202400,"AFIBRINOGENEMIA, CONGENITAL",
4581,202500,"PROTEIN KINASE, DNA-ACTIVATED, CATALYTIC SUBUNIT",
4582,202550,"AGANGLIONOSIS, TOTAL INTESTINAL",
4583,202600,AGENESIS OF CEREBRAL WHITE MATTER,
4584,202650,AGNATHIA-OTOCEPHALY COMPLEX, AGOTC
4585,202660,PAGOD SYNDROME,
4586,202700,"NEUTROPENIA, SEVERE CONGENITAL, 1, AUTOSOMAL DOMINANT", SCN1
4587,202900,"ALANINURIA WITH MICROCEPHALY, DWARFISM, ENAMEL HYPOPLASIA, AND DIABETES MELLITUS",
4588,203000,FRONTONASAL DYSPLASIA WITH ALAR CLEFTS,
4589,203100,"ALBINISM, OCULOCUTANEOUS, TYPE IA", OCA1A
4590,203200,"ALBINISM, OCULOCUTANEOUS, TYPE II", OCA2
4591,203280,"ALBINISM, OCULOCUTANEOUS, TYPE IB",
4592,203285,HERMANSKY-PUDLAK SYNDROME 2,
4593,203290,"ALBINISM, OCULOCUTANEOUS, TYPE III", OCA3
4594,203300,HERMANSKY-PUDLAK SYNDROME 1, HPS1
4595,203310,"ALBINISM, OCULOCUTANEOUS, TYPE II",
4596,203330,"PSEUDOHYPOPARATHYROIDISM, TYPE II", PHP2
4597,203340,ALBINISM-MICROCEPHALY-DIGITAL ANOMALIES SYNDROME,
4598,203400,CORTICOSTERONE METHYLOXIDASE TYPE I DEFICIENCY,
4599,203450,ALEXANDER DISEASE, ALXDRD
4600,203500,ALKAPTONURIA, AKU
4601,203550,"INTELLECTUAL DEVELOPMENTAL SYNDROME WITH ALOPECIA, CONTRACTURES, AND DWARFISM",
4602,203600,ALOPECIA-EPILEPSY-OLIGOPHRENIA SYNDROME OF MOYNAHAN,
4603,203650,ALOPECIA-INTELLECTUAL DISABILITY SYNDROME 1, APMR1
4604,203655,ALOPECIA UNIVERSALIS CONGENITA, ALUNC
4605,203700,MITOCHONDRIAL DNA DEPLETION SYNDROME 4A (ALPERS TYPE), MTDPS4A
4606,203740,OXOGLUTARATE DEHYDROGENASE DEFICIENCY, OGDHD
4607,203750,ALPHA-METHYLACETOACETIC ACIDURIA,
4608,203760,ALPHA-2-DEFICIENT COLLAGEN DISEASE,
4609,203780,"ALPORT SYNDROME 2, AUTOSOMAL RECESSIVE", ATS2
4610,203800,ALSTROM SYNDROME, ALMS
4611,204000,LEBER CONGENITAL AMAUROSIS 1, LCA1
4612,204100,LEBER CONGENITAL AMAUROSIS 2, LCA2
4613,204110,"AMAUROSIS CONGENITA, CONE-ROD TYPE, WITH CONGENITAL HYPERTRICHOSIS",
4614,204200,"CEROID LIPOFUSCINOSIS, NEURONAL, 3", CLN3
4615,204300,"CEROID LIPOFUSCINOSIS, NEURONAL, 6B (KUFS TYPE)", CLN6B
4616,204400,TITLE NOT AVAILABLE AT THIS MOMENT,
4617,204500,"CEROID LIPOFUSCINOSIS, NEURONAL, 2", CLN2
4618,204600,"CEROID LIPOFUSCINOSIS, NEURONAL, 2",
4619,204650,"AMELOGENESIS IMPERFECTA, TYPE IC", AI1C
4620,204690,"AMELOGENESIS IMPERFECTA, TYPE IG", AI1G
4621,204700,"AMELOGENESIS IMPERFECTA, HYPOMATURATION TYPE, IIA1", AI2A1
4622,204730,"AMINO ACIDURIA WITH MENTAL DEFICIENCY, DWARFISM, MUSCULAR DYSTROPHY, OSTEOPOROSIS, AND ACIDOSIS",
4623,204750,ALPHA-AMINOADIPIC AND ALPHA-KETOADIPIC ACIDURIA, AAKAD
4624,204800,"AMOBARBITAL, DEFICIENT N-HYDROXYLATION OF",
4625,204850,AMYLOIDOSIS OF GINGIVA AND CONJUNCTIVA WITH IMPAIRED INTELLECTUAL DEVELOPMENT,
4626,204870,"CORNEAL DYSTROPHY, GELATINOUS DROP-LIKE", GDLD
4627,204900,"AMYLOIDOSIS, CUTANEOUS BULLOUS",
4628,205000,AMYOTONIA CONGENITA,
4629,205100,"AMYOTROPHIC LATERAL SCLEROSIS 2, JUVENILE", ALS2
4630,205200,"AMYOTROPHIC LATERAL SCLEROSIS, JUVENILE, WITH DEMENTIA",
4631,205250,AMYOTROPHIC LATERAL SCLEROSIS WITH POLYGLUCOSAN BODIES,
4632,205400,TANGIER DISEASE, TGD
4633,205600,DIAMOND-BLACKFAN ANEMIA 1,
4634,205700,"ANEMIA, AUTOIMMUNE HEMOLYTIC",
4635,205900,DIAMOND-BLACKFAN ANEMIA 1,
4636,205950,"ANEMIA, SIDEROBLASTIC, 2, PYRIDOXINE-REFRACTORY", SIDBA2
4637,206000,"ANEMIA, SIDEROBLASTIC, PYRIDOXINE-RESPONSIVE, AUTOSOMAL RECESSIVE",
4638,206100,"ANEMIA, HYPOCHROMIC MICROCYTIC, WITH IRON OVERLOAD 1", AHMIO1
4639,206200,IRON-REFRACTORY IRON DEFICIENCY ANEMIA, IRIDA
4640,206300,"ANEMIA, NONSPHEROCYTIC HEMOLYTIC, ASSOCIATED WITH ABNORMALITY OF RED CELL MEMBRANE",
4641,206400,"ANEMIA, NONSPHEROCYTIC HEMOLYTIC, POSSIBLY DUE TO DEFECT IN PORPHYRIN METABOLISM",
4642,206500,ANENCEPHALY 1, ANPH1
4643,206550,"ANGIOLIPOMATOSIS, FAMILIAL",
4644,206570,"ANGIOMATOSIS, DIFFUSE CORTICOMENINGEAL, OF DIVRY AND VAN BOGAERT",
4645,206600,"ANHIDROSIS, FAMILIAL GENERALIZED, WITH ABNORMAL OR ABSENT SWEAT GLANDS",
4646,206700,GILLESPIE SYNDROME, GLSP
4647,206750,"ANIRIDIA, PARTIAL, WITH UNILATERAL RENAL AGENESIS AND PSYCHOMOTOR RETARDATION",
4648,206780,ANODONTIA OF PERMANENT DENTITION,
4649,206800,"NAIL DISORDER, NONSYNDROMIC CONGENITAL, 4", NDNC4
4650,206900,"MICROPHTHALMIA, SYNDROMIC 3", MCOPS3
4651,206920,MICROPHTHALMIA WITH LIMB ANOMALIES, MLA
4652,207000,ANOSMIA FOR ISOBUTYRIC ACID,
4653,207300,"ANTITHROMBIN, FAMILIAL HEMORRHAGIC DIATHESIS DUE TO",
4654,207410,ANTLEY-BIXLER SYNDROME WITHOUT GENITAL ANOMALIES OR DISORDERED STEROIDOGENESIS, ABS2
4655,207500,"ANUS, IMPERFORATE",
4656,207600,TAKAYASU ARTERITIS,
4657,207620,APHALANGY WITH HEMIVERTEBRAE,
4658,207700,"APLASIA CUTIS CONGENITA, NONSYNDROMIC",
4659,207720,"APNEA, CENTRAL SLEEP",
4660,207731,APLASIA CUTIS CONGENITA WITH INTESTINAL LYMPHANGIECTASIA,
4661,207740,"APLASIA OF EXTENSOR MUSCLES OF FINGERS, UNILATERAL, WITH GENERALIZED POLYNEUROPATHY",
4662,207750,APOLIPOPROTEIN C-II DEFICIENCY,
4663,207765,APPARENT MINERALOCORTICOID EXCESS,
4664,207770,APROSENCEPHALY SYNDROME,
4665,207780,AREDYLD,
4666,207790,"ARACHNOID CYSTS, INTRACRANIAL",
4667,207800,ARGININEMIA,
4668,207900,ARGININOSUCCINIC ACIDURIA,
4669,207950,CHIARI MALFORMATION TYPE II,
4670,208000,"ARTERIAL CALCIFICATION, GENERALIZED, OF INFANCY, 1", GACI1
4671,208050,ARTERIAL TORTUOSITY SYNDROME, ATORS
4672,208060,"ARTERIOSCLEROSIS, SEVERE JUVENILE",
4673,208080,SCHAAF-YANG SYNDROME,
4674,208081,"ARTHROGRYPOSIS, DISTAL, WITH IMPAIRED INTELLECTUAL DEVELOPMENT AND CHARACTERISTIC FACIES",
4675,208085,"ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 1", ARCS1
4676,208100,"ARTHROGRYPOSIS MULTIPLEX CONGENITA 2, NEUROGENIC TYPE", AMC2
4677,208110,ILLUM SYNDROME,
4678,208150,FETAL AKINESIA DEFORMATION SEQUENCE 1, FADS1
4679,208155,ILLUM SYNDROME,
4680,208158,ARTHROGRYPOSIS WITH HYPERKERATOSIS,
4681,208200,BRUCK SYNDROME 1,
4682,208230,PROGRESSIVE PSEUDORHEUMATOID DYSPLASIA, PPRD
4683,208250,CAMPTODACTYLY-ARTHROPATHY-COXA VARA-PERICARDITIS SYNDROME, CACP
4684,208300,"ASCITES, CHYLOUS",
4685,208400,ASPARTYLGLUCOSAMINURIA, AGU
4686,208500,SHORT-RIB THORACIC DYSPLASIA 1 WITH OR WITHOUT POLYDACTYLY, SRTD1
4687,208530,RIGHT ATRIAL ISOMERISM, RAI
4688,208540,RENAL-HEPATIC-PANCREATIC DYSPLASIA 1, RHPD1
4689,208550,"ASTHMA, NASAL POLYPS, AND ASPIRIN INTOLERANCE",
4690,208600,"ASTHMA, SHORT STATURE, AND ELEVATED IgA",
4691,208700,ATAXIA WITH MYOCLONIC EPILEPSY AND PRESENILE DEMENTIA,
4692,208750,"ATAXIA, DEAFNESS, AND CARDIOMYOPATHY",
4693,208800,PYRUVATE DEHYDROGENASE E1-ALPHA DEFICIENCY,
4694,208850,ATAXIA-DEAFNESS-RETARDATION SYNDROME,
4695,208870,ATAXIA-MICROCEPHALY-CATARACT SYNDROME,
4696,208900,ATAXIA-TELANGIECTASIA, AT
4697,208905,ATAXIA-TELANGIECTASIA,
4698,208910,ATAXIA-TELANGIECTASIA WITH GENERALIZED SKIN PIGMENTATION AND EARLY DEATH,
4699,208920,"ATAXIA, EARLY-ONSET, WITH OCULOMOTOR APRAXIA AND HYPOALBUMINEMIA", EAOH
4700,209000,PURINE NUCLEOSIDE PHOSPHORYLASE DEFICIENCY,
4701,209010,"ATHEROSCLEROSIS, PREMATURE, WITH DEAFNESS, NEPHROPATHY, DIABETES MELLITUS, PHOTOMYOCLONUS, AND DEGENERATIVE NEUROLOGIC DISEASE",
4702,209050,"ATHROMBIA, ESSENTIAL",
4703,209100,ATONIC-ASTATIC SYNDROME OF FOERSTER,
4704,209300,ATRANSFERRINEMIA,
4705,209400,ATRIOVENTRICULAR SEPTAL DEFECT,
4706,209500,ATRICHIA WITH PAPULAR LESIONS, APL
4707,209600,ATRIOVENTRICULAR DISSOCIATION,
4708,209700,ATROPHODERMA VERMICULATA, AVA
4709,209750,IMMUNODEFICIENCY 27A,
4710,209770,"AURAL ATRESIA, MULTIPLE CONGENITAL ANOMALIES, AND IMPAIRED INTELLECTUAL DEVELOPMENT",
4711,209800,AUSTRALIA ANTIGEN,
4712,209850,AUTISM,
4713,209880,"CENTRAL HYPOVENTILATION SYNDROME, CONGENITAL, 1", CCHS1
4714,209885,BARBER-SAY SYNDROME, BBRSAY
4715,209900,BARDET-BIEDL SYNDROME 1, BBS1
4716,209901,BBS1 GENE, BBS1
4717,209920,MHC CLASS II DEFICIENCY 1, MHC2D1
4718,209930,"BARTTER SYNDROME, TYPE 2, ANTENATAL",
4719,209950,IMMUNODEFICIENCY 27A, IMD27A
4720,209970,BEEMER LETHAL MALFORMATION SYNDROME,
4721,210000,BEHR SYNDROME, BEHRS
4722,210050,"BERRY ANEURYSM, CIRRHOSIS, PULMONARY EMPHYSEMA, AND CEREBRAL CALCIFICATION",
4723,210100,BETA-AMINOISOBUTYRIC ACIDURIA, BAIBA
4724,210200,3-METHYLCROTONYL-CoA CARBOXYLASE 1 DEFICIENCY, MCC1D
4725,210210,3-METHYLCROTONYL-CoA CARBOXYLASE 2 DEFICIENCY, MCC2D
4726,210250,SITOSTEROLEMIA 1, STSL1
4727,210300,"NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE IIA",
4728,210350,BIEMOND SYNDROME II,
4729,210370,BIETTI CRYSTALLINE CORNEORETINAL DYSTROPHY, BCD
4730,210400,"BIFID NOSE, AUTOSOMAL RECESSIVE",
4731,210450,"BILE ACID SYNTHESIS DEFECT, CONGENITAL, 1",
4732,210500,"BILIARY ATRESIA, EXTRAHEPATIC", EHBA
4733,210550,"ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 1",
4734,210600,SECKEL SYNDROME 1, SCKL1
4735,210700,"MICROCEPHALIC PRIMORDIAL DWARFISM, MONTREAL TYPE",
4736,210710,"MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE I", MOPD1
4737,210720,"MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE II", MOPD2
4738,210730,"MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE I",
4739,210740,BANGSTAD SYNDROME,
4740,210745,"BLEPHAROPHIMOSIS WITH PTOSIS, SYNDACTYLY, AND SHORT STATURE",
4741,210750,"SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 6", SHEP6
4742,210900,BLOOM SYNDROME, BLM
4743,211000,BLUE DIAPER SYNDROME,
4744,211100,FUCOSYLTRANSFERASE 1, FUT1
4745,211120,"BONE DYSPLASIA, LETHAL, HOLMGREN TYPE",
4746,211170,FRANK-TER HAAR SYNDROME,
4747,211180,BOWEN-CONRADI SYNDROME, BWCNS
4748,211200,BOWEN SYNDROME OF MULTIPLE MALFORMATIONS,
4749,211350,KYPHOMELIC DYSPLASIA, KMD
4750,211355,"BOWING OF LONG BONES, ASYMMETRIC AND SYMMETRIC",
4751,211369,"BRACHYDACTYLY, TYPE A2, WITH MICROCEPHALY",
4752,211370,BRACHYMETAPODY-ANODONTIA-HYPOTRICHOSIS-ALBINOIDISM,
4753,211380,ELSAHY-WATERS SYNDROME, ESWS
4754,211390,SABINAS BRITTLE HAIR SYNDROME,
4755,211400,BRONCHIECTASIS WITH OR WITHOUT ELEVATED SWEAT CHLORIDE 1, BESC1
4756,211410,"CANCER, FAMILIAL, WITH IN VITRO RADIORESISTANCE",
4757,211420,TITLE NOT AVAILABLE AT THIS MOMENT,
4758,211450,WILLIAMS-CAMPBELL SYNDROME,
4759,211480,BUERGER DISEASE,
4760,211500,FAZIO-LONDE DISEASE,
4761,211530,BROWN-VIALETTO-VAN LAERE SYNDROME 1, BVVLS1
4762,211550,"PROGRESSIVE FAMILIAL HEART BLOCK, TYPE IA",
4763,211600,"CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC, 1", PFIC1
4764,211750,C SYNDROME,
4765,211770,CAHMR SYNDROME,
4766,211800,CALCIFICATION OF JOINTS AND ARTERIES, CALJA
4767,211890,"CAMPOMELIA, CUMMING TYPE",
4768,211900,"TUMORAL CALCINOSIS, HYPERPHOSPHATEMIC, FAMILIAL, 1", HFTC1
4769,211910,"CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE I", GCS1
4770,211920,"CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE II",
4771,211930,CAMPTODACTYLY WITH FIBROUS TISSUE HYPERPLASIA AND SKELETAL DYSPLASIA,
4772,211960,"CAMPTODACTYLY WITH MUSCULAR HYPOPLASIA, SKELETAL DYSPLASIA, AND ABNORMAL PALMAR CREASES",
4773,211965,CAMPTODACTYLY-ICHTHYOSIS SYNDROME,
4774,211970,CAMPOMELIC DYSPLASIA,
4775,211980,LUNG CANCER,
4776,211990,"CAMPTOMELIC SYNDROME, LONG-LIMB TYPE",
4777,212050,"IMMUNODEFICIENCY 103, SUSCEPTIBILITY TO FUNGAL INFECTIONS", IMD103
4778,212060,CARBIMAZOLE SENSITIVITY,
4779,212065,"CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ia", CDG1A
4780,212066,"CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIa", CDG2A
4781,212067,"CONGENITAL DISORDER OF GLYCOSYLATION, TYPE I/IIx",
4782,212070,CARBOXYPEPTIDASE N DEFICIENCY, CPND
4783,212080,"CARDIAC LIPIDOSIS, FAMILIAL",
4784,212090,CARDIAC SEPTAL DEFECTS WITH COARCTATION OF THE AORTA,
4785,212093,CARDIAC VALVULAR DYSPLASIA 1, CVDP1
4786,212100,CARDIOAUDITORY SYNDROME OF SANCHEZ CASCOS,
4787,212110,"CARDIOMYOPATHY, DILATED, 2A",
4788,212112,"CARDIOMYOPATHY, DILATED, WITH HYPERGONADOTROPIC HYPOGONADISM",
4789,212120,"CARDIOMYOPATHY, DILATED, WITH HYPERGONADOTROPIC HYPOGONADISM",
4790,212130,CARDIOMYOPATHY ASSOCIATED WITH MYOPATHY AND SUDDEN DEATH,
4791,212135,"CARDIOSKELETAL SYNDROME, KUWAITI TYPE",
4792,212138,CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY, CACTD
4793,212140,"CARNITINE DEFICIENCY, SYSTEMIC PRIMARY", CDSP
4794,212160,"CARNITINE DEFICIENCY, MYOPATHIC",
4795,212200,CARNOSINEMIA,
4796,212350,SENGERS SYNDROME,
4797,212360,PALMOPLANTAR KERATODERMA AND CONGENITAL ALOPECIA 2, PPKCA2
4798,212400,CATARACT AND CONGENITAL ICHTHYOSIS,
4799,212500,"CATARACT 46, JUVENILE-ONSET, WITH OR WITHOUT ARRHYTHMIC CARDIOMYOPATHY", CTRCT46
4800,212540,"CATARACT, MICROCEPHALY, FAILURE TO THRIVE, KYPHOSCOLIOSIS SYNDROME",
4801,212550,OPTIC DISC ANOMALIES WITH RETINAL AND/OR MACULAR DYSTROPHY, ODRMD
4802,212600,TITLE NOT AVAILABLE AT THIS MOMENT,
4803,212700,TITLE NOT AVAILABLE AT THIS MOMENT,
4804,212710,CATARACT-ATAXIA-DEAFNESS-RETARDATION SYNDROME,
4805,212720,MARTSOLF SYNDROME 1, MARTS1
4806,212750,"CELIAC DISEASE, SUSCEPTIBILITY TO, 1", CELIAC1
4807,212780,CENANI-LENZ SYNDACTYLY SYNDROME, CLSS
4808,212790,PREMATURE CENTROMERE DIVISION, PCD
4809,212800,CEPHALIN LIPIDOSIS,
4810,212835,CEREBELLAR ATAXIA AND ECTODERMAL DYSPLASIA,
4811,212840,GORDON HOLMES SYNDROME, GDHS
4812,212850,CEREBELLAR ATAXIA AND NEUROSENSORY DEAFNESS,
4813,212890,"CEREBELLAR ATAXIA, BENIGN, WITH THERMOANALGESIA",
4814,212895,"CEREBELLAR ATAXIA, EARLY-ONSET, WITH RETAINED TENDON REFLEXES", EOCA
4815,212900,"PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 1",
4816,212905,"CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 14A (BILATERAL FRONTOPARIETAL)",
4817,213000,"CEREBELLAR HYPOPLASIA/ATROPHY, EPILEPSY, AND GLOBAL DEVELOPMENTAL DELAY", CHEGDD
4818,213002,"LEUKODYSTROPHY, HYPOMYELINATING, 8, WITH OR WITHOUT OLIGODONTIA AND/OR HYPOGONADOTROPIC HYPOGONADISM",
4819,213010,CEREBELLAR VERMIS APLASIA WITH ASSOCIATED FEATURES SUGGESTING SMITH-LEMLI-OPITZ SYNDROME AND MECKEL SYNDROME,
4820,213100,SPINOCEREBELLAR ATAXIA 17,
4821,213200,"SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 2", SCAR2
4822,213300,JOUBERT SYNDROME 1, JBTS1
4823,213400,DYSSYNERGIA CEREBELLARIS MYOCLONICA OF HUNT,
4824,213500,"CEREBRAL ANGIOPATHY, DYSPHORIC",
4825,213600,"BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 1", IBGC1
4826,213700,CEREBROTENDINOUS XANTHOMATOSIS, CTX
4827,213820,"CEREBRAL MALFORMATION, SEIZURES, HYPERTRICHOSIS, AND OVERLAPPING FINGERS",
4828,213900,CEREBRAL SCLEROSIS SIMILAR TO PELIZAEUS-MERZBACHER DISEASE,
4829,213950,CEREBROCORTICAL DEGENERATION OF INFANCY,
4830,213980,"CRANIOFACIAL DYSMORPHISM, SKELETAL ANOMALIES, AND IMPAIRED INTELLECTUAL DEVELOPMENT SYNDROME 1", CFSMR1
4831,214100,PEROXISOME BIOGENESIS DISORDER 1A (ZELLWEGER), PBD1A
4832,214110,PEROXISOME BIOGENESIS DISORDER 2A (ZELLWEGER), PBD2A
4833,214150,CEREBROOCULOFACIOSKELETAL SYNDROME 1, COFS1
4834,214200,"CEROID LIPOFUSCINOSIS, NEURONAL, 1",
4835,214290,"CERVICAL VERTEBRAE, AGENESIS OF",
4836,214300,"KLIPPEL-FEIL SYNDROME 2, AUTOSOMAL RECESSIVE", KFS2
4837,214350,CHAND SYNDROME, CHANDS
4838,214370,"NEUROPATHY, HEREDITARY MOTOR AND SENSORY, WITH DEAFNESS, IMPAIRED INTELLECTUAL DEVELOPMENT, AND ABSENT SENSORY LARGE MYELINATED FIBERS",
4839,214380,"SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE, WITH AXONAL NEUROPATHY 2",
4840,214400,"CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 4A", CMT4A
4841,214450,"GRISCELLI SYNDROME, TYPE 1", GS1
4842,214500,CHEDIAK-HIGASHI SYNDROME, CHS
4843,214700,"DIARRHEA 1, SECRETORY CHLORIDE, CONGENITAL", DIAR1
4844,214800,CHARGE SYNDROME,
4845,214900,CHOLESTASIS-LYMPHEDEMA SYNDROME,
4846,214950,"BILE ACID SYNTHESIS DEFECT, CONGENITAL, 4", CBAS4
4847,214980,"CHOLESTASIS WITH GALLSTONE, ATAXIA, AND VISUAL DISTURBANCE",
4848,215030,CHOLESTEROL PNEUMONIA,
4849,215045,"CHONDRODYSPLASIA, BLOMSTRAND TYPE", BOCD
4850,215050,CHONDRODYSPLASIA CALCIFICANS METAPHYSEALIS,
4851,215100,"RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 1", RCDP1
4852,215105,CHONDRODYSPLASIA PUNCTATA SYNDROME,
4853,215140,GREENBERG DYSPLASIA, GRBGD
4854,215150,"OTOSPONDYLOMEGAEPIPHYSEAL DYSPLASIA, AUTOSOMAL RECESSIVE", OSMEDB
4855,215250,"CHONDROITIN-6-SULFATURIA, DEFECTIVE CELLULAR IMMUNITY, NEPHROTIC SYNDROME",
4856,215300,CHONDROSARCOMA,
4857,215400,"CHORDOMA, SUSCEPTIBILITY TO", CHDM
4858,215450,"CHOREA, BENIGN FAMILIAL",
4859,215470,BOUCHER-NEUHAUSER SYNDROME, BNHS
4860,215480,CHOROID PLEXUS CALCIFICATION AND IMPAIRED INTELLECTUAL DEVELOPMENT,
4861,215500,"CHOROIDAL DYSTROPHY, CENTRAL AREOLAR, 1", CACD1
4862,215510,CHROMOSOMAL INSTABILITY WITH TISSUE-SPECIFIC RADIOSENSITIVITY,
4863,215518,CILIARY DISCOORDINATION DUE TO RANDOM CILIARY ORIENTATION,
4864,215520,CILIARY DYSKINESIA WITH TRANSPOSITION OF CILIARY MICROTUBULES,
4865,215550,CIRCUMVALLATE PLACENTA SYNDROME,
4866,215600,"CIRRHOSIS, FAMILIAL",
4867,215700,"CITRULLINEMIA, CLASSIC",
4868,215720,CITRULLINE TRANSPORT DEFECT,
4869,215800,"CLEFT LARYNX, POSTERIOR",
4870,215850,CLEFT-LIMB-HEART MALFORMATION SYNDROME,
4871,216100,JUBERG-HAYWARD SYNDROME, JHS
4872,216300,"CLEFT PALATE, DEAFNESS, AND OLIGODONTIA",
4873,216330,"CLEIDOCRANIAL DYSPLASIA, RECESSIVE FORM",
4874,216340,YUNIS-VARON SYNDROME, YVS
4875,216360,COACH SYNDROME 1, COACH1
4876,216400,COCKAYNE SYNDROME A, CSA
4877,216411,COCKAYNE SYNDROME A,
4878,216550,COHEN SYNDROME, COH1
4879,216700,"COLLAGENOSIS, FAMILIAL REACTIVE PERFORATING", RPC
4880,216800,COLOBOMA OF MACULA AND SKELETAL ANOMALIES,
4881,216820,"COLOBOMA, OCULAR, AUTOSOMAL RECESSIVE",
4882,216900,ACHROMATOPSIA 2, ACHM2
4883,216920,IMMUNODEFICIENCY 23,
4884,216950,COMPLEMENT COMPONENT C1r/C1s DEFICIENCY,
4885,217000,COMPLEMENT COMPONENT 2 DEFICIENCY, C2D
4886,217030,COMPLEMENT FACTOR I, CFI
4887,217050,COMPLEMENT COMPONENT 6, C6
4888,217070,COMPLEMENT COMPONENT 7, C7
4889,217080,JALILI SYNDROME,
4890,217085,"CONGENITAL HEART DEFECTS, HAMARTOMAS OF TONGUE, AND POLYSYNDACTYLY", CHDTHP
4891,217090,"PLASMINOGEN DEFICIENCY, TYPE I",
4892,217095,CONOTRUNCAL HEART MALFORMATIONS, CTHM
4893,217100,"CONSTRICTING BANDS, CONGENITAL",
4894,217150,"CONTRACTURES, CONGENITAL, TORTICOLLIS, AND MALIGNANT HYPERTHERMIA",
4895,217200,"CONVULSIVE DISORDER, FAMILIAL, WITH PRENATAL OR EARLY ONSET",
4896,217300,"CORNEA PLANA 2, AUTOSOMAL RECESSIVE", CNA2
4897,217400,CORNEAL DYSTROPHY AND PERCEPTIVE DEAFNESS, CDPD
4898,217500,"CORNEAL DYSTROPHY, BAND-SHAPED",
4899,217520,"CORNEAL DEGENERATION, BAND-SHAPED SPHEROID",
4900,217600,CENTRAL CLOUDY DYSTROPHY OF FRANCOIS, CCDF
4901,217700,CORNEAL ENDOTHELIAL DYSTROPHY, CHED
4902,217800,"MACULAR DYSTROPHY, CORNEAL", MCD
4903,217980,"CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND ROBIN SEQUENCE",
4904,217990,"CORPUS CALLOSUM, AGENESIS OF",
4905,218000,AGENESIS OF THE CORPUS CALLOSUM WITH PERIPHERAL NEUROPATHY, ACCPN
4906,218010,"CORTICAL BLINDNESS, RETARDATION, AND POSTAXIAL POLYDACTYLY",
4907,218030,APPARENT MINERALOCORTICOID EXCESS, AME
4908,218040,COSTELLO SYNDROME, CSTLO
4909,218050,"CRAMPS, FAMILIAL ADOLESCENT",
4910,218090,CRANE-HEISE SYNDROME,
4911,218100,"CRANIAL NERVES, CONGENITAL PARESIS OF",
4912,218200,"CRANIAL NERVES, RECURRENT PARESIS OF",
4913,218300,CRANIODIAPHYSEAL DYSPLASIA, CDD
4914,218330,CRANIOECTODERMAL DYSPLASIA 1, CED1
4915,218340,TEMTAMY SYNDROME, TEMTYS
4916,218350,CRANIOFACIAL DYSSYNOSTOSIS WITH SHORT STATURE,
4917,218400,"CRANIOMETAPHYSEAL DYSPLASIA, AUTOSOMAL RECESSIVE", CMDR
4918,218450,"CRANIOSTENOSIS, SAGITTAL, WITH CONGENITAL HEART DISEASE, MENTAL DEFICIENCY, AND MANDIBULAR ANKYLOSIS",
4919,218455,"MICROCEPHALY 1, PRIMARY, AUTOSOMAL RECESSIVE",
4920,218500,CRANIOSYNOSTOSIS 1,
4921,218530,CRANIOSYNOSTOSIS WITH ANOMALIES OF THE CRANIAL BASE AND DIGITS,
4922,218550,CRANIOSYNOSTOSIS WITH FIBULAR APLASIA,
4923,218600,BALLER-GEROLD SYNDROME, BGS
4924,218649,LIN-GETTING SYNDROME,
4925,218650,CRANIOSYNOSTOSIS-IMPAIRED INTELLECTUAL DEVELOPMENT-CLEFTING SYNDROME,
4926,218670,CRANIOTELENCEPHALIC DYSPLASIA,
4927,218700,"HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 2", CHNG2
4928,218800,"CRIGLER-NAJJAR SYNDROME, TYPE I",
4929,218900,CROME SYNDROME,
4930,219000,FRASER SYNDROME 1, FRASRS1
4931,219050,"CRYPTORCHIDISM, UNILATERAL OR BILATERAL",
4932,219070,CURVED NAIL OF FOURTH TOE,
4933,219080,ACTH-INDEPENDENT MACRONODULAR ADRENAL HYPERPLASIA, AIMAH1
4934,219090,"PITUITARY ADENOMA 4, ACTH-SECRETING", PITA4
4935,219095,"CUTANEOUS PHOTOSENSITIVITY AND COLITIS, LETHAL",
4936,219100,"CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IA", ARCL1A
4937,219150,"CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIIA", ARCL3A
4938,219200,"CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIA", ARCL2A
4939,219250,CUTIS MARMORATA TELANGIECTATICA CONGENITA, CMTC
4940,219300,CUTIS VERTICIS GYRATA AND IMPAIRED INTELLECTUAL DEVELOPMENT,
4941,219400,CYANOSIS AND HEPATIC DISEASE,
4942,219500,CYSTATHIONINURIA,
4943,219550,CYSTEINE PEPTIDURIA,
4944,219600,POLYCYSTIC LUNG DISEASE, PCLUD
4945,219700,CYSTIC FIBROSIS, CF
4946,219721,"CYSTIC FIBROSIS WITH HELICOBACTER PYLORI GASTRITIS, MEGALOBLASTIC ANEMIA, AND IMPAIRED INTELLECTUAL DEVELOPMENT",
4947,219730,VENTRICULOMEGALY WITH CYSTIC KIDNEY DISEASE, VMCKD
4948,219750,"CYSTINOSIS, ADULT NONNEPHROPATHIC",
4949,219800,"CYSTINOSIS, NEPHROPATHIC", CTNS
4950,219900,"CYSTINOSIS, LATE-ONSET JUVENILE OR ADOLESCENT NEPHROPATHIC TYPE",
4951,220100,CYSTINURIA,
4952,220110,"MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 1", MC4DN1
4953,220111,"MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 5", MC4DN5
4954,220120,D-GLYCERIC ACIDURIA,
4955,220150,"HYPOURICEMIA, RENAL, 1", RHUC1
4956,220200,DANDY-WALKER SYNDROME, DWS
4957,220210,RITSCHER-SCHINZEL SYNDROME 1, RTSC1
4958,220219,"DANDY-WALKER MALFORMATION WITH IMPAIRED INTELLECTUAL DEVELOPMENT, MACROCEPHALY, MYOPIA, AND BRACHYTELEPHALANGY",
4959,220220,DANDY-WALKER MALFORMATION WITH POSTAXIAL POLYDACTYLY,
4960,220290,"DEAFNESS, AUTOSOMAL RECESSIVE 1A", DFNB1A
4961,220300,"DEAFNESS, CONGENITAL, AND FAMILIAL MYOCLONIC EPILEPSY",
4962,220400,JERVELL AND LANGE-NIELSEN SYNDROME 1, JLNS1
4963,220500,"DEAFNESS, ONYCHODYSTROPHY, OSTEODYSTROPHY, IMPAIRED INTELLECTUAL DEVELOPMENT, AND SEIZURES SYNDROME", DOORS
4964,220600,"SPLIT-HAND/FOOT MALFORMATION 1 WITH SENSORINEURAL HEARING LOSS, AUTOSOMAL RECESSIVE", SHFM1D
4965,220700,"DEAFNESS, AUTOSOMAL RECESSIVE 1A",
4966,220800,"DEAFNESS, AUTOSOMAL RECESSIVE 1A",
4967,220900,"DEAFNESS, CONGENITAL, WITH TOTAL ALBINISM",
4968,221000,TITLE NOT AVAILABLE AT THIS MOMENT,
4969,221200,DEAFNESS AND MYOPIA, DFNMYP
4970,221300,"DEAFNESS, CONDUCTIVE, WITH MALFORMED EXTERNAL EAR",
4971,221320,"DEAFNESS, CONDUCTIVE, WITH PTOSIS AND SKELETAL ANOMALIES",
4972,221350,"DEAFNESS, CONGENITAL, WITH VITILIGO AND ACHALASIA",
4973,221400,"DEAFNESS, NERVE TYPE, WITH MESENTERIC DIVERTICULA OF SMALL BOWEL AND PROGRESSIVE SENSORY NEUROPATHY",
4974,221500,"DEAFNESS, NEURAL, CONGENITAL MODERATE",
4975,221600,"DEAFNESS, AUTOSOMAL RECESSIVE 1A",
4976,221650,"DEAFNESS, AUTOSOMAL RECESSIVE 1A",
4977,221700,"DEAFNESS, NEURAL, WITH ATYPICAL ATOPIC DERMATITIS",
4978,221740,DEAFNESS-OLIGODONTIA SYNDROME,
4979,221745,"DEAFNESS, SENSORINEURAL, AUTOSOMAL-MITOCHONDRIAL TYPE",
4980,221750,"PITUITARY HORMONE DEFICIENCY, COMBINED, 3", CPHD3
4981,221760,"DERMATOGLYPHICS--PALMAR TRIRADIUS d, ABSENCE OF",
4982,221770,POLYCYSTIC LIPOMEMBRANOUS OSTEODYSPLASIA WITH SCLEROSING LEUKOENCEPHALOPATHY 1, PLOSL1
4983,221780,DERMATOGLYPHICS--HYPOTHENAR RADIAL ARCH,
4984,221790,DERMATOLEUKODYSTROPHY,
4985,221800,DERMOCHONDROCORNEAL DYSTROPHY,
4986,221810,"DERMATOOSTEOLYSIS, KIRGHIZIAN TYPE",
4987,221820,"LEUKOENCEPHALOPATHY, HEREDITARY DIFFUSE, WITH SPHEROIDS 1", HDLS1
4988,221900,"PERSISTENT HYPERPLASTIC PRIMARY VITREOUS, AUTOSOMAL RECESSIVE", PHPVAR
4989,221950,DEXTROCARDIA WITH UNUSUAL FACIES AND MICROPHTHALMIA,
4990,221995,"DIABETES INSIPIDUS, NEPHROGENIC, WITH IMPAIRED INTELLECTUAL DEVELOPMENT AND INTRACEREBRAL CALCIFICATION",
4991,222000,"DIABETES INSIPIDUS, NEPHROGENIC, 2, AUTOSOMAL",
4992,222100,TYPE 1 DIABETES MELLITUS, T1D
4993,222300,WOLFRAM SYNDROME 1, WFS1
4994,222350,DIAMINOPENTANURIA,
4995,222400,DIAPHRAGMATIC HERNIA 2, DIH2
4996,222448,DONNAI-BARROW SYNDROME, DBS
4997,222470,TRICHOHEPATOENTERIC SYNDROME 1, THES1
4998,222500,DIASTEMATOMYELIA,
4999,222600,DIASTROPHIC DYSPLASIA, DTD
5000,222690,DIBASIC AMINO ACIDURIA I,
5001,222700,LYSINURIC PROTEIN INTOLERANCE, LPI
5002,222730,DICARBOXYLIC AMINOACIDURIA, DCBXA
5003,222745,"2,4-DIENOYL-CoA REDUCTASE 1, MITOCHONDRIAL", DECR1
5004,222748,DIHYDROPYRIMIDINASE DEFICIENCY, DPYSD
5005,222760,"DEAFNESS, ONYCHODYSTROPHY, OSTEODYSTROPHY, IMPAIRED INTELLECTUAL DEVELOPMENT, AND SEIZURES SYNDROME",
5006,222765,"RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 2", RCDP2
5007,222800,"ERYTHROCYTOSIS, FAMILIAL, 8", ECYT8
5008,222900,"SUCRASE-ISOMALTASE DEFICIENCY, CONGENITAL", CSID
5009,223000,"LACTASE DEFICIENCY, CONGENITAL",
5010,223100,"LACTOSE INTOLERANCE, ADULT TYPE",
5011,223200,"DISORGANIZATION, MOUSE, HOMOLOG OF",
5012,223300,DISSEMINATED SCLEROSIS WITH NARCOLEPSY,
5013,223320,"DIVERTICULOSIS, SMALL-INTESTINAL",
5014,223330,"DIVERTICULOSIS OF BOWEL, HERNIA, AND RETINAL DETACHMENT",
5015,223340,DK PHOCOMELIA SYNDROME,
5016,223350,DOHLE BODIES AND LEUKEMIA,
5017,223360,ORTHOSTATIC HYPOTENSION 1, ORTHYP1
5018,223370,DUBOWITZ SYNDROME,
5019,223380,"DOPAMINE BETA-HYDROXYLASE, PLASMA, THERMOLABILITY OF",
5020,223400,DUODENAL ATRESIA,
5021,223500,"DWARFISM, LOW-BIRTH-WEIGHT TYPE, WITH UNRESPONSIVENESS TO GROWTH HORMONE",
5022,223540,MOLLICA SYNDROME,
5023,223550,"DWARFISM, PROPORTIONATE, WITH HIP DISLOCATION",
5024,223600,"DWARFISM, LEVI TYPE",
5025,223610,ACROMESOMELIC DYSPLASIA 2B,
5026,223800,DYGGVE-MELCHIOR-CLAUSEN DISEASE, DMC
5027,223900,"NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE III", HSAN3
5028,224000,DYSAUTONOMIA-LIKE DISORDER,
5029,224050,"CEREBELLAR ATAXIA, IMPAIRED INTELLECTUAL DEVELOPMENT, AND DYSEQUILIBRIUM SYNDROME 1", CAMRQ1
5030,224100,"ANEMIA, CONGENITAL DYSERYTHROPOIETIC, TYPE II", CDAN2
5031,224120,"ANEMIA, CONGENITAL DYSERYTHROPOIETIC, TYPE Ia", CDAN1A
5032,224200,BRITTLE CORNEA SYNDROME 1,
5033,224230,"DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 1", DKCB1
5034,224250,DYSMYELINATION WITH JAUNDICE,
5035,224300,DYSOSTEOSCLEROSIS,
5036,224400,"DYSSEGMENTAL DYSPLASIA, ROLLAND-DESBUQUOIS TYPE", DDRD
5037,224410,"DYSSEGMENTAL DYSPLASIA, SILVERMAN-HANDMAKER TYPE", DDSH
5038,224500,"DYSTONIA 2, TORSION, AUTOSOMAL RECESSIVE", DYT2
5039,224550,DYSTONIA WITH RINGBINDEN,
5040,224570,LEBER OPTIC ATROPHY AND DYSTONIA,
5041,224600,EPISODIC KINESIGENIC DYSKINESIA 1,
5042,224690,MEIER-GORLIN SYNDROME 1, MGORS1
5043,224700,EBSTEIN ANOMALY,
5044,224750,SCHOPF-SCHULZ-PASSARGE SYNDROME, SSPS
5045,224800,ECTODERMAL DYSPLASIA AND NEUROSENSORY DEAFNESS,
5046,224900,"ECTODERMAL DYSPLASIA 10B, HYPOHIDROTIC/HAIR/TOOTH TYPE, AUTOSOMAL RECESSIVE", ECTD10B
5047,225000,ROSSELLI-GULIENETTI SYNDROME,
5048,225040,"ECTODERMAL DYSPLASIA, HYPOHIDROTIC, WITH HYPOTHYROIDISM AND AGENESIS OF THE CORPUS CALLOSUM",
5049,225050,"ECTODERMAL DYSPLASIA, HYPOHIDROTIC, WITH HYPOTHYROIDISM AND CILIARY DYSKINESIA",
5050,225060,CLEFT LIP/PALATE-ECTODERMAL DYSPLASIA SYNDROME, CLPED1
5051,225100,"ECTOPIA LENTIS 2, ISOLATED, AUTOSOMAL RECESSIVE", ECTOL2
5052,225200,ECTOPIA LENTIS ET PUPILLAE,
5053,225250,"HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 5", CHNG5
5054,225280,"ECTODERMAL DYSPLASIA, ECTRODACTYLY, AND MACULAR DYSTROPHY SYNDROME", EEMS
5055,225290,ECTRODACTYLY-POLYDACTYLY,
5056,225300,SPLIT-HAND/FOOT MALFORMATION 6, SHFM6
5057,225310,EHLERS-DANLOS SYNDROME WITH PLATELET DYSFUNCTION FROM FIBRONECTIN ABNORMALITY,
5058,225320,"EHLERS-DANLOS SYNDROME, CARDIAC VALVULAR TYPE", EDSCV
5059,225350,"EHLERS-DANLOS SYNDROME, VASCULAR TYPE",
5060,225360,TITLE NOT AVAILABLE AT THIS MOMENT,
5061,225400,"EHLERS-DANLOS SYNDROME, KYPHOSCOLIOTIC TYPE, 1", EDSKSCL1
5062,225410,"EHLERS-DANLOS SYNDROME, DERMATOSPARAXIS TYPE", EDSDERMS
5063,225450,"SPECTRIN, ALPHA, ERYTHROCYTIC 1",
5064,225500,ELLIS-VAN CREVELD SYNDROME, EVC
5065,225700,"ENCEPHALOMALACIA, MULTILOCULAR",
5066,225740,"ENCEPHALOPATHY, AXONAL, WITH NECROTIZING MYOPATHY, CARDIOMYOPATHY, AND CATARACTS",
5067,225750,AICARDI-GOUTIERES SYNDROME 1, AGS1
5068,225753,"PONTOCEREBELLAR HYPOPLASIA, TYPE 4", PCH4
5069,225755,"ENCEPHALOPATHY WITH INTRACRANIAL CALCIFICATION, GROWTH HORMONE DEFICIENCY, MICROCEPHALY, AND RETINAL DEGENERATION",
5070,225790,PROLIFERATIVE VASCULOPATHY AND HYDRANENCEPHALY-HYDROCEPHALY SYNDROME, PVHH
5071,225795,"ENCHONDROMATOSIS, MULTIPLE, OLLIER TYPE",
5072,226000,ENDOCARDIAL FIBROELASTOSIS, EFE
5073,226100,ENDOCARDIAL FIBROELASTOSIS AND COARCTATION OF ABDOMINAL AORTA,
5074,226110,"ENDOTHELIAL DYSTROPHY, CONGENITAL HEREDITARY, WITH NAIL HYPOPLASIA",
5075,226150,ENTEROCOLITIS,
5076,226200,ENTEROKINASE DEFICIENCY,
5077,226300,"COMPLEMENT HYPERACTIVATION, ANGIOPATHIC THROMBOSIS, AND PROTEIN-LOSING ENTEROPATHY", CHAPLE
5078,226350,EOSINOPHILIC FASCIITIS,
5079,226400,"EPIDERMODYSPLASIA VERRUCIFORMIS, SUSCEPTIBILITY TO, 1", EV1
5080,226440,"EPIDERMOLYSIS BULLOSA, LATE-ONSET LOCALIZED JUNCTIONAL, WITH IMPAIRED INTELLECTUAL DEVELOPMENT",
5081,226450,"EPIDERMOLYSIS BULLOSA DYSTROPHICA, AUTOSOMAL RECESSIVE",
5082,226500,EPIDERMOLYSIS BULLOSA DYSTROPHICA NEUROTROPHICA,
5083,226600,"EPIDERMOLYSIS BULLOSA DYSTROPHICA, AUTOSOMAL RECESSIVE", RDEB
5084,226650,"EPIDERMOLYSIS BULLOSA, JUNCTIONAL 1A, INTERMEDIATE", JEB1A
5085,226670,"EPIDERMOLYSIS BULLOSA SIMPLEX 5B, WITH MUSCULAR DYSTROPHY", EBS5B
5086,226700,"EPIDERMOLYSIS BULLOSA, JUNCTIONAL 1B, SEVERE", JEB1B
5087,226730,"EPIDERMOLYSIS BULLOSA, JUNCTIONAL 5B, WITH PYLORIC ATRESIA", JEB5B
5088,226735,EPIDERMOLYSIS BULLOSA WITH DIAPHRAGMATIC HERNIA,
5089,226750,KOHLSCHUTTER-TONZ SYNDROME, KTZS
5090,226800,"EPILEPSY, PHOTOGENIC, WITH SPASTIC DIPLEGIA AND IMPAIRED INTELLECTUAL DEVELOPMENT",
5091,226810,EPILEPSY WITH BILATERAL OCCIPITAL CALCIFICATIONS,
5092,226850,EPILEPSY-TELANGIECTASIA,
5093,226900,"EPIPHYSEAL DYSPLASIA, MULTIPLE, 4", EDM4
5094,226950,"EPIPHYSEAL DYSPLASIA OF FEMORAL HEAD, MYOPIA, AND DEAFNESS",
5095,226960,LOWRY-WOOD SYNDROME, LWS
5096,226980,"EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH EARLY-ONSET DIABETES MELLITUS",
5097,226985,"EPITHELIAL SQUAMOUS DYSPLASIA, KERATINIZING DESQUAMATIVE, OF URINARY TRACT",
5098,226990,IMMUNODEFICIENCY 32B, IMD32B
5099,227000,ERYTHEMA OF ACRAL REGIONS,
5100,227010,ERMINE PHENOTYPE,
5101,227050,TRANSIENT ERYTHROBLASTOPENIA OF CHILDHOOD, TEC
5102,227090,"ERYTHRODERMA, LETHAL CONGENITAL",
5103,227100,COMPLEMENT COMPONENT 5,
5104,227150,ETHANOLAMINOSIS,
5105,227200,HYPOGONADOTROPIC HYPOGONADISM 12 WITH OR WITHOUT ANOSMIA,
5106,227210,"EYEBROWS, DUPLICATION OF, WITH STRETCHABLE SKIN AND SYNDACTYLY",
5107,227220,"SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 1", SHEP1
5108,227240,"SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 5", SHEP5
5109,227250,"FACIAL ABNORMALITIES, KYPHOSCOLIOSIS, AND IMPAIRED INTELLECTUAL DEVELOPMENT",
5110,227255,FACIAL DYSMORPHISM WITH MULTIPLE MALFORMATIONS,
5111,227260,"FOCAL FACIAL DERMAL DYSPLASIA 3, SETLEIS TYPE", FFDD3
5112,227270,"FACIOCARDIOMELIC DYSPLASIA, LETHAL",
5113,227280,FACIOCARDIORENAL SYNDROME,
5114,227290,DONNAI-BARROW SYNDROME,
5115,227295,"CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE I",
5116,227300,"FACTOR V AND FACTOR VIII, COMBINED DEFICIENCY OF, 1", F5F8D1
5117,227310,"FACTOR V AND FACTOR VIII, COMBINED DEFICIENCY OF, WITH NORMAL PROTEIN C AND PROTEIN C INHIBITOR",
5118,227320,FACIOTHORACOGENITAL SYNDROME,
5119,227330,"FACIODIGITOGENITAL SYNDROME, AUTOSOMAL RECESSIVE",
5120,227400,FACTOR V DEFICIENCY,
5121,227500,FACTOR VII DEFICIENCY,
5122,227600,FACTOR X DEFICIENCY,
5123,227645,"FANCONI ANEMIA, COMPLEMENTATION GROUP C", FANCC
5124,227646,"FANCONI ANEMIA, COMPLEMENTATION GROUP D2", FANCD2
5125,227650,"FANCONI ANEMIA, COMPLEMENTATION GROUP A", FANCA
5126,227660,"FANCONI ANEMIA, COMPLEMENTATION GROUP B",
5127,227700,FANCONI RENOTUBULAR SYNDROME 1,
5128,227800,FANCONI RENOTUBULAR SYNDROME 1,
5129,227810,FANCONI-BICKEL SYNDROME, FBS
5130,227850,FANCONI-LIKE SYNDROME,
5131,228000,FARBER LIPOGRANULOMATOSIS, FRBRL
5132,228020,"FASCIAL DYSTROPHY, CONGENITAL",
5133,228100,"VISCERAL STEATOSIS, CONGENITAL",
5134,228200,FEMUR-FIBULA-ULNA SYNDROME,
5135,228250,GOLLOP-WOLFGANG COMPLEX, GWC
5136,228300,HYPOGONADOTROPIC HYPOGONADISM 23 WITH OR WITHOUT ANOSMIA, HH23
5137,228355,FETAL IODINE DEFICIENCY DISORDER, FIDD
5138,228400,"FEVER, FAMILIAL LIFELONG PERSISTENT",
5139,228520,FIBROCHONDROGENESIS 1, FBCG1
5140,228550,"MYOFIBROMATOSIS, INFANTILE, 1", IMF1
5141,228560,"FIBROMATOSIS, GINGIVAL, WITH DISTINCTIVE FACIES",
5142,228600,HYALINE FIBROMATOSIS SYNDROME, HFS
5143,228800,"FIBROSCLEROSIS, MULTIFOCAL",
5144,228900,ACROMESOMELIC DYSPLASIA 2B, AMD2B
5145,228930,"FIBULAR APLASIA OR HYPOPLASIA, FEMORAL BOWING, AND POLY-, SYN-, AND OLIGODACTYLY",
5146,228940,FIBULOULNAR APLASIA OR HYPOPLASIA WITH RENAL ABNORMALITIES,
5147,228960,HIGH MOLECULAR WEIGHT KININOGEN DEFICIENCY,
5148,228980,"FLECK RETINA, FAMILIAL BENIGN", FRFB
5149,228990,FLECK RETINA OF KANDORI,
5150,229000,"KALLIKREIN B, PLASMA, 1", KLKB1
5151,229045,"FOCAL EPITHELIAL HYPERPLASIA, ORAL",
5152,229050,"FOLATE MALABSORPTION, HEREDITARY",
5153,229070,HYPOGONADOTROPIC HYPOGONADISM 24 WITH OR WITHOUT ANOSMIA, HH24
5154,229100,GLUTAMATE FORMIMINOTRANSFERASE DEFICIENCY,
5155,229120,FOUNTAIN SYNDROME,
5156,229150,FRAGILE X SYNDROME,
5157,229200,BRITTLE CORNEA SYNDROME 1, BCS1
5158,229230,FRASER-LIKE SYNDROME,
5159,229250,"FREESIA FLOWERS, INABILITY TO SMELL",
5160,229300,FRIEDREICH ATAXIA, FRDA
5161,229310,FRIEDREICH ATAXIA AND CONGENITAL GLAUCOMA,
5162,229400,FRONTOFACIONASAL DYSPLASIA,
5163,229500,FRUCTOSE AND GALACTOSE INTOLERANCE,
5164,229600,"FRUCTOSE INTOLERANCE, HEREDITARY", HFI
5165,229650,FRUCTOSE UTILIZATION,
5166,229700,"FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY", FBP1D
5167,229800,"FRUCTOSURIA, ESSENTIAL",
5168,229850,FRYNS SYNDROME, FRNS
5169,229900,GYRATE ATROPHY OF CHOROID AND RETINA,
5170,229950,"FUCOSIDASE, ALPHA-L, 2",
5171,230000,FUCOSIDOSIS,
5172,230200,GALACTOSEMIA II, GALAC2
5173,230300,GALACTORRHEA,
5174,230350,GALACTOSEMIA III, GALAC3
5175,230400,GALACTOSEMIA I, GALAC1
5176,230430,TN POLYAGGLUTINATION SYNDROME,
5177,230450,"ANEMIA, CONGENITAL, NONSPHEROCYTIC HEMOLYTIC, 7", CNSHA7
5178,230500,"GM1-GANGLIOSIDOSIS, TYPE I", GM1G1
5179,230600,"GM1-GANGLIOSIDOSIS, TYPE II", GM1G2
5180,230650,"GM1-GANGLIOSIDOSIS, TYPE III", GM1G3
5181,230700,TAY-SACHS DISEASE,
5182,230710,TAY-SACHS DISEASE,
5183,230740,GAPO SYNDROME, GAPOS
5184,230750,GASTROSCHISIS,
5185,230800,"GAUCHER DISEASE, TYPE I", GD1
5186,230900,"GAUCHER DISEASE, TYPE II", GD2
5187,231000,"GAUCHER DISEASE, TYPE III", GD3
5188,231005,"GAUCHER DISEASE, TYPE IIIC", GD3C
5189,231050,GELEOPHYSIC DYSPLASIA 1, GPHYSD1
5190,231060,GENITOPALATOCARDIAC SYNDROME,
5191,231070,GERODERMA OSTEODYSPLASTICUM, GO
5192,231080,GERMAN SYNDROME,
5193,231090,"HYDATIDIFORM MOLE, RECURRENT, 1", HYDM1
5194,231095,GHOSAL HEMATODIAPHYSEAL DYSPLASIA, GHDD
5195,231100,"HEMOCHROMATOSIS, NEONATAL",
5196,231200,BERNARD-SOULIER SYNDROME, BSS
5197,231300,"GLAUCOMA 3, PRIMARY CONGENITAL, A", GLC3A
5198,231400,TITLE NOT AVAILABLE AT THIS MOMENT,
5199,231500,"GLAUCOMA 3, PRIMARY CONGENITAL, A",
5200,231520,THREE M SYNDROME 1,
5201,231530,3-HYDROXYACYL-CoA DEHYDROGENASE DEFICIENCY,
5202,231550,ACHALASIA-ADDISONIANISM-ALACRIMA SYNDROME, AAAS
5203,231610,TITLE NOT AVAILABLE AT THIS MOMENT,
5204,231630,MONOSODIUM GLUTAMATE SENSITIVITY,
5205,231670,GLUTARIC ACIDEMIA I, GA1
5206,231675,ELECTRON TRANSFER FLAVOPROTEIN DEHYDROGENASE, ETFDH
5207,231680,MULTIPLE ACYL-CoA DEHYDROGENASE DEFICIENCY, MADD
5208,231690,GLUTARIC ACIDURIA III, GA3
5209,231900,"ANEMIA, CONGENITAL, NONSPHEROCYTIC HEMOLYTIC, 6", CNSHA6
5210,231950,GLUTATHIONURIA,
5211,231970,"GLUTEAL MUSCLES, ABSENCE OF",
5212,232000,"PROPIONYL-CoA CARBOXYLASE, ALPHA SUBUNIT", PCCA
5213,232050,"PROPIONYL-CoA CARBOXYLASE, BETA SUBUNIT", PCCB
5214,232200,GLYCOGEN STORAGE DISEASE Ia, GSD1A
5215,232210,GLYCOGEN STORAGE DISEASE Ia,
5216,232220,GLYCOGEN STORAGE DISEASE Ib, GSD1B
5217,232240,GLYCOGEN STORAGE DISEASE Ic, GSD1C
5218,232300,POMPE DISEASE,
5219,232330,DANON DISEASE,
5220,232400,GLYCOGEN STORAGE DISEASE III, GSD3
5221,232500,GLYCOGEN STORAGE DISEASE IV, GSD4
5222,232600,GLYCOGEN STORAGE DISEASE V, GSD5
5223,232700,GLYCOGEN STORAGE DISEASE VI, GSD6
5224,232800,GLYCOGEN STORAGE DISEASE VII, GSD7
5225,232900,GLYCOPROTEIN STORAGE DISEASE,
5226,233100,RENAL GLUCOSURIA, GLYS
5227,233270,GOMBO SYNDROME,
5228,233300,OVARIAN DYSGENESIS 1, ODG1
5229,233400,PERRAULT SYNDROME 1, PRLTS1
5230,233420,"46,XY SEX REVERSAL 7", SRXY7
5231,233430,MYOECTODERMAL GONADAL DYSGENESIS SYNDROME,
5232,233450,GOODPASTURE SYNDROME,
5233,233500,FONTAINE PROGEROID SYNDROME,
5234,233600,IMMUNODEFICIENCY 59 AND HYPOGLYCEMIA, IMD59
5235,233650,COMBINED CELLULAR AND HUMORAL IMMUNE DEFECTS WITH GRANULOMAS, CCHIDG
5236,233670,"GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, 1",
5237,233690,"GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, 4", CGD4
5238,233700,"GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, 1", CGD1
5239,233710,"GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, 2", CGD2
5240,233800,GROUPED PIGMENTATION OF THE RETINA,
5241,233805,"GROWTH FACTORS, COMBINED DEFECT OF",
5242,233810,"GROWTH RETARDATION, SMALL AND PUFFY HANDS AND FEET, AND ECZEMA",
5243,233910,"HYPERPHENYLALANINEMIA, BH4-DEFICIENT, B", HPABH4B
5244,234000,FACTOR XII DEFICIENCY,
5245,234030,HAIR DEFECT WITH PHOTOSENSITIVITY AND IMPAIRED INTELLECTUAL DEVELOPMENT,
5246,234050,"TRICHOTHIODYSTROPHY 4, NONPHOTOSENSITIVE", TTD4
5247,234100,HALLERMANN-STREIFF SYNDROME, HSS
5248,234200,NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 1, NBIA1
5249,234250,HALL-RIGGS SYNDROME,
5250,234280,HALLUX VARUS AND PREAXIAL POLYSYNDACTYLY,
5251,234300,HALO NEVI,
5252,234350,HALOTHANE HEPATITIS,
5253,234500,HARTNUP DISORDER, HND
5254,234580,HEIMLER SYNDROME 1, HMLR1
5255,234700,"HEART BLOCK, CONGENITAL",
5256,234750,"HEART, MALFORMATION OF",
5257,234800,"HEMANGIOMATOSIS, CUTANEOUS, WITH ASSOCIATED FEATURES",
5258,234810,"PULMONARY VENOOCCLUSIVE DISEASE 2, AUTOSOMAL RECESSIVE", PVOD2
5259,234820,"HEMANGIOPERICYTOMA, MALIGNANT",
5260,235000,"HEMIHYPERPLASIA, ISOLATED", IH
5261,235200,"HEMOCHROMATOSIS, TYPE 1", HFE1
5262,235255,"MULLERIAN DERIVATIVES, PERSISTENCE OF, WITH LYMPHANGIECTASIA AND POSTAXIAL POLYDACTYLY",
5263,235360,"CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IA",
5264,235370,HEMOLYTIC ANEMIA WITH THERMAL SENSITIVITY OF RED CELLS,
5265,235400,"HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 1", AHUS1
5266,235500,"HEMOSIDEROSIS, PULMONARY, WITH DEFICIENCY OF GAMMA-A GLOBULIN",
5267,235510,HENNEKAM LYMPHANGIECTASIA-LYMPHEDEMA SYNDROME 1, HKLLS1
5268,235550,HEPATIC VENOOCCLUSIVE DISEASE WITH IMMUNODEFICIENCY, VODI
5269,235555,"BILE ACID SYNTHESIS DEFECT, CONGENITAL, 2", CBAS2
5270,235600,"46,XX SEX REVERSAL 1",
5271,235700,"ANEMIA, CONGENITAL, NONSPHEROCYTIC HEMOLYTIC, 5", CNSHA5
5272,235730,MOWAT-WILSON SYNDROME, MOWS
5273,235735,"WAARDENBURG SYNDROME, TYPE 4A",
5274,235740,"HIRSCHSPRUNG DISEASE WITH POLYDACTYLY, RENAL AGENESIS, AND DEAFNESS",
5275,235750,"HIRSCHSPRUNG DISEASE WITH ULNAR POLYDACTYLY, POLYSYNDACTYLY OF BIG TOES, AND VENTRICULAR SEPTAL DEFECT",
5276,235760,HIRSCHSPRUNG DISEASE WITH HYPOPLASTIC NAILS AND DYSMORPHIC FACIAL FEATURES,
5277,235800,HISTIDINEMIA,
5278,235830,HISTIDINURIA DUE TO A RENAL TUBULAR DEFECT,
5279,235900,"HISTIOCYTOSIS, FAMILIAL LIPOCHROME",
5280,236000,"LYMPHOMA, HODGKIN, CLASSIC", CHL
5281,236100,HOLOPROSENCEPHALY 1, HPE1
5282,236110,HOLZGREVE SYNDROME,
5283,236130,HOMOCARNOSINOSIS,
5284,236200,HOMOCYSTINURIA DUE TO CYSTATHIONINE BETA-SYNTHASE DEFICIENCY,
5285,236250,"HOMOCYSTINURIA DUE TO DEFICIENCY OF N(5,10)-METHYLENETETRAHYDROFOLATE REDUCTASE ACTIVITY",
5286,236270,"HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, cblE TYPE", HMAE
5287,236300,HOOFT DISEASE,
5288,236400,HUMERORADIAL SYNOSTOSIS,
5289,236410,HUMERORADIAL SYNOSTOSIS WITH CRANIOFACIAL ANOMALIES,
5290,236450,HUTTERITE CEREBROOSTEONEPHRODYSPLASIA SYNDROME,
5291,236490,HYALINE FIBROMATOSIS SYNDROME,
5292,236500,"MULTINUCLEATED NEURONS, ANHYDRAMNIOS, RENAL DYSPLASIA, CEREBELLAR HYPOPLASIA, AND HYDRANENCEPHALY", MARCH
5293,236600,"HYDROCEPHALUS, CONGENITAL, 1", HYC1
5294,236635,HYDROCEPHALUS DUE TO CONGENITAL STENOSIS OF AQUEDUCT OF SYLVIUS,
5295,236640,HYDROCEPHALUS WITH ASSOCIATED MALFORMATIONS,
5296,236660,"HYDROCEPHALUS, TALL STATURE, JOINT LAXITY, AND KYPHOSCOLIOSIS",
5297,236670,"MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 1", MDDGA1
5298,236680,HYDROLETHALUS SYNDROME 1, HLS1
5299,236690,"HYDROCEPHALUS, NORMAL-PRESSURE, 1", HYDNP1
5300,236700,MCKUSICK-KAUFMAN SYNDROME, MKKS
5301,236730,UROFACIAL SYNDROME 1, UFS1
5302,236750,"HYDROPS FETALIS, NONIMMUNE", NIHF
5303,236792,L-2-HYDROXYGLUTARIC ACIDURIA, L2HGA
5304,236795,3-HYDROXYISOBUTYRIC ACIDURIA,
5305,236800,HYDROXYKYNURENINURIA,
5306,236900,HYDROXYLYSINURIA,
5307,237000,HYDROXYPROLINEMIA,
5308,237100,"HYMEN, IMPERFORATE",
5309,237300,"CARBAMOYL PHOSPHATE SYNTHETASE I DEFICIENCY, HYPERAMMONEMIA DUE TO",
5310,237310,N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY, NAGSD
5311,237400,HYPER-BETA-ALANINEMIA,
5312,237450,"HYPERBILIRUBINEMIA, ROTOR TYPE", HBLRR
5313,237500,DUBIN-JOHNSON SYNDROME, DJS
5314,237550,"HYPERBILIRUBINEMIA, CONJUGATED, TYPE III",
5315,237800,"HYPERBILIRUBINEMIA, SHUNT, PRIMARY", PSHB
5316,237900,"HYPERBILIRUBINEMIA, TRANSIENT FAMILIAL NEONATAL", HBLRTFN
5317,238200,CYSTINURIA,
5318,238300,GLYCINE DECARBOXYLASE, GLDC
5319,238310,AMINOMETHYLTRANSFERASE, AMT
5320,238320,"LEYDIG CELL HYPOPLASIA, TYPE I",
5321,238330,GLYCINE CLEAVAGE SYSTEM H PROTEIN, GCSH
5322,238331,DIHYDROLIPOAMIDE DEHYDROGENASE, DLD
5323,238340,HYPERLEUCINE-ISOLEUCINEMIA,
5324,238350,HYPERLEXIA,
5325,238400,"HYPERLIPOPROTEINEMIA, TYPE V",
5326,238500,"HYPERLIPOPROTEINEMIA, TYPE V",
5327,238600,"HYPERLIPOPROTEINEMIA, TYPE I",
5328,238700,"HYPERLYSINEMIA, TYPE I",
5329,238710,HYPERLYSINEMIA DUE TO DEFECT IN LYSINE TRANSPORT INTO MITOCHONDRIA,
5330,238750,HYPERLYSINURIA WITH HYPERAMMONEMIA,
5331,238800,HYPERMETABOLISM DUE TO UNCOUPLED MITOCHONDRIAL OXIDATIVE PHOSPHORYLATION 1, HUMOP1
5332,238950,"HYPEROPIA, HIGH",
5333,238970,HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME, HHHS
5334,239000,"PAGET DISEASE OF BONE 5, JUVENILE-ONSET", PDB5
5335,239100,VAN BUCHEM DISEASE, VBCH
5336,239199,"HYPERPARATHYROIDISM, NEONATAL SELF-LIMITED PRIMARY, WITH HYPERCALCIURIA",
5337,239200,"HYPERPARATHYROIDISM, NEONATAL SEVERE", NSHPT
5338,239300,HYPERPHOSPHATASIA WITH IMPAIRED INTELLECTUAL DEVELOPMENT SYNDROME 1, HPMRS1
5339,239350,"HYPERPHOSPHATEMIA, POLYURIA, AND SEIZURES",
5340,239400,TITLE NOT AVAILABLE AT THIS MOMENT,
5341,239500,"HYPERPROLINEMIA, TYPE I", HYRPRO1
5342,239510,"HYPERPROLINEMIA, TYPE II", HYRPRO2
5343,239710,ACROFRONTOFACIONASAL DYSOSTOSIS 2,
5344,239711,HYPERTELORISM AND TETRALOGY OF FALLOT,
5345,239800,"HYPERTELORISM, MICROTIA, FACIAL CLEFTING SYNDROME",
5346,239840,"HYPERTRICHOSIS, CONGENITAL ANTERIOR CERVICAL, WITH PERIPHERAL SENSORY AND MOTOR NEUROPATHY",
5347,239850,CANTU SYNDROME,
5348,239900,HYPERTROPHIC NEUROPATHY AND CATARACT,
5349,240000,"HYPERURICEMIA, INFANTILE, WITH ABNORMAL BEHAVIOR AND NORMAL HYPOXANTHINE GUANINE PHOSPHORIBOSYLTRANSFERASE",
5350,240100,TITLE NOT AVAILABLE AT THIS MOMENT,
5351,240150,"HYPERVITAMINOSIS A, SUSCEPTIBILITY TO",
5352,240200,"HYPOADRENOCORTICISM, FAMILIAL",
5353,240300,"AUTOIMMUNE POLYENDOCRINE SYNDROME, TYPE I, WITH OR WITHOUT REVERSIBLE METAPHYSEAL DYSPLASIA", APS1
5354,240400,HYPOASCORBEMIA,
5355,240500,"IMMUNODEFICIENCY, COMMON VARIABLE, 2", CVID2
5356,240600,"GLYCOGEN STORAGE DISEASE 0, LIVER", GSD0A
5357,240800,"HYPOGLYCEMIA, LEUCINE-INDUCED", LIH
5358,240900,HYPOINSULINEMIC HYPOGLYCEMIA WITH HEMIHYPERTROPHY, HIHGHH
5359,240950,HYPOGONADISM-CATARACT SYNDROME,
5360,241000,HYPOGONADISM WITH LOW-GRADE MENTAL DEFICIENCY AND MICROCEPHALY,
5361,241080,WOODHOUSE-SAKATI SYNDROME, WDSKS
5362,241090,HYPERGONADOTROPIC HYPOGONADISM AND PARTIAL ALOPECIA,
5363,241100,"HYPOGONADISM, MALE",
5364,241120,HYPOHIDROSIS WITH ABNORMAL PALMAR DERMAL RIDGES,
5365,241150,"HYPOKALEMIC ALKALOSIS, FAMILIAL, WITH SPECIFIC RENAL TUBULOPATHY",
5366,241200,"BARTTER SYNDROME, TYPE 2, ANTENATAL", BARTS2
5367,241310,HYPOMANDIBULAR FACIOCRANIAL DYSOSTOSIS,
5368,241400,"HYPOPARATHYROIDISM, FAMILIAL ISOLATED, 1",
5369,241410,HYPOPARATHYROIDISM-RETARDATION-DYSMORPHISM SYNDROME, HRDS
5370,241500,"HYPOPHOSPHATASIA, INFANTILE", HPPI
5371,241510,"HYPOPHOSPHATASIA, CHILDHOOD", HPPC
5372,241519,"HYPOPHOSPHATEMIA, RENAL, WITH INTRACEREBRAL CALCIFICATIONS",
5373,241520,"HYPOPHOSPHATEMIC RICKETS, AUTOSOMAL RECESSIVE, 1", ARHR1
5374,241530,"HYPOPHOSPHATEMIC RICKETS WITH HYPERCALCIURIA, HEREDITARY", HHRH
5375,241540,"HYPOPITUITARISM, CONGENITAL, WITH CENTRAL DIABETES INSIPIDUS",
5376,241550,HYPOPLASTIC LEFT HEART SYNDROME 1, HLHS1
5377,241600,IMMUNODEFICIENCY 43, IMD43
5378,241750,"HYPOSPADIAS 3, AUTOSOMAL",
5379,241760,HYPOSPADIAS-IMPAIRED INTELLECTUAL DEVELOPMENT SYNDROME,
5380,241800,PALLISTER-HALL-LIKE SYNDROME, PHLS
5381,241850,BAMFORTH-LAZARUS SYNDROME, BAMLAZ
5382,241900,ALOPECIA UNIVERSALIS CONGENITA,
5383,242050,"HYPOURICEMIA, HYPERCALCINURIA, AND DECREASED BONE DENSITY",
5384,242100,"ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 2", ARCI2
5385,242150,"KERATITIS-ICHTHYOSIS-DEAFNESS SYNDROME, AUTOSOMAL RECESSIVE", KIDAR
5386,242170,"TRICHOTHIODYSTROPHY 1, PHOTOSENSITIVE",
5387,242300,"ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 1", ARCI1
5388,242400,ICHTHYOSIS CONGENITA WITH BILIARY ATRESIA,
5389,242500,"ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 4B", ARCI4B
5390,242510,"ICHTHYOSIS WITH ALOPECIA, ECLABIUM, ECTROPION, AND IMPAIRED INTELLECTUAL DEVELOPMENT",
5391,242520,"ICHTHYOSIS, HEPATOSPLENOMEGALY, AND CEREBELLAR DEGENERATION",
5392,242530,"ICHTHYOSIS, IMPAIRED INTELLECTUAL DEVELOPMENT, DWARFISM, AND RENAL IMPAIRMENT",
5393,242550,"ICHTHYOSIS, SPLIT HAIRS, AND AMINO ACIDURIA",
5394,242600,IMINOGLYCINURIA,
5395,242650,"CILIARY DYSKINESIA, PRIMARY, 1",
5396,242670,CILIARY DYSKINESIA WITH DEFECTIVE RADIAL SPOKES,
5397,242680,CILIARY DYSKINESIA WITH EXCESSIVELY LONG CILIA,
5398,242700,T-CELL IMMUNODEFICIENCY WITH THYMIC APLASIA, TIDTA
5399,242800,TITLE NOT AVAILABLE AT THIS MOMENT,
5400,242840,VICI SYNDROME, VICIS
5401,242850,IMMUNE DEFICIENCY DISEASE,
5402,242860,IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 1, ICF1
5403,242870,MHC CLASS I DEFICIENCY 1,
5404,242880,IMMUNOERYTHROMYELOID HYPOPLASIA,
5405,242890,"IMMUNOGLOBULIN D LEVEL IN PLASMA, LOW",
5406,242900,SCHIMKE IMMUNOOSSEOUS DYSPLASIA, SIOD
5407,243000,"INDIFFERENCE TO PAIN, CONGENITAL, AUTOSOMAL RECESSIVE", CIP
5408,243050,INDOLYLACROYL GLYCINURIA WITH IMPAIRED INTELLECTUAL DEVELOPMENT,
5409,243060,SPERMATOGENIC FAILURE 5, SPGF5
5410,243080,"INOSINE PHOSPHORYLASE DEFICIENCY, IMMUNE DEFECT DUE TO",
5411,243095,"INSULIN-LIKE GROWTH FACTOR I, RESISTANCE TO",
5412,243100,"INTERNAL CAROTID ARTERIES, HYPOPLASIA OF",
5413,243110,IMMUNODEFICIENCY WITH DEFECTIVE T-CELL RESPONSE TO INTERLEUKIN 1,
5414,243150,GASTROINTESTINAL DEFECTS AND IMMUNODEFICIENCY SYNDROME 1, GIDID1
5415,243180,"VISCERAL NEUROPATHY, FAMILIAL, 1, AUTOSOMAL RECESSIVE", VSCN1
5416,243185,INTESTINAL PSEUDOOBSTRUCTION WITH PATENT DUCTUS ARTERIOSUS AND NATAL TEETH,
5417,243200,"INTRACRANIAL HYPERTENSION, IDIOPATHIC",
5418,243300,"CHOLESTASIS, BENIGN RECURRENT INTRAHEPATIC, 1", BRIC1
5419,243305,INVERSIN, INVS
5420,243310,BARAITSER-WINTER SYNDROME 1, BRWS1
5421,243320,"INTRINSIC FACTOR AND R BINDER, COMBINED CONGENITAL DEFICIENCY OF",
5422,243340,IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 1,
5423,243400,"ACETYLATION, SLOW",
5424,243440,ISOTRETINOIN EMBRYOPATHY-LIKE SYNDROME,
5425,243450,"ISOVALERIC ACID, INABILITY TO SMELL",
5426,243500,ISOVALERIC ACIDEMIA, IVA
5427,243600,JEJUNAL ATRESIA,
5428,243605,STROMME SYNDROME, STROMS
5429,243700,"HYPER-IgE SYNDROME 2, AUTOSOMAL RECESSIVE, WITH RECURRENT INFECTIONS", HIES2
5430,243800,JOHANSON-BLIZZARD SYNDROME, JBS
5431,243910,ARIMA SYNDROME,
5432,244100,JUMPING FRENCHMEN OF MAINE,
5433,244200,HYPOGONADOTROPIC HYPOGONADISM 3 WITH OR WITHOUT ANOSMIA, HH3
5434,244300,KAPUR-TORIELLO SYNDROME,
5435,244400,"CILIARY DYSKINESIA, PRIMARY, 1", CILD1
5436,244450,KAUFMAN OCULOCEREBROFACIAL SYNDROME, KOS
5437,244460,"KENNY-CAFFEY SYNDROME, TYPE 1", KCS1
5438,244500,KERATOCONUS 1,
5439,244510,KERATOCONUS AND CONGENITAL HIP DYSPLASIA,
5440,244600,KERATOCONUS POSTICUS CIRCUMSCRIPTUS, KPC
5441,244850,MAL DE MELEDA,
5442,245000,PAPILLON-LEFEVRE SYNDROME, PALS
5443,245010,HAIM-MUNK SYNDROME, HMS
5444,245050,SUCCINYL-CoA:3-OXOACID-CoA TRANSFERASE DEFICIENCY, SCOTD
5445,245100,RICHARDS-RUNDLE SYNDROME, RRNS
5446,245130,ALPHA-AMINOADIPIC AND ALPHA-KETOADIPIC ACIDURIA,
5447,245150,KEUTEL SYNDROME, KTLS
5448,245160,KNIEST-LIKE DYSPLASIA WITH PURSED LIPS AND ECTOPIA LENTIS,
5449,245180,KIFAFA SEIZURE DISORDER,
5450,245190,"KNIEST-LIKE DYSPLASIA, LETHAL",
5451,245200,KRABBE DISEASE, KRB
5452,245210,VELOCARDIOFACIAL SYNDROME,
5453,245300,"KURU, SUSCEPTIBILITY TO",
5454,245340,ERYTHROCYTE LACTATE TRANSPORTER DEFECT,
5455,245348,PYRUVATE DEHYDROGENASE E2 DEFICIENCY, PDHDD
5456,245349,PYRUVATE DEHYDROGENASE E3-BINDING PROTEIN DEFICIENCY, PDHXD
5457,245400,MITOCHONDRIAL DNA DEPLETION SYNDROME 9 (ENCEPHALOMYOPATHIC TYPE WITH METHYLMALONIC ACIDURIA), MTDPS9
5458,245450,D-LACTIC ACIDURIA WITH GOUT, DLACD
5459,245480,SPECIFIC GRANULE DEFICIENCY 1, SGD1
5460,245500,TITLE NOT AVAILABLE AT THIS MOMENT,
5461,245550,LAMBERT SYNDROME,
5462,245552,LAMBOTTE SYNDROME,
5463,245570,"EPILEPSY, FOCAL, WITH SPEECH DISORDER AND WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT", FESD
5464,245590,"GROWTH HORMONE INSENSITIVITY SYNDROME WITH IMMUNE DYSREGULATION 1, AUTOSOMAL RECESSIVE", GHISID1
5465,245600,"MULTIPLE JOINT DISLOCATIONS, SHORT STATURE, AND CRANIOFACIAL DYSMORPHISM WITH OR WITHOUT CONGENITAL HEART DEFECTS", JDSCD
5466,245650,"LARSEN-LIKE SYNDROME, LETHAL TYPE",
5467,245660,"EPIDERMOLYSIS BULLOSA, JUNCTIONAL 2C, LARYNGOONYCHOCUTANEOUS", JEB2C
5468,245800,LAURENCE-MOON SYNDROME, LNMS
5469,245900,LECITHIN:CHOLESTEROL ACYLTRANSFERASE DEFICIENCY,
5470,246000,"LEG, ABSENCE DEFORMITY OF, WITH CONGENITAL CATARACT",
5471,246200,DONOHUE SYNDROME,
5472,246300,"LEPROSY, SUSCEPTIBILITY TO, 3", LPRS3
5473,246400,LETTERER-SIWE DISEASE,
5474,246450,3-HYDROXY-3-METHYLGLUTARYL-CoA LYASE DEFICIENCY, HMGCLD
5475,246470,"LEUKEMIA, ACUTE MYELOCYTIC, WITH POLYPOSIS COLI AND COLON CANCER",
5476,246490,"CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIc",
5477,246500,"LEUKOMELANODERMA, INFANTILISM, IMPAIRED INTELLECTUAL DEVELOPMENT, HYPODONTIA, HYPOTRICHOSIS",
5478,246530,LEUKOTRIENE C4 SYNTHASE, LTC4S
5479,246550,LICHTENSTEIN SYNDROME,
5480,246555,"LIMB DEFECTS, DISTAL TRANSVERSE, WITH IMPAIRED INTELLECTUAL DEVELOPMENT AND SPASTICITY",
5481,246560,SPLIT-HAND/FOOT MALFORMATION 3, SHFM3
5482,246570,"FIBULAR APLASIA, TIBIAL CAMPOMELIA, AND OLIGOSYNDACTYLY SYNDROME",
5483,246600,PANCREATIC LIPASE, PNLIP
5484,246650,"LIPASE DEFICIENCY, COMBINED",
5485,246700,CHYLOMICRON RETENTION DISEASE, CMRD
5486,246800,"NIEMANN-PICK DISEASE, TYPE C1",
5487,246900,DIHYDROLIPOAMIDE DEHYDROGENASE DEFICIENCY, DLDD
5488,247100,LIPOID PROTEINOSIS OF URBACH AND WIETHE,
5489,247150,LIP PRINTS,
5490,247200,MILLER-DIEKER LISSENCEPHALY SYNDROME, MDLS
5491,247400,"MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE I",
5492,247410,LYMPHEDEMA-HYPOPARATHYROIDISM SYNDROME,
5493,247420,LUTHERAN NULL,
5494,247430,"LYMPHOBLASTIC TRANSFORMATION, INHIBITION OF",
5495,247440,LYMPHATIC MALFORMATION 1,
5496,247450,"LYMPHOBLASTIC TRANSFORMATION, INTRINSIC DEFECT IN",
5497,247610,LYMPHOID INTERSTITIAL PNEUMONIA, LIP
5498,247630,"LYMPHOID SYSTEM DETERIORATION, PROGRESSIVE",
5499,247640,"LYMPHOBLASTIC LEUKEMIA, ACUTE, WITH LYMPHOMATOUS FEATURES", LALL
5500,247650,LYMPHOKINE DEFICIENCY,
5501,247800,"LYMPHOPENIC HYPERGAMMAGLOBULINEMIA, ANTIBODY DEFICIENCY, AUTOIMMUNE HEMOLYTIC ANEMIA, AND GLOMERULONEPHRITIS",
5502,247900,"HYPERLYSINEMIA, TYPE I",
5503,247950,LYSINE MALABSORPTION SYNDROME,
5504,247980,"LIPASE B, LYSOSOMAL ACID", LIPB
5505,247990,MACDERMOT-WINTER SYNDROME,
5506,248000,"MACROCEPHALY/MEGALENCEPHALY SYNDROME, AUTOSOMAL RECESSIVE", MGCPH
5507,248010,"MACROEPIPHYSEAL DYSPLASIA WITH OSTEOPOROSIS, WRINKLED SKIN, AND AGED APPEARANCE",
5508,248100,MACROSOMIA ADIPOSA CONGENITA,
5509,248110,"MACROSOMIA WITH MICROPHTHALMIA, LETHAL",
5510,248190,"HYPOMAGNESEMIA 5, RENAL, WITH OR WITHOUT OCULAR INVOLVEMENT", HOMG5
5511,248200,STARGARDT DISEASE 1, STGD1
5512,248250,"HYPOMAGNESEMIA 3, RENAL", HOMG3
5513,248260,"MAGNESIUM, ELEVATED RED CELL",
5514,248300,MAL DE MELEDA, MDM
5515,248310,PLASMODIUM FALCIPARUM BLOOD INFECTION LEVEL,
5516,248340,3MC SYNDROME 3, 3MC3
5517,248350,MALOCCLUSION AND SHORT STATURE,
5518,248360,MALONYL-CoA DECARBOXYLASE DEFICIENCY,
5519,248370,MANDIBULOACRAL DYSPLASIA WITH TYPE A LIPODYSTROPHY, MADA
5520,248390,TREACHER COLLINS SYNDROME 3, TCS3
5521,248400,MANDIBULOFACIAL DYSOSTOSIS WITH IMPAIRED INTELLECTUAL DEVELOPMENT,
5522,248450,MANITOBA OCULOTRICHOANAL SYNDROME, MOTA
5523,248500,"MANNOSIDOSIS, ALPHA B, LYSOSOMAL", MANSA
5524,248510,"MANNOSIDOSIS, BETA A, LYSOSOMAL", MANSB
5525,248600,"MAPLE SYRUP URINE DISEASE, TYPE IA", MSUD1A
5526,248610,DIHYDROLIPOAMIDE BRANCHED-CHAIN TRANSACYLASE, DBT
5527,248611,"BRANCHED-CHAIN KETO ACID DEHYDROGENASE E1, BETA POLYPEPTIDE", BCKDHB
5528,248700,MARDEN-WALKER SYNDROME, MWKS
5529,248750,MARFAN SYNDROME,
5530,248760,MARFANOID HABITUS WITH MICROCEPHALY AND GLOMERULONEPHRITIS,
5531,248770,"MARFANOID IMPAIRED INTELLECTUAL DEVELOPMENTAL SYNDROME, AUTOSOMAL",
5532,248800,MARINESCO-SJOGREN SYNDROME, MSS
5533,248810,MARINESCO-SJOGREN SYNDROME,
5534,248900,MAST SYNDROME, MASTS
5535,248910,"CUTANEOUS MASTOCYTOSIS, CONDUCTIVE HEARING LOSS AND MICROTIA",
5536,248950,MCDONOUGH SYNDROME,
5537,249000,"MECKEL SYNDROME, TYPE 1", MKS1
5538,249100,FAMILIAL MEDITERRANEAN FEVER, FMF
5539,249210,MEGACYSTIS-MICROCOLON-INTESTINAL HYPOPERISTALSIS SYNDROME 1, MMIHS1
5540,249230,MEGAEPIPHYSEAL DWARFISM,
5541,249240,MEGALENCEPHALY WITH DYSMYELINATION,
5542,249270,THIAMINE-RESPONSIVE MEGALOBLASTIC ANEMIA SYNDROME, TRMA
5543,249300,MEGALOCORNEA,
5544,249310,NEUHAUSER SYNDROME,
5545,249400,"MELANOSIS, NEUROCUTANEOUS", NCMS
5546,249420,FRANK-TER HAAR SYNDROME, FTHS
5547,249500,"INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 1", MRT1
5548,249599,"INTELLECTUAL DEVELOPMENTAL DISORDER, BELGIAN TYPE",
5549,249600,MIETENS-WEBER SYNDROME,
5550,249620,OHDO SYNDROME,
5551,249630,MUTCHINICK SYNDROME,
5552,249650,MERCAPTOLACTATE-CYSTEINE DISULFIDURIA, MCDU
5553,249660,"NEPHROTIC SYNDROME, TYPE 5, WITH OR WITHOUT OCULAR ABNORMALITIES",
5554,249670,MESOAXIAL HEXADACTYLY AND CARDIAC MALFORMATION,
5555,249700,LANGER MESOMELIC DYSPLASIA, LMD
5556,249710,MESOMELIC LIMB SHORTENING AND BOWING,
5557,249800,TITLE NOT AVAILABLE AT THIS MOMENT,
5558,249900,METACHROMATIC LEUKODYSTROPHY DUE TO SAPOSIN B DEFICIENCY, MLDSAPB
5559,250100,METACHROMATIC LEUKODYSTROPHY, MLD
5560,250215,METAPHYSEAL ACROSCYPHODYSPLASIA,
5561,250220,"SPONDYLOMETAPHYSEAL DYSPLASIA, SEDAGHATIAN TYPE", SMDS
5562,250230,"METAPHYSEAL CHONDRODYSPLASIA, KAITILA TYPE",
5563,250250,CARTILAGE-HAIR HYPOPLASIA, CHH
5564,250300,"METAPHYSEAL CHONDRODYSPLASIA, PENA TYPE",
5565,250400,"METAPHYSEAL DYSPLASIA, SPAHR TYPE", MDST
5566,250410,RETINITIS PIGMENTOSA WITH OR WITHOUT SKELETAL ANOMALIES, RPSKA
5567,250420,"METAPHYSEAL DYSOSTOSIS, IMPAIRED INTELLECTUAL DEVELOPMENT, AND CONDUCTIVE DEAFNESS",
5568,250450,"METAPHYSEAL DYSPLASIA, ANETODERMA, AND OPTIC ATROPHY",
5569,250460,METAPHYSEAL DYSPLASIA WITHOUT HYPOTRICHOSIS, MDWH
5570,250500,"METAPHYSEAL MODELING ABNORMALITY, SKIN LESIONS, AND SPASTIC PARAPLEGIA",
5571,250600,METATROPIC DYSPLASIA,
5572,250620,3-HYDROXYISOBUTYRYL-CoA HYDROLASE DEFICIENCY, HIBCHD
5573,250650,METHANE PRODUCTION,
5574,250700,METHEMOGLOBIN REDUCTASE DEFICIENCY,
5575,250790,METHEMOGLOBINEMIA AND AMBIGUOUS GENITALIA, METAG
5576,250800,METHEMOGLOBINEMIA DUE TO DEFICIENCY OF METHEMOGLOBIN REDUCTASE,
5577,250850,METHIONINE ADENOSYLTRANSFERASE I/III DEFICIENCY,
5578,250900,METHIONINE MALABSORPTION SYNDROME,
5579,250940,"HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, cblG TYPE", HMAG
5580,250950,"3-METHYLGLUTACONIC ACIDURIA, TYPE I", MGCA1
5581,250951,"3-METHYLGLUTACONIC ACIDURIA, TYPE IV", MGCA4
5582,251000,METHYLMALONIC ACIDURIA DUE TO METHYLMALONYL-CoA MUTASE DEFICIENCY, MAMM
5583,251100,"METHYLMALONIC ACIDURIA, cblA TYPE", MACA
5584,251110,"METHYLMALONIC ACIDURIA, cblB TYPE", MACB
5585,251120,METHYLMALONYL-CoA EPIMERASE DEFICIENCY,
5586,251170,MEVALONATE KINASE, MVK
5587,251190,"MICROCEPHALIC PRIMORDIAL DWARFISM, TORIELLO TYPE",
5588,251200,"MICROCEPHALY 1, PRIMARY, AUTOSOMAL RECESSIVE", MCPH1
5589,251220,MICROCEPHALY-CARDIOMYOPATHY,
5590,251230,MICROCEPHALY-MICROMELIA SYNDROME, MIMIS
5591,251240,MICROCEPHALY WITH CHEMOTACTIC DEFECT AND TRANSIENT HYPOGAMMAGLOBULINEMIA,
5592,251250,MICROCEPHALY WITH CERVICAL SPINE FUSION ANOMALIES,
5593,251255,JAWAD SYNDROME, JWDS
5594,251260,NIJMEGEN BREAKAGE SYNDROME, NBS
5595,251270,"MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 1", MCCRP1
5596,251280,DIENCEPHALIC-MESENCEPHALIC JUNCTION DYSPLASIA SYNDROME 1, DMJDS1
5597,251290,PSEUDO-TORCH SYNDROME 1, PTORCH1
5598,251300,GALLOWAY-MOWAT SYNDROME 1, GAMOS1
5599,251400,MICROCOLON,
5600,251450,DESBUQUOIS DYSPLASIA 1, DBQD1
5601,251455,OMODYSPLASIA 1,
5602,251500,WARBURG MICRO SYNDROME 1,
5603,251505,MICROPHTHALMIA/COLOBOMA 4, MCOPCB4
5604,251600,"MICROPHTHALMIA, ISOLATED 1", MCOP1
5605,251700,"MICROPHTHALMIA WITH HYPEROPIA, RETINAL DEGENERATION, MACROPHAKIA, AND DENTAL ANOMALIES",
5606,251750,"MICROSPHEROPHAKIA AND/OR MEGALOCORNEA, WITH ECTOPIA LENTIS AND WITH OR WITHOUT SECONDARY GLAUCOMA", MSPKA
5607,251800,MICROTIA WITH MEATAL ATRESIA AND CONDUCTIVE DEAFNESS,
5608,251850,"DIARRHEA 2, WITH MICROVILLUS ATROPHY, WITH OR WITHOUT CHOLESTASIS", DIAR2
5609,251880,MITOCHONDRIAL DNA DEPLETION SYNDROME 3 (HEPATOCEREBRAL TYPE), MTDPS3
5610,251890,"HYDROXYACYL-CoA DEHYDROGENASE/3-KETOACYL-CoA THIOLASE/ENOYL-CoA HYDRATASE, BETA SUBUNIT",
5611,251900,"MITOCHONDRIAL MYOPATHY, EPISODIC, WITH OR WITHOUT OPTIC ATROPHY AND REVERSIBLE LEUKOENCEPHALOPATHY", MEOAL
5612,251945,MITOCHONDRIAL MYOPATHY WITH A DEFECT IN MITOCHONDRIAL-PROTEIN TRANSPORT,
5613,251950,MITOCHONDRIAL MYOPATHY WITH LACTIC ACIDOSIS, MMLA
5614,252010,"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 1", MC1DN1
5615,252011,"MITOCHONDRIAL COMPLEX II DEFICIENCY, NUCLEAR TYPE 1", MC2DN1
5616,252030,TITLE NOT AVAILABLE AT THIS MOMENT,
5617,252100,OROFACIODIGITAL SYNDROME II, OFD2
5618,252150,"MOLYBDENUM COFACTOR DEFICIENCY, TYPE A", MOCODA
5619,252160,"MOLYBDENUM COFACTOR DEFICIENCY, TYPE B", MOCODB
5620,252200,MONILETHRIX,
5621,252250,MONOCYTE CHEMOTACTIC DISORDER,
5622,252270,MONOSOMY 7 MYELODYSPLASIA AND LEUKEMIA SYNDROME 1, M7MLS1
5623,252300,MORQUIO SYNDROME C,
5624,252320,"MOTOR NEUROPATHY, PERIPHERAL, WITH DYSAUTONOMIA",
5625,252350,MOYAMOYA DISEASE 1, MYMY1
5626,252500,MUCOLIPIDOSIS II ALPHA/BETA,
5627,252600,MUCOLIPIDOSIS III ALPHA/BETA,
5628,252605,MUCOLIPIDOSIS III GAMMA,
5629,252650,MUCOLIPIDOSIS IV, ML4
5630,252700,HURLER SYNDROME,
5631,252800,ALPHA-L-IDURONIDASE, IDUA
5632,252900,"MUCOPOLYSACCHARIDOSIS, TYPE IIIA", MPS3A
5633,252920,"MUCOPOLYSACCHARIDOSIS, TYPE IIIB", MPS3B
5634,252930,"MUCOPOLYSACCHARIDOSIS, TYPE IIIC", MPS3C
5635,252940,"MUCOPOLYSACCHARIDOSIS, TYPE IIID", MPS3D
5636,253000,"MUCOPOLYSACCHARIDOSIS, TYPE IVA", MPS4A
5637,253010,"MUCOPOLYSACCHARIDOSIS, TYPE IVB", MPS4B
5638,253200,"MUCOPOLYSACCHARIDOSIS, TYPE VI", MPS6
5639,253220,"MUCOPOLYSACCHARIDOSIS, TYPE VII", MPS7
5640,253230,"MUCOPOLYSACCHARIDOSIS, TYPE IX",
5641,253240,MUCUS INSPISSATION OF RESPIRATORY TRACT,
5642,253250,MULIBREY NANISM, MUL
5643,253260,BIOTINIDASE DEFICIENCY,
5644,253270,HOLOCARBOXYLASE SYNTHETASE DEFICIENCY,
5645,253280,"MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 3", MDDGA3
5646,253290,"MULTIPLE PTERYGIUM SYNDROME, LETHAL TYPE", LMPS
5647,253300,"SPINAL MUSCULAR ATROPHY, TYPE I", SMA1
5648,253310,LETHAL CONGENITAL CONTRACTURE SYNDROME 1, LCCS1
5649,253320,CHUDLEY SYNDROME,
5650,253400,"SPINAL MUSCULAR ATROPHY, TYPE III", SMA3
5651,253500,TITLE NOT AVAILABLE AT THIS MOMENT,
5652,253550,"SPINAL MUSCULAR ATROPHY, TYPE II", SMA2
5653,253590,"MUSCULAR DYSTROPHY, ADULT-ONSET, WITH LEUKOENCEPHALOPATHY",
5654,253600,"MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 1", LGMDR1
5655,253601,"MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 2", LGMDR2
5656,253700,"MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 5", LGMDR5
5657,253800,"MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 4", MDDGA4
5658,253850,CONGENITAL MYOPATHY 3 WITH RIGID SPINE,
5659,253900,"ARTHROGRYPOSIS MULTIPLEX CONGENITA 3, MYOGENIC TYPE",
5660,254000,"MUSCULAR DYSTROPHY, CONGENITAL, WITH INFANTILE CATARACT AND HYPOGONADISM",
5661,254090,ULLRICH CONGENITAL MUSCULAR DYSTROPHY 1A, UCMD1A
5662,254100,"MUSCULAR DYSTROPHY, CONGENITAL, WITH RAPID PROGRESSION", MDRP
5663,254110,"MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 8", LGMDR8
5664,254120,"MUSCULAR HYPERTONIA, LETHAL",
5665,254130,MIYOSHI MUSCULAR DYSTROPHY 1, MMD1
5666,254150,"MUSK, INABILITY TO SMELL",
5667,254190,"MYASTHENIA, CONGENITAL, REFRACTORY TO ACETYLCHOLINESTERASE INHIBITORS",
5668,254195,"MYASTHENIC SYNDROME, CONGENITAL, 4C, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY",
5669,254200,MYASTHENIA GRAVIS, MG
5670,254210,"MYASTHENIC SYNDROME, CONGENITAL, 6, PRESYNAPTIC", CMS6
5671,254300,"MYASTHENIC SYNDROME, CONGENITAL, 10", CMS10
5672,254400,MYCOSIS FUNGOIDES,
5673,254450,MYELOFIBROSIS,
5674,254500,"MYELOMA, MULTIPLE",
5675,254600,MYELOPEROXIDASE DEFICIENCY, MPOD
5676,254700,"MYELOPROLIFERATIVE DISEASE, AUTOSOMAL RECESSIVE",
5677,254770,"EPILEPSY, MYOCLONIC JUVENILE", EJM
5678,254780,MYOCLONIC EPILEPSY OF LAFORA 1, MELF1
5679,254800,MYOCLONIC EPILEPSY OF UNVERRICHT AND LUNDBORG,
5680,254900,"EPILEPSY, PROGRESSIVE MYOCLONIC, 4, WITH OR WITHOUT RENAL FAILURE", EPM4
5681,254940,CAREY-FINEMAN-ZITER SYNDROME 1, CFZS1
5682,254950,"MYOPATHY, GRANULOVACUOLAR LOBULAR, WITH ELECTRICAL MYOTONIA",
5683,254960,MYOPATHY DUE TO MALATE-ASPARTATE SHUTTLE DEFECT,
5684,255100,LIPID STORAGE MYOPATHY DUE TO FLAVIN ADENINE DINUCLEOTIDE SYNTHETASE DEFICIENCY, LSMFLAD
5685,255110,"CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, MYOPATHIC, STRESS-INDUCED",
5686,255120,CARNITINE PALMITOYLTRANSFERASE I DEFICIENCY,
5687,255125,"MYOPATHY WITH LACTIC ACIDOSIS, HEREDITARY", HML
5688,255140,MYOPATHY WITH GIANT ABNORMAL MITOCHONDRIA,
5689,255160,"CONGENITAL MYOPATHY 7B, MYOSIN STORAGE, AUTOSOMAL RECESSIVE", CMYO7B
5690,255170,"PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 1",
5691,255200,"MYOPATHY, CENTRONUCLEAR, 2", CNM2
5692,255300,BATTEN-TURNER CONGENITAL MYOPATHY,
5693,255310,"CONGENITAL MYOPATHY 4A, AUTOSOMAL DOMINANT", CMYO4A
5694,255320,"CONGENITAL MYOPATHY 1B, AUTOSOMAL RECESSIVE", CMYO1B
5695,255500,"MYOPIA 18, AUTOSOMAL RECESSIVE", MYP18
5696,255600,"MYOSCLEROSIS, AUTOSOMAL RECESSIVE",
5697,255700,"MYOTONIA CONGENITA, AUTOSOMAL RECESSIVE",
5698,255710,MYOTONIA WITH SKELETAL ABNORMALITIES AND IMPAIRED INTELLECTUAL DEVELOPMENT,
5699,255800,"SCHWARTZ-JAMPEL SYNDROME, TYPE 1", SJS1
5700,255900,MYXEDEMA,
5701,255960,"MYXOMA, INTRACARDIAC",
5702,255980,KEIPERT SYNDROME,
5703,255990,NATHALIE SYNDROME,
5704,255995,CONGENITAL MYOPATHY 13, CMYO13
5705,256000,"LEIGH SYNDROME, NUCLEAR", NULS
5706,256020,FOCAL SEGMENTAL GLOMERULOSCLEROSIS 10, FSGS10
5707,256030,NEMALINE MYOPATHY 2, NEM2
5708,256040,PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 1, PRAAS1
5709,256050,"ATELOSTEOGENESIS, TYPE II", AO2
5710,256100,NEPHRONOPHTHISIS 1, NPHP1
5711,256120,"NEPHROPATHY, DEAFNESS, AND HYPERPARATHYROIDISM",
5712,256150,NEPHROSIALIDOSIS,
5713,256200,NEPHROSIS WITH DEAFNESS AND URINARY TRACT AND DIGITAL MALFORMATIONS,
5714,256300,"NEPHROTIC SYNDROME, TYPE 1", NPHS1
5715,256340,"HYPOPARATHYROIDISM, SENSORINEURAL DEAFNESS, AND RENAL DYSPLASIA SYNDROME",
5716,256350,"NEPHROTIC SYNDROME, TYPE 2",
5717,256370,"NEPHROTIC SYNDROME, TYPE 4", NPHS4
5718,256450,"HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 1", HHF1
5719,256500,NETHERTON SYNDROME, NETH
5720,256520,NEU-LAXOVA SYNDROME 1, NLS1
5721,256540,GALACTOSIALIDOSIS, GSL
5722,256550,NEURAMINIDASE DEFICIENCY,
5723,256600,NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2A, NBIA2A
5724,256690,NEUROFACIODIGITORENAL SYNDROME,
5725,256700,"NEUROBLASTOMA, SUSCEPTIBILITY TO, 1", NBLST1
5726,256710,ELEJALDE NEUROECTODERMAL MELANOLYSOSOMAL SYNDROME,
5727,256720,"NEUROLOGIC DISEASE, INFANTILE MULTISYSTEM, WITH OSSEOUS FRAGILITY",
5728,256730,"CEROID LIPOFUSCINOSIS, NEURONAL, 1", CLN1
5729,256731,"CEROID LIPOFUSCINOSIS, NEURONAL, 5", CLN5
5730,256800,"INSENSITIVITY TO PAIN, CONGENITAL, WITH ANHIDROSIS", CIPA
5731,256810,MITOCHONDRIAL DNA DEPLETION SYNDROME 6 (HEPATOCEREBRAL TYPE), MTDPS6
5732,256840,"NEUROPATHY, HEREDITARY SENSORY, WITH SPASTIC PARAPLEGIA, AUTOSOMAL RECESSIVE", HSNSP
5733,256850,"GIANT AXONAL NEUROPATHY 1, AUTOSOMAL RECESSIVE", GAN1
5734,256851,"GIANT AXONAL NEUROPATHY 1, AUTOSOMAL RECESSIVE",
5735,256855,"NEUROPATHY, HEREDITARY MOTOR AND SENSORY, WITH EXCESSIVE MYELIN FOLDING COMPLEX, AUTOSOMAL RECESSIVE",
5736,256860,"NEUROPATHY, HEREDITARY SENSORY, ATYPICAL",
5737,256870,"NEUROPATHY, PAINFUL",
5738,257000,NEUROVISCERAL STORAGE DISEASE WITH CURVILINEAR BODIES,
5739,257050,"NIEMANN-PICK DISEASE, TYPE C1",
5740,257100,"NEUTROPENIA, LETHAL CONGENITAL, WITH EOSINOPHILIA",
5741,257150,NEUTROPHIL ACTIN DYSFUNCTION, NAD
5742,257200,"NIEMANN-PICK DISEASE, TYPE A",
5743,257220,"NIEMANN-PICK DISEASE, TYPE C1", NPC1
5744,257250,"NIEMANN-PICK DISEASE, TYPE C1",
5745,257270,"NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1B", CSNB1B
5746,257300,MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 1, MVA1
5747,257320,LISSENCEPHALY 2, LIS2
5748,257350,"NUCHAL BLEB, FAMILIAL",
5749,257400,"NYSTAGMUS 8, CONGENITAL, AUTOSOMAL RECESSIVE", NYS8
5750,257500,OBESITY-HYPOVENTILATION SYNDROME,
5751,257550,OCULAR MOTOR APRAXIA,
5752,257600,OCULAR MYOPATHY WITH CURARE SENSITIVITY,
5753,257790,OCULOCEREBRAL HYPOPIGMENTATION SYNDROME OF PREUS,
5754,257800,OCULOCEREBRAL SYNDROME WITH HYPOPIGMENTATION,
5755,257850,"OCULODENTODIGITAL DYSPLASIA, AUTOSOMAL RECESSIVE",
5756,257910,OCULOPALATOCEREBRAL SYNDROME,
5757,257920,3MC SYNDROME 1, 3MC1
5758,257950,OCULOPHARYNGEAL MUSCULAR DYSTROPHY 1,
5759,257960,OCULOTRICHODYSPLASIA, OTD
5760,257970,OCULORENOCEREBELLAR SYNDROME,
5761,257980,ODONTOONYCHODERMAL DYSPLASIA, OODD
5762,258040,OEIS COMPLEX,
5763,258100,OGUCHI DISEASE 1,
5764,258120,MITOCHONDRIAL DNA DEPLETION SYNDROME 7 (HEPATOCEREBRAL TYPE),
5765,258150,SPERMATOGENIC FAILURE 1, SPGF1
5766,258200,OLIVER SYNDROME,
5767,258300,CEREBELLAR ATAXIA AND ALBINISM,
5768,258315,OMODYSPLASIA 1, OMOD1
5769,258320,"OMPHALOCELE-CLEFT PALATE SYNDROME, LETHAL",
5770,258360,ONYCHOTRICHODYSPLASIA AND NEUTROPENIA,
5771,258400,OPHTHALMOPLEGIA TOTALIS WITH PTOSIS AND MIOSIS,
5772,258450,"PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 1", PEOB1
5773,258470,OPHTHALMOPLEGIC NEUROMUSCULAR DISORDER WITH ABNORMAL MITOCHONDRIA,
5774,258480,OPSISMODYSPLASIA, OPSMD
5775,258500,OPTIC ATROPHY 6, OPA6
5776,258501,"3-METHYLGLUTACONIC ACIDURIA, TYPE III", MGCA3
5777,258650,"OPTIC ATROPHY, HEARING LOSS, AND PERIPHERAL NEUROPATHY, AUTOSOMAL RECESSIVE",
5778,258660,"NONARTERITIC ANTERIOR ISCHEMIC OPTIC NEUROPATHY, SUSCEPTIBILITY TO", NAION
5779,258700,OPTICOCOCHLEODENTATE DEGENERATION,
5780,258800,"ORAL SENSIBILITY, DISTURBANCE OF",
5781,258840,ORAL AND DIGITAL ANOMALIES WITH ICHTHYOSIS,
5782,258850,OROFACIODIGITAL SYNDROME III, OFD3
5783,258860,OROFACIODIGITAL SYNDROME IV, OFD4
5784,258865,OROFACIODIGITAL SYNDROME IX, OFD9
5785,258870,GYRATE ATROPHY OF CHOROID AND RETINA, GACR
5786,258900,OROTIC ACIDURIA,
5787,258920,OROTIC ACIDURIA,
5788,259050,PRIMROSE SYNDROME, PRIMS
5789,259100,"HYPERTROPHIC OSTEOARTHROPATHY, PRIMARY, AUTOSOMAL RECESSIVE, 1", PHOAR1
5790,259200,"BLOUNT DISEASE, ADOLESCENT",
5791,259250,"OSTEODYSPLASIA, FAMILIAL, ANDERSON TYPE",
5792,259270,"OSTEODYSPLASTY, PRECOCIOUS, OF DANKS, MAYNE, AND KOZLOWSKI",
5793,259400,"OSTEOGENESIS IMPERFECTA, TYPE II",
5794,259410,"OSTEOGENESIS IMPERFECTA CONGENITA, MICROCEPHALY, AND CATARACTS",
5795,259420,"OSTEOGENESIS IMPERFECTA, TYPE III", OI3
5796,259440,"OSTEOGENESIS IMPERFECTA, TYPE IX", OI9
5797,259450,BRUCK SYNDROME 1, BRKS1
5798,259500,OSTEOGENIC SARCOMA,
5799,259550,OSTEOID OSTEOMA,
5800,259600,"MULTICENTRIC OSTEOLYSIS, NODULOSIS, AND ARTHROPATHY", MONA
5801,259610,"OSTEOLYSIS SYNDROME, RECESSIVE",
5802,259650,OSTEOMA OF MIDDLE EAR,
5803,259660,RAINE SYNDROME,
5804,259680,CHRONIC RECURRENT MULTIFOCAL OSTEOMYELITIS 3, CRMO3
5805,259690,OSTEOPENIA AND SPARSE HAIR,
5806,259700,"OSTEOPETROSIS, AUTOSOMAL RECESSIVE 1", OPTB1
5807,259710,"OSTEOPETROSIS, AUTOSOMAL RECESSIVE 2", OPTB2
5808,259720,"OSTEOPETROSIS, AUTOSOMAL RECESSIVE 5", OPTB5
5809,259730,"OSTEOPETROSIS, AUTOSOMAL RECESSIVE 3", OPTB3
5810,259750,"OSTEOPOROSIS, JUVENILE",
5811,259770,OSTEOPOROSIS-PSEUDOGLIOMA SYNDROME, OPPG
5812,259775,RAINE SYNDROME, RNS
5813,259780,OTOONYCHOPERONEAL SYNDROME,
5814,259900,"HYPEROXALURIA, PRIMARY, TYPE I", HP1
5815,260000,"HYPEROXALURIA, PRIMARY, TYPE II", HP2
5816,260005,5-OXOPROLINASE DEFICIENCY, OPLAHD
5817,260100,PA POLYMORPHISM OF ALPHA-2-GLOBULIN,
5818,260130,"PACHYONYCHIA CONGENITA, AUTOSOMAL RECESSIVE",
5819,260150,PALANT CLEFT PALATE SYNDROME,
5820,260200,"PALLIDAL DEGENERATION, PROGRESSIVE, WITH RETINITIS PIGMENTOSA",
5821,260300,"PARKINSON DISEASE 15, AUTOSOMAL RECESSIVE EARLY-ONSET", PARK15
5822,260350,PANCREATIC CANCER,
5823,260370,PANCREATIC AGENESIS 1, PAGEN1
5824,260400,SHWACHMAN-DIAMOND SYNDROME 1, SDS1
5825,260450,JOHANSON-BLIZZARD SYNDROME,
5826,260470,SUBACUTE SCLEROSING PANENCEPHALITIS, SSPE
5827,260480,"PANCREATITIS, SCLEROSING CHOLANGITIS, AND SICCA COMPLEX",
5828,260490,MCCUNE-ALBRIGHT SYNDROME,
5829,260500,PAPILLOMA OF CHOROID PLEXUS, CPP
5830,260530,PARANA HARD-SKIN SYNDROME,
5831,260540,PARKINSON-DEMENTIA SYNDROME,
5832,260555,PARTINGTON-ANDERSON SYNDROME,
5833,260565,PEHO SYNDROME, PEHO
5834,260570,IMMUNODEFICIENCY 108 WITH AUTOINFLAMMATION, IMD108
5835,260600,"LEUKODYSTROPHY, HYPOMYELINATING, 3", HLD3
5836,260650,PELLAGRA-LIKE SYNDROME,
5837,260660,COUSIN SYNDROME,
5838,260800,PENTOSURIA, PNTSU
5839,260900,"PERICARDIAL EFFUSION, CHRONIC",
5840,260910,"PERIFOLLICULITIS CAPITIS ABSCEDENS ET SUFFODIENS, FAMILIAL",
5841,260920,HYPER-IgD SYNDROME, HIDS
5842,260950,"PERIODONTITIS, CHRONIC",
5843,260970,"PERIPHERAL NEUROPATHY, ATAXIA, FOCAL NECROTIZING ENCEPHALOPATHY, AND SPONGY DEGENERATION OF BRAIN",
5844,260980,"POLYMICROGYRIA, BILATERAL PERISYLVIAN, X-LINKED",
5845,261000,INTRINSIC FACTOR DEFICIENCY, IFD
5846,261100,IMERSLUND-GRASBECK SYNDROME 1, IGS1
5847,261400,"PERONEUS TERTIUS MUSCLE, ABSENCE OF",
5848,261500,EOSINOPHIL PEROXIDASE DEFICIENCY, EPXD
5849,261510,D-BIFUNCTIONAL PROTEIN DEFICIENCY,
5850,261515,D-BIFUNCTIONAL PROTEIN DEFICIENCY,
5851,261540,PETERS-PLUS SYNDROME, PTRPLS
5852,261550,"PERSISTENT MULLERIAN DUCT SYNDROME, TYPES I AND II", PMDS
5853,261560,PFEIFFER-PALM-TELLER SYNDROME,
5854,261575,PHAVER SYNDROME,
5855,261590,PHENFORMIN 4-HYDROXYLATION,
5856,261600,PHENYLKETONURIA, PKU
5857,261630,"HYPERPHENYLALANINEMIA, BH4-DEFICIENT, C", HPABH4C
5858,261640,"HYPERPHENYLALANINEMIA, BH4-DEFICIENT, A", HPABH4A
5859,261650,"PHOSPHOENOLPYRUVATE CARBOXYKINASE DEFICIENCY, MITOCHONDRIAL", PCKDM
5860,261660,TITLE NOT AVAILABLE AT THIS MOMENT,
5861,261670,GLYCOGEN STORAGE DISEASE X, GSD10
5862,261680,"PHOSPHOENOLPYRUVATE CARBOXYKINASE DEFICIENCY, CYTOSOLIC", PCKDC
5863,261740,"GLYCOGEN STORAGE DISEASE OF HEART, LETHAL CONGENITAL",
5864,261750,GLYCOGEN STORAGE DISEASE IXb, GSD9B
5865,261800,PIERRE ROBIN SYNDROME, PRBNS
5866,261900,"PILI TORTI, EARLY-ONSET",
5867,261990,"ABNORMAL HAIR, JOINT LAXITY, AND DEVELOPMENTAL DELAY", HJDD
5868,262000,BJORNSTAD SYNDROME, BJS
5869,262020,PILODENTAL DYSPLASIA WITH REFRACTIVE ERRORS,
5870,262190,"PINEAL HYPERPLASIA, INSULIN-RESISTANT DIABETES MELLITUS, AND SOMATIC ABNORMALITIES",
5871,262300,ACHROMATOPSIA 3, ACHM3
5872,262350,WOLF-HIRSCHHORN SYNDROME,
5873,262400,"ISOLATED GROWTH HORMONE DEFICIENCY, TYPE IA", IGHD1A
5874,262500,LARON SYNDROME,
5875,262600,"PITUITARY HORMONE DEFICIENCY, COMBINED, 2", CPHD2
5876,262650,KOWARSKI SYNDROME,
5877,262700,"PITUITARY HORMONE DEFICIENCY, COMBINED, 4", CPHD4
5878,262710,PITUITARY DWARFISM WITH LARGE SELLA TURCICA,
5879,262780,"CYTOCHROME P450, FAMILY 19, SUBFAMILY A, POLYPEPTIDE 1",
5880,262800,"PLASMA CLOT RETRACTION FACTOR, DEFICIENCY OF",
5881,262850,ALPHA-2-PLASMIN INHIBITOR DEFICIENCY,
5882,262875,PLATELET PROSTACYCLIN RECEPTOR DEFECT,
5883,262890,SCOTT SYNDROME, SCTS
5884,262900,PLEOCONIAL MYOPATHY WITH SALT CRAVING,
5885,263000,"INTERSTITIAL PNEUMONITIS, DESQUAMATIVE, FAMILIAL", DIP
5886,263100,"POLYCYSTIC KIDNEY, CATARACT, AND CONGENITAL BLINDNESS",
5887,263200,POLYCYSTIC KIDNEY DISEASE 4 WITH OR WITHOUT POLYCYSTIC LIVER DISEASE, PKD4
5888,263210,GILLESSEN-KAESBACH-NISHIMURA SYNDROME, GIKANIS
5889,263300,POLYCYTHEMIA VERA, PV
5890,263400,"ERYTHROCYTOSIS, FAMILIAL, 2", ECYT2
5891,263450,"POLYDACTYLY, POSTAXIAL, TYPE A5", PAPA5
5892,263510,SHORT-RIB THORACIC DYSPLASIA 3 WITH OR WITHOUT POLYDACTYLY,
5893,263520,SHORT-RIB THORACIC DYSPLASIA 6 WITH OR WITHOUT POLYDACTYLY, SRTD6
5894,263530,SHORT-RIB THORACIC DYSPLASIA 3 WITH OR WITHOUT POLYDACTYLY,
5895,263540,"POLYDACTYLY, POSTAXIAL, WITH DENTAL AND VERTEBRAL ANOMALIES",
5896,263550,"POLYMYOCLONUS, INFANTILE",
5897,263560,"CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 4A",
5898,263570,"POLYGLUCOSAN BODY NEUROPATHY, ADULT FORM", APBN
5899,263600,"POLYSACCHARIDE, STORAGE OF UNUSUAL",
5900,263610,"POLYHYDRAMNIOS, CHRONIC IDIOPATHIC",
5901,263620,"AUTOIMMUNE POLYENDOCRINE SYNDROME, TYPE I, WITH OR WITHOUT REVERSIBLE METAPHYSEAL DYSPLASIA",
5902,263630,POLYSYNDACTYLY WITH CARDIAC MALFORMATION,
5903,263650,BARTSOCAS-PAPAS SYNDROME 1, BPS1
5904,263700,"PORPHYRIA, CONGENITAL ERYTHROPOIETIC", CEP
5905,263750,MILLER SYNDROME,
5906,263800,GITELMAN SYNDROME, GTLMNS
5907,264010,"PRADER-WILLI HABITUS, OSTEOPENIA, AND CAMPTODACTYLY",
5908,264050,PRENATAL BOWING,
5909,264060,PREPAPILLARY VASCULAR LOOPS,
5910,264070,"HYPERPHENYLALANINEMIA, BH4-DEFICIENT, D", HPABH4D
5911,264080,PROGESTERONE RESISTANCE,
5912,264090,WIEDEMANN-RAUTENSTRAUCH SYNDROME, WDRTS
5913,264110,"PROLACTIN DEFICIENCY, ISOLATED",
5914,264120,PROLACTIN DEFICIENCY WITH OBESITY AND ENLARGED TESTES,
5915,264140,"PRUNE BELLY SYNDROME WITH PULMONIC STENOSIS, IMPAIRED INTELLECTUAL DEVELOPMENT, AND DEAFNESS",
5916,264150,PSEUDOACHONDROPLASIA,
5917,264160,PSEUDOACHONDROPLASIA,
5918,264180,PSEUDODIASTROPHIC DYSPLASIA, PDD
5919,264200,"PERSISTENT HYPERPLASTIC PRIMARY VITREOUS, AUTOSOMAL RECESSIVE",
5920,264270,"PSEUDOHERMAPHRODITISM, FEMALE, WITH SKELETAL ANOMALIES",
5921,264300,17-BETA HYDROXYSTEROID DEHYDROGENASE III DEFICIENCY,
5922,264350,"PSEUDOHYPOALDOSTERONISM, TYPE IB1, AUTOSOMAL RECESSIVE", PHA1B1
5923,264420,"FUNDUS DYSTROPHY, PSEUDOINFLAMMATORY, RECESSIVE FORM",
5924,264450,DOWN SYNDROME,
5925,264470,PEROXISOMAL ACYL-CoA OXIDASE DEFICIENCY,
5926,264475,"PSEUDOPAPILLEDEMA, OCULAR HYPOTELORISM, BLEPHAROPHIMOSIS, AND HAND ANOMALIES",
5927,264480,PSEUDOTRISOMY 13 SYNDROME,
5928,264500,PSEUDOURIDINURIA AND MENTAL DEFECT,
5929,264600,PSEUDOVAGINAL PERINEOSCROTAL HYPOSPADIAS, PPSH
5930,264700,"VITAMIN D HYDROXYLATION-DEFICIENT RICKETS, TYPE 1A", VDDR1A
5931,264800,PSEUDOXANTHOMA ELASTICUM, PXE
5932,264810,TITLE NOT AVAILABLE AT THIS MOMENT,
5933,264900,COAGULATION FACTOR XI, F11
5934,265000,"MULTIPLE PTERYGIUM SYNDROME, ESCOBAR VARIANT", EVMPS
5935,265050,3MC SYNDROME 2, 3MC2
5936,265100,PULMONARY ALVEOLAR MICROLITHIASIS, PULAM
5937,265120,"SURFACTANT METABOLISM DYSFUNCTION, PULMONARY, 1", SMDP1
5938,265140,PULMONARY ARTERIOVENOUS FISTULAS,
5939,265150,PULMONARY ATRESIA WITH INTACT VENTRICULAR SEPTUM,
5940,265200,PULMONARY BULLAE CAUSING PNEUMOTHORAX,
5941,265300,"LYMPHANGIECTASIA, PULMONARY, CONGENITAL", CPL
5942,265380,ALVEOLAR CAPILLARY DYSPLASIA WITH MISALIGNMENT OF PULMONARY VEINS, ACDMPV
5943,265400,"PULMONARY HYPERTENSION, PRIMARY, 5", PPH5
5944,265430,"PULMONARY HYPOPLASIA, PRIMARY",
5945,265450,"PULMONARY VENOOCCLUSIVE DISEASE 1, AUTOSOMAL DOMINANT", PVOD1
5946,265500,PULMONIC STENOSIS,
5947,265600,PULMONIC STENOSIS AND CONGENITAL NEPHROSIS,
5948,265800,PYCNODYSOSTOSIS,
5949,265850,PYGMY,
5950,265880,PYKNOACHONDROGENESIS,
5951,265900,PYLE DISEASE, PYL
5952,265950,PYLORIC ATRESIA,
5953,266100,"EPILEPSY, EARLY-ONSET, 4, VITAMIN B6-DEPENDENT", EPEO4
5954,266120,"ANEMIA, CONGENITAL, NONSPHEROCYTIC HEMOLYTIC, 8", CNSHA8
5955,266130,GLUTATHIONE SYNTHETASE DEFICIENCY, GSSD
5956,266140,"PYROPOIKILOCYTOSIS, HEREDITARY", HPP
5957,266150,PYRUVATE CARBOXYLASE DEFICIENCY,
5958,266200,"ANEMIA, CONGENITAL, NONSPHEROCYTIC HEMOLYTIC, 2", CNSHA2
5959,266250,"RADICULONEUROPATHY, FATAL NEONATAL",
5960,266255,"RADIOULNAR SYNOSTOSIS, UNILATERAL, WITH DEVELOPMENTAL RETARDATION AND HYPOTONIA",
5961,266265,"CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIc", CDG2C
5962,266270,RAMON SYNDROME,
5963,266280,RAPADILINO SYNDROME,
5964,266300,"SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 2", SHEP2
5965,266350,RED SKIN PIGMENT ANOMALY OF NEW GUINEA,
5966,266400,REESE RETINAL DYSPLASIA,
5967,266500,"REFSUM DISEASE, CLASSIC",
5968,266510,PEROXISOME BIOGENESIS DISORDER 3B, PBD3B
5969,266600,INFLAMMATORY BOWEL DISEASE (CROHN DISEASE) 1, IBD1
5970,266810,RENAL AND MULLERIAN DUCT HYPOPLASIA,
5971,266900,SENIOR-LOKEN SYNDROME 1, SLSN1
5972,266910,RENAL DYSPLASIA-LIMB DEFECTS SYNDROME,
5973,266920,SHORT-RIB THORACIC DYSPLASIA 9 WITH OR WITHOUT POLYDACTYLY, SRTD9
5974,267000,PERLMAN SYNDROME, PRLMNS
5975,267010,"MECKEL SYNDROME, TYPE 7", MKS7
5976,267200,RENAL TUBULAR ACIDOSIS III,
5977,267300,"RENAL TUBULAR ACIDOSIS, DISTAL, 2, WITH PROGRESSIVE SENSORINEURAL HEARING LOSS", DRTA2
5978,267400,"RENAL, GENITAL, AND MIDDLE EAR ANOMALIES",
5979,267430,RENAL TUBULAR DYSGENESIS, RTD
5980,267450,RESPIRATORY DISTRESS SYNDROME IN PREMATURE INFANTS,
5981,267480,RESPIRATORY UNDERRESPONSIVENESS TO HYPOXIA AND HYPERCAPNIA,
5982,267500,RETICULAR DYSGENESIS,
5983,267700,"HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 1", FHL1
5984,267730,RETICULUM CELL SARCOMA,
5985,267740,RETINAL DEGENERATION AND EPILEPSY,
5986,267750,KNOBLOCH SYNDROME 1, KNO1
5987,267760,"RETINAL DEGENERATION WITH NANOPHTHALMOS, CYSTIC MACULAR DEGENERATION, AND ANGLE CLOSURE GLAUCOMA",
5988,267800,"RETINAL DYSTROPHY, RETICULAR PIGMENTARY, OF POSTERIOR POLE",
5989,267900,RETINAL TELANGIECTASIA AND HYPOGAMMAGLOBULINEMIA,
5990,268000,RETINITIS PIGMENTOSA, RP
5991,268010,RETINITIS PIGMENTOSA INVERSA WITH DEAFNESS,
5992,268020,"RETINITIS PIGMENTOSA, DEAFNESS, IMPAIRED INTELLECTUAL DEVELOPMENT, AND HYPOGONADISM",
5993,268025,"RETINITIS PIGMENTOSA, LATE-ADULT ONSET",
5994,268030,RETINITIS PIGMENTOSA 12,
5995,268040,RETINOHEPATOENDOCRINOLOGIC SYNDROME,
5996,268050,MIRHOSSEINI-HOLMES-WALTON SYNDROME,
5997,268060,"RETINOPATHY, PERICENTRAL PIGMENTARY, AUTOSOMAL RECESSIVE",
5998,268080,RETINOSCHISIS OF FOVEA,
5999,268100,ENHANCED S-CONE SYNDROME, ESCS
6000,268130,REVESZ SYNDROME,
6001,268150,"RH-NULL, REGULATOR TYPE", RHNR
6002,268200,"MYOGLOBINURIA, ACUTE RECURRENT, AUTOSOMAL RECESSIVE",
6003,268210,"RHABDOMYOSARCOMA, EMBRYONAL, 1", RMSE1
6004,268220,RHABDOMYOSARCOMA 2, RMS2
6005,268240,RHEUMATIC FEVER-RELATED ANTIGEN,
6006,268250,RHIZOMELIC SYNDROME,
6007,268300,ROBERTS-SC PHOCOMELIA SYNDROME, RBS
6008,268305,ROBIN SEQUENCE WITH CLEFT MANDIBLE AND LIMB ANOMALIES,
6009,268310,"ROBINOW SYNDROME, AUTOSOMAL RECESSIVE 1", RRS1
6010,268315,"ROD-CONE DYSTROPHY, SENSORINEURAL DEAFNESS, AND FANCONI-TYPE RENAL DYSFUNCTION", RCDFRD
6011,268320,RODRIGUES BLINDNESS,
6012,268400,"ROTHMUND-THOMSON SYNDROME, TYPE 2", RTS2
6013,268500,ROWLEY-ROSENBERG SYNDROME,
6014,268650,RUDIGER SYNDROME,
6015,268670,SMITH-LEMLI-OPITZ SYNDROME,
6016,268700,SACCHAROPINURIA,
6017,268800,SANDHOFF DISEASE,
6018,268850,RICHIERI-COSTA/GUION-ALMEIDA SYNDROME,
6019,268900,SARCOSINEMIA, SARCOS
6020,268950,"MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 8",
6021,269000,ROBERTS-SC PHOCOMELIA SYNDROME,
6022,269150,SCHINZEL-GIEDION MIDFACE RETRACTION SYNDROME,
6023,269160,SCHIZENCEPHALY,
6024,269200,"AUTOIMMUNE POLYENDOCRINE SYNDROME, TYPE II", APS2
6025,269250,SCHNECKENBECKEN DYSPLASIA, SHNKND
6026,269300,CRANIOMETADIAPHYSEAL DYSPLASIA, CRMDD
6027,269400,ANTERIOR SEGMENT DYSGENESIS 7, ASGD7
6028,269500,SCLEROSTEOSIS 1, SOST1
6029,269600,SEA-BLUE HISTIOCYTE DISEASE,
6030,269630,SECOND METATARSAL-METACARPAL SYNDROME,
6031,269650,SECRETORY COMPONENT DEFICIENCY,
6032,269700,"LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 2", CGL2
6033,269720,"SEIZURES, BENIGN FAMILIAL NEONATAL, AUTOSOMAL RECESSIVE",
6034,269800,SENILE PLAQUE FORMATION,
6035,269840,IMMUNODEFICIENCY 48, IMD48
6036,269860,SHORT-RIB THORACIC DYSPLASIA 12, SRTD12
6037,269870,SHORT STATURE-OBESITY SYNDROME, SSOS
6038,269880,SHORT SYNDROME,
6039,269920,INFANTILE SIALIC ACID STORAGE DISEASE, ISSD
6040,269921,SIALURIA,
6041,269950,"ANEMIA, SIDEROBLASTIC, PYRIDOXINE-RESPONSIVE, AUTOSOMAL RECESSIVE",
6042,270050,SILVER-RUSSELL SYNDROME 1,
6043,270100,"HETEROTAXY, VISCERAL, 5, AUTOSOMAL", HTX5
6044,270150,SJOGREN SYNDROME,
6045,270200,SJOGREN-LARSSON SYNDROME, SLS
6046,270220,SJOGREN-LARSSON-LIKE ICHTHYOSIS WITHOUT CNS OR EYE INVOLVEMENT,
6047,270230,"THANATOPHORIC DYSPLASIA, TYPE I",
6048,270240,"ROTHMUND-THOMSON SYNDROME, TYPE 2",
6049,270300,PEELING SKIN SYNDROME 1, PSS1
6050,270350,ANOSMIA FOR BUTYL MERCAPTAN,
6051,270400,SMITH-LEMLI-OPITZ SYNDROME, SLOS
6052,270420,"DIARRHEA 3, SECRETORY SODIUM, CONGENITAL, WITH OR WITHOUT OTHER CONGENITAL ANOMALIES", DIAR3
6053,270425,SODIUM-POTASSIUM-ATPase ACTIVITY OF RED CELL,
6054,270450,"INSULIN-LIKE GROWTH FACTOR I, RESISTANCE TO", IGF1RES
6055,270460,SONODA SYNDROME,
6056,270500,"ATAXIA, SPASTIC, CHILDHOOD-ONSET, AUTOSOMAL RECESSIVE, WITH OPTIC ATROPHY AND IMPAIRED INTELLECTUAL DEVELOPMENT",
6057,270550,"SPASTIC ATAXIA, CHARLEVOIX-SAGUENAY TYPE", SACS
6058,270600,SPASTIC DIPLEGIA AND IMPAIRED INTELLECTUAL DEVELOPMENT,
6059,270680,"SPASTIC PARAPLEGIA 23, AUTOSOMAL RECESSIVE",
6060,270685,"SPASTIC PARAPLEGIA 17, AUTOSOMAL DOMINANT", SPG17
6061,270700,"SPASTIC PARAPLEGIA 15, AUTOSOMAL RECESSIVE", SPG15
6062,270710,"SPASTIC ATAXIA, CHARLEVOIX-SAGUENAY TYPE",
6063,270750,"SPASTIC PARAPLEGIA 23, AUTOSOMAL RECESSIVE", SPG23
6064,270800,"SPASTIC PARAPLEGIA 5A, AUTOSOMAL RECESSIVE", SPG5A
6065,270805,SPASTIC PARAPLEGIA WITH MYOCLONIC EPILEPSY,
6066,270850,"SPASTIC PARESIS, GLAUCOMA, AND IMPAIRED INTELLECTUAL DEVELOPMENT",
6067,270900,SPASTIC PSEUDOSCLEROSIS,
6068,270950,"SPASTIC QUADRIPLEGIA, RETINITIS PIGMENTOSA, AND IMPAIRED INTELLECTUAL DEVELOPMENT",
6069,270960,SPERMATOGENIC FAILURE 4, SPGF4
6070,270970,"SPHEROCYTOSIS, TYPE 3", SPH3
6071,271100,LYMPHEDEMA-DISTICHIASIS SYNDROME,
6072,271109,SPINAL MUSCULAR ATROPHY WITH IMPAIRED INTELLECTUAL DEVELOPMENT,
6073,271110,SPINAL MUSCULAR ATROPHY WITH MICROCEPHALY AND IMPAIRED INTELLECTUAL DEVELOPMENT,
6074,271120,"NEURONOPATHY, DISTAL HEREDITARY MOTOR, AUTOSOMAL DOMINANT 1",
6075,271150,"SPINAL MUSCULAR ATROPHY, TYPE IV", SMA4
6076,271200,"SPINAL MUSCULAR ATROPHY, RYUKYUAN TYPE",
6077,271220,"SPINAL MUSCULAR ATROPHY, SCAPULOPERONEAL",
6078,271225,SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 1,
6079,271245,MITOCHONDRIAL DNA DEPLETION SYNDROME 7 (HEPATOCEREBRAL TYPE), MTDPS7
6080,271250,"SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 3", SCAR3
6081,271270,SPINOCEREBELLAR ATAXIA WITH DYSMORPHISM,
6082,271310,SPINOCEREBELLAR DEGENERATION AND CORNEAL DYSTROPHY,
6083,271320,"SPINOCEREBELLAR DEGENERATION WITH MACULAR CORNEAL DYSTROPHY, CONGENITAL CATARACTS, AND MYOPIA",
6084,271322,SPINOCEREBELLAR DEGENERATION WITH SLOW EYE MOVEMENTS, SDSEM
6085,271400,"ASPLENIA, ISOLATED CONGENITAL", ICAS
6086,271500,SPLENOPORTAL VASCULAR ANOMALIES,
6087,271510,"SPONDYLOEPIMETAPHYSEAL DYSPLASIA, SPONASTRIME TYPE", SEMDSP
6088,271520,SPONDYLOCOSTAL DYSOSTOSIS WITH ANAL ATRESIA AND UROGENITAL ANOMALIES,
6089,271530,"BRACHYOLMIA TYPE 1, HOBAEK TYPE", BCYM1A
6090,271550,SPONDYLOENCHONDRODYSPLASIA WITH IMMUNE DYSREGULATION,
6091,271600,"SPONDYLOEPIPHYSEAL DYSPLASIA TARDA, AUTOSOMAL RECESSIVE",
6092,271620,SPONDYLOEPIPHYSEAL DYSPLASIA TARDA WITH IMPAIRED INTELLECTUAL DEVELOPMENT,
6093,271630,"BRACHYOLMIA TYPE 1, TOLEDO TYPE", BCYM1B
6094,271640,"SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY, TYPE 1, WITH OR WITHOUT FRACTURES", SEMDJL1
6095,271650,"SPONDYLOEPIMETAPHYSEAL DYSPLASIA, IRAPA TYPE", SEMDIT
6096,271665,"SPONDYLOMETAEPIPHYSEAL DYSPLASIA, SHORT LIMB-HAND TYPE",
6097,271700,SPONDYLOPERIPHERAL DYSPLASIA,
6098,271900,CANAVAN DISEASE,
6099,271930,"STRIATONIGRAL DEGENERATION, INFANTILE", SNDI
6100,271950,"SUBAORTIC STENOSIS, MEMBRANOUS",
6101,271960,SUBAORTIC STENOSIS--SHORT STATURE SYNDROME,
6102,271980,SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY, SSADHD
6103,272000,"SUCROSURIA, HIATUS HERNIA, AND IMPAIRED INTELLECTUAL DEVELOPMENT",
6104,272100,SUDANOPHILIC CEREBRAL SCLEROSIS,
6105,272120,SUDDEN INFANT DEATH SYNDROME,
6106,272150,SUGARMAN BRACHYDACTYLY,
6107,272200,MULTIPLE SULFATASE DEFICIENCY, MSD
6108,272300,"SULFITE OXIDASE DEFICIENCY, ISOLATED", ISOD
6109,272350,SUMMITT SYNDROME,
6110,272370,SUSCEPTIBILITY TO LYSIS BY ALLOREACTIVE NATURAL KILLER CELLS, EC1
6111,272430,CRISPONI/COLD-INDUCED SWEATING SYNDROME 1, CISS1
6112,272440,FILIPPI SYNDROME, FLPIS
6113,272450,SYNDESMODYSPLASIC DWARFISM,
6114,272460,SPONDYLOCARPOTARSAL SYNOSTOSIS SYNDROME, SCT
6115,272480,"SYRINGOMYELIA, NONCOMMUNICATING ISOLATED",
6116,272500,"LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 2",
6117,272550,HYPERGLYCINURIA,
6118,272600,TAPETORETINAL DEGENERATION WITH ATAXIA,
6119,272620,TARDIVE DYSKINESIA,
6120,272650,TATSUMI FACTOR DEFICIENCY,
6121,272700,TAURODONTISM,
6122,272750,"GM2-GANGLIOSIDOSIS, AB VARIANT",
6123,272800,TAY-SACHS DISEASE, TSD
6124,272950,TEEBI-SHALTOUT SYNDROME, TBSH
6125,272980,"TEETH, CONGENITAL ABSENCE OF, WITH TAURODONTIA AND SPARSE HAIR",
6126,273000,"TEETH, FUSED",
6127,273050,"TEETH, NONERUPTION OF, WITH MAXILLARY HYPOPLASIA AND GENU VALGUM",
6128,273120,"TERATOMA, PINEAL",
6129,273150,"TESTES, RUDIMENTARY",
6130,273250,"46,XY SEX REVERSAL 11", SRXY11
6131,273300,TESTICULAR GERM CELL TUMOR, TGCT
6132,273350,"46,XY SEX REVERSAL 4",
6133,273390,TETRAAMELIA WITH ECTODERMAL DYSPLASIA AND LACRIMAL DUCT ABNORMALITIES,
6134,273395,TETRAAMELIA SYNDROME 1, TETAMS1
6135,273400,"TETRAMELIC DEFICIENCIES, ECTODERMAL DYSPLASIA, DEFORMED EARS, AND OTHER ABNORMALITIES",
6136,273490,"THALAMIC DEGENERATION, SYMMETRIC INFANTILE",
6137,273600,THALIDOMIDE SUSCEPTIBILITY,
6138,273680,"THANATOPHORIC DYSPLASIA, GLASGOW VARIANT",
6139,273730,THORACIC DYSPLASIA-HYDROCEPHALUS SYNDROME,
6140,273740,THORACOMELIC DYSPLASIA,
6141,273750,THREE M SYNDROME 1, 3M1
6142,273770,THREONINEMIA,
6143,273800,GLANZMANN THROMBASTHENIA 1, GT1
6144,273900,THROMBOCYTOPENIA 3, THC3
6145,274000,THROMBOCYTOPENIA-ABSENT RADIUS SYNDROME, TAR
6146,274150,"THROMBOTIC THROMBOCYTOPENIC PURPURA, HEREDITARY", TTP
6147,274180,THROMBOXANE A SYNTHASE 1, TBXAS1
6148,274190,"THUMB AGENESIS, SHORT STATURE, AND IMMUNODEFICIENCY",
6149,274200,"THUMB, DISTAL HYPEREXTENSIBILITY OF",
6150,274205,"THUMB, HYPOPLASTIC, WITH CHOROID COLOBOMA, POORLY DEVELOPED ANTIHELIX, AND DEAFNESS",
6151,274210,THYMIC APLASIA WITH FETAL DEATH,
6152,274230,"THYMOMA, FAMILIAL",
6153,274240,THYROCEREBRORETINAL SYNDROME,
6154,274260,"THYMOMA, FAMILIAL",
6155,274265,THYMIC-RENAL-ANAL-LUNG DYSPLASIA,
6156,274270,DIHYDROPYRIMIDINE DEHYDROGENASE DEFICIENCY, DPYDD
6157,274300,"THYROID HORMONE RESISTANCE, GENERALIZED, AUTOSOMAL RECESSIVE", GRTHR
6158,274400,THYROID DYSHORMONOGENESIS 1, TDH1
6159,274500,THYROID DYSHORMONOGENESIS 2A, TDH2A
6160,274600,PENDRED SYNDROME, PDS
6161,274700,THYROID DYSHORMONOGENESIS 3, TDH3
6162,274800,THYROID DYSHORMONOGENESIS 4, TDH4
6163,274900,THYROID DYSHORMONOGENESIS 5, TDH5
6164,275000,GRAVES DISEASE, GRD
6165,275100,"HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 4", CHNG4
6166,275120,THYROTROPIN-RELEASING HORMONE DEFICIENCY,
6167,275190,TIGLIC ACIDEMIA,
6168,275200,"HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 1", CHNG1
6169,275210,RESTRICTIVE DERMOPATHY 1, RSDM1
6170,275220,TIBIAL HEMIMELIA,
6171,275230,"TIBIA, ABSENCE OF, WITH CONGENITAL DEAFNESS",
6172,275240,"TINEA IMBRICATA, SUSCEPTIBILITY TO",
6173,275250,"TONGUE, PIGMENTED FUNGIFORM PAPILLAE OF",
6174,275300,TRACHEOBRONCHOMEGALY,
6175,275350,TRANSCOBALAMIN II DEFICIENCY, TCN2D
6176,275355,"SQUAMOUS CELL CARCINOMA, HEAD AND NECK", HNSCC
6177,275360,TREHALASE, TREH
6178,275370,"TRICARBOXYLIC ACID CYCLE, DEFECT OF",
6179,275400,OLIVER-MCFARLANE SYNDROME, OMCS
6180,275450,TRICHOODONTOONYCHIAL DYSPLASIA WITH BONE DEFICIENCY,
6181,275500,"TRICHORHINOPHALANGEAL SYNDROME, TYPE I",
6182,275550,"TRICHOTHIODYSTROPHY 4, NONPHOTOSENSITIVE",
6183,275595,"TRIGONOBRACHYCEPHALY, BULBOUS BIFID NOSE, MICROGNATHIA, AND ABNORMALITIES OF THE HANDS AND FEET",
6184,275600,TITLE NOT AVAILABLE AT THIS MOMENT,
6185,275630,CHANARIN-DORFMAN SYNDROME, CDS
6186,275650,"BILE ACID SYNTHESIS DEFECT, CONGENITAL, 4",
6187,275900,"SPASTIC PARAPLEGIA 20, AUTOSOMAL RECESSIVE", SPG20
6188,276000,"PROTEASE, SERINE, 1", PRSS1
6189,276100,TRYPTOPHANURIA WITH DWARFISM,
6190,276200,T-SUBSTANCE ANOMALY,
6191,276300,MISMATCH REPAIR CANCER SYNDROME 1, MMRCS1
6192,276400,"TWINNING, DIZYGOTIC",
6193,276410,"TWINNING, MONOZYGOTIC",
6194,276500,"TYROSINEMIA, TYPE III",
6195,276600,"TYROSINEMIA, TYPE II", TYRSN2
6196,276700,"TYROSINEMIA, TYPE I", TYRSN1
6197,276710,"TYROSINEMIA, TYPE III", TYRSN3
6198,276800,TYROSINOSIS,
6199,276820,"ULNA AND FIBULA, ABSENCE OF, WITH SEVERE LIMB DEFICIENCY",
6200,276821,ULNAR HYPOPLASIA WITH IMPAIRED INTELLECTUAL DEVELOPMENT,
6201,276822,ULNAR AGENESIS AND ENDOCARDIAL FIBROELASTOSIS,
6202,276850,"THROMBOTIC THROMBOCYTOPENIC PURPURA, HEREDITARY",
6203,276880,UROCANASE DEFICIENCY, UROCD
6204,276900,"USHER SYNDROME, TYPE I", USH1
6205,276901,"USHER SYNDROME, TYPE IIA", USH2A
6206,276902,"USHER SYNDROME, TYPE IIIA", USH3A
6207,276903,MYOSIN VIIA, MYO7A
6208,276904,"USHER SYNDROME, TYPE IC", USH1C
6209,276905,"USHER SYNDROME, TYPE IIC",
6210,276950,VACTERL ASSOCIATION WITH HYDROCEPHALUS,
6211,277000,MAYER-ROKITANSKY-KUSTER-HAUSER SYNDROME, MRKH
6212,277100,VALINEMIA,
6213,277150,VAN BOGAERT-HOZAY SYNDROME,
6214,277170,OROFACIODIGITAL SYNDROME VI, OFD6
6215,277175,VASCULAR HYALINOSIS,
6216,277180,"VAS DEFERENS, CONGENITAL BILATERAL APLASIA OF", CBAVD
6217,277200,"RIGHT VENTRICULAR HYPOPLASIA, ISOLATED",
6218,277300,"SPONDYLOCOSTAL DYSOSTOSIS 1, AUTOSOMAL RECESSIVE", SCDO1
6219,277320,"VISCERAL MYOPATHY, FAMILIAL, WITH EXTERNAL OPHTHALMOPLEGIA",
6220,277350,"HYPERCAROTENEMIA AND VITAMIN A DEFICIENCY, AUTOSOMAL RECESSIVE",
6221,277380,"METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, cblF TYPE", MAHCF
6222,277400,"METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, cblC TYPE", MAHCC
6223,277410,"METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, cblD TYPE", MAHCD
6224,277420,"VITAMIN D-DEPENDENT RICKETS, TYPE 2A",
6225,277440,"VITAMIN D-DEPENDENT RICKETS, TYPE 2A", VDDR2A
6226,277450,"VITAMIN K-DEPENDENT CLOTTING FACTORS, COMBINED DEFICIENCY OF, 1", VKCFD1
6227,277460,ATAXIA WITH VITAMIN E DEFICIENCY, AVED
6228,277465,"VITILIGO, PROGRESSIVE, WITH IMPAIRED INTELLECTUAL DEVELOPMENT AND URETHRAL DUPLICATION",
6229,277470,"PONTOCEREBELLAR HYPOPLASIA, TYPE 2A", PCH2A
6230,277480,"VON WILLEBRAND DISEASE, TYPE 3", VWD3
6231,277580,"WAARDENBURG SYNDROME, TYPE 4A", WS4A
6232,277590,WEAVER SYNDROME, WVS
6233,277600,WEILL-MARCHESANI SYNDROME 1, WMS1
6234,277610,"OTOSPONDYLOMEGAEPIPHYSEAL DYSPLASIA, AUTOSOMAL DOMINANT",
6235,277700,WERNER SYNDROME, WRN
6236,277720,"WHISTLING FACE SYNDROME, RECESSIVE FORM",
6237,277730,WERNICKE-KORSAKOFF SYNDROME,
6238,277740,WHITE FORELOCK WITH MALFORMATIONS,
6239,277900,WILSON DISEASE, WND
6240,277950,WINCHESTER SYNDROME, WNCHRS
6241,277970,WISKOTT-ALDRICH SYNDROME 2,
6242,277990,WOLFF SYNDROME,
6243,278000,CHOLESTERYL ESTER STORAGE DISEASE, CESD
6244,278100,CHOLESTERYL ESTER STORAGE DISEASE,
6245,278150,HYPOTRICHOSIS 8, HYPT8
6246,278200,"WOOLLY HAIR, HYPOTRICHOSIS, EVERTED LOWER LIP, AND OUTSTANDING EARS",
6247,278205,NAXOS DISEASE,
6248,278250,WRINKLY SKIN SYNDROME, WSS
6249,278300,"XANTHINURIA, TYPE I", XAN1
6250,278400,"ALBINISM, OCULOCUTANEOUS, TYPE III",
6251,278600,HYDROXYKYNURENINURIA,
6252,278700,"XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP A", XPA
6253,278720,"XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP C", XPC
6254,278730,"XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP D", XPD
6255,278740,"XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP E", XPE
6256,278750,"XERODERMA PIGMENTOSUM, VARIANT TYPE", XPV
6257,278760,"XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP F", XPF
6258,278780,"XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP G", XPG
6259,278800,DE SANCTIS-CACCHIONE SYNDROME,
6260,278810,"XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP C",
6261,278850,"46,XX SEX REVERSAL 2", SRXX2
6262,278900,XYLOSIDASE DEFICIENCY,
6263,279000,YOUNG SYNDROME,
6264,280000,"COLOBOMA, CONGENITAL HEART DISEASE, ICHTHYOSIFORM DERMATOSIS, IMPAIRED INTELLECTUAL DEVELOPMENT, AND EAR ANOMALIES SYNDROME", CHIME
6265,300000,OPITZ GBBB SYNDROME, GBBB
6266,300001,"ICHTHYOSIS, X-LINKED, WITHOUT STEROID SULFATASE DEFICIENCY",
6267,300002,ARYLSULFATASE D, ARSD
6268,300003,ARYLSULFATASE F, ARSF
6269,300004,"CORPUS CALLOSUM, AGENESIS OF, WITH ABNORMAL GENITALIA",
6270,300005,METHYL-CpG-BINDING PROTEIN 2, MECP2
6271,300006,CENTRIN 2, CETN2
6272,300007,INTERLEUKIN 9 RECEPTOR, IL9R
6273,300008,CHLORIDE CHANNEL 5, CLCN5
6274,300009,DENT DISEASE 1, DENT1
6275,300010,A-11 GENE, A11
6276,300011,"ATPase, Cu(2+)-TRANSPORTING, ALPHA POLYPEPTIDE", ATP7A
6277,300012,"SWI/SNF-RELATED, MATRIX-ASSOCIATED, ACTIN-DEPENDENT REGULATOR OF CHROMATIN, SUBFAMILY A, MEMBER 1", SMARCA1
6278,300013,"N-ALPHA-ACETYLTRANSFERASE 10, NatA CATALYTIC SUBUNIT", NAA10
6279,300014,"ATPase, Ca(2+)-TRANSPORTING, PLASMA MEMBRANE, 3", ATP2B3
6280,300015,"ACETYLSEROTONIN METHYLTRANSFERASE, X-CHROMOSOMAL", ASMT
6281,300016,"MELANOMA ANTIGEN, FAMILY A, 1", MAGEA1
6282,300017,FILAMIN A, FLNA
6283,300018,"46,XY SEX REVERSAL 2", SRXY2
6284,300019,HOST CELL FACTOR C1, HCFC1
6285,300020,"ACTIN, ALPHA-1, SKELETAL MUSCLE",
6286,300021,"SPINAL MUSCULAR ATROPHY, X-LINKED 2",
6287,300022,PLEXIN A3, PLXNA3
6288,300023,RHO GTPase-ACTIVATING PROTEIN 4, ARHGAP4
6289,300024,ZINC FINGER PROTEIN 157, ZNF157
6290,300025,CAUDAL-TYPE HOMEOBOX TRANSCRIPTION FACTOR 4, CDX4
6291,300026,NUCLEOSOME ASSEMBLY PROTEIN 1-LIKE 2, NAP1L2
6292,300027,RNA-BINDING MOTIF PROTEIN 3, RBM3
6293,300028,"ZINC FINGER-, CCCH DOMAIN-, AND RNA-BINDING MOTIF-CONTAINING SERINE/ARGININE-RICH PROTEIN 2", ZRSR2
6294,300029,RETINITIS PIGMENTOSA 3, RP3
6295,300030,"DEAFNESS, X-LINKED 3", DFNX3
6296,300031,"FAMILY WITH SEQUENCE SIMILARITY 11, MEMBER A", FAM11A
6297,300032,ATRX CHROMATIN REMODELER, ATRX
6298,300033,FORKHEAD BOX O4, FOXO4
6299,300034,"ANGIOTENSIN II RECEPTOR, TYPE 2", AGTR2
6300,300035,EPHRIN B1, EFNB1
6301,300036,"SOLUTE CARRIER FAMILY 6 (NEUROTRANSMITTER TRANSPORTER, CREATINE), MEMBER 8", SLC6A8
6302,300037,GLYPICAN 3, GPC3
6303,300038,"PYRIMIDINERGIC RECEPTOR P2Y, G PROTEIN-COUPLED, 4", P2RY4
6304,300039,"POU DOMAIN, CLASS 3, TRANSCRIPTION FACTOR 4", POU3F4
6305,300040,STRUCTURAL MAINTENANCE OF CHROMOSOMES 1A, SMC1A
6306,300041,"GUANYLATE CYCLASE 2F, RETINAL", GUCY2F
6307,300042,"ALOPECIA, CONGENITAL", ALPC
6308,300043,"TBC1 DOMAIN FAMILY, MEMBER 20",
6309,300044,TRANSKETOLASE-LIKE 1, TKTL1
6310,300045,SPEECH-LANGUAGE DISORDER 1,
6311,300046,"INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 23", XLID23
6312,300047,"INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 20", XLID20
6313,300048,"INTESTINAL PSEUDOOBSTRUCTION, NEURONAL, CHRONIC IDIOPATHIC, X-LINKED", CIIPX
6314,300049,PERIVENTRICULAR NODULAR HETEROTOPIA 1, PVNH1
6315,300050,UBIQUITIN-SPECIFIC PROTEASE 11, USP11
6316,300051,GLYCOPROTEIN M6B, GPM6B
6317,300052,DYSTROPHIN-RELATED PROTEIN 2, DRP2
6318,300053,VESICLE-ASSOCIATED MEMBRANE PROTEIN 7: VAMP7,
6319,300054,"BODY LENGTH, MOUSE, HUMAN HOMOLOG",
6320,300055,"INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC 13", MRXS13
6321,300056,HOLOCYTOCHROME C SYNTHASE, HCCS
6322,300057,HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN D,
6323,300058,"RHOX HOMEOBOX FAMILY, MEMBER 1",
6324,300059,TRANSMEMBRANE PROTEIN 187, TMEM187
6325,300060,"L ANTIGEN FAMILY, MEMBER 3", LAGE3
6326,300061,"ZINC FINGER, MYM-TYPE 3", ZMYM3
6327,300062,"INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 14", XLID14
6328,300063,"IMMUNODYSREGULATION, POLYENDOCRINOPATHY, AND ENTEROPATHY, X-LINKED",
6329,300064,HYDE-FORSTER SYNDROME,
6330,300065,CENTROMERIC PROTEIN I, CENPI
6331,300066,"DEAFNESS, X-LINKED 4", DFNX4
6332,300067,"LISSENCEPHALY, X-LINKED, 1", LISX1
6333,300068,ANDROGEN INSENSITIVITY SYNDROME, AIS
6334,300069,BARTH SYNDROME,
6335,300070,FIBROBLAST GROWTH FACTOR 13, FGF13
6336,300071,"NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 2A", CSNB2A
6337,300072,"UBIQUITIN-SPECIFIC PROTEASE 9, X-LINKED", USP9X
6338,300073,"FETAL AKINESIA SYNDROME, X-LINKED",
6339,300074,X CHROMOSOME-CONTROLLING ELEMENT, XCE
6340,300075,RIBOSOMAL PROTEIN S6 KINASE A3, RPS6KA3
6341,300076,"IMMUNONEUROLOGIC DISORDER, X-LINKED",
6342,300077,"INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 29",
6343,300078,NADH-UBIQUINONE OXIDOREDUCTASE SUBUNIT A1, NDUFA1
6344,300079,"INHIBITOR OF APOPTOSIS, X-LINKED", XIAP
6345,300080,RNA-BINDING MOTIF PROTEIN 10, RBM10
6346,300081,DEOXYRIBONUCLEASE I-LIKE 1, DNASE1L1
6347,300082,"COGNITIVE FUNCTION 1, SOCIAL", CGF1
6348,300083,"PROTEIN KINASE, X-LINKED", PRKX
6349,300084,NON-POU DOMAIN-CONTAINING OCTAMER-BINDING PROTEIN, NONO
6350,300085,"CONE-ROD DYSTROPHY, X-LINKED, 2", CORDX2
6351,300086,LYSOPHOSPHATIDIC ACID RECEPTOR 4, LPAR4
6352,300087,"X INACTIVATION, FAMILIAL SKEWED, 1", SXI1
6353,300088,DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 9, DEE9
6354,300089,"ISOCITRATE DEHYDROGENASE, NAD(+), 3, NONCATALYTIC SUBUNIT GAMMA", IDH3G
6355,300090,"SIGNAL SEQUENCE RECEPTOR, DELTA", SSR4
6356,300091,FOS-INDUCED GROWTH FACTOR, FIGF
6357,300092,TESTIS-EXPRESSED GENE 28, TEX28
6358,300093,"GAMMA-AMINOBUTYRIC ACID RECEPTOR, EPSILON", GABRE
6359,300094,"PROTEIN KINASE C, IOTA FORM",
6360,300095,"SOLUTE CARRIER FAMILY 16 (MONOCARBOXYLIC ACID TRANSPORTER), MEMBER 2", SLC16A2
6361,300096,TETRASPANIN 7, TSPAN7
6362,300097,"MELANOMA ANTIGEN, FAMILY B, 1", MAGEB1
6363,300098,"MELANOMA ANTIGEN, FAMILY B, 2", MAGEB2
6364,300099,"MELANOMA ANTIGEN, FAMILY B, 1",
6365,300100,ADRENOLEUKODYSTROPHY, ALD
6366,300101,"BONE MARROW KINASE, X-LINKED", BMX
6367,300102,PATATIN-LIKE PHOSPHOLIPASE DOMAIN-CONTAINING PROTEIN 4, PNPLA4
6368,300103,SHROOM FAMILY MEMBER 2, SHROOM2
6369,300104,GDP DISSOCIATION INHIBITOR 1, GDI1
6370,300105,SPERMINE SYNTHASE, SMS
6371,300106,"SPONDYLOEPIMETAPHYSEAL DYSPLASIA, X-LINKED", SEMDX
6372,300107,BOMBESIN-LIKE RECEPTOR 3, BRS3
6373,300108,DIAPHANOUS-RELATED FORMIN 2, DIAPH2
6374,300109,"PROTEIN PHOSPHATASE, EF-HAND CALCIUM-BINDING DOMAIN 1", PPEF1
6375,300110,"CALCIUM CHANNEL, VOLTAGE-DEPENDENT, ALPHA-1F SUBUNIT", CACNA1F
6376,300111,PRICKLE PLANAR CELL POLARITY PROTEIN 3, PRICKLE3
6377,300112,PROTEOLIPID PROTEIN 2, PLP2
6378,300113,"X-LINKED B CELL SURFACE ANTIGEN, MOUSE, HOMOLOG-LIKE 1", XLRL
6379,300114,RAYNAUD-CLAES SYNDROME, MRXSRC
6380,300115,"INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 50", XLID50
6381,300116,MATURE T-CELL PROLIFERATION 1, MTCP1
6382,300117,NUCLEOSOME ASSEMBLY PROTEIN 1-LIKE 3, NAP1L3
6383,300118,RHO GTPase-ACTIVATING PROTEIN 6, ARHGAP6
6384,300119,"INTERLEUKIN 13 RECEPTOR, ALPHA-1", IL13RA1
6385,300120,MASTERMIND-LIKE DOMAIN-CONTAINING PROTEIN 1, MAMLD1
6386,300121,DOUBLECORTIN, DCX
6387,300122,OPITZ GBBB SYNDROME,
6388,300123,"INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, WITH PANHYPOPITUITARISM",
6389,300124,GTP-BINDING PROTEIN 6, GTPBP6
6390,300125,"MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 2",
6391,300126,DYSKERIN, DKC1
6392,300127,OLIGOPHRENIN 1, OPHN1
6393,300128,LYSINE DEMETHYLASE 6A, KDM6A
6394,300129,"HEMATOPOIETIC STEM CELL KINETICS, CONTROL OF",
6395,300130,"INTERLEUKIN 13 RECEPTOR, ALPHA-2", IL13RA2
6396,300131,PLASTIN 3, PLS3
6397,300132,TROPHININ, TRO
6398,300133,VON HIPPEL-LINDAU BINDING PROTEIN 1, VBP1
6399,300134,DUAL-SPECIFICITY PHOSPHATASE 9, DUSP9
6400,300135,"ATP-BINDING CASSETTE, SUBFAMILY B, MEMBER 7", ABCB7
6401,300136,"TYPE 1 DIABETES MELLITUS, X-LINKED, SUSCEPTIBILITY TO", T1DX
6402,300137,"IMMUNOGLOBULIN SUPERFAMILY, MEMBER 1", IGSF1
6403,300138,CHLORIDE INTRACELLULAR CHANNEL 2, CLIC2
6404,300139,IMMUNOGLOBULIN-BINDING PROTEIN 1, IGBP1
6405,300140,"EUKARYOTIC TRANSLATION ELONGATION FACTOR 1, BETA-2",
6406,300141,"PROTEIN PHOSPHATASE 6, CATALYTIC SUBUNIT",
6407,300142,p21 PROTEIN-ACTIVATED KINASE 3, PAK3
6408,300143,"INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 21", XLID21
6409,300144,GLUTAMATE DEHYDROGENASE 2, GLUD2
6410,300145,X-PROLYL AMINOPEPTIDASE 2, XPNPEP2
6411,300146,CALPAIN 6, CAPN6
6412,300147,"PROSTATE CANCER, HEREDITARY, X-LINKED 1", HPCX1
6413,300148,MEHMO SYNDROME, MEHMO
6414,300149,"CBP/p300-INTERACTING TRANSACTIVATOR WITH GLU/ASP-RICH C-TERMINAL DOMAIN, 1", CITED1
6415,300150,"SOLUTE CARRIER FAMILY 25 (MITOCHONDRIAL CARRIER, ADENINE NUCLEOTIDE TRANSLOCATOR), MEMBER A5", SLC25A5
6416,300151,"SOLUTE CARRIER FAMILY 25 (MITOCHONDRIAL CARRIER, ADENINE NUCLEOTIDE TRANSLOCATOR), MEMBER A6", SLC25A6
6417,300152,"MELANOMA ANTIGEN, FAMILY B, 3", MAGEB3
6418,300153,"MELANOMA ANTIGEN, FAMILY B, 4", MAGEB4
6419,300154,ESX1-LIKE PROTEIN, ESX1L
6420,300155,RETINITIS PIGMENTOSA 24, RP24
6421,300156,CANCER/TESTIS ANTIGEN 1B, CTAG1B
6422,300157,"ACYL-CoA SYNTHETASE LONG CHAIN FAMILY, MEMBER 4", ACSL4
6423,300158,"ARTHROGRYPOSIS, CONGENITAL, LOWER LIMB, X-LINKED", ACLLX
6424,300159,"THYMOSIN, BETA-4, X CHROMOSOME", TMSB4X
6425,300160,"DEAD-BOX HELICASE 3, X-LINKED", DDX3X
6426,300161,"EUKARYOTIC TRANSLATION INITIATION FACTOR 2, SUBUNIT 3", EIF2S3
6427,300162,ACETYLSEROTONIN METHYLTRANSFERASE-LIKE, ASMTL
6428,300163,FOUR-AND-A-HALF LIM DOMAINS 1, FHL1
6429,300164,INACTIVATION ESCAPE 1, INE1
6430,300165,INACTIVATION ESCAPE 2, INE2
6431,300166,"MICROPHTHALMIA, SYNDROMIC 2", MCOPS2
6432,300167,HEPHAESTIN, HEPH
6433,300168,GLYPICAN 4, GPC4
6434,300169,"APOPTOSIS-INDUCING FACTOR, MITOCHONDRIA-ASSOCIATED, 1", AIFM1
6435,300170,OFD1 CENTRIOLE AND CENTRIOLAR SATELLITE PROTEIN, OFD1
6436,300171,MYOTUBULARIN-RELATED PROTEIN 1, MTMR1
6437,300172,CALCIUM/CALMODULIN-DEPENDENT SERINE PROTEIN KINASE, CASK
6438,300173,"MELANOMA ANTIGEN, FAMILY A, 2", MAGEA2
6439,300174,"MELANOMA ANTIGEN, FAMILY A, 3", MAGEA3
6440,300175,"MELANOMA ANTIGEN, FAMILY A, 4", MAGEA4
6441,300176,"MELANOMA ANTIGEN, FAMILY A, 6", MAGEA6
6442,300177,"MELANOMA ANTIGEN, FAMILY A, 12", MAGEA12
6443,300178,ZINC FINGER BED DOMAIN-CONTAINING PROTEIN 1, ZBED1
6444,300179,"X INACTIVATION, FAMILIAL SKEWED, 2", SXI2
6445,300180,ARYLSULFATASE L, ARSL
6446,300181,X INACTIVATION-SPECIFIC TRANSCRIPT-ANTISENSE, TSIX
6447,300182,MEDIATOR COMPLEX SUBUNIT 14, MED14
6448,300183,BARTH SYNDROME,
6449,300184,"HYPOTONIA, CONGENITAL NYSTAGMUS, ATAXIA, AND ABNORMAL AUDITORY BRAINSTEM RESPONSES",
6450,300185,A-KINASE ANCHOR PROTEIN 4, AKAP4
6451,300186,"EUKARYOTIC TRANSLATION INITIATION FACTOR 1A, X-LINKED", EIF1AX
6452,300187,"SUSHI REPEAT-CONTAINING PROTEIN, X-LINKED", SRPX
6453,300188,MEDIATOR COMPLEX SUBUNIT 12, MED12
6454,300189,DISCS LARGE MAGUK SCAFFOLD PROTEIN 3, DLG3
6455,300190,SH3 DOMAIN-BINDING GLUTAMIC ACID-RICH PROTEIN-LIKE PROTEIN, SH3BGRL
6456,300191,TETRASPANIN 6, TSPAN6
6457,300192,"SARCOMA, SYNOVIAL, X BREAKPOINT 2", SSX2
6458,300193,HIGH MOBILITY GROUP BOX 3, HMGB3
6459,300194,AMME COMPLEX,
6460,300195,AMMECR NUCLEAR PROTEIN 1, AMMECR1
6461,300196,"TRANSDUCIN-BETA-LIKE 1, X-LINKED", TBL1X
6462,300197,"ATPase, H+ TRANSPORTING, LYSOSOMAL, ACCESSORY PROTEIN 1", ATP6AP1
6463,300198,GLYCOGENIN 2, GYG2
6464,300199,"RNA-BINDING MOTIF PROTEIN, X CHROMOSOME", RBMX
6465,300200,"ADRENAL HYPOPLASIA, CONGENITAL", AHC
6466,300201,CYSTEINYL LEUKOTRIENE RECEPTOR 1, CYSLTR1
6467,300202,"TRACKING PROTEIN PARTICLE COMPLEX, SUBUNIT 2", TRAPPC2
6468,300203,CYCLIN-DEPENDENT KINASE-LIKE 5, CDKL5
6469,300204,MIDLINE 2, MID2
6470,300205,EMOPAMIL-BINDING PROTEIN, EBP
6471,300206,INTERLEUKIN 1 RECEPTOR ACCESSORY PROTEIN-LIKE 1, IL1RAPL1
6472,300207,G PROTEIN-COUPLED RECEPTOR 50, GPR50
6473,300208,SCM POLYCOMB GROUP PROTEIN-LIKE 2, SCML2
6474,300209,"SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 2", SGBS2
6475,300210,"INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 58", XLID58
6476,300211,"EPISODIC MUSCLE WEAKNESS, X-LINKED", EMWX
6477,300212,REGUCALCIN, RGN
6478,300213,RETROTRANSPOSON GAG-LIKE 8C, RTL8C
6479,300214,PLEXIN B3, PLXNB3
6480,300215,"LISSENCEPHALY, X-LINKED, 2", LISX2
6481,300216,COATS DISEASE,
6482,300217,RETINOIC ACID-INDUCED 2, RAI2
6483,300218,"INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC 7", MRXS7
6484,300219,MYOTUBULAR MYOPATHY WITH ABNORMAL GENITAL DEVELOPMENT,
6485,300220,HSD10 MITOCHONDRIAL DISEASE,
6486,300221,"LYMPHOMA, HODGKIN, X-LINKED PSEUDOAUTOSOMAL",
6487,300222,INTEGRAL MEMBRANE PROTEIN 2A, ITM2A
6488,300223,"MELANOMA ANTIGEN, FAMILY C, 1", MAGEC1
6489,300224,"MELANOMA ANTIGEN, FAMILY D, 1", MAGED1
6490,300225,NADPH OXIDASE 1, NOX1
6491,300226,"SMALL MUSCLE PROTEIN, X-LINKED", SMPX
6492,300227,SCM POLYCOMB GROUP PROTEIN-LIKE 1, SCML1
6493,300228,TESTICULAR GERM CELL TUMOR 1, TGCT1
6494,300229,"VARIABLY CHARGED, X CHROMOSOME", VCX
6495,300230,"CARBONIC ANHYDRASE VB, MITOCHONDRIAL", CA5B
6496,300231,"SOLUTE CARRIER FAMILY 9, MEMBER 6", SLC9A6
6497,300232,"SPONDYLOEPIMETAPHYSEAL DYSPLASIA, X-LINKED, WITH HYPOMYELINATING LEUKODYSTROPHY", SEMDHL
6498,300233,"RADIOULNAR SYNOSTOSIS, RADIAL RAY ABNORMALITIES, AND SEVERE MALFORMATIONS IN THE MALE",
6499,300234,UBIQUITOUSLY EXPRESSED TRANSCRIPT, UXT
6500,300235,"ZINC FINGER-ENCODING GENE, X-LINKED, DUPLICATED, A", ZXDA
6501,300236,"ZINC FINGER-ENCODING GENE, X-LINKED, DUPLICATED, B", ZXDB
6502,300237,TRANSCRIPTION ELONGATION FACTOR A-LIKE 1, TCEAL1
6503,300238,"INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, SHASHI TYPE", MRXSSH
6504,300239,EPIDERMAL GROWTH FACTOR-LIKE 6, EGFL6
6505,300240,"DYSKERATOSIS CONGENITA, X-LINKED",
6506,300241,G PROTEIN-COUPLED RECEPTOR 34, GPR34
6507,300242,"SOLUTE CARRIER FAMILY 25 (MITOCHONDRIAL CARRIER, BRAIN), MEMBER 14", SLC25A14
6508,300243,"INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, CHRISTIANSON TYPE", MRXSCH
6509,300244,TERMINAL OSSEOUS DYSPLASIA, TOD
6510,300245,"PTOSIS, HEREDITARY CONGENITAL 2",
6511,300246,"PROTOCADHERIN 11, X-LINKED", PCDH11X
6512,300247,BONE MORPHOGENETIC PROTEIN 15, BMP15
6513,300248,"INHIBITOR OF NUCLEAR FACTOR KAPPA-B KINASE, REGULATORY SUBUNIT GAMMA", IKBKG
6514,300249,TRANSLOCASE OF INNER MITOCHONDRIAL MEMBRANE 17B, TIMM17B
6515,300250,GLUCOCORTICOID DEFICIENCY 1,
6516,300251,"WASP PROTEIN FAMILY, MEMBER 2",
6517,300252,"PEPTIDYL-PROLYL CIS/TRANS ISOMERASE, NIMA-INTERACTING, 4", PIN4
6518,300253,G PROTEIN-COUPLED RECEPTOR 173, GPR173
6519,300254,SUV39H1 HISTONE LYSINE METHYLTRANSFERASE, SUV39H1
6520,300255,O-LINKED N-ACETYLGLUCOSAMINE TRANSFERASE, OGT
6521,300256,17-BETA-HYDROXYSTEROID DEHYDROGENASE X, HSD17B10
6522,300257,DANON DISEASE,
6523,300258,ROIFMAN SYNDROME,
6524,300259,"MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO, X-LINKED",
6525,300260,"INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, LUBS TYPE", MRXSL
6526,300261,"INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, ARMFIELD TYPE", MRXSA
6527,300262,"INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, ABIDI TYPE", MRXSAB
6528,300263,"INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, SIDERIUS TYPE", MRXSSD
6529,300264,UBIQUILIN 2, UBQLN2
6530,300265,"ZIC FAMILY, MEMBER 3", ZIC3
6531,300266,"SPASTIC PARAPLEGIA 16, X-LINKED", SPG16
6532,300267,RHO GUANINE NUCLEOTIDE EXCHANGE FACTOR 6, ARHGEF6
6533,300268,"ANGIOEDEMA, HEREDITARY, 3",
6534,300269,HISTONE DEACETYLASE 8, HDAC8
6535,300270,ADRENOMYODYSTROPHY,
6536,300271,"INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 72", XLID72
6537,300272,HISTONE DEACETYLASE 6, HDAC6
6538,300273,"GOITER, MULTINODULAR 2", MNG2
6539,300274,ANDROGEN INSENSITIVITY SYNDROME,
6540,300275,NAD(P)H STEROID DEHYDROGENASE-LIKE PROTEIN, NSDHL
6541,300276,ECTODYSPLASIN A2 RECEPTOR, EDA2R
6542,300277,INTERLEUKIN 1 RECEPTOR ACCESSORY PROTEIN-LIKE 2, IL1RAPL2
6543,300278,NYCTALOPIN, NYX
6544,300279,"INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, LUBS TYPE",
6545,300280,URUGUAY FACIOCARDIOMUSCULOSKELETAL SYNDROME, FCMSU
6546,300281,"POTASSIUM VOLTAGE-GATED CHANNEL, SHAL-RELATED SUBFAMILY, MEMBER 1", KCND1
6547,300282,ECTO-NOX DISULFIDE-THIOL EXCHANGER 2, ENOX2
6548,300283,INTERLEUKIN 1 RECEPTOR-ASSOCIATED KINASE 1, IRAK1
6549,300284,RAS-ASSOCIATED PROTEIN RAB9, RAB9
6550,300285,RAS-ASSOCIATED PROTEIN 9B, RAB9B
6551,300286,KRUPPEL-LIKE FACTOR 8, KLF8
6552,300287,"P ANTIGEN FAMILY, MEMBER 4", PAGE4
6553,300288,"P ANTIGEN FAMILY, MEMBER 1", PAGE1
6554,300289,"X ANTIGEN FAMILY, MEMBER 1B", XAGE1B
6555,300290,"INTRAUTERINE GROWTH RETARDATION, METAPHYSEAL DYSPLASIA, ADRENAL HYPOPLASIA CONGENITA, AND GENITAL ANOMALIES",
6556,300291,ECTODERMAL DYSPLASIA AND IMMUNODEFICIENCY 1, EDAID1
6557,300292,FORKHEAD BOX P3, FOXP3
6558,300293,"NEURAL TUBE DEFECTS, X-LINKED",
6559,300294,"MEMBRANE-BOUND TRANSCRIPTION FACTOR PROTEASE, SITE 2", MBTPS2
6560,300295,"PIM2 PROTOONCOGENE, SERINE/THREONINE KINASE", PIM2
6561,300296,PLACENTA-SPECIFIC GENE 1, PLAC1
6562,300297,APELIN, APLN
6563,300298,UPF3B REGULATOR OF NONSENSE-MEDIATED mRNA DECAY, UPF3B
6564,300299,"NEUTROPENIA, SEVERE CONGENITAL, X-LINKED", SCNX
6565,300300,BRUTON AGAMMAGLOBULINEMIA TYROSINE KINASE, BTK
6566,300301,ECTODERMAL DYSPLASIA AND IMMUNODEFICIENCY 1,
6567,300302,"DYNEIN, LIGHT CHAIN, TCTEX TYPE, 3", DYNLT3
6568,300303,RIBOSOMAL PROTEIN S6 KINASE A6, RPS6KA6
6569,300304,CULLIN 4B, CUL4B
6570,300305,"SPERM PROTEIN ASSOCIATED WITH THE NUCLEUS, X CHROMOSOME, FAMILY MEMBER A1", SPANXA1
6571,300306,BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 11, BMIQ11
6572,300307,T-BOX TRANSCRIPTION FACTOR 22, TBX22
6573,300308,FERRITIN HEAVY POLYPEPTIDE-LIKE 17, FTHL17
6574,300309,UBIQUITIN-SPECIFIC PROTEASE 26, USP26
6575,300310,IMMUNODEFICIENCY 61, IMD61
6576,300311,TESTIS-EXPRESSED GENE 11, TEX11
6577,300312,TESTIS-EXPRESSED GENE 13A, TEX13A
6578,300313,TESTIS-EXPRESSED GENE 13B, TEX13B
6579,300314,TATA BOX-BINDING PROTEIN-ASSOCIATED FACTOR 7-LIKE, TAF7L
6580,300315,NUCLEAR RNA EXPORT FACTOR 2, NXF2
6581,300316,NUCLEAR RNA EXPORT FACTOR 3, NXF3
6582,300317,RALBP1-ASSOCIATED EPS DOMAIN-CONTAINING PROTEIN 2, REPS2
6583,300318,NUCLEAR RNA EXPORT FACTOR 4, NXF4
6584,300319,NUCLEAR RNA EXPORT FACTOR 5, NXF5
6585,300320,NTF2-LIKE EXPORT FACTOR 2, NXT2
6586,300321,FG SYNDROME 2, FGS2
6587,300322,LESCH-NYHAN SYNDROME, LNS
6588,300323,"HYPERURICEMIA, HPRT-RELATED", HRH
6589,300324,"INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 53", XLID53
6590,300325,"SYNOVIAL SARCOMA, X BREAKPOINT 3", SSX3
6591,300326,"SYNOVIAL SARCOMA, X BREAKPOINT 4", SSX4
6592,300327,"SYNOVIAL SARCOMA, X BREAKPOINT 5", SSX5
6593,300328,"POTASSIUM CHANNEL, VOLTAGE-GATED, ISK-RELATED FAMILY, MEMBER 1-LIKE", KCNE1L
6594,300329,ZINC FINGER- AND BTB DOMAIN-CONTAINING PROTEIN 33, ZBTB33
6595,300330,"SPANX FAMILY, MEMBER C", SPANXC
6596,300331,THROMBOCYTHEMIA 1,
6597,300332,"INTEGRIN, BETA-1, BINDING PROTEIN OF, 2", ITGB1BP2
6598,300333,RAS-ASSOCIATED PROTEIN RAB33A, RAB33A
6599,300334,"TRANSIENT RECEPTOR POTENTIAL CATION CHANNEL, SUBFAMILY C, MEMBER 5", TRPC5
6600,300335,ANGIOTENSIN I-CONVERTING ENZYME 2, ACE2
6601,300336,NEUROLIGIN 3, NLGN3
6602,300337,HYPOMELANOSIS OF ITO, HMI
6603,300338,"CYCLIC NUCLEOTIDE-GATED CHANNEL, ALPHA-2", CNGA2
6604,300339,"PROTEIN PHOSPHATASE 2, REGULATORY SUBUNIT B-DOUBLE PRIME, BETA", PPP2R3B
6605,300340,"MELANOMA ANTIGEN, FAMILY A, 5", MAGEA5
6606,300341,"MELANOMA ANTIGEN, FAMILY A, 8", MAGEA8
6607,300342,"MELANOMA ANTIGEN, FAMILY A, 9", MAGEA9
6608,300343,"MELANOMA ANTIGEN, FAMILY A, 10", MAGEA10
6609,300344,"MELANOMA ANTIGEN, FAMILY A, 11", MAGEA11
6610,300345,MICROPHTHALMIA/COLOBOMA 1, MCOPCB1
6611,300346,HIV-1 TAT STIMULATORY FACTOR 1, HTATSF1
6612,300347,DIAPH2 ANTISENSE RNA 1, DIAPH2AS1
6613,300348,KELCH-LIKE 4, KLHL4
6614,300349,"GAMMA-AMINOBUTYRIC ACID RECEPTOR, THETA", GABRQ
6615,300350,CHORDIN-LIKE 1, CHRDL1
6616,300351,"GRAVES DISEASE, SUSCEPTIBILITY TO, X-LINKED 1",
6617,300352,CEREBRAL CREATINE DEFICIENCY SYNDROME 1, CCDS1
6618,300353,V-SET AND IMMUNOGLOBULIN DOMAINS-CONTAINING PROTEIN 4, VSIG4
6619,300354,"INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, CABEZAS TYPE", MRXSC
6620,300355,"INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 73", XLID73
6621,300356,TRANSLOCASE OF INNER MITOCHONDRIAL MEMBRANE 8A, TIMM8A
6622,300357,CYTOKINE RECEPTOR-LIKE FACTOR 2, CRLF2
6623,300358,"PROTEIN KINASE, LYSINE-DEFICIENT 3", WNK3
6624,300359,SARCOMA ANTIGEN 1, SAGE1
6625,300360,"INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, CABEZAS TYPE",
6626,300361,NERVE GROWTH FACTOR RECEPTOR-ASSOCIATED PROTEIN 1, NGFRAP1
6627,300362,"ARMADILLO REPEAT-CONTAINING PROTEIN, X-LINKED 1", ARMCX1
6628,300363,"ARMADILLO REPEAT-CONTAINING PROTEIN, X-LINKED 2", ARMCX2
6629,300364,"ARMADILLO REPEAT-CONTAINING PROTEIN, X-LINKED 3", ARMCX3
6630,300365,TOLL-LIKE RECEPTOR 7, TLR7
6631,300366,TOLL-LIKE RECEPTOR 8, TLR8
6632,300367,"THROMBOCYTOPENIA, X-LINKED, WITH OR WITHOUT DYSERYTHROPOIETIC ANEMIA", XLTDA
6633,300368,"SOLUTE CARRIER FAMILY 9, MEMBER 7", SLC9A7
6634,300369,GERM CELL NUCLEAR ACIDIC PEPTIDASE, GCNA
6635,300370,3-PRIME REPAIR EXONUCLEASE 2, TREX2
6636,300371,"ATP-BINDING CASSETTE, SUBFAMILY D, MEMBER 1", ABCD1
6637,300372,"INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 42", XLID42
6638,300373,OSTEOPATHIA STRIATA WITH CRANIAL SCLEROSIS, OSCS
6639,300374,SH3-DOMAIN KINASE-BINDING PROTEIN 1, SH3KBP1
6640,300375,CARBOHYDRATE SULFOTRANSFERASE 7, CHST7
6641,300376,"MUSCULAR DYSTROPHY, BECKER TYPE", BMD
6642,300377,DYSTROPHIN, DMD
6643,300378,"RADIAL RAY DEFICIENCY, X-LINKED",
6644,300379,"RING FINGER PROTEIN, LIM DOMAIN-INTERACTING", RLIM
6645,300380,CYTIDINE 5-PRIME TRIPHOSPHATE SYNTHETASE 2, CTPS2
6646,300381,ZINC FINGER PROTEIN 185, ZNF185
6647,300382,"ARISTALESS-RELATED HOMEOBOX, X-LINKED", ARX
6648,300383,COMPLEMENT FACTOR PROPERDIN, CFP
6649,300384,EMERIN, EMD
6650,300385,NUCLEOSOMAL BINDING PROTEIN 1, NSBP1
6651,300386,CD40 LIGAND, CD40LG
6652,300387,"INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 63", XLID63
6653,300388,"POLYMICROGYRIA, BILATERAL PERISYLVIAN, X-LINKED", BPPX
6654,300389,RETINITIS PIGMENTOSA 3,
6655,300390,CHM RAB ESCORT PROTEIN, CHM
6656,300391,AMELOGENIN, AMELX
6657,300392,WASP ACTIN NUCLEATION PROMOTING FACTOR, WAS
6658,300393,G PROTEIN-COUPLED RECEPTOR 101, GPR101
6659,300394,"TAFAZZIN, PHOSPHOLIPID-LYSOPHOSPHOLIPID TRANSACYLASE", TAFAZZIN
6660,300395,"THO COMPLEX, SUBUNIT 2", THOC2
6661,300396,CANCER/TESTIS ANTIGEN 2, CTAG2
6662,300397,CEREBRAL CREATINE DEFICIENCY SYNDROME 1,
6663,300398,B-CELL RECEPTOR-ASSOCIATED PROTEIN 31, BCAP31
6664,300399,"PROPROTEIN CONVERTASE, SUBTILISIN/KEXIN-TYPE, 1, INHIBITOR OF", PCSK1N
6665,300400,"SEVERE COMBINED IMMUNODEFICIENCY, X-LINKED", SCIDX1
6666,300401,PROTEOLIPID PROTEIN 1, PLP1
6667,300402,"LEUCINE ZIPPER, DOWNREGULATED IN CANCER 1", LDOC1
6668,300403,"NADH-UBIQUINONE OXIDOREDUCTASE 1 BETA SUBCOMPLEX, 11", NDUFB11
6669,300404,"IFAP SYNDROME 1, WITH OR WITHOUT BRESHECK SYNDROME",
6670,300405,RAS-ASSOCIATED PROTEIN RAB40A-LIKE, RAB40AL
6671,300406,FG SYNDROME 3, FGS3
6672,300407,"POLYADENYLATE-BINDING PROTEIN, CYTOPLASMIC, 5", PABPC5
6673,300408,GRIP1-ASSOCIATED PROTEIN 1, GRIPAP1
6674,300409,MORTALITY FACTOR 4-LIKE PROTEIN 2, MORF4L2
6675,300410,ANGIOMOTIN, AMOT
6676,300411,"TRANSFORMING GROWTH FACTOR-BETA-INDUCED FACTOR 2-LIKE, X-LINKED", TGIF2LX
6677,300412,"MICROPHTHALMIA, SYNDROMIC 2",
6678,300413,MUSCLEBLIND-LIKE SPLICING REGULATOR 3, MBNL3
6679,300414,PHD FINGER PROTEIN 6, PHF6
6680,300415,MYOTUBULARIN, MTM1
6681,300416,"X ANTIGEN FAMILY, MEMBER 2", XAGE2
6682,300417,G PROTEIN-COUPLED RECEPTOR-ASSOCIATED SORTING PROTEIN 1, GPRASP1
6683,300418,G1- TO S-PHASE TRANSITION 2, GSPT2
6684,300419,"INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 29", XLID29
6685,300420,PRAJA RING FINGER UBIQUITIN LIGASE 1, PJA1
6686,300421,WOLF-HIRSCHHORN SYNDROME,
6687,300422,FG SYNDROME 4, FGS4
6688,300423,"INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, HEDERA TYPE", MRXSH
6689,300424,RETINITIS PIGMENTOSA 23, RP23
6690,300425,"AUTISM, SUSCEPTIBILITY TO, X-LINKED 1", AUTSX1
6691,300426,"INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 21",
6692,300427,"NEUROLIGIN 4, X-LINKED", NLGN4X
6693,300428,"INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 2", XLID2
6694,300429,RHO GUANINE NUCLEOTIDE EXCHANGE FACTOR 9, ARHGEF9
6695,300430,"INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 29",
6696,300431,ATKIN-FLAITZ SYNDROME,
6697,300432,DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 1,
6698,300433,"INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 81", XLID81
6699,300434,"INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, STOCCO DOS SANTOS TYPE", SDSX
6700,300435,PROGESTERONE RECEPTOR MEMBRANE COMPONENT 1, PGRMC1
6701,300436,"INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 46", XLID46
6702,300437,EMBRYONIC STEM CELL-EXPRESSED RAS, ERAS
6703,300438,HSD10 MITOCHONDRIAL DISEASE, HSD10MD
6704,300439,RING FINGER PROTEIN 128, RNF128
6705,300440,NFKB-REPRESSING FACTOR, NKRF
6706,300441,SAM- AND SH3 DOMAIN-CONTAINING PROTEIN 3, SASH3
6707,300442,TARP SYNDROME,
6708,300443,"SOLUTE CARRIER FAMILY 7 (CATIONIC AMINO ACID TRANSPORTER, y+ SYSTEM), MEMBER 3", SLC7A3
6709,300444,"SOLUTE CARRIER FAMILY 6 (NEUROTRANSMITTER TRANSPORTER), MEMBER 14", SLC6A14
6710,300445,H2A.B VARIANT HISTONE 3, H2AB3
6711,300446,"RHOX HOMEOBOX FAMILY, MEMBER 1", RHOXF1
6712,300447,"RHOX HOMEOBOX FAMILY, MEMBER 2", RHOXF2
6713,300448,ALPHA-THALASSEMIA MYELODYSPLASIA SYNDROME, ATMDS
6714,300449,ALPHA-THALASSEMIA MYELODYSPLASIA SYNDROME,
6715,300450,FETAL AND ADULT TESTIS-EXPRESSED GENE 1, FATE1
6716,300451,ECTODYSPLASIN A, EDA
6717,300452,"INHIBITOR OF GROWTH, X-LINKED", INGX
6718,300453,"FAMILY WITH SEQUENCE SIMILARITY 50, MEMBER A", FAM50A
6719,300454,"INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 77", XLID77
6720,300455,"RETINITIS PIGMENTOSA, X-LINKED, AND SINORESPIRATORY INFECTIONS WITH OR WITHOUT DEAFNESS", RPSRDF
6721,300456,CYCLIN B3, CCNB3
6722,300457,NHS ACTIN REMODELING REGULATOR, NHS
6723,300458,"INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC 13",
6724,300459,TENOMODULIN, TNMD
6725,300460,PROTOCADHERIN 19, PCDH19
6726,300461,ORNITHINE CARBAMOYLTRANSFERASE, OTC
6727,300462,A-KINASE ANCHOR PROTEIN 14, AKAP14
6728,300463,POLYGLUTAMINE-BINDING PROTEIN 1, PQBP1
6729,300464,"CORONARY HEART DISEASE, SUSCEPTIBILITY TO, 3",
6730,300465,"ALPHA-THALASSEMIA/IMPAIRED INTELLECTUAL DEVELOPMENT SYNDROME, X-LINKED",
6731,300466,"MELANOMA ANTIGEN, FAMILY B, 5", MAGEB5
6732,300467,"MELANOMA ANTIGEN, FAMILY B, 6", MAGEB6
6733,300468,"MELANOMA ANTIGEN, FAMILY C, 2", MAGEC2
6734,300469,"MELANOMA ANTIGEN, FAMILY C, 3", MAGEC3
6735,300470,"MELANOMA ANTIGEN, FAMILY D, 2", MAGED2
6736,300471,CUBITUS VALGUS WITH IMPAIRED INTELLECTUAL DEVELOPMENT AND UNUSUAL FACIES,
6737,300472,"CORPUS CALLOSUM, AGENESIS OF, WITH IMPAIRED INTELLECTUAL DEVELOPMENT, OCULAR COLOBOMA, AND MICROGNATHIA",
6738,300473,"NUCLEAR RECEPTOR SUBFAMILY 0, GROUP B, MEMBER 1", NR0B1
6739,300474,GLYCEROL KINASE, GK
6740,300475,"DEAFNESS, DYSTONIA, AND CEREBRAL HYPOMYELINATION", DDCH
6741,300476,"CONE-ROD DYSTROPHY, X-LINKED, 3", CORDX3
6742,300477,"FAMILY WITH SEQUENCE SIMILARITY 9, MEMBER A", FAM9A
6743,300478,"FAMILY WITH SEQUENCE SIMILARITY 9, MEMBER B", FAM9B
6744,300479,"FAMILY WITH SEQUENCE SIMILARITY 9, MEMBER C", FAM9C
6745,300480,TAK1-BINDING PROTEIN 3, TAB3
6746,300481,"CYTOCHROME b(-245), BETA SUBUNIT", CYBB
6747,300482,GRB2-ASSOCIATED BINDING PROTEIN 3, GAB3
6748,300483,"FAMILY WITH SEQUENCE SIMILARITY 11, MEMBER A",
6749,300484,OROFACIODIGITAL SYNDROME VIII, OFD8
6750,300485,BCL6 COREPRESSOR, BCOR
6751,300486,"INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, BILLUART TYPE", MRXSBL
6752,300487,ACTIN-RELATED PROTEIN T1, ACTRT1
6753,300488,"MENOPAUSE, NATURAL, AGE AT, QUANTITATIVE TRAIT LOCUS 1", MENOQ1
6754,300489,"NEURONOPATHY, DISTAL HEREDITARY MOTOR, X-LINKED", HMNX
6755,300490,SH2 DOMAIN PROTEIN 1A, SH2D1A
6756,300491,"EPILEPSY, X-LINKED 1, WITH VARIABLE LEARNING DISABILITIES AND BEHAVIOR DISORDERS", EPILX1
6757,300492,"FAMILY WITH SEQUENCE SIMILARITY 3, MEMBER A", FAM3A
6758,300493,"SPERM PROTEIN ASSOCIATED WITH THE NUCLEUS, X CHROMOSOME, FAMILY MEMBER A2", SPANXA2
6759,300494,"AUTISM, SUSCEPTIBILITY TO, X-LINKED 1",
6760,300495,"AUTISM, SUSCEPTIBILITY TO, X-LINKED 2", AUTSX2
6761,300496,"AUTISM, SUSCEPTIBILITY TO, X-LINKED 3", AUTSX3
6762,300497,"AUTISM, SUSCEPTIBILITY TO, X-LINKED 2",
6763,300498,"INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 45", XLID45
6764,300499,FTSJ RNA 2-PRIME-O-METHYLTRANSFERASE 1, FTSJ1
6765,300500,"ALBINISM, OCULAR, TYPE I", OA1
6766,300501,"INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 9",
6767,300502,"PYRUVATE DEHYDROGENASE E1, SUBUNIT ALPHA-1", PDHA1
6768,300503,"INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 29",
6769,300504,"INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 29",
6770,300505,"INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 84", XLID84
6771,300506,"TSC22 DOMAIN FAMILY, MEMBER 3", TSC22D3
6772,300507,"H2B HISTONE FAMILY, MEMBER W, TESTIS-SPECIFIC", H2BFWT
6773,300508,UTP14A SMALL SUBUNIT PROCESSOME COMPONENT, UTP14A
6774,300509,"DYSLEXIA, SUSCEPTIBILITY TO, 9", DYX9
6775,300510,OVARIAN DYSGENESIS 2, ODG2
6776,300511,PREMATURE OVARIAN FAILURE 2A, POF2A
6777,300512,WD REPEAT-CONTAINING PROTEIN 13, WDR13
6778,300513,G PROTEIN-COUPLED RECEPTOR 119, GPR119
6779,300514,"FANCONI ANEMIA, COMPLEMENTATION GROUP B", FANCB
6780,300515,FANCB GENE, FANCB
6781,300516,"ATPase, CLASS VI, TYPE 11C", ATP11C
6782,300517,"SPINDLIN FAMILY, MEMBER 2B", SPIN2B
6783,300518,"INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 82", XLID82
6784,300519,MARTIN-PROBST SYNDROME, MRXSMP
6785,300520,CLAUDIN 2, CLDN2
6786,300521,KINESIN FAMILY MEMBER 4A, KIF4A
6787,300522,IQ MOTIF- AND SEC7 DOMAIN-CONTAINING PROTEIN 2, IQSEC2
6788,300523,ALLAN-HERNDON-DUDLEY SYNDROME, AHDS
6789,300524,NEURITE EXTENSION AND MIGRATION FACTOR, NEXMIF
6790,300525,"PYRIMIDINERGIC RECEPTOR P2Y, G PROTEIN-COUPLED, 8", P2RY8
6791,300526,WD REPEAT-CONTAINING PROTEIN 45, WDR45
6792,300527,NUDIX HYDROLASE 10, NUDT10
6793,300528,NUDIX HYDROLASE 11, NUDT11
6794,300529,"PURINERGIC RECEPTOR P2Y, G PROTEIN-COUPLED, 10", P2RY10
6795,300530,KAWASAKI DISEASE,
6796,300531,SPROUTY RTK SIGNALING ANTAGONIST 3, SPRY3
6797,300532,"VARIABLY CHARGED, X CHROMOSOME, 2", VCX2
6798,300533,"VARIABLY CHARGED, X CHROMOSOME, 3A", VCX3A
6799,300534,"INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, CLAES-JENSEN TYPE", MRXSCJ
6800,300535,OCRL INOSITOL POLYPHOSPHATE-5-PHOSPHATASE, OCRL
6801,300536,BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 4, BMND4
6802,300537,PERIVENTRICULAR NODULAR HETEROTOPIA 1,
6803,300538,ARGININE VASOPRESSIN RECEPTOR 2, AVPR2
6804,300539,NEPHROGENIC SYNDROME OF INAPPROPRIATE ANTIDIURESIS, NSIAD
6805,300540,"HAUS AUGMIN-LIKE COMPLEX, SUBUNIT 7", HAUS7
6806,300541,"SARCOMA, SYNOVIAL, X BREAKPOINT 6", SSX6
6807,300542,"SARCOMA, SYNOVIAL, X BREAKPOINT 7", SSX7
6808,300543,"SARCOMA, SYNOVIAL, X BREAKPOINT 8", SSX8
6809,300544,"SARCOMA, SYNOVIAL, X BREAKPOINT 9", SSX9
6810,300545,HEPARAN SULFATE 6-O-SULFOTRANSFERASE 2, HS6ST2
6811,300546,"FYVE, RhoGEF, AND PH DOMAIN-CONTAINING PROTEIN 1", FGD1
6812,300547,SERINE/THREONINE KINASE 26, STK26
6813,300548,"MELANOMA ANTIGEN, FAMILY H, 1", MAGEH1
6814,300549,"MELANOMA ANTIGEN, FAMILY A, 2B", MAGEA2B
6815,300550,"PHOSPHATE-REGULATING ENDOPEPTIDASE, X-LINKED", PHEX
6816,300551,"INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 1",
6817,300552,MIDLINE 1, MID1
6818,300553,BROMODOMAIN- AND WD REPEAT-CONTAINING PROTEIN 3, BRWD3
6819,300554,"HYPOPHOSPHATEMIC RICKETS, X-LINKED RECESSIVE", XLHRR
6820,300555,DENT DISEASE 2, DENT2
6821,300556,"ATPase, H+ TRANSPORTING, LYSOSOMAL, ACCESSORY PROTEIN 2", ATP6AP2
6822,300557,PARKINSON DISEASE 12, PARK12
6823,300558,"INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 30", XLID30
6824,300559,GLYCOGEN STORAGE DISEASE IXd, GSD9D
6825,300560,PHD FINGER PROTEIN 8, PHF8
6826,300561,"SLIT- AND NTRK-LIKE FAMILY, MEMBER 2", SLITRK2
6827,300562,"SLIT- AND NTRK-LIKE FAMILY, MEMBER 4", SLITRK4
6828,300563,"CHARCOT-MARIE-TOOTH DISEASE, X-LINKED RECESSIVE, 5",
6829,300564,TSPY-LIKE 2, TSPYL2
6830,300565,"SLIT- AND NTRK-LIKE FAMILY, MEMBER 2",
6831,300566,"LHFPL TETRASPAN SUBFAMILY, MEMBER 1", LHFPL1
6832,300567,PHOSPHOGLYCERATE MUTASE FAMILY MEMBER 4, PGAM4
6833,300568,MICRO RNA 221, MIR221
6834,300569,MICRO RNA 222, MIR222
6835,300570,TRANSCRIPTION FACTOR YY2, YY2
6836,300571,HARTSFIELD SYNDROME,
6837,300572,ADHESION G PROTEIN-COUPLED RECEPTOR G2, ADGRG2
6838,300573,ZINC FINGER PROTEIN 674, ZNF674
6839,300574,"CHEMOKINE, CXC MOTIF, RECEPTOR 3", CXCR3
6840,300575,RIPPLY TRANSCRIPTIONAL REPRESSOR 1, RIPPLY1
6841,300576,ZINC FINGER DHHC DOMAIN-CONTAINING PROTEIN 15, ZDHHC15
6842,300577,"INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 91", XLID91
6843,300578,CHROMOSOME Xp11.3 DELETION SYNDROME,
6844,300579,SHROOM FAMILY MEMBER 4, SHROOM4
6845,300580,"MYOPATHY, CONGENITAL, WITH FIBER-TYPE DISPROPORTION, X-LINKED", CFTDX
6846,300581,FG SYNDROME 5, FGS5
6847,300582,"SHORT STATURE, IDIOPATHIC, X-LINKED", ISS
6848,300583,VESTIGIAL-LIKE 1, VGLL1
6849,300584,IMMUNODEFICIENCY 33,
6850,300585,ZINC FINGER PROTEIN 673, ZNF673
6851,300586,ARYLSULFATASE H, ARSH
6852,300587,MALIGNANT T-CELL AMPLIFIED SEQUENCE 1, MCTS1
6853,300588,TENEURIN TRANSMEMBRANE PROTEIN 1, TENM1
6854,300589,"NYSTAGMUS 5, CONGENITAL, X-LINKED", NYS5
6855,300590,CORNELIA DE LANGE SYNDROME 2, CDLS2
6856,300591,STATURE QUANTITATIVE TRAIT LOCUS 6, STQTL6
6857,300592,"CANCER/TESTIS ANTIGEN FAMILY 47, MEMBER A11", CT47A11
6858,300593,SPERM ACROSOME-ASSOCIATED PROTEIN 5, SPACA5
6859,300594,G ANTIGEN 1, GAGE1
6860,300595,G ANTIGEN 2C, GAGE2C
6861,300596,G ANTIGEN 3, GAGE3
6862,300597,G ANTIGEN 4, GAGE4
6863,300598,G ANTIGEN 5, GAGE5
6864,300599,G ANTIGEN 6, GAGE6
6865,300600,ALAND ISLAND EYE DISEASE, AIED
6866,300601,G ANTIGEN 7, GAGE7
6867,300602,CLARK-BARAITSER SYNDROME,
6868,300603,POF1B ACTIN-BINDING PROTEIN, POF1B
6869,300604,PREMATURE OVARIAN FAILURE 2B, POF2B
6870,300605,RETINITIS PIGMENTOSA 34, RP34
6871,300606,"TOOTH AGENESIS, SELECTIVE, X-LINKED, 1",
6872,300607,DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 8, DEE8
6873,300608,DACHSHUND FAMILY TRANSCRIPTION FACTOR 2, DACH2
6874,300609,MSL COMPLEX SUBUNIT 3, MSL3
6875,300610,HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN H2, HNRNPH2
6876,300611,C1GALT1-SPECIFIC CHAPERONE 1, C1GALT1C1
6877,300612,"INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, TURNER TYPE",
6878,300613,"MYOPIA 13, X-LINKED", MYP13
6879,300614,"DEAFNESS, X-LINKED 5, WITH PERIPHERAL NEUROPATHY", DFNX5
6880,300615,BRUNNER SYNDROME, BRNRS
6881,300616,LEUCINE ZIPPER PROTEIN 4, LUZP4
6882,300617,"BRCA1/BRCA2-CONTAINING COMPLEX, SUBUNIT 3", BRCC3
6883,300618,JADE FAMILY PHD FINGER 3, JADE3
6884,300619,"CATARACT, ATAXIA, SHORT STATURE, AND IMPAIRED INTELLECTUAL DEVELOPMENT",
6885,300620,V-SET AND IMMUNOGLOBULIN DOMAINS-CONTAINING PROTEIN 1, VSIG1
6886,300621,"SPINDLIN FAMILY, MEMBER 2A", SPIN2A
6887,300622,TN POLYAGGLUTINATION SYNDROME, TNPS
6888,300623,FRAGILE X TREMOR/ATAXIA SYNDROME, FXTAS
6889,300624,FRAGILE X SYNDROME, FXS
6890,300625,CANCER/TESTIS ANTIGEN 83, CT83
6891,300626,ANKYRIN REPEAT- AND SOCS BOX-CONTAINING PROTEIN 11, ASB11
6892,300627,ZINC FINGER PROTEIN 449, ZNF449
6893,300628,FERM DOMAIN-CONTAINING PROTEIN 7, FRMD7
6894,300629,"ADAPTOR-RELATED PROTEIN COMPLEX 1, SIGMA-2 SUBUNIT", AP1S2
6895,300630,PETTIGREW SYNDROME,
6896,300631,"COLLECTRIN, AMINO ACID TRANSPORT REGULATOR", CLTRN
6897,300632,PDZ DOMAIN-CONTAINING 11, PDZD11
6898,300633,"HYPOSPADIAS 1, X-LINKED", HYSP1
6899,300634,PDZ DOMAIN-CONTAINING 4, PDZD4
6900,300635,"LYMPHOPROLIFERATIVE SYNDROME, X-LINKED, 2", XLP2
6901,300636,IMMUNODEFICIENCY 33, IMD33
6902,300637,G ANTIGEN 12I, GAGE12I
6903,300638,G ANTIGEN 8, GAGE8
6904,300639,"INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, CABEZAS TYPE",
6905,300640,IMMUNODEFICIENCY 33,
6906,300641,"SOLUTE CARRIER FAMILY 25, MEMBER 43", SLC25A43
6907,300642,"SUSHI REPEAT-CONTAINING PROTEIN, X-LINKED, 2", SRPX2
6908,300643,"ROLANDIC EPILEPSY, IMPAIRED INTELLECTUAL DEVELOPMENT, AND SPEECH DYSPRAXIA, X-LINKED", RESDX
6909,300644,"GALACTOSIDASE, ALPHA", GLA
6910,300645,IMMUNODEFICIENCY 34, IMD34
6911,300646,ZINC FINGER DHHC DOMAIN-CONTAINING PROTEIN 9, ZDHHC9
6912,300647,APC MEMBRANE RECRUITMENT PROTEIN 1, AMER1
6913,300648,"CANCER/TESTIS ANTIGEN FAMILY 45, MEMBER A1", CT45A1
6914,300649,"SOLUTE CARRIER FAMILY 38 (AMINO ACID TRANSPORTER), MEMBER 5", SLC38A5
6915,300650,"ALBINISM, OCULAR, WITH LATE-ONSET SENSORINEURAL DEAFNESS", OASD
6916,300651,PORCUPINE O-ACYLTRANSFERASE, PORCN
6917,300652,"ANGIOMA SERPIGINOSUM, X-LINKED",
6918,300653,PHOSPHOGLYCERATE KINASE 1 DEFICIENCY,
6919,300654,FATTY ACID AMIDE HYDROLASE 2, FAAH2
6920,300655,KELCH-LIKE 13, KLHL13
6921,300656,URACIL PHOSPHORIBOSYLTRANSFERASE HOMOLOG, UPRT
6922,300657,CANCER/TESTIS ANTIGEN 1A, CTAG1A
6923,300658,NORRIN CYSTINE KNOT GROWTH FACTOR NDP, NDP
6924,300659,"INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 93", XLID93
6925,300660,"SPONDYLOEPIMETAPHYSEAL DYSPLASIA, X-LINKED, WITH HYPOMYELINATING LEUKODYSTROPHY",
6926,300661,PHOSPHORIBOSYLPYROPHOSPHATE SYNTHETASE SUPERACTIVITY,
6927,300662,"SMALL NUCLEOLAR RNA, H/ACA BOX, 11", SNORA11
6928,300663,AUTOPHAGY-RELATED 4A CYSTEINE PEPTIDASE, ATG4A
6929,300664,"SPANX FAMILY, MEMBER N1", SPANXN1
6930,300665,"SPANX FAMILY, MEMBER N2", SPANXN2
6931,300666,"SPANX FAMILY, MEMBER N3", SPANXN3
6932,300667,"SPANX FAMILY, MEMBER N4", SPANXN4
6933,300668,"SPANX FAMILY, MEMBER N5", SPANXN5
6934,300669,"SPANX FAMILY, MEMBER B1", SPANXB1
6935,300670,"SPANX FAMILY, MEMBER D", SPANXD
6936,300671,"SPANX FAMILY, MEMBER D",
6937,300672,DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 2, DEE2
6938,300673,"ENCEPHALOPATHY, NEONATAL SEVERE, DUE TO MECP2 MUTATIONS",
6939,300674,MOTILE SPERM DOMAIN-CONTAINING PROTEIN 1, MOSPD1
6940,300675,PARANEOPLASTIC MA ANTIGEN 3, PNMA3
6941,300676,"INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC 14", MRXS14
6942,300677,"TAXILIN, GAMMA", TXLNG
6943,300678,DUAL-SPECIFICITY PHOSPHATASE 21, DUSP21
6944,300679,CHROMOSOME Xp21 DELETION SYNDROME,
6945,300680,"PREGNANCY-UPREGULATED, NONUBIQUITOUS, CAM KINASE", PNCK
6946,300681,DEDICATOR OF CYTOKINESIS 11, DOCK11
6947,300682,MICRO RNA 424, MIR424
6948,300683,SEPTIN 6, SEPT6
6949,300684,"X KELL BLOOD GROUP PRECURSOR-RELATED, X-LINKED", XKRX
6950,300685,PROLINE-RICH GAMMA-CARBOXYGLUTAMIC ACID PROTEIN 3, PRRG3
6951,300686,MICRO RNA 448, MIR448
6952,300687,"ERCC EXCISION REPAIR 6-LIKE, SPINDLE ASSEMBLY CHECKPOINT HELICASE", ERCC6L
6953,300688,BCL6 COREPRESSOR-LIKE 1, BCORL1
6954,300689,START DOMAIN-CONTAINING PROTEIN 8, STARD8
6955,300690,BRAIN-EXPRESSED X-LINKED GENE 1, BEX1
6956,300691,BRAIN-EXPRESSED X-LINKED GENE 2, BEX2
6957,300692,BEX FAMILY MEMBER 4, BEX4
6958,300693,BEX FAMILY MEMBER 5, BEX5
6959,300694,MICRO RNA 223, MIR223
6960,300695,"SCAPULOPERONEAL MYOPATHY, X-LINKED DOMINANT", SPM
6961,300696,"MYOPATHY, X-LINKED, WITH POSTURAL MUSCLE ATROPHY", XMPMA
6962,300697,"HECT, UBA, AND WWE DOMAINS-CONTAINING PROTEIN 1", HUWE1
6963,300698,TRANSMEMBRANE PROTEIN 47, TMEM47
6964,300699,"INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, WU TYPE", MRXSW
6965,300700,ALBINISM-DEAFNESS SYNDROME, ADFN
6966,300701,ZINC FINGER CCHC DOMAIN-CONTAINING PROTEIN 12, ZCCHC12
6967,300702,"MELANOMA ANTIGEN, FAMILY D, 4", MAGED4
6968,300703,"SPINOCEREBELLAR ATAXIA, X-LINKED 5", SCAX5
6969,300704,"PROSTATE CANCER, HEREDITARY, X-LINKED 2", HPCX2
6970,300705,CHROMOSOME Xp11.22 DUPLICATION SYNDROME,
6971,300706,"INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, TURNER TYPE",
6972,300707,"TOE SYNDACTYLY, TELECANTHUS, AND ANOGENITAL AND RENAL MALFORMATIONS", STAR
6973,300708,CYCLIN Q, CCNQ
6974,300709,"INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC 9", MRXS9
6975,300710,"ALOPECIA, ANDROGENETIC, 2", AGA2
6976,300711,"PYLORIC STENOSIS, INFANTILE HYPERTROPHIC, 4", IHPS4
6977,300712,CRANIOFACIOSKELETAL SYNDROME,
6978,300713,OTU DOMAIN-CONTAINING PROTEIN 5, OTUD5
6979,300714,OTU DOMAIN-CONTAINING PROTEIN 6A, OTUD6A
6980,300715,MAGNESIUM TRANSPORTER 1, MAGT1
6981,300716,"INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 95", XLID95
6982,300717,"REDUCING BODY MYOPATHY, X-LINKED 1A, SEVERE, WITH INFANTILE OR EARLY CHILDHOOD ONSET", RBMX1A
6983,300718,"REDUCING BODY MYOPATHY, X-LINKED 1B, WITH LATE CHILDHOOD OR ADULT ONSET", RBMX1B
6984,300719,"DEAFNESS, CATARACT, RETINITIS PIGMENTOSA, AND SPERM ABNORMALITIES",
6985,300720,G ANTIGEN 2A, GAGE2A
6986,300721,MICRO RNA LET7F2, MIRLET7F2
6987,300722,MICRO RNA 19B2, MIR19B2
6988,300723,SYNAPTOTAGMIN-LIKE 4, SYTL4
6989,300724,CONNECTOR ENHANCER OF KINASE SUPPRESSOR OF RAS 2, CNKSR2
6990,300725,RAS-RELATED GTP-BINDING PROTEIN B, RRAGB
6991,300726,G ANTIGEN 2B, GAGE2B
6992,300727,G ANTIGEN 12C, GAGE12C
6993,300728,G ANTIGEN 12D, GAGE12D
6994,300729,G ANTIGEN 12E, GAGE12E
6995,300730,G ANTIGEN 12F, GAGE12F
6996,300731,G ANTIGEN 12G, GAGE12G
6997,300732,G ANTIGEN 12H, GAGE12H
6998,300733,G ANTIGEN 12J, GAGE12J
6999,300734,G ANTIGEN 13, GAGE13
7000,300735,G ANTIGEN 2D, GAGE2D
7001,300736,G ANTIGEN 2E, GAGE2E
7002,300737,G ANTIGEN 10, GAGE10
7003,300738,"P ANTIGEN FAMILY, MEMBER 2", PAGE2
7004,300739,"P ANTIGEN FAMILY, MEMBER 3", PAGE3
7005,300740,"X ANTIGEN FAMILY, MEMBER 3", XAGE3
7006,300741,"FAMILY WITH SEQUENCE SIMILARITY 120, MEMBER C", FAM120C
7007,300742,"X ANTIGEN FAMILY, MEMBER 1A", XAGE1A
7008,300743,"X ANTIGEN FAMILY, MEMBER 1A",
7009,300744,"X ANTIGEN FAMILY, MEMBER 1B",
7010,300745,"X ANTIGEN FAMILY, MEMBER 1B",
7011,300746,COAGULATION FACTOR IX, F9
7012,300747,STEROID SULFATASE, STS
7013,300748,G PROTEIN-COUPLED RECEPTOR 82, GPR82
7014,300749,INTELLECTUAL DEVELOPMENTAL DISORDER WITH MICROCEPHALY AND PONTINE AND CEREBELLAR HYPOPLASIA, MICPCH
7015,300750,"SPASTIC PARAPLEGIA 34, X-LINKED", SPG34
7016,300751,"ANEMIA, SIDEROBLASTIC, 1", SIDBA1
7017,300752,"PROTOPORPHYRIA, ERYTHROPOIETIC, X-LINKED", XLEPP
7018,300753,APOLIPOPROTEIN O, APOO
7019,300754,"TAF9B RNA POLYMERASE II, TATA BOX-BINDING PROTEIN-ASSOCIATED FACTOR, 31-KD", TAF9B
7020,300755,"AGAMMAGLOBULINEMIA, X-LINKED", XLA
7021,300756,ALZHEIMER DISEASE 16, AD16
7022,300757,RP2 ACTIVATOR OF ARL3 GTPase, RP2
7023,300758,"HYPOSPADIAS 2, X-LINKED", HYSP2
7024,300759,"MELANOMA ANTIGEN, FAMILY E, 1", MAGEE1
7025,300760,"MELANOMA ANTIGEN, FAMILY E, 2", MAGEE2
7026,300761,"MELANOMA ANTIGEN, FAMILY B, 10", MAGEB10
7027,300762,"MELANOMA ANTIGEN, FAMILY B, 16", MAGEB16
7028,300763,"MELANOMA ANTIGEN, FAMILY B, 17", MAGEB17
7029,300764,"MELANOMA ANTIGEN, FAMILY A, 9B", MAGEA9B
7030,300765,"MELANOMA ANTIGEN, FAMILY D, 4B", MAGED4B
7031,300766,NFKB-ACTIVATING PROTEIN, NKAP
7032,300767,REPLICATION PROTEIN A4, RPA4
7033,300768,CYLICIN 1, CYLC1
7034,300769,MICRO RNA 224, MIR224
7035,300770,"SURFACTANT METABOLISM DYSFUNCTION, PULMONARY, 4", SMDP4
7036,300771,TRANSCRIPTION ELONGATION FACTOR A-LIKE 7, TCEAL7
7037,300772,"TRANSCRIPTION FACTOR DP FAMILY, MEMBER 3", TFDP3
7038,300773,APEX NUCLEASE (APURINIC/APYRIMIDINIC ENDONUCLEASE) 2, APEX2
7039,300774,"RAB39B, MEMBER RAS ONCOGENE FAMILY", RAB39B
7040,300775,E74-LIKE ETS TRANSCRIPTION FACTOR 4, ELF4
7041,300776,ALG13 UDP-N-ACETYLGLUCOSAMINYLTRANSFERASE SUBUNIT, ALG13
7042,300777,EPSILON-TRIMETHYLLYSINE HYDROXYLASE, TMLHE
7043,300778,"CORNEAL DYSTROPHY, LISCH EPITHELIAL",
7044,300779,"CORNEAL DYSTROPHY, ENDOTHELIAL, X-LINKED", XECD
7045,300780,"CANCER/TESTIS ANTIGEN FAMILY 47, MEMBER A1", CT47A1
7046,300781,"CANCER/TESTIS ANTIGEN FAMILY 47, MEMBER A2", CT47A2
7047,300782,"CANCER/TESTIS ANTIGEN FAMILY 47, MEMBER A3", CT47A3
7048,300783,"CANCER/TESTIS ANTIGEN FAMILY 47, MEMBER A4", CT47A4
7049,300784,"CANCER/TESTIS ANTIGEN FAMILY 47, MEMBER A5", CT47A5
7050,300785,"CANCER/TESTIS ANTIGEN FAMILY 47, MEMBER A6", CT47A6
7051,300786,"CANCER/TESTIS ANTIGEN FAMILY 47, MEMBER A7", CT47A7
7052,300787,"CANCER/TESTIS ANTIGEN FAMILY 47, MEMBER A8", CT47A8
7053,300788,"CANCER/TESTIS ANTIGEN FAMILY 47, MEMBER A9", CT47A9
7054,300789,"CANCER/TESTIS ANTIGEN FAMILY 47, MEMBER A10", CT47A10
7055,300790,"CANCER/TESTIS ANTIGEN FAMILY 47, MEMBER B1", CT47B1
7056,300791,NIK-RELATED KINASE, NRK
7057,300792,MICRO RNA 106A, MIR106A
7058,300793,"CANCER/TESTIS ANTIGEN FAMILY 45, MEMBER A2", CT45A2
7059,300794,"CANCER/TESTIS ANTIGEN FAMILY 45, MEMBER A3", CT45A3
7060,300795,"CANCER/TESTIS ANTIGEN FAMILY 45, MEMBER A4", CT45A4
7061,300796,"CANCER/TESTIS ANTIGEN FAMILY 45, MEMBER A5", CT45A5
7062,300797,"CANCER/TESTIS ANTIGEN FAMILY 45, MEMBER A6", CT45A6
7063,300798,"PHOSPHORYLASE KINASE, LIVER, ALPHA-2 SUBUNIT", PHKA2
7064,300799,"INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, RAYMOND TYPE", MRXSR
7065,300800,"PSEUDOHYPOPARATHYROIDISM, TYPE IA",
7066,300801,CHROMOSOME Xp11.23-p11.22 DUPLICATION SYNDROME,
7067,300802,"INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 96", XLID96
7068,300803,"INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 97", XLID97
7069,300804,JOUBERT SYNDROME 10, JBTS10
7070,300805,FMR1 ANTISENSE RNA 1, FMR1AS1
7071,300806,ALF TRANSCRIPTION ELONGATION FACTOR 2, AFF2
7072,300807,"THROMBOPHILIA, X-LINKED, DUE TO FACTOR IX DEFECT", THPH8
7073,300808,G PROTEIN-COUPLED RECEPTOR 143, GPR143
7074,300809,"SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 15", SLEB15
7075,300810,MICRO RNA 98, MIR98
7076,300811,MICRO RNA 105-1, MIR105-1
7077,300812,MICRO RNA 105-2, MIR105-2
7078,300813,"SARCOMA, SYNOVIAL",
7079,300814,"NYSTAGMUS 6, CONGENITAL, X-LINKED", NYS6
7080,300815,CHROMOSOME Xq28 DUPLICATION SYNDROME,
7081,300816,COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 6, COXPD6
7082,300817,EF-HAND DOMAIN (C-TERMINAL)-CONTAINING PROTEIN 2, EFHC2
7083,300818,PAROXYSMAL NOCTURNAL HEMOGLOBINURIA 1, PNH1
7084,300819,ZINC FINGER PROTEIN 630, ZNF630
7085,300820,MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 15, MAP3K15
7086,300821,"OPSIN 1, MEDIUM-WAVE-SENSITIVE", OPN1MW
7087,300822,"OPSIN 1, LONG-WAVE-SENSITIVE", OPN1LW
7088,300823,IDURONATE 2-SULFATASE, IDS
7089,300824,"OPN1LW AND OPN1MW GENES, CONTROLLER OF",
7090,300825,RETINOBLASTOMA-BINDING PROTEIN 7, RBBP7
7091,300826,STROMAL ANTIGEN 2, STAG2
7092,300827,FIBROBLAST GROWTH FACTOR 16, FGF16
7093,300828,PATCHED DOMAIN-CONTAINING PROTEIN 1, PTCHD1
7094,300829,"CARDIOMYOPATHY, FATAL FETAL, DUE TO MYOCARDIAL CALCIFICATION",
7095,300830,"AUTISM, SUSCEPTIBILITY TO, X-LINKED 4", AUTSX4
7096,300831,CK SYNDROME, CKS
7097,300832,JUST PROXIMAL TO XIST, JPX
7098,300833,"46,XX SEX REVERSAL 3", SRXX3
7099,300834,"MACULAR DEGENERATION, ATROPHIC, X-LINKED",
7100,300835,"ANEMIA, X-LINKED, WITH OR WITHOUT NEUTROPENIA AND/OR PLATELET ABNORMALITIES", XLANP
7101,300836,ANOSMIN 1, ANOS1
7102,300837,"DIACYLGLYCEROL KINASE, KAPPA, 142-KD", DGKK
7103,300838,FERM AND PDZ DOMAINS-CONTAINING PROTEIN 4, FRMPD4
7104,300839,RETINOSCHISIN, RS1
7105,300840,"PRA1 DOMAIN FAMILY, MEMBER 2", PRAF2
7106,300841,COAGULATION FACTOR VIII, F8
7107,300842,MCLEOD SYNDROME, MCLDS
7108,300843,BORNHOLM EYE DISEASE, BED
7109,300844,"INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 19", XLID19
7110,300845,"MOYAMOYA DISEASE 4 WITH SHORT STATURE, HYPERGONADOTROPIC HYPOGONADISM, AND FACIAL DYSMORPHISM", MYMY4
7111,300846,CD99 ANTIGEN-LIKE 2, CD99L2
7112,300847,"AUTISM, SUSCEPTIBILITY TO, X-LINKED 5", AUTSX5
7113,300848,"INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 89", XLID89
7114,300849,"INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 41", XLID41
7115,300850,"INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 90", XLID90
7116,300851,"INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 92", XLID92
7117,300852,"INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 88", XLID88
7118,300853,"IMMUNODEFICIENCY, X-LINKED, WITH MAGNESIUM DEFECT, EPSTEIN-BARR VIRUS INFECTION, AND NEOPLASIA", XMEN
7119,300854,"RENAL CELL CARCINOMA, Xp11-ASSOCIATED", RCCX1
7120,300855,OGDEN SYNDROME, OGDNS
7121,300856,"HYPOSPADIAS 4, X-LINKED, SUSCEPTIBILITY TO", HYSP4
7122,300857,AMYOTROPHIC LATERAL SCLEROSIS 15 WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA, ALS15
7123,300858,"INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC 17", MRXS17
7124,300859,COILED-COIL DOMAIN-CONTAINING PROTEIN 22, CCDC22
7125,300860,"INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, NASCIMENTO TYPE", MRXSN
7126,300861,"INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, CHUDLEY-SCHWARTZ TYPE", MRXSCS
7127,300862,ACYL-CoA THIOESTERASE 9, ACOT9
7128,300863,"CHONDRODYSPLASIA WITH PLATYSPONDYLY, DISTINCTIVE BRACHYDACTYLY, HYDROCEPHALY, AND MICROPHTHALMIA",
7129,300864,"CEREBRAL-CEREBELLAR-COLOBOMA SYNDROME, X-LINKED",
7130,300865,MICRO RNA 503, MIR503
7131,300866,MICRO RNA 510, MIR510
7132,300867,KABUKI SYNDROME 2, KABUK2
7133,300868,MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 2, MCAHS2
7134,300869,CHROMOSOME Xq27.3-q28 DUPLICATION SYNDROME,
7135,300870,"ANEURYSM, INTRACRANIAL BERRY, 5", ANIB5
7136,300871,FUN14 DOMAIN-CONTAINING PROTEIN 1, FUNDC1
7137,300872,"AUTISM, SUSCEPTIBILITY TO, X-LINKED 6", AUTSX6
7138,300873,GUANINE NUCLEOTIDE-BINDING PROTEIN-LIKE 3-LIKE PROTEIN, GNL3L
7139,300874,MICRO RNA 508, MIR508
7140,300875,MICRO RNA 509-1, MIR509-1
7141,300876,MICRO RNA 509-3, MIR509-3
7142,300877,MICRO RNA 506, MIR506
7143,300878,DOUBLESEX- AND MAB3-RELATED TRANSCRIPTION FACTOR C1, DMRTC1
7144,300879,XG GLYCOPROTEIN, XG
7145,300880,"PROTEASOME 26S SUBUNIT, NON-ATPase, 10", PSMD10
7146,300881,DESBUQUOIS DYSPLASIA 2,
7147,300882,CORNELIA DE LANGE SYNDROME 5, CDLS5
7148,300883,SORTING NEXIN 12, SNX12
7149,300884,DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 36, DEE36
7150,300885,"CYTOCHROME c OXIDASE, SUBUNIT 7B", COX7B
7151,300886,"INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC 32", MRXS32
7152,300887,LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 2, LSDMCA2
7153,300888,"HYPOTHYROIDISM, CENTRAL, WITH TESTICULAR ENLARGEMENT", CHTE
7154,300889,ZINC FINGER CCCH DOMAIN-CONTAINING PROTEIN 12B, ZC3H12B
7155,300890,ANKYRIN REPEAT- AND SOCS BOX-CONTAINING PROTEIN 9, ASB9
7156,300891,ANKYRIN REPEAT- AND SOCS BOX-CONTAINING PROTEIN 12, ASB12
7157,300892,LONG INTERGENIC NONCODING RNA 850, LINC00850
7158,300893,MICRO RNA 502, MIR502
7159,300894,NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 5, NBIA5
7160,300895,"OHDO SYNDROME, X-LINKED", OHDOX
7161,300896,"CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIm", CDG2M
7162,300897,ZINC FINGER C4H2 DOMAIN-CONTAINING PROTEIN, ZC4H2
7163,300898,CDR1 ANTISENSE RNA , CDR1AS
7164,300899,RIBOSOMAL PROTEIN L39, RPL39
7165,300900,TITLE NOT AVAILABLE AT THIS MOMENT,
7166,300901,X-ACTIVE-SPECIFIC NONCODING TRANSCRIPT, XACT
7167,300902,RIBOSOMAL PROTEIN L36A, RPL36A
7168,300903,G PROTEIN-COUPLED RECEPTOR 174, GPR174
7169,300904,INSULIN RECEPTOR SUBSTRATE 4, IRS4
7170,300905,"CHARCOT-MARIE-TOOTH DISEASE, X-LINKED DOMINANT, 6", CMTX6
7171,300906,"PYRUVATE DEHYDROGENASE KINASE, ISOENZYME 3", PDK3
7172,300907,"CLEAVAGE STIMULATION FACTOR, 3-PRIME PRE-RNA, SUBUNIT 2, 64-KD", CSTF2
7173,300908,"ANEMIA, CONGENITAL, NONSPHEROCYTIC HEMOLYTIC, 1", CNSHA1
7174,300909,"ANGIOEDEMA INDUCED BY ACE INHIBITORS, SUSCEPTIBILITY TO", AEACEI
7175,300910,BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 18, BMND18
7176,300911,"PARKINSONISM WITH SPASTICITY, X-LINKED", XPDS
7177,300912,"INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 98", XLID98
7178,300913,VACUOLAR ATPase ASSEMBLY FACTOR VMA21, VMA21
7179,300914,"DEAFNESS, X-LINKED 6", DFNX6
7180,300915,"MICROPHTHALMIA, SYNDROMIC 13", MCOPS13
7181,300916,"PARANEOPLASTIC MA ANTIGEN FAMILY, MEMBER 5", PNMA5
7182,300917,"PARANEOPLASTIC MA ANTIGEN FAMILY, MEMBER 6A", PNMA6A
7183,300918,"OLMSTED SYNDROME, X-LINKED", OLMSX
7184,300919,"INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 99", XLID99
7185,300920,ATAXIN 3-LIKE, ATXN3L
7186,300921,"BASIC HELIX-LOOP-HELIX DOMAIN-CONTAINING PROTEIN, CLASS B, 9", BHLHB9
7187,300922,CYSTEINE-RICH HYDROPHOBIC DOMAIN PROTEIN 1, CHIC1
7188,300923,"INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 100", XLID100
7189,300924,ACYL-CoA WAX ALCOHOL ACYLTRANSFERASE 1, AWAT1
7190,300925,ACYL-CoA WAX ALCOHOL ACYLTRANSFERASE 2, AWAT2
7191,300926,DIACYLGLYCEROL O-ACYLTRANSFERASE 2-LIKE 6, DGAT2L6
7192,300927,PEROXIREDOXIN 4, PRDX4
7193,300928,"INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 101", XLID101
7194,300929,MICRO RNA 718, MIR718
7195,300930,MAP7 DOMAIN-CONTAINING PROTEIN 3, MAP7D3
7196,300931,PIRIN, PIR
7197,300932,THYROXINE-BINDING GLOBULIN QUANTITATIVE TRAIT LOCUS, TBGQTL
7198,300933,"DYNEIN, AXONEMAL, ASSEMBLY FACTOR 6", DNAAF6
7199,300934,"CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Iy", CDG1Y
7200,300935,PROLINE-RICH GAMMA-CARBOXYGLUTAMIC ACID PROTEIN 1, PRRG1
7201,300936,"FTX TRANSCRIPT, XIST REGULATOR, NONCODING", FTX
7202,300937,RHO GTPase-ACTIVATING PROTEIN 36, ARHGAP36
7203,300938,MATRIX REMODELING-ASSOCIATED PROTEIN 5, MXRA5
7204,300939,"THYMOSIN, BETA-15A", TMSB15A
7205,300940,GLYCEROPHOSPHODIESTER PHOSPHODIESTERASE DOMAIN-CONTAINING PROTEIN 2, GDPD2
7206,300941,"SOLUTE CARRIER FAMILY 25, MEMBER 53", SLC25A53
7207,300942,CHROMOSOME Xq26.3 DUPLICATION SYNDROME,
7208,300943,"PITUITARY ADENOMA 2, GROWTH HORMONE-SECRETING", PITA2
7209,300944,"CSAG FAMILY, MEMBER 1", CSAG1
7210,300945,TSR2 RIBOSOME MATURATION FACTOR, TSR2
7211,300946,DIAMOND-BLACKFAN ANEMIA 14 WITH MANDIBULOFACIAL DYSOSTOSIS, DBA14
7212,300947,COILED-COIL DOMAIN-CONTAINING PROTEIN 120, CCDC120
7213,300948,"PHOSPHATE CYTIDYLYLTRANSFERASE 1, CHOLINE, BETA ISOFORM", PCYT1B
7214,300949,FORKHEAD BOX R2, FOXR2
7215,300950,MICRO RNA 20B, MIR20B
7216,300951,RING FINGER PROTEIN 113A, RNF113A
7217,300952,LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 3, LSDMCA3
7218,300953,"TRICHOTHIODYSTROPHY 5, NONPHOTOSENSITIVE", TTD5
7219,300954,ENDOTHELIUM- AND LYMPHOCYTE-ASSOCIATED ASCH DOMAIN 1, EOLA1
7220,300955,APOLIPOPROTEIN O-LIKE, APOOL
7221,300956,BRAF PSEUDOGENE 1, BRAFP1
7222,300957,"INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, KUMAR TYPE", MRXSK
7223,300958,"INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, SNIJDERS BLOK TYPE", MRXSSB
7224,300959,DIVERGENT PROTEIN KINASE DOMAIN 2B, DIPK2B
7225,300960,MEND SYNDROME, MEND
7226,300961,MID1-INTERACTING PROTEIN 1, MID1IP1
7227,300962,GEM NUCLEAR ORGANELLE-ASSOCIATED PROTEIN 8, GEMIN8
7228,300963,RITSCHER-SCHINZEL SYNDROME 2, RTSC2
7229,300964,LAS1-LIKE RIBOSOME BIOGENESIS FACTOR, LAS1L
7230,300965,RETROTRANSPOSON GAG-LIKE 9, RTL9
7231,300966,"INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC 33", MRXS33
7232,300967,"INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC 34", MRXS34
7233,300968,"INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 99, SYNDROMIC, FEMALE-RESTRICTED", MRXS99F
7234,300969,G PROTEIN-COUPLED RECEPTOR-ASSOCIATED SORTING PROTEIN 2, GPRASP2
7235,300970,MORC FAMILY CW-TYPE ZINC FINGER PROTEIN 4, MORC4
7236,300971,"BARTTER SYNDROME, TYPE 5, ANTENATAL, TRANSIENT", BARTS5
7237,300972,IMMUNODEFICIENCY 47, IMD47
7238,300973,"RHOX HOMEOBOX FAMILY MEMBER 1, PSEUDOGENE 1", RHOXF1P1
7239,300974,"PHOSPHOLIPASE C, PHOSPHATIDYLINOSITOL-SPECIFIC, X DOMAIN-CONTAINING PROTEIN 1", PLCXD1
7240,300975,"UBIQUITIN-SPECIFIC PROTEASE 27, X-LINKED", USP27X
7241,300976,"FAMILY WITH SEQUENCE SIMILARITY 46, MEMBER D", FAM46D
7242,300977,SCHOLTE SYNDROME, SHLTS
7243,300978,TONNE-KALSCHEUER SYNDROME, TOKAS
7244,300979,CHROMOSOME Xq25 DUPLICATION SYNDROME,
7245,300980,KELCH-LIKE 15, KLHL15
7246,300981,"VARIABLY CHARGED, X CHROMOSOME, 3B", VCX3B
7247,300982,"INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 103", XLID103
7248,300983,"INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 104", XLID104
7249,300984,"INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 105", XLID105
7250,300985,"VAS DEFERENS, CONGENITAL BILATERAL APLASIA OF, X-LINKED", CBAVDX
7251,300986,"INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, BAIN TYPE", MRXSB
7252,300987,MEHMO SYNDROME,
7253,300988,IMMUNODEFICIENCY 50, IMD50
7254,300989,MEESTER-LOEYS SYNDROME, MRLS
7255,300990,"MIDFACE HYPOPLASIA, HEARING IMPAIRMENT, ELLIPTOCYTOSIS, AND NEPHROCALCINOSIS", MFHIEN
7256,300991,"CILIARY DYSKINESIA, PRIMARY, 36, X-LINKED", CILD36
7257,300992,NEGATIVE REGULATOR OF P-BODY ASSOCIATION, NBDY
7258,300993,PAS DOMAIN-CONTAINING REPRESSOR 1, PASD1
7259,300994,HIGHLY DIVERGENT HOMEOBOX, HDX
7260,300995,KIAA1210 GENE, KIAA1210
7261,300996,"YIP1 DOMAIN FAMILY, MEMBER 6", YIPF6
7262,300997,"INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 106", XLID106
7263,300998,"INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC 35", MRXS35
7264,300999,FUNCTIONAL INTERGENIC REPEATING RNA ELEMENT, FIRRE
7265,301000,WISKOTT-ALDRICH SYNDROME, WAS
7266,301001,"DXZ4-ASSOCIATED NONCODING TRANSCRIPT 1, PROXIMAL", DANT1
7267,301002,SRSF PROTEIN KINASE 3, SRPK3
7268,301003,G-PATCH DOMAIN AND KOW MOTIFS, GPKOW
7269,301004,"DXZ4-ASSOCIATED NONCODING TRANSCRIPT 2, DISTAL", DANT2
7270,301005,FERM- AND PDZ DOMAIN-CONTAINING PROTEIN 3, FRMPD3
7271,301006,"GALLOWAY-MOWAT SYNDROME 2, X-LINKED", GAMOS2
7272,301007,"ZINC FINGER, MATRIN-TYPE 1", ZMAT1
7273,301008,"INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, HOUGE TYPE", MRXSHG
7274,301009,"P ANTIGEN FAMILY, MEMBER 5", PAGE5
7275,301010,"MYOPIA 26, X-LINKED, FEMALE-LIMITED", MYP26
7276,301011,"THYMOSIN, BETA-15B", TMSB15B
7277,301012,STING1 ER EXIT PROTEIN 1, STEEP1
7278,301013,"INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 107", XLID107
7279,301014,"OSTEOGENESIS IMPERFECTA, TYPE XIX", OI19
7280,301015,"HEMOLYTIC ANEMIA, CONGENITAL, X-LINKED", HACXL
7281,301016,RAS-RELATED PROTEIN 2C, RAP2C
7282,301017,"PROTEIN PHOSPHATASE 1, REGULATORY SUBUNIT 2C", PPP1R2C
7283,301018,"DEAFNESS, X-LINKED 7", DFNX7
7284,301019,"KDM5C ADJACENT TRANSCRIPT, NONCODING", KANTR
7285,301020,"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 12", MC1DN12
7286,301021,"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 30", MC1DN30
7287,301022,MULLEGAMA-KLEIN-MARTINEZ SYNDROME, MKMS
7288,301023,MICRO RNA 532, MIR532
7289,301024,"INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 108", MRX108
7290,301025,PAGANINI-MIOZZO SYNDROME, MRXSPM
7291,301026,KEIPERT SYNDROME, KPTS
7292,301027,"TBC1 DOMAIN FAMILY, MEMBER 8B", TBC1D8B
7293,301028,"NEPHROTIC SYNDROME, TYPE 20", NPHS20
7294,301029,SHUKLA-VERNON SYNDROME, SHUVER
7295,301030,VAN ESCH-O'DRISCOLL SYNDROME, VEODS
7296,301031,"CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Icc", CDG1CC
7297,301032,BASILICATA-AKHTAR SYNDROME, MRXSBA
7298,301033,"HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 8", CHNG8
7299,301034,"DEHYDROGENASE/REDUCTASE, X-LINKED", DHRSX
7300,301035,"HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 9", CHNG9
7301,301036,EZH INHIBITORY PROTEIN, EZHIP
7302,301037,H2A.B VARIANT HISTONE 1, H2AB1
7303,301038,H2A.B VARIANT HISTONE 2, H2AB2
7304,301039,"INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, HACKMANN-DI DONATO TYPE", MRXSHD
7305,301040,"ALPHA-THALASSEMIA/IMPAIRED INTELLECTUAL DEVELOPMENT SYNDROME, X-LINKED", ATRX
7306,301041,"WIEACKER-WOLFF SYNDROME, FEMALE-RESTRICTED", WRWFFR
7307,301042,FUN14 DOMAIN-CONTAINING PROTEIN 2, FUNDC2
7308,301043,"HOLOPROSENCEPHALY 13, X-LINKED", HPE13
7309,301044,DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 85 WITH OR WITHOUT MIDLINE BRAIN DEFECTS, DEE85
7310,301045,"CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIr", CDG2R
7311,301046,"ARMADILLO REPEAT-CONTAINING PROTEIN, X-LINKED 4", ARMCX4
7312,301047,"ARMADILLO REPEAT-CONTAINING PROTEIN, X-LINKED 5", ARMCX5
7313,301048,"ARMADILLO REPEAT-CONTAINING PROTEIN, X-LINKED 6", ARMCX6
7314,301049,TLR ADAPTOR INTERACTING WITH ENDOLYSOSOMAL SLC15A4, TASL
7315,301050,"ALPORT SYNDROME 1, X-LINKED", ATS1
7316,301051,"IMMUNODEFICIENCY 74, COVID19-RELATED, X-LINKED", IMD74
7317,301052,"WARFARIN SENSITIVITY, X-LINKED",
7318,301053,MICRO RNA 505, MIR505
7319,301054,VEXAS SYNDROME, VEXAS
7320,301055,"CPX CHROMOSOME REGION, CANDIDATE GENE 1", CPXCR1
7321,301056,"MULTIPLE CONGENITAL ANOMALIES-NEURODEVELOPMENTAL SYNDROME, X-LINKED", MCAND
7322,301057,CILIA- AND FLAGELLA-ASSOCIATED PROTEIN 47, CFAP47
7323,301058,DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 90, DEE90
7324,301059,"SPERMATOGENIC FAILURE, X-LINKED, 3", SPGFX3
7325,301060,"AZOOSPERMIA, OBSTRUCTIVE, WITH NEPHROLITHIASIS", OAZON
7326,301061,MYOTUBULARIN-RELATED PROTEIN 8, MTMR8
7327,301062,MICRO RNA 766, MIR766
7328,301063,"X ANTIGEN FAMILY, MEMBER 5", XAGE5
7329,301064,"MELANOMA ANTIGEN, FAMILY B, 18", MAGEB18
7330,301065,"RAB40A, MEMBER RAS ONCOGENE FAMILY", RAB40A
7331,301066,"INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, WITH PIGMENTARY MOSAICISM AND COARSE FACIES", MRXSPF
7332,301067,"FAMILY WITH SEQUENCE SIMILARITY 47, MEMBER C", FAM47C
7333,301068,HARDIKAR SYNDROME, HDKR
7334,301069,CHROMOSOME Xq13 DUPLICATION SYNDROME,
7335,301070,WD REPEAT DOMAIN-CONTAINING PROTEIN 44, WDR44
7336,301071,"THROMBOPHILIA, X-LINKED, DUE TO FACTOR VIII DEFECT", THPH13
7337,301072,NEURODEVELOPMENTAL DISORDER WITH EPILEPSY AND HEMOCHROMATOSIS, NEDEPH
7338,301073,"ATPase, NA+/K+ TRANSPORTING FAMILY, MEMBER BETA-4", ATP1B4
7339,301074,"AUTOINFLAMMATORY SYNDROME, FAMILIAL, X-LINKED, BEHCET-LIKE 2", AIFBL2
7340,301075,"MYOPATHY, DISTAL, 7, ADULT-ONSET, X-LINKED", MPD7
7341,301076,"INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, PILORGE TYPE", MRXSP
7342,301077,"SPERMATOGENIC FAILURE, X-LINKED, 4", SPGFX4
7343,301078,"IMMUNODEFICIENCY 98 WITH AUTOINFLAMMATION, X-LINKED", IMD98
7344,301079,DEAD-BOX HELICASE 53, DDX53
7345,301080,SYSTEMIC LUPUS ERYTHEMATOSUS 17, SLEB17
7346,301081,"AUTOINFLAMMATORY DISEASE, SYSTEMIC, X-LINKED", SAIDX
7347,301082,IMMUNODEFICIENCY 102, IMD102
7348,301083,"ANEMIA, CONGENITAL, NONSPHEROCYTIC HEMOLYTIC, 9", CNSHA9
7349,301084,TRANSCRIPTION ELONGATION FACTOR A N-TERMINAL AND CENTRAL DOMAIN-CONTAINING PROTEIN, TCEANC
7350,301085,ADHESION G PROTEIN-COUPLED RECEPTOR G4, ADGRG4
7351,301086,MOTILE SPERM DOMAIN-CONTAINING PROTEIN 2, MOSPD2
7352,301087,"FGF13 ANTISENSE RNA 1, NONCODING", FGF13AS1
7353,301088,C-X9-C MOTIF-CONTAINING PROTEIN 4, CMC4
7354,301089,"WWC FAMILY, MEMBER 3", WWC3
7355,301090,TETRAAMELIA SYNDROME 1,
7356,301091,"EPILEPSY, X-LINKED 2, WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT AND DYSMORPHIC FEATURES", EPILX2
7357,301092,MICRO RNA 92A2, MIR92A2
7358,301093,NHS-LIKE PROTEIN 2, NHSL2
7359,301094,HIJAZI-REIS SYNDROME, HIJRS
7360,301095,"INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 110", XLID110
7361,301096,"CSAG FAMILY, MEMBER 2", CSAG2
7362,301097,"CSAG FAMILY, MEMBER 3", CSAG3
7363,301098,MEMBRANE MAGNESIUM TRANSPORTER 1, MMGT1
7364,301099,"SPERMATOGENIC FAILURE, X-LINKED, 5", SPGFX5
7365,301100,"AMELOGENESIS IMPERFECTA, TYPE IE",
7366,301101,"SPERMATOGENIC FAILURE, X-LINKED, 6", SPGFX6
7367,301102,TRANSMEMBRANE PROTEIN 31, TMEM31
7368,301103,MITOCHONDRIAL PYRUVATE CARRIER 1-LIKE PROTEIN, MPC1L
7369,301104,"PROTEIN PHOSPHATASE 1, REGULATORY SUBUNIT 3F", PPP1R3F
7370,301105,CANCER/TESTIS ANTIGEN 55, CT55
7371,301106,"SPERMATOGENIC FAILURE, X-LINKED, 7", SPGFX7
7372,301107,"INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 111", XLID111
7373,301108,"CATARACTS, HEARING IMPAIRMENT, NEPHROTIC SYNDROME, AND ENTEROCOLITIS 1", CHINE1
7374,301109,"AUTOINFLAMMATORY DISEASE, MULTISYSTEM, WITH IMMUNE DYSREGULATION, X-LINKED", ADMIDX
7375,301110,"HEMOLYTIC UREMIC SYNDROME, ATYPICAL, 8, WITH RHIZOMELIC SHORT STATURE", AHUS8
7376,301111,"INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 112", XLID112
7377,301112,GLYOXALASE DOMAIN-CONTAINING PROTEIN 5, GLOD5
7378,301113,"SPINDLIN FAMILY, MEMBER 4", SPIN4
7379,301114,LUI-JEE-BARON SYNDROME, LJBS
7380,301115,IMMUNODEFICIENCY 118, IMD118
7381,301116,"INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 113", XLID113
7382,301117,CHROMOSOME X OPEN READING FRAME 38, CXORF38
7383,301118,"INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC 37", MRXS37
7384,301119,"SPERMATOGENIC FAILURE, X-LINKED, 8", SPGFX8
7385,301120,"PROSTATE CANCER, HEREDITARY, X-LINKED 3", HPCX3
7386,301121,MAP7 DOMAIN-CONTAINING PROTEIN 2, MAP7D2
7387,301122,ZINC FINGER CCHC DOMAIN-CONTAINING PROTEIN 18, ZCCHC18
7388,301123,TESTIS-EXPRESSED GENE 13C, TEX13C
7389,301124,TESTIS-EXPRESSED GENE 13D, TEX13D
7390,301125,ZINC FINGER CCHC DOMAIN-CONTAINING PROTEIN 13, ZCCHC13
7391,301126,SYNAPTOTAGMIN-LIKE 5, SYTL5
7392,301127,"ARTHROGRYPOSIS MULTIPLEX CONGENITA 7, X-LINKED", AMC7
7393,301128,tRNA METHYLTRANSFERASE 2 HOMOLOG B, TRMT2B
7394,301129,SPERMIDINE/SPERMINE N1-ACETYLTRANSFERASE-LIKE 1, SATL1
7395,301130,RETROTRANSPOSON GAG-LIKE 3, RTL3
7396,301131,RETROTRANSPOSON GAG-LIKE 4, RTL4
7397,301132,OROFACIODIGITAL SYNDROME XXI, OFD21
7398,301133,"CONGENITAL DISORDER OF GLYCOSYLATION, TYPE 1DD", CDG1DD
7399,301134,"INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 114", XLID114
7400,301135,RETROTRANSPOSON GAG-LIKE PROTEIN 5, RTL5
7401,301136,RBMX-LIKE PROTEIN 3, RBMXL3
7402,301137,"SPERMATOGENIC FAILURE, X-LINKED, 9", SPGFX9
7403,301138,MICRO RNA 934, MIR934
7404,301139,ZINC FINGER PROTEIN 92, ZFP92
7405,301140,"PTCHD1 ANTISENSE RNA, NONCODING", PTCHD1AS
7406,301141,"VCP NUCLEAR COFACTOR FAMILY, MEMBER 2", VCF2
7407,301200,"AMELOGENESIS IMPERFECTA, TYPE IE", AI1E
7408,301201,"AMELOGENESIS IMPERFECTA, HYPOPLASTIC/HYPOMATURATION, X-LINKED 2",
7409,301220,"PIGMENTARY DISORDER, RETICULATE, WITH SYSTEMIC MANIFESTATIONS, X-LINKED", PDR
7410,301300,DELTA-AMINOLEVULINATE SYNTHASE 2, ALAS2
7411,301310,"SPINOCEREBELLAR ATAXIA, X-LINKED 6, WITH OR WITHOUT SIDEROBLASTIC ANEMIA", SCAX6
7412,301410,"NEURAL TUBE DEFECTS, X-LINKED",
7413,301500,FABRY DISEASE,
7414,301590,"MICROPHTHALMIA, SYNDROMIC 1",
7415,301700,"ANOSMIA, ISOLATED CONGENITAL, X-LINKED",
7416,301770,"ARRESTIN 3, RETINAL", ARR3
7417,301780,"ARYLSULFATASE C, ISOZYME F", ARSC2
7418,301790,"SPINOCEREBELLAR ATAXIA, X-LINKED 3",
7419,301800,"ANUS, IMPERFORATE",
7420,301810,"CITRULLINEMIA, CLASSIC",
7421,301815,"ARTHROGRYPOSIS, ECTODERMAL DYSPLASIA, CLEFT LIP/PALATE, AND DEVELOPMENTAL DELAY",
7422,301820,"ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 1",
7423,301830,"SPINAL MUSCULAR ATROPHY, X-LINKED 2", SMAX2
7424,301835,ARTS SYNDROME, ARTS
7425,301840,"SPINOCEREBELLAR ATAXIA, X-LINKED 4",
7426,301845,BAZEX-DUPRE-CHRISTOL SYNDROME, BDCS
7427,301850,"TUBULIN, BETA",
7428,301870,BIGLYCAN, BGN
7429,301880,TITLE NOT AVAILABLE AT THIS MOMENT,
7430,301900,BORJESON-FORSSMAN-LEHMANN SYNDROME, BFLS
7431,301940,"BRACHYDACTYLY, MONONEN TYPE",
7432,301950,"BRANCHIAL ARCH SYNDROME, X-LINKED",
7433,302000,"BULLOUS DYSTROPHY, HEREDITARY MACULAR TYPE", HBDM
7434,302020,S100 CALCIUM-BINDING PROTEIN G, S100G
7435,302030,CALVARIAL HYPEROSTOSIS,
7436,302045,"CARDIOMYOPATHY, DILATED, 3B", CMD3B
7437,302060,BARTH SYNDROME, BTHS
7438,302200,CATARACT 40, CTRCT40
7439,302300,CATARACT 40,
7440,302350,NANCE-HORAN SYNDROME, NHS
7441,302380,CATEL-MANZKE SYNDROME,
7442,302400,"CENTRAL INCISORS, ABSENCE OF",
7443,302500,"SPINOCEREBELLAR ATAXIA, X-LINKED 1", SCAX1
7444,302600,"SPINOCEREBELLAR ATAXIA, X-LINKED 2",
7445,302650,CEREBELLAR DEGENERATION-RELATED AUTOANTIGEN 1, CDR1
7446,302700,"CEREBRAL SCLEROSIS, DIFFUSE, SCHOLZ TYPE",
7447,302800,"CHARCOT-MARIE-TOOTH DISEASE, X-LINKED DOMINANT, 1", CMTX1
7448,302801,"CHARCOT-MARIE-TOOTH DISEASE, X-LINKED RECESSIVE, 2", CMTX2
7449,302802,"CHARCOT-MARIE-TOOTH DISEASE, X-LINKED RECESSIVE, 3", CMTX3
7450,302803,"CHARCOT-MARIE-TOOTH PERONEAL MUSCULAR ATROPHY, X-LINKED, WITH APLASIA CUTIS CONGENITA",
7451,302900,"CHARCOT-MARIE-TOOTH PERONEAL MUSCULAR ATROPHY AND FRIEDREICH ATAXIA, COMBINED",
7452,302905,ABRUZZO-ERICKSON SYNDROME, ABERS
7453,302910,CHLORIDE CHANNEL 4, CLCN4
7454,302920,FARNESYL DIPHOSPHATE SYNTHASE,
7455,302940,"CHONDRODYSPLASIA PUNCTATA 1, X-LINKED RECESSIVE",
7456,302950,"CHONDRODYSPLASIA PUNCTATA 1, X-LINKED RECESSIVE", CDPX1
7457,302960,"CHONDRODYSPLASIA PUNCTATA 2, X-LINKED DOMINANT", CDPX2
7458,303100,CHOROIDEREMIA, CHM
7459,303110,CHROMOSOME Xq21 DELETION SYNDROME,
7460,303350,MASA SYNDROME,
7461,303400,"CLEFT PALATE WITH OR WITHOUT ANKYLOGLOSSIA, X-LINKED", CPX
7462,303600,COFFIN-LOWRY SYNDROME, CLS
7463,303630,"COLLAGEN, TYPE IV, ALPHA-5", COL4A5
7464,303631,"COLLAGEN, TYPE IV, ALPHA-6", COL4A6
7465,303650,COLONIC ATRESIA,
7466,303700,BLUE CONE MONOCHROMACY, BCM
7467,303800,"COLORBLINDNESS, PARTIAL, DEUTAN SERIES", CBD
7468,303900,"COLORBLINDNESS, PARTIAL, PROTAN SERIES", CBP
7469,304000,"OPSIN 1, SHORT-WAVE-SENSITIVE",
7470,304020,"CONE-ROD DYSTROPHY, X-LINKED, 1", CORDX1
7471,304030,"CONE DYSTROPHY, X-LINKED, WITH TAPETAL-LIKE SHEEN",
7472,304040,"GAP JUNCTION PROTEIN, BETA-1", GJB1
7473,304050,AICARDI SYNDROME, AIC
7474,304100,"CORPUS CALLOSUM, PARTIAL AGENESIS OF, X-LINKED",
7475,304110,CRANIOFRONTONASAL SYNDROME, CFNS
7476,304120,"OTOPALATODIGITAL SYNDROME, TYPE II", OPD2
7477,304150,OCCIPITAL HORN SYNDROME, OHS
7478,304200,"CUTIS VERTICIS GYRATA, THYROID APLASIA, AND IMPAIRED INTELLECTUAL DEVELOPMENT",
7479,304300,"CYANIDE, INABILITY TO SMELL",
7480,304340,PETTIGREW SYNDROME, PGS
7481,304350,DEAFNESS-HYPOGONADISM SYNDROME,
7482,304400,"DEAFNESS, X-LINKED 2", DFNX2
7483,304500,"DEAFNESS, X-LINKED 1", DFNX1
7484,304590,"DEAFNESS, X-LINKED 1",
7485,304600,"DEAFNESS, X-LINKED 1",
7486,304700,MOHR-TRANEBJAERG SYNDROME, MTS
7487,304730,DERMOIDS OF CORNEA, CND
7488,304750,"HETEROTAXY, VISCERAL, 1, X-LINKED",
7489,304790,"IMMUNODYSREGULATION, POLYENDOCRINOPATHY, AND ENTEROPATHY, X-LINKED", IPEX
7490,304800,"DIABETES INSIPIDUS, NEPHROGENIC, 1, X-LINKED", NDI1
7491,304900,"DIABETES INSIPIDUS, NEUROHYPOPHYSEAL, X-LINKED",
7492,304930,"IMMUNODYSREGULATION, POLYENDOCRINOPATHY, AND ENTEROPATHY, X-LINKED",
7493,304950,"DYGGVE-MELCHIOR-CLAUSEN SYNDROME, X-LINKED",
7494,304990,TITLE NOT AVAILABLE AT THIS MOMENT,
7495,305000,"DYSKERATOSIS CONGENITA, X-LINKED", DKCX
7496,305050,MOHR-TRANEBJAERG SYNDROME,
7497,305100,"ECTODERMAL DYSPLASIA 1, HYPOHIDROTIC, X-LINKED", XHED
7498,305200,"CARDIAC VALVULAR DYSPLASIA, X-LINKED",
7499,305300,BARTH SYNDROME,
7500,305350,"EPIDERMODYSPLASIA VERRUCIFORMIS, X-LINKED", EVX
7501,305360,"MEMBRANE PROTEIN, PALMITOYLATED 1", MPP1
7502,305370,TISSUE INHIBITOR OF METALLOPROTEINASE 1, TIMP1
7503,305371,GATA-BINDING PROTEIN 1, GATA1
7504,305390,"EXUDATIVE VITREORETINOPATHY 2, X-LINKED", EVR2
7505,305400,AARSKOG-SCOTT SYNDROME, AAS
7506,305423,COAGULATION FACTOR VIII-ASSOCIATED PROTEIN 1, F8A1
7507,305424,FACTOR VIII-ASSOCIATED GENE 2,
7508,305425,FARNESYL DIPHOSPHATE SYNTHASE,
7509,305435,FETAL HEMOGLOBIN QUANTITATIVE TRAIT LOCUS 3, HBFQTL3
7510,305450,OPITZ-KAVEGGIA SYNDROME, OKS
7511,305550,FINGERPRINT BODY MYOPATHY,
7512,305600,FOCAL DERMAL HYPOPLASIA, FDH
7513,305620,FRONTOMETAPHYSEAL DYSPLASIA 1, FMD1
7514,305645,FRONTONASAL DYSPLASIA 1,
7515,305650,TITLE NOT AVAILABLE AT THIS MOMENT,
7516,305660,"GAMMA-AMINOBUTYRIC ACID RECEPTOR, ALPHA-3", GABRA3
7517,305670,GASTRIN-RELEASING PEPTIDE RECEPTOR, GRPR
7518,305690,GENITOURINARY TRACT ANOMALIES,
7519,305700,"SPERMATOGENIC FAILURE, X-LINKED, 1", SPGFX1
7520,305800,"MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS, X-LINKED",
7521,305900,GLUCOSE-6-PHOSPHATE DEHYDROGENASE, G6PD
7522,305910,GLUTAMATE DEHYDROGENASE 1,
7523,305915,"GLUTAMATE RECEPTOR, IONOTROPIC, AMPA 3", GRIA3
7524,305920,GLUTAMYL RIBOSE-5-PHOSPHATE STORAGE DISEASE,
7525,305980,GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE,
7526,305990,"GLYCINE RECEPTOR, ALPHA-2 SUBUNIT", GLRA2
7527,306000,GLYCOGEN STORAGE DISEASE IXa1, GSD9A1
7528,306100,"46,XY SEX REVERSAL 1",
7529,306190,"ADRENAL HYPOPLASIA, CONGENITAL",
7530,306250,"COLONY-STIMULATING FACTOR 2 RECEPTOR, ALPHA", CSF2RA
7531,306300,"GRANULOMAS, CONGENITAL CEREBRAL",
7532,306400,"GRANULOMATOUS DISEASE, CHRONIC, X-LINKED", CGDX
7533,306480,HALOACID DEHALOGENASE-LIKE HYDROLASE DOMAIN-CONTAINING 1A, HDHD1A
7534,306500,"ANDROGEN INSENSITIVITY, PARTIAL",
7535,306600,TITLE NOT AVAILABLE AT THIS MOMENT,
7536,306700,HEMOPHILIA A, HEMA
7537,306800,HEMOPHILIA A WITH VASCULAR ABNORMALITY,
7538,306900,HEMOPHILIA B, HEMB
7539,306930,HEMOPOIETIC PROLIFERATION,
7540,306950,"DIAPHRAGMATIC HERNIA 5, X-LINKED", DIH5
7541,306955,"HETEROTAXY, VISCERAL, 1, X-LINKED", HTX1
7542,306960,HHHH SYNDROME,
7543,306970,LYSINE DEMETHYLASE 5D,
7544,306980,HIRSCHSPRUNG DISEASE WITH TYPE D BRACHYDACTYLY,
7545,306990,"MICROHYDRANENCEPHALY, X-LINKED", MHACX
7546,306995,HOMOSEXUALITY 1, HMS1
7547,307000,"HYDROCEPHALUS, CONGENITAL, X-LINKED", HYCX
7548,307010,HYDROCEPHALUS WITH CEREBELLAR AGENESIS,
7549,307030,GLYCEROL KINASE DEFICIENCY, GKD
7550,307150,"HYPERTRICHOSIS, CONGENITAL GENERALIZED, 2", HTC2
7551,307200,"ISOLATED GROWTH HORMONE DEFICIENCY, TYPE III, WITH AGAMMAGLOBULINEMIA", IGHD3
7552,307300,"ANDROGEN INSENSITIVITY, PARTIAL",
7553,307500,"HYPOGONADISM, MALE, WITH IMPAIRED INTELLECTUAL DEVELOPMENT AND SKELETAL ANOMALIES",
7554,307600,"HYPOMAGNESEMIA 1, INTESTINAL",
7555,307700,"HYPOPARATHYROIDISM, X-LINKED", HYPX
7556,307800,"HYPOPHOSPHATEMIC RICKETS, X-LINKED DOMINANT", XLHRD
7557,307810,"HYPOPHOSPHATEMIC RICKETS, X-LINKED DOMINANT",
7558,307830,"HYPOURICEMIA, FAMILIAL RENAL, DUE TO TUBULAR HYPERSECRETION",
7559,308000,HYPOXANTHINE GUANINE PHOSPHORIBOSYLTRANSFERASE 1, HPRT1
7560,308050,CONGENITAL HEMIDYSPLASIA WITH ICHTHYOSIFORM ERYTHRODERMA AND LIMB DEFECTS,
7561,308100,"ICHTHYOSIS, X-LINKED", XLI
7562,308200,ICHTHYOSIS AND MALE HYPOGONADISM,
7563,308205,"IFAP SYNDROME 1, WITH OR WITHOUT BRESHECK SYNDROME", IFAP1
7564,308210,TITLE NOT AVAILABLE AT THIS MOMENT,
7565,308220,"IMMUNODEFICIENCY, X-LINKED, WITH DEFICIENCY OF 115,000 DALTON SURFACE GLYCOPROTEIN",
7566,308230,"IMMUNODEFICIENCY WITH HYPER-IgM, TYPE 1", HIGM1
7567,308240,"LYMPHOPROLIFERATIVE SYNDROME, X-LINKED, 1", XLP1
7568,308250,"IMMUNOGLOBULIN M, LEVEL OF",
7569,308280,"IMPACTED TEETH, MULTIPLE",
7570,308290,IMPRINTING GENE RELATED TO RETINOBLASTOMA,
7571,308300,INCONTINENTIA PIGMENTI, IP
7572,308310,INCONTINENTIA PIGMENTI,
7573,308350,DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 1, DEE1
7574,308370,"ANDROGEN INSENSITIVITY, PARTIAL",
7575,308380,"INTERLEUKIN 2 RECEPTOR, GAMMA", IL2RG
7576,308385,"INTERLEUKIN 3 RECEPTOR, ALPHA", IL3RA
7577,308400,TITLE NOT AVAILABLE AT THIS MOMENT,
7578,308500,IRIS HYPOPLASIA WITH GLAUCOMA, IHG
7579,308600,"JAUNDICE, FAMILIAL OBSTRUCTIVE, OF INFANCY",
7580,308700,HYPOGONADOTROPIC HYPOGONADISM 1 WITH OR WITHOUT ANOSMIA, HH1
7581,308750,KALLMANN SYNDROME WITH SPASTIC PARAPLEGIA,
7582,308800,"KERATOSIS FOLLICULARIS SPINULOSA DECALVANS, X-LINKED", KFSDX
7583,308830,"KERATOSIS FOLLICULARIS, DWARFISM, AND CEREBRAL ATROPHY",
7584,308840,L1 CELL ADHESION MOLECULE, L1CAM
7585,308850,"LARYNGEAL ABDUCTOR PARALYSIS, X-LINKED",
7586,308905,"LEBER HEREDITARY OPTIC NEUROPATHY, MODIFIER OF", LOAM
7587,308930,PYRUVATE DEHYDROGENASE E1-ALPHA DEFICIENCY,
7588,308940,"LEIOMYOMATOSIS, DIFFUSE, WITH ALPORT SYNDROME", DL-ATS
7589,308950,LESCH-NYHAN PHENOTYPE WITH NORMAL HGPRT,
7590,308960,"LEUKEMIA, ACUTE, X-LINKED",
7591,308980,"LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 2",
7592,308990,"PROTEINURIA, LOW MOLECULAR WEIGHT, WITH HYPERCALCIURIA AND NEPHROCALCINOSIS",
7593,309000,LOWE OCULOCEREBRORENAL SYNDROME, OCRL
7594,309050,"LUTHERAN SUPPRESSOR, X-LINKED", XS
7595,309060,LYSOSOME-ASSOCIATED MEMBRANE PROTEIN 2, LAMP2
7596,309100,"MACULAR DYSTROPHY, X-LINKED",
7597,309120,"SPERMATOGENIC FAILURE, X-LINKED, 2", SPGFX2
7598,309150,"46,XY SEX REVERSAL 8",
7599,309200,MAJOR AFFECTIVE DISORDER 2, MAFD2
7600,309300,MEGALOCORNEA, MGC1
7601,309350,MELNICK-NEEDLES SYNDROME, MNS
7602,309400,MENKES DISEASE, MNK
7603,309470,RENPENNING SYNDROME 1,
7604,309480,IMPAIRED INTELLECTUAL DEVELOPMENT AND PSORIASIS,
7605,309490,"INTELLECTUAL DISABILITY-HYPOTONIC FACIES SYNDROME, X-LINKED, 1",
7606,309500,RENPENNING SYNDROME 1, RENS1
7607,309510,PARTINGTON SYNDROME, PRTS
7608,309520,"INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, LUJAN-FRYNS TYPE", MRXSLF
7609,309530,"INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 1", XLID1
7610,309540,"INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 109",
7611,309541,"METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, cblX TYPE", MAHCX
7612,309545,"INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC 12", MRXS12
7613,309548,"INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 109", XLID109
7614,309549,"INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 9", XLID9
7615,309550,FRAGILE X MESSENGER RIBONUCLEOPROTEIN 1, FMR1
7616,309555,"INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, GUSTAVSON TYPE", MRXSG
7617,309560,IMPAIRED INTELLECTUAL DEVELOPMENT WITH SPASTIC PARAPLEGIA AND PALMOPLANTAR HYPERKERATOSIS,
7618,309580,"INTELLECTUAL DISABILITY-HYPOTONIC FACIES SYNDROME, X-LINKED, 1", MRXHF1
7619,309583,"INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, SNYDER-ROBINSON TYPE", MRXSSR
7620,309585,"INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, WILSON-TURNER TYPE", WTS
7621,309590,"INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, TURNER TYPE", MRXST
7622,309600,ALLAN-HERNDON-DUDLEY SYNDROME,
7623,309605,WIEACKER-WOLFF SYNDROME,
7624,309610,PRIETO SYNDROME, PRS
7625,309620,CHRISTIAN SYNDROME, CHRS
7626,309630,METACARPAL 4-5 FUSION, MF4
7627,309640,MENTAL RETARDATION WITH SPASTIC PARAPLEGIA,
7628,309645,"SPONDYLOEPIMETAPHYSEAL DYSPLASIA, MISSOURI TYPE",
7629,309660,DANON DISEASE,
7630,309700,NORRIE DISEASE,
7631,309800,"MICROPHTHALMIA, SYNDROMIC 1", MCOPS1
7632,309801,LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 1, LSDMCA1
7633,309840,"MODIFIER, X-LINKED, FOR NEUROFUNCTIONAL DEFECTS",
7634,309845,MOESIN, MSN
7635,309850,MONOAMINE OXIDASE A, MAOA
7636,309860,MONOAMINE OXIDASE B, MAOB
7637,309900,"MUCOPOLYSACCHARIDOSIS, TYPE II", MPS2
7638,309930,"MUSCULAR DYSTROPHY, CARDIAC TYPE",
7639,309950,"MUSCULAR DYSTROPHY, HEMIZYGOUS LETHAL TYPE",
7640,310000,"MUSCULAR DYSTROPHY, MABRY TYPE",
7641,310095,"MUSCULAR DYSTROPHY, PROGRESSIVE PECTORODORSAL",
7642,310200,"MUSCULAR DYSTROPHY, DUCHENNE TYPE", DMD
7643,310300,"EMERY-DREIFUSS MUSCULAR DYSTROPHY 1, X-LINKED", EDMD1
7644,310305,MYB PROTOONCOGENE LIKE 2,
7645,310310,MYCL-RELATED PROCESSED GENE, MYCL2
7646,310350,MYELOLYMPHATIC INSUFFICIENCY,
7647,310370,"MYOCLONIC EPILEPSY, PROGRESSIVE",
7648,310400,"MYOPATHY, CENTRONUCLEAR, X-LINKED", CNMX
7649,310440,"MYOPATHY, X-LINKED, WITH EXCESSIVE AUTOPHAGY", MEAX
7650,310450,"MYOPATHY, MYOFIBRILLAR, 3",
7651,310460,"MYOPIA 1, X-LINKED", MYP1
7652,310465,N SYNDROME, NSX
7653,310468,"NEPHROLITHIASIS, X-LINKED RECESSIVE, WITH RENAL FAILURE", XRN
7654,310470,"NEUROPATHY, HEREDITARY SENSORY, X-LINKED",
7655,310490,"CHARCOT-MARIE-TOOTH DISEASE, X-LINKED RECESSIVE, 4, WITH OR WITHOUT CEREBELLAR ATAXIA", CMTX4
7656,310500,"NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1A", CSNB1A
7657,310600,NORRIE DISEASE, ND
7658,310650,NUCLEAR RIBONUCLEIC ACID, nRNA
7659,310700,"NYSTAGMUS 1, CONGENITAL, X-LINKED", NYS1
7660,310800,"NYSTAGMUS, MYOCLONIC",
7661,310900,"OCCIPITAL HAIR, WHITE LOCK OF",
7662,310980,"OMPHALOCELE, X-LINKED",
7663,310990,"HRAS PROTOONCOGENE, GTPase",
7664,311000,"OPHTHALMOPLEGIA, EXTERNAL, AND MYOPIA", OPEM
7665,311010,"ARAF PROTOONCOGENE, SERINE/THREONINE KINASE", ARAF
7666,311020,"ARAF PROTOONCOGENE, SERINE/THREONINE KINASE",
7667,311030,MCF.2 CELL LINE-DERIVED TRANSFORMING SEQUENCE, MCF2
7668,311040,"ELK1, MEMBER OF ETS ONCOGENE FAMILY", ELK1
7669,311050,OPTIC ATROPHY 2, OPA2
7670,311070,"CHARCOT-MARIE-TOOTH DISEASE, X-LINKED RECESSIVE, 5", CMTX5
7671,311100,OPTIC ATROPHY--SPASTIC PARAPLEGIA SYNDROME,
7672,311150,MOHR-TRANEBJAERG SYNDROME,
7673,311200,OROFACIODIGITAL SYNDROME I, OFD1
7674,311240,"TBC1 DOMAIN FAMILY, MEMBER 25", TBC1D25
7675,311241,GYRATE ATROPHY OF CHOROID AND RETINA,
7676,311250,"ORNITHINE TRANSCARBAMYLASE DEFICIENCY, HYPERAMMONEMIA DUE TO",
7677,311280,OSTEOPATHIA STRIATA WITH CRANIAL SCLEROSIS,
7678,311300,"OTOPALATODIGITAL SYNDROME, TYPE I", OPD1
7679,311350,OUABAIN RESISTANCE, OUBR
7680,311360,PREMATURE OVARIAN FAILURE 1, POF1
7681,311400,PAINE SYNDROME,
7682,311450,PALLISTER W SYNDROME,
7683,311510,WAISMAN SYNDROME, WSMN
7684,311550,CYCLIN-DEPENDENT KINASE 16, CDK16
7685,311601,PELIZAEUS-MERZBACHER DISEASE,
7686,311700,TITLE NOT AVAILABLE AT THIS MOMENT,
7687,311750,"PERIODONTITIS, AGGRESSIVE, 1",
7688,311770,PHOSPHATIDYLINOSITOL GLYCAN ANCHOR BIOSYNTHESIS CLASS A PROTEIN, PIGA
7689,311790,"6-PHOSPHOFRUCTO-2-KINASE/FRUCTOSE-2,6-BISPHOSPHATASE 1", PFKFB1
7690,311800,PHOSPHOGLYCERATE KINASE 1, PGK1
7691,311810,PHOSPHOGLYCERATE KINASE 1,
7692,311850,PHOSPHORIBOSYLPYROPHOSPHATE SYNTHETASE I, PRPS1
7693,311860,PHOSPHORIBOSYLPYROPHOSPHATE SYNTHETASE II, PRPS2
7694,311870,"PHOSPHORYLASE KINASE, MUSCLE, ALPHA-1 SUBUNIT", PHKA1
7695,311895,PIERRE ROBIN SEQUENCE WITH FACIAL AND DIGITAL ANOMALIES,
7696,311900,TARP SYNDROME, TARPS
7697,312000,"PANHYPOPITUITARISM, X-LINKED", PHPX
7698,312030,TITLE NOT AVAILABLE AT THIS MOMENT,
7699,312040,"DNA POLYMERASE ALPHA-1, CATALYTIC SUBUNIT", POLA1
7700,312060,"PROPERDIN DEFICIENCY, X-LINKED", CFPD
7701,312070,UBIQUITIN-LIKE 4A, UBL4A
7702,312080,PELIZAEUS-MERZBACHER DISEASE, PMD
7703,312090,SOLUTE CARRIER FAMILY 10 (SODIUM/BILE ACID COTRANSPORTER FAMILY) MEMBER 3, SLC10A3
7704,312095,A-KINASE ANCHOR PROTEIN 17A, AKAP17A
7705,312100,"ANDROGEN INSENSITIVITY, PARTIAL",
7706,312150,"MULTIPLE PTERYGIUM SYNDROME, X-LINKED",
7707,312170,PYRUVATE DEHYDROGENASE E1-ALPHA DEFICIENCY, PDHAD
7708,312173,RIBOSOMAL PROTEIN L10, RPL10
7709,312180,UBIQUITIN-CONJUGATING ENZYME E2 A, UBE2A
7710,312190,"RADIAL APLASIA, X-LINKED",
7711,312200,"RADIAL LOOP, PLAIN, ON RIGHT INDEX FINGER",
7712,312210,RADIATION SENSITIVITY OF NATURAL KILLER ACTIVITY,
7713,312300,"ANDROGEN INSENSITIVITY, PARTIAL", PAIS
7714,312390,TRANSCRIPTION FACTOR FOR IMMUNOGLOBULIN HEAVY-CHAIN ENHANCER 3,
7715,312400,PROXIMAL RENAL TUBULAR ACIDOSIS-OCULAR ANOMALY SYNDROME,
7716,312420,RENIN-BINDING PROTEIN, RENBP
7717,312450,"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 1",
7718,312500,"RETICULOENDOTHELIOSIS, X-LINKED",
7719,312530,TITLE NOT AVAILABLE AT THIS MOMENT,
7720,312550,"RETINAL DYSPLASIA, PRIMARY", PRD
7721,312600,RETINITIS PIGMENTOSA 2, RP2
7722,312610,RETINITIS PIGMENTOSA GTPase REGULATOR, RPGR
7723,312612,RETINITIS PIGMENTOSA 6, RP6
7724,312700,"RETINOSCHISIS 1, X-LINKED, JUVENILE", RS1
7725,312750,RETT SYNDROME, RTT
7726,312760,"RIBOSOMAL PROTEIN S4, X-LINKED", RPS4X
7727,312780,"RUSSELL-SILVER SYNDROME, X-LINKED",
7728,312800,SACRAL DEFECT WITH ANTERIOR MENINGOCELE,
7729,312820,"SARCOMA, SYNOVIAL, X BREAKPOINT 1", SSX1
7730,312830,SCARF SYNDROME,
7731,312840,SCHIMKE SYNDROME,
7732,312860,FILIPPI SYNDROME,
7733,312861,5-HYDROXYTRYPTAMINE RECEPTOR 2C, HTR2C
7734,312863,"COMBINED IMMUNODEFICIENCY, X-LINKED", CIDX
7735,312865,SHORT STATURE HOMEOBOX, SHOX
7736,312870,"SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 1", SGBS1
7737,312890,"SPASTIC PARAPLEGIA 2, X-LINKED",
7738,312900,MASA SYNDROME,
7739,312910,SPASTIC PARAPARESIS AND DEAFNESS,
7740,312920,"SPASTIC PARAPLEGIA 2, X-LINKED", SPG2
7741,313000,"SPATIAL VISUALIZATION, APTITUDE FOR",
7742,313020,SPERMIDINE/SPERMINE N1-ACETYLTRANSFERASE 1, SAT1
7743,313100,BROOKE-SPIEGLER SYNDROME,
7744,313200,"SPINAL AND BULBAR MUSCULAR ATROPHY, X-LINKED 1", SMAX1
7745,313350,SPLIT-HAND/FOOT MALFORMATION 2, SHFM2
7746,313400,"SPONDYLOEPIPHYSEAL DYSPLASIA TARDA, X-LINKED", SEDT
7747,313420,"SPONDYLOMETAPHYSEAL DYSPLASIA, X-LINKED", SMDXL
7748,313430,SRY-BOX 3, SOX3
7749,313440,SYNAPSIN I, SYN1
7750,313450,TITLE NOT AVAILABLE AT THIS MOMENT,
7751,313460,TITLE NOT AVAILABLE AT THIS MOMENT,
7752,313470,"CD99 ANTIGEN, X CHROMOSOME", CD99
7753,313475,SYNAPTOPHYSIN, SYP
7754,313480,TaqI POLYMORPHISM, TAQ1
7755,313490,"TAURODONTISM, MICRODONTIA, AND DENS INVAGINATUS", TMDI
7756,313500,"TOOTH AGENESIS, SELECTIVE, X-LINKED, 1", STHAGX1
7757,313550,TITLE NOT AVAILABLE AT THIS MOMENT,
7758,313650,"TAF1 RNA POLYMERASE II, TATA BOX-BINDING PROTEIN-ASSOCIATED FACTOR, 250-KD", TAF1
7759,313680,"CRIPTO, EGF-CFC FAMILY MEMBER",
7760,313700,ANDROGEN RECEPTOR, AR
7761,313850,THORACOABDOMINAL SYNDROME, THAS
7762,313900,THROMBOCYTOPENIA 1, THC1
7763,314000,THROMBOCYTOPENIA WITH ELEVATED SERUM IgA AND RENAL DISEASE,
7764,314050,"THROMBOCYTOPENIA WITH BETA-THALASSEMIA, X-LINKED", XLTT
7765,314100,"ADDUCTED THUMBS, CONGENITAL",
7766,314200,THYROXINE-BINDING GLOBULIN OF SERUM, TBG
7767,314240,TOOTH SIZE,
7768,314250,"DYSTONIA 3, TORSION, X-LINKED", DYT3
7769,314300,"TORTICOLLIS, KELOIDS, CRYPTORCHIDISM, AND RENAL DYSPLASIA", TKCR
7770,314310,TRANSCRIPTION FACTOR FOR IMMUNOGLOBULIN HEAVY-CHAIN ENHANCER 3, TFE3
7771,314320,TRIGONOCEPHALY WITH SHORT STATURE AND DEVELOPMENTAL DELAY,
7772,314350,TITLE NOT AVAILABLE AT THIS MOMENT,
7773,314360,ULNAR HYPOPLASIA WITH LOBSTER-CLAW DEFORMITY OF FEET,
7774,314370,UBIQUITIN-LIKE MODIFIER-ACTIVATING ENZYME 1, UBA1
7775,314375,"SOLUTE CARRIER FAMILY 35 (UDP-GALACTOSE TRANSPORTER), MEMBER 2", SLC35A2
7776,314380,UNIQUE GREEN PHENOMENON,
7777,314390,"VACTERL ASSOCIATION, X-LINKED, WITH OR WITHOUT HYDROCEPHALUS", VACTERLX
7778,314400,"CARDIAC VALVULAR DYSPLASIA, X-LINKED", CVDPX
7779,314500,VAN DEN BOSCH SYNDROME,
7780,314550,"VESICOURETERAL REFLUX, X-LINKED", VURX
7781,314555,VOLTAGE-DEPENDENT ANION CHANNEL 1,
7782,314560,"VON WILLEBRAND DISEASE, X-LINKED FORM",
7783,314570,WIDOW'S PEAK SYNDROME,
7784,314580,WIEACKER-WOLFF SYNDROME, WRWF
7785,314600,WILDERVANCK SYNDROME,
7786,314670,X INACTIVATION-SPECIFIC TRANSCRIPT, XIST
7787,314690,LYSINE DEMETHYLASE 5C, KDM5C
7788,314700,"BLOOD GROUP, XG SYSTEM", XG
7789,314705,XG REGULATOR, XGR
7790,314800,PA POLYMORPHISM OF ALPHA-2-GLOBULIN,
7791,314850,"KELL BLOOD GROUP PROTEIN, MCLEOD SYNDROME-ASSOCIATED", XK
7792,314900,XM SYSTEM,
7793,314920,TITLE NOT AVAILABLE AT THIS MOMENT,
7794,314940,TITLE NOT AVAILABLE AT THIS MOMENT,
7795,314960,TITLE NOT AVAILABLE AT THIS MOMENT,
7796,314980,"ZINC FINGER PROTEIN, X-LINKED", ZFX
7797,314990,ZINC FINGER PROTEIN 711, ZNF711
7798,314993,ZINC FINGER PROTEIN 182, ZNF182
7799,314995,ZINC FINGER PROTEIN 41, ZNF41
7800,314997,ZINC FINGER PROTEIN 75D, ZNF75D
7801,314998,ZINC FINGER PROTEIN 81, ZNF81
7802,315000,CATARACT 40,
7803,400000,TITLE NOT AVAILABLE AT THIS MOMENT,
7804,400001,LYSINE DEMETHYLASE 5D,
7805,400002,"BLOOD GROUP, XG SYSTEM",
7806,400003,DELETED IN AZOOSPERMIA 1, DAZ1
7807,400004,"RETINITIS PIGMENTOSA, Y-LINKED", RPY
7808,400005,"UBIQUITIN-SPECIFIC PROTEASE 9, Y CHROMOSOME", USP9Y
7809,400006,"RNA-BINDING MOTIF PROTEIN, Y CHROMOSOME, FAMILY 1, MEMBER A1", RBMY1A1
7810,400007,"RNA-BINDING MOTIF PROTEIN, Y CHROMOSOME, FAMILY 1, MEMBER A1",
7811,400008,"PROTEIN KINASE, Y-LINKED", PRKY
7812,400009,UBIQUITOUSLY TRANSCRIBED TETRATRICOPEPTIDE REPEAT GENE ON Y CHROMOSOME, UTY
7813,400010,"DEAD-BOX HELICASE 3, Y-LINKED", DDX3Y
7814,400011,"ACETYLSEROTONIN METHYLTRANSFERASE-LIKE, Y-LINKED",
7815,400012,"VARIABLY CHARGED, Y CHROMOSOME", VCY
7816,400013,"BASIC PROTEIN, Y CHROMOSOME, 2", BPY2
7817,400014,"EUKARYOTIC TRANSLATION INITIATION FACTOR 1A, Y-LINKED", EIF1AY
7818,400015,XK-RELATED PROTEIN ON Y CHROMOSOME,
7819,400016,"CHROMODOMAIN PROTEIN, Y-LINKED, 1", CDY1
7820,400017,"THYMOSIN, BETA-4, Y CHROMOSOME", TMSB4Y
7821,400018,"CHROMODOMAIN PROTEIN, Y-LINKED, 2A", CDY2A
7822,400019,PTPBL-RELATED GENE ON Y, PRY
7823,400020,"SHORT STATURE HOMEOBOX, Y-LINKED", SHOXY
7824,400021,"LYMPHOMA, HODGKIN, Y-LINKED PSEUDOAUTOSOMAL",
7825,400022,"PROTOCADHERIN 11, Y-LINKED", PCDH11Y
7826,400023,"CYTOKINE RECEPTOR-LIKE FACTOR 2, Y-LINKED", CRLF2Y
7827,400024,"SPERMATOGENIC FAILURE, Y-LINKED, 2",
7828,400025,"TRANSFORMING GROWTH FACTOR-BETA-INDUCED FACTOR 2-LIKE, Y-LINKED", TGIF2LY
7829,400026,DELETED IN AZOOSPERMIA 2, DAZ2
7830,400027,DELETED IN AZOOSPERMIA 3, DAZ3
7831,400028,"NEUROLIGIN 4, Y-LINKED", NLGN4Y
7832,400029,"HEAT-SHOCK TRANSCRIPTION FACTOR, Y-LINKED", HSFY
7833,400030,"RIBOSOMAL PROTEIN S4, Y-LINKED, 2", RPS4Y2
7834,400031,"TAXILIN, GAMMA, Y-LINKED, PSEUDOGENE", TXLNGY
7835,400032,"TAXILIN, GAMMA, Y-LINKED, PSEUDOGENE",
7836,400033,"TRANSDUCIN-BETA-LIKE 1, Y-LINKED", TBL1Y
7837,400034,"CHONDROITIN SULFATE PROTEOGLYCAN 4 PSEUDOGENE 1, Y-LINKED", CSPG4P1Y
7838,400035,"GOLGA2 PSEUDOGENE 2, Y-LINKED", GOLGA2P2Y
7839,400036,"TESTIS-SPECIFIC TRANSCRIPT, Y-LINKED, 3", TTTY3
7840,400037,"TESTIS-SPECIFIC TRANSCRIPT, Y-LINKED, 4", TTTY4
7841,400038,"TESTIS-SPECIFIC TRANSCRIPT, Y-LINKED, 5", TTTY5
7842,400039,"TESTIS-SPECIFIC TRANSCRIPT, Y-LINKED, 6", TTTY6
7843,400040,"TESTIS-SPECIFIC TRANSCRIPT, Y-LINKED, 17", TTTY17
7844,400041,"PTPBL-RELATED GENE ON Y, 2", PRY2
7845,400042,"SPERMATOGENIC FAILURE, Y-LINKED, 1", SPGFY1
7846,400043,"DEAFNESS, Y-LINKED 1", DFNY1
7847,400044,"46,XY SEX REVERSAL 1", SRXY1
7848,400045,"46,XX SEX REVERSAL 1", SRXX1
7849,400046,"PHOSPHOLIPASE C, PHOSPHATIDYLINOSITOL-SPECIFIC, X DOMAIN-CONTAINING PROTEIN 1, Y-LINKED",
7850,400047,"DEAFNESS, Y-LINKED 2", DFNY2
7851,400048,DELETED IN AZOOSPERMIA 4, DAZ4
7852,400049,"DEHYDROGENASE/REDUCTASE, Y-LINKED", DHRSY
7853,400050,"VARIABLY CHARGED, Y CHROMOSOME, 1B", VCY1B
7854,402500,"ACETYLSEROTONIN METHYLTRANSFERASE, Y-CHROMOSOMAL", ASMT
7855,403000,"SOLUTE CARRIER FAMILY 25 (MITOCHONDRIAL CARRIER, ADENINE NUCLEOTIDE TRANSLOCATOR), MEMBER A6, Y-CHROMOSOMAL", SLC25A6
7856,410000,"AMELOGENIN, Y-CHROMOSOMAL", AMELY
7857,415000,"SPERMATOGENIC FAILURE, Y-LINKED, 2", SPGFY2
7858,424000,TITLE NOT AVAILABLE AT THIS MOMENT,
7859,424500,GONADOBLASTOMA, GBY
7860,425000,"GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR RECEPTOR, ALPHA SUBUNIT, Y-CHROMOSOMAL", CSF2RY
7861,425500,"HAIRY EARS, Y-LINKED",
7862,426000,LYSINE DEMETHYLASE 5D, KDM5D
7863,430000,"INTERLEUKIN 3 RECEPTOR, Y-CHROMOSOMAL", IL3RA
7864,450000,"CD99 ANTIGEN, Y CHROMOSOME",
7865,465000,"A-KINASE ANCHOR PROTEIN 17A, Y-CHROMOSOMAL", AKAP17A
7866,470000,"RIBOSOMAL PROTEIN S4, Y-LINKED, 1", RPS4Y1
7867,475000,"GROWTH CONTROL, Y-CHROMOSOME INFLUENCED", GCY
7868,480000,SEX-DETERMINING REGION Y, SRY
7869,480100,"TESTIS-SPECIFIC PROTEIN, Y-LINKED, 1", TSPY1
7870,488000,"GROWTH CONTROL, Y-CHROMOSOME INFLUENCED",
7871,489000,"UBIQUITIN-ACTIVATING ENZYME, Y-LINKED",
7872,489500,XG REGULATOR, XGR
7873,490000,"ZINC FINGER PROTEIN, Y-LINKED", ZFY
7874,500000,"CARDIOMYOPATHY, INFANTILE HISTIOCYTOID",
7875,500001,LEBER OPTIC ATROPHY AND DYSTONIA,
7876,500002,MITOCHONDRIAL MYOPATHY WITH DIABETES,
7877,500003,"STRIATONIGRAL DEGENERATION, INFANTILE, MITOCHONDRIAL",
7878,500004,RETINITIS PIGMENTOSA-DEAFNESS SYNDROME,
7879,500005,"HYPOMAGNESEMIA, HYPERTENSION, AND HYPERCHOLESTEROLEMIA, MITOCHONDRIAL",
7880,500006,"CARDIOMYOPATHY, INFANTILE HYPERTROPHIC",
7881,500007,CYCLIC VOMITING SYNDROME, CVS
7882,500008,"DEAFNESS, NONSYNDROMIC SENSORINEURAL, MITOCHONDRIAL",
7883,500009,"MITOCHONDRIAL MYOPATHY, INFANTILE, TRANSIENT", MMIT
7884,500010,"ATAXIA AND POLYNEUROPATHY, ADULT-ONSET",
7885,500011,"MYOPATHY, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA 3", MLASA3
7886,500013,"CHARCOT-MARIE-TOOTH DISEASE, AXONAL, MITOCHONDRIAL", CMTMA
7887,500014,"MITOCHONDRIAL COMPLEX I DEFICIENCY, MITOCHONDRIAL TYPE 1", MC1DM1
7888,500015,"MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, MITOCHONDRIAL TYPE 1", MC5DM1
7889,500017,"LEIGH SYNDROME, MITOCHONDRIAL", MILS
7890,500018,"SPASTIC PARAPLEGIA, MITOCHONDRIAL", SPGM
7891,502000,AGING,
7892,502500,"ALZHEIMER DISEASE, SUSCEPTIBILITY TO, MITOCHONDRIAL",
7893,510000,TITLE NOT AVAILABLE AT THIS MOMENT,
7894,515000,CHLORAMPHENICOL TOXICITY,
7895,516000,"COMPLEX I, SUBUNIT ND1", MTND1
7896,516001,"COMPLEX I, SUBUNIT ND2", MTND2
7897,516002,"COMPLEX I, SUBUNIT ND3", MTND3
7898,516003,"COMPLEX I, SUBUNIT ND4", MTND4
7899,516004,"COMPLEX I, SUBUNIT ND4L", MTND4L
7900,516005,"COMPLEX I, SUBUNIT ND5", MTND5
7901,516006,"COMPLEX I, SUBUNIT ND6", MTND6
7902,516020,CYTOCHROME b OF COMPLEX III, MTCYB
7903,516030,"COMPLEX IV, CYTOCHROME c OXIDASE SUBUNIT I", MTCO1
7904,516040,"COMPLEX IV, CYTOCHROME c OXIDASE SUBUNIT II", MTCO2
7905,516050,CYTOCHROME c OXIDASE III, MTCO3
7906,516060,ATP SYNTHASE 6, MTATP6
7907,516070,ATP SYNTHASE 8, MTATP8
7908,520000,"DIABETES AND DEAFNESS, MATERNALLY INHERITED", MIDD
7909,520100,"DIARRHEA, CHRONIC, WITH VILLOUS ATROPHY",
7910,530000,KEARNS-SAYRE SYNDROME, KSS
7911,535000,LEBER OPTIC ATROPHY,
7912,540000,"MITOCHONDRIAL MYOPATHY, ENCEPHALOPATHY, LACTIC ACIDOSIS, AND STROKE-LIKE EPISODES", MELAS
7913,545000,MYOCLONIC EPILEPSY ASSOCIATED WITH RAGGED-RED FIBERS, MERRF
7914,550000,"PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 1",
7915,550500,"MYOGLOBINURIA, RECURRENT",
7916,550900,MITOCHONDRIAL DNA DEPLETION SYNDROME 1 (MNGIE TYPE),
7917,551000,"MITOCHONDRIAL MYOPATHY, LETHAL, INFANTILE", LIMM
7918,551200,"NEPHROPATHY, CHRONIC TUBULOINTERSTITIAL",
7919,551500,"NEUROPATHY, ATAXIA, AND RETINITIS PIGMENTOSA",
7920,553000,ONCOCYTOMA,
7921,555000,"GAZE PALSY, FAMILIAL HORIZONTAL, WITH PROGRESSIVE SCOLIOSIS 1",
7922,556500,"PARKINSON DISEASE, MITOCHONDRIAL",
7923,557000,PEARSON MARROW-PANCREAS SYNDROME,
7924,560000,"RENAL TUBULOPATHY, DIABETES MELLITUS, AND CEREBELLAR ATAXIA",
7925,561000,"RIBOSOMAL RNA, MITOCHONDRIAL, 12S", MTRNR1
7926,561010,"RIBOSOMAL RNA, MITOCHONDRIAL, 16S", MTRNR2
7927,580000,"DEAFNESS, AMINOGLYCOSIDE-INDUCED",
7928,590000,"TRANSFER RNA, MITOCHONDRIAL, ALANINE", MTTA
7929,590005,"TRANSFER RNA, MITOCHONDRIAL, ARGININE", MTTR
7930,590010,"TRANSFER RNA, MITOCHONDRIAL, ASPARAGINE", MTTN
7931,590015,"TRANSFER RNA, MITOCHONDRIAL, ASPARTIC ACID", MTTD
7932,590020,"TRANSFER RNA, MITOCHONDRIAL, CYSTEINE", MTTC
7933,590025,"TRANSFER RNA, MITOCHONDRIAL, GLUTAMIC ACID", MTTE
7934,590030,"TRANSFER RNA, MITOCHONDRIAL, GLUTAMINE", MTTQ
7935,590035,"TRANSFER RNA, MITOCHONDRIAL, GLYCINE", MTTG
7936,590040,"TRANSFER RNA, MITOCHONDRIAL, HISTIDINE", MTTH
7937,590045,"TRANSFER RNA, MITOCHONDRIAL, ISOLEUCINE", MTTI
7938,590050,"TRANSFER RNA, MITOCHONDRIAL, LEUCINE, 1", MTTL1
7939,590055,"TRANSFER RNA, MITOCHONDRIAL, LEUCINE, 2", MTTL2
7940,590060,"TRANSFER RNA, MITOCHONDRIAL, LYSINE", MTTK
7941,590065,"TRANSFER RNA, MITOCHONDRIAL, METHIONINE", MTTM
7942,590070,"TRANSFER RNA, MITOCHONDRIAL, PHENYLALANINE", MTTF
7943,590075,"TRANSFER RNA, MITOCHONDRIAL, PROLINE", MTTP
7944,590080,"TRANSFER RNA, MITOCHONDRIAL, SERINE, 1", MTTS1
7945,590085,"TRANSFER RNA, MITOCHONDRIAL, SERINE, 2", MTTS2
7946,590090,"TRANSFER RNA, MITOCHONDRIAL, THREONINE", MTTT
7947,590095,"TRANSFER RNA, MITOCHONDRIAL, TRYPTOPHAN", MTTW
7948,590100,"TRANSFER RNA, MITOCHONDRIAL, TYROSINE", MTTY
7949,590105,"TRANSFER RNA, MITOCHONDRIAL, VALINE", MTTV
7950,598500,"WOLFRAM SYNDROME, MITOCHONDRIAL FORM",
7951,600000,SPONDYLOCAMPTODACTYLY,
7952,600001,"HEART DEFECTS, CONGENITAL, AND OTHER CONGENITAL ANOMALIES", HDCA
7953,600002,EIKEN SYNDROME, EKNS
7954,600003,"CALCIUM CHANNEL, VOLTAGE-DEPENDENT, BETA-2 SUBUNIT", CACNB2
7955,600004,EPHRIN RECEPTOR EphA5, EPHA5
7956,600005,CLASS II MAJOR HISTOCOMPATIBILITY COMPLEX TRANSACTIVATOR, CIITA
7957,600006,"REGULATORY FACTOR X, 1", RFX1
7958,600007,FMS-RELATED TYROSINE KINASE 3 LIGAND, FLT3LG
7959,600008,NICOTINAMIDE N-METHYLTRANSFERASE, NNMT
7960,600009,INTERFERON-ALPHA-INDUCIBLE PROTEIN 27, IFI27
7961,600010,INSULINOMA-ASSOCIATED 1, INSM1
7962,600011,EPHRIN RECEPTOR EphB4, EPHB4
7963,600012,"UBIQUITIN-CONJUGATING ENZYME E2 L1, PSEUDOGENE", UBE2L1
7964,600013,TRANSCRIPTION FACTOR YY1, YY1
7965,600014,"SWI/SNF-RELATED, MATRIX-ASSOCIATED, ACTIN-DEPENDENT REGULATOR OF CHROMATIN, SUBFAMILY A, MEMBER 2", SMARCA2
7966,600015,"ANGIOTENSIN II RECEPTOR, TYPE 1",
7967,600016,CONTACTIN 1, CNTN1
7968,600017,SYNDECAN 4, SDC4
7969,600018,"OPIOID RECEPTOR, MU-1", OPRM1
7970,600019,CYTOCHROME b561, CYB561
7971,600020,MAX-INTERACTING PROTEIN 1, MXI1
7972,600021,MAX DIMERIZATION PROTEIN 1, MXD1
7973,600022,PROSTAGLANDIN I2 RECEPTOR, PTGIR
7974,600023,CADHERIN 11, CDH11
7975,600024,LAMIN B RECEPTOR, LBR
7976,600025,KINESIN LIGHT CHAIN 1, KLC1
7977,600026,"SYNTROPHIN, BETA-1", SNTB1
7978,600027,"SYNTROPHIN, BETA-2", SNTB2
7979,600028,DISTAL-LESS HOMEOBOX 5, DLX5
7980,600029,DISTAL-LESS HOMEOBOX 1, DLX1
7981,600030,DISTAL-LESS HOMEOBOX 6, DLX6
7982,600031,CHITINASE 1, CHIT1
7983,600032,SOMATOSTATIN RECEPTOR 5,
7984,600033,TISSUE FACTOR PATHWAY INHIBITOR 2, TFPI2
7985,600034,EMPTY SPIRACLES HOMEOBOX 1, EMX1
7986,600035,EMPTY SPIRACLES HOMEOBOX 2, EMX2
7987,600036,ORTHODENTICLE HOMEOBOX 1, OTX1
7988,600037,ORTHODENTICLE HOMEOBOX 2, OTX2
7989,600038,MEGAKARYOCYTE-ASSOCIATED TYROSINE KINASE, MATK
7990,600039,BCL2-LIKE 1, BCL2L1
7991,600040,BCL2-ASSOCIATED X PROTEIN, BAX
7992,600041,"PURINERGIC RECEPTOR P2Y, G PROTEIN-COUPLED, 2", P2RY2
7993,600042,MELANOCORTIN 5 RECEPTOR, MC5R
7994,600043,"SULFOTRANSFERASE FAMILY 1E, ESTROGEN-PREFERRING, MEMBER 1", SULT1E1
7995,600044,THROMBOPOIETIN, THPO
7996,600045,DNA DAMAGE-BINDING PROTEIN 1, DDB1
7997,600046,"ATP-BINDING CASSETTE, SUBFAMILY A, MEMBER 1", ABCA1
7998,600047,"ATP-BINDING CASSETTE, SUBFAMILY A, MEMBER 2", ABCA2
7999,600048,BREAST CANCER,
8000,600049,MDS1 GENE, MDS1
8001,600050,MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 11, MAP3K11
8002,600051,EPIDERMAL GROWTH FACTOR RECEPTOR PATHWAY SUBSTRATE 15, EPS15
8003,600052,APELIN RECEPTOR, APLNR
8004,600053,"CYCLIC NUCLEOTIDE-GATED CHANNEL, ALPHA-3", CNGA3
8005,600054,"CYCLIC NUCLEOTIDE-GATED CHANNEL, ALPHA-2",
8006,600055,LYSINE DEMETHYLASE 5D,
8007,600056,LYSINE DEMETHYLASE 5C,
8008,600057,BLADDER EXSTROPHY AND EPISPADIAS COMPLEX, BEEC
8009,600058,PROTEIN TYROSINE KINASE TXK, TXK
8010,600059,RETINITIS PIGMENTOSA 13, RP13
8011,600060,"DEAFNESS, AUTOSOMAL RECESSIVE 2", DFNB2
8012,600061,"RAD23 HOMOLOG A, NUCLEOTIDE EXCISION REPAIR PROTEIN", RAD23A
8013,600062,"RAD23 HOMOLOG B, NUCLEOTIDE EXCISION REPAIR PROTEIN", RAD23B
8014,600063,"TROVE DOMAIN FAMILY, MEMBER 2", TROVE2
8015,600064,KERATIN-ASSOCIATED PROTEIN 11-1, KRTAP11-1
8016,600065,"INTEGRIN, BETA-2", ITGB2
8017,600066,EPHRIN RECEPTOR EphA6, EPHA6
8018,600067,"URIDINE DIPHOSPHATE GLYCOSYLTRANSFERASE 2 FAMILY, MEMBER B4", UGT2B4
8019,600068,"URIDINE DIPHOSPHATE GLYCOSYLTRANSFERASE 2 FAMILY, MEMBER B7", UGT2B7
8020,600069,"URIDINE DIPHOSPHATE GLYCOSYLTRANSFERASE 2 FAMILY, MEMBER B15", UGT2B15
8021,600070,"URIDINE DIPHOSPHATE GLYCOSYLTRANSFERASE 2 FAMILY, MEMBER B10", UGT2B10
8022,600071,"URIDINE DIPHOSPHATE GLYCOSYLTRANSFERASE 2 FAMILY, MEMBER B4",
8023,600072,FATAL FAMILIAL INSOMNIA, FFI
8024,600073,LOW DENSITY LIPOPROTEIN RECEPTOR-RELATED PROTEIN 2, LRP2
8025,600074,CD24 ANTIGEN, CD24
8026,600075,TATA BOX-BINDING PROTEIN, TBP
8027,600076,TENSIN 1, TNS1
8028,600077,SCHOPF-SCHULZ-PASSARGE SYNDROME,
8029,600078,"SWI/SNF-RELATED, MATRIX-ASSOCIATED, ACTIN-DEPENDENT REGULATOR OF CHROMATIN, SUBFAMILY A, MEMBER 1",
8030,600079,"PROTEIN-TYROSINE PHOSPHATASE, NONRECEPTOR-TYPE, 12", PTPN12
8031,600080,"MYELOCYTIC LEUKEMIA-LIKE SYNDROME, FAMILIAL, CHRONIC",
8032,600081,"VITAMIN D HYDROXYLATION-DEFICIENT RICKETS, TYPE 1B", VDDR1B
8033,600082,"PROSTATIC HYPERPLASIA, BENIGN", BPH
8034,600083,GLUTAMATE DEHYDROGENASE 2,
8035,600084,"MACROCYTOSIS, FAMILIAL",
8036,600085,PROTEIN-TYROSINE KINASE SYK, SYK
8037,600086,ALCOHOL DEHYDROGENASE 7, ADH7
8038,600087,TUFTELIN, TUFT1
8039,600088,DYSTONIN,
8040,600089,PANCREATIC BETA CELL AGENESIS WITH NEONATAL DIABETES MELLITUS,
8041,600090,"N-ALPHA-ACETYLTRANSFERASE 10, NatA CATALYTIC SUBUNIT",
8042,600091,"SPINAL MUSCULAR ATROPHY, LOWER EXTREMITY-PREDOMINANT, 1, AUTOSOMAL DOMINANT",
8043,600092,NIVELON-NIVELON-MABILLE SYNDROME, NNMS
8044,600093,SPONDYLOEPIPHYSEAL DYSPLASIA TARDA WITH CHARACTERISTIC FACIES,
8045,600094,"SOLUTE CARRIER FAMILY 16 (MONOCARBOXYLIC ACID TRANSPORTER), MEMBER 2",
8046,600095,SPLIT-HAND/FOOT MALFORMATION 3,
8047,600096,PUERTO RICAN INFANT HYPOTONIA SYNDROME,
8048,600097,"SPONDYLOEPIMETAPHYSEAL DYSPLASIA, X-LINKED",
8049,600098,RELATED RAS VIRAL ONCOGENE HOMOLOG 2, RRAS2
8050,600099,LEUKOTRIENE C4 SYNTHASE,
8051,600100,"PROTEIN PHOSPHATASE 1, REGULATORY SUBUNIT 2",
8052,600101,"DEAFNESS, AUTOSOMAL DOMINANT 2A", DFNA2A
8053,600102,"LISSENCEPHALY, X-LINKED, 1",
8054,600103,SYNAPTOTAGMIN 4, SYT4
8055,600104,SYNAPTOTAGMIN 2, SYT2
8056,600105,RETINITIS PIGMENTOSA 12, RP12
8057,600106,"INOSITOL POLYPHOSPHATE-5-PHOSPHATASE, 40-KD", INPP5A
8058,600107,"ATPase, Ca(2+)-TRANSPORTING, PLASMA MEMBRANE, 3",
8059,600108,MATRIX METALLOPROTEINASE 13, MMP13
8060,600109,MYOTONIC DYSTROPHY 2,
8061,600110,STARGARDT DISEASE 3, STGD3
8062,600111,"SOLUTE CARRIER FAMILY 1 (GLIAL HIGH AFFINITY GLUTAMATE TRANSPORTER), MEMBER 3", SLC1A3
8063,600112,"DYNEIN, CYTOPLASMIC 1, HEAVY CHAIN 1", DYNC1H1
8064,600113,METHYL-CpG-BINDING PROTEIN 2,
8065,600114,"CHAPERONIN CONTAINING T-COMPLEX POLYPEPTIDE 1, SUBUNIT 3", CCT3
8066,600115,NUCLEAR FACTOR ERYTHROID 2-LIKE 1,
8067,600116,"PARKINSON DISEASE 2, AUTOSOMAL RECESSIVE JUVENILE", PARK2
8068,600117,"DYSPHASIA, FAMILIAL DEVELOPMENTAL",
8069,600118,WARBURG MICRO SYNDROME 1, WARBM1
8070,600119,"SARCOGLYCAN, ALPHA", SGCA
8071,600120,"SYNDACTYLY, TYPE III",
8072,600121,"RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 3", RCDP3
8073,600122,VERLOES SYNDROME,
8074,600123,ATRIOVENTRICULAR SEPTAL DEFECT WITH BLEPHAROPHIMOSIS AND ANAL AND RADIAL DEFECTS,
8075,600124,HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN A2/B1, HNRNPA2B1
8076,600125,"CYTOCHROME P450, FAMILY 24, SUBFAMILY A, POLYPEPTIDE 1",
8077,600126,PHOSPHODIESTERASE 4A, PDE4A
8078,600127,PHOSPHODIESTERASE 4B, PDE4B
8079,600128,PHOSPHODIESTERASE 4C, PDE4C
8080,600129,PHOSPHODIESTERASE 4D, PDE4D
8081,600130,"APOLIPOPROTEIN B mRNA-EDITING ENZYME, CATALYTIC POLYPEPTIDE 1", APOBEC1
8082,600131,"EPILEPSY, CHILDHOOD ABSENCE, SUSCEPTIBILITY TO, 1", ECA1
8083,600132,RETINITIS PIGMENTOSA 14, RP14
8084,600133,"LAMININ, ALPHA-4", LAMA4
8085,600134,PEROXIDASIN,
8086,600135,CORTEXIN 1, CTXN1
8087,600136,MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 9, MAP3K9
8088,600137,MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 10, MAP3K10
8089,600138,RETINITIS PIGMENTOSA 11, RP11
8090,600139,GLIOMA SUSCEPTIBILITY 1,
8091,600140,CREB-BINDING PROTEIN, CREBBP
8092,600141,HEAT-SHOCK 10-KD PROTEIN, HSPE1
8093,600142,"CEREBRAL ARTERIOPATHY, AUTOSOMAL RECESSIVE, WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY", CARASIL
8094,600143,"CEROID LIPOFUSCINOSIS, NEURONAL, 8", CLN8
8095,600144,"INOSITOL 1,4,5-TRIPHOSPHATE RECEPTOR, TYPE 2", ITPR2
8096,600145,SACRAL DEFECT WITH ANTERIOR MENINGOCELE,
8097,600146,"SPASTIC PARAPLEGIA 5A, AUTOSOMAL RECESSIVE",
8098,600147,MESENCHYME HOMEOBOX 1, MEOX1
8099,600148,GLYCEROL KINASE 2, GK2
8100,600149,GLYCEROL KINASE 3 PSEUDOGENE, GK3P
8101,600150,"POTASSIUM CHANNEL, CALCIUM-ACTIVATED, LARGE CONDUCTANCE, SUBFAMILY M, ALPHA MEMBER 1", KCNMA1
8102,600151,BARDET-BIEDL SYNDROME 3, BBS3
8103,600152,"SEC13 HOMOLOG, NUCLEAR PORE AND COPII COAT COMPLEX COMPONENT", SEC13
8104,600153,PHOSPHATIDYLINOSITOL GLYCAN ANCHOR BIOSYNTHESIS CLASS F PROTEIN, PIGF
8105,600154,PHOSPHATIDYLINOSITOL GLYCAN ANCHOR BIOSYNTHESIS CLASS H PROTEIN, PIGH
8106,600155,"HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 2", HSCR2
8107,600156,"HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 5", HSCR5
8108,600157,"ADAPTOR-RELATED PROTEIN COMPLEX 1, BETA-1 SUBUNIT", AP1B1
8109,600158,PSEUDO-TORCH SYNDROME 1,
8110,600159,PTERYGIUM COLLI AND IMPAIRED INTELLECTUAL DEVELOPMENT WITH FACIAL AND DIGITAL ANOMALIES,
8111,600160,CYCLIN-DEPENDENT KINASE INHIBITOR 2A, CDKN2A
8112,600161,PRADER-WILLI/ANGELMAN REGION RNA 1, PWAR1
8113,600162,PRADER-WILLI/ANGELMAN REGION RNA 5, PWAR5
8114,600163,"SODIUM VOLTAGE-GATED CHANNEL, ALPHA SUBUNIT 5", SCN5A
8115,600164,GTP-BINDING MITOGEN-INDUCED T-CELL PROTEIN, GEM
8116,600165,NANOPHTHALMOS 1, NNO1
8117,600166,"HYPERPARATHYROIDISM, PRIMARY, CAUSED BY WATER CLEAR CELL HYPERPLASIA",
8118,600167,HISTAMINE RECEPTOR H1, HRH1
8119,600168,MACROPHAGE STIMULATING 1 RECEPTOR, MST1R
8120,600169,MAJOR HISTOCOMPATIBILITY COMPLEX CLASS I CHAIN-RELATED GENE A, MICA
8121,600170,AQUAPORIN 3, AQP3
8122,600171,GONADAL AGENESIS,
8123,600172,METAL-REGULATORY TRANSCRIPTION FACTOR 1, MTF1
8124,600173,JANUS KINASE 3, JAK3
8125,600174,"PHOSPHATIDYLINOSITOL TRANSFER PROTEIN, ALPHA", PITPNA
8126,600175,"NEURONOPATHY, DISTAL HEREDITARY MOTOR, AUTOSOMAL DOMINANT 8", HMND8
8127,600176,"PACHYGYRIA WITH IMPAIRED INTELLECTUAL DEVELOPMENT, SEIZURES, AND ARACHNOID CYSTS",
8128,600177,PATATIN-LIKE PHOSPHOLIPASE DOMAIN-CONTAINING PROTEIN 4,
8129,600178,MICROTUBULE-ASSOCIATED PROTEIN 1A, MAP1A
8130,600179,"GUANYLATE CYCLASE 2D, RETINAL", GUCY2D
8131,600180,GROWTH FACTOR RECEPTOR-BOUND PROTEIN 2,
8132,600181,LIPOCALIN 2, LCN2
8133,600182,"SOLUTE CARRIER FAMILY 7 (CATIONIC AMINO ACID TRANSPORTER, y+ SYSTEM), MEMBER 5", SLC7A5
8134,600183,DUAL-SPECIFICITY PHOSPHATASE 3, DUSP3
8135,600184,CARNITINE ACETYLTRANSFERASE, CRAT
8136,600185,BRCA2 DNA REPAIR-ASSOCIATED PROTEIN, BRCA2
8137,600186,"MELANOMA ANTIGEN, FAMILY A, 1",
8138,600187,EUKARYOTIC TRANSLATION INITIATION FACTOR 5A, EIF5A
8139,600188,"TLE FAMILY MEMBER 5, TRANSCRIPTIONAL MODULATOR", TLE5
8140,600189,"TLE FAMILY MEMBER 1, TRANSCRIPTIONAL COREPRESSOR", TLE1
8141,600190,"TLE FAMILY MEMBER 3, TRANSCRIPTIONAL COREPRESSOR", TLE3
8142,600191,"46,XY SEX REVERSAL 2",
8143,600192,SS18 SUBUNIT OF BAF CHROMATIN REMODELING COMPLEX, SS18
8144,600193,"WAARDENBURG SYNDROME, TYPE 2B", WS2B
8145,600194,"KERATIN 2, TYPE II", KRT2
8146,600195,"VENOUS MALFORMATIONS, MULTIPLE CUTANEOUS AND MUCOSAL", VMCM
8147,600196,HOST CELL FACTOR C1,
8148,600197,MAF bZIP TRANSCRIPTION FACTOR K, MAFK
8149,600198,NUCLEAR FACTOR ERYTHROID 2-LIKE 1,
8150,600199,"SPINAL MUSCULAR ATROPHY, X-LINKED 2",
8151,600200,EUKARYOTIC TRANSLATION INITIATION FACTOR 4E,
8152,600201,AGOUTI SIGNALING PROTEIN, ASIP
8153,600202,"DYSLEXIA, SUSCEPTIBILITY TO, 2", DYX2
8154,600203,"DEAFNESS, X-LINKED 3",
8155,600204,"EPIPHYSEAL DYSPLASIA, MULTIPLE, 2", EDM2
8156,600205,APEX NUCLEASE 1,
8157,600206,EPIDERMAL GROWTH FACTOR RECEPTOR PATHWAY SUBSTRATE 8, EPS8
8158,600207,HIPPOCALCIN-LIKE 1, HPCAL1
8159,600208,MACROTHROMBOCYTOPENIA AND GRANULOCYTE INCLUSIONS WITH OR WITHOUT NEPHRITIS OR SENSORINEURAL HEARING LOSS,
8160,600209,"EXOSTOSES, MULTIPLE, TYPE III", EXT3
8161,600210,RUNT-RELATED TRANSCRIPTION FACTOR 3, RUNX3
8162,600211,RUNT-RELATED TRANSCRIPTION FACTOR 2, RUNX2
8163,600212,FATTY ACID SYNTHASE, FASN
8164,600213,PRE-B-CELL LEUKEMIA TRANSCRIPTION FACTOR 1,
8165,600214,ADVANCED GLYCOSYLATION END PRODUCT-SPECIFIC RECEPTOR, AGER
8166,600215,MICROFIBRILLAR-ASSOCIATED PROTEIN 1, MFAP1
8167,600216,"BLOOD GROUP, XG SYSTEM",
8168,600217,"PLATELET-ACTIVATING FACTOR ACETYLHYDROLASE, ISOFORM 1B, ALPHA SUBUNIT",
8169,600218,"URIDINE DIPHOSPHATE GLYCOSYLTRANSFERASE 2 FAMILY, MEMBER B7",
8170,600219,"URIDINE DIPHOSPHATE GLYCOSYLTRANSFERASE 2 FAMILY, MEMBER B15",
8171,600220,"PHOSPHOLIPASE C, GAMMA-2", PLCG2
8172,600221,"TEK TYROSINE KINASE, ENDOTHELIAL", TEK
8173,600222,TYROSINE KINASE WITH IMMUNOGLOBULIN AND EGF FACTOR HOMOLOGY DOMAINS 1, TIE1
8174,600223,SPINOCEREBELLAR ATAXIA 4, SCA4
8175,600224,SPINOCEREBELLAR ATAXIA 5, SCA5
8176,600225,GTP CYCLOHYDROLASE I, GCH1
8177,600226,"FAMILY WITH SEQUENCE SIMILARITY 11, MEMBER A",
8178,600227,CYCLIN F, CCNF
8179,600228,"SODIUM CHANNEL, EPITHELIAL 1, ALPHA SUBUNIT", SCNN1A
8180,600229,"SOLUTE CARRIER FAMILY 1 (GLUTAMATE/NEUTRAL AMINO ACID TRANSPORTER), MEMBER 4", SLC1A4
8181,600230,"PHOSPHOLIPASE C, BETA-3", PLCB3
8182,600231,"PALMOPLANTAR KERATODERMA, BOTHNIAN TYPE", PPKB
8183,600232,"GAMMA-AMINOBUTYRIC ACID RECEPTOR, BETA-2", GABRB2
8184,600233,"GAMMA-AMINOBUTYRIC ACID RECEPTOR, GAMMA-3", GABRG3
8185,600234,3-HYDROXY-3-METHYLGLUTARYL-CoA SYNTHASE 2, HMGCS2
8186,600235,"SODIUM VOLTAGE-GATED CHANNEL, BETA SUBUNIT 1", SCN1B
8187,600236,CENTROMERIC PROTEIN F, CENPF
8188,600237,HISTONE CELL CYCLE REGULATOR, HIRA
8189,600238,TRANSGLUTAMINASE 3, TGM3
8190,600239,CHEMERIN CHEMOKINE-LIKE RECEPTOR 2, CMKLR2
8191,600240,CHEMOKINE (C-C) RECEPTOR 10, CCR10
8192,600241,G PROTEIN-COUPLED RECEPTOR 3, GPR3
8193,600242,"CHEMOKINE, CC MOTIF, RECEPTOR 7", CCR7
8194,600243,DEFENDER AGAINST CELL DEATH 1, DAD1
8195,600244,PROGRAMMED CELL DEATH 1, PDCD1
8196,600245,FIBROMODULIN, FMOD
8197,600246,"ELK4, ETS-DOMAIN PROTEIN", ELK4
8198,600247,"ELK3, ETS-DOMAIN PROTEIN", ELK3
8199,600248,DENT DISEASE 1,
8200,600249,"ALDEHYDE DEHYDROGENASE 1 FAMILY, MEMBER L1", ALDH1L1
8201,600250,"CHEMOKINE, C MOTIF, LIGAND 1", XCL1
8202,600251,"FACIAL CLEFTING, OBLIQUE, 1", OBLFC1
8203,600252,LOWRY-MACLEAN SYNDROME,
8204,600253,ARYL HYDROCARBON RECEPTOR, AHR
8205,600254,ATRX CHROMATIN REMODELER,
8206,600255,TITLE NOT AVAILABLE AT THIS MOMENT,
8207,600256,"HYDROCEPHALUS, AUTOSOMAL DOMINANT",
8208,600257,CHROMOSOME 8q12.1-q21.2 DELETION SYNDROME,
8209,600258,"PMS1 HOMOLOG 1, MISMATCH REPAIR SYSTEM COMPONENT", PMS1
8210,600259,"PMS1 HOMOLOG 2, MISMATCH REPAIR SYSTEM COMPONENT", PMS2
8211,600260,CHLORIDE CHANNEL 5,
8212,600261,TITLE NOT AVAILABLE AT THIS MOMENT,
8213,600262,PROSTAGLANDIN-ENDOPEROXIDE SYNTHASE 2, PTGS2
8214,600263,"HELICOBACTER PYLORI INFECTION, SUSCEPTIBILITY TO",
8215,600264,ARGININE VASOPRESSIN RECEPTOR 1B, AVPR1B
8216,600265,FORKHEAD BOX O4,
8217,600266,"SOLUTE CARRIER FAMILY 11 (PROTON-COUPLED DIVALENT METAL ION TRANSPORTER), MEMBER 1", SLC11A1
8218,600267,"PROTEIN-TYROSINE PHOSPHATASE, NONRECEPTOR-TYPE, 13", PTPN13
8219,600268,OCULOECTODERMAL SYNDROME, OES
8220,600269,SHORT TARSUS WITH ABSENCE OF LOWER EYELASHES, STALE
8221,600270,PROCOLLAGEN C-ENDOPEPTIDASE ENHANCER, PCOLCE
8222,600271,DESMOCOLLIN 3, DSC3
8223,600272,COILIN, COIL
8224,600273,"POLYCYSTIC KIDNEY DISEASE, INFANTILE SEVERE, WITH TUBEROUS SCLEROSIS", PKDTS
8225,600274,FRONTOTEMPORAL DEMENTIA 1, FTD1
8226,600275,NOTCH RECEPTOR 2, NOTCH2
8227,600276,NOTCH RECEPTOR 3, NOTCH3
8228,600277,INHIBITOR OF DNA BINDING 3, ID3
8229,600278,RAP1 GTPase-ACTIVATING PROTEIN, RAP1GAP
8230,600279,PEROXISOME BIOGENESIS FACTOR 19, PEX19
8231,600280,NUCLEOTIDE-BINDING PROTEIN 1, NUBP1
8232,600281,HEPATOCYTE NUCLEAR FACTOR 4-ALPHA, HNF4A
8233,600282,"GLUTAMATE RECEPTOR, IONOTROPIC, KAINATE 4", GRIK4
8234,600283,"GLUTAMATE RECEPTOR, IONOTROPIC, KAINATE 5", GRIK5
8235,600284,ELONGATION FACTOR RNA POLYMERASE II, ELL
8236,600285,EUKARYOTIC TRANSLATION TERMINATION FACTOR 1, ETF1
8237,600286,"PHOSPHATIDYLINOSITOL 4-KINASE, ALPHA", PI4KA
8238,600287,GLYCYL-tRNA SYNTHETASE 1, GARS1
8239,600288,FORKHEAD BOX A2, FOXA2
8240,600289,MITOGEN-ACTIVATED PROTEIN KINASE 14, MAPK14
8241,600290,MITOGEN-ACTIVATED PROTEIN KINASE 14,
8242,600291,ADENYLATE CYCLASE 3, ADCY3
8243,600292,ADENYLATE CYCLASE 4, ADCY4
8244,600293,ADENYLATE CYCLASE 5, ADCY5
8245,600294,ADENYLATE CYCLASE 6, ADCY6
8246,600295,NATRIURETIC PEPTIDE PRECURSOR B, NPPB
8247,600296,NATRIURETIC PEPTIDE PRECURSOR C, NPPC
8248,600297,CAUDAL-TYPE HOMEOBOX TRANSCRIPTION FACTOR 2, CDX2
8249,600298,"LIM HOMEOBOX TRANSCRIPTION FACTOR 1, ALPHA", LMX1A
8250,600299,PERICENTRIOLAR MATERIAL 1, PCM1
8251,600300,"SOLUTE CARRIER FAMILY 1 (GLIAL HIGH AFFINITY GLUTAMATE TRANSPORTER), MEMBER 2", SLC1A2
8252,600301,"ACYL-CoA DEHYDROGENASE, SHORT/BRANCHED CHAIN", ACADSB
8253,600302,FRYNS MACROCEPHALY,
8254,600303,RAP GUANINE NUCLEOTIDE EXCHANGE FACTOR 1, RAPGEF1
8255,600304,"HYPOKALEMIC PERIODIC PARALYSIS, TYPE 1",
8256,600305,ENOYL-CoA DELTA ISOMERASE 1, ECI1
8257,600306,"PROTEASOME SUBUNIT, BETA-TYPE, 5", PSMB5
8258,600307,"PROTEASOME SUBUNIT, BETA-TYPE, 6", PSMB6
8259,600308,AQUAPORIN 4, AQP4
8260,600309,ATRIOVENTRICULAR SEPTAL DEFECT,
8261,600310,CARTILAGE OLIGOMERIC MATRIX PROTEIN, COMP
8262,600311,GRANZYME M, GZMM
8263,600312,NUDIX HYDROLASE 1, NUDT1
8264,600313,MESENCHYME HOMEOBOX 2,
8265,600314,SH2 DOMAIN-CONTAINING ADAPTOR PROTEIN B, SHB
8266,600315,"TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY, MEMBER 4", TNFRSF4
8267,600316,"DEAFNESS, AUTOSOMAL RECESSIVE 3", DFNB3
8268,600317,TROPOMYOSIN 4, TPM4
8269,600318,TYPE 1 DIABETES MELLITUS 3, T1D3
8270,600319,TYPE 1 DIABETES MELLITUS 4, T1D4
8271,600320,TYPE 1 DIABETES MELLITUS 5, T1D5
8272,600321,TYPE 1 DIABETES MELLITUS 7, T1D7
8273,600322,"SYNAPTOSOMAL-ASSOCIATED PROTEIN, 25-KD", SNAP25
8274,600323,REGULATOR OF G PROTEIN SIGNALING 1, RGS1
8275,600324,"CHEMOKINE, CXC MOTIF, LIGAND 5", CXCL5
8276,600325,AMINOPTERIN SYNDROME SINE AMINOPTERIN, ASSA
8277,600326,DEAD-BOX HELICASE 6, DDX6
8278,600327,SYNAPTOTAGMIN 3, SYT3
8279,600328,"MLLT6, PHD FINGER-CONTAINING", MLLT6
8280,600329,OSTEOPETROSIS AND INFANTILE NEUROAXONAL DYSTROPHY,
8281,600330,HAJDU-CHENEY SYNDROME,
8282,600331,PARC SYNDROME,
8283,600332,RIPPLING MUSCLE DISEASE 1, RMD1
8284,600333,MOTOR NEURON DISEASE WITH DEMENTIA AND OPHTHALMOPLEGIA,
8285,600334,"TIBIAL MUSCULAR DYSTROPHY, TARDIVE", TMD
8286,600335,SUCCINIC ACIDEMIA,
8287,600336,"SOLUTE CARRIER FAMILY 18 (VESICULAR ACETYLCHOLINE), MEMBER 3", SLC18A3
8288,600337,BRADYKININ RECEPTOR B1, BDKRB1
8289,600338,ARYLACETAMIDE DEACETYLASE, AADAC
8290,600339,HEPATOMA-DERIVED GROWTH FACTOR, HDGF
8291,600340,PLASMOLIPIN, PLLP
8292,600341,TYRO3 PROTEIN TYROSINE KINASE, TYRO3
8293,600342,"G PROTEIN-COUPLED RECEPTOR, RETINAL", RGR
8294,600343,"PAROTID SALIVARY GLANDS, POLYCYSTIC DYSGENETIC DISEASE OF", PDDP
8295,600344,"RHOX HOMEOBOX FAMILY, MEMBER 1",
8296,600345,BETACELLULIN, BTC
8297,600346,POLYCOMB GROUP RING FINGER PROTEIN 2, PCGF2
8298,600347,BREVICAN, BCAN
8299,600348,BAND HETEROTOPIA, BH
8300,600349,INHIBITOR OF DNA BINDING 1, ID1
8301,600350,"ANGIOTENSIN II RECEPTOR, TYPE 2",
8302,600351,"ENTEROPATHY, FAMILIAL, WITH VILLOUS EDEMA AND IMMUNOGLOBULIN G2 DEFICIENCY",
8303,600352,CD79A ANTIGEN,
8304,600353,S100 CALCIUM-BINDING PROTEIN A7, S100A7
8305,600354,SURVIVAL OF MOTOR NEURON 1, SMN1
8306,600355,NEURONAL APOPTOSIS INHIBITORY PROTEIN, NAIP
8307,600356,"PACHYDERMODACTYLY, FAMILIAL",
8308,600357,RIBOSOMAL PROTEIN S8, RPS8
8309,600358,GUANINE MONOPHOSPHATE SYNTHETASE, GMPS
8310,600359,"POTASSIUM CHANNEL, INWARDLY RECTIFYING, SUBFAMILY J, MEMBER 1", KCNJ1
8311,600360,"APLASIA CUTIS CONGENITA OF LIMBS, AUTOSOMAL RECESSIVE",
8312,600361,HEREDITARY MOTOR AND SENSORY NEUROPATHY V,
8313,600362,FLII ACTIN REMODELING PROTEIN, FLII
8314,600363,"SPASTIC PARAPLEGIA 6, AUTOSOMAL DOMINANT", SPG6
8315,600364,GUANYLATE CYCLASE ACTIVATOR 1A, GUCA1A
8316,600365,ABR ACTIVATOR OF RhoGEF AND GTPase, ABR
8317,600366,ISL LIM HOMEOBOX 1, ISL1
8318,600367,"CLEAVAGE STIMULATION FACTOR, 3-PRIME PRE-RNA, SUBUNIT 3, 77-KD", CSTF3
8319,600368,"CLEAVAGE STIMULATION FACTOR, 3-PRIME PRE-RNA, SUBUNIT 2, 64-KD",
8320,600369,"CLEAVAGE STIMULATION FACTOR, 3-PRIME PRE-RNA, SUBUNIT 1, 50-KD", CSTF1
8321,600370,"SOLUTE CARRIER FAMILY 25 (MITOCHONDRIAL CARRIER), MEMBER 3", SLC25A3
8322,600371,HIGH DENSITY LIPOPROTEIN-BINDING PROTEIN,
8323,600372,"NEURAL PRECURSOR CELL EXPRESSED, DEVELOPMENTALLY DOWNREGULATED 1", NEDD1
8324,600373,CODAS SYNDROME,
8325,600374,BBS4 GENE, BBS4
8326,600375,X-RAY REPAIR CROSS COMPLEMENTING 2, XRCC2
8327,600376,"TELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 2", HHT2
8328,600377,GALANIN RECEPTOR 1, GALR1
8329,600378,"INNER MEMBRANE PROTEIN, MITOCHONDRIAL", IMMT
8330,600379,MYELIN TRANSCRIPTION FACTOR 1, MYT1
8331,600380,"NUCLEAR RECEPTOR SUBFAMILY 1, GROUP H, MEMBER 2", NR1H2
8332,600381,KINECTIN, KTN1
8333,600382,MYC PROMOTER-BINDING PROTEIN,
8334,600383,MESOMELIA-SYNOSTOSES SYNDROME,
8335,600384,"APHALANGIA, PARTIAL, WITH SYNDACTYLY AND DUPLICATION OF METATARSAL IV",
8336,600385,ADENYLATE CYCLASE 7, ADCY7
8337,600386,INHIBITOR OF DNA BINDING 2, ID2
8338,600387,BONE MARROW STROMAL CELL ANTIGEN 1, BST1
8339,600388,"MEPRIN, ALPHA SUBUNIT", MEP1A
8340,600389,"MEPRIN, BETA SUBUNIT", MEP1B
8341,600390,"UPSTREAM TRANSCRIPTION FACTOR 2, FOS-INTERACTING", USF2
8342,600391,"GLUCOSAMINYL (N-ACETYL) TRANSFERASE 1, CORE 2", GCNT1
8343,600392,"RAD52 HOMOLOG, DNA REPAIR PROTEIN", RAD52
8344,600393,FLAP STRUCTURE-SPECIFIC ENDONUCLEASE 1, FEN1
8345,600394,"SOLUTE CARRIER FAMILY 6 (NEUROTRANSMITTER TRANSPORTER, CREATINE), MEMBER 8",
8346,600395,GLYPICAN 1, GPC1
8347,600396,DEAH-BOX HELICASE 8, DHX8
8348,600397,"POTASSIUM CHANNEL, VOLTAGE-GATED, SHAB-RELATED SUBFAMILY, MEMBER 1", KCNB1
8349,600398,ZINC FINGER PROTEIN 160, ZNF160
8350,600399,"PECTUS EXCAVATUM, MACROCEPHALY, SHORT STATURE, AND DYSPLASTIC NAILS",
8351,600400,PROLYL ENDOPEPTIDASE, PREP
8352,600401,"ELK3, ETS-DOMAIN PROTEIN",
8353,600402,EPHRIN B1,
8354,600403,"FIBROBLAST ACTIVATION PROTEIN, ALPHA", FAP
8355,600404,"REPLICATION FACTOR C, SUBUNIT 2", RFC2
8356,600405,"REPLICATION FACTOR C, SUBUNIT 3", RFC3
8357,600406,"REPLICATION FACTOR C, SUBUNIT 4",
8358,600407,"REPLICATION FACTOR C, SUBUNIT 5", RFC5
8359,600408,"DISCOIDIN DOMAIN RECEPTOR FAMILY, MEMBER 1", DDR1
8360,600409,PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR-DELTA, PPARD
8361,600410,TUMOR NECROSIS FACTOR-ALPHA-INDUCED PROTEIN 6, TNFAIP6
8362,600411,"GUANYLATE-BINDING PROTEIN 1, INTERFERON-INDUCIBLE, 67-KD", GBP1
8363,600412,"GUANYLATE-BINDING PROTEIN 2, INTERFERON-INDUCIBLE", GBP2
8364,600413,GUANYLATE-BINDING PROTEIN 3, GBP3
8365,600414,PEROXISOME BIOGENESIS FACTOR 5, PEX5
8366,600415,"TOCOPHEROL TRANSFER PROTEIN, ALPHA", TTPA
8367,600416,"MUSCULAR DYSTROPHY, SCAPULOHUMERAL",
8368,600417,"5-PRIME-NUCLEOTIDASE, CYTOSOLIC II", NT5C2
8369,600418,AMPHIPHYSIN, AMPH
8370,600419,ANGIOKERATOMA CORPORIS DIFFUSUM WITH ARTERIOVENOUS FISTULAS,
8371,600420,"POU DOMAIN, CLASS 3, TRANSCRIPTION FACTOR 4",
8372,600421,"GLYCINE RECEPTOR, ALPHA-3 SUBUNIT", GLRA3
8373,600422,FATTY ACID-BINDING PROTEIN 6, FABP6
8374,600423,ENDOTHELIN-CONVERTING ENZYME 1, ECE1
8375,600424,"SOLUTE CARRIER FAMILY 19 (FOLATE TRANSPORTER), MEMBER 1", SLC19A1
8376,600425,TRANSCRIPTION FACTOR DP1,
8377,600426,E2F TRANSCRIPTION FACTOR 2, E2F2
8378,600427,E2F TRANSCRIPTION FACTOR 3, E2F3
8379,600428,VAV GUANINE NUCLEOTIDE EXCHANGE FACTOR 2, VAV2
8380,600429,"GLUCOSAMINYL (N-ACETYL) TRANSFERASE 2, I-BRANCHING ENZYME", GCNT2
8381,600430,CHROMOSOME 2q37 DELETION SYNDROME,
8382,600431,CYCLIN-DEPENDENT KINASE INHIBITOR 2B, CDKN2B
8383,600432,PRECEREBELLIN 1, CBLN1
8384,600433,PRECEREBELLIN 2, CBLN2
8385,600434,FATTY ACID-BINDING PROTEIN 4, FABP4
8386,600435,CARDIOTROPHIN 1, CTF1
8387,600436,"GLUTATHIONE S-TRANSFERASE, THETA-1", GSTT1
8388,600437,"GLUTATHIONE S-TRANSFERASE, THETA-2", GSTT2
8389,600438,"TRANSCRIPTION FACTOR A, MITOCHONDRIAL", TFAM
8390,600439,SINGLE-STRANDED DNA-BINDING PROTEIN 1, SSBP1
8391,600440,"ENDONUCLEASE G, MITOCHONDRIAL", ENDOG
8392,600441,GROWTH ARREST-SPECIFIC 6, GAS6
8393,600442,AQUAPORIN 5, AQP5
8394,600443,GLUTAREDOXIN, GLRX
8395,600444,"SOLUTE CARRIER FAMILY 5 (INOSITOL TRANSPORTER), MEMBER 3", SLC5A3
8396,600445,ADENOSINE A3 RECEPTOR, ADORA3
8397,600446,ADENOSINE A2B RECEPTOR, ADORA2B
8398,600447,MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 12, MAP3K12
8399,600448,"PROTEIN KINASE C, THETA", PRKCQ
8400,600449,"ALDO-KETO REDUCTASE FAMILY 1, MEMBER 1", AKR1C1
8401,600450,"ALDO-KETO REDUCTASE FAMILY 1, MEMBER C2", AKR1C2
8402,600451,"ALDO-KETO REDUCTASE FAMILY 1, MEMBER C4", AKR1C4
8403,600452,"DISCOIDIN DOMAIN RECEPTOR FAMILY, MEMBER 1",
8404,600453,TRIPARTITE MOTIF-CONTAINING PROTEIN 25, TRIM25
8405,600454,RIBOSOMAL PROTEIN S3, RPS3
8406,600455,"RNA, U15A SMALL NUCLEOLAR", RNU15A
8407,600456,"NEUROTROPHIC TYROSINE KINASE, RECEPTOR, TYPE 2", NTRK2
8408,600457,"HYPERTRICHOSIS, ANTERIOR CERVICAL",
8409,600458,ADENOMYOSIS,
8410,600459,ARTERIAL DISSECTION WITH LENTIGINOSIS,
8411,600460,"CLEFT PALATE, CARDIAC DEFECTS, GENITAL ANOMALIES, AND ECTRODACTYLY", CCGE
8412,600461,"HEMOLYTIC ANEMIA, LETHAL CONGENITAL NONSPHEROCYTIC, WITH GENITAL AND OTHER ABNORMALITIES",
8413,600462,"MYOPATHY, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA 1", MLASA1
8414,600463,"ALDEHYDE DEHYDROGENASE 1 FAMILY, MEMBER A3", ALDH1A3
8415,600464,ADP-RIBOSYLATION FACTOR 6, ARF6
8416,600465,ANKYRIN 3, ANK3
8417,600466,"ALDEHYDE DEHYDROGENASE 3 FAMILY, MEMBER B1", ALDH3B1
8418,600467,"MALIGNANT HYPERTHERMIA, SUSCEPTIBILITY TO, 4",
8419,600468,"ATPase, Cu(2+)-TRANSPORTING, ALPHA POLYPEPTIDE",
8420,600469,NUCLEAR CAP-BINDING PROTEIN 1, NCBP1
8421,600470,"ZIC FAMILY, MEMBER 1", ZIC1
8422,600471,"DEFENSIN, ALPHA, 6", DEFA6
8423,600472,"DEFENSIN, ALPHA, 5", DEFA5
8424,600473,PURINE-RICH ELEMENT-BINDING PROTEIN A, PURA
8425,600474,CATHELICIDIN ANTIMICROBIAL PEPTIDE, CAMP
8426,600475,"TAF10 RNA POLYMERASE II, TATA BOX-BINDING PROTEIN-ASSOCIATED FACTOR, 30-KD", TAF10
8427,600476,STRUCTURAL MAINTENANCE OF CHROMOSOMES 1A,
8428,600477,"SOLUTE CARRIER FAMILY 9, MEMBER 5", SLC9A5
8429,600478,SKI2 SUBUNIT OF SUPERKILLER COMPLEX, SKIC2
8430,600479,"COLLAGEN, TYPE XIV, ALPHA-1",
8431,600480,TRANSCRIPTION FACTOR 12, TCF12
8432,600481,STEROL REGULATORY ELEMENT-BINDING TRANSCRIPTION FACTOR 2, SREBF2
8433,600482,MATURE T-CELL PROLIFERATION 1,
8434,600483,FIBROBLAST GROWTH FACTOR 8, FGF8
8435,600484,ARYLSULFATASE D,
8436,600485,ARYLSULFATASE F,
8437,600486,"IMMUNONEUROLOGIC DISORDER, X-LINKED",
8438,600487,"PROPROTEIN CONVERTASE, SUBTILISIN/KEXIN-TYPE, 4", PCSK4
8439,600488,"PROPROTEIN CONVERTASE, SUBTILISIN/KEXIN-TYPE, 5", PCSK5
8440,600489,"NUCLEAR FACTOR OF ACTIVATED T CELLS, CYTOPLASMIC, CALCINEURIN-DEPENDENT 1", NFATC1
8441,600490,"NUCLEAR FACTOR OF ACTIVATED T CELLS, CYTOPLASMIC, CALCINEURIN-DEPENDENT 2", NFATC2
8442,600491,MICROFIBRILLAR-ASSOCIATED PROTEIN 3, MFAP3
8443,600492,NUCLEAR FACTOR ERYTHROID 2-LIKE 2, NFE2L2
8444,600493,ADHESION G PROTEIN-COUPLED RECEPTOR E1, ADGRE1
8445,600494,"POU DOMAIN, CLASS 3, TRANSCRIPTION FACTOR 2", POU3F2
8446,600495,"EUKARYOTIC TRANSLATION INITIATION FACTOR 4-GAMMA, 1", EIF4G1
8447,600496,"MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 3", MODY3
8448,600497,"PROTEIN KINASE, AMP-ACTIVATED, CATALYTIC, ALPHA-2", PRKAA2
8449,600498,"CD99 ANTIGEN, X CHROMOSOME",
8450,600499,TITLE NOT AVAILABLE AT THIS MOMENT,
8451,600500,"PROTEIN-TYROSINE KINASE, CYTOPLASMIC",
8452,600501,ABCD SYNDROME, ABCDS
8453,600502,IMMUNOGLOBULIN MU-BINDING PROTEIN 2, IGHMBP2
8454,600503,SUB1 REGULATOR OF TRANSCRIPTION, SUB1
8455,600504,"POTASSIUM CHANNEL, INWARDLY RECTIFYING, SUBFAMILY J, MEMBER 4", KCNJ4
8456,600505,"CASEIN KINASE I, ALPHA-1", CSNK1A1
8457,600506,"MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 4",
8458,600507,ADP-RIBOSYLATION FACTOR 4,
8459,600508,NCK ADAPTOR PROTEIN 1, NCK1
8460,600509,"ATP-BINDING CASSETTE, SUBFAMILY C, MEMBER 8", ABCC8
8461,600510,OCULAR PIGMENT DISPERSION WITH OR WITHOUT GLAUCOMA, OPDG
8462,600511,SCHIZOPHRENIA 3, SCZD3
8463,600512,"EPILEPSY, FAMILIAL TEMPORAL LOBE, 1", ETL1
8464,600513,"EPILEPSY, NOCTURNAL FRONTAL LOBE, 1", ENFL1
8465,600514,REELIN, RELN
8466,600515,"PURINERGIC RECEPTOR P2Y, G PROTEIN-COUPLED, 12", P2RY12
8467,600516,BCL2 ANTAGONIST KILLER 1, BAK1
8468,600517,"SERPIN PEPTIDASE INHIBITOR, CLADE B (OVALBUMIN), MEMBER 3", SERPINB3
8469,600518,"SERPIN PEPTIDASE INHIBITOR, CLADE B (OVALBUMIN), MEMBER 4", SERPINB4
8470,600519,"GENERAL TRANSCRIPTION FACTOR IIA, GAMMA SUBUNIT", GTF2A2
8471,600520,"GENERAL TRANSCRIPTION FACTOR IIA, ALPHA/BETA SUBUNITS", GTF2A1
8472,600521,MANNAN-BINDING LECTIN SERINE PROTEASE 1, MASP1
8473,600522,"PHOSPHOLIPASE A2, GROUP IVA", PLA2G4A
8474,600523,"SOLUTE CARRIER FAMILY 11 (PROTON-COUPLED DIVALENT METAL ION TRANSPORTER), MEMBER 2", SLC11A2
8475,600524,RYK RECEPTOR-LIKE TYROSINE KINASE, RYK
8476,600525,DISTAL-LESS HOMEOBOX 3, DLX3
8477,600526,MAP/MICROTUBULE AFFINITY-REGULATING KINASE 2, MARK2
8478,600527,EPHRIN B2, EFNB2
8479,600528,"CARNITINE PALMITOYLTRANSFERASE I, LIVER", CPT1A
8480,600529,AU-SPECIFIC RNA-BINDING PROTEIN, AUH
8481,600530,"SOLUTE CARRIER FAMILY 9, MEMBER 2", SLC9A2
8482,600531,"SOLUTE CARRIER FAMILY 9, MEMBER 4", SLC9A4
8483,600532,NADH-UBIQUINONE OXIDOREDUCTASE FLAVOPROTEIN 2, NDUFV2
8484,600533,VANGL PLANAR CELL POLARITY PROTEIN 2, VANGL2
8485,600534,BONE MARROW STROMAL CELL ANTIGEN 2, BST2
8486,600535,MESENCHYME HOMEOBOX 2, MEOX2
8487,600536,"INTEGRIN, ALPHA-7", ITGA7
8488,600537,RECQ PROTEIN-LIKE, RECQL
8489,600538,PEROXIREDOXIN 2, PRDX2
8490,600539,"PROTEIN KINASE C, IOTA FORM", PRKCI
8491,600540,TRANSCRIPTION FACTOR Sp4, SP4
8492,600541,ETS VARIANT TRANSCRIPTION FACTOR 1, ETV1
8493,600542,"NUCLEAR RECEPTOR SUBFAMILY 4, GROUP A, MEMBER 3", NR4A3
8494,600543,ERB-B2 RECEPTOR TYROSINE KINASE 4, ERBB4
8495,600544,"SOLUTE CARRIER FAMILY 15 (OLIGOPEPTIDE TRANSPORTER), MEMBER 1", SLC15A1
8496,600545,"DYSKERATOSIS CONGENITA, X-LINKED",
8497,600546,INTRAUTERINE GROWTH RETARDATION WITH INCREASED MITOMYCIN C SENSITIVITY,
8498,600547,CYSTEINE CONJUGATE BETA-LYASE 1, CCBL1
8499,600548,HEAT-SHOCK 70-KD PROTEIN 9, HSPA9
8500,600549,"IK CYTOKINE, DOWNREGULATOR OF HLA II", IK
8501,600550,CATHEPSIN O, CTSO
8502,600551,G PROTEIN-COUPLED RECEPTOR 4, GPR4
8503,600552,"CHEMOKINE, C MOTIF, RECEPTOR 1", XCR1
8504,600553,G PROTEIN-COUPLED RECEPTOR 6, GPR6
8505,600554,INTERLEUKIN 15, IL15
8506,600555,SIGNAL TRANSDUCER AND ACTIVATOR OF TRANSCRIPTION 1, STAT1
8507,600556,SIGNAL TRANSDUCER AND ACTIVATOR OF TRANSCRIPTION 2, STAT2
8508,600557,SIGNAL TRANSDUCER AND ACTIVATOR OF TRANSCRIPTION 3,
8509,600558,SIGNAL TRANSDUCER AND ACTIVATOR OF TRANSCRIPTION 4, STAT4
8510,600559,"HYDROCEPHALUS, ENDOCARDIAL FIBROELASTOSIS, AND CATARACTS",
8511,600560,SHC TRANSFORMING PROTEIN 1, SHC1
8512,600561,SPONDYLOEPIPHYSEAL DYSPLASIA WITH ATLANTOAXIAL INSTABILITY,
8513,600562,CADHERIN 12, CDH12
8514,600563,PROSTAGLANDIN F RECEPTOR, PTGFR
8515,600564,"INTER-ALPHA-TRYPSIN INHIBITOR, HEAVY CHAIN 4", ITIH4
8516,600565,NEUREXIN I, NRXN1
8517,600566,NEUREXIN II, NRXN2
8518,600567,NEUREXIN III, NRXN3
8519,600568,NEUROLIGIN 1, NLGN1
8520,600569,SHROOM FAMILY MEMBER 2,
8521,600570,CHLORIDE CHANNEL 2, CLCN2
8522,600571,RE1-SILENCING TRANSCRIPTION FACTOR, REST
8523,600572,"SPLICING FACTOR, SERINE/ARGININE-RICH, 7", SRSF7
8524,600573,"TAF7 RNA POLYMERASE II, TATA BOX-BINDING PROTEIN-ASSOCIATED FACTOR, 55-KD", TAF7
8525,600574,LEUCINE ZIPPER-LIKE TRANSCRIPTIONAL REGULATOR 1, LZTR1
8526,600575,TRANSLIN, TSN
8527,600576,GATA-BINDING PROTEIN 4, GATA4
8528,600577,LIM HOMEOBOX GENE 3, LHX3
8529,600578,"OLFACTORY RECEPTOR, FAMILY 2, SUBFAMILY H, MEMBER 3", OR2H3
8530,600579,"PROTEIN-TYROSINE PHOSPHATASE, RECEPTOR-TYPE, O", PTPRO
8531,600580,CHLORIDE CHANNEL 3, CLCN3
8532,600581,INHIBITOR OF DNA BINDING 4, ID4
8533,600582,ASPARTATE BETA-HYDROXYLASE, ASPH
8534,600583,TEC PROTEIN TYROSINE KINASE, TEC
8535,600584,NK2 HOMEOBOX 5, NKX2-5
8536,600585,TRANSGLUTAMINASE 4, TGM4
8537,600586,EPITHELIAL CELL TRANSFORMING SEQUENCE 2 ONCOGENE, ECT2
8538,600587,POM121/ZP3 FUSION PROTEIN, POMZP3
8539,600588,"THROMBOCYTOPENIA, PARIS-TROUSSEAU TYPE",
8540,600589,SERUM RESPONSE FACTOR, SRF
8541,600590,"PROTEIN PHOSPHATASE 1, CATALYTIC SUBUNIT, BETA ISOFORM", PPP1CB
8542,600591,"SMALL NUCLEAR RNA-ACTIVATING PROTEIN COMPLEX, POLYPEPTIDE 1", SNAPC1
8543,600592,MINICHROMOSOME MAINTENANCE COMPLEX COMPONENT 7, MCM7
8544,600593,"CRANIOSYNOSTOSIS, ADELAIDE TYPE", CRSA
8545,600594,DIGEORGE SYNDROME CRITICAL REGION GENE 2, DGCR2
8546,600595,INTRAFLAGELLAR TRANSPORT 88, IFT88
8547,600596,MICROFIBRILLAR-ASSOCIATED PROTEIN 4, MFAP4
8548,600597,PHOSPHOLIPASE C-LIKE 1, PLCL1
8549,600598,"SETTING-SUN PHENOMENON, FAMILIAL BENIGN",
8550,600599,KRUPPEL-LIKE FACTOR 1, KLF1
8551,600600,EPHRIN RECEPTOR EphB1, EPHB1
8552,600601,MITOGEN-ACTIVATED PROTEIN KINASE 14,
8553,600602,"PROTEIN KINASE, X-LINKED",
8554,600603,"NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 2A",
8555,600604,"TELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 2",
8556,600605,METAXIN 1, MTX1
8557,600606,TITLE NOT AVAILABLE AT THIS MOMENT,
8558,600607,VACUOLAR PROTEIN SORTING 72 HOMOLOG, VPS72
8559,600608,"PROCOLLAGEN-PROLINE, 2-OXOGLUTARATE-4-DIOXYGENASE, ALPHA SUBUNIT, ISOFORM 2", P4HA2
8560,600609,"GA-BINDING PROTEIN TRANSCRIPTION FACTOR, ALPHA SUBUNIT", GABPA
8561,600610,"GA-BINDING PROTEIN TRANSCRIPTION FACTOR, BETA SUBUNIT", GABPB
8562,600611,FK506-BINDING PROTEIN 4, FKBP4
8563,600612,"BONE MARROW KINASE, X-LINKED",
8564,600613,"NEUROBLASTOMA CANDIDATE REGION, SUPPRESSION OF TUMORIGENICITY 1", NBL1
8565,600614,S100 CALCIUM-BINDING PROTEIN P, S100P
8566,600615,"LECTIN, GALACTOSIDE-BINDING, SOLUBLE, 7", LGALS7
8567,600616,LUMICAN, LUM
8568,600617,STEROIDOGENIC ACUTE REGULATORY PROTEIN, STAR
8569,600618,ETS VARIANT TRANSCRIPTION FACTOR 6, ETV6
8570,600619,"MELANOMA ANTIGEN, FAMILY B, 1",
8571,600620,FK506-BINDING PROTEIN 1B, FKBP1B
8572,600621,STATHMIN-LIKE 2, STMN2
8573,600622,BARTH SYNDROME,
8574,600623,CD82 ANTIGEN, CD82
8575,600624,CONE-ROD DYSTROPHY 1, CORD1
8576,600625,OROFACIAL CLEFT 11, OFC11
8577,600626,"LECTIN, GALACTOSIDE-BINDING, SOLUBLE, 3 BINDING PROTEIN", LGALS3BP
8578,600627,HYPERTRYPTOPHANEMIA, HYPTRP
8579,600628,LOOSE ANAGEN HAIR SYNDROME,
8580,600629,"MAJOR HISTOCOMPATIBILITY COMPLEX, CLASS II, DO BETA", HLA-DOB
8581,600630,UV-SENSITIVE SYNDROME 1, UVSS1
8582,600631,"ENURESIS, NOCTURNAL, 1", ENUR1
8583,600632,OPIOID-BINDING PROTEIN/CELL ADHESION MOLECULE-LIKE, OPCML
8584,600633,TREFOIL FACTOR 3, TFF3
8585,600634,"PITUITARY ADENOMA 1, MULTIPLE TYPES",
8586,600635,NK2 HOMEOBOX 1, NKX2-1
8587,600636,"CASPASE 3, APOPTOSIS-RELATED CYSTEINE PROTEASE", CASP3
8588,600637,"SOLUTE CARRIER FAMILY 1 (HIGH AFFINITY ASPARTATE/GLUTAMATE TRANSPORTER), MEMBER 6", SLC1A6
8589,600638,"FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, 3A, WITH OR WITHOUT EXTRAOCULAR INVOLVEMENT", CFEOM3A
8590,600639,"CASPASE 2, APOPTOSIS-RELATED CYSTEINE PROTEASE", CASP2
8591,600640,PHOSPHATIDYLINOSITOL GLYCAN ANCHOR BIOSYNTHESIS CLASS A PROTEIN,
8592,600641,"SULFOTRANSFERASE FAMILY 1A, CYTOSOLIC, PHENOL-PREFERRING, MEMBER 3", SULT1A3
8593,600642,MYOSIN IG, MYO1G
8594,600643,"CAROLI DISEASE, ISOLATED",
8595,600644,NECTIN CELL ADHESION MOLECULE 1, NECTIN1
8596,600645,"PROTEIN-TYROSINE PHOSPHATASE, RECEPTOR-TYPE, O",
8597,600646,PROTEIN C RECEPTOR, PROCR
8598,600647,H6 FAMILY HOMEOBOX 2, HMX2
8599,600648,EPIDERMOLYTIC HYPERKERATOSIS 1,
8600,600649,"CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, INFANTILE",
8601,600650,CARNITINE PALMITOYLTRANSFERASE II, CPT2
8602,600651,FRAGILE SITE 11B, FRA11B
8603,600652,"DEAFNESS, AUTOSOMAL DOMINANT 4A", DFNA4A
8604,600653,KINECTIN,
8605,600654,PROTEASOME ACTIVATOR SUBUNIT 1, PSME1
8606,600655,"EUKARYOTIC TRANSLATION ELONGATION FACTOR 1, BETA-2", EEF1B2
8607,600656,"EUKARYOTIC TRANSLATION ELONGATION FACTOR 1, BETA-2",
8608,600657,"EUKARYOTIC TRANSLATION ELONGATION FACTOR 1, BETA-2",
8609,600658,"PROTEIN PHOSPHATASE 5, CATALYTIC SUBUNIT", PPP5C
8610,600659,E2F TRANSCRIPTION FACTOR 4, E2F4
8611,600660,MYOCYTE ENHANCER FACTOR 2A, MEF2A
8612,600661,MYOCYTE ENHANCER FACTOR 2B, MEF2B
8613,600662,MYOCYTE ENHANCER FACTOR 2C, MEF2C
8614,600663,MYOCYTE ENHANCER FACTOR 2D, MEF2D
8615,600664,COMPONENT OF NUCLEAR FACTOR KAPPA-B KINASE COMPLEX, CHUK
8616,600665,MELATONIN RECEPTOR 1A, MTNR1A
8617,600666,POLYCYSTIC KIDNEY DISEASE 3 WITH OR WITHOUT POLYCYSTIC LIVER DISEASE, PKD3
8618,600667,FRIZZLED CLASS RECEPTOR 2, FZD2
8619,600668,CHONDROCALCINOSIS 1, CCAL1
8620,600669,"EPILEPSY, IDIOPATHIC GENERALIZED", EIG
8621,600670,"VARICELLA, SEVERE RECURRENT",
8622,600671,DIGEORGE SYNDROME CRITICAL REGION GENE 2,
8623,600672,CAUDAL-TYPE HOMEOBOX TRANSCRIPTION FACTOR 4,
8624,600673,UPSTREAM BINDING TRANSCRIPTION FACTOR (RNA POLYMERASE I), UBTF
8625,600674,MICROTIA-ANOTIA,
8626,600675,X-RAY REPAIR CROSS COMPLEMENTING 3, XRCC3
8627,600676,CATR TUMORIGENIC CONVERSION 1, CATR1
8628,600677,"SARCOMA, SYNOVIAL, X BREAKPOINT 2",
8629,600678,MutS HOMOLOG 6, MSH6
8630,600679,"DERMOID CYSTS, FAMILIAL FRONTONASAL",
8631,600680,"CEROID LIPOFUSCINOSIS, NEURONAL, 1",
8632,600681,"POTASSIUM CHANNEL, INWARDLY RECTIFYING, SUBFAMILY J, MEMBER 2", KCNJ2
8633,600682,"SOLUTE CARRIER FAMILY 16 (MONOCARBOXYLIC ACID TRANSPORTER), MEMBER 1", SLC16A1
8634,600683,"SOLUTE CARRIER FAMILY 1 (NEUTRAL AMINO ACID TRANSPORTER), MEMBER 5",
8635,600684,T-LYMPHOCYTE SURFACE ANTIGEN LY-9, LY9
8636,600685,KARYOPHERIN ALPHA-2, KPNA2
8637,600686,KARYOPHERIN ALPHA-1, KPNA1
8638,600687,T-CELL LYMPHOMA INVASION AND METASTASIS 1, TIAM1
8639,600688,"CARBOXYPEPTIDASE A2, PANCREATIC", CPA2
8640,600689,TETRASPANIN 7,
8641,600690,T-CELL LEUKEMIA TRANSLOCATION-ASSOCIATED GENE, TCTA
8642,600691,"SOLUTE CARRIER FAMILY 27 (FATTY ACID TRANSPORTER), MEMBER 1", SLC27A1
8643,600692,"TROPONIN T3, FAST SKELETAL", TNNT3
8644,600693,POLYPYRIMIDINE TRACT-BINDING PROTEIN 1, PTBP1
8645,600694,INTERLEUKIN 6 CYTOKINE FAMILY SIGNAL TRANSDUCER, IL6ST
8646,600695,S-PHASE KINASE-ASSOCIATED PROTEIN 1,
8647,600696,"ENOYL-CoA HYDRATASE 1, PEROXISOMAL", ECH1
8648,600697,RETINOBLASTOMA-BINDING PROTEIN 5, RBBP5
8649,600698,HIGH MOBILITY GROUP AT-HOOK 2, HMGA2
8650,600699,DELETED IN AZOOSPERMIA 1,
8651,600700,LIM DOMAIN-CONTAINING PREFERRED TRANSLOCATION PARTNER IN LIPOMA, LPP
8652,600701,HIGH MOBILITY GROUP AT-HOOK 1, HMGA1
8653,600702,"SODIUM VOLTAGE-GATED CHANNEL, ALPHA SUBUNIT 8", SCN8A
8654,600703,RIBOSOMAL PROTEIN S1-LIKE, RPS1L
8655,600704,"INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 20",
8656,600705,SATOYOSHI SYNDROME,
8657,600706,PROXIMAL MYOPATHY WITH FOCAL DEPLETION OF MITOCHONDRIA,
8658,600707,"SIGNAL RECOGNITION PARTICLE, 9-KD", SRP9
8659,600708,"SIGNAL RECOGNITION PARTICLE, 14-KD", SRP14
8660,600709,ISOLEUCYL-tRNA SYNTHETASE 1, IARS1
8661,600710,"INTER-ALPHA-TRYPSIN INHIBITOR, HEAVY CHAIN 4",
8662,600711,ETS VARIANT TRANSCRIPTION FACTOR 4, ETV4
8663,600712,HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN K, HNRNPK
8664,600713,"11-BETA-HYDROXYSTEROID DEHYDROGENASE, TYPE I", HSD11B1
8665,600714,DUAL-SPECIFICITY PHOSPHATASE 1, DUSP1
8666,600715,THROMBOSPONDIN IV, THBS4
8667,600716,"PROTEIN TYROSINE PHOSPHATASE, NONRECEPTOR-TYPE, 22", PTPN22
8668,600717,"COLLAGEN, TYPE XIX, ALPHA-1",
8669,600718,EPITHELIAL CELLULAR ADHESION MOLECULE,
8670,600719,NITRIC OXIDE SYNTHASE 2B, NOS2B
8671,600720,NITRIC OXIDE SYNTHASE 2 PSEUDOGENE 1, NOS2P1
8672,600721,D-2-HYDROXYGLUTARIC ACIDURIA 1, D2HGA1
8673,600722,PALMITOYL-PROTEIN THIOESTERASE 1, PPT1
8674,600723,"MEMBRANE PROTEIN, PALMITOYLATED 2", MPP2
8675,600724,"CYCLIC NUCLEOTIDE-GATED CHANNEL, BETA-1", CNGB1
8676,600725,SONIC HEDGEHOG SIGNALING MOLECULE, SHH
8677,600726,INDIAN HEDGEHOG SIGNALING MOLECULE, IHH
8678,600727,NUCLEAR FACTOR I/A, NFIA
8679,600728,NUCLEAR FACTOR I/B, NFIB
8680,600729,NUCLEAR FACTOR I/C, NFIC
8681,600730,NEUROPEPTIDES B AND W RECEPTOR 1, NPBWR1
8682,600731,G PROTEIN-COUPLED RECEPTOR 8, GPR8
8683,600732,ADP-RIBOSYLATION FACTOR-LIKE GTPase 4D, ARL4D
8684,600733,PANCREAS/DUODENUM HOMEOBOX PROTEIN 1, PDX1
8685,600734,"POTASSIUM CHANNEL, INWARDLY RECTIFYING, SUBFAMILY J, MEMBER 5", KCNJ5
8686,600735,INTERFERON-INDUCED PROTEIN 35, IFI35
8687,600736,VELOFACIOSKELETAL SYNDROME,
8688,600737,NONAKA MYOPATHY,
8689,600738,SELECTIN P LIGAND, SELPLG
8690,600739,SHC-LIKE PROTEIN, SHCL1
8691,600740,"HYPOCALCIURIC HYPERCALCEMIA, FAMILIAL, TYPE III", HHC3
8692,600741,PRIMASE POLYPEPTIDE 2A,
8693,600742,"TRANSFORMING GROWTH FACTOR-BETA RECEPTOR, TYPE III", TGFBR3
8694,600743,TRANSCRIPTION FACTOR AP4, TFAP4
8695,600744,T-CELL TRANSCRIPTION FACTOR EB, TFEB
8696,600745,APOLIPOPROTEIN C-IV, APOC4
8697,600746,CAUDAL-TYPE HOMEOBOX TRANSCRIPTION FACTOR 1, CDX1
8698,600747,T-BOX TRANSCRIPTION FACTOR 2, TBX2
8699,600748,TRANSMEMBRANE BAX INHIBITOR MOTIF-CONTAINING PROTEIN 6, TMBIM6
8700,600749,"CCAAT/ENHANCER-BINDING PROTEIN, EPSILON", CEBPE
8701,600750,NEURONAL PENTRAXIN 2, NPTX2
8702,600751,SIALIC ACID-BINDING IMMUNOGLOBULIN-LIKE LECTIN 1, SIGLEC1
8703,600752,G PROTEIN-COUPLED RECEPTOR 12, GPR12
8704,600753,GOLGI APPARATUS PROTEIN 1, GLG1
8705,600754,MATRIX METALLOPROTEINASE 14, MMP14
8706,600755,SYNAPSIN II, SYN2
8707,600756,PROTEIN PHOSPHATASE 2 PHOSPHATASE ACTIVATOR, PTPA
8708,600757,OROFACIAL CLEFT 3, OFC3
8709,600758,"PROTEIN-TYROSINE KINASE, CYTOPLASMIC", PTK2
8710,600759,PRESENILIN 2, PSEN2
8711,600760,"SODIUM CHANNEL, EPITHELIAL 1, BETA SUBUNIT", SCNN1B
8712,600761,"SODIUM CHANNEL, EPITHELIAL 1, GAMMA SUBUNIT", SCNN1G
8713,600762,HUMAN PAPILLOMAVIRUS E5 CENTRAL SEQUENCE-LIKE 1, HPVC1
8714,600763,"TUMOR PROTEIN, TRANSLATIONALLY-CONTROLLED 1", TPT1
8715,600764,"MAJOR HISTOCOMPATIBILITY COMPLEX, CLASS I-RELATED", MR1
8716,600765,MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 10,
8717,600766,GDP DISSOCIATION INHIBITOR 1,
8718,600767,GDP-DISSOCIATION INHIBITOR 2, GDI2
8719,600768,"PROTEIN-TYROSINE PHOSPHATASE, NONRECEPTOR-TYPE, 9", PTPN9
8720,600769,TETRASPANIN 8, TSPAN8
8721,600770,"MUCIN 5, SUBTYPE B, TRACHEOBRONCHIAL", MUC5B
8722,600771,"DWARFISM, FAMILIAL, WITH MUSCLE SPASMS",
8723,600772,"TAF11 RNA POLYMERASE II, TATA BOX-BINDING PROTEIN-ASSOCIATED FACTOR, 28-KD", TAF11
8724,600773,"TAF12 RNA POLYMERASE II, TATA BOX-BINDING PROTEIN-ASSOCIATED FACTOR, 20-KD", TAF12
8725,600774,"TAF13 RNA POLYMERASE II, TATA BOX-BINDING PROTEIN-ASSOCIATED FACTOR, 18-KD", TAF13
8726,600775,CRANIOSYNOSTOSIS 4, CRS4
8727,600776,FRYNS MICROPHTHALMIA SYNDROME,
8728,600777,"TRANSCRIPTION TERMINATION FACTOR, RNA POLYMERASE I", TTF1
8729,600778,CYCLIN-DEPENDENT KINASE INHIBITOR 1B, CDKN1B
8730,600779,FORKHEAD BOX G1,
8731,600780,HYPOPARATHYROIDISM-RETARDATION-DYSMORPHISM SYNDROME,
8732,600781,PEPTIDE YY, PYY
8733,600782,SYNAPTOTAGMIN 5, SYT5
8734,600783,HISTIDYL-tRNA SYNTHETASE 2, HARS2
8735,600784,GRANZYME K, GZMK
8736,600785,"VITAMIN D-DEPENDENT RICKETS, TYPE 2B, WITH NORMAL VITAMIN D RECEPTOR", VDDR2B
8737,600786,ELONGIN A, ELOA
8738,600787,ELONGIN B, ELOB
8739,600788,ELONGIN C, ELOC
8740,600789,RIBOSOMAL PROTEIN L23-LIKE, RPL23L
8741,600790,"CHORIORETINAL ATROPHY, PROGRESSIVE BIFOCAL", PBCRA
8742,600791,"DEAFNESS, AUTOSOMAL RECESSIVE 4, WITH ENLARGED VESTIBULAR AQUEDUCT", DFNB4
8743,600792,"DEAFNESS, AUTOSOMAL RECESSIVE 5", DFNB5
8744,600793,DEOXYRIBONUCLEASE I-LIKE 1,
8745,600794,"NEURONOPATHY, DISTAL HEREDITARY MOTOR, AUTOSOMAL DOMINANT 5", HMND5
8746,600795,FRONTOTEMPORAL DEMENTIA AND/OR AMYOTROPHIC LATERAL SCLEROSIS 7, FTDALS7
8747,600796,"SPLICING FACTOR 3A, SUBUNIT 2", SF3A2
8748,600797,INSULIN RECEPTOR SUBSTRATE 2, IRS2
8749,600798,NECTIN CELL ADHESION MOLECULE 2, NECTIN2
8750,600799,"BONE MORPHOGENETIC PROTEIN RECEPTOR, TYPE II", BMPR2
8751,600800,NGFIA-BINDING PROTEIN, NAB1
8752,600801,ISOPROTERENOL-MEDIATED VASODILATATION,
8753,600802,"SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-POSITIVE, NK CELL-NEGATIVE",
8754,600803,GALLBLADDER DISEASE 1, GBD1
8755,600804,MELATONIN RECEPTOR 1B, MTNR1B
8756,600805,"LAMININ, ALPHA-3", LAMA3
8757,600806,CALPONIN 1, CNN1
8758,600807,"ASTHMA, SUSCEPTIBILITY TO",
8759,600808,"ENURESIS, NOCTURNAL, 2", ENUR2
8760,600809,"NUCLEAR RECEPTOR SUBFAMILY 2, GROUP F, MEMBER 1",
8761,600810,"PHOSPHOLIPASE C, BETA-4", PLCB4
8762,600811,DNA DAMAGE-BINDING PROTEIN 2, DDB2
8763,600812,"SPLICING FACTOR, SERINE/ARGININE-RICH, 1", SRSF1
8764,600813,"SPLICING FACTOR, SERINE/ARGININE-RICH, 2", SRSF2
8765,600814,"MRE11 HOMOLOG, DOUBLE-STRAND BREAK REPAIR NUCLEASE", MRE11
8766,600815,"POLYMERASE (DNA-DIRECTED), DELTA 2, REGULATORY SUBUNIT", POLD2
8767,600816,HEAT-SHOCK 70-KD PROTEIN 8, HSPA8
8768,600817,VISININ-LIKE 1, VSNL1
8769,600818,TRANSGELIN, TAGLN
8770,600819,FMR1 AUTOSOMAL HOMOLOG 1, FXR1
8771,600820,ARCHAIN 1, ARCN1
8772,600821,ARGININE VASOPRESSIN RECEPTOR 1A, AVPR1A
8773,600822,TATA BOX-BINDING PROTEIN-ASSOCIATED FACTOR 9, TAF9
8774,600823,"PROTEASE, SERINE, 8", PRSS8
8775,600824,CYSTEINE- AND GLYCINE-RICH PROTEIN 3, CSRP3
8776,600825,RAR-RELATED ORPHAN RECEPTOR A, RORA
8777,600826,CHONDROITIN SULFATE PROTEOGLYCAN 3, CSPG3
8778,600827,PHOSPHODIESTERASE 6C, PDE6C
8779,600828,"ATP SYNTHASE PERIPHERAL STALK, SUBUNIT OSCP", ATP5PO
8780,600829,INOSITOL POLYPHOSPHATE PHOSPHATASE-LIKE 1, INPPL1
8781,600830,TRIPARTITE MOTIF-CONTAINING PROTEIN 26, TRIM26
8782,600831,DEATH-ASSOCIATED PROTEIN KINASE 1, DAPK1
8783,600832,"ACIDIC NUCLEAR PHOSPHOPROTEIN 32 FAMILY, MEMBER A", ANP32A
8784,600833,SUPPRESSOR OF TUMORIGENICITY 7, ST7
8785,600834,ZINC FINGER PROTEIN 165, ZNF165
8786,600835,"CHEMOKINE, CXC MOTIF, LIGAND 12", CXCL12
8787,600836,"CRYSTALLIN, BETA-A2", CRYBA2
8788,600837,GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR, GDNF
8789,600838,FORKHEAD BOX N1, FOXN1
8790,600839,"SOLUTE CARRIER FAMILY 12 (SODIUM/POTASSIUM/CHLORIDE TRANSPORTER), MEMBER 1", SLC12A1
8791,600840,"SOLUTE CARRIER FAMILY 12 (SODIUM/POTASSIUM/CHLORIDE TRANSPORTER), MEMBER 2", SLC12A2
8792,600841,EUKARYOTIC TRANSLATION ELONGATION FACTOR 1 ALPHA-1-LIKE 14, EEF1A1L14
8793,600842,GLUCOKINASE REGULATORY PROTEIN, GCKR
8794,600843,"PURINERGIC RECEPTOR P2X, LIGAND-GATED ION CHANNEL, 3", P2RX3
8795,600844,"PURINERGIC RECEPTOR P2X, LIGAND-GATED ION CHANNEL, 2", P2RX2
8796,600845,"PURINERGIC RECEPTOR P2X, LIGAND-GATED ION CHANNEL, 1", P2RX1
8797,600846,"PURINERGIC RECEPTOR P2X, LIGAND-GATED ION CHANNEL, 4", P2RX4
8798,600847,S-PHASE KINASE-ASSOCIATED PROTEIN 1,
8799,600848,NUCLEAR RECEPTOR COREPRESSOR 2, NCOR2
8800,600849,NUCLEAR RECEPTOR COREPRESSOR 1, NCOR1
8801,600850,SCHIZOPHRENIA 4, SCZD4
8802,600851,MITOCHONDRIAL IMPORT-STIMULATING FACTOR,
8803,600852,RETINITIS PIGMENTOSA 17, RP17
8804,600853,N-DEACETYLASE/N-SULFOTRANSFERASE 1, NDST1
8805,600854,"POTASSIUM CHANNEL, INWARDLY RECTIFYING, SUBFAMILY J, MEMBER 6",
8806,600855,DUAL-SPECIFICITY TYROSINE PHOSPHORYLATION-REGULATED KINASE 1A, DYRK1A
8807,600856,CYCLIN-DEPENDENT KINASE INHIBITOR 1C, CDKN1C
8808,600857,"SUCCINATE DEHYDROGENASE COMPLEX, FLAVOPROTEIN SUBUNIT A", SDHA
8809,600858,"CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 6", CMH6
8810,600859,AMINOACYL tRNA SYNTHETASE COMPLEX-INTERACTING MULTIFUNCTIONAL PROTEIN 2, AIMP2
8811,600860,GENERAL TRANSCRIPTION FACTOR IIIA, GTF3A
8812,600861,REGULATOR OF G PROTEIN SIGNALING 2, RGS2
8813,600862,ADP-RIBOSYLATION FACTOR GTPase-ACTIVATING PROTEIN WITH FG REPEATS 1, AGFG1
8814,600863,"CASEIN KINASE I, EPSILON", CSNK1E
8815,600864,"CASEIN KINASE I, DELTA", CSNK1D
8816,600865,RETICULON 1, RTN1
8817,600866,PROGRAMMED CELL DEATH 2, PDCD2
8818,600867,"SIGNAL SEQUENCE RECEPTOR, BETA", SSR2
8819,600868,"SIGNAL SEQUENCE RECEPTOR, ALPHA", SSR1
8820,600869,G PROTEIN-COUPLED RECEPTOR KINASE 6, GRK6
8821,600870,G PROTEIN-COUPLED RECEPTOR KINASE 5, GRK5
8822,600871,GROWTH FACTOR-INDEPENDENT 1, GFI1
8823,600872,"X-LINKED B CELL SURFACE ANTIGEN, MOUSE, HOMOLOG-LIKE 1",
8824,600873,"CHITOBIASE, DI-N-ACETYL-", CTBS
8825,600874,"GUANINE NUCLEOTIDE-BINDING PROTEIN, GAMMA-5", GNG5
8826,600875,"ACYLPHOSPHATASE, ERYTHROCYTE", ACYP1
8827,600876,SYNTAXIN 3, STX3
8828,600877,"POTASSIUM CHANNEL, INWARDLY RECTIFYING, SUBFAMILY J, MEMBER 6", KCNJ6
8829,600878,"MUSCLE, SKELETAL, RECEPTOR TYROSINE KINASE",
8830,600879,NUCLEAR RESPIRATORY FACTOR 1, NRF1
8831,600880,BUDD-CHIARI SYNDROME, BDCHS
8832,600881,"CATARACT 10, MULTIPLE TYPES", CTRCT10
8833,600882,"CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2B", CMT2B
8834,600883,TYPE 1 DIABETES MELLITUS 8, T1D8
8835,600884,"CARDIOMYOPATHY, DILATED, 1B", CMD1B
8836,600885,NIJMEGEN BREAKAGE SYNDROME,
8837,600886,HYPERFERRITINEMIA WITH OR WITHOUT CATARACT, HRFTC
8838,600887,MutS HOMOLOG 3, MSH3
8839,600888,RHO GUANINE NUCLEOTIDE EXCHANGE FACTOR 5, ARHGEF5
8840,600889,COMPLEMENT FACTOR H-RELATED 2, CFHR2
8841,600890,"HYDROXYACYL-CoA DEHYDROGENASE/3-KETOACYL-CoA THIOLASE/ENOYL-CoA HYDRATASE, ALPHA SUBUNIT", HADHA
8842,600891,"MELANOMA ANTIGEN, FAMILY B, 2",
8843,600892,SIM bHLH TRANSCRIPTION FACTOR 2, SIM2
8844,600893,"MELANOMA ANTIGEN, FAMILY B, 1",
8845,600894,"CHEMOKINE, CXC MOTIF, RECEPTOR 3",
8846,600895,PROLACTIN-RELEASING HORMONE RECEPTOR, PRLHR
8847,600896,G PROTEIN-COUPLED RECEPTOR 14, GPR14
8848,600897,"GAP JUNCTION PROTEIN, ALPHA-8", GJA8
8849,600898,SRY-BOX 11, SOX11
8850,600899,"PROTEIN KINASE, DNA-ACTIVATED, CATALYTIC SUBUNIT", PRKDC
8851,600900,"SARCOGLYCAN, BETA", SGCB
8852,600901,"FANCONI ANEMIA, COMPLEMENTATION GROUP E", FANCE
8853,600902,SELENOPHOSPHATE SYNTHETASE 1, SEPHS1
8854,600903,"WISKOTT-ALDRICH SYNDROME, AUTOSOMAL DOMINANT",
8855,600904,ASTROTACTIN 1, ASTN1
8856,600905,EPHRIN RECEPTOR EphB1,
8857,600906,ECTODERMAL DYSPLASIA WITH IMPAIRED INTELLECTUAL DEVELOPMENT AND SYNDACTYLY,
8858,600907,"ENAMEL HYPOPLASIA, CATARACTS, AND AQUEDUCTAL STENOSIS",
8859,600908,MYOECTODERMAL GONADAL DYSGENESIS SYNDROME,
8860,600909,LANOSTEROL SYNTHASE, LSS
8861,600910,INSULIN-LIKE 4, INSL4
8862,600911,METALLOPHOSPHOESTERASE DOMAIN-CONTAINING PROTEIN 2, MPPED2
8863,600912,TRANSCRIPTION FACTOR 19, TCF19
8864,600913,INSULIN-INDUCED GENE 1,
8865,600914,"SPLICING FACTOR, SERINE/ARGININE-RICH, 5", SRSF5
8866,600915,NESTIN, NES
8867,600916,"INOSITOL POLYPHOSPHATE-4-PHOSPHATASE, TYPE I, 107-KD", INPP4A
8868,600917,"PROTEIN PHOSPHATASE 1, REGULATORY SUBUNIT 3A", PPP1R3A
8869,600918,CYSTINURIA,
8870,600919,"CARDIAC ARRHYTHMIA, ANKYRIN-B-RELATED",
8871,600920,VAN DEN ENDE-GUPTA SYNDROME, VDEGS
8872,600921,FIBROBLAST GROWTH FACTOR 9, FGF9
8873,600922,MYOSIN LIGHT CHAIN KINASE, MYLK
8874,600923,PROTOPORPHYRINOGEN OXIDASE, PPOX
8875,600924,"GROWTH FACTOR, ERV1-LIKE", GFER
8876,600925,"PROTEIN-TYROSINE PHOSPHATASE, RECEPTOR-TYPE, J", PTPRJ
8877,600926,"PROTEIN-TYROSINE PHOSPHATASE, RECEPTOR-TYPE, EPSILON", PTPRE
8878,600927,CYCLIN-DEPENDENT KINASE INHIBITOR 2D, CDKN2D
8879,600928,NITROGEN PERMEASE REGULATOR-LIKE 3, NPRL3
8880,600929,"CRYSTALLIN, BETA-B1", CRYBB1
8881,600930,SPERM ADHESION MOLECULE 1, SPAM1
8882,600931,PROTOCADHERIN 3,
8883,600932,"POTASSIUM INWARDLY-RECTIFYING CHANNEL, SUBFAMILY J, MEMBER 9", KCNJ9
8884,600933,COAGULATION FACTOR II RECEPTOR-LIKE 1, F2RL1
8885,600934,FOLATE HYDROLASE 1, FOLH1
8886,600935,"POTASSIUM CHANNEL, INWARDLY RECTIFYING, SUBFAMILY J, MEMBER 8", KCNJ8
8887,600936,HYALURONAN-MEDIATED MOTILITY RECEPTOR, HMMR
8888,600937,"POTASSIUM CHANNEL, INWARDLY RECTIFYING, SUBFAMILY J, MEMBER 11", KCNJ11
8889,600938,RETINOBLASTOMA-BINDING PROTEIN 6, RBBP6
8890,600939,"INTERLEUKIN 11 RECEPTOR, ALPHA", IL11RA
8891,600940,"LIGASE III, DNA, ATP-DEPENDENT", LIG3
8892,600941,BILIVERDIN REDUCTASE B, BLVRB
8893,600942,"SERPIN PEPTIDASE INHIBITOR, CLADE H, MEMBER 1",
8894,600943,"SERPIN PEPTIDASE INHIBITOR, CLADE H, MEMBER 1", SERPINH1
8895,600944,DEOXYHYPUSINE SYNTHASE, DHPS
8896,600945,UROCORTIN, UCN
8897,600946,GROWTH HORMONE RECEPTOR, GHR
8898,600947,HUNTINGTIN-ASSOCIATED PROTEIN 1, HAP1
8899,600948,MYELIN-ASSOCIATED OLIGODENDROCYTE BASIC PROTEIN, MOBP
8900,600949,IMMUNOGLOBULIN HEAVY CHAIN VARIABLE REGION-2,
8901,600950,ARYLALKYLAMINE N-ACETYLTRANSFERASE, AANAT
8902,600951,TELOMERIC REPEAT-BINDING FACTOR 1, TERF1
8903,600952,TRANSSEXUALITY,
8904,600953,INTERLEUKIN 18, IL18
8905,600954,DEATH-ASSOCIATED PROTEIN, DAP
8906,600955,PROPROTEIN CONVERTASE 1/3 DEFICIENCY,
8907,600956,ANTI-MULLERIAN HORMONE TYPE II RECEPTOR, AMHR2
8908,600957,ANTI-MULLERIAN HORMONE, AMH
8909,600958,"MYOSIN-BINDING PROTEIN C, CARDIAC", MYBPC3
8910,600959,"COATOMER PROTEIN COMPLEX, SUBUNIT BETA 1", COPB1
8911,600960,SET NUCLEAR PROTOONCOGENE, SET
8912,600961,PEROXISOME BIOGENESIS FACTOR 6,
8913,600962,"PALMOPLANTAR KERATODERMA, NONEPIDERMOLYTIC", NEPPK
8914,600963,SIX HOMEOBOX 5, SIX5
8915,600964,"REFSUM DISEASE, CLASSIC",
8916,600965,"DEAFNESS, AUTOSOMAL DOMINANT 6", DFNA6
8917,600966,LLGL SCRIBBLE CELL POLARITY COMPLEX COMPONENT 1, LLGL1
8918,600967,E2F TRANSCRIPTION FACTOR 5, E2F5
8919,600968,"SOLUTE CARRIER FAMILY 12 (SODIUM/CHLORIDE TRANSPORTER), MEMBER 3", SLC12A3
8920,600969,"EPIPHYSEAL DYSPLASIA, MULTIPLE, 3", EDM3
8921,600970,MYOSIN VI, MYO6
8922,600971,"DEAFNESS, AUTOSOMAL RECESSIVE 6", DFNB6
8923,600972,"ACHONDROGENESIS, TYPE IB", ACG1B
8924,600973,AQUAPORIN 4,
8925,600974,"DEAFNESS, AUTOSOMAL RECESSIVE 7", DFNB7
8926,600975,"GLAUCOMA 3, PRIMARY INFANTILE, B", GLC3B
8927,600976,FAT ATYPICAL CADHERIN 1, FAT1
8928,600977,CONE-ROD DYSTROPHY 5, CORD5
8929,600978,LYMPHOTOXIN-BETA, LTB
8930,600979,LYMPHOTOXIN B RECEPTOR, LTBR
8931,600980,DENTIN MATRIX ACIDIC PHOSPHOPROTEIN 1, DMP1
8932,600981,PHOSPHOGLUCOMUTASE 5, PGM5
8933,600982,MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 1, MAP3K1
8934,600983,"NUCLEAR RECEPTOR SUBFAMILY 3, GROUP C, MEMBER 2", NR3C2
8935,600984,"ACTIVATING TRANSCRIPTION FACTOR 6, BETA", ATF6B
8936,600985,TENASCIN XB, TNXB
8937,600986,TRIPARTITE MOTIF-CONTAINING PROTEIN 46, TRIM46
8938,600987,"CLEFT PALATE, CARDIAC DEFECTS, AND IMPAIRED INTELLECTUAL DEVELOPMENT", CPCMR
8939,600988,"MANNOSIDASE, ALPHA, CLASS 2A, MEMBER 2", MAN2A2
8940,600989,INFUNDIBULOPELVIC DYSGENESIS,
8941,600990,BLEPHAROCHEILODONTIC SYNDROME 1,
8942,600991,"HYDROCEPHALUS, SPRENGEL ANOMALY, AND COSTOVERTEBRAL DYSPLASIA",
8943,600992,"MICROPHTHALMIA, SYNDROMIC 3",
8944,600993,SMAD FAMILY MEMBER 4, SMAD4
8945,600994,"DEAFNESS, AUTOSOMAL DOMINANT 5", DFNA5
8946,600995,"NEPHROTIC SYNDROME, TYPE 2", NPHS2
8947,600996,"VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 1, WITH OR WITHOUT ATRIAL DYSFUNCTION AND/OR DILATED CARDIOMYOPATHY",
8948,600997,EPHRIN RECEPTOR EphB2, EPHB2
8949,600998,"GUANINE NUCLEOTIDE-BINDING PROTEIN, Q POLYPEPTIDE", GNAQ
8950,600999,MYC-ASSOCIATED ZINC FINGER PROTEIN, MAZ
8951,601000,LEUKOCYTE-SPECIFIC TRANSCRIPT 1,
8952,601001,"EPIDERMOLYSIS BULLOSA SIMPLEX 1D, GENERALIZED, INTERMEDIATE OR SEVERE, AUTOSOMAL RECESSIVE", EBS1D
8953,601002,GLUTATHIONE SYNTHETASE, GSS
8954,601003,BRODY DISEASE, BROD
8955,601004,"PORTAL VEIN, CAVERNOUS TRANSFORMATION OF",
8956,601005,TIMOTHY SYNDROME, TS
8957,601006,GOOSECOID HOMEOBOX,
8958,601007,LEPTIN RECEPTOR, LEPR
8959,601008,KINESIN FAMILY MEMBER 11,
8960,601009,TIGHT JUNCTION PROTEIN 1, TJP1
8961,601010,TRANSCRIPTION FACTOR 15, TCF15
8962,601011,"CALCIUM CHANNEL, VOLTAGE-DEPENDENT, P/Q TYPE, ALPHA-1A SUBUNIT", CACNA1A
8963,601012,"CALCIUM CHANNEL, VOLTAGE-DEPENDENT, N TYPE, ALPHA-1B SUBUNIT", CACNA1B
8964,601013,"CALCIUM CHANNEL, VOLTAGE-DEPENDENT, ALPHA-1E SUBUNIT", CACNA1E
8965,601014,DISCS LARGE MAGUK SCAFFOLD PROTEIN 1, DLG1
8966,601015,NPC INTRACELLULAR CHOLESTEROL TRANSPORTER 2, NPC2
8967,601016,"MIDLINE MALFORMATIONS, MULTIPLE, WITH LIMB ABNORMALITIES AND HYPOPITUITARISM",
8968,601017,"SYNTROPHIN, ALPHA-1", SNTA1
8969,601018,"SYNTROPHIN, BETA-2",
8970,601019,"SOLUTE CARRIER FAMILY 6 (NEUROTRANSMITTER TRANSPORTER, GLYCINE), MEMBER 9", SLC6A9
8971,601020,CD86 ANTIGEN, CD86
8972,601021,"NUCLEOPORIN, 98-KD", NUP98
8973,601022,NUCLEAR FACTOR-KAPPA-B INHIBITOR-LIKE PROTEIN 1, NFKBIL1
8974,601023,VALOSIN-CONTAINING PROTEIN, VCP
8975,601024,"ADAPTOR-RELATED PROTEIN COMPLEX 2, MU-1 SUBUNIT", AP2M1
8976,601025,"ADAPTOR-RELATED PROTEIN COMPLEX 2, BETA-1 SUBUNIT", AP2B1
8977,601026,"ADAPTOR-RELATED PROTEIN COMPLEX 2, ALPHA-1 SUBUNIT", AP2A1
8978,601027,"TIBIA, ABSENCE OR HYPOPLASIA OF, WITH POLYDACTYLY, RETROCEREBELLAR ARACHNOID CYST, AND OTHER ANOMALIES",
8979,601028,CD47 ANTIGEN, CD47
8980,601029,MESODERM-SPECIFIC TRANSCRIPT, MEST
8981,601030,"RIBONUCLEASE A FAMILY, MEMBER 4", RNASE4
8982,601031,RHOPHILIN 1, RHPN1
8983,601032,PROTEIN KINASE N1, PKN1
8984,601033,"LAMININ, ALPHA-5", LAMA5
8985,601034,MELANOMA ADHESION MOLECULE,
8986,601035,HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN H1, HNRNPH1
8987,601036,HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN H2,
8988,601037,HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN F, HNRNPF
8989,601038,"DEIODINASE, IODOTHYRONINE, TYPE III", DIO3
8990,601039,ICHTHYOSIS-IMPAIRED INTELLECTUAL DEVELOPMENTAL SYNDROME WITH LARGE KERATOHYALIN GRANULES IN THE SKIN,
8991,601040,"SCAVENGER RECEPTOR CLASS B, MEMBER 1", SCARB1
8992,601041,"TLE FAMILY MEMBER 2, TRANSCRIPTIONAL COREPRESSOR", TLE2
8993,601042,DYSTONIA 9, DYT9
8994,601043,HIGH MOBILITY GROUP AT-HOOK 1,
8995,601044,HIGH MOBILITY GROUP AT-HOOK 1,
8996,601045,"CATENIN, DELTA-1", CTNND1
8997,601046,MATRIX METALLOPROTEINASE 12, MMP12
8998,601047,CAVEOLIN 1, CAV1
8999,601048,CAVEOLIN 2, CAV2
9000,601049,"INTERLEUKIN 13 RECEPTOR, ALPHA-1",
9001,601050,TITLE NOT AVAILABLE AT THIS MOMENT,
9002,601051,MESOTHELIN, MSLN
9003,601052,"PEPTIDYL-PROLYL CIS/TRANS ISOMERASE, NIMA-INTERACTING, 1", PIN1
9004,601053,PLEXIN B1, PLXNB1
9005,601054,PLEXIN A2, PLXNA2
9006,601055,PLEXIN A1, PLXNA1
9007,601056,BCL2-RELATED PROTEIN A1, BCL2A1
9008,601057,PROGRAMMED CELL DEATH 6, PDCD6
9009,601058,"H3 HISTONE, FAMILY 3B", H3F3B
9010,601059,"ADENOSINE DEAMINASE, RNA-SPECIFIC",
9011,601060,ECTONUCLEOTIDE PYROPHOSPHATASE/PHOSPHODIESTERASE 2, ENPP2
9012,601061,SMALL NUCLEAR RIBONUCLEOPROTEIN POLYPEPTIDE D2, SNRPD2
9013,601062,SMALL NUCLEAR RIBONUCLEOPROTEIN POLYPEPTIDE D3, SNRPD3
9014,601063,SMALL NUCLEAR RIBONUCLEOPROTEIN POLYPEPTIDE D1, SNRPD1
9015,601064,ZINC FINGER PROTEIN 36-LIKE 1, ZFP36L1
9016,601065,ALANYL-tRNA SYNTHETASE 1, AARS1
9017,601066,"OXIDASE, CYTOCHROME c, ASSEMBLY 1-LIKE", OXA1L
9018,601067,"USHER SYNDROME, TYPE ID", USH1D
9019,601068,"EPILEPSY, FAMILIAL ADULT MYOCLONIC, 1", FAME1
9020,601069,ZINC FINGER PROTEIN 239, ZNF239
9021,601070,"INTERLEUKIN 15 RECEPTOR, ALPHA", IL15RA
9022,601071,"DEAFNESS, AUTOSOMAL RECESSIVE 9", DFNB9
9023,601072,"DEAFNESS, AUTOSOMAL RECESSIVE 8", DFNB8
9024,601073,NONAKA MYOPATHY,
9025,601074,"CUGBP- AND ELAV-LIKE FAMILY, MEMBER 1", CELF1
9026,601075,"APLASIA CUTIS CONGENITA, HIGH MYOPIA, AND CONE-ROD DYSFUNCTION",
9027,601076,"MULLERIAN DUCT APLASIA, UNILATERAL RENAL AGENESIS, AND CERVICOTHORACIC SOMITE ANOMALIES", MURCS
9028,601077,"KERATIN 31, TYPE I", KRT31
9029,601078,"KERATIN 82, TYPE II", KRT82
9030,601079,ZRSR2 PSEUDOGENE 1, ZRSR2P1
9031,601080,U2 SMALL NUCLEAR RNA AUXILIARY FACTOR 1-LIKE 4, U2AF1L4
9032,601081,"ATP-BINDING CASSETTE, SUBFAMILY 3, MEMBER 2", ABCD2
9033,601082,UBIQUITIN-CONJUGATING ENZYME E2 H, UBE2H
9034,601083,CD4/CD8 T-CELL RATIO,
9035,601084,DERMCIDIN,
9036,601085,"EPILEPSY, FOCAL, WITH SPEECH DISORDER AND WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT",
9037,601086,"LATERALITY DEFECTS, AUTOSOMAL DOMINANT",
9038,601087,"FEBRILE SEIZURES, FAMILIAL, 1",
9039,601088,AYME-GRIPP SYNDROME, AYGRP
9040,601089,FORKHEAD BOX F1, FOXF1
9041,601090,FORKHEAD BOX C1, FOXC1
9042,601091,FORKHEAD BOX D1, FOXD1
9043,601092,FORKHEAD BOX D4, FOXD4
9044,601093,FORKHEAD BOX I1, FOXI1
9045,601094,FORKHEAD BOX E3, FOXE3
9046,601095,HARROD SYNDROME,
9047,601096,"SPONDYLOEPIMETAPHYSEAL DYSPLASIA, MICROMELIC",
9048,601097,PERIPHERAL MYELIN PROTEIN 22, PMP22
9049,601098,"CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1C", CMT1C
9050,601099,SRC-LIKE ADAPTOR, SLA
9051,601100,HEAT SHOCK 70-KD PROTEIN 13, HSPA13
9052,601101,"TELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 1",
9053,601102,"EUKARYOTIC TRANSLATION INITIATION FACTOR 4A, ISOFORM 2", EIF4A2
9054,601103,MICROFIBRILLAR-ASSOCIATED PROTEIN 5, MFAP5
9055,601104,"SUPRANUCLEAR PALSY, PROGRESSIVE, 1", PSNP1
9056,601105,CATHEPSIN K, CTSK
9057,601106,TITLE NOT AVAILABLE AT THIS MOMENT,
9058,601107,"ATP-BINDING CASSETTE, SUBFAMILY C, MEMBER 2", ABCC2
9059,601108,INTERLEUKIN 1 RECEPTOR-ASSOCIATED KINASE 1,
9060,601109,5-HYDROXYTRYPTAMINE RECEPTOR 6, HTR6
9061,601110,"CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Id", CDG1D
9062,601111,BILIVERDIN REDUCTASE B,
9063,601112,THIOREDOXIN REDUCTASE 1, TXNRD1
9064,601113,"HEAT-SHOCK PROTEIN FAMILY A (HSP70), MEMBER 4", HSPA4
9065,601114,"MEMBRANE PROTEIN, PALMITOYLATED 3", MPP3
9066,601115,"GLUTAMATE RECEPTOR, METABOTROPIC, 3", GRM3
9067,601116,"GLUTAMATE RECEPTOR, METABOTROPIC, 8", GRM8
9068,601117,THIMET OLIGOPEPTIDASE 1, THOP1
9069,601118,CALCIUM-MODULATING LIGAND, CAMLG
9070,601119,CASEINOLYTIC MITOCHONDRIAL MATRIX PEPTIDASE PROTEOLYTIC SUBUNIT, CLPP
9071,601120,CADHERIN 5, CDH5
9072,601121,PLACENTAL GROWTH FACTOR, PGF
9073,601122,5-HYDROXYTRYPTAMINE RECEPTOR 2B, HTR2B
9074,601123,"ST8 ALPHA-N-ACETYL-NEURAMINIDE ALPHA-2,8-SIALYLTRANSFERASE 1", ST8SIA1
9075,601124,SEMAPHORIN 3F, SEMA3F
9076,601125,HEXOKINASE 2, HK2
9077,601126,TATA ELEMENT MODULATORY FACTOR 1, TMF1
9078,601127,FALLOT COMPLEX WITH SEVERE MENTAL AND GROWTH RETARDATION,
9079,601128,"H3 HISTONE, FAMILY 3A", H3F3A
9080,601129,"CYTOCHROME P450, SUBFAMILY IIC, POLYPEPTIDE 8", CYP2C8
9081,601130,"CYTOCHROME P450, SUBFAMILY IIC, POLYPEPTIDE 9", CYP2C9
9082,601131,"CYTOCHROME P450, SUBFAMILY IIC, POLYPEPTIDE 18", CYP2C18
9083,601132,KINASE SUPPRESSOR OF RAS 1, KSR1
9084,601133,"CYTOCHROME P450, FAMILY 2, SUBFAMILY G, MEMBER 1, PSEUDOGENE", CYP2G1P
9085,601134,"OLIGOSACCHARYLTRANSFERASE COMPLEX, CATALYTIC SUBUNIT STT3A", STT3A
9086,601135,GASTRULATION BRAIN HOMEOBOX 2, GBX2
9087,601136,TRANSSUPPRESSOR OF EXPRESSION 2,
9088,601137,"GUANYLATE CYCLASE 2E, PSEUDOGENE",
9089,601138,"GUANYLATE CYCLASE 2E, PSEUDOGENE", GUCY2EP
9090,601139,ZINC FINGER PROTEIN 175, ZNF175
9091,601140,"PROTEIN PHOSPHATASE 1, REGULATORY SUBUNIT 14B", PPP1R14B
9092,601141,"POTASSIUM CHANNEL, VOLTAGE-GATED, SHAKER-RELATED SUBFAMILY, BETA MEMBER 1", KCNAB1
9093,601142,"POTASSIUM CHANNEL, VOLTAGE-GATED, SHAKER-RELATED SUBFAMILY, BETA MEMBER 2", KCNAB2
9094,601143,DYNACTIN 1, DCTN1
9095,601144,BRUGADA SYNDROME 1, BRGDA1
9096,601145,CYSTATIN B, CSTB
9097,601146,GROWTH/DIFFERENTIATION FACTOR 5, GDF5
9098,601147,GROWTH/DIFFERENTIATION FACTOR 6, GDF6
9099,601148,SPERM MITOCHONDRIA-ASSOCIATED CYSTEINE-RICH PROTEIN, SMCP
9100,601149,"ISOCITRATE DEHYDROGENASE, NAD(+), 3, CATALYTIC SUBUNIT ALPHA", IDH3A
9101,601150,DEAD/H-BOX HELICASE 11, DDX11
9102,601151,"DEAD/H-BOX HELICASE 12, PSEUDOGENE", DDX12P
9103,601152,"NEUROPATHY, HEREDITARY MOTOR AND SENSORY, TYPE VIA, WITH OPTIC ATROPHY", HMSN6A
9104,601153,FRAGILE HISTIDINE TRIAD DIADENOSINE TRIPHOSPHATASE, FHIT
9105,601154,"CARDIOMYOPATHY, DILATED, 1E", CMD1E
9106,601155,MINOR HISTOCOMPATIBILITY ANTIGEN HA-1, HMHA1
9107,601156,"CHEMOKINE, CC MOTIF, LIGAND 11", CCL11
9108,601157,"DEFENSIN, ALPHA, 4", DEFA4
9109,601158,MITOGEN-ACTIVATED PROTEIN KINASE 8, MAPK8
9110,601159,"CHEMOKINE, CC MOTIF, RECEPTOR 1", CCR1
9111,601160,LISSENCEPHALY TYPE III AND BONE DYSPLASIA,
9112,601161,TRISOMY 18-LIKE SYNDROME,
9113,601162,"SPASTIC PARAPLEGIA 9A, AUTOSOMAL DOMINANT", SPG9A
9114,601163,"DIAPHRAGMATIC DEFECTS, LIMB DEFICIENCIES, AND OSSIFICATION DEFECTS OF SKULL",
9115,601164,WOODHOUSE-SAKATI SYNDROME,
9116,601165,"CLEFT LIP/PALATE WITH CHARACTERISTIC FACIES, INTESTINAL MALROTATION, AND LETHAL CONGENITAL HEART DISEASE",
9117,601166,G PROTEIN-COUPLED RECEPTOR 15, GPR15
9118,601167,"PURINERGIC RECEPTOR P2Y, G PROTEIN-COUPLED, 1", P2RY1
9119,601168,DIHYDROPYRIMIDINASE-LIKE 3, DPYSL3
9120,601169,TITLE NOT AVAILABLE AT THIS MOMENT,
9121,601170,"MUSCULAR DYSTROPHY, CONGENITAL, WITH SEVERE CENTRAL NERVOUS SYSTEM ATROPHY AND ABSENCE OF LARGE MYELINATED FIBERS",
9122,601171,"SERPIN PEPTIDASE INHIBITOR, CLADE B (OVALBUMIN), MEMBER 6",
9123,601172,CHONDROITIN SULFATE PROTEOGLYCAN 4, CSPG4
9124,601173,"MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 1",
9125,601174,"CREATINE KINASE, BRAIN TYPE",
9126,601175,ADP-RIBOSYLATION FACTOR-LIKE GTPase 2, ARL2
9127,601176,"GLUTAMATE-CYSTEINE LIGASE, MODIFIER SUBUNIT", GCLM
9128,601177,ADP-RIBOSYLATION FACTOR 4, ARF4
9129,601178,CELL CYCLE-ASSOCIATED PROTEIN 1, CAPRIN1
9130,601179,RAS-RELATED NUCLEAR PROTEIN, RAN
9131,601180,RAN-BINDING PROTEIN 1, RANBP1
9132,601181,RAN-BINDING PROTEIN 2, RANBP2
9133,601182,"ORIGIN RECOGNITION COMPLEX, SUBUNIT 2", ORC2
9134,601183,CYSTEINE-RICH INTESTINAL PROTEIN 2, CRIP2
9135,601184,"DNAJ/HSP40 HOMOLOG, SUBFAMILY C, MEMBER 3", DNAJC3
9136,601185,STANNIOCALCIN 1, STC1
9137,601186,"MICROPHTHALMIA, SYNDROMIC 9", MCOPS9
9138,601187,GURRIERI SYNDROME,
9139,601188,SUPPRESSION OF TUMORIGENICITY 12, ST12
9140,601189,"POLYMERASE II, RNA, SUBUNIT L", POLR2L
9141,601190,PHOSPHODIESTERASE 6H, PDE6H
9142,601191,ERH mRNA SPLICING AND MITOSIS FACTOR, ERH
9143,601192,"PHOSPHOLIPASE A2, GROUP V", PLA2G5
9144,601193,CYSTEINE-RICH SECRETORY PROTEIN 1, CRISP1
9145,601194,TOLL-LIKE RECEPTOR 1, TLR1
9146,601195,IRON OVERLOAD IN AFRICA,
9147,601196,PR DOMAIN-CONTAINING PROTEIN 2, PRDM2
9148,601197,TUB BIPARTITE TRANSCRIPTION FACTOR, TUB
9149,601198,"HYPOCALCEMIA, AUTOSOMAL DOMINANT 1", HYPOC1
9150,601199,CALCIUM-SENSING RECEPTOR, CASR
9151,601200,PLEUROPULMONARY BLASTOMA, PPB
9152,601201,METHYLATION MODIFIER FOR CLASS I HLA,
9153,601202,CATARACT 24, CTRCT24
9154,601203,INTERLEUKIN 1 RECEPTOR-LIKE 1, IL1RL1
9155,601204,PROSTAGLANDIN F2 RECEPTOR NEGATIVE REGULATOR, PTGFRN
9156,601205,SIX HOMEOBOX 1, SIX1
9157,601206,POU CLASS 2 HOMEOBOX-ASSOCIATING FACTOR 1, POU2AF1
9158,601207,"DIACYLGLYCEROL KINASE, THETA, 110-KD", DGKQ
9159,601208,TYPE 1 DIABETES MELLITUS 11, T1D11
9160,601209,POLY(rC)-BINDING PROTEIN 1, PCBP1
9161,601210,POLY(rC)-BINDING PROTEIN 2, PCBP2
9162,601211,ADHESION G PROTEIN-COUPLED RECEPTOR E5, ADGRE5
9163,601212,"PROTEIN-TYROSINE KINASE 2, BETA", PTK2B
9164,601213,"ATP-BINDING CASSETTE, SUBFAMILY E, MEMBER 1", ABCE1
9165,601214,NAXOS DISEASE, NXD
9166,601215,ATR SERINE/THREONINE KINASE, ATR
9167,601216,DENTAL ANOMALIES AND SHORT STATURE, DASS
9168,601217,ALOPECIA-IMPAIRED INTELLECTUAL DEVELOPMENTAL SYNDROME WITH CONVULSIONS AND HYPERGONADOTROPIC HYPOGONADISM,
9169,601218,"ADENOSINE DEAMINASE, RNA-SPECIFIC, B1", ADARB1
9170,601219,"SODIUM VOLTAGE-GATED CHANNEL, ALPHA SUBUNIT 2",
9171,601220,OSTEOPOROSIS AND OCULOCUTANEOUS HYPOPIGMENTATION SYNDROME, OOCH
9172,601221,TISSUE-SPECIFIC EXTINGUISHER 3,
9173,601222,CHROMOSOME 2q35 DUPLICATION SYNDROME,
9174,601223,"NEURONAL INTESTINAL DYSPLASIA, TYPE B",
9175,601224,POTOCKI-SHAFFER SYNDROME,
9176,601225,DISHEVELLED 1-LIKE 1, DVL1L1
9177,601226,"PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 1",
9178,601227,"PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 1",
9179,601228,"POLYPOSIS SYNDROME, HEREDITARY MIXED, 1", HMPS1
9180,601229,B-CELL CLL/LYMPHOMA 2,
9181,601230,"DERMATITIS HERPETIFORMIS, FAMILIAL",
9182,601231,MECHANISTIC TARGET OF RAPAMYCIN, MTOR
9183,601232,"PHOSPHATIDYLINOSITOL 3-KINASE, CATALYTIC, GAMMA", PIK3CG
9184,601233,"INHIBIN, BETA C", INHBC
9185,601234,"NASCENT POLYPEPTIDE-ASSOCIATED COMPLEX, ALPHA POLYPEPTIDE", NACA
9186,601235,DEAD-BOX HELICASE 10, DDX10
9187,601236,DAB ADAPTOR PROTEIN 2, DAB2
9188,601237,RING FINGER PROTEIN 112, RNF112
9189,601238,"CEREBELLAR ATAXIA, CAYMAN TYPE", ATCAY
9190,601239,"DYSTROBREVIN, ALPHA", DTNA
9191,601240,GUANIDINOACETATE METHYLTRANSFERASE, GAMT
9192,601241,HISTONE DEACETYLASE 1, HDAC1
9193,601242,"MICROTUBULE-ASSOCIATED PROTEIN 1, LIGHT CHAIN 3, ALPHA", MAP1LC3A
9194,601243,"TOPOISOMERASE, DNA, III, ALPHA", TOP3A
9195,601244,"GUANYLATE CYCLASE 1, SOLUBLE, ALPHA-2", GUCY1A2
9196,601245,"CHROMATIN ASSEMBLY FACTOR I, SUBUNIT B", CHAF1B
9197,601246,"CHROMATIN ASSEMBLY FACTOR I, SUBUNIT A", CHAF1A
9198,601247,SOS RAS/RAC GUANINE NUCLEOTIDE EXCHANGE FACTOR 2, SOS2
9199,601248,BRIDGING INTEGRATOR 1, BIN1
9200,601249,PHOSPHORIBOSYLPYROPHOSPHATE SYNTHETASE-ASSOCIATED PROTEIN 1, PRPSAP1
9201,601250,PEPTIDE METHIONINE SULFOXIDE REDUCTASE, MSRA
9202,601251,CONE-ROD DYSTROPHY 6,
9203,601252,FICOLIN 1, FCN1
9204,601253,CAVEOLIN 3, CAV3
9205,601254,MITOGEN-ACTIVATED PROTEIN KINASE KINASE 6, MAP2K6
9206,601255,KINESIN FAMILY MEMBER 1A, KIF1A
9207,601256,"ANGIOTENSIN II RECEPTOR, TYPE 1",
9208,601257,DEAD-BOX HELICASE 1, DDX1
9209,601258,"CYTOCHROME P450, SUBFAMILY IIJ, POLYPEPTIDE 2", CYP2J2
9210,601259,AMELOBLASTIN ENAMEL MATRIX PROTEIN, AMBN
9211,601260,ZINC FINGER PROTEIN WITH KRAB AND SCAN DOMAINS 1, ZKSCAN1
9212,601261,ZINC FINGER- AND SCAN DOMAIN-CONTAINING PROTEIN 21, ZSCAN21
9213,601262,ZINC FINGER PROTEIN 16, ZNF16
9214,601263,MITOGEN-ACTIVATED PROTEIN KINASE KINASE 2, MAP2K2
9215,601264,GUANYLATE CYCLASE ACTIVATOR 2B,
9216,601265,NODAL GROWTH DIFFERENTIATION FACTOR, NODAL
9217,601266,dUTP PYROPHOSPHATASE, DUT
9218,601267,"CHEMOKINE, CC MOTIF, RECEPTOR 2", CCR2
9219,601268,"CHEMOKINE, CC MOTIF, RECEPTOR 3", CCR3
9220,601269,COMPLEMENT COMPONENT C1q-BINDING PROTEIN, C1QBP
9221,601270,"CYTOCHROME P450, FAMILY 4, SUBFAMILY F, POLYPEPTIDE 3", CYP4F3
9222,601271,GUANYLATE CYCLASE ACTIVATOR 2B, GUCA2B
9223,601272,SORTING NEXIN 1, SNX1
9224,601273,"CLATHRIN, HEAVY POLYPEPTIDE-LIKE 1", CLTCL1
9225,601274,PROSTAGLANDIN REDUCTASE 1, PTGR1
9226,601275,GLYCOPROTEIN M6A, GPM6A
9227,601276,ZINC FINGER PROTEIN 177, ZNF177
9228,601277,"ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 4A", ARCI4A
9229,601278,FSHD REGION GENE 1, FRG1
9230,601279,DIGEORGE SYNDROME CRITICAL REGION GENE 6, DGCR6
9231,601280,MAB21-LIKE 1, MAB21L1
9232,601281,SEMAPHORIN 3B, SEMA3B
9233,601282,PLECTIN, PLEC
9234,601283,TYPE 2 DIABETES MELLITUS 1, T2D1
9235,601284,"ACTIVIN A RECEPTOR, TYPE II-LIKE 1", ACVRL1
9236,601285,PROTEASOME 26S SUBUNIT SEM1, SEM1
9237,601286,"CATARACT 4, MULTIPLE TYPES",
9238,601287,"MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 6", LGMDR6
9239,601288,"TYROSINE 3-MONOOXYGENASE/TRYPTOPHAN 5-MONOOXYGENASE ACTIVATION PROTEIN, ZETA ISOFORM", YWHAZ
9240,601289,"TYROSINE 3-MONOOXYGENASE/TRYPTOPHAN 5-MONOOXYGENASE ACTIVATION PROTEIN, BETA ISOFORM", YWHAB
9241,601290,STRATIFIN, SFN
9242,601291,URIDINE DIPHOSPHATE GLYCOSYLTRANSFERASE 8, UGT8
9243,601292,"SULFOTRANSFERASE FAMILY 1A, CYTOSOLIC, PHENOL-PREFERRING, MEMBER 2", SULT1A2
9244,601293,RAS HOMOLOG ENRICHED IN BRAIN, RHEB
9245,601294,TITLE NOT AVAILABLE AT THIS MOMENT,
9246,601295,"SOLUTE CARRIER FAMILY 10 (SODIUM/BILE ACID COTRANSPORTER FAMILY), MEMBER 2", SLC10A2
9247,601296,"MUSCLE, SKELETAL, RECEPTOR TYROSINE KINASE", MUSK
9248,601297,SRY-BOX 15, SOX15
9249,601298,"ACTIVIN A RECEPTOR, TYPE I",
9250,601299,"BONE MORPHOGENETIC PROTEIN RECEPTOR, TYPE IA", BMPR1A
9251,601300,"ACTIVIN A RECEPTOR, TYPE IB", ACVR1B
9252,601301,PEPTIDYL-PROLYL ISOMERASE-LIKE 1, PPIL1
9253,601302,"PROTEIN PHOSPHATASE 3, REGULATORY SUBUNIT B, ALPHA", PPP3R1
9254,601303,CYTOSKELETON-ASSOCIATED PROTEIN 1, CKAP1
9255,601304,"SMALL NUCLEAR RIBONUCLEOPROTEIN (U4/U6.U5), SNU13 HOMOLOG", SNU13
9256,601305,5-HYDROXYTRYPTAMINE RECEPTOR 5A, HTR5A
9257,601306,HEMATOPOIETIC CELL-SPECIFIC LYN SUBSTRATE 1, HCLS1
9258,601307,"GROWTH FACTOR, ERV1-LIKE",
9259,601308,MYELOID TUMOR SUPPRESSOR,
9260,601309,PATCHED 1, PTCH1
9261,601310,"CYTOCHROME P450, SUBFAMILY IVA, POLYPEPTIDE 11", CYP4A11
9262,601311,STEROL O-ACYLTRANSFERASE 2, SOAT2
9263,601312,"DISCOIDIN DOMAIN RECEPTOR FAMILY, MEMBER 1",
9264,601313,POLYCYSTIN 1, PKD1
9265,601314,HISTIDINE TRIAD NUCLEOTIDE-BINDING PROTEIN 1, HINT1
9266,601315,"EPITHELIAL BASOLATERAL CHLORIDE CONDUCTANCE REGULATOR, RABBIT, HOMOLOG OF",
9267,601316,"DEAFNESS, AUTOSOMAL DOMINANT 10", DFNA10
9268,601317,"DEAFNESS, AUTOSOMAL DOMINANT 11", DFNA11
9269,601318,TYPE 1 DIABETES MELLITUS 13, T1D13
9270,601319,ODONTOMICRONYCHIAL DYSPLASIA,
9271,601320,NUCLEAR RECEPTOR COACTIVATOR 4,
9272,601321,NEUROFIBROMATOSIS-NOONAN SYNDROME, NFNS
9273,601322,"PORENCEPHALY, CEREBELLAR HYPOPLASIA, AND INTERNAL MALFORMATIONS",
9274,601323,NUCLEOBINDIN 1, NUCB1
9275,601324,HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN D, HNRNPD
9276,601325,CONTACTIN 3, CNTN3
9277,601326,CLAUDIN 11, CLDN11
9278,601327,"SODIUM VOLTAGE-GATED CHANNEL, BETA SUBUNIT 2", SCN2B
9279,601328,"SODIUM CHANNEL, EPITHELIAL 1, DELTA SUBUNIT", SCNN1D
9280,601329,LIM DOMAIN KINASE 1, LIMK1
9281,601330,GUANYLATE CYCLASE 2C, GUCY2C
9282,601331,"RENAL DYSPLASIA, CYSTIC, SUSCEPTIBILITY TO", CYSRD
9283,601332,MOHAWK HOMEOBOX, MKX
9284,601333,"SPT6 HOMOLOG, HISTONE CHAPERONE AND TRANSCRIPTION ELONGATION FACTOR", SUPT6H
9285,601334,KINESIN LIGHT CHAIN 3, KLC3
9286,601335,MITOGEN-ACTIVATED PROTEIN KINASE KINASE 4, MAP2K4
9287,601336,MANNOSYL-OLIGOSACCHARIDE GLYCOSIDASE, MOGS
9288,601337,"REGULATORY FACTOR X, 3", RFX3
9289,601338,"CEREBELLAR ATAXIA, AREFLEXIA, PES CAVUS, OPTIC ATROPHY, AND SENSORINEURAL HEARING LOSS", CAPOS
9290,601339,THIOREDOXIN REDUCTASE 1,
9291,601340,MIA SH3 DOMAIN-CONTAINING PROTEIN, MIA
9292,601341,"ATROPHIA MACULOSA VARIOLIFORMIS CUTIS, FAMILIAL", AMVC
9293,601342,CHROMOSOME SEGREGATION 1-LIKE, CSE1L
9294,601343,ULNAR HYPOPLASIA WITH IMPAIRED INTELLECTUAL DEVELOPMENT,
9295,601344,"SPINAL DYSPLASIA, ANHALT TYPE",
9296,601345,"ECTODERMAL DYSPLASIA WITH NATAL TEETH, TURNPENNY TYPE",
9297,601346,MARTINEZ-FRIAS SYNDROME,
9298,601347,"MYELODYSPLASIA, IMMUNODEFICIENCY, FACIAL DYSMORPHISM, SHORT STATURE, AND PSYCHOMOTOR DELAY",
9299,601348,"ECTRODACTYLY OF LOWER LIMBS, CONGENITAL HEART DEFECT, AND MICROGNATHIA",
9300,601349,"MICROPHTHALMIA, SYNDROMIC 8", MCOPS8
9301,601350,"SHORT STATURE SYNDROME, BRUSSELS TYPE",
9302,601351,"GROWTH RETARDATION, DEAFNESS, FEMORAL EPIPHYSEAL DYSPLASIA, AND LACRIMAL DUCT OBSTRUCTION",
9303,601352,"IMPAIRED INTELLECTUAL DEVELOPMENT, MICROCEPHALY, EPILEPSY, AND COARSE FACE",
9304,601353,"BRACHYCEPHALY, DEAFNESS, CATARACT, MICROSTOMIA, AND IMPAIRED INTELLECTUAL DEVELOPMENT",
9305,601354,"MICROPHTHALMIA, SYNDROMIC 2",
9306,601355,"MICROCEPHALY, CONGENITAL HEART DISEASE, UNILATERAL RENAL AGENESIS, AND HYPOSEGMENTED LUNGS",
9307,601356,"LETHAL SHORT-LIMB SKELETAL DYSPLASIA, AL GAZALI TYPE",
9308,601357,"BRACHIAL AMELIA, CLEFT LIP, AND HOLOPROSENCEPHALY", ACLH
9309,601358,NICOLAIDES-BARAITSER SYNDROME, NCBRS
9310,601359,SCHIMMELPENNING-FEUERSTEIN-MIMS SYNDROME,
9311,601360,"AMELIA, POSTERIOR, WITH PELVIC AND PULMONARY HYPOPLASIA SYNDROME", PAPPAS
9312,601361,GROWTH/DIFFERENTIATION FACTOR 10, GDF10
9313,601362,DIGEORGE SYNDROME/VELOCARDIOFACIAL SYNDROME COMPLEX 2,
9314,601363,WILMS TUMOR 4, WT4
9315,601364,CADHERIN 13, CDH13
9316,601365,DISHEVELLED 1, DVL1
9317,601366,SMAD FAMILY MEMBER 2, SMAD2
9318,601367,"STROKE, ISCHEMIC",
9319,601368,DISHEVELLED 3, DVL3
9320,601369,"DEAFNESS, AUTOSOMAL DOMINANT 9", DFNA9
9321,601370,"HOLOPROSENCEPHALY, SEMILOBAR, WITH CRANIOSYNOSTOSIS",
9322,601371,"CATARACT, AGE-RELATED NUCLEAR",
9323,601372,"CHOREA, REMITTING, WITH NYSTAGMUS AND CATARACT",
9324,601373,"CHEMOKINE, CC MOTIF, RECEPTOR 5", CCR5
9325,601374,APROSENCEPHALY AND CEREBELLAR DYSGENESIS,
9326,601375,"ECTODERMAL DYSPLASIA, HIDROTIC, CHRISTIANSON-FOURIE TYPE",
9327,601376,"CHONDRODYSPLASIA, LETHAL, WITH LONG BONE ANGULATION AND MIXED BONE DENSITY",
9328,601377,TEMTAMY SYNDROME,
9329,601378,CRISPONI/COLD-INDUCED SWEATING SYNDROME 1,
9330,601379,HUNTER-MCALPINE CRANIOSYNOSTOSIS SYNDROME,
9331,601380,EPHRIN A4, EFNA4
9332,601381,EPHRIN A3, EFNA3
9333,601382,"CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 4B1", CMT4B1
9334,601383,AQUAPORIN 6, AQP6
9335,601384,"LYMPHOCYTE ANTIGEN 6 COMPLEX, LOCUS E", LY6E
9336,601385,TUMOR SUPPRESSOR CANDIDATE 3, TUSC3
9337,601386,"DEAFNESS, AUTOSOMAL RECESSIVE 12", DFNB12
9338,601387,TUMOR SUSCEPTIBILITY GENE 101, TSG101
9339,601388,TYPE 1 DIABETES MELLITUS 12, T1D12
9340,601389,"CERVICAL RIBS, SPRENGEL ANOMALY, ANAL ATRESIA, AND URETHRAL OBSTRUCTION",
9341,601390,VAN MALDERGEM SYNDROME 1, VMLDS1
9342,601391,"CHEMOKINE, CC MOTIF, LIGAND 13", CCL13
9343,601392,"CHEMOKINE, CC MOTIF, LIGAND 14", CCL14
9344,601393,"CHEMOKINE, CC MOTIF, LIGAND 15", CCL15
9345,601394,"CHEMOKINE, CC MOTIF, LIGAND 16", CCL16
9346,601395,"CHEMOKINE, CC MOTIF, LIGAND 3-LIKE 1", CCL3L1
9347,601396,"WINGLESS-TYPE MMTV INTEGRATION SITE FAMILY, MEMBER 8B", WNT8B
9348,601397,T-BOX TRANSCRIPTION FACTOR T, TBXT
9349,601398,VASCULAR ENDOTHELIAL GROWTH FACTOR B, VEGFB
9350,601399,"PLATELET DISORDER, FAMILIAL, WITH ASSOCIATED MYELOID MALIGNANCY", FPDMM
9351,601400,"SQUAMOUS CELL CARCINOMA, HEAD AND NECK",
9352,601401,MYELOID LEUKEMIA FACTOR 2, MLF2
9353,601402,MYELOID LEUKEMIA FACTOR 1, MLF1
9354,601403,DEDICATOR OF CYTOKINESIS 1, DOCK1
9355,601404,G PROTEIN-COUPLED RECEPTOR 68, GPR68
9356,601405,CHYMOTRYPSIN C, CTRC
9357,601406,BAF CHROMATIN REMODELING COMPLEX SUBUNIT BCL7A, BCL7A
9358,601407,TYPE 2 DIABETES MELLITUS 2, T2D2
9359,601408,LYSINE ACETYLTRANSFERASE 6A, KAT6A
9360,601409,LYSINE ACETYLTRANSFERASE 5, KAT5
9361,601410,"DIABETES MELLITUS, TRANSIENT NEONATAL, 1", TNDM1
9362,601411,"SARCOGLYCAN, DELTA", SGCD
9363,601412,"DEAFNESS, AUTOSOMAL DOMINANT 7", DFNA7
9364,601413,"DEIODINASE, IODOTHYRONINE, TYPE II", DIO2
9365,601414,RETINITIS PIGMENTOSA 18, RP18
9366,601415,MYB PROTOONCOGENE LIKE 2, MYBL2
9367,601416,"SOLUTE CARRIER FAMILY 39 (ZINC TRANSPORTER), MEMBER 7", SLC39A7
9368,601417,17-BETA-HYDROXYSTEROID DEHYDROGENASE VIII, HSD17B8
9369,601418,RIBOSOME BINDING PROTEIN 1, RRBP1
9370,601419,"MYOPATHY, MYOFIBRILLAR, 1", MFM1
9371,601420,"MICROCEPHALY, CORPUS CALLOSUM DYSGENESIS, AND CLEFT LIP/PALATE",
9372,601421,LYSYL-tRNA SYNTHETASE 1, KARS1
9373,601422,LEUCINE ZIPPER PROTEIN 1, LUZP1
9374,601423,THYMINE-DNA GLYCOSYLASE, TDG
9375,601424,3-OXOACID CoA TRANSFERASE 1, OXCT1
9376,601425,"TRANSCRIPTION ELONGATION FACTOR A, 1", TCEA1
9377,601426,"NUCLEAR RECEPTOR SUBFAMILY 2, GROUP C, MEMBER 2", NR2C2
9378,601427,"ANTERIOR CHAMBER CLEAVAGE DISORDER, CEREBELLAR HYPOPLASIA, HYPOTHYROIDISM, AND TRACHEAL STENOSIS",
9379,601428,"RNA, U4ATAC SMALL NUCLEAR", RNU4ATAC
9380,601429,"RNA, U6ATAC SMALL NUCLEAR", RNU6ATAC
9381,601430,UPF1 RNA HELICASE AND ATPase, UPF1
9382,601431,tRNA ALANINE (ANTICODON TGC) 7-1, TRA-TGC7-1
9383,601432,tRNA ARGININE (ANTICODON TCG) 4-1, TRR-TCG4-1
9384,601433,tRNA INITIATOR METHIONINE (ANTICODON CAT) 1-2,
9385,601434,S-PHASE KINASE-ASSOCIATED PROTEIN 1, SKP1
9386,601435,S-PHASE KINASE-ASSOCIATED PROTEIN 1 PSEUDOGENE 2, SKP1P2
9387,601436,S-PHASE KINASE-ASSOCIATED PROTEIN 2, SKP2
9388,601437,Fc FRAGMENT OF IgG RECEPTOR AND TRANSPORTER, FCGRT
9389,601438,"RHIZOMELIC DYSPLASIA, PATTERSON-LOWRY TYPE",
9390,601439,"ATP-BINDING CASSETTE, SUBFAMILY C, MEMBER 9", ABCC9
9391,601440,"DIACYLGLYCEROL KINASE, EPSILON, 64-KD", DGKE
9392,601441,"DIACYLGLYCEROL KINASE, ZETA, 104-KD: DGKZ",
9393,601442,COFILIN 1, CFL1
9394,601443,COFILIN 2, CFL2
9395,601444,"BIOGENESIS OF LYSOSOME-RELATED ORGANELLES COMPLEX 1, SUBUNIT 1", BLOC1S1
9396,601445,NADH-UBIQUINONE OXIDOREDUCTASE SUBUNIT B9, NDUFB9
9397,601446,"TOE SYNDACTYLY, TELECANTHUS, AND ANOGENITAL AND RENAL MALFORMATIONS",
9398,601447,UBIQUITIN-SPECIFIC PROTEASE 5, USP5
9399,601448,"NUCLEAR PROTEIN, ATAXIA-TELANGIECTASIA LOCUS", NPAT
9400,601449,"DEAFNESS, PROGRESSIVE, WITH STAPES FIXATION",
9401,601450,"DISLOCATION OF HIP, CONGENITAL, WITH HYPEREXTENSIBILITY OF FINGERS AND FACIAL DYSMORPHISM",
9402,601451,"EHLERS-DANLOS SYNDROME, KYPHOSCOLIOTIC TYPE, 1",
9403,601452,OCULOAURICULOFRONTONASAL SYNDROME, OAFNS
9404,601453,TRICHODENTAL DYSPLASIA,
9405,601454,"PSORIASIS 3, SUSCEPTIBILITY TO", PSORS3
9406,601455,"CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 4D", CMT4D
9407,601456,MULTIMERIN 1, MMRN1
9408,601457,"SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-NEGATIVE, NK CELL-POSITIVE",
9409,601458,INFLAMMATORY BOWEL DISEASE 2, IBD2
9410,601459,PREPRONOCICEPTIN, PNOC
9411,601460,"SOLUTE CARRIER ORGANIC ANION TRANSPORTER FAMILY, MEMBER 2A1", SLCO2A1
9412,601461,ATONAL bHLH TRANSCRIPTION FACTOR 1, ATOH1
9413,601462,"MYASTHENIC SYNDROME, CONGENITAL, 1A, SLOW-CHANNEL", CMS1A
9414,601463,HYALURONAN SYNTHASE 1, HAS1
9415,601464,ALF TRANSCRIPTION ELONGATION FACTOR 3, AFF3
9416,601465,DEOXYGUANOSINE KINASE, DGUOK
9417,601466,PATENT DUCTUS VENOSUS, PDV
9418,601467,MITOTIC ARREST-DEFICIENT 2 LIKE 1, MAD2L1
9419,601468,"METHIONINE ADENOSYLTRANSFERASE II, ALPHA", MAT2A
9420,601469,PARATHYROID HORMONE 2 RECEPTOR, PTH2R
9421,601470,"CHEMOKINE, CX3C MOTIF, RECEPTOR 1", CX3CR1
9422,601471,"FACIAL PARESIS, HEREDITARY CONGENITAL, 1", HCFP1
9423,601472,"CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2D", CMT2D
9424,601473,ZINC FINGER PROTEIN 75A, ZNF75A
9425,601474,ZINC FINGER PROTEIN 75D,
9426,601475,PWP2 SMALL SUBUNIT PROCESSOME COMPONENT, PWP2
9427,601476,"LYSOSOME-ASSOCIATED PROTEIN, TRANSMEMBRANE 5", LAPTM5
9428,601477,RIBBING DISEASE,
9429,601478,MYOSIN IA, MYO1A
9430,601479,MYOSIN IE, MYO1E
9431,601480,MYOSIN IF, MYO1F
9432,601481,MYOSIN X, MYO10
9433,601482,"DOWNREGULATOR OF TRANSCRIPTION 1, TBP-BINDING", DR1
9434,601483,PATERNALLY EXPRESSED GENE 3, PEG3
9435,601484,SELENOPROTEIN P, SELENOP
9436,601485,SYNTAXIN 1B, STX1B
9437,601486,DELETED IN AZOOSPERMIA-LIKE, DAZL
9438,601487,PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR-GAMMA, PPARG
9439,601488,NEUTROPHIL CYTOSOLIC FACTOR 4, NCF4
9440,601489,"INSULIN-LIKE GROWTH FACTOR-BINDING PROTEIN, ACID-LABILE SUBUNIT", IGFALS
9441,601490,"NUCLEAR FACTOR ERYTHROID 2, p45 SUBUNIT", NFE2
9442,601491,IMPRINTED IN PRADER-WILLI SYNDROME, IPW
9443,601492,"MUCOPOLYSACCHARIDOSIS, TYPE IX", MPS9
9444,601493,"CARDIOMYOPATHY, DILATED, 1C, WITH OR WITHOUT LEFT VENTRICULAR NONCOMPACTION", CMD1C
9445,601494,"CARDIOMYOPATHY, DILATED, 1D", CMD1D
9446,601495,"AGAMMAGLOBULINEMIA 1, AUTOSOMAL RECESSIVE", AGM1
9447,601496,GDNF FAMILY RECEPTOR ALPHA-1, GFRA1
9448,601497,BAG COCHAPERONE 1, BAG1
9449,601498,PEROXISOME BIOGENESIS FACTOR 6, PEX6
9450,601499,"AXENFELD-RIEGER SYNDROME, TYPE 2", RIEG2
9451,601500,"SMOOTHENED, FRIZZLED CLASS RECEPTOR", SMO
9452,601501,VPS35 RETROMER COMPLEX COMPONENT, VPS35
9453,601502,Fc FRAGMENT OF IgG RECEPTOR Ib, FCGR1B
9454,601503,"Fc FRAGMENT OF IgG RECEPTOR Ic, PSEUDOGENE", FCGR1CP
9455,601504,SEC14-LIKE LIPID-BINDING PROTEIN 1, SEC14L1
9456,601505,ZINC FINGER PROTEIN 146, ZNF146
9457,601506,SEPTIN 2, SEPT2
9458,601507,"ADAPTOR-RELATED PROTEIN COMPLEX 3, SIGMA-1 SUBUNIT", AP3S1
9459,601508,"PARKINSON DISEASE 1, AUTOSOMAL DOMINANT",
9460,601509,GAMMA-GLUTAMYL HYDROLASE, GGH
9461,601510,SREBP CLEAVAGE-ACTIVATING PROTEIN, SCAP
9462,601511,SIGNAL TRANSDUCER AND ACTIVATOR OF TRANSCRIPTION 5A, STAT5A
9463,601512,SIGNAL TRANSDUCER AND ACTIVATOR OF TRANSCRIPTION 6, STAT6
9464,601513,FIBROBLAST GROWTH FACTOR 12, FGF12
9465,601514,FIBROBLAST GROWTH FACTOR 11, FGF11
9466,601515,FIBROBLAST GROWTH FACTOR 14, FGF14
9467,601516,SPLICING FACTOR 1, SF1
9468,601517,ATAXIN 2, ATXN2
9469,601518,"PROSTATE CANCER, HEREDITARY, 1", HPC1
9470,601519,ATP SYNTHASE MEMBRANE SUBUNIT E, ATP5ME
9471,601520,"CHEMOKINE, CC MOTIF, LIGAND 17", CCL17
9472,601521,ENDOTHELIAL CELL-SPECIFIC MOLECULE 1, ESM1
9473,601522,GROWTH FACTOR RECEPTOR-BOUND PROTEIN 7, GRB7
9474,601523,GROWTH FACTOR RECEPTOR-BOUND PROTEIN 10, GRB10
9475,601524,GROWTH FACTOR RECEPTOR-BOUND PROTEIN 14, GRB14
9476,601525,CHITINASE 3-LIKE 1, CHI3L1
9477,601526,CHITINASE 3-LIKE 2, CHI3L2
9478,601527,ARISTALESS-LIKE HOMEOBOX 1, ALX1
9479,601528,VASCULAR ENDOTHELIAL GROWTH FACTOR C, VEGFC
9480,601529,"NUCLEAR RECEPTOR SUBFAMILY 2, GROUP C, MEMBER 1", NR2C1
9481,601530,SEQUESTOSOME 1, SQSTM1
9482,601531,LEUKOTRIENE B4 RECEPTOR, LTB4R
9483,601532,"CASPASE 6, APOPTOSIS-RELATED CYSTEINE PROTEASE", CASP6
9484,601533,A DISINTEGRIN AND METALLOPROTEINASE DOMAIN 2, ADAM2
9485,601534,"POTASSIUM CHANNEL, INWARDLY RECTIFYING, SUBFAMILY J, MEMBER 3", KCNJ3
9486,601535,EPHRIN A5, EFNA5
9487,601536,ATHABASKAN BRAINSTEM DYSGENESIS SYNDROME, ABDS
9488,601537,"MICROCEPHALY, RETINITIS PIGMENTOSA, AND SUTURAL CATARACT",
9489,601538,PROP PAIRED-LIKE HOMEOBOX 1, PROP1
9490,601539,PEROXISOME BIOGENESIS DISORDER 1B, PBD1B
9491,601540,BROMODOMAIN-CONTAINING PROTEIN 2, BRD2
9492,601541,BROMODOMAIN-CONTAINING PROTEIN 3, BRD3
9493,601542,PAIRED-LIKE HOMEODOMAIN TRANSCRIPTION FACTOR 2, PITX2
9494,601543,"DEAFNESS, AUTOSOMAL DOMINANT 12", DFNA12
9495,601544,"DEAFNESS, AUTOSOMAL DOMINANT 3A", DFNA3A
9496,601545,"PLATELET-ACTIVATING FACTOR ACETYLHYDROLASE, ISOFORM 1B, ALPHA SUBUNIT", PAFAH1B1
9497,601546,PROSPERO-RELATED HOMEOBOX 1, PROX1
9498,601547,"CATARACT 3, MULTIPLE TYPES", CTRCT3
9499,601548,EGF-CONTAINING FIBULIN-LIKE EXTRACELLULAR MATRIX PROTEIN 1, EFEMP1
9500,601549,"ALACRIMA, CONGENITAL, AUTOSOMAL RECESSIVE",
9501,601550,BLOOD GROUP--SWANN SYSTEM, SW
9502,601551,BLOOD GROUP--FROESE,
9503,601552,TRABOULSI SYNDROME,
9504,601553,"HYPOTRICHOSIS, CONGENITAL, WITH JUVENILE MACULAR DYSTROPHY", HJMD
9505,601554,"DYNEIN, LIGHT CHAIN, TCTEX TYPE, 1", DYNLT1
9506,601555,RHO FAMILY GTPase 2, RND2
9507,601556,ATAXIN 1, ATXN1
9508,601557,ACETYL-CoA CARBOXYLASE-BETA, ACACB
9509,601558,"RNA-BINDING PROTEIN, mRNA-PROCESSING FACTOR", RBPMS
9510,601559,STUVE-WIEDEMANN SYNDROME 1, STWS1
9511,601560,MULTIPLE EPIPHYSEAL DYSPLASIA WITH ROBIN PHENOTYPE,
9512,601561,DYSSEGMENTAL DYSPLASIA WITH GLAUCOMA,
9513,601562,"DYNEIN, LIGHT CHAIN, LC8 TYPE, 1", DYNLL1
9514,601563,RELAXIN/INSULIN-LIKE FAMILY PEPTIDE RECEPTOR 2,
9515,601564,"PROTEASE, SERINE, 2", PRSS2
9516,601565,INTERFERON REGULATORY FACTOR 8, IRF8
9517,601566,INHIBITOR OF GROWTH 1, ING1
9518,601567,"LECTIN, MANNOSE-BINDING 1", LMAN1
9519,601568,ADDUCIN 3, ADD3
9520,601569,UBIQUITIN-CONJUGATING ENZYME E2 G1, UBE2G1
9521,601570,"WINGLESS-TYPE MMTV INTEGRATION SITE FAMILY, MEMBER 7A", WNT7A
9522,601571,"CAPPING PROTEIN, ALPHA-2", CAPZA2
9523,601572,"CAPPING PROTEIN, BETA", CAPZB
9524,601573,ENHANCER OF ZESTE 2 POLYCOMB REPRESSIVE COMPLEX 2 SUBUNIT, EZH2
9525,601574,"TAF15 RNA POLYMERASE II, TATA BOX-BINDING PROTEIN-ASSOCIATED FACTOR, 68-KD", TAF15
9526,601575,"FOS-LIKE 2, AP-1 TRANSCRIPTION FACTOR SUBUNIT", FOSL2
9527,601576,"PROTEIN-TYROSINE PHOSPHATASE, RECEPTOR-TYPE, SIGMA", PTPRS
9528,601577,"PROTEIN-TYROSINE PHOSPHATASE, RECEPTOR-TYPE, C POLYPEPTIDE-ASSOCIATED PROTEIN", PTPRCAP
9529,601578,CYCLIN G1, CCNG1
9530,601579,ORNITHINE DECARBOXYLASE ANTIZYME 1, OAZ1
9531,601580,"CAPPING PROTEIN, ALPHA-1", CAPZA1
9532,601581,NEURONAL CELL ADHESION MOLECULE, NRCAM
9533,601582,"INOSITOL POLYPHOSPHATE-5-PHOSPHATASE, 145-KD", INPP5D
9534,601583,WILMS TUMOR 5, WT5
9535,601584,"PROTEIN-TYROSINE PHOSPHATASE, TYPE 4A, 2", PTP4A2
9536,601585,"PROTEIN-TYROSINE PHOSPHATASE, TYPE 4A, 1", PTP4A1
9537,601586,"PROSTAGLANDIN E RECEPTOR 4, EP4 SUBTYPE", PTGER4
9538,601587,"THYMOSIN, BETA-15A",
9539,601588,LORICRIN,
9540,601589,RAS p21 PROTEIN ACTIVATOR 2, RASA2
9541,601590,ENVOPLAKIN, EVPL
9542,601591,"PROTEIN KINASE, cGMP-DEPENDENT, TYPE II", PRKG2
9543,601592,"RECEPTOR-ASSOCIATED PROTEIN OF THE SYNAPSE, 43-KD", RAPSN
9544,601593,BRCA1-ASSOCIATED RING DOMAIN 1, BARD1
9545,601594,"JUMONJI, AT-RICH INTERACTIVE DOMAIN 2", JARID2
9546,601595,SMAD FAMILY MEMBER 1, SMAD1
9547,601596,"CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 4C", CMT4C
9548,601597,B-CELL ANTIPROLIFERATION FACTOR 2, BTG2
9549,601598,"PROTEIN-TYROSINE PHOSPHATASE, RECEPTOR-TYPE, DELTA", PTPRD
9550,601599,SARCOSPAN, SSPN
9551,601600,ETS VARIANT TRANSCRIPTION FACTOR 5, ETV5
9552,601601,TRANSCRIPTION FACTOR AP2-BETA, TFAP2B
9553,601602,TRANSCRIPTION FACTOR AP2-GAMMA, TFAP2C
9554,601603,LYMPHOCYTE CYTOSOLIC PROTEIN 2, LCP2
9555,601604,"INTERLEUKIN 12 RECEPTOR, BETA-1", IL12RB1
9556,601605,"NUCLEAR PROTEIN, ATAXIA-TELANGIECTASIA LOCUS",
9557,601606,"TRICHOEPITHELIOMA, MULTIPLE FAMILIAL, 1", MFT1
9558,601607,"SWI/SNF-RELATED, MATRIX-ASSOCIATED, ACTIN-DEPENDENT REGULATOR OF CHROMATIN, SUBFAMILY B, MEMBER 1", SMARCB1
9559,601608,SPASTIC PARAPLEGIA AND EVANS SYNDROME,
9560,601609,3-HYDROXYACYL-CoA DEHYDROGENASE, HADH
9561,601610,"BUTYROPHILIN, SUBFAMILY 1, MEMBER A1", BTN1A1
9562,601611,"SOLUTE CARRIER FAMILY 14 (UREA TRANSPORTER), MEMBER 2", SLC14A2
9563,601612,"LUNG AGENESIS, CONGENITAL HEART DEFECTS, AND THUMB ANOMALIES SYNDROME", LACHT
9564,601613,"CHEMOKINE, CXC MOTIF, RECEPTOR 5", CXCR5
9565,601614,NETRIN 1, NTN1
9566,601615,"ATP-BINDING CASSETTE, SUBFAMILY A, MEMBER 3", ABCA3
9567,601616,IRIS PIGMENT EPITHELIUM ANOMALIES,
9568,601617,RETINOL DEHYDROGENASE 5, RDH5
9569,601618,SRY-BOX 18, SOX18
9570,601619,RAL GUANINE NUCLEOTIDE DISSOCIATION STIMULATOR, RALGDS
9571,601620,T-BOX TRANSCRIPTION FACTOR 5, TBX5
9572,601621,T-BOX TRANSCRIPTION FACTOR 3, TBX3
9573,601622,TWIST FAMILY bHLH TRANSCRIPTION FACTOR 1, TWIST1
9574,601623,UBIQUITIN-PROTEIN LIGASE E3A, UBE3A
9575,601624,FICOLIN 2, FCN2
9576,601625,ADP-RIBOSYLTRANSFERASE 1, ART1
9577,601626,"LEUKEMIA, ACUTE MYELOID", AML
9578,601627,SURVIVAL OF MOTOR NEURON 2, SMN2
9579,601628,"BETA-1,4-N-ACETYL-GALACTOSAMINYLTRANSFERASE 2",
9580,601629,PURKINJE CELL PROTEIN 4, PCP4
9581,601630,FRONTOTEMPORAL DEMENTIA 1,
9582,601631,ANTERIOR SEGMENT DYSGENESIS 3, ASGD3
9583,601632,"POU DOMAIN, CLASS 4, TRANSCRIPTION FACTOR 1", POU4F1
9584,601633,N-ETHYLMALEIMIDE-SENSITIVE FACTOR, NSF
9585,601634,"NEURAL TUBE DEFECTS, FOLATE-SENSITIVE", NTDFS
9586,601635,GRAINYHEAD-LIKE 3,
9587,601636,HYALURONAN SYNTHASE 2, HAS2
9588,601637,"CYTOCHROME P450, FAMILY 51, SUBFAMILY A, POLYPEPTIDE 1", CYP51A1
9589,601638,ADP-RIBOSYLATION FACTOR-INTERACTING PROTEIN 2, ARFIP2
9590,601639,"PROTEIN KINASE, cAMP-DEPENDENT, CATALYTIC, ALPHA", PRKACA
9591,601640,HISTIDINE TRIAD NUCLEOTIDE-BINDING PROTEIN 1,
9592,601641,"ACYL-CoA OXIDASE 2, BRANCHED-CHAIN", ACOX2
9593,601642,"INTERLEUKIN 12 RECEPTOR, BETA-2", IL12RB2
9594,601643,"PROTEIN PHOSPHATASE 2, REGULATORY SUBUNIT B (B56), ALPHA", PPP2R5A
9595,601644,"PROTEIN PHOSPHATASE 2, REGULATORY SUBUNIT B (B56), BETA", PPP2R5B
9596,601645,"PROTEIN PHOSPHATASE 2, REGULATORY SUBUNIT B (B56), GAMMA", PPP2R5C
9597,601646,"PROTEIN PHOSPHATASE 2, REGULATORY SUBUNIT B (B56), DELTA", PPP2R5D
9598,601647,"PROTEIN PHOSPHATASE 2, REGULATORY SUBUNIT B (B56), EPSILON", PPP2R5E
9599,601648,"PROTEASOME 26S SUBUNIT, NON-ATPase, 4", PSMD4
9600,601649,SAETHRE-CHOTZEN SYNDROME,
9601,601650,PHEOCHROMOCYTOMA/PARAGANGLIOMA SYNDROME 2, PPGL2
9602,601651,NUCLEOSOME ASSEMBLY PROTEIN 1-LIKE 4, NAP1L4
9603,601652,MYOCILIN, MYOC
9604,601653,EYA TRANSCRIPTIONAL COACTIVATOR AND PHOSPHATASE 1, EYA1
9605,601654,EYA TRANSCRIPTIONAL COACTIVATOR AND PHOSPHATASE 2, EYA2
9606,601655,EYA TRANSCRIPTIONAL COACTIVATOR AND PHOSPHATASE 3, EYA3
9607,601656,GATA-BINDING PROTEIN 6, GATA6
9608,601657,EPIPHYCAN, EPYC
9609,601658,OTOCONIN 90, OC90
9610,601659,GLUTAMINE AMIDOTRANSFERASE-LIKE CLASS 1 DOMAIN-CONTAINING PROTEIN 3A, GATD3A
9611,601660,DEAD/H-BOX HELICASE 11,
9612,601661,UBIQUITIN-CONJUGATING ENZYME E2 I, UBE2I
9613,601662,ACTIVATED LEUKOCYTE CELL ADHESION MOLECULE, ALCAM
9614,601663,ESTROGEN RECEPTOR 2, ESR2
9615,601664,"SMALL NUCLEAR RIBONUCLEOPROTEIN, 200-KD", SNRNP200
9616,601665,OBESITY,
9617,601666,TYPE 1 DIABETES MELLITUS 15, T1D15
9618,601667,ANGIOPOIETIN 1, ANGPT1
9619,601668,SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH ABNORMAL DENTITION, SEMDAD
9620,601669,SRY-BOX 10,
9621,601670,"D4, ZINC, AND DOUBLE PHD FINGERS FAMILY, MEMBER 1", DPF1
9622,601671,"D4, ZINC, AND DOUBLE PHD FINGERS FAMILY, MEMBER 2", DPF2
9623,601672,"D4, ZINC, AND DOUBLE PHD FINGERS FAMILY, MEMBER 3", DPF3
9624,601673,ELAV-LIKE RNA-BINDING PROTEIN 2, ELAVL2
9625,601674,ENHANCER OF ZESTE 1 POLYCOMB REPRESSIVE COMPLEX 2 SUBUNIT, EZH1
9626,601675,"TRICHOTHIODYSTROPHY 1, PHOTOSENSITIVE", TTD1
9627,601676,ACUTE INSULIN RESPONSE,
9628,601677,NADH-UBIQUINONE OXIDOREDUCTASE SUBUNIT A5, NDUFA5
9629,601678,"BARTTER SYNDROME, TYPE 1, ANTENATAL", BARTS1
9630,601679,GENERAL TRANSCRIPTION FACTOR II-I, GTF2I
9631,601680,"ARTHROGRYPOSIS, DISTAL, TYPE 2B1", DA2B1
9632,601681,"PROTEASOME 26S SUBUNIT, ATPase, 5", PSMC5
9633,601682,"GLAUCOMA 1, PRIMARY OPEN ANGLE, C", GLC1C
9634,601683,"COENZYME Q7, HYDROXYLASE", COQ7
9635,601684,RIBOSOMAL PROTEIN S6 KINASE A1, RPS6KA1
9636,601685,RIBOSOMAL PROTEIN S6 KINASE A2, RPS6KA2
9637,601686,TELOMERASE-ASSOCIATED PROTEIN 1, TEP1
9638,601687,"KERATIN 12, TYPE I", KRT12
9639,601688,15-HYDROXYPROSTAGLANDIN DEHYDROGENASE, HPGD
9640,601689,"TAF4B RNA POLYMERASE II, TATA BOX-BINDING PROTEIN-ASSOCIATED FACTOR, 105-KD", TAF4B
9641,601690,"PHOSPHOLIPASE A2, GROUP VII", PLA2G7
9642,601691,"ATP-BINDING CASSETTE, SUBFAMILY A, MEMBER 4", ABCA4
9643,601692,"TRANSFORMING GROWTH FACTOR, BETA-INDUCED, 68-KD", TGFBI
9644,601693,UNCOUPLING PROTEIN 2, UCP2
9645,601694,"LEPTIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 1", LEPQTL1
9646,601695,"CASEIN, KAPPA", CSN3
9647,601696,NOVELTY SEEKING PERSONALITY TRAIT,
9648,601697,"SERPIN FAMILY B, MEMBER 8", SERPINB8
9649,601698,"PROTEIN-TYROSINE PHOSPHATASE, RECEPTOR-TYPE, N, POLYPEPTIDE 2", PTPRN2
9650,601699,PROSTAGLANDIN I2 SYNTHASE, PTGIS
9651,601700,"SEBACEOUS GLAND HYPERPLASIA, FAMILIAL PRESENILE",
9652,601701,ARTHROGRYPOSIS AND ECTODERMAL DYSPLASIA,
9653,601702,RHO-ASSOCIATED COILED-COIL-CONTAINING PROTEIN KINASE 1, ROCK1
9654,601703,VASODILATOR-STIMULATED PHOSPHOPROTEIN, VASP
9655,601704,"CHEMOKINE, CXC MOTIF, LIGAND 9", CXCL9
9656,601705,"T-CELL IMMUNODEFICIENCY, CONGENITAL ALOPECIA, AND NAIL DYSTROPHY", TIDAND
9657,601706,YEMENITE DEAF-BLIND HYPOPIGMENTATION SYNDROME,
9658,601707,CURRY-JONES SYNDROME, CRJS
9659,601708,"SUPERIOR TRANSVERSE SCAPULAR LIGAMENT, CALCIFICATION OF, FAMILIAL",
9660,601709,QUEBEC PLATELET DISORDER, QPD
9661,601710,EUKARYOTIC TRANSLATION INITIATION FACTOR 5, EIF5
9662,601711,TNF RECEPTOR-ASSOCIATED FACTOR 1, TRAF1
9663,601712,BACULOVIRAL IAP REPEAT-CONTAINING PROTEIN 2, BIRC2
9664,601713,"GLIA MATURATION FACTOR, BETA", GMFB
9665,601714,TEA DOMAIN FAMILY MEMBER 4, TEAD4
9666,601715,"INOSITOL POLYPHOSPHATE-5-PHOSPHATASE, 145-KD",
9667,601716,STAUFEN DOUBLE-STRANDED RNA-BINDING PROTEIN 1, STAU1
9668,601717,SYNTAXIN-BINDING PROTEIN 2, STXBP2
9669,601718,RETINITIS PIGMENTOSA 19, RP19
9670,601719,T-BOX TRANSCRIPTION FACTOR 4, TBX4
9671,601720,KIN17 DNA- AND RNA-BINDING PROTEIN, KIN
9672,601721,BACULOVIRAL IAP REPEAT-CONTAINING PROTEIN 3, BIRC3
9673,601722,BACULOVIRAL IAP REPEAT-CONTAINING PROTEIN 2,
9674,601723,FRIZZLED CLASS RECEPTOR 5, FZD5
9675,601724,NEUROGENIC DIFFERENTIATION 1, NEUROD1
9676,601725,NEUROGENIC DIFFERENTIATION 2, NEUROD2
9677,601726,NEUROGENIN 1, NEUROG1
9678,601727,TEA DOMAIN FAMILY MEMBER 4,
9679,601728,PHOSPHATASE AND TENSIN HOMOLOG, PTEN
9680,601729,TEA DOMAIN FAMILY MEMBER 2, TEAD2
9681,601730,PHOSPHATIDYLINOSITOL GLYCAN ANCHOR BIOSYNTHESIS CLASS C PROTEIN, PIGC
9682,601731,5-AMINOIMIDAZOLE-4-CARBOXAMIDE RIBONUCLEOTIDE FORMYLTRANSFERASE/IMP CYCLOHYDROLASE, ATIC
9683,601732,"SWI/SNF-RELATED, MATRIX-ASSOCIATED, ACTIN-DEPENDENT REGULATOR OF CHROMATIN, SUBFAMILY C, MEMBER 1", SMARCC1
9684,601733,"GLUTATHIONE S-TRANSFERASE, MICROSOMAL, 2", MGST2
9685,601734,"SWI/SNF-RELATED, MATRIX-ASSOCIATED, ACTIN-DEPENDENT REGULATOR OF CHROMATIN, SUBFAMILY C, MEMBER 2", SMARCC2
9686,601735,"SWI/SNF-RELATED, MATRIX-ASSOCIATED, ACTIN-DEPENDENT REGULATOR OF CHROMATIN, SUBFAMILY D, MEMBER 1", SMARCD1
9687,601736,"SWI/SNF-RELATED, MATRIX-ASSOCIATED, ACTIN-DEPENDENT REGULATOR OF CHROMATIN, SUBFAMILY D, MEMBER 2", SMARCD2
9688,601737,"SWI/SNF-RELATED, MATRIX-ASSOCIATED, ACTIN-DEPENDENT REGULATOR OF CHROMATIN, SUBFAMILY D, MEMBER 3", SMARCD3
9689,601738,EXOSTOSIN-LIKE GLYCOSYLTRANSFERASE 1, EXTL1
9690,601739,MEIS HOMEOBOX 1, MEIS1
9691,601740,MEIS HOMEOBOX 2, MEIS2
9692,601741,CULLIN 5, CUL5
9693,601742,TRIPARTITE MOTIF-CONTAINING PROTEIN 28, TRIM28
9694,601743,ONCOSTATIN M RECEPTOR, OSMR
9695,601744,"SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 1", SLEB1
9696,601745,"POTASSIUM CHANNEL, SUBFAMILY K, MEMBER 1", KCNK1
9697,601746,HYPOXIA UP-REGULATED 1, HYOU1
9698,601747,TRIPARTITE MOTIF-CONTAINING PROTEIN 23, TRIM23
9699,601748,"GENERAL TRANSCRIPTION FACTOR IIH, POLYPEPTIDE 2", GTF2H2
9700,601749,GLOMULIN, GLMN
9701,601750,"GENERAL TRANSCRIPTION FACTOR IIH, POLYPEPTIDE 3", GTF2H3
9702,601751,MELANIN-CONCENTRATING HORMONE RECEPTOR 1, MCHR1
9703,601752,ECTONUCLEOSIDE TRIPHOSPHATE DIPHOSPHOHYDROLASE 1, ENTPD1
9704,601753,PEPTIDYL-PROLYL ISOMERASE D, PPID
9705,601754,UBIQUITIN FUSION DEGRADATION 1-LIKE, UFD1L
9706,601755,ESS2 SPLICING FACTOR HOMOLOG, ESS2
9707,601756,UDP-N-ACETYL-ALPHA-D-GALACTOSAMINE:POLYPEPTIDE N-ACETYLGALACTOSAMINYLTRANSFERASE 3, GALNT3
9708,601757,PEROXISOME BIOGENESIS FACTOR 7, PEX7
9709,601758,PEROXISOME BIOGENESIS FACTOR 12, PEX12
9710,601759,PREAXIAL HALLUCAL POLYDACTYLY,
9711,601760,"GENERAL TRANSCRIPTION FACTOR IIH, POLYPEPTIDE 4", GTF2H4
9712,601761,"CASPASE 7, APOPTOSIS-RELATED CYSTEINE PROTEASE", CASP7
9713,601762,"CASPASE 10, APOPTOSIS-RELATED CYSTEINE PROTEASE", CASP10
9714,601763,"CASPASE 8, APOPTOSIS-RELATED CYSTEINE PROTEASE", CASP8
9715,601764,"SEIZURES, BENIGN FAMILIAL INFANTILE, 1", BFIS1
9716,601765,PAIRED-LIKE HOMEODOMAIN TRANSCRIPTION FACTOR 2,
9717,601766,FRIZZLED CLASS RECEPTOR 9, FZD9
9718,601767,HUNTINGTIN-INTERACTING PROTEIN 1, HIP1
9719,601768,"SH3 DOMAIN, GRB2-LIKE, 1", SH3GL1
9720,601769,VITAMIN D RECEPTOR, VDR
9721,601770,NEUROPEPTIDE Y RECEPTOR Y6, NPY6R
9722,601771,"CYTOCHROME P450, SUBFAMILY I, POLYPEPTIDE 1", CYP1B1
9723,601772,"H2A HISTONE FAMILY, MEMBER X", H2AFX
9724,601773,"PROTEIN-TYROSINE PHOSPHATASE, RECEPTOR-TYPE, N", PTPRN
9725,601774,"ALPHA-1,6-MANNOSYL-GLYCOPROTEIN BETA-1,6-N-ACETYLGLUCOSAMINYLTRANSFERASE", MGAT5
9726,601775,"MEGALOBLASTIC ANEMIA, FOLATE-RESPONSIVE", MEGAF
9727,601776,"EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE, 1", EDSMC1
9728,601777,CONE-ROD DYSTROPHY 6, CORD6
9729,601778,"POLYMERASE, RNA, MITOCHONDRIAL", POLRMT
9730,601779,"PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 1",
9731,601780,"CEROID LIPOFUSCINOSIS, NEURONAL, 6A", CLN6A
9732,601781,ZINC FINGER PROTEIN 45,
9733,601782,TESTIS-ASSOCIATED ACTIN-MODELING KINASE 1, TESK1
9734,601783,MICROTUBULE-ASSOCIATED PROTEIN 6, MAP6
9735,601784,"ACID-SENSING ION CHANNEL, SUBUNIT 2", ASIC2
9736,601785,PHOSPHOMANNOMUTASE 2, PMM2
9737,601786,PHOSPHOMANNOMUTASE 1, PMM1
9738,601787,"TAF5 RNA POLYMERASE II, TATA BOX-BINDING PROTEIN-ASSOCIATED FACTOR, 100-KD", TAF5
9739,601788,MYOSTATIN, MSTN
9740,601789,PEROXISOME BIOGENESIS FACTOR 13, PEX13
9741,601790,PANCREATIC POLYPEPTIDE RECEPTOR 1, PPYR1
9742,601791,PEROXISOME BIOGENESIS FACTOR 14, PEX14
9743,601792,"PROTEIN PHOSPHATASE 1, REGULATORY SUBUNIT 2", PPP1R2
9744,601793,"CYCLIC NUCLEOTIDE-GATED CHANNEL, BETA-1",
9745,601794,COLOBOMA-OBESITY-HYPOGENITALISM-IMPAIRED INTELLECTUAL DEVELOPMENT SYNDROME,
9746,601795,MITOGEN-ACTIVATED PROTEIN KINASE 3, MAPK3
9747,601796,"TAF4 RNA POLYMERASE II, TATA BOX-BINDING PROTEIN-ASSOCIATED FACTOR, 135-KD", TAF4
9748,601797,CRYSTALLIN BETA-GAMMA DOMAIN-CONTAINING PROTEIN 1, CRYBG1
9749,601798,GLUCOSAMINE-6-PHOSPHATE DEAMINASE 1, GNPDA1
9750,601799,"PROTEASE INHIBITOR 9, OVALBUMIN TYPE", PI9
9751,601800,"SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 3", SHEP3
9752,601801,TRANSCRIPTION FACTOR Sp2, SP2
9753,601802,HESX HOMEOBOX 1, HESX1
9754,601803,PALLISTER-KILLIAN SYNDROME, PKS
9755,601804,TRANSCRIPTION FACTOR Sp3, SP3
9756,601805,G PROTEIN-COUPLED ESTROGEN RECEPTOR 1, GPER1
9757,601806,MINICHROMOSOME MAINTENANCE COMPLEX COMPONENT 6, MCM6
9758,601807,MATRIX METALLOPROTEINASE 19, MMP19
9759,601808,CHROMOSOME 18q DELETION SYNDROME,
9760,601809,SPONDYLOSPINAL THORACIC DYSOSTOSIS,
9761,601810,DNA REPLICATION HELICASE/NUCLEASE 2, DNA2
9762,601811,"PREMATURE AGING SYNDROME, OKAMOTO TYPE",
9763,601812,"PREMATURE AGING SYNDROME, PENTTINEN TYPE", PENTT
9764,601813,EXUDATIVE VITREORETINOPATHY 4, EVR4
9765,601814,FXYD DOMAIN-CONTAINING ION TRANSPORT REGULATOR 2, FXYD2
9766,601815,PHOSPHOGLYCERATE DEHYDROGENASE DEFICIENCY, PHGDHD
9767,601816,"BILIRUBIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 1", BILIQTL1
9768,601817,NME/NM23 NUCLEOSIDE DIPHOSPHATE KINASE 3, NME3
9769,601818,NME/NM23 NUCLEOSIDE DIPHOSPHATE KINASE 4, NME4
9770,601819,BROMODOMAIN PHD FINGER TRANSCRIPTION FACTOR, BPTF
9771,601820,"HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 2", HHF2
9772,601821,"RNA, Y1 SMALL CYTOPLASMIC", RNY1
9773,601822,"RNA, Y3 SMALL CYTOPLASMIC", RNY3
9774,601823,"RNA, Y4 SMALL CYTOPLASMIC", RNY4
9775,601824,"RNA, Y5 SMALL CYTOPLASMIC", RNY5
9776,601825,NADH-UBIQUINONE OXIDOREDUCTASE Fe-S PROTEIN 7, NDUFS7
9777,601826,"DIACYLGLYCEROL KINASE, DELTA, 130-KD", DGKD
9778,601827,GLUTAMINE AMIDOTRANSFERASE-LIKE CLASS 1 DOMAIN-CONTAINING PROTEIN 3A,
9779,601828,"NUCLEAR RECEPTOR SUBFAMILY 4, GROUP A, MEMBER 2", NR4A2
9780,601829,"ACROFACIAL DYSOSTOSIS, PALAGONIA TYPE",
9781,601830,NEUROPEPTIDE Y RECEPTOR Y6,
9782,601831,"HISTONE GENE CLUSTER 2, H2B HISTONE FAMILY, MEMBER E", HIST2H2BE
9783,601832,RIBOSOMAL PROTEIN L29, RPL29
9784,601833,ALLOGRAFT INFLAMMATORY FACTOR 1, AIF1
9785,601834,"CHEMOKINE, CC MOTIF, RECEPTOR 8", CCR8
9786,601835,"CHEMOKINE, CC MOTIF, RECEPTOR 6", CCR6
9787,601836,KINESIN-ASSOCIATED PROTEIN 3, KIFAP3
9788,601837,"LIGASE IV, DNA, ATP-DEPENDENT", LIG4
9789,601838,"INOSITOL 1,3,4-TRISPHOSPHATE 5/6-KINASE", ITPK1
9790,601839,EPHRIN RECEPTOR EphB3, EPHB3
9791,601840,"PHOSPHATIDYLINOSITOL 4-KINASE, ALPHA",
9792,601841,"SERPIN PEPTIDASE INHIBITOR, CLADE A, MEMBER 5", SERPINA5
9793,601842,"DEAFNESS, AUTOSOMAL DOMINANT 12",
9794,601843,"SOLUTE CARRIER FAMILY 5 (SODIUM IODIDE SYMPORTER), MEMBER 5", SLC5A5
9795,601844,"PROTEIN KINASE, LYSINE-DEFICIENT 4", WNK4
9796,601845,GOOSECOID HOMEOBOX 2, GSC2
9797,601846,"MYOPATHY WITH RIMMED UBIQUITIN-POSITIVE AUTOPHAGIC VACUOLATION, AUTOSOMAL DOMINANT", MRUPAV
9798,601847,"CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC, 2", PFIC2
9799,601848,TRANSLOCASE OF OUTER MITOCHONDRIAL MEMBRANE 20, TOMM20
9800,601849,"FIBULAR APLASIA OR HYPOPLASIA, FEMORAL BOWING, AND POLY-, SYN-, AND OLIGODACTYLY",
9801,601850,RETINITIS PIGMENTOSA-DEAFNESS SYNDROME,
9802,601851,CIRCADIAN LOCOMOTOR OUTPUT CYCLES KAPUT, CLOCK
9803,601852,INTERCELLULAR ADHESION MOLECULE 5, ICAM5
9804,601853,GOMEZ-LOPEZ-HERNANDEZ SYNDROME, GLHS
9805,601854,"DIACYLGLYCEROL KINASE, GAMMA, 90-KD", DGKG
9806,601855,RHO GUANINE NUCLEOTIDE EXCHANGE FACTOR 1, ARHGEF1
9807,601856,ZINC FINGER PROTEIN 211, ZNF211
9808,601857,BCL2-RELATED PROTEIN A1,
9809,601858,CALMEGIN, CLGN
9810,601859,AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME, ALPS
9811,601860,17-BETA-HYDROXYSTEROID DEHYDROGENASE IV, HSD17B4
9812,601861,REGULATORY FACTOR X-ASSOCIATED PROTEIN, RFXAP
9813,601862,"GLUCOSIDASE, ALPHA, NEUTRAL AB",
9814,601863,"REGULATORY FACTOR X, 5", RFX5
9815,601864,"PROTEIN KINASE C SUBSTRATE, 80-KD, HEAVY CHAIN",
9816,601865,"PROCOLLAGEN-LYSINE, 2-OXOGLUTARATE 5-DIOXYGENASE 2", PLOD2
9817,601866,SEMAPHORIN 4D, SEMA4D
9818,601867,"ATPase, Na+/K+ TRANSPORTING, BETA-3 POLYPEPTIDE", ATP1B3
9819,601868,"DEAFNESS, AUTOSOMAL DOMINANT 13", DFNA13
9820,601869,"DEAFNESS, AUTOSOMAL RECESSIVE 15", DFNB15
9821,601870,METHIONINE AMINOPEPTIDASE 2, METAP2
9822,601871,CYSTEINE- AND GLYCINE-RICH PROTEIN 2, CSRP2
9823,601872,"SOLUTE CARRIER FAMILY 7 (CATIONIC AMINO ACID TRANSPORTER, y+ SYSTEM), MEMBER 2", SLC7A2
9824,601873,"BETA-1,4-N-ACETYLGALACTOSAMINYLTRANSFERASE 1", B4GALNT1
9825,601874,"ELONGATION FACTOR, RNA POLYMERASE II, 2", ELL2
9826,601875,FRONTOTEMPORAL DEMENTIA 1,
9827,601876,SPERM-SPECIFIC ANTIGEN 1, SSFA1
9828,601877,LEFT-RIGHT DETERMINATION FACTOR 2, LEFTY2
9829,601878,KRUPPEL-LIKE FACTOR 10, KLF10
9830,601879,"LECTIN, GALACTOSIDE-BINDING, SOLUBLE, 9", LGALS9
9831,601880,"CHEMOKINE, CX3C MOTIF, LIGAND 1", CX3CL1
9832,601881,RETINA AND ANTERIOR NEURAL FOLD HOMEOBOX GENE, RAX
9833,601882,"DNA FRAGMENTATION FACTOR, 45-KD, ALPHA SUBUNIT", DFFA
9834,601883,"DNA FRAGMENTATION FACTOR, 40-KD, BETA SUBUNIT", DFFB
9835,601884,BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 1, BMND1
9836,601885,"CATARACT 14, MULTIPLE TYPES", CTRCT14
9837,601886,ACHAETE-SCUTE FAMILY bHLH TRANSCRIPTION FACTOR 2, ASCL2
9838,601887,"MALIGNANT HYPERTHERMIA, SUSCEPTIBILITY TO, 5", MHS5
9839,601888,"MALIGNANT HYPERTHERMIA, SUSCEPTIBILITY TO, 6",
9840,601889,NEUROBEACHIN PSEUDOGENE 1, NBEAP1
9841,601890,PROTEIN-TYROSINE KINASE PTK7, PTK7
9842,601891,CYSTATIN 6, CST6
9843,601892,KARYOPHERIN ALPHA-3, KPNA3
9844,601893,TRIPLE FUNCTIONAL DOMAIN, TRIO
9845,601894,GLOMERULOPATHY WITH FIBRONECTIN DEPOSITS 2, GFND2
9846,601895,TNF RECEPTOR-ASSOCIATED FACTOR 2, TRAF2
9847,601896,TNF RECEPTOR-ASSOCIATED FACTOR 3, TRAF3
9848,601897,ZINC FINGER PROTEIN 148, ZNF148
9849,601898,GROWTH HORMONE SECRETAGOGUE RECEPTOR, GHSR
9850,601899,SIGNAL-TRANSDUCING ADAPTOR MOLECULE 1, STAM
9851,601900,INTERFERON REGULATORY FACTOR 4, IRF4
9852,601901,"SOLUTE CARRIER FAMILY 8 (SODIUM-CALCIUM EXCHANGER), MEMBER A2", SLC8A2
9853,601902,"ORIGIN RECOGNITION COMPLEX, SUBUNIT 1", ORC1
9854,601903,"URIDINE DIPHOSPHATE GLYCOSYLTRANSFERASE 2 FAMILY, MEMBER B17", UGT2B17
9855,601904,RIBOSOMAL PROTEIN L39,
9856,601905,"RAB GERANYLGERANYL TRANSFERASE, ALPHA SUBUNIT", RABGGTA
9857,601906,"WINGLESS-TYPE MMTV INTEGRATION SITE FAMILY, MEMBER 10B", WNT10B
9858,601907,NEOGENIN, NEO1
9859,601908,G PROTEIN-COUPLED RECEPTOR 20, GPR20
9860,601909,G PROTEIN-COUPLED RECEPTOR 21, GPR21
9861,601910,G PROTEIN-COUPLED RECEPTOR 22, GPR22
9862,601911,DISTAL-LESS HOMEOBOX 4, DLX4
9863,601912,SMALL UBIQUITIN-LIKE MODIFIER 1, SUMO1
9864,601913,"GUIDED ENTRY OF TAIL-ANCHORED PROTEINS FACTOR 3, ATPase", GET3
9865,601914,PROLINE-ARGININE-RICH END LEUCINE-RICH REPEAT PROTEIN, PRELP
9866,601915,TISSUE INHIBITOR OF METALLOPROTEINASE 4, TIMP4
9867,601916,MESENCEPHALIC ASTROCYTE-DERIVED NEUROTROPHIC FACTOR, MANF
9868,601917,"ALDEHYDE DEHYDROGENASE 3 FAMILY, MEMBER B2", ALDH3B2
9869,601918,GROWTH/DIFFERENTIATION FACTOR 9, GDF9
9870,601919,COAGULATION FACTOR II RECEPTOR-LIKE 2, F2RL2
9871,601920,JAGGED 1, JAG1
9872,601921,METHYL-CpG-BINDING DOMAIN PROTEIN 1,
9873,601922,ANGIOPOIETIN 2, ANGPT2
9874,601923,SEMAPHORIN 3F,
9875,601924,"COATOMER PROTEIN COMPLEX, SUBUNIT ALPHA", COPA
9876,601925,RHO GDP-DISSOCIATION INHIBITOR ALPHA, ARHGDIA
9877,601926,THYROID HORMONE-RESPONSIVE PROTEIN, THRSP
9878,601927,"LYMPHEDEMA, CARDIAC SEPTAL DEFECTS, AND CHARACTERISTIC FACIES",
9879,601928,"KERATIN 86, TYPE II", KRT86
9880,601929,"ATPase, Ca(2+)-TRANSPORTING, UBIQUITOUS", ATP2A3
9881,601930,BASONUCLIN 1, BNC1
9882,601931,BCL2-LIKE 2, BCL2L2
9883,601932,"MUCIN 8, TRACHEOBRONCHIAL", MUC8
9884,601933,CRYPTOCHROME 1, CRY1
9885,601934,G PROTEIN PATHWAY SUPPRESSOR 1, GPS1
9886,601935,G PROTEIN PATHWAY SUPPRESSOR 2, GPS2
9887,601936,"PRKC, APOPTOSIS, WT1, REGULATOR", PAWR
9888,601937,NUCLEAR RECEPTOR COACTIVATOR 3, NCOA3
9889,601938,"SOLUTE CARRIER FAMILY 11 (PROTON-COUPLED DIVALENT METAL ION TRANSPORTER), MEMBER 2",
9890,601939,SRSF PROTEIN KINASE 1, SRPK1
9891,601940,"SPLICING FACTOR, SERINE/ARGININE-RICH, 4", SRSF4
9892,601941,TYPE 1 DIABETES MELLITUS 6, T1D6
9893,601942,TYPE 1 DIABETES MELLITUS 10, T1D10
9894,601943,"SPLICING FACTOR, SERINE/ARGININE-RICH, 9", SRSF9
9895,601944,"SPLICING FACTOR, SERINE/ARGININE-RICH, 6", SRSF6
9896,601945,"SPLICING FACTOR, SUPPRESSOR-OF-WHITE-APRICOT FAMILY", SFSWAP
9897,601946,LEUKOTRIENE B4 RECEPTOR,
9898,601947,SRY-BOX 12, SOX12
9899,601948,"ACID-SENSING ION CHANNEL, SUBUNIT 2",
9900,601949,"CALCIUM CHANNEL, VOLTAGE-DEPENDENT, BETA-4 SUBUNIT", CACNB4
9901,601950,"ZINC FINGER PROTEIN, FOG FAMILY MEMBER 1", ZFPM1
9902,601951,CDC-LIKE KINASE 1, CLK1
9903,601952,KERATOSIS LINEARIS WITH ICHTHYOSIS CONGENITA AND SCLEROSING KERATODERMA, KLICK
9904,601953,CYCLIN H, CCNH
9905,601954,"MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 7", LGMDR7
9906,601955,CYCLIN-DEPENDENT KINASE 7, CDK7
9907,601956,GDNF FAMILY RECEPTOR ALPHA-2, GFRA2
9908,601957,ODONTOTRICHOUNGUAL-DIGITAL-PALMAR SYNDROME,
9909,601958,"CALCIUM CHANNEL, VOLTAGE-DEPENDENT, BETA-3 SUBUNIT", CACNB3
9910,601959,NIMA-RELATED KINASE 4, NEK4
9911,601960,"CHEMOKINE, CC MOTIF, LIGAND 20", CCL20
9912,601961,PROTEIN ARGININE METHYLTRANSFERASE 2, PRMT2
9913,601962,TAP-BINDING PROTEIN, TAPBP
9914,601963,TETRATRICOPEPTIDE REPEAT DOMAIN-CONTAINING PROTEIN 1, TTC1
9915,601964,"DNAJ/HSP40 HOMOLOG, SUBFAMILY C, MEMBER 7", DNAJC7
9916,601965,SPHINGOSINE-1-PHOSPHATE RECEPTOR 3, S1PR3
9917,601966,"REGULATORY SOLUTE CARRIER PROTEIN, FAMILY 1, MEMBER 1", RSC1A1
9918,601967,"WINGLESS-TYPE MMTV INTEGRATION SITE FAMILY, MEMBER 7B", WNT7B
9919,601968,"WINGLESS-TYPE MMTV INTEGRATION SITE FAMILY, MEMBER 2B", WNT2B
9920,601969,DELETED IN MALIGNANT BRAIN TUMORS 1, DMBT1
9921,601970,VASOACTIVE INTESTINAL PEPTIDE RECEPTOR 2, VIPR2
9922,601971,RAR-RELATED ORPHAN RECEPTOR A,
9923,601972,RAR-RELATED ORPHAN RECEPTOR B, RORB
9924,601973,RETINOIC ACID RECEPTOR RESPONDER 2, RARRES2
9925,601974,SPHINGOSINE-1-PHOSPHATE RECEPTOR 1, S1PR1
9926,601975,PLAKOPHILIN 1, PKP1
9927,601976,OTOFACIOOSSEOUS-GONADAL SYNDROME,
9928,601977,THROMBOCYTHEMIA 2, THCYT2
9929,601978,SIGMA NONOPIOID INTRACELLULAR RECEPTOR 1, SIGMAR1
9930,601979,"AUTOINFLAMMATORY SYNDROME WITH CYTOPENIA, HYPERZINCEMIA, AND HYPERCALPROTECTINEMIA", AICZC
9931,601980,"LIPASE, GASTRIC", LIPF
9932,601981,"RIBONUCLEASE A FAMILY, MEMBER 6", RNASE6
9933,601982,8-OXOGUANINE DNA GLYCOSYLASE, OGG1
9934,601983,MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE KINASE 1, MAP4K1
9935,601984,NUCLEAR RECEPTOR COACTIVATOR 4, NCOA4
9936,601985,COILED-COIL DOMAIN-CONTAINING PROTEIN 6, CCDC6
9937,601986,"PROTEIN-TYROSINE PHOSPHATASE, RECEPTOR-TYPE, N, POLYPEPTIDE 2",
9938,601987,"CARNITINE PALMITOYLTRANSFERASE I, MUSCLE", CPT1B
9939,601988,LIM DOMAIN KINASE 2, LIMK2
9940,601989,S100 CALCIUM-BINDING PROTEIN A13, S100A13
9941,601990,TUMOR PROTEIN p73, TP73
9942,601991,NOVA ALTERNATIVE SPLICING REGULATOR 2, NOVA2
9943,601992,FRIEDREICH ATAXIA 2, FRDA2
9944,601993,NUCLEAR RECEPTOR COACTIVATOR 2, NCOA2
9945,601994,TRANSFER RNA ARGININE,
9946,601995,TENASCIN R, TNR
9947,601996,PHYTANOYL-CoA HYDROXYLASE,
9948,601997,BH3-INTERACTING DOMAIN DEATH AGONIST, BID
9949,601998,"ESTROGEN-RELATED RECEPTOR, ALPHA", ESRRA
9950,601999,LIM HOMEOBOX GENE 1, LHX1
9951,602000,"POLYMERASE I, RNA, SUBUNIT B", POLR1B
9952,602001,NEUROPEPTIDE Y RECEPTOR Y5, NPY5R
9953,602002,ZYXIN, ZYX
9954,602003,LYMPHOID-RESTRICTED MEMBRANE PROTEIN, LRMP
9955,602004,PROTEIN-TYROSINE KINASE 6, PTK6
9956,602005,SORTILIN-RELATED RECEPTOR, SORL1
9957,602006,MITOGEN-ACTIVATED PROTEIN KINASE-ACTIVATED PROTEIN KINASE 2, MAPKAPK2
9958,602007,"CRK-LIKE PROTOONCOGENE, ADAPTOR PROTEIN", CRKL
9959,602008,IMPORTIN 5, IPO5
9960,602009,"CYTOCHROME c OXIDASE, SUBUNIT 6A2", COX6A2
9961,602010,"SPLICING FACTOR, SERINE/ARGININE-RICH, 11", SRSF11
9962,602011,SUPPRESSOR OF TUMORIGENICITY 11, ST11
9963,602012,ECTONUCLEOSIDE TRIPHOSPHATE DIPHOSPHOHYDROLASE 2, ENTPD2
9964,602013,"POLYMERASE II, RNA, SUBUNIT G", POLR2G
9965,602014,"HYPOMAGNESEMIA 1, INTESTINAL", HOMG1
9966,602015,OUTER DENSE FIBER OF SPERM TAILS 2, ODF2
9967,602016,KRUPPEL-LIKE FACTOR 2, KLF2
9968,602017,"PROTEASOME SUBUNIT, BETA-TYPE, 1", PSMB1
9969,602018,NEURTURIN, NRTN
9970,602019,SQUALENE EPOXIDASE, SQLE
9971,602020,MAF bZIP TRANSCRIPTION FACTOR G, MAFG
9972,602021,"PROTEIN PHOSPHATASE 1, REGULATORY SUBUNIT 12A", PPP1R12A
9973,602022,MAL-LIKE, MALL
9974,602023,"CHLORIDE CHANNEL, KIDNEY, B", CLCNKB
9975,602024,"CHLORIDE CHANNEL, KIDNEY, A", CLCNKA
9976,602025,BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 9, BMIQ9
9977,602026,PHYTANOYL-CoA HYDROXYLASE, PHYH
9978,602027,TELOMERIC REPEAT-BINDING FACTOR 2, TERF2
9979,602028,INTERFERON REGULATORY FACTOR 4,
9980,602029,TITLE NOT AVAILABLE AT THIS MOMENT,
9981,602030,FUCOSYLTRANSFERASE 7, FUT7
9982,602031,"PROTEIN GERANYLGERANYLTRANSFERASE TYPE I, BETA SUBUNIT", PGGT1B
9983,602032,"ECTODERMAL DYSPLASIA 4, HAIR/NAIL TYPE", ECTD4
9984,602033,ECHINODERM MICROTUBULE-ASSOCIATED PROTEIN-LIKE 1, EML1
9985,602034,CORTICOTROPIN-RELEASING HORMONE RECEPTOR 2, CRHR2
9986,602035,"PROTEIN PHOSPHATASE 4, CATALYTIC SUBUNIT", PPP4C
9987,602036,ERYTHROKERATODERMIA VARIABILIS ET PROGRESSIVA 1,
9988,602037,"RAS HOMOLOG GENE FAMILY, MEMBER H", RHOH
9989,602038,DUAL-SPECIFICITY PHOSPHATASE 8, DUSP8
9990,602039,"EUKARYOTIC TRANSLATION INITIATION FACTOR 3, SUBUNIT A", EIF3A
9991,602040,"CELL ADHESION MOLECULE, NEURAL, 2", NCAM2
9992,602041,NK3 HOMEOBOX 1, NKX3-1
9993,602042,G PROTEIN-COUPLED RECEPTOR 18, GPR18
9994,602043,G PROTEIN-COUPLED RECEPTOR 31, GPR31
9995,602044,UNCOUPLING PROTEIN 3, UCP3
9996,602045,RING FINGER PROTEIN 1, RING1
9997,602046,"PROTEIN DISULFIDE ISOMERASE, FAMILY A, MEMBER 3", PDIA3
9998,602047,PHOSPHODIESTERASE 3B, PDE3B
9999,602048,RAS-RELATED C3 BOTULINUM TOXIN SUBSTRATE 1, RAC1
10000,602049,RAS-RELATED C3 BOTULINUM TOXIN SUBSTRATE 2, RAC2
10001,602050,RAS-RELATED C3 BOTULINUM TOXIN SUBSTRATE 3, RAC3
10002,602051,"PEPTIDYL-PROLYL CIS/TRANS ISOMERASE, NIMA-INTERACTING, 1-LIKE", PIN1L
10003,602052,CYCLIN G-ASSOCIATED KINASE, GAK
10004,602053,KRUPPEL-LIKE FACTOR 6, KLF6
10005,602054,T-BOX TRANSCRIPTION FACTOR 1, TBX1
10006,602055,INSULIN-INDUCED GENE 1, INSIG1
10007,602056,"DEFENSIN, BETA, 1", DEFB1
10008,602057,17-BETA-HYDROXYSTEROID DEHYDROGENASE X,
10009,602058,PROTEASE INHIBITOR 10, PI10
10010,602059,IMMUNOGLOBULIN SUPERFAMILY CONTAINING LEUCINE-RICH REPEAT, ISLR
10011,602060,TRANSMEMBRANE SERINE PROTEASE 2, TMPRSS2
10012,602061,EPIREGULIN, EREG
10013,602062,NERVE INJURY-INDUCED PROTEIN 1, NINJ1
10014,602063,TRANSALDOLASE 1, TALDO1
10015,602064,MYOINOSITOL MONOPHOSPHATASE 1, IMPA1
10016,602065,"ADENOSINE DEAMINASE, RNA-SPECIFIC, B2", ADARB2
10017,602066,"CONVULSIONS, FAMILIAL INFANTILE, WITH PAROXYSMAL CHOREOATHETOSIS", ICCA
10018,602067,"MYOPATHY, MYOFIBRILLAR, 1",
10019,602068,"LEISHMANIASIS, TEGUMENTARY, SUSCEPTIBILITY TO",
10020,602069,NEUROPILIN 1, NRP1
10021,602070,NEUROPILIN 2, NRP2
10022,602071,"BROAD TERMINAL PHALANGES, FAMILIAL",
10023,602072,"CYTOCHROME c OXIDASE, SUBUNIT 6A1", COX6A1
10024,602073,A DISINTEGRIN AND METALLOPROTEINASE DOMAIN 2,
10025,602074,DEATH-ASSOCIATED PROTEIN 3, DAP3
10026,602075,SPECIAL AT-RICH SEQUENCE-BINDING PROTEIN 1, SATB1
10027,602076,"TRANSIENT RECEPTOR POTENTIAL CATION CHANNEL, SUBFAMILY V, MEMBER 1", TRPV1
10028,602077,"ECTRODACTYLY, ECTODERMAL DYSPLASIA, AND CLEFT LIP/PALATE SYNDROME 3",
10029,602078,"FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, 2", CFEOM2
10030,602079,TRIMETHYLAMINURIA, TMAU
10031,602080,"PAGET DISEASE OF BONE 2, EARLY-ONSET", PDB2
10032,602081,SPEECH-LANGUAGE DISORDER 1, SPCH1
10033,602082,"CORNEAL DYSTROPHY, THIEL-BEHNKE TYPE", CDTB
10034,602083,"USHER SYNDROME, TYPE IF", USH1F
10035,602084,PHOSPHATASE AND TENSIN HOMOLOG,
10036,602085,"POLYDACTYLY, POSTAXIAL, TYPE A2", PAPA2
10037,602086,"ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 3", ARVD3
10038,602087,"ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 4", ARVD4
10039,602088,NEPHRONOPHTHISIS 2, NPHP2
10040,602089,"HEMANGIOMA, CAPILLARY INFANTILE",
10041,602090,LATENT TRANSFORMING GROWTH FACTOR-BETA-BINDING PROTEIN 3, LTBP3
10042,602091,LATENT TRANSFORMING GROWTH FACTOR-BETA-BINDING PROTEIN 2, LTBP2
10043,602092,"DEAFNESS, AUTOSOMAL RECESSIVE 18A", DFNB18A
10044,602093,CONE DYSTROPHY 3, COD3
10045,602094,"LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 2",
10046,602095,"SOLUTE CARRIER FAMILY 30 (ZINC TRANSPORTER), MEMBER 4", SLC30A4
10047,602096,ALZHEIMER DISEASE 5,
10048,602097,"USHER SYNDROME, TYPE IE", USH1E
10049,602098,POLO-LIKE KINASE 1, PLK1
10050,602099,"AMYOTROPHIC LATERAL SCLEROSIS 5, JUVENILE", ALS5
10051,602100,PBX/KNOTTED 1 HOMEOBOX 1, PKNOX1
10052,602101,CLAUDIN 5, CLDN5
10053,602102,"SPT5 HOMOLOG, DSIF ELONGATION FACTOR SUBUNIT", SUPT5H
10054,602103,"TRAFFICKING PROTEIN PARTICLE COMPLEX, SUBUNIT 10", TRAPPC10
10055,602104,SH3 DOMAIN-BINDING PROTEIN 2, SH3BP2
10056,602105,MutS HOMOLOG 4, MSH4
10057,602106,"POTASSIUM CHANNEL, INWARDLY RECTIFYING, SUBFAMILY J, MEMBER 15", KCNJ15
10058,602107,"NEUROPATHY, HEREDITARY THERMOSENSITIVE",
10059,602108,MATRILIN 2, MATN2
10060,602109,MATRILIN 3, MATN3
10061,602110,"SOLUTE CARRIER FAMILY 29 (NUCLEOSIDE TRANSPORTER), MEMBER 2", SLC29A2
10062,602111,"SPONDYLOEPIMETAPHYSEAL DYSPLASIA, MISSOURI TYPE", SEMDM
10063,602112,METALLOPHOSPHOESTERASE DOMAIN-CONTAINING PROTEIN 1, MPPED1
10064,602113,LYSINE-SPECIFIC METHYLTRANSFERASE 2D, KMT2D
10065,602114,"NEPHROPATHY, PROGRESSIVE TUBULOINTERSTITIAL, WITH CHOLESTATIC LIVER DISEASE",
10066,602115,FIBROBLAST GROWTH FACTOR 10, FGF10
10067,602116,YEATS DOMAIN-CONTAINING PROTEIN 4, YEATS4
10068,602117,NECDIN, NDN
10069,602118,CHROMODOMAIN HELICASE DNA-BINDING PROTEIN 1, CHD1
10070,602119,CHROMODOMAIN HELICASE DNA-BINDING PROTEIN 2, CHD2
10071,602120,CHROMODOMAIN HELICASE DNA-BINDING PROTEIN 3, CHD3
10072,602121,DIAPHANOUS-RELATED FORMIN 1, DIAPH1
10073,602122,"SIGNAL RECOGNITION PARTICLE, 72-KD", SRP72
10074,602123,CALCIUM/CALMODULIN-DEPENDENT PROTEIN KINASE II-GAMMA, CAMK2G
10075,602124,"DYSTONIA 7, TORSION", DYT7
10076,602125,CYTOCHROME c OXIDASE ASSEMBLY FACTOR COX10, COX10
10077,602126,ZINC FINGER- AND BTB DOMAIN-CONTAINING PROTEIN 14, ZBTB14
10078,602127,SMOOTHELIN, SMTN
10079,602128,GROWTH ARREST-SPECIFIC 2-LIKE 1, GAS2L1
10080,602129,MYOSIN IXB, MYO9B
10081,602130,MITOGEN-ACTIVATED PROTEIN KINASE-ACTIVATED PROTEIN KINASE 3, MAPKAPK3
10082,602131,"PLECKSTRIN HOMOLOGY-LIKE DOMAIN, FAMILY A, MEMBER 2", PHLDA2
10083,602132,MIA SH3 DOMAIN ER EXPORT FACTOR 2, MIA2
10084,602133,PHOSPHORIBOSYLFORMYLGLYCINAMIDINE SYNTHASE, PFAS
10085,602134,"TREMOR, HEREDITARY ESSENTIAL, 2", ETM2
10086,602135,"DYNEIN, AXONEMAL, LIGHT INTERMEDIATE POLYPEPTIDE 1", DNALI1
10087,602136,PEROXISOME BIOGENESIS FACTOR 1, PEX1
10088,602137,NADH-UBIQUINONE OXIDOREDUCTASE SUBUNIT A2, NDUFA2
10089,602138,NADH-UBIQUINONE OXIDOREDUCTASE SUBUNIT A6, NDUFA6
10090,602139,NADH-UBIQUINONE OXIDOREDUCTASE SUBUNIT A7, NDUFA7
10091,602140,NADH-UBIQUINONE OXIDOREDUCTASE SUBUNIT B8, NDUFB8
10092,602141,NADH-UBIQUINONE OXIDOREDUCTASE Fe-S PROTEIN 8, NDUFS8
10093,602142,"PHOSPHOLIPASE C, DELTA-1", PLCD1
10094,602143,TUMOR PROTEIN p53-BINDING PROTEIN 2, TP53BP2
10095,602144,"BROMODOMAIN, TESTIS-SPECIFIC", BRDT
10096,602145,"PROLIFERATION-ASSOCIATED 2G4, 38-KD", PA2G4
10097,602146,LIM HOMEOBOX GENE 4, LHX4
10098,602147,TITLE NOT AVAILABLE AT THIS MOMENT,
10099,602148,SRY-BOX 1, SOX1
10100,602149,PAIRED-LIKE HOMEODOMAIN TRANSCRIPTION FACTOR 1, PITX1
10101,602150,SNAIL FAMILY TRANSCRIPTIONAL REPRESSOR 2, SNAI2
10102,602151,DISHEVELLED 2, DVL2
10103,602152,RHYNS SYNDROME, RHYNS
10104,602153,"KERATIN 81, TYPE II", KRT81
10105,602154,NONCODING TRANSCRIPT IN T CELLS,
10106,602155,UBX DOMAIN PROTEIN 8, UBXN8
10107,602156,"OLIGOSACCHARYLTRANSFERASE COMPLEX, CATALYTIC SUBUNIT STT3A",
10108,602157,NOVA ALTERNATIVE SPLICING REGULATOR 1, NOVA1
10109,602158,"CHLORIDE CHANNEL, NUCLEOTIDE SENSITIVE, 1A", CLNS1A
10110,602159,CORONIN 2A, CORO2A
10111,602160,TRANSCRIPTION FACTOR DP2, TFDP2
10112,602161,PROTEASOME ACTIVATOR SUBUNIT 2, PSME2
10113,602162,SYNAPTONEMAL COMPLEX PROTEIN 1, SYCP1
10114,602163,UBIQUITIN-CONJUGATING ENZYME E2 E2, UBE2E2
10115,602164,5-HYDROXYTRYPTAMINE RECEPTOR 4, HTR4
10116,602165,TRIPARTITE MOTIF-CONTAINING PROTEIN 27, TRIM27
10117,602166,"ADAPTOR-RELATED PROTEIN COMPLEX 3, BETA-2 SUBUNIT", AP3B2
10118,602167,"ESTROGEN-RELATED RECEPTOR, BETA", ESRRB
10119,602168,VRK SERINE/THREONINE KINASE 1, VRK1
10120,602169,VRK SERINE/THREONINE KINASE 2, VRK2
10121,602170,MYD88 INNATE IMMUNE SIGNAL TRANSDUCTION ADAPTOR, MYD88
10122,602171,GLYCOPROTEIN A33, GPA33
10123,602172,"CYTOCHROME P450, SUBFAMILY VIIIB, POLYPEPTIDE 1", CYP8B1
10124,602173,"SEC62 HOMOLOG, PREPROTEIN TRANSLOCATION FACTOR", SEC62
10125,602174,G PROTEIN-COUPLED RECEPTOR 25, GPR25
10126,602175,"PROTEASOME SUBUNIT, BETA-TYPE, 2", PSMB2
10127,602176,"PROTEASOME SUBUNIT, BETA-TYPE, 3", PSMB3
10128,602177,"PROTEASOME SUBUNIT, BETA-TYPE, 4", PSMB4
10129,602178,CHONDROADHERIN, CHAD
10130,602179,HEAT-SHOCK 27-KD PROTEIN 2, HSPB2
10131,602180,SIGNAL-INDUCED PROLIFERATION-ASSOCIATED GENE 1, SIPA1
10132,602181,STAPHYLOCOCCAL NUCLEASE DOMAIN- AND TUDOR DOMAIN-CONTAINING PROTEIN 1, SND1
10133,602182,ECTONUCLEOTIDE PYROPHOSPHATASE/PHOSPHODIESTERASE 3, ENPP3
10134,602183,NK3 HOMEOBOX 2, NKX3-2
10135,602184,NADH-UBIQUINONE OXIDOREDUCTASE FLAVOPROTEIN 3, NDUFV3
10136,602185,EPHRIN RECEPTOR EphA5,
10137,602186,"VGF, NERVE GROWTH FACTOR-INDUCIBLE", VGF
10138,602187,ZINC FINGER PROTEIN 195, ZNF195
10139,602188,EPHRIN RECEPTOR EphA4, EPHA4
10140,602189,REGULATOR OF G PROTEIN SIGNALING 3, RGS3
10141,602190,EPHRIN RECEPTOR EphA7, EPHA7
10142,602191,E74-LIKE ETS TRANSCRIPTION FACTOR 3, ELF3
10143,602192,A DISINTEGRIN AND METALLOPROTEINASE DOMAIN 10, ADAM10
10144,602193,"SOLUTE CARRIER FAMILY 29 (NUCLEOSIDE TRANSPORTER), MEMBER 1", SLC29A1
10145,602194,HTRA SERINE PEPTIDASE 1, HTRA1
10146,602195,HEAT-SHOCK 27-KD PROTEIN 1, HSPB1
10147,602196,PIERRE ROBIN SEQUENCE WITH PECTUS EXCAVATUM AND RIB AND SCAPULAR ANOMALIES,
10148,602197,CEREBELLAR DEGENERATION-RELATED AUTOANTIGEN 3,
10149,602198,CDK2-ASSOCIATED PROTEIN 1, CDK2AP1
10150,602199,MEDIUM CHAIN 3-KETOACYL-CoA THIOLASE DEFICIENCY,
10151,602200,VENTRICULOMEGALY WITH DEFECTS OF THE RADIUS AND KIDNEY,
10152,602201,EXTRACELLULAR MATRIX PROTEIN 1, ECM1
10153,602202,DOLICHYL-DIPHOSPHOOLIGOSACCHARIDE-PROTEIN GLYCOSYLTRANSFERASE, DDOST
10154,602203,SARCOLIPIN, SLN
10155,602204,BICD CARGO ADAPTOR 1, BICD1
10156,602205,G PROTEIN-COUPLED ESTROGEN RECEPTOR 1,
10157,602206,RAS-ASSOCIATED PROTEIN RAB17, RAB17
10158,602207,RAS-ASSOCIATED PROTEIN RAB18, RAB18
10159,602208,"POTASSIUM CHANNEL, INWARDLY RECTIFYING, SUBFAMILY J, MEMBER 10", KCNJ10
10160,602209,RAS-RESPONSIVE ELEMENT BINDING PROTEIN 1, RREB1
10161,602210,"EUKARYOTIC TRANSLATION INITIATION FACTOR 3, SUBUNIT E", EIF3E
10162,602211,FORKHEAD BOX D2, FOXD2
10163,602212,"SIAH E3 UBIQUITIN PROTEIN LIGASE FAMILY, MEMBER 1", SIAH1
10164,602213,"SIAH E3 UBIQUITIN PROTEIN LIGASE FAMILY, MEMBER 2", SIAH2
10165,602214,"CASEIN KINASE I, GAMMA-2", CSNK1G2
10166,602215,"DEFENSIN, BETA, 4A", DEFB4A
10167,602216,SERINE/THREONINE PROTEIN KINASE 11, STK11
10168,602217,SYNDECAN-BINDING PROTEIN, SDCBP
10169,602218,SAL-LIKE 1, SALL1
10170,602219,SAL-LIKE 2, SALL2
10171,602220,"RAS-LIKE, FAMILY 10, MEMBER A", RASL10A
10172,602221,"ZINC FINGER, MYM-TYPE 2", ZMYM2
10173,602222,MAL-LIKE,
10174,602223,EUKARYOTIC TRANSLATION INITIATION FACTOR 4E-BINDING PROTEIN 1, EIF4EBP1
10175,602224,EUKARYOTIC TRANSLATION INITIATION FACTOR 4E-BINDING PROTEIN 2, EIF4EBP2
10176,602225,CONE-ROD HOMEOBOX-CONTAINING GENE, CRX
10177,602226,CD180 ANTIGEN, CD180
10178,602227,"CHEMOKINE, CC MOTIF, LIGAND 19", CCL19
10179,602228,TRANSCRIPTION FACTOR 7-LIKE 2, TCF7L2
10180,602229,SRY-BOX 10, SOX10
10181,602230,SH3 DOMAIN-BINDING GLUTAMIC ACID-RICH PROTEIN, SH3BGR
10182,602231,SMALL UBIQUITIN-LIKE MODIFIER 3, SUMO3
10183,602232,"POTASSIUM CHANNEL, VOLTAGE-GATED, KQT-LIKE SUBFAMILY, MEMBER 3", KCNQ3
10184,602233,APOPTOTIC PROTEASE ACTIVATING FACTOR 1, APAF1
10185,602234,"CASPASE 9, APOPTOSIS-RELATED CYSTEINE PROTEASE", CASP9
10186,602235,"POTASSIUM CHANNEL, VOLTAGE-GATED, KQT-LIKE SUBFAMILY, MEMBER 2", KCNQ2
10187,602236,"CHEMOKINE, CX3C MOTIF, LIGAND 1",
10188,602237,"CHEMOKINE, CX3C MOTIF, RECEPTOR 1",
10189,602238,EXOSOME COMPONENT 2, EXOSC2
10190,602239,"CYTOCHROME P450, SUBFAMILY XXVIA, POLYPEPTIDE 1", CYP26A1
10191,602240,ZINC FINGER PROTEIN 192, ZNF192
10192,602241,MITOCHONDRIAL INTERMEDIATE PEPTIDASE, MIPEP
10193,602242,"ADAPTOR-RELATED PROTEIN COMPLEX 2, SIGMA-1 SUBUNIT", AP2S1
10194,602243,CD151 ANTIGEN, CD151
10195,602244,DEOXYRIBONUCLEASE I-LIKE 3, DNASE1L3
10196,602245,GTP-BINDING PROTEIN 1, GTPBP1
10197,602246,ZINC FINGER PROTEIN 193, ZNF193
10198,602247,"XANTHOMATOSIS, SUSCEPTIBILITY TO",
10199,602248,MALIGNANT ATROPHIC PAPULOSIS,
10200,602249,PROGEROID FACIAL APPEARANCE WITH HAND ANOMALIES,
10201,602250,"TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY, MEMBER 9", TNFRSF9
10202,602251,TRANSLOCASE OF INNER MITOCHONDRIAL MEMBRANE 10, TIMM10
10203,602252,"MITOCHONDRIAL INTERMEMBRANE SPACE PROTEIN TIM12, YEAST, HOMOLOG OF",
10204,602253,KRUPPEL-LIKE FACTOR 4, KLF4
10205,602254,SRR1 DOMAIN-CONTAINING PROTEIN, SRRD
10206,602255,SERINE/THREONINE PROTEIN KINASE 25, STK25
10207,602256,"PROTEIN PHOSPHATASE, EF-HAND CALCIUM-BINDING DOMAIN 2", PPEF2
10208,602257,"SCAVENGER RECEPTOR CLASS B, MEMBER 2", SCARB2
10209,602258,"SCAVENGER RECEPTOR CLASS B, MEMBER 1",
10210,602259,TETRATRICOPEPTIDE REPEAT DOMAIN-CONTAINING PROTEIN 3, TTC3
10211,602260,PERIOD CIRCADIAN REGULATOR 1, PER1
10212,602261,MATRIX METALLOPROTEINASE 15, MMP15
10213,602262,MATRIX METALLOPROTEINASE 16, MMP16
10214,602263,MATRIX METALLOPROTEINASE 19,
10215,602264,"SPARC/OSTEONECTIN, CWCV, AND KAZAL-LIKE DOMAINS PROTEOGLYCAN", SPOCK1
10216,602265,"NEURAL PRECURSOR CELL EXPRESSED, DEVELOPMENTALLY DOWNREGULATED 9", NEDD9
10217,602266,"ATP-BINDING CASSETTE, SUBFAMILY B, MEMBER 7",
10218,602267,A DISINTEGRIN AND METALLOPROTEINASE DOMAIN 8, ADAM8
10219,602268,"AMINE OXIDASE, COPPER-CONTAINING, 2", AOC2
10220,602269,ARVCF DELTA CATENIN FAMILY MEMBER, ARVCF
10221,602270,ANTIOXIDANT PROTEIN 1, ATOX1
10222,602271,"SPONDYLOMETAPHYSEAL DYSPLASIA, AXIAL", SMDAX
10223,602272,TRANSCRIPTION FACTOR 4, TCF4
10224,602273,UDP-N-ACETYL-ALPHA-D-GALACTOSAMINE:POLYPEPTIDE N-ACETYLGALACTOSAMINYLTRANSFERASE 1, GALNT1
10225,602274,UDP-N-ACETYL-ALPHA-D-GALACTOSAMINE:POLYPEPTIDE N-ACETYLGALACTOSAMINYLTRANSFERASE 2, GALNT2
10226,602275,GUANYLATE CYCLASE ACTIVATOR 1B, GUCA1B
10227,602276,TRANSCRIPTIONAL ADAPTOR 2A, TADA2A
10228,602277,ZINC FINGER PROTEIN 184, ZNF184
10229,602278,"NEURAL PRECURSOR CELL EXPRESSED, DEVELOPMENTALLY DOWNREGULATED 4", NEDD4
10230,602279,"POLYADENYLATE-BINDING PROTEIN, NUCLEAR, 1", PABPN1
10231,602280,TUB-LIKE PROTEIN 1, TULP1
10232,602281,MILK FAT GLOBULE-EGF FACTOR 8, MFGE8
10233,602282,LYSOPHOSPHATIDIC ACID RECEPTOR 1, LPAR1
10234,602283,"CHEMOKINE, CC MOTIF, LIGAND 8", CCL8
10235,602284,BONE MORPHOGENETIC PROTEIN 8B, BMP8B
10236,602285,MATRIX METALLOPROTEINASE 17, MMP17
10237,602286,STEROL C5-DESATURASE, SC5D
10238,602287,"ENDOPLASMIC RETICULUM PROTEIN, 29-KD", ERP29
10239,602288,RHOTEKIN, RTKN
10240,602289,DR1-ASSOCIATED PROTEIN 1, DRAP1
10241,602290,TRIPARTITE MOTIF-CONTAINING PROTEIN 32, TRIM32
10242,602291,FORKHEAD BOX J1, FOXJ1
10243,602292,"ENOYL-CoA HYDRATASE, SHORT-CHAIN, 1, MITOCHONDRIAL", ECHS1
10244,602293,CALCIUM- AND INTEGRIN-BINDING PROTEIN 1, CIB1
10245,602294,FORKHEAD BOX A1, FOXA1
10246,602295,FORKHEAD BOX A3, FOXA3
10247,602296,"ADAPTOR-RELATED PROTEIN COMPLEX 4, MU-1 SUBUNIT", AP4M1
10248,602297,EPHRIN B3, EFNB3
10249,602298,RAS-ASSOCIATED PROTEIN RAB7, RAB7
10250,602299,RAS-ASSOCIATED PROTEIN RAB9,
10251,602300,GALACTOSE-3-O-SULFOTRANSFERASE 1, GAL3ST1
10252,602301,LYSINE ACETYLTRANSFERASE 2A, KAT2A
10253,602302,HR LYSINE DEMETHYLASE AND NUCLEAR RECEPTOR COREPRESSOR, HR
10254,602303,LYSINE ACETYLTRANSFERASE 2B, KAT2B
10255,602304,"NUCLEAR RECEPTOR SUBFAMILY 1, GROUP D, MEMBER 2", NR1D2
10256,602305,SYNAPTONEMAL COMPLEX PROTEIN 1,
10257,602306,RAL GUANINE NUCLEOTIDE DISSOCIATION STIMULATOR-LIKE 2, RGL2
10258,602307,WW DOMAIN-CONTAINING PROTEIN 1, WWP1
10259,602308,WW DOMAIN-CONTAINING PROTEIN 2, WWP2
10260,602309,TUB-LIKE PROTEIN 2, TULP2
10261,602310,"RNA-BINDING MOTIF PROTEIN, SINGLE STRAND-INTERACTING, 1", RBMS1
10262,602311,AGOUTI-RELATED NEUROPEPTIDE, AGRP
10263,602312,"HISTONE GENE CLUSTER 1, H1 HISTONE FAMILY, MEMBER B",
10264,602313,OVO-LIKE 1, OVOL1
10265,602314,LADININ 1, LAD1
10266,602315,MITOGEN-ACTIVATED PROTEIN KINASE KINASE 3, MAP2K3
10267,602316,PEROXIREDOXIN 6, PRDX6
10268,602317,SH3 AND CYSTEINE-RICH DOMAINS 1, STAC1
10269,602318,"TRANSCRIPTION TERMINATION FACTOR 1, MITOCHONDRIAL", MTERF1
10270,602319,NEURAL EPIDERMAL GROWTH FACTOR-LIKE PROTEIN 1, NELL1
10271,602320,NEURAL EPIDERMAL GROWTH FACTOR-LIKE PROTEIN 2, NELL2
10272,602321,"GLUTATHIONE S-TRANSFERASE, KAPPA-1", GSTK1
10273,602322,TELOMERASE RNA COMPONENT, TERC
10274,602323,"POTASSIUM CHANNEL, INWARDLY RECTIFYING, SUBFAMILY J, MEMBER 12", KCNJ12
10275,602324,HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN H3, HNRNPH3
10276,602325,"EUKARYOTIC TRANSLATION INITIATION FACTOR 4-GAMMA, 2", EIF4G2
10277,602326,RIBOSOMAL PROTEIN L23A, RPL23A
10278,602327,PLECKSTRIN AND SEC7 DOMAINS-CONTAINING PROTEIN, PSD
10279,602328,RHO GTPase-ACTIVATING PROTEIN 6,
10280,602329,SUPPRESSOR OF LIN12-LIKE, SEL1L
10281,602330,"ACTIN-BINDING LIM PROTEIN FAMILY, MEMBER 1", ABLIM1
10282,602331,"ORIGIN RECOGNITION COMPLEX, SUBUNIT 5", ORC5
10283,602332,NON-SMC CONDENSIN I COMPLEX SUBUNIT H, NCAPH
10284,602333,EPITHELIAL MEMBRANE PROTEIN 1, EMP1
10285,602334,EPITHELIAL MEMBRANE PROTEIN 2, EMP2
10286,602335,EPITHELIAL MEMBRANE PROTEIN 3, EMP3
10287,602336,RECEPTOR TYROSINE KINASE-LIKE ORPHAN RECEPTOR 1, ROR1
10288,602337,RECEPTOR TYROSINE KINASE-LIKE ORPHAN RECEPTOR 2, ROR2
10289,602338,PRE-mRNA-PROCESSING FACTOR KINASE PRP4K, PRP4K
10290,602339,"SOLUTE CARRIER FAMILY 15 (H+/PEPTIDE TRANSPORTER), MEMBER 2", SLC15A2
10291,602340,"SENSORINEURAL HEARING LOSS, RETINAL PIGMENT EPITHELIUM LESIONS, DISCOLORED TEETH",
10292,602341,FORKHEAD BOX M1, FOXM1
10293,602342,PIERPONT SYNDROME, PRPTS
10294,602343,"TRANSIENT RECEPTOR POTENTIAL CATION CHANNEL, SUBFAMILY C, MEMBER 1", TRPC1
10295,602344,PLATELET-ACTIVATING FACTOR ACETYLHYDROLASE 2, PAFAH2
10296,602345,"TRANSIENT RECEPTOR POTENTIAL CATION CHANNEL, SUBFAMILY C, MEMBER 3", TRPC3
10297,602346,CONTACTIN-ASSOCIATED PROTEIN 1, CNTNAP1
10298,602347,"CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC, 3", PFIC3
10299,602348,"SMALL NUCLEAR RNA-ACTIVATING PROTEIN COMPLEX, POLYPEPTIDE 3", SNAPC3
10300,602349,NETRIN 3, NTN3
10301,602350,NEUROGRANIN, NRGN
10302,602351,CHEMERIN CHEMOKINE-LIKE RECEPTOR 1, CMKLR1
10303,602352,GONADOTROPIN-RELEASING HORMONE 2, GNRH2
10304,602353,"TRANSFORMING GROWTH FACTOR, BETA-1-INDUCED 1", TGFB1I1
10305,602354,LINKER FOR ACTIVATION OF T CELLS, LAT
10306,602355,TNF RECEPTOR-ASSOCIATED FACTOR 6, TRAF6
10307,602356,TNF RECEPTOR-ASSOCIATED FACTOR 5, TRAF5
10308,602357,"WAS/WASL-INTERACTING PROTEIN FAMILY, MEMBER 1", WIPF1
10309,602358,HYPOCRETIN, HCRT
10310,602359,FXYD DOMAIN-CONTAINING ION TRANSPORT REGULATOR 1, FXYD1
10311,602360,L-ARGININE:GLYCINE AMIDINOTRANSFERASE, GATM
10312,602361,GRACILE BONE DYSPLASIA, GCLEB
10313,602362,"GTPase-ACTIVATING PROTEIN, RAN, 1", RANGAP1
10314,602363,ELLIS-VAN CREVELD SYNDROME,
10315,602364,CATHEPSIN W, CTSW
10316,602365,CATHEPSIN C, CTSC
10317,602366,INTEGRIN-LINKED KINASE, ILK
10318,602367,NEURONAL PENTRAXIN 1, NPTX1
10319,602368,"GLUTAMATE RECEPTOR, IONOTROPIC, DELTA 2", GRID2
10320,602369,CELLULAR COMMUNICATION NETWORK FACTOR 1, CCN1
10321,602370,GLYCOSYLPHOSPHATIDYLINOSITOL-ANCHORED MOLECULE-LIKE PROTEIN, GML
10322,602371,"ACYL-CoA SYNTHETASE LONG CHAIN FAMILY, MEMBER 3", ACSL3
10323,602372,ZONADHESIN, ZAN
10324,602373,CALPONIN 2, CNN2
10325,602374,CALPONIN 3, CNN3
10326,602375,MITOCHONDRIAL RIBOSOMAL PROTEIN L12, MRPL12
10327,602376,"INTERFERON-ALPHA, -BETA, AND -OMEGA RECEPTOR 2", IFNAR2
10328,602377,DYNAMIN 1, DNM1
10329,602378,DYNAMIN 2, DNM2
10330,602379,"PROTEIN PHOSPHATASE 6, CATALYTIC SUBUNIT",
10331,602380,UROPLAKIN 1B, UPK1B
10332,602381,NGFIA-BINDING PROTEIN 2, NAB2
10333,602382,"PHOSPHOLIPASE D1, PHOSPHATIDYLCHOLINE-SPECIFIC", PLD1
10334,602383,OSTEOGLYCIN, OGN
10335,602384,PHOSPHOLIPASE D2, PLD2
10336,602385,"SULFOTRANSFERASE FAMILY 1C, MEMBER 2", SULT1C2
10337,602386,ZINC FINGER PROTEIN 212, ZNF212
10338,602387,"RNA-BINDING MOTIF PROTEIN, SINGLE STRAND-INTERACTING, 2", RBMS2
10339,602388,SYMPLEKIN, SYMPK
10340,602389,"Tu TRANSLATION ELONGATION FACTOR, MITOCHONDRIAL", TUFM
10341,602390,"HEMOCHROMATOSIS, TYPE 2A", HFE2A
10342,602391,PHOSPHATIDYLETHANOLAMINE N-METHYLTRANSFERASE, PEMT
10343,602392,HYPOCRETIN RECEPTOR 1, HCRTR1
10344,602393,HYPOCRETIN RECEPTOR 2, HCRTR2
10345,602394,NUCLEOLAR AND COILED-BODY PHOSPHOPROTEIN 1, NOLC1
10346,602395,"GLYCEROL-3-PHOSPHATE ACYLTRANSFERASE, MITOCHONDRIAL", GPAM
10347,602396,ANNEXIN A8, ANXA8
10348,602397,"ATPase, CLASS I, TYPE 8B, MEMBER 1", ATP8B1
10349,602398,DESMOSTEROLOSIS,
10350,602399,MITOGEN-ACTIVATED PROTEIN KINASE 12, MAPK12
10351,602400,"ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 11", ARCI11
10352,602401,"ECTODERMAL DYSPLASIA 8, HAIR/TOOTH/NAIL TYPE", ECTD8
10353,602402,FORKHEAD BOX C2, FOXC2
10354,602403,BLEOMYCIN HYDROLASE, BLMH
10355,602404,"PARKINSON DISEASE 3, AUTOSOMAL DOMINANT", PARK3
10356,602405,INSULIN-LIKE 4,
10357,602406,HEART- AND NEURAL CREST DERIVATIVES-EXPRESSED 1, HAND1
10358,602407,HEART- AND NEURAL CREST DERIVATIVES-EXPRESSED 2, HAND2
10359,602408,"NUCLEAR RECEPTOR SUBFAMILY 1, GROUP D, MEMBER 1", NR1D1
10360,602409,MLLT10 HISTONE LYSINE METHYLTRANSFERASE DOT1L COFACTOR, MLLT10
10361,602410,BROMODOMAIN- AND PHD FINGER-CONTAINING PROTEIN, BRPF1
10362,602411,EXOSTOSIN-LIKE GLYCOSYLTRANSFERASE 2, EXTL2
10363,602412,RIBOSOMAL PROTEIN S24, RPS24
10364,602413,"SUCCINATE DEHYDROGENASE COMPLEX, SUBUNIT C", SDHC
10365,602414,"AMYLOID BETA A4 PRECURSOR PROTEIN-BINDING, FAMILY A, MEMBER 1", APBA1
10366,602415,"DYSTROBREVIN, BETA", DTNB
10367,602416,"ADAPTOR-RELATED PROTEIN COMPLEX 3, SIGMA-2 SUBUNIT", AP3S2
10368,602417,AQUAPORIN 7,
10369,602418,WEYERS ULNAR RAY/OLIGODACTYLY SYNDROME,
10370,602419,EARLY GROWTH RESPONSE 3, EGR3
10371,602420,"POTASSIUM CHANNEL, VOLTAGE-GATED, SHAKER-RELATED SUBFAMILY, MEMBER 10", KCNA10
10372,602421,CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR, CFTR
10373,602422,STEM-LOOP BINDING PROTEIN, SLBP
10374,602423,"NUCLEAR RECEPTOR SUBFAMILY 1, GROUP H, MEMBER 3", NR1H3
10375,602424,DOUBLESEX- AND MAB3-RELATED TRANSCRIPTION FACTOR 1, DMRT1
10376,602425,MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 4, MAP3K4
10377,602426,NUCLEAR VALOSIN-CONTAINING PROTEIN-LIKE, NVL
10378,602427,T-BOX TRANSCRIPTION FACTOR 6, TBX6
10379,602428,HYALURONAN SYNTHASE 3, HAS3
10380,602429,"GLAUCOMA 1, OPEN ANGLE, D", GLC1D
10381,602430,ROUNDABOUT GUIDANCE RECEPTOR 1, ROBO1
10382,602431,ROUNDABOUT GUIDANCE RECEPTOR 2, ROBO2
10383,602432,OPTINEURIN, OPTN
10384,602433,"AMYOTROPHIC LATERAL SCLEROSIS 4, JUVENILE", ALS4
10385,602434,ANCIENT UBIQUITOUS PROTEIN 1, AUP1
10386,602435,PEPTIDYL-PROLYL ISOMERASE E, PPIE
10387,602436,MAJOR HISTOCOMPATIBILITY COMPLEX CLASS I CHAIN-RELATED GENE B, MICB
10388,602437,GTP CYCLOHYDROLASE I FEEDBACK REGULATORY PROTEIN, GCHFR
10389,602438,HEAT-SHOCK TRANSCRIPTION FACTOR 4, HSF4
10390,602439,"LEUKEMIA, ACUTE MYELOID",
10391,602440,"AMYOTROPHY, MONOMELIC",
10392,602441,CYTOKINE-INDUCIBLE SH2-CONTAINING PROTEIN, CISH
10393,602442,INTERSECTIN 1, ITSN1
10394,602443,X-PROLYL AMINOPEPTIDASE 1, XPNPEP1
10395,602444,ZINC FINGER PROTEIN 354A, ZNF354A
10396,602445,"SERINE PROTEASE INHIBITOR, CLADE I, MEMBER 1", SERPINI1
10397,602446,GLYPICAN 5, GPC5
10398,602447,PARAOXONASE 2, PON2
10399,602448,MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 5, MAP3K5
10400,602449,A-KINASE ANCHOR PROTEIN 1, AKAP1
10401,602450,SEVERE COMBINED IMMUNODEFICIENCY WITH SENSITIVITY TO IONIZING RADIATION,
10402,602451,"PYRIMIDINERGIC RECEPTOR P2Y, G PROTEIN-COUPLED, 6", P2RY6
10403,602452,BUB1 MITOTIC CHECKPOINT SERINE/THREONINE KINASE, BUB1
10404,602453,"INTEGRIN, ALPHA-D", ITGAD
10405,602454,"PROTEIN-TYROSINE PHOSPHATASE, RECEPTOR-TYPE, U", PTPRU
10406,602455,"SERPIN PEPTIDASE INHIBITOR, CLADE A, MEMBER 10",
10407,602456,TITLE NOT AVAILABLE AT THIS MOMENT,
10408,602457,FAS-ASSOCIATED VIA DEATH DOMAIN, FADD
10409,602458,SORTILIN, SORT1
10410,602459,"DEAFNESS, AUTOSOMAL DOMINANT 15", DFNA15
10411,602460,"POU DOMAIN, CLASS 4, TRANSCRIPTION FACTOR 3", POU4F3
10412,602461,"PROTEIN-TYROSINE PHOSPHATASE, NONRECEPTOR TYPE, SUBSTRATE 1", PTPNS1
10413,602462,COLLAPSIN RESPONSE MEDIATOR PROTEIN 1, CRMP1
10414,602463,DIHYDROPYRIMIDINASE-LIKE 2, DPYSL2
10415,602464,TNF RECEPTOR-ASSOCIATED FACTOR 4, TRAF4
10416,602465,SPROUTY RTK SIGNALING ANTAGONIST 1, SPRY1
10417,602466,SPROUTY RTK SIGNALING ANTAGONIST 2, SPRY2
10418,602467,SPROUTY RTK SIGNALING ANTAGONIST 3,
10419,602468,"PROTEIN PHOSPHATASE 1, REGULATORY SUBUNIT 9A", PPP1R9A
10420,602469,FOLATE RECEPTOR 3, FOLR3
10421,602470,PROSTATE STEM CELL ANTIGEN, PSCA
10422,602471,"SHORT STATURE, AUDITORY CANAL ATRESIA, MANDIBULAR HYPOPLASIA, AND SKELETAL ABNORMALITIES", SAMS
10423,602472,"CREASES, INFRA-AURICULAR CUTANEOUS, WITH TALL STATURE AND ADVANCED BONE AGE",
10424,602473,"ENCEPHALOPATHY, ETHYLMALONIC", EE
10425,602474,"PROTEIN KINASE, MEMBRANE-ASSOCIATED TYROSINE/THREONINE, 1", PKMYT1
10426,602475,OSSIFICATION OF THE POSTERIOR LONGITUDINAL LIGAMENT OF SPINE, OPLL
10427,602476,"FEBRILE SEIZURES, FAMILIAL, 1",
10428,602477,"EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 17", EIG17
10429,602478,tRNA ASPARTIC ACID METHYLTRANSFERASE 1, TRDMT1
10430,602479,"POU DOMAIN, CLASS 3, TRANSCRIPTION FACTOR 1", POU3F1
10431,602480,"POU DOMAIN, CLASS 3, TRANSCRIPTION FACTOR 3", POU3F3
10432,602481,"MIGRAINE, FAMILIAL HEMIPLEGIC, 2", FHM2
10433,602482,"AXENFELD-RIEGER SYNDROME, TYPE 3", RIEG3
10434,602483,AURICULOCONDYLAR SYNDROME 1, ARCND1
10435,602484,PELVIC HYPOPLASIA WITH LOWER-LIMB ARTHROGRYPOSIS,
10436,602485,"HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 3", HHF3
10437,602486,"POP1 HOMOLOG, RIBONUCLEASE P/MRP SUBUNIT", POP1
10438,602487,HEAT-RESPONSIVE PROTEIN 12, HRSP12
10439,602488,CYTOHESIN 2, CYTH2
10440,602489,"KH DOMAIN-CONTAINING, RNA-BINDING, SIGNAL TRANSDUCTION-ASSOCIATED PROTEIN 1", KHDRBS1
10441,602490,NUCLEAR RECEPTOR-INTERACTING PROTEIN 1, NRIP1
10442,602491,"HYPERLIPIDEMIA, FAMILIAL COMBINED, 1", FCHL1
10443,602492,PENTRAXIN 3, PTX3
10444,602493,UV RADIATION RESISTANCE-ASSOCIATED GENE, UVRAG
10445,602494,"CHEMOKINE, CC MOTIF, LIGAND 23", CCL23
10446,602495,"CHEMOKINE, CC MOTIF, LIGAND 24", CCL24
10447,602496,MERCAPTOPYRUVATE SULFURTRANSFERASE, MPST
10448,602497,"CHONDRODYSPLASIA PUNCTATA, BRACHYTELEPHALANGIC, AUTOSOMAL",
10449,602498,TRAFFICKING FROM ER TO GOLGI REGULATOR, TFG
10450,602499,"MACROPHTHALMIA, COLOBOMATOUS, WITH MICROCORNEA", MACOM
10451,602500,"GOLGI AUTOANTIGEN, GOLGIN SUBFAMILY B, 1", GOLGB1
10452,602501,MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME, MCAP
10453,602502,GOLGIN A1, GOLGA1
10454,602503,FREQUENTLY REARRANGED IN ADVANCED T-CELL LYMPHOMAS, FRAT1
10455,602504,SHORT STATURE HOMEOBOX 2, SHOX2
10456,602505,PAXILLIN, PXN
10457,602506,CYCLIN T1,
10458,602507,RING FINGER PROTEIN 103, RNF103
10459,602508,"PLATELET-ACTIVATING FACTOR ACETYLHYDROLASE, ISOFORM 1B, BETA SUBUNIT", PAFAH1B2
10460,602509,GOLGIN A4, GOLGA4
10461,602510,"PROTEIN-TYROSINE PHOSPHATASE, RECEPTOR-TYPE, H", PTPRH
10462,602511,PSEUDOACROMEGALY WITH SEVERE INSULIN RESISTANCE,
10463,602512,REGULATOR OF G PROTEIN SIGNALING 12, RGS12
10464,602513,REGULATOR OF G PROTEIN SIGNALING 14, RGS14
10465,602514,REGULATOR OF G PROTEIN SIGNALING 16, RGS16
10466,602515,"PHOSPHOLIPASE D1, GLYCOSYLPHOSPHATIDYLINOSITOL-SPECIFIC", GPLD1
10467,602516,REGULATOR OF G PROTEIN SIGNALING 4, RGS4
10468,602517,REGULATOR OF G PROTEIN SIGNALING 7, RGS7
10469,602518,"LECTIN, GALACTOSIDE-BINDING, SOLUBLE, 4", LGALS4
10470,602519,UBIQUITIN-SPECIFIC PROTEASE 7, USP7
10471,602520,MITOGEN-ACTIVATED PROTEIN KINASE KINASE 5, MAP2K5
10472,602521,MITOGEN-ACTIVATED PROTEIN KINASE 7, MAPK7
10473,602522,"BARTTER SYNDROME, TYPE 4A, NEONATAL, WITH SENSORINEURAL DEAFNESS", BARTS4A
10474,602523,DOWN SYNDROME CELL ADHESION MOLECULE, DSCAM
10475,602524,"PYRUVATE DEHYDROGENASE KINASE, ISOENZYME 1", PDK1
10476,602525,"PYRUVATE DEHYDROGENASE KINASE, ISOENZYME 2", PDK2
10477,602526,"PYRUVATE DEHYDROGENASE KINASE, ISOENZYME 3",
10478,602527,"PYRUVATE DEHYDROGENASE KINASE, ISOENZYME 4", PDK4
10479,602528,"TUBULIN, ALPHA-3C", TUBA3C
10480,602529,"TUBULIN, ALPHA-1A", TUBA1A
10481,602530,"TUBULIN, ALPHA-1B", TUBA1B
10482,602531,GRANGE SYNDROME, GRNG
10483,602532,RNF217 ANTISENSE RNA 1, RNF217AS1
10484,602533,ONCOGENE DJ1, DJ1
10485,602534,"SYNAPTOSOMAL-ASSOCIATED PROTEIN, 23-KD", SNAP23
10486,602535,MARSHALL-SMITH SYNDROME, MRSHSS
10487,602536,"RAB3 GTPase-ACTIVATING PROTEIN, CATALYTIC SUBUNIT", RAB3GAP1
10488,602537,CALPAIN 5, CAPN5
10489,602538,"CUGBP- AND ELAV-LIKE FAMILY, MEMBER 2", CELF2
10490,602539,MITOGEN-ACTIVATED KINASE KINASE KINASE 3, MAP3K3
10491,602540,"ICHTHYOSIS, HYSTRIX-LIKE, WITH DEAFNESS",
10492,602541,"MUSCULAR DYSTROPHY, CONGENITAL, MEGACONIAL TYPE", MDCMC
10493,602542,BASIC TRANSCRIPTION FACTOR 3, BTF3
10494,602543,BASIC TRANSCRIPTION FACTOR 3 PSEUDOGENE 11, BTF3P11
10495,602544,PARKIN RBR E3 UBIQUITIN PROTEIN LIGASE, PRKN
10496,602545,"PROTEIN-TYROSINE PHOSPHATASE, RECEPTOR-TYPE, KAPPA", PTPRK
10497,602546,"ST8 ALPHA-N-ACETYL-NEURAMINIDE ALPHA-2,8-SIALYLTRANSFERASE 2", ST8SIA2
10498,602547,"ST8 ALPHA-N-ACETYL-NEURAMINIDE ALPHA-2,8-SIALYLTRANSFERASE 4", ST8SIA4
10499,602548,OPIOID RECEPTOR-LIKE 1, OPRL1
10500,602549,PROTEIN KINASE N2, PKN2
10501,602550,BRAIN AND MUSCLE ARNT-LIKE PROTEIN 1, BMAL1
10502,602551,JEJUNAL ATRESIA WITH RENAL ADYSPLASIA,
10503,602552,"NUCLEOPORIN, 88-KD", NUP88
10504,602553,"ANAL ATRESIA, HYPOSPADIAS, AND PENOSCROTAL INVERSION",
10505,602554,TORSION DYSTONIA WITH ONSET IN INFANCY,
10506,602555,"MICROCEPHALY, MACROTIA, AND IMPAIRED INTELLECTUAL DEVELOPMENT",
10507,602556,"FACIAL DYSMORPHISM, CLEFT PALATE, HEARING LOSS, AND CAMPTODACTYLY",
10508,602557,"SPONDYLOEPIMETAPHYSEAL DYSPLASIA, SHOHAT TYPE", SEMDSH
10509,602558,CRANIOMICROMELIC SYNDROME,
10510,602559,EXPORTIN 1, XPO1
10511,602560,TRACHEAL ANTIMICROBIAL PEPTIDE,
10512,602561,"BRACHYDACTYLY, INTRAVENTRICULAR SEPTAL DEFECT, AND DEAFNESS",
10513,602562,MANDIBULOFACIAL DYSOSTOSIS WITH MACROBLEPHARON AND MACROSTOMIA,
10514,602563,NK6 HOMEOBOX 1, NKX6-1
10515,602564,"EMPHYSEMA, CONGENITAL, WITH DEAFNESS, PENOSCROTAL WEB, AND INTELLECTUAL DEVELOPMENTAL DISORDER",
10516,602565,"CHEMOKINE, CC MOTIF, LIGAND 25", CCL25
10517,602566,"PURINERGIC RECEPTOR P2X, LIGAND-GATED ION CHANNEL, 7", P2RX7
10518,602567,LIM ZINC FINGER-CONTAINING PROTEIN 1, LIMS1
10519,602568,METHIONINE SYNTHASE REDUCTASE, MTRR
10520,602569,"SYNUCLEIN, BETA", SNCB
10521,602570,JAGGED 2, JAG2
10522,602571,RNA-BINDING MOTIF PROTEIN 4, RBM4
10523,602572,ANNEXIN A11, ANXA11
10524,602573,ANNEXIN A13, ANXA13
10525,602574,"TECTORIN, ALPHA", TECTA
10526,602575,"LIM HOMEOBOX TRANSCRIPTION FACTOR 1, BETA", LMX1B
10527,602576,LFNG O-FUCOSYLPEPTIDE 3-BETA-N-ACETYLGLUCOSAMINYLTRANSFERASE, LFNG
10528,602577,MFNG O-FUCOSYLPEPTIDE 3-BETA-N-ACETYLGLUCOSAMINYLTRANSFERASE, MFNG
10529,602578,RFNG O-FUCOSYLPEPTIDE 3-BETA-N-ACETYLGLUCOSAMINYLTRANSFERASE, RFNG
10530,602579,"CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ib", CDG1B
10531,602580,GOLGIN A2, GOLGA2
10532,602581,GOLGIN A3, GOLGA3
10533,602582,DELTEX E3 UBIQUITIN LIGASE 1, DTX1
10534,602583,G PROTEIN-COUPLED RECEPTOR 37, GPR37
10535,602584,RETICULOCALBIN 2, RCN2
10536,602585,FEINGOLD SYNDROME 1,
10537,602586,CHIMERIN 2,
10538,602587,ACYL-CoA THIOESTERASE 7, ACOT7
10539,602588,BRANCHIOOTIC SYNDROME 1, BOS1
10540,602589,FUCOSYLTRANSFERASE 8, FUT8
10541,602590,p21 PROTEIN-ACTIVATED KINASE 1, PAK1
10542,602591,KINESIN FAMILY MEMBER 2A, KIF2A
10543,602592,LYMPHOCYTE ANTIGEN CD5-LIKE, CD5L
10544,602593,CORNEODESMOSIN, CDSN
10545,602594,RETINITIS PIGMENTOSA 22, RP22
10546,602595,GEM NUCLEAR ORGANELLE-ASSOCIATED PROTEIN 2, GEMIN2
10547,602596,"PANCREATIC LYMPHOMA, FAMILIAL",
10548,602597,B-CELL CLL/LYMPHOMA 9, BCL9
10549,602598,"PROSTAGLANDIN D SYNTHASE, HEMATOPOIETIC", HPGDS
10550,602599,"SOLUTE CARRIER FAMILY 22 (ORGANIC CATION TRANSPORTER), MEMBER 18",
10551,602600,LOW DENSITY LIPOPROTEIN RECEPTOR-RELATED PROTEIN 8, LRP8
10552,602601,"LOW DENSITY LIPOPROTEIN, OXIDIZED, RECEPTOR 1", OLR1
10553,602602,SECRETED AND TRANSMEMBRANE 1, SECTM1
10554,602603,"MAGO HOMOLOG, EXON JUNCTION COMPLEX SUBUNIT", MAGOH
10555,602604,"POTASSIUM CHANNEL, INWARDLY RECTIFYING, SUBFAMILY J, MEMBER 12",
10556,602605,"ZINC FINGER, MYM-TYPE 2",
10557,602606,CART PREPROPEPTIDE, CARTPT
10558,602607,"SOLUTE CARRIER FAMILY 22 (ORGANIC CATION TRANSPORTER), MEMBER 1", SLC22A1
10559,602608,"SOLUTE CARRIER FAMILY 22 (ORGANIC CATION TRANSPORTER), MEMBER 2", SLC22A2
10560,602609,"PHOSPHATIDYLINOSITOL 3-KINASE, CLASS 3", PIK3C3
10561,602610,"PHOSPHATIDYLINOSITOL 3-KINASE, REGULATORY SUBUNIT 4", PIK3R4
10562,602611,"SPONDYLOEPIPHYSEAL DYSPLASIA WITH CORONAL CRANIOSYNOSTOSIS, CATARACTS, CLEFT PALATE, AND IMPAIRED INTELLECTUAL DEVELOPMENT",
10563,602612,"CAMPTODACTYLY, MYOPIA, AND FIBROSIS OF THE MEDIAL RECTUS MUSCLE OF EYE",
10564,602613,"SKELETAL DYSPLASIA AND PROGRESSIVE CENTRAL NERVOUS SYSTEM DEGENERATION, LETHAL",
10565,602614,MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 7, MAP3K7
10566,602615,TAK1-BINDING PROTEIN 1, TAB1
10567,602616,"ALPHA-1,6-MANNOSYL-GLYCOPROTEIN BETA-1,2-N-ACETYLGLUCOSAMINYLTRANSFERASE", MGAT2
10568,602617,FORKHEAD BOX E1, FOXE1
10569,602618,C-TERMINAL-BINDING PROTEIN 1, CTBP1
10570,602619,C-TERMINAL-BINDING PROTEIN 2, CTBP2
10571,602620,LEGUMAIN, LGMN
10572,602621,COXSACKIEVIRUS AND ADENOVIRUS RECEPTOR, CXADR
10573,602622,DEOXYRIBONUCLEASE I-LIKE 2, DNASE1L2
10574,602623,FK506-BINDING PROTEIN 5, FKBP5
10575,602624,JAGGED 2,
10576,602625,"MEMBRANE-ASSOCIATED GUANYLATE KINASE, WW AND PDZ DOMAINS-CONTAINING, 1", MAGI1
10577,602626,INTERLEUKIN 1 RECEPTOR ACCESSORY PROTEIN, IL1RAP
10578,602627,CELL DIVISION CYCLE 6, CDC6
10579,602628,FORKHEAD BOX N3, FOXN3
10580,602629,"DYSTONIA 6, TORSION", DYT6
10581,602630,TRANSFORMING GROWTH FACTOR-BETA-INDUCED FACTOR, TGIF
10582,602631,"SOLUTE CARRIER FAMILY 22 (ORGANIC CATION TRANSPORTER), MEMBER 18", SLC22A18
10583,602632,PODOCALYXIN-LIKE, PODXL
10584,602633,FOUR-AND-A-HALF LIM DOMAINS 2, FHL2
10585,602634,"DNAJ/HSP40 HOMOLOG, SUBFAMILY B, MEMBER 9", DNAJB9
10586,602635,DEAF1 TRANSCRIPTION FACTOR, DEAF1
10587,602636,"PROTEIN PHOSPHATASE 1, REGULATORY SUBUNIT 8", PPP1R8
10588,602637,SECRETED PHOSPHOPROTEIN 2, SPP2
10589,602638,MINICHROMOSOME MAINTENANCE COMPLEX COMPONENT 4, MCM4
10590,602639,"TOOTH AGENESIS, SELECTIVE, 2", STHAG2
10591,602640,N-ACETYLATED ALPHA-LINKED ACIDIC DIPEPTIDASE-LIKE 1, NAALADL1
10592,602641,"EUKARYOTIC TRANSLATION INITIATION FACTOR 4A, ISOFORM 1", EIF4A1
10593,602642,"TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY, MEMBER 11", TNFSF11
10594,602643,"TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY, MEMBER 11B", TNFRSF11B
10595,602644,TETRASPANIN 4, TSPAN4
10596,602645,SEMAPHORIN 3C, SEMA3C
10597,602646,G PROTEIN-COUPLED RECEPTOR 35, GPR35
10598,602647,NUCLEAR RNA EXPORT FACTOR 1, NXF1
10599,602648,ATYPICAL CHEMOKINE RECEPTOR 2, ACKR2
10600,602649,COLD-INDUCIBLE RNA-BINDING PROTEIN, CIRBP
10601,602650,SPECKLE-TYPE BTB/POZ PROTEIN, SPOP
10602,602651,NARDILYSIN, NRD1
10603,602652,KALLIKREIN-RELATED PEPTIDASE 6, KLK6
10604,602653,"TECTORIN, BETA", TECTB
10605,602654,"FERM, ARHGEF, AND PLECKSTRIN DOMAINS-CONTAINING PROTEIN 1", FARP1
10606,602655,"SOLUTE CARRIER FAMILY 4 (ANION EXCHANGER), MEMBER 1, ADAPTOR PROTEIN", SLC4A1AP
10607,602656,ENDONUCLEASE III-LIKE 1, NTHL1
10608,602657,ADHESION G PROTEIN-COUPLED RECEPTOR G2,
10609,602658,PHOSPHODIESTERASE 2A, PDE2A
10610,602659,MENAGE A TROIS 1, MNAT1
10611,602660,"TUBULIN, BETA-4B", TUBB4B
10612,602661,"TUBULIN, BETA-3", TUBB3
10613,602662,"TUBULIN, BETA-4A", TUBB4A
10614,602663,PROLACTIN-RELEASING HORMONE, PRLH
10615,602664,"CASPASE 4, APOPTOSIS-RELATED CYSTEINE PROTEASE", CASP4
10616,602665,"CASPASE 5, APOPTOSIS-RELATED CYSTEINE PROTEASE", CASP5
10617,602666,MYOSIN XVA, MYO15A
10618,602667,NIBRIN, NBN
10619,602668,MYOTONIC DYSTROPHY 2, DM2
10620,602669,PAIRED-LIKE HOMEODOMAIN TRANSCRIPTION FACTOR 3, PITX3
10621,602670,"POLYMERASE, DNA, EPSILON-2", POLE2
10622,602671,"SOLUTE CARRIER FAMILY 37 (GLUCOSE-6-PHOSPHATE TRANSPORTER), MEMBER 4", SLC37A4
10623,602672,RAS-ASSOCIATED PROTEIN RAB13, RAB13
10624,602673,KALLIKREIN-RELATED PEPTIDASE 10, KLK10
10625,602674,HESX HOMEOBOX 1,
10626,602675,ARGINYL AMINOPEPTIDASE, RNPEP
10627,602676,PHOSPHODIESTERASE 6D, PDE6D
10628,602677,RING FINGER PROTEIN 5, RNF5
10629,602678,MAP/MICROTUBULE AFFINITY-REGULATING KINASE 3, MARK3
10630,602679,"PHOSPHATE CYTIDYLYLTRANSFERASE 2, ETHANOLAMINE", PCYT2
10631,602680,RHO GTPase-ACTIVATING PROTEIN 5, ARHGAP5
10632,602681,FORKHEAD BOX O3A, FOXO3A
10633,602682,ADHESION G PROTEIN-COUPLED RECEPTOR B1, ADGRB1
10634,602683,ADHESION G PROTEIN-COUPLED RECEPTOR B2, ADGRB2
10635,602684,ADHESION G PROTEIN-COUPLED RECEPTOR B3, ADGRB3
10636,602685,INTELLECTUAL DEVELOPMENTAL DISORDER WITH SPASTICITY AND PIGMENTARY TAPETORETINAL DEGENERATION,
10637,602686,MITOTIC ARREST DEFICIENT 1 LIKE 1, MAD1L1
10638,602687,AURORA KINASE A,
10639,602688,HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN A/B, HNRNPAB
10640,602689,FASCIN ACTIN-BUNDLING PROTEIN 1, FSCN1
10641,602690,"SUCCINATE DEHYDROGENASE COMPLEX, SUBUNIT D", SDHD
10642,602691,NUCLEAR RECEPTOR COACTIVATOR 1, NCOA1
10643,602692,GLIOMA PATHOGENESIS-RELATED PROTEIN 1, GLIPR1
10644,602693,MINICHROMOSOME MAINTENANCE COMPLEX COMPONENT 3, MCM3
10645,602694,NADH-UBIQUINONE OXIDOREDUCTASE Fe-S PROTEIN 4, NDUFS4
10646,602695,"TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY, MEMBER 12", TNFSF12
10647,602696,MINICHROMOSOME MAINTENANCE COMPLEX COMPONENT 5, MCM5
10648,602697,"PURINERGIC RECEPTOR P2Y, G PROTEIN-COUPLED, 11", P2RY11
10649,602698,"NUCLEAR FACTOR OF ACTIVATED T CELLS, CYTOPLASMIC, CALCINEURIN-DEPENDENT 3", NFATC3
10650,602699,"NUCLEAR FACTOR OF ACTIVATED T CELLS, CYTOPLASMIC, CALCINEURIN-DEPENDENT 4", NFATC4
10651,602700,"E1A-BINDING PROTEIN, 300-KD", EP300
10652,602701,SARCOLEMMAL-ASSOCIATED PROTEIN, SLMAP
10653,602702,PERILIPIN 3, PLIN3
10654,602703,"KATANIN, p80 SUBUNIT, B1", KATNB1
10655,602704,MDM4 REGULATOR OF p53, MDM4
10656,602705,SYNAPSIN III, SYN3
10657,602706,"PROTEASOME 26S SUBUNIT, ATPase, 1", PSMC1
10658,602707,"PROTEASOME 26S SUBUNIT, ATPase, 4", PSMC4
10659,602708,"PROTEASOME 26S SUBUNIT, ATPase, 6", PSMC6
10660,602709,"AMYLOID BETA A4 PRECURSOR PROTEIN-BINDING, FAMILY B, MEMBER 1", APBB1
10661,602710,"AMYLOID BETA A4 PRECURSOR PROTEIN-BINDING, FAMILY B, MEMBER 2", APBB2
10662,602711,"AMYLOID BETA A4 PRECURSOR PROTEIN-BINDING, FAMILY B, MEMBER 3", APBB3
10663,602712,"AMYLOID BETA A4 PRECURSOR PROTEIN-BINDING, FAMILY A, MEMBER 2", APBA2
10664,602713,A DISINTEGRIN AND METALLOPROTEINASE DOMAIN 9, ADAM9
10665,602714,A DISINTEGRIN AND METALLOPROTEINASE DOMAIN 12, ADAM12
10666,602715,LEIOMODIN 1, LMOD1
10667,602716,NEPHRIN, NPHS1
10668,602717,"GLUTAMATE RECEPTOR, IONOTROPIC, N-METHYL-D-ASPARTATE, SUBUNIT 2D", GRIN2D
10669,602718,TRANSFORMER 2 ALPHA HOMOLOG, TRA2A
10670,602719,TRANSFORMER 2 BETA HOMOLOG, TRA2B
10671,602720,PARAOXONASE 3, PON3
10672,602721,DNA MEIOTIC RECOMBINASE 1, DMC1
10673,602722,"RENAL TUBULAR ACIDOSIS, DISTAL, 3, WITH OR WITHOUT SENSORINEURAL HEARING LOSS", DRTA3
10674,602723,PSORIASIS 2, PSORS2
10675,602724,SEPTIN 5, SEPT5
10676,602725,INTERFERON-RELATED DEVELOPMENTAL REGULATOR 2, IFRD2
10677,602726,CHLORIDE CHANNEL 6, CLCN6
10678,602727,CHLORIDE CHANNEL 7, CLCN7
10679,602728,"SCAVENGER RECEPTOR CLASS A, MEMBER 3", SCARA3
10680,602729,"GAMMA-AMINOBUTYRIC ACID RECEPTOR, PI", GABRP
10681,602730,"ACTIVIN A RECEPTOR, TYPE IIB", ACVR2B
10682,602731,FYN-BINDING PROTEIN 1, FYB1
10683,602732,RHO GTPase-ACTIVATING PROTEIN 1, ARHGAP1
10684,602733,"ALDEHYDE DEHYDROGENASE, FAMILY 9, SUBFAMILY A, MEMBER 1", ALDH9A1
10685,602734,PLASTIN 1, PLS1
10686,602735,RETICULOCALBIN 1, RCN1
10687,602736,"ATP SYNTHASE MEMBRANE SUBUNIT C, LOCUS 3", ATP5MC3
10688,602737,"CHEMOKINE, CC MOTIF, LIGAND 21", CCL21
10689,602738,KARYOPHERIN BETA-1, KPNB1
10690,602739,"PROTEIN KINASE, AMP-ACTIVATED, CATALYTIC, ALPHA-1", PRKAA1
10691,602740,"PROTEIN KINASE, AMP-ACTIVATED, NONCATALYTIC, BETA-1", PRKAB1
10692,602741,"PROTEIN KINASE, AMP-ACTIVATED, NONCATALYTIC, BETA-2", PRKAB2
10693,602742,"PROTEIN KINASE, AMP-ACTIVATED, NONCATALYTIC, GAMMA-1", PRKAG1
10694,602743,"PROTEIN KINASE, AMP-ACTIVATED, NONCATALYTIC, GAMMA-2", PRKAG2
10695,602744,GLYCERONEPHOSPHATE O-ACYLTRANSFERASE, GNPAT
10696,602745,"PHOSPHATIDYLINOSITOL 4-PHOSPHATE 5-KINASE, TYPE I, BETA", PIP5K1B
10697,602746,"TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY, MEMBER 14", TNFRSF14
10698,602747,DUAL-SPECIFICITY PHOSPHATASE 4, DUSP4
10699,602748,DUAL-SPECIFICITY PHOSPHATASE 6, DUSP6
10700,602749,DUAL-SPECIFICITY PHOSPHATASE 7, DUSP7
10701,602750,D-DOPACHROME TAUTOMERASE, DDT
10702,602751,BTB AND CNC HOMOLOGY 1, BACH1
10703,602752,RANBP2-LIKE AND GRIP DOMAIN-CONTAINING PROTEIN 8, RGPD8
10704,602753,PAIRED-LIKE HOMEOBOX 2A, PHOX2A
10705,602754,"POTASSIUM CHANNEL, CALCIUM-ACTIVATED, INTERMEDIATE/SMALL CONDUCTANCE, SUBFAMILY N, MEMBER 4", KCNN4
10706,602755,CYCLIN B2, CCNB2
10707,602756,EPHRIN A2, EFNA2
10708,602757,EPHRIN RECEPTOR EphB6, EPHB6
10709,602758,"PHOSPHATIDYLINOSITOL 4-KINASE, BETA", PI4KB
10710,602759,"PROSTATE CANCER, HEREDITARY, 8", HPC8
10711,602760,"KERATIN 32, TYPE I", KRT32
10712,602761,"KERATIN 33A, TYPE I", KRT33A
10713,602762,"KERATIN 33B, TYPE I", KRT33B
10714,602763,"KERATIN 34, TYPE I", KRT34
10715,602764,"KERATIN 35, TYPE I", KRT35
10716,602765,"KERATIN 83, TYPE II", KRT83
10717,602766,"KERATIN 84, TYPE II", KRT84
10718,602767,"KERATIN 85, TYPE II", KRT85
10719,602768,DELTA-LIKE CANONICAL NOTCH LIGAND 3, DLL3
10720,602769,DNA METHYLTRANSFERASE 3A, DNMT3A
10721,602770,CHROMOBOX 2, CBX2
10722,602771,CONGENITAL MYOPATHY 3 WITH RIGID SPINE, CMYO3
10723,602772,RETINITIS PIGMENTOSA 25, RP25
10724,602773,"SOLUTE CARRIER FAMILY 49, MEMBER 4", SLC49A4
10725,602774,RAD51 PARALOG C, RAD51C
10726,602775,SHOC2 LEUCINE-RICH REPEAT SCAFFOLD PROTEIN, SHOC2
10727,602776,"REV3-LIKE, DNA-DIRECTED POLYMERASE ZETA CATALYTIC SUBUNIT", REV3L
10728,602777,"SMALL NUCLEAR RNA-ACTIVATING PROTEIN COMPLEX, POLYPEPTIDE 4", SNAPC4
10729,602778,"NUCLEAR RECEPTOR SUBFAMILY 6, GROUP A, MEMBER 1", NR6A1
10730,602779,COAGULATION FACTOR II RECEPTOR-LIKE 3, F2RL3
10731,602780,HYPERPOLARIZATION-ACTIVATED CYCLIC NUCLEOTIDE-GATED POTASSIUM CHANNEL 1, HCN1
10732,602781,HYPERPOLARIZATION-ACTIVATED CYCLIC NUCLEOTIDE-GATED POTASSIUM CHANNEL 2, HCN2
10733,602782,HISTIOCYTOSIS-LYMPHADENOPATHY PLUS SYNDROME,
10734,602783,"SPG7 MATRIX AAA PEPTIDASE SUBUNIT, PARAPLEGIN", SPG7
10735,602784,CORTISTATIN, CORT
10736,602785,"H1 HISTONE FAMILY, MEMBER X", H1FX
10737,602786,"HISTONE GENE CLUSTER 1, H2A HISTONE FAMILY, MEMBER E", HIST1H2AE
10738,602787,"HISTONE GENE CLUSTER 1, H2A HISTONE FAMILY, MEMBER I", HIST1H2AI
10739,602788,"HISTONE GENE CLUSTER 1, H2A HISTONE FAMILY, MEMBER K", HIST1H2AK
10740,602789,FOUR-AND-A-HALF LIM DOMAINS 1,
10741,602790,FOUR-AND-A-HALF LIM DOMAINS 3, FHL3
10742,602791,"HISTONE GENE CLUSTER 1, H2A HISTONE FAMILY, MEMBER J", HIST1H2AJ
10743,602792,"HISTONE GENE CLUSTER 1, H2A HISTONE FAMILY, MEMBER D", HIST1H2AD
10744,602793,"HISTONE GENE CLUSTER 1, H2A HISTONE FAMILY, MEMBER L", HIST1H2AL
10745,602794,"HISTONE GENE CLUSTER 1, H2A HISTONE FAMILY, MEMBER C", HIST1H2AC
10746,602795,"HISTONE GENE CLUSTER 1, H2A HISTONE FAMILY, MEMBER B", HIST1H2AB
10747,602796,"HISTONE GENE CLUSTER 1, H2A HISTONE FAMILY, MEMBER M", HIST1H2AM
10748,602797,"HISTONE GENE CLUSTER 2, H2A HISTONE FAMILY, MEMBER C", HIST2H2AC
10749,602798,"HISTONE GENE CLUSTER 1, H2B HISTONE FAMILY, MEMBER G", HIST1H2BG
10750,602799,"HISTONE GENE CLUSTER 1, H2B HISTONE FAMILY, MEMBER D", HIST1H2BD
10751,602800,"HISTONE GENE CLUSTER 1, H2B HISTONE FAMILY, MEMBER L", HIST1H2BL
10752,602801,"HISTONE GENE CLUSTER 1, H2B HISTONE FAMILY, MEMBER N", HIST1H2BN
10753,602802,"HISTONE GENE CLUSTER 1, H2B HISTONE FAMILY, MEMBER M", HIST1H2BM
10754,602803,"HISTONE GENE CLUSTER 1, H2B HISTONE FAMILY, MEMBER B", HIST1H2BB
10755,602804,"HISTONE GENE CLUSTER 1, H2B HISTONE FAMILY, MEMBER F", HIST1H2BF
10756,602805,"HISTONE GENE CLUSTER 1, H2B HISTONE FAMILY, MEMBER E", HIST1H2BE
10757,602806,"HISTONE GENE CLUSTER 1, H2B HISTONE FAMILY, MEMBER H", HIST1H2BH
10758,602807,"HISTONE GENE CLUSTER 1, H2B HISTONE FAMILY, MEMBER I", HIST1H2BI
10759,602808,"HISTONE GENE CLUSTER 1, H2B HISTONE FAMILY, MEMBER O", HIST1H2BO
10760,602809,KINESIN FAMILY MEMBER 5B, KIF5B
10761,602810,"HISTONE GENE CLUSTER 1, H3 HISTONE FAMILY, MEMBER A", HIST1H3A
10762,602811,"HISTONE GENE CLUSTER 1, H3 HISTONE FAMILY, MEMBER D", HIST1H3D
10763,602812,"HISTONE GENE CLUSTER 1, H3 HISTONE FAMILY, MEMBER C", HIST1H3C
10764,602813,"HISTONE GENE CLUSTER 1, H3 HISTONE FAMILY, MEMBER E", HIST1H3E
10765,602814,"HISTONE GENE CLUSTER 1, H3 HISTONE FAMILY, MEMBER I", HIST1H3I
10766,602815,"HISTONE GENE CLUSTER 1, H3 HISTONE FAMILY, MEMBER G", HIST1H3G
10767,602816,"HISTONE GENE CLUSTER 1, H3 HISTONE FAMILY, MEMBER F", HIST1H3F
10768,602817,"HISTONE GENE CLUSTER 1, H3 HISTONE FAMILY, MEMBER J", HIST1H3J
10769,602818,"HISTONE GENE CLUSTER 1, H3 HISTONE FAMILY, MEMBER H", HIST1H3H
10770,602819,"HISTONE GENE CLUSTER 1, H3 HISTONE FAMILY, MEMBER B", HIST1H3B
10771,602820,"HISTONE GENE CLUSTER 3, H3 HISTONE", HIST3H3
10772,602821,KINESIN FAMILY MEMBER 5A, KIF5A
10773,602822,H4 CLUSTERED HISTONE 1, H4C1
10774,602823,H4 CLUSTERED HISTONE 4, H4C4
10775,602824,H4 CLUSTERED HISTONE 6, H4C6
10776,602825,H4 CLUSTERED HISTONE 12, H4C12
10777,602826,H4 CLUSTERED HISTONE 11, H4C11
10778,602827,H4 CLUSTERED HISTONE 3, H4C3
10779,602828,H4 CLUSTERED HISTONE 8, H4C8
10780,602829,H4 CLUSTERED HISTONE 2, H4C2
10781,602830,H4 CLUSTERED HISTONE 5, H4C5
10782,602831,H4 CLUSTERED HISTONE 13, H4C13
10783,602832,H4 CLUSTERED HISTONE 7, H4C7
10784,602833,H4 CLUSTERED HISTONE 9, H4C9
10785,602834,PEROXISOME BIOGENESIS FACTOR 19,
10786,602835,GROWTH ARREST-SPECIFIC 2, GAS2
10787,602836,"PURINERGIC RECEPTOR P2X, LIGAND-GATED ION CHANNEL, 5", P2RX5
10788,602837,"DNAJ/HSP40 HOMOLOG, SUBFAMILY A, MEMBER 1", DNAJA1
10789,602838,"PHOSPHATIDYLINOSITOL 3-KINASE, CLASS 2, BETA", PIK3C2B
10790,602839,"PHOSPHATIDYLINOSITOL 3-KINASE, CATALYTIC, DELTA", PIK3CD
10791,602840,CD70 ANTIGEN, CD70
10792,602841,ALDEHYDE OXIDASE 1, AOX1
10793,602842,GEMININ DNA REPLICATION INHIBITOR, GMNN
10794,602843,RHO GDP-DISSOCIATION INHIBITOR BETA, ARHGDIB
10795,602844,RHO GDP-DISSOCIATION INHIBITOR GAMMA, ARHGDIG
10796,602845,KINESIN FAMILY MEMBER 3C, KIF3C
10797,602846,UBIQUITIN-CONJUGATING ENZYME E2 K, UBE2K
10798,602847,"HISTONE GENE CLUSTER 1, H2B HISTONE FAMILY, MEMBER C", HIST1H2BC
10799,602848,BROMODOMAIN-CONTAINING PROTEIN 8, BRD8
10800,602849,MUENKE SYNDROME, MNKES
10801,602850,RING FINGER PROTEIN 4, RNF4
10802,602851,ADHESION G PROTEIN-COUPLED RECEPTOR V1, ADGRV1
10803,602852,NUDIX HYDROLASE 2, NUDT2
10804,602853,"PROTEIN-TYROSINE PHOSPHATASE, RECEPTOR-TYPE, R", PTPRR
10805,602854,"PROTEASOME SUBUNIT, ALPHA-TYPE, 1", PSMA1
10806,602855,"PROTEASOME SUBUNIT, ALPHA-TYPE, 6", PSMA6
10807,602856,REGULATOR OF G PROTEIN SIGNALING 10, RGS10
10808,602857,CHIMERIN 2, CHN2
10809,602858,7-DEHYDROCHOLESTEROL REDUCTASE, DHCR7
10810,602859,PEROXISOME BIOGENESIS FACTOR 10, PEX10
10811,602860,BUB1 MITOTIC CHECKPOINT SERINE/THREONINE KINASE B, BUB1B
10812,602861,PLAKOPHILIN 2, PKP2
10813,602862,UDP-N-ACETYLGLUCOSAMINE PYROPHOSPHORYLASE 1, UAP1
10814,602863,"WINGLESS-TYPE MMTV INTEGRATION SITE FAMILY, MEMBER 9A", WNT9A
10815,602864,"WINGLESS-TYPE MMTV INTEGRATION SITE FAMILY, MEMBER 9B", WNT9B
10816,602865,BONE MORPHOGENETIC PROTEIN/RETINOIC ACID-INDUCIBLE NEURAL-SPECIFIC PROTEIN 1, BRINP1
10817,602866,"ACID-SENSING ION CHANNEL, SUBUNIT 1", ASIC1
10818,602867,INSULIN-LIKE GROWTH FACTOR-BINDING PROTEIN 7, IGFBP7
10819,602868,CELL DIVISION CYCLE 5-LIKE, CDC5L
10820,602869,HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN U, HNRNPU
10821,602870,INTERPHOTORECEPTOR MATRIX PROTEOGLYCAN 1, IMPG1
10822,602871,PERIPLAKIN, PPL
10823,602872,CHLORIDE INTRACELLULAR CHANNEL 1, CLIC1
10824,602873,NEBULIN-RELATED ANCHORING PROTEIN, NRAP
10825,602874,UDP-GLUCOSE CERAMIDE GLUCOSYLTRANSFERASE, UGCG
10826,602875,ACROMESOMELIC DYSPLASIA 1, AMD1
10827,602876,OCCLUDIN, OCLN
10828,602877,"PROTEIN PHOSPHATASE 1, REGULATORY SUBUNIT 7", PPP1R7
10829,602878,"SOLUTE CARRIER FAMILY 30 (ZINC TRANSPORTER), MEMBER 3", SLC30A3
10830,602879,ERYTHROCYTE MEMBRANE PROTEIN BAND 4.1-LIKE 1, EPB41L1
10831,602880,GROWTH/DIFFERENTIATION FACTOR 1, GDF1
10832,602881,PHD FINGER PROTEIN 1, PHF1
10833,602882,LEUKOCYTE CELL-DERIVED CHEMOTAXIN 2, LECT2
10834,602883,"SOLUTE CARRIER ORGANIC ANION TRANSPORTER FAMILY, MEMBER 1A2", SLCO1A2
10835,602884,"GDP-MANNOSE 4,6-DEHYDRATASE", GMDS
10836,602885,MOTILIN RECEPTOR, MLNR
10837,602886,G PROTEIN-COUPLED RECEPTOR 39, GPR39
10838,602887,DISCS LARGE MAGUK SCAFFOLD PROTEIN 4, DLG4
10839,602888,BETAINE-HOMOCYSTEINE METHYLTRANSFERASE, BHMT
10840,602889,A DISINTEGRIN AND METALLOPROTEINASE DOMAIN 2,
10841,602890,"KILLER CELL LECTIN-LIKE RECEPTOR, SUBFAMILY B, MEMBER 1", KLRB1
10842,602891,"KILLER CELL LECTIN-LIKE RECEPTOR, SUBFAMILY C, MEMBER 2", KLRC2
10843,602892,"KILLER CELL LECTIN-LIKE RECEPTOR, SUBFAMILY C, MEMBER 3", KLRC3
10844,602893,"KILLER CELL LECTIN-LIKE RECEPTOR, SUBFAMILY C, MEMBER 4", KLRC4
10845,602894,"KILLER CELL LECTIN-LIKE RECEPTOR, SUBFAMILY D, MEMBER 1", KLRD1
10846,602895,SCAFFOLD ATTACHMENT FACTOR B, SAFB
10847,602896,MITOGEN-ACTIVATED PROTEIN KINASE 9, MAPK9
10848,602897,MITOGEN-ACTIVATED PROTEIN KINASE 10, MAPK10
10849,602898,MITOGEN-ACTIVATED PROTEIN KINASE 11, MAPK11
10850,602899,MITOGEN-ACTIVATED PROTEIN KINASE 13, MAPK13
10851,602900,DNA METHYLTRANSFERASE 3B, DNMT3B
10852,602901,TRANSPORTIN 1, TNPO1
10853,602902,KRUPPEL-LIKE FACTOR 9, KLF9
10854,602903,KRUPPEL-LIKE FACTOR 5, KLF5
10855,602904,MITOGEN-ACTIVATED PROTEIN KINASE 6, MAPK6
10856,602905,"POTASSIUM CHANNEL, VOLTAGE-GATED, DELAYED-RECTIFIER, SUBFAMILY S, MEMBER 1", KCNS1
10857,602906,"POTASSIUM CHANNEL, VOLTAGE-GATED, DELAYED-RECTIFIER, SUBFAMILY S, MEMBER 2", KCNS2
10858,602907,CENTRIN 3, CETN3
10859,602908,RETINOBLASTOMA-BINDING PROTEIN 9, RBBP9
10860,602909,CLAUDIN 4, CLDN4
10861,602910,CLAUDIN 3, CLDN3
10862,602911,"CALCIUM CHANNEL, VOLTAGE-DEPENDENT, GAMMA-2 SUBUNIT", CACNG2
10863,602912,EUKARYOTIC TRANSLATION INITIATION FACTOR 6, EIF6
10864,602913,POLO-LIKE KINASE 3, PLK3
10865,602914,AQUAPORIN 9, AQP9
10866,602915,GUIDED ENTRY OF TAIL-ANCHORED PROTEINS FACTOR 1, GET1
10867,602916,UBIQUITIN-CONJUGATING ENZYME E2 E1, UBE2E1
10868,602917,REGULATOR OF CALCINEURIN 1, RCAN1
10869,602918,"PHENYLALANINE-tRNA SYNTHETASE, ALPHA SUBUNIT", FARSA
10870,602919,DOCKING PROTEIN 1, DOK1
10871,602920,LIM AND SH3 PROTEIN 1, LASP1
10872,602921,PERSEPHIN, PSPN
10873,602922,RETINOBLASTOMA-BINDING PROTEIN 7,
10874,602923,RETINOBLASTOMA-BINDING PROTEIN 4, RBBP4
10875,602924,RHO FAMILY GTPase 3, RND3
10876,602925,"PHOSPHATIDYLINOSITOL 3-KINASE, CATALYTIC, BETA", PIK3CB
10877,602926,SYNTAXIN-BINDING PROTEIN 1, STXBP1
10878,602927,G PROTEIN-COUPLED RECEPTOR 19, GPR19
10879,602928,TROPOMODULIN 2, TMOD2
10880,602929,VON WILLEBRAND FACTOR A DOMAIN-CONTAINING PROTEIN 5A, VWA5A
10881,602930,"REX4 HOMOLOG, 3-PRIME,5-PRIME-EXONUCLEASE", REXO4
10882,602931,SMAD FAMILY MEMBER 6, SMAD6
10883,602932,SMAD FAMILY MEMBER 7, SMAD7
10884,602933,THYROID HORMONE RECEPTOR INTERACTOR 6, TRIP6
10885,602934,STROMAL CELL-DERIVED FACTOR 2, SDF2
10886,602935,FATTY ACID AMIDE HYDROLASE, FAAH
10887,602936,"CBP/p300-INTERACTING TRANSACTIVATOR WITH GLU/ASP-RICH C-TERMINAL DOMAIN, 1",
10888,602937,"CBP/p300-INTERACTING TRANSACTIVATOR, WITH GLU/ASP-RICH C-TERMINAL DOMAIN, 2", CITED2
10889,602938,BILE ACID CoA:AMINO ACID N-ACYLTRANSFERASE, BAAT
10890,602939,FORKHEAD BOX S1, FOXS1
10891,602940,MARCKS-LIKE PROTEIN 1, MARCKSL1
10892,602941,"BCAR1 SCAFFOLD PROTEIN, CAS FAMILY MEMBER", BCAR1
10893,602942,ECOTROPIC VIRAL INTEGRATION SITE 5, EVI5
10894,602943,RAR-RELATED ORPHAN RECEPTOR C, RORC
10895,602944,E2F TRANSCRIPTION FACTOR 6, E2F6
10896,602945,TRANSCRIPTIONAL ADAPTOR 3, TADA3
10897,602946,TAF6-LIKE RNA POLYMERASE II, TAF6L
10898,602947,"SPT3 HOMOLOG, SAGA AND STAGA COMPLEX COMPONENT", SUPT3H
10899,602948,RAD51 PARALOG B, RAD51B
10900,602949,"SIN3-ASSOCIATED POLYPEPTIDE, 18-KD", SAP18
10901,602950,PROTEIN ARGININE METHYLTRANSFERASE 1, PRMT1
10902,602951,ZFP37 ZINC FINGER PROTEIN, ZFP37
10903,602952,NUCLEAR RECEPTOR-BINDING SET DOMAIN PROTEIN 2, NSD2
10904,602953,HES-RELATED FAMILY bHLH TRANSCRIPTION FACTOR WITH YRPW MOTIF 1, HEY1
10905,602954,RAD51 PARALOG D, RAD51D
10906,602955,"TAF6 RNA POLYMERASE II, TATA BOX-BINDING PROTEIN-ASSOCIATED FACTOR, 80-KD", TAF6
10907,602956,FANCG GENE, FANCG
10908,602957,"CHEMOKINE, CC MOTIF, LIGAND 22", CCL22
10909,602958,SERUM/GLUCOCORTICOID-REGULATED KINASE 1, SGK1
10910,602959,"EUKARYOTIC TRANSLATION ELONGATION FACTOR 1, ALPHA-2", EEF1A2
10911,602960,"TSC22 DOMAIN FAMILY, MEMBER 3",
10912,602961,UBIQUITIN-CONJUGATING ENZYME E2 D1, UBE2D1
10913,602962,UBIQUITIN-CONJUGATING ENZYME E2 D2, UBE2D2
10914,602963,UBIQUITIN-CONJUGATING ENZYME E2 D3, UBE2D3
10915,602964,TRANSLIN-ASSOCIATED FACTOR X, TSNAX
10916,602965,FATTY ACID-BINDING PROTEIN 7, FABP7
10917,602966,OROFACIAL CLEFT 2, OFC2
10918,602967,ZINC FINGER PROTEIN 217, ZNF217
10919,602968,BRAIN-ENRICHED MYELIN-ASSOCIATED PROTEIN 1, BCAS1
10920,602969,"ESTROGEN-RELATED RECEPTOR, GAMMA", ESRRG
10921,602970,KARYOPHERIN ALPHA-4, KPNA4
10922,602971,TUBULIN-SPECIFIC CHAPERONE C, TBCC
10923,602972,PHOSPHODIESTERASE 8A, PDE8A
10924,602973,PHOSPHODIESTERASE 9A, PDE9A
10925,602974,AQUAPORIN 7, AQP7
10926,602975,REGULATOR OF TELOMERE ELONGATION HELICASE 1,
10927,602976,MAX-LIKE PROTEIN X, MLX
10928,602977,"GLYCOPROTEIN 2, ZYMOGEN GRANULE MEMBRANE", GP2
10929,602978,POLYHOMEOTIC HOMOLOG 1, PHC1
10930,602979,POLYHOMEOTIC HOMOLOG 2, PHC2
10931,602980,SRSF PROTEIN KINASE 2, SRPK2
10932,602981,AE-BINDING PROTEIN 1, AEBP1
10933,602982,"POTASSIUM CHANNEL, CALCIUM-ACTIVATED, INTERMEDIATE/SMALL CONDUCTANCE, SUBFAMILY N, MEMBER 1", KCNN1
10934,602983,"POTASSIUM CHANNEL, CALCIUM-ACTIVATED, INTERMEDIATE/SMALL CONDUCTANCE, SUBFAMILY N, MEMBER 3", KCNN3
10935,602984,MEDIATOR COMPLEX SUBUNIT 6, MED6
10936,602985,NADH-UBIQUINONE OXIDOREDUCTASE Fe-S PROTEIN 2, NDUFS2
10937,602986,DEVELOPMENTALLY REGULATED GTP-BINDING PROTEIN 2, DRG2
10938,602987,PHOSPHODIESTERASE 1C, PDE1C
10939,602988,PROTOCADHERIN 7, PCDH7
10940,602989,CDC-LIKE KINASE 2, CLK2
10941,602990,CDC-LIKE KINASE 3, CLK3
10942,602991,NOGGIN, NOG
10943,602992,LEUKOCYTE-ASSOCIATED IMMUNOGLOBULIN-LIKE RECEPTOR 1, LAIR1
10944,602993,LEUKOCYTE-ASSOCIATED IMMUNOGLOBULIN-LIKE RECEPTOR 2, LAIR2
10945,602994,LEUKOREGULIN,
10946,602995,UBIQUITIN-CONJUGATING ENZYME E2 V1, UBE2V1
10947,602996,IMMEDIATE-EARLY RESPONSE 3, IER3
10948,602997,CUBILIN, CUBN
10949,602998,"SYNUCLEIN, GAMMA", SNCG
10950,602999,"PROTEIN PHOSPHATASE 1, REGULATORY SUBUNIT 3C", PPP1R3C
10951,603000,MITOCHONDRIAL RIBOSOMAL PROTEIN L58, MRPL58
10952,603001,UBIQUITIN-CONJUGATING ENZYME E2 V2, UBE2V2
10953,603002,TRANSPORTIN 2, TNPO2
10954,603003,BILE DUCT CYSTS,
10955,603004,NIPSNAP HOMOLOG 2, NIPSNAP2
10956,603005,3-PRIME-PHOSPHOADENOSINE 5-PRIME-PHOSPHOSULFATE SYNTHASE 2, PAPSS2
10957,603006,CADHERIN 4, CDH4
10958,603007,CADHERIN 6, CDH6
10959,603008,CADHERIN 8, CDH8
10960,603009,DYSFERLIN, DYSF
10961,603010,"DEAFNESS, AUTOSOMAL RECESSIVE 17", DFNB17
10962,603011,SMALL EDRK-RICH FACTOR 1A, SERF1A
10963,603012,HEAT-SHOCK 70-KD PROTEIN 1B, HSPA1B
10964,603013,SCHIZOPHRENIA 6, SCZD6
10965,603014,MITOGEN-ACTIVATED PROTEIN KINASE KINASE 7, MAP2K7
10966,603015,TRANSFORMATION/TRANSCRIPTION DOMAIN-ASSOCIATED PROTEIN, TRRAP
10967,603016,CADHERIN 19, CDH19
10968,603017,CADHERIN 17, CDH17
10969,603018,BETA-3-GALACTOSYLTRANSFERASE 2, B3GALT2
10970,603019,CADHERIN 18, CDH18
10971,603020,"AFG3-LIKE MATRIX AAA PEPTIDASE, SUBUNIT 1, PSEUDOGENE", AFG3L1P
10972,603021,MITOCHONDRIAL RIBOSOMAL PROTEIN S12, MRPS12
10973,603022,E4F TRANSCRIPTION FACTOR 1, E4F1
10974,603023,IKAROS FAMILY ZINC FINGER 1, IKZF1
10975,603024,AT-RICH INTERACTION DOMAIN-CONTAINING PROTEIN 1A, ARID1A
10976,603025,PHOSPHATIDYLINOSITOL-BINDING CLATHRIN ASSEMBLY PROTEIN, PICALM
10977,603026,PLAG1 ZINC FINGER PROTEIN, PLAG1
10978,603027,"FRUCTOSE-1,6-BISPHOSPHATASE 2", FBP2
10979,603028,TOLL-LIKE RECEPTOR 2, TLR2
10980,603029,TOLL-LIKE RECEPTOR 3, TLR3
10981,603030,TOLL-LIKE RECEPTOR 4, TLR4
10982,603031,TOLL-LIKE RECEPTOR 5, TLR5
10983,603032,STANNIN, SNN
10984,603033,COLLAGENIC TAIL OF ENDPLATE ACETYLCHOLINESTERASE, COLQ
10985,603034,"MYASTHENIC SYNDROME, CONGENITAL, 5", CMS5
10986,603035,INTERLEUKIN 16, IL16
10987,603036,LEFT-RIGHT DETERMINATION FACTOR 2,
10988,603037,LEFT-RIGHT DETERMINATION FACTOR 1, LEFTY1
10989,603038,SPERM-ASSOCIATED ANTIGEN 4, SPAG4
10990,603039,MAX NETWORK TRANSCRIPTIONAL REPRESSOR, MNT
10991,603040,TUMOR SUPPRESSOR GENE ON CHROMOSOME 11,
10992,603041,MITOCHONDRIAL DNA DEPLETION SYNDROME 1 (MNGIE TYPE), MTDPS1
10993,603042,SMALL UBIQUITIN-LIKE MODIFIER 2, SUMO2
10994,603043,NEUTRAL SPHINGOMYELINASE ACTIVATION-ASSOCIATED FACTOR, NSMAF
10995,603044,PLAG1-LIKE ZINC FINGER 1, PLAGL1
10996,603045,"TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY, MEMBER 11A",
10997,603046,RING FINGER PROTEIN 139, RNF139
10998,603047,ASTIGMATISM,
10999,603048,GLYCOSYLPHOSPHATIDYLINOSITOL ANCHOR ATTACHMENT PROTEIN 1, GPAA1
11000,603049,THIOREDOXIN-LIKE 1, TXNL1
11001,603050,ABL INTERACTOR 1, ABI1
11002,603051,ALKYLGLYCERONE-PHOSPHATE SYNTHASE, AGPS
11003,603052,CLEAVAGE AND POLYADENYLATION SPECIFICITY FACTOR 4, CPSF4
11004,603053,HISTONE ACETYLTRANSFERASE 1, HAT1
11005,603054,"GREMLIN 1, DAN FAMILY BMP ANTAGONIST", GREM1
11006,603055,SKI-INTERACTING PROTEIN, SKIIP
11007,603056,"ORIGIN RECOGNITION COMPLEX, SUBUNIT 4", ORC4
11008,603057,DACHSOUS CADHERIN-RELATED 1, DCHS1
11009,603058,"PROTOCADHERIN-GAMMA, SUBFAMILY B, MEMBER 4", PCDHGB4
11010,603059,"PROTOCADHERIN-GAMMA, SUBFAMILY A, MEMBER 12", PCDHGA12
11011,603060,KINESIN FAMILY MEMBER 1C, KIF1C
11012,603061,"ENDOSULFINE, ALPHA", ENSA
11013,603062,TRANS-GOLGI NETWORK PROTEIN 2, TGOLN2
11014,603063,3-HYDROXYBUTYRATE DEHYDROGENASE 1, BDH1
11015,603064,"URIDINE DIPHOSPHATE GLYCOSYLTRANSFERASE 2 FAMILY, MEMBER B11", UGT2B11
11016,603065,"NUCLEAR RECEPTOR SUBFAMILY 1, GROUP I, MEMBER 2", NR1I2
11017,603066,"PROCOLLAGEN-LYSINE, 2-OXOGLUTARATE 5-DIOXYGENASE 3", PLOD3
11018,603067,"SUCCINATE DEHYDROGENASE COMPLEX, SUBUNIT C",
11019,603068,DUAL-SPECIFICITY PHOSPHATASE 2, DUSP2
11020,603069,DUAL-SPECIFICITY PHOSPHATASE 5, DUSP5
11021,603070,RAD51-ASSOCIATED PROTEIN 1, RAD51AP1
11022,603071,G PROTEIN-COUPLED RECEPTOR 17, GPR17
11023,603072,AURORA KINASE A, AURKA
11024,603073,"ZIC FAMILY, MEMBER 2", ZIC2
11025,603074,"PLATELET-ACTIVATING FACTOR ACETYLHYDROLASE, ISOFORM 1B, GAMMA SUBUNIT", PAFAH1B3
11026,603075,"MACULAR DEGENERATION, AGE-RELATED, 1", ARMD1
11027,603076,"ATP-BINDING CASSETTE, SUBFAMILY G, MEMBER 1", ABCG1
11028,603077,"ACYL-CoA SYNTHETASE LONG CHAIN FAMILY, MEMBER 4",
11029,603078,CHECKPOINT KINASE 1, CHEK1
11030,603079,CHROMOBOX 4, CBX4
11031,603080,"SOLUTE CARRIER FAMILY 6 (NEUROTRANSMITTER TRANSPORTER, BETAINE/GABA), MEMBER 12", SLC6A12
11032,603081,ADP-RIBOSYLARGININE HYDROLASE, ADPRH
11033,603082,GRANULYSIN,
11034,603083,HETEROGENEOUS NUCLEAR RIBOPROTEIN L, HNRNPL
11035,603084,ASPARTYL-tRNA SYNTHETASE 1, DARS1
11036,603085,"SOLUTE CARRIER FAMILY 31 (COPPER TRANSPORTER), MEMBER 1", SLC31A1
11037,603086,ADP-RIBOSYLTRANSFERASE 3, ART3
11038,603087,ADP-RIBOSYLTRANSFERASE 4,
11039,603088,"SOLUTE CARRIER FAMILY 31 (COPPER TRANSPORTER), MEMBER 2", SLC31A2
11040,603089,BRCA1-ASSOCIATED PROTEIN 1, BAP1
11041,603090,UBIQUITIN CARBOXYL-TERMINAL ESTERASE L3, UCHL3
11042,603091,UBIQUITIN-SPECIFIC PROTEASE 12, USP12
11043,603092,DUAL-SPECIFICITY PHOSPHATASE 11, DUSP11
11044,603093,BETA-3-GALACTOSYLTRANSFERASE 1, B3GALT1
11045,603094,"BETA-1,3-N-ACETYLGALACTOSAMINYLTRANSFERASE 1", B3GALNT1
11046,603095,"UDP-GAL:BETA-GlcNAc BETA-1,3-GALACTOSYLTRANSFERASE, POLYPEPTIDE 4", B3GALT4
11047,603096,ACHROMATOPSIA 3,
11048,603097,"ATPase, H+ TRANSPORTING, LYSOSOMAL, 42-KD, V1 SUBUNIT C, ISOFORM 1", ATP6V1C1
11049,603098,"DEAFNESS, AUTOSOMAL RECESSIVE 13", DFNB13
11050,603099,1-ACYLGLYCEROL-3-PHOSPHATE O-ACYLTRANSFERASE 1, AGPAT1
11051,603100,1-ACYLGLYCEROL-3-PHOSPHATE O-ACYLTRANSFERASE 2, AGPAT2
11052,603101,"CARBOXYPEPTIDASE B2, PLASMA", CPB2
11053,603102,CARBOXYPEPTIDASE D, CPD
11054,603103,"CARBOXYPEPTIDASE N, POLYPEPTIDE 1, 50-KD", CPN1
11055,603104,"CARBOXYPEPTIDASE N, POLYPEPTIDE 2, 83-KD", CPN2
11056,603105,CARBOXYPEPTIDASE Z, CPZ
11057,603106,NEURONATIN, NNAT
11058,603107,TRANSCRIPTION FACTOR 20, TCF20
11059,603108,"MICROTUBULE-ASSOCIATED PROTEIN, RP/EB FAMILY, MEMBER 1", MAPRE1
11060,603109,SMAD FAMILY MEMBER 3, SMAD3
11061,603110,SMAD FAMILY MEMBER 5, SMAD5
11062,603111,"SWI/SNF-RELATED, MATRIX-ASSOCIATED, ACTIN-DEPENDENT REGULATOR OF CHROMATIN, SUBFAMILY E, MEMBER 1", SMARCE1
11063,603112,S100 CALCIUM-BINDING PROTEIN A12, S100A12
11064,603113,"PROTEIN PHOSPHATASE 2, STRUCTURAL/REGULATORY SUBUNIT A, BETA", PPP2R1B
11065,603114,S100 CALCIUM-BINDING PROTEIN A11, S100A11
11066,603115,DExH-BOX HELICASE 9, DHX9
11067,603116,CDAGS SYNDROME,
11068,603117,"SPASTIC PARAPLEGIA, OPTIC ATROPHY, MICROCEPHALY, AND XY SEX REVERSAL",
11069,603118,CADHERIN 16, CDH16
11070,603119,APRAXIA OF EYELID OPENING,
11071,603120,QUIESCIN Q6 SULFHYDRYL OXIDASE 1, QSOX1
11072,603121,CYLICIN 1,
11073,603122,DEDICATOR OF CYTOKINESIS 2, DOCK2
11074,603123,DEDICATOR OF CYTOKINESIS 3, DOCK3
11075,603124,UBIQUITIN-CONJUGATING ENZYME E2 G2, UBE2G2
11076,603125,TYROSYLPROTEIN SULFOTRANSFERASE 1, TPST1
11077,603126,TYROSYLPROTEIN SULFOTRANSFERASE 2, TPST2
11078,603127,GROWTH ARREST-SPECIFIC 7, GAS7
11079,603128,SIM bHLH TRANSCRIPTION FACTOR 1, SIM1
11080,603129,LIM DOMAIN ONLY 4, LMO4
11081,603130,ATTRACTIN, ATRN
11082,603131,"PEPTIDASE, MITOCHONDRIAL PROCESSING, BETA", PMPCB
11083,603132,ZINC FINGER PROTEIN 189, ZNF189
11084,603133,"DISLOCATED ELBOWS, BOWED TIBIAS, SCOLIOSIS, DEAFNESS, CATARACT, MICROCEPHALY, AND IMPAIRED INTELLECTUAL DEVELOPMENT",
11085,603134,CULLIN 1, CUL1
11086,603135,CULLIN 2, CUL2
11087,603136,CULLIN 3, CUL3
11088,603137,CULLIN 4A, CUL4A
11089,603138,CULLIN 4B,
11090,603139,RAD17 CHECKPOINT CLAMP LOADER COMPONENT, RAD17
11091,603140,"PHOSPHATIDYLINOSITOL 5-PHOSPHATE 4-KINASE, TYPE II, ALPHA", PIP4K2A
11092,603141,PPFIA-BINDING PROTEIN 1, PPFIBP1
11093,603142,PPFIA-BINDING PROTEIN 2, PPFIBP2
11094,603143,PTPRF-INTERACTING PROTEIN ALPHA-2, PPFIA2
11095,603144,PTPRF-INTERACTING PROTEIN ALPHA-3, PPFIA3
11096,603145,PTPRF-INTERACTING PROTEIN ALPHA-4, PPFIA4
11097,603146,"PROTEASOME 26S SUBUNIT, NON-ATPase, 9", PSMD9
11098,603147,"CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ic", CDG1C
11099,603148,ACTIVATING TRANSCRIPTION FACTOR 3, ATF3
11100,603149,INTERLEUKIN 17A, IL17A
11101,603150,"ATP SYNTHASE F1, SUBUNIT DELTA", ATP5F1D
11102,603151,SEPTIN 7, SEPTIN7
11103,603152,"ATP SYNTHASE PERIPHERAL STALK, SUBUNIT F6", ATP5PF
11104,603153,RAD1 CHECKPOINT DNA EXONUCLEASE, RAD1
11105,603154,PININ, PNN
11106,603155,"PROTEIN-TYROSINE PHOSPHATASE, NONRECEPTOR-TYPE, 14", PTPN14
11107,603156,BIPHENYL HYDROLASE-LIKE, BPHL
11108,603157,"PHOSPHATIDYLINOSITOL 3-KINASE, REGULATORY SUBUNIT 2", PIK3R2
11109,603158,UBIQUITIN-SPECIFIC PROTEASE 8, USP8
11110,603159,LOW DENSITY LIPOPROTEIN RECEPTOR-RELATED PROTEIN 3, LRP3
11111,603160,ECTONUCLEOSIDE TRIPHOSPHATE DIPHOSPHOHYDROLASE 6, ENTPD6
11112,603161,ECTONUCLEOSIDE TRIPHOSPHATE DIPHOSPHOHYDROLASE 3, ENTPD3
11113,603162,ECTONUCLEOSIDE TRIPHOSPHATE DIPHOSPHOHYDROLASE 5, ENTPD5
11114,603163,STIMULATOR OF CHONDROGENESIS 1, SCRG1
11115,603164,PEROXISOME BIOGENESIS FACTOR 3, PEX3
11116,603165,"DERMATITIS, ATOPIC",
11117,603166,MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE KINASE 2, MAP4K2
11118,603167,BCL2-ASSOCIATED AGONIST OF CELL DEATH, BAD
11119,603168,UNC51-LIKE AUTOPHAGY-ACTIVATING KINASE 1, ULK1
11120,603169,CATHEPSIN Z, CTSZ
11121,603170,TEA DOMAIN FAMILY MEMBER 3, TEAD3
11122,603171,"NEURAL PRECURSOR CELL EXPRESSED, DEVELOPMENTALLY DOWNREGULATED 8", NEDD8
11123,603172,UBIQUITIN-LIKE MODIFIER-ACTIVATING ENZYME 3, UBA3
11124,603173,UBIQUITIN-CONJUGATING ENZYME E2 M, UBE2M
11125,603174,HYPERHOMOCYSTEINEMIA,
11126,603175,SCHIZOPHRENIA 5, SCZD5
11127,603176,SCHIZOPHRENIA 7, SCZD7
11128,603177,VESICLE-ASSOCIATED MEMBRANE PROTEIN 8, VAMP8
11129,603178,"ALDEHYDE DEHYDROGENASE 6 FAMILY, MEMBER A1", ALDH6A1
11130,603179,CARBONIC ANHYDRASE IX, CA9
11131,603180,"EXPORTIN, tRNA", XPOT
11132,603181,INTERLEUKIN ENHANCER-BINDING FACTOR 2, ILF2
11133,603182,INTERLEUKIN ENHANCER-BINDING FACTOR 3, ILF3
11134,603183,RETICULON 2, RTN2
11135,603184,CYCLIN-DEPENDENT KINASE 8, CDK8
11136,603185,NUCLEAR AUTOANTIGENIC SPERM PROTEIN, NASP
11137,603186,DEATH-ASSOCIATED PROTEIN 6, DAXX
11138,603187,CENTRIN 1, CETN1
11139,603188,BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 8, BMIQ8
11140,603189,SYNTAXIN 5, STX5
11141,603190,PROTEIN ARGININE METHYLTRANSFERASE 3, PRMT3
11142,603191,CILIA- AND FLAGELLA-ASSOCIATED PROTEIN 410, CFAP410
11143,603192,"ATP SYNTHASE, H+ TRANSPORTING, MITOCHONDRIAL FO COMPLEX, SUBUNIT C, ISOFORM 1", ATP5G1
11144,603193,"ATP SYNTHASE, H+ TRANSPORTING, MITOCHONDRIAL FO COMPLEX, SUBUNIT C, ISOFORM 2", ATP5G2
11145,603194,"MECKEL SYNDROME, TYPE 2", MKS2
11146,603195,G PROTEIN-COUPLED RECEPTOR 32, GPR32
11147,603196,COCHLIN, COCH
11148,603197,PATATIN-LIKE PHOSPHOLIPASE DOMAIN-CONTAINING PROTEIN 6, PNPLA6
11149,603198,CAVEOLAE-ASSOCIATED PROTEIN 1, CAVIN1
11150,603199,PALS1-ASSOCIATED TIGHT JUNCTION PROTEIN, PATJ
11151,603200,"REGULATORY FACTOR X, ANKYRIN REPEAT-CONTAINING", RFXANK
11152,603201,"ATP-BINDING CASSETTE, SUBFAMILY B, MEMBER 11", ABCB11
11153,603202,LACTASE, LCT
11154,603203,CYCLIN G2, CCNG2
11155,603204,"EPILEPSY, NOCTURNAL FRONTAL LOBE, 2", ENFL2
11156,603205,MORC FAMILY CW-TYPE ZINC FINGER PROTEIN 1, MORC1
11157,603206,SCHIZOPHRENIA 8, SCZD8
11158,603207,VESICLE TRANSPORT THROUGH INTERACTION WITH T-SNARES 1B, VTI1B
11159,603208,"POTASSIUM CHANNEL, INWARDLY RECTIFYING, SUBFAMILY J, MEMBER 13", KCNJ13
11160,603209,"CYTIDINE MONOPHOSPHO-N-ACETYLNEURAMINIC ACID HYDROXYLASE, PSEUDOGENE", CMAHP
11161,603210,JRK HELIX-TURN-HELIX PROTEIN, JRK
11162,603211,JRK-LIKE PROTEIN, JRKL
11163,603212,BEADED FILAMENT STRUCTURAL PROTEIN 2, BFSP2
11164,603213,KINESIN FAMILY MEMBER 22, KIF22
11165,603214,"ATP-BINDING CASSETTE, SUBFAMILY D, MEMBER 4", ABCD4
11166,603215,NSF ATTACHMENT PROTEIN ALPHA, NAPA
11167,603216,NSF ATTACHMENT PROTEIN GAMMA, NAPG
11168,603217,SYNTAXIN 7, STX7
11169,603218,HUNTINGTON DISEASE-LIKE 1, HDL1
11170,603219,"POTASSIUM CHANNEL, SUBFAMILY K, MEMBER 2", KCNK2
11171,603220,"POTASSIUM CHANNEL, SUBFAMILY K, MEMBER 3", KCNK3
11172,603221,"MYOPIA 3, AUTOSOMAL DOMINANT", MYP3
11173,603222,U22 HOST GENE,
11174,603223,"RNA, U22 SMALL NUCLEOLAR", RNU22
11175,603224,"RNA, U25 SMALL NUCLEOLAR", RNU25
11176,603225,"RNA, U26 SMALL NUCLEOLAR", RNU26
11177,603226,"RNA, U27 SMALL NUCLEOLAR", RNU27
11178,603227,"RNA, U28 SMALL NUCLEOLAR", RNU28
11179,603228,"RNA, U29 SMALL NUCLEOLAR", RNU29
11180,603229,"RNA, U30 SMALL NUCLEOLAR", RNU30
11181,603230,"RNA, U31 SMALL NUCLEOLAR", RNU31
11182,603231,ZINC FINGER PROTEIN 200, ZNF200
11183,603232,"OLFACTORY RECEPTOR, FAMILY 1, SUBFAMILY F, MEMBER 1", OR1F1
11184,603233,"PSEUDOHYPOPARATHYROIDISM, TYPE IB", PHP1B
11185,603234,"ATP-BINDING CASSETTE, SUBFAMILY C, MEMBER 6", ABCC6
11186,603235,SELENOPROTEIN W, SELENOW
11187,603236,MEVALONATE PYROPHOSPHATE DECARBOXYLASE, MVD
11188,603237,ERYTHROCYTE MEMBRANE PROTEIN 4.1-LIKE 2, EPB41L2
11189,603238,"RNA, U17D SMALL NUCLEOLAR", RNU17D
11190,603239,"SMALL NUCLEOLAR RNA, H/ACA BOX, 73B", SNORA73B
11191,603240,"SOLUTE CARRIER FAMILY 22 (ORGANIC CATION TRANSPORTER), MEMBER 18, ANTISENSE", SLC22A18AS
11192,603241,LIMBIC SYSTEM-ASSOCIATED MEMBRANE PROTEIN, LSAMP
11193,603242,"C-TYPE LECTIN DOMAIN FAMILY 2, MEMBER B", CLEC2B
11194,603243,AUTOCRINE MOTILITY FACTOR RECEPTOR, AMFR
11195,603244,HEPARAN SULFATE-GLUCOSAMINE 3-SULFOTRANSFERASE 1, HS3ST1
11196,603245,NK2 HOMEOBOX 8, NKX2-8
11197,603246,"GENERAL TRANSCRIPTION FACTOR 3C, POLYPEPTIDE 1", GTF3C1
11198,603247,"SOLUTE CARRIER FAMILY 27 (FATTY ACID TRANSPORTER), MEMBER 2", SLC27A2
11199,603248,"BONE MORPHOGENETIC PROTEIN RECEPTOR, TYPE IB", BMPR1B
11200,603249,NIPSNAP HOMOLOG 1, NIPSNAP1
11201,603250,FORKHEAD BOX F2, FOXF2
11202,603251,CYCLIN-DEPENDENT KINASE 9, CDK9
11203,603252,FORKHEAD BOX L1, FOXL1
11204,603253,CYSTATIN 7, CST7
11205,603254,"SWI/SNF-RELATED, MATRIX-ASSOCIATED, ACTIN-DEPENDENT REGULATOR OF CHROMATIN, SUBFAMILY A, MEMBER 4", SMARCA4
11206,603255,"NUCLEAR TRANSCRIPTION FACTOR, X BOX-BINDING, 1", NFX1
11207,603256,LEUCINE-RICH REPEAT IN FLII-INTERACTING PROTEIN 1, LRRFIP1
11208,603257,"SWI/SNF-RELATED, MATRIX-ASSOCIATED, ACTIN-DEPENDENT REGULATOR OF CHROMATIN, SUBFAMILY A, MEMBER 3", SMARCA3
11209,603258,"INHIBITOR OF NUCLEAR FACTOR KAPPA-B KINASE, SUBUNIT BETA", IKBKB
11210,603259,MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 8,
11211,603260,BARX HOMEOBOX 1, BARX1
11212,603261,"PHOSPHATIDYLINOSITOL 5-PHOSPHATE 4-KINASE, TYPE II, BETA", PIP4K2B
11213,603262,3-PRIME-PHOSPHOADENOSINE 5-PRIME-PHOSPHOSULFATE SYNTHASE 1, PAPSS1
11214,603263,CARBONIC ANHYDRASE XII, CA12
11215,603264,RHOMBOID-LIKE 1, RHBDL1
11216,603265,AT-RICH INTERACTION DOMAIN-CONTAINING PROTEIN 3A, ARID3A
11217,603266,TYPE 1 DIABETES MELLITUS 17, TID17
11218,603267,CALPAIN 15, CAPN15
11219,603268,N-DEACETYLASE/N-SULFOTRANSFERASE 2, NDST2
11220,603269,"SPLICING FACTOR, SERINE/ARGININE-RICH, 8", SRSF8
11221,603270,"ATP SYNTHASE PERIPHERAL STALK MEMBRANE, SUBUNIT B", ATP5PB
11222,603271,"PROTEIN-TYROSINE PHOSPHATASE, NONRECEPTOR-TYPE, 21", PTPN21
11223,603272,CONNECTOR ENHANCER OF KINASE SUPPRESSOR OF RAS 1, CNKSR1
11224,603273,TUMOR PROTEIN p63, TP63
11225,603274,UBIQUITIN-CONJUGATING ENZYME E2 D1,
11226,603275,"PHOSPHATIDYLINOSITOL 4-PHOSPHATE 5-KINASE, TYPE I, ALPHA", PIP5K1A
11227,603276,REGULATOR OF G PROTEIN SIGNALING 5, RGS5
11228,603277,CHROMODOMAIN HELICASE DNA-BINDING PROTEIN 4, CHD4
11229,603278,FOCAL SEGMENTAL GLOMERULOSCLEROSIS 1, FSGS1
11230,603279,"EXPANDED REPEAT DOMAIN, CAG/CTG, 1", ERDA1
11231,603280,"PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 1",
11232,603281,"2-PRIME,5-PRIME-OLIGOADENYLATE SYNTHETASE-LIKE", OASL
11233,603282,ZINC FINGER PROTEIN 204, ZNF204
11234,603283,TRIADIN, TRDN
11235,603284,CEREBRAL CAVERNOUS MALFORMATIONS 2, CCM2
11236,603285,CEREBRAL CAVERNOUS MALFORMATIONS 3, CCM3
11237,603286,KISS1 METASTASIS SUPPRESSOR, KISS1
11238,603287,PYRIDOXAMINE 5-PRIME-PHOSPHATE OXIDASE, PNPO
11239,603288,KERATOCAN, KERA
11240,603289,DEATH-ASSOCIATED PROTEIN KINASE 3, DAPK3
11241,603290,SH3 AND MULTIPLE ANKYRIN REPEAT DOMAINS 2, SHANK2
11242,603291,BCL2/ADENOVIRUS E1B 19-KD PROTEIN-INTERACTING PROTEIN 1, BNIP1
11243,603292,BCL2/ADENOVIRUS E1B 19-KD PROTEIN-INTERACTING PROTEIN 2, BNIP2
11244,603293,BCL2/ADENOVIRUS E1B 19-KD PROTEIN-INTERACTING PROTEIN 3, BNIP3
11245,603294,MINICHROMOSOME MAINTENANCE 3-ASSOCIATED PROTEIN, MCM3AP
11246,603295,SMAD FAMILY MEMBER 9, SMAD9
11247,603296,"LATE ENDOSOMAL/LYSOSOMAL ADAPTOR, MITOGEN-ACTIVATED PROTEIN KINASE AND MAMMALIAN TARGET OF RAPAMYCIN ACTIVATOR 3", LAMTOR3
11248,603297,"DYNEIN, CYTOPLASMIC 2, HEAVY CHAIN 1", DYNC2H1
11249,603298,PALMITOYL-PROTEIN THIOESTERASE 2, PPT2
11250,603299,"DYNEIN, AXONEMAL, HEAVY CHAIN 11",
11251,603300,TUMOR NECROSIS FACTOR-ALPHA-INDUCED PROTEIN 2, TNFAIP2
11252,603301,KRUPPEL-LIKE FACTOR 11, KLF11
11253,603302,ADENYLATE CYCLASE 9, ADCY9
11254,603303,TANKYRASE, TNKS
11255,603304,INTERLEUKIN 1 RECEPTOR-ASSOCIATED KINASE 2, IRAK2
11256,603305,"POTASSIUM CHANNEL, VOLTAGE-GATED, SUBFAMILY H, MEMBER 1", KCNH1
11257,603306,TRANSCRIPTION FACTOR 21, TCF21
11258,603307,BEADED FILAMENT STRUCTURAL PROTEIN 1, BFSP1
11259,603308,CATHEPSIN V, CTSV
11260,603309,CYCLIN-DEPENDENT KINASE 13, CDK13
11261,603310,PHOSPHODIESTERASE 5A, PDE5A
11262,603311,CELL DIVISION CYCLE 7, CDC7
11263,603312,"BUTYROBETAINE-GAMMA,2-OXOGLUTARATE DIOXYGENASE 1", BBOX1
11264,603313,"ALG10 ALPHA-1,2-GLUCOSYLTRANSFERASE B", ALG10B
11265,603314,"SOLUTE CARRIER FAMILY 27 (FATTY ACID TRANSPORTER), MEMBER 5", SLC27A5
11266,603315,NEURONAL CALCIUM SENSOR 1, NCS1
11267,603316,CYTIDINE 5-PRIME-MONOPHOSPHATE N-ACETYLNEURAMINIC ACID SYNTHETASE, CMAS
11268,603317,"PROTEIN-TYROSINE PHOSPHATASE, RECEPTOR-TYPE, Q", PTPRQ
11269,603318,"SOLUTE CARRIER FAMILY 4 (SODIUM BICARBONATE COTRANSPORTER), MEMBER 4",
11270,603319,ANNEXIN A9, ANXA9
11271,603320,MATRIX METALLOPROTEINASE 23A, MMP23A
11272,603321,MATRIX METALLOPROTEINASE 23B, MMP23B
11273,603322,"NADH-UBIQUINONE OXIDOREDUCTASE 1 BETA SUBCOMPLEX, 6", NDUFB6
11274,603323,"MUSCULAR DYSTROPHY, CONGENITAL, WITH CEREBELLAR ATROPHY",
11275,603324,"GAP JUNCTION PROTEIN, BETA-3", GJB3
11276,603325,"PROTEIN PHOSPHATASE 1, REGULATORY SUBUNIT 9B", PPP1R9B
11277,603326,"PROTEIN PHOSPHATASE 1, REGULATORY SUBUNIT 3D", PPP1R3D
11278,603327,RAN-BINDING PROTEIN 3, RANBP3
11279,603328,MUSASHI RNA BINDING PROTEIN 1, MSI1
11280,603329,PIRIN,
11281,603330,"DYNEIN, AXONEMAL, HEAVY CHAIN 9", DNAH9
11282,603331,"DYNEIN, CYTOPLASMIC 1, INTERMEDIATE CHAIN 2", DYNC1I2
11283,603332,"DYNEIN, AXONEMAL, HEAVY CHAIN 1", DNAH1
11284,603333,"DYNEIN, AXONEMAL, HEAVY CHAIN 2", DNAH2
11285,603334,"DYNEIN, AXONEMAL, HEAVY CHAIN 3", DNAH3
11286,603335,"DYNEIN, AXONEMAL, HEAVY CHAIN 5", DNAH5
11287,603336,"DYNEIN, AXONEMAL, HEAVY CHAIN 6", DNAH6
11288,603337,"DYNEIN, AXONEMAL, HEAVY CHAIN 8", DNAH8
11289,603338,"DYNEIN, AXONEMAL, HEAVY CHAIN 9",
11290,603339,"DYNEIN, AXONEMAL, HEAVY CHAIN 11", DNAH11
11291,603340,"DYNEIN, AXONEMAL, HEAVY CHAIN 12", DNAH12
11292,603341,"DYNEIN, AXONEMAL, HEAVY CHAIN 14", DNAH14
11293,603342,SCHIZOPHRENIA 2, SCZD2
11294,603343,RIBONUCLEIC ACID EXPORT PROTEIN 1, RAE1
11295,603344,USO1 VESICLE TRANSPORT FACTOR, USO1
11296,603345,"SOLUTE CARRIER FAMILY 4 (SODIUM BICARBONATE COTRANSPORTER), MEMBER 4", SLC4A4
11297,603346,NEURONAL PAS DOMAIN PROTEIN 1, NPAS1
11298,603347,NEURONAL PAS DOMAIN PROTEIN 2, NPAS2
11299,603348,"HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT", HIF1A
11300,603349,ENDOTHELIAL PAS DOMAIN PROTEIN 1, EPAS1
11301,603350,"2-PRIME,5-PRIME-OLIGOADENYLATE SYNTHETASE 2", OAS2
11302,603351,"2-PRIME,5-PRIME-OLIGOADENYLATE SYNTHETASE 3", OAS3
11303,603352,BACULOVIRAL IAP REPEAT-CONTAINING PROTEIN 5, BIRC5
11304,603353,"SOLUTE CARRIER FAMILY 4 (SODIUM BICARBONATE COTRANSPORTER), MEMBER 7", SLC4A7
11305,603354,GASTRULATION BRAIN HOMEOBOX 1, GBX1
11306,603355,"MEMBRANE-BOUND TRANSCRIPTION FACTOR PROTEASE, SITE 1", MBTPS1
11307,603356,CD164 ANTIGEN, CD164
11308,603357,"SERPIN PEPTIDASE INHIBITOR, CLADE B (OVALBUMIN), MEMBER 7", SERPINB7
11309,603358,GRACILE SYNDROME,
11310,603359,NADH-UBIQUINONE OXIDOREDUCTASE SUBUNIT A8, NDUFA8
11311,603360,PEROXISOME BIOGENESIS FACTOR 16, PEX16
11312,603361,"TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY, MEMBER 6B", TNFRSF6B
11313,603362,"SH3 DOMAIN, GRB2-LIKE, 3", SH3GL3
11314,603363,CGG-BINDING PROTEIN 1, CGGBP1
11315,603364,"SPLICING FACTOR, SERINE/ARGININE-RICH, 3", SRSF3
11316,603365,HIRA-INTERACTING PROTEIN 3, HIRIP3
11317,603366,"TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY, MEMBER 25", TNFRSF25
11318,603367,O-LINKED N-ACETYLGLUCOSAMINE TRANSFERASE,
11319,603368,CYCLIN-DEPENDENT KINASE 6, CDK6
11320,603369,CYCLIN-DEPENDENT KINASE INHIBITOR 2C, CDKN2C
11321,603370,UDP-GLUCOSE DEHYDROGENASE, UGDH
11322,603371,"GLE1, RNA EXPORT MEDIATOR", GLE1
11323,603372,THYROID-STIMULATING HORMONE RECEPTOR, TSHR
11324,603373,"HYPERTHYROIDISM, FAMILIAL GESTATIONAL",
11325,603374,"EUKARYOTIC TRANSLATION INITIATION FACTOR 1A, X-LINKED",
11326,603375,"SWI/SNF-RELATED, MATRIX-ASSOCIATED, ACTIN-DEPENDENT REGULATOR OF CHROMATIN, SUBFAMILY A, MEMBER 5", SMARCA5
11327,603376,"LONG CHAIN FATTY ACIDS, DEFECT IN TRANSPORT OF",
11328,603377,"SOLUTE CARRIER FAMILY 22 (ORGANIC CATION TRANSPORTER), MEMBER 5", SLC22A5
11329,603378,"SIN3-ASSOCIATED POLYPEPTIDE, 30-KD", SAP30
11330,603379,IQ MOTIF-CONTAINING GTPase-ACTIVATING PROTEIN 1, IQGAP1
11331,603380,"LIN7 HOMOLOG A, CRUMBS CELL POLARITY COMPLEX COMPONENT", LIN7A
11332,603381,FILAMIN B, FLNB
11333,603382,MutS HOMOLOG 5, MSH5
11334,603383,"GLAUCOMA 1, OPEN ANGLE, F", GLC1F
11335,603384,SYNAPTIC RAS-GTPase-ACTIVATING PROTEIN 1, SYNGAP1
11336,603385,"NEDD8-ACTIVATING ENZYME E1, SUBUNIT 1", NAE1
11337,603386,"THYROID CARCINOMA, NONMEDULLARY, WITH OR WITHOUT CELL OXYPHILIA",
11338,603387,MEGALENCEPHALY-POLYMICROGYRIA-POLYDACTYLY-HYDROCEPHALUS SYNDROME 1, MPPH1
11339,603388,"GRAVES DISEASE, SUSCEPTIBILITY TO, 2",
11340,603389,OSEBOLD SKELETAL DYSPLASIA/OSTEOLYSIS SYNDROME,
11341,603390,PHOSPHODIESTERASE 8B, PDE8B
11342,603391,MYHRE SYNDROME,
11343,603392,BCL2-INTERACTING KILLER, BIK
11344,603393,"OSTEOSCLEROTIC CHONDRODYSPLASIA, LETHAL, WITH INTRACELLULAR INCLUSIONS",
11345,603394,"MICROCEPHALY, SEVERE, WITH SKELETAL ANOMALIES INCLUDING POSTERIOR RIB-GAP DEFECTS",
11346,603395,SPERM-ASSOCIATED ANTIGEN 1, SPAG1
11347,603396,TONOKI SYNDROME,
11348,603397,ZINC FINGER PROTEIN 282, ZNF282
11349,603398,CELLULAR COMMUNICATION NETWORK FACTOR 4, CCN4
11350,603399,CELLULAR COMMUNICATION NETWORK FACTOR 5, CCN5
11351,603400,CELLULAR COMMUNICATION NETWORK FACTOR 6, CCN6
11352,603401,"ADAPTOR-RELATED PROTEIN COMPLEX 3, BETA-1 SUBUNIT", AP3B1
11353,603402,"ACYL-CoA OXIDASE 3, PRISTANOYL", ACOX3
11354,603403,DEAH-BOX HELICASE 15, DHX15
11355,603404,ZINC FINGER PROTEIN 169, ZNF169
11356,603405,DEAH-BOX HELICASE 16, DHX16
11357,603406,TRIPARTITE MOTIF-CONTAINING PROTEIN 24, TRIM24
11358,603407,"POLYADENYLATE-BINDING PROTEIN, CYTOPLASMIC, 4", PABPC4
11359,603408,FRIZZLED CLASS RECEPTOR 1, FZD1
11360,603409,FRIZZLED CLASS RECEPTOR 6, FZD6
11361,603410,FRIZZLED CLASS RECEPTOR 7, FZD7
11362,603411,EFFECTOR CELL PROTEASE RECEPTOR 1, EPR1
11363,603412,"CDC42-BINDING PROTEIN KINASE, ALPHA", CDC42BPA
11364,603413,TIA1 CYTOTOXIC GRANULE-ASSOCIATED RNA-BINDING PROTEIN-LIKE 1, TIAL1
11365,603414,"TRANSMEMBRANE 7 SUPERFAMILY, MEMBER 2", TM7SF2
11366,603415,"SODIUM VOLTAGE-GATED CHANNEL, ALPHA SUBUNIT 9", SCN9A
11367,603416,RIBOSOMAL PROTEIN L21 PSEUDOGENE 1, RPL21P1
11368,603417,RAB-INTERACTING FACTOR, RABIF
11369,603418,"ALDO-KETO REDUCTASE FAMILY 7, MEMBER A2", AKR7A2
11370,603419,"SMALL GLUTAMINE-RICH TETRATRICOPEPTIDE REPEAT-CONTAINING COCHAPERONE, ALPHA", SGTA
11371,603420,CALUMENIN, CALU
11372,603421,TRANSMEMBRANE PROTEIN WITH EGF-LIKE AND 2 FOLLISTATIN-LIKE DOMAINS 1, TMEFF1
11373,603422,PDZ AND LIM DOMAIN PROTEIN 4, PDLIM4
11374,603423,PR DOMAIN-CONTAINING PROTEIN 1, PRDM1
11375,603424,"PROTEIN KINASE, INTERFERON-INDUCIBLE DOUBLE-STRANDED RNA-DEPENDENT ACTIVATOR", PRKRA
11376,603425,ADP-RIBOSYLATION FACTOR-LIKE GTPase 1, ARL1
11377,603426,PERIOD CIRCADIAN REGULATOR 2, PER2
11378,603427,PERIOD CIRCADIAN REGULATOR 3, PER3
11379,603428,ZINC FINGER PROTEIN 207, ZNF207
11380,603429,"ATP-BINDING CASSETTE, SUBFAMILY F, MEMBER 1", ABCF1
11381,603430,ZINC FINGER PROTEIN 202, ZNF202
11382,603431,EUKARYOTIC TRANSLATION INITIATION FACTOR 4H, EIF4H
11383,603432,CAP-GLY DOMAIN-CONTAINING LINKER PROTEIN 2, CLIP2
11384,603433,ZINC FINGER PROTEIN 143, ZNF143
11385,603434,PROLIFERATION AND APOPTOSIS ADAPTOR PROTEIN 15, PEA15
11386,603435,GLUTATHIONE PEROXIDASE 5, GPX5
11387,603436,ZINC FINGER PROTEIN 205, ZNF205
11388,603437,Y-BOX BINDING PROTEIN 3, YBX3
11389,603438,TSUKAHARA SYNDROME,
11390,603439,EXPANSILE BONE LESIONS,
11391,603440,CYCLIN-DEPENDENT KINASE 17, CDK17
11392,603441,CYCLIN-DEPENDENT KINASE-LIKE 1, CDKL1
11393,603442,CYCLIN-DEPENDENT KINASE-LIKE 2, CDKL2
11394,603443,VPS52 SUBUNIT OF GARP COMPLEX, VPS52
11395,603444,FAR UPSTREAM ELEMENT-BINDING PROTEIN 1, FUBP1
11396,603445,KH-TYPE SPLICING REGULATORY PROTEIN, KHSRP
11397,603446,"OROACRAL SYNDROME, VERLOES-KOULISCHER TYPE",
11398,603447,HARAKIRI, HRK
11399,603448,DAB ADAPTOR PROTEIN 1, DAB1
11400,603449,RUVB-LIKE AAA ATPase 1, RUVBL1
11401,603450,LIM DOMAIN-BINDING 2, LDB2
11402,603451,LIM DOMAIN-BINDING 1, LDB1
11403,603452,"AMYLOID BETA A4 PRECURSOR PROTEIN-BINDING, FAMILY A, MEMBER 2",
11404,603453,RECEPTOR-INTERACTING SERINE/THREONINE KINASE 1, RIPK1
11405,603454,CASP2 AND RIPK1 DOMAIN-CONTAINING ADAPTOR WITH DEATH DOMAIN, CRADD
11406,603455,RECEPTOR-INTERACTING SERINE/THREONINE KINASE 2, RIPK2
11407,603456,DIPHTHAMIDE BIOSYNTHESIS PROTEIN 2, DPH2
11408,603457,BOSMA ARHINIA MICROPHTHALMIA SYNDROME, BAMS
11409,603458,ELAV-LIKE RNA-BINDING PROTEIN 3, ELAVL3
11410,603459,"CARNEY COMPLEX, TYPE 1",
11411,603460,"CYCLIN-DEPENDENT KINASE 5, REGULATORY SUBUNIT 1", CDK5R1
11412,603461,CELL DIVISION CYCLE 16, CDC16
11413,603462,CELL DIVISION CYCLE 23, CDC23
11414,603463,ELSAHY-WATERS SYNDROME,
11415,603464,CYCLIN-DEPENDENT KINASE 10, CDK10
11416,603465,CELL DIVISION CYCLE 45, CDC45
11417,603466,ELAV-LIKE RNA-BINDING PROTEIN 1, ELAVL1
11418,603467,"FANCONI ANEMIA, COMPLEMENTATION GROUP F", FANCF
11419,603468,"FANCONI ANEMIA, COMPLEMENTATION GROUP A",
11420,603469,"SOLUTE CARRIER FAMILY 22 (ORGANIC CATION TRANSPORTER), MEMBER 18, ANTISENSE",
11421,603470,ARGININOSUCCINATE SYNTHETASE 1, ASS1
11422,603471,"CITRULLINEMIA, TYPE II, ADULT-ONSET", CTLN2
11423,603472,NEURONAL INTRANUCLEAR INCLUSION DISEASE, NIID
11424,603473,LARGE TUMOR SUPPRESSOR KINASE 1, LATS1
11425,603474,RIBOSOMAL PROTEIN S19, RPS19
11426,603475,CHORDIN, CHRD
11427,603476,cAMP RESPONSE ELEMENT-BINDING PROTEIN-LIKE 2, CREBL2
11428,603477,BUD31 HOMOLOG, BUD31
11429,603478,UBIQUITIN-SPECIFIC PROTEASE 1, USP1
11430,603479,EXTRACELLULAR MATRIX PROTEIN 2, ECM2
11431,603480,"PROTEASOME 26S SUBUNIT, NON-ATPase, 10",
11432,603481,"PROTEASOME 26S SUBUNIT, NON-ATPase, 13", PSMD13
11433,603482,BETA-TRANSDUCIN REPEAT-CONTAINING PROTEIN, BTRC
11434,603483,EUKARYOTIC TRANSLATION INITIATION FACTOR 4E-BINDING PROTEIN 3, EIF4EBP3
11435,603484,PROTEIN REGULATING CYTOKINESIS 1, PRC1
11436,603485,NFS1 CYSTEINE DESULFURASE 1, NFS1
11437,603486,UBIQUITIN-SPECIFIC PROTEASE 4, USP4
11438,603487,"MYOSIN, SKELETAL MUSCLE, HEAVY CHAIN 13", MYH13
11439,603488,ANGIO-ASSOCIATED MIGRATORY CELL PROTEIN, AAMP
11440,603489,CARTILAGE INTERMEDIATE LAYER PROTEIN, CILP
11441,603490,"WINGLESS-TYPE MMTV INTEGRATION SITE FAMILY, MEMBER 4", WNT4
11442,603491,"IMMUNOGLOBULIN SUPERFAMILY, MEMBER 3", IGSF3
11443,603492,"SLAM FAMILY, MEMBER 1", SLAMF1
11444,603493,"POTASSIUM CHANNEL, SUBFAMILY K, MEMBER 5", KCNK5
11445,603494,PREFOLDIN-LIKE CHAPERONE URI1, URI1
11446,603495,AURORA KINASE C, AURKC
11447,603496,DUAL-SPECIFICITY TYROSINE PHOSPHORYLATION-REGULATED KINASE 2, DYRK2
11448,603497,DUAL-SPECIFICITY TYROSINE PHOSPHORYLATION-REGULATED KINASE 3, DYRK3
11449,603498,"SPHINGOMYELIN PHOSPHODIESTERASE 2, NEUTRAL MEMBRANE", SMPD2
11450,603499,"TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY, MEMBER 11A", TNFRSF11A
11451,603500,TUMOR NECROSIS FACTOR RECEPTOR 1-ASSOCIATED DEATH DOMAIN PROTEIN, TRADD
11452,603501,POLY(ADP-RIBOSE) GLYCOHYDROLASE, PARG
11453,603502,INTERFERON-RELATED DEVELOPMENTAL REGULATOR 1, IFRD1
11454,603503,"DOLICHYL-PHOSPHATE MANNOSYLTRANSFERASE 1, CATALYTIC SUBUNIT", DPM1
11455,603504,CELL DIVISION CYCLE 14A, CDC14A
11456,603505,CELL DIVISION CYCLE 14B, CDC14B
11457,603506,LOW DENSITY LIPOPROTEIN RECEPTOR-RELATED PROTEIN 5, LRP5
11458,603507,LOW DENSITY LIPOPROTEIN RECEPTOR-RELATED PROTEIN 6, LRP6
11459,603508,MYOMESIN 1, MYOM1
11460,603509,MYOMESIN 2, MYOM2
11461,603510,INSULIN RECEPTOR SUBSTRATE 4,
11462,603511,"MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL DOMINANT 1", LGMDD1
11463,603512,RNA GUANYLYLTRANSFERASE AND 5-PRIME-PHOSPHATASE, RNGTT
11464,603513,NEURODEVELOPMENTAL DISORDER WITH PROGRESSIVE SPASTICITY AND BRAIN WHITE MATTER ABNORMALITIES,
11465,603514,RNA GUANINE-7-METHYLTRANSFERASE, RNMT
11466,603515,CHORIONIC SOMATOMAMMOTROPIN HORMONE-LIKE 1, CSHL1
11467,603516,SPINOCEREBELLAR ATAXIA 10, SCA10
11468,603517,BCL10 IMMUNE SIGNALING ADAPTOR, BCL10
11469,603518,TIA1 CYTOTOXIC GRANULE-ASSOCIATED RNA-BINDING PROTEIN, TIA1
11470,603519,SURVIVAL MOTOR NEURON DOMAIN-CONTAINING PROTEIN 1, SMNDC1
11471,603520,SMALL NUCLEAR RIBONUCLEOPROTEIN POLYPEPTIDE B-DOUBLE PRIME, SNRPB2
11472,603521,SMALL NUCLEAR RIBONUCLEOPROTEIN POLYPEPTIDE A-PRIME, SNRPA1
11473,603522,SMALL NUCLEAR RIBONUCLEOPROTEIN POLYPEPTIDE C, SNRPC
11474,603523,"CHYLOTHORAX, CONGENITAL",
11475,603524,RCC1 DOMAIN- AND BTB DOMAIN-CONTAINING PROTEIN 2, RCBTB2
11476,603525,NMYC INTERACTOR, NMI
11477,603526,METASTASIS-ASSOCIATED GENE 1, MTA1
11478,603527,DIPHTHAMIDE BIOSYNTHESIS PROTEIN 1, DPH1
11479,603528,DEHYDRATED HEREDITARY STOMATOCYTOSIS 1 WITH OR WITHOUT PSEUDOHYPERKALEMIA AND/OR PERINATAL EDEMA,
11480,603529,"DYSERYTHROPOIESIS, CONGENITAL, WITH ULTRASTRUCTURALLY NORMAL ERYTHROBLAST HETEROCHROMATIN",
11481,603530,MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 3,
11482,603531,"ADAPTOR-RELATED PROTEIN COMPLEX 1, SIGMA-1 SUBUNIT", AP1S1
11483,603532,"ADAPTOR-RELATED PROTEIN COMPLEX 1, SIGMA-2 SUBUNIT",
11484,603533,"ADAPTOR-RELATED PROTEIN COMPLEX 1, GAMMA-1 SUBUNIT", AP1G1
11485,603534,"ADAPTOR-RELATED PROTEIN COMPLEX 1, GAMMA-2 SUBUNIT", AP1G2
11486,603535,"ADAPTOR-RELATED PROTEIN COMPLEX 1, MU-1 SUBUNIT", AP1M1
11487,603536,FAR UPSTREAM ELEMENT-BINDING PROTEIN 3, FUBP3
11488,603537,"POTASSIUM CHANNEL, VOLTAGE-GATED, KQT-LIKE SUBFAMILY, MEMBER 4", KCNQ4
11489,603538,KYNURENINE 3-MONOOXYGENASE, KMO
11490,603539,CATHEPSIN F, CTSF
11491,603540,GAMMA-AMINOBUTYRIC ACID B RECEPTOR 1, GABBR1
11492,603541,SMALL NUCLEAR RIBONUCLEOPROTEIN POLYPEPTIDE F, SNRPF
11493,603542,SMALL NUCLEAR RIBONUCLEOPROTEIN POLYPEPTIDE G, SNRPG
11494,603543,LIMB-MAMMARY SYNDROME, LMS
11495,603544,CYCLIN K, CCNK
11496,603545,"DEAFNESS, AUTOSOMAL RECESSIVE 4, WITH ENLARGED VESTIBULAR AQUEDUCT",
11497,603546,"SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY, TYPE 2", SEMDJL2
11498,603547,METHYL-CpG-BINDING DOMAIN PROTEIN 2, MBD2
11499,603548,CDP-DIACYLGLYCEROL SYNTHASE 1, CDS1
11500,603549,CDP-DIACYLGLYCEROL SYNTHASE 2, CDS2
11501,603550,EYA TRANSCRIPTIONAL COACTIVATOR AND PHOSPHATASE 4, EYA4
11502,603551,HYALURONOGLUCOSAMINIDASE 2, HYAL2
11503,603552,"HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 4", FHL4
11504,603553,"HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 2", FHL2
11505,603554,OMENN SYNDROME,
11506,603555,"SPT4 HOMOLOG, DSIF ELONGATION FACTOR SUBUNIT", SUPT4H1
11507,603556,MYOTUBULARIN-RELATED PROTEIN 1,
11508,603557,MYOTUBULARIN-RELATED PROTEIN 2, MTMR2
11509,603558,MYOTUBULARIN-RELATED PROTEIN 3, MTMR3
11510,603559,MYOTUBULARIN-RELATED PROTEIN 4, MTMR4
11511,603560,SET-BINDING FACTOR 1, SBF1
11512,603561,MYOTUBULARIN-RELATED PROTEIN 6, MTMR6
11513,603562,MYOTUBULARIN-RELATED PROTEIN 7, MTMR7
11514,603563,"SPASTIC PARAPLEGIA 8, AUTOSOMAL DOMINANT", SPG8
11515,603564,"DOLICHYL-PHOSPHATE MANNOSYLTRANSFERASE 2, REGULATORY SUBUNIT", DPM2
11516,603565,UDP-N-ACETYL-ALPHA-D-GALACTOSAMINE:POLYPEPTIDE N-ACETYLGALACTOSAMINYLTRANSFERASE 4, GALNT4
11517,603566,PROTEIN INHIBITOR OF ACTIVATED STAT1, PIAS1
11518,603567,PROTEIN INHIBITOR OF ACTIVATED STAT2, PIAS2
11519,603568,"RNA, U73 SMALL NUCLEOLAR", RNU73
11520,603569,"TRACHEOBRONCHIAL STENOSIS, CONGENITAL",
11521,603570,VANIN 1, VNN1
11522,603571,VANIN 2, VNN2
11523,603572,"MICROCEPHALY, FACIAL ABNORMALITIES, MICROMELIA, AND IMPAIRED INTELLECTUAL DEVELOPMENT",
11524,603573,METHYL-CpG-BINDING DOMAIN PROTEIN 3, MBD3
11525,603574,METHYL-CpG-BINDING DOMAIN PROTEIN 4, MBD4
11526,603575,"NME/NM23 FAMILY, MEMBER 5", NME5
11527,603576,"TRANSIENT RECEPTOR POTENTIAL CATION CHANNEL, SUBFAMILY M, MEMBER 1", TRPM1
11528,603577,NUCLEOLAR PROTEIN 4, NOL4
11529,603578,OVIDUCTAL GLYCOPROTEIN 1, OVGP1
11530,603579,RIO KINASE 3, RIOK3
11531,603580,PROTOCADHERIN 8, PCDH8
11532,603581,PROTOCADHERIN 9, PCDH9
11533,603582,"TOPOISOMERASE, DNA, III, BETA", TOP3B
11534,603583,DISCS LARGE MAGUK SCAFFOLD PROTEIN 2, DLG2
11535,603584,MAP KINASE-ACTIVATING DEATH DOMAIN, MADD
11536,603585,"CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIf", CDG2F
11537,603586,"CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ic",
11538,603587,"FOLLICULAR ATROPHODERMA, PERIORAL PIGMENTED, WITH MILIA AND EPIDERMOID CYSTS",
11539,603588,"PAROTITIS, JUVENILE RECURRENT",
11540,603589,"FACIAL DYSMORPHISM, SELECTIVE TOOTH AGENESIS, AND CHOROID CALCIFICATION",
11541,603590,ACETYLGLUCOSAMINYLTRANSFERASE-LIKE PROTEIN, LARGE1
11542,603591,UBIQUITIN-SPECIFIC PROTEASE 13, USP13
11543,603592,"XANTHINURIA, TYPE II", XAN2
11544,603593,"SOLUTE CARRIER FAMILY 7 (CATIONIC AMINO ACID TRANSPORTER, y+ SYSTEM), MEMBER 7", SLC7A7
11545,603594,"TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY, MEMBER 4", TNFSF4
11546,603595,CRANIOSYNOSTOSIS WITH ECTOPIA LENTIS,
11547,603596,POLYDACTYLY,
11548,603597,SUPPRESSOR OF CYTOKINE SIGNALING 1, SOCS1
11549,603598,"TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY, MEMBER 10", TNFSF10
11550,603599,CASP8- AND FADD-LIKE APOPTOSIS REGULATOR, CFLAR
11551,603600,"OSTEOMA OF CRANIAL VAULT, FAMILIAL",
11552,603601,"PHOSPHATIDYLINOSITOL 3-KINASE, CLASS 2, ALPHA", PIK3C2A
11553,603602,"PHOSPHOLIPASE A2, GROUP IVC", PLA2G4C
11554,603603,"PHOSPHOLIPASE A2, GROUP X", PLA2G10
11555,603604,"PHOSPHOLIPASE A2, GROUP VI", PLA2G6
11556,603605,AMINOACYL-tRNA SYNTHETASE COMPLEX-INTERACTING MULTIFUNCTIONAL PROTEIN 1, AIMP1
11557,603606,RIBOSOMAL PROTEIN S6 KINASE A4, RPS6KA4
11558,603607,RIBOSOMAL PROTEIN S6 KINASE A5, RPS6KA5
11559,603608,CARBONYL REDUCTASE 3, CBR3
11560,603609,FUCOSE-1-PHOSPHATE GUANYLYLTRANSFERASE, FPGT
11561,603610,UNC5 NETRIN RECEPTOR C, UNC5C
11562,603611,"TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY, MEMBER 10A", TNFRSF10A
11563,603612,"TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY, MEMBER 10B", TNFRSF10B
11564,603613,"TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY, MEMBER 10C", TNFRSF10C
11565,603614,"TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY, MEMBER 10D", TNFRSF10D
11566,603615,RAD54-LIKE, RAD54L
11567,603616,"RABAPTIN, RAB GTPase-BINDING EFFECTOR PROTEIN 1", RABEP1
11568,603617,"SOLUTE CARRIER FAMILY 24 (SODIUM/POTASSIUM/CALCIUM EXCHANGER), MEMBER 1", SLC24A1
11569,603618,CELL DIVISION CYCLE 20, CDC20
11570,603619,FIZZY AND CELL DIVISION CYCLE 20-RELATED PROTEIN 1, FZR1
11571,603620,PC4- AND SFRS1-INTERACTING PROTEIN 1, PSIP1
11572,603621,FORKHEAD BOX H1, FOXH1
11573,603622,"DEAFNESS, AUTOSOMAL DOMINANT 17", DFNA17
11574,603623,TYROSYL-tRNA SYNTHETASE 1, YARS1
11575,603624,RIBOSOMAL PROTEIN S2, RPS2
11576,603625,"LYMPHOCYTE ANTIGEN 6 COMPLEX, LOCUS H", LY6H
11577,603626,PROTOCADHERIN 1, PCDH1
11578,603627,"PROTOCADHERIN-GAMMA, SUBFAMILY C, MEMBER 3", PCDHGC3
11579,603628,MUSCULIN, MSC
11580,603629,"DEAFNESS, AUTOSOMAL RECESSIVE 21", DFNB21
11581,603630,RIBOSOMAL PROTEIN S5, RPS5
11582,603631,RIBOSOMAL PROTEIN S9, RPS9
11583,603632,RIBOSOMAL PROTEIN S10, RPS10
11584,603633,RIBOSOMAL PROTEIN S29, RPS29
11585,603634,RIBOSOMAL PROTEIN L5, RPL5
11586,603635,"SMALL NUCLEOLAR RNA, C/D box, 21", SNORD21
11587,603636,RIBOSOMAL PROTEIN L21, RPL21
11588,603637,RIBOSOMAL PROTEIN L27a, RPL27A
11589,603638,RIBOSOMAL PROTEIN L28, RPL28
11590,603639,A DISINTEGRIN AND METALLOPROTEINASE DOMAIN 17, ADAM17
11591,603640,A DISINTEGRIN AND METALLOPROTEINASE DOMAIN 19, ADAM19
11592,603641,"NEUROENDOCRINE CARCINOMA OF SALIVARY GLANDS, SENSORINEURAL HEARING LOSS, AND ENAMEL HYPOPLASIA",
11593,603642,"ATRIAL SEPTAL DEFECT, SECUNDUM, WITH VARIOUS CARDIAC AND NONCARDIAC DEFECTS",
11594,603643,SITUS INVERSUS TOTALIS WITH CYSTIC DYSPLASIA OF KIDNEYS AND PANCREAS,
11595,603644,SYNTHESIS OF CYTOCHROME c OXIDASE 1, SCO1
11596,603645,"GLUTAMYL-tRNA AMIDOTRANSFERASE, SUBUNIT B", GATB
11597,603646,CYTOCHROME c OXIDASE ASSEMBLY FACTOR COX15, COX15
11598,603647,"BCS1 HOMOLOG, UBIQUINOL-CYTOCHROME C REDUCTASE COMPLEX CHAPERONE", BCS1L
11599,603648,CYTOCHROME c OXIDASE COPPER CHAPERONE COX11, COX11
11600,603649,CONE-ROD DYSTROPHY 7, CORD7
11601,603650,BBS5 GENE, BBS5
11602,603651,"TRANSIENT RECEPTOR POTENTIAL CATION CHANNEL, SUBFAMILY C, MEMBER 4", TRPC4
11603,603652,"TRANSIENT RECEPTOR POTENTIAL CATION CHANNEL, SUBFAMILY C, MEMBER 6", TRPC6
11604,603653,TITLE NOT AVAILABLE AT THIS MOMENT,
11605,603654,"SOLUTE CARRIER FAMILY 16 (MONOCARBOXYLIC ACID TRANSPORTER), MEMBER 7", SLC16A7
11606,603655,"GUANINE NUCLEOTIDE-BINDING PROTEIN, GAMMA-TRANSDUCING ACTIVITY POLYPEPTIDE 2",
11607,603656,"EXOSTOSIS, DUPUYTREN SUBUNGUAL",
11608,603657,VESICLE-ASSOCIATED MEMBRANE PROTEIN 3, VAMP3
11609,603658,RIBOSOMAL PROTEIN S7, RPS7
11610,603659,GLUCAGON-LIKE PEPTIDE 2 RECEPTOR, GLP2R
11611,603660,RIBOSOMAL PROTEIN S12, RPS12
11612,603661,RIBOSOMAL PROTEIN L17, RPL17
11613,603662,RIBOSOMAL PROTEIN L23, RPL23
11614,603663,MENTAL HEALTH WELLNESS 1,
11615,603664,MENTAL HEALTH WELLNESS 2,
11616,603665,STANNIOCALCIN 2, STC2
11617,603666,SYNTAXIN 16, STX16
11618,603667,"SOLUTE CARRIER FAMILY 25 (MITOCHONDRIAL CARRIER, ARALAR), MEMBER 12", SLC25A12
11619,603668,SR-RELATED C-TERMINAL DOMAIN-ASSOCIATED FACTOR 11, SCAF11
11620,603669,ECCRINE SYRINGOFIBROADENOMATOSIS WITH EYELID ABNORMALITIES,
11621,603670,"BLUE NEVI, FAMILIAL MULTIPLE",
11622,603671,ACROMELIC FRONTONASAL DYSOSTOSIS, AFND
11623,603672,"CORE-BINDING FACTOR, RUNT DOMAIN, ALPHA SUBUNIT 2, TRANSLOCATED TO, 2", CBFA2T2
11624,603673,PATCHED 2, PTCH2
11625,603674,RIBOSOMAL PROTEIN S15a, RPS15A
11626,603675,RIBOSOMAL PROTEIN S16, RPS16
11627,603676,"EMERY-DREIFUSS MUSCULAR DYSTROPHY 2, AUTOSOMAL DOMINANT",
11628,603677,MYELIN TRANSCRIPTION FACTOR 2, MYT2
11629,603678,"DEAFNESS, AUTOSOMAL RECESSIVE 14", DFNB14
11630,603679,UBIQUITIN-CONJUGATING ENZYME E2 N, UBE2N
11631,603680,ATAXIN 8 OPPOSITE STRAND, ATXN8OS
11632,603681,OTOFERLIN, OTOF
11633,603682,RIBOSOMAL PROTEIN S20, RPS20
11634,603683,RIBOSOMAL PROTEIN S23, RPS23
11635,603684,"LIPASE, ENDOTHELIAL", LIPG
11636,603685,RIBOSOMAL PROTEIN S28, RPS28
11637,603686,RIBOSOMAL PROTEIN L9, RPL9
11638,603687,"ALDEHYDE DEHYDROGENASE 1 FAMILY, MEMBER A2", ALDH1A2
11639,603688,PROSTATE CANCER/BRAIN CANCER SUSCEPTIBILITY,
11640,603689,"MYOPATHY, MYOFIBRILLAR, 9, WITH EARLY RESPIRATORY FAILURE", MFM9
11641,603690,"SOLUTE CARRIER FAMILY 33 (ACETYL-CoA TRANSPORTER), MEMBER 1", SLC33A1
11642,603691,GALANIN RECEPTOR 2, GALR2
11643,603692,GALANIN RECEPTOR 3, GALR3
11644,603693,"ZINC FINGER PROTEIN, FOG FAMILY MEMBER 2", ZFPM2
11645,603694,TYPE 2 DIABETES MELLITUS 3, T2D3
11646,603695,"GUANYLATE CYCLASE 1, SOLUBLE, BETA-2", GUCY1B2
11647,603696,SEPTIN 4, SEPTIN4
11648,603697,"ARACHIDONATE 15-LIPOXYGENASE, SECOND TYPE", ALOX15B
11649,603698,GOLGI-SPECIFIC BREFELDIN-A RESISTANCE FACTOR 1, GBF1
11650,603699,"WINGLESS-TYPE MMTV INTEGRATION SITE FAMILY, MEMBER 11", WNT11
11651,603700,ARACHIDONATE 5-LIPOXYGENASE-ACTIVATING PROTEIN, ALOX5AP
11652,603701,RIBOSOMAL PROTEIN S26, RPS26
11653,603702,RIBOSOMAL PROTEIN S27, RPS27
11654,603703,RIBOSOMAL PROTEIN L6, RPL6
11655,603704,RIBOSOMAL PROTEIN L26, RPL26
11656,603705,ANGIOPOIETIN 4, ANGPT4
11657,603706,SEMAPHORIN 4F, SEMA4F
11658,603707,MOLYBDENUM COFACTOR SYNTHESIS GENE 1, MOCS1
11659,603708,MOLYBDENUM COFACTOR SYNTHESIS GENE 2, MOCS2
11660,603709,A DISINTEGRIN AND METALLOPROTEINASE DOMAIN 22, ADAM22
11661,603710,A DISINTEGRIN AND METALLOPROTEINASE DOMAIN 23, ADAM23
11662,603711,"CYTOCHROME P450, FAMILY 7, SUBFAMILY B, POLYPEPTIDE 1", CYP7B1
11663,603712,A DISINTEGRIN AND METALLOPROTEINASE DOMAIN 20, ADAM20
11664,603713,A DISINTEGRIN AND METALLOPROTEINASE DOMAIN 21, ADAM21
11665,603714,SIX HOMEOBOX 3, SIX3
11666,603715,GLIAL CELLS MISSING TRANSCRIPTION FACTOR 1, GCM1
11667,603716,GLIAL CELLS MISSING TRANSCRIPTION FACTOR 2, GCM2
11668,603717,"ATPase, H+ TRANSPORTING, LYSOSOMAL, 21-KD, V0 SUBUNIT C-PRIME, PRIME", ATP6V0B
11669,603718,CLAUDIN 1, CLDN1
11670,603719,BUB3 MITOTIC CHECKPOINT PROTEIN, BUB3
11671,603720,"DEAFNESS, AUTOSOMAL RECESSIVE 16", DFNB16
11672,603721,UBIQUITIN-CONJUGATING ENZYME E2 L3, UBE2L3
11673,603722,ELONGATOR COMPLEX PROTEIN 1, ELP1
11674,603723,"INHIBITOR OF NUCLEAR FACTOR KAPPA-B KINASE, REGULATORY SUBUNIT GAMMA",
11675,603724,FIBROBLAST GROWTH FACTOR 16,
11676,603725,FIBROBLAST GROWTH FACTOR 17, FGF17
11677,603726,FIBROBLAST GROWTH FACTOR 18, FGF18
11678,603727,GLUTAMINYL-tRNA SYNTHETASE 1, QARS1
11679,603728,NUMB ENDOCYTIC ADAPTOR PROTEIN, NUMB
11680,603729,SPHINGOSINE-1-PHOSPHATE LYASE 1, SGPL1
11681,603730,SPHINGOSINE KINASE 1, SPHK1
11682,603731,"CCR4-NOT TRANSCRIPTION COMPLEX, SUBUNIT 8", CNOT8
11683,603732,CRYPTOCHROME 2, CRY2
11684,603733,"SOLUTE CARRIER FAMILY 43 (L-TYPE AMINO ACID TRANSPORTER), MEMBER 1", SLC43A1
11685,603734,INTERFERON REGULATORY FACTOR 3, IRF3
11686,603735,"AMINE OXIDASE, COPPER-CONTAINING, 3", AOC3
11687,603736,"OHDO SYNDROME, SBBYS VARIANT", SBBYSS
11688,603737,OVARIAN GERM CELL CANCER,
11689,603738,BASIC TRANSCRIPTION FACTOR 3 PSEUDOGENE 12, BTF3P12
11690,603739,BASIC TRANSCRIPTION FACTOR 3 PSEUDOGENE 13, BTF3P13
11691,603740,"ACRODYSPLASIA WITH OSSIFICATION ABNORMALITIES, SHORT STATURE, AND FIBULAR HYPOPLASIA",
11692,603741,"ARACHIDONATE 12-LIPOXYGENASE, R TYPE", ALOX12B
11693,603742,SLIT GUIDANCE LIGAND 1, SLIT1
11694,603743,APOLIPOPROTEIN L1, APOL1
11695,603744,PAPILLARY THYROID MICROCARCINOMA,
11696,603745,SLIT GUIDANCE LIGAND 3, SLIT3
11697,603746,SLIT GUIDANCE LIGAND 2, SLIT2
11698,603747,TUMOR PROTEIN D52-LIKE 2, TPD52L2
11699,603748,APELIN,
11700,603749,"TRANSIENT RECEPTOR POTENTIAL CATION CHANNEL, SUBFAMILY M, MEMBER 2", TRPM2
11701,603750,AQUAPORIN 8, AQP8
11702,603751,SPHINGOSINE-1-PHOSPHATE RECEPTOR 4, S1PR4
11703,603752,"SOLUTE CARRIER FAMILY 7 (CATIONIC AMINO ACID TRANSPORTER, y+ SYSTEM), MEMBER 4", SLC7A4
11704,603753,UBIQUITINATION FACTOR E4A, UBE4A
11705,603754,KINESIN FAMILY MEMBER 3B, KIF3B
11706,603755,ZINC FINGER FYVE TYPE-CONTAINING PROTEIN 9, ZFYVE9
11707,603756,"ATP-BINDING CASSETTE, SUBFAMILY G, MEMBER 2", ABCG2
11708,603757,"CHEMOKINE, CC MOTIF, LIGAND 18", CCL18
11709,603758,"GLUTATHIONE S-TRANSFERASE, ZETA-1", GSTZ1
11710,603759,LIM HOMEOBOX GENE 2, LHX2
11711,603760,HUS1 CHECKPOINT CLAMP COMPONENT, HUS1
11712,603761,RAD9A CHECKPOINT CLAMP COMPONENT A, RAD9A
11713,603762,PHOSPHORIBOSYLPYROPHOSPHATE SYNTHETASE-ASSOCIATED PROTEIN 2, PRPSAP2
11714,603763,KINESIN FAMILY MEMBER C1, KIFC1
11715,603764,"CYCLIN-DEPENDENT KINASE 5, REGULATORY SUBUNIT 2", CDK5R2
11716,603765,SYNTAXIN 10, STX10
11717,603766,MITOCHONDRIAL TRANSLATIONAL INITIATION FACTOR 2, MTIF2
11718,603767,KALLIKREIN-RELATED PEPTIDASE 4, KLK4
11719,603768,"PROTEIN PHOSPHATASE 1, REGULATORY SUBUNIT 12B", PPP1R12B
11720,603769,T-CELL LYMPHOMA/LEUKEMIA 1B, TCL1B
11721,603770,"PROTEIN PHOSPHATASE, MAGNESIUM/MANGANESE-DEPENDENT, 1B", PPM1B
11722,603771,"PROTEIN PHOSPHATASE 1, REGULATORY SUBUNIT 10", PPP1R10
11723,603772,"DYNEIN, CYTOPLASMIC 1, INTERMEDIATE CHAIN 1", DYNC1I1
11724,603773,"CYTOCHROME c OXIDASE, SUBUNIT 5A", COX5A
11725,603774,"CYTOCHROME c OXIDASE, SUBUNIT 7C", COX7C
11726,603775,CYCLIN E2, CCNE2
11727,603776,"HYPERCHOLESTEROLEMIA, FAMILIAL, 3", FHCL3
11728,603777,"CERBERUS 1, DAN FAMILY BMP ANTAGONIST", CER1
11729,603778,CDY-LIKE PROTEIN, CDYL
11730,603779,SYNUCLEIN-ALPHA-INTERACTING PROTEIN, SNCAIP
11731,603780,RECQ PROTEIN-LIKE 4, RECQL4
11732,603781,RECQ PROTEIN-LIKE 5, RECQL5
11733,603782,"CHEMOKINE, CC MOTIF, LIGAND 4-LIKE 1", CCL4L1
11734,603783,INTELLIGENCE QUANTITATIVE TRAIT LOCUS 1,
11735,603784,PPTG1-INTERACTING PROTEIN, PTTG1IP
11736,603785,MULTIPLE PDZ DOMAIN CRUMBS CELL POLARITY COMPLEX COMPONENT, MPDZ
11737,603786,STARGARDT DISEASE 4, STGD4
11738,603787,"POTASSIUM CHANNEL, VOLTAGE-GATED, SUBFAMILY F, MEMBER 1", KCNF1
11739,603788,"POTASSIUM CHANNEL, VOLTAGE-GATED, SUBFAMILY G, MEMBER 1", KCNG1
11740,603789,TRANSCRIPTION ELONGATION FACTOR A-LIKE 1,
11741,603790,"SOLUTE CARRIER FAMILY 23 (NUCLEOBASE TRANSPORTER), MEMBER 1", SLC23A1
11742,603791,"SOLUTE CARRIER FAMILY 23 (NUCLEOBASE TRANSPORTER), MEMBER 2", SLC23A2
11743,603792,"CYTOCHROME c OXIDASE, SUBUNIT 7B",
11744,603793,TITLE NOT AVAILABLE AT THIS MOMENT,
11745,603794,"HYDROA VACCINIFORME, FAMILIAL",
11746,603795,LIPOPOLYSACCHARIDE-INDUCED TUMOR NECROSIS FACTOR, LITAF
11747,603796,"POTASSIUM CHANNEL, VOLTAGE-GATED, ISK-RELATED SUBFAMILY, MEMBER 2", KCNE2
11748,603797,CARBOHYDRATE SULFOTRANSFERASE 1, CHST1
11749,603798,CARBOHYDRATE SULFOTRANSFERASE 2, CHST2
11750,603799,CARBOHYDRATE SULFOTRANSFERASE 3, CHST3
11751,603800,MEDIATOR COMPLEX SUBUNIT 21, MED21
11752,603801,N-MYRISTOYLTRANSFERASE 2, NMT2
11753,603802,MICROCEPHALY WITH SIMPLIFIED GYRAL PATTERN,
11754,603803,DACHSHUND FAMILY TRANSCRIPTION FACTOR 1, DACH1
11755,603804,NEURALIZED E3 UBIQUITIN PROTEIN LIGASE 1, NEURL1
11756,603805,TRANSGLUTAMINASE 5, TGM5
11757,603806,"URINARY TRACT INFECTIONS, RECURRENT, SUSCEPTIBILITY TO",
11758,603807,ANTERIOR SEGMENT DYSGENESIS 1,
11759,603808,MEDIATOR COMPLEX SUBUNIT 13, MED13
11760,603809,THYROID HORMONE RECEPTOR-ASSOCIATED PROTEIN 3, THRAP3
11761,603810,MEDIATOR COMPLEX SUBUNIT 17, MED17
11762,603811,BARRIER-TO-AUTOINTEGRATION FACTOR 1, BANF1
11763,603812,DDB1- AND CUL4-ASSOCIATED FACTOR 5, DCAF5
11764,603813,"HYPERCHOLESTEROLEMIA, FAMILIAL, 4", FHCL4
11765,603814,RING-BOX 1, RBX1
11766,603815,KINESIN FAMILY MEMBER 25, KIF25
11767,603816,AXIS INHIBITOR 1, AXIN1
11768,603817,DEVELOPMENT- AND DIFFERENTIATION-ENHANCING FACTOR 2, DDEF2
11769,603818,NEUREGULIN 2, NRG2
11770,603819,STEROID RECEPTOR RNA ACTIVATOR 1, SRA1
11771,603820,FREE FATTY ACID RECEPTOR 1, FFAR1
11772,603821,FREE FATTY ACID RECEPTOR 3, FFAR3
11773,603822,G PROTEIN-COUPLED RECEPTOR 42, GPR42
11774,603823,FREE FATTY ACID RECEPTOR 2, FFAR2
11775,603824,UDP-N-ACETYLGLUCOSAMINE 2-EPIMERASE/N-ACETYLMANNOSAMINE KINASE, GNE
11776,603825,HYPERMETHYLATED IN CANCER 1, HIC1
11777,603826,"NUCLEAR RECEPTOR SUBFAMILY 1, GROUP H, MEMBER 4", NR1H4
11778,603827,BCL2-LIKE 11, BCL2L11
11779,603828,BRITTLE BONE DISORDER,
11780,603829,"VENTRICULAR FIBRILLATION, PAROXYSMAL FAMILIAL, 1", VF1
11781,603830,LONG QT SYNDROME 3, LQT3
11782,603831,PDZ DOMAIN-CONTAINING 1, PDZK1
11783,603832,NADH-UBIQUINONE OXIDOREDUCTASE SUBUNIT A3, NDUFA3
11784,603833,CYTOCHROME C OXIDASE SUBUNIT FA4, COXFA4
11785,603834,NADH-UBIQUINONE OXIDOREDUCTASE SUBUNIT A9, NDUFA9
11786,603835,NADH-UBIQUINONE OXIDOREDUCTASE SUBUNIT A10, NDUFA10
11787,603836,NADH-UBIQUINONE OXIDOREDUCTASE SUBUNIT AB1, NDUFAB1
11788,603837,NADH-UBIQUINONE OXIDOREDUCTASE SUBUNIT B1, NDUFB1
11789,603838,"NADH-UBIQUINONE OXIDOREDUCTASE 1 BETA SUBCOMPLEX, 2", NDUFB2
11790,603839,NADH-UBIQUINONE OXIDOREDUCTASE SUBUNIT B3, NDUFB3
11791,603840,NADH-UBIQUINONE OXIDOREDUCTASE SUBUNIT B4, NDUFB4
11792,603841,NADH-UBIQUINONE OXIDOREDUCTASE SUBUNIT B5, NDUFB5
11793,603842,NADH-UBIQUINONE OXIDOREDUCTASE SUBUNIT B7, NDUFB7
11794,603843,NADH-UBIQUINONE OXIDOREDUCTASE SUBUNIT B10, NDUFB10
11795,603844,NADH-UBIQUINONE OXIDOREDUCTASE SUBUNIT C1, NDUFC1
11796,603845,NADH-UBIQUINONE OXIDOREDUCTASE SUBUNIT C2, NDUFC2
11797,603846,NADH-UBIQUINONE OXIDOREDUCTASE Fe-S PROTEIN 3, NDUFS3
11798,603847,NADH-UBIQUINONE OXIDOREDUCTASE Fe-S PROTEIN 5, NDUFS5
11799,603848,NADH-UBIQUINONE OXIDOREDUCTASE Fe-S PROTEIN 6, NDUFS6
11800,603849,"NUCLEAR RECEPTOR SUBFAMILY 2, GROUP E, MEMBER 1", NR2E1
11801,603850,DYNAMIN 1-LIKE, DNM1L
11802,603851,PAIRED-LIKE HOMEOBOX 2B, PHOX2B
11803,603852,TUMOR-SUPPRESSING SUBCHROMOSOMAL TRANSFERABLE FRAGMENT CANDIDATE GENE 4, TSSC4
11804,603853,TETRASPANIN 32, TSPAN32
11805,603854,RAN-BINDING PROTEIN 9, RANBP9
11806,603855,"CYSTIC FIBROSIS, MODIFIER OF, 1", CFM1
11807,603856,MAKORIN 3, MKRN3
11808,603857,MKRN3 ANTISENSE RNA, MKRN3AS
11809,603858,"NEPHROTIC SYNDROME, TYPE 4",
11810,603859,"SOLUTE CARRIER FAMILY 25 (CITRIN), MEMBER 13", SLC25A13
11811,603860,"TUBULOINTERSTITIAL KIDNEY DISEASE, AUTOSOMAL DOMINANT 1",
11812,603861,"SOLUTE CARRIER FAMILY 25 (MITOCHONDRIAL CARRIER, ORNITHINE TRANSPORTER), MEMBER 15", SLC25A15
11813,603862,CYCLIN T2, CCNT2
11814,603863,RING FINGER PROTEIN 7, RNF7
11815,603864,COPPER CHAPERONE FOR SUPEROXIDE DISMUTASE, CCS
11816,603865,GLUTAMINE:FRUCTOSE-6-PHOSPHATE AMIDOTRANSFERASE 2, GFPT2
11817,603866,PEROXISOME BIOGENESIS FACTOR 11A, PEX11A
11818,603867,PEROXISOME BIOGENESIS FACTOR 11B, PEX11B
11819,603868,RAS-ASSOCIATED PROTEIN RAB27A, RAB27A
11820,603869,RAS-ASSOCIATED PROTEIN RAB27B, RAB27B
11821,603870,"CORE-BINDING FACTOR, ALPHA SUBUNIT 2, TRANSLOCATED TO, 3", CBFA2T3
11822,603871,BYSTIN-LIKE, BYSL
11823,603872,TROPHININ-ASSOCIATED PROTEIN, TROAP
11824,603873,PHOSPHOLIPASE A2-ACTIVATING PROTEIN, PLAA
11825,603874,ANGIOPOIETIN-LIKE 1, ANGPTL1
11826,603875,"TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY, MEMBER 8", TNFSF8
11827,603876,"A DISINTEGRIN-LIKE AND METALLOPROTEINASE WITH THROMBOSPONDIN TYPE 1 MOTIF, 4", ADAMTS4
11828,603877,"SOLUTE CARRIER FAMILY 16 (MONOCARBOXYLIC ACID TRANSPORTER), MEMBER 3", SLC16A3
11829,603878,"SOLUTE CARRIER FAMILY 16 (MONOCARBOXYLIC ACID TRANSPORTER), MEMBER 4", SLC16A4
11830,603879,"SOLUTE CARRIER FAMILY 16 (MONOCARBOXYLIC ACID TRANSPORTER), MEMBER 5", SLC16A5
11831,603880,"SOLUTE CARRIER FAMILY 16 (MONOCARBOXYLIC ACID TRANSPORTER), MEMBER 6", SLC16A6
11832,603881,"NUCLEAR RECEPTOR SUBFAMILY 1, GROUP I, MEMBER 3", NR1I3
11833,603882,BAG COCHAPERONE 2, BAG2
11834,603883,BAG COCHAPERONE 3, BAG3
11835,603884,BAG COCHAPERONE 4, BAG4
11836,603885,BAG COCHAPERONE 5, BAG5
11837,603886,ARTEMIN, ARTN
11838,603887,TIMELESS CIRCADIAN REGULATOR, TIMELESS
11839,603888,"POTASSIUM CHANNEL, VOLTAGE-GATED, DELAYED-RECTIFIER, SUBFAMILY S, MEMBER 3", KCNS3
11840,603889,"SIGNAL REGULATORY PROTEIN, BETA-1", SIRPB1
11841,603890,UBIQUITIN-CONJUGATING ENZYME E2 L6, UBE2L6
11842,603891,FIBROBLAST GROWTH FACTOR 19, FGF19
11843,603892,ELONGATION FACTOR Tu GTP-BINDING DOMAIN-CONTAINING 2, EFTUD2
11844,603893,TRAF FAMILY MEMBER-ASSOCIATED NF-KAPPA-B ACTIVATOR, TANK
11845,603894,REGULATOR OF G PROTEIN SIGNALING 6, RGS6
11846,603895,REGULATOR OF G PROTEIN SIGNALING 11, RGS11
11847,603896,LEUKOENCEPHALOPATHY WITH VANISHING WHITE MATTER 1, VWM1
11848,603897,MATRILIN 4, MATN4
11849,603898,"TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY, MEMBER 18", TNFSF18
11850,603899,ZINC FINGER PROTEIN 85, ZNF85
11851,603900,ZINC FINGER PROTEIN 174, ZNF174
11852,603901,ZPR1 ZINC FINGER PROTEIN, ZPR1
11853,603902,"BETA-THALASSEMIA, DOMINANT INCLUSION BODY TYPE",
11854,603903,SICKLE CELL DISEASE,
11855,603904,INTEGRAL MEMBRANE PROTEIN 2B, ITM2B
11856,603905,"TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY, MEMBER 18", TNFRSF18
11857,603906,CHLORIDE CHANNEL ACCESSORY 1, CLCA1
11858,603907,"EUKARYOTIC TRANSLATION INITIATION FACTOR 2, SUBUNIT 1", EIF2S1
11859,603908,"EUKARYOTIC TRANSLATION INITIATION FACTOR 2, SUBUNIT 2", EIF2S2
11860,603909,"AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME, TYPE IIA", ALPS2A
11861,603910,"EUKARYOTIC TRANSLATION INITIATION FACTOR 3, SUBUNIT J", EIF3J
11862,603911,"EUKARYOTIC TRANSLATION INITIATION FACTOR 3, SUBUNIT I", EIF3I
11863,603912,"EUKARYOTIC TRANSLATION INITIATION FACTOR 3, SUBUNIT H", EIF3H
11864,603913,"EUKARYOTIC TRANSLATION INITIATION FACTOR 3, SUBUNIT G", EIF3G
11865,603914,"EUKARYOTIC TRANSLATION INITIATION FACTOR 3, SUBUNIT F", EIF3F
11866,603915,"EUKARYOTIC TRANSLATION INITIATION FACTOR 3, SUBUNIT D", EIF3D
11867,603916,"EUKARYOTIC TRANSLATION INITIATION FACTOR 3, SUBUNIT C", EIF3C
11868,603917,"EUKARYOTIC TRANSLATION INITIATION FACTOR 3, SUBUNIT B", EIF3B
11869,603918,"HYPERTENSION, ESSENTIAL, SUSCEPTIBILITY TO, 1",
11870,603919,SERINE/THREONINE PROTEIN KINASE 10, STK10
11871,603920,"CRYSTALLIN, ZETA-LIKE 1", CRYZL1
11872,603921,"SUCCINATE-CoA LIGASE, ADP-FORMING, SUBUNIT BETA", SUCLA2
11873,603922,"SUCCINATE-CoA LIGASE, GDP-FORMING, SUBUNIT BETA", SUCLG2
11874,603923,GUANINE DEAMINASE,
11875,603924,HYALURONAN-BINDING PROTEIN 2, HABP2
11876,603925,SYNAPTOGYRIN 1, SYNGR1
11877,603926,SYNAPTOGYRIN 2, SYNGR2
11878,603927,SYNAPTOGYRIN 3, SYNGR3
11879,603928,EUKARYOTIC TRANSLATION INITIATION FACTOR 4B, EIF4B
11880,603929,"EUKARYOTIC TRANSLATION INITIATION FACTOR 4-GAMMA, 3", EIF4G3
11881,603930,GEPHYRIN, GPHN
11882,603931,"ATPase, H+ TRANSPORTING, LYSOSOMAL, 9-KD, V0 SUBUNIT E1", ATP6V0E1
11883,603932,INTERVERTEBRAL DISC DISEASE, IDD
11884,603933,"MICROVASCULAR COMPLICATIONS OF DIABETES, SUSCEPTIBILITY TO, 1", MVCD1
11885,603934,COACTIVATOR-ASSOCIATED ARGININE METHYLTRANSFERASE 1, CARM1
11886,603935,"PSORIASIS 4, SUSCEPTIBILITY TO", PSORS4
11887,603936,GROWTH/DIFFERENTIATION FACTOR 11, GDF11
11888,603937,RP1 AXONEMAL MICROTUBULE-ASSOCIATED PROTEIN, RP1
11889,603938,EMOPAMIL-BINDING PROTEIN,
11890,603939,"POTASSIUM CHANNEL, SUBFAMILY K, MEMBER 6", KCNK6
11891,603940,"POTASSIUM CHANNEL, SUBFAMILY K, MEMBER 7", KCNK7
11892,603941,"SOLUTE CARRIER FAMILY 19 (THIAMINE TRANSPORTER), MEMBER 2", SLC19A2
11893,603942,GLYCOGENIN 1, GYG1
11894,603943,CYSTEINE DIOXYGENASE, CDO
11895,603944,SYNTAXIN 6, STX6
11896,603945,"EUKARYOTIC TRANSLATION INITIATION FACTOR 2B, SUBUNIT 5", EIF2B5
11897,603946,"HELICASE, LYMPHOID-SPECIFIC", HELLS
11898,603947,METASTASIS-ASSOCIATED PROTEIN 2, MTA2
11899,603948,"NUCLEOPORIN, 153-KD", NUP153
11900,603949,RAB7-LIKE 1, RAB7L1
11901,603950,N-DEACETYLASE/N-SULFOTRANSFERASE 3, NDST3
11902,603951,"POTASSIUM CHANNEL, CALCIUM-ACTIVATED, LARGE CONDUCTANCE, SUBFAMILY M, BETA MEMBER 1", KCNMB1
11903,603952,DEVELOPMENTALLY REGULATED GTP-BINDING PROTEIN 1, DRG1
11904,603953,"POTASSIUM INWARDLY-RECTIFYING CHANNEL, SUBFAMILY J, MEMBER 14", KCNJ14
11905,603954,ZW10 KINETOCHORE PROTEIN, ZW10
11906,603955,FLAVIN-CONTAINING DIMETHYLANILINE MONOOXYGENASE 2, FMO2
11907,603956,CERVICAL CANCER,
11908,603957,FLAVIN-CONTAINING DIMETHYLANILINE MONOOXYGENASE 5, FMO5
11909,603958,"REGULATORY FACTOR X, 4", RFX4
11910,603959,CLAUDIN 16, CLDN16
11911,603960,CALICIN, CCIN
11912,603961,SEMAPHORIN 3A, SEMA3A
11913,603962,RAS GUANYL NUCLEOTIDE-RELEASING PROTEIN 1, RASGRP1
11914,603963,"INTEGRIN, ALPHA-9", ITGA9
11915,603964,"DEAFNESS, AUTOSOMAL DOMINANT 16", DFNA16
11916,603965,FOCAL SEGMENTAL GLOMERULOSCLEROSIS 2, FSGS2
11917,603966,"ALDO-KETO REDUCTASE FAMILY 1, MEMBER C3", AKR1C3
11918,603967,"SODIUM VOLTAGE-GATED CHANNEL, ALPHA SUBUNIT 4", SCN4A
11919,603968,"POLYMERASE, DNA, ETA", POLH
11920,603969,"TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY, MEMBER 13B", TNFSF13B
11921,603970,PARANEOPLASTIC MA ANTIGEN 2, PNMA2
11922,603971,ZINC FINGER PROTEIN 91, ZNF91
11923,603972,ZINC FINGER PROTEIN 43, ZNF43
11924,603973,ZINC FINGER PROTEIN 90, ZNF90
11925,603974,ZINC FINGER PROTEIN 92, ZNF92
11926,603975,ZINC FINGER PROTEIN 93, ZNF93
11927,603976,ZINC FINGER PROTEIN 94, ZNF94
11928,603977,ZINC FINGER PROTEIN 208, ZNF208
11929,603978,ZINC FINGER- AND SCAN DOMAIN-CONTAINING PROTEIN 12, ZSCAN12
11930,603979,ZINC FINGER PROTEIN 97, ZNF97
11931,603980,ZINC FINGER PROTEIN 98, ZNF98
11932,603981,ZINC FINGER PROTEIN 99, ZNF99
11933,603982,ZINC FINGER PROTEIN 100, ZNF100
11934,603983,ZINC FINGER PROTEIN 101, ZNF101
11935,603984,ZINC FINGER PROTEIN 737, ZNF737
11936,603985,ZINC FINGER PROTEIN 103, ZNF103
11937,603986,TITLE NOT AVAILABLE AT THIS MOMENT,
11938,603987,ZINC FINGER PROTEIN 105, ZNF105
11939,603988,ZINC FINGER PROTEIN 106, ZNF106
11940,603989,ZINC FINGER PROTEIN 107, ZNF107
11941,603990,TITLE NOT AVAILABLE AT THIS MOMENT,
11942,603991,ZINC FINGER PROTEIN 109, ZNF109
11943,603992,ZINC FINGER PROTEIN 110, ZNF110
11944,603993,ZINC FINGER PROTEIN 111, ZNF111
11945,603994,ZINC FINGER PROTEIN 112, ZNF112
11946,603995,ZINC FINGER PROTEIN 113, ZNF113
11947,603996,ZINC FINGER PROTEIN 114, ZNF114
11948,603997,ZINC FINGER PROTEIN 118, ZNF118
11949,603998,ZINC FINGER PROTEIN 119, ZNF119
11950,603999,ZINC FINGER PROTEIN 120, ZNF120
11951,604000,ZINC FINGER PROTEIN 122, ZNF122
11952,604001,A-KINASE ANCHOR PROTEIN 9, AKAP9
11953,604002,RHO-ASSOCIATED COILED-COIL-CONTAINING PROTEIN KINASE 2, ROCK2
11954,604003,CHLORIDE CHANNEL ACCESSORY 2, CLCA2
11955,604004,MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 1, MLC1
11956,604005,"PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 1",
11957,604006,TITLE NOT AVAILABLE AT THIS MOMENT,
11958,604007,TITLE NOT AVAILABLE AT THIS MOMENT,
11959,604008,"PROTEIN-TYROSINE PHOSPHATASE, RECEPTOR-TYPE, ZETA-2", PTPRZ2
11960,604009,BAI1-ASSOCIATED PROTEIN 3, BAIAP3
11961,604010,PARANEOPLASTIC MA ANTIGEN 1, PNMA1
11962,604011,UNC119 LIPID-BINDING CHAPERONE, UNC119
11963,604012,"RNA, U20 SMALL NUCLEOLAR", RNU20
11964,604013,"UDP-GAL:BETA-GlcNAc BETA-1,4-GALACTOSYLTRANSFERASE, POLYPEPTIDE 2", B4GALT2
11965,604014,"UDP-GAL:BETA-GlcNAc BETA-1,4-GALACTOSYLTRANSFERASE, POLYPEPTIDE 3", B4GALT3
11966,604015,"UDP-GAL:BETA-GlcNAc BETA-1,4-GALACTOSYLTRANSFERASE, POLYPEPTIDE 4", B4GALT4
11967,604016,"UDP-GAL:BETA-GlcNAc BETA-1,4-GALACTOSYLTRANSFERASE, POLYPEPTIDE 5", B4GALT5
11968,604017,"UDP-GAL:BETA-GlcNAc BETA-1,4-GALACTOSYLTRANSFERASE, POLYPEPTIDE 6", B4GALT6
11969,604018,NUMB-LIKE ENDOCYTIC ADAPTOR PROTEIN, NUMBL
11970,604019,ADP-RIBOSYLATION FACTOR GTPase-ACTIVATING PROTEIN WITH FG REPEATS 2, AGFG2
11971,604020,BASSOON PRESYNAPTIC CYTOMATRIX PROTEIN, BSN
11972,604021,NEUROTROPHIN 4,
11973,604022,NEUROTROPHIN 4,
11974,604023,NEUROTROPHIN 4,
11975,604024,"SOLUTE CARRIER FAMILY 5 (SODIUM-DEPENDENT VITAMIN TRANSPORTER), MEMBER 6", SLC5A6
11976,604025,AXIS INHIBITOR 2, AXIN2
11977,604026,GOLGI SNAP RECEPTOR COMPLEX MEMBER 1, GOSR1
11978,604027,GOLGI SNAP RECEPTOR COMPLEX MEMBER 2, GOSR2
11979,604028,"SEC22 HOMOLOG C, VESICLE TRAFFICKING PROTEIN", SEC22C
11980,604029,"SEC22 HOMOLOG B, VESICLE TRAFFICKING PROTEIN", SEC22B
11981,604030,"PROTEASOME SUBUNIT, BETA-TYPE, 7", PSMB7
11982,604031,STEAROYL-CoA DESATURASE, SCD
11983,604032,EUKARYOTIC TRANSLATION INITIATION FACTOR 2-ALPHA KINASE 3, EIF2AK3
11984,604033,ENDOPLASMIC RETICULUM-TO-NUCLEUS SIGNALING 1, ERN1
11985,604034,ENDOPLASMIC RETICULUM-TO-NUCLEUS SIGNALING 2, ERN2
11986,604035,CYLICIN 2, CYLC2
11987,604036,CYCLIN A1, CCNA1
11988,604037,RAS-ASSOCIATED PROTEIN RAB5C, RAB5C
11989,604038,HYALURONOGLUCOSAMINIDASE 3, HYAL3
11990,604039,O-GlcNAcase, OGA
11991,604040,RAD50 DOUBLE-STRAND BREAK REPAIR PROTEIN, RAD50
11992,604041,MANNOSE-P-DOLICHOL UTILIZATION DEFECT 1, MPDU1
11993,604042,"INTEGRIN, ALPHA-10", ITGA10
11994,604043,NIMA-RELATED KINASE 2, NEK2
11995,604044,NIMA-RELATED KINASE 3, NEK3
11996,604045,PROTEIN ARGININE METHYLTRANSFERASE 5, PRMT5
11997,604046,OXIDATIVE STRESS-RESPONSIVE 1, OXSR1
11998,604047,"SOLUTE CARRIER FAMILY 22 (ORGANIC ANION/URATE TRANSPORTER), MEMBER 13", SLC22A13
11999,604048,"SOLUTE CARRIER FAMILY 22, MEMBER 14", SLC22A14
12000,604049,XYLULOKINASE, XYLB
12001,604050,DELETED IN LUNG AND ESOPHAGEAL CANCER 1, DLEC1
12002,604051,"ENDO/EXONUCLEASE, ENDOG-LIKE", EXOG
12003,604052,"TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY, MEMBER 15", TNFSF15
12004,604053,"3-PRIME(2-PRIME),5-PRIME-BISPHOSPHATE NUCLEOTIDASE 1", BPNT1
12005,604054,ACETYL-CoA ACYLTRANSFERASE 1, ACAA1
12006,604055,ISOPENTENYL-DIPHOSPHATE DELTA ISOMERASE 1, IDI1
12007,604056,HEPARAN SULFATE-GLUCOSAMINE 3-SULFOTRANSFERASE 2, HS3ST2
12008,604057,HEPARAN SULFATE-GLUCOSAMINE 3-SULFOTRANSFERASE 3A1, HS3ST3A1
12009,604058,HEPARAN SULFATE-GLUCOSAMINE 3-SULFOTRANSFERASE 3B1, HS3ST3B1
12010,604059,HEPARAN SULFATE-GLUCOSAMINE 3-SULFOTRANSFERASE 4, HS3ST4
12011,604060,"DEAFNESS, AUTOSOMAL RECESSIVE 20", DFNB20
12012,604061,SEPTIN 9, SEPTIN9
12013,604062,MEDIATOR COMPLEX SUBUNIT 16, MED16
12014,604063,"INTEGRIN, ALPHA-8", ITGA8
12015,604064,ACTIVATING TRANSCRIPTION FACTOR 4, ATF4
12016,604065,"CALCIUM CHANNEL, VOLTAGE-DEPENDENT, T TYPE, ALPHA-1G SUBUNIT", CACNA1G
12017,604066,"UDP-GAL:BETA-GlcNAc BETA-1,3-GALACTOSYLTRANSFERASE, POLYPEPTIDE 5", B3GALT5
12018,604067,REGULATOR OF G PROTEIN SIGNALING 9, RGS9
12019,604068,TUMOR PROTEIN D52, TPD52
12020,604069,TUMOR PROTEIN D52-LIKE 1, TPD52L1
12021,604070,"DIACYLGLYCEROL KINASE, BETA, 90-KD", DGKB
12022,604071,"DIACYLGLYCEROL KINASE, ETA, 130-KD", DGKH
12023,604072,"DIACYLGLYCEROL KINASE, IOTA, 130-KD", DGKI
12024,604073,ZINC FINGER PROTEIN 131, ZNF131
12025,604074,ZINC FINGER PROTEIN 132, ZNF132
12026,604075,ZINC FINGER PROTEIN 133, ZNF133
12027,604076,ZINC FINGER PROTEIN 134, ZNF134
12028,604077,ZINC FINGER PROTEIN 135, ZNF135
12029,604078,ZINC FINGER PROTEIN 136, ZNF136
12030,604079,ZINC FINGER PROTEIN 137, ZNF137
12031,604080,ZINC FINGER PROTEIN 138, ZNF138
12032,604081,ZINC FINGER PROTEIN WITH KRAB AND SCAN DOMAINS 1,
12033,604082,ZINC FINGER PROTEIN 140, ZNF140
12034,604083,ZINC FINGER PROTEIN 142, ZNF142
12035,604084,ZINC FINGER- AND BTB DOMAIN-CONTAINING PROTEIN 17, ZBTB17
12036,604085,ZINC FINGER PROTEIN 154, ZNF154
12037,604086,ZINC FINGER PROTEIN 155, ZNF155
12038,604087,"CYTOCHROME P450, FAMILY 46, SUBFAMILY A, POLYPEPTIDE 1", CYP46A1
12039,604088,"PROTEIN PHOSPHATASE 1, REGULATORY SUBUNIT 17", PPP1R17
12040,604089,HEMATOPOIETIC CELL SIGNAL TRANSDUCER, HCST
12041,604090,DISCS LARGE MAGUK SCAFFOLD PROTEIN 5, DLG5
12042,604091,"HYPOALPHALIPOPROTEINEMIA, PRIMARY, 1",
12043,604092,TTK PROTEIN KINASE, TTK
12044,604093,KERATOSIS PILARIS ATROPHICANS, KPA
12045,604094,MITOTIC ARREST-DEFICIENT 2 LIKE 2, MAD2L2
12046,604095,ECTODYSPLASIN A RECEPTOR, EDAR
12047,604096,"GLUTAMATE RECEPTOR, METABOTROPIC, 6", GRM6
12048,604097,UROTENSIN II, UTS2
12049,604098,"SGT1 HOMOLOG, MIS12 KINETOCHORE COMPLEX ASSEMBLY COCHAPERONE", SUGT1
12050,604099,"GLUTAMATE RECEPTOR, METABOTROPIC, 2", GRM2
12051,604100,"GLUTAMATE RECEPTOR, METABOTROPIC, 4", GRM4
12052,604101,"GLUTAMATE RECEPTOR, METABOTROPIC, 7", GRM7
12053,604102,"GLUTAMATE RECEPTOR, METABOTROPIC, 5", GRM5
12054,604103,MYOTILIN, MYOT
12055,604104,"GLIA MATURATION FACTOR, GAMMA", GMFG
12056,604105,SYNAPTONEMAL COMPLEX PROTEIN 2, SYCP2
12057,604106,G PROTEIN-COUPLED RECEPTOR 52, GPR52
12058,604107,G PROTEIN-COUPLED RECEPTOR 55, GPR55
12059,604108,MICROTUBULE-ASSOCIATED PROTEIN 7, MAP7
12060,604109,HUMAN ENDOGENOUS RETROVIRUS-H LONG TERMINAL REPEAT-ASSOCIATING 1, HHLA1
12061,604110,ADHESION G PROTEIN-COUPLED RECEPTOR G1, ADGRG1
12062,604111,"POTASSIUM CHANNEL, VOLTAGE-GATED, SHAKER-RELATED SUBFAMILY, BETA MEMBER 3", KCNAB3
12063,604112,SCIELLIN, SCEL
12064,604113,INTERLEUKIN 18-BINDING PROTEIN, IL18BP
12065,604114,"PHOSPHOLIPASE C, BETA-2", PLCB2
12066,604115,KCNQ1-OPPOSITE STRAND/ANTISENSE TRANSCRIPT 1, KCNQ1OT1
12067,604116,CONE-ROD DYSTROPHY 3, CORD3
12068,604117,"VOHWINKEL SYNDROME, VARIANT FORM",
12069,604118,RAS PROTEIN ACTIVATOR-LIKE 1, RASAL1
12070,604119,"SOLUTE CARRIER FAMILY 12 (POTASSIUM/CHLORIDE TRANSPORTER), MEMBER 4", SLC12A4
12071,604120,"CHEMOKINE, CXC MOTIF, RECEPTOR 3",
12072,604121,"CEREBELLAR ATAXIA, DEAFNESS, AND NARCOLEPSY, AUTOSOMAL DOMINANT", ADCADN
12073,604122,PHOSPHATIDYLINOSITOL GLYCAN ANCHOR BIOSYNTHESIS CLASS B PROTEIN, PIGB
12074,604123,RIBONUCLEASE H1, RNASEH1
12075,604124,RETINOBLASTOMA-BINDING PROTEIN 8, RBBP8
12076,604125,"SULFOTRANSFERASE FAMILY 2B, MEMBER 1", SULT2B1
12077,604126,SUPERVILLIN, SVIL
12078,604127,T-BOX TRANSCRIPTION FACTOR 15, TBX15
12079,604128,"TRANSCRIPTION ELONGATION FACTOR A, 3", TCEA3
12080,604129,EPIDERMOLYSIS BULLOSA PRURIGINOSA,
12081,604130,UNDIFFERENTIATED EMBRYONIC CELL TRANSCRIPTION FACTOR 1, UTF1
12082,604131,ALPHA-THALASSEMIA,
12083,604132,G ANTIGEN 7,
12084,604133,"P ANTIGEN FAMILY, MEMBER 1",
12085,604134,"A DISINTEGRIN-LIKE AND METALLOPROTEASE WITH THROMBOSPONDIN TYPE 1 MOTIF, 13", ADAMTS13
12086,604135,NUCLEAR FACTOR ERYTHROID 2-LIKE 3, NFE2L3
12087,604136,INTERLEUKIN 24, IL24
12088,604137,VALYL-tRNA SYNTHETASE 1,
12089,604138,"G PROTEIN-COUPLED RECEPTOR, FAMILY C, GROUP 5, MEMBER A", GPRC5A
12090,604139,"DNAJ/HSP40 HOMOLOG, SUBFAMILY B, MEMBER 2", DNAJB2
12091,604140,DEATH INDUCER-OBLITERATOR 1, DIDO1
12092,604141,ADP-RIBOSYLATION FACTOR GUANINE NUCLEOTIDE EXCHANGE FACTOR 1, ARFGEF1
12093,604142,TYRO PROTEIN TYROSINE KINASE-BINDING PROTEIN, TYROBP
12094,604143,EXTRA SPINDLE POLES-LIKE 1, ESPL1
12095,604144,"SOLUTE CARRIER FAMILY 7 (CATIONIC AMINO ACID TRANSPORTER, y+ SYSTEM), MEMBER 9", SLC7A9
12096,604145,"CARDIOMYOPATHY, DILATED, 1G", CMD1G
12097,604146,SYNAPTOTAGMIN 7, SYT7
12098,604147,"PTTG1 REGULATOR OF SISTER CHROMATID SEPARATION, SECURIN", PTTG1
12099,604148,"SOLUTE CARRIER FAMILY 13 (SODIUM-DEPENDENT DICARBOXYLATE TRANSPORTER), MEMBER 2", SLC13A2
12100,604149,"SARCOGLYCAN, EPSILON", SGCE
12101,604150,"POLYMERASE II, RNA, SUBUNIT J", POLR2J
12102,604151,UBIQUITIN-CONJUGATING ENZYME E2 E3, UBE2E3
12103,604152,ORNITHINE DECARBOXYLASE ANTIZYME 2, OAZ2
12104,604153,NEUROMEDIN U RECEPTOR 1, NMUR1
12105,604154,ALZHEIMER DISEASE 15, AD15
12106,604155,LanC-LIKE 1, LANCL1
12107,604156,SECRETED FRIZZLED-RELATED PROTEIN 1, SFRP1
12108,604157,SECRETED FRIZZLED-RELATED PROTEIN 2, SFRP2
12109,604158,SECRETED FRIZZLED-RELATED PROTEIN 5, SFRP5
12110,604159,"SOLUTE CARRIER FAMILY 6 (NEUROTRANSMITTER TRANSPORTER, GLYCINE), MEMBER 5", SLC6A5
12111,604160,"INTEGRIN, BETA-8", ITGB8
12112,604161,KISS1 RECEPTOR, KISS1R
12113,604162,HEAT-SHOCK 70-KD PROTEIN 8,
12114,604163,RIBOSOMAL PROTEIN L3, RPL3
12115,604164,ONE CUT HOMEOBOX 1, ONECUT1
12116,604165,"SOLUTE CARRIER FAMILY 25 (MITOCHONDRIAL CARRIER, OXOGLUTARATE CARRIER), MEMBER 11", SLC25A11
12117,604166,RIBOSOMAL PROTEIN L7, RPL7
12118,604167,CCCTC-BINDING FACTOR, CTCF
12119,604168,"CONGENITAL CATARACTS, FACIAL DYSMORPHISM, AND NEUROPATHY", CCFDN
12120,604169,LEFT VENTRICULAR NONCOMPACTION 1, LVNC1
12121,604170,PHOSPHOLIPID SCRAMBLASE 1, PLSCR1
12122,604171,ALY/REF EXPORT FACTOR, ALYREF
12123,604172,CARONTE,
12124,604173,POIKILODERMA WITH NEUTROPENIA, PN
12125,604174,RIBOSOMAL PROTEIN L15, RPL15
12126,604175,RIBOSOMAL PROTEIN L11, RPL11
12127,604176,SUPPRESSOR OF CYTOKINE SIGNALING 3, SOCS3
12128,604177,RIBOSOMAL PROTEIN L8, RPL8
12129,604178,RIBOSOMAL PROTEIN L18A, RPL18A
12130,604179,RIBOSOMAL PROTEIN L18, RPL18
12131,604180,RIBOSOMAL PROTEIN L24, RPL24
12132,604181,RIBOSOMAL PROTEIN L37, RPL37
12133,604182,RIBOSOMAL PROTEIN L38, RPL38
12134,604183,"CHOLESTEATOMA, CONGENITAL",
12135,604184,PUTATIVE NEURONAL CELL ADHESION MOLECULE, PUNC
12136,604185,"FACIAL PARESIS, HEREDITARY CONGENITAL, 2", HCFP2
12137,604186,"CHEMOKINE, CXC MOTIF, LIGAND 14", CXCL14
12138,604187,"SPASTIC PARAPLEGIA 10, AUTOSOMAL DOMINANT", SPG10
12139,604188,SELENIUM-BINDING PROTEIN 1, SELENBP1
12140,604189,"DNAJ/HSP40 HOMOLOG, SUBFAMILY C, MEMBER 4", DNAJC4
12141,604190,"SOLUTE CARRIER FAMILY 22 (ORGANIC CATION TRANSPORTER), MEMBER 4", SLC22A4
12142,604191,ZINC FINGER PROTEIN 263, ZNF263
12143,604192,"SOLUTE CARRIER FAMILY 27 (FATTY ACID TRANSPORTER), MEMBER 2",
12144,604193,"SOLUTE CARRIER FAMILY 27 (FATTY ACID TRANSPORTER), MEMBER 3", SLC27A3
12145,604194,"SOLUTE CARRIER FAMILY 27 (FATTY ACID TRANSPORTER), MEMBER 4", SLC27A4
12146,604195,"SOLUTE CARRIER FAMILY 27 (FATTY ACID TRANSPORTER), MEMBER 5",
12147,604196,"SOLUTE CARRIER FAMILY 27 (FATTY ACID TRANSPORTER), MEMBER 6", SLC27A6
12148,604197,"5,10-METHENYLTETRAHYDROFOLATE SYNTHETASE", MTHFS
12149,604198,RAS-ASSOCIATED PROTEIN RAB11B, RAB11B
12150,604199,RAS-ASSOCIATED PROTEIN RAB35, RAB35
12151,604200,SIALIC ACID-BINDING IMMUNOGLOBULIN-LIKE LECTIN 5, SIGLEC5
12152,604201,"HEPATIC FIBROSIS, SEVERE, SUSCEPTIBILITY TO, DUE TO SCHISTOSOMA MANSONI INFECTION",
12153,604202,"SYNAPTOSOMAL-ASSOCIATED PROTEIN, 29-KD", SNAP29
12154,604203,SYNTAXIN 8, STX8
12155,604204,SYNTAXIN 17, STX17
12156,604205,COPINE I, CPNE1
12157,604206,COPINE II, CPNE2
12158,604207,COPINE III, CPNE3
12159,604208,COPINE IV, CPNE4
12160,604209,COPINE V, CPNE5
12161,604210,CRUMBS CELL POLARITY COMPLEX COMPONENT 1, CRB1
12162,604211,"HIRSCHSPRUNG DISEASE WITH HEART DEFECTS, LARYNGEAL ANOMALIES, AND PREAXIAL POLYDACTYLY",
12163,604212,POLYADENYLATE-SPECIFIC RIBONUCLEASE, PARN
12164,604213,CHUDLEY-MCCULLOUGH SYNDROME, CMCS
12165,604214,KRIT1 ANKYRIN REPEAT-CONTAINING PROTEIN 1, KRIT1
12166,604215,INHIBITOR OF GROWTH 2, ING2
12167,604216,"SOLUTE CARRIER FAMILY 17, MEMBER 4", SLC17A4
12168,604217,"SOLUTE CARRIER FAMILY 34 (SODIUM/PHOSPHATE COTRANSPORTER), MEMBER 2", SLC34A2
12169,604218,"ENCEPHALOPATHY, FAMILIAL, WITH NEUROSERPIN INCLUSION BODIES", FENIB
12170,604219,"CATARACT 9, MULTIPLE TYPES", CTRCT9
12171,604220,"ACTIN-RELATED PROTEIN 2/3 COMPLEX, SUBUNIT 1A", ARPC1A
12172,604221,ACTIN-RELATED PROTEIN 2, ACTR2
12173,604222,ACTIN-RELATED PROTEIN 3, ACTR3
12174,604223,"ACTIN-RELATED PROTEIN 2/3 COMPLEX, SUBUNIT 1B", ARPC1B
12175,604224,"ACTIN-RELATED PROTEIN 2/3 COMPLEX, SUBUNIT 2", ARPC2
12176,604225,"ACTIN-RELATED PROTEIN 2/3 COMPLEX, SUBUNIT 3", ARPC3
12177,604226,"ACTIN-RELATED PROTEIN 2/3 COMPLEX, SUBUNIT 4", ARPC4
12178,604227,"ACTIN-RELATED PROTEIN 2/3 COMPLEX, SUBUNIT 5", ARPC5
12179,604228,"GRISCELLI SYNDROME, TYPE 2",
12180,604229,ANTERIOR SEGMENT DYSGENESIS 5, ASGD5
12181,604230,"ADENOSINE DEAMINASE, tRNA-SPECIFIC, 1", ADAT1
12182,604231,PITUITARY TUMOR-TRANSFORMING GENE 2, PTTG2
12183,604232,LEBER CONGENITAL AMAUROSIS 3, LCA3
12184,604233,"GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 1", GEFSP1
12185,604234,"INTEGRIN, BETA-LIKE 1", ITGBL1
12186,604235,"SOLUTE CARRIER FAMILY 7 (CATIONIC AMINO ACID TRANSPORTER, y+ SYSTEM), MEMBER 8", SLC7A8
12187,604236,"GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 1",
12188,604237,CYTOKINE RECEPTOR-LIKE FACTOR 1, CRLF1
12189,604238,SNAIL FAMILY TRANSCRIPTIONAL REPRESSOR 1, SNAI1
12190,604239,PHOSPHOSERINE PHOSPHATASE-LIKE, PSPHL
12191,604240,"T-CELL LEUKEMIA, HOMEOBOX 2", TLX2
12192,604241,CD2-ASSOCIATED PROTEIN, CD2AP
12193,604242,RING FINGER PROTEIN 6, RNF6
12194,604243,G ANTIGEN 1,
12195,604244,G ANTIGEN 2C,
12196,604245,G ANTIGEN 3,
12197,604246,G ANTIGEN 4,
12198,604247,G ANTIGEN 5,
12199,604248,G ANTIGEN 6,
12200,604249,RETICULON 3, RTN3
12201,604250,"HEMOCHROMATOSIS, TYPE 3", HFE3
12202,604251,CALCINEURIN-BINDING PROTEIN 1,
12203,604252,BETA-SITE AMYLOID BETA A4 PRECURSOR PROTEIN-CLEAVING ENZYME 1, BACE1
12204,604253,"CASEIN KINASE I, GAMMA-3", CSNK1G3
12205,604254,"DYSLEXIA, SUSCEPTIBILITY TO, 3", DYX3
12206,604255,LADYBIRD HOMEOBOX 1, LBX1
12207,604256,"BASIC HELIX-LOOP-HELIX FAMILY, MEMBER E40", BHLHE40
12208,604257,CAMERA-MARUGO-COHEN SYNDROME,
12209,604258,DLC1 RHO GTPase ACTIVATING PROTEIN, DLC1
12210,604259,PLEXIN C1, PLXNC1
12211,604260,SIGNAL TRANSDUCER AND ACTIVATOR OF TRANSCRIPTION 5B, STAT5B
12212,604261,AUTOPHAGY-RELATED 5, ATG5
12213,604262,"AMYLOID BETA A4 PRECURSOR PROTEIN-BINDING, FAMILY A, MEMBER 3", APBA3
12214,604263,PRION-LIKE PROTEIN DOPPEL, PRND
12215,604264,CADHERIN EGF LAG SEVEN-PASS G-TYPE RECEPTOR 3, CELSR3
12216,604265,CADHERIN EGF LAG SEVEN-PASS G-TYPE RECEPTOR 2, CELSR2
12217,604266,MULTIPLE EPIDERMAL GROWTH FACTOR-LIKE DOMAINS 6, MEGF6
12218,604267,MULTIPLE EPIDERMAL GROWTH FACTOR-LIKE DOMAINS 8, MEGF8
12219,604268,MULTIPLE EPIDERMAL GROWTH FACTOR-LIKE DOMAINS 9, MEGF9
12220,604269,FAT ATYPICAL CADHERIN 2, FAT2
12221,604270,LOW DENSITY LIPOPROTEIN RECEPTOR-RELATED PROTEIN 4, LRP4
12222,604271,"GROWTH HORMONE INSENSITIVITY, PARTIAL", GHIP
12223,604272,SCO CYTOCHROME c OXIDASE ASSEMBLY PROTEIN 2, SCO2
12224,604273,"MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 1", MC5DN1
12225,604274,"KILLER CELL LECTIN-LIKE RECEPTOR A1, PSEUDOGENE", KLRA1P
12226,604275,"CATENIN, DELTA-2", CTNND2
12227,604276,PLAKOPHILIN 4, PKP4
12228,604277,SPASTIN, SPAST
12229,604278,PROXIMAL RENAL TUBULAR ACIDOSIS-OCULAR ANOMALY SYNDROME, PRTAO
12230,604279,JUNCTION-MEDIATING AND REGULATORY PROTEIN, JMY
12231,604280,PLEXIN A4, PLXNA4
12232,604281,DBF4 ZINC FINGER, DBF4
12233,604282,PLEXIN D1, PLXND1
12234,604283,PROTEOGLYCAN 4, PRG4
12235,604284,RENAL CYSTS AND DIABETES SYNDROME,
12236,604285,ALANINE-GLYOXYLATE AMINOTRANSFERASE, AGXT
12237,604286,"MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 4", LGMDR4
12238,604287,CARNEY TRIAD,
12239,604288,"CARDIOMYOPATHY, DILATED, 1H", CMD1H
12240,604289,RAD54 HOMOLOG B, RAD54B
12241,604290,ACERULOPLASMINEMIA, ACEP
12242,604291,"ASCARIS LUMBRICOIDES INFECTION, SUSCEPTIBILITY TO",
12243,604292,"ECTRODACTYLY, ECTODERMAL DYSPLASIA, AND CLEFT LIP/PALATE SYNDROME 3", EEC3
12244,604293,PLEXIN B2, PLXNB2
12245,604294,VENTRAL ANTERIOR HOMEOBOX 1, VAX1
12246,604295,VENTRAL ANTERIOR HOMEOBOX 2, VAX2
12247,604296,GLYOXYLATE REDUCTASE/HYDROXYPYRUVATE REDUCTASE, GRHPR
12248,604297,SYNAPTOJANIN 1, SYNJ1
12249,604298,SIGNAL TRANSDUCING ADAPTOR FAMILY MEMBER 1, STAP1
12250,604299,"ADAPTOR PROTEIN, PHOSPHOTYROSINE INTERACTION, PH DOMAIN, AND LEUCINE ZIPPER-CONTAINING PROTEIN 1", APPL1
12251,604300,2-HYDROXYACYL-CoA LYASE 1, HACL1
12252,604301,OCULOMEDIN, OCLM
12253,604302,"RHEUMATOID ARTHRITIS, SYSTEMIC JUVENILE",
12254,604303,ACTIN-LIKE 7A, ACTL7A
12255,604304,ACTIN-LIKE 7B, ACTL7B
12256,604305,"MAJOR HISTOCOMPATIBILITY COMPLEX, CLASS II, DQ BETA-1", HLA-DQB1
12257,604306,FAS APOPTOTIC INHIBITORY MOLECULE 2, FAIM2
12258,604307,"CATARACT 2, MULTIPLE TYPES", CTRCT2
12259,604308,MASS SYNDROME,
12260,604309,"SOLUTE CARRIER FAMILY 13 (SODIUM-DEPENDENT DICARBOXYLATE TRANSPORTER), MEMBER 4", SLC13A4
12261,604310,"BIOGENESIS OF LYSOSOME-RELATED ORGANELLES COMPLEX 1, SUBUNIT 6", BLOC1S6
12262,604311,MEDIATOR COMPLEX SUBUNIT 1, MED1
12263,604312,CYSTATIN 3, CST3
12264,604313,GALACTOKINASE 1, GALK1
12265,604314,BLEPHAROPHIMOSIS WITH FACIAL AND GENITAL ANOMALIES AND IMPAIRED INTELLECTUAL DEVELOPMENT,
12266,604315,"ANEMIA, CONGENITAL HYPOPLASTIC, WITH MULTIPLE CONGENITAL ANOMALIES/IMPAIRED INTELLECTUAL DEVELOPMENT SYNDROME",
12267,604316,"PSORIASIS 5, SUSCEPTIBILITY TO", PSORS5
12268,604317,"MICROCEPHALY 2, PRIMARY, AUTOSOMAL RECESSIVE, WITH OR WITHOUT CORTICAL MALFORMATIONS", MCPH2
12269,604318,GTF2I REPEAT DOMAIN-CONTAINING PROTEIN 1, GTF2IRD1
12270,604319,TERF1-INTERACTING NUCLEAR FACTOR 2, TINF2
12271,604320,"NEURONOPATHY, DISTAL HEREDITARY MOTOR, AUTOSOMAL RECESSIVE 1", HMNR1
12272,604321,"MICROCEPHALY 4, PRIMARY, AUTOSOMAL RECESSIVE", MCPH4
12273,604322,"SOLUTE CARRIER FAMILY 17 (ACIDIC SUGAR TRANSPORTER), MEMBER 5", SLC17A5
12274,604323,"ATP-BINDING CASSETTE, SUBFAMILY C, MEMBER 3", ABCC3
12275,604324,"ACNE, ADULT",
12276,604325,"PROTEIN PHOSPHATASE 2, REGULATORY SUBUNIT B, BETA", PPP2R2B
12277,604326,SPINOCEREBELLAR ATAXIA 12, SCA12
12278,604327,"BETA-1,4-GALACTOSYLTRANSFERASE 7", B4GALT7
12279,604328,STRUCTURE-SPECIFIC RECOGNITION PROTEIN 1, SSRP1
12280,604329,"HYPERTENSION, ESSENTIAL, SUSCEPTIBILITY TO, 2",
12281,604330,GRB2-RELATED ADAPTOR PROTEIN, GRAP
12282,604331,INTEGRATOR COMPLEX SUBUNIT 6, INTS6
12283,604332,CYSTEINE-RICH HYDROPHOBIC DOMAIN PROTEIN 2, CHIC2
12284,604333,WD40 REPEAT-CONTAINING PROTEIN CIAO1, CIAO1
12285,604334,UBIQUITIN-SPECIFIC PROTEASE 6, USP6
12286,604335,REFLEX SYMPATHETIC DYSTROPHY,
12287,604336,TRANSMEMBRANE PHOSPHATASE WITH TENSIN HOMOLOGY, TPTE
12288,604337,"CHLORIDE CHANNEL ACCESSORY 3, PSEUDOGENE", CLCA3P
12289,604338,TITLE NOT AVAILABLE AT THIS MOMENT,
12290,604339,TITLE NOT AVAILABLE AT THIS MOMENT,
12291,604340,TITLE NOT AVAILABLE AT THIS MOMENT,
12292,604341,TITLE NOT AVAILABLE AT THIS MOMENT,
12293,604342,TITLE NOT AVAILABLE AT THIS MOMENT,
12294,604343,TITLE NOT AVAILABLE AT THIS MOMENT,
12295,604344,"MANNOSIDASE, ALPHA, CLASS 1A, MEMBER 1", MAN1A1
12296,604345,"MANNOSIDASE, ALPHA, CLASS 1A, MEMBER 2", MAN1A2
12297,604346,"MANNOSIDASE, ALPHA, CLASS 1B, MEMBER 1", MAN1B1
12298,604347,ZINC FINGER RANBP2-TYPE DOMAIN-CONTAINING PROTEIN 2, ZRANB2
12299,604348,"ADVANCED SLEEP PHASE SYNDROME, FAMILIAL, 1", FASPS1
12300,604349,"LAMININ, GAMMA-3", LAMC3
12301,604350,RAS-ASSOCIATED PROTEIN RAB3D, RAB3D
12302,604351,PHD FINGER PROTEIN 2, PHF2
12303,604352,"FEBRILE SEIZURES, FAMILIAL, 4", FEB4
12304,604353,CYSTEINE- AND HISTIDINE-RICH DOMAIN-CONTAINING PROTEIN 1, CHORDC1
12305,604354,NUCLEAR FMRP-INTERACTING PROTEIN 1, NUFIP1
12306,604355,"COATOMER PROTEIN COMPLEX, SUBUNIT GAMMA-2", COPG2
12307,604356,DUANE RETRACTION SYNDROME 2, DURS2
12308,604357,MAB21-LIKE 2, MAB21L2
12309,604358,STROMAL ANTIGEN 1, STAG1
12310,604359,STROMAL ANTIGEN 2,
12311,604360,"SPASTIC PARAPLEGIA 11, AUTOSOMAL RECESSIVE", SPG11
12312,604361,"FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, 3A, WITH OR WITHOUT EXTRAOCULAR INVOLVEMENT",
12313,604362,LIM DOMAIN ONLY 7, LMO7
12314,604363,"MYOCLONIC EPILEPSY, CONGENITAL DEAFNESS, MACULAR DYSTROPHY, AND PSYCHIATRIC DISORDERS",
12315,604364,"EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 1", FFEVF1
12316,604365,PROMININ 1, PROM1
12317,604366,"DYNEIN, AXONEMAL, INTERMEDIATE CHAIN 1", DNAI1
12318,604367,"LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 3", FPLD3
12319,604368,GLYCOPROTEIN NMB, GPNMB
12320,604369,SALLA DISEASE, SD
12321,604370,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1", BROVCA1
12322,604371,HUMAN ENDOGENOUS RETROVIRUS-H LONG TERMINAL REPEAT-ASSOCIATING 2, HHLA2
12323,604372,HUMAN ENDOGENOUS RETROVIRUS-H LONG TERMINAL REPEAT-ASSOCIATING 3, HHLA3
12324,604373,CHECKPOINT KINASE 2, CHEK2
12325,604374,"METALLOTHIONEIN-LIKE 5, TESTIS-SPECIFIC", MTL5
12326,604375,HUMAN GROWTH FACTOR-REGULATED TYROSINE KINASE SUBSTRATE, HGS
12327,604376,MYELIN PROTEIN ZERO-LIKE 1, MPZL1
12328,604377,"MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 2", MC4DN2
12329,604378,BECLIN 1, BECN1
12330,604379,HYPOTRICHOSIS 7, HYPT7
12331,604380,ULNAR RAY DYSGENESIS WITH POSTAXIAL POLYDACTYLY AND RENAL CYSTIC DYSPLASIA,
12332,604381,PATENT DUCTUS ARTERIOSUS AND BICUSPID AORTIC VALVE WITH HAND ANOMALIES,
12333,604382,"LISSENCEPHALY, FAMILIAL, WITH CLEFT PALATE AND CEREBELLAR HYPOPLASIA",
12334,604383,GROWTH FACTOR-INDEPENDENT 1B, GFI1B
12335,604384,"ATPase, Ca(2+)-TRANSPORTING, TYPE 2C, MEMBER 1", ATP2C1
12336,604385,"SODIUM VOLTAGE-GATED CHANNEL, ALPHA SUBUNIT 11", SCN11A
12337,604386,"TRANSCRIPTIONAL REPRESSOR, GATA-BINDING 1", TRPS1
12338,604387,NEPHRONOPHTHISIS 3, NPHP3
12339,604388,"GUANINE NUCLEOTIDE-BINDING PROTEIN, GAMMA-4", GNG4
12340,604389,"GUANINE NUCLEOTIDE-BINDING PROTEIN, GAMMA-10", GNG10
12341,604390,"GUANINE NUCLEOTIDE-BINDING PROTEIN, GAMMA-11", GNG11
12342,604391,ATAXIA-TELANGIECTASIA-LIKE DISORDER 1, ATLD1
12343,604392,ARYLHYDROCARBON-INTERACTING RECEPTOR PROTEIN-LIKE 1, AIPL1
12344,604393,LEBER CONGENITAL AMAUROSIS 4, LCA4
12345,604394,"GUANINE NUCLEOTIDE-BINDING PROTEIN, ALPHA-12", GNA12
12346,604395,DNA MISMATCH REPAIR PROTEIN MLH3, MLH3
12347,604396,"SET DOMAIN PROTEIN, BIFURCATED, 1", SETDB1
12348,604397,"GUANINE NUCLEOTIDE-BINDING PROTEIN, ALPHA-14", GNA14
12349,604398,"SECRETOGLOBIN, FAMILY 2A, MEMBER 1", SCGB2A1
12350,604399,"PROTEIN PHOSPHATASE 1, REGULATORY SUBUNIT 1B", PPP1R1B
12351,604400,"ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 5", ARVD5
12352,604401,"ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 6", ARVD6
12353,604402,"ST3 BETA-GALACTOSIDE ALPHA-2,3-SIALYLTRANSFERASE 5", ST3GAL5
12354,604403,"GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 2", GEFSP2
12355,604404,GLYPICAN 6, GPC6
12356,604405,SIALIC ACID-BINDING IMMUNOGLOBULIN-LIKE LECTIN 6, SIGLEC6
12357,604406,"GUANINE NUCLEOTIDE-BINDING PROTEIN, ALPHA-13", GNA13
12358,604407,LEUCINE ZIPPER/EF-HAND-CONTAINING TRANSMEMBRANE PROTEIN 1, LETM1
12359,604408,"GA-BINDING PROTEIN TRANSCRIPTION FACTOR, BETA SUBUNIT",
12360,604409,GLUCOCORTICOID MODULATORY ELEMENT-BINDING PROTEIN 1, GMEB1
12361,604410,SIALIC ACID-BINDING IMMUNOGLOBULIN-LIKE LECTIN 7, SIGLEC7
12362,604411,INNER CENTROMERE PROTEIN, INCENP
12363,604412,T-CELL LEUKEMIA/LYMPHOMA 6, TCL6
12364,604413,T-CELL LEUKEMIA/LYMPHOMA 6,
12365,604414,"POLYMERASE II, RNA, SUBUNIT F", POLR2F
12366,604415,STEAP FAMILY MEMBER 1, STEAP1
12367,604416,"PYOGENIC STERILE ARTHRITIS, PYODERMA GANGRENOSUM, AND ACNE", PAPA
12368,604417,ALF TRANSCRIPTION ELONGATION FACTOR 4, AFF4
12369,604418,"GAP JUNCTION PROTEIN, BETA-6", GJB6
12370,604419,"POLYMERASE, DNA, THETA", POLQ
12371,604420,HEMATOPOIETICALLY EXPRESSED HOMEOBOX, HHEX
12372,604421,PHOSDUCIN-LIKE, PDCL
12373,604422,PANCREATIC LIPASE-RELATED PROTEIN 1, PNLIPRP1
12374,604423,PANCREATIC LIPASE-RELATED PROTEIN 2, PNLIPRP2
12375,604424,HOMEODOMAIN-INTERACTING PROTEIN KINASE 3, HIPK3
12376,604425,LIM HOMEOBOX GENE 8, LHX8
12377,604426,"CYTOCHROME P450, FAMILY 4, SUBFAMILY F, POLYPEPTIDE 2", CYP4F2
12378,604427,"SODIUM VOLTAGE-GATED CHANNEL, ALPHA SUBUNIT 10", SCN10A
12379,604428,PROLINE-RICH GAMMA-CARBOXYGLUTAMIC ACID PROTEIN 1,
12380,604429,PROLINE-RICH GAMMA-CARBOXYGLUTAMIC ACID PROTEIN 2, PRRG2
12381,604430,"GUANINE NUCLEOTIDE-BINDING PROTEIN, GAMMA-7", GNG7
12382,604431,"POLYNEUROPATHY, LETHAL NEONATAL, AXONAL SENSORIMOTOR, AUTOSOMAL RECESSIVE",
12383,604432,SPINOCEREBELLAR ATAXIA 11, SCA11
12384,604433,"POTASSIUM CHANNEL, VOLTAGE-GATED, ISK-RELATED SUBFAMILY, MEMBER 3", KCNE3
12385,604434,KALLIKREIN-RELATED PEPTIDASE 11, KLK11
12386,604435,CHARGED MULTIVESICULAR BODY PROTEIN 1A,
12387,604436,PYRIDOXAL PHOSPHATE-BINDING PROTEIN, PLPBP
12388,604437,"SOLUTE CARRIER FAMILY 38 (AMINO ACID TRANSPORTER), MEMBER 3", SLC38A3
12389,604438,KALLIKREIN-RELATED PEPTIDASE 7, KLK7
12390,604439,GRB2-ASSOCIATED BINDING PROTEIN 1, GAB1
12391,604440,CELL DEATH-INDUCING DFFA-LIKE EFFECTOR A, CIDEA
12392,604441,CELL DEATH-INDUCING DFFA-LIKE EFFECTOR B, CIDEB
12393,604442,"RENAL CELL CARCINOMA, NONPAPILLARY",
12394,604443,"ACYL-CoA SYNTHETASE LONG CHAIN FAMILY, MEMBER 6", ACSL6
12395,604444,BMP AND ACTIVIN MEMBRANE-BOUND INHIBITOR, BAMBI
12396,604445,PROTEASE INHIBITOR 13, PI13
12397,604446,PHOSPHOTRIESTERASE-RELATED PROTEIN, PTER
12398,604447,"GUANINE NUCLEOTIDE-BINDING PROTEIN, BETA-5", GNB5
12399,604448,CYTOHESIN 1-INTERACTING PROTEIN, CYTIP
12400,604449,"PROTEASOME 26S SUBUNIT, NON-ATPase, 11", PSMD11
12401,604450,"PROTEASOME 26S SUBUNIT, NON-ATPase, 12", PSMD12
12402,604451,"BASAL CELL CARCINOMA, INFUNDIBULOCYSTIC",
12403,604452,"PROTEASOME 26S SUBUNIT, NON-ATPase, 5", PSMD5
12404,604453,"NUCLEAR RECEPTOR SUBFAMILY 5, GROUP A, MEMBER 2", NR5A2
12405,604454,WELANDER DISTAL MYOPATHY, WDM
12406,604455,SARCOSINE DEHYDROGENASE, SARDH
12407,604456,INTERFERON-INDUCED TRANSMEMBRANE PROTEIN 1, IFITM1
12408,604457,NUCLEAR BODY PROTEIN SP110, SP110
12409,604458,NUCLEAR BODY PROTEIN SP110,
12410,604459,INTERLEUKIN 1 RECEPTOR-ASSOCIATED KINASE 3, IRAK3
12411,604460,FAS-ASSOCIATED FACTOR 1, FAF1
12412,604461,HUMAN PAPILLOMAVIRUS TYPE 6A INTEGRATION SITE 1, HPV6AI1
12413,604462,SEMAPHORIN 4C, SEMA4C
12414,604463,CD160 ANTIGEN, CD160
12415,604464,INTERSECTIN 2, ITSN2
12416,604465,"SH3 DOMAIN, GRB2-LIKE, 2", SH3GL2
12417,604466,"METHYLTRANSFERASE 1, tRNA METHYLGUANOSINE", METTL1
12418,604467,MONOCYTE-TO-MACROPHAGE DIFFERENTIATION-ASSOCIATED PROTEIN, MMD
12419,604468,MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 6, MAP3K6
12420,604469,EXOCYST COMPLEX COMPONENT 5, EXOC5
12421,604470,CD2 ANTIGEN-BINDING PROTEIN 2, CD2BP2
12422,604471,"SOLUTE CARRIER FAMILY 1 (GLUTAMATE TRANSPORTER), MEMBER 7", SLC1A7
12423,604472,"TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY, MEMBER 13", TNFSF13
12424,604473,"GLUTAMATE RECEPTOR, METABOTROPIC, 1", GRM1
12425,604474,"HUMAN HERPESVIRUS TYPE 6, INTEGRATED",
12426,604475,RETICULON 4, RTN4
12427,604476,RAS-ASSOCIATED PROTEIN RAB3D,
12428,604477,CHROMOBOX 3, CBX3
12429,604478,CHROMOBOX 5, CBX5
12430,604479,SIRTUIN 1, SIRT1
12431,604480,SIRTUIN 2, SIRT2
12432,604481,SIRTUIN 3, SIRT3
12433,604482,SIRTUIN 4, SIRT4
12434,604483,SIRTUIN 5, SIRT5
12435,604484,"NEUROPATHY, HEREDITARY MOTOR AND SENSORY, OKINAWA TYPE", HMSNO
12436,604485,"NUCLEAR RECEPTOR SUBFAMILY 2, GROUP E, MEMBER 3", NR2E3
12437,604486,"PEPTIDYL-PROLYL CIS/TRANS ISOMERASE, MITOCHONDRIAL", PPIF
12438,604487,OTOGELIN, OTOG
12439,604488,TITIN-CAP, TCAP
12440,604489,ALPHA-METHYLACYL-CoA RACEMASE, AMACR
12441,604490,SACSIN, SACS
12442,604491,CAS-BR-M MURINE ECOTROPIC RETROVIRAL TRANSFORMING SEQUENCE B, CBLB
12443,604492,VOLTAGE-DEPENDENT ANION CHANNEL 1, VDAC1
12444,604493,"GAP JUNCTION PROTEIN, BETA-5", GJB5
12445,604494,INTERLEUKIN 18 RECEPTOR 1, IL18R1
12446,604495,"NUCLEAR FACTOR KAPPA-B INHIBITOR, BETA", NFKBIB
12447,604496,NFKB INHIBITOR-INTERACTING RAS-LIKE PROTEIN 1, NKIRAS1
12448,604497,NFKB INHIBITOR-INTERACTING RAS-LIKE PROTEIN 2, NKIRAS2
12449,604498,"AMEGAKARYOCYTIC THROMBOCYTOPENIA, CONGENITAL, 1", CAMT1
12450,604499,"HYPERLIPIDEMIA, FAMILIAL COMBINED, 2", FCHL2
12451,604500,ZINC FINGER HIT DOMAIN-CONTAINING PROTEIN 3, ZNHIT3
12452,604501,THYROID HORMONE RECEPTOR INTERACTOR 4, TRIP4
12453,604502,HIGH MOBILITY GROUP NUCLEOSOMAL BINDING PROTEIN 3, HMGN3
12454,604503,JUMONJI DOMAIN-CONTAINING PROTEIN 1C, JMJD1C
12455,604504,THYROID HORMONE RECEPTOR INTERACTOR 10, TRIP10
12456,604505,THYROID HORMONE RECEPTOR INTERACTOR 11, TRIP11
12457,604506,THYROID HORMONE RECEPTOR INTERACTOR 12, TRIP12
12458,604507,THYROID HORMONE RECEPTOR INTERACTOR 13, TRIP13
12459,604508,"COP9 SIGNALOSOME, SUBUNIT 2", COPS2
12460,604509,INTERLEUKIN 18 RECEPTOR ACCESSORY PROTEIN, IL18RAP
12461,604510,HYALURONOGLUCOSAMINIDASE 4, HYAL4
12462,604511,CHROMOBOX 1, CBX1
12463,604512,INTERLEUKIN 1 RECEPTOR-LIKE 2, IL1RL2
12464,604513,CD84 ANTIGEN, CD84
12465,604514,SH2 DOMAIN PROTEIN 2A, SH2D2A
12466,604515,B-CELL LINKER PROTEIN, BLNK
12467,604516,"IMMUNOGLOBULIN SUPERFAMILY, MEMBER 2", IGSF2
12468,604517,"PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR-GAMMA, COACTIVATOR 1, ALPHA", PPARGC1A
12469,604518,GRB2-RELATED ADAPTOR PROTEIN 2, GRAP2
12470,604519,INFLAMMATORY BOWEL DISEASE 3, IBD3
12471,604520,"TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY, MEMBER 14", TNFSF14
12472,604521,"3-HYDROXYANTHRANILATE 3,4-DIOXYGENASE", HAAO
12473,604522,"DEFENSIN, ALPHA, 3", DEFA3
12474,604523,CADHERIN EGF LAG SEVEN-PASS G-TYPE RECEPTOR 1, CELSR1
12475,604524,LYMPHOCYTE ANTIGEN 75, LY75
12476,604525,HISTAMINE RECEPTOR H3, HRH3
12477,604526,"ISOCITRATE DEHYDROGENASE, NAD(+), 3, NONCATALYTIC SUBUNIT BETA", IDH3B
12478,604527,"POTASSIUM CHANNEL, VOLTAGE-GATED, SUBFAMILY H, MEMBER 3", KCNH3
12479,604528,"POTASSIUM CHANNEL, VOLTAGE-GATED, SUBFAMILY H, MEMBER 4", KCNH4
12480,604529,ORTHOPEDIA HOMEOBOX, OTP
12481,604530,NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 1, NCR1
12482,604531,NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 2, NCR2
12483,604532,POLYCYSTIN 2-LIKE 1, PKD2L1
12484,604533,INTERFERON-STIMULATED EXONUCLEASE GENE 20, ISG20
12485,604534,CD83 ANTIGEN, CD83
12486,604535,KINESIN FAMILY MEMBER C3, KIFC3
12487,604536,ECTODERMAL DYSPLASIA/SKIN FRAGILITY SYNDROME, EDSFS
12488,604537,LEBER CONGENITAL AMAUROSIS 5, LCA5
12489,604538,KINESIN FAMILY MEMBER 2C, KIF2C
12490,604539,"A DISINTEGRIN-LIKE AND METALLOPROTEINASE WITH THROMBOSPONDIN TYPE 1 MOTIF, 2", ADAMTS2
12491,604540,"KERATIN 36, TYPE I", KRT36
12492,604541,"KERATIN 37, TYPE I", KRT37
12493,604542,"KERATIN 38, TYPE I", KRT38
12494,604543,LIM DOMAIN-CONTAINING PROTEIN 1, LIMD1
12495,604544,LEUCYL-tRNA SYNTHETASE 2, LARS2
12496,604545,KARYOPHERIN ALPHA-5, KPNA5
12497,604546,TONSOKU-LIKE DNA REPAIR PROTEIN, TONSL
12498,604547,"VAN DER WOUDE SYNDROME 1, MODIFIER OF",
12499,604548,"NUCLEAR FACTOR KAPPA-B INHIBITOR, EPSILON", NFKBIE
12500,604549,"PHOSPHORYLASE KINASE, TESTIS/LIVER, GAMMA-2",
12501,604550,DENSITY-REGULATED PROTEIN, DENR
12502,604551,CHOLESTEROL 25-HYDROXYLASE, CH25H
12503,604552,HEPATOCYTE GROWTH FACTOR ACTIVATOR, HGFAC
12504,604553,HEAT-SHOCK FACTOR-BINDING PROTEIN 1, HSBP1
12505,604554,HEAT-SHOCK TRANSCRIPTION FACTOR 2-BINDING PROTEIN, HSF2BP
12506,604555,CADHERIN 10, CDH10
12507,604556,DUAL-SPECIFICITY TYROSINE PHOSPHORYLATION-REGULATED KINASE 1B, DYRK1B
12508,604557,ZINC FINGER PROTEIN 423, ZNF423
12509,604558,INDUCIBLE T-CELL COSTIMULATOR, ICOS
12510,604559,"PROGRESSIVE FAMILIAL HEART BLOCK, TYPE IB", PFHB1B
12511,604560,"NUCLEAR RECEPTOR SUBFAMILY 5, GROUP A, MEMBER 2",
12512,604561,"ALPHA-1,3-MANNOSYL-GLYCOPROTEIN BETA-1,4-N-ACETYLGLUCOSAMINYLTRANSFERASE, ISOZYME B", MGAT4B
12513,604562,APOPTOTIC CHROMATIN CONDENSATION INDUCER 1, ACIN1
12514,604563,"CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 4B2", CMT4B2
12515,604564,"GLUTATHIONE S-TRANSFERASE, MICROSOMAL, 3", MGST3
12516,604565,ALG5 DOLICHYL-PHOSPHATE BETA-GLUCOSYLTRANSFERASE, ALG5
12517,604566,"ALG6 ALPHA-1,3-GLUCOSYLTRANSFERASE", ALG6
12518,604567,"DOUBLE C2-LIKE DOMAIN-CONTAINING PROTEIN, ALPHA", DOC2A
12519,604568,"DOUBLE C2-LIKE DOMAIN-CONTAINING PROTEIN, BETA", DOC2B
12520,604569,CONTACTIN-ASSOCIATED PROTEIN-LIKE 2, CNTNAP2
12521,604570,SHROOM FAMILY MEMBER 3, SHROOM3
12522,604571,MHC CLASS I DEFICIENCY 1, MHC1D1
12523,604572,"DNAJ/HSP40 HOMOLOG, SUBFAMILY B, MEMBER 1", DNAJB1
12524,604573,ATP SYNTHASE MEMBRANE SUBUNIT 6.8PL, ATP5MPL
12525,604574,FERRIC CHELATE REDUCTASE 1-LIKE, FRRS1L
12526,604575,ZINC FINGER HIT DOMAIN-CONTAINING PROTEIN 2, ZNHIT2
12527,604576,ERGOSTEROL BIOSYNTHESIS 28 HOMOLOG, ERG28
12528,604577,BLOOD VESSEL EPICARDIAL SUBSTANCE, BVES
12529,604578,ABSENT IN MELANOMA 2, AIM2
12530,604579,FRIZZLED CLASS RECEPTOR 4, FZD4
12531,604580,FIBULIN 5, FBLN5
12532,604581,"AFG3-LIKE MATRIX AAA PEPTIDASE, SUBUNIT 2", AFG3L2
12533,604582,PALM2 AND AKAP2 FUSION GENE,  PALM2AKAP2
12534,604583,PROGRAMMED CELL DEATH 5, PDCD5
12535,604584,PLATELET-DERIVED GROWTH FACTOR RECEPTOR-LIKE, PDGFRL
12536,604585,NUCLEAR BODY PROTEIN SP100, SP100
12537,604586,SYNTAXIN-BINDING PROTEIN 5, STXBP5
12538,604587,CALCIUM BINDING AND COILED-COIL DOMAIN PROTEIN 2, CALCOCO2
12539,604588,NIMA-RELATED KINASE 1, NEK1
12540,604589,BROMODOMAIN-CONTAINING PROTEIN 1, BRD1
12541,604590,Fc FRAGMENT OF IgG RECEPTOR IIb, FCGR2B
12542,604591,PHOSPHATIDYLETHANOLAMINE-BINDING PROTEIN 1, PEBP1
12543,604592,T CELL IMMUNE REGULATOR 1, TCIRG1
12544,604593,KINESIN FAMILY MEMBER 5C, KIF5C
12545,604594,CYSTEINE-RICH PDZ DOMAIN-BINDING PROTEIN, CRIPT
12546,604595,CHOLESTEROL LEVEL QUANTITATIVE TRAIT LOCUS 1,
12547,604596,F-BOX AND WD REPEAT DOMAIN 10B, FBXW10B
12548,604597,GLUTAMATE RECEPTOR-INTERACTING PROTEIN 1, GRIP1
12549,604598,OXIDATIVE STRESS-INDUCED GROWTH INHIBITOR FAMILY MEMBER 2, OSGIN2
12550,604599,EUCHROMATIC HISTONE-LYSINE N-METHYLTRANSFERASE 2, EHMT2
12551,604600,"TRANSIENT RECEPTOR POTENTIAL CATION CHANNEL, SUBFAMILY M, MEMBER 5", TRPM5
12552,604601,"TRANSLATIONAL RELEASE FACTOR, MITOCHONDRIAL, 1", MTRF1
12553,604602,"RIBOSOME-RECYCLING FACTOR, MITOCHONDRIAL", MRRF
12554,604603,MYOFERLIN, MYOF
12555,604604,"SOLUTE CARRIER FAMILY 30 (ZINC TRANSPORTER), MEMBER 9", SLC30A9
12556,604605,KALIRIN, KALRN
12557,604606,ODORANT-BINDING PROTEIN 2B, OBP2B
12558,604607,HOMEOBOX B13, HOXB13
12559,604608,MUCIN 12,
12560,604609,MUCIN 12, MUC12
12561,604610,RECQ PROTEIN-LIKE 3, RECQL3
12562,604611,RECQ PROTEIN-LIKE 2, RECQL2
12563,604612,NK2 HOMEOBOX 2, NKX2-2
12564,604613,T-BOX TRANSCRIPTION FACTOR 18, TBX18
12565,604614,T-BOX TRANSCRIPTION FACTOR 19, TBX19
12566,604615,EOMESODERMIN, EOMES
12567,604616,"T-BOX, BRAIN, 1", TBR1
12568,604617,NEURAMINIDASE 3, NEU3
12569,604618,NITRILASE 1, NIT1
12570,604619,"LEUCINE-RICH GENE, GLIOMA-INACTIVATED, 1", LGI1
12571,604620,G PROTEIN-COUPLED RECEPTOR 65, GPR65
12572,604621,"BETA-1,4-MANNOSYL-GLYCOPROTEIN BETA-1,4-N-ACETYLGLUCOSAMINYLTRANSFERASE", MGAT3
12573,604622,PHACE ASSOCIATION,
12574,604623,"ALPHA-1,3-MANNOSYL-GLYCOPROTEIN BETA-1,4-N-ACETYLGLUCOSAMINYLTRANSFERASE, ISOZYME A", MGAT4A
12575,604624,HEAT-SHOCK 27-KD PROTEIN 3, HSPB3
12576,604625,"TOOTH AGENESIS, SELECTIVE, 3", STHAG3
12577,604626,MALIC ENZYME 3, ME3
12578,604627,INTERLEUKIN 17B, IL17B
12579,604628,INTERLEUKIN 17C, IL17C
12580,604629,MATRIX METALLOPROTEINASE 20, MMP20
12581,604630,"NUCLEAR RECEPTOR SUBFAMILY 0, GROUP B, MEMBER 2", NR0B2
12582,604631,VESICLE AMINE TRANSPORT PROTEIN 1, VAT1
12583,604632,VAC14 COMPONENT OF PIKFYVE COMPLEX, VAC14
12584,604633,EGF-CONTAINING FIBULIN-LIKE EXTRACELLULAR MATRIX PROTEIN 2, EFEMP2
12585,604634,TRANSGELIN 2, TAGLN2
12586,604635,NEUREXOPHILIN 2, NXPH2
12587,604636,NEUREXOPHILIN 3, NXPH3
12588,604637,NEUREXOPHILIN 4, NXPH4
12589,604638,"ACTININ, ALPHA-4", ACTN4
12590,604639,NEUREXOPHILIN 1, NXPH1
12591,604640,T-CELL LEUKEMIA HOMEOBOX 3, TLX3
12592,604641,MITOGEN-ACTIVATED PROTEIN KINASE 8-INTERACTING PROTEIN 1, MAPK8IP1
12593,604642,CARBONIC ANHYDRASE X, CA10
12594,604643,NEUROPEPTIDE FF-AMIDE PEPTIDE, NPFF
12595,604644,CARBONIC ANHYDRASE XI, CA11
12596,604645,"PHOSPHODIESTERASE 7B, cAMP-SPECIFIC, HIGH AFFINITY", PDE7B
12597,604646,"NUCLEOPORIN, 50-KD", NUP50
12598,604647,CALCYON, CALY
12599,604648,T-BOX TRANSCRIPTION FACTOR 10, TBX10
12600,604649,TUBULIN-SPECIFIC CHAPERONE D, TBCD
12601,604650,INTERFERON-INDUCED PROTEIN WITH TETRATRICOPEPTIDE REPEATS 3, IFIT3
12602,604651,GROWTH/DIFFERENTIATION FACTOR 7, GDF7
12603,604652,TRANSCRIPTION FACTOR 7-LIKE 1, TCF7L1
12604,604653,"SOLUTE CARRIER FAMILY 40 (IRON-REGULATED TRANSPORTER), MEMBER 1", SLC40A1
12605,604654,5-HYDROXYTRYPTAMINE RECEPTOR 3B, HTR3B
12606,604655,MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 14, MAP3K14
12607,604656,FORMIN-LIKE 1, FMNL1
12608,604657,"TRANSMEMBRANE 4 SUPERFAMILY, MEMBER 5", TM4SF5
12609,604658,"TRANSMEMBRANE 7 SUPERFAMILY, MEMBER 1", TM7SF1
12610,604659,"ENDOGENOUS RETROVIRAL FAMILY W, MEMBER 1", ERVW1
12611,604660,POTASSIUM CHANNEL-INTERACTING PROTEIN 1, KCNIP1
12612,604661,POTASSIUM CHANNEL-INTERACTING PROTEIN 2, KCNIP2
12613,604662,POTASSIUM CHANNEL-INTERACTING PROTEIN 3, KCNIP3
12614,604663,"WINGLESS-TYPE MMTV INTEGRATION SITE FAMILY, MEMBER 6", WNT6
12615,604664,INTERFERON-GAMMA-INDUCIBLE PROTEIN 30, IFI30
12616,604665,"COP9 SIGNALOSOME, SUBUNIT 3", COPS3
12617,604666,MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE KINASE 4, MAP4K4
12618,604667,CALCIUM-DEPENDENT ACTIVATOR PROTEIN FOR SECRETION, CADPS
12619,604668,ZINC FINGER PROTEIN 264, ZNF264
12620,604669,POLYCYSTIN 2-LIKE 2, PKD2L2
12621,604670,POLYCYSTIN AND SEA URCHIN REJ HOMOLOG-LIKE, PKDREJ
12622,604671,JUMPING TRANSLOCATION BREAKPOINT, JTB
12623,604672,CD209 ANTIGEN, CD209
12624,604673,"INOSITOL 1,4,5-TRIPHOSPHATE RECEPTOR ASSOCIATED 1", IRAG1
12625,604674,HES-RELATED FAMILY bHLH TRANSCRIPTION FACTOR WITH YRPW MOTIF 2, HEY2
12626,604675,PAIRED-RELATED HOMEOBOX GENE 2, PRRX2
12627,604676,HLA COMPLEX P5 GENE, HCP5
12628,604677,CERAMIDE TRANSPORTER 1, CERT1
12629,604678,"TRANSMEMBRANE 9 SUPERFAMILY, MEMBER 2", TM9SF2
12630,604679,"POLYADENYLATE-BINDING PROTEIN, CYTOPLASMIC, 1", PABPC1
12631,604680,"POLYADENYLATE-BINDING PROTEIN, CYTOPLASMIC, 3", PABPC3
12632,604681,"POLYADENYLATE-BINDING PROTEIN, CYTOPLASMIC, 3",
12633,604682,"INTEGRIN, ALPHA-E", ITGAE
12634,604683,KINESIN FAMILY MEMBER 3A, KIF3A
12635,604684,MLLT11 TRANSCRIPTION FACTOR 7 COFACTOR, MLLT11
12636,604685,HOMEOBOX A2, HOXA2
12637,604686,A-KINASE ANCHOR PROTEIN 13, AKAP13
12638,604687,PROSTAGLANDIN D2 RECEPTOR, PTGDR
12639,604688,A-KINASE ANCHOR PROTEIN 5, AKAP5
12640,604689,A-KINASE ANCHOR PROTEIN 3, AKAP3
12641,604690,"GROWTH AND DEVELOPMENTAL RETARDATION, OCULAR PTOSIS, CARDIAC DEFECT, AND ANAL ATRESIA",
12642,604691,A-KINASE ANCHOR PROTEIN 6, AKAP6
12643,604692,A-KINASE ANCHOR PROTEIN 8, AKAP8
12644,604693,A-KINASE ANCHOR PROTEIN 7, AKAP7
12645,604694,A-KINASE ANCHOR PROTEIN 10, AKAP10
12646,604695,ADP-RIBOSYLATION FACTOR-LIKE GTPase 3, ARL3
12647,604696,A-KINASE ANCHOR PROTEIN 11, AKAP11
12648,604697,"CHEMOKINE, CC MOTIF, LIGAND 26", CCL26
12649,604698,A-KINASE ANCHOR PROTEIN 12, AKAP12
12650,604699,ADP-RIBOSYLATION FACTOR-RELATED PROTEIN 1, ARFRP1
12651,604700,TARGET OF MYB1 MEMBRANE TRAFFICKING PROTEIN, TOM1
12652,604701,TARGET OF MYB1-LIKE 1 MEMBRANE TRAFFICKING PROTEIN, TOM1L1
12653,604702,HMG BOX DOMAIN-CONTAINING 4, HMGXB4
12654,604703,HMG BOX DOMAIN-CONTAINING 4,
12655,604704,BREAST CANCER ANTIESTROGEN RESISTANCE 3, BCAR3
12656,604705,MER TYROSINE KINASE PROTOONCOGENE, MERTK
12657,604706,MATRIN 3,
12658,604707,"ALDO-KETO REDUCTASE FAMILY 1, MEMBER B10", AKR1B10
12659,604708,NUCLEAR FACTOR OF ACTIVATED T CELLS 5, NFAT5
12660,604709,T-CELL LYMPHOMA INVASION AND METASTASIS 2, TIAM2
12661,604710,LATENT TRANSFORMING GROWTH FACTOR-BETA-BINDING PROTEIN 4, LTBP4
12662,604711,UBIQUITIN-LIKE 3, UBL3
12663,604712,RIBONUCLEOTIDE REDUCTASE REGULATORY TP53 INDUCIBLE SUBUNIT M2B, RRM2B
12664,604713,"C-TYPE LECTIN DOMAIN FAMILY 11, MEMBER A", CLEC11A
12665,604714,TSPY-LIKE 1, TSPYL1
12666,604715,ORTHOSTATIC INTOLERANCE, ORSTI
12667,604716,"UDP GLUCURONOSYLTRANSFERASE FAMILY 2, MEMBER A1", UGT2A1
12668,604717,"DEAFNESS, AUTOSOMAL DOMINANT 20", DFNA20
12669,604718,TRANSCRIPTION TERMINATION FACTOR 2, TTF2
12670,604719,SERINE/THREONINE PROTEIN KINASE 16, STK16
12671,604720,TRANSFERRIN RECEPTOR 2, TFR2
12672,604721,SH2 DOMAIN-CONTAINING PROTEIN 3A, SH2D3A
12673,604722,SH2 DOMAIN-CONTAINING PROTEIN 3C, SH2D3C
12674,604723,"Ts TRANSLATION ELONGATION FACTOR, MITOCHONDRIAL", TSFM
12675,604724,HEPARANASE, HPSE
12676,604725,UBIQUITIN-SPECIFIC PROTEASE 2, USP2
12677,604726,SERINE/THREONINE PROTEIN KINASE 17A, STK17A
12678,604727,SERINE/THREONINE PROTEIN KINASE 17B, STK17B
12679,604728,UBIQUITIN-SPECIFIC PROTEASE 3, USP3
12680,604729,UBIQUITIN-SPECIFIC PROTEASE 21, USP21
12681,604730,TUB-LIKE PROTEIN 3, TULP3
12682,604731,UBIQUITIN-SPECIFIC PROTEASE 15, USP15
12683,604732,TRANSCRIPTION FACTOR EC, TFEC
12684,604733,TRYPTOPHANYL-tRNA SYNTHETASE 2, WARS2
12685,604734,WD REPEAT-CONTAINING PROTEIN 1, WDR1
12686,604735,UBIQUITIN-SPECIFIC PROTEASE 16, USP16
12687,604736,UBIQUITIN-SPECIFIC PROTEASE 25, USP25
12688,604737,WD REPEAT-CONTAINING PROTEIN 3, WDR3
12689,604738,"CHEMOKINE, CC MOTIF, RECEPTOR 9", CCR9
12690,604739,RNA-BINDING MOTIF PROTEIN 39, RBM39
12691,604740,"SOLUTE CARRIER FAMILY 39 (ZINC TRANSPORTER), MEMBER 1", SLC39A1
12692,604741,"ALDO-KETO REDUCTASE FAMILY 1, MEMBER D1", AKR1D1
12693,604742,DOUBLECORTIN-LIKE KINASE 1, DCLK1
12694,604743,DIMETHYLARGININE DIMETHYLAMINOHYDROLASE 1, DDAH1
12695,604744,DIMETHYLARGININE DIMETHYLAMINOHYDROLASE 2, DDAH2
12696,604745,TRANSCRIPTION FACTOR-LIKE 5, TCFL5
12697,604746,TESTIS-ASSOCIATED ACTIN-MODELING KINASE 2, TESK2
12698,604747,SRY-BOX 14, SOX14
12699,604748,SRY-BOX 13, SOX13
12700,604749,ZINC FINGER PROTEIN 235, ZNF235
12701,604750,ZINC FINGER PROTEIN 234, ZNF234
12702,604751,ZINC FINGER PROTEIN 266, ZNF266
12703,604752,ZINC FINGER PROTEIN 267, ZNF267
12704,604753,ZINC FINGER PROTEIN 268, ZNF268
12705,604754,"ZINC FINGER PROTEIN 271, PSEUDOGENE", ZNF271P
12706,604755,ZINC FINGER PROTEIN 272, ZNF272
12707,604756,ZINC FINGER PROTEIN 273, ZNF273
12708,604757,CRANIOSYNOSTOSIS 2, CRS2
12709,604758,"RELB PROTOONCOGENE, NFKB-SUBUNIT", RELB
12710,604759,SYNAPTONEMAL COMPLEX PROTEIN 3, SYCP3
12711,604760,ZINC FINGER PROTEIN 236, ZNF236
12712,604761,ZINC FINGER AN1 DOMAIN-CONTAINING PROTEIN 5, ZFAND5
12713,604762,SWITCH-ASSOCIATED PROTEIN 70,
12714,604763,RHO GUANINE NUCLEOTIDE EXCHANGE FACTOR 12, ARHGEF12
12715,604764,ZINC FINGER AND HOMEODOMAIN PROTEIN 1, ZHX1
12716,604765,"CARDIOMYOPATHY, DILATED, 1I", CMD1I
12717,604766,"NPHS2 STOMATIN FAMILY MEMBER, PODOCIN", NPHS2
12718,604767,DELETED IN ESOPHAGEAL CANCER 1, DEC1
12719,604768,ZINC FINGER PROTEIN 254, ZNF254
12720,604769,PEROXIREDOXIN 3, PRDX3
12721,604770,ACETYL-CoA ACYLTRANSFERASE 2, ACAA2
12722,604771,POLYCYSTIC BONE DISEASE,
12723,604772,"VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 1, WITH OR WITHOUT ATRIAL DYSFUNCTION AND/OR DILATED CARDIOMYOPATHY", CPVT1
12724,604773,"ACYL-CoA DEHYDROGENASE FAMILY, MEMBER 8", ACAD8
12725,604774,ANGIOPOIETIN-LIKE 3, ANGPTL3
12726,604775,"TRANSIENT RECEPTOR POTENTIAL CATION CHANNEL, SUBFAMILY A, MEMBER 1", TRPA1
12727,604776,"MAJOR HISTOCOMPATIBILITY COMPLEX, CLASS II, DR BETA-5", HLA-DRB5
12728,604777,"ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 5", ARCI5
12729,604778,A DISINTEGRIN AND METALLOPROTEINASE DOMAIN 29, ADAM29
12730,604779,A DISINTEGRIN AND METALLOPROTEINASE DOMAIN 30, ADAM30
12731,604780,"ABHYDROLASE DOMAIN-CONTAINING PROTEIN 5, LYSOPHOSPHATIDIC ACID ACYLTRANSFERASE", ABHD5
12732,604781,"ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 5",
12733,604782,ASH2-LIKE, ASH2L
12734,604783,CLEFT LIP AND PALATE-ASSOCIATED TRANSMEMBRANE PROTEIN 1, CLPTM1
12735,604784,"TRANSCRIPTION ELONGATION FACTOR A, 2", TCEA2
12736,604785,"CATENIN, ALPHA-LIKE, 1", CTNNAL1
12737,604786,ADP-RIBOSYLATION FACTOR-LIKE GTPase 4A, ARL4A
12738,604787,ADP-RIBOSYLATION FACTOR-LIKE GTPase 4C, ARL4C
12739,604788,RUVB-LIKE AAA ATPase 2, RUVBL2
12740,604789,"INTEGRIN, ALPHA-11", ITGA11
12741,604790,"TASTE RECEPTOR, TYPE 2, MEMBER 14", TAS2R14
12742,604791,"TASTE RECEPTOR, TYPE 2, MEMBER 10", TAS2R10
12743,604792,"TASTE RECEPTOR, TYPE 2, MEMBER 13", TAS2R13
12744,604793,"TASTE RECEPTOR, TYPE 2, MEMBER 7", TAS2R7
12745,604794,"TASTE RECEPTOR, TYPE 2, MEMBER 8", TAS2R8
12746,604795,"TASTE RECEPTOR, TYPE 2, MEMBER 9", TAS2R9
12747,604796,"TASTE RECEPTOR, TYPE 2, MEMBER 1", TAS2R1
12748,604797,"APOLIPOPROTEIN B mRNA-EDITING ENZYME, CATALYTIC POLYPEPTIDE-LIKE 2", APOBEC2
12749,604798,HOMER SCAFFOLD PROTEIN 1, HOMER1
12750,604799,HOMER SCAFFOLD PROTEIN 2, HOMER2
12751,604800,HOMER SCAFFOLD PROTEIN 3, HOMER3
12752,604801,"MUSCULAR DYSTROPHY, CONGENITAL, 1B", MDC1B
12753,604802,HUNTINGTON DISEASE-LIKE 3, HDL3
12754,604803,DOP1 LEUCINE ZIPPER-LIKE PROTEIN B, DOP1B
12755,604804,"MICROCEPHALY 3, PRIMARY, AUTOSOMAL RECESSIVE", MCPH3
12756,604805,"SPASTIC PARAPLEGIA 12, AUTOSOMAL DOMINANT", SPG12
12757,604806,FIBRONECTIN-LIKE DOMAIN-CONTAINING LEUCINE-RICH TRANSMEMBRANE PROTEIN 1, FLRT1
12758,604807,FIBRONECTIN-LIKE DOMAIN-CONTAINING LEUCINE-RICH TRANSMEMBRANE PROTEIN 2, FLRT2
12759,604808,FIBRONECTIN-LIKE DOMAIN-CONTAINING LEUCINE-RICH TRANSMEMBRANE PROTEIN 3, FLRT3
12760,604809,"PANBRONCHIOLITIS, DIFFUSE",
12761,604810,"LEUKOCYTE IMMUNOGLOBULIN-LIKE RECEPTOR, SUBFAMILY A, MEMBER 1", LILRA1
12762,604811,"LEUKOCYTE IMMUNOGLOBULIN-LIKE RECEPTOR, SUBFAMILY B, MEMBER 1", LILRB1
12763,604812,"LEUKOCYTE IMMUNOGLOBULIN-LIKE RECEPTOR, SUBFAMILY A, MEMBER 2", LILRA2
12764,604813,CYTOCHROME c OXIDASE COPPER CHAPERONE COX17, COX17
12765,604814,"LEUKOCYTE IMMUNOGLOBULIN-LIKE RECEPTOR, SUBFAMILY B, MEMBER 5", LILRB5
12766,604815,"LEUKOCYTE IMMUNOGLOBULIN-LIKE RECEPTOR, SUBFAMILY B, MEMBER 2", LILRB2
12767,604816,CHUDLEY-MCCULLOUGH SYNDROME,
12768,604817,CARBOHYDRATE SULFOTRANSFERASE 5, CHST5
12769,604818,"LEUKOCYTE IMMUNOGLOBULIN-LIKE RECEPTOR, SUBFAMILY A, MEMBER 3", LILRA3
12770,604819,"POLY-U-BINDING SPLICING FACTOR, 60-KD", PUF60
12771,604820,"LEUKOCYTE IMMUNOGLOBULIN-LIKE RECEPTOR, SUBFAMILY B, MEMBER 3", LILRB3
12772,604821,"LEUKOCYTE IMMUNOGLOBULIN-LIKE RECEPTOR, SUBFAMILY B, MEMBER 4", LILRB4
12773,604822,CALPAIN 11, CAPN11
12774,604823,BARX HOMEOBOX 2, BARX2
12775,604824,KLOTHO, KL
12776,604825,FASCICULATION AND ELONGATION PROTEIN ZETA 1, FEZ1
12777,604826,FASCICULATION AND ELONGATION PROTEIN ZETA 2, FEZ2
12778,604827,"EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 7", EIG7
12779,604828,"CHEMOKINE, C MOTIF, LIGAND 2", XCL2
12780,604829,DOWN SYNDROME CRITICAL REGION GENE 4, DSCR4
12781,604830,"MANDIBULOFACIAL DYSOSTOSIS SYNDROME, BAURU TYPE",
12782,604831,EVC CILIARY COMPLEX SUBUNIT 1, EVC
12783,604832,CARBONIC ANHYDRASE XIV, CA14
12784,604833,"CHEMOKINE, CC MOTIF, LIGAND 27", CCL27
12785,604834,TANK-BINDING KINASE 1, TBK1
12786,604835,DUAL-SPECIFICITY PHOSPHATASE 12, DUSP12
12787,604836,"CHEMOKINE, CC MOTIF, RECEPTOR 4", CCR4
12788,604837,PROSTAGLANDIN D2 RECEPTOR 2, PTGDR2
12789,604838,G PROTEIN-COUPLED RECEPTOR 45, GPR45
12790,604839,FK506-BINDING PROTEIN 6, FKBP6
12791,604840,FK506-BINDING PROTEIN 8, FKBP8
12792,604841,"STICKLER SYNDROME, TYPE II", STL2
12793,604842,"SOLUTE CARRIER FAMILY 22 (EXTRANEURONAL MONOAMINE TRANSPORTER), MEMBER 3", SLC22A3
12794,604843,"SOLUTE CARRIER ORGANIC ANION TRANSPORTER FAMILY, MEMBER 1B1", SLCO1B1
12795,604844,HEPARAN SULFATE 2-O-SULFOTRANSFERASE 1, HS2ST1
12796,604845,PROSTATE CANCER ANTIGEN 3, PCA3
12797,604846,HEPARAN SULFATE 6-O-SULFOTRANSFERASE 1, HS6ST1
12798,604847,G PROTEIN-COUPLED RECEPTOR 26, GPR26
12799,604848,TRACE AMINE-ASSOCIATED RECEPTOR 2,
12800,604849,TRACE AMINE-ASSOCIATED RECEPTOR 2, TAAR2
12801,604850,"COP9 SIGNALOSOME, SUBUNIT 5", COPS5
12802,604851,G-RICH RNA SEQUENCE-BINDING FACTOR 1, GRSF1
12803,604852,"CHEMOKINE, CXC MOTIF, LIGAND 11", CXCL11
12804,604853,MITOCHONDRIAL RIBOSOMAL PROTEIN L28, MRPL28
12805,604854,INDOLETHYLAMINE N-METHYLTRANSFERASE, INMT
12806,604855,"HYALURONAN METABOLISM, DEFECT IN",
12807,604856,LANGERHANS CELL HISTIOCYTOSIS,
12808,604857,"SIGNAL RECOGNITION PARTICLE, 54-KD", SRP54
12809,604858,"SIGNAL RECOGNITION PARTICLE, 68-KD", SRP68
12810,604859,LIM AND CYSTEINE-RICH DOMAINS 1, LMCD1
12811,604860,MALT1 PARACASPASE, MALT1
12812,604861,LARGE TUMOR SUPPRESSOR KINASE 2, LATS2
12813,604862,CD207 ANTIGEN, CD207
12814,604863,LECITHIN RETINOL ACYLTRANSFERASE, LRAT
12815,604864,OSTEOARTHRITIS WITH MILD CHONDRODYSPLASIA, OSCDP
12816,604865,KRUPPEL-LIKE FACTOR 7, KLF7
12817,604866,PLAG1-LIKE ZINC FINGER 2, PLAGL2
12818,604867,"TASTE RECEPTOR, TYPE 2, MEMBER 16", TAS2R16
12819,604868,"TASTE RECEPTOR, TYPE 2, MEMBER 3", TAS2R3
12820,604869,"TASTE RECEPTOR, TYPE 2, MEMBER 4", TAS2R4
12821,604870,MACROPHAGE RECEPTOR WITH COLLAGENOUS STRUCTURE, MARCO
12822,604871,MATRIX METALLOPROTEINASE 24, MMP24
12823,604872,"PROPROTEIN CONVERTASE, SUBTILISIN/KEXIN-TYPE, 7", PCSK7
12824,604873,MYELIN PROTEIN ZERO-LIKE 2, MPZL2
12825,604874,"KILLER CELL LECTIN-LIKE RECEPTOR, SUBFAMILY G, MEMBER 1", KLRG1
12826,604875,MYOSIN IXA, MYO9A
12827,604876,REGULATOR OF CALCINEURIN 2, RCAN2
12828,604877,MAF bZIP TRANSCRIPTION FACTOR F, MAFF
12829,604878,"SOLUTE CARRIER FAMILY 12 (POTASSIUM/CHLORIDE TRANSPORTER), MEMBER 6", SLC12A6
12830,604879,"SOLUTE CARRIER FAMILY 12 (POTASSIUM/CHLORIDE TRANSPORTER), MEMBER 7", SLC12A7
12831,604880,MSL COMPLEX SUBUNIT 3,
12832,604881,RABPHILIN 3A-LIKE, RPH3AL
12833,604882,NEUROGENIN 3, NEUROG3
12834,604883,"GENERAL TRANSCRIPTION FACTOR 3C, POLYPEPTIDE 2", GTF3C2
12835,604884,NIMA-RELATED KINASE 6, NEK6
12836,604885,MYB-BINDING PROTEIN 1A, MYBBP1A
12837,604886,"ENDOPLASMIC RETICULUM MEMBRANE PROTEIN COMPLEX, SUBUNIT 8", EMC8
12838,604887,METHYLENETETRAHYDROFOLATE DEHYDROGENASE 2, MTHFD2
12839,604888,"GENERAL TRANSCRIPTION FACTOR 3C, POLYPEPTIDE 3", GTF3C3
12840,604889,NEUROBEACHIN, NBEA
12841,604890,"GENERAL TRANSCRIPTION FACTOR 3C, POLYPEPTIDE 5", GTF3C5
12842,604891,NCK-ASSOCIATED PROTEIN 1, NCKAP1
12843,604892,"GENERAL TRANSCRIPTION FACTOR 3C, POLYPEPTIDE 4", GTF3C4
12844,604893,"ANTISENSE IGF2R RNA, NONCODING", AIRN
12845,604894,ONE CUT HOMEOBOX 2, ONECUT2
12846,604895,T-BOX TRANSCRIPTION FACTOR 21, TBX21
12847,604896,MKKS CENTROSOMAL SHUTTLING PROTEIN, MKKS
12848,604897,PREFOLDIN 1, PFDN1
12849,604898,PREFOLDIN 4, PFDN4
12850,604899,PREFOLDIN 5, PFDN5
12851,604900,DIACYLGLYCEROL O-ACYLTRANSFERASE 1, DGAT1
12852,604901,NORTH AMERICAN INDIAN CHILDHOOD CIRRHOSIS, NAIC
12853,604902,BRF1 SUBUNIT OF RNA POLYMERASE III TRANSCRIPTION INITIATION FACTOR, BRF1
12854,604903,TATA BOX-BINDING PROTEIN-ASSOCIATED FACTOR 1A, TAF1A
12855,604904,TATA BOX-BINDING PROTEIN-ASSOCIATED FACTOR 1B, TAF1B
12856,604905,TATA BOX-BINDING PROTEIN-ASSOCIATED FACTOR 1C, TAF1C
12857,604906,SCHIZOPHRENIA 9, SCZD9
12858,604907,"TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY, MEMBER 13B", TNFRSF13B
12859,604908,"PROTEIN PHOSPHATASE 4, REGULATORY SUBUNIT 1", PPP4R1
12860,604909,"CCR4-NOT TRANSCRIPTION COMPLEX, SUBUNIT 2", CNOT2
12861,604910,"CCR4-NOT TRANSCRIPTION COMPLEX, SUBUNIT 3", CNOT3
12862,604911,"CCR4-NOT TRANSCRIPTION COMPLEX, SUBUNIT 4", CNOT4
12863,604912,"TAF2 RNA POLYMERASE II, TATA BOX-BINDING PROTEIN-ASSOCIATED FACTOR, 150-KD", TAF2
12864,604913,"CCR4-NOT TRANSCRIPTION COMPLEX, SUBUNIT 7", CNOT7
12865,604914,JUMONJI DOMAIN-CONTAINING PROTEIN 6, JMJD6
12866,604915,MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 13, MAP3K13
12867,604916,AU-KLINE SYNDROME,
12868,604917,"CCR4-NOT TRANSCRIPTION COMPLEX, SUBUNIT 1", CNOT1
12869,604918,PICCOLO PRESYNAPTIC CYTOMATRIX PROTEIN, PCLO
12870,604919,BECKER NEVUS SYNDROME, BNS
12871,604920,HUNTINGTON DISEASE-LIKE 1,
12872,604921,MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE KINASE 3, MAP4K3
12873,604922,"CORTICAL DEFECTS, WORMIAN BONES, AND DENTINOGENESIS IMPERFECTA",
12874,604923,MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE KINASE 5, MAP4K5
12875,604924,PHOSPHORYLATED ADAPTOR FOR RNA EXPORT, PHAX
12876,604925,RAB ACCEPTOR 1, RABAC1
12877,604926,"PHOSPHATE CYTIDYLYLTRANSFERASE 1, CHOLINE, BETA ISOFORM",
12878,604927,"C-TERMINAL DOMAIN OF RNA POLYMERASE II SUBUNIT A, PHOSPHATASE OF, SUBUNIT 1", CTDP1
12879,604928,WOLFRAM SYNDROME 2, WFS2
12880,604929,"EMERY-DREIFUSS MUSCULAR DYSTROPHY 2, AUTOSOMAL DOMINANT",
12881,604930,NCK ADAPTOR PROTEIN 2, NCK2
12882,604931,CORTISONE REDUCTASE DEFICIENCY 1, CORTRD1
12883,604932,"PROTEIN KINASE, cAMP-DEPENDENT CATALYTIC, INHIBITOR GAMMA", PKIG
12884,604933,MutY DNA GLYCOSYLASE, MUTYH
12885,604934,TUBULIN-SPECIFIC CHAPERONE E, TBCE
12886,604935,DOUBLESEX- AND MAB3-RELATED TRANSCRIPTION FACTOR 2, DMRT2
12887,604936,"KILLER CELL IMMUNOGLOBULIN-LIKE RECEPTOR, TWO DOMAINS, LONG CYTOPLASMIC TAIL, 1", KIR2DL1
12888,604937,"KILLER CELL IMMUNOGLOBULIN-LIKE RECEPTOR, TWO DOMAINS, LONG CYTOPLASMIC TAIL, 2", KIR2DL2
12889,604938,"KILLER CELL IMMUNOGLOBULIN-LIKE RECEPTOR, TWO DOMAINS, LONG CYTOPLASMIC TAIL, 3", KIR2DL3
12890,604939,PHOSPHOLIPASE A2 RECEPTOR 1, PLA2R1
12891,604940,"POLYPOSIS SYNDROME, HEREDITARY MIXED, 1",
12892,604941,"PROTEIN PHOSPHATASE 2, REGULATORY SUBUNIT B, ALPHA", PPP2R2A
12893,604942,SYNTAPHILIN, SNPH
12894,604943,"SOLUTE CARRIER FAMILY 26, MEMBER 5", SLC26A5
12895,604944,"PROTEIN PHOSPHATASE 2, REGULATORY SUBUNIT B-DOUBLE PRIME, ALPHA", PPP2R3A
12896,604945,"KILLER CELL IMMUNOGLOBULIN-LIKE RECEPTOR, TWO DOMAINS, LONG CYTOPLASMIC TAIL, 4", KIR2DL4
12897,604946,"KILLER CELL IMMUNOGLOBULIN-LIKE RECEPTOR, THREE DOMAINS, LONG CYTOPLASMIC TAIL, 1", KIR3DL1
12898,604947,"KILLER CELL IMMUNOGLOBULIN-LIKE RECEPTOR, THREE DOMAINS, LONG CYTOPLASMIC TAIL, 2", KIR3DL2
12899,604948,"GROWTH ARREST- AND DNA DAMAGE-INDUCIBLE GENE, BETA", GADD45B
12900,604949,"GROWTH ARREST- AND DNA DAMAGE-INDUCIBLE GENE, GAMMA", GADD45G
12901,604950,PUTATIVE HOMEODOMAIN TRANSCRIPTION FACTOR 1, PHTF1
12902,604951,6-PHOSPHOGLUCONOLACTONASE, PGLS
12903,604952,"KILLER CELL IMMUNOGLOBULIN-LIKE RECEPTOR, TWO DOMAINS, SHORT CYTOPLASMIC TAIL, 1", KIR2DS1
12904,604953,"KILLER CELL IMMUNOGLOBULIN-LIKE RECEPTOR, TWO DOMAINS, SHORT CYTOPLASMIC TAIL, 2", KIR2DS2
12905,604954,"KILLER CELL IMMUNOGLOBULIN-LIKE RECEPTOR, TWO DOMAINS, SHORT CYTOPLASMIC TAIL, 3", KIR2DS3
12906,604955,"KILLER CELL IMMUNOGLOBULIN-LIKE RECEPTOR, TWO DOMAINS, SHORT CYTOPLASMIC TAIL, 4", KIR2DS4
12907,604956,"KILLER CELL IMMUNOGLOBULIN-LIKE RECEPTOR, TWO DOMAINS, SHORT CYTOPLASMIC TAIL, 5", KIR2DS5
12908,604957,"KILLER CELL IMMUNOGLOBULIN-LIKE RECEPTOR, THREE DOMAINS, LONG CYTOPLASMIC TAIL, 1",
12909,604958,ACTIN-LIKE 6A, ACTL6A
12910,604959,PHORBOL-12-MYRISTATE-13-ACETATE-INDUCED PROTEIN 1, PMAIP1
12911,604960,PROTEIN KINASE C AND CASEIN KINASE SUBSTRATE IN NEURONS 2, PACSIN2
12912,604961,PHOSPHODIESTERASE 11A, PDE11A
12913,604962,T-CELL RECEPTOR-ASSOCIATED TRANSMEMBRANE ADAPTOR 1, TRAT1
12914,604963,PEPTIDOGLYCAN RECOGNITION PROTEIN 1, PGLYRP1
12915,604964,SHP2-INTERACTING TRANSMEMBRANE ADAPTOR PROTEIN 1, SIT1
12916,604965,SERINE/THREONINE PROTEIN KINASE 4, STK4
12917,604966,PROTOCADHERIN-ALPHA GENE CLUSTER, PCDHA@
12918,604967,PROTOCADHERIN-BETA GENE CLUSTER, PCDHB@
12919,604968,PROTOCADHERIN-GAMMA GENE CLUSTER, PCDHG@
12920,604969,SRC KINASE-ASSOCIATED PHOSPHOPROTEIN 1, SKAP1
12921,604970,AURORA KINASE B, AURKB
12922,604971,MYOD FAMILY INHIBITOR, MDFI
12923,604972,"ORIGIN RECOGNITION COMPLEX, SUBUNIT 3", ORC3
12924,604973,FICOLIN 3, FCN3
12925,604974,SRY-BOX 21, SOX21
12926,604975,SRY-BOX 5, SOX5
12927,604976,"PROTEIN KINASE, AMP-ACTIVATED, NONCATALYTIC, GAMMA-3", PRKAG3
12928,604977,SERINE/THREONINE PROTEIN KINASE 19, STK19
12929,604978,NUDIX HYDROLASE 21, NUDT21
12930,604979,CLEAVAGE AND POLYADENYLATION SPECIFICITY FACTOR 6, CPSF6
12931,604980,RAC GTPase-ACTIVATING PROTEIN 1, RACGAP1
12932,604981,WW DOMAIN-CONTAINING BINDING PROTEIN 4, WBP4
12933,604982,"HPS1 BIOGENESIS OF LYSOSOMAL ORGANELLES COMPLEX 3, SUBUNIT 1", HPS1
12934,604983,"POLYMERASE, DNA, GAMMA-2", POLG2
12935,604984,SERINE/THREONINE PROTEIN KINASE 24, STK24
12936,604985,"SPECTRIN, BETA, NONERYTHROCYTIC, 2", SPTBN2
12937,604986,BRCA1-ASSOCIATED PROTEIN, BRAP
12938,604987,"C-TYPE LECTIN DOMAIN FAMILY 5, MEMBER A", CLEC5A
12939,604988,"SOLUTE CARRIER ORGANIC ANION TRANSPORTER FAMILY, MEMBER 2B1", SLCO2B1
12940,604989,SPONDIN 1, SPON1
12941,604990,"SOLUTE CARRIER FAMILY 9, MEMBER 3, REGULATOR 1", SLC9A3R1
12942,604991,PROSTATE ANDROGEN-REGULATED TRANSCRIPT 1, PART1
12943,604992,SARCALUMENIN, SRL
12944,604993,PRE-mRNA-PROCESSING FACTOR 18, PRPF18
12945,604994,SIX HOMEOBOX 2, SIX2
12946,604995,"SOLUTE CARRIER FAMILY 22 (ORGANIC ANION TRANSPORTER), MEMBER 7", SLC22A7
12947,604996,FXYD DOMAIN-CONTAINING ION TRANSPORT REGULATOR 3, FXYD3
12948,604997,DOCKING PROTEIN 2, DOK2
12949,604998,CALCIUM/CALMODULIN-DEPENDENT PROTEIN KINASE I, CAMK1
12950,604999,SH3 AND MULTIPLE ANKYRIN REPEAT DOMAINS 1, SHANK1
12951,605000,CORONIN 1A, CORO1A
12952,605001,ANGIOPOIETIN-LIKE 2, ANGPTL2
12953,605002,CORONIN 2B, CORO2B
12954,605003,"SENTRIN-SPECIFIC PROTEASE FAMILY, MEMBER 6", SENP6
12955,605004,GLYCOGEN SYNTHASE KINASE 3-BETA, GSK3B
12956,605005,UDP-N-ACETYL-ALPHA-D-GALACTOSAMINE:POLYPEPTIDE N-ACETYLGALACTOSAMINYLTRANSFERASE 7, GALNT7
12957,605006,FREQUENTLY REARRANGED IN ADVANCED T-CELL LYMPHOMAS 2, FRAT2
12958,605007,"A DISINTEGRIN-LIKE AND METALLOPROTEINASE WITH THROMBOSPONDIN TYPE 1 MOTIF, 5", ADAMTS5
12959,605008,"A DISINTEGRIN-LIKE AND METALLOPROTEINASE WITH THROMBOSPONDIN TYPE 1 MOTIF, 6", ADAMTS6
12960,605009,"A DISINTEGRIN-LIKE AND METALLOPROTEINASE WITH THROMBOSPONDIN TYPE 1 MOTIF, 7", ADAMTS7
12961,605010,"SERINE PROTEASE INHIBITOR, KAZAL-TYPE, 5", SPINK5
12962,605011,"A DISINTEGRIN-LIKE AND METALLOPROTEINASE WITH THROMBOSPONDIN TYPE 1 MOTIF, 3", ADAMTS3
12963,605012,"SPT16 HOMOLOG, FACILITATES CHROMATIN REMODELING SUBUNIT", SUPT16H
12964,605013,MICROHYDRANENCEPHALY, MHAC
12965,605014,SYNTAXIN 11, STX11
12966,605015,ZINC FINGER PROTEIN 214, ZNF214
12967,605016,ZINC FINGER PROTEIN 215, ZNF215
12968,605017,PRE-B-LYMPHOCYTE GENE 3, VPREB3
12969,605018,CYLD LYSINE-63 DEUBIQUITINASE, CYLD
12970,605019,"HYPOBETALIPOPROTEINEMIA, FAMILIAL, 2", FHBL2
12971,605020,VISUAL SYSTEM HOMEOBOX 1, VSX1
12972,605021,"MYOCLONIC EPILEPSY, FAMILIAL INFANTILE", FIME
12973,605022,p21 PROTEIN-ACTIVATED KINASE 2, PAK2
12974,605023,HYDROXYACID OXIDASE 1, HAO1
12975,605024,"SOLUTE CARRIER FAMILY 4 (SODIUM BICARBONATE COTRANSPORTER), MEMBER 8", SLC4A8
12976,605025,"INTEGRIN, ALPHA-3", ITGA3
12977,605026,"DIABETES MELLITUS, CONGENITAL AUTOIMMUNE",
12978,605027,"LYMPHOMA, NON-HODGKIN, FAMILIAL",
12979,605028,"LOW DENSITY LIPOPROTEIN CHOLESTEROL, MILD ELEVATION OF",
12980,605029,KILLER CELL LECTIN-LIKE RECEPTOR F1, KLRF1
12981,605030,SERINE/THREONINE PROTEIN KINASE 3, STK3
12982,605031,POLO-LIKE KINASE 4, PLK4
12983,605032,COMPLEXIN 1, CPLX1
12984,605033,COMPLEXIN 2, CPLX2
12985,605034,TRANSLOCASE OF INNER MITOCHONDRIAL MEMBRANE 23, TIMM23
12986,605035,"WASP PROTEIN FAMILY, MEMBER 1", WASF1
12987,605036,ZINC FINGER PROTEIN 219, ZNF219
12988,605037,KINESIN FAMILY MEMBER 17, KIF17
12989,605038,POSTMEIOTIC SEGREGATION INCREASED 2-LIKE 1, PMS2L1
12990,605039,BOHRING-OPITZ SYNDROME, BOPS
12991,605040,"CLAVICULAR HYPOPLASIA, ZYGOMATIC ARCH HYPOPLASIA, AND MICROGNATHIA",
12992,605041,BROOKE-SPIEGLER SYNDROME, BRSS
12993,605042,MEDIATOR COMPLEX SUBUNIT 23, MED23
12994,605043,MEDIATOR COMPLEX SUBUNIT 26, MED26
12995,605044,MEDIATOR COMPLEX SUBUNIT 27, MED27
12996,605045,MEDIATOR COMPLEX SUBUNIT 7, MED7
12997,605046,UBIQUILIN 1, UBQLN1
12998,605047,INTERFERON REGULATORY FACTOR 7, IRF7
12999,605048,"INHIBITOR OF NUCLEAR FACTOR KAPPA-B KINASE, SUBUNIT EPSILON", IKBKE
13000,605049,TWISTED GASTRULATION BMP MODULATOR 1, TWSG1
13001,605050,H4 CLUSTERED HISTONE 14,
13002,605051,CANNABINOID RECEPTOR 2, CNR2
13003,605052,TAR RNA-BINDING PROTEIN 1, TARBP1
13004,605053,TAR RNA-BINDING PROTEIN 2, TARBP2
13005,605054,SMALL EDRK-RICH FACTOR 2, SERF2
13006,605055,"ALZHEIMER DISEASE, FAMILIAL EARLY-ONSET, WITH COEXISTING AMYLOID AND PRION PATHOLOGY",
13007,605056,WASP-LIKE ACTIN NUCLEATION-PROMOTING FACTOR, WASL
13008,605057,TRANSLOCASE OF INNER MITOCHONDRIAL MEMBRANE 17A, TIMM17A
13009,605058,TRANSLOCASE OF INNER MITOCHONDRIAL MEMBRANE 44, TIMM44
13010,605059,"CYTOCHROME P450, SUBFAMILY IIB, POLYPEPTIDE 6",
13011,605060,SEDOHEPTULOKINASE, SHPK
13012,605061,TERF2-INTERACTING PROTEIN, TERF2IP
13013,605062,"TASTE RECEPTOR, TYPE 2, MEMBER 5", TAS2R5
13014,605063,STRESS-INDUCED PHOSPHOPROTEIN 1, STIP1
13015,605064,KINESIN FAMILY MEMBER 23, KIF23
13016,605065,"CELL DIVISION CYCLE 37, HSP90 COCHAPERONE", CDC37
13017,605066,"TYROSINE 3-MONOOXYGENASE/TRYPTOPHAN 5-MONOOXYGENASE ACTIVATION PROTEIN, EPSILON ISOFORM", YWHAE
13018,605067,TRICUSPID ATRESIA,
13019,605068,"WASP PROTEIN FAMILY, MEMBER 3", WASF3
13020,605069,MITOGEN-ACTIVATED PROTEIN KINASE-INTERACTING SERINE/THREONINE KINASE 2, MKNK2
13021,605070,EARLY ENDOSOME ANTIGEN 1, EEA1
13022,605071,REGULATOR OF G PROTEIN SIGNALING 19, RGS19
13023,605072,"GIPC PDZ DOMAIN-CONTAINING FAMILY, MEMBER 1", GIPC1
13024,605073,TRIPARTITE MOTIF-CONTAINING PROTEIN 37, TRIM37
13025,605074,"RENAL CELL CARCINOMA, PAPILLARY, 1", RCCP1
13026,605075,"RENAL CELL CARCINOMA, PAPILLARY, 1",
13027,605076,"SMALL NUCLEAR RNA-ACTIVATING PROTEIN COMPLEX, POLYPEPTIDE 2", SNAPC2
13028,605077,DNA METHYLTRANSFERASE 1-ASSOCIATED PROTEIN 1, DMAP1
13029,605078,TAR DNA-BINDING PROTEIN, TARDBP
13030,605079,SAL-LIKE 3, SALL3
13031,605080,"CYCLIC NUCLEOTIDE-GATED CHANNEL, BETA-3", CNGB3
13032,605081,CYTOHESIN 3, CYTH3
13033,605082,RAS ASSOCIATION DOMAIN FAMILY PROTEIN 1, RASSF1
13034,605083,FRIZZLED-RELATED PROTEIN, FRZB
13035,605084,MITOCHONDRIAL CALCIUM UPTAKE PROTEIN 1, MICU1
13036,605085,TRIGGERING RECEPTOR EXPRESSED ON MYELOID CELLS 1, TREM1
13037,605086,TRIGGERING RECEPTOR EXPRESSED ON MYELOID CELLS 2, TREM2
13038,605087,PHOSPHATIDYLINOSITOL GLYCAN ANCHOR BIOSYNTHESIS CLASS K PROTEIN, PIGK
13039,605088,MAJOR VAULT PROTEIN, MVP
13040,605089,MITOCHONDRIAL RIBOSOMAL PROTEIN L40, MRPL40
13041,605090,RETINOIC ACID RECEPTOR RESPONDER 1, RARRES1
13042,605091,"FYVE, RhoGEF, AND PH DOMAIN-CONTAINING PROTEIN 2", FGD2
13043,605092,PHOSPHOLIPASE A AND ACYLTRANSFERASE 4, PLAAT4
13044,605093,SH2B ADAPTOR PROTEIN 3, SH2B3
13045,605094,STEAP2 METALLOREDUCTASE, STEAP2
13046,605095,"SOLUTE CARRIER FAMILY 45, MEMBER 3",
13047,605096,ANOCTAMIN 7, ANO7
13048,605097,"SOLUTE CARRIER FAMILY 45, MEMBER 3", SLC45A3
13049,605098,SYNAPTOTAGMIN 7,
13050,605099,"SOLUTE CARRIER FAMILY 45, MEMBER 3",
13051,605100,"PROTEIN PHOSPHATASE, MAGNESIUM/MANGANESE-DEPENDENT, 1D", PPM1D
13052,605101,TAK1-BINDING PROTEIN 2, TAB2
13053,605102,MANNAN-BINDING LECTIN SERINE PROTEASE 2, MASP2
13054,605103,NEUROMEDIN U, NMU
13055,605104,RNA-BINDING FOX1 HOMOLOG 1, RBFOX1
13056,605105,EARLY RESPONSE TO NEURAL INDUCTION GENE,
13057,605106,LYSOPHOSPHATIDIC ACID RECEPTOR 3, LPAR3
13058,605107,ENDOTHELIAL DIFFERENTIATION-RELATED FACTOR 1, EDF1
13059,605108,NEUROMEDIN U RECEPTOR 2, NMUR2
13060,605109,HECT DOMAIN AND RCC1-LIKE DOMAIN 1, HERC1
13061,605110,LYSOPHOSPHATIDIC ACID RECEPTOR 2, LPAR2
13062,605111,SPHINGOSINE-1-PHOSPHATE RECEPTOR 2, S1PR2
13063,605112,TROPOMODULIN 3, TMOD3
13064,605113,ALPHA-AMINOADIPIC SEMIALDEHYDE SYNTHASE, AASS
13065,605114,SPO11 INITIATOR OF MEIOTIC DOUBLE-STRANDED BREAKS, SPO11
13066,605115,"HYPERTENSION, EARLY-ONSET, AUTOSOMAL DOMINANT, WITH SEVERE EXACERBATION IN PREGNANCY",
13067,605116,"CHOLINERGIC RECEPTOR, NEURONAL NICOTINIC, ALPHA POLYPEPTIDE 9", CHRNA9
13068,605117,SUPPRESSOR OF CYTOKINE SIGNALING 2, SOCS2
13069,605118,SUPPRESSOR OF CYTOKINE SIGNALING 6, SOCS6
13070,605119,"PROTEIN PHOSPHATASE, MAGNESIUM/MANGANESE-DEPENDENT, 1G", PPM1G
13071,605120,GROWTH/DIFFERENTIATION FACTOR 2, GDF2
13072,605121,"RRN3 HOMOLOG, RNA POLYMERASE I TRANSCRIPTION FACTOR", RRN3
13073,605122,SUV3-LIKE 1, SUPV3L1
13074,605123,"SERINE PEPTIDASE INHIBITOR, KUNITZ-TYPE, 1", SPINT1
13075,605124,"SERINE PEPTIDASE INHIBITOR, KUNITZ-TYPE, 2", SPINT2
13076,605125,GABA-A RECEPTOR-ASSOCIATED PROTEIN, GABARAP
13077,605126,FOUR-AND-A-HALF LIM DOMAINS 5, FHL5
13078,605127,OPTICIN, OPTC
13079,605128,GUANYLATE CYCLASE ACTIVATOR 1C, GUCA1C
13080,605129,PROTEASOME ACTIVATOR SUBUNIT 3, PSME3
13081,605130,WIEDEMANN-STEINER SYNDROME, WDSTS
13082,605131,WW DOMAIN-CONTAINING OXIDOREDUCTASE, WWOX
13083,605132,"TLE FAMILY MEMBER 4, TRANSCRIPTIONAL COREPRESSOR", TLE4
13084,605133,NUCLEAR CAP-BINDING PROTEIN 2, NCBP2
13085,605134,"PHOSPHATIDYLINOSITOL TRANSFER PROTEIN, CYTOPLASMIC, 1", PITPNC1
13086,605135,PHOSPHOGLUCOMUTASE 3,
13087,605136,SRY-BOX 21,
13088,605137,SRY-BOX 15,
13089,605138,ORNITHINE DECARBOXYLASE ANTIZYME 3, OAZ3
13090,605139,"CHAPERONIN CONTAINING T-COMPLEX POLYPEPTIDE 1, SUBUNIT 2", CCT2
13091,605140,"CHAPERONIN CONTAINING T-COMPLEX POLYPEPTIDE 1, SUBUNIT 7", CCT7
13092,605141,PRE-B-LYMPHOCYTE GENE 1, VPREB1
13093,605142,"CHAPERONIN CONTAINING T-COMPLEX POLYPEPTIDE 1, SUBUNIT 4", CCT4
13094,605143,ACTIN-RELATED PROTEIN 1A, ACTR1A
13095,605144,ACTIN-RELATED PROTEIN 1B, ACTR1B
13096,605145,ANKH INORGANIC PYROPHOSPHATE TRANSPORT REGULATOR, ANKH
13097,605146,SPHINGOSINE-1-PHOSPHATE RECEPTOR 5, S1PR5
13098,605147,LEUKOCYTE CELL-DERIVED CHEMOTAXIN 1, LECT1
13099,605148,UDP-N-ACETYL-ALPHA-D-GALACTOSAMINE:POLYPEPTIDE N-ACETYLGALACTOSAMINYLTRANSFERASE 6, GALNT6
13100,605149,"CHEMOKINE, CXC MOTIF, LIGAND 13", CXCL13
13101,605150,SRY-BOX 15,
13102,605151,SRY-BOX 14,
13103,605152,CILIA- AND FLAGELLA-ASSOCIATED PROTEIN 45, CFAP45
13104,605153,RECEPTOR ACTIVITY-MODIFYING PROTEIN 1, RAMP1
13105,605154,RECEPTOR ACTIVITY-MODIFYING PROTEIN 2, RAMP2
13106,605155,RECEPTOR ACTIVITY-MODIFYING PROTEIN 3, RAMP3
13107,605156,"MULTICENTRIC OSTEOLYSIS, NODULOSIS, AND ARTHROPATHY",
13108,605157,p53-RESPONSIVE GENE 1,
13109,605158,PEROXIDASIN, PXDN
13110,605159,"APOPTOSIS-INDUCING FACTOR, MITOCHONDRIA-ASSOCIATED, 2", AIFM2
13111,605160,p53-RESPONSIVE GENE 4,
13112,605161,WAP 4-DISULFIDE CORE DOMAIN 5, WFDC5
13113,605162,GADD45G-INTERACTING PROTEIN, GADD45GIP1
13114,605163,"CHEMOKINE, CXC MOTIF, RECEPTOR 6", CXCR6
13115,605164,HISTONE DEACETYLASE 2, HDAC2
13116,605165,ZINC FINGER PROTEIN 278, ZNF278
13117,605166,HISTONE DEACETYLASE 3, HDAC3
13118,605167,B MELANOMA ANTIGEN, BAGE
13119,605168,FATTY ACID-BINDING PROTEIN 5, FABP5
13120,605169,E74-LIKE ETS TRANSCRIPTION FACTOR 5, ELF5
13121,605170,ETOPOSIDE-INDUCED 1.4 mRNA, EI24
13122,605171,TUMOR PROTEIN p53-INDUCIBLE PROTEIN 3, TP53I3
13123,605172,PROSTAGLANDIN E SYNTHASE, PTGES
13124,605173,ECTODERMAL-NEURAL CORTEX 1, ENC1
13125,605174,"A DISINTEGRIN-LIKE AND METALLOPROTEINASE WITH THROMBOSPONDIN TYPE 1 MOTIF, 1", ADAMTS1
13126,605175,"A DISINTEGRIN-LIKE AND METALLOPROTEINASE WITH THROMBOSPONDIN TYPE 1 MOTIF, 8", ADAMTS8
13127,605176,HYDROXYACID OXIDASE 2, HAO2
13128,605177,TITLE NOT AVAILABLE AT THIS MOMENT,
13129,605178,GROWTH ARREST-SPECIFIC 8, GAS8
13130,605179,"GAS8 ANTISENSE RNA 1, NONCODING", GAS8AS1
13131,605180,"SOLUTE CARRIER FAMILY 38 (AMINO ACID TRANSPORTER), MEMBER 2", SLC38A2
13132,605181,"TRANSMEMBRANE 7 SUPERFAMILY, MEMBER 3", TM7SF3
13133,605182,RAS p21 PROTEIN ACTIVATOR 3, RASA3
13134,605183,CALMODULIN-LIKE 5, CALML5
13135,605184,POLYADENYLATE-BINDING PROTEIN-INTERACTING PROTEIN 1, PAIP1
13136,605185,DELTA-LIKE CANONICAL NOTCH LIGAND 4, DLL4
13137,605186,WNT INHIBITORY FACTOR 1, WIF1
13138,605187,G PROTEIN-COUPLED RECEPTOR 27, GPR27
13139,605188,G PROTEIN-COUPLED RECEPTOR 85, GPR85
13140,605189,DICKKOPF WNT SIGNALING PATHWAY INHIBITOR 1, DKK1
13141,605190,TRANSLOCATION-ASSOCIATING MEMBRANE PROTEIN 1, TRAM1
13142,605191,"BTAF1 RNA POLYMERASE II, B-TFIID TRANSCRIPTION FACTOR-ASSOCIATED, 170-KD",  BTAF1
13143,605192,"DEAFNESS, AUTOSOMAL DOMINANT 23", DFNA23
13144,605193,"DIRAS FAMILY, GTP-BINDING RAS-LIKE PROTEIN 3", DIRAS3
13145,605194,"CRYPTIC, EGF-CFC FAMILY MEMBER 1", CFC1
13146,605195,MESODERM POSTERIOR BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTOR 2, MESP2
13147,605196,"COENZYME Q3, METHYLTRANSFERASE", COQ3
13148,605197,KYNURENINASE, KYNU
13149,605198,TERMINAL NUCLEOTIDYLTRANSFERASE 4A, TENT4A
13150,605199,"SPLICING FACTOR, PROLINE- AND GLUTAMINE-RICH", SFPQ
13151,605200,HECT DOMAIN AND RCC1-LIKE DOMAIN 3, HERC3
13152,605201,HIGH DENSITY LIPOPROTEIN CHOLESTEROL LEVEL QUANTITATIVE TRAIT LOCUS 14, HDLCQ14
13153,605202,N-ACETYLNEURAMINIC ACID PHOSPHATE SYNTHASE, NANS
13154,605203,BARTSOCAS-PAPAS SYNDROME 1,
13155,605204,TORSIN 1A, TOR1A
13156,605205,ADENYLATE CYCLASE 10, ADCY10
13157,605206,HYPERPOLARIZATION-ACTIVATED CYCLIC NUCLEOTIDE-GATED POTASSIUM CHANNEL 4, HCN4
13158,605207,"CYTOCHROME P450, SUBFAMILY XXVIB, POLYPEPTIDE 1", CYP26B1
13159,605208,"SOLUTE CARRIER FAMILY 17 (VESICULAR GLUTAMATE COTRANSPORTER), MEMBER 7", SLC17A7
13160,605209,CHECKPOINT PROTEIN WITH FHA AND RING FINGER DOMAINS, CHFR
13161,605210,DISRUPTED IN SCHIZOPHRENIA 1, DISC1
13162,605211,BARH-LIKE 1, BARHL1
13163,605212,BARH-LIKE 2, BARHL2
13164,605213,3-PHOSPHOINOSITIDE-DEPENDENT PROTEIN KINASE 1, PDPK1
13165,605214,"POTASSIUM CHANNEL, CALCIUM-ACTIVATED, LARGE CONDUCTANCE, SUBFAMILY M, BETA MEMBER 2", KCNMB2
13166,605215,SRC KINASE-ASSOCIATED PHOSPHOPROTEIN 2, SKAP2
13167,605216,RHO GUANINE NUCLEOTIDE EXCHANGE FACTOR 4, ARHGEF4
13168,605217,SHC TRANSFORMING PROTEIN 2, SHC2
13169,605218,"SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 2", SLEB2
13170,605219,DIRECT IAP-BINDING PROTEIN WITH LOW pI, DIABLO
13171,605220,APOLIPOPROTEIN B RECEPTOR, APOBR
13172,605221,"SPLICING FACTOR, SERINE/ARGININE-RICH, 10", SRSF10
13173,605222,"POTASSIUM CHANNEL, CALCIUM-ACTIVATED, LARGE CONDUCTANCE, SUBFAMILY M, BETA MEMBER 3", KCNMB3
13174,605223,"POTASSIUM CHANNEL, CALCIUM-ACTIVATED, LARGE CONDUCTANCE, SUBFAMILY M, BETA MEMBER 4", KCNMB4
13175,605224,"RHODOPSIN HOMOLOG, RETINAL PIGMENT EPITHELIUM-DERIVED", RRH
13176,605225,INFLAMMATORY BOWEL DISEASE 7, IBD7
13177,605226,ARGININE-GLUTAMIC ACID DIPEPTIDE REPEATS, RERE
13178,605227,REVERSION-INDUCING CYSTEINE-RICH PROTEIN WITH KAZAL MOTIFS, RECK
13179,605228,"COREPRESSOR INTERACTING WITH RBPJ, 1", CIR1
13180,605229,"SPASTIC PARAPLEGIA 14, AUTOSOMAL RECESSIVE", SPG14
13181,605230,TUMOR PROTEIN p53-BINDING PROTEIN 1, TP53BP1
13182,605231,BARDET-BIEDL SYNDROME 6, BBS6
13183,605232,"PROTEIN KINASE, LYSINE-DEFICIENT 1", WNK1
13184,605233,DIANZANI AUTOIMMUNE LYMPHOPROLIFERATIVE DISEASE,
13185,605234,VOMERONASAL 1 RECEPTOR 1, VN1R1
13186,605235,NUCLEOLAR PROTEIN 3, NOL3
13187,605236,"CORIN, SERINE PEPTIDASE", CORIN
13188,605237,XENOTROPIC AND POLYTROPIC RETROVIRUS RECEPTOR, XPR1
13189,605238,HISTAMINE N-METHYLTRANSFERASE, HNMT
13190,605239,"ATPase, H+ TRANSPORTING, LYSOSOMAL, V0 SUBUNIT A, ISOFORM 4", ATP6V0A4
13191,605240,"CHEMOKINE, CC MOTIF, LIGAND 28", CCL28
13192,605241,LYMPHOCYTE ANTIGEN 86, LY86
13193,605242,USH1 PROTEIN NETWORK COMPONENT HARMONIN, USH1C
13194,605243,LYMPHOCYTE ANTIGEN 96, LY96
13195,605244,"CARNEY COMPLEX, TYPE 2", CNC2
13196,605245,"SOLUTE CARRIER FAMILY 2 (FACILITATED GLUCOSE TRANSPORTER), MEMBER 8", SLC2A8
13197,605246,COMPLEMENT COMPONENT 3a RECEPTOR 1, C3AR1
13198,605247,p53-INDUCED DEATH DOMAIN PROTEIN 1, PIDD1
13199,605248,MUCOLIPIN 1, MCOLN1
13200,605249,MACROTHROMBOCYTOPENIA AND GRANULOCYTE INCLUSIONS WITH OR WITHOUT NEPHRITIS OR SENSORINEURAL HEARING LOSS,
13201,605250,"ATP-BINDING CASSETTE, SUBFAMILY C, MEMBER 4", ABCC4
13202,605251,"ATP-BINDING CASSETTE, SUBFAMILY C, MEMBER 5", ABCC5
13203,605252,"POLYMERASE, DNA, IOTA", POLI
13204,605253,"NEUROPATHY, CONGENITAL HYPOMYELINATING, 1, AUTOSOMAL RECESSIVE", CHN1
13205,605254,NICASTRIN, NCSTN
13206,605255,ETS VARIANT TRANSCRIPTION FACTOR 7, ETV7
13207,605256,RAD18 E3 UBIQUITIN PROTEIN LIGASE, RAD18
13208,605257,ACTIVATION-INDUCED CYTIDINE DEAMINASE, AICDA
13209,605258,"IMMUNODEFICIENCY WITH HYPER-IgM, TYPE 2", HIGM2
13210,605259,SPINOCEREBELLAR ATAXIA 13, SCA13
13211,605260,HYPERTROPHIC NEUROPATHY OF DEJERINE-SOTTAS,
13212,605261,NADPH OXIDASE 4, NOX4
13213,605262,NMYC DOWNSTREAM-REGULATED GENE 1, NDRG1
13214,605263,SHC TRANSFORMING PROTEIN 3, SHC3
13215,605264,SORBIN AND SH3-DOMAINS CONTAINING PROTEIN 1, SORBS1
13216,605265,APOPTOSIS AND CASPASE ACTIVATION INHIBITOR, AVEN
13217,605266,JUNCTOPHILIN 1, JPH1
13218,605267,JUNCTOPHILIN 2, JPH2
13219,605268,JUNCTOPHILIN 3, JPH3
13220,605269,CORONIN 1C, CORO1C
13221,605270,N-SULFOGLUCOSAMINE SULFOHYDROLASE, SGSH
13222,605271,"SERPIN PEPTIDASE INHIBITOR, CLADE A, MEMBER 10", SERPINA10
13223,605272,NMYC DOWNSTREAM-REGULATED GENE 2, NDRG2
13224,605273,NMYC DOWNSTREAM-REGULATED GENE 3, NDRG3
13225,605274,"MESOMELIC DYSPLASIA, SAVARIRAYAN TYPE",
13226,605275,NOONAN SYNDROME 2, NS2
13227,605276,APOPTOSIS-ASSOCIATED TYROSINE KINASE, AATK
13228,605277,RHO GTPase-ACTIVATING PROTEIN 35, ARHGAP35
13229,605278,CARBOXYLESTERASE 2, CES2
13230,605279,CARBOXYLESTERASE 3, CES3
13231,605280,"SPASTIC PARAPLEGIA 13, AUTOSOMAL DOMINANT", SPG13
13232,605281,DEAD-BOX HELICASE 4, DDX4
13233,605282,TEMTAMY PREAXIAL BRACHYDACTYLY SYNDROME, TPBS
13234,605283,MAGE-LIKE 2, MAGEL2
13235,605284,TSC COMPLEX SUBUNIT 1, TSC1
13236,605285,"NEUROPATHY, HEREDITARY MOTOR AND SENSORY, RUSSE TYPE", HMSNR
13237,605286,CALPAIN 10, CAPN10
13238,605287,ARGINYL AMINOPEPTIDASE-LIKE 1, RNPEPL1
13239,605288,TESTICULAR GERM CELL TUMOR,
13240,605289,SPLIT-HAND/FOOT MALFORMATION 4, SHFM4
13241,605290,OPA1 MITOCHONDRIAL DYNAMIN-LIKE GTPase, OPA1
13242,605291,"5-PRIME,3-PRIME-NUCLEOTIDASE, CYTOSOLIC",
13243,605292,"5-PRIME-NUCLEOTIDASE, MITOCHONDRIAL", NT5M
13244,605293,OPTIC ATROPHY 4, OPA4
13245,605294,CARBOHYDRATE SULFOTRANSFERASE 6, CHST6
13246,605295,FIDGETIN, FIGN
13247,605296,PROTEASOME ASSEMBLY CHAPERONE 1, PSMG1
13248,605297,"NEGATIVE ELONGATION FACTOR COMPLEX, MEMBER C/D", NELFCD
13249,605298,VPS26 ENDOSOMAL PROTEIN-SORTING FACTOR C, VPS26C
13250,605299,NUCLEAR RECEPTOR COACTIVATOR 6, NCOA6
13251,605300,SH2B ADAPTOR PROTEIN 2, SH2B2
13252,605301,"TRANSFORMING, ACIDIC, COILED-COIL-CONTAINING PROTEIN 1", TACC1
13253,605302,"TRANSFORMING, ACIDIC, COILED-COIL-CONTAINING PROTEIN 2", TACC2
13254,605303,"TRANSFORMING, ACIDIC, COILED-COIL-CONTAINING PROTEIN 3", TACC3
13255,605304,NEUROGLOBIN, NGB
13256,605305,"KILLER CELL IMMUNOGLOBULIN-LIKE RECEPTOR, TWO DOMAINS, LONG CYTOPLASMIC TAIL, 5A", KIR2DL5A
13257,605306,"C-TYPE LECTIN DOMAIN FAMILY 4, MEMBER A", CLEC4A
13258,605307,ADRENOMEDULLIN RECEPTOR, ADMR
13259,605308,ZINC FINGER PROTEIN 346, ZNF346
13260,605309,MACROCEPHALY/AUTISM SYNDROME,
13261,605310,COILED-COIL ALPHA-HELICAL ROD PROTEIN 1, CCHCR1
13262,605311,"EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE, 1",
13263,605312,GROWTH/DIFFERENTIATION FACTOR 15, GDF15
13264,605313,RNA-BINDING MOTIF PROTEIN 8A, RBM8A
13265,605314,HISTONE DEACETYLASE 4, HDAC4
13266,605315,HISTONE DEACETYLASE 5, HDAC5
13267,605316,"DEAFNESS, AUTOSOMAL RECESSIVE 8",
13268,605317,FORKHEAD BOX P2, FOXP2
13269,605318,SUPPRESSOR OF TUMORIGENICITY 7,
13270,605319,"6-PHOSPHOFRUCTO-2-KINASE/FRUCTOSE-2,6-BISPHOSPHATASE 3", PFKFB3
13271,605320,"6-PHOSPHOFRUCTO-2-KINASE/FRUCTOSE-2,6-BISPHOSPHATASE 4", PFKFB4
13272,605321,FRONTOOCULAR SYNDROME,
13273,605322,WAP 4-DISULFIDE CORE DOMAIN 1, WFDC1
13274,605323,"C-TERMINAL DOMAIN OF RNA POLYMERASE II POLYPEPTIDE A, SMALL PHOSPHATASE OF, 1", CTDSP1
13275,605324,AMYLOID BETA PRECURSOR PROTEIN-BINDING PROTEIN 2, APPBP2
13276,605325,"CYTOCHROME P450, SUBFAMILY IIIA, POLYPEPTIDE 5", CYP3A5
13277,605326,TAX1-BINDING PROTEIN 1, TAX1BP1
13278,605327,"NUCLEAR FACTOR, INTERLEUKIN 3-REGULATED", NFIL3
13279,605328,KRUPPEL-LIKE FACTOR 13, KLF13
13280,605329,ADENYLATE CYCLASE 10,
13281,605330,INTERLEUKIN 22, IL22
13282,605331,ERYTHROCYTE MEMBRANE PROTEIN BAND 4.1-LIKE 3, EPB41L3
13283,605332,KELCH-LIKE 1, KLHL1
13284,605333,PDS5 COHESIN-ASSOCIATED FACTOR B, PDS5B
13285,605334,"INTRAUTERINE GROWTH RETARDATION, METAPHYSEAL DYSPLASIA, ADRENAL HYPOPLASIA CONGENITA, AND GENITAL ANOMALIES",
13286,605335,"PLECKSTRIN HOMOLOGY-LIKE DOMAIN, FAMILY A, MEMBER 1", PHLDA1
13287,605336,COMPLEMENT FACTOR H-RELATED 3, CFHR3
13288,605337,COMPLEMENT FACTOR H-RELATED 4, CFHR4
13289,605338,"INTERNEXIN, ALPHA", INA
13290,605339,FMR1 AUTOSOMAL HOMOLOG 2, FXR2
13291,605340,"CYTOCHROME P450, SUBFAMILY IIIA, POLYPEPTIDE 7", CYP3A7
13292,605341,"PAIRED IMMUNOGLOBULIN-LIKE TYPE 2 RECEPTOR, ALPHA", PILRA
13293,605342,"PAIRED IMMUNOGLOBULIN-LIKE TYPE 2 RECEPTOR, BETA", PILRB
13294,605343,FOLLISTATIN-LIKE 3, FSTL3
13295,605344,"NUCLEAR TRANSCRIPTION FACTOR Y, GAMMA", NFYC
13296,605345,"AlkB HOMOLOG 1, HISTONE H2A DIOXYGENASE", ALKBH1
13297,605346,INSULIN,
13298,605347,"PEPTIDYLARGININE DEIMINASE, TYPE IV", PADI4
13299,605348,TRANSMEMBRANE PROTEIN 50A, TMEM50A
13300,605349,NUCLEAR PRELAMIN A RECOGNITION FACTOR, NARF
13301,605350,"INTERLEUKIN 27 RECEPTOR, ALPHA", IL27RA
13302,605351,FIBRINOGEN-LIKE 2, FGL2
13303,605352,MALIGNANT FIBROUS HISTIOCYTOMA-AMPLIFIED SEQUENCE 1, MFHAS1
13304,605353,GHRELIN, GHRL
13305,605354,CASPASE RECRUITMENT DOMAIN-CONTAINING PROTEIN 18, CARD18
13306,605355,"NEMALINE MYOPATHY 5A, AUTOSOMAL RECESSIVE, SEVERE INFANTILE", NEM5A
13307,605356,"TYROSINE 3-MONOOXYGENASE/TRYPTOPHAN 5-MONOOXYGENASE ACTIVATION PROTEIN, GAMMA ISOFORM", YWHAG
13308,605357,STONIN 1, STON1
13309,605358,"GENERAL TRANSCRIPTION FACTOR IIA, 1-LIKE", GTF2A1L
13310,605359,PROLINE-RICH PROTEIN 4, PRR4
13311,605360,COILED-COIL DOMAIN-CONTAINING PROTEIN 85B, CCDC85B
13312,605361,SPINOCEREBELLAR ATAXIA 14, SCA14
13313,605362,"CARDIOMYOPATHY, DILATED, 1J", CMD1J
13314,605363,GLUTAMATE DECARBOXYLASE 1, GAD1
13315,605364,"PSORIASIS 6, SUSCEPTIBILITY TO", PSORS6
13316,605365,BREAST CANCER,
13317,605366,OLFACTOMEDIN 1, OLFM1
13318,605367,ELAC RIBONUCLEASE Z 2, ELAC2
13319,605368,BCL2/ADENOVIRUS E1B 19-KD PROTEIN-INTERACTING PROTEIN 3-LIKE, BNIP3L
13320,605369,"TRANSMEMBRANE PROTEASE, SERINE 11D", TMPRSS11D
13321,605370,RHO GTPase-ACTIVATING PROTEIN 26, ARHGAP26
13322,605371,ADP-RIBOSYLATION FACTOR GUANINE NUCLEOTIDE EXCHANGE FACTOR 2, ARFGEF2
13323,605372,HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN A3, HNRNPA3
13324,605373,PHEOCHROMOCYTOMA/PARAGANGLIOMA SYNDROME 3, PPGL3
13325,605374,"MYCN, OPPOSITE STRAND", MYCNOS
13326,605375,"EPILEPSY, NOCTURNAL FRONTAL LOBE, 3", ENFL3
13327,605376,"HETEROTAXY, VISCERAL, 2, AUTOSOMAL", HTX2
13328,605377,DYSTROPHIA MYOTONICA PROTEIN KINASE, DMPK
13329,605378,ALADIN WD REPEAT NUCLEOPORIN, AAAS
13330,605379,GIGAXONIN, GAN
13331,605380,FIBROBLAST GROWTH FACTOR 23, FGF23
13332,605381,"RHESUS BLOOD GROUP, C GLYCOPROTEIN", RHCG
13333,605382,INCLUSION BODY MYOPATHY WITH EARLY-ONSET PAGET DISEASE WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA 1,
13334,605383,INTERLEUKIN 21 RECEPTOR, IL21R
13335,605384,INTERLEUKIN 21, IL21
13336,605385,PRENYL PROTEIN PROTEASE RCE1, RCE1
13337,605386,MICRO RNA LET7A1, MIRLET7A1
13338,605387,"CATARACT 31, MULTIPLE TYPES", CTRCT31
13339,605388,"CEREBRAL PALSY, ATAXIC, AUTOSOMAL RECESSIVE",
13340,605389,HYPOTRICHOSIS 1, HYPT1
13341,605390,LEUPAXIN, LPXN
13342,605391,MULTIPLE INOSITOL POLYPHOSPHATE PHOSPHATASE 1, MINPP1
13343,605392,FIBROBLAST GROWTH FACTOR RECEPTOR 1 ONCOGENE PARTNER, FGFR1OP
13344,605393,LYSINE DEMETHYLASE 5B, KDM5B
13345,605394,BTB AND CNC HOMOLOGY 2, BACH2
13346,605395,TRANSMEMBRANE p24 TRAFFICKING PROTEIN 1, TMED1
13347,605396,A-KINASE ANCHOR PROTEIN 13,
13348,605397,CD226 ANTIGEN, CD226
13349,605398,"CHEMOKINE, CXC MOTIF, LIGAND 16", CXCL16
13350,605399,NIDOGEN 2, NID2
13351,605400,"FIBROMATOSIS, GINGIVAL, WITH HYPERTRICHOSIS AND IMPAIRED INTELLECTUAL DEVELOPMENT",
13352,605401,IQ MOTIF-CONTAINING GTPase-ACTIVATING PROTEIN 2, IQGAP2
13353,605402,CD274 MOLECULE, CD274
13354,605403,TOLL-LIKE RECEPTOR 6, TLR6
13355,605404,BCL2-RELATED OVARIAN KILLER, BOK
13356,605405,USP6 N-TERMINAL-LIKE, USP6NL
13357,605406,TRANSMEMBRANE p24 TRAFFICKING PROTEIN 10, TMED10
13358,605407,"SEGAWA SYNDROME, AUTOSOMAL RECESSIVE",
13359,605408,"DYSTONIA 11, MYOCLONIC",
13360,605409,TRANSCRIPTION ELONGATION REGULATOR 1, TCERG1
13361,605410,"POTASSIUM VOLTAGE-GATED CHANNEL, SHAL-RELATED SUBFAMILY, MEMBER 2", KCND2
13362,605411,"POTASSIUM VOLTAGE-GATED CHANNEL, SHAL-RELATED SUBFAMILY, MEMBER 3", KCND3
13363,605412,"RAB, MEMBER OF RAS ONCOGENE FAMILY-LIKE 2A", RABL2A
13364,605413,"RAB, MEMBER OF RAS ONCOGENE FAMILY-LIKE 2B", RABL2B
13365,605414,"ATP-BINDING CASSETTE, SUBFAMILY A, MEMBER 7", ABCA7
13366,605415,DICKKOPF WNT SIGNALING PATHWAY INHIBITOR 2, DKK2
13367,605416,DICKKOPF WNT SIGNALING PATHWAY INHIBITOR 3, DKK3
13368,605417,DICKKOPF WNT SIGNALING PATHWAY INHIBITOR 4, DKK4
13369,605418,DICKKOPF-LIKE 1, DKKL1
13370,605419,SCHIZOPHRENIA 10, SCZD10
13371,605420,ARISTALESS HOMEOBOX 4, ALX4
13372,605421,"A DISINTEGRIN-LIKE AND METALLOPROTEINASE WITH THROMBOSPONDIN TYPE 1 MOTIF, 9", ADAMTS9
13373,605422,ZINC FINGER PROTEIN 350, ZNF350
13374,605423,DESERT HEDGEHOG SIGNALING MOLECULE, DHH
13375,605424,MASTERMIND-LIKE 1, MAML1
13376,605425,"GAP JUNCTION PROTEIN, BETA-4", GJB4
13377,605426,TUMOR PROTEIN p53-REGULATED APOPTOSIS-INDUCING PROTEIN 1, TP53AIP1
13378,605427,"TRANSIENT RECEPTOR POTENTIAL CATION CHANNEL, SUBFAMILY V, MEMBER 4", TRPV4
13379,605428,"DEAFNESS, AUTOSOMAL RECESSIVE 26", DFNB26
13380,605429,"DEAFNESS, AUTOSOMAL RECESSIVE 26, MODIFIER OF", DFNB26M
13381,605430,SPERM-ASSOCIATED ANTIGEN 9, SPAG9
13382,605431,MITOGEN-ACTIVATED PROTEIN KINASE 8-INTERACTING PROTEIN 3, MAPK8IP3
13383,605432,RADIOULNAR SYNOSTOSIS WITH AMEGAKARYOCYTIC THROMBOCYTOPENIA 1, RUSAT1
13384,605433,KINESIN FAMILY MEMBER 13A, KIF13A
13385,605434,CLASPIN, CLSPN
13386,605435,PROTEIN KINASE D1, PRKD1
13387,605436,"SMALL NUCLEOLAR RNA, C/D BOX, 116-1", SNORD116-1
13388,605437,"PROTEIN KINASE C, ETA", PRKCH
13389,605438,DISCS LARGE-ASSOCIATED PROTEIN 2, DLGAP2
13390,605439,ETS HOMOLOGOUS FACTOR, EHF
13391,605440,UBIQUILIN 4, UBQLN4
13392,605441,"ADIPOCYTE-, C1q-, AND COLLAGEN DOMAIN-CONTAINING", ADIPOQ
13393,605442,WT1-ASSOCIATED PROTEIN, WTAP
13394,605443,PCGEM1 PROSTATE-SPECIFIC TRANSCRIPT, PCGEM1
13395,605444,RBMX-LIKE PROTEIN 2, RBMXL2
13396,605445,DISCS LARGE-ASSOCIATED PROTEIN 1, DLGAP1
13397,605446,RETINITIS PIGMENTOSA GTPase REGULATOR-INTERACTING PROTEIN, RPGRIP1
13398,605447,SMALL NUCLEOLAR RNA HOST GENE 32, SNHG32
13399,605448,RUN DOMAIN-CONTAINING PROTEIN 3A, RUNDC3A
13400,605449,"GLUTATHIONE S-TRANSFERASE, ALPHA-3", GSTA3
13401,605450,"GLUTATHIONE S-TRANSFERASE, ALPHA-4", GSTA4
13402,605451,p21 PROTEIN-ACTIVATED KINASE 4, PAK4
13403,605452,"ATP-BINDING CASSETTE, SUBFAMILY B, MEMBER 6", ABCB6
13404,605453,"ATP-BINDING CASSETTE, SUBFAMILY B, MEMBER 9", ABCB9
13405,605454,"ATP-BINDING CASSETTE, SUBFAMILY B, MEMBER 10", ABCB10
13406,605455,RAS-ASSOCIATED PROTEIN RAB26, RAB26
13407,605456,BET1 GOLGI VESICULAR MEMBRANE-TRAFFICKING PROTEIN, BET1
13408,605457,"INTERLEUKIN 22 RECEPTOR, ALPHA-1", IL22RA1
13409,605458,INTERLEUKIN 17 RECEPTOR B, IL17RB
13410,605459,"ATP-BINDING CASSETTE, SUBFAMILY G, MEMBER 5", ABCG5
13411,605460,"ATP-BINDING CASSETTE, SUBFAMILY G, MEMBER 8", ABCG8
13412,605461,INTERLEUKIN 17 RECEPTOR A, IL17RA
13413,605462,"BASAL CELL CARCINOMA, SUSCEPTIBILITY TO, 1", BCC1
13414,605463,"RADIATION SENSITIVITY/CHROMOSOME INSTABILITY SYNDROME, AUTOSOMAL DOMINANT",
13415,605464,"ATP-BINDING CASSETTE, SUBFAMILY B, MEMBER 8", ABCB8
13416,605465,ZINC FINGER PROTEIN 277, ZNF277
13417,605466,"SIGNAL REGULATORY PROTEIN, GAMMA", SIRPG
13418,605467,ZINC FINGER PROTEIN 274, ZNF274
13419,605468,CDC42 EFFECTOR PROTEIN 4, CDC42EP4
13420,605469,LYSINE DEMETHYLASE 4C, KDM4C
13421,605470,MATRIX METALLOPROTEINASE 26, MMP26
13422,605471,ZINC FINGER FYVE TYPE-CONTAINING PROTEIN 1, ZFYVE1
13423,605472,"USHER SYNDROME, TYPE IIC", USH2C
13424,605473,UBIQUILIN 3, UBQLN3
13425,605474,TOLL-LIKE RECEPTOR 9, TLR9
13426,605475,BAI1-ASSOCIATED PROTEIN 2, BAIAP2
13427,605476,"ARF GTPase-ACTIVATING PROTEIN WITH GTPase DOMAIN, ANKYRIN REPEAT, AND PLECKSTRIN HOMOLOGY DOMAIN 2", AGAP2
13428,605477,RHO GUANINE NUCLEOTIDE EXCHANGE FACTOR 7, ARHGEF7
13429,605478,SINGLE IMMUNOGLOBULIN DOMAIN-CONTAINING IL1R-RELATED PROTEIN, SIGIRR
13430,605479,"CHOLESTASIS, BENIGN RECURRENT INTRAHEPATIC, 2", BRIC2
13431,605480,"SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 3", SLEB3
13432,605481,"ABNORMAL SPINDLE-LIKE, MICROCEPHALY-ASSOCIATED", ASPM
13433,605482,"GLUTATHIONE S-TRANSFERASE, OMEGA-1", GSTO1
13434,605483,"DYNEIN, AXONEMAL, INTERMEDIATE CHAIN 2", DNAI2
13435,605484,"Fc FRAGMENT OF IgA AND IgM, RECEPTOR FOR", FCAMR
13436,605485,VPS41 SUBUNIT OF HOPS COMPLEX, VPS41
13437,605486,RNA-BINDING MOTIF PROTEIN 8A,
13438,605487,cAMP-REGULATED PHOSPHOPROTEIN 19, ARPP19
13439,605488,cAMP-REGULATED PHOSPHOPROTEIN 21, ARPP21
13440,605489,INTRAFLAGELLAR TRANSPORT 81, IFT81
13441,605490,"LON PEPTIDASE 1, MITOCHONDRIAL", LONP1
13442,605491,NEBULETTE, NEBL
13443,605492,"LEUCINE-RICH REPEAT PROTEIN, NEURONAL, 2", LRRN2
13444,605493,TRIPARTITE MOTIF-CONTAINING PROTEIN 3, TRIM3
13445,605494,"INTEGRIN, BETA-3, BINDING PROTEIN OF", ITGB3BP
13446,605495,"SOLUTE CARRIER ORGANIC ANION TRANSPORTER FAMILY, MEMBER 1B3", SLCO1B3
13447,605496,CENTROSOMAL PROTEIN 1, CEP1
13448,605497,CARTILAGE-ASSOCIATED PROTEIN, CRTAP
13449,605498,M-PHASE PHOSPHOPROTEIN 1, MPHOSPH1
13450,605499,"ZW10 INTERACTOR, ANTISENSE", ZWINTAS
13451,605500,M-PHASE PHOSPHOPROTEIN 6, MPHOSPH6
13452,605501,M-PHASE PHOSPHOPROTEIN 9, MPHOSPH9
13453,605502,"DNAJ/HSP40 HOMOLOG, SUBFAMILY C, MEMBER 2", DNAJC2
13454,605503,M-PHASE PHOSPHOPROTEIN 10, MPHOSPH10
13455,605504,KALLIKREIN-RELATED PEPTIDASE 9, KLK9
13456,605505,KALLIKREIN-RELATED PEPTIDASE 13, KLK13
13457,605506,VPS26 RETROMER COMPLEX COMPONENT A, VPS26A
13458,605507,INTERLEUKIN 36 RECEPTOR ANTAGONIST, IL36RN
13459,605508,"INTERLEUKIN 36, BETA", IL36B
13460,605509,"INTERLEUKIN 36, ALPHA", IL36A
13461,605510,INTERLEUKIN 37, IL37
13462,605511,"TRANSMEMBRANE PROTEASE, SERINE 3", TMPRSS3
13463,605512,ELONGATION OF VERY LONG CHAIN FATTY ACIDS-LIKE 4, ELOVL4
13464,605513,MELAN A, MLANA
13465,605514,PROTOCADHERIN 15, PCDH15
13466,605515,FORKHEAD BOX P1, FOXP1
13467,605516,CADHERIN 23, CDH23
13468,605517,"BETA-1,4-GLUCURONYLTRANSFERASE 1", B4GAT1
13469,605518,LIPIN 1, LPIN1
13470,605519,LIPIN 2, LPIN2
13471,605520,LIPIN 3, LPIN3
13472,605521,TATA BOX-BINDING PROTEIN-LIKE PROTEIN 1, TBPL1
13473,605522,LIMB DEVELOPMENT MEMBRANE PROTEIN 1, LMBR1
13474,605523,"TRANSDUCER OF ERBB2, 1", TOB1
13475,605524,FORKHEAD BOX G1,
13476,605525,CHROMATIN LICENSING AND DNA REPLICATION FACTOR 1, CDT1
13477,605526,ALZHEIMER DISEASE 6,
13478,605527,"METHIONINE ADENOSYLTRANSFERASE II, BETA", MAT2B
13479,605528,NEURAMINIDASE 2, NEU2
13480,605529,UPF2 REGULATOR OF NONSENSE-MEDIATED mRNA DECAY, UPF2
13481,605530,UPF3A REGULATOR OF NONSENSE-MEDIATED mRNA DECAY, UPF3A
13482,605531,UPF3B REGULATOR OF NONSENSE-MEDIATED mRNA DECAY,
13483,605532,SMAD-SPECIFIC E3 UBIQUITIN PROTEIN LIGASE 2, SMURF2
13484,605533,NEUREGULIN 3, NRG3
13485,605534,HIGH MOBILITY GROUP PROTEIN 20A, HMG20A
13486,605535,HIGH MOBILITY GROUP PROTEIN 20B, HMG20B
13487,605536,RAB11 FAMILY-INTERACTING PROTEIN 5, RAB11FIP5
13488,605537,ACTIVATING TRANSCRIPTION FACTOR 6, ATF6
13489,605538,NEUROTENSIN RECEPTOR 2, NTSR2
13490,605539,KALLIKREIN-RELATED PEPTIDASE 12, KLK12
13491,605540,TERMINAL NUCLEOTIDYLTRANSFERASE 4B, TENT4B
13492,605541,VAV GUANINE NUCLEOTIDE EXCHANGE FACTOR 3, VAV3
13493,605542,"INTERLEUKIN 36, GAMMA", IL36G
13494,605543,"PARKINSON DISEASE 4, AUTOSOMAL DOMINANT", PARK4
13495,605544,"FIBROMATOSIS, GINGIVAL, 2", GINGF2
13496,605545,CD163 ANTIGEN, CD163
13497,605546,"GLYCOPROTEIN VI, PLATELET", GP6
13498,605547,FOLLISTATIN-LIKE 1, FSTL1
13499,605548,A DISINTEGRIN AND METALLOPROTEINASE DOMAIN 15, ADAM15
13500,605549,CONE-ROD DYSTROPHY 8, CORD8
13501,605550,"RAS PROTEIN, DEXAMETHASONE-INDUCED, 1", RASD1
13502,605551,NITRIC OXIDE SYNTHASE 1 (NEURONAL) ADAPTOR PROTEIN, NOS1AP
13503,605552,ABDOMINAL OBESITY-METABOLIC SYNDROME 1, AOMS1
13504,605553,"POLY(A) POLYMERASE, ALPHA", PAPOLA
13505,605554,CD244 ANTIGEN, CD244
13506,605555,ARYL HYDROCARBON RECEPTOR-INTERACTING PROTEIN, AIP
13507,605556,"SOLUTE CARRIER FAMILY 4 (SODIUM BICARBONATE TRANSPORTER-LIKE), MEMBER 10", SLC4A10
13508,605557,PR DOMAIN-CONTAINING PROTEIN 16, PRDM16
13509,605558,FIBROBLAST GROWTH FACTOR 20, FGF20
13510,605559,HOMEOBOX C11, HOXC11
13511,605560,HOMEOBOX C10, HOXC10
13512,605561,PLAKOPHILIN 3, PKP3
13513,605562,"SECRETOGLOBIN, FAMILY 2A, MEMBER 2", SCGB2A2
13514,605563,CALCIUM-BINDING PROTEIN 1, CABP1
13515,605564,CALCIUM- AND INTEGRIN-BINDING PROTEIN 2, CIB2
13516,605565,RESISTIN, RETN
13517,605566,RETICULON 4 RECEPTOR, RTN4R
13518,605567,SIVA APOPTOSIS-INDUCING FACTOR 1, SIVA1
13519,605568,SMAD-SPECIFIC E3 UBIQUITIN PROTEIN LIGASE 1, SMURF1
13520,605569,G PROTEIN-COUPLED RECEPTOR 83, GPR83
13521,605570,RAS-ASSOCIATED PROTEIN RAB11A, RAB11A
13522,605571,PIWI-LIKE RNA-MEDIATED GENE SILENCING 1, PIWIL1
13523,605572,ABDOMINAL OBESITY-METABOLIC SYNDROME QUANTITATIVE TRAIT LOCUS 2,
13524,605573,17-BETA HYDROXYSTEROID DEHYDROGENASE III, HSD17B3
13525,605574,UBIQUITIN-CONJUGATING ENZYME E2 C, UBE2C
13526,605575,STRUCTURAL MAINTENANCE OF CHROMOSOMES 4, SMC4
13527,605576,STRUCTURAL MAINTENANCE OF CHROMOSOMES 2, SMC2
13528,605577,RAS GUANYL NUCLEOTIDE-RELEASING PROTEIN 2, RASGRP2
13529,605578,INTERFERON-INDUCED TRANSMEMBRANE PROTEIN 2, IFITM2
13530,605579,INTERFERON-INDUCED TRANSMEMBRANE PROTEIN 3, IFITM3
13531,605580,INTERLEUKIN 23-ALPHA, IL23A
13532,605581,"BETA-1,3-N-ACETYLGLUCOSYAMINYLTRANSFERASE 2", B3GNT2
13533,605582,"CARDIOMYOPATHY, DILATED, 1K", CMD1K
13534,605583,"DEAFNESS, AUTOSOMAL DOMINANT 25", DFNA25
13535,605584,DEAH-BOX HELICASE 38, DHX38
13536,605585,CELL DIVISION CYCLE 40, CDC40
13537,605586,IMPORTIN 7, IPO7
13538,605587,PROTEASE INHIBITOR 14, PI14
13539,605588,"CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2B1", CMT2B1
13540,605589,"CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2B2", CMT2B2
13541,605590,"SPLICING FACTOR 3B, SUBUNIT 1", SF3B1
13542,605591,"SPLICING FACTOR 3B, SUBUNIT 2", SF3B2
13543,605592,"SPLICING FACTOR 3B, SUBUNIT 3", SF3B3
13544,605593,"SPLICING FACTOR 3B, SUBUNIT 4", SF3B4
13545,605594,"DEAFNESS, AUTOSOMAL DOMINANT 39, WITH DENTINOGENESIS IMPERFECTA 1",
13546,605595,"SPLICING FACTOR 3A, SUBUNIT 1", SF3A1
13547,605596,"SPLICING FACTOR 3A, SUBUNIT 3", SF3A3
13548,605597,FORKHEAD TRANSCRIPTION FACTOR FOXL2, FOXL2
13549,605598,TYPE 1 DIABETES MELLITUS 18, T1D18
13550,605599,LYSOPHOSPHOLIPASE I, LYPLA1
13551,605600,IMPORTIN 8, IPO8
13552,605601,PROTEOGLYCAN 2, PRG2
13553,605602,MYOZENIN 2, MYOZ2
13554,605603,MYOZENIN 1, MYOZ1
13555,605604,POLYADENYLATE-BINDING PROTEIN-INTERACTING PROTEIN 2, PAIP2
13556,605605,HIGH MOBILITY GROUP PROTEIN 20B,
13557,605606,"PSORIASIS 7, SUSCEPTIBILITY TO", PSORS7
13558,605607,CENTROMERIC PROTEIN H, CENPH
13559,605608,CLAUDIN 14, CLDN14
13560,605609,OXIDATION RESISTANCE 1, OXR1
13561,605610,POLYNUCLEOTIDE KINASE 3-PRIME PHOSPHATASE, PNKP
13562,605611,SH3 DOMAIN-BINDING PROTEIN 4, SH3BP4
13563,605612,SH3 DOMAIN-BINDING PROTEIN 5, SH3BP5
13564,605613,HUNTINGTIN-INTERACTING PROTEIN 1-RELATED PROTEIN, HIP1R
13565,605614,GCN1 ACTIVATOR OF EIF2AK4, GCN1
13566,605615,ARIADNE RBR E3 UBIQUITIN PROTEIN LIGASE 2, ARIH2
13567,605616,"SOLUTE CARRIER FAMILY 6 (PROLINE IMINO TRANSPORTER), MEMBER 20", SLC6A20
13568,605617,"SPLIT-HAND/FOOT MALFORMATION 1 WITH SENSORINEURAL HEARING LOSS, AUTOSOMAL RECESSIVE",
13569,605618,"TETRALOGY OF FALLOT SYNDROME, AUTOSOMAL RECESSIVE",
13570,605619,INTERLEUKIN 20, IL20
13571,605620,"INTERLEUKIN 20 RECEPTOR, ALPHA", IL20RA
13572,605621,"INTERLEUKIN 20 RECEPTOR, BETA", IL20RB
13573,605622,PROTOCADHERIN 12, PCDH12
13574,605623,MUSKELIN 1, MKLN1
13575,605624,ARIADNE RBR E3 UBIQUITIN PROTEIN LIGASE 1, ARIH1
13576,605625,MYELOMA OVEREXPRESSED GENE, MYEOV
13577,605626,"ENDOGENOUS RETROVIRUS GROUP K, MEMBER 6", ERVK-6
13578,605627,CEREBROOCULONASAL SYNDROME,
13579,605628,"HIV-1 TAT-INTERACTING PROTEIN 2, 30-KD", HTATIP2
13580,605629,CITRON RHO-INTERACTING SERINE/THREONINE KINASE, CIT
13581,605630,"PHOSPHOLIPASE A2, GROUP IID", PLA2G2D
13582,605631,NAPSIN A, NAPSA
13583,605632,"SOLUTE CARRIER FAMILY 35 (UDP-N-ACETYLGLUCOSAMINE TRANSPORTER), MEMBER 3", SLC35A3
13584,605633,"MUCIN 3B, INTESTINAL", MUC3B
13585,605634,"SOLUTE CARRIER FAMILY 35 (CMP-SIALIC ACID TRANSPORTER), MEMBER 1", SLC35A1
13586,605635,"HYPERALDOSTERONISM, FAMILIAL, TYPE II", HALD2
13587,605636,MATERNALLY EXPRESSED GENE 3, MEG3
13588,605637,CONGENITAL MYOPATHY 6 WITH OPHTHALMOPLEGIA, CMYO6
13589,605638,BACULOVIRAL IAP REPEAT-CONTAINING PROTEIN 6, BIRC6
13590,605639,SIALIC ACID-BINDING IMMUNOGLOBULIN-LIKE LECTIN 8, SIGLEC8
13591,605640,SIALIC ACID-BINDING IMMUNOGLOBULIN-LIKE LECTIN 9, SIGLEC9
13592,605641,"SOLUTE CARRIER FAMILY 7 (CATIONIC AMINO ACID TRANSPORTER, y+ SYSTEM), MEMBER 6", SLC7A6
13593,605642,"THYROID CARCINOMA, PAPILLARY, WITH PAPILLARY RENAL NEOPLASIA",
13594,605643,KALLIKREIN-RELATED PEPTIDASE 5, KLK5
13595,605644,KALLIKREIN-RELATED PEPTIDASE 8, KLK8
13596,605645,"RESISTIN-LIKE PROTEIN, BETA", RETNLB
13597,605646,"SOLUTE CARRIER FAMILY 26, MEMBER 4", SLC26A4
13598,605647,F-BOX ONLY PROTEIN 6, FBXO6
13599,605648,F-BOX ONLY PROTEIN 7, FBXO7
13600,605649,F-BOX ONLY PROTEIN 8, FBXO8
13601,605650,"POLYMERASE, DNA, KAPPA", POLK
13602,605651,F-BOX AND WD40 DOMAIN PROTEIN 11, FBXW11
13603,605652,F-BOX AND LEUCINE-RICH REPEAT PROTEIN 2, FBXL2
13604,605653,F-BOX AND LEUCINE-RICH REPEAT PROTEIN 3, FBXL3
13605,605654,F-BOX AND LEUCINE-RICH REPEAT PROTEIN 4, FBXL4
13606,605655,F-BOX AND LEUCINE-RICH REPEAT PROTEIN 5, FBXL5
13607,605656,F-BOX AND LEUCINE-RICH REPEAT PROTEIN 7, FBXL7
13608,605657,LYSINE DEMETHYLASE 2A, KDM2A
13609,605658,INTERLEUKIN 25, IL25
13610,605659,"C-TYPE LECTIN DOMAIN FAMILY 2, MEMBER D", CLEC2D
13611,605660,PREFOLDIN 6, PFDN6
13612,605661,TRIPARTITE MOTIF-CONTAINING PROTEIN 13, TRIM13
13613,605662,RAS-ASSOCIATED PROTEIN RAB36, RAB36
13614,605663,RADIAL SPOKE HEAD 14 HOMOLOG, RSPH14
13615,605664,KINESIN FAMILY MEMBER 20A, KIF20A
13616,605665,ASPARTATE BETA-HYDROXYLASE,
13617,605666,CYSTEINYL LEUKOTRIENE RECEPTOR 2, CYSLTR2
13618,605667,RAL GUANINE NUCLEOTIDE DISSOCIATION STIMULATOR-LIKE 1, RGL1
13619,605668,BETA-SITE AMYLOID BETA A4 PRECURSOR PROTEIN-CLEAVING ENZYME 2, BACE2
13620,605669,PROSTATE AND BREAST CANCER OVEREXPRESSED 1, PBOV1
13621,605670,LATE-ONSET RETINAL DEGENERATION, LORD
13622,605671,DMX-LIKE 1, DMXL1
13623,605672,CEREBELLAR ATAXIA AND HYPERGONADOTROPIC HYPOGONADISM,
13624,605673,B-CELL ANTIPROLIFERATION FACTOR 4, BTG4
13625,605674,B-CELL ANTIPROLIFERATION FACTOR 3, BTG3
13626,605675,RING FINGER PROTEIN 14, RNF14
13627,605676,"CARDIOMYOPATHY, DILATED, WITH WOOLLY HAIR AND KERATODERMA", DCWHK
13628,605677,"ACYL-CoA SYNTHETASE LONG CHAIN FAMILY, MEMBER 5", ACSL5
13629,605678,MLX-INTERACTING PROTEIN-LIKE, MLXIPL
13630,605679,INTERLEUKIN 26, IL26
13631,605680,"BROMODOMAIN ADJACENT TO ZINC FINGER DOMAIN, 1A", BAZ1A
13632,605681,"BROMODOMAIN ADJACENT TO ZINC FINGER DOMAIN, 1B", BAZ1B
13633,605682,"BROMODOMAIN ADJACENT TO ZINC FINGER DOMAIN, 2A", BAZ2A
13634,605683,"BROMODOMAIN ADJACENT TO ZINC FINGER DOMAIN, 2B", BAZ2B
13635,605684,TRIPARTITE MOTIF-CONTAINING PROTEIN 34, TRIM34
13636,605685,COHEN SYNDROME,
13637,605686,CELL ADHESION MOLECULE 1, CADM1
13638,605687,INTERLEUKIN 19, IL19
13639,605688,COPINE VI, CPNE6
13640,605689,COPINE VII, CPNE7
13641,605690,BRD4-INTERACTING CHROMATIN REMODELING COMPLEX-ASSOCIATED PROTEIN, BICRA
13642,605691,RIBOSOME BIOGENESIS FACTOR NOP53, NOP53
13643,605692,"TRANSIENT RECEPTOR POTENTIAL CATION CHANNEL, SUBFAMILY M, MEMBER 7", TRPM7
13644,605693,RAS-ASSOCIATED PROTEIN RAB30, RAB30
13645,605694,RAS-ASSOCIATED PROTEIN RAB31, RAB31
13646,605695,"BIOGENESIS OF LYSOSOME-RELATED ORGANELLES COMPLEX 1, SUBUNIT 4", BLOC1S4
13647,605696,"POTASSIUM CHANNEL, VOLTAGE-GATED, SUBFAMILY G, MEMBER 2", KCNG2
13648,605697,UL16-BINDING PROTEIN 1, ULBP1
13649,605698,UL16-BINDING PROTEIN 2, ULBP2
13650,605699,UL16-BINDING PROTEIN 3, ULBP3
13651,605700,TRIPARTITE MOTIF-CONTAINING PROTEIN 39, TRIM39
13652,605701,TRIPARTITE MOTIF-CONTAINING PROTEIN 10, TRIM10
13653,605702,LYMPHATIC VESSEL ENDOTHELIAL HYALURONAN RECEPTOR 1, LYVE1
13654,605703,VAMP-ASSOCIATED PROTEIN A, VAPA
13655,605704,VAMP-ASSOCIATED PROTEIN B AND C, VAPB
13656,605705,SALT-INDUCIBLE KINASE 1, SIK1
13657,605706,RECEPTOR-INTERACTING SERINE-THREONINE KINASE 4, RIPK4
13658,605707,"SPECTRIN, BETA, NONERYTHROCYTIC, 2",
13659,605708,RHO GUANINE NUCLEOTIDE EXCHANGE FACTOR 11, ARHGEF11
13660,605709,ADP-RIBOSYLATION FACTOR-LIKE GTPase 6-INTERACTING PROTEIN 5, ARL6IP5
13661,605710,GDNF FAMILY RECEPTOR ALPHA-3, GFRA3
13662,605711,MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 1, MMDS1
13663,605712,"SERINE PALMITOYLTRANSFERASE, LONG-CHAIN BASE SUBUNIT 1", SPTLC1
13664,605713,"SERINE PALMITOYLTRANSFERASE, LONG-CHAIN BASE SUBUNIT 2", SPTLC2
13665,605714,"CEREBRAL AMYLOID ANGIOPATHY, APP-RELATED",
13666,605715,CD276 ANTIGEN, CD276
13667,605716,"POTASSIUM CHANNEL, VOLTAGE-GATED, SUBFAMILY H, MEMBER 5", KCNH5
13668,605717,INDUCIBLE T-CELL COSTIMULATOR LIGAND, ICOSLG
13669,605718,MEDIATOR COMPLEX SUBUNIT 4, MED4
13670,605719,"LINKER FOR ACTIVATION OF T CELLS FAMILY, MEMBER 2", LAT2
13671,605720,"POTASSIUM CHANNEL, SUBFAMILY K, MEMBER 4", KCNK4
13672,605721,JUNCTION ADHESION MOLECULE 1, JAM1
13673,605722,"POTASSIUM CHANNEL, INWARDLY RECTIFYING, SUBFAMILY J, MEMBER 16", KCNJ16
13674,605723,PROGRAMMED CELL DEATH 1 LIGAND 2, PDCD1LG2
13675,605724,"FANCONI ANEMIA, COMPLEMENTATION GROUP D1", FANCD1
13676,605725,PERIAXIN, PRX
13677,605726,"NEURONOPATHY, DISTAL HEREDITARY MOTOR, AUTOSOMAL RECESSIVE 2", HMNR2
13678,605727,OTOSCLEROSIS 2, OTSC2
13679,605728,CATARACT 25, CTRCT25
13680,605729,AT-HOOK TRANSCRIPTION FACTOR AKNA, AKNA
13681,605730,SPERM-ASSOCIATED ANTIGEN 6, SPAG6
13682,605731,SPERM-ASSOCIATED ANTIGEN 8, SPAG8
13683,605732,"TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY, MEMBER 21", TNFRSF21
13684,605733,PRELI DOMAIN-CONTAINING PROTEIN 1, PRELID1
13685,605734,TRANSMEMBRANE PROTEIN WITH EGF-LIKE AND 2 FOLLISTATIN-LIKE DOMAINS 2, TMEFF2
13686,605735,"BLEEDING DISORDER, PLATELET-TYPE, 12", BDPLT12
13687,605736,UBIQUITIN-ASSOCIATED AND SH3 DOMAIN-CONTAINING PROTEIN A, UBASH3A
13688,605737,BACULOVIRAL IAP REPEAT-CONTAINING PROTEIN 7, BIRC7
13689,605738,MICROPHTHALMIA/COLOBOMA 2, MCOPCB2
13690,605739,KYPHOSCOLIOSIS PEPTIDASE, KY
13691,605740,SCLEROSTIN, SOST
13692,605741,G PROTEIN-COUPLED RECEPTOR 183, GPR183
13693,605742,"TUBULIN, ALPHA-8", TUBA8
13694,605743,HEDGEHOG ACYLTRANSFERASE, HHAT
13695,605744,EXOSTOSIN-LIKE GLYCOSYLTRANSFERASE 3, EXTL3
13696,605745,CYTOCHROME b REDUCTASE 1, CYBRD1
13697,605746,ANISOMASTIA,
13698,605747,LOW DENSITY LIPOPROTEIN RECEPTOR ADAPTOR PROTEIN 1, LDLRAP1
13699,605748,BETA-CAROTENE OXYGENASE 1, BCO1
13700,605749,"CATARACT 26, MULTIPLE TYPES", CTRCT26
13701,605750,EXUDATIVE VITREORETINOPATHY 3, EVR3
13702,605751,"SEIZURES, BENIGN FAMILIAL INFANTILE, 2", BFIS2
13703,605752,HID1 DOMAIN-CONTAINING PROTEIN 1, HID1
13704,605753,"SERINE PROTEASE INHIBITOR, KAZAL-TYPE, 2", SPINK2
13705,605754,PHOSPHATIDYLINOSITOL GLYCAN ANCHOR BIOSYNTHESIS CLASS Q PROTEIN, PIGQ
13706,605755,DOUBLECORTIN DOMAIN-CONTAINING PROTEIN 2, DCDC2
13707,605756,"OVARIAN DYSGENESIS, HYPERGONADOTROPIC, WITH SHORT STATURE AND RECURRENT METABOLIC ACIDOSIS",
13708,605757,PELOTA mRNA SURVEILLANCE AND RIBOSOME RESCUE FACTOR, PELO
13709,605758,ANKYRIN REPEAT- AND SOCS BOX-CONTAINING PROTEIN 1, ASB1
13710,605759,ANKYRIN REPEAT- AND SOCS BOX-CONTAINING PROTEIN 2, ASB2
13711,605760,ANKYRIN REPEAT- AND SOCS BOX-CONTAINING PROTEIN 3, ASB3
13712,605761,ANKYRIN REPEAT- AND SOCS BOX-CONTAINING PROTEIN 4, ASB4
13713,605762,MOK PROTEIN KINASE, MOK
13714,605763,"SOLUTE CARRIER FAMILY 45, MEMBER 1", SLC45A1
13715,605764,TYROSYL-DNA PHOSPHODIESTERASE 2, TDP2
13716,605765,DELETED IN LYMPHOCYTIC LEUKEMIA 1, DLEU1
13717,605766,DELETED IN LYMPHOCYTIC LEUKEMIA 2, DLEU2
13718,605767,PHOSPHOPROTEIN ASSOCIATED WITH GLYCOSPHINGOLIPID-ENRICHED MICRODOMAINS 1, PAG1
13719,605768,DUAL ADAPTOR OF PHOSPHOTYROSINE AND 3-PHOSPHOINOSITIDES 1,
13720,605769,TRIPARTITE MOTIF-CONTAINING PROTEIN 33, TRIM33
13721,605770,ILVB-LIKE, ILVBL
13722,605771,COX7A2-LIKE PROTEIN, COX7A2L
13723,605772,"ESTROGEN RECEPTOR-BINDING SITE-ASSOCIATED ANTIGEN, 9", EBAG9
13724,605773,LEUKOTRIENE B4 RECEPTOR 2, LTB4R2
13725,605774,KELCH-LIKE 2, KLHL2
13726,605775,KELCH-LIKE 3, KLHL3
13727,605776,FIBRINOGEN-LIKE 1, FGL1
13728,605777,"SPHINGOMYELIN PHOSPHODIESTERASE 3, NEUTRAL MEMBRANE", SMPD3
13729,605778,NIF3-LIKE 1, NIF3L1
13730,605779,"NAIL DISORDER, NONSYNDROMIC CONGENITAL, 7", NDNC7
13731,605780,PR DOMAIN-CONTAINING PROTEIN 4, PRDM4
13732,605781,"RAS HOMOLOG GENE FAMILY, MEMBER D", RHOD
13733,605782,EUKARYOTIC TRANSLATION INITIATION FACTOR 5A2, EIF5A2
13734,605783,BCAS2 PRE-mRNA PROCESSING FACTOR, BCAS2
13735,605784,TWEETY FAMILY MEMBER 1, TTYH1
13736,605785,"TUBULIN, GAMMA-2", TUBG2
13737,605786,"RNA-BINDING MOTIF PROTEIN, SINGLE STRAND-INTERACTING, 3", RBMS3
13738,605787,"ANKYRIN REPEAT-CONTAINING PROTEIN, FAMILY A, MEMBER 2", ANKRA2
13739,605788,"MICROTUBULE-ASSOCIATED PROTEIN, RP/EB FAMILY, MEMBER 3", MAPRE3
13740,605789,"MICROTUBULE-ASSOCIATED PROTEIN, RP/EB FAMILY, MEMBER 2", MAPRE2
13741,605790,SERINE/THREONINE KINASE 31, STK31
13742,605791,TESTIS-EXPRESSED GENE 12, TEX12
13743,605792,TESTIS-EXPRESSED GENE 14, TEX14
13744,605793,RING FINGER PROTEIN 17, RNF17
13745,605794,MOV10-LIKE RISC COMPLEX RNA HELICASE 1, MOV10L1
13746,605795,TESTIS-EXPRESSED GENE 15, TEX15
13747,605796,TUDOR DOMAIN-CONTAINING PROTEIN 1, TDRD1
13748,605797,"ANKYRIN REPEAT, SAM, AND BASIC LEUCINE ZIPPER DOMAIN-CONTAINING 1", ASZ1
13749,605798,"NEURAL PROLIFERATION, DIFFERENTIATION, AND CONTROL PROTEIN 1", NPDC1
13750,605799,AMNION-ASSOCIATED TRANSMEMBRANE PROTEIN, AMN
13751,605800,HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN U-LIKE 1, HNRNPUL1
13752,605801,RALA-BINDING PROTEIN 1, RALBP1
13753,605802,ZINC FINGER E BOX-BINDING HOMEOBOX 2, ZEB2
13754,605803,"DERMATITIS, ATOPIC, 2", ATOD2
13755,605804,"DERMATITIS, ATOPIC, 3", ATOD3
13756,605805,"DERMATITIS, ATOPIC, 4", ATOD4
13757,605806,CADHERIN 7, CDH7
13758,605807,CADHERIN 20, CDH20
13759,605808,BIRDSHOT CHORIORETINOPATHY,
13760,605809,"MYASTHENIC SYNDROME, CONGENITAL, 4A, SLOW-CHANNEL", CMS4A
13761,605810,MITOCHONDRIAL RIBOSOMAL PROTEIN S22, MRPS22
13762,605811,NTF2-LIKE EXPORT FACTOR 1, NXT1
13763,605812,DEAD-BOX HELICASE 19B, DDX19B
13764,605813,NUCLEAR TRANSPORT FACTOR 2, NUTF2
13765,605814,"CITRULLINEMIA, TYPE II, NEONATAL-ONSET",
13766,605815,"NUCLEOPORIN, 62-KD", NUP62
13767,605816,EPSTEIN-BARR VIRUS-INDUCED GENE 3, EBI3
13768,605817,RECEPTOR-INTERACTING SERINE/THREONINE KINASE 3, RIPK3
13769,605818,"DEAFNESS, AUTOSOMAL RECESSIVE 27", DFNB27
13770,605819,PESCADILLO RIBOSOMAL BIOGENESIS FACTOR 1, PES1
13771,605820,NONAKA MYOPATHY, NM
13772,605821,ALPHA-HEMOGLOBIN STABILIZING PROTEIN, AHSP
13773,605822,SPONDYLOOCULAR SYNDROME, SOS
13774,605823,POPEYE DOMAIN-CONTAINING PROTEIN 2, POPDC2
13775,605824,POPEYE DOMAIN-CONTAINING PROTEIN 3, POPDC3
13776,605825,HEME-BINDING PROTEIN 2, HEBP2
13777,605826,HEME-BINDING PROTEIN 1, HEBP1
13778,605827,"BASALOID FOLLICULAR HAMARTOMA SYNDROME, GENERALIZED, AUTOSOMAL DOMINANT", GBFHS
13779,605828,TRANSMEMBRANE CHANNEL-LIKE PROTEIN 6, TMC6
13780,605829,TRANSMEMBRANE CHANNEL-LIKE PROTEIN 8, TMC8
13781,605830,FIBROBLAST GROWTH FACTOR RECEPTOR-LIKE 1, FGFRL1
13782,605831,FIBROBLAST GROWTH FACTOR 22, FGF22
13783,605832,"ACETYL-CoA SYNTHETASE SHORT CHAIN FAMILY, MEMBER 2", ACSS2
13784,605833,BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 2, BMND2
13785,605834,TROPOMODULIN 4, TMOD4
13786,605835,CELL MIGRATION-INDUCING HYALURONIDASE 2, CEMIP2
13787,605836,UNC13 HOMOLOG B, UNC13B
13788,605837,HECT DOMAIN AND RCC1-LIKE DOMAIN 2, HERC2
13789,605838,BABY RATTLE PELVIS DYSPLASIA,
13790,605839,HEREDITARY LEIOMYOMATOSIS AND RENAL CELL CANCER,
13791,605840,RING FINGER PROTEIN 111, RNF111
13792,605841,"NARCOLEPSY 2, SUSCEPTIBILITY TO", NRCLP2
13793,605842,TRANSDUCIN-BETA-LIKE 2, TBL2
13794,605843,PEROXISOMAL TRANS-2-ENOYL-CoA REDUCTASE, PECR
13795,605844,"DERMATITIS, ATOPIC, 5", ATOD5
13796,605845,"DERMATITIS, ATOPIC, 6", ATOD6
13797,605846,BAF CHROMATIN REMODELING COMPLEX SUBUNIT BCL7B, BCL7B
13798,605847,BAF CHROMATIN REMODELING COMPLEX SUBUNIT BCL7C, BCL7C
13799,605848,"CASPASE 14, APOPTOSIS-RELATED CYSTEINE PROTEASE", CASP14
13800,605849,DIMETHYLGLYCINE DEHYDROGENASE, DMGDH
13801,605850,DIMETHYLGLYCINE DEHYDROGENASE DEFICIENCY, DMGDHD
13802,605851,ISOPRENYLCYSTEINE CARBOXYLMETHYLTRANSFERASE, ICMT
13803,605852,CYTOPLASMIC LINKER-ASSOCIATED PROTEIN 1, CLASP1
13804,605853,CYTOPLASMIC LINKER-ASSOCIATED PROTEIN 2, CLASP2
13805,605854,BCL2-BINDING COMPONENT 3, BBC3
13806,605855,"ATPase, PHOSPHOLIPID-TRANSPORTING, 10A", ATP10A
13807,605856,"SHORT STATURE, IMPAIRED INTELLECTUAL DEVELOPMENT, CALLOSAL AGENESIS, HEMINASAL HYPOPLASIA, MICROPHTHALMIA, AND ATYPICAL CLEFTING",
13808,605857,"RAS HOMOLOG GENE FAMILY, MEMBER Q", RHOQ
13809,605858,SCRATCH FAMILY TRANSCRIPTIONAL REPRESSOR 1, SCRT1
13810,605859,ZINC FINGER- AND BTB DOMAIN-CONTAINING PROTEIN 32, ZBTB32
13811,605860,RCAN FAMILY MEMBER 3, RCAN3
13812,605861,CANOPY FGF SIGNALING REGULATOR 2, CNPY2
13813,605862,RIBITOL XYLOSYLTRANSFERASE 1, RXYLT1
13814,605863,"BETA-1,3-N-ACETYLGLUCOSAMINYLTRANSFERASE 3", B3GNT3
13815,605864,"BETA-1,3-N-ACETYLGLUCOSAMINYLTRANSFERASE 4", B3GNT4
13816,605865,"TASTE RECEPTOR TYPE 1, MEMBER 3", TAS1R3
13817,605866,"ATPase, CLASS I, TYPE 8B, MEMBER 3", ATP8B3
13818,605867,"ATPase, CLASS I, TYPE 8B, MEMBER 2", ATP8B2
13819,605868,"ATPase, PHOSPHOLIPID TRANSPORTING, 11A", ATP11A
13820,605869,"ATPase, CLASS VI, TYPE 11B", ATP11B
13821,605870,"ATPase, CLASS I, TYPE 8A, MEMBER 2", ATP8A2
13822,605871,TRANSCOBALAMIN I DEFICIENCY,
13823,605872,"C-TYPE LECTIN DOMAIN FAMILY 4, MEMBER M", CLEC4M
13824,605873,"POTASSIUM CHANNEL, SUBFAMILY K, MEMBER 10", KCNK10
13825,605874,"POTASSIUM CHANNEL, SUBFAMILY K, MEMBER 9", KCNK9
13826,605875,"WASP PROTEIN FAMILY, MEMBER 2", WASF2
13827,605876,Fc RECEPTOR-LIKE PROTEIN 4, FCRL4
13828,605877,Fc RECEPTOR-LIKE PROTEIN 5, FCRL5
13829,605878,ZINC FINGER- AND BTB DOMAIN-CONTAINING PROTEIN 7A, ZBTB7A
13830,605879,"POTASSIUM CHANNEL, CALCIUM-ACTIVATED, INTERMEDIATE/SMALL CONDUCTANCE, SUBFAMILY N, MEMBER 2", KCNN2
13831,605880,LYSINE ACETYLTRANSFERASE 6B, KAT6B
13832,605881,"SOLUTE CARRIER FAMILY 35, MEMBER C1", SLC35C1
13833,605882,BRCA1-INTERACTING PROTEIN 1, BRIP1
13834,605883,LYSOSOME-ASSOCIATED MEMBRANE PROTEIN 3, LAMP3
13835,605884,"DYNEIN, AXONEMAL, HEAVY CHAIN 10", DNAH10
13836,605885,SEMAPHORIN 6A, SEMA6A
13837,605886,COMPLEMENT COMPONENT RECEPTOR 1-LIKE, CR1L
13838,605887,CYTOKINE RECEPTOR-LIKE FACTOR 2,
13839,605888,EH DOMAIN-CONTAINING 1, EHD1
13840,605889,PDZ AND LIM DOMAIN PROTEIN 3, PDLIM3
13841,605890,EH DOMAIN-CONTAINING 2, EHD2
13842,605891,EH DOMAIN-CONTAINING 3, EHD3
13843,605892,EH DOMAIN-CONTAINING 4, EHD4
13844,605893,CDP-DIACYLGLYCEROL-INOSITOL 3-PHOSPHATIDYLTRANSFERASE, CDIPT
13845,605894,EP300-INTERACTING INHIBITOR OF DIFFERENTIATION 1, EID1
13846,605895,"EUKARYOTIC TRANSLATION INITIATION FACTOR 4E FAMILY, MEMBER 2", EIF4E2
13847,605896,ENDOTHELIN-CONVERTING ENZYME-LIKE 1, ECEL1
13848,605897,UDP-GLUCOSE:GLYCOPROTEIN GLUCOSYLTRANSFERASE 1, UGGT1
13849,605898,UDP-GLUCOSE:GLYCOPROTEIN GLUCOSYLTRANSFERASE 2, UGGT2
13850,605899,GLYCINE ENCEPHALOPATHY 1, GCE1
13851,605900,PDZ AND LIM DOMAIN PROTEIN 1, PDLIM1
13852,605901,UROCORTIN III, UCN3
13853,605902,UROCORTIN II, UCN2
13854,605903,PDZ AND LIM DOMAIN PROTEIN 7, PDLIM7
13855,605904,PDZ AND LIM DOMAIN PROTEIN 5, PDLIM5
13856,605905,DCN1 DOMAIN-CONTAINING PROTEIN 1, DCUN1D1
13857,605906,LIM DOMAIN-BINDING 3, LDB3
13858,605907,ALG1 CHITOBIOSYLDIPHOSPHODOLICHOL BETA-MANNOSYLTRANSFERASE, ALG1
13859,605908,MODULATOR OF VRAC CURRENT 1, MLC1
13860,605909,"PARKINSON DISEASE 6, AUTOSOMAL RECESSIVE EARLY-ONSET", PARK6
13861,605910,ANGIOPOIETIN-LIKE 4, ANGPTL4
13862,605911,3-HYDROXY-3-METHYLGLUTARYL-CoA SYNTHASE-2 DEFICIENCY, HMGCS2D
13863,605912,"MATRIX, EXTRACELLULAR, PHOSPHOGLYCOPROTEIN", MEPE
13864,605913,"BLEEDING DISORDER, EAST TEXAS TYPE",
13865,605914,"TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY, MEMBER 12A", TNFRSF12A
13866,605915,TRANSDUCIN-BETA-LIKE 3, TBL3
13867,605916,"SPECTRIN, BETA, NONERYTHROCYTIC, 5", SPTBN5
13868,605917,TPX2 MICROTUBULE NUCLEATION FACTOR, TPX2
13869,605918,SPONDIN 2, SPON2
13870,605919,NERVE GROWTH FACTOR RECEPTOR-ASSOCIATED PROTEIN 1,
13871,605920,STAUFEN DOUBLE-STRANDED RNA-BINDING PROTEIN 2, STAU2
13872,605921,STROMAL INTERACTION MOLECULE 1, STIM1
13873,605922,MYOINOSITOL MONOPHOSPHATASE 2, IMPA2
13874,605923,SRY-BOX 8, SOX8
13875,605924,WD REPEAT-CONTAINING PROTEIN 4, WDR4
13876,605925,PERICENTRIN, PCNT
13877,605926,PROTEIN INTERACTING WITH C KINASE 1, PICK1
13878,605927,MDM2-BINDING PROTEIN, MDM2BP
13879,605928,ADP-RIBOSYLATION FACTOR-INTERACTING PROTEIN 1, ARFIP1
13880,605929,SORTING NEXIN 2, SNX2
13881,605930,SORTING NEXIN 3, SNX3
13882,605931,SORTING NEXIN 4, SNX4
13883,605932,BETAINE-HOMOCYSTEINE METHYLTRANSFERASE 2, BHMT2
13884,605933,DENDROCYTE-EXPRESSED 7-TRANSMEMBRANE PROTEIN, DCSTAMP
13885,605934,HOLOPROSENCEPHALY 6, HPE6
13886,605935,"ARTHROPATHY, EROSIVE",
13887,605936,BRIDGING INTEGRATOR 2, BIN2
13888,605937,SORTING NEXIN 5, SNX5
13889,605938,PHOSPHATIDYLINOSITOL GLYCAN ANCHOR BIOSYNTHESIS CLASS P PROTEIN, PIGP
13890,605939,"PHOSPHOLIPASE C, DELTA-4", PLCD4
13891,605940,"BRAIN-ABUNDANT SIGNAL PROTEIN, MEMBRANE-ATTACHED, 1", BASP1
13892,605941,"SPLICEOSOME-ASSOCIATED FACTOR 1, RECRUITER OF U4/U6.U5 tri-snRNP", SART1
13893,605942,DERMATAN SULFATE EPIMERASE, DSE
13894,605943,GLYCEROPHOSPHODIESTER PHOSPHODIESTERASE 1, GDE1
13895,605944,LIVER FIBROCYSTIC DISEASE AND POLYDACTYLY,
13896,605945,CRUMPLED HELICES AND SMALL MOUTH,
13897,605946,"METAPHYSEAL DYSPLASIA, BRAUN-TINSCHERT TYPE",
13898,605947,PHOSPHATIDYLINOSITOL GLYCAN ANCHOR BIOSYNTHESIS CLASS L PROTEIN, PIGL
13899,605948,"G PROTEIN-COUPLED RECEPTOR, FAMILY C, GROUP 5, MEMBER B", GPRC5B
13900,605949,"G PROTEIN-COUPLED RECEPTOR, FAMILY C, GROUP 5, MEMBER C", GPRC5C
13901,605950,RAS-ASSOCIATED PROTEIN RAB33B, RAB33B
13902,605951,DOLICHYL-PHOSPHATE MANNOSYLTRANSFERASE 3, DPM3
13903,605952,SORTING NEXIN 9, SNX9
13904,605953,"ARF GTPase-ACTIVATING PROTEIN WITH SH3 DOMAIN, ANKYRIN REPEAT, AND PH DOMAIN 1", ASAP1
13905,605954,FETUIN B, FETUB
13906,605955,NK6 HOMEOBOX 2, NKX6-2
13907,605956,NUCLEOTIDE-BINDING OLIGOMERIZATION DOMAIN PROTEIN 2, NOD2
13908,605957,"DEAFNESS, AUTOSOMAL DOMINANT 6",
13909,605958,TRAF-INTERACTING PROTEIN, TRAIP
13910,605959,HR44 ANTIGEN,
13911,605960,EXOSOME COMPONENT 10, EXOSC10
13912,605961,PLEIOTROPIC REGULATOR 1, PLRG1
13913,605962,RAB9 EFFECTOR PROTEIN WITH KELCH MOTIFS, RABEPK
13914,605963,SORTING NEXIN 17, SNX17
13915,605964,SORTING NEXIN 15, SNX15
13916,605965,RAS AND RAB INTERACTOR 1, RIN1
13917,605966,HEPATOCYTE NUCLEAR FACTOR 4-GAMMA, HNF4G
13918,605967,ACROPECTORAL SYNDROME, ACRPS
13919,605968,RET FINGER PROTEIN-LIKE 1, RFPL1
13920,605969,RET FINGER PROTEIN-LIKE 2, RFPL2
13921,605970,RET FINGER PROTEIN-LIKE 3, RFPL3
13922,605971,"RET FINGER PROTEIN-LIKE 3, ANTISENSE", RFPL3S
13923,605972,"RET FINGER PROTEIN-LIKE 1, ANTISENSE", RFPL1S
13924,605973,DDB1- AND CUL4-ASSOCIATED FACTOR 7, DCAF7
13925,605974,"SLU7 HOMOLOG, SPLICING FACTOR", SLU7
13926,605975,SERINE/ARGININE REPETITIVE MATRIX PROTEIN 1, SRRM1
13927,605976,ZINC FINGER- AND BTB DOMAIN-CONTAINING PROTEIN 6, ZBTB6
13928,605977,"INNER MITOCHONDRIAL MEMBRANE PEPTIDASE, SUBUNIT 2", IMMP2L
13929,605978,VACUOLAR PROTEIN SORTING 13 HOMOLOG A, VPS13A
13930,605979,"SMALL NUCLEAR RNA-ACTIVATING PROTEIN COMPLEX, POLYPEPTIDE 5", SNAPC5
13931,605980,NUCLEOTIDE-BINDING OLIGOMERIZATION DOMAIN PROTEIN 1, NOD1
13932,605981,UBIQUITIN-PROTEIN LIGASE E3 COMPONENT N-RECOGNIN 1, UBR1
13933,605982,WILMS TUMOR 1,
13934,605983,"PROTEIN PHOSPHATASE 2, STRUCTURAL/REGULATORY SUBUNIT A, ALPHA", PPP2R1A
13935,605984,EMBRYONIC ECTODERM DEVELOPMENT, EED
13936,605985,GRIP1-ASSOCIATED PROTEIN 1,
13937,605986,SERINE/THREONINE KINASE RECEPTOR-ASSOCIATED PROTEIN, STRAP
13938,605987,PROTEIN INHIBITOR OF ACTIVATED STAT3, PIAS3
13939,605988,DNA CROSS-LINK REPAIR PROTEIN 1C, DCLRE1C
13940,605989,PROTEIN INHIBITOR OF ACTIVATED STAT4, PIAS4
13941,605990,"NEPHROLITHIASIS, URIC ACID, SUSCEPTIBILITY TO",
13942,605991,NEURONAL GUANINE NUCLEOTIDE EXCHANGE FACTOR, NGEF
13943,605992,LIM HOMEOBOX PROTEIN 5, LHX5
13944,605993,"PYRUVATE DEHYDROGENASE PHOSPHATASE, CATALYTIC SUBUNIT 1", PDP1
13945,605994,"CYTOCHROME P450, FAMILY 39, SUBFAMILY A, POLYPEPTIDE 1", CYP39A1
13946,605995,KINESIN FAMILY MEMBER 1B, KIF1B
13947,605996,DECAPPING EXORIBONUCLEASE, DXO
13948,605997,"PROTEIN PHOSPHATASE 2, REGULATORY SUBUNIT B, GAMMA ISOFORM", PPP2R2C
13949,605998,HCLS1-ASSOCIATED PROTEIN X1, HAX1
13950,605999,"C-TYPE LECTIN DOMAIN FAMILY 10, MEMBER A", CLEC10A
13951,606000,BUTYROPHILIN-LIKE PROTEIN 2, BTNL2
13952,606001,INTERLEUKIN 32, IL32
13953,606002,"SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE, WITH AXONAL NEUROPATHY 2", SCAN2
13954,606003,TRANSALDOLASE DEFICIENCY, TALDOD
13955,606004,"GOLGI-ASSOCIATED, GAMMA-ADAPTIN EAR-CONTAINING, ARF-BINDING PROTEIN 1", GGA1
13956,606005,"GOLGI-ASSOCIATED, GAMMA-ADAPTIN EAR-CONTAINING, ARF-BINDING PROTEIN 2", GGA2
13957,606006,"GOLGI-ASSOCIATED, GAMMA-ADAPTIN EAR-CONTAINING, ARF-BINDING PROTEIN 3", GGA3
13958,606007,"POLYMERASE III, RNA, SUBUNIT K", POLR3K
13959,606008,NATURAL KILLER CELL GROUP 7 SEQUENCE, NKG7
13960,606009,DOUBLE HOMEOBOX PROTEIN 4, DUX4
13961,606010,NUCLEAR RECEPTOR-BINDING PROTEIN 1, NRBP1
13962,606011,V-SET AND IMMUNOGLOBULIN DOMAINS-CONTAINING PROTEIN 2, VSIG2
13963,606012,"DEAFNESS, AUTOSOMAL DOMINANT 18", DFNA18
13964,606013,F-BOX ONLY PROTEIN 5, FBXO5
13965,606014,ARISTALESS-LIKE HOMEOBOX 3, ALX3
13966,606015,FAS APOPTOTIC INHIBITORY MOLECULE 3, FAIM3
13967,606016,KELCH-LIKE ECH-ASSOCIATED PROTEIN 1, KEAP1
13968,606017,"POLYMERASE II, RNA, SUBUNIT D", POLR2D
13969,606018,EGF-LIKE REPEATS- AND DISCOIDIN I-LIKE DOMAINS-CONTAINING PROTEIN 3, EDIL3
13970,606019,EXOSOME COMPONENT 8, EXOSC8
13971,606020,OPA-INTERACTING PROTEIN 5, OIP5
13972,606021,PRAME NUCLEAR RECEPTOR TRANSCRIPTIONAL REGULATOR, PRAME
13973,606022,NUDIX HYDROLASE 9, NUDT9
13974,606023,"POLYMERASE II, RNA, SUBUNIT H", POLR2H
13975,606024,ZINC FINGER PROTEIN 268,
13976,606025,ZINC FINGER- AND BTB DOMAIN-CONTAINING PROTEIN 20, ZBTB20
13977,606026,"NEGATIVE ELONGATION FACTOR COMPLEX, MEMBER A", NELFA
13978,606027,CLEAVAGE AND POLYADENYLATION SPECIFICITY FACTOR 1, CPSF1
13979,606028,CLEAVAGE AND POLYADENYLATION SPECIFICITY FACTOR 2, CPSF2
13980,606029,CLEAVAGE AND POLYADENYLATION SPECIFICITY FACTOR 3, CPSF3
13981,606030,ENHANCER OF mRNA DECAPPING 4, EDC4
13982,606031,WD REPEAT-CONTAINING PROTEIN 6, WDR6
13983,606032,SERINE/ARGININE REPETITIVE MATRIX PROTEIN 2, SRRM2
13984,606033,"POLYMERASE II, RNA, SUBUNIT K", POLR2K
13985,606034,"RIBONUCLEASE H2, SUBUNIT A", RNASEH2A
13986,606035,FASTING INSULIN LEVEL QUANTITATIVE TRAIT LOCUS 1, FIQTL1
13987,606036,ARYL HYDROCARBON RECEPTOR NUCLEAR TRANSLOCATOR 2, ARNT2
13988,606037,CD96 ANTIGEN, CD96
13989,606038,"LYMPHOCYTE ANTIGEN 6 COMPLEX, LOCUS G6D", LY6G6D
13990,606039,HYDROXYCARBOXYLIC ACID RECEPTOR 3, HCAR3
13991,606040,WD REPEAT-CONTAINING PROTEIN 8, WDR8
13992,606041,SPARC-LIKE PROTEIN 1, SPARCL1
13993,606042,MYONEURIN, MYNN
13994,606043,ZINC FINGER PROTEIN 331, ZNF331
13995,606044,ZINC RIBBON DOMAIN-CONTAINING PROTEIN 2, ZNRD2
13996,606045,INTRAFLAGELLAR TRANSPORT 122, IFT122
13997,606046,SYNTAXIN 18, STX18
13998,606047,"LEUKOCYTE IMMUNOGLOBULIN-LIKE RECEPTOR, SUBFAMILY A, MEMBER 5", LILRA5
13999,606048,MEMBRANE-BOUND O-ACETYLTRANSFERASE DOMAIN-CONTAINING PROTEIN 7, MBOAT7
14000,606049,"ACROMEGALOID FEATURES, OVERGROWTH, CLEFT PALATE, AND HERNIA",
14001,606050,UBIQUITIN D, UBD
14002,606051,SECRETION-REGULATING GUANINE NUCLEOTIDE EXCHANGE FACTOR, SERGEF
14003,606052,"SEIZURES, BENIGN FAMILIAL INFANTILE, 3",
14004,606053,INTELLECTUAL DEVELOPMENTAL DISORDER WITH AUTISM AND SPEECH DELAY, IDDAS
14005,606054,PROPIONIC ACIDEMIA,
14006,606055,PHOSPHATIDYLCHOLINE TRANSFER PROTEIN, PCTP
14007,606056,"CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIb", CDG2B
14008,606057,RAP GUANINE NUCLEOTIDE EXCHANGE FACTOR 3, RAPGEF3
14009,606058,RAP GUANINE NUCLEOTIDE EXCHANGE FACTOR, RAPGEF4
14010,606059,"PROTEIN KINASE, cAMP-DEPENDENT CATALYTIC, INHIBITOR ALPHA", PKIA
14011,606060,"DNAJ/HSP40 HOMOLOG, SUBFAMILY C, MEMBER 12", DNAJC12
14012,606061,T-BOX TRANSCRIPTION FACTOR 20, TBX20
14013,606062,STRUCTURAL MAINTENANCE OF CHROMOSOMES 3, SMC3
14014,606063,EXONUCLEASE 1, EXO1
14015,606064,CD248 ANTIGEN, CD248
14016,606065,ATYPICAL CHEMOKINE RECEPTOR 4, ACKR4
14017,606066,LIM HOMEOBOX GENE 9, LHX9
14018,606067,OTORAPLIN, OTOR
14019,606068,RETINITIS PIGMENTOSA 28, RP28
14020,606069,"HEMOCHROMATOSIS, TYPE 4", HFE4
14021,606070,AMYOTROPHIC LATERAL SCLEROSIS 21, ALS21
14022,606071,"HEREDITARY MOTOR AND SENSORY NEUROPATHY, TYPE IIC", HMSN2C
14023,606072,RIPPLING MUSCLE DISEASE 2, RMD2
14024,606073,NADPH-DEPENDENT DIFLAVIN OXIDOREDUCTASE 1, NDOR1
14025,606074,"GLOBOSIDE ALPHA-1,3-N-ACETYLGALACTOSAMINYLTRANSFERASE", GBGT1
14026,606075,TWINKLE mtDNA HELICASE, TWNK
14027,606076,"PHOSPHATIDYLINOSITOL 3-KINASE, REGULATORY SUBUNIT 3", PIK3R3
14028,606077,RNA-BINDING MOTIF PROTEIN 15, RBM15
14029,606078,MYOCARDIN-RELATED TRANSCRIPTION FACTOR A, MRTFA
14030,606079,CD163 ANTIGEN-LIKE 1, CD163L1
14031,606080,"CHITINASE, ACIDIC", CHIA
14032,606081,TRANSLOCASE OF OUTER MITOCHONDRIAL MEMBRANE 70, TOMM70
14033,606082,"GOITER, MULTINODULAR 3", MNG3
14034,606083,POLYBROMO 1, PBRM1
14035,606084,CDC42 EFFECTOR PROTEIN 1, CDC42EP1
14036,606085,TESTIS-DERIVED TRANSCRIPT, TES
14037,606086,EUKARYOTIC TRANSLATION INITIATION FACTOR 5B, EIF5B
14038,606087,SYNEMIN, SYNM
14039,606088,"PHOSPHOLIPASE A2, GROUP IVB", PLA2G4B
14040,606089,BRAIN CYTOPLASMIC RNA 1, BCYRN1
14041,606090,CARNITINE OCTANOYLTRANSFERASE, CROT
14042,606091,SIALIC ACID-BINDING IMMUNOGLOBULIN-LIKE LECTIN 10, SIGLEC10
14043,606092,"DNAJ/HSP40 HOMOLOG, SUBFAMILY C, MEMBER 14", DNAJC14
14044,606093,PEPTIDYL-PROLYL ISOMERASE G, PPIG
14045,606094,SIALIC ACID-BINDING IMMUNOGLOBULIN-LIKE LECTIN 12, SIGLEC12
14046,606095,PEPTIDYL-PROLYL ISOMERASE H, PPIH
14047,606096,"LECTIN, GALACTOSIDE-BINDING, SOLUBLE, 12",
14048,606097,PHOSPHATIDYLINOSITOL GLYCAN ANCHOR BIOSYNTHESIS CLASS N PROTEIN, PIGN
14049,606098,SORTING NEXIN 6, SNX6
14050,606099,"LECTIN, GALACTOSIDE-BINDING, SOLUBLE, 8", LGALS8
14051,606100,ADHESION G PROTEIN-COUPLED RECEPTOR E2, ADGRE2
14052,606101,ADHESION G PROTEIN-COUPLED RECEPTOR E3, ADGRE3
14053,606102,"PHOSPHATIDYLINOSITOL 4-PHOSPHATE 5-KINASE, TYPE I, GAMMA", PIP5K1C
14054,606103,SESTRIN 1, SESN1
14055,606104,"MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 1",
14056,606105,"SOLUTE CARRIER FAMILY 44, MEMBER 1", SLC44A1
14057,606106,"SOLUTE CARRIER FAMILY 44, MEMBER 2", SLC44A2
14058,606107,"SOLUTE CARRIER FAMILY 44, MEMBER 4", SLC44A4
14059,606108,"PROTEIN PHOSPHATASE, MAGNESIUM/MANGANESE-DEPENDENT, 1A", PPM1A
14060,606109,NUDC DOMAIN-CONTAINING PROTEIN 1, NUDCD1
14061,606110,LY6/NEUROTOXIN 1, LYNX1
14062,606111,MELANIN-CONCENTRATING HORMONE RECEPTOR 2, MCHR2
14063,606112,RIBONUCLEASE P/MRP SUBUNIT p14, RPP14
14064,606113,"POP7 HOMOLOG, RIBONUCLEASE P/MRP SUBUNIT", POP7
14065,606114,"POP4 HOMOLOG, RIBONUCLEASE P/MRP SUBUNIT", POP4
14066,606115,RIBONUCLEASE P/MRP SUBUNIT p30, RPP30
14067,606116,RIBONUCLEASE P/MRP SUBUNIT p38, RPP38
14068,606117,RIBONUCLEASE P/MRP SUBUNIT p40, RPP40
14069,606118,"HPS3 BIOGENESIS OF LYSOSOMAL ORGANELLES COMPLEX 2, SUBUNIT 1", HPS3
14070,606119,SECRETED LY6/PLAUR DOMAIN-CONTAINING PROTEIN 1, SLURP1
14071,606120,"RIBOSOMAL RNA, MITOCHONDRIAL, 16S",
14072,606121,CGRP RECEPTOR COMPONENT, CRCP
14073,606122,"TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY, MEMBER 19", TNFRSF19
14074,606123,RING FINGER PROTEIN 16, RNF16
14075,606124,RING FINGER PROTEIN 18, RNF18
14076,606125,TRIPARTITE MOTIF-CONTAINING PROTEIN 8, TRIM8
14077,606126,BCL2-LIKE 14, BCL2L14
14078,606127,MYOCARDIN, MYOCD
14079,606128,MYOCARDIN-RELATED TRANSCRIPTION FACTOR A,
14080,606129,DIAMOND-BLACKFAN ANEMIA 2, DBA2
14081,606130,RING FINGER PROTEIN 26, RNF26
14082,606131,TRIPARTITE MOTIF-CONTAINING PROTEIN 63, TRIM63
14083,606132,CDC42 EFFECTOR PROTEIN 2, CDC42EP2
14084,606133,CDC42 EFFECTOR PROTEIN 3, CDC42EP3
14085,606134,REV1 DNA-DIRECTED POLYMERASE, REV1
14086,606135,KALLIKREIN-RELATED PEPTIDASE 14, KLK14
14087,606136,RAS PROTEIN ACTIVATOR-LIKE 2, RASAL2
14088,606137,CELL GROWTH REGULATOR WITH EF-HAND DOMAIN 1, CGREF1
14089,606138,CELL GROWTH REGULATOR WITH RING FINGER DOMAIN 1, CGRRF1
14090,606139,KRUPPEL-LIKE FACTOR 16, KLF16
14091,606140,EXPORTIN 7, XPO7
14092,606141,RAN-BINDING PROTEIN 17, RANBP17
14093,606142,"SOLUTE CARRIER FAMILY 2 (FACILITATED GLUCOSE TRANSPORTER), MEMBER 9", SLC2A9
14094,606143,FRIZZLED CLASS RECEPTOR 3, FZD3
14095,606144,RAS-ASSOCIATED PROTEIN RAB23, RAB23
14096,606145,"SOLUTE CARRIER FAMILY 2 (FACILITATED GLUCOSE TRANSPORTER), MEMBER 10", SLC2A10
14097,606146,FRIZZLED CLASS RECEPTOR 8, FZD8
14098,606147,FRIZZLED CLASS RECEPTOR 10, FZD10
14099,606148,FATTY ACID DESATURASE 1, FADS1
14100,606149,FATTY ACID DESATURASE 2, FADS2
14101,606150,FATTY ACID DESATURASE 3, FADS3
14102,606151,BBS2 GENE, BBS2
14103,606152,"SOLUTE CARRIER FAMILY 19 (THIAMINE TRANSPORTER), MEMBER 3", SLC19A3
14104,606153,"ATP SYNTHASE F1, SUBUNIT EPSILON", ATP5F1E
14105,606154,MUCIN 16, MUC16
14106,606155,BARAITSER-WINTER SYNDROME 1,
14107,606156,SENER SYNDROME,
14108,606157,PANTOTHENATE KINASE 2, PANK2
14109,606158,BSCL2 GENE, BSCL2
14110,606159,NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 3, NBIA3
14111,606160,PANTOTHENATE KINASE 1, PANK1
14112,606161,PANTOTHENATE KINASE 3, PANK3
14113,606162,PANTOTHENATE KINASE 4, PANK4
14114,606163,"CARDIOMYOPATHY, FATAL FETAL, DUE TO MYOCARDIAL CALCIFICATION",
14115,606164,DIAMOND-BLACKFAN ANEMIA 15 WITH MANDIBULOFACIAL DYSOSTOSIS, DBA15
14116,606165,BOL-LIKE, BOLL
14117,606166,1-ACYLGLYCEROL-3-PHOSPHATE O-ACYLTRANSFERASE 2,
14118,606167,G PROTEIN-COUPLED RECEPTOR 132, GPR132
14119,606168,DEAD-BOX HELICASE 20, DDX20
14120,606169,"METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, cblD TYPE",
14121,606170,GENITOPATELLAR SYNDROME, GTPTS
14122,606171,tRNA SERINE (ANTICODON TGA) 2-1, TRS-TGA2-1
14123,606172,tRNA SERINE (ANTICODON TGA) 4-1, TRS-TGA4-1
14124,606173,"GRPE-LIKE 1, MITOCHONDRIAL", GRPEL1
14125,606174,"BACULUM, CONGENITAL ABSENCE OF",
14126,606175,CARNITINE ACETYLTRANSFERASE DEFICIENCY,
14127,606176,"DIABETES MELLITUS, PERMANENT NEONATAL, 1", PNDM1
14128,606177,PARS PLANITIS,
14129,606178,HEDGEHOG-INTERACTING PROTEIN, HHIP
14130,606179,ANEURYSMAL BONE CYSTS,
14131,606180,EXOSOME COMPONENT 9, EXOSC9
14132,606181,DEAD-BOX HELICASE 24, DDX24
14133,606182,"TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY, MEMBER 9", TNFSF9
14134,606183,LARYNGEAL ABDUCTOR PARALYSIS WITH CEREBELLAR ATAXIA AND MOTOR NEUROPATHY,
14135,606184,"A DISINTEGRIN-LIKE AND METALLOPROTEINASE WITH THROMBOSPONDIN TYPE 1 MOTIF, 12", ADAMTS12
14136,606185,TUMOR PROTEIN p53-INDUCIBLE NUCLEAR PROTEIN 1, TP53INP1
14137,606186,CALCYCLIN-BINDING PROTEIN, CACYBP
14138,606187,ALZHEIMER DISEASE 7,
14139,606188,A DISINTEGRIN AND METALLOPROTEINASE DOMAIN 28, ADAM28
14140,606189,CYSTEINE-RICH MOTOR NEURON PROTEIN 1, CRIM1
14141,606190,"MENINGIOMA, RADIATION-INDUCED",
14142,606191,FORMIN-BINDING PROTEIN 1, FNBP1
14143,606192,BUTYROPHILIN-LIKE PROTEIN 3, BTNL3
14144,606193,"SOLUTE CARRIER FAMILY 13 (SODIUM/SULFATE SYMPORTER), MEMBER 1", SLC13A1
14145,606194,"KERATIN 23, TYPE I", KRT23
14146,606195,IROQUOIS HOMEOBOX PROTEIN 5, IRX5
14147,606196,IROQUOIS HOMEOBOX PROTEIN 6, IRX6
14148,606197,IROQUOIS HOMEOBOX PROTEIN 1, IRX1
14149,606198,IROQUOIS HOMEOBOX PROTEIN 2, IRX2
14150,606199,IROQUOIS HOMEOBOX PROTEIN 4, IRX4
14151,606200,"BASIC HELIX-LOOP-HELIX FAMILY, MEMBER E41", BHLHE41
14152,606201,WOLFRAMIN ER TRANSMEMBRANE GLYCOPROTEIN, WFS1
14153,606202,"SOLUTE CARRIER FAMILY 45, MEMBER 2", SLC45A2
14154,606203,GRB2-ASSOCIATED BINDING PROTEIN 2, GAB2
14155,606204,"LYMPHOCYTE ANTIGEN 6 COMPLEX, LOCUS D", LY6D
14156,606205,"SOLUTE CARRIER FAMILY 6 (NEUROTRANSMITTER TRANSPORTER, L-PROLINE), MEMBER 7", SLC6A7
14157,606206,METALLOTHIONEIN 4, MT4
14158,606207,"SOLUTE CARRIER FAMILY 28 (SODIUM-COUPLED NUCLEOSIDE TRANSPORTER), MEMBER 1", SLC28A1
14159,606208,"SOLUTE CARRIER FAMILY 28 (SODIUM-COUPLED NUCLEOSIDE TRANSPORTER), MEMBER 2", SLC28A2
14160,606209,YKT6 v-SNARE HOMOLOG, YKT6
14161,606210,SELENOPROTEIN N, SELENON
14162,606211,SIRTUIN 6, SIRT6
14163,606212,SIRTUIN 7, SIRT7
14164,606213,"SIGNAL SEQUENCE RECEPTOR, GAMMA", SSR3
14165,606214,"SPECTRIN, BETA, NONERYTHROCYTIC, 4", SPTBN4
14166,606215,ATRIOVENTRICULAR SEPTAL DEFECT, AVSD
14167,606216,METHIONINE SULFOXIDE REDUCTASE B1, MSRB1
14168,606217,"ATRIOVENTRICULAR SEPTAL DEFECT, SUSCEPTIBILITY TO, 2", AVSD2
14169,606218,SELENOPHOSPHATE SYNTHETASE 2, SEPHS2
14170,606219,TUMOR NECROSIS FACTOR RECEPTOR-ASSOCIATED PROTEIN 1, TRAP1
14171,606220,"INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE, FACIAL ANOMALIES, AND SPEECH DEFECTS", IDDSFAS
14172,606221,IKAROS FAMILY ZINC FINGER 3, IKZF3
14173,606222,"IMMUNOGLOBULIN SUPERFAMILY, MEMBER 6", IGSF6
14174,606223,"PROTEASOME 26S SUBUNIT, NON-ATPASE, 2", PSMD2
14175,606224,"5-PRIME-NUCLEOTIDASE, CYTOSOLIC IIIA", NT5C3A
14176,606225,"TASTE RECEPTOR TYPE 1, MEMBER 1", TAS1R1
14177,606226,"TASTE RECEPTOR TYPE 1, MEMBER 2", TAS1R2
14178,606227,MEMBRANE-TYPE FRIZZLED-RELATED PROTEIN, MFRP
14179,606228,ARGONAUTE RISC COMPONENT 1, AGO1
14180,606229,ARGONAUTE RISC COMPONENT 2, AGO2
14181,606230,SH3 AND MULTIPLE ANKYRIN REPEAT DOMAINS 3, SHANK3
14182,606231,"ADAPTOR PROTEIN, PHOSPHOTYROSINE INTERACTION, PH DOMAIN, AND LEUCINE ZIPPER-CONTAINING PROTEIN 2", APPL2
14183,606232,PHELAN-MCDERMID SYNDROME, PHMDS
14184,606233,PROKINETICIN 1, PROK1
14185,606234,IKAROS FAMILY ZINC FINGER 2, IKZF2
14186,606235,THIOREDOXIN REDUCTASE 3, TXNRD3
14187,606236,"ASPSCR1 TETHER FOR SLC2A4, UBX DOMAIN-CONTAINING", ASPSCR1
14188,606237,TRANSFORMING GROWTH FACTOR-BETA RECEPTOR-ASSOCIATED PROTEIN 1, TGFBRAP1
14189,606238,IKAROS FAMILY ZINC FINGER 5, IKZF5
14190,606239,IKAROS FAMILY ZINC FINGER 4, IKZF4
14191,606240,"THYROID CANCER, NONMEDULLARY, 3", NMTC3
14192,606241,"DICER 1, RIBONUCLEASE III", DICER1
14193,606242,KONDOH SYNDROME,
14194,606243,ALVEOLAR SOFT PART SARCOMA, ASPS
14195,606244,SIGNAL-TRANSDUCING ADAPTOR MOLECULE 2, STAM2
14196,606245,SUZ12 POLYCOMB REPRESSIVE COMPLEX 2 SUBUNIT, SUZ12
14197,606246,JAZF ZINC FINGER 1, JAZF1
14198,606247,STAM-BINDING PROTEIN, STAMBP
14199,606248,QUINOLINATE PHOSPHORIBOSYLTRANSFERASE, QPRT
14200,606249,"PROTEIN KINASE, LYSINE-DEFICIENT 2", WNK2
14201,606250,UDP-N-ACETYL-ALPHA-D-GALACTOSAMINE:POLYPEPTIDE N-ACETYLGALACTOSAMINYLTRANSFERASE 8, GALNT8
14202,606251,UDP-N-ACETYL-ALPHA-D-GALACTOSAMINE:POLYPEPTIDE N-ACETYLGALACTOSAMINYLTRANSFERASE 9, GALNT9
14203,606252,TIR DOMAIN-CONTAINING ADAPTOR PROTEIN, TIRAP
14204,606253,RIBOSOMAL PROTEIN S27a,
14205,606254,SELENOPROTEIN F, SELENOF
14206,606255,STATURE AS A QUANTITATIVE TRAIT,
14207,606256,STATURE QUANTITATIVE TRAIT LOCUS 2, STQTL2
14208,606257,STATURE QUANTITATIVE TRAIT LOCUS 3, STQTL3
14209,606258,STATURE QUANTITATIVE TRAIT LOCUS 4, STQTL4
14210,606259,BRMS1 TRANSCRIPTIONAL REPRESSOR AND ANOIKIS REGULATOR, BRMS1
14211,606260,MYOTUBULARIN-RELATED PROTEIN 9, MTMR9
14212,606261,NUDIX HYDROLASE 6, NUDT6
14213,606262,"PAGET DISEASE OF BONE 2, EARLY-ONSET",
14214,606263,PAGET DISEASE OF BONE 4, PDB4
14215,606264,"C-TYPE LECTIN DOMAIN FAMILY 7, MEMBER A", CLEC7A
14216,606265,"E1A-BINDING PROTEIN, 400-KD", EP400
14217,606266,BCL2-MODIFYING FACTOR, BMF
14218,606267,"WINGLESS-TYPE MMTV INTEGRATION SITE FAMILY, MEMBER 16", WNT16
14219,606268,"WINGLESS-TYPE MMTV INTEGRATION SITE FAMILY, MEMBER 10A", WNT10A
14220,606269,"TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY, MEMBER 13C", TNFRSF13C
14221,606270,TOLL-LIKE RECEPTOR 10, TLR10
14222,606271,DISRUPTED IN SCHIZOPHRENIA 2, DISC2
14223,606272,CYSTINOSIN, CTNS
14224,606273,"EUKARYOTIC TRANSLATION INITIATION FACTOR 2B, SUBUNIT 3", EIF2B3
14225,606274,"CASEIN KINASE I, GAMMA-1", CSNK1G1
14226,606275,CHONDROITIN SULFATE PROTEOGLYCAN 4,
14227,606276,CARTILAGE ACIDIC PROTEIN 1, CRTAC1
14228,606277,TOLL-INTERACTING PROTEIN, TOLLIP
14229,606278,F-BOX AND WD40 DOMAIN PROTEIN 7, FBXW7
14230,606279,ABI FAMILY MEMBER 3 BINDING PROTEIN, ABI3BP
14231,606280,NON-SMC CONDENSIN I COMPLEX SUBUNIT G, NCAPG
14232,606281,RAS-ASSOCIATED PROTEIN RAB38, RAB38
14233,606282,"DEAFNESS, AUTOSOMAL DOMINANT 24", DFNA24
14234,606283,SORTILIN-RELATED VPS10 DOMAIN-CONTAINING RECEPTOR 1, SORCS1
14235,606284,SORTILIN-RELATED VPS10 DOMAIN-CONTAINING RECEPTOR 2, SORCS2
14236,606285,SORTILIN-RELATED VPS10 DOMAIN-CONTAINING RECEPTOR 3, SORCS3
14237,606286,DEAD-BOX HELICASE 43, DDX43
14238,606287,HEDGEHOG ACYLTRANSFERASE,
14239,606288,"PROTOCADHERIN-GAMMA, SUBFAMILY A, MEMBER 1", PCDHGA1
14240,606289,"PROTOCADHERIN-GAMMA, SUBFAMILY A, MEMBER 2", PCDHGA2
14241,606290,"PROTOCADHERIN-GAMMA, SUBFAMILY A, MEMBER 3", PCDHGA3
14242,606291,"PROTOCADHERIN-GAMMA, SUBFAMILY A, MEMBER 4", PCDHGA4
14243,606292,"PROTOCADHERIN-GAMMA, SUBFAMILY A, MEMBER 5", PCDHGA5
14244,606293,"PROTOCADHERIN-GAMMA, SUBFAMILY A, MEMBER 6", PCDHGA6
14245,606294,"PROTOCADHERIN-GAMMA, SUBFAMILY A, MEMBER 7", PCDHGA7
14246,606295,"PROTOCADHERIN-GAMMA, SUBFAMILY A, MEMBER 8", PCDHGA8
14247,606296,"PROTOCADHERIN-GAMMA, SUBFAMILY A, MEMBER 9", PCDHGA9
14248,606297,"PROTOCADHERIN-GAMMA, SUBFAMILY A, MEMBER 10", PCDHGA10
14249,606298,"PROTOCADHERIN-GAMMA, SUBFAMILY A, MEMBER 11", PCDHGA11
14250,606299,"PROTOCADHERIN-GAMMA, SUBFAMILY B, MEMBER 1", PCDHGB1
14251,606300,"PROTOCADHERIN-GAMMA, SUBFAMILY B, MEMBER 2", PCDHGB2
14252,606301,"PROTOCADHERIN-GAMMA, SUBFAMILY B, MEMBER 3", PCDHGB3
14253,606302,"PROTOCADHERIN-GAMMA, SUBFAMILY B, MEMBER 5", PCDHGB5
14254,606303,"PROTOCADHERIN-GAMMA, SUBFAMILY B, MEMBER 6", PCDHGB6
14255,606304,"PROTOCADHERIN-GAMMA, SUBFAMILY B, MEMBER 7", PCDHGB7
14256,606305,"PROTOCADHERIN-GAMMA, SUBFAMILY C, MEMBER 4", PCDHGC4
14257,606306,"PROTOCADHERIN-GAMMA, SUBFAMILY C, MEMBER 5", PCDHGC5
14258,606307,PROTOCADHERIN-ALPHA 1, PCDHA1
14259,606308,PROTOCADHERIN-ALPHA 2, PCDHA2
14260,606309,PROTOCADHERIN-ALPHA 3, PCDHA3
14261,606310,PROTOCADHERIN-ALPHA 4, PCDHA4
14262,606311,PROTOCADHERIN-ALPHA 5, PCDHA5
14263,606312,PROTOCADHERIN-ALPHA 6, PCDHA6
14264,606313,PROTOCADHERIN-ALPHA 7, PCDHA7
14265,606314,PROTOCADHERIN-ALPHA 8, PCDHA8
14266,606315,PROTOCADHERIN-ALPHA 9, PCDHA9
14267,606316,PROTOCADHERIN-ALPHA 10, PCDHA10
14268,606317,PROTOCADHERIN-ALPHA 11, PCDHA11
14269,606318,PROTOCADHERIN-ALPHA 12, PCDHA12
14270,606319,PROTOCADHERIN-ALPHA 13, PCDHA13
14271,606320,"PROTOCADHERIN-ALPHA, SUBFAMILY C, MEMBER 1", PCDHAC1
14272,606321,"PROTOCADHERIN-ALPHA, SUBFAMILY C, MEMBER 2", PCDHAC2
14273,606322,CYTOPLASMIC FMRP-INTERACTING PROTEIN 1, CYFIP1
14274,606323,CYTOPLASMIC FMRP-INTERACTING PROTEIN 2, CYFIP2
14275,606324,"PARKINSON DISEASE 7, AUTOSOMAL RECESSIVE EARLY-ONSET", PARK7
14276,606325,"HETEROTAXY, VISCERAL, 3, AUTOSOMAL", HTX3
14277,606326,SIX HOMEOBOX 6, SIX6
14278,606327,PROTOCADHERIN-BETA 1, PCDHB1
14279,606328,PROTOCADHERIN-BETA 2, PCDHB2
14280,606329,PROTOCADHERIN-BETA 3, PCDHB3
14281,606330,PROTOCADHERIN-BETA 4, PCDHB4
14282,606331,PROTOCADHERIN-BETA 5, PCDHB5
14283,606332,PROTOCADHERIN-BETA 6, PCDHB6
14284,606333,PROTOCADHERIN-BETA 7, PCDHB7
14285,606334,PROTOCADHERIN-BETA 8, PCDHB8
14286,606335,PROTOCADHERIN-BETA 9, PCDHB9
14287,606336,PROTOCADHERIN-BETA 10, PCDHB10
14288,606337,PROTOCADHERIN-BETA 11, PCDHB11
14289,606338,PROTOCADHERIN-BETA 12, PCDHB12
14290,606339,PROTOCADHERIN-BETA 13, PCDHB13
14291,606340,PROTOCADHERIN-BETA 14, PCDHB14
14292,606341,PROTOCADHERIN-BETA 15, PCDHB15
14293,606342,SIX HOMEOBOX 4, SIX4
14294,606343,"POLYMERASE, DNA, LAMBDA", POLL
14295,606344,"POLYMERASE, DNA, MU", POLM
14296,606345,PROTOCADHERIN-BETA 16, PCDHB16
14297,606346,"DEAFNESS, AUTOSOMAL DOMINANT 22", DFNA22
14298,606347,PROLINE/SERINE/THREONINE PHOSPHATASE-INTERACTING PROTEIN 1, PSTPIP1
14299,606348,INFLAMMATORY BOWEL DISEASE 5, IBD5
14300,606349,"GAMBLING, PATHOLOGIC",
14301,606350,APRATAXIN, APTX
14302,606351,ESPIN, ESPN
14303,606352,ALSIN RHO GUANINE NUCLEOTIDE EXCHANGE FACTOR ALS2, ALS2
14304,606353,"PRIMARY LATERAL SCLEROSIS, JUVENILE", PLSJ
14305,606354,FORKHEAD BOX P2,
14306,606355,DEAD-BOX HELICASE 18, DDX18
14307,606356,TRANSMEMBRANE PROTEIN 123, TMEM123
14308,606357,DExD-BOX HELICASE 21, DDX21
14309,606358,"ANTERIOR GRADIENT 2, PROTEIN DISULPHIDE ISOMERASE FAMILY MEMBER", AGR2
14310,606359,"WINGLESS-TYPE MMTV INTEGRATION SITE FAMILY, MEMBER 3A", WNT3A
14311,606360,"WINGLESS-TYPE MMTV INTEGRATION SITE FAMILY, MEMBER 8A", WNT8A
14312,606361,"WINGLESS-TYPE MMTV INTEGRATION SITE FAMILY, MEMBER 5B", WNT5B
14313,606362,ACID PHOSPHATASE 4, ACP4
14314,606363,ABI FAMILY MEMBER 3, ABI3
14315,606364,SPINOCEREBELLAR ATAXIA 15,
14316,606365,GLUTAMINASE 2, GLS2
14317,606366,"RAS HOMOLOG GENE FAMILY, MEMBER U", RHOU
14318,606367,IMMUNODEFICIENCY 41 WITH LYMPHOPROLIFERATION AND AUTOIMMUNITY, IMD41
14319,606368,APOLIPOPROTEIN A-V, APOA5
14320,606369,MACROCEPHALY AND EPILEPTIC ENCEPHALOPATHY,
14321,606370,THIAMINE PYROPHOSPHOKINASE, TPK1
14322,606371,ACTIVATING TRANSCRIPTION FACTOR 7, ATF7
14323,606372,"CHOLINERGIC RECEPTOR, NEURONAL NICOTINIC, ALPHA POLYPEPTIDE 10", CHRNA10
14324,606373,FORMIN 2, FMN2
14325,606374,"BETA-1,3-GLUCURONYLTRANSFERASE 3", B3GAT3
14326,606375,"BETA-1,3-GLUCURONYLTRANSFERASE 1",
14327,606376,CARBOHYDRATE SULFOTRANSFERASE 10, CHST10
14328,606377,DIMERIC DIHYDRODIOL DEHYDROGENASE, DHDH
14329,606378,"ST6 ALPHA-N-ACETYL-NEURAMINYL-2,3-BETA-GALACTOSYL-1,3-N-ACETYLGALACTOSAMINIDE ALPHA-2,6-SIALYLTRANSFERASE 4", ST6GALNAC4
14330,606379,G PROTEIN-COUPLED RECEPTOR 87, GPR87
14331,606380,"PURINERGIC RECEPTOR P2Y, G PROTEIN-COUPLED, 13", P2RY13
14332,606381,SUCCINATE RECEPTOR 1, SUCNR1
14333,606382,"MEMBRANE-ASSOCIATED GUANYLATE KINASE, WW AND PDZ DOMAINS-CONTAINING, 2", MAGI2
14334,606383,G PROTEIN-COUPLED RECEPTOR 84, GPR84
14335,606384,UBIQUITIN PROTEIN LIGASE NEDD4-LIKE, NEDD4L
14336,606385,OLIGODENDROCYTE LINEAGE TRANSCRIPTION FACTOR 1, OLIG1
14337,606386,OLIGODENDROCYTE LINEAGE TRANSCRIPTION FACTOR 2, OLIG2
14338,606387,"TOPOISOMERASE I, MITOCHONDRIAL", TOP1MT
14339,606388,THIOESTERASE SUPERFAMILY MEMBER 4, THEM4
14340,606389,"CATION CHANNEL, SPERM-ASSOCIATED, 1", CATSPER1
14341,606390,DExD-BOX HELICASE 39B,
14342,606391,MATURITY-ONSET DIABETES OF THE YOUNG, MODY
14343,606392,"MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 4", MODY4
14344,606393,A DISINTEGRIN AND METALLOPROTEINASE DOMAIN-LIKE PROTEIN DECYSIN 1, ADAMDEC1
14345,606394,"MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 6", MODY6
14346,606395,PROLACTIN REGULATORY ELEMENT-BINDING PROTEIN, PREB
14347,606396,BRIDGING INTEGRATOR 3, BIN3
14348,606397,CLARIN 1, CLRN1
14349,606398,ACTIVATING TRANSCRIPTION FACTOR 5, ATF5
14350,606399,"CALCIUM CHANNEL, VOLTAGE-DEPENDENT, ALPHA-2/DELTA SUBUNIT 3", CACNA2D3
14351,606400,CALPAIN 7, CAPN7
14352,606401,CALPAIN 9, CAPN9
14353,606402,GASTROKINE 1, GKN1
14354,606403,"CALCIUM CHANNEL, VOLTAGE-DEPENDENT, GAMMA-3 SUBUNIT", CACNG3
14355,606404,"CALCIUM CHANNEL, VOLTAGE-DEPENDENT, GAMMA-4 SUBUNIT", CACNG4
14356,606405,"CALCIUM CHANNEL, VOLTAGE-DEPENDENT, GAMMA-5 SUBUNIT", CACNG5
14357,606406,"NUCLEAR PORE COMPLEX-INTERACTING PROTEIN FAMILY, MEMBER A1", NPIPA1
14358,606407,HYPOTONIA-CYSTINURIA SYNDROME,
14359,606408,"EHLERS-DANLOS SYNDROME, CLASSIC-LIKE, 1", EDSCLL1
14360,606409,ITCHY E3 UBIQUITIN PROTEIN LIGASE, ITCH
14361,606410,ANTHRAX TOXIN RECEPTOR 1, ANTXR1
14362,606411,"SOLUTE CARRIER FAMILY 13 (SODIUM-DEPENDENT DICARBOXYLATE TRANSPORTER), MEMBER 3", SLC13A3
14363,606412,BARTTIN CLCNK-TYPE ACCESSORY SUBUNIT BETA, BSND
14364,606413,INSULIN-LIKE 5, INSL5
14365,606414,INSULIN-LIKE 6, INSL6
14366,606415,"CANDIDIASIS, FAMILIAL, 1",
14367,606416,"NLR FAMILY, PYRIN DOMAIN-CONTAINING 3", NLRP3
14368,606417,WD REPEAT-CONTAINING PROTEIN 11, WDR11
14369,606418,24-DEHYDROCHOLESTEROL REDUCTASE, DHCR24
14370,606419,PRE-mRNA-PROCESSING FACTOR 31, PRPF31
14371,606420,ENGULFMENT AND CELL MOTILITY GENE 1, ELMO1
14372,606421,ENGULFMENT AND CELL MOTILITY GENE 2, ELMO2
14373,606422,ENGULFMENT AND CELL MOTILITY GENE 3, ELMO3
14374,606423,DISRUPTED IN RENAL CARCINOMA 1, DIRC1
14375,606424,EGL9 FAMILY HYPOXIA-INDUCIBLE FACTOR 2, EGLN2
14376,606425,EGL9 FAMILY HYPOXIA-INDUCIBLE FACTOR 1, EGLN1
14377,606426,EGL9 FAMILY HYPOXIA-INDUCIBLE FACTOR 3, EGLN3
14378,606427,ZINC FINGER PROTEIN 320, ZNF320
14379,606428,"UDP-GLYCOSYLTRANSFERASE 1 FAMILY, POLYPEPTIDE A3", UGT1A3
14380,606429,"UDP-GLYCOSYLTRANSFERASE 1 FAMILY, POLYPEPTIDE A4", UGT1A4
14381,606430,"UDP-GLYCOSYLTRANSFERASE 1 FAMILY, POLYPEPTIDE A5", UGT1A5
14382,606431,"UDP-GLYCOSYLTRANSFERASE 1 FAMILY, POLYPEPTIDE A6", UGT1A6
14383,606432,"UDP-GLYCOSYLTRANSFERASE 1 FAMILY, POLYPEPTIDE A7", UGT1A7
14384,606433,"UDP-GLYCOSYLTRANSFERASE 1 FAMILY, POLYPEPTIDE A8", UGT1A8
14385,606434,"UDP-GLYCOSYLTRANSFERASE 1 FAMILY, POLYPEPTIDE A9", UGT1A9
14386,606435,"UDP-GLYCOSYLTRANSFERASE 1 FAMILY, POLYPEPTIDE A10", UGT1A10
14387,606436,SYNAPTOTAGMIN 12, SYT12
14388,606437,"SEIZURES, BENIGN FAMILIAL NEONATAL, 1",
14389,606438,HUNTINGTON DISEASE-LIKE 2, HDL2
14390,606439,ATLASTIN GTPase 1, ATL1
14391,606440,STEREOCILIN, STRC
14392,606441,HTRA SERINE PEPTIDASE 2, HTRA2
14393,606442,ABL INTERACTOR 2, ABI2
14394,606443,cAMP RESPONSE ELEMENT-BINDING PROTEIN 3, CREB3
14395,606444,CREB/ATF BASIC LEUCINE ZIPPER TRANSCRIPTION FACTOR, CREBZF
14396,606445,PERSISTENT POLYCLONAL B-CELL LYMPHOCYTOSIS, PPBL
14397,606446,"SLAM FAMILY, MEMBER 6", SLAMF6
14398,606447,RNA-BINDING PROTEIN S1, RNPS1
14399,606448,THIOREDOXIN REDUCTASE 2, TXNRD2
14400,606449,"PROTEIN-TYROSINE PHOSPHATASE, TYPE 4A, 3", PTP4A3
14401,606450,NEUROEPITHELIAL CELL TRANSFORMING GENE 1, NET1
14402,606451,"DEAFNESS, AUTOSOMAL DOMINANT 30", DFNA30
14403,606452,"ZINC FINGER, MATRIN-TYPE 3", ZMAT3
14404,606453,"LIPOPOLYSACCHARIDE-RESPONSIVE, BEIGE-LIKE ANCHOR PROTEIN", LRBA
14405,606454,"EUKARYOTIC TRANSLATION INITIATION FACTOR 2B, SUBUNIT 2", EIF2B2
14406,606455,"PROTEIN PHOSPHATASE 1, REGULATORY SUBUNIT 13B", PPP1R13B
14407,606456,"NUCLEOPHOSMIN/NUCLEOPLASMIN FAMILY, MEMBER 3", NPM3
14408,606457,INHIBITOR OF BRUTON AGAMMAGLOBULINEMIA TYROSINE KINASE, IBTK
14409,606458,CYSTEINE- AND SERINE-RICH NUCLEAR PROTEIN 1, CSRNP1
14410,606459,OPIOID GROWTH FACTOR RECEPTOR, OGFR
14411,606460,LONGEVITY 2,
14412,606461,TRIMETHYLGUANOSINE SYNTHASE 1, TGS1
14413,606462,RAD21 COHESIN COMPLEX COMPONENT, RAD21
14414,606463,"GLUCOSIDASE, BETA, ACID", GBA
14415,606464,HEPCIDIN ANTIMICROBIAL PEPTIDE, HAMP
14416,606465,KRUPPEL-LIKE FACTOR 15, KLF15
14417,606466,PML-RARA REGULATED ADAPTOR MOLECULE 1, PRAM1
14418,606467,"ALDEHYDE DEHYDROGENASE 8 FAMILY, MEMBER A1", ALDH8A1
14419,606468,GAR1 RIBONUCLEOPROTEIN, GAR1
14420,606469,RING FINGER PROTEIN 29, RNF29
14421,606470,NHP2 RIBONUCLEOPROTEIN, NHP2
14422,606471,NOP10 RIBONUCLEOPROTEIN, NOP10
14423,606472,SS18L1 SUBUNIT OF BAF CHROMATIN REMODELING COMPLEX, SS18L1
14424,606473,SS18-LIKE GENE 2, SS18L2
14425,606474,RING FINGER PROTEIN 30, RNF30
14426,606475,CD320 ANTIGEN, CD320
14427,606476,"INOSITOL 1,4,5-TRISPHOSPHATE 3-KINASE C", ITPKC
14428,606477,SERINE RACEMASE, SRR
14429,606478,PROTECTION OF TELOMERES 1, POT1
14430,606479,NEUROLIGIN 2, NLGN2
14431,606480,ZINC METALLOPROTEINASE STE24, ZMPSTE24
14432,606481,"PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE 5-PHOSPHATASE, A", PIB5PA
14433,606482,"CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE B", CMTDIB
14434,606483,"CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2GG", CMT2GG
14435,606484,MYOTROPHIN, MTPN
14436,606485,"POLYMERASE II, RNA, SUBUNIT M", POLR2M
14437,606486,CHARGED MULTIVESICULAR BODY PROTEIN 1B, CHMP1B
14438,606487,PHOSPHOLIPASE A AND ACETYLTRANSFERASE 1, PLAAT1
14439,606488,EXOSOME COMPONENT 7, EXOSC7
14440,606489,EXOSOME COMPONENT 3, EXOSC3
14441,606490,EXOSOME COMPONENT 6, EXOSC6
14442,606491,EXOSOME COMPONENT 4, EXOSC4
14443,606492,EXOSOME COMPONENT 5, EXOSC5
14444,606493,EXOSOME COMPONENT 1, EXOSC1
14445,606494,"ST3 BETA-GALACTOSIDE ALPHA-2,3-SIALYLTRANSFERASE 3", ST3GAL3
14446,606495,MAP/MICROTUBULE AFFINITY-REGULATING KINASE 4, MARK4
14447,606496,INTERLEUKIN 17F, IL17F
14448,606497,"URIDINE DIPHOSPHATE GLYCOSYLTRANSFERASE 2 FAMILY, MEMBER B28", UGT2B28
14449,606498,"MEMBRANE-SPANNING 4-DOMAINS, SUBFAMILY A, MEMBER 3", MS4A3
14450,606499,"MEMBRANE-SPANNING 4-DOMAINS, SUBFAMILY A, MEMBER 5", MS4A5
14451,606500,"SECRETOGLOBIN, FAMILY 3A, MEMBER 1", SCGB3A1
14452,606501,MYOTUBULARIN-RELATED PROTEIN 12, MTMR12
14453,606502,"MEMBRANE-SPANNING 4-DOMAINS, SUBFAMILY A, MEMBER 7", MS4A7
14454,606503,SUV39H2 HISTONE LYSINE METHYLTRANSFERASE, SUV39H2
14455,606504,CANCER SUSCEPTIBILITY CANDIDATE 3, CASC3
14456,606505,PIN2-INTERACTING PROTEIN 1, PINX1
14457,606506,PEROXIREDOXIN 4,
14458,606507,CYTOHESIN 2,
14459,606508,Fc RECEPTOR-LIKE PROTEIN 1, FCRL1
14460,606509,Fc RECEPTOR-LIKE PROTEIN 2, FCRL2
14461,606510,Fc RECEPTOR-LIKE PROTEIN 3, FCRL3
14462,606511,MAP/MICROTUBULE AFFINITY-REGULATING KINASE 1, MARK1
14463,606512,PROTEIN KINASE C AND CASEIN KINASE SUBSTRATE IN NEURONS 1, PACSIN1
14464,606513,PROTEIN KINASE C AND CASEIN KINASE SUBSTRATE IN NEURONS 3, PACSIN3
14465,606514,CYTOHESIN 4, CYTH4
14466,606515,"RNA, 7SK, SMALL NUCLEAR", RN7SK
14467,606516,MUSCLEBLIND-LIKE SPLICING REGULATOR 1, MBNL1
14468,606517,ARYLHYDROCARBON RECEPTOR REPRESSOR, AHRR
14469,606518,HEPATITIS A VIRUS CELLULAR RECEPTOR 1, HAVCR1
14470,606519,PHACE ASSOCIATION,
14471,606520,MEGAKARYOCYTE AND PLATELET INHIBITORY RECEPTOR G6B, MPIG6B
14472,606521,"SOLUTE CARRIER FAMILY 25 (MITOCHONDRIAL THIAMINE PYROPHOSPHATE CARRIER), MEMBER 19", SLC25A19
14473,606522,GROWTH/DIFFERENTIATION FACTOR 3, GDF3
14474,606523,SLIT-ROBO RHO GTPase-ACTIVATING PROTEIN 1, SRGAP1
14475,606524,SLIT-ROBO RHO GTPase-ACTIVATING PROTEIN 2, SRGAP2
14476,606525,SLIT-ROBO RHO GTPase-ACTIVATING PROTEIN 3, SRGAP3
14477,606526,MELANOPHILIN, MLPH
14478,606527,MEGARBANE SYNDROME,
14479,606528,HOMOZYGOUS 11p15-p14 DELETION SYNDROME,
14480,606529,"CRANIOSYNOSTOSIS SYNDROME, AUTOSOMAL RECESSIVE",
14481,606530,"CYTOCHROME P450, SUBFAMILY XXVIIA, POLYPEPTIDE 1", CYP27A1
14482,606531,"SECRETOGLOBIN, FAMILY 3A, MEMBER 2", SCGB3A2
14483,606532,HORMONALLY UPREGULATED NEU-ASSOCIATED KINASE, HUNK
14484,606533,CHLORIDE INTRACELLULAR CHANNEL 3, CLIC3
14485,606534,"CYTOCHROME P450, SUBFAMILY IIIA, POLYPEPTIDE 43", CYP3A43
14486,606535,MYC-BINDING PROTEIN, MYCBP
14487,606536,CHLORIDE INTRACELLULAR CHANNEL 4, CLIC4
14488,606537,MYOSIN IB, MYO1B
14489,606538,MYOSIN IC, MYO1C
14490,606539,MYOSIN ID, MYO1D
14491,606540,MYOSIN VB, MYO5B
14492,606541,MYOSIN VIIB, MYO7B
14493,606542,HISTONE DEACETYLASE 7A, HDAC7A
14494,606543,HISTONE DEACETYLASE 9, HDAC9
14495,606544,MITOCHONDRIAL ELONGATION FACTOR G2, GFM2
14496,606545,"ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 3", ARCI3
14497,606546,HYDATIDIFORM MOLE-ASSOCIATED AND IMPRINTED TRANSCRIPT, HYMAI
14498,606547,"MEMBRANE-SPANNING 4-DOMAINS, SUBFAMILY A, MEMBER 4A", MS4A4A
14499,606548,"MEMBRANE-SPANNING 4-DOMAINS, SUBFAMILY A, MEMBER 6A", MS4A6A
14500,606549,"MEMBRANE-SPANNING 4-DOMAINS, SUBFAMILY A, MEMBER 8B", MS4A8B
14501,606550,"MEMBRANE-SPANNING 4-DOMAINS, SUBFAMILY A, MEMBER 12",
14502,606551,"LEUCINE ZIPPER, PUTATIVE TUMOR SUPPRESSOR 1", LZTS1
14503,606552,"EPISODIC ATAXIA, TYPE 4", EA4
14504,606553,"SOLUTE CARRIER FAMILY 9, MEMBER 3, REGULATOR 2", SLC9A3R2
14505,606554,"EPISODIC ATAXIA, TYPE 3", EA3
14506,606555,TRIPARTITE MOTIF-CONTAINING PROTEIN 9, TRIM9
14507,606556,TRIPARTITE MOTIF-CONTAINING PROTEIN 14, TRIM14
14508,606557,BAF CHROMATIN REMODELING COMPLEX SUBUNIT BCL11A, BCL11A
14509,606558,BAF CHROMATIN REMODELING COMPLEX SUBUNIT BCL11B, BCL11B
14510,606559,TRIPARTITE MOTIF-CONTAINING PROTEIN 22, TRIM22
14511,606560,SPERM-ASSOCIATED ANTIGEN 11B, SPAG11B
14512,606561,"SOLUTE CARRIER FAMILY 36 (PROTON/AMINO ACID SYMPORTER), MEMBER 1", SLC36A1
14513,606562,"TRANSMEMBRANE 6 SUPERFAMILY, MEMBER 1", TM6SF1
14514,606563,"TRANSMEMBRANE 6 SUPERFAMILY, MEMBER 2", TM6SF2
14515,606564,"PROSTATE TRANSMEMBRANE PROTEIN, ANDROGEN-INDUCED", PMEPA1
14516,606565,"TRANSMEMBRANE PROTEASE, SERINE 4", TMPRSS4
14517,606566,MYOSIN LIGHT CHAIN KINASE 2, MYLK2
14518,606567,"TRANSMEMBRANE 4 SUPERFAMILY, MEMBER 4", TM4SF4
14519,606568,LEUCINE ZIPPER TRANSCRIPTION FACTOR-LIKE 1, LZTFL1
14520,606569,SUPPRESSOR OF ACTIN MUTATIONS 1-LIKE, SACM1L
14521,606570,SECRETED FRIZZLED-RELATED PROTEIN 4, SFRP4
14522,606571,LOW DENSITY LIPOPROTEIN RECEPTOR CLASS A DOMAIN-CONTAINING PROTEIN 4, LDLRAD4
14523,606572,NADPH OXIDASE 5, NOX5
14524,606573,FYN-RELATED SRC FAMILY TYROSINE KINASE, FRK
14525,606574,"ALBINISM, OCULOCUTANEOUS, TYPE IV", OCA4
14526,606575,"MEMBRANE PROTEIN, PALMITOYLATED 4", MPP4
14527,606576,"TAF3 RNA POLYMERASE II, TATA BOX-BINDING PROTEIN-ASSOCIATED FACTOR, 140-KD", TAF3
14528,606577,SRC-LIKE ADAPTOR 2, SLA2
14529,606578,AQUAPORIN 10, AQP10
14530,606579,VITILIGO-ASSOCIATED MULTIPLE AUTOIMMUNE DISEASE SUSCEPTIBILITY 1, VAMAS1
14531,606580,OUTER MITOCHONDRIAL MEMBRANE LIPID METABOLISM REGULATOR OPA3, OPA3
14532,606581,"POLYSUBSTANCE ABUSE, SUSCEPTIBILITY TO", PSAB
14533,606582,DELTA-LIKE CANONICAL NOTCH LIGAND 1, DLL1
14534,606583,PEROXIREDOXIN 5, PRDX5
14535,606584,"PROTEIN-TYROSINE PHOSPHATASE, NONRECEPTOR-TYPE, 23", PTPN23
14536,606585,ENAMELIN, ENAM
14537,606586,RETINOIC ACID-INDUCED 14, RAI14
14538,606587,"PROTEIN-TYROSINE PHOSPHATASE, NONRECEPTOR-TYPE, 18", PTPN18
14539,606588,DNA METHYLTRANSFERASE 3-LIKE PROTEIN, DNMT3L
14540,606589,SORTING NEXIN 13, SNX13
14541,606590,"NPL4 HOMOLOG, UBIQUITIN RECOGNITION FACTOR", NPLOC4
14542,606591,MUS81 STRUCTURE-SPECIFIC ENDONUCLEASE SUBUNIT, MUS81
14543,606592,VANIN 3, VNN3
14544,606593,LIG4 SYNDROME,
14545,606594,SET DOMAIN-CONTAINING PROTEIN 7, SETD7
14546,606595,"CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2F", CMT2F
14547,606596,FUKUTIN-RELATED PROTEIN, FKRP
14548,606597,PAIRED BOX GENE 3, PAX3
14549,606598,GANGLIOSIDE-INDUCED DIFFERENTIATION-ASSOCIATED PROTEIN 1, GDAP1
14550,606599,THIOREDOXIN-INTERACTING PROTEIN, TXNIP
14551,606600,RAS PROTEIN-SPECIFIC GUANINE NUCLEOTIDE-RELEASING FACTOR 1, RASGRF1
14552,606601,"ENDOGENOUS RETROVIRAL SEQUENCE E, 1", ERVE1
14553,606602,"BRAIN AND ACUTE LEUKEMIA GENE, CYTOPLASMIC", BAALC
14554,606603,EDAR-ASSOCIATED DEATH DOMAIN, EDARADD
14555,606604,F-BOX ONLY PROTEIN 32, FBXO32
14556,606605,ATR-INTERACTING PROTEIN, ATRIP
14557,606606,"PITUITARY HORMONE DEFICIENCY, COMBINED, 4",
14558,606607,"PROTEASOME SUBUNIT, ALPHA-TYPE, 7", PSMA7
14559,606608,YES1-ASSOCIATED TRANSCRIPTIONAL REGULATOR, YAP1
14560,606609,3-PRIME REPAIR EXONUCLEASE 1, TREX1
14561,606610,NSFL1 COFACTOR, NSFL1C
14562,606611,"DEFENSIN, BETA, 103A", DEFB103A
14563,606612,"MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT), TYPE B, 5", MDDGB5
14564,606613,HIGH DENSITY LIPOPROTEIN CHOLESTEROL LEVEL QUANTITATIVE TRAIT LOCUS 1, HDLCQ1
14565,606614,RAS PROTEIN-SPECIFIC GUANINE NUCLEOTIDE-RELEASING FACTOR 2, RASGRF2
14566,606615,HYPOXIA-INDUCIBLE FACTOR 1-ALPHA INHIBITOR, HIF1AN
14567,606616,"DYSLEXIA, SUSCEPTIBILITY TO, 6", DYX6
14568,606617,LEFT VENTRICULAR NONCOMPACTION 1,
14569,606618,DUAL-SPECIFICITY PHOSPHATASE 14, DUSP14
14570,606619,"GLUCOSIDASE, BETA, ACID 3", GBA3
14571,606620,"SLAM FAMILY, MEMBER 8", SLAMF8
14572,606621,INTRAFLAGELLAR TRANSPORT 57, IFT57
14573,606622,"SWI/SNF-RELATED, MATRIX-ASSOCIATED, ACTIN-DEPENDENT REGULATOR OF CHROMATIN, SUBFAMILY A-LIKE PROTEIN 1", SMARCAL1
14574,606623,17-BETA-HYDROXYSTEROID DEHYDROGENASE VI, HSD17B6
14575,606624,NEUROGENIN 2, NEUROG2
14576,606625,"SLAM FAMILY, MEMBER 7", SLAMF7
14577,606626,DISHEVELLED-ASSOCIATED ACTIVATOR OF MORPHOGENESIS 1, DAAM1
14578,606627,DISHEVELLED-ASSOCIATED ACTIVATOR OF MORPHOGENESIS 2, DAAM2
14579,606628,GLYCINE N-METHYLTRANSFERASE, GNMT
14580,606629,PROTEIN REGULATING SYNAPTIC MEMBRANE EXOCYTOSIS 1, RIMS1
14581,606630,PROTEIN REGULATING SYNAPTIC MEMBRANE EXOCYTOSIS 2, RIMS2
14582,606631,"CAMURATI-ENGELMANN DISEASE, TYPE 2",
14583,606632,"ODOR, MALE, WOMEN'S CHOICE OF",
14584,606633,TRANSCRIPTION FACTOR Sp7, SP7
14585,606634,DERMCIDIN, DCD
14586,606635,"TRANSMEMBRANE PROTEASE, SERINE 15", TMPRSS15
14587,606636,"NLR FAMILY, PYRIN DOMAIN-CONTAINING 1", NLRP1
14588,606637,"PEPTIDE YY, 2", PYY2
14589,606638,PANCREATIC POLYPEPTIDE 2, PPY2
14590,606639,MITOCHONDRIAL ELONGATION FACTOR G1, GFM1
14591,606640,AMYOTROPHIC LATERAL SCLEROSIS 3, ALS3
14592,606641,BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 1, BMIQ1
14593,606642,BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 1,
14594,606643,BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 2, BMIQ2
14595,606644,"IMMUNOGLOBULIN SUPERFAMILY, MEMBER 8", IGSF8
14596,606645,"ARF-GAP, RHO-GAP, ANKYRIN REPEAT, AND PLECKSTRIN HOMOLOGY DOMAINS-CONTAINING PROTEIN 2", ARAP2
14597,606646,"ARF-GAP, RHO-GAP, ANKYRIN REPEAT, AND PLECKSTRIN HOMOLOGY DOMAINS-CONTAINING PROTEIN 1", ARAP1
14598,606647,"CENTAURIN, DELTA-3", CENTD3
14599,606648,"INTERLEUKIN 22 RECEPTOR, ALPHA-2", IL22RA2
14600,606649,HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 ENHANCER-BINDING PROTEIN 3, HIVEP3
14601,606650,"GLUTAMATE RECEPTOR, IONOTROPIC, N-METHYL-D-ASPARTATE 3A", GRIN3A
14602,606651,"GLUTAMATE RECEPTOR, IONOTROPIC, N-METHYL-D-ASPARTATE 3B", GRIN3B
14603,606652,HEPATITIS A VIRUS CELLULAR RECEPTOR 2, HAVCR2
14604,606653,LEUCINE-RICH REPEAT-CONTAINING G PROTEIN-COUPLED RECEPTOR 6, LGR6
14605,606654,RELAXIN/INSULIN-LIKE FAMILY PEPTIDE RECEPTOR 1, RXFP1
14606,606655,RELAXIN/INSULIN-LIKE FAMILY PEPTIDE RECEPTOR 2, RXFP2
14607,606656,"BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 1",
14608,606657,"GLAUCOMA, NORMAL TENSION, SUSCEPTIBILITY TO",
14609,606658,SPINOCEREBELLAR ATAXIA 15, SCA15
14610,606659,TRANSLOCASE OF INNER MITOCHONDRIAL MEMBRANE 8B, TIMM8B
14611,606660,"MELANOMA, UVEAL, SUSCEPTIBILITY TO, 1", UVM1
14612,606661,"MELANOMA, UVEAL, SUSCEPTIBILITY TO, 2", UVM2
14613,606662,"WAARDENBURG SYNDROME, TYPE 2C", WS2C
14614,606663,LYSYL OXIDASE-LIKE 2, LOXL2
14615,606664,GLYCINE N-METHYLTRANSFERASE DEFICIENCY,
14616,606665,OPSIN 4, OPN4
14617,606666,LEUCINE-RICH REPEAT-CONTAINING G PROTEIN-COUPLED RECEPTOR 4, LGR4
14618,606667,LEUCINE-RICH REPEAT-CONTAINING G PROTEIN-COUPLED RECEPTOR 5, LGR5
14619,606668,INFLAMMATORY BOWEL DISEASE 8, IBD8
14620,606669,FXYD DOMAIN-CONTAINING ION TRANSPORT REGULATOR 5, FXYD5
14621,606670,"PROTEIN PHOSPHATASE 1, REGULATORY SUBUNIT 11", PPP1R11
14622,606671,NCK-INTERACTING PROTEIN WITH SH3 DOMAIN, NCKIPSD
14623,606672,"GLYCOPROTEIN Ib, PLATELET, ALPHA POLYPEPTIDE", GP1BA
14624,606673,BETA-UREIDOPROPIONASE, UPB1
14625,606674,INFLAMMATORY BOWEL DISEASE 6, IBD6
14626,606675,INFLAMMATORY BOWEL DISEASE 4, IBD4
14627,606676,"TRANSIENT RECEPTOR POTENTIAL CATION CHANNEL, SUBFAMILY V, MEMBER 2", TRPV2
14628,606677,"C-TYPE LECTIN DOMAIN FAMILY 4, MEMBER C", CLEC4C
14629,606678,"TRANSIENT RECEPTOR POTENTIAL CATION CHANNEL, SUBFAMILY M, MEMBER 8", TRPM8
14630,606679,"TRANSIENT RECEPTOR POTENTIAL CATION CHANNEL, SUBFAMILY V, MEMBER 5", TRPV5
14631,606680,"TRANSIENT RECEPTOR POTENTIAL CATION CHANNEL, SUBFAMILY V, MEMBER 6", TRPV6
14632,606681,NUCLEAR RECEPTOR-BINDING SET DOMAIN PROTEIN 1, NSD1
14633,606682,"HPS4 BIOGENESIS OF LYSOSOMAL ORGANELLES COMPLEX 3, SUBUNIT 2", HPS4
14634,606683,FXYD DOMAIN-CONTAINING ION TRANSPORT REGULATOR 6, FXYD6
14635,606684,FXYD DOMAIN-CONTAINING ION TRANSPORT REGULATOR 7, FXYD7
14636,606685,"CARDIOMYOPATHY, DILATED, 1L", CMD1L
14637,606686,"EUKARYOTIC TRANSLATION INITIATION FACTOR 2B, SUBUNIT 1", EIF2B1
14638,606687,"EUKARYOTIC TRANSLATION INITIATION FACTOR 2B, SUBUNIT 4", EIF2B4
14639,606688,SPONGIFORM ENCEPHALOPATHY WITH NEUROPSYCHIATRIC FEATURES,
14640,606689,"GLAUCOMA 1, OPEN ANGLE, B", GLC1B
14641,606690,LYMPHANGIOLEIOMYOMATOSIS, LAM
14642,606691,CEA CELL ADHESION MOLECULE 19, CEACAM19
14643,606692,TNF RECEPTOR-ASSOCIATED FACTOR 7, TRAF7
14644,606693,KUFOR-RAKEB SYNDROME, KRS
14645,606694,"NUCLEOPORIN, 155-KD", NUP155
14646,606695,OPSIN 3, OPN3
14647,606696,"KATANIN, p60 SUBUNIT, A1", KATNA1
14648,606697,ZINC FINGER PROTEIN ZK1,
14649,606698,SRY-BOX 30,
14650,606699,HELICASE WITH ZINC FINGER DOMAIN, HELZ
14651,606700,MIDNOLIN, MIDN
14652,606701,DORSAL ROOT GANGLIA HOMEOBOX, DRGX
14653,606702,PKHD1 CILIARY IPT DOMAIN-CONTAINING FIBROCYSTIN/POLYDUCTIN, PKHD1
14654,606703,"DYSKINESIA WITH OROFACIAL INVOLVEMENT, AUTOSOMAL DOMINANT", DSKOD
14655,606704,G PROTEIN-COUPLED RECEPTOR 75, GPR75
14656,606705,"DEAFNESS, AUTOSOMAL DOMINANT 36", DFNA36
14657,606706,TRANSMEMBRANE CHANNEL-LIKE PROTEIN 1, TMC1
14658,606707,TRANSMEMBRANE CHANNEL-LIKE PROTEIN 2, TMC2
14659,606708,SPLIT-HAND/FOOT MALFORMATION 5, SHFM5
14660,606709,"PROTEASE, SERINE, 12", PRSS12
14661,606710,"LHFPL TETRASPAN SUBFAMILY, MEMBER 6", LHFPL6
14662,606711,SPECIFIC LANGUAGE IMPAIRMENT 1, SLI1
14663,606712,SPECIFIC LANGUAGE IMPAIRMENT 2, SLI2
14664,606713,VAN DER WOUDE SYNDROME 2, VWS2
14665,606714,PROLINE-RICH NUCLEAR RECEPTOR COACTIVATOR 1, PNRC1
14666,606715,"ACID-SENSING ION CHANNEL, SUBUNIT 4", ASIC4
14667,606716,N-ACETYLTRANSFERASE 8, NAT8
14668,606717,XIAP-ASSOCIATED FACTOR 1, XAF1
14669,606718,"SOLUTE CARRIER FAMILY 26 (SULFATE TRANSPORTER), MEMBER 2", SLC26A2
14670,606719,MELANOMA-PANCREATIC CANCER SYNDROME,
14671,606720,"ENDONUCLEASE, POLY(U)-SPECIFIC", ENDOU
14672,606721,"LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 7", FPLD7
14673,606722,"NEUROCALCIN, DELTA", NCALD
14674,606723,MITOGEN-ACTIVATED PROTEIN KINASE-ACTIVATED PROTEIN KINASE 5, MAPKAPK5
14675,606724,MITOGEN-ACTIVATED PROTEIN KINASE-INTERACTING SERINE/THREONINE KINASE 1, MKNK1
14676,606725,CLN6 TRANSMEMBRANE ER PROTEIN, CLN6
14677,606726,"SOLUTE CARRIER FAMILY 12 (POTASSIUM/CHLORIDE TRANSPORTER), MEMBER 5", SLC12A5
14678,606727,NK2 HOMEOBOX 3, NKX2-3
14679,606728,CAVEOLAE-ASSOCIATED PROTEIN 2, CAVIN2
14680,606729,OXYSTEROL-BINDING PROTEIN 2, OSBP2
14681,606730,OXYSTEROL-BINDING PROTEIN-LIKE PROTEIN 1A, OSBPL1A
14682,606731,OXYSTEROL-BINDING PROTEIN-LIKE PROTEIN 2, OSBPL2
14683,606732,OXYSTEROL-BINDING PROTEIN-LIKE PROTEIN 3, OSBPL3
14684,606733,OXYSTEROL-BINDING PROTEIN-LIKE PROTEIN 5, OSBPL5
14685,606734,OXYSTEROL-BINDING PROTEIN-LIKE PROTEIN 6, OSBPL6
14686,606735,OXYSTEROL-BINDING PROTEIN-LIKE PROTEIN 7, OSBPL7
14687,606736,OXYSTEROL-BINDING PROTEIN-LIKE PROTEIN 8, OSBPL8
14688,606737,OXYSTEROL-BINDING PROTEIN-LIKE PROTEIN 9, OSBPL9
14689,606738,OXYSTEROL-BINDING PROTEIN-LIKE PROTEIN 10, OSBPL10
14690,606739,OXYSTEROL-BINDING PROTEIN-LIKE PROTEIN 11, OSBPL11
14691,606740,ZINC FINGER PROTEIN 180, ZNF180
14692,606741,ZINC FINGER PROTEIN 181, ZNF181
14693,606742,TOLLOID-LIKE 1, TLL1
14694,606743,TOLLOID-LIKE 2, TLL2
14695,606744,SECKEL SYNDROME 2, SCKL2
14696,606745,PAR3 FAMILY CELL POLARITY REGULATOR, PARD3
14697,606746,MYELOID-DERIVED GROWTH FACTOR, MYDGF
14698,606747,VASCULAR ENDOTHELIAL ZINC FINGER 1, VEZF1
14699,606748,COACTOSIN-LIKE PROTEIN 1, COTL1
14700,606749,TUBULOINTERSTITIAL NEPHRITIS ANTIGEN, TINAG
14701,606750,Z-DNA BINDING PROTEIN 1, ZBP1
14702,606751,"TRANSMEMBRANE PROTEASE, SERINE 5", TMPRSS5
14703,606752,ACUTE HEMORRHAGIC LEUKOENCEPHALITIS,
14704,606753,TETRATRICOPEPTIDE REPEAT DOMAIN-CONTAINING PROTEIN 4, TTC4
14705,606754,SAM DOMAIN- AND HD DOMAIN-CONTAINING PROTEIN 1, SAMHD1
14706,606755,"PEPTIDYLARGININE DEIMINASE, TYPE III", PADI3
14707,606756,17-BETA-HYDROXYSTEROID DEHYDROGENASE VII, HSD17B7
14708,606757,"SOLUTE CARRIER FAMILY 4 (SODIUM BICARBONATE COTRANSPORTER), MEMBER 5", SLC4A5
14709,606758,DUAL OXIDASE 1, DUOX1
14710,606759,DUAL OXIDASE 2, DUOX2
14711,606760,ZINC FINGER PROTEIN 208,
14712,606761,MALONYL-CoA DECARBOXYLASE, MLYCD
14713,606762,"HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 6", HHF6
14714,606763,"CILIARY DYSKINESIA, PRIMARY, 2", CILD2
14715,606764,GASTROINTESTINAL STROMAL TUMOR, GIST
14716,606765,THYROID PEROXIDASE, TPO
14717,606766,SPERMATOGENIC FAILURE 3, SPGF3
14718,606767,"POTASSIUM CHANNEL, VOLTAGE-GATED, SUBFAMILY G, MEMBER 3", KCNG3
14719,606768,"MYOPATHY, DISTAL, WITH ANTERIOR TIBIAL ONSET", DMAT
14720,606769,"HELICASE, POLQ-LIKE", HELQ
14721,606770,"ADIPONECTIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 2", ADIPQTL2
14722,606771,"ADIPONECTIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 3", ADIPQTL3
14723,606772,"IMPAIRED INTELLECTUAL DEVELOPMENT, OBESITY, MANDIBULAR PROGNATHISM, AND EYE AND SKIN ANOMALIES",
14724,606773,HEMIFACIAL MYOHYPERPLASIA, HFMH
14725,606774,MYOINOSITOL OXYGENASE, MIOX
14726,606775,CHONDROITIN SULFATE PROTEOGLYCAN 5, CSPG5
14727,606776,TRANSGLUTAMINASE 7, TGM7
14728,606777,GLUT1 DEFICIENCY SYNDROME 1, GLUT1DS1
14729,606778,SLINGSHOT PROTEIN PHOSPHATASE 1, SSH1
14730,606779,SLINGSHOT PROTEIN PHOSPHATASE 2, SSH2
14731,606780,SLINGSHOT PROTEIN PHOSPHATASE 3, SSH3
14732,606781,TRANSKETOLASE, TKT
14733,606782,"C-TYPE LECTIN DOMAIN FAMILY 1, MEMBER A", CLEC1A
14734,606783,"C-TYPE LECTIN DOMAIN FAMILY 1, MEMBER B", CLEC1B
14735,606784,GLYCOGEN SYNTHASE KINASE 3-ALPHA, GSK3A
14736,606785,"CRIGLER-NAJJAR SYNDROME, TYPE II",
14737,606786,CD300C ANTIGEN, CD300C
14738,606787,PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 1,
14739,606788,"ANOREXIA NERVOSA, SUSCEPTIBILITY TO", ANON
14740,606789,FETAL HEMOGLOBIN QUANTITATIVE TRAIT LOCUS 4, HBFQTL4
14741,606790,CD300A ANTIGEN, CD300A
14742,606791,TRANSMEMBRANE PHOSPHOINOSITIDE 3-PHOSPHATASE AND TENSIN HOMOLOG 2, TPTE2
14743,606792,HISTAMINE RECEPTOR H4, HRH4
14744,606793,"AMINOPEPTIDASE, PUROMYCIN-SENSITIVE", NPEPPS
14745,606794,"SOLUTE CARRIER FAMILY 25 (MITOCHONDRIAL CARRIER), MEMBER 10", SLC25A10
14746,606795,"SOLUTE CARRIER FAMILY 25 (MITOCHONDRIAL CARRIER), MEMBER 17", SLC25A17
14747,606796,SUPPRESSION OF TUMORIGENICITY 13, ST13
14748,606797,ST14 TRANSMEMBRANE SERINE PROTEASE MATRIPTASE, ST14
14749,606798,"BLEPHAROSPASM, BENIGN ESSENTIAL, SUSCEPTIBILITY TO",
14750,606799,"STROKE, SUSCEPTIBILITY TO, 1",
14751,606800,"GLUCOSIDASE, ALPHA, ACID", GAA
14752,606801,MACROPHAGE ERYTHROBLAST ATTACHER, MAEA
14753,606802,SPIB TRANSCRIPTION FACTOR, SPIB
14754,606803,ACYL-CoA THIOESTERASE 11, ACOT11
14755,606804,GOLGI MEMBRANE PROTEIN 1, GOLM1
14756,606805,GOLGI INTEGRAL MEMBRANE PROTEIN 4, GOLIM4
14757,606806,FORMIMINOTRANSFERASE CYCLODEAMINASE, FTCD
14758,606807,INTERLEUKIN 17 RECEPTOR D, IL17RD
14759,606808,MYOSIN IIIA, MYO3A
14760,606809,ACYL-CoA-BINDING DOMAIN-CONTAINING PROTEIN 3, ACBD3
14761,606810,PROLINE DEHYDROGENASE 1, PRODH
14762,606811,"ALDEHYDE DEHYDROGENASE, FAMILY 4, SUBFAMILY A, MEMBER 1", ALDH4A1
14763,606812,FUMARASE DEFICIENCY, FMRD
14764,606813,"SOLUTE CARRIER FAMILY 2i (FACILITATED GLUCOSE TRANSPORTER), MEMBER 6", SLC2A6
14765,606814,PROTEOGLYCAN 3, PRG3
14766,606815,"CBP/P300-INTERACTING TRANSACTIVATOR, WITH GLU/ASP-RICH CARBOXY TERMINAL DOMAIN, 4", CITED4
14767,606816,"SID1 TRANSMEMBRANE FAMILY, MEMBER 1", SIDT1
14768,606817,"PRE-T-CELL RECEPTOR, ALPHA-CHAIN PRECURSOR", PTCRA
14769,606818,DIPEPTIDYL PEPTIDASE III, DPP3
14770,606819,DIPEPTIDYL PEPTIDASE VIII, DPP8
14771,606820,GLUTAREDOXIN 2, GLRX2
14772,606821,COMPONENT OF OLIGOMERIC GOLGI COMPLEX 5, COG5
14773,606822,"PROTEIN O-MANNOSE BETA-1,2-N-ACETYLGLUCOSAMINYLTRANSFERASE", POMGNT1
14774,606823,ADHESION G PROTEIN-COUPLED RECEPTOR A2, ADGRA2
14775,606824,GLUCOSE/GALACTOSE MALABSORPTION, GGM
14776,606825,TENSIN 3, TNS3
14777,606826,PLEXIN DOMAIN-CONTAINING PROTEIN 1, PLXDC1
14778,606827,PLEXIN DOMAIN-CONTAINING PROTEIN 2, PLXDC2
14779,606828,N-ACETYLGLUCOSAMINE KINASE, NAGK
14780,606829,FRATAXIN, FXN
14781,606830,ATP/GTP-BINDING PROTEIN 1, AGTPBP1
14782,606831,"NLR FAMILY, CASPASE RECRUITMENT DOMAIN-CONTAINING 4", NLRC4
14783,606832,ENDOPLASMIC RETICULUM AMINOPEPTIDASE 1, ERAP1
14784,606833,LYSINE-SPECIFIC METHYLTRANSFERASE 2C, KMT2C
14785,606834,LYSINE-SPECIFIC METHYLTRANSFERASE 2B, KMT2B
14786,606835,"DIGITAL ARTHROPATHY-BRACHYDACTYLY, FAMILIAL", FDAB
14787,606836,"GLUCOSAMINYL (N-ACETYL) TRANSFERASE 3, MUCIN-TYPE", GCNT3
14788,606837,RB1-INDUCIBLE COILED-COIL 1, RB1CC1
14789,606838,PYD AND CARD DOMAIN-CONTAINING PROTEIN, PYCARD
14790,606839,"CADHERIN-RELATED FAMILY, MEMBER 5", CDHR5
14791,606840,"PARASOMNIA, SLEEP BRUXISM TYPE", PSMNSB
14792,606841,DEATH EFFECTOR DOMAIN-CONTAINING PROTEIN, DEDD
14793,606842,CARDIONEUROMYOPATHY WITH HYALINE MASSES AND NEMALINE RODS,
14794,606843,"IMMUNODEFICIENCY WITH HYPER-IgM, TYPE 3", HIGM3
14795,606844,ALMS1 CENTROSOME AND BASAL BODY ASSOCIATED PROTEIN, ALMS1
14796,606845,GOLGI-ASSOCIATED PDZ AND COILED-COIL DOMAINS-CONTAINING PROTEIN, GOPC
14797,606846,SET AND MYND DOMAIN-CONTAINING PROTEIN 1, SMYD1
14798,606847,TREACLE RIBOSOME BIOGENESIS FACTOR 1, TCOF1
14799,606848,NIMA-RELATED KINASE 7, NEK7
14800,606849,UBIQUITIN-LIKE 5, UBL5
14801,606850,MIPOL1 GENE, MIPOL1
14802,606851,CREE IMPAIRED INTELLECTUAL DEVELOPMENT SYNDROME,
14803,606852,PARKINSON DISEASE 10, PARK10
14804,606853,"ATPase, H+ TRANSPORTING, LYSOSOMAL, 13-KD, V1 SUBUNIT G, ISOFORM 2", ATP6V1G2
14805,606854,"CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 14A (BILATERAL FRONTOPARIETAL)", CDCBM14A
14806,606855,RELAXIN 3, RLN3
14807,606856,"PANCREATIC CANCER, SUSCEPTIBILITY TO, 1",
14808,606857,"GLUTAMATE-CYSTEINE LIGASE, CATALYTIC SUBUNIT", GCLC
14809,606858,"MICROCEPHALY 1, PRIMARY, AUTOSOMAL RECESSIVE",
14810,606859,"SPASTIC PARAPLEGIA 15, AUTOSOMAL RECESSIVE",
14811,606860,COMPLEMENT COMPONENT 1 INHIBITOR, C1NH
14812,606861,PROSTATE- AND TESTIS-EXPRESSED GENE, PATE
14813,606862,OSTEOCLAST-ASSOCIATED RECEPTOR, OSCAR
14814,606863,THYMOCYTE SELECTION-ASSOCIATED HIGH MOBILITY GROUP BOX, TOX
14815,606864,PARAGANGLIOMA AND GASTRIC STROMAL SARCOMA,
14816,606865,FUCOSYLTRANSFERASE 9, FUT9
14817,606866,MITOCHONDRIAL RIBOSOMAL PROTEIN L49, MRPL49
14818,606867,GOLGI REASSEMBLY STACKING PROTEIN 1, GORASP1
14819,606868,HOMEODOMAIN-INTERACTING PROTEIN KINASE 2, HIPK2
14820,606869,HEXOSAMINIDASE A, HEXA
14821,606870,JUNCTIONAL ADHESION MOLECULE 2, JAM2
14822,606871,JUNCTIONAL ADHESION MOLECULE 3, JAM3
14823,606872,CAS-BR-M MURINE ECTOPIC RETROVIRAL TRANSFORMING SEQUENCE LIKE-1, CBLL1
14824,606873,HEXOSAMINIDASE B, HEXB
14825,606874,"HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 6", HSCR6
14826,606875,"HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 7", HSCR7
14827,606876,"PHOSPHATIDYLINOSITOL TRANSFER PROTEIN, BETA", PITPNB
14828,606877,"ACIDIC LEUCINE-RICH NUCLEAR PHOSPHOPROTEIN 32 FAMILY, MEMBER C", ANP32C
14829,606878,"ACIDIC LEUCINE-RICH NUCLEAR PHOSPHOPROTEIN 32 FAMILY, MEMBER D", ANP32D
14830,606879,PHOSPHOGLYCERATE DEHYDROGENASE, PHGDH
14831,606880,CASPASE 8-ASSOCIATED PROTEIN 2, CASP8AP2
14832,606881,FORMIN HOMOLOGY-2 DOMAIN-CONTAINING PROTEIN 1, FHOD1
14833,606882,"ATPase, Cu(2+)-TRANSPORTING, BETA POLYPEPTIDE", ATP7B
14834,606883,INTERLEUKIN 1 RECEPTOR-ASSOCIATED KINASE 4, IRAK4
14835,606884,RNA-BINDING MOTIF PROTEIN 5, RBM5
14836,606885,"ACYL-CoA DEHYDROGENASE, SHORT-CHAIN", ACADS
14837,606886,RNA-BINDING MOTIF PROTEIN 6, RBM6
14838,606887,SULFITE OXIDASE, SUOX
14839,606888,"CHOLINERGIC RECEPTOR, NEURONAL NICOTINIC, ALPHA POLYPEPTIDE 6", CHRNA6
14840,606889,ALZHEIMER DISEASE 4, AD4
14841,606890,GALACTOSYLCERAMIDASE, GALC
14842,606891,Fc RECEPTOR-LIKE PROTEIN A, FCRLA
14843,606892,SYNTAXIN 12, STX12
14844,606893,"VASCULAR MALFORMATION, PRIMARY INTRAOSSEOUS", VMPI
14845,606894,"DUODENOJEJUNAL ATRESIA WITH VOLVULUS, ABSENT DORSAL MESENTERY, AND ABSENT SUPERIOR MESENTERIC ARTERY",
14846,606895,"SYMPHALANGISM, DISTAL, WITH MICRODONTIA, DENTAL PULP STONES, AND NARROWED ZYGOMATIC ARCH",
14847,606896,"DYSLEXIA, SUSCEPTIBILITY TO, 5", DYX5
14848,606897,LYSOSOMAL TRAFFICKING REGULATOR, LYST
14849,606898,"CALCIUM CHANNEL, VOLTAGE-DEPENDENT, GAMMA-6 SUBUNIT", CACNG6
14850,606899,"CALCIUM CHANNEL, VOLTAGE-DEPENDENT, GAMMA-7 SUBUNIT", CACNG7
14851,606900,"CALCIUM CHANNEL, VOLTAGE-DEPENDENT, GAMMA-8 SUBUNIT", CACNG8
14852,606901,"ZINC FINGER PROTEIN 271, PSEUDOGENE",
14853,606902,PYGOPUS FAMILY PHD FINGER 1, PYGO1
14854,606903,PYGOPUS FAMILY PHD FINGER 2, PYGO2
14855,606904,"EPILEPSY, MYOCLONIC JUVENILE",
14856,606905,"PHOSPHATIDYLINOSITOL 3,4,5-TRISPHOSPHATE-DEPENDENT RAC EXCHANGER 1", PREX1
14857,606906,MITOCHONDRIAL RIBOSOMAL RNA METHYLTRANSFERASE 2, MRM2
14858,606907,APOLIPOPROTEIN M, APOM
14859,606908,ADP-RIBOSYLATION FACTOR GTPase-ACTIVATING PROTEIN 2, ARFGAP2
14860,606909,VESICLE-ASSOCIATED MEMBRANE PROTEIN 4, VAMP4
14861,606910,BCL2-LIKE 10, BCL2L10
14862,606911,SECRETORY CARRIER MEMBRANE PROTEIN 1, SCAMP1
14863,606912,SECRETORY CARRIER MEMBRANE PROTEIN 2, SCAMP2
14864,606913,SECRETORY CARRIER MEMBRANE PROTEIN 3, SCAMP3
14865,606914,"PROTEIN KINASE, cAMP-DEPENDENT CATALYTIC, INHIBITOR BETA", PKIB
14866,606915,G PROTEIN-COUPLED RECEPTOR 63, GPR63
14867,606916,G PROTEIN-COUPLED RECEPTOR 61, GPR61
14868,606917,G PROTEIN-COUPLED RECEPTOR 62, GPR62
14869,606918,GOLGIN A5, GOLGA5
14870,606919,CERAMIDE SYNTHASE 1, CERS1
14871,606920,CERAMIDE SYNTHASE 2, CERS2
14872,606921,G PROTEIN-COUPLED RECEPTOR 78, GPR78
14873,606922,OXOGLUTARATE RECEPTOR 1, OXGR1
14874,606923,HYDROXYCARBOXYLIC ACID RECEPTOR 1, HCAR1
14875,606924,G PROTEIN-COUPLED RECEPTOR 82,
14876,606925,PYROGLUTAMYLATED RF-AMIDE PEPTIDE RECEPTOR, QRFPR
14877,606926,LYSOPHOSPHATIDIC ACID RECEPTOR 5, LPAR5
14878,606927,TRACE AMINE-ASSOCIATED RECEPTOR 8, TAAR8
14879,606928,BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 3, BMND3
14880,606929,"THO COMPLEX, SUBUNIT 3", THOC3
14881,606930,"THO COMPLEX, SUBUNIT 1", THOC1
14882,606931,VPS35 RETROMER COMPLEX COMPONENT,
14883,606932,VPS29 RETROMER COMPLEX COMPONENT, VPS29
14884,606933,TYROSINASE, TYR
14885,606934,"NADH DEHYDROGENASE (UBIQUINONE) COMPLEX I, ASSEMBLY FACTOR 1", NDUFAF1
14886,606935,RNA-BINDING MOTIF PROTEIN 17, RBM17
14887,606936,"TRANSIENT RECEPTOR POTENTIAL CATION CHANNEL, SUBFAMILY M, MEMBER 4", TRPM4
14888,606937,GALLOWAY-MOWAT SYNDROME 1,
14889,606938,UROPORPHYRINOGEN III SYNTHASE, UROS
14890,606939,"ATPase, H+ TRANSPORTING, LYSOSOMAL, 56/58-KD, V1 SUBUNIT B, ISOFORM 2", ATP6V1B2
14891,606940,ZINC FINGER HOMEOBOX 4, ZFHX4
14892,606941,"ALG9 ALPHA-1,2-MANNOSYLTRANSFERASE", ALG9
14893,606942,"COATOMER PROTEIN COMPLEX, SUBUNIT EPSILON", COPE
14894,606943,"USHER SYNDROME, TYPE IG", USH1G
14895,606944,ERBB2 INTERACTING PROTEIN, ERBIN
14896,606945,LOW DENSITY LIPOPROTEIN RECEPTOR, LDLR
14897,606946,"ANAPHASE-PROMOTING COMPLEX, SUBUNIT 2", ANAPC2
14898,606947,"ANAPHASE-PROMOTING COMPLEX, SUBUNIT 4", ANAPC4
14899,606948,"ANAPHASE-PROMOTING COMPLEX, SUBUNIT 5", ANAPC5
14900,606949,"ANAPHASE-PROMOTING COMPLEX, SUBUNIT 7", ANAPC7
14901,606950,THYROTROPIN-RELEASING HORMONE-DEGRADING ECTOENZYME, TRHDE
14902,606951,INTERFERON-INDUCED HELICASE C DOMAIN-CONTAINING PROTEIN 1, IFIH1
14903,606952,"ALBINISM, OCULOCUTANEOUS, TYPE IB", OCA1B
14904,606953,UDP-GALACTOSE-4-EPIMERASE, GALE
14905,606954,ZINC FINGER PROTEIN 253, ZNF253
14906,606955,ZINC FINGER PROTEIN 224,
14907,606956,ZINC FINGER PROTEIN 256, ZNF256
14908,606957,ZINC FINGER PROTEIN 257, ZNF257
14909,606958,"PROTEIN ASSOCIATED WITH LIN7 1, MAGUK p55 FAMILY MEMBER", PALS1
14910,606959,"PROTEIN ASSOCIATED WITH LIN7 2, MAGUK p55 FAMILY MEMBER", PALS2
14911,606960,INSULINOMA TUMOR SUPPRESSOR GENE LOCUS,
14912,606961,WW DOMAIN-BINDING PROTEIN 1, WBP1
14913,606962,WW DOMAIN-BINDING PROTEIN 2, WBP2
14914,606963,"PULMONARY DISEASE, CHRONIC OBSTRUCTIVE", COPD
14915,606964,SERINE/THREONINE PROTEIN KINASE 38, STK38
14916,606965,FAS-ACTIVATED SERINE/THREONINE KINASE, FASTK
14917,606966,NEPHRONOPHTHISIS 4, NPHP4
14918,606967,LECITHIN:CHOLESTEROL ACYLTRANSFERASE, LCAT
14919,606968,EUKARYOTIC ELONGATION FACTOR 2 KINASE, EEF2K
14920,606969,GEM NUCLEAR ORGANELLE-ASSOCIATED PROTEIN 4, GEMIN4
14921,606970,"EPILEPSY, IDIOPATHIC GENERALIZED",
14922,606971,"EPILEPSY, JUVENILE ABSENCE, SUSCEPTIBILITY TO, 1",
14923,606972,"EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 2", EIG2
14924,606973,COMPONENT OF OLIGOMERIC GOLGI COMPLEX 1, COG1
14925,606974,COMPONENT OF OLIGOMERIC GOLGI COMPLEX 2, COG2
14926,606975,COMPONENT OF OLIGOMERIC GOLGI COMPLEX 3, COG3
14927,606976,COMPONENT OF OLIGOMERIC GOLGI COMPLEX 4, COG4
14928,606977,COMPONENT OF OLIGOMERIC GOLGI COMPLEX 6, COG6
14929,606978,COMPONENT OF OLIGOMERIC GOLGI COMPLEX 7, COG7
14930,606979,COMPONENT OF OLIGOMERIC GOLGI COMPLEX 8, COG8
14931,606980,COENZYME Q8A, COQ8A
14932,606981,"GUANINE NUCLEOTIDE-BINDING PROTEIN, GAMMA-2", GNG2
14933,606982,GERANYLGERANYL DIPHOSPHATE SYNTHASE 1, GGPS1
14934,606983,DIACYLGLYCEROL O-ACYLTRANSFERASE 2, DGAT2
14935,606984,"HYPERRENINEMIC HYPOALDOSTERONISM, FAMILIAL, 2",
14936,606985,"ELONGATOR ACETYLTRANSFERASE COMPLEX, SUBUNIT 4", ELP4
14937,606986,"PROTEIN TYROSINE PHOSPHATASE, NONRECEPTOR-TYPE, 22",
14938,606987,G PROTEIN-COUPLED RECEPTOR KINASE 7, GRK7
14939,606988,CALCINEURIN-LIKE EF-HAND PROTEIN 1, CHP1
14940,606989,MYELOPEROXIDASE, MPO
14941,606990,"COATOMER PROTEIN COMPLEX, SUBUNIT BETA-2", COPB2
14942,606991,INOSITOL HEXAPHOSPHATE KINASE 1, IP6K1
14943,606992,INOSITOL HEXAPHOSPHATE KINASE 2, IP6K2
14944,606993,INOSITOL HEXAPHOSPHATE KINASE 3, IP6K3
14945,606994,"TYROSINE KINASE, NONRECEPTOR, 2", TNK2
14946,606995,SENIOR-LOKEN SYNDROME 3, SLSN3
14947,606996,SENIOR-LOKEN SYNDROME 4, SLSN4
14948,606997,C1D NUCLEAR RECEPTOR COREPRESSOR, C1D
14949,606998,FLOTILLIN 1, FLOT1
14950,606999,GALACTOSE-1-PHOSPHATE URIDYLYLTRANSFERASE, GALT
14951,607000,MEDIATOR COMPLEX SUBUNIT 24, MED24
14952,607001,EUCHROMATIC HISTONE METHYLTRANSFERASE 1, EHMT1
14953,607002,PROKINETICIN 2, PROK2
14954,607003,THYMIC STROMAL LYMPHOPOIETIN, TSLP
14955,607004,"BRACHYDACTYLY, TYPE A1, B", BDA1B
14956,607005,GEM NUCLEAR ORGANELLE-ASSOCIATED PROTEIN 5, GEMIN5
14957,607006,GEM NUCLEAR ORGANELLE-ASSOCIATED PROTEIN 6, GEMIN6
14958,607007,SNAP-ASSOCIATED PROTEIN, SNAPIN
14959,607008,"ACYL-CoA DEHYDROGENASE, MEDIUM-CHAIN", ACADM
14960,607009,"TRANSIENT RECEPTOR POTENTIAL CATION CHANNEL, SUBFAMILY M, MEMBER 6", TRPM6
14961,607010,DECAPPING mRNA 1A, DCP1A
14962,607011,UBIQUITIN-SPECIFIC PROTEASE 17, USP17
14963,607012,"B-DOUBLE PRIME 1, SUBUNIT OF RNA POLYMERASE III TRANSCRIPTION INITIATION FACTOR IIIB", BDP1
14964,607013,BRF2 SUBUNIT OF RNA POLYMERASE III TRANSCRIPTION INITIATION FACTOR, BRF2
14965,607014,HURLER SYNDROME,
14966,607015,HURLER-SCHEIE SYNDROME,
14967,607016,SCHEIE SYNDROME,
14968,607017,"DEAFNESS, AUTOSOMAL DOMINANT 21", DFNA21
14969,607018,ADHESION G PROTEIN-COUPLED RECEPTOR L2, ADGRL2
14970,607019,RAS ASSOCIATION DOMAIN FAMILY PROTEIN 3, RASSF3
14971,607020,RAS ASSOCIATION DOMAIN FAMILY PROTEIN 5, RASSF5
14972,607021,SEZ6-LIKE PROTEIN, SEZ6L
14973,607022,CCCTC-BINDING FACTOR-LIKE PROTEIN, CTCFL
14974,607023,POLO-LIKE KINASE 2, PLK2
14975,607024,DEBRANCHING RNA LARIATS 1, DBR1
14976,607025,MATERNAL EMBRYONIC LEUCINE ZIPPER KINASE, MELK
14977,607026,NEURON NAVIGATOR 2, NAV2
14978,607027,"ATPase, H+ TRANSPORTING, LYSOSOMAL, 70-KD, VI SUBUNIT A", ATP6V1A
14979,607028,"ATPase, H+ TRANSPORTING, LYSOSOMAL, 38-KD, V0 SUBUNIT D, ISOFORM 1", ATP6V0D1
14980,607029,VESICLE-ASSOCIATED MEMBRANE PROTEIN 5, VAMP5
14981,607030,GRANCALCIN, GCA
14982,607031,LIPOIC ACID SYNTHASE, LIAS
14983,607032,SMG1 NONSENSE-MEDIATED mRNA DECAY-ASSOCIATED PI3K-RELATED KINASE, SMG1
14984,607033,"TRANSCRIPTION FACTOR B1, MITOCHONDRIAL", TFB1M
14985,607034,"FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, 1",
14986,607035,SUFU NEGATIVE REGULATOR OF HEDGEHOG SIGNALING, SUFU
14987,607036,ISOVALERYL-CoA DEHYDROGENASE, IVD
14988,607037,ENOYL-CoA HYDRATASE/3-HYDROXYACYL CoA DEHYDROGENASE, EHHADH
14989,607038,OTOANCORIN, OTOA
14990,607039,"DEAFNESS, AUTOSOMAL RECESSIVE 22", DFNB22
14991,607040,"ATP-BINDING CASSETTE, SUBFAMILY C, MEMBER 11", ABCC11
14992,607041,"ATP-BINDING CASSETTE, SUBFAMILY C, MEMBER 12", ABCC12
14993,607042,"CLN3 LYSOSOMAL/ENDOSOMAL TRANSMEMBRANE PROTEIN, BATTENIN", CLN3
14994,607043,TRAF3-INTERACTING PROTEIN 2, TRAF3IP2
14995,607044,T-BOX 24,
14996,607045,RHABDOMYOSARCOMA 2-ASSOCIATED TRANSCRIPT, RMST
14997,607046,TRANSLOCASE OF OUTER MITOCHONDRIAL MEMBRANE 22, TOMM22
14998,607047,ATAXIN 3, ATXN3
14999,607048,START DOMAIN-CONTAINING PROTEIN 3, STARD3
15000,607049,START DOMAIN-CONTAINING PROTEIN 4, STARD4
15001,607050,START DOMAIN-CONTAINING PROTEIN 5, STARD5
15002,607051,START DOMAIN-CONTAINING PROTEIN 6, STARD6
15003,607052,TUMOR SUPPRESSOR CANDIDATE 2, TUSC2
15004,607053,HIGH DENSITY LIPOPROTEIN CHOLESTEROL LEVEL QUANTITATIVE TRAIT LOCUS 2, HDLCQ2
15005,607054,"PLECKSTRIN HOMOLOGY-LIKE DOMAIN, FAMILY A, MEMBER 3", PHLDA3
15006,607055,"TRANSCRIPTION FACTOR B2, MITOCHONDRIAL", TFB2M
15007,607056,INTERPHOTORECEPTOR MATRIX PROTEOGLYCAN 2, IMPG2
15008,607057,UBIQUITIN-SPECIFIC PROTEASE 18, USP18
15009,607058,"GAP JUNCTION PROTEIN, DELTA-2", GJD2
15010,607059,"SOLUTE CARRIER FAMILY 39 (ZINC TRANSPORTER), MEMBER 4", SLC39A4
15011,607060,"PARKINSON DISEASE 8, AUTOSOMAL DOMINANT", PARK8
15012,607061,PROSTAGLANDIN E SYNTHASE 3, PTGES3
15013,607062,FK506-BINDING PROTEIN 7, FKBP7
15014,607063,FK506-BINDING PROTEIN 10, FKBP10
15015,607064,PROCOLLAGEN C-ENDOPEPTIDASE ENHANCER 2, PCOLCE2
15016,607065,GLUTAMINYL-PEPTIDE CYCLOTRANSFERASE, QPCT
15017,607066,"TRANSIENT RECEPTOR POTENTIAL CATION CHANNEL, SUBFAMILY V, MEMBER 3", TRPV3
15018,607067,SAITOHIN, STH
15019,607068,CYTOCHROME b561 DOMAIN-CONTAINING PROTEIN 2, CYB561D2
15020,607069,TRANSMEMBRANE PROTEIN 115, TMEM115
15021,607070,ZINC FINGER MYND DOMAIN-CONTAINING PROTEIN 10, ZMYND10
15022,607071,HYALURONOGLUCOSAMINIDASE 1, HYAL1
15023,607072,"NPR2-LIKE PROTEIN, GATOR1 COMPLEX SUBUNIT", NPRL2
15024,607073,"N-ALPHA-ACETYLTRANSFERASE 80, NatH CATALYTIC SUBUNIT", NAA80
15025,607074,PROTEIN KINASE D2, PRKD2
15026,607075,PDGFA-ASSOCIATED PROTEIN 1, PDAP1
15027,607076,PROTEASE INHIBITOR 15, PI15
15028,607077,"PROTEIN KINASE C, NU", PRKCN
15029,607078,"EPIPHYSEAL DYSPLASIA, MULTIPLE, 5", EDM5
15030,607079,"RHESUS BLOOD GROUP, B GLYCOPROTEIN", RHBG
15031,607080,"46,XY GONADAL DYSGENESIS WITH MINIFASCICULAR NEUROPATHY", GDMN
15032,607081,TAP-BINDING PROTEIN-LIKE, TAPBPL
15033,607082,"CALCIUM CHANNEL, VOLTAGE-DEPENDENT, ALPHA-2/DELTA SUBUNIT 2", CACNA2D2
15034,607083,NUCLEAR RECEPTOR-BINDING SET DOMAIN PROTEIN 3, NSD3
15035,607084,"DEAFNESS, AUTOSOMAL RECESSIVE 31", DFNB31
15036,607085,MYASTHENIA GRAVIS WITH THYMUS HYPERPLASIA,
15037,607086,"AORTIC ANEURYSM, FAMILIAL THORACIC 1", AAT1
15038,607087,"AORTIC ANEURYSM, FAMILIAL THORACIC 2", AAT2
15039,607088,"NEURONOPATHY, DISTAL HEREDITARY MOTOR, AUTOSOMAL RECESSIVE 3", HMNR3
15040,607089,CYCLIN D-TYPE-BINDING PROTEIN 1, CCNDBP1
15041,607090,SYF2 PRE-mRNA SPLICING FACTOR, SYF2
15042,607091,"CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IId", CDG2D
15043,607092,SPHINGOSINE KINASE 2, SPHK2
15044,607093,"5,10-METHYLENETETRAHYDROFOLATE REDUCTASE", MTHFR
15045,607094,SUPPRESSOR OF CYTOKINE SIGNALING 5, SOCS5
15046,607095,ANAUXETIC DYSPLASIA 1, ANXD1
15047,607096,"SOLUTE CARRIER FAMILY 22 (URATE TRANSPORTER), MEMBER 12", SLC22A12
15048,607097,"SOLUTE CARRIER FAMILY 22 (ORGANIC ANION/CATION TRANSPORTER), MEMBER 11",
15049,607098,"ENOLASE ALPHA, LUNG-SPECIFIC", ENO1B
15050,607099,HISTONE H4 TRANSCRIPTION FACTOR, HINFP
15051,607100,NEPHROCYSTIN 1, NPHP1
15052,607101,"DEAFNESS, AUTOSOMAL RECESSIVE 30", DFNB30
15053,607102,WT1 TRANSCRIPTION FACTOR, WT1
15054,607103,ARGINYLTRANSFERASE 1, ATE1
15055,607104,TANKYRASE 1-BINDING PROTEIN 1, TNKS1BP1
15056,607105,NADPH OXIDASE 3, NOX3
15057,607106,MINOR HISTOCOMPATIBILITY 13, HM13
15058,607107,NASOPHARYNGEAL CARCINOMA,
15059,607108,PAIRED BOX GENE 6, PAX6
15060,607109,"APOLIPOPROTEIN B mRNA-EDITING ENZYME, CATALYTIC POLYPEPTIDE-LIKE 3A", APOBEC3A
15061,607110,"APOLIPOPROTEIN B mRNA-EDITING ENZYME, CATALYTIC POLYPEPTIDE-LIKE 3B", APOBEC3B
15062,607111,SPARTIN, SPART
15063,607112,F-BOX ONLY PROTEIN 2, FBXO2
15064,607113,"APOLIPOPROTEIN B mRNA-EDITING ENZYME, CATALYTIC POLYPEPTIDE-LIKE 3G", APOBEC3G
15065,607114,A DISINTEGRIN AND METALLOPROTEINASE DOMAIN 33, ADAM33
15066,607115,CINCA SYNDROME, CINCA
15067,607116,ALZHEIMER DISEASE 8,
15068,607117,MICROCEPHALIN 1, MCPH1
15069,607118,MITOCHONDRIAL RIBOSOMAL PROTEIN L3, MRPL3
15070,607119,"RING FINGER PROTEIN 19A, RBR E3 UBIQUITIN PROTEIN LIGASE", RNF19A
15071,607120,"PHOSPHOLIPASE C, BETA-1", PLCB1
15072,607121,G PROTEIN-COUPLED RECEPTOR 83,
15073,607122,PROKINETICIN RECEPTOR 1, PROKR1
15074,607123,PROKINETICIN RECEPTOR 2, PROKR2
15075,607124,PHOSPHOLIPID PHOSPHATASE 1, PLPP1
15076,607125,PHOSPHOLIPID PHOSPHATASE 3, PLPP3
15077,607126,PHOSPHOLIPID PHOSPHATASE 2, PLPP2
15078,607127,"ELKS/RAB6-INTERACTING/CAST FAMILY, MEMBER 1", ERC1
15079,607128,TANKYRASE 2, TNKS2
15080,607129,"MICROTUBULE-ASSOCIATED MONOOXYGENASE, CALPONIN AND LIM DOMAINS-CONTAINING, 1", MICAL1
15081,607130,REGULATORY ASSOCIATED PROTEIN OF MTOR, RPTOR
15082,607131,AL-GAZALI-BAKALINOVA SYNDROME, AGBK
15083,607132,"LARYNGEAL ATRESIA, ENCEPHALOCELE, AND LIMB DEFORMITIES",
15084,607133,"CATARACT 3, MULTIPLE TYPES",
15085,607134,SPECIFIC LANGUAGE IMPAIRMENT 3, SLI3
15086,607135,CREATININE CLEARANCE QUANTITATIVE TRAIT LOCUS,
15087,607136,SPINOCEREBELLAR ATAXIA 17, SCA17
15088,607137,HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN D-LIKE PROTEIN, HNRNPDL
15089,607138,cAMP RESPONSE ELEMENT-BINDING PROTEIN 3-LIKE 4, CREB3L4
15090,607139,FANCA GENE, FANCA
15091,607140,ANGIOID STREAKS,
15092,607141,GLIOMA PATHOGENESIS-RELATED PROTEIN 2, GLIPR2
15093,607142,FORKHEAD BOX E1,
15094,607143,"CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ig", CDG1G
15095,607144,"ALG12 ALPHA-1,6-MANNOSYLTRANSFERASE", ALG12
15096,607145,DYSTROBREVIN-BINDING PROTEIN 1, DTNBP1
15097,607146,PDZ DOMAIN-CONTAINING 3, PDZD3
15098,607147,NECTIN CELL ADHESION MOLECULE 3, NECTIN3
15099,607148,G PROTEIN-COUPLED RECEPTOR-ASSOCIATED SORTING PROTEIN 1,
15100,607149,RNA EXONUCLEASE 2, REXO2
15101,607150,"FEV TRANSCRIPTION FACTOR, ETS FAMILY MEMBER", FEV
15102,607151,MOYAMOYA DISEASE 2, MYMY2
15103,607152,"SPASTIC PARAPLEGIA 19, AUTOSOMAL DOMINANT", SPG19
15104,607153,"INTEGRIN, BETA-1, BINDING PROTEIN OF, 1", ITGB1BP1
15105,607154,ALLERGIC RHINITIS,
15106,607155,"MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 5", MDDGC5
15107,607156,"ST3 BETA-GALACTOSIDE ALPHA-2,3-SIALYLTRANSFERASE 6", ST3GAL6
15108,607157,SIALIC ACID-BINDING IMMUNOGLOBULIN-LIKE LECTIN 11, SIGLEC11
15109,607158,VENT HOMEOBOX, VENTX
15110,607159,ZINC FINGER MIZ-DOMAIN CONTAINING 1, ZMIZ1
15111,607160,"ATPase, H+ TRANSPORTING, LYSOSOMAL, 14-KD, V1 SUBUNIT F", ATP6V1F
15112,607161,MULTIPLE CONGENITAL ANOMALIES SYNDROME WITH CLOVERLEAF SKULL,
15113,607162,"ST8 ALPHA-N-ACETYL-NEURAMINIDE ALPHA-2,8-SIALYLTRANSFERASE 5", ST8SIA5
15114,607163,LYSYL OXIDASE-LIKE 3, LOXL3
15115,607164,LADYBIRD HOMEOBOX 2, LBX2
15116,607165,SERINE INCORPORATOR 3, SERINC3
15117,607166,TESTIS-SPECIFIC PROTEIN 10, TSGA10
15118,607167,"DYNEIN, LIGHT CHAIN, ROADBLOCK TYPE, 1", DYNLRB1
15119,607168,"DYNEIN, LIGHT CHAIN, ROADBLOCK TYPE, 2", DYNLRB2
15120,607169,"PROTEASE, SERINE, 16", PRSS16
15121,607170,CYSTEINE-RICH PROTEIN WITH EGF-LIKE DOMAINS 1, CRELD1
15122,607171,CYSTEINE-RICH PROTEIN WITH EGF-LIKE DOMAINS 2,
15123,607172,SERINE/THREONINE KINASE 11-INTERACTING PROTEIN, STK11IP
15124,607173,"PROTEASOME 26S SUBUNIT, NON-ATPase, 14", PSMD14
15125,607174,"MENINGIOMA, FAMILIAL, SUSCEPTIBILITY TO",
15126,607175,DUAL-SPECIFICITY PHOSPHATASE 16, DUSP16
15127,607176,CALNEURON 1, CALN1
15128,607177,IMMEDIATE-EARLY RESPONSE GENE 5, IER5
15129,607178,PDZK1-INTERACTING PROTEIN 1, PDZK1IP1
15130,607179,RNA-BINDING MOTIF PROTEIN 12, RBM12
15131,607180,LEUCINE-RICH REPEAT-CONTAINING PROTEIN 2, LRRC2
15132,607181,RECEPTOR-TRANSPORTING PROTEIN 3, RTP3
15133,607182,FYVE AND COILED-COIL DOMAIN CONTAINING 1, FYCO1
15134,607183,"SEC24-RELATED GENE FAMILY, MEMBER A", SEC24A
15135,607184,"SEC24-RELATED GENE FAMILY, MEMBER B", SEC24B
15136,607185,"SEC24-RELATED GENE FAMILY, MEMBER C", SEC24C
15137,607186,"SEC24-RELATED GENE FAMILY, MEMBER D", SEC24D
15138,607187,"ST3 BETA-GALACTOSIDE ALPHA-2,3-SIALYLTRANSFERASE 1", ST3GAL1
15139,607188,"ST3 BETA-GALACTOSIDE ALPHA-2,3-SIALYLTRANSFERASE 2", ST3GAL2
15140,607189,REGULATOR OF G PROTEIN SIGNALING 8, RGS8
15141,607190,REGULATOR OF G PROTEIN SIGNALING 13, RGS13
15142,607191,REGULATOR OF G PROTEIN SIGNALING 17, RGS17
15143,607192,REGULATOR OF G PROTEIN SIGNALING 18, RGS18
15144,607193,REGULATOR OF G PROTEIN SIGNALING 20, RGS20
15145,607194,"PANCREAS TRANSCRIPTION FACTOR 1, ALPHA SUBUNIT", PTF1A
15146,607195,"DYSTONIA, DOPA-RESPONSIVE",
15147,607196,"MICROCEPHALY, AMISH TYPE", MCPHA
15148,607197,"DEAFNESS, AUTOSOMAL RECESSIVE",
15149,607198,TYROSYL-DNA PHOSPHODIESTERASE 1, TDP1
15150,607199,INTERFERON REGULATORY FACTOR 6, IRF6
15151,607200,THYROID DYSHORMONOGENESIS 6, TDH6
15152,607201,HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN R, HNRNPR
15153,607202,"CELIAC DISEASE, SUSCEPTIBILITY TO, 5", CELIAC5
15154,607203,"SALVADOR FAMILY, WW DOMAIN-CONTAINING PROTEIN 1", SAV1
15155,607204,PUMILIO RNA BINDING FAMILY MEMBER 1, PUM1
15156,607205,PUMILIO RNA BINDING FAMILY MEMBER 2, PUM2
15157,607206,ARACHIDONATE LIPOXYGENASE 3, ALOXE3
15158,607207,STIP1 HOMOLOGOUS AND U BOX-CONTAINING PROTEIN 1, STUB1
15159,607208,DRAVET SYNDROME, DRVT
15160,607209,CASPASE RECRUITMENT DOMAIN-CONTAINING PROTEIN 10, CARD10
15161,607210,CASPASE RECRUITMENT DOMAIN-CONTAINING PROTEIN 11, CARD11
15162,607211,CASPASE RECRUITMENT DOMAIN-CONTAINING PROTEIN 14, CARD14
15163,607212,CASPASE RECRUITMENT DOMAIN-CONTAINING PROTEIN 9, CARD9
15164,607213,"ORIGIN RECOGNITION COMPLEX, SUBUNIT 6", ORC6
15165,607214,"ANONYCHIA, TOTAL, WITH MICROCEPHALY",
15166,607215,NEPHROCYSTIN 4, NPHP4
15167,607216,SIDEKICK CELL ADHESION MOLECULE 1, SDK1
15168,607217,SIDEKICK CELL ADHESION MOLECULE 2, SDK2
15169,607218,INTERFERON REGULATORY FACTOR 5, IRF5
15170,607219,CONTACTIN 5, CNTN5
15171,607220,CONTACTIN 6, CNTN6
15172,607221,"EPILEPSY, PARTIAL, WITH PERICENTRAL SPIKES", PEPS
15173,607222,F-BOX ONLY PROTEIN 18, FBXO18
15174,607223,SPARC-RELATED MODULAR CALCIUM-BINDING PROTEIN 2, SMOC2
15175,607224,ORAL CANCER OVEREXPRESSED GENE 1, ORAOV1
15176,607225,"SPASTIC PARALYSIS, INFANTILE-ONSET ASCENDING", IAHSP
15177,607226,HISTONE DEACETYLASE 11, HDAC11
15178,607227,"MAS-RELATED G PROTEIN-COUPLED RECEPTOR FAMILY, MEMBER X1", MRGPRX1
15179,607228,"MAS-RELATED G PROTEIN-COUPLED RECEPTOR FAMILY, MEMBER X2", MRGPRX2
15180,607229,"MAS-RELATED G PROTEIN-COUPLED RECEPTOR FAMILY, MEMBER X3", MRGPRX3
15181,607230,"MAS-RELATED G PROTEIN-COUPLED RECEPTOR FAMILY, MEMBER X4", MRGPRX4
15182,607231,"MAS-RELATED G PROTEIN-COUPLED RECEPTOR FAMILY, MEMBER D", MRGPRD
15183,607232,"MAS-RELATED G PROTEIN-COUPLED RECEPTOR FAMILY, MEMBER E", MRGPRE
15184,607233,"MAS-RELATED G PROTEIN-COUPLED RECEPTOR FAMILY, MEMBER F", MRGPRF
15185,607234,"MAS-RELATED G PROTEIN-COUPLED RECEPTOR FAMILY, MEMBER G", MRGPRG
15186,607235,MAS1 ONCOGENE-LIKE, MAS1L
15187,607236,NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 1,
15188,607237,TRANSMEMBRANE INNER EAR-EXPRESSED GENE, TMIE
15189,607238,COMM DOMAIN-CONTAINING PROTEIN 1, COMMD1
15190,607239,"DEAFNESS, AUTOSOMAL RECESSIVE 33", DFNB33
15191,607240,LYSINE METHYLTRANSFERASE 5A, KMT5A
15192,607241,FOLLICULAR DENDRITIC CELL SECRETED PROTEIN, FDCSP
15193,607242,"ADAPTOR-RELATED PROTEIN COMPLEX 2, ALPHA-2 SUBUNIT", AP2A2
15194,607243,"ADAPTOR-RELATED PROTEIN COMPLEX 4, SIGMA-1 SUBUNIT", AP4S1
15195,607244,"ADAPTOR-RELATED PROTEIN COMPLEX 4, EPSILON-1 SUBUNIT", AP4E1
15196,607245,"ADAPTOR-RELATED PROTEIN COMPLEX 4, BETA-1 SUBUNIT", AP4B1
15197,607246,"ADAPTOR-RELATED PROTEIN COMPLEX 3, DELTA-1 SUBUNIT", AP3D1
15198,607247,CHONDROLECTIN, CHODL
15199,607248,GLIOMA SUSCEPTIBILITY 4, GLM4
15200,607249,"CATION CHANNEL, SPERM-ASSOCIATED, 2", CATSPER2
15201,607250,"SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE, WITH AXONAL NEUROPATHY 1", SCAN1
15202,607251,TRANSLOCASE OF INNER MITOCHONDRIAL MEMBRANE 22, TIMM22
15203,607252,APOLIPOPROTEIN L2, APOL2
15204,607253,APOLIPOPROTEIN L3, APOL3
15205,607254,APOLIPOPROTEIN L4, APOL4
15206,607255,APOLIPOPROTEIN L5, APOL5
15207,607256,APOLIPOPROTEIN L6, APOL6
15208,607257,SRY-BOX 6, SOX6
15209,607258,"HYPERCALCIURIA, ABSORPTIVE, 1",
15210,607259,"SPASTIC PARAPLEGIA 7, AUTOSOMAL RECESSIVE", SPG7
15211,607260,PLACENTAL PROTEIN 13-LIKE PROTEIN,
15212,607261,EVC CILIARY COMPLEX SUBUNIT 2, EVC2
15213,607262,EPSIN 1, EPN1
15214,607263,EPSIN 2, EPN2
15215,607264,EPSIN 3, EPN3
15216,607265,CLATHRIN INTERACTOR 1, CLINT1
15217,607266,"SNF2, LINKER HISTONE, PHD FINGER, RING FINGER, AND HELICASE DOMAINS-CONTAINING PROTEIN",
15218,607267,"POLYMERASE, DNA, EPSILON-3", POLE3
15219,607268,"CHROMATIN ACCESSIBILITY COMPLEX, SUBUNIT 1", CHRAC1
15220,607269,"POLYMERASE, DNA, EPSILON-4", POLE4
15221,607270,ACTIVATOR OF TRANSCRIPTION AND DEVELOPMENTAL REGULATOR AUTS2, AUTS2
15222,607271,CASPASE 8 DEFICIENCY,
15223,607272,NDC80 KINETOCHORE COMPLEX COMPONENT, NDC80
15224,607273,FOLLICULIN, FLCN
15225,607274,UBIQUITIN-SPECIFIC PROTEASE 14, USP14
15226,607275,HOP HOMEOBOX, HOPX
15227,607276,"RESTING HEART RATE, VARIATION IN",
15228,607277,"ASTHMA-RELATED TRAITS, SUSCEPTIBILITY TO, 1",
15229,607278,"OSTEOFIBROUS DYSPLASIA, SUSCEPTIBILITY TO", OSFD
15230,607279,"SYSTEMIC LUPUS ERYTHEMATOSUS WITH HEMOLYTIC ANEMIA, SUSCEPTIBILITY TO, 1", SLEH1
15231,607280,CONTACTIN 4, CNTN4
15232,607281,"LSM1 HOMOLOG, mRNA DEGRADATION-ASSOCIATED", LSM1
15233,607282,LSM2 PROTEIN, LSM2
15234,607283,LSM3 PROTEIN, LSM3
15235,607284,LSM4 PROTEIN, LSM4
15236,607285,LSM5 PROTEIN, LSM5
15237,607286,LSM6 PROTEIN, LSM6
15238,607287,LSM7 PROTEIN, LSM7
15239,607288,LSM8 PROTEIN, LSM8
15240,607289,"BIOGENESIS OF LYSOSOME-RELATED ORGANELLES COMPLEX 1, SUBUNIT 5", BLOC1S5
15241,607290,"SHISA FAMILY, MEMBER 5", SHISA5
15242,607291,"SYNERGIN, GAMMA", SYNRG
15243,607292,SEMAPHORIN 4A, SEMA4A
15244,607293,CHLORIDE INTRACELLULAR CHANNEL 5, CLIC5
15245,607294,TRANSFORMING GROWTH FACTOR-BETA-INDUCED FACTOR 2, TGIF2
15246,607295,MYOSIN XVIIIB, MYO18B
15247,607296,"ATPase, H+ TRANSPORTING, LYSOSOMAL, 13-KD, V1 SUBUNIT G, ISOFORM 1", ATP6V1G1
15248,607297,NERVE INJURY-INDUCED PROTEIN 2, NINJ2
15249,607298,"GUANINE NUCLEOTIDE-BINDING PROTEIN, GAMMA-13", GNG13
15250,607299,DELTA- AND NOTCH-LIKE EPIDERMAL GROWTH FACTOR-RELATED RECEPTOR, DNER
15251,607300,PRE-mRNA-PROCESSING FACTOR 8, PRPF8
15252,607301,PRE-mRNA PROCESSING FACTOR 3, PRPF3
15253,607302,"MORTALITY FACTOR 4, PSEUDOGENE",
15254,607303,MORTALITY FACTOR 4-LIKE PROTEIN 1, MORF4L1
15255,607304,CATARACT 27, CTRCT27
15256,607305,MDS2 GENE,
15257,607306,STEROID 5-ALPHA-REDUCTASE 2, SRD5A2
15258,607307,FILAMIN A-INTERACTING PROTEIN 1, FILIP1
15259,607308,MAMMOGRAPHIC DENSITY,
15260,607309,"ADAPTOR-RELATED PROTEIN COMPLEX 1, MU-2 SUBUNIT", AP1M2
15261,607310,A DISINTEGRIN AND METALLOPROTEINASE DOMAIN 7, ADAM7
15262,607311,PROGESTERONE RECEPTOR, PGR
15263,607312,ZINC FINGER CCCH DOMAIN-CONTAINING ANTIVIRAL PROTEIN 1, ZC3HAV1
15264,607313,"GAZE PALSY, FAMILIAL HORIZONTAL, WITH PROGRESSIVE SCOLIOSIS 1", HGPPS1
15265,607314,CALCIUM-BINDING PROTEIN 2, CABP2
15266,607315,CALCIUM-BINDING PROTEIN 5, CABP5
15267,607316,CALCIUM-BINDING PROTEIN 5,
15268,607317,"SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 4", SCAR4
15269,607318,LYSYL OXIDASE-LIKE 4, LOXL4
15270,607319,SCM-LIKE PROTEIN WITH 4 MBT DOMAINS 1, SFMBT1
15271,607320,RAS GUANYL NUCLEOTIDE-RELEASING PROTEIN 4, RASGRP4
15272,607321,"ATPase, Na+/K+ TRANSPORTING, ALPHA-4 POLYPEPTIDE", ATP1A4
15273,607322,HYPERALPHALIPOPROTEINEMIA 1,
15274,607323,DUANE-RADIAL RAY SYNDROME, DRRS
15275,607324,"POLYDACTYLY, POSTAXIAL, TYPE A3", PAPA3
15276,607325,DEDICATOR OF CYTOKINESIS 9, DOCK9
15277,607326,SMITH-MCCORT DYSPLASIA 1, SMC1
15278,607327,MUSCLEBLIND-LIKE SPLICING REGULATOR 2, MBNL2
15279,607328,HEXAMETHYLENE BIS ACETAMIDE-INDUCIBLE PROTEIN 1, HEXIM1
15280,607329,"HYPERTENSION, ESSENTIAL, SUSCEPTIBILITY TO, 3",
15281,607330,LATHOSTEROLOSIS, LATHOS
15282,607331,RP9 PRE-mRNA SPLICING FACTOR, RP9
15283,607332,NEURONAL REGENERATION-RELATED PROTEIN, NREP
15284,607333,STE20-RELATED KINASE ADAPTOR BETA, STRADB
15285,607334,"TRAFFICKING PROTEIN, KINESIN-BINDING 2", TRAK2
15286,607335,BESTROPHIN 2, BEST2
15287,607336,BESTROPHIN 4, BEST4
15288,607337,BESTROPHIN 3, BEST3
15289,607338,LEPTIN RECEPTOR OVERLAPPING TRANSCRIPT-LIKE 1, LEPROTL1
15290,607339,"CORONARY HEART DISEASE, SUSCEPTIBILITY TO, 1",
15291,607340,GAMMA-AMINOBUTYRIC ACID B RECEPTOR 2, GABBR2
15292,607341,"FOCAL CORTICAL DYSPLASIA, TYPE II", FCORD2
15293,607342,CYTOPLASMIC POLYADENYLATION ELEMENT-BINDING PROTEIN 1, CPEB1
15294,607343,SAL-LIKE 4, SALL4
15295,607344,"TUBULIN, DELTA-1", TUBD1
15296,607345,"TUBULIN, EPSILON-1", TUBE1
15297,607346,SPINOCEREBELLAR ATAXIA 19, SCA19
15298,607347,ALPHA KINASE 1, ALPK1
15299,607348,HES FAMILY bHLH TRANSCRIPTION FACTOR 5, HES5
15300,607349,TALIN 2, TLN2
15301,607350,KINESIN FAMILY MEMBER 13B, KIF13B
15302,607351,RHO-RELATED BTB DOMAIN-CONTAINING PROTEIN 1, RHOBTB1
15303,607352,RHO-RELATED BTB DOMAIN-CONTAINING PROTEIN 2, RHOBTB2
15304,607353,RHO-RELATED BTB DOMAIN-CONTAINING PROTEIN 3, RHOBTB3
15305,607354,"SCOLIOSIS, ISOLATED, SUSCEPTIBILITY TO, 2", IS2
15306,607355,ARGONAUTE RISC COMPONENT 3, AGO3
15307,607356,ARGONAUTE RISC COMPONENT 4, AGO4
15308,607357,"POTASSIUM CHANNEL, VOLTAGE-GATED, KQT-LIKE SUBFAMILY, MEMBER 5", KCNQ5
15309,607358,AUTOIMMUNE REGULATOR, AIRE
15310,607359,CELL DIVISION CYCLE AND APOPTOSIS REGULATOR 2, CCAR2
15311,607360,LACRITIN, LACRT
15312,607361,"MECKEL SYNDROME, TYPE 3", MKS3
15313,607362,"RGM DOMAIN FAMILY, MEMBER A", RGMA
15314,607363,KINETOCHORE-ASSOCIATED PROTEIN 1, KNTC1
15315,607364,"BARTTER SYNDROME, TYPE 3", BARTS3
15316,607365,LIPASE H, LIPH
15317,607366,"POTASSIUM CHANNEL, SUBFAMILY K, MEMBER 12", KCNK12
15318,607367,"POTASSIUM CHANNEL, SUBFAMILY K, MEMBER 13", KCNK13
15319,607368,"POTASSIUM CHANNEL, SUBFAMILY K, MEMBER 15", KCNK15
15320,607369,"POTASSIUM CHANNEL, SUBFAMILY K, MEMBER 16", KCNK16
15321,607370,"POTASSIUM CHANNEL, SUBFAMILY K, MEMBER 17", KCNK17
15322,607371,DYSTONIA-DEAFNESS SYNDROME 1, DDS1
15323,607372,MEDIATOR COMPLEX SUBUNIT 15, MED15
15324,607373,"AUTISM, SUSCEPTIBILITY TO, 8", AUTS8
15325,607374,"PRKR INHIBITOR, REPRESSOR OF", PRKRIR
15326,607375,DOT1-LIKE, DOT1L
15327,607376,DYNACTIN 2, DCTN2
15328,607377,LENS EPITHELIAL PROTEIN, LENEP
15329,607378,SERPINE1 mRNA-BINDING PROTEIN 1, SERBP1
15330,607379,"NF2, MOESIN-EZRIN-RADIXIN-LIKE (MERLIN) TUMOR SUPPRESSOR", NF2
15331,607380,TNF RECEPTOR-ASSOCIATED FACTOR 3-INTERACTING PROTEIN 1, TRAF3IP1
15332,607381,TRANSLOCASE OF INNER MITOCHONDRIAL MEMBRANE 50, TIMM50
15333,607382,CAP-GLY DOMAIN-CONTAINING LINKER PROTEIN 3, CLIP3
15334,607383,TRANSLOCASE OF INNER MITOCHONDRIAL MEMBRANE 13, TIMM13
15335,607384,TRANSLOCASE OF INNER MITOCHONDRIAL MEMBRANE 9, TIMM9
15336,607385,"UDP-N-ACETYLGLUCOSAMINE:ALPHA-1,3-D-MANNOSIDE BETA-1,4-N-ACETYLGLUCOSAMINYLTRANSFERASE IV",
15337,607386,INTRAFLAGELLAR TRANSPORT 172, IFT172
15338,607387,DYNACTIN 3, DCTN3
15339,607388,TRANSLOCASE OF INNER MITOCHONDRIAL MEMBRANE 10B, TIMM10B
15340,607389,SINGLE-STRANDED DNA-BINDING PROTEIN 2, SSBP2
15341,607390,SINGLE-STRANDED DNA-BINDING PROTEIN 3, SSBP3
15342,607391,SINGLE-STRANDED DNA-BINDING PROTEIN 4, SSBP4
15343,607392,WW DOMAIN-CONTAINING TRANSCRIPTION REGULATOR 1, WWTR1
15344,607393,CELL DIVISION CYCLE 73, CDC73
15345,607394,"POU DOMAIN, CLASS 2, TRANSCRIPTION FACTOR 3", POU2F3
15346,607395,"STREPTOCOCCUS, GROUP A, SEVERITY OF INFECTION BY",
15347,607396,"TRANSDUCER OF ERBB2, 2", TOB2
15348,607397,MELANOCORTIN 2 RECEPTOR, MC2R
15349,607398,GLUCOCORTICOID DEFICIENCY 2, GCCD2
15350,607399,MUCOLIPIN 2, MCOLN2
15351,607400,MUCOLIPIN 3, MCOLN3
15352,607401,"INTERFERON, LAMBDA-2", IFNL2
15353,607402,"INTERFERON, LAMBDA-3", IFNL3
15354,607403,"INTERFERON, LAMBDA-1", IFNL1
15355,607404,INTERFERON-LAMBDA RECEPTOR 1, IFNLR1
15356,607405,TRACE AMINE-ASSOCIATED RECEPTOR 5, TAAR5
15357,607406,STARCH-BINDING DOMAIN-CONTAINING PROTEIN 1, STBD1
15358,607407,EARLY B-CELL FACTOR 3, EBF3
15359,607408,D-AMINO ACID OXIDASE ACTIVATOR, DAOA
15360,607409,NEURITIN 1, NRN1
15361,607410,DIENCEPHALON/MESENCEPHALON HOMEOBOX 1, DMBX1
15362,607411,PATENT DUCTUS ARTERIOSUS 1, PDA1
15363,607412,"BPI FOLD-CONTAINING PROTEIN, FAMILY A, MEMBER 1", BPIFA1
15364,607413,ALZHEIMER DISEASE NEURONAL THREAD PROTEIN,
15365,607414,FEZ FAMILY ZINC FINGER PROTEIN 2, FEZF2
15366,607415,DAOA ANTISENSE RNA, DAOAAS
15367,607416,CELL ADHESION MOLECULE L1-LIKE, CHL1
15368,607417,"INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 2", MRT2
15369,607418,GRIP AND COILED-COIL DOMAINS-CONTAINING PROTEIN 1, GCC1
15370,607419,GEM NUCLEAR ORGANELLE-ASSOCIATED PROTEIN 7, GEMIN7
15371,607420,GABA-A RECEPTOR-ASSOCIATED PROTEIN-LIKE PROTEIN 1, GABARAPL1
15372,607421,"NME/NM23 FAMILY, MEMBER 8", NME8
15373,607422,GLYCINE C-ACETYLTRANSFERASE, GCAT
15374,607423,PROTEIN O-MANNOSYLTRANSFERASE 1, POMT1
15375,607424,GLYCINE N-ACYLTRANSFERASE, GLYAT
15376,607425,"GAP JUNCTION PROTEIN, DELTA-3", GJD3
15377,607426,"COENZYME Q10 DEFICIENCY, PRIMARY, 1", COQ10D1
15378,607427,ENOLASE SUPERFAMILY MEMBER 1, ENOSF1
15379,607428,KIRRE-LIKE NEPHRIN FAMILY ADHESION MOLECULE 1, KIRREL1
15380,607429,"PRENYL DIPHOSPHATE SYNTHASE, SUBUNIT 1", PDSS1
15381,607430,DAZ-ASSOCIATED PROTEIN 1, DAZAP1
15382,607431,DAZ-ASSOCIATED PROTEIN 2, DAZAP2
15383,607432,LISSENCEPHALY 1, LIS1
15384,607433,TWINFILIN ACTIN-BINDING PROTEIN 2, TWF2
15385,607434,GTP-BINDING PROTEIN 2, GTPBP2
15386,607435,ERA G-PROTEIN-LIKE 1, ERAL1
15387,607436,"POLY(A) POLYMERASE, BETA", PAPOLB
15388,607437,"G PROTEIN-COUPLED RECEPTOR, FAMILY C, GROUP 5, MEMBER D", GPRC5D
15389,607438,GLUTAMATE PYRUVATE TRANSAMINASE 2,
15390,607439,PROTEIN O-MANNOSYLTRANSFERASE 2, POMT2
15391,607440,FUKUTIN, FKTN
15392,607441,EPITHELIAL STROMAL INTERACTION 1, EPSTI1
15393,607442,ECHINODERM MICROTUBULE-ASSOCIATED PROTEIN-LIKE 4, EML4
15394,607443,EPIDIDYMAL SPERM BINDING PROTEIN 1, ELSPBP1
15395,607444,SBDS RIBOSOME MATURATION FACTOR, SBDS
15396,607445,EUKARYOTIC TRANSLATION INITIATION FACTOR 4E NUCLEAR IMPORT FACTOR 1, EIF4ENIF1
15397,607446,BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 3, BMIQ3
15398,607447,BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 4, BMIQ4
15399,607448,NEUROPEPTIDE FF RECEPTOR 1, NPFFR1
15400,607449,NEUROPEPTIDE FF RECEPTOR 2, NPFFR2
15401,607450,"ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 8", ARVD8
15402,607451,GLUCOCORTICOID MODULATORY ELEMENT-BINDING PROTEIN 2, GMEB2
15403,607452,GABA-A RECEPTOR-ASSOCIATED PROTEIN-LIKE PROTEIN 2, GABARAPL2
15404,607453,"DEAFNESS, AUTOSOMAL DOMINANT 44", DFNA44
15405,607454,SPINOCEREBELLAR ATAXIA 21, SCA21
15406,607455,ZINC FINGER AN1 DOMAIN-CONTAINING PROTEIN 3, ZFAND3
15407,607456,UTP4 SMALL SUBUNIT PROCESSOME COMPONENT, UTP4
15408,607457,GIL BLOOD GROUP,
15409,607458,SPINOCEREBELLAR ATAXIA 18, SCA18
15410,607459,"SENSORY ATAXIC NEUROPATHY, DYSARTHRIA, AND OPHTHALMOPARESIS", SANDO
15411,607460,PHOSPHATIDYLSERINE-SPECIFIC PHOSPHOLIPASE A1-ALPHA, PLA1A
15412,607461,DYMECLIN, DYM
15413,607462,ATROPHIN 1, ATN1
15414,607463,"PROTEIN PHOSPHATASE 1, REGULATORY SUBUNIT 13-LIKE", PPP1R13L
15415,607464,"THYROID CARCINOMA, HURTHLE CELL",
15416,607465,CODANIN 1, CDAN1
15417,607466,RAS-ASSOCIATED PROTEIN RAB2B, RAB2B
15418,607467,C-TYPE LECTIN-LIKE 1, CLECL1
15419,607468,G PROTEIN-COUPLED RECEPTOR 88, GPR88
15420,607469,N-ACYLETHANOLAMINE ACID AMIDASE, NAAA
15421,607470,BCAS3 MICROTUBULE-ASSOCIATED CELL MIGRATION FACTOR, BCAS3
15422,607471,BREAST CARCINOMA AMPLIFIED SEQUENCE 4, BCAS4
15423,607472,MITOCHONDRIAL ESCAPE 1-LIKE 1, YME1L1
15424,607473,"VITAMIN K-DEPENDENT CLOTTING FACTORS, COMBINED DEFICIENCY OF, 2", VKCFD2
15425,607474,"HOMOGENTISATE 1,2-DIOXYGENASE", HGD
15426,607475,BOTHNIA RETINAL DYSTROPHY,
15427,607476,NEWFOUNDLAND ROD-CONE DYSTROPHY, NFRCD
15428,607477,G2- AND S-PHASE EXPRESSED GENE 1, GTSE1
15429,607478,TRYPTOPHAN HYDROXYLASE 2, TPH2
15430,607479,APC DOWNREGULATED 1, APCDD1
15431,607480,RETINITIS PIGMENTOSA 23,
15432,607481,METABOLISM OF COBALAMIN ASSOCIATED A, MMAA
15433,607482,"CARDIOMYOPATHY, DILATED, 1M", CMD1M
15434,607483,"BASAL GANGLIA DISEASE, BIOTIN-THIAMINE RESPONSIVE", BTBGD
15435,607484,PAR6 FAMILY CELL POLARITY REGULATOR ALPHA, PARD6A
15436,607485,FRONTOTEMPORAL DEMENTIA 2, FTD2
15437,607486,KNOPS BLOOD GROUP SYSTEM, KN
15438,607487,"CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 25", CMH25
15439,607488,"DYSTONIA 15, MYOCLONIC", DYT15
15440,607489,CULLIN 9, CUL9
15441,607490,LACTATE DEHYDROGENASE D, LDHD
15442,607491,PROTEIN O-FUCOSYLTRANSFERASE 1, POFUT1
15443,607492,PHOSPHOFURIN ACIDIC CLUSTER SORTING PROTEIN 1, PACS1
15444,607493,INHIBITOR OF GROWTH 3, ING3
15445,607494,"INOSITOL POLYPHOSPHATE-4-PHOSPHATASE, TYPE II, 105-KD", INPP4B
15446,607495,cAMP RESPONSE ELEMENT-BINDING PROTEIN 3-LIKE 4,
15447,607496,NITRIC OXIDE SYNTHASE TRAFFICKER, NOSTRIN
15448,607497,"BETA-1,3-GLUCURONYLTRANSFERASE 2", B3GAT2
15449,607498,"MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 3",
15450,607499,"BULIMIA NERVOSA, SUSCEPTIBILITY TO", BULN
15451,607500,CHROMOSOME 18p DELETION SYNDROME,
15452,607501,"MIGRAINE WITHOUT AURA, SUSCEPTIBILITY TO, 4",
15453,607502,"DISPATCHED RND TRANSPORTER FAMILY, MEMBER 1", DISP1
15454,607503,"DISPATCHED RND TRANSPORTER FAMILY, MEMBER 2", DISP2
15455,607504,HEADACHE ASSOCIATED WITH SEXUAL ACTIVITY, HSA
15456,607505,PAS DOMAIN-CONTAINING SERINE/THREONINE KINASE, PASK
15457,607506,"A DISINTEGRIN-LIKE AND METALLOPROTEINASE WITH THROMBOSPONDIN TYPE 1 MOTIF, 14", ADAMTS14
15458,607507,"PSORIATIC ARTHRITIS, SUSCEPTIBILITY TO",
15459,607508,"MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 5",
15460,607509,"A DISINTEGRIN-LIKE AND METALLOPROTEINASE WITH THROMBOSPONDIN TYPE 1 MOTIF, 15", ADAMTS15
15461,607510,"A DISINTEGRIN-LIKE AND METALLOPROTEINASE WITH THROMBOSPONDIN TYPE 1 MOTIF, 16", ADAMTS16
15462,607511,"A DISINTEGRIN-LIKE AND METALLOPROTEINASE WITH THROMBOSPONDIN TYPE 1 MOTIF, 17", ADAMTS17
15463,607512,"A DISINTEGRIN-LIKE AND METALLOPROTEINASE WITH THROMBOSPONDIN TYPE 1 MOTIF, 18", ADAMTS18
15464,607513,"A DISINTEGRIN-LIKE AND METALLOPROTEINASE WITH THROMBOSPONDIN TYPE 1 MOTIF, 19", ADAMTS19
15465,607514,BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 10, BMIQ10
15466,607515,PLACENTA-SPECIFIC GENE 8, PLAC8
15467,607516,"MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 6",
15468,607517,"LEUKOCYTE IMMUNOGLOBULIN-LIKE RECEPTOR, SUBFAMILY A, MEMBER 4", LILRA4
15469,607518,MONOCYTE AND PLASMACYTOID ACTIVATED MOLECULE,
15470,607519,"POLY(ADP-RIBOSE) POLYMERASE FAMILY, MEMBER 4", PARP4
15471,607520,ZYGOTE ARREST 1, ZAR1
15472,607521,"HPS5 BIOGENESIS OF LYSOSOMAL ORGANELLES COMPLEX 2, SUBUNIT 2", HPS5
15473,607522,"HPS6 BIOGENESIS OF LYSOSOMAL ORGANELLES COMPLEX 2, SUBUNIT 3", HPS6
15474,607523,"NAIL DISORDER, NONSYNDROMIC CONGENITAL, 8", NDNC8
15475,607524,RING FINGER PROTEIN 39, RNF39
15476,607525,"POLYMERASE I, RNA, SUBUNIT H", POLR1H
15477,607526,RIBOSOMAL PROTEIN L27, RPL27
15478,607527,POLYPYRIMIDINE TRACT BINDING PROTEIN 3, PTBP3
15479,607528,ROUNDABOUT GUIDANCE RECEPTOR 4, ROBO4
15480,607529,SERYL-tRNA SYNTHETASE 1, SARS1
15481,607530,"HOMEOBOX A11, ANTISENSE", HOXA11AS
15482,607531,KRUPPEL-LIKE FACTOR 12, KLF12
15483,607532,PROGESTERONE-INDUCED BLOCKING FACTOR 1, PIBF1
15484,607533,"DIS3 HOMOLOG, EXOSOME ENDORIBONUCLEASE AND 3-PRIME-5-PRIME EXORIBONUCLEASE", DIS3
15485,607534,YY1-ASSOCIATED FACTOR 2, YAF2
15486,607535,RING1- AND YY1-BINDING PROTEIN, RYBP
15487,607536,CREB-REGULATED TRANSCRIPTION COACTIVATOR 1, CRTC1
15488,607537,MASTERMIND-LIKE 2, MAML2
15489,607538,NUDE NEURODEVELOPMENT PROTEIN 1-LIKE 1, NDEL1
15490,607539,"CAMPTOSYNPOLYDACTYLY, COMPLEX", CCSPD
15491,607540,"SECRETORY DIARRHEA, MYOPATHY, AND DEAFNESS",
15492,607541,"CORNEAL DYSTROPHY, AVELLINO TYPE", CDA
15493,607542,"POTASSIUM CHANNEL, VOLTAGE-GATED, KQT-LIKE SUBFAMILY, MEMBER 1", KCNQ1
15494,607543,SPONDYLOMETAPHYSEAL DYSPLASIA WITH BOWED FOREARMS AND FACIAL DYSMORPHISM,
15495,607544,LEUCINE-RICH PPR MOTIF-CONTAINING PROTEIN, LRPPRC
15496,607545,METHYLSTEROL MONOOXYGENASE 1, MSMO1
15497,607546,CD200 RECEPTOR 1, CD200R1
15498,607547,RIBOSOMAL PROTEIN L39-LIKE, RPL39L
15499,607548,RADIAL SPOKE HEAD 6 HOMOLOG A, RSPH6A
15500,607549,"POTE ANKYRIN DOMAIN FAMILY, MEMBER D", POTED
15501,607550,"SOLUTE CARRIER FAMILY 16 (MONOCARBOXYLIC ACID TRANSPORTER), MEMBER 10", SLC16A10
15502,607551,STROMAL CELL-DERIVED FACTOR 2-LIKE 1, SDF2L1
15503,607552,"CONGENITAL MYOPATHY 1B, AUTOSOMAL RECESSIVE",
15504,607553,EPIPLAKIN 1, EPPK1
15505,607554,"ATRIAL FIBRILLATION, FAMILIAL, 3", ATFB3
15506,607555,TORSIN 3A, TOR3A
15507,607556,TWIST FAMILY bHLH TRANSCRIPTION FACTOR 2, TWIST2
15508,607557,"SOLUTE CARRIER FAMILY 17 (VESICULAR GLUTAMATE COTRANSPORTER), MEMBER 8", SLC17A8
15509,607558,SEC14-LIKE LIPID-BINDING PROTEIN 2, SEC14L2
15510,607559,"MAHOGUNIN, RING FINGER 1", MGRN1
15511,607560,RHO GUANINE NUCLEOTIDE EXCHANGE FACTOR 2, ARHGEF2
15512,607561,"MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE II",
15513,607562,INTERLEUKIN 23 RECEPTOR, IL23R
15514,607563,"SOLUTE CARRIER FAMILY 17 (VESICULAR GLUTAMATE COTRANSPORTER), MEMBER 6", SLC17A6
15515,607564,TRIPARTITE MOTIF-CONTAINING PROTEIN 6, TRIM6
15516,607565,"SPASTIC PARAPLEGIA, ATAXIA, AND IMPAIRED INTELLECTUAL DEVELOPMENT",
15517,607566,"EPM2A GLUCAN PHOSPHATASE, LAFORIN", EPM2A
15518,607567,OLFACTOMEDIN 3, OLFM3
15519,607568,METABOLISM OF COBALAMIN ASSOCIATED B, MMAB
15520,607569,"MYOPATHY, MYOFIBRILLAR, 9, WITH EARLY RESPIRATORY FAILURE",
15521,607570,DEAH-BOX HELICASE 40, DHX40
15522,607571,"SOLUTE CARRIER FAMILY 25 (MITOCHONDRIAL OXODICARBOXYLATE CARRIER), MEMBER 21", SLC25A21
15523,607572,"LEPROSY, SUSCEPTIBILITY TO, 2", LPRS2
15524,607573,MICROTUBULE-ASSOCIATED PROTEIN 1S, MAP1S
15525,607574,ARYLSULFATASE A, ARSA
15526,607575,ADENOSINE DEAMINASE 2, ADA2
15527,607576,CECR2 HISTONE ACETYL-LYSINE READER, CECR2
15528,607577,ECTONUCLEOSIDE TRIPHOSPHATE DIPHOSPHOHYDROLASE 4, ENTPD4
15529,607578,BREATH-HOLDING SPELLS,
15530,607579,"SOLUTE CARRIER FAMILY 22 (ORGANIC ANION/CATION TRANSPORTER), MEMBER 9", SLC22A9
15531,607580,"SOLUTE CARRIER FAMILY 22 (ORGANIC ANION/CATION TRANSPORTER), MEMBER 10", SLC22A10
15532,607581,"SOLUTE CARRIER FAMILY 22 (ORGANIC ANION TRANSPORTER), MEMBER 8", SLC22A8
15533,607582,"SOLUTE CARRIER FAMILY 22 (ORGANIC ANION TRANSPORTER), MEMBER 6", SLC22A6
15534,607583,PEROXISOME BIOGENESIS FACTOR 11G, PEX11G
15535,607584,"SPASTIC PARAPLEGIA 24, AUTOSOMAL RECESSIVE", SPG24
15536,607585,ATM SERINE/THREONINE KINASE, ATM
15537,607586,CALCIUM RESPONSE FACTOR, CARF
15538,607587,INTERLEUKIN 17D, IL17D
15539,607588,PEPTIDYL-PROLYL ISOMERASE-LIKE 2, PPIL2
15540,607589,SERUM/GLUCOCORTICOID-REGULATED KINASE 2, SGK2
15541,607590,BBS7 GENE, BBS7
15542,607591,SERUM/GLUCOCORTICOID-REGULATED KINASE 3, SGK3
15543,607592,PROSTATE CANCER AGGRESSIVENESS QUANTITATIVE TRAIT LOCUS ON CHROMOSOME 19,
15544,607593,MEDIATOR OF DNA DAMAGE CHECKPOINT PROTEIN 1, MDC1
15545,607594,"IMMUNODEFICIENCY, COMMON VARIABLE, 1", CVID1
15546,607595,BRAIN SMALL VESSEL DISEASE 1 WITH OR WITHOUT OCULAR ANOMALIES,
15547,607596,"PONTOCEREBELLAR HYPOPLASIA, TYPE 1A", PCH1A
15548,607597,"MICROPHTHALMIA WITH CYST, BILATERAL FACIAL CLEFTS, AND LIMB ANOMALIES",
15549,607598,LETHAL CONGENITAL CONTRACTURE SYNDROME 2, LCCS2
15550,607599,RETINOL DEHYDROGENASE 10, RDH10
15551,607600,EPIDERMOLYSIS BULLOSA SIMPLEX SUPERFICIALIS, EBSS
15552,607601,TIR DOMAIN-CONTAINING ADAPTOR MOLECULE 1, TICAM1
15553,607602,"ICHTHYOSIS, ANNULAR EPIDERMOLYTIC, 1", AEI1
15554,607603,"POTASSIUM CHANNEL, VOLTAGE-GATED, SUBFAMILY G, MEMBER 4", KCNG4
15555,607604,"POTASSIUM CHANNEL, VOLTAGE-GATED, SUBFAMILY V, MEMBER 2", KCNV2
15556,607605,"GLUTATHIONE S-TRANSFERASE, ALPHA-5", GSTA5
15557,607606,"KERATIN 9, TYPE I", KRT9
15558,607607,"NUCLEOPORIN, 54-KD", NUP54
15559,607608,"SPHINGOMYELIN PHOSPHODIESTERASE 1, ACID LYSOSOMAL", SMPD1
15560,607609,PEPTIDYL-PROLYL ISOMERASE-LIKE 4, PPIL4
15561,607610,PHOSPHOLIPID SCRAMBLASE 2, PLSCR2
15562,607611,PHOSPHOLIPID SCRAMBLASE 3, PLSCR3
15563,607612,PHOSPHOLIPID SCRAMBLASE 4, PLSCR4
15564,607613,"NUCLEOPORIN, 133-KD", NUP133
15565,607614,"NUCLEOPORIN, 160-KD", NUP160
15566,607615,"NUCLEOPORIN, 58-KD", NUP58
15567,607616,"NIEMANN-PICK DISEASE, TYPE B",
15568,607617,"NUCLEOPORIN, 107-KD", NUP107
15569,607618,DEAD-BOX HELICASE 28, DDX28
15570,607619,FERM DOMAIN-CONTAINING PROTEIN 3, FRMD3
15571,607620,COLLECTIN 10, COLEC10
15572,607621,COLLECTIN 12, COLEC12
15573,607622,PHOSPHOMEVALONATE KINASE, PMVK
15574,607623,NPC INTRACELLULAR CHOLESTEROL TRANSPORTER 1, NPC1
15575,607624,"GRISCELLI SYNDROME, TYPE 2", GS2
15576,607625,"NIEMANN-PICK DISEASE, TYPE C2", NPC2
15577,607626,"ICHTHYOSIS, LEUKOCYTE VACUOLES, ALOPECIA, AND SCLEROSING CHOLANGITIS", ILVASC
15578,607627,"BPI FOLD-CONTAINING PROTEIN, FAMILY A, MEMBER 4, PSEUDOGENE", BPIFA4P
15579,607628,"EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 11", EIG11
15580,607629,"APH1 HOMOLOG A, GAMMA SECRETASE SUBUNIT", APH1A
15581,607630,"APH1 HOMOLOG B, GAMMA-SECRETASE SUBUNIT", APH1B
15582,607631,"EPILEPSY, JUVENILE ABSENCE, SUSCEPTIBILITY TO, 1", EJA1
15583,607632,"PRESENILIN ENHANCER, GAMMA-SECRETASE SUBUNIT", PSENEN
15584,607633,XANTHINE DEHYDROGENASE, XDH
15585,607634,"OSTEOPETROSIS, AUTOSOMAL DOMINANT 1", OPTA1
15586,607635,CARBOXYPEPTIDASE A4, CPA4
15587,607636,"ENDOSTEAL HYPEROSTOSIS, AUTOSOMAL DOMINANT",
15588,607637,EMX2 OPPOSITE STRAND/ANTISENSE RNA, EMX2OS
15589,607638,DEOXYCYTIDYLATE DEAMINASE, DCTD
15590,607639,SCAVENGER RECEPTOR CYSTEINE-RICH FAMILY MEMBER WITH 4 DOMAINS, SSC4D
15591,607640,ATAXIN 7, ATXN7
15592,607641,"NEURONOPATHY, DISTAL HEREDITARY MOTOR, AUTOSOMAL DOMINANT 14", HMND14
15593,607642,RETINOIC ACID-INDUCED GENE 1, RAI1
15594,607643,"FASCIN ACTIN-BUNDLING PROTEIN 2, RETINAL", FSCN2
15595,607644,"CANDIDIASIS, FAMILIAL, 3", CANDF3
15596,607645,NEURONAL VESICLE TRAFFICKING-ASSOCIATED PROTEIN 1, NSG1
15597,607646,ZINC FINGER- AND BTB DOMAIN-CONTAINING PROTEIN 7B, ZBTB7B
15598,607647,PLASMALEMMA VESICLE-ASSOCIATED PROTEIN, PLVAP
15599,607648,SERINE/THREONINE PROTEIN KINASE 39, STK39
15600,607649,OSTEOPETROSIS-ASSOCIATED TRANSMEMBRANE PROTEIN 1, OSTM1
15601,607650,"DEFENSIN, BETA, 118", DEFB118
15602,607651,"PLECKSTRIN HOMOLOGY DOMAIN-CONTAINING PROTEIN, FAMILY B, MEMBER 1", PLEKHB1
15603,607652,SERINE/THREONINE PROTEIN KINASE 36, STK36
15604,607653,"RAS HOMOLOG GENE FAMILY, MEMBER J", RHOJ
15605,607654,KERATOSIS PALMOPLANTARIS STRIATA III, PPKS3
15606,607655,"CARDIOMYOPATHY, DILATED, WITH WOOLLY HAIR AND KERATODERMA",
15607,607656,CURLY HAIR-ACRAL KERATODERMA-CARIES SYNDROME,
15608,607657,CYSTATHIONINE GAMMA-LYASE, CTH
15609,607658,HYPOTRICHOSIS-OSTEOLYSIS-PERIODONTITIS-PALMOPLANTAR KERATODERMA SYNDROME,
15610,607659,ELL-ASSOCIATED FACTOR 2, EAF2
15611,607660,TESTIS-SPECIFIC SERINE/THREONINE KINASE 3, TSSK3
15612,607661,MILK FAT GLOBULE-EGF FACTOR 8,
15613,607662,SPERMATOGENESIS-ASSOCIATED PROTEIN 2, SPATA2
15614,607663,DEAD-BOX HELICASE 25, DDX25
15615,607664,N-ACETYLGLUCOSAMINE-6-SULFATASE, GNS
15616,607665,TUBULOINTERSTITIAL NEPHRITIS WITH UVEITIS, TINU
15617,607666,ANGIOPOIETIN-LIKE 5, ANGPTL5
15618,607667,"CATENIN, ALPHA-3", CTNNA3
15619,607668,ADP-RIBOSYLATION FACTOR-LIKE GTPase 6-INTERACTING PROTEIN 4, ARL6IP4
15620,607669,ADP-RIBOSYLATION FACTOR-LIKE GTPase 6-INTERACTING PROTEIN 1, ARL6IP1
15621,607670,SERINE/THREONINE PROTEIN KINASE 33, STK33
15622,607671,"DYSTONIA 13, TORSION, AUTOSOMAL DOMINANT", DYT13
15623,607672,CARDIOTROPHIN-LIKE CYTOKINE FACTOR 1, CLCF1
15624,607673,ENDOPLASMIC RETICULUM DEGRADATION-ENHANCING ALPHA-MANNOSIDASE-LIKE PROTEIN 1, EDEM1
15625,607674,"CATARACT, CONGENITAL, WITH MENTAL IMPAIRMENT AND DENTATE GYRUS ATROPHY",
15626,607675,REST COREPRESSOR, RCOR
15627,607676,IMMUNODEFICIENCY 67, IMD67
15628,607677,"CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2I", CMT2I
15629,607678,"CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1D", CMT1D
15630,607679,DEDICATOR OF CYTOKINESIS 4, DOCK4
15631,607680,ZINC FINGER PROTEIN 363, ZNF363
15632,607681,"FEBRILE SEIZURES, FAMILIAL, 8", FEB8
15633,607682,"EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 9", EIG9
15634,607683,"DEAFNESS, AUTOSOMAL DOMINANT 15",
15635,607684,"CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2E", CMT2E
15636,607685,"HYPEREOSINOPHILIC SYNDROME, IDIOPATHIC", HES
15637,607686,FIP1-LIKE 1, FIP1L1
15638,607687,HIGH DENSITY LIPOPROTEIN CHOLESTEROL LEVEL QUANTITATIVE TRAIT LOCUS 3,
15639,607688,"PARKINSON DISEASE 11, AUTOSOMAL DOMINANT, SUSCEPTIBILITY TO", PARK11
15640,607689,CHYLOMICRON RETENTION DISEASE,
15641,607690,SECRETION-ASSOCIATED RAS-RELATED GTPase 1B, SAR1B
15642,607691,SECRETION-ASSOCIATED RAS-RELATED GTPase 1A, SAR1A
15643,607692,MARINESCO-SJOGREN SYNDROME,
15644,607693,SELENOCYSTEINE INSERTION SEQUENCE-BINDING PROTEIN 2, SECISBP2
15645,607694,"LEUKODYSTROPHY, HYPOMYELINATING, 7, WITH OR WITHOUT OLIGODONTIA AND/OR HYPOGONADOTROPIC HYPOGONADISM", HLD7
15646,607695,"EUKARYOTIC ELONGATION FACTOR, SELENOCYSTEINE-tRNA-SPECIFIC", EEFSEC
15647,607696,USH1 PROTEIN NETWORK COMPONENT SANS, USH1G
15648,607697,SET-BINDING FACTOR 2, SBF2
15649,607698,LIGAND-DEPENDENT NUCLEAR RECEPTOR COREPRESSOR, LCOR
15650,607699,RING FINGER PROTEIN 20, RNF20
15651,607700,RING FINGER PROTEIN 40, RNF40
15652,607701,KELCH-LIKE 41, KLHL41
15653,607702,TRANSCRIPTIONAL AND IMMUNE RESPONSE REGULATOR, TCIM
15654,607703,"NUCLEOPORIN, 210-KD", NUP210
15655,607704,KN MOTIF- AND ANKYRIN REPEAT DOMAIN-CONTAINING PROTEIN 1, KANK1
15656,607705,PROTEASOME ACTIVATOR SUBUNIT 4, PSME4
15657,607706,"CHARCOT-MARIE-TOOTH DISEASE, AXONAL, WITH VOCAL CORD PARESIS, AUTOSOMAL RECESSIVE",
15658,607707,CALCIUM/CALMODULIN-DEPENDENT PROTEIN KINASE II-BETA, CAMK2B
15659,607708,CALCIUM/CALMODULIN-DEPENDENT PROTEIN KINASE II-DELTA, CAMK2D
15660,607709,TIGHT JUNCTION PROTEIN 2, TJP2
15661,607710,ENDOSOMAL TRANSMEMBRANE EPSIN INTERACTOR 1, ENTREP1
15662,607711,DISCO-INTERACTING PROTEIN 2 HOMOLOG A, DIP2A
15663,607712,HYPERMETHYLATED IN CANCER 2, HIC2
15664,607713,FIBROBLAST GROWTH FACTOR-BINDING PROTEIN 2, FGFBP2
15665,607714,TNFAIP3-INTERACTING PROTEIN 1, TNIP1
15666,607715,"TSC22 DOMAIN FAMILY, MEMBER 1", TSC22D1
15667,607716,SYNAPTOTAGMIN 13, SYT13
15668,607717,TENSIN 2, TNS2
15669,607718,SYNAPTOTAGMIN 6, SYT6
15670,607719,SYNAPTOTAGMIN 8, SYT8
15671,607720,TRANSLIN-ASSOCIATED FACTOR X-INTERACTING PROTEIN 1, TSNAXIP1
15672,607721,NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 1, NSLH1
15673,607722,"ENDOPLASMIC RETICULUM MEMBRANE PROTEIN COMPLEX, SUBUNIT 2", EMC2
15674,607723,SAD1 AND UNC84 DOMAIN-CONTAINING PROTEIN 1, SUN1
15675,607724,CALCYPHOSINE 2, CAPS2
15676,607725,POLY(ADP-RIBOSE) POLYMERASE 2, PARP2
15677,607726,"POLY(ADP-RIBOSE) POLYMERASE FAMILY, MEMBER 3", PARP3
15678,607727,CULLIN-ASSOCIATED NEDDYLATION-DISSOCIATED PROTEIN 1, CAND1
15679,607728,"POROKERATOSIS 4, DISSEMINATED SUPERFICIAL ACTINIC TYPE", POROK4
15680,607729,DNA DAMAGE-INDUCIBLE TRANSCRIPT 4, DDIT4
15681,607730,DNA DAMAGE-INDUCIBLE TRANSCRIPT 4-LIKE, DDIT4L
15682,607731,"CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2H", CMT2H
15683,607732,STERILE ALPHA AND TIR MOTIFS-CONTAINING PROTEIN 1, SARM1
15684,607733,SCRIBBLE PLANAR CELL POLARITY PROTEIN, SCRIB
15685,607734,"CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1F", CMT1F
15686,607735,PROGESTERONE RECEPTOR MEMBRANE COMPONENT 2, PGRMC2
15687,607736,"CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2J", CMT2J
15688,607737,FIBROBLAST GROWTH FACTOR-BINDING PROTEIN 1, FGFBP1
15689,607738,"POTASSIUM CHANNEL, VOLTAGE-GATED, SHAB-RELATED SUBFAMILY, MEMBER 2", KCNB2
15690,607739,"CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 4B2",
15691,607740,UBIQUITIN-SPECIFIC PROTEASE 32, USP32
15692,607741,"TBC1 DOMAIN FAMILY, MEMBER 3", TBC1D3
15693,607742,"KERATIN 24, TYPE I", KRT24
15694,607743,FIBROBLAST GROWTH FACTOR RECEPTOR SUBSTRATE 2, FRS2
15695,607744,FIBROBLAST GROWTH FACTOR RECEPTOR SUBSTRATE 3, FRS3
15696,607745,"SEIZURES, BENIGN FAMILIAL INFANTILE, 3", BFIS3
15697,607746,FERM DOMAIN-CONTAINING KINDLIN 2, FERMT2
15698,607747,FILAMIN-BINDING LIM PROTEIN 1, FBLIM1
15699,607748,"HYPERCHOLANEMIA, FAMILIAL 1", FHCA1
15700,607749,CELL DIVISION CYCLE-ASSOCIATED PROTEIN 3, CDCA3
15701,607750,"APOLIPOPROTEIN B mRNA-EDITING ENZYME, CATALYTIC POLYPEPTIDE-LIKE 3C", APOBEC3C
15702,607751,"TASTE RECEPTOR, TYPE 2, MEMBER 38", TAS2R38
15703,607752,CYCLIN O, CCNO
15704,607753,SINGLE-STRAND-SELECTIVE MONOFUNCTIONAL URACIL-DNA GLYCOSYLASE 1, SMUG1
15705,607754,MAKORIN 1, MKRN1
15706,607755,MITOGEN-ACTIVATED PROTEIN KINASE 8-INTERACTING PROTEIN 2, MAPK8IP2
15707,607756,ALPHA-AMINOADIPATE SEMIALDEHYDE DEHYDROGENASE-PHOSPHOPANTETHEINYL TRANSFERASE, AASDHPPT
15708,607757,"CHIBBY FAMILY, MEMBER 1, BETA-CATENIN ANTAGONIST", CBY1
15709,607758,"CATENIN, BETA-INTERACTING PROTEIN 1", CTNNBIP1
15710,607759,"INTEGRIN, ALPHA-2B", ITGA2B
15711,607760,DNA TOPOISOMERASE II-BINDING PROTEIN 1, TOPBP1
15712,607761,KIRRE-LIKE NEPHRIN FAMILY ADHESION MOLECULE 3, KIRREL3
15713,607762,KIRRE-LIKE NEPHRIN FAMILY ADHESION MOLECULE 2, KIRREL2
15714,607763,"CENTAURIN, BETA-1", CENTB1
15715,607764,3-BETA-HYDROXY-DELTA-5-C27-STEROID OXIDOREDUCTASE, HSD3B7
15716,607765,"BILE ACID SYNTHESIS DEFECT, CONGENITAL, 1", CBAS1
15717,607766,"CENTAURIN, BETA-2", CENTB2
15718,607767,SESTRIN 2, SESN2
15719,607768,SESTRIN 3, SESN3
15720,607769,"PLECKSTRIN HOMOLOGY DOMAIN-CONTAINING PROTEIN, FAMILY A, MEMBER 4", PLEKHA4
15721,607770,"PLECKSTRIN HOMOLOGY DOMAIN-CONTAINING PROTEIN, FAMILY A, MEMBER 5", PLEKHA5
15722,607771,"PLECKSTRIN HOMOLOGY DOMAIN-CONTAINING PROTEIN, FAMILY A, MEMBER 6", PLEKHA6
15723,607772,"PLECKSTRIN HOMOLOGY DOMAIN-CONTAINING PROTEIN, FAMILY A, MEMBER 1", PLEKHA1
15724,607773,"PLECKSTRIN HOMOLOGY DOMAIN-CONTAINING PROTEIN, FAMILY A, MEMBER 2", PLEKHA2
15725,607774,"PLECKSTRIN HOMOLOGY DOMAIN-CONTAINING PROTEIN, FAMILY A, MEMBER 3", PLEKHA3
15726,607775,"POTASSIUM CHANNEL, VOLTAGE-GATED, ISK-RELATED SUBFAMILY, MEMBER 4", KCNE4
15727,607776,SIN3 TRANSCRIPTION REGULATOR FAMILY MEMBER A, SIN3A
15728,607777,SIN3 TRANSCRIPTION REGULATOR FAMILY MEMBER B, SIN3B
15729,607778,ACROCAPITOFEMORAL DYSPLASIA, ACFD
15730,607779,"PROGESTIN AND ADIPOQ RECEPTOR FAMILY, MEMBER 7", PAQR7
15731,607780,"PROGESTIN AND ADIPOQ RECEPTOR FAMILY, MEMBER 8", PAQR8
15732,607781,"PROGESTIN AND ADIPOQ RECEPTOR FAMILY, MEMBER 5", PAQR5
15733,607782,LUC7-LIKE, LUC7L
15734,607783,MESODERM DEVELOPMENT LRP CHAPERONE, MESD
15735,607784,"ATP-BINDING CASSETTE, SUBFAMILY G, MEMBER 4", ABCG4
15736,607785,JUVENILE MYELOMONOCYTIC LEUKEMIA, JMML
15737,607786,"PROPROTEIN CONVERTASE, SUBTILISIN/KEXIN-TYPE, 9", PCSK9
15738,607787,G PROTEIN-COUPLED RECEPTOR 180, GPR180
15739,607788,MULTIPLE COAGULATION FACTOR DEFICIENCY PROTEIN 2, MCFD2
15740,607789,PHD FINGER PROTEIN 3, PHF3
15741,607790,TET METHYLCYTOSINE DIOXYGENASE 1, TET1
15742,607791,"CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE D", CMTDID
15743,607792,"GERMINAL CENTER-ASSOCIATED, SIGNALING AND MOTILITY", GCSAM
15744,607793,"PETER PAN, DROSOPHILA, HOMOLOG OF", PPAN
15745,607794,MEST INTRONIC TRANSCRIPT 1, MESTIT1
15746,607795,PRE-mRNA-PROCESSING FACTOR 4, PRPF4
15747,607796,PHD FINGER PROTEIN 11, PHF11
15748,607797,"SMALL NUCLEAR RIBONUCLEOPROTEIN, 40-KD", SNRNP40
15749,607798,TATA BOX-BINDING PROTEIN-ASSOCIATED FACTOR 1-LIKE, TAF1L
15750,607799,ZINC FINGER DHHC DOMAIN-CONTAINING PROTEIN 17, ZDHHC17
15751,607800,"ATP-BINDING CASSETTE, SUBFAMILY A, MEMBER 12", ABCA12
15752,607801,RIPPLING MUSCLE DISEASE 2,
15753,607802,CYCLIN M1, CNNM1
15754,607803,CYCLIN M2, CNNM2
15755,607804,CYCLIN M3, CNNM3
15756,607805,CYCLIN M4, CNNM4
15757,607806,OTOPETRIN 1, OTOP1
15758,607807,"ATP-BINDING CASSETTE, SUBFAMILY A, MEMBER 13", ABCA13
15759,607808,NK2 HOMEOBOX 4, NKX2-4
15760,607809,ACETYL-CoA ACETYLTRANSFERASE 1, ACAT1
15761,607810,RADICAL S-ADENOSYL METHIONINE DOMAIN-CONTAINING PROTEIN 2, RSAD2
15762,607811,p21-ACTIVATED KINASE- AND PHOSPHOLIPASE C-INTERACTING PROTEIN 1, PAK1IP1
15763,607812,CRANIOLENTICULOSUTURAL DYSPLASIA, CLSD
15764,607813,PHOSPHOLIPID PHOSPHATASE-RELATED PROTEIN 4, PLPPR4
15765,607814,REGULATOR OF G PROTEIN SIGNALING 9-BINDING PROTEIN, RGS9BP
15766,607815,ANKYRIN REPEAT AND STERILE ALPHA MOTIF DOMAINS-CONTAINING PROTEIN 1B, ANKS1B
15767,607816,POLYCOMB GROUP RING FINGER PROTEIN 6, PCGF6
15768,607817,VACUOLAR PROTEIN SORTING 13 HOMOLOG B, VPS13B
15769,607818,ZINC FINGER PROTEIN 365, ZNF365
15770,607819,"SOLUTE CARRIER FAMILY 30 (ZINC TRANSPORTER), MEMBER 5", SLC30A5
15771,607820,HOOK MICROTUBULE TETHERING PROTEIN 1, HOOK1
15772,607821,"DEAFNESS, AUTOSOMAL RECESSIVE 37", DFNB37
15773,607822,ALZHEIMER DISEASE 3, AD3
15774,607823,HYPOTRICHOSIS-LYMPHEDEMA-TELANGIECTASIA SYNDROME, HLTS
15775,607824,HOOK MICROTUBULE TETHERING PROTEIN 2, HOOK2
15776,607825,HOOK MICROTUBULE TETHERING PROTEIN 3, HOOK3
15777,607826,ADENOSYLHOMOCYSTEINASE-LIKE 1, AHCYL1
15778,607827,OTOPETRIN 2, OTOP2
15779,607828,OTOPETRIN 3, OTOP3
15780,607829,MITRAL VALVE PROLAPSE 2, MVP2
15781,607830,FRASER EXTRACELLULAR MATRIX COMPLEX SUBUNIT 1, FRAS1
15782,607831,"CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2K", CMT2K
15783,607832,"FOCAL SEGMENTAL GLOMERULOSCLEROSIS 3, SUSCEPTIBILITY TO", FSGS3
15784,607833,TACHYKININ 4, TAC4
15785,607834,ANXIETY,
15786,607835,"SPLICING FACTOR 3B, SUBUNIT 6", SF3B6
15787,607836,"AUTOIMMUNE DISEASE, SUSCEPTIBILITY TO, 1", AIS1
15788,607837,CLN8 TRANSMEMBRANE ER AND ERGIC PROTEIN, CLN8
15789,607838,"N-ACETYLGLUCOSAMINE-1-PHOSPHOTRANSFERASE, GAMMA SUBUNIT", GNPTG
15790,607839,GLYCOGEN BRANCHING ENZYME, GBE1
15791,607840,"N-ACETYLGLUCOSAMINE-1-PHOSPHOTRANSFERASE, ALPHA/BETA SUBUNITS", GNPTAB
15792,607841,"DEAFNESS, AUTOSOMAL DOMINANT 48", DFNA48
15793,607842,"AURAL ATRESIA, CONGENITAL", CAA
15794,607843,PKHD1-LIKE 1, PKHD1L1
15795,607844,LEM DOMAIN-CONTAINING PROTEIN 3, LEMD3
15796,607845,EXPORTIN 5, XPO5
15797,607846,"METHYLTRANSFERASE 2B, METHYLCYTIDINE", METTL2B
15798,607847,"NEUTROPENIA, NONIMMUNE CHRONIC IDIOPATHIC, OF ADULTS",
15799,607848,RAB-INTERACTING LYSOSOMAL PROTEIN, RILP
15800,607849,RETINOL DEHYDROGENASE 11, RDH11
15801,607850,OSTEOARTHRITIS SUSCEPTIBILITY 3, OS3
15802,607851,NKD INHIBITOR OF WNT SIGNALING PATHWAY 1, NKD1
15803,607852,NKD INHIBITOR OF WNT SIGNALING PATHWAY 2, NKD2
15804,607853,PANIC DISORDER 2, PAND2
15805,607854,BESTROPHIN 1, BEST1
15806,607855,"MUSCULAR DYSTROPHY, CONGENITAL MEROSIN-DEFICIENT, 1A", MDC1A
15807,607856,CINGULIN-LIKE 1, CGNL1
15808,607857,"PSORIASIS 9, SUSCEPTIBILITY TO", PSORS9
15809,607858,PRESENILIN-ASSOCIATED RHOMBOID-LIKE PROTEIN, PARL
15810,607859,"ANGIOMA, TUFTED",
15811,607860,YY1 ASSOCIATED PROTEIN 1, YY1AP1
15812,607861,"DAPPER, ANTAGONIST OF BETA-CATENIN, 1", DACT1
15813,607862,"DIRAS FAMILY, GTP-BINDING RAS-LIKE PROTEIN 1", DIRAS1
15814,607863,"DIRAS FAMILY, GTP-BINDING RAS-LIKE PROTEIN 2", DIRAS2
15815,607864,CAUDAL DUPLICATION ANOMALY,
15816,607865,"SET DOMAIN PROTEIN, BIFURCATED, 2", SETDB2
15817,607866,SPRY DOMAIN-CONTAINING PROTEIN 7, SPRYD7
15818,607867,RCC1 DOMAIN- AND BTB DOMAIN-CONTAINING PROTEIN 1, RCBTB1
15819,607868,TRIPARTITE MOTIF-CONTAINING PROTEIN 11, TRIM11
15820,607869,UNC5 NETRIN RECEPTOR A, UNC5A
15821,607870,UNC5 NETRIN RECEPTOR B, UNC5B
15822,607871,F-BOX ONLY PROTEIN 11, FBXO11
15823,607872,"CHROMOSOME 1p36 DELETION SYNDROME, DISTAL",
15824,607873,"SCAVENGER RECEPTOR CLASS F, MEMBER 1", SCARF1
15825,607874,ZINC FINGER PROTEIN 444, ZNF444
15826,607875,INOSITOL POLYPHOSPHATE-5-PHOSPHATASE K, INPP5K
15827,607876,"EPILEPSY, FAMILIAL ADULT MYOCLONIC, 2", FAME2
15828,607877,OTOSPIRALIN,
15829,607878,NICOTINAMIDE NUCLEOTIDE TRANSHYDROGENASE, NNT
15830,607879,EXOCYST COMPLEX COMPONENT 1, EXOC1
15831,607880,EXOCYST COMPLEX COMPONENT 6B, EXOC6B
15832,607881,SIGNAL-TRANSDUCING ADAPTOR PROTEIN 2,
15833,607882,"SOLUTE CARRIER FAMILY 52 (RIBOFLAVIN TRANSPORTER), MEMBER 2", SLC52A2
15834,607883,"SOLUTE CARRIER FAMILY 52 (RIBOFLAVIN TRANSPORTER), MEMBER 1", SLC52A1
15835,607884,CKLF-LIKE MARVEL TRANSMEMBRANE DOMAIN-CONTAINING 1, CMTM1
15836,607885,CKLF-LIKE MARVEL TRANSMEMBRANE DOMAIN-CONTAINING 2, CMTM2
15837,607886,CKLF-LIKE MARVEL TRANSMEMBRANE DOMAIN-CONTAINING 3, CMTM3
15838,607887,CKLF-LIKE MARVEL TRANSMEMBRANE DOMAIN-CONTAINING 4, CMTM4
15839,607888,CKLF-LIKE MARVEL TRANSMEMBRANE DOMAIN-CONTAINING 5, CMTM5
15840,607889,CKLF-LIKE MARVEL TRANSMEMBRANE DOMAIN-CONTAINING 6, CMTM6
15841,607890,CKLF-LIKE MARVEL TRANSMEMBRANE DOMAIN-CONTAINING 7, CMTM7
15842,607891,CKLF-LIKE MARVEL TRANSMEMBRANE DOMAIN-CONTAINING 8, CMTM8
15843,607892,DESMOGLEIN 4, DSG4
15844,607893,"OVARIAN CANCER, SUSCEPTIBILITY TO, 1", OVCAS1
15845,607894,POLYCYSTIN 1-LIKE 2, PKD1L2
15846,607895,POLYCYSTIN 1-LIKE 3, PKD1L3
15847,607896,OVCA2 SERINE HYDROLASE DOMAIN-CONTAINING PROTEIN, OVCA2
15848,607897,MUSASHI RNA BINDING PROTEIN 2, MSI2
15849,607898,TRIBBLES PSEUDOKINASE 3, TRIB3
15850,607899,WT1 ANTISENSE RNA, WT1AS
15851,607900,FERM DOMAIN-CONTAINING KINDLIN 1, FERMT1
15852,607901,FERM DOMAIN-CONTAINING KINDLIN 3, FERMT3
15853,607902,SNURPORTIN 1, SNUPN
15854,607903,HYPOTRICHOSIS 6, HYPT6
15855,607904,"CALCIUM CHANNEL, VOLTAGE-DEPENDENT, T TYPE, ALPHA-1H SUBUNIT", CACNA1H
15856,607905,"ALG2 ALPHA-1,3/1,6-MANNOSYLTRANSFERASE", ALG2
15857,607906,"CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ii", CDG1I
15858,607907,DERMATOFIBROSARCOMA PROTUBERANS, DFSP
15859,607908,LIM ZINC FINGER DOMAIN-CONTAINING PROTEIN 2, LIMS2
15860,607909,ANTIZYME INHIBITOR 1, AZIN1
15861,607910,KINESIN FAMILY MEMBER 9, KIF9
15862,607911,EPM2A-INTERACTING PROTEIN 1, EPM2AIP1
15863,607912,SELENOPROTEIN T, SELENOT
15864,607913,GLUTATHIONE PEROXIDASE 6, GPX6
15865,607914,SELENOPROTEIN H, SELENOH
15866,607915,SELENOPROTEIN I, SELENOI
15867,607916,SELENOPROTEIN K, SELENOK
15868,607917,SELENOPROTEIN O, SELENOO
15869,607918,SELENOPROTEIN S, SELENOS
15870,607919,SELENOPROTEIN V, SELENOV
15871,607920,"EMERY-DREIFUSS MUSCULAR DYSTROPHY 2, AUTOSOMAL DOMINANT",
15872,607921,RETINITIS PIGMENTOSA 30, RP30
15873,607922,"ALPHA-1,4-GALACTOSYLTRANSFERASE", A4GALT
15874,607923,"SYNAPTOSOMAL-ASSOCIATED PROTEIN, 91-KD", SNAP91
15875,607924,METASTASIS-ASSOCIATED LUNG ADENOCARCINOMA TRANSCRIPT 1, MALAT1
15876,607925,B- AND T-LYMPHOCYTE ATTENUATOR, BTLA
15877,607926,HOST CELL FACTOR C2, HCFC2
15878,607927,ANKYRIN REPEATS- AND FYVE DOMAIN-CONTAINING PROTEIN 1, ANKFY1
15879,607928,WHIRLIN, WHRN
15880,607929,CCM2 SCAFFOLD PROTEIN, CCM2
15881,607930,CYTOKINE-LIKE PROTEIN 1, CYTL1
15882,607931,ATAXIN 2-LIKE, ATXN2L
15883,607932,"MICROPHTHALMIA, SYNDROMIC 6", MCOPS6
15884,607933,"SOLUTE CARRIER FAMILY 7 (CATIONIC AMINO ACID TRANSPORTER, y+ SYSTEM), MEMBER 11", SLC7A11
15885,607934,"PEPTIDYLARGININE DEIMINASE, TYPE I", PADI1
15886,607935,"PEPTIDYLARGININE DEIMINASE, TYPE II", PADI2
15887,607936,PEELING SKIN SYNDROME 4, PSS4
15888,607937,NANOG HOMEOBOX, NANOG
15889,607938,NEUROTRIMIN, NTM
15890,607939,SULFATASE-MODIFYING FACTOR 1, SUMF1
15891,607940,SULFATASE-MODIFYING FACTOR 2, SUMF2
15892,607941,ATRIAL SEPTAL DEFECT 2, ASD2
15893,607942,PHOSPHOINOSITIDE 3-KINASE ADAPTOR PROTEIN 1, PIK3AP1
15894,607943,RAS p21 PROTEIN ACTIVATOR 4, RASA4
15895,607944,SPONDYLOENCHONDRODYSPLASIA WITH IMMUNE DYSREGULATION, SPENCDI
15896,607945,ADIPONECTIN RECEPTOR 1, ADIPOR1
15897,607946,ADIPONECTIN RECEPTOR 2, ADIPOR2
15898,607947,POTASSIUM CHANNEL REGULATOR, KCNRG
15899,607948,"MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO",
15900,607949,"MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO, 1",
15901,607950,TESTIS-SPECIFIC PROTEASE 50,
15902,607951,"CENTROSOMAL PROTEIN, 57-KD", CEP57
15903,607952,"SOLUTE CARRIER FAMILY 6 (NEUROTRANSMITTER TRANSPORTER, GABA), MEMBER 11", SLC6A11
15904,607953,TRANSGELIN 3, TAGLN3
15905,607954,RAN GUANINE NUCLEOTIDE RELEASE FACTOR, RANGRF
15906,607955,SAM- AND SH3 DOMAIN-CONTAINING PROTEIN 1, SASH1
15907,607956,MEDIATOR COMPLEX SUBUNIT 8, MED8
15908,607957,CALCIUM/CALMODULIN-DEPENDENT PROTEIN KINASE I-DELTA, CAMK1D
15909,607958,SYNTAXIN-BINDING PROTEIN 6, STXBP6
15910,607959,"SOLUTE CARRIER FAMILY 7 (CATIONIC AMINO ACID TRANSPORTER, y+ SYSTEM), MEMBER 10", SLC7A10
15911,607960,"DEAH-BOX HELICASE 32, PUTATIVE", DHX32
15912,607961,SEMAPHORIN 7A, SEMA7A
15913,607962,MICRO RNA 23A, MIR23A
15914,607963,METHYL-CpG BINDING DOMAIN PROTEIN 3-LIKE 1, MBD3L1
15915,607964,METHYL-CpG BINDING DOMAIN PROTEIN 3-LIKE 2, MBD3L2
15916,607965,"SYSTEMIC LUPUS ERYTHEMATOSUS WITH NEPHRITIS, SUSCEPTIBILITY TO, 1", SLEN1
15917,607966,"SYSTEMIC LUPUS ERYTHEMATOSUS WITH NEPHRITIS, SUSCEPTIBILITY TO, 2", SLEN2
15918,607967,"SYSTEMIC LUPUS ERYTHEMATOSUS WITH NEPHRITIS, SUSCEPTIBILITY TO, 3", SLEN3
15919,607968,PARATHYROID HORMONE-RESPONSIVE B1 GENE,
15920,607969,CDC-LIKE KINASE 4, CLK4
15921,607970,G PROTEIN-COUPLED RECEPTOR 135, GPR135
15922,607971,"SOLUTE CARRIER FAMILY 6 (NEUROTRANSMITTER TRANSPORTER), MEMBER 15", SLC6A15
15923,607972,"SOLUTE CARRIER FAMILY 6 (NEUROTRANSMITTER TRANSPORTER), MEMBER 16", SLC6A16
15924,607973,NEUROPILIN- AND TOLLOID-LIKE 1, NETO1
15925,607974,NEUROPILIN- AND TOLLOID-LIKE 2, NETO2
15926,607975,OXIDATIVE STRESS-INDUCED GROWTH INHIBITOR 1, OSGIN1
15927,607976,"CYTOCHROME c OXIDASE, SUBUNIT 4I2", COX4I2
15928,607977,"HDC HOMOLOG, CELL CYCLE REGULATOR", HECA
15929,607978,"SAM DOMAIN, SH3 DOMAIN, AND NUCLEAR LOCALIZATION SIGNALS 1", SAMSN1
15930,607979,"SERINE HYDROLASE-LIKE, PSEUDOGENE", SERHL
15931,607980,TRANSLOCASE OF OUTER MITOCHONDRIAL MEMBRANE 7, TOMM7
15932,607981,NEGATIVE REGULATOR OF UBIQUITIN-LIKE PROTEINS 1, NUB1
15933,607982,SCY1-LIKE 1, SCYL1
15934,607983,"GOLGIN, RAB6-INTERACTING", GORAB
15935,607984,SPROUTY RTK SIGNALING ANTAGONIST 4, SPRY4
15936,607985,N-ACETYLGLUCOSAMINE-1-PHOSPHODIESTER ALPHA-N-ACETYLGLUCOSAMINIDASE, NAGPA
15937,607986,S100 CALCIUM-BINDING PROTEIN A14, S100A14
15938,607987,"DNAJ/HSP40 HOMOLOG, SUBFAMILY C, MEMBER 10", DNAJC10
15939,607988,"SPARC/OSTEONECTIN, CWCV, AND KAZAL-LIKE DOMAINS PROTEOGLYCAN 2", SPOCK2
15940,607989,"SPARC/OSTEONECTIN, CWCV, AND KAZAL-LIKE DOMAINS PROTEOGLYCAN 3", SPOCK3
15941,607990,UBIQUITIN-LIKE PROTEIN CONTAINING PHD AND RING FINGER DOMAINS 1, UHRF1
15942,607991,"SOLUTE CARRIER FAMILY 8 (SODIUM-CALCIUM EXCHANGER), MEMBER A3", SLC8A3
15943,607992,SURP AND G-PATCH DOMAINS-CONTAINING PROTEIN 1, SUGP1
15944,607993,SURP AND G-PATCH DOMAINS-CONTAINING PROTEIN 2, SUGP2
15945,607994,"5-PRIME,3-PRIME-EXORIBONUCLEASE 1", XRN1
15946,607995,UNC93 HOMOLOG A, UNC93A
15947,607996,PREPRONEUROPEPTIDE B,
15948,607997,NEUROPEPTIDE W, NPW
15949,607998,TRIPEPTIDYL PEPTIDASE I, TPP1
15950,607999,ASH1-LIKE HISTONE LYSINE METHYLTRANSFERASE, ASH1L
15951,608000,"N-ALPHA-ACETYLTRANSFERASE 15, NatA AUXILIARY SUBUNIT", NAA15
15952,608001,MIA SH3 DOMAIN ER EXPORT FACTOR 2,
15953,608002,NEPHROCYSTIN 3, NPHP3
15954,608003,HOMEODOMAIN-INTERACTING PROTEIN KINASE 1, HIPK1
15955,608004,"NUCLEAR FACTOR KAPPA-B INHIBITOR, ZETA", NFKBIZ
15956,608005,SIL1 NUCLEOTIDE EXCHANGE FACTOR, SIL1
15957,608006,LEIOMODIN 2, LMOD2
15958,608007,PLECKSTRIN 2, PLEK2
15959,608008,ANNEXIN A10, ANXA10
15960,608009,ADENYLATE KINASE 5, AK5
15961,608010,NPC1-LIKE INTRACELLULAR CHOLESTEROL TRANSPORTER 1, NPC1L1
15962,608011,GUANINE NUCLEOTIDE-BINDING PROTEIN-LIKE 3, GNL3
15963,608012,"PROTEIN DISULFIDE ISOMERASE, FAMILY A, MEMBER 2", PDIA2
15964,608013,"GAUCHER DISEASE, PERINATAL LETHAL",
15965,608014,HEAT-SHOCK 22-KD PROTEIN 8, HSPB8
15966,608015,TSUKUSHIN, TSKU
15967,608016,CYTOCHROME c OXIDASE ASSEMBLY FACTOR 4 HOMOLOG, COA4
15968,608017,"FAMILY WITH SEQUENCE SIMILARITY 162, MEMBER A", FAM162A
15969,608018,"PROTEASE, SERINE, 27", PRSS27
15970,608019,TNFAIP3-INTERACTING PROTEIN 3, TNIP3
15971,608020,NUCLEOBINDIN 2, NUCB2
15972,608021,"WAP, FOLLISTATIN, IMMUNOGLOBULIN, KUNITZ, AND NTR DOMAINS-CONTAINING PROTEIN 1", WFIKKN1
15973,608022,DIAPHANOSPONDYLODYSOSTOSIS,
15974,608023,DEAD-BOX HELICASE 56, DDX56
15975,608024,ENOYL-CoA DELTA ISOMERASE 2, ECI2
15976,608025,NBAS SUBUNIT OF NRZ TETHERING COMPLEX, NBAS
15977,608026,HYPERTENSIVE NEPHROPATHY, HNP1
15978,608027,"PONTOCEREBELLAR HYPOPLASIA, TYPE 3", PCH3
15979,608028,THAI SYMPHALANGISM SYNDROME,
15980,608029,"SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 6", SCAR6
15981,608030,AMYOTROPHIC LATERAL SCLEROSIS 6 WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA, ALS6
15982,608031,AMYOTROPHIC LATERAL SCLEROSIS 7, ALS7
15983,608032,DYSCHROMATOSIS UNIVERSALIS HEREDITARIA 1,
15984,608033,"ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 3", IIAE3
15985,608034,ASPARTOACYLASE, ASPA
15986,608035,"MELANOMA, CUTANEOUS MALIGNANT, SUSCEPTIBILITY TO, 4", CMM4
15987,608036,TYPE 2 DIABETES MELLITUS 4, T2D4
15988,608037,CHONDROITIN POLYMERIZING FACTOR 2, CHPF2
15989,608038,p21 PROTEIN-ACTIVATED KINASE 5, PAK5
15990,608039,SPERMATOGENESIS-ASSOCIATED PROTEIN 9, SPATA9
15991,608040,INTRAFLAGELLAR TRANSPORT 74, IFT74
15992,608041,ANTHRAX TOXIN RECEPTOR 2, ANTXR2
15993,608042,SYNAPTOTAGMIN-LIKE 1, SYTL1
15994,608043,UDP-N-ACETYL-ALPHA-D-GALACTOSAMINE:POLYPEPTIDE N-ACETYLGALACTOSAMINYLTRANSFERASE 10, GALNT10
15995,608044,"SOLUTE CARRIER FAMILY 5 (IODIDE TRANSPORTER), MEMBER 8", SLC5A8
15996,608045,REPRESSOR OF TELOMERASE EXPRESSION 1,
15997,608046,SYNOVIAL APOPTOSIS INHIBITOR 1, SYVN1
15998,608047,UBIQUITIN-PROTEIN LIGASE E3B, UBE3B
15999,608048,"SNF2, LINKER HISTONE, PHD FINGER, RING FINGER, AND HELICASE DOMAINS-CONTAINING PROTEIN", SHPRH
16000,608049,"AUTISM, SUSCEPTIBILITY TO, 3", AUTS3
16001,608050,TORSIN 1B, TOR1B
16002,608051,"MACULAR DYSTROPHY, RETINAL, 2", MCDR2
16003,608052,TORSIN 2A, TOR2A
16004,608053,"ELECTRON TRANSFER FLAVOPROTEIN, ALPHA POLYPEPTIDE", ETFA
16005,608054,"CYTOCHROME P450, SUBFAMILY IIA, POLYPEPTIDE 7", CYP2A7
16006,608055,"CYTOCHROME P450, SUBFAMILY IIA, POLYPEPTIDE 13", CYP2A13
16007,608056,"LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 2",
16008,608057,DEOXYRIBONUCLEASE II BETA, DNASE2B
16009,608058,"GLUCOSE-6-PHOSPHATASE, CATALYTIC, 2", G6PC2
16010,608059,HES FAMILY bHLH TRANSCRIPTION FACTOR 7, HES7
16011,608060,HES FAMILY bHLH TRANSCRIPTION FACTOR 4, HES4
16012,608061,TRANSLOCASE OF OUTER MITOCHONDRIAL MEMBRANE 40, TOMM40
16013,608062,DOUBLECORTIN DOMAIN-CONTAINING PROTEIN 1, DCDC1
16014,608063,"BILE AND PANCREATIC DUCTS, COMPLETE ABSENCE OF",
16015,608064,KELCH-LIKE 5, KLHL5
16016,608065,"SOLUTE CARRIER FAMILY 38 (AMINO ACID TRANSPORTER), MEMBER 4", SLC38A4
16017,608066,SCAFFOLD ATTACHMENT FACTOR B2, SAFB2
16018,608067,RING FINGER AND WD REPEAT DOMAINS-CONTAINING PROTEIN 2, RFWD2
16019,608068,"NEUTROPHILIC DERMATOSIS, ACUTE FEBRILE", AFND
16020,608069,ERBB RECEPTOR FEEDBACK INHIBITOR 1, ERRFI1
16021,608070,"HOMOCYSTEINE- AND ENDOPLASMIC RETICULUM STRESS-INDUCIBLE PROTEIN, UBIQUITIN-LIKE DOMAIN-CONTAINING, 1", HERPUD1
16022,608071,F-BOX AND WD40 DOMAIN PROTEIN 4, FBXW4
16023,608072,NHL REPEAT-CONTAINING PROTEIN 1, NHLRC1
16024,608073,"NUCLEOPHOSMIN/NUCLEOPLASMIN FAMILY, MEMBER 2", NPM2
16025,608074,PROGRAMMED CELL DEATH 6-INTERACTING PROTEIN, PDCD6IP
16026,608075,"PHOSPHOLIPASE C, ZETA-1", PLCZ1
16027,608076,"TYROSINE KINASE, NONRECEPTOR, 1", TNK1
16028,608077,PURINERGIC RECEPTOR P2X-LIKE 1, P2RXL1
16029,608078,SCHIZOPHRENIA 11,
16030,608079,ELAC RIBONUCLEASE Z 1, ELAC1
16031,608080,MAESTRO, MRO
16032,608081,SYNAPTOTAGMIN 15, SYT15
16033,608082,YIPPEE-LIKE 1, YPEL1
16034,608083,APOLIPOPROTEIN C-II, APOC2
16035,608084,"GTPase, IMAP FAMILY, MEMBER 1", GIMAP1
16036,608085,"GTPase, IMAP FAMILY, MEMBER 2", GIMAP2
16037,608086,"GTPase, IMAP FAMILY, MEMBER 5", GIMAP5
16038,608087,"GTPase, IMAP FAMILY, MEMBER 4", GIMAP4
16039,608088,"NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE I, WITH COUGH AND GASTROESOPHAGEAL REFLUX",
16040,608089,ENDOMETRIAL CANCER,
16041,608090,MLX-INTERACTING PROTEIN, MLXIP
16042,608091,JOUBERT SYNDROME 2, JBTS2
16043,608092,"PALLADIN, CYTOSKELETAL-ASSOCIATED PROTEIN", PALLD
16044,608093,"CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ij", CDG1J
16045,608094,"SOLUTE CARRIER FAMILY 37 (SUGAR-PHOSPHATE TRANSPORTER), MEMBER 1", SLC37A1
16046,608095,SODIUM CHANNEL MODIFIER 1, SCNM1
16047,608096,"EPILEPSY, FAMILIAL TEMPORAL LOBE, 2", ETL2
16048,608097,"PERIVENTRICULAR HETEROTOPIA WITH MICROCEPHALY, AUTOSOMAL RECESSIVE", ARPHM
16049,608098,PERIVENTRICULAR NODULAR HETEROTOPIA 3, PVNH3
16050,608099,"MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 3", LGMDR3
16051,608100,NFU1 IRON-SULFUR CLUSTER SCAFFOLD, NFU1
16052,608101,SPERMATID-SPECIFIC LINKER HISTONE H1-LIKE PROTEIN,
16053,608102,CLN5 INTRACELLULAR TRAFFICKING PROTEIN, CLN5
16054,608103,"ALG8 ALPHA-1,3-GLUCOSYLTRANSFERASE", ALG8
16055,608104,"CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ih", CDG1H
16056,608105,"EPILEPSY, ROLANDIC, WITH PAROXYSMAL EXERCISE-INDUCED DYSTONIA AND WRITER'S CRAMP", EPRPDC
16057,608106,"IMMUNODEFICIENCY WITH HYPER-IgM, TYPE 5", HIGM5
16058,608107,"MEFV INNATE IMMUNITY REGULATOR, PYRIN", MEFV
16059,608108,CRANIOFACIAL DEVELOPMENT PROTEIN 1, CFDP1
16060,608109,PSEUDOURIDINE SYNTHASE 1, PUS1
16061,608110,p21 PROTEIN-ACTIVATED KINASE 6, PAK6
16062,608111,FANCL GENE, FANCL
16063,608112,"TRAFFICKING PROTEIN, KINESIN-BINDING 1", TRAK1
16064,608113,"SARCOGLYCAN, ZETA", SGCZ
16065,608114,"CENTAURIN, ALPHA-1", CENTA1
16066,608115,OVARIAN HYPERSTIMULATION SYNDROME, OHSS
16067,608116,HEDGEHOG ACYLTRANSFERASE-LIKE PROTEIN, HHATL
16068,608117,PHOSPHODIESTERASE 4D-INTERACTING PROTEIN, PDE4DIP
16069,608118,"ZINC DEFICIENCY, TRANSIENT NEONATAL", TNZD
16070,608119,HOMEODOMAIN LEUCINE ZIPPER-CONTAINING FACTOR, HOMEZ
16071,608120,"PARVIN, ALPHA", PARVA
16072,608121,"PARVIN, BETA", PARVB
16073,608122,"PARVIN, GAMMA", PARVG
16074,608123,ACYL-CoA THIOESTERASE 8, ACOT8
16075,608124,XYLOSYLTRANSFERASE 1, XYLT1
16076,608125,XYLOSYLTRANSFERASE 2, XYLT2
16077,608126,WD REPEAT AND HMG-BOX DNA-BINDING PROTEIN 1, WDHD1
16078,608127,PRE-B-CELL LEUKEMIA TRANSCRIPTION FACTOR 4, PBX4
16079,608128,KALIRIN,
16080,608129,UBIQUITIN-ASSOCIATED DOMAIN-CONTAINING PROTEIN 1, UBAC1
16081,608130,"NUAK FAMILY, SNF1-LIKE KINASE, 1", NUAK1
16082,608131,"NUAK FAMILY, SNF1-LIKE KINASE, 2", NUAK2
16083,608132,TETRATRICOPEPTIDE REPEAT DOMAIN-CONTAINING PROTEIN 8, TTC8
16084,608133,RETINITIS PIGMENTOSA 7, RP7
16085,608134,PARALEMMIN, PALM
16086,608135,ASPORIN, ASPN
16087,608136,RHO GUANINE NUCLEOTIDE EXCHANGE FACTOR 10, ARHGEF10
16088,608137,NMDA RECEPTOR SYNAPTONUCLEAR SIGNALING AND NEURONAL MIGRATION FACTOR, NSMF
16089,608138,PROGRAMMED CELL DEATH 7, PDCD7
16090,608139,CENTROMERE PROTEIN V, CENPV
16091,608140,"NUCLEOPORIN, 35-KD", NUP35
16092,608141,"NUCLEOPORIN, 43-KD", NUP43
16093,608142,HSCB MITOCHONDRIAL IRON-SULFUR CLUSTER COCHAPERONE, HSCB
16094,608143,1-ACYLGLYCEROL-3-PHOSPHATE O-ACYLTRANSFERASE 6, AGPAT6
16095,608144,SAM POINTED DOMAIN-CONTAINING ETS TRANSCRIPTION FACTOR, SPDEF
16096,608145,NIPA MAGNESIUM TRANSPORTER 1, NIPA1
16097,608146,NIPA MAGNESIUM TRANSPORTER 2, NIPA2
16098,608147,TUBULIN-GAMMA COMPLEX-ASSOCIATED PROTEIN 5, TUBGCP5
16099,608148,SPECIAL AT-RICH SEQUENCE-BINDING PROTEIN 2, SATB2
16100,608149,KAGAMI-OGATA SYNDROME,
16101,608150,PERIPHILIN 1, PPHLN1
16102,608151,WD REPEAT-CONTAINING PROTEIN 19, WDR19
16103,608152,PROSTAGLANDIN E SYNTHASE 2, PTGES2
16104,608153,"PROTEIN PHOSPHATASE 1, REGULATORY SUBUNIT 14A", PPP1R14A
16105,608154,"LIPODYSTROPHY, GENERALIZED, WITH IMPAIRED INTELLECTUAL DEVELOPMENT, DEAFNESS, SHORT STATURE, AND SLENDER BONES",
16106,608155,SYNAPTOPODIN, SYNPO
16107,608156,NABLUS MASK-LIKE FACIAL SYNDROME, NMLFS
16108,608157,"SOLUTE CARRIER FAMILY 25 (MITOCHONDRIAL CARRIER, ORNITHINE TRANSPORTER), MEMBER 2", SLC25A2
16109,608158,CoQ-RESPONSIVE OXPHOS DEFICIENCY,
16110,608159,"PROTEASE, SERINE, 21", PRSS21
16111,608160,SRY-BOX 9, SOX9
16112,608161,"MACULAR DYSTROPHY, VITELLIFORM, 3", VMD3
16113,608162,V-SET DOMAIN-CONTAINING T-CELL ACTIVATION INHIBITOR 1, VTCN1
16114,608163,EXOCYST COMPLEX COMPONENT 7, EXOC7
16115,608164,"POTASSIUM CHANNEL, VOLTAGE-GATED, SUBFAMILY V, MEMBER 1", KCNV1
16116,608165,PTB DOMAIN-CONTAINING ENGULFMENT ADAPTOR PROTEIN 1, GULP1
16117,608166,SEMAPHORIN 3E, SEMA3E
16118,608167,"POTASSIUM CHANNEL, SUBFAMILY T, MEMBER 1", KCNT1
16119,608168,"POTASSIUM CHANNEL, VOLTAGE-GATED, SUBFAMILY H, MEMBER 6", KCNH6
16120,608169,"POTASSIUM CHANNEL, VOLTAGE-GATED, SUBFAMILY H, MEMBER 7", KCNH7
16121,608170,DEAD-BOX HELICASE 41, DDX41
16122,608171,"CALCIUM CHANNEL, VOLTAGE-DEPENDENT, ALPHA-2/DELTA SUBUNIT 4", CACNA2D4
16123,608172,DEHYDRODOLICHYL DIPHOSPHATE SYNTHASE, DHDDS
16124,608173,"AUTOIMMUNE THYROID DISEASE, SUSCEPTIBILITY TO, 1",
16125,608174,"AUTOIMMUNE THYROID DISEASE, SUSCEPTIBILITY TO, 2",
16126,608175,"AUTOIMMUNE THYROID DISEASE, SUSCEPTIBILITY TO, 3", AITD3
16127,608176,"AUTOIMMUNE THYROID DISEASE, SUSCEPTIBILITY TO, 4",
16128,608177,EXOSTOSIN GLYCOSYLTRANSFERASE 1, EXT1
16129,608178,LEUCINE ZIPPER PROTEIN 2, LUZP2
16130,608179,CAYTAXIN, ATCAY
16131,608180,SYNPOLYDACTYLY 2, SPD2
16132,608181,"ACIDIC CLUSTER PROTEIN, 33-KD", ACP33
16133,608182,POTASSIUM CHANNEL-INTERACTING PROTEIN 4,
16134,608183,CHONDROITIN SULFATE SYNTHASE 1, CHSY1
16135,608184,"IMMUNODEFICIENCY WITH HYPER-IgM, TYPE 4", HIGM4
16136,608185,EXOCYST COMPLEX COMPONENT 4, EXOC4
16137,608186,EXOCYST COMPLEX COMPONENT 3, EXOC3
16138,608187,MINICHROMOSOME MAINTENANCE COMPLEX COMPONENT 8, MCM8
16139,608188,CARDIOLIPIN SYNTHASE 1, CRLS1
16140,608189,TROPICAL CALCIFIC PANCREATITIS,
16141,608190,N-ACETYLTRANSFERASE 8B, NAT8B
16142,608191,RB-ASSOCIATED KRAB ZINC FINGER, RBAK
16143,608192,SCY1-LIKE PROTEIN 3, SCYL3
16144,608193,REC8 MEIOTIC RECOMBINATION PROTEIN, REC8
16145,608194,CONE-ROD DYSTROPHY 13, CORD13
16146,608195,LEUCINE-RICH REPEAT-CONTAINING PROTEIN 1, LRRC1
16147,608196,WERNER HELICASE-INTERACTING PROTEIN 1, WRNIP1
16148,608197,PEPTIDOGLYCAN RECOGNITION PROTEIN 3, PGLYRP3
16149,608198,PEPTIDOGLYCAN RECOGNITION PROTEIN 4, PGLYRP4
16150,608199,PEPTIDOGLYCAN RECOGNITION PROTEIN 2, PGLYRP2
16151,608200,CDK5 REGULATORY SUBUNIT-ASSOCIATED PROTEIN 1, CDK5RAP1
16152,608201,CDK5 REGULATORY SUBUNIT-ASSOCIATED PROTEIN 2, CDK5RAP2
16153,608202,CDK5 REGULATORY SUBUNIT-ASSOCIATED PROTEIN 3, CDK5RAP3
16154,608203,IMMUNODEFICIENCY 73A WITH DEFECTIVE NEUTROPHIL CHEMOTAXIS AND LEUKOCYTOSIS, IMD73A
16155,608204,"UNC93 HOMOLOG B1, TLR SIGNALING REGULATOR", UNC93B1
16156,608205,MITOCHONDRIAL TRANS-2-ENOYL-CoA REDUCTASE, MECR
16157,608206,SH3 DOMAIN AND TETRATRICOPEPTIDE REPEAT DOMAIN 2, SH3TC2
16158,608207,"KALA-AZAR, SUSCEPTIBILITY TO, 1", KAZA1
16159,608208,MEMBRANE-ASSOCIATED RING-CH FINGER PROTEIN 4, MARCHF4
16160,608209,DIPEPTIDYL PEPTIDASE X, DPP10
16161,608210,EXOSTOSIN GLYCOSYLTRANSFERASE 2, EXT2
16162,608211,KIDNEY-ASSOCIATED ANTIGEN 1, KAAG1
16163,608212,IMMUNITY-RELATED GTPase M, IRGM
16164,608213,CELL CYCLE EXIT AND NEURONAL DIFFERENTIATION 1, CEND1
16165,608214,"SODIUM VOLTAGE-GATED CHANNEL, BETA SUBUNIT 3", SCN3B
16166,608215,LIM HOMEOBOX GENE 6, LHX6
16167,608216,COMM DOMAIN-CONTAINING PROTEIN 5, COMMD5
16168,608217,"SEIZURES, BENIGN FAMILIAL NEONATAL, 3", BFNS3
16169,608218,"KERATIN 20, TYPE I", KRT20
16170,608219,"DEAFNESS, AUTOSOMAL RECESSIVE 38", DFNB38
16171,608220,"SPASTIC PARAPLEGIA 25, AUTOSOMAL RECESSIVE", SPG25
16172,608221,MICROTUBULE-ASSOCIATED SERINE/THREONINE KINASE-LIKE, MASTL
16173,608222,ADENYLOSUCCINATE LYASE, ADSL
16174,608223,ASPIRIN RESISTANCE,
16175,608224,"DEAFNESS, AUTOSOMAL DOMINANT 41", DFNA41
16176,608225,UDP-N-ACETYL-ALPHA-D-GALACTOSAMINE:POLYPEPTIDE N-ACETYLGALACTOSAMINYLTRANSFERASE 14, GALNT14
16177,608226,NANOS C2HC-TYPE ZINC FINGER 1, NANOS1
16178,608227,"CRANIOFACIAL ABNORMALITIES, CATARACTS, CONGENITAL HEART DISEASE, SACRAL NEURAL TUBE DEFECTS, AND GROWTH AND DEVELOPMENTAL RETARDATION",
16179,608228,NANOS C2HC-TYPE ZINC FINGER 2, NANOS2
16180,608229,NANOS C2HC-TYPE ZINC FINGER 3, NANOS3
16181,608230,"CALCIUM CHANNEL, VOLTAGE-DEPENDENT, T TYPE, ALPHA-1I SUBUNIT", CACNA1I
16182,608231,"RAS ASSOCIATION DOMAIN FAMILY, MEMBER 8", RASSF8
16183,608232,"LEUKEMIA, CHRONIC MYELOID", CML
16184,608233,HERMANSKY-PUDLAK SYNDROME 2, HPS2
16185,608234,GALACTOSE-3-O-SULFOTRANSFERASE 3, GAL3ST3
16186,608235,GALACTOSE-3-O-SULFOTRANSFERASE 4, GAL3ST4
16187,608236,"SLOWED NERVE CONDUCTION VELOCITY, AUTOSOMAL DOMINANT", SNCV
16188,608237,GALACTOSE-3-O-SULFOTRANSFERASE 2, GAL3ST2
16189,608238,SIGNAL PEPTIDE PEPTIDASE-LIKE 2A, SPPL2A
16190,608239,SIGNAL PEPTIDE PEPTIDASE-LIKE 2B, SPPL2B
16191,608240,SIGNAL PEPTIDE PEPTIDASE-LIKE 3, SPPL3
16192,608241,SMAD NUCLEAR INTERACTING PROTEIN 1, SNIP1
16193,608242,HECT DOMAIN AND RCC1-LIKE DOMAIN 5, HERC5
16194,608243,"NSE3 HOMOLOG, SMC5-SMC6 COMPLEX COMPONENT", NSMCE3
16195,608244,OTOSCLEROSIS 3, OTSC3
16196,608245,"KERATIN 71, TYPE II", KRT71
16197,608246,"KERATIN 72, TYPE II", KRT72
16198,608247,"KERATIN 73, TYPE II", KRT73
16199,608248,"KERATIN 74, TYPE II", KRT74
16200,608249,CYCLIN B1 INTERACTING PROTEIN 1, CCNB1IP1
16201,608250,"SDS3 HOMOLOG, SIN3A COREPRESSOR COMPLEX COMPONENT", SUDS3
16202,608251,"PHOBIA, SPECIFIC",
16203,608252,ACTIN FILAMENT-ASSOCIATED PROTEIN 1, AFAP1
16204,608253,TESTIS-SPECIFIC KINASE SUBSTRATE, TSKS
16205,608254,PAX TRANSCRIPTION ACTIVATION DOMAIN-INTERACTING PROTEIN 1, PAXIP1
16206,608255,TRAF3-INTERACTING PROTEIN 3, TRAF3IP3
16207,608256,"SODIUM VOLTAGE-GATED CHANNEL, BETA SUBUNIT 4", SCN4B
16208,608257,"MANDIBULOFACIAL DYSOSTOSIS WITH PTOSIS, AUTOSOMAL DOMINANT",
16209,608258,DIPEPTIDYL PEPTIDASE IX, DPP9
16210,608259,INSULIN-LIKE GROWTH FACTOR 2 mRNA-BINDING PROTEIN 3, IGF2BP3
16211,608260,"POTASSIUM CHANNEL, VOLTAGE-GATED, SUBFAMILY H, MEMBER 8", KCNH8
16212,608261,"SENTRIN-SPECIFIC PROTEASE FAMILY, MEMBER 2", SENP2
16213,608262,DISRUPTED IN RENAL CARCINOMA 3, DIRC3
16214,608263,HEAT-SHOCK 27-KD PROTEIN-ASSOCIATED PROTEIN 1, HSPBAP1
16215,608264,"DEAFNESS, AUTOSOMAL RECESSIVE 40", DFNB40
16216,608265,"DEAFNESS, AUTOSOMAL RECESSIVE 39", DFNB39
16217,608266,PARATHYROID CARCINOMA,
16218,608267,RAS-RELATED GTP-BINDING PROTEIN C, RRAGC
16219,608268,RAS-RELATED GTP-BINDING PROTEIN D, RRAGD
16220,608269,"SOLUTE CARRIER FAMILY 28 (SODIUM-COUPLED NUCLEOSIDE TRANSPORTER), MEMBER 3", SLC28A3
16221,608270,THREONINE ASPARTASE 1, TASP1
16222,608271,MICROTUBULE-ACTIN CROSS-LINKING FACTOR 1, MACF1
16223,608272,NEURAMINIDASE 1, NEU1
16224,608273,INTERLEUKIN 27, IL27
16225,608274,PROTEIN ARGININE METHYLTRANSFERASE 6, PRMT6
16226,608275,"SOLUTE CARRIER FAMILY 22 (ORGANIC CATION TRANSPORTER), MEMBER 15", SLC22A15
16227,608276,"SOLUTE CARRIER FAMILY 22 (ORGANIC CATION TRANSPORTER), MEMBER 16", SLC22A16
16228,608277,CARBOHYDRATE SULFOTRANSFERASE 15, CHST15
16229,608278,"GROWTH FAILURE, MICROCEPHALY, IMPAIRED INTELLECTUAL DEVELOPMENT, CATARACTS, LARGE JOINT CONTRACTURES, OSTEOPOROSIS, CORTICAL DYSPLASIA, AND CEREBELLAR ATROPHY",
16230,608279,CRANIOSYNOSTOSIS WITH OCULAR ABNORMALITIES AND HALLUCAL DEFECTS,
16231,608280,GROWTH ARREST-SPECIFIC 5, GAS5
16232,608281,"SCIMITAR ANOMALY, MULTIPLE CARDIAC MALFORMATIONS, AND CRANIOFACIAL AND CENTRAL NERVOUS SYSTEM ABNORMALITIES",
16233,608282,TRACE AMINE-ASSOCIATED RECEPTOR 9, TAAR9
16234,608283,KINESIN FAMILY MEMBER 21A, KIF21A
16235,608284,INTRAMEMBRANE PROTEASE 5,
16236,608285,NAD SYNTHETASE 1, NADSYN1
16237,608286,PROTOCADHERIN 10, PCDH10
16238,608287,PROTOCADHERIN 18, PCDH18
16239,608288,INSULIN-LIKE GROWTH FACTOR 2 mRNA-BINDING PROTEIN 1, IGF2BP1
16240,608289,INSULIN-LIKE GROWTH FACTOR 2 mRNA-BINDING PROTEIN 2, IGF2BP2
16241,608290,LELIS SYNDROME,
16242,608291,TUBULIN-TYROSINE LIGASE, TTL
16243,608292,STOMATIN-LIKE PROTEIN 2, STOML2
16244,608293,RHO GTPase-ACTIVATING PROTEIN 17, ARHGAP17
16245,608294,NME/NM23 NUCLEOSIDE DIPHOSPHATE KINASE 6, NME6
16246,608295,"FAMILY WITH SEQUENCE SIMILARITY 107, MEMBER A", FAM107A
16247,608296,"FIBROBLAST GROWTH FACTOR, ACIDIC, INTRACELLULAR BINDING PROTEIN", FIBP
16248,608297,TITLE NOT AVAILABLE AT THIS MOMENT,
16249,608298,COILED-COIL DOMAIN-CONTAINING PROTEIN 80, CCDS80
16250,608299,RING FINGER PROTEIN 34, RNF34
16251,608300,N-ACETYLGLUTAMATE SYNTHASE, NAGS
16252,608301,"LEUCINE-RICH GENE, GLIOMA-INACTIVATED, 2", LGI2
16253,608302,"LEUCINE-RICH GENE, GLIOMA-INACTIVATED, 3", LGI3
16254,608303,"LEUCINE-RICH GENE, GLIOMA-INACTIVATED, 4", LGI4
16255,608304,CANCER/TESTIS ANTIGEN 3, CTAG3
16256,608305,"SOLUTE CARRIER FAMILY 13 (SODIUM-DEPENDENT CITRATE TRANSPORTER), MEMBER 5", SLC13A5
16257,608306,TRANSCRIPTION FACTOR Sp8, SP8
16258,608307,CARBAMOYL PHOSPHATE SYNTHETASE I, CPS1
16259,608308,ANKYRIN REPEAT- AND BTB DOMAIN-CONTAINING PROTEIN 1, ABTB1
16260,608309,PTEN-INDUCED KINASE 1, PINK1
16261,608310,ARGININOSUCCINATE LYASE, ASL
16262,608311,"GLUTAMATE RECEPTOR, IONOTROPIC, N-METHYL D-ASPARTATE-LIKE 1B", GRINL1B
16263,608312,"POLYMERASE I, RNA, SUBUNIT F", POLR1F
16264,608313,ARGINASE 1, ARG1
16265,608314,SEPTIN 3, SEPT3
16266,608315,ELL-ASSOCIATED FACTOR 1, EAF1
16267,608316,"CORONARY HEART DISEASE, SUSCEPTIBILITY TO, 2",
16268,608317,GRAINYHEAD-LIKE 3, GRHL3
16269,608318,"CORONARY HEART DISEASE, SUSCEPTIBILITY TO, 4",
16270,608319,"SOLUTE CARRIER FAMILY 45, MEMBER 3",
16271,608320,"CORONARY ARTERY DISEASE, AUTOSOMAL DOMINANT, 1", ADCAD1
16272,608321,TIR DOMAIN-CONTAINING ADAPTOR MOLECULE 2, TICAM2
16273,608322,KINESIN FAMILY MEMBER 21B, KIF21B
16274,608323,"CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE C", CMTDIC
16275,608324,SMALL INTEGRAL MEMBRANE PROTEIN 3, SMIM3
16276,608325,PHD FINGER PROTEIN 21A, PHF21A
16277,608326,STOMATIN-LIKE PROTEIN 1, STOML1
16278,608327,STOMATIN-LIKE PROTEIN 3, STOML3
16279,608328,WEILL-MARCHESANI SYNDROME 2, WMS2
16280,608329,MYELIN REGULATORY FACTOR, MYRF
16281,608330,PRE-mRNA-PROCESSING FACTOR 19, PRPF19
16282,608331,"SOLUTE CARRIER FAMILY 36 (PROTON/AMINO ACID SYMPORTER), MEMBER 2", SLC36A2
16283,608332,"SOLUTE CARRIER FAMILY 36 (PROTON/AMINO ACID SYMPORTER), MEMBER 3", SLC36A3
16284,608333,DOCKING PROTEIN 4, DOK4
16285,608334,DOCKING PROTEIN 5, DOK5
16286,608335,"PLECKSTRIN HOMOLOGY DOMAIN-CONTAINING PROTEIN, FAMILY O, MEMBER 1", PLEKHO1
16287,608336,"TRANSMEMBRANE PROTEIN, ADIPOCYTE-ASSOCIATED 1", TPRA1
16288,608337,OTU DOMAIN-CONTAINING UBIQUITIN ALDEHYDE-BINDING PROTEIN 1, OTUB1
16289,608338,OTU DOMAIN-CONTAINING UBIQUITIN ALDEHYDE-BINDING PROTEIN 2, OTUB2
16290,608339,SYNTAXIN-BINDING PROTEIN 3, STXBP3
16291,608340,"CHARCOT-MARIE-TOOTH DISEASE, RECESSIVE INTERMEDIATE A", CMTRIA
16292,608341,CYTOCHROME b5 REDUCTASE 1, CYB5R1
16293,608342,CYTOCHROME b5 REDUCTASE 2, CYB5R2
16294,608343,CYTOCHROME b5 REDUCTASE 4, CYB5R4
16295,608344,HEAT-SHOCK 27-KD PROTEIN 9, HSPB9
16296,608345,"NYSTAGMUS 3, CONGENITAL, AUTOSOMAL DOMINANT", NYS3
16297,608346,"MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 1",
16298,608347,DICARBONYL/L-XYLULOSE REDUCTASE, DCXR
16299,608348,"BRANCHED-CHAIN KETO ACID DEHYDROGENASE E1, ALPHA POLYPEPTIDE", BCKDHA
16300,608349,HEMATOPOIETIC SH2 DOMAIN-CONTAINING PROTEIN, HSH2D
16301,608350,ENDOMUCIN, EMCN
16302,608351,"IMMUNOGLOBULIN SUPERFAMILY, MEMBER 11", IGSF11
16303,608352,ACROSIN-BINDING PROTEIN, ACRBP
16304,608353,ANTIZYME INHIBITOR 2, AZIN2
16305,608354,CAPILLARY MALFORMATION-ARTERIOVENOUS MALFORMATION 1, CMAVM1
16306,608355,CAPILLARY MALFORMATION-ARTERIOVENOUS MALFORMATION 1,
16307,608356,OUTER DENSE FIBER OF SPERM TAILS 3, ODF3
16308,608357,"SULFOTRANSFERASE FAMILY 1C, MEMBER 4", SULT1C4
16309,608358,"CONGENITAL MYOPATHY 7A, MYOSIN STORAGE, AUTOSOMAL DOMINANT", CMYO7A
16310,608359,"SULFOTRANSFERASE FAMILY 4A, MEMBER 1", SULT4A1
16311,608360,LEUCINE-RICH REPEAT-CONTAINING PROTEIN 8A, LRRC8A
16312,608361,"SPONDYLOEPIPHYSEAL DYSPLASIA, KIMBERLEY TYPE", SEDK
16313,608362,STATHMIN-LIKE 3, STMN3
16314,608363,CHROMOSOME 22q11.2 DUPLICATION SYNDROME,
16315,608364,LIM DOMAIN AND ACTIN-BINDING PROTEIN 1, LIMA1
16316,608365,T-COMPLEX PROTEIN 10-LIKE, TCP10L
16317,608366,CELL MIGRATION-INDUCING HYALURONIDASE 1, CEMIP
16318,608367,"MYOPIA 17, AUTOSOMAL DOMINANT", MYP17
16319,608368,RAD9 CHECKPOINT CLAMP COMPONENT B, RAD9B
16320,608369,UDP-N-ACETYL-ALPHA-D-GALACTOSAMINE:POLYPEPTIDE N-ACETYLGALACTOSAMINYLTRANSFERASE 13, GALNT13
16321,608370,STEAROYL-CoA DESATURASE 5, SCD5
16322,608371,OROFACIAL CLEFT 4, OFC4
16323,608372,"DEAFNESS, AUTOSOMAL DOMINANT 49", DFNA49
16324,608373,SYNAPTOGYRIN 4, SYNGR4
16325,608374,HEMOJUVELIN BMP CORECEPTOR, HJV
16326,608375,"DNAJ/HSP40 HOMOLOG, SUBFAMILY C, MEMBER 6", DNAJC6
16327,608376,"DNAJ/HSP40 HOMOLOG, SUBFAMILY B, MEMBER 12", DNAJB12
16328,608377,ADP-RIBOSYLATION FACTOR GTPase-ACTIVATING PROTEIN 1, ARFGAP1
16329,608378,NUCLEAR EXPORT MEDIATOR FACTOR, NEMF
16330,608379,"CHEMOKINE, CC MOTIF, RECEPTOR-LIKE PROTEIN 2", CCRL2
16331,608380,RETINITIS PIGMENTOSA 26, RP26
16332,608381,CERAMIDE KINASE-LIKE, CERKL
16333,608382,"DNAJ/HSP40 HOMOLOG, SUBFAMILY A, MEMBER 3", DNAJA3
16334,608383,DIHYDROPYRIMIDINASE-LIKE 5, DPYSL5
16335,608384,GASDERMIN C, GSDMC
16336,608385,TENSIN 4, TNS4
16337,608386,PARATHYROID HORMONE 2, PTH2
16338,608387,ZINC FINGER PROTEIN 213, ZNF213
16339,608388,ECSIT SIGNALING INTEGRATOR, ECSIT
16340,608389,BRANCHIOOTIC SYNDROME 3, BOS3
16341,608390,"MYOTONIA, POTASSIUM-AGGRAVATED",
16342,608391,"AUTOIMMUNE DISEASE, SUSCEPTIBILITY TO, 2", AIS2
16343,608392,"AUTOIMMUNE DISEASE, SUSCEPTIBILITY TO, 3", AIS3
16344,608393,"MICROCEPHALY 6, PRIMARY, AUTOSOMAL RECESSIVE", MCPH6
16345,608394,"DEAFNESS, AUTOSOMAL DOMINANT 43", DFNA43
16346,608395,NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2B,
16347,608396,"SOLUTE CARRIER FAMILY 9 (SODIUM/HYDROGEN EXCHANGER), MEMBER 9", SLC9A9
16348,608397,CUB AND SUSHI MULTIPLE DOMAINS 1, CSMD1
16349,608398,CUB AND SUSHI MULTIPLE DOMAINS 2, CSMD2
16350,608399,CUB AND SUSHI MULTIPLE DOMAINS 3, CSMD3
16351,608400,USHERIN, USH2A
16352,608401,"MEMBRANE-SPANNING 4-DOMAINS, SUBFAMILY A, MEMBER 4E", MS4A4E
16353,608402,"MEMBRANE-SPANNING 4-DOMAINS, SUBFAMILY A, MEMBER 6E", MS4A6E
16354,608403,"MEMBRANE-SPANNING 4-DOMAINS, SUBFAMILY A, MEMBER 10", MS4A10
16355,608404,PLATELET GLYCOPROTEIN IV DEFICIENCY,
16356,608405,1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYNTHASE, ACCS
16357,608406,"VATER-LIKE DEFECTS WITH PULMONARY HYPERTENSION, LARYNGEAL WEBS, AND GROWTH DEFICIENCY",
16358,608407,DIHYDROPYRIMIDINASE-LIKE 4, DPYSL4
16359,608408,DEVELOPMENTAL PLURIPOTENCY-ASSOCIATED GENE 3, DPPA3
16360,608409,CHROMOSOME 15 OPEN READING FRAME 48, C15ORF48
16361,608410,BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 7, BMIQ7
16362,608411,EXPORTIN 6, XPO6
16363,608412,GC-RICH PROMOTER-BINDING PROTEIN 1, GPBP1
16364,608413,UBIQUITIN-PROTEIN LIGASE E3 COMPONENT N-RECOGNIN 5, UBR5
16365,608414,"PHOSPHOLIPASE C, EPSILON-1", PLCE1
16366,608415,PROLONGED ELECTRORETINAL RESPONSE SUPPRESSION 1, PERRS1
16367,608416,MATRIX METALLOPROTEINASE 21, MMP21
16368,608417,MATRIX METALLOPROTEINASE 28, MMP28
16369,608418,SEPTIN 8, SEPT8
16370,608419,METHYLMALONYL-CoA EPIMERASE, MCEE
16371,608420,PANNEXIN 1, PANX1
16372,608421,PANNEXIN 2, PANX2
16373,608422,PANNEXIN 3, PANX3
16374,608423,"MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL DOMINANT 2", LGMDD2
16375,608424,MUCIN 17, MUC17
16376,608425,FRUCTOSAMINE 3-KINASE,
16377,608426,MAKORIN 2, MKRN2
16378,608427,PARKIN COREGULATED GENE, PACRG
16379,608428,"CYTOCHROME P450, SUBFAMILY XXVIC, POLYPEPTIDE 1", CYP26C1
16380,608429,CARBOHYDRATE SULFOTRANSFERASE 14, CHST14
16381,608430,TRPC4-ASSOCIATED PROTEIN, TRPC4AP
16382,608431,G3BP STRESS GRANULE ASSEMBLY FACTOR 1, G3BP1
16383,608432,"CRANIOSYNOSTOSIS, CALCIFICATION OF BASAL GANGLIA, AND FACIAL DYSMORPHISM",
16384,608433,ZINC FINGER- AND BTB DOMAIN-CONTAINING PROTEIN 18, ZBTB18
16385,608434,GIT ArfGAP 1, GIT1
16386,608435,MUSCLE RAS VIRAL ONCOGENE HOMOLOG, MRAS
16387,608436,"SULFOTRANSFERASE FAMILY 1B, MEMBER 1", SULT1B1
16388,608437,"SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 4", SLEB4
16389,608438,TOUSLED-LIKE KINASE 1, TLK1
16390,608439,TOUSLED-LIKE KINASE 2, TLK2
16391,608440,"LACTAMASE, BETA", LACTB
16392,608441,SPECTRIN REPEAT-CONTAINING NUCLEAR ENVELOPE PROTEIN 1, SYNE1
16393,608442,SPECTRIN REPEAT-CONTAINING NUCLEAR ENVELOPE PROTEIN 2, SYNE2
16394,608443,"INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 3", MRT3
16395,608444,LYSINE-SPECIFIC METHYLTRANSFERASE 2E, KMT2E
16396,608445,SPEECH-SOUND DISORDER,
16397,608446,"MYOCARDIAL INFARCTION, SUSCEPTIBILITY TO",
16398,608447,CAROTID INTIMAL MEDIAL THICKNESS 2, IMT2
16399,608448,INFLAMMATORY BOWEL DISEASE 9, IBD9
16400,608449,POLYPYRIMIDINE TRACT-BINDING PROTEIN 2, PTBP2
16401,608450,B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA-EXPRESSED GENE, BLACE
16402,608451,ETHE1 PERSULFIDE DIOXYGENASE, ETHE1
16403,608452,PLATELET-DERIVED GROWTH FACTOR C, PDGFC
16404,608453,CAS-BR-M MURINE ECOTROPIC RETROVIRAL TRANSFORMING SEQUENCE C, CBLC
16405,608454,KNOBLOCH SYNDROME 1,
16406,608455,"GLYCOGEN PHOSPHORYLASE, MUSCLE", PYGM
16407,608456,FAMILIAL ADENOMATOUS POLYPOSIS 2, FAP2
16408,608457,CHROMOBOX 7, CBX7
16409,608458,NEUROCHONDRIN, NCDN
16410,608459,CYCLIN-DEPENDENT KINASE-LIKE 3, CDKL3
16411,608460,ZINC FINGER PROTEIN 276, ZFP276
16412,608461,"COLLAGEN, TYPE XXVII, ALPHA-1", COL27A1
16413,608462,"HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 8", HSCR8
16414,608463,APOPTOSIS-ANTAGONIZING TRANSCRIPTION FACTOR, AATF
16415,608464,ANGIOGENIC FACTOR WITH G-PATCH AND FHA DOMAINS 1, AGGF1
16416,608465,SENATAXIN, SETX
16417,608466,ACTIVATOR OF HEAT-SHOCK 90-KD PROTEIN ATPase 1, AHSA1
16418,608467,STONIN 2, STON2
16419,608468,NOCTURNIN, NOCT
16420,608469,DEAD-BOX HELICASE 17, DDX17
16421,608470,"CORNEAL DYSTROPHY, REIS-BUCKLERS TYPE", CDRB
16422,608471,"CORNEAL DYSTROPHY, LATTICE TYPE IIIA", CDL3A
16423,608472,"ST6 BETA-GALACTOSAMIDE ALPHA-2,6-SIALYLTRANSFERASE 2", ST6GAL2
16424,608473,"ANAPHASE-PROMOTING COMPLEX, SUBUNIT 1", ANAPC1
16425,608474,"MYOPIA 5, AUTOSOMAL DOMINANT", MYP5
16426,608475,3-HYDROXYISOBUTYRATE DEHYDROGENASE, HIBADH
16427,608476,TBK1-BINDING PROTEIN 1, TBKBP1
16428,608477,"ALDO-KETO REDUCTASE FAMILY 7, MEMBER A3", AKR7A3
16429,608478,"ALDO-KETO REDUCTASE FAMILY 7, MEMBER A4",
16430,608479,"SOLUTE CARRIER FAMILY 26 (SULFATE TRANSPORTER), MEMBER 7", SLC26A7
16431,608480,"SOLUTE CARRIER FAMILY 26 (SULFATE TRANSPORTER), MEMBER 8", SLC26A8
16432,608481,"SOLUTE CARRIER FAMILY 26 (SULFATE TRANSPORTER), MEMBER 9", SLC26A9
16433,608482,MATRIX METALLOPROTEINASE 25, MMP25
16434,608483,AKT-INTERACTING PROTEIN, AKTIP
16435,608484,"CONGENITAL CORNEAL OPACITIES, CORNEA GUTTATA, AND CORECTOPIA",
16436,608485,TRANSLOCATION-ASSOCIATED MEMBRANE PROTEIN 2, TRAM2
16437,608486,MTTS I-BAR DOMAIN-CONTAINING PROTEIN 1, MTSS1
16438,608487,TRIPARTITE MOTIF-CONTAINING PROTEIN 5, TRIM5
16439,608488,SPARC-RELATED MODULAR CALCIUM-BINDING PROTEIN 1, SMOC1
16440,608489,STROMAL ANTIGEN 3, STAG3
16441,608490,"SOLUTE CARRIER FAMILY 38 (AMINO ACID TRANSPORTER), MEMBER 1", SLC38A1
16442,608491,CYCLIN D-BINDING MYB-LIKE TRANSCRIPTION FACTOR 1, DMTF1
16443,608492,"OLFACTORY RECEPTOR, FAMILY 5, SUBFAMILY F, MEMBER 1", OR5F1
16444,608493,"OLFACTORY RECEPTOR, FAMILY 10, SUBFAMILY A, MEMBER 1", OR10A1
16445,608494,"OLFACTORY RECEPTOR, FAMILY 2, SUBFAMILY D, MEMBER 2", OR2D2
16446,608495,"OLFACTORY RECEPTOR, FAMILY 6, SUBFAMILY A, MEMBER 2", OR6A2
16447,608496,"OLFACTORY RECEPTOR, FAMILY 5, SUBFAMILY I, MEMBER 1", OR5I1
16448,608497,"OLFACTORY RECEPTOR, FAMILY 2, SUBFAMILY F, MEMBER 1", OR2F1
16449,608498,ZONA PELLUCIDA-BINDING PROTEIN, ZPBP
16450,608499,ZONA PELLUCIDA-BINDING PROTEIN 2, ZPBP2
16451,608500,PRICKLE PLANAR CELL POLARITY PROTEIN 1, PRICKLE1
16452,608501,"PRICKLE, PLANAR CELL POLARITY PROTEIN 2", PRICKLE2
16453,608502,POLY(rC)-BINDING PROTEIN 3, PCBP3
16454,608503,POLY(rC)-BINDING PROTEIN 4, PCBP4
16455,608504,RHO GUANINE NUCLEOTIDE EXCHANGE FACTOR 15, ARHGEF15
16456,608505,AICARDI-GOUTIERES SYNDROME 1,
16457,608506,MITOFUSIN 1, MFN1
16458,608507,MITOFUSIN 2, MFN2
16459,608508,"CYTOCHROME b(-245), ALPHA SUBUNIT", CYBA
16460,608509,"ALOPECIA UNIVERSALIS CONGENITA, XY GONADAL DYSGENESIS, AND LARYNGOMALACIA",
16461,608510,SH2 DOMAIN-CONTAINING 1B, SH2D1B
16462,608511,PHYTANOYL-CoA HYDROXYLASE-INTERACTING PROTEIN, PHYHIP
16463,608512,NEUTROPHIL CYTOSOLIC FACTOR 1, NCF1
16464,608513,"RIBONUCLEASE P, RNA COMPONENT H1", RPPH1
16465,608514,ANDROGEN-INDUCED GENE 1, AIG1
16466,608515,NEUTROPHIL CYTOSOLIC FACTOR 2, NCF2
16467,608516,MAJOR DEPRESSIVE DISORDER, MDD
16468,608517,MYOPALLADIN, MYPN
16469,608518,OROFACIODIGITAL SYNDROME VII, OFD7
16470,608519,F-BOX ONLY PROTEIN 16, FBXO16
16471,608520,MAJOR DEPRESSIVE DISORDER 1,
16472,608521,"LATE ENDOSOMAL/LYSOSOMAL ADAPTOR, MITOGEN-ACTIVATED PROTEIN KINASE AND MAMMALIAN TARGET OF RAPAMYCIN ACTIVATOR 5", LAMTOR5
16473,608522,HEPATITIS B VIRUS X-ASSOCIATED PROTEIN, HBXAP
16474,608523,"DIO3, OPPOSITE STRAND", DIO3OS
16475,608524,INHIBITOR OF GROWTH 4, ING4
16476,608525,INHIBITOR OF GROWTH 5, ING5
16477,608526,"PERIODONTITIS, AGGRESSIVE, 2",
16478,608527,NEURAMINIDASE 4, NEU4
16479,608528,PHOSPHATIDYLINOSITOL GLYCAN ANCHOR BIOSYNTHESIS CLASS U PROTEIN, PIGU
16480,608529,FIBRILLIN 3, FBN3
16481,608530,BTB/POZ DOMAIN-CONTAINING PROTEIN 1, BTBD1
16482,608531,BTB/POZ DOMAIN-CONTAINING PROTEIN 2, BTBD2
16483,608532,NON-SMC CONDENSIN II COMPLEX SUBUNIT G2, NCAPG2
16484,608533,F-BOX ONLY PROTEIN 38, FBXO38
16485,608534,ACTIN-RELATED PROTEIN M1,
16486,608535,ACTIN-RELATED PROTEIN T2, ACTRT2
16487,608536,GTP-BINDING PROTEIN 3, GTPBP3
16488,608537,VON HIPPEL-LINDAU TUMOR SUPPRESSOR, VHL
16489,608538,AT-RICH INTERACTION DOMAIN-CONTAINING PROTEIN 5B, ARID5B
16490,608539,GLIS FAMILY ZINC FINGER PROTEIN 2, GLIS2
16491,608540,"CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ik", CDG1K
16492,608541,RHO GTPase-ACTIVATING PROTEIN 32, ARHGAP32
16493,608542,"ANEURYSM, INTRACRANIAL BERRY, 2", ANIB2
16494,608543,SCHIZOPHRENIA 12,
16495,608544,HISTONE DEACETYLASE 10, HDAC10
16496,608545,LARSEN-LIKE SYNDROME,
16497,608546,"EUKARYOTIC TRANSLATION INITIATION FACTOR 4A, ISOFORM 3", EIF4A3
16498,608547,"VITAMIN K EPOXIDE REDUCTASE COMPLEX, SUBUNIT 1", VKORC1
16499,608548,HEMICENTIN, HMCN1
16500,608549,VPS11 CORE SUBUNIT OF CORVET AND HOPS COMPLEXES, VPS11
16501,608550,VPS16 CORE SUBUNIT OF CORVET AND HOPS COMPLEXES, VPS16
16502,608551,VPS18 CORE SUBUNIT OF CORVET AND HOPS COMPLEXES, VPS18
16503,608552,VPS33B LATE ENDOSOME AND LYSOSOME ASSOCIATED, VPS33B
16504,608553,LEBER CONGENITAL AMAUROSIS 9, LCA9
16505,608554,NEURONAL PAS DOMAIN PROTEIN 4, NPAS4
16506,608555,METAXIN 2, MTX2
16507,608556,"LEGIONNAIRE DISEASE, SUSCEPTIBILITY TO",
16508,608557,"MYOCARDIAL INFARCTION, SUSCEPTIBILITY TO, 2",
16509,608558,BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 5, BMIQ5
16510,608559,BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 6, BMIQ6
16511,608560,STABILIN 1, STAB1
16512,608561,STABILIN 2, STAB2
16513,608562,"POLYDACTYLY, POSTAXIAL, TYPE A4",
16514,608563,"AMELOGENESIS IMPERFECTA, TYPE IC",
16515,608564,GIT ArfGAP 2, GIT2
16516,608565,"DEAFNESS, AUTOSOMAL RECESSIVE 35", DFNB35
16517,608566,"MUCIN 15, TRANSMEMBRANE", MUC15
16518,608567,SICK SINUS SYNDROME 1, SSS1
16519,608568,"MYOSIN, HEAVY CHAIN 14, NONMUSCLE", MYH14
16520,608569,"CARDIOMYOPATHY, DILATED, 1O", CMD1O
16521,608570,AHNAK NUCLEOPROTEIN 2, AHNAK2
16522,608571,ULNAR/FIBULAR RAY DEFECT AND BRACHYDACTYLY,
16523,608572,BURN-MCKEOWN SYNDROME, BMKS
16524,608573,ANOCTAMIN 7,
16525,608574,"EMSY TRANSCRIPTIONAL REPRESSOR, BRCA2 INTERACTING", EMSY
16526,608575,RETINOL DEHYDROGENASE 8, RDH8
16527,608576,GRAINYHEAD-LIKE 2, GRHL2
16528,608577,CHURCHILL DOMAIN-CONTAINING 1, CHURC1
16529,608578,BARAITSER-WINTER SYNDROME 1,
16530,608579,"SEVERE CUTANEOUS ADVERSE REACTION, SUSCEPTIBILITY TO",
16531,608580,"MYOSIN, HEAVY CHAIN 16, SKELETAL MUSCLE, PSEUDOGENE", MYH16
16532,608581,RP1-LIKE PROTEIN 1, RP1L1
16533,608582,EPIDERMAL GROWTH FACTOR-LIKE 7, EGFL7
16534,608583,"ATRIAL FIBRILLATION, FAMILIAL, 1", ATFB1
16535,608584,"ASTHMA-RELATED TRAITS, SUSCEPTIBILITY TO, 2",
16536,608585,"BRACHIAL PALSY, FAMILIAL CONGENITAL",
16537,608586,KERATOCONUS 3, KTCN3
16538,608587,GH3 DOMAIN-CONTAINING PROTEIN, GHDC
16539,608588,DExH-BOX HELICASE 58, DHX58
16540,608589,"SLAM FAMILY, MEMBER 9", SLAMF9
16541,608590,"CONGENITAL MYOPATHY 7A, MYOSIN STORAGE, AUTOSOMAL DOMINANT",
16542,608591,"CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2P",
16543,608592,CTD SMALL PHOSPHATASE-LIKE, CTDSPL
16544,608593,COMPLEMENT FACTOR H-RELATED 5, CFHR5
16545,608594,"LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 1", CGL1
16546,608595,NEUROPEPTIDE S RECEPTOR 1, NPSR1
16547,608596,NPSR1 ANTISENSE RNA 1, NPSRAS1
16548,608597,NEURALIZED E3 UBIQUITIN PROTEIN LIGASE 2, NEURL2
16549,608598,CANCER SUSCEPTIBILITY CANDIDATE 2, CASC2
16550,608599,RAB11 FAMILY-INTERACTING PROTEIN 2, RAB11FIP2
16551,608600,"LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 1", FPLD1
16552,608601,FIBROSIN 1, FBS1
16553,608602,NUCLEAR BODY PROTEIN SP140, SP140
16554,608603,GLIOMEDIN, GLDN
16555,608604,RETINOL-BINDING PROTEIN 7, RBP7
16556,608605,"OLIGOSACCHARYLTRANSFERASE COMPLEX, CATALYTIC SUBUNIT STT3B", STT3B
16557,608606,"BASIC HELIX-LOOP-HELIX FAMILY, MEMBER A15", BHLHA15
16558,608607,"NEUROBLASTOMA BREAKPOINT FAMILY, MEMBER 12", NBPF12
16559,608608,PEPTIDYL-PROLYL ISOMERASE A-LIKE PROTEIN 4E, PPIAL4E
16560,608609,CHROMOSOME 1 OPEN READING FRAME 152, C1ORF152
16561,608610,PROGRAMMED CELL DEATH 4, PDCD4
16562,608611,RIBOSE 5-PHOSPHATE ISOMERASE DEFICIENCY, RPIAD
16563,608612,MANDIBULOACRAL DYSPLASIA WITH TYPE B LIPODYSTROPHY, MADB
16564,608613,TRANSCRIPTION FACTOR Sp6, SP6
16565,608614,"CYTOCHROME P450, FAMILY 4, SUBFAMILY V, POLYPEPTIDE 2", CYP4V2
16566,608615,OLIGODONTIA-COLORECTAL CANCER SYNDROME, ODCRCS
16567,608616,OBSCURIN, OBSCN
16568,608617,"FAMILY WITH SEQUENCE SIMILARITY 3, MEMBER B", FAM3B
16569,608618,"FAMILY WITH SEQUENCE SIMILARITY 3, MEMBER C", FAM3C
16570,608619,"FAMILY WITH SEQUENCE SIMILARITY 3, MEMBER D", FAM3D
16571,608620,"PROTEIN KINASE, LYSINE-DEFICIENT 1",
16572,608621,SPERM AUTOANTIGENIC PROTEIN 17, SPA17
16573,608622,"HYPERTENSION, DIASTOLIC, RESISTANCE TO",
16574,608623,MISMATCH REPAIR CANCER SYNDROME 1,
16575,608624,"MIDFACE HYPOPLASIA, OBESITY, DEVELOPMENTAL DELAY, AND NEONATAL HYPOTONIA",
16576,608625,PEPTIDYL-tRNA HYDROLASE 2, PTRH2
16577,608626,STE20-RELATED KINASE ADAPTOR ALPHA, STRADA
16578,608627,AMYOTROPHIC LATERAL SCLEROSIS 8, ALS8
16579,608628,TRANSDUCIN-BETA-LIKE 1 RECEPTOR 1, TBL1XR1
16580,608629,JOUBERT SYNDROME 3, JBTS3
16581,608630,ROUNDABOUT GUIDANCE RECEPTOR 3, ROBO3
16582,608631,"ASPERGER SYNDROME, SUSCEPTIBILITY TO, 2", ASPG2
16583,608632,MICRO RNA 196A1, MIR196A1
16584,608633,"CASPASE 12, APOPTOSIS-RELATED CYSTEINE PROTEASE", CASP12
16585,608634,"NEURONOPATHY, DISTAL HEREDITARY MOTOR, AUTOSOMAL DOMINANT 3", HMND3
16586,608635,ARFGAP WITH DUAL PLECKSTRIN HOMOLOGY DOMAINS 2, ADAP2
16587,608636,CHROMOSOME 15q11-q13 DUPLICATION SYNDROME,
16588,608637,SPONDYLOEPIPHYSEAL DYSPLASIA WITH CONGENITAL JOINT DISLOCATIONS,
16589,608638,"ASPERGER SYNDROME, SUSCEPTIBILITY TO, 1", ASPG1
16590,608639,"PLECKSTRIN HOMOLOGY DOMAIN-CONTAINING PROTEIN, FAMILY A, MEMBER 8", PLEKHA8
16591,608640,ZINC FINGER PROTEIN 461, ZNF461
16592,608641,"DEAFNESS, AUTOSOMAL DOMINANT 28", DFNA28
16593,608642,ZINC-BINDING ALCOHOL DEHYDROGENASE DOMAIN-CONTAINING PROTEIN 1, ZADH1
16594,608643,AROMATIC L-AMINO ACID DECARBOXYLASE DEFICIENCY, AADCD
16595,608644,"CILIARY DYSKINESIA, PRIMARY, 3", CILD3
16596,608645,"DEAFNESS, AUTOSOMAL DOMINANT 31", DFNA31
16597,608646,"CILIARY DYSKINESIA, PRIMARY, 4", CILD4
16598,608647,"CILIARY DYSKINESIA, PRIMARY, 5", CILD5
16599,608648,"SEC63 HOMOLOG, PROTEIN TRANSLOCATION REGULATOR", SEC63
16600,608649,ICHTHYOSIS PREMATURITY SYNDROME, IPS
16601,608650,UNC51-LIKE AUTOPHAGY-ACTIVATING KINASE 2, ULK2
16602,608651,"ARF GTPase-ACTIVATING PROTEIN WITH GTPase DOMAIN, ANKYRIN REPEAT, AND PLECKSTRIN HOMOLOGY DOMAIN 1", AGAP1
16603,608652,"DEAFNESS, AUTOSOMAL DOMINANT 47", DFNA47
16604,608653,"DEAFNESS, AUTOSOMAL RECESSIVE 32, WITH OR WITHOUT IMMOTILE SPERM", DFNB32
16605,608654,"NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE V", HSAN5
16606,608655,"GAP JUNCTION PROTEIN, GAMMA-1", GJC1
16607,608656,"PROSTATE CANCER, HEREDITARY, 3",
16608,608657,JUN DIMERIZATION PROTEIN 2, JDP2
16609,608658,"PROSTATE CANCER, HEREDITARY, 4",
16610,608659,"SENTRIN-SPECIFIC PROTEASE FAMILY, MEMBER 8", SENP8
16611,608660,INSULIN-INDUCED GENE 2, INSIG2
16612,608661,PODOCAN, PODN
16613,608662,ANOCTAMIN 5, ANO5
16614,608663,ANOCTAMIN 6, ANO6
16615,608664,SECKEL SYNDROME 1,
16616,608665,PSMC3-INTERACTING PROTEIN, PSMC3IP
16617,608666,PEROXISOME BIOGENESIS FACTOR 26, PEX26
16618,608667,NIPPED-B-LIKE, NIPBL
16619,608668,ZINC FINGER MYND DOMAIN-CONTAINING PROTEIN 11, ZMYND11
16620,608669,BASONUCLIN 2, BNC2
16621,608670,ROBIN SEQUENCE WITH DISTINCTIVE FACIAL APPEARANCE AND BRACHYDACTYLY,
16622,608671,DAZ-INTERACTING ZINC FINGER PROTEIN 1, DZIP1
16623,608672,DAZ-INTERACTING ZINC FINGER PROTEIN 3, DZIP3
16624,608673,"CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2L", CMT2L
16625,608674,SH3 DOMAIN PROTEIN 19,
16626,608675,FUCOSE KINASE, FCSK
16627,608676,"TAXILIN, ALPHA", TXLNA
16628,608677,MINDBOMB E3 UBIQUITIN PROTEIN LIGASE 1, MIB1
16629,608678,INTERLEUKIN 33, IL33
16630,608679,TP53-REGULATING KINASE, TP53RK
16631,608680,TP53RK-BINDING PROTEIN, TPRKB
16632,608681,"SPONDYLOCOSTAL DYSOSTOSIS 2, AUTOSOMAL RECESSIVE", SCDO2
16633,608682,ADRENOMEDULLIN 2, ADM2
16634,608683,CYSTATIN 8, CST8
16635,608684,NINEIN, NIN
16636,608685,STRUCTURAL MAINTENANCE OF CHROMOSOMES 1B, SMC1B
16637,608686,RAB3A-INTERACTING PROTEIN, RAB3IP
16638,608687,SPINOCEREBELLAR ATAXIA 20, SCA20
16639,608688,AICA-RIBOSIDURIA DUE TO ATIC DEFICIENCY,
16640,608689,MESODERM POSTERIOR BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTOR 1, MESP1
16641,608690,SSX2-INTERACTING PROTEIN, SSX2IP
16642,608691,MAJOR DEPRESSIVE DISORDER 2,
16643,608692,BASIC LEUCINE ZIPPER NUCLEAR FACTOR 1, BLZF1
16644,608693,GOLGI REASSEMBLY STACKING PROTEIN 2, GORASP2
16645,608694,ZINC FINGER PROTEIN 622, ZNF622
16646,608695,"GLAUCOMA 1, OPEN ANGLE, J", GLC1J
16647,608696,"GLAUCOMA 1, OPEN ANGLE, K", GLC1K
16648,608697,FOLLICULOGENESIS-SPECIFIC bHLH TRANSCRIPTION FACTOR, FIGLA
16649,608698,"DISCOIDIN, CUB, AND LCCL DOMAIN-CONTAINING PROTEIN 2", DCBLD2
16650,608699,BONE MORPHOGENETIC PROTEIN-BINDING ENDOTHELIAL REGULATOR PROTEIN, BMPER
16651,608700,NICOTINAMIDE NUCLEOTIDE ADENYLYLTRANSFERASE 1, NMNAT1
16652,608701,NICOTINAMIDE NUCLEOTIDE ADENYLYLTRANSFERASE 2, NMNAT2
16653,608702,NICOTINAMIDE NUCLEOTIDE ADENYLYLTRANSFERASE 3, NMNAT3
16654,608703,SPINOCEREBELLAR ATAXIA 25, SCA25
16655,608704,NICOTINAMIDE RIBOSIDE KINASE 1, NMRK1
16656,608705,"INTEGRIN, BETA-1, BINDING PROTEIN OF, 3", ITGB1BP3
16657,608706,"DYNEIN, AXONEMAL, ASSEMBLY FACTOR 4", DNAAF4
16658,608707,CELL ADHESION MOLECULE-RELATED/DOWNREGULATED BY ONCOGENES, CDON
16659,608708,BROTHER OF CDON, BOC
16660,608709,"LIPODYSTROPHY, PARTIAL, ACQUIRED, SUSCEPTIBILITY TO", APLD
16661,608710,GRANULOMATOSIS WITH POLYANGIITIS, GPA
16662,608711,CTD SMALL PHOSPHATASE 2, CTDSP2
16663,608712,"PROTEIN-TYROSINE PHOSPHATASE, RECEPTOR-TYPE, T", PTPRT
16664,608713,"CYTOCHROME P450, SUBFAMILY IIR, POLYPEPTIDE 1", CYP2R1
16665,608714,"SYNTROPHIN, GAMMA-1", SNTG1
16666,608715,"SYNTROPHIN, GAMMA-2", SNTG2
16667,608716,"MICROCEPHALY 5, PRIMARY, AUTOSOMAL RECESSIVE", MCPH5
16668,608717,"LECTIN, GALACTOSIDE-BINDING, SOLUBLE, 13", LGALS13
16669,608718,KERATIN-ASSOCIATED PROTEIN 13-1, KRTAP13-1
16670,608719,"TR4-ASSOCIATED PROTEIN, 16-KD",
16671,608720,"NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, ADULT-ONSET, WITH ANOSMIA",
16672,608721,CALCIUM/CALMODULIN-DEPENDENT PROTEIN KINASE II INHIBITOR 2, CAMK2N2
16673,608722,"CAPPING PROTEIN, ALPHA-3", CAPZA3
16674,608723,PHOSPHATASE AND ACTIN REGULATOR 1, PHACTR1
16675,608724,PHOSPHATASE AND ACTIN REGULATOR 2, PHACTR2
16676,608725,PHOSPHATASE AND ACTIN REGULATOR 3, PHACTR3
16677,608726,PHOSPHATASE AND ACTIN REGULATOR 4, PHACTR4
16678,608727,DET1 PARTNER OF COP1 E3 UBIQUITIN LIGASE, DET1
16679,608728,"SPONDYLOEPIMETAPHYSEAL DYSPLASIA, BOROCHOWITZ-CORMIER-DAIRE TYPE", SEMDBCD
16680,608729,ANGIOTENSIN II RECEPTOR-ASSOCIATED PROTEIN, AGTRAP
16681,608730,"SOLUTE CARRIER FAMILY 39 (ZINC TRANSPORTER), MEMBER 5", SLC39A5
16682,608731,"SOLUTE CARRIER FAMILY 39 (ZINC TRANSPORTER), MEMBER 6", SLC39A6
16683,608732,"SOLUTE CARRIER FAMILY 39 (ZINC TRANSPORTER), MEMBER 8", SLC39A8
16684,608733,"SOLUTE CARRIER FAMILY 39 (ZINC TRANSPORTER), MEMBER 10", SLC39A10
16685,608734,"SOLUTE CARRIER FAMILY 39 (ZINC TRANSPORTER), MEMBER 12", SLC39A12
16686,608735,"SOLUTE CARRIER FAMILY 39 (ZINC TRANSPORTER), MEMBER 13", SLC39A13
16687,608736,"SOLUTE CARRIER FAMILY 39 (ZINC TRANSPORTER), MEMBER 14", SLC39A14
16688,608737,RAB11 FAMILY-INTERACTING PROTEIN 1, RAB11FIP1
16689,608738,RAB11 FAMILY-INTERACTING PROTEIN 3, RAB11FIP3
16690,608739,EXORIBONUCLEASE 1, ERI1
16691,608740,NFAT ACTIVATING PROTEIN WITH ITAM MOTIF 1, NFAM1
16692,608741,SYNAPTOTAGMIN 11, SYT11
16693,608742,"HYPERTENSION, ESSENTIAL, SUSCEPTIBILITY TO, 4",
16694,608743,JUNCTIONAL SARCOPLASMIC RETICULUM PROTEIN 1, JSRP1
16695,608744,"SOLUTE CARRIER FAMILY 25 (MITOCHONDRIAL CARRIER, PHOSPHATE CARRIER), MEMBER 24", SLC25A24
16696,608745,"SOLUTE CARRIER FAMILY 25 (MITOCHONDRIAL CARRIER, PHOSPHATE CARRIER), MEMBER 25", SLC25A25
16697,608746,"SOLUTE CARRIER FAMILY 25 (MITOCHONDRIAL CARRIER, PHOSPHATE CARRIER), MEMBER 23", SLC25A23
16698,608747,INSULIN-LIKE GROWTH FACTOR I DEFICIENCY, IGF1D
16699,608748,BONE MORPHOGENETIC PROTEIN 10, BMP10
16700,608749,BROMODOMAIN-CONTAINING PROTEIN 4, BRD4
16701,608750,"ALG3 ALPHA-1,3-MANNOSYLTRANSFERASE", ALG3
16702,608751,"CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 8", CMH8
16703,608752,C1q- AND TUMOR NECROSIS FACTOR-RELATED PROTEIN 5, C1QTNF5
16704,608753,"tRNA SPLICING ENDONUCLEASE, SUBUNIT 2", TSEN2
16705,608754,"tRNA SPLICING ENDONUCLEASE, SUBUNIT 34", TSEN34
16706,608755,"tRNA SPLICING ENDONUCLEASE, SUBUNIT 54", TSEN54
16707,608756,"tRNA SPLICING ENDONUCLEASE, SUBUNIT 15", TSEN15
16708,608757,CLEAVAGE FACTOR POLYNUCLEOTIDE KINASE SUBUNIT 1, CLP1
16709,608758,"CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 10", CMH10
16710,608759,CYTOGLOBIN, CYGB
16711,608760,AUTOPHAGY-RELATED 7, ATG7
16712,608761,"SOLUTE CARRIER FAMILY 5 (CHOLINE TRANSPORTER), MEMBER 7", SLC5A7
16713,608762,"EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 3", EIG3
16714,608763,"EHLERS-DANLOS SYNDROME, BEASLEY-COHEN TYPE",
16715,608764,NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE, NAMPT
16716,608765,"SCOLIOSIS, ISOLATED, SUSCEPTIBILITY TO, 3", IS3
16717,608766,LOW DENSITY LIPOPROTEIN RECEPTOR-RELATED PROTEIN 1B, LRP1B
16718,608767,FEM1 HOMOLOG C, FEM1C
16719,608768,SPINOCEREBELLAR ATAXIA 8, SCA8
16720,608769,"PYRUVATE DEHYDROGENASE COMPLEX, COMPONENT X", PDHX
16721,608770,DIHYDROLIPOAMIDE S-ACETYLTRANSFERASE, DLAT
16722,608771,MEDIATOR COMPLEX SUBUNIT 13-LIKE, MED13L
16723,608772,"INVASION INHIBITORY PROTEIN, 45-KD",
16724,608773,TUBULIN POLYMERIZATION-PROMOTING PROTEIN, TPPP
16725,608774,ANKYRIN REPEAT- AND KINASE DOMAIN-CONTAINING PROTEIN 1, ANKK1
16726,608775,"HAUS AUGMIN-LIKE COMPLEX, SUBUNIT 1", HAUS1
16727,608776,"CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Il", CDG1L
16728,608777,PERIOSTIN, POSTN
16729,608778,KELCH-LIKE 10, KLHL10
16730,608779,"CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIe", CDG2E
16731,608780,"GENERAL TRANSCRIPTION FACTOR IIH, POLYPEPTIDE 5", GTF2H5
16732,608781,"ASPERGER SYNDROME, SUSCEPTIBILITY TO, 3", ASPG3
16733,608782,PYRUVATE DEHYDROGENASE PHOSPHATASE DEFICIENCY, PDHPD
16734,608783,SET AND MYND DOMAIN-CONTAINING PROTEIN 3, SMYD3
16735,608784,ZINC FINGER DHHC DOMAIN-CONTAINING PROTEIN 8, ZDHHC8
16736,608785,HTRA SERINE PEPTIDASE 3, HTRA3
16737,608786,PYRUVATE CARBOXYLASE, PC
16738,608787,OTOSCLEROSIS 5, OTSC5
16739,608788,SUPPRESSOR OF CYTOKINE SIGNALING 7, SOCS7
16740,608789,NCK-ASSOCIATED PROTEIN 5, NCKAP5
16741,608790,TRANSCRIPTIONAL ADAPTOR 2B, TADA2B
16742,608791,NUCLEOREDOXIN-LIKE PROTEIN 1, NXNL1
16743,608792,"GIPC PDZ DOMAIN-CONTAINING FAMILY, MEMBER 3", GIPC3
16744,608793,SPERM ANTIGEN WITH CALPONIN HOMOLOGY AND COILED-COIL DOMAINS 1, SPECC1
16745,608794,"PHOSPHATIDYLINOSITOL TRANSFER PROTEIN, MEMBRANE-ASSOCIATED, 1", PITPNM1
16746,608795,"PHOSPHOLIPASE C, DELTA-3", PLCD3
16747,608796,MOYAMOYA DISEASE 3, MYMY3
16748,608797,MEIOTIC DOUBLE-STRANDED BREAK FORMATION PROTEIN 1, MEI1
16749,608798,GASDERMIN E, GSDME
16750,608799,"CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ie", CDG1E
16751,608800,SUDDEN INFANT DEATH WITH DYSGENESIS OF THE TESTES SYNDROME, SIDDT
16752,608801,GLUTARYL-CoA DEHYDROGENASE, GCDH
16753,608802,L3MBTL HISTONE METHYL-LYSINE-BINDING PROTEIN 1, L3MBTL1
16754,608803,"GAP JUNCTION PROTEIN, GAMMA-2", GJC2
16755,608804,"LEUKODYSTROPHY, HYPOMYELINATING, 2", HLD2
16756,608805,"AVASCULAR NECROSIS OF FEMORAL HEAD, PRIMARY, 1", ANFH1
16757,608806,N-ACETYLATED ALPHA-LINKED ACIDIC DIPEPTIDASE-LIKE 2, NAALADL2
16758,608807,"MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 10", LGMDR10
16759,608808,"TRANSPOSITION OF THE GREAT ARTERIES, DEXTRO-LOOPED", DTGA
16760,608809,"LEUKOENCEPHALOPATHY, ARTHRITIS, COLITIS, AND HYPOGAMMAGLOBULINEMA", LACH
16761,608810,"MYOPATHY, MYOFIBRILLAR, 2", MFM2
16762,608811,"METAPHYSEAL UNDERMODELING, SPONDYLAR DYSPLASIA, AND OVERGROWTH",
16763,608812,"COLORECTAL CANCER, SUSCEPTIBILITY TO, 1", CRCS1
16764,608813,"DER1-LIKE DOMAIN FAMILY, MEMBER 1", DERL1
16765,608814,"LATERAL SEMICIRCULAR CANAL MALFORMATION, FAMILIAL, WITH EXTERNAL AND MIDDLE EAR ABNORMALITIES",
16766,608815,EF-HAND DOMAIN (C-TERMINAL)-CONTAINING PROTEIN 1, EFHC1
16767,608816,"MYOCLONIC EPILEPSY, JUVENILE, SUSCEPTIBILITY TO, 3", EJM3
16768,608817,LEUCINE-RICH REPEAT-CONTAINING PROTEIN 4C, LRRC4C
16769,608818,NETRIN G1, NTNG1
16770,608819,KERATIN-ASSOCIATED PROTEIN 1-1, KRTAP1-1
16771,608820,KERATIN-ASSOCIATED PROTEIN 1-3, KRTAP1-3
16772,608821,KERATIN-ASSOCIATED PROTEIN 1-4, KRTAP1-4
16773,608822,KERATIN-ASSOCIATED PROTEIN 1-5, KRTAP1-5
16774,608823,"CHORIONIC GONADOTROPIN, BETA POLYPEPTIDE 1", CGB1
16775,608824,"CHORIONIC GONADOTROPIN, BETA POLYPEPTIDE 2", CGB2
16776,608825,"CHORIONIC GONADOTROPIN, BETA POLYPEPTIDE 5", CGB5
16777,608826,"CHORIONIC GONADOTROPIN, BETA POLYPEPTIDE 7", CGB7
16778,608827,"CHORIONIC GONADOTROPIN, BETA POLYPEPTIDE 8", CGB8
16779,608828,DROSHA RIBONUCLEASE III, DROSHA
16780,608829,SMALL UBIQUITIN-LIKE MODIFIER 4, SUMO4
16781,608830,RETINOL DEHYDROGENASE 12, RDH12
16782,608831,"RESTLESS LEGS SYNDROME, SUSCEPTIBILITY TO, 2", RLS2
16783,608832,"GREMLIN 2, DAN FAMILY BMP ANTAGONIST", GREM2
16784,608833,REGULATOR OF TELOMERE ELONGATION HELICASE 1, RTEL1
16785,608834,cAMP RESPONSE ELEMENT-BINDING PROTEIN 3-LIKE 2, CREB3L2
16786,608835,"ATP-BINDING CASSETTE, SUBFAMILY C, MEMBER 13", ABCC13
16787,608836,"CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, LETHAL NEONATAL",
16788,608837,CARNEY COMPLEX VARIANT,
16789,608838,"VITAMIN K EPOXIDE REDUCTASE COMPLEX, SUBUNIT 1-LIKE 1", VKORC1L1
16790,608839,CALPAIN 12, CAPN12
16791,608840,"MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH IMPAIRED INTELLECTUAL DEVELOPMENT), TYPE B, 6", MDDGB6
16792,608841,COMPLEMENT COMPONENT 3- AND PREGNANCY ZONE PROTEIN-LIKE ALPHA-2-MACROGLOBULIN DOMAIN-CONTAINING PROTEIN 8, CPAMD8
16793,608842,COILED-COIL-HELIX-COILED-COIL-HELIX DOMAIN-CONTAINING PROTEIN 1, CHCHD1
16794,608843,VASORIN,
16795,608844,NEI-LIKE DNA GLYCOSYLASE 1, NEIL1
16796,608845,ADP-RIBOSYLATION FACTOR-LIKE GTPase 6, ARL6
16797,608846,CARNITINE PALMITOYLTRANSFERASE IC, CPT1C
16798,608847,"FERRITIN, MITOCHONDRIAL", FTMT
16799,608848,FORMIN-BINDING PROTEIN 1-LIKE, FNBP1L
16800,608849,U2AF HOMOLOGY MOTIF KINASE 1, UHMK1
16801,608850,"MACULAR DYSTROPHY, RETINAL, 3", MCDR3
16802,608851,"5-PRIME,3-PRIME-EXORIBONUCLEASE 2", XRN2
16803,608852,PULMONARY FUNCTION,
16804,608853,BH3-LIKE MOTIF-CONTAINING CELL DEATH INDUCER, BLID
16805,608854,OXIDORED-NITRO DOMAIN-CONTAINING PROTEIN 1,
16806,608855,TWEETY FAMILY MEMBER 2, TTYH2
16807,608856,CUTANEOUS T-CELL LYMPHOMA-ASSOCIATED ANTIGEN 1, CTAGE1
16808,608857,CUTANEOUS T-CELL LYMPHOMA-ASSOCIATED ANTIGEN 3, CTAGE3
16809,608858,FIBROBLAST GROWTH FACTOR RECEPTOR 1 ONCOGENE PARTNER 2, FGFR1OP2
16810,608859,CD109 ANTIGEN, CD109
16811,608860,ASTACIN-LIKE METALLOENDOPEPTIDASE, ASTL
16812,608861,"ATPase, H+ TRANSPORTING, LYSOSOMAL, 50/57-KD, V1 SUBUNIT H", ATP6V1H
16813,608862,NAD(P)HX EPIMERASE, NAXE
16814,608863,PODOPLANIN, PDPN
16815,608864,"OROFACIAL CLEFT 6, SUSCEPTIBILITY TO", OFC6
16816,608865,"URB1 RIBOSOME BIOGENESIS 1, S. CEREVISIAE, HOMOLOG OF", URB1
16817,608866,FRA10A-ASSOCIATED CGG REPEAT 1, FRA10AC1
16818,608867,DUAL-SPECIFICITY PHOSPHATASE 10, DUSP10
16819,608868,LEUCINE-RICH REPEATS- AND IMMUNOGLOBULIN-LIKE DOMAINS-CONTAINING PROTEIN 1, LRIG1
16820,608869,LEUCINE-RICH REPEATS- AND IMMUNOGLOBULIN-LIKE DOMAINS-CONTAINING PROTEIN 2, LRIG2
16821,608870,LEUCINE-RICH REPEATS- AND IMMUNOGLOBULIN-LIKE DOMAINS-CONTAINING PROTEIN 3, LRIG3
16822,608871,NIPSNAP HOMOLOG 3A, NIPSNAP3A
16823,608872,NIPSNAP HOMOLOG 3B, NIPSNAP3B
16824,608873,SEMAPHORIN 6B, SEMA6B
16825,608874,OROFACIAL CLEFT 5, OFC5
16826,608875,"GENE EXPRESSION, VARIATION IN, QUANTITATIVE TRAIT LOCUS ON CHROMOSOME 14",
16827,608876,PCF11 CLEAVAGE AND POLYADENYLATION FACTOR SUBUNIT, PCF11
16828,608877,VACUOLAR PROTEIN SORTING 13 HOMOLOG D, VPS13D
16829,608878,"GENE EXPRESSION, VARIATION IN, QUANTITATIVE TRAIT LOCUS ON CHROMOSOME 20",
16830,608879,VACUOLAR PROTEIN SORTING 13 HOMOLOG C, VPS13C
16831,608880,ZINC FINGER FYVE DOMAIN-CONTAINING PROTEIN 16, ZFYVE16
16832,608881,"MICROTUBULE-ASSOCIATED MONOOXYGENASE, CALPONIN AND LIM DOMAINS-CONTAINING, 2", MICAL2
16833,608882,"MICROTUBULE-ASSOCIATED MONOOXYGENASE, CALPONIN AND LIM DOMAINS-CONTAINING, 3", MICAL3
16834,608883,GALACTOSE MUTAROTASE,
16835,608884,"RAL GTPase-ACTIVATING PROTEIN, CATALYTIC SUBUNIT ALPHA-1", RALGAPA1
16836,608885,STOMATIN-DEFICIENT CRYOHYDROCYTOSIS WITH NEUROLOGIC DEFECTS, SDCHCN
16837,608886,"PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR-GAMMA, COACTIVATOR 1, BETA", PPARGC1B
16838,608887,PURINE-RICH ELEMENT-BINDING PROTEIN B, PURB
16839,608888,RNA-BINDING MOTIF PROTEIN 45, RBM45
16840,608889,AMINOCARBOXYMUCONATE SEMIALDEHYDE DECARBOXYLASE, ACMSD
16841,608890,"WAARDENBURG SYNDROME, TYPE 2A",
16842,608891,ODD-SKIPPED-RELATED TRANSCRIPTION FACTOR 1, OSR1
16843,608892,CHROMODOMAIN HELICASE DNA-BINDING PROTEIN 7, CHD7
16844,608893,"SOLUTE CARRIER FAMILY 6 (NEUROTRANSMITTER TRANSPORTER), MEMBER 19", SLC6A19
16845,608894,ABELSON HELPER INTEGRATION SITE 1, AHI1
16846,608895,"MACULAR DEGENERATION, AGE-RELATED, 3", ARMD3
16847,608896,"SARCOGLYCAN, GAMMA", SGCG
16848,608897,UNC13 HOMOLOG D, UNC13D
16849,608898,"HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 3", FHL3
16850,608899,"GTF2I REPEAT DOMAIN-CONTAINING PROTEIN 2, ALPHA",
16851,608900,"GTF2I REPEAT DOMAIN-CONTAINING PROTEIN 2, BETA",
16852,608901,"CORONARY HEART DISEASE, SUSCEPTIBILITY TO, 5",
16853,608902,"DRUG METABOLISM, POOR, CYP2D6-RELATED",
16854,608903,"ATTENTION DEFICIT-HYPERACTIVITY DISORDER, SUSCEPTIBILITY TO, 1",
16855,608904,"ATTENTION DEFICIT-HYPERACTIVITY DISORDER, SUSCEPTIBILITY TO, 2",
16856,608905,"ATTENTION DEFICIT-HYPERACTIVITY DISORDER, SUSCEPTIBILITY TO, 3",
16857,608906,"ATTENTION DEFICIT-HYPERACTIVITY DISORDER, SUSCEPTIBILITY TO, 4",
16858,608907,"ALZHEIMER DISEASE 9, SUSCEPTIBILITY TO", AD9
16859,608908,MYOPIA 6, MYP6
16860,608909,ADP-RIBOSYLATION FACTOR-LIKE GTPase 5B, ARL5B
16861,608910,CUTANEOUS T-CELL LYMPHOMA-ASSOCIATED ANTIGEN 4, CTAGE4
16862,608911,"CHOANAL ATRESIA, POSTERIOR", PCA
16863,608912,"POTE ANKYRIN DOMAIN FAMILY, MEMBER B", POTEB
16864,608913,"POTE ANKYRIN DOMAIN FAMILY, MEMBER H", POTEH
16865,608914,"POTE ANKYRIN DOMAIN FAMILY, MEMBER E", POTEE
16866,608915,"POTE ANKYRIN DOMAIN FAMILY, MEMBER A", POTEA
16867,608916,"POTE ANKYRIN DOMAIN FAMILY, MEMBER G", POTEG
16868,608917,"ATP SYNTHASE, MITOCHONDRIAL F1 COMPLEX, ASSEMBLY FACTOR 1", ATPAF1
16869,608918,"ATP SYNTHASE, MITOCHONDRIAL F1 COMPLEX, ASSEMBLY FACTOR 2", ATPAF2
16870,608919,TWEETY FAMILY MEMBER 3, TTYH3
16871,608920,"PHOSPHATIDYLINOSITOL TRANSFER PROTEIN, MEMBRANE-ASSOCIATED, 2", PITPNM2
16872,608921,"PHOSPHATIDYLINOSITOL TRANSFER PROTEIN, MEMBRANE-ASSOCIATED, 3", PITPNM3
16873,608922,ADP-RIBOSYLATION FACTOR-LIKE GTPase 13B, ARL13B
16874,608923,TRACE AMINE-ASSOCIATED RECEPTOR 6, TAAR6
16875,608924,FORKHEAD BOX P4, FOXP4
16876,608925,MULTIMERIN 2, MMRN2
16877,608926,EMI DOMAIN-CONTAINING PROTEIN 1, EMID1
16878,608927,EMI DOMAIN-CONTAINING PROTEIN 2, EMID2
16879,608928,ELASTIN MICROFIBRIL INTERFACER 2, EMILIN2
16880,608929,ELASTIN MICROFIBRIL INTERFACER 3, EMILIN3
16881,608930,"MYASTHENIC SYNDROME, CONGENITAL, 1B, FAST-CHANNEL", CMS1B
16882,608931,"MYASTHENIC SYNDROME, CONGENITAL, 4C, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY", CMS4C
16883,608932,KERATOCONUS 2, KTCN2
16884,608933,ENDONUCLEASE VIII-LIKE 2, NEIL2
16885,608934,ENDONUCLEASE VIII-LIKE 3, NEIL3
16886,608935,LUNG CANCER SUSCEPTIBILITY 1, LNCR1
16887,608936,OPIORPHIN PREPROPEPTIDE, OPRPN
16888,608937,SH2B ADAPTOR PROTEIN 1, SH2B1
16889,608938,RIBOSOMAL PROTEIN S6 KINASE B1, RPS6KB1
16890,608939,RIBOSOMAL PROTEIN S6 KINASE B2, RPS6KB2
16891,608940,SPONDYLOMETAPHYSEAL DYSPLASIA WITH CONE-ROD DYSTROPHY, SMDCRD
16892,608941,"GUANINE NUCLEOTIDE-BINDING PROTEIN, GAMMA-3", GNG3
16893,608942,"DYNEIN, LIGHT CHAIN, LC8 TYPE, 2", DYNLL2
16894,608943,CYTOKINE-INDUCED APOPTOSIS INHIBITOR 1, CIAPIN1
16895,608944,FRAS1-RELATED EXTRACELLULAR MATRIX PROTEIN 1, FREM1
16896,608945,FRAS1-RELATED EXTRACELLULAR MATRIX PROTEIN 2, FREM2
16897,608946,FRAS1-RELATED EXTRACELLULAR MATRIX PROTEIN 3, FREM3
16898,608947,POTASSIUM CHANNEL TETRAMERIZATION DOMAIN-CONTAINING PROTEIN 13, KCTD13
16899,608948,"ZIC FAMILY, MEMBER 4", ZIC4
16900,608949,GLYCOLIPID TRANSFER PROTEIN, GLTP
16901,608950,MAGI2 INTRONIC TRANSCRIPT, MAGI2IT
16902,608951,"CCR4-NOT TRANSCRIPTION COMPLEX, SUBUNIT 6", CNOT6
16903,608952,REPLICATION TIMING REGULATORY FACTOR 1, RIF1
16904,608953,TEKTIN 2, TEKT2
16905,608954,"MON1 HOMOLOG B, SECRETORY TRAFFICKING-ASSOCIATED", MON1B
16906,608955,TUBULIN TYROSINE LIGASE-LIKE 1, TTLL1
16907,608956,"SOLUTE CARRIER FAMILY 46, MEMBER 2", SLC46A2
16908,608957,IMMUNODEFICIENCY 116, IMD116
16909,608958,ADENOSINE DEAMINASE, ADA
16910,608959,DIPHTHAMIDE BIOSYNTHESIS PROTEIN 3, DPH3
16911,608960,ADP-RIBOSYLATION FACTOR-LIKE GTPase 5A, ARL5A
16912,608961,"TRANSIENT RECEPTOR POTENTIAL CATION CHANNEL, SUBFAMILY M, MEMBER 3", TRPM3
16913,608962,RHOMBOID-LIKE 2, RHBDL2
16914,608963,NUT MIDLINE CARCINOMA FAMILY MEMBER 1, NUTM1
16915,608964,TATA BOX-BINDING PROTEIN-LIKE PROTEIN 2, TBPL2
16916,608965,CALCIUM-BINDING PROTEIN 4, CABP4
16917,608966,"DAPPER, ANTAGONIST OF BETA-CATENIN, 2", DACT2
16918,608967,LOEYS-DIETZ SYNDROME 1,
16919,608968,MAF bZIP TRANSCRIPTION FACTOR B, MAFB
16920,608969,UTP14C SMALL SUBUNIT PROCESSOME COMPONENT, UTP14C
16921,608970,"MACULAR DYSTROPHY, PATTERNED, 2", MDPT2
16922,608971,"IMMUNODEFICIENCY 104, SEVERE COMBINED", IMD104
16923,608972,CREB-REGULATED TRANSCRIPTION COACTIVATOR 2, CRTC2
16924,608973,SALT-INDUCIBLE KINASE 2, SIK2
16925,608974,COMPLEMENT COMPONENT C1r-LIKE PROTEIN, C1RL
16926,608975,PAR6 FAMILY CELL POLARITY REGULATOR BETA, PARD6B
16927,608976,PAR6 FAMILY CELL POLARITY REGULATOR GAMMA, PARD6G
16928,608977,"DNAJ/HSP40 HOMOLOG, SUBFAMILY C, MEMBER 19", DNAJC19
16929,608978,MEACHAM SYNDROME,
16930,608979,"PROTEIN PHOSPHATASE, MAGNESIUM/MANGANESE-DEPENDENT, 1M", PPM1M
16931,608980,BIFID NOSE WITH OR WITHOUT ANORECTAL AND RENAL ANOMALIES, BNAR
16932,608981,"ACTIVIN A RECEPTOR, TYPE IC", ACVR1C
16933,608982,STATURE QUANTITATIVE TRAIT LOCUS 5, STQTL5
16934,608983,"CATARACT 4, MULTIPLE TYPES",
16935,608984,"ATAXIA, SENSORY, 1, AUTOSOMAL DOMINANT", SNAX1
16936,608985,RING FINGER PROTEIN 2, RNF2
16937,608986,CREB-REGULATED TRANSCRIPTION COACTIVATOR 3, CRTC3
16938,608987,"PROCOLLAGEN-PROLINE, 2-OXOGLUTARATE-4-DIOXYGENASE, ALPHA SUBUNIT, ISOFORM 3", P4HA3
16939,608988,"ATRIAL FIBRILLATION, FAMILIAL, 2", ATFB2
16940,608989,"RETINAL DEHYDROGENASE, EPIDERMAL, 2",
16941,608990,"A DISINTEGRIN-LIKE AND METALLOPROTEINASE WITH THROMBOSPONDIN TYPE 1 MOTIF, 10", ADAMTS10
16942,608991,MASTERMIND-LIKE 3, MAML3
16943,608992,BCL6B TRANSCRIPTION REPRESSOR, BCL6B
16944,608993,"APOLIPOPROTEIN B mRNA-EDITING ENZYME, CATALYTIC POLYPEPTIDE-LIKE 3F", APOBEC3F
16945,608994,ANKYRIN REPEAT AND STERILE ALPHA MOTIF DOMAINS-CONTAINING PROTEIN 1A, ANKS1A
16946,608995,"DYSLEXIA, SUSCEPTIBILITY TO, 8", DYX8
16947,608996,PREMATURE OVARIAN FAILURE 3, POF3
16948,608997,WD REPEAT-CONTAINING PROTEIN 13,
16949,608998,EARP COMPLEX AND GARP COMPLEX INTERACTING PROTEIN 1, EIPR1
16950,608999,TUMOR-SUPPRESSING SUBTRANSFERABLE FRAGMENT CANDIDATE GENE 2, TSSC2
16951,609000,"MONOOXYGENASE, DBH-LIKE, 1", MOXD1
16952,609001,"PHOSPHATIDYLINOSITOL 3-KINASE, CLASS 2, GAMMA", PIK3C2G
16953,609002,TEKTIN 1, TEKT1
16954,609003,"FISSION, MITOCHONDRIAL 1", FIS1
16955,609004,B-CELL CLL/LYMPHOMA 9-LIKE, BCL9L
16956,609005,WD REPEAT-CONTAINING PROTEIN 17, WDR17
16957,609006,"DEAFNESS, AUTOSOMAL RECESSIVE 36, WITH OR WITHOUT VESTIBULAR INVOLVEMENT", DFNB36
16958,609007,LEUCINE-RICH REPEAT KINASE 2, LRRK2
16959,609008,MARFANOID HABITUS WITH SITUS INVERSUS,
16960,609009,"TYROSINE 3-MONOOXYGENASE/TRYPTOPHAN 5-MONOOXYGENASE ACTIVATION PROTEIN, THETA ISOFORM", YWHAQ
16961,609010,3-METHYLCROTONYL-CoA CARBOXYLASE 1, MCCC1
16962,609011,VASOHIBIN 1, VASH1
16963,609012,WD REPEAT-CONTAINING PROTEIN 5, WDR5
16964,609013,"SOLUTE CARRIER ORGANIC ANION TRANSPORTER FAMILY, MEMBER 4C1", SLCO4C1
16965,609014,3-METHYLCROTONYL-CoA CARBOXYLASE 2, MCCC2
16966,609015,MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFICIENCY 1, MTPD1
16967,609016,LONG-CHAIN 3-HYDROXYACYL-CoA DEHYDROGENASE DEFICIENCY,
16968,609017,ERYTHROBLAST MEMBRANE-ASSOCIATED PROTEIN, ERMAP
16969,609018,HOLOCARBOXYLASE SYNTHETASE, HLCS
16970,609019,BIOTINIDASE, BTD
16971,609020,FOLATE HYDROLASE 1B, FOLH1B
16972,609021,PERIPHERAL CONE DYSTROPHY,
16973,609022,RAPAMYCIN-INSENSITIVE COMPANION OF MTOR, RICTOR
16974,609023,PNKD METALLO-BETA-LACTAMASE DOMAIN-CONTAINING PROTEIN, PNKD
16975,609024,KDEL ENDOPLASMIC RETICULUM PROTEIN RETENTION RECEPTOR 2, KDELR2
16976,609025,"KERATIN 75, TYPE II", KRT75
16977,609026,CATARACT 28, CTRCT28
16978,609027,"BLOOD GROUP, INDIAN SYSTEM", IN
16979,609028,TRAF-INTERACTING PROTEIN WITH FORKHEAD-ASSOCIATED DOMAIN, TIFA
16980,609029,EMANUEL SYNDROME,
16981,609030,DGCR8 MICROPROCESSOR COMPLEX SUBUNIT, DGCR8
16982,609031,EPIDIDYMAL PROTEASE INHIBITOR, EPPIN
16983,609032,FSHD REGION GENE 2, FRG2
16984,609033,RETINOPATHY-SENSORY NEUROPATHY SYNDROME, RETSNS
16985,609034,HES-RELATED bHLH TRANSCRIPTION FACTOR WITH YRPW MOTIF-LIKE PROTEIN, HEYL
16986,609035,RAS ASSOCIATION AND PLECKSTRIN HOMOLOGY DOMAINS-CONTAINING PROTEIN 1, RAPH1
16987,609036,APBB1-INTERACTING PROTEIN, APBB1IP
16988,609037,"INTELLECTUAL DEVELOPMENTAL DISORDER WITH OPTIC ATROPHY, FACIAL DYSMORPHISM, MICROCEPHALY, AND SHORT STATURE",
16989,609038,RHO FAMILY GTPase 1, RND1
16990,609039,NARCOLEPSY 3, NRCLP3
16991,609040,"ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 9", ARVD9
16992,609041,"SPASTIC PARAPLEGIA 27, AUTOSOMAL RECESSIVE", SPG27
16993,609042,OPSIN 5, OPN5
16994,609043,RELAXIN/INSULIN-LIKE FAMILY PEPTIDE RECEPTOR 4, RXFP4
16995,609044,FREE FATTY ACID RECEPTOR 4, FFAR4
16996,609045,G PROTEIN-COUPLED RECEPTOR 141, GPR141
16997,609046,G PROTEIN-COUPLED RECEPTOR 142, GPR142
16998,609047,"SKELETAL DYSPLASIA, RHIZOMELIC, WITH RETINITIS PIGMENTOSA",
16999,609048,"MELANOMA, CUTANEOUS MALIGNANT, SUSCEPTIBILITY TO, 3", CMM3
17000,609049,PIERSON SYNDROME, PIERS
17001,609050,METASTASIS-ASSOCIATED GENE 3, MTA3
17002,609051,CASPASE RECRUITMENT DOMAIN-CONTAINING PROTEIN 8, CARD8
17003,609052,"SPONDYLOMETAPHYSEAL DYSPLASIA, TYPE A4", SMDA4
17004,609053,"FANCONI ANEMIA, COMPLEMENTATION GROUP I", FANCI
17005,609054,"FANCONI ANEMIA, COMPLEMENTATION GROUP J", FANCJ
17006,609055,"CEROID LIPOFUSCINOSIS, NEURONAL, 9", CLN9
17007,609056,SALT AND PEPPER DEVELOPMENTAL REGRESSION SYNDROME, SPDRS
17008,609057,"EPIDERMOLYSIS BULLOSA SIMPLEX 7, WITH NEPHROPATHY AND DEAFNESS", EBS7
17009,609058,METHYLMALONYL-CoA MUTASE, MMUT
17010,609059,PATATIN-LIKE PHOSPHOLIPASE DOMAIN-CONTAINING PROTEIN 2, PNPLA2
17011,609060,COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 1, COXPD1
17012,609061,ENAH ACTIN REGULATOR, ENAH
17013,609062,"POU DOMAIN, CLASS 6, TRANSCRIPTION FACTOR 2", POU6F2
17014,609063,THIOREDOXIN 2, TXN2
17015,609064,CARNOSINE DIPEPTIDASE 1, CNDP1
17016,609065,"CEREBRAL AMYLOID ANGIOPATHY, APP-RELATED",
17017,609066,AJUBA LIM PROTEIN, AJUBA
17018,609067,SCLERAXIS bHLH TRANSCRIPTION FACTOR, SCX
17019,609068,"DAN DOMAIN FAMILY, MEMBER 5", DAND5
17020,609069,PANCREATIC AND CEREBELLAR AGENESIS, PACA
17021,609070,"HEMOGLOBIN, HIGH ALTITUDE ADAPTATION", HALAH
17022,609071,F-BOX AND WD40 DOMAIN PROTEIN 2, FBXW2
17023,609072,F-BOX AND WD40 DOMAIN PROTEIN 5, FBXW5
17024,609073,F-BOX AND WD40 DOMAIN PROTEIN 8, FBXW8
17025,609074,F-BOX AND WD40 DOMAIN PROTEIN 9, FBXW9
17026,609075,F-BOX AND WD40 DOMAIN PROTEIN 12, FBXW12
17027,609076,F-BOX AND LEUCINE-RICH REPEAT PROTEIN 6, FBXL6
17028,609077,F-BOX AND LEUCINE-RICH REPEAT PROTEIN 8, FBXL8
17029,609078,LYSINE DEMETHYLASE 2B, KDM2B
17030,609079,F-BOX AND LEUCINE-RICH REPEAT PROTEIN 12, FBXL12
17031,609080,F-BOX AND LEUCINE-RICH REPEAT PROTEIN 13, FBXL13
17032,609081,F-BOX AND LEUCINE-RICH REPEAT PROTEIN 14, FBXL14
17033,609082,F-BOX AND LEUCINE-RICH REPEAT PROTEIN 16, FBXL16
17034,609083,F-BOX AND LEUCINE-RICH REPEAT PROTEIN 17, FBXL17
17035,609084,F-BOX AND LEUCINE-RICH REPEAT PROTEIN 18, FBXL18
17036,609085,F-BOX AND LEUCINE-RICH REPEAT PROTEIN 19, FBXL19
17037,609086,F-BOX AND LEUCINE-RICH REPEAT PROTEIN 20, FBXL20
17038,609087,F-BOX AND LEUCINE-RICH REPEAT PROTEIN 21, FBXL21
17039,609088,F-BOX AND LEUCINE-RICH REPEAT PROTEIN 22, FBXL22
17040,609089,F-BOX ONLY PROTEIN 3, FBXO3
17041,609090,F-BOX ONLY PROTEIN 4, FBXO4
17042,609091,F-BOX ONLY PROTEIN 9, FBXO9
17043,609092,F-BOX ONLY PROTEIN 10, FBXO10
17044,609093,F-BOX ONLY PROTEIN 15, FBXO15
17045,609094,F-BOX ONLY PROTEIN 17, FBXO17
17046,609095,F-BOX ONLY PROTEIN 21, FBXO21
17047,609096,F-BOX ONLY PROTEIN 22, FBXO22
17048,609097,F-BOX ONLY PROTEIN 24, FBXO24
17049,609098,F-BOX ONLY PROTEIN 25, FBXO25
17050,609099,F-BOX ONLY PROTEIN 27, FBXO27
17051,609100,F-BOX ONLY PROTEIN 28, FBXO28
17052,609101,F-BOX ONLY PROTEIN 30, FBXO30
17053,609102,F-BOX ONLY PROTEIN 31, FBXO31
17054,609103,F-BOX ONLY PROTEIN 33, FBXO33
17055,609104,F-BOX ONLY PROTEIN 34, FBXO34
17056,609105,F-BOX ONLY PROTEIN 36, FBXO36
17057,609106,F-BOX ONLY PROTEIN 39, FBXO39
17058,609107,F-BOX ONLY PROTEIN 40, FBXO40
17059,609108,F-BOX ONLY PROTEIN 41, FBXO41
17060,609109,F-BOX ONLY PROTEIN 42, FBXO42
17061,609110,F-BOX ONLY PROTEIN 43, FBXO43
17062,609111,F-BOX ONLY PROTEIN 44, FBXO44
17063,609112,F-BOX ONLY PROTEIN 45, FBXO45
17064,609113,"TELOMERE LENGTH, MEAN LEUKOCYTE", LTL
17065,609114,DESTRIN, DSTN
17066,609115,"MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL DOMINANT 3", LGMDD3
17067,609116,RESPIRATORY RHYTHMICITY IN SLEEP,
17068,609117,F-BOX ONLY PROTEIN 46, FBXO46
17069,609118,PROGRAMMED CELL DEATH 10, PDCD10
17070,609119,THAP DOMAIN-CONTAINING PROTEIN 11, THAP11
17071,609120,"CATION CHANNEL, SPERM-ASSOCIATED, 3", CATSPER3
17072,609121,"CATION CHANNEL, SPERM-ASSOCIATED, 4", CATSPER4
17073,609122,"ANEURYSM, INTRACRANIAL BERRY, 3", ANIB3
17074,609123,"ATPase, CLASS I, TYPE 8B, MEMBER 4", ATP8B4
17075,609124,ZINC FINGER PROTEIN 385A, ZNF385A
17076,609125,MOTILE SPERM DOMAIN-CONTAINING PROTEIN 3, MOSPD3
17077,609126,"ATPase, CLASS II, TYPE 9A", ATP9A
17078,609127,"ATPase, CLASS VI, TYPE 11C",
17079,609128,"ARTHROGRYPOSIS, DISTAL, TYPE 4", DA4
17080,609129,"AUDITORY NEUROPATHY, AUTOSOMAL DOMINANT 1", AUNA1
17081,609130,CENTROMERIC PROTEIN S, CENPS
17082,609131,CLAUDIN 7, CLDN7
17083,609132,LYSINE DEMETHYLASE 1A, KDM1A
17084,609133,FLT3-INTERACTING ZINC FINGER PROTEIN 1, FIZ1
17085,609134,UBIQUITIN-PROTEIN LIGASE E3 COMPONENT N-RECOGNIN 2, UBR2
17086,609135,APLASTIC ANEMIA,
17087,609136,"PERIPHERAL DEMYELINATING NEUROPATHY, CENTRAL DYSMYELINATION, WAARDENBURG SYNDROME, AND HIRSCHSPRUNG DISEASE", PCWH
17088,609137,RECEPTOR-TRANSPORTING PROTEIN 1, RTP1
17089,609138,RECEPTOR-TRANSPORTING PROTEIN 2, RTP2
17090,609139,RECEPTOR EXPRESSION-ENHANCING PROTEIN 1, REEP1
17091,609140,"CORNEAL DYSTROPHY, POSTERIOR POLYMORPHOUS, 2", PPCD2
17092,609141,"CORNEAL DYSTROPHY, POSTERIOR POLYMORPHOUS, 3", PPCD3
17093,609142,CEA CELL ADHESION MOLECULE 3, CEACAM3
17094,609143,"OSTEOFIBROUS DYSPLASIA, SUSCEPTIBILITY TO",
17095,609144,FLVCR HEME TRANSPORTER 1, FLVCR1
17096,609145,NEUROFASCIN, NFASC
17097,609146,RIC8 GUANINE NUCLEOTIDE EXCHANGE FACTOR A, RIC8A
17098,609147,RIC8 GUANINE NUCLEOTIDE EXCHANGE FACTOR B, RIC8B
17099,609148,"MALARIA, MILD, SUSCEPTIBILITY TO",
17100,609149,"SOLUTE CARRIER FAMILY 29 (MONOAMINE TRANSPORTER), MEMBER 4", SLC29A4
17101,609150,CXXC FINGER PROTEIN 1, CXXC1
17102,609151,UBX DOMAIN PROTEIN 11, UBXN11
17103,609152,"HYPERTHYROIDISM, NONAUTOIMMUNE",
17104,609153,"PSEUDOHYPERKALEMIA, FAMILIAL, 2, DUE TO RED CELL LEAK", PSHK2
17105,609154,ACHAETE-SCUTE FAMILY bHLH TRANSCRIPTION FACTOR 3, ASCL3
17106,609155,ACHAETE-SCUTE FAMILY bHLH TRANSCRIPTION FACTOR 4, ASCL4
17107,609156,NICALIN, NCLN
17108,609157,NODAL MODULATOR 1, NOMO1
17109,609158,NODAL MODULATOR 2, NOMO2
17110,609159,NODAL MODULATOR 3, NOMO3
17111,609160,"MYOPATHY, MYOFIBRILLAR, 1",
17112,609161,"STRIATAL DEGENERATION, AUTOSOMAL DOMINANT 1", ADSD1
17113,609162,CZECH DYSPLASIA,
17114,609163,HYDROXYCARBOXYLIC ACID RECEPTOR 2, HCAR2
17115,609164,"UMBILICUS, FAMILIAL FLAT",
17116,609165,ICHTHYOSIS WITH CONFETTI, IWC
17117,609166,BRANCHIOGENIC-DEAFNESS SYNDROME,
17118,609167,HYPOTRICHOSIS 7,
17119,609168,SHUGOSHIN-LIKE 1, SGOL1
17120,609169,"GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE, SPERMATOGENIC", GAPDHS
17121,609170,THIOREDOXIN DOMAIN-CONTAINING PROTEIN 4, TXNDC4
17122,609171,CDC42 EFFECTOR PROTEIN 5, CDC42EP5
17123,609172,"PROTEIN PHOSPHATASE 1, REGULATORY SUBUNIT 16A", PPP1R16A
17124,609173,KINETOCHORE SCAFFOLD 1, KNL1
17125,609174,"NSL1, MIS12 KINETOCHORE COMPLEX COMPONENT", NSL1
17126,609175,"DSN1, MIS12 KINETOCHORE COMPLEX COMPONENT", DSN1
17127,609176,POLYAMINE-MODULATED FACTOR 1, PMF1
17128,609177,ZW10 INTERACTING KINETOCHORE PROTEIN, ZWINT
17129,609178,MIS12 KINETOCHORE COMPLEX COMPONENT, MIS12
17130,609179,"MIGRAINE WITH AURA, SUSCEPTIBILITY TO, 7",
17131,609180,"CONGENITAL DISORDER OF GLYCOSYLATION, TYPE If", CDG1F
17132,609181,DUAL-SPECIFICITY TYROSINE PHOSPHORYLATION-REGULATED KINASE 4, DYRK4
17133,609182,"SOLUTE CARRIER FAMILY 35, MEMBER D2", SLC35D2
17134,609183,AURORA KINASE A-INTERACTING PROTEIN 1, AURKAIP1
17135,609184,KINESIN FAMILY MEMBER 4B, KIF4B
17136,609185,ZINC FINGER AND HOMEODOMAIN PROTEIN 2, ZHX2
17137,609186,D-2-HYDROXYGLUTARATE DEHYDROGENASE, D2HGDH
17138,609187,SUCCINYL-CoA:GLUTARATE-CoA TRANSFERASE, SUGCT
17139,609188,M-PHASE-SPECIFIC PLK1-INTERACTING PROTEIN, MPLKIP
17140,609189,ANTI-SILENCING FUNCTION 1A HISTONE CHAPERONE, ASF1A
17141,609190,ANTI-SILENCING FUNCTION 1B HISTONE CHAPERONE, ASF1B
17142,609191,PROTEIN KINASE A-INTERACTING PROTEIN 1, AKIP1
17143,609192,LOEYS-DIETZ SYNDROME 1, LDS1
17144,609193,LEUCINE-RICH REPEAT PROTEIN 1, LRR1
17145,609194,CDK5 AND ABL ENZYME SUBSTRATE 1, CABLES1
17146,609195,"SPASTIC PARAPLEGIA 26, AUTOSOMAL RECESSIVE", SPG26
17147,609196,MELANOCORTIN 2 RECEPTOR ACCESSORY PROTEIN, MRAP
17148,609197,GLUCOCORTICOID DEFICIENCY 3, GCCD3
17149,609198,ADAMTS-LIKE PROTEIN 1, ADAMTSL1
17150,609199,ADAMTS-LIKE PROTEIN 3, ADAMTSL3
17151,609200,"MYOPATHY, MYOFIBRILLAR, 3", MFM3
17152,609201,UBIQUITIN-ASSOCIATED AND SH3 DOMAIN-CONTAINING PROTEIN B, UBASH3B
17153,609202,SECRETAGOGIN, SCGN
17154,609203,CLAUDIN 23, CLDN23
17155,609204,MITOCHONDRIAL RIBOSOMAL PROTEIN S16: MRPS16,
17156,609205,DAB2-INTERACTING PROTEIN, DAB2IP
17157,609206,"EUKARYOTIC TRANSLATION ELONGATION FACTOR 1, EPSILON-1", EEF1E1
17158,609207,MELANOREGULIN, MREG
17159,609208,KAZAL-TYPE SERINE PEPTIDASE INHIBITOR DOMAIN 1, KAZALD1
17160,609209,INFLUENZA VIRUS NS1A-BINDING PROTEIN, IVNS1ABP
17161,609210,CLAUDIN 18, CLDN18
17162,609211,"MYOSIN, LIGHT CHAIN 12B, REGULATORY", MYL12B
17163,609212,ASPARAGINASE-LIKE PROTEIN 1, ASRGL1
17164,609213,"SEC61 TRANSLOCON, ALPHA-1 SUBUNIT", SEC61A1
17165,609214,"SEC61 TRANSLOCON, BETA SUBUNIT", SEC61B
17166,609215,"SEC61 TRANSLOCON, GAMMA SUBUNIT", SEC61G
17167,609216,SPIRE-TYPE ACTIN NUCLEATION FACTOR 1, SPIRE1
17168,609217,SPIRE-TYPE ACTIN NUCLEATION FACTOR 2, SPIRE2
17169,609218,FOVEAL HYPOPLASIA 2, FVH2
17170,609219,NUDIX HYDROLASE 14, NUDT14
17171,609220,BRUCK SYNDROME 2, BRKS2
17172,609221,N-ACETYLTRANSFERASE 10, NAT10
17173,609222,"DANDY-WALKER MALFORMATION WITH OCCIPITAL CEPHALOCELE, AUTOSOMAL DOMINANT", ADDWOC
17174,609223,"SPONDYLOEPIPHYSEAL DYSPLASIA TARDA, AUTOSOMAL RECESSIVE, LEROY-SPRANGER TYPE",
17175,609224,WD40 REPEAT PROTEIN INTERACTING WITH PHOSPHOINOSITIDES 1, WIPI1
17176,609225,WD40 REPEAT PROTEIN INTERACTING WITH PHOSPHOINOSITIDES 2, WIPI2
17177,609226,WD REPEAT-CONTAINING PROTEIN 45B, WDR45B
17178,609227,"GRISCELLI SYNDROME, TYPE 3", GS3
17179,609228,NUDIX HYDROLASE 3, NUDT3
17180,609229,NUDIX HYDROLASE 4, NUDT4
17181,609230,NUDIX HYDROLASE 5, NUDT5
17182,609231,NUDIX HYDROLASE 7, NUDT7
17183,609232,NUDIX HYDROLASE 12, NUDT12
17184,609233,NUDIX HYDROLASE 13, NUDT13
17185,609234,EUKARYOTIC TRANSLATION INITIATION FACTOR 2A, EIF2A
17186,609235,BR SERINE/THREONINE KINASE 1, BRSK1
17187,609236,BR SERINE/THREONINE KINASE 2, BRSK2
17188,609237,IQ MOTIF-CONTAINING PROTEIN B1, IQCB1
17189,609238,RAB GTPase-ACTIVATING PROTEIN 1-LIKE, RABGAP1L
17190,609239,LYSOPHOSPHATIDIC ACID RECEPTOR 6, LPAR6
17191,609240,HISTONE H3-ASSOCIATED PROTEIN KINASE, HASPIN
17192,609241,"SCHINDLER DISEASE, TYPE I",
17193,609242,KANZAKI DISEASE,
17194,609243,RETINOIC ACID EARLY TRANSCRIPT 1E, RAET1E
17195,609244,RETINOIC ACID EARLY TRANSCRIPT 1G, RAET1G
17196,609245,G PROTEIN SIGNALING MODULATOR 2, GPSM2
17197,609246,PYRIDOXAL PHOSPHATASE, PDXP
17198,609247,RING FINGER PROTEIN 13, RNF13
17199,609248,HECT DOMAIN AND RCC1-LIKE DOMAIN 4, HERC4
17200,609249,HECT DOMAIN AND RCC1-LIKE DOMAIN 6, HERC6
17201,609250,"HYPOTRICHOSIS, PROGRESSIVE PATTERNED SCALP, WITH WIRY HAIR, ONYCHOLYSIS, AND CLEFT LIP/PALATE",
17202,609251,Fc RECEPTOR-LIKE PROTEIN B, FCRLB
17203,609252,LIPASE I, LIPI
17204,609253,"FEBRILE SEIZURES, FAMILIAL, 6", FEB6
17205,609254,SENIOR-LOKEN SYNDROME 5, SLSN5
17206,609255,"FEBRILE SEIZURES, FAMILIAL, 5", FEB5
17207,609256,MYOPIA 7, MYP7
17208,609257,MYOPIA 8, MYP8
17209,609258,MYOPIA 9, MYP9
17210,609259,MYOPIA 10, MYP10
17211,609260,"CHARCOT-MARIE-TOOTH DISEASE, AXONAL, AUTOSOMAL DOMINANT, TYPE 2A2A", CMT2A2A
17212,609261,"STUTTERING, FAMILIAL PERSISTENT, 2", STUT2
17213,609262,CEREBLON, CRBN
17214,609263,SEH1-LIKE PROTEIN, SEH1L
17215,609264,"NUCLEOPORIN, 37-KD", NUP37
17216,609265,TUMOR PREDISPOSITION SYNDROME 4, TPDS4
17217,609266,LI-FRAUMENI SYNDROME,
17218,609267,"MELANOMA ANTIGEN, FAMILY F, 1", MAGEF1
17219,609268,"SPLICING REGULATORY PROTEIN, GLUTAMINE/LYSINE-RICH, 1", SREK1
17220,609269,KIAA0319 GENE, KIAA0319
17221,609270,"SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 7", SCAR7
17222,609271,KERATOCONUS 4, KTCN4
17223,609272,"TRYPTASE, DELTA-1", TPSD1
17224,609273,NEMALINE MYOPATHY 6, NEM6
17225,609274,"NASCENT POLYPEPTIDE-ASSOCIATED COMPLEX, ALPHA POLYPEPTIDE, 2", NACA2
17226,609275,"RAB3 GTPase-ACTIVATING PROTEIN, NONCATALYTIC SUBUNIT", RAB3GAP2
17227,609276,NON-SMC CONDENSIN II COMPLEX SUBUNIT D3, NCAPD3
17228,609277,MOLYBDENUM COFACTOR SYNTHESIS 3, MOCS3
17229,609278,IZUMO SPERM-EGG FUSION PROTEIN 1, IZUMO1
17230,609279,CENTROMERIC PROTEIN J, CENPJ
17231,609280,EUKARYOTIC TRANSLATION INITIATION FACTOR 2-ALPHA KINASE 4, EIF2AK4
17232,609281,MOB KINASE ACTIVATOR 1A, MOB1A
17233,609282,MOB KINASE ACTIVATOR 1B, MOB1B
17234,609283,"PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 2", PEOA2
17235,609284,"CONGENITAL MYOPATHY 4B, AUTOSOMAL RECESSIVE", CMYO4B
17236,609285,CONGENITAL MYOPATHY 23, CMYO23
17237,609286,"PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 3", PEOA3
17238,609287,"SH3 DOMAIN, GRB2-LIKE, ENDOPHILIN B1", SH3GLB1
17239,609288,"SH3 DOMAIN, GRB2-LIKE, ENDOPHILIN B2", SH3GLB2
17240,609289,"SYNCOPE, FAMILIAL VASOVAGAL", VVS
17241,609290,ADENYLATE KINASE 3, AK3
17242,609291,SPROUTY-RELATED EVH1 DOMAIN-CONTAINING PROTEIN 1, SPRED1
17243,609292,SPROUTY-RELATED EVH1 DOMAIN-CONTAINING PROTEIN 2, SPRED2
17244,609293,SPROUTY-RELATED EVH1 DOMAIN-CONTAINING PROTEIN 3, SPRED3
17245,609294,SEMAPHORIN 6C, SEMA6C
17246,609295,SEMAPHORIN 6D, SEMA6D
17247,609296,"B-CELL IMMUNODEFICIENCY, DISTAL LIMB ANOMALIES, AND UROGENITAL MALFORMATIONS", BILU
17248,609297,SEMAPHORIN 5A, SEMA5A
17249,609298,SEMAPHORIN 5B, SEMA5B
17250,609299,"PROSTATE CANCER, HEREDITARY, 5", HPC5
17251,609300,"CYTOCHROME P450, FAMILY 17, SUBFAMILY A, POLYPEPTIDE 1", CYP17A1
17252,609301,p53 EFFECTOR RELATED TO PMP22, PERP
17253,609302,"SOLUTE CARRIER FAMILY 25 (MITOCHONDRIAL CARRIER, GLUTAMATE), MEMBER 22", SLC25A22
17254,609303,"SOLUTE CARRIER FAMILY 25 (MITOCHONDRIAL CARRIER, GLUTAMATE), MEMBER 18", SLC25A18
17255,609304,DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 3, DEE3
17256,609305,LATEXIN, LXN
17257,609306,SPINOCEREBELLAR ATAXIA 26, SCA26
17258,609307,SPINOCEREBELLAR ATAXIA 27A,
17259,609308,"MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 1", MDDGC1
17260,609309,MutS HOMOLOG 2, MSH2
17261,609310,LYNCH SYNDROME 2, LYNCH2
17262,609311,"CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 4H", CMT4H
17263,609312,"DOPAMINE BETA-HYDROXYLASE, PLASMA", DBH
17264,609313,MEDNIK SYNDROME, MEDNIK
17265,609314,RADIAL SPOKE HEAD COMPONENT 1, RSPH1
17266,609315,TRIPARTITE MOTIF-CONTAINING PROTEIN 7, TRIM7
17267,609316,TRIPARTITE MOTIF-CONTAINING PROTEIN 31, TRIM31
17268,609317,TRIPARTITE MOTIF-CONTAINING PROTEIN 36, TRIM36
17269,609318,TRIPARTITE MOTIF-CONTAINING PROTEIN 45, TRIM45
17270,609319,HEMATOCRIT/HEMOGLOBIN QUANTITATIVE TRAIT LOCUS 1, HCHGQ1
17271,609320,HEMATOCRIT/HEMOGLOBIN QUANTITATIVE TRAIT LOCUS 2, HCHGQ2
17272,609321,SAS6 CENTRIOLAR ASSEMBLY PROTEIN, SASS6
17273,609322,RHABDOID TUMOR PREDISPOSITION SYNDROME 1, RTPS1
17274,609323,OLIGODENDROCYTE LINEAGE TRANSCRIPTION FACTOR 3, OLIG3
17275,609324,"EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH SEVERE PROXIMAL FEMORAL DYSPLASIA",
17276,609325,"EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH MINIEPIPHYSES",
17277,609326,MICRO RNA 1-1, MIR1-1
17278,609327,MICRO RNA 124-1, MIR124-1
17279,609328,URIDINE/CYTIDINE KINASE 1, UCK1
17280,609329,URIDINE/CYTIDINE KINASE 2, UCK2
17281,609330,ONCOPROTEIN-INDUCED TRANSCRIPT 3, OIT3
17282,609331,"BASIC HELIX-LOOP-HELIX FAMILY, MEMBER E23", BHLHE23
17283,609332,TETRATRICOPEPTIDE REPEAT DOMAIN-CONTAINING PROTEIN 7A, TTC7A
17284,609333,TRACE AMINE-ASSOCIATED RECEPTOR 1, TAAR1
17285,609334,CHROMOSOME 18 PERICENTRIC INVERSION,
17286,609335,ODR4 GPCR LOCALIZATION FACTOR HOMOLOG, ODR4
17287,609336,ANGIOPOIETIN-LIKE 6, ANGPTL6
17288,609337,MICRO RNA 155, MIR155
17289,609338,CAROTID INTIMAL MEDIAL THICKNESS 1, IMT1
17290,609339,"MULTIPLE PTERYGIUM SYNDROME, ESCOBAR VARIANT",
17291,609340,"SPASTIC PARAPLEGIA 28, AUTOSOMAL RECESSIVE", SPG28
17292,609341,"TRYPTASE, GAMMA-1", TPSG1
17293,609342,COBALAMIN-BINDING INTRINSIC FACTOR, CBLIF
17294,609343,"PROTEASE, SERINE, 22", PRSS22
17295,609344,KIELIN/CHORDIN-LIKE PROTEIN,
17296,609345,CEREBRORENODIGITAL SYNDROME WITH LIMB MALFORMATIONS AND TRIRADIATE ACETABULA,
17297,609346,RECEPTOR EXPRESSION-ENHANCING PROTEIN 6, REEP6
17298,609347,RECEPTOR EXPRESSION-ENHANCING PROTEIN 2, REEP2
17299,609348,RECEPTOR EXPRESSION-ENHANCING PROTEIN 3, REEP3
17300,609349,RECEPTOR EXPRESSION-ENHANCING PROTEIN 4, REEP4
17301,609350,RECEPTOR-TRANSPORTING PROTEIN 4, RTP4
17302,609351,ADP-RIBOSYLATION FACTOR-LIKE GTPase 11, ARL11
17303,609352,"EPIDERMOLYSIS BULLOSA SIMPLEX 2E, WITH MIGRATORY CIRCINATE ERYTHEMA", EBS2E
17304,609353,ESTABLISHMENT OF SISTER CHROMATID COHESION N-ACETYLTRANSFERASE 2, ESCO2
17305,609354,BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 5, BMND5
17306,609355,MICRO RNA 32, MIR32
17307,609356,NUCLEAR FMRP-INTERACTING PROTEIN 2, NUFIP2
17308,609357,MINICHROMOSOME MAINTENANCE COMPLEX COMPONENT 10, MCM10
17309,609358,ETS VARIANT TRANSCRIPTION FACTOR 2, ETV2
17310,609359,HS1-BINDING PROTEIN 3, HS1BP3
17311,609360,RENALASE, RNLS
17312,609361,"MOB FAMILY, MEMBER 4", MOB4
17313,609362,LYSOPHOSPHOLIPASE 3, LYPLA3
17314,609363,COLLOID CYSTS OF THIRD VENTRICLE,
17315,609364,"NLR FAMILY, PYRIN DOMAIN-CONTAINING 2", NLRP2
17316,609365,GUANINE NUCLEOTIDE-BINDING PROTEIN-LIKE 2, GNL2
17317,609366,"CTR9 HOMOLOG, PAF1/RNA POLYMERASE II COMPLEX COMPONENT", CTR9
17318,609367,KINESIN FAMILY BINDING PROTEIN, KIFBP
17319,609368,ATLASTIN GTPase 2, ATL2
17320,609369,ATLASTIN GTPase 3, ATL3
17321,609370,SERINE/THREONINE KINASE 35, STK35
17322,609371,"FAMILY WITH SEQUENCE SIMILARITY 13, MEMBER B", FAM13B
17323,609372,"FAMILY WITH SEQUENCE SIMILARITY 53, MEMBER C", FAM53C
17324,609373,LYSINE DEMETHYLASE 3B, KDM3B
17325,609374,CELL DIVISION CYCLE-ASSOCIATED PROTEIN 5, CDCA5
17326,609375,LIN9 DREAM MUVB CORE COMPLEX COMPONENT, LIN9
17327,609376,CATARACT 35, CTRCT35
17328,609377,ACD SHELTERIN COMPLEX SUBUNIT AND TELOMERASE RECRUITMENT FACTOR, ACD
17329,609378,"AUTISM, SUSCEPTIBILITY TO, 6", AUTS6
17330,609379,LIPOCALIN 6, LCN6
17331,609380,LEISHMANOLYSIN-LIKE, LMLN
17332,609381,SYNTAXIN-BINDING PROTEIN 5-LIKE, STXBP5L
17333,609382,IMMEDIATE-EARLY RESPONSE 3-INTERACTING PROTEIN 1, IER3IP1
17334,609383,NIPA-LIKE DOMAIN-CONTAINING PROTEIN 4, NIPAL4
17335,609384,"FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, 3C", CFEOM3C
17336,609385,DND MICRO RNA-MEDIATED REPRESSION INHIBITOR 1, DND1
17337,609386,STRUCTURAL MAINTENANCE OF CHROMOSOMES 5, SMC5
17338,609387,STRUCTURAL MAINTENANCE OF CHROMOSOMES 6, SMC6
17339,609388,METHYLTRANSFERASE-LIKE 9, METTL9
17340,609389,INOSITOL POLYPHOSPHATE 5-PHOSPHATASE F, INPP5F
17341,609390,FIG4 PHOSPHOINOSITIDE 5-PHOSPHATASE, FIG4
17342,609391,TRANSCRIPTION FACTOR Sp5, SP5
17343,609392,KRUPPEL-LIKE FACTOR 3, KLF3
17344,609393,KRUPPEL-LIKE FACTOR 14, KLF14
17345,609394,"SPC24, NDC80 KINETOCHORE COMPLEX COMPONENT", SPC24
17346,609395,"SPC25, NDC80 KINETOCHORE COMPLEX COMPONENT", SPC25
17347,609396,PH DOMAIN AND LEUCINE-RICH REPEAT PROTEIN PHOSPHATASE 1, PHLPP1
17348,609397,STORKHEAD BOX 1, STOX1
17349,609398,"ATPase, H+ TRANSPORTING, LYSOSOMAL, 34-KD, V1 SUBUNIT D", ATP6V1D
17350,609399,SPERM EQUATORIAL SEGMENT PROTEIN 1, SPESP1
17351,609400,"AUTOIMMUNE DISEASE, SUSCEPTIBILITY TO, 4", AIS4
17352,609401,HEPARAN SULFATE 6-O-SULFOTRANSFERASE 3, HS6ST3
17353,609402,PREECLAMPSIA/ECLAMPSIA 2, PEE2
17354,609403,PREECLAMPSIA/ECLAMPSIA 3, PEE3
17355,609404,PREECLAMPSIA/ECLAMPSIA 4, PEE4
17356,609405,RHO GTPase-ACTIVATING PROTEIN 8, ARHGAP8
17357,609406,PROLINE-RICH PROTEIN 5, PRR5
17358,609407,HEPARAN SULFATE-GLUCOSAMINE 3-SULFOTRANSFERASE 5, HS3ST5
17359,609408,HOLOPROSENCEPHALY 8, HPE8
17360,609409,HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN A0, HNRNPA0
17361,609410,SYNAPTOJANIN 2, SYNJ2
17362,609411,SYNAPTOJANIN 2-BINDING PROTEIN, SYNJ2BP
17363,609412,"ERCC EXCISION REPAIR 8, CSA UBIQUITIN LIGASE COMPLEX SUBUNIT", ERCC8
17364,609413,"ERCC EXCISION REPAIR 6, CHROMATIN REMODELING FACTOR", ERCC6
17365,609414,"PHOSPHOINOSITIDE KINASE, FYVE FINGER-CONTAINING", PIKFYVE
17366,609415,MICRO RNA 17 HOST GENE, MIR17HG
17367,609416,MICRO RNA 17, MIR17
17368,609417,MICRO RNA 18A, MIR18A
17369,609418,MICRO RNA 19A, MIR19A
17370,609419,MICRO RNA 19B1, MIR19B1
17371,609420,MICRO RNA 20A, MIR20A
17372,609421,MICRO RNA 17,
17373,609422,MICRO RNA 92A1, MIR92A1
17374,609423,"HUMAN IMMUNODEFICIENCY VIRUS TYPE 1, SUSCEPTIBILITY TO",
17375,609424,RING FINGER AND CCCH-TYPE ZINC FINGER DOMAINS-CONTAINING 1, RC3H1
17376,609425,CHROMOSOME 3q29 DELETION SYNDROME,
17377,609426,MISSHAPEN/NIK-RELATED KINASE 1, MINK1
17378,609427,"LHFPL TETRASPAN SUBFAMILY, MEMBER 5", LHFPL5
17379,609428,TUKEL SYNDROME,
17380,609429,FORKHEAD BOX N4, FOXN4
17381,609430,NEURONAL PAS DOMAIN PROTEIN 3, NPAS3
17382,609431,MAP3K12-BINDING INHIBITORY PROTEIN, MBIP
17383,609432,"SYNDACTYLY, MESOAXIAL SYNOSTOTIC, WITH PHALANGEAL REDUCTION", MSSD
17384,609433,UBIQUITIN INTERACTION MOTIF-CONTAINING PROTEIN 1, UIMC1
17385,609434,LUC7-LIKE 3 PRE-mRNA SPLICING FACTOR, LUC7L3
17386,609435,NADH-UBIQUINONE OXIDOREDUCTASE SUBUNIT A13, NDUFA13
17387,609436,FIBROBLAST GROWTH FACTOR 21, FGF21
17388,609437,SERINE/THREONINE PROTEIN KINASE 40, STK40
17389,609438,"INTELLECTUAL DEVELOPMENTAL DISORDER WITH KERATOCONUS, FEBRILE SEIZURES, AND SINOATRIAL BLOCK",
17390,609439,"DEAFNESS, AUTOSOMAL RECESSIVE 48", DFNB48
17391,609440,UTP11-LIKE PROTEIN, UTP11L
17392,609441,ACROMESOMELIC DYSPLASIA 3, AMD3
17393,609442,"VALPROATE EMBRYOPATHY, SUSCEPTIBILITY TO",
17394,609443,"CHYMOTRYPSIN-LIKE ELASTASE FAMILY, MEMBER 2A", CELA2A
17395,609444,"CHYMOTRYPSIN-LIKE ELASTASE FAMILY, MEMBER 2B", CELA2B
17396,609445,RELAXIN/INSULIN-LIKE FAMILY PEPTIDE RECEPTOR 3, RXFP3
17397,609446,PAROXYSMAL NONKINESIGENIC DYSKINESIA 3 WITH OR WITHOUT GENERALIZED EPILEPSY, PNKD3
17398,609447,MARGINAL ZONE B AND B1 CELL-SPECIFIC PROTEIN, MZB1
17399,609448,THIOREDOXIN DOMAIN-CONTAINING PROTEIN 12, TXNDC12
17400,609449,NUDE NEURODEVELOPMENT PROTEIN 1, NDE1
17401,609450,MAX DIMERIZATION PROTEIN 3, MXD3
17402,609451,ZFP90 ZINC FINGER PROTEIN, ZFP90
17403,609452,"MYOPATHY, MYOFIBRILLAR, 4", MFM4
17404,609453,GOLGIN A7, GOLGA7
17405,609454,"SUPRANUCLEAR PALSY, PROGRESSIVE, 2", PSNP2
17406,609455,"PROLINE-, GLUTAMIC ACID-, AND LEUCINE-RICH PROTEIN 1", PELP1
17407,609456,"MYASTHENIC SYNDROME, CONGENITAL, 10",
17408,609457,HISTIDINE AMMONIA-LYASE, HAL
17409,609458,"MANNOSIDASE, ALPHA, CLASS 2B, MEMBER 1", MAN2B1
17410,609459,DIGEORGE SYNDROME CRITICAL REGION GENE 6-LIKE, DGCR6L
17411,609460,GOLDBERG-SHPRINTZEN SYNDROME, GOSHS
17412,609461,TRIBBLES PSEUDOKINASE 1, TRIB1
17413,609462,TRIBBLES PSEUDOKINASE 2, TRIB2
17414,609463,MYOCARDIN-RELATED TRANSCRIPTION FACTOR B, MRTFB
17415,609464,BLAU SYNDROME,
17416,609465,AL-GAZALI SYNDROME, ALGAZ
17417,609466,"CLEFT PALATE, MIDFACIAL HYPOPLASIA, TRIANGULAR FACIES, AND SENSORINEURAL HEARING LOSS",
17418,609467,"CHEMOKINE, CC MOTIF, LIGAND 3, PSEUDOGENE 1", CCL3P1
17419,609468,"CHEMOKINE, CC MOTIF, LIGAND 3-LIKE 3", CCL3L3
17420,609469,"NEPHROPATHY, PROGRESSIVE, WITH DEAFNESS",
17421,609470,LEFT VENTRICULAR NONCOMPACTION 2, LVNC2
17422,609471,"GLUCOSIDASE, BETA, ACID 2", GBA2
17423,609472,"CYCLIC NUCLEOTIDE-GATED CHANNEL, ALPHA-4", CNGA4
17424,609473,CINGULIN, CGN
17425,609474,NEURONAL PENTRAXIN RECEPTOR, NPTXR
17426,609475,A-KINASE ANCHOR PROTEIN 8-LIKE PROTEIN, AKAP8L
17427,609476,NEMO-LIKE KINASE, NLK
17428,609477,SINGLE-PASS MEMBRANE PROTEIN WITH COILED-COIL DOMAINS 4, SMCO4
17429,609478,"ST8 ALPHA-N-ACETYL-NEURAMINIDE ALPHA-2,8-SIALYLTRANSFERASE 3", ST8SIA3
17430,609479,MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 20, MAP3K20
17431,609480,ZINC FINGER PROTEIN 33A,
17432,609481,"ISL2 TRANSCRIPTION FACTOR, LIM/HOMEODOMAIN", ISL2
17433,609482,"ANTERIOR GRADIENT 3, PROTEIN DISULPHIDE ISOMERASE FAMILY MEMBER", AGR3
17434,609483,"FAMILY WITH SEQUENCE SIMILARITY 84, MEMBER B", FAM84B
17435,609484,LY6/PLAUR DOMAIN-CONTAINING PROTEIN 3, LYPD3
17436,609485,MODULATOR OF APOPTOSIS 1, MOAP1
17437,609486,E2F-ASSOCIATED PHOSPHOPROTEIN, EAPP
17438,609487,MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 2, MAP3K2
17439,609488,CANCER/TESTIS ANTIGEN KM-HN-1,
17440,609489,"MANNOSIDASE, BETA A, LYSOSOMAL", MANBA
17441,609490,INHIBITORY CASPASE RECRUITMENT DOMAIN PROTEIN,
17442,609491,G PROTEIN SIGNALING MODULATOR 1, GPSM1
17443,609492,RAS ASSOCIATION DOMAIN FAMILY PROTEIN 2, RASSF2
17444,609493,SLC2A4 REGULATOR, SLC2A4RG
17445,609494,ZINC FINGER PROTEIN 395, ZNF395
17446,609495,GAMETOGENETIN-BINDING PROTEIN 1, GGNBP1
17447,609496,COMPLEMENT FACTOR H DEFICIENCY,
17448,609497,ENDOPLASMIC RETICULUM AMINOPEPTIDASE 2, ERAP2
17449,609498,F-BOX ONLY PROTEIN 47,
17450,609499,MCF.2 CELL LINE-DERIVED TRANSFORMING SEQUENCE-LIKE, MCF2L
17451,609500,"MYOPATHY, AUTOPHAGIC VACUOLAR, INFANTILE-ONSET",
17452,609501,TUDOR AND KH DOMAINS-CONTAINING PROTEIN, TDRKH
17453,609502,"CADHERIN-RELATED FAMILY, MEMBER 1", CDHR1
17454,609503,SPERM MICROTUBULE-ASSOCIATED PROTEIN 2, SPMAP2
17455,609504,MICROSPHERULE PROTEIN 1, MCRS1
17456,609505,TRIPARTITE MOTIF-CONTAINING PROTEIN 16, TRIM16
17457,609506,"CYTOCHROME P450, SUBFAMILY XXVIIB, POLYPEPTIDE 1", CYP27B1
17458,609507,TOPOISOMERASE I-BINDING ARGININE/SERINE-RICH PROTEIN, TOPORS
17459,609508,"STICKLER SYNDROME, TYPE I, NONSYNDROMIC OCULAR",
17460,609509,INTERLEUKIN 31, IL31
17461,609510,INTERLEUKIN 31 RECEPTOR A, IL31RA
17462,609511,"RABENOSYN, RAB EFFECTOR", RBSN
17463,609512,CHARGED MULTIVESICULAR BODY PROTEIN 2B, CHMP2B
17464,609513,NEUROPEPTIDE S,
17465,609514,TATA BOX-BINDING PROTEIN-ASSOCIATED FACTOR 8, TAF8
17466,609515,IRIDOGONIODYSGENESIS AND SKELETAL ANOMALIES,
17467,609516,ZINC FINGER PROTEIN 382, ZNF382
17468,609517,TGFB1-INDUCED ANTIAPOPTOTIC FACTOR 1, TIAF1
17469,609518,THAP DOMAIN-CONTAINING PROTEIN 7, THAP7
17470,609519,TCF3 FUSION PARTNER, TFPT
17471,609520,THAP DOMAIN-CONTAINING PROTEIN 1, THAP1
17472,609521,"SOLUTE CARRIER FAMILY 30 (ZINC TRANSPORTER), MEMBER 1", SLC30A1
17473,609522,ELONGIN A2, ELOA2
17474,609523,"ALDEHYDE DEHYDROGENASE, FAMILY 3, SUBFAMILY A, MEMBER 2", ALDH3A2
17475,609524,"MYOPATHY, MYOFIBRILLAR, 5", MFM5
17476,609525,"METHYLTRANSFERASE 8, METHYLCYTIDINE", METTL8
17477,609526,PLECKSTRIN HOMOLOGY DOMAIN- AND RhoGEF DOMAIN-CONTAINING PROTEIN G4, PLEKHG4
17478,609527,RAP GUANINE NUCLEOTIDE EXCHANGE FACTOR 5, RAPGEF5
17479,609528,"CEREBRAL DYSGENESIS, NEUROPATHY, ICHTHYOSIS, AND PALMOPLANTAR KERATODERMA SYNDROME", CEDNIK
17480,609529,IMMUNOGLOBULIN A DEFICIENCY 2, IGAD2
17481,609530,RAP GUANINE NUCLEOTIDE EXCHANGE FACTOR 2, RAPGEF2
17482,609531,RAS GUANYL NUCLEOTIDE-RELEASING PROTEIN 3, RASGRP3
17483,609532,"HEPATITIS C VIRUS, SUSCEPTIBILITY TO",
17484,609533,"DEAFNESS, AUTOSOMAL RECESSIVE 23", DFNB23
17485,609534,"ATPase FAMILY, AAA DOMAIN-CONTAINING, MEMBER 5", ATAD5
17486,609535,"DRUG METABOLISM, POOR, CYP2C19-RELATED",
17487,609536,COMPLEMENT COMPONENT 5 DEFICIENCY, C5D
17488,609537,LIPOMYELOMENINGOCELE,
17489,609538,"PROTEIN-TYROSINE PHOSPHATASE, MITOCHONDRIAL, 1", PTPMT1
17490,609539,AT-RICH INTERACTION DOMAIN-CONTAINING PROTEIN 2, ARID2
17491,609540,SKI8 SUBUNIT OF SUPERKILLER COMPLEX, SKIC8
17492,609541,"SPASTIC PARAPLEGIA, OPTIC ATROPHY, AND NEUROPATHY", SPOAN
17493,609542,"ATPase, CLASS I, TYPE 8A, MEMBER 1", ATP8A1
17494,609543,LONG INTERGENIC NONCODING RNA 293, LINC00293
17495,609544,"CENTRIOLAR COILED-COIL PROTEIN, 110-KD", CCP110
17496,609545,"OMPHALOCELE, DIAPHRAGMATIC HERNIA, AND RADIAL RAY DEFECTS",
17497,609546,UBIQUITIN-SPECIFIC PROTEASE 29, USP29
17498,609547,"ENDOMETRIOSIS, SUSCEPTIBILITY TO, 1",
17499,609548,"LECTIN, MANNOSE-BINDING 1-LIKE", LMAN1L
17500,609549,NANOPHTHALMOS 2, NNO2
17501,609550,ZINC FINGER PROTEIN 330, ZNF330
17502,609551,"LECTIN, MANNOSE-BINDING 2", LMAN2
17503,609552,"LECTIN, MANNOSE-BINDING 2-LIKE", LMAN2L
17504,609553,RETBINDIN,
17505,609554,INTEGRAL MEMBRANE PROTEIN 2C, ITM2C
17506,609555,"CARBOXYPEPTIDASE X, M14 FAMILY, MEMBER 1", CPXM1
17507,609556,ATPase 13A4, ATP13A4
17508,609557,PROLYL ENDOPEPTIDASE-LIKE, PREPL
17509,609558,"PROSTATE CANCER, HEREDITARY, 6",
17510,609559,CALMODULIN LYSINE N-METHYLTRANSFERASE, CAMKMT
17511,609560,MITOCHONDRIAL DNA DEPLETION SYNDROME 2 (MYOPATHIC TYPE), MTDPS2
17512,609561,CARBOXYPEPTIDASE A5, CPA5
17513,609562,CARBOXYPEPTIDASE A6, CPA6
17514,609563,CARBOXYPEPTIDASE O, CPO
17515,609564,"POLY(ADP-RIBOSE) POLYMERASE FAMILY, MEMBER 10", PARP10
17516,609565,MAST CELL-EXPRESSED MEMBRANE PROTEIN 1,
17517,609566,PARIETAL FORAMINA 3, PFM3
17518,609567,PATATIN-LIKE PHOSPHOLIPASE DOMAIN-CONTAINING PROTEIN 3, PNPLA3
17519,609568,RHO GTPase-ACTIVATING PROTEIN 20, ARHGAP20
17520,609569,PHOTOPAROXYSMAL RESPONSE 1,
17521,609570,"MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 8",
17522,609571,ZINC FINGER PROTEIN 699, ZNF699
17523,609572,PHOTOPAROXYSMAL RESPONSE 2, PPR2
17524,609573,PHOTOPAROXYSMAL RESPONSE 3, PPR3
17525,609574,17-BETA-HYDROXYSTEROID DEHYDROGENASE XII, HSD17B12
17526,609575,"ACYL-CoA DEHYDROGENASE, VERY LONG-CHAIN", ACADVL
17527,609576,"ACYL-CoA DEHYDROGENASE, LONG-CHAIN", ACADL
17528,609577,CULLIN 7, CUL7
17529,609578,"CARDIOMYOPATHY, FAMILIAL RESTRICTIVE, 2", RCM2
17530,609579,"SCAPHOCEPHALY, MAXILLARY RETRUSION, AND IMPAIRED INTELLECTUAL DEVELOPMENT",
17531,609580,NINEIN-LIKE PROTEIN, NINL
17532,609581,LATERAL MENINGOCELE SYNDROME,
17533,609582,MICRO RNA 122A, MIR122A
17534,609583,JOUBERT SYNDROME 4, JBTS4
17535,609584,L-2-HYDROXYGLUTARATE DEHYDROGENASE, L2HGDH
17536,609585,COMPLEXIN 3, CPLX3
17537,609586,COMPLEXIN 4, CPLX4
17538,609587,REGULATOR OF CHROMOSOME CONDENSATION 2, RCC2
17539,609588,GLUTAREDOXIN 5, GLRX5
17540,609589,MICROTUBULE-ASSOCIATED SCAFFOLD PROTEIN 1, MTUS1
17541,609590,"QKI, KH DOMAIN-CONTAINING RNA-BINDING PROTEIN", QKI
17542,609591,RIC-LIKE PROTEIN WITHOUT CAAX MOTIF 1, RIT1
17543,609592,RIC-LIKE PROTEIN WITHOUT CAAX MOTIF 2, RIT2
17544,609593,CAPPING PROTEIN REGULATOR AND MYOSIN 1 LINKER 1, CARMIL1
17545,609594,"VENTRICULAR ZONE-EXPRESSED PH DOMAIN-CONTAINING PROTEIN, ZEBRAFISH, HOMOLOG OF, 1", VEPH1
17546,609595,R-SPONDIN 1, RSPO1
17547,609596,"EUKARYOTIC TRANSLATION INITIATION FACTOR 3, SUBUNIT K", EIF3K
17548,609597,PARIETAL FORAMINA 2, PFM2
17549,609598,ZINC FINGER AND HOMEODOMAIN PROTEIN 3, ZHX3
17550,609599,ANKYRIN REPEAT DOMAIN-CONTAINING PROTEIN 1, ANKRD1
17551,609600,ZINC FINGER PROTEIN 396, ZNF396
17552,609601,ZINC FINGER PROTEIN 397, ZNF397
17553,609602,KRUPPEL-LIKE FACTOR 17, KLF17
17554,609603,"CRYSTALLIN, GAMMA-N", CRYGN
17555,609604,"MICROTUBULE-ASSOCIATED PROTEIN 1, LIGHT CHAIN 3, BETA", MAP1LC3B
17556,609605,"MICROTUBULE-ASSOCIATED PROTEIN 1, LIGHT CHAIN 3, GAMMA", MAP1LC3C
17557,609606,AUTOPHAGY-RELATED 3, ATG3
17558,609607,NECTIN CELL ADHESION MOLECULE 4, NECTIN4
17559,609608,AUTOPHAGY-RELATED 12, ATG12
17560,609609,3-HYDROXYACYL-CoA DEHYDROGENASE DEFICIENCY,
17561,609610,TUBULIN-GAMMA COMPLEX-ASSOCIATED PROTEIN 4, TUBGCP4
17562,609611,"ACIDIC LEUCINE-RICH NUCLEAR PHOSPHOPROTEIN 32 FAMILY, MEMBER E", ANP32E
17563,609612,"FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, WITH SYNERGISTIC DIVERGENCE",
17564,609613,"PLECKSTRIN HOMOLOGY DOMAIN-CONTAINING PROTEIN, FAMILY M, MEMBER 2", PLEKHM2
17565,609614,RNA EXONUCLEASE 1 HOMOLOG, REXO1
17566,609615,QUEUINE tRNA-RIBOSYLTRANSFERASE 1, QTRT1
17567,609616,"SPONDYLOMEGAEPIPHYSEAL DYSPLASIA WITH UPPER LIMB MESOMELIA, PUNCTATE CALCIFICATIONS, AND DEAFNESS",
17568,609617,"SOLUTE CARRIER FAMILY 30 (ZINC TRANSPORTER), MEMBER 2", SLC30A2
17569,609618,NONCODING REPRESSOR OF NFAT, NRON
17570,609619,"GOLGIN A8 FAMILY, MEMBER B", GOLGA8B
17571,609620,SHORT QT SYNDROME 1, SQT1
17572,609621,SHORT QT SYNDROME 2, SQT2
17573,609622,SHORT QT SYNDROME 3, SQT3
17574,609623,RAS-INTERACTING PROTEIN 1, RASIP1
17575,609624,MITOCHONDRIAL COILED-COIL DOMAIN 1, MCCD1
17576,609625,CHROMOSOME 10q26 DELETION SYNDROME,
17577,609626,MAM DOMAIN-CONTAINING GLYCOSYLPHOSPHATIDYLINOSITOL ANCHOR 1, MDGA1
17578,609627,"TASTE RECEPTOR, TYPE 2, MEMBER 50", TAS2R50
17579,609628,MAJEED SYNDROME, MJDS
17580,609629,"VISCERAL NEUROPATHY, FAMILIAL, 3, AUTOSOMAL DOMINANT", VSCN3
17581,609630,"LEUKEMIA, CHRONIC LYMPHOCYTIC, SUSCEPTIBILITY TO, 1",
17582,609631,RNA SENSOR RIGI, RIGI
17583,609632,GLYCEROPHOSPHODIESTER PHOSPHODIESTERASE DOMAIN-CONTAINING PROTEIN 5, GDPD5
17584,609633,MAJOR AFFECTIVE DISORDER 3, MAFD3
17585,609634,"MIGRAINE, FAMILIAL HEMIPLEGIC, 3", FHM3
17586,609635,TRANSCRIPTION FACTOR 23, TCF23
17587,609636,ALZHEIMER DISEASE 10,
17588,609637,HOLOPROSENCEPHALY 5, HPE5
17589,609638,"EPIDERMOLYSIS BULLOSA, LETHAL ACANTHOLYTIC", EBLA
17590,609639,HEMOGLOBIN MU,
17591,609640,FRIAS SYNDROME,
17592,609641,"EUKARYOTIC TRANSLATION INITIATION FACTOR 3, SUBUNIT M", EIF3M
17593,609642,"T-CELL ANTIGEN RECEPTOR, GAMMA SUBUNIT, ALTERNATE READING FRAME PROTEIN",
17594,609643,NGUYEN SYNDROME,
17595,609644,FANCM GENE, FANCM
17596,609645,"NLR FAMILY, PYRIN DOMAIN-CONTAINING 4", NLRP4
17597,609646,"DEAFNESS, AUTOSOMAL RECESSIVE 42", DFNB42
17598,609647,"DEAFNESS, AUTOSOMAL RECESSIVE 46", DFNB46
17599,609648,"NLR FAMILY, PYRIN DOMAIN-CONTAINING 12", NLRP12
17600,609649,TRICHILEMMAL CYST 1, TRICY1
17601,609650,"NLR FAMILY, PYRIN DOMAIN-CONTAINING 6", NLRP6
17602,609651,"GLYCOPROTEIN HORMONE, ALPHA-2", GPHA2
17603,609652,"GLYCOPROTEIN HORMONE, BETA-5", GPHB5
17604,609653,"NADH DEHYDROGENASE (UBIQUINONE) COMPLEX I, ASSEMBLY FACTOR 2", NDUFAF2
17605,609654,SHORT STATURE AND FACIOAURICULOTHORACIC MALFORMATIONS,
17606,609655,"TALO-PATELLO-SCAPHOID OSTEOLYSIS, SYNOVITIS, AND SHORT FOURTH METACARPALS",
17607,609656,BONE SIZE QUANTITATIVE TRAIT LOCUS 1,
17608,609657,BONE SIZE QUANTITATIVE TRAIT LOCUS 2,
17609,609658,"NLR FAMILY, PYRIN DOMAIN-CONTAINING 5", NLRP5
17610,609659,"NLR FAMILY, PYRIN DOMAIN-CONTAINING 8", NLRP8
17611,609660,"NLR FAMILY, PYRIN DOMAIN-CONTAINING 13", NLRP13
17612,609661,"NLR FAMILY, PYRIN DOMAIN-CONTAINING 7", NLRP7
17613,609662,"NLR FAMILY, PYRIN DOMAIN-CONTAINING 10", NLRP10
17614,609663,"NLR FAMILY, PYRIN DOMAIN-CONTAINING 9", NLRP9
17615,609664,"NLR FAMILY, PYRIN DOMAIN-CONTAINING 11", NLRP11
17616,609665,"NLR FAMILY, PYRIN DOMAIN-CONTAINING 14", NLRP14
17617,609666,TWO-PORE SEGMENT CHANNEL 1, TPCN1
17618,609667,T-CELL ACTIVATION GTPase-ACTIVATING PROTEIN, TAGAP
17619,609668,PROTEIN PHOSPHATASE TARGETING COQ7, PPTC7
17620,609669,WD REPEAT-CONTAINING PROTEIN 36, WDR36
17621,609670,"MIGRAINE WITH AURA, SUSCEPTIBILITY TO, 9",
17622,609671,STEAP3 METALLOREDUCTASE, STEAP3
17623,609672,EXOCYST COMPLEX COMPONENT 6, EXOC6
17624,609673,PLATELET-DERIVED GROWTH FACTOR D, PDGFD
17625,609674,ESTABLISHMENT OF SISTER CHROMATID COHESION N-ACEYTLTRANSFERASE 1, ESCO1
17626,609675,SCLEROSTIN DOMAIN-CONTAINING PROTEIN 1, SOSTDC1
17627,609676,MITOCHONDRIAL ANTIVIRAL SIGNALING PROTEIN, MAVS
17628,609677,OS9 ENDOPLASMIC RETICULUM LECTIN, OS9
17629,609678,"SLIT- AND NTRK-LIKE FAMILY, MEMBER 1", SLITRK1
17630,609679,"SLIT- AND NTRK-LIKE FAMILY, MEMBER 3", SLITRK3
17631,609680,"SLIT- AND NTRK-LIKE FAMILY, MEMBER 5", SLITRK5
17632,609681,"SLIT- AND NTRK-LIKE FAMILY, MEMBER 6", SLITRK6
17633,609682,DNA CROSS-LINK REPAIR PROTEIN 1A, DCLRE1A
17634,609683,DNA CROSS-LINK REPAIR PROTEIN 1B, DCLRE1B
17635,609684,MAL PROTEOLIPID PROTEIN 2, MAL2
17636,609685,CELL DIVISION CYCLE-ASSOCIATED PROTEIN 7-LIKE, CDCA7L
17637,609686,CITRATE LYASE BETA-LIKE, CLYBL
17638,609687,MICRO RNA 196A2, MIR196A2
17639,609688,MICRO RNA 196B, MIR196B
17640,609689,"CENTROSOMAL PROTEIN, 250-KD", CEP250
17641,609690,"PHENYLALANINE-tRNA SYNTHETASE, BETA SUBUNIT", FARSB
17642,609691,FORMIN HOMOLOGY-2 DOMAIN-CONTAINING PROTEIN 3, FHOD3
17643,609692,"WAS/WASL-INTERACTING PROTEIN FAMILY, MEMBER 2", WIPF2
17644,609693,VON WILLEBRAND FACTOR A DOMAIN-CONTAINING PROTEIN 7, VWA7
17645,609694,GEM-INTERACTING PROTEIN, GMIP
17646,609695,4-HYDROXYPHENYLPYRUVATE DIOXYGENASE, HPD
17647,609696,AT-RICH INTERACTION DOMAIN-CONTAINING PROTEIN 4B, ARID4B
17648,609697,"SIN3A-ASSOCIATED PROTEIN, 130-KD", SAP130
17649,609698,"THYROID HORMONE METABOLISM, ABNORMAL, 1", THMA1
17650,609699,MONOGLYCERIDE LIPASE, MGLL
17651,609700,RAB GUANINE NUCLEOTIDE EXCHANGE FACTOR 1, RABGEF1
17652,609701,"N-ACETYLGLUCOSAMINIDASE, ALPHA-", NAGLU
17653,609702,PROTEASOME ASSEMBLY CHAPERONE 2, PSMG2
17654,609703,MICRO RNA 15A, MIR15A
17655,609704,MICRO RNA 16-1, MIR16-1
17656,609705,MICRO RNA 24-1, MIR24-1
17657,609706,"DEAFNESS, AUTOSOMAL RECESSIVE 53", DFNB53
17658,609707,DIHYDROURIDINE SYNTHASE 2-LIKE, DUS2L
17659,609708,LIPOPROTEIN LIPASE, LPL
17660,609709,GLYCOSYLTRANSFERASE-LIKE 1B, GYLTL1B
17661,609710,DENDRITIC CELL-ASSOCIATED NUCLEAR PROTEIN 1, DCANP1
17662,609711,"UBIQUINOL-CYTOCHROME C REDUCTASE, COMPLEX III SUBUNIT XI", UQCR11
17663,609712,"PYRUVATE KINASE, LIVER AND RED BLOOD CELL", PKLR
17664,609713,HUS1 CHECKPOINT CLAMP COMPONENT B, HUS1B
17665,609714,TRIGGERING RECEPTOR EXPRESSED ON MYELOID CELLS-LIKE PROTEIN 1, TREML1
17666,609715,TRIGGERING RECEPTOR EXPRESSED ON MYELOID CELLS-LIKE PROTEIN 2, TREML2
17667,609716,TRIGGERING RECEPTOR EXPRESSED ON MYELOID CELLS-LIKE PROTEIN 3, TREML3
17668,609717,PROSTATE CANCER-ASSOCIATED TRANSCRIPT 4, PCAT4
17669,609718,"LHFPL TETRASPAN SUBFAMILY, MEMBER 2", LHFPL2
17670,609719,"LHFPL TETRASPAN SUBFAMILY, MEMBER 3", LHFPL3
17671,609720,CRUMBS CELL POLARITY COMPLEX COMPONENT 2, CRB2
17672,609721,POLYCYSTIN 1-LIKE 1, PKD1L1
17673,609722,PDZ AND LIM DOMAIN PROTEIN 2, PDLIM2
17674,609723,YIPPEE-LIKE 2, YPEL2
17675,609724,YIPPEE-LIKE 3, YPEL3
17676,609725,YIPPEE-LIKE 4, YPEL4
17677,609726,YIPPEE-LIKE 5, YPEL5
17678,609727,"SPASTIC PARAPLEGIA 29, AUTOSOMAL DOMINANT", SPG29
17679,609728,METHIONYL-tRNA SYNTHETASE 2, MARS2
17680,609729,PDZ DOMAIN-CONTAINING RING FINGER PROTEIN 3, PDZRN3
17681,609730,PDZ DOMAIN-CONTAINING RING FINGER PROTEIN 4, PDZRN4
17682,609731,CYSTATIN 11, CST11
17683,609732,LIGAND OF NUMB PROTEIN X1, LNX1
17684,609733,LIGAND OF NUMB PROTEIN X2, LNX2
17685,609734,"OBESITY, EARLY-ONSET, WITH ADRENAL INSUFFICIENCY AND RED HAIR", OBAIRH
17686,609735,RING FINGER AND FYVE-LIKE DOMAIN CONTAINING 1, RFFL
17687,609736,COILED-COIL DOMAIN-CONTAINING PROTEIN 88A, CCDC88A
17688,609737,CRUMBS CELL POLARITY COMPLEX COMPONENT 3, CRB3
17689,609738,"IMMUNOGLOBULIN SUPERFAMILY, MEMBER 9", IGSF9
17690,609739,IMMUNOGLOBULIN-LIKE DOMAIN-CONTAINING RECEPTOR 1, ILDR1
17691,609740,PHD FINGER PROTEIN 19, PHF19
17692,609741,"CATARACT 22, MULTIPLE TYPES", CTRCT22
17693,609742,INTERLEUKIN 4-INDUCED GENE 1, IL4I1
17694,609743,CELL ADHESION MOLECULE 3, CADM3
17695,609744,CELL ADHESION MOLECULE 4, CADM4
17696,609745,"GLAUCOMA 1, OPEN ANGLE, I", GLC1I
17697,609746,RHO GTPase-ACTIVATING PROTEIN 10, ARHGAP10
17698,609747,ACTIN-BINDING RHO-ACTIVATING PROTEIN, ABRA
17699,609748,UBIQUITIN-LIKE 7, UBL7
17700,609749,UDP-GLUCURONATE DECARBOXYLASE 1, UXS1
17701,609750,"EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 4", EIG4
17702,609751,"ACYL-CoA OXIDASE 1, PALMITOYL", ACOX1
17703,609752,NUCLEAR RECEPTOR COACTIVATOR 7, NCOA7
17704,609753,"CELIAC DISEASE, SUSCEPTIBILITY TO, 4", CELIAC4
17705,609754,"CELIAC DISEASE, SUSCEPTIBILITY TO, 2", CELIAC2
17706,609755,"CELIAC DISEASE, SUSCEPTIBILITY TO, 3", CELIAC3
17707,609756,CHRNA7/FAM7A FUSION GENE, CHRFAM7A
17708,609757,WILLIAMS-BEUREN REGION DUPLICATION SYNDROME,
17709,609758,Na+/K+ TRANSPORTING ATPase-INTERACTING 2, NKAIN2
17710,609759,PR DOMAIN-CONTAINING PROTEIN 7, PRDM7
17711,609760,PR DOMAIN-CONTAINING PROTEIN 9, PRDM9
17712,609761,TRIO- AND F-ACTIN-BINDING PROTEIN, TRIOBP
17713,609762,"BIOGENESIS OF LYSOSOME-RELATED ORGANELLES COMPLEX 1, SUBUNIT 3", BLOC1S3
17714,609763,"PHOSPHATIDYLINOSITOL 4-KINASE, TYPE 2, ALPHA", PI4K2A
17715,609764,LYSINE DEMETHYLASE 4A, KDM4A
17716,609765,LYSINE DEMETHYLASE 4B, KDM4B
17717,609766,LYSINE DEMETHYLASE 4D, KDM4D
17718,609767,"SOLUTE CARRIER FAMILY 25 (MITOCHONDRIAL CARRIER), MEMBER 28", SLC25A28
17719,609768,"BIOGENESIS OF LYSOSOME-RELATED ORGANELLES COMPLEX 1, SUBUNIT 2", BLOC1S2
17720,609769,"SHORT CHAIN DEHYDROGENASE/REDUCTASE FAMILY 9C, MEMBER 7", SDR9C7
17721,609770,JUNCTIONAL ADHESION MOLECULE-LIKE, JAML
17722,609771,UBINUCLEIN 1, UBN1
17723,609772,CORTACTIN-BINDING PROTEIN 2, CTTNBP2
17724,609773,EP300-INTERACTING INHIBITOR OF DIFFERENTIATION 2, EID2
17725,609774,APOPTOSIS INHIBITOR 5, API5
17726,609775,"YIP1 DOMAIN FAMILY, MEMBER 3", YIPF3
17727,609776,PROLINE-RICH ACIDIC PROTEIN 1, PRAP1
17728,609777,XIN ACTIN-BINDING REPEAT-CONTAINING PROTEIN 1, XIRP1
17729,609778,XIN ACTIN-BINDING REPEAT-CONTAINING PROTEIN 2, XIRP2
17730,609779,NIMA-RELATED KINASE 11, NEK11
17731,609780,"CARBOXYPEPTIDASE, VITELLOGENIC-LIKE", CPVL
17732,609781,"AORTIC ANEURYSM, FAMILIAL ABDOMINAL, 1",
17733,609782,"AORTIC ANEURYSM, FAMILIAL ABDOMINAL, 2", AAA2
17734,609783,"INTER-ALPHA-TRYPSIN INHIBITOR, HEAVY CHAIN 5", ITIH5
17735,609784,UPSTREAM BINDING PROTEIN 1, UBP1
17736,609785,TRANSCRIPTION FACTOR CP2-LIKE 1, TFCP2L1
17737,609786,GRAINYHEAD-LIKE 1, GRHL1
17738,609787,UBIQUITIN-ASSOCIATED PROTEIN 1, UBAP1
17739,609788,X-RAY RADIATION RESISTANCE-ASSOCIATED 1, XRRA1
17740,609789,AQUAPORIN 12A, AQP12A
17741,609790,ALZHEIMER DISEASE 11,
17742,609791,LEUCINE-RICH REPEAT- AND Ig DOMAIN-CONTAINING NOGO RECEPTOR-INTERACTING PROTEIN 1, LINGO1
17743,609792,LEUCINE-RICH REPEAT- AND Ig DOMAIN-CONTAINING NOGO RECEPTOR-INTERACTING PROTEIN 3, LINGO3
17744,609793,LEUCINE-RICH REPEAT- AND Ig DOMAIN-CONTAINING NOGO RECEPTOR-INTERACTING PROTEIN 2, LINGO2
17745,609794,LEUCINE-RICH REPEAT- AND Ig DOMAIN-CONTAINING NOGO RECEPTOR-INTERACTING PROTEIN 4, LINGO4
17746,609795,PYROGLUTAMYLATED RF-AMIDE PEPTIDE PRECURSOR PROTEIN, QRFP
17747,609796,PEELING SKIN SYNDROME 2, PSS2
17748,609797,BICD CARGO ADAPTOR 2, BICD2
17749,609798,NIMA-RELATED KINASE 9, NEK9
17750,609799,NIMA-RELATED KINASE 8, NEK8
17751,609800,"GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 4", GEFSP4
17752,609801,CD300E ANTIGEN, CD300E
17753,609802,"SOLUTE CARRIER FAMILY 24 (SODIUM/POTASSIUM/CALCIUM EXCHANGER), MEMBER 5", SLC24A5
17754,609803,ANKYRIN AND ARMADILLO REPEATS-CONTAINING PROTEIN, ANKAR
17755,609804,CILIA- AND FLAGELLA-ASSOCIATED PROTEIN 52, CFAP52
17756,609805,SPERMATOGENESIS-ASSOCIATED PROTEIN 19, SPATA19
17757,609806,HYDROXYMETHYLBILANE SYNTHASE, HMBS
17758,609807,"CD300 ANTIGEN-LIKE FAMILY, MEMBER F", CD300LF
17759,609808,"HAMARTOMA, PRECALCANEAL CONGENITAL FIBROLIPOMATOUS",
17760,609809,LCK-INTERACTING TRANSMEMBRANE ADAPTOR 1, LIME1
17761,609810,PATERNALLY EXPRESSED GENE 10, PEG10
17762,609811,"CYTOCHROME C OXIDASE, SUBUNIT 7B2", COX7B2
17763,609812,"MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 8, WITH EXOCRINE DYSFUNCTION", MODY8
17764,609813,"SPONDYLOCOSTAL DYSOSTOSIS 3, AUTOSOMAL RECESSIVE", SCDO3
17765,609814,COMPLEMENT FACTOR H DEFICIENCY, CFHD
17766,609815,ZYGODACTYLY 1,
17767,609816,NEUROBEACHIN-LIKE 1, NBEAL1
17768,609817,"VASCULITIS, LYMPHOCYTIC, CUTANEOUS SMALL VESSEL",
17769,609818,UBIQUITIN-SPECIFIC PROTEIN 10, USP10
17770,609819,PRAC1 SMALL NUCLEAR PROTEIN, PRAC1
17771,609820,"ERYTHROCYTOSIS, FAMILIAL, 3", ECYT3
17772,609821,"BLEEDING DISORDER, PLATELET-TYPE, 8", BDPLT8
17773,609822,STATURE QUANTITATIVE TRAIT LOCUS 7, STQTL7
17774,609823,"DEAFNESS, AUTOSOMAL RECESSIVE 28", DFNB28
17775,609824,HORMA DOMAIN-CONTAINING PROTEIN 1, HORMAD1
17776,609825,"COENZYME Q2, POLYPRENYLTRANSFERASE", COQ2
17777,609826,"SOLUTE CARRIER FAMILY 34 (SODIUM/PHOSPHATE COTRANSPORTER), MEMBER 3", SLC34A3
17778,609827,PELLINO E3 UBIQUITIN PROTEIN LIGASE 3, PELI3
17779,609828,FIBRONECTIN TYPE III AND SPRY DOMAINS-CONTAINING PROTEIN 1, FSD1
17780,609829,FSD1 N-TERMINUS-LIKE PROTEIN, FSD1NL
17781,609830,TITLE NOT AVAILABLE AT THIS MOMENT,
17782,609831,METABOLISM OF COBALAMIN ASSOCIATED C, MMACHC
17783,609832,"SOLUTE CARRIER FAMILY 47, MEMBER 1", SLC47A1
17784,609833,"SOLUTE CARRIER FAMILY 47, MEMBER 2", SLC47A2
17785,609834,SET AND MARINER TRANSPOSASE DOMAINS-CONTAINING PROTEIN, SETMAR
17786,609835,MYCBP-ASSOCIATED PROTEIN, MYCBPAP
17787,609836,PTERIN-4-ALPHA-CARBINOLAMINE DEHYDRATASE 2, PCBD2
17788,609837,"SMALL NUCLEOLAR RNA, C/D BOX, 115-1", SNORD115-1
17789,609838,"SOLUTE CARRIER FAMILY 24 (SODIUM/POTASSIUM/CALCIUM EXCHANGER), MEMBER 2", SLC24A2
17790,609839,"SOLUTE CARRIER FAMILY 24 (SODIUM/POTASSIUM/CALCIUM EXCHANGER), MEMBER 3", SLC24A3
17791,609840,"SOLUTE CARRIER FAMILY 24 (SODIUM/POTASSIUM/CALCIUM EXCHANGER), MEMBER 4", SLC24A4
17792,609841,"SOLUTE CARRIER FAMILY 8 (SODIUM/LITHIUM/CALCIUM EXCHANGER), MEMBER B1", SLC8B1
17793,609842,ENHANCER OF mRNA DECAPPING 3, EDC3
17794,609843,DECAPPING mRNA 1B, DCP1B
17795,609844,DECAPPING mRNA 2, DCP2
17796,609845,SUCRASE-ISOMALTASE, SI
17797,609846,"REGENERATING ISLET-DERIVED FAMILY, MEMBER 4", REG4
17798,609847,"NOTUM, PALMITOLEOYL-PROTEIN CARBOXYLESTERASE", NOTUM
17799,609848,POTASSIUM CHANNEL TETRAMERIZATION DOMAIN-CONTAINING PROTEIN 11, KCTD11
17800,609849,CORONIN 1B, CORO1B
17801,609850,"TBC1 DOMAIN FAMILY, MEMBER 1", TBC1D1
17802,609851,INOSITOL POLYPHOSPHATE MULTIKINASE, IPMK
17803,609852,MIX1 HOMEOBOX-LIKE PROTEIN 1, MIXL1
17804,609853,PHOSPHOPANTOTHENOYLCYSTEINE SYNTHETASE, PPCS
17805,609854,PHOSPHOPANTOTHENOYLCYSTEINE DECARBOXYLASE, PPCDC
17806,609855,COENZYME A SYNTHASE, COASY
17807,609856,SPERMATOGENESIS-ASSOCIATED PROTEIN 16, SPATA16
17808,609857,DYSTROPHIA MYOTONICA WD REPEAT-CONTAINING PROTEIN, DMWD
17809,609858,ETHANOLAMINE KINASE 1, ETNK1
17810,609859,ETHANOLAMINE KINASE 2, ETNK2
17811,609860,DAD1-RELATED GENE,
17812,609861,I-KAPPA-B KINASE-INTERACTING PROTEIN, IKBIP
17813,609862,"TRANSMEMBRANE PROTEASE, SERINE 6", TMPRSS6
17814,609863,"TECTONIC FAMILY, MEMBER 1", TCTN1
17815,609864,"PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE 4-PHOSPHATASE, TYPE II", PIP4P2
17816,609865,"PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE 4-PHOSPHATASE, TYPE I", PIP4P1
17817,609866,START DOMAIN-CONTAINING PROTEIN 13, STARD13
17818,609867,UBIQUITIN-LIKE DOMAIN-CONTAINING CTD PHOSPHATASE 1, UBLCP1
17819,609868,SPERMATOGENESIS-ASSOCIATED PROTEIN 7, SPATA7
17820,609869,SPERMATOGENESIS-ASSOCIATED PROTEIN 12, SPATA12
17821,609870,RHO GTPase-ACTIVATING PROTEIN 21, ARHGAP21
17822,609871,"TBC1 DOMAIN FAMILY, MEMBER 2", TBC1D2
17823,609872,WAP 4-DISULFIDE CORE DOMAIN 12, WFDC12
17824,609873,INTELECTIN 1, ITLN1
17825,609874,INTELECTIN 2, ITLN2
17826,609875,ATONAL bHLH TRANSCRIPTION FACTOR 7, ATOH7
17827,609876,BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 6, BMND6
17828,609877,"CRYSTALLIN, LAMBDA-1", CRYL1
17829,609878,MEDIATOR COMPLEX SUBUNIT 9, MED9
17830,609879,SPERMATOGENESIS-ASSOCIATED PROTEIN 4, SPATA4
17831,609880,LYSINE ACETYLTRANSFERASE 7, KAT7
17832,609881,"RNA POLYMERASE II, SUBUNIT J2", POLR2J2
17833,609882,METAL-REGULATORY TRANSCRIPTION FACTOR 2, MTF2
17834,609883,MKS TRANSITION ZONE COMPLEX SUBUNIT 1, MKS1
17835,609884,TRANSMEMBRANE PROTEIN 67, TMEM67
17836,609885,"ELONGATION FACTOR, RNA POLYMERASE II, 3", ELL3
17837,609886,"TUBULOINTERSTITIAL KIDNEY DISEASE, AUTOSOMAL DOMINANT 1",
17838,609887,"GLAUCOMA 1, OPEN ANGLE, G", GLC1G
17839,609888,"LEPROSY, SUSCEPTIBILITY TO, 1", LPRS1
17840,609889,"ALPHA/BETA T-CELL LYMPHOPENIA WITH GAMMA/DELTA T-CELL EXPANSION, SEVERE CYTOMEGALOVIRUS INFECTION, AND AUTOIMMUNITY",
17841,609890,UBIQUITIN PROTEIN LIGASE E3 COMPONENT N-RECOGNIN 4, UBR4
17842,609891,RIPPLY TRANSCRIPTIONAL REPRESSOR 2, RIPPLY2
17843,609892,RIPPLY TRANSCRIPTIONAL REPRESSOR 3, RIPPLY3
17844,609893,"HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 3", CHNG3
17845,609894,UNC13 HOMOLOG A, UNC13A
17846,609895,CASTOR ZINC FINGER PROTEIN 1, CASZ1
17847,609896,"EUKARYOTIC TRANSLATION INITIATION FACTOR 4E FAMILY, MEMBER 3", EIF4E3
17848,609897,EPIDERMAL GROWTH FACTOR-LIKE 8, EGFL8
17849,609898,KRINGLE DOMAIN-CONTAINING TRANSMEMBRANE PROTEIN 1, KREMEN1
17850,609899,KRINGLE DOMAIN-CONTAINING TRANSMEMBRANE PROTEIN 2, KREMEN2
17851,609900,"APOLIPOPROTEIN B mRNA-EDITING ENZYME, CATALYTIC POLYPEPTIDE-LIKE 3D", APOBEC3D
17852,609901,ANKYRIN REPEAT AND STERILE ALPHA MOTIF DOMAINS-CONTAINING PROTEIN 4B, ANKS4B
17853,609902,"PROTEIN-TYROSINE PHOSPHATASE, RECEPTOR-TYPE, Q",
17854,609903,"SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 5", SLEB5
17855,609904,"HISTONE GENE CLUSTER 1, H2B HISTONE FAMILY, MEMBER A", HIST1H2BA
17856,609905,"MYOSIN LIGHT CHAIN 9, REGULATORY", MYL9
17857,609906,EMBRYONAL FYN-ASSOCIATED SUBSTRATE, EFS
17858,609907,SEMAPHORIN 3D, SEMA3D
17859,609908,"APOLIPOPROTEIN B mRNA-EDITING ENZYME, CATALYTIC POLYPEPTIDE-LIKE 4", APOBEC4
17860,609909,"CARDIOMYOPATHY, DILATED, 1P", CMD1P
17861,609910,CILIA- AND FLAGELLA-ASSOCIATED PROTEIN 91, CFAP91
17862,609911,HEPATOCELLULAR CARCINOMA-DOWNREGULATED MITOCHONDRIAL CARRIER PROTEIN,
17863,609912,LYSINE ACETYLTRANSFERASE 8, KAT8
17864,609913,RETINITIS PIGMENTOSA 32, RP32
17865,609914,AQUAPORIN 11, AQP11
17866,609915,"CARDIOMYOPATHY, DILATED, 1Q", CMD1Q
17867,609916,5-AZACYTIDINE-INDUCED PROTEIN 2, AZI2
17868,609917,PRION PROTEIN-INTERACTING PROTEIN, PRNPIP
17869,609918,GALLBLADDER DISEASE 2, GBD2
17870,609919,GALLBLADDER DISEASE 3, GBD3
17871,609920,CADHERIN 22, CDH22
17872,609921,LOW DENSITY LIPOPROTEIN RECEPTOR-RELATED PROTEIN 10, LRP10
17873,609922,EH DOMAIN-BINDING PROTEIN 1, EHBP1
17874,609923,RETINITIS PIGMENTOSA 31, RP31
17875,609924,AMINOACYLASE 1 DEFICIENCY, ACY1D
17876,609925,DIPEPTIDASE 2, DPEP2
17877,609926,DIPEPTIDASE 3, DPEP3
17878,609927,VPS37A SUBUNIT OF ESCRIT-I, VPS37A
17879,609928,"MYOSIN, HEAVY CHAIN 7B, CARDIAC MUSCLE, BETA", MYH7B
17880,609929,"MYOSIN, HEAVY CHAIN 15", MYH15
17881,609930,"MYOSIN, LIGHT CHAIN 6B, ALKALI, SMOOTH MUSCLE AND NONMUSCLE, SLOW", MYL6B
17882,609931,"MYOSIN LIGHT CHAIN 6, ALKALI, SMOOTH MUSCLE AND NONMUSCLE", MYL6
17883,609932,SPERM ACROSOME-ASSOCIATED PROTEIN 4, SPACA4
17884,609933,REGENERATING ISLET-DERIVED 3-GAMMA, REG3G
17885,609934,EARLY B-CELL FACTOR 2, EBF2
17886,609935,EARLY B-CELL FACTOR 4, EBF4
17887,609936,SPINDLIN 1, SPIN1
17888,609937,CELL DIVISION CYCLE-ASSOCIATED PROTEIN 7, CDCA7
17889,609938,CELL ADHESION MOLECULE 2, CADM2
17890,609939,"SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 6", SLEB6
17891,609940,DIAPHYSEAL MEDULLARY STENOSIS WITH MALIGNANT FIBROUS HISTIOCYTOMA,
17892,609941,"DEAFNESS, AUTOSOMAL RECESSIVE 51", DFNB51
17893,609942,NOONAN SYNDROME 3, NS3
17894,609943,COFFIN-SIRIS SYNDROME 1,
17895,609944,"ECTODERMAL DYSPLASIA, SENSORINEURAL HEARING LOSS, AND DISTINCTIVE FACIAL FEATURES",
17896,609945,"BRACHYPHALANGY, POLYDACTYLY, AND TIBIAL APLASIA/HYPOPLASIA",
17897,609946,"DEAFNESS, AUTOSOMAL RECESSIVE 47", DFNB47
17898,609947,PROTEIN ONLY RNASE P CATALYTIC SUBUNIT, PRORP
17899,609948,RING FINGER PROTEIN 216, RNF216
17900,609949,COMPLEMENT COMPONENT 5a RECEPTOR 2, C5AR2
17901,609950,"RIBONUCLEOPROTEIN, PTB-BINDING 1", RAVER1
17902,609951,ZINC FINGER PROTEIN 384, ZNF384
17903,609952,"DEAFNESS, AUTOSOMAL RECESSIVE 55", DFNB55
17904,609953,"RIBONUCLEOPROTEIN, PTB-BINDING 2", RAVER2
17905,609954,"ASPERGER SYNDROME, SUSCEPTIBILITY TO, 4", ASPG4
17906,609955,"FIBROMATOSIS, GINGIVAL, 3", GINGF3
17907,609956,RAS-ASSOCIATED PROTEIN RAB37, RAB37
17908,609957,"PROTEIN PHOSPHATASE, MAGNESIUM/MANGANESE-DEPENDENT, 1J", PPM1J
17909,609958,"ASTHMA-RELATED TRAITS, SUSCEPTIBILITY TO, 3",
17910,609959,MYELOID-ASSOCIATED DIFFERENTIATION MARKER, MYADM
17911,609960,"PUMILIO RNA-BINDING FAMILY, MEMBER 3", PUM3
17912,609961,MINOR HISTOCOMPATIBILITY ANTIGEN HB-1, HMHB1
17913,609962,"C-TYPE LECTIN DOMAIN FAMILY 4, MEMBER E", CLEC4E
17914,609963,CHONDROITIN SULFATE SYNTHASE 3, CHSY3
17915,609964,"C-TYPE LECTIN DOMAIN FAMILY 4, MEMBER D", CLEC4D
17916,609965,"DEAFNESS, AUTOSOMAL DOMINANT 53", DFNA53
17917,609966,GAMETOGENETIN, GGN
17918,609967,B-CELL NOVEL PROTEIN 1,
17919,609968,"HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 5", HHF5
17920,609969,SUPRABASIN,
17921,609970,HES FAMILY bHLH TRANSCRIPTION FACTOR 2, HES2
17922,609971,HES FAMILY bHLH TRANSCRIPTION FACTOR 3, HES3
17923,609972,ACYL-CoA THIOESTERASE 2, ACOT2
17924,609973,HYPERPOLARIZATION-ACTIVATED CYCLIC NUCLEOTIDE-GATED POTASSIUM CHANNEL 3, HCN3
17925,609974,CADHERIN 9, CDH9
17926,609975,"HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 4", HHF4
17927,609976,"HYPOXIA-INDUCIBLE FACTOR 3, ALPHA SUBUNIT", HIF3A
17928,609977,CELL DIVISION CYCLE-ASSOCIATED PROTEIN 8, CDCA8
17929,609978,CALCIUM-DEPENDENT ACTIVATOR PROTEIN FOR SECRETION 2, CADPS2
17930,609979,VESTIGIAL-LIKE 2, VGLL2
17931,609980,VESTIGIAL-LIKE 3, VGLL3
17932,609981,IMMUNODEFICIENCY 54, IMD54
17933,609982,VACUOLAR PROTEIN SORTING 4 HOMOLOG A, VPS4A
17934,609983,VACUOLAR PROTEIN SORTING 4 HOMOLOG B, VPS4B
17935,609984,ZWILCH KINETOCHORE PROTEIN, ZWILCH
17936,609985,PANIC DISORDER 3, PAND3
17937,609986,CASPASE RECRUITMENT DOMAIN-CONTAINING PROTEIN 6, CARD6
17938,609987,STIMULATED BY RETINOIC ACID 8, STRA8
17939,609988,"PYROPHOSPHATASE, INORGANIC, 2", PPA2
17940,609989,"METAPHYSEAL CHONDRODYSPLASIA WITH CONE-SHAPED EPIPHYSES, NORMAL HAIR, AND NORMAL HANDS",
17941,609990,TRICHOSCYPHODYSPLASIA,
17942,609991,FIBRONECTIN TYPE III DOMAIN-CONTAINING PROTEIN 1, FNDC1
17943,609992,"POP5 HOMOLOG, RIBONUCLEASE P/MRP SUBUNIT", POP5
17944,609993,OSTEOSCLEROSIS WITH ICHTHYOSIS AND PREMATURE OVARIAN FAILURE,
17945,609994,"MYOPIA 11, AUTOSOMAL DOMINANT", MYP11
17946,609995,"MYOPIA 12, AUTOSOMAL DOMINANT", MYP12
17947,609996,"COLLAGEN, TYPE XXVIII, ALPHA-1", COL28A1
17948,609997,HISTIDINE TRIAD NUCLEOTIDE-BINDING PROTEIN 2, HINT2
17949,609998,HISTIDINE TRIAD NUCLEOTIDE-BINDING PROTEIN 3, HINT3
17950,609999,SYNAPSE DIFFERENTIATION-INDUCED GENE 1-LIKE, SYNDIG1L
17951,610000,"CENTROSOMAL PROTEIN, 55-KD", CEP55
17952,610001,"ARTHROGRYPOSIS MULTIPLEX WITH DEAFNESS, INGUINAL HERNIAS, AND EARLY DEATH",
17953,610002,"COLLAGEN, TYPE XXI, ALPHA-1", COL21A1
17954,610003,"CEROID LIPOFUSCINOSIS, NEURONAL, 8, NORTHERN EPILEPSY VARIANT",
17955,610004,"COLLAGEN, TYPE XXV, ALPHA-1", COL25A1
17956,610005,TRAF2- AND NCK-INTERACTING KINASE, TNIK
17957,610006,2-METHYLBUTYRYL-CoA DEHYDROGENASE DEFICIENCY,
17958,610007,LIMB REGION 1 HOMOLOG-LIKE, LMBR1L
17959,610008,ARYLSULFATASE G, ARSG
17960,610009,ARYLSULFATASE I, ARSI
17961,610010,ARYLSULFATASE J, ARSJ
17962,610011,ARYLSULFATASE K, ARSK
17963,610012,SULFATASE 1, SULF1
17964,610013,SULFATASE 2, SULF2
17965,610014,TM2 DOMAIN-CONTAINING PROTEIN 3, TM2D3
17966,610015,"GLUTAMINE DEFICIENCY, CONGENITAL", GLND
17967,610016,MICRO RNA 132, MIR132
17968,610017,MULTIPLE SYNOSTOSES SYNDROME 2, SYNS2
17969,610018,RHO GUANINE NUCLEOTIDE EXCHANGE FACTOR 40, ARHGEF40
17970,610019,CATARACT 18, CTRCT18
17971,610020,"TBC1 DOMAIN FAMILY, MEMBER 10A", TBC1D10A
17972,610021,"HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 7", HHF7
17973,610022,MYOSIN VC, MYO5C
17974,610023,"BRACHYDACTYLY, COLOBOMA, AND ANTERIOR SEGMENT DYSGENESIS",
17975,610024,RETINAL CONE DYSTROPHY 3A, RCD3A
17976,610025,"COLLAGEN, TYPE XXIV, ALPHA-1", COL24A1
17977,610026,"COLLAGEN, TYPE XXII, ALPHA-1", COL22A1
17978,610027,VPS26 RETROMER COMPLEX COMPONENT B, VPS26B
17979,610028,"POLY(ADP-RIBOSE) POLYMERASE FAMILY, MEMBER 14", PARP14
17980,610029,VOLTAGE-DEPENDENT ANION CHANNEL 3, VDAC3
17981,610030,VOLTAGE-DEPENDENT ANION CHANNEL 1 PSEUDOGENE 4, VDAC1P4
17982,610031,"CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 7", CDCBM7
17983,610032,TRANSPORTIN 3, TNPO3
17984,610033,PENTA-EF-HAND DOMAIN-CONTAINING PROTEIN 1, PEF1
17985,610034,VPS33A CORE SUBUNIT OF CORVET AND HOPS COMPLEXES, VPS33A
17986,610035,VACUOLAR PROTEIN SORTING 45 HOMOLOG, VPS45
17987,610036,CLAUDIN 19, CLDN19
17988,610037,VPS37B SUBUNIT OF ESCRT-I, VPS37B
17989,610038,VPS37C SUBUNIT OF ESCRT-I, VPS37C
17990,610039,VPS37D SUBUNIT OF ESCRT-I, VPS37D
17991,610040,MYOSIN IIIB, MYO3B
17992,610041,NEDD4 FAMILY-INTERACTING PROTEIN 2, NDFIP2
17993,610042,PITT-HOPKINS-LIKE SYNDROME 1, PTHSL1
17994,610043,"COLLAGEN, TYPE XXIII, ALPHA-1", COL23A1
17995,610044,"POTASSIUM CHANNEL, SUBFAMILY T, MEMBER 2", KCNT2
17996,610045,"ALDEHYDE DEHYDROGENASE 5 FAMILY, MEMBER A1", ALDH5A1
17997,610046,LAEVERIN, LVRN
17998,610047,CANOPY FGF SIGNALING REGULATOR 4, CNPY4
17999,610048,"CORNEAL DYSTROPHY, CONGENITAL STROMAL", CSCD
18000,610049,SAP DOMAIN-CONTAINING RIBONUCLEOPROTEIN, SARNP
18001,610050,"TRANSMEMBRANE PROTEASE, SERINE 13", TMPRSS13
18002,610051,CHARGED MULTIVESICULAR BODY PROTEIN 4A, CHMP4A
18003,610052,CHARGED MULTIVESICULAR BODY PROTEIN 3, CHMP3
18004,610053,TUBULIN-GAMMA COMPLEX-ASSOCIATED PROTEIN 6, TUBGCP6
18005,610054,MACRO H2A.1 HISTONE, MACROH2A1
18006,610055,COILED-COIL AND C2 DOMAINS-CONTAINING PROTEIN 1A, CC2D1A
18007,610056,SPERM-ASSOCIATED ANTIGEN 7, SPAG7
18008,610057,"TRANS-2,3-ENOYL-CoA REDUCTASE", TECR
18009,610058,TUBULIN-SPECIFIC CHAPERONE A, TBCA
18010,610059,MITOCHONDRIAL RIBOSOMAL PROTEIN L33, MRPL33
18011,610060,"POLYMERASE I, RNA, SUBUNIT C", POLR1C
18012,610061,"DYNEIN, AXONEMAL, HEAVY CHAIN 7", DNAH7
18013,610062,"DYNEIN, AXONEMAL, LIGHT CHAIN 1", DNAL1
18014,610063,"DYNEIN, AXONEMAL, HEAVY CHAIN 17", DNAH17
18015,610064,"OPIOID DEPENDENCE, SUSCEPTIBILITY TO, 1",
18016,610065,"SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 7", SLEB7
18017,610066,"SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 8", SLEB8
18018,610067,MYOSIN XVIIIA, MYO18A
18019,610068,"SOLUTE CARRIER FAMILY 26 (ANION TRANSPORTER), MEMBER 6: SLC26A6",
18020,610069,"POLYPOSIS SYNDROME, HEREDITARY MIXED, 2", HMPS2
18021,610070,ASTER-ASSOCIATED PROTEIN,
18022,610071,HYPERPARATHYROIDISM 3, HRPT3
18023,610072,ERMIN, ERMN
18024,610073,ORM1-LIKE PROTEIN 1, ORMDL1
18025,610074,ORM1-LIKE PROTEIN 2, ORMDL2
18026,610075,ORM1-LIKE PROTEIN 3, ORMDL3
18027,610076,CYCLIN-DEPENDENT KINASE 20, CDK20
18028,610077,REGULATOR OF CELL CYCLE, RGCC
18029,610078,MORC FAMILY CW-TYPE ZINC FINGER PROTEIN 3, MORC3
18030,610079,SIALIC ACID ACETYLESTERASE, SIAE
18031,610080,TM2 DOMAIN-CONTAINING PROTEIN 1, TM2D1
18032,610081,TM2 DOMAIN-CONTAINING PROTEIN 2, TM2D2
18033,610082,MYOSIN REGULATORY LIGHT CHAIN-INTERACTING PROTEIN, MYLIP
18034,610083,TENEURIN TRANSMEMBRANE PROTEIN 3, TENM3
18035,610084,TENEURIN TRANSMEMBRANE PROTEIN 4, TENM4
18036,610085,"FAMILY WITH SEQUENCE SIMILARITY 167, MEMBER A", FAM167A
18037,610086,PROTEIN ARGININE METHYLTRANSFERASE 8, PRMT8
18038,610087,PROTEIN ARGININE METHYLTRANSFERASE 7, PRMT7
18039,610088,OLFACTOMEDIN-LIKE 3, OLFML3
18040,610089,RAD50-INTERACTING PROTEIN 1, RINT1
18041,610090,PYRIDOXAMINE 5-PRIME-PHOSPHATE OXIDASE DEFICIENCY, PNPOD
18042,610091,WD REPEAT- AND SOCS BOX-CONTAINING PROTEIN 1, WSB1
18043,610092,MICROPHTHALMIA/COLOBOMA 3, MCOPCB3
18044,610093,"MICROPHTHALMIA, ISOLATED 2", MCOP2
18045,610094,DEF6 GUANINE NUCLEOTIDE EXCHANGE FACTOR, DEF6
18046,610095,"KILLER CELL IMMUNOGLOBULIN-LIKE RECEPTOR, THREE DOMAINS, LONG CYTOPLASMIC TAIL, 3", KIR3DL3
18047,610096,T-CELL IMMUNOGLOBULIN AND MUCIN DOMAINS-CONTAINING PROTEIN 4, TIMD4
18048,610097,OUTER DENSE FIBER OF SPERM TAILS 4, ODF4
18049,610098,MINICHROMOSOME MAINTENANCE COMPLEX COMPONENT 9, MCM9
18050,610099,"MYOPATHY, DISTAL, 3", MPD3
18051,610100,"GIANT AXONAL NEUROPATHY 2, AUTOSOMAL DOMINANT", GAN2
18052,610101,CUTC COPPER TRANSPORTER, CUTC
18053,610102,COMPLEMENT COMPONENT 7 DEFICIENCY, C7D
18054,610103,"S100 CALCIUM-BINDING PROTEIN, ZETA", S100Z
18055,610104,MICRO RNA 125B1, MIR125B1
18056,610105,MICRO RNA 125B2, MIR125B2
18057,610106,DREBRIN-LIKE, DBNL
18058,610107,O-SIALOGLYCOPROTEIN ENDOPEPTIDASE, OSGEP
18059,610108,"ANOCTAMIN 1, CALCIUM-ACTIVATED CHLORIDE CHANNEL", ANO1
18060,610109,ANOCTAMIN 2, ANO2
18061,610110,ANOCTAMIN 3, ANO3
18062,610111,ANOCTAMIN 4, ANO4
18063,610112,C-MAF-INDUCING PROTEIN, CMIP
18064,610113,ADAMTS-LIKE 4, ADAMTSL4
18065,610114,STATURE QUANTITATIVE TRAIT LOCUS 8, STQTL8
18066,610115,TRANSMEMBRANE PROTEIN 48, TMEM48
18067,610116,"PURINERGIC RECEPTOR P2Y, G PROTEIN-COUPLED, 14", P2RY14
18068,610117,"SOLUTE CARRIER FAMILY 26 (SULFATE TRANSPORTER), MEMBER 11", SLC26A11
18069,610118,G PROTEIN-COUPLED RECEPTOR 33, GPR33
18070,610119,TENEURIN TRANSMEMBRANE PROTEIN 2, TENM2
18071,610120,TETRASPANIN 33, TSPAN33
18072,610121,5-HYDROXYTRYPTAMINE RECEPTOR 3C, HTR3C
18073,610122,5-HYDROXYTRYPTAMINE RECEPTOR 3D, HTR3D
18074,610123,5-HYDROXYTRYPTAMINE RECEPTOR 3E, HTR3E
18075,610124,CARBOHYDRATE SULFOTRANSFERASE 13, CHST13
18076,610125,"MICROPHTHALMIA, SYNDROMIC 5", MCOPS5
18077,610126,"MICROPHTHALMIA, SYNDROMIC 6",
18078,610127,"CEROID LIPOFUSCINOSIS, NEURONAL, 10", CLN10
18079,610128,CARBOHYDRATE SULFOTRANSFERASE 11, CHST11
18080,610129,CARBOHYDRATE SULFOTRANSFERASE 12, CHST12
18081,610130,"SOLUTE CARRIER FAMILY 26 (SULFATE TRANSPORTER), MEMBER 1", SLC26A1
18082,610131,"PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 4", PEOA4
18083,610132,VANGL PLANAR CELL POLARITY PROTEIN 1, VANGL1
18084,610133,"ST6 ALPHA-N-ACETYL-NEURAMINYL-2,3-BETA-GALACTOSYL-1,3-N-ACETYLGALACTOSAMINIDE ALPHA-2,6-SIALYLTRANSFERASE 3", ST6GALNAC3
18085,610134,"ST6 ALPHA-N-ACETYL-NEURAMINYL-2,3-BETA-GALACTOSYL-1,3-N-ACETYLGALACTOSAMINIDE ALPHA-2,6-SIALYLTRANSFERASE 5", ST6GALNAC5
18086,610135,"ST6 ALPHA-N-ACETYL-NEURAMINYL-2,3-BETA-GALACTOSYL-1,3-N-ACETYLGALACTOSAMINIDE ALPHA-2,6-SIALYLTRANSFERASE 6", ST6GALNAC6
18087,610136,DEVRIENDT SYNDROME,
18088,610137,"ST6 ALPHA-N-ACETYL-NEURAMINYL-2,3-BETA-GALACTOSYL-1,3-N-ACETYLGALACTOSAMINIDE ALPHA-2,6-SIALYLTRANSFERASE 2", ST6GALNAC2
18089,610138,"ST6 ALPHA-N-ACETYL-NEURAMINYL-2,3-BETA-GALACTOSYL-1,3-N-ACETYLGALACTOSAMINIDE ALPHA-2,6-SIALYLTRANSFERASE 1", ST6GALNAC1
18090,610139,"ST8 ALPHA-N-ACETYL-NEURAMINIDE ALPHA-2,8-SIALYLTRANSFERASE 6", ST8SIA6
18091,610140,"HEART-HAND SYNDROME, SLOVENIAN TYPE",
18092,610141,"QT INTERVAL, VARIATION IN",
18093,610142,"CENTROSOMAL PROTEIN, 290-KD", CEP290
18094,610143,"DEAFNESS, AUTOSOMAL RECESSIVE 62", DFNB62
18095,610144,"TBC1 DOMAIN FAMILY, MEMBER 3B", TBC1D3B
18096,610145,ENDOTHELIN-CONVERTING ENZYME 2, ECE2
18097,610146,"INSULIN-LIKE GROWTH FACTOR II, ANTISENSE", IGF2AS
18098,610147,G PROTEIN-COUPLED BILE ACID RECEPTOR 1, GPBAR1
18099,610148,BBS10 GENE, BBS10
18100,610149,"MACULAR DEGENERATION, AGE-RELATED, 7", ARMD7
18101,610150,"CHAPERONIN CONTAINING T-COMPLEX POLYPEPTIDE 1, SUBUNIT 5", CCT5
18102,610151,METHIONYL AMINOPEPTIDASE 1, METAP1
18103,610152,CENTROMERIC PROTEIN M, CENPM
18104,610153,"DEAFNESS, AUTOSOMAL RECESSIVE 49", DFNB49
18105,610154,"DEAFNESS, AUTOSOMAL RECESSIVE 44", DFNB44
18106,610155,TYPE 1 DIABETES MELLITUS 19, T1D19
18107,610156,"IMPAIRED INTELLECTUAL DEVELOPMENT, TRUNCAL OBESITY, RETINAL DYSTROPHY, AND MICROPENIS SYNDROME", MORMS
18108,610157,HEAT-SHOCK RNA 1,
18109,610158,"CORNEAL DYSTROPHY, FUCHS ENDOTHELIAL, 2", FECD2
18110,610159,ZINC FINGER PROTEIN 366, ZNF366
18111,610160,ZINC FINGER PROTEIN 367, ZNF367
18112,610161,TRANSCRIPTION FACTOR AP2-DELTA, TFAP2D
18113,610162,COILED-COIL DOMAIN-CONTAINING PROTEIN 28B, CCDC28B
18114,610163,IMMUNODEFICIENCY 25, IMD25
18115,610164,MICRO RNA 134, MIRN134
18116,610165,GLYCOSYLTRANSFERASE-LIKE DOMAIN-CONTAINING PROTEIN 1, GTDC1
18117,610166,IQ MOTIF- AND SEC7 DOMAIN-CONTAINING PROTEIN 1, IQSEC1
18118,610167,PHOSPHOHISTIDINE PHOSPHATASE 1, PHPT1
18119,610168,LOEYS-DIETZ SYNDROME 2, LDS2
18120,610169,"INO80 COMPLEX, ATPase SUBUNIT", INO80
18121,610170,KYPHOSCOLIOSIS 1, KYPSC1
18122,610171,CALMODULIN-LIKE 6, CALML6
18123,610172,SPERM FLAGELLAR PROTEIN 2, SPEF2
18124,610173,MICRO RNA 10A, MIR10A
18125,610174,UBIQUITIN DOMAIN-CONTAINING PROTEIN 2, UBTD2
18126,610175,MICRO RNA 130A, MIR130A
18127,610176,"SECRETOGLOBIN, FAMILY 1C, MEMBER 1", SCGB1C1
18128,610177,APOPTOSIS-ENHANCING NUCLEASE, AEN
18129,610178,KIAA0586 GENE, KIAA0586
18130,610179,PHOSPHOLIPASE B1, PLB1
18131,610180,OSTEOCLAST-STIMULATING FACTOR 1, OSTF1
18132,610181,AICARDI-GOUTIERES SYNDROME 2, AGS2
18133,610182,PALMDELPHIN, PALMD
18134,610183,ZINC FINGER AN1 DOMAIN-CONTAINING PROTEIN 6, ZFAND6
18135,610184,MONOACYLGLYCEROL O-ACYLTRANSFERASE 3, MOGAT3
18136,610185,"CEREBELLAR ATAXIA, IMPAIRED INTELLECTUAL DEVELOPMENT, AND DYSEQUILIBRIUM SYNDROME 2", CAMRQ2
18137,610186,UBIQUITIN-SPECIFIC PEPTIDASE 17-LIKE FAMILY MEMBER 2, USP17L2
18138,610187,DIAPHRAGMATIC HERNIA 3, DIH3
18139,610188,JOUBERT SYNDROME 5, JBTS5
18140,610189,SENIOR-LOKEN SYNDROME 6, SLSN6
18141,610190,CARBOHYDRATE SULFOTRANSFERASE 8, CHST8
18142,610191,CARBOHYDRATE SULFOTRANSFERASE 9, CHST9
18143,610192,GLIS FAMILY ZINC FINGER PROTEIN 3, GLIS3
18144,610193,"ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 10", ARVD10
18145,610194,"BETA-1,3-N-ACETYLGALACTOSAMINYLTRANSFERASE 2", B3GALNT2
18146,610195,PTOV1 EXTENDED AT-HOOK-CONTAINING ADAPTOR PROTEIN, PTOV1
18147,610196,ELMO/CED12 DOMAIN-CONTAINING PROTEIN 2, ELMOD2
18148,610197,MEDIATOR COMPLEX SUBUNIT 25, MED25
18149,610198,"3-METHYLGLUTACONIC ACIDURIA, TYPE V", MGCA5
18150,610199,"DIABETES MELLITUS, NEONATAL, WITH CONGENITAL HYPOTHYROIDISM", NDH
18151,610200,MITOCHONDRIAL RIBOSOMAL PROTEIN L13, MRPL13
18152,610201,"CENTROSOMAL PROTEIN, 162-KD", CEP162
18153,610202,"CATARACT 21, MULTIPLE TYPES", CTRCT21
18154,610203,CYSTEINE-RICH PAK1 INHIBITOR, CRIPAK
18155,610204,"PONTOCEREBELLAR HYPOPLASIA, TYPE 5", PCH5
18156,610205,ALAGILLE SYNDROME 2, ALGS2
18157,610206,"SOLUTE CARRIER FAMILY 4 (SODIUM BORATE COTRANSPORTER), MEMBER 11", SLC4A11
18158,610207,"SOLUTE CARRIER FAMILY 4 (ANION EXCHANGER), MEMBER 9", SLC4A9
18159,610208,"MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 10",
18160,610209,"MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 11",
18161,610210,"MAF1 HOMOLOG, NEGATIVE REGULATOR OF RNA POLYMERASE III", MAF1
18162,610211,SRA STEM LOOP-INTERACTING RNA-BINDING PROTEIN, SLIRP
18163,610212,"DEAFNESS, AUTOSOMAL RECESSIVE 66", DFNB66
18164,610213,"ANEURYSM, INTRACRANIAL BERRY, 4", ANIB4
18165,610214,ENDOPLASMIC RETICULUM DEGRADATION-ENHANCING ALPHA-MANNOSIDASE-LIKE PROTEIN 3, EDEM3
18166,610215,RHO GUANINE NUCLEOTIDE EXCHANGE FACTOR 25, ARHGEF25
18167,610216,ANOCTAMIN 8, ANO8
18168,610217,NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2B, NBIA2B
18169,610218,SAP30-BINDING PROTEIN, SAP30BP
18170,610219,PEJVAKIN, PJVK
18171,610220,"DEAFNESS, AUTOSOMAL RECESSIVE 59", DFNB59
18172,610221,"AKT1 SUBSTRATE 1, PROLINE-RICH", AKT1S1
18173,610222,RAS AND RAB INTERACTOR 2, RIN2
18174,610223,RAS AND RAB INTERACTOR 3, RIN3
18175,610224,SPERMATOGENESIS- AND OOGENESIS-SPECIFIC BASIC HELIX-LOOP-HELIX PROTEIN 1, SOHLH1
18176,610225,RIBOSOMAL PROTEIN S19 BINDING PROTEIN 1, RPS19BP1
18177,610226,ZINC FINGER PROTEIN 750, ZNF750
18178,610227,SEBORRHEA-LIKE DERMATITIS WITH PSORIASIFORM ELEMENTS,
18179,610228,CALPAIN 13, CAPN13
18180,610229,CALPAIN 14, CAPN14
18181,610230,tRNA 5-METHYLAMINOMETHYL-2-THIOURIDYLATE METHYLTRANSFERASE, TRMU
18182,610231,POLYCOMB GROUP RING FINGER PROTEIN 1, PCGF1
18183,610232,ATPase 13A3, ATP13A3
18184,610233,"TUMORAL CALCINOSIS, HYPERPHOSPHATEMIC, FAMILIAL, 1",
18185,610234,SYNPOLYDACTYLY 3, SPD3
18186,610235,MITOCHONDRIAL FISSION PROCESS 1, MTFP1
18187,610236,LUNAPARK, LNPK
18188,610237,MEDIATOR COMPLEX SUBUNIT 30, MED30
18189,610238,"SOLUTE CARRIER FAMILY 5 (SODIUM/GLUCOSE COTRANSPORTER), MEMBER 11", SLC5A11
18190,610239,HIGH DENSITY LIPOPROTEIN CHOLESTEROL LEVEL QUANTITATIVE TRAIT LOCUS 4,
18191,610240,"LHFPL TETRASPAN SUBFAMILY, MEMBER 4", LHFPL4
18192,610241,RING FINGER PROTEIN 32, RNF32
18193,610242,CHROMOSOME 7 OPEN READING FRAME 13, C7ORF13
18194,610243,ZINC FINGER FYVE DOMAIN-CONTAINING PROTEIN 27, ZFYVE27
18195,610244,"SPASTIC PARAPLEGIA 33, AUTOSOMAL DOMINANT", SPG33
18196,610245,SPINOCEREBELLAR ATAXIA 23, SCA23
18197,610246,SPINOCEREBELLAR ATAXIA 28, SCA28
18198,610247,"ESOPHAGITIS, EOSINOPHILIC, 1", EOE1
18199,610248,"DEAFNESS, AUTOSOMAL RECESSIVE 65", DFNB65
18200,610249,PROTEIN O-FUCOSYLTRANSFERASE 2, POFUT2
18201,610250,"SPASTIC PARAPLEGIA 31, AUTOSOMAL DOMINANT", SPG31
18202,610251,"ALCOHOL SENSITIVITY, ACUTE",
18203,610252,MICRO RNA 1-2, MIR1-2
18204,610253,KLEEFSTRA SYNDROME 1, KLEFS1
18205,610254,MICRO RNA 133A1, MIR133A1
18206,610255,MICRO RNA 133A2, MIR133A2
18207,610256,ANTERIOR SEGMENT DYSGENESIS 2, ASGD2
18208,610257,"SEC31 HOMOLOG A, COPII COAT COMPLEX COMPONENT", SEC31A
18209,610258,"SEC31 HOMOLOG B, COPII COAT COMPLEX COMPONENT", SEC31B
18210,610259,LONG INTERGENIC NONCODING RNA 163, LINC00163
18211,610260,"PYLORIC STENOSIS, INFANTILE HYPERTROPHIC, 2", IHPS2
18212,610261,"HYPERTENSION, ESSENTIAL, SUSCEPTIBILITY TO, 5",
18213,610262,"HYPERTENSION, ESSENTIAL, SUSCEPTIBILITY TO, 6",
18214,610263,"DNAJ/HSP40 HOMOLOG, SUBFAMILY B, MEMBER 13", DNAJB13
18215,610264,TESTIS-PROSTATE-PLACENTA-EXPRESSED PROTEIN, TEPP
18216,610265,"DEAFNESS, AUTOSOMAL RECESSIVE 67", DFNB67
18217,610266,TAO KINASE 1, TAOK1
18218,610267,METHIONINE AMINOPEPTIDASE 1D, METAP1D
18219,610268,MONOACYLGLYCEROL O-ACYLTRANSFERASE 1, MOGAT1
18220,610269,"BULIMIA NERVOSA, SUSCEPTIBILITY TO",
18221,610270,MONOACYLGLYCEROL O-ACYLTRANSFERASE 2, MOGAT2
18222,610271,PHOSPHATIDYLINOSITOL GLYCAN ANCHOR BIOSYNTHESIS CLASS S PROTEIN, PIGS
18223,610272,PHOSPHATIDYLINOSITOL GLYCAN ANCHOR BIOSYNTHESIS CLASS T PROTEIN, PIGT
18224,610273,PHOSPHATIDYLINOSITOL GLYCAN ANCHOR BIOSYNTHESIS CLASS M PROTEIN, PIGM
18225,610274,PHOSPHATIDYLINOSITOL GLYCAN ANCHOR BIOSYNTHESIS CLASS V PROTEIN, PIGV
18226,610275,PHOSPHATIDYLINOSITOL GLYCAN ANCHOR BIOSYNTHESIS CLASS W PROTEIN, PIGW
18227,610276,PHOSPHATIDYLINOSITOL GLYCAN ANCHOR BIOSYNTHESIS CLASS X PROTEIN, PIGX
18228,610277,ORAI CALCIUM RELEASE-ACTIVATED CALCIUM MODULATOR 1, ORAI1
18229,610278,PLATELET ENDOTHELIAL AGGREGATION RECEPTOR 1,
18230,610279,"PACHYGYRIA, FRONTOTEMPORAL",
18231,610280,OSTEOCRIN, OSTN
18232,610281,ZINC FINGER PROTEIN 62, ZFP62
18233,610282,RETINITIS PIGMENTOSA 35, RP35
18234,610283,CONE-ROD DYSTROPHY 10, CORD10
18235,610284,LIPOYLTRANSFERASE 1, LIPT1
18236,610285,DOWNSTREAM OF TYROSINE KINASE 7, DOK7
18237,610286,LEUCINE CARBOXYL METHYLTRANSFERASE 1, LCMT1
18238,610287,F-BOX AND LEUCINE-RICH REPEAT PROTEIN 15, FBXL15
18239,610288,"GOLGIN A6 FAMILY, MEMBER A", GOLGA6A
18240,610289,3-OXOACID CoA TRANSFERASE 2, OXCT2
18241,610290,UDP-N-ACETYL-ALPHA-D-GALACTOSAMINE:POLYPEPTIDE N-ACETYLGALACTOSAMINYLTRANSFERASE 12, GALNT12
18242,610291,SYNAPTIC VESICLE GLYCOPROTEIN 2C, SV2C
18243,610292,B-CELL SCAFFOLD PROTEIN WITH ANKYRIN REPEATS 1, BANK1
18244,610293,GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 1, GPIBD1
18245,610294,INTELLIGENCE QUANTITATIVE TRAIT LOCUS 2,
18246,610295,INTELLIGENCE QUANTITATIVE TRAIT LOCUS 3,
18247,610296,NUDC DOMAIN-CONTAINING PROTEIN 3, NUDCD3
18248,610297,"PARKINSON DISEASE 13, AUTOSOMAL DOMINANT, SUSCEPTIBILITY TO", PARK13
18249,610298,"PLECKSTRIN HOMOLOGY-LIKE DOMAIN, FAMILY B, MEMBER 2", PHLDB2
18250,610299,"SOLUTE CARRIER FAMILY 6 (NEUROTRANSMITTER TRANSPORTER), MEMBER 17", SLC6A17
18251,610300,"SOLUTE CARRIER FAMILY 6 (NEUROTRANSMITTER TRANSPORTER), MEMBER 18", SLC6A18
18252,610301,TRANSMEMBRANE PROTEIN 57, TMEM57
18253,610302,ENDOPLASMIC RETICULUM DEGRADATION-ENHANCING ALPHA-MANNOSIDASE-LIKE PROTEIN 2, EDEM2
18254,610303,MAF bZIP TRANSCRIPTION FACTOR A, MAFA
18255,610304,"DER1-LIKE DOMAIN FAMILY, MEMBER 2", DERL2
18256,610305,"DER1-LIKE DOMAIN FAMILY, MEMBER 3", DERL3
18257,610306,NEPHRONECTIN, NPNT
18258,610307,CERAMIDE KINASE, CERK
18259,610308,BETA-3-GLUCOSYLTRANSFERASE, B3GLCT
18260,610309,UBIQUITIN-CONJUGATING ENZYME E2 S, UBE2S
18261,610310,"MGAT4 FAMILY, MEMBER D", MGAT4D
18262,610311,MEDIATOR COMPLEX SUBUNIT 28, MED28
18263,610312,PIWI-LIKE RNA-MEDIATED GENE SILENCING 2, PIWIL2
18264,610313,CRISPONI/COLD-INDUCED SWEATING SYNDROME 2, CISS2
18265,610314,PIWI-LIKE RNA-MEDIATED GENE SILENCING 3: PIWIL3,
18266,610315,PIWI-LIKE RNA-MEDIATED GENE SILENCING 4, PIWIL4
18267,610316,POLYRIBONUCLEOTIDE NUCLEOTIDYLTRANSFERASE 1, PNPT1
18268,610317,CORDON-BLEU WH2 REPEAT PROTEIN, COBL
18269,610318,COBL-LIKE PROTEIN 1: COBLL1,
18270,610319,"RHIZOMELIC DYSPLASIA, SCOLIOSIS, AND RETINITIS PIGMENTOSA",
18271,610320,MYOPIA 14, MYP14
18272,610321,"PROSTATE CANCER, HEREDITARY, 7", HPC7
18273,610322,TRANSCRIPTIONAL REGULATING FACTOR 1, TRERF1
18274,610323,METADHERIN, MTDH
18275,610324,"3-OXOACYL-ACP SYNTHASE, MITOCHONDRIAL", OXSM
18276,610325,"NUCLEAR DISTRIBUTION C, DYNEIN COMPLEX REGULATOR", NUDC
18277,610326,"RIBONUCLEASE H2, SUBUNIT B", RNASEH2B
18278,610327,RUN AND FYVE DOMAINS-CONTAINING PROTEIN 1, RUFY1
18279,610328,RUN AND FYVE DOMAINS-CONTAINING PROTEIN 2, RUFY2
18280,610329,AICARDI-GOUTIERES SYNDROME 3, AGS3
18281,610330,"RIBONUCLEASE H2, SUBUNIT C", RNASEH2C
18282,610331,HES FAMILY bHLH TRANSCRIPTION FACTOR 6, HES6
18283,610332,BURN-MCKEOWN SYNDROME,
18284,610333,AICARDI-GOUTIERES SYNDROME 4, AGS4
18285,610334,TRANSMEMBRANE PROTEIN 176A, TMEM176A
18286,610335,PHD FINGER PROTEIN 20, PHF20
18287,610336,C2 CALCIUM-DEPENDENT DOMAIN-CONTAINING PROTEIN 4C, C2CD4C
18288,610337,UPREGULATOR OF CELL PROLIFERATION, URGCP
18289,610338,"RIGHT PULMONARY ARTERY, ANOMALOUS ORIGIN OF, FAMILIAL",
18290,610339,PROLYL 3-HYDROXYLASE 1, P3H1
18291,610340,ERYTHROCYTE MEMBRANE PROTEIN BAND 4.1-LIKE 4B, EPB41L4B
18292,610341,PROLYL 3-HYDROXYLASE 2, P3H2
18293,610342,PROLYL 3-HYDROXYLASE 3, P3H3
18294,610343,C2 CALCIUM-DEPENDENT DOMAIN-CONTAINING PROTEIN 4A, C2CD4A
18295,610344,C2 CALCIUM-DEPENDENT DOMAIN-CONTAINING PROTEIN 4B, C2CD4B
18296,610345,ACYLGLYCEROL KINASE, AGK
18297,610346,CELL DIVISION CYCLE 37-LIKE 1, CDC37L1
18298,610347,REGULATION OF NUCLEAR PRE-mRNA DOMAIN-CONTAINING PROTEIN 1A, RPRD1A
18299,610348,SMC5-SMC6 COMPLEX LOCALIZATION FACTOR 2, SLF2
18300,610349,MEF2-ACTIVATING SAP TRANSCRIPTIONAL REGULATOR, MAMSTR
18301,610350,LINES HOMOLOG 1, LINS1
18302,610351,"PROTEIN PHOSPHATASE 4, REGULATORY SUBUNIT 3, ALPHA", PPP4R3A
18303,610352,"PROTEIN PHOSPHATASE 4, REGULATORY SUBUNIT 3, BETA", PPP4R3B
18304,610353,"EPILEPSY, NOCTURNAL FRONTAL LOBE, 4", ENFL4
18305,610354,"RIC1 HOMOLOG, RAB6A GEF COMPLEX PARTNER 1", RIC1
18306,610355,PARTNER AND LOCALIZER OF BRCA2, PALB2
18307,610356,RETINAL CONE DYSTROPHY 3B, RCD3B
18308,610357,"SPASTIC PARAPLEGIA 30A, AUTOSOMAL DOMINANT", SPG30A
18309,610358,"SIGNAL PEPTIDASE COMPLEX, SUBUNIT 1", SPCS1
18310,610359,RETINITIS PIGMENTOSA 33, RP33
18311,610360,"MUCIN 20, CELL SURFACE-ASSOCIATED", MUC20
18312,610361,OROFACIAL CLEFT 9, OFC9
18313,610362,RETINA AND ANTERIOR NEURAL FOLD HOMEOBOX 2, RAX2
18314,610363,"PEPTIDYLARGININE DEIMINASE, TYPE VI", PADI6
18315,610364,TRANSMEMBRANE BAX INHIBITOR MOTIF-CONTAINING PROTEIN 1, TMBIM1
18316,610365,C1q- AND TUMOR NECROSIS FACTOR-RELATED PROTEIN 1, C1QTNF1
18317,610366,"ADAPTOR-RELATED PROTEIN COMPLEX 3, MU-1 SUBUNIT", AP3M1
18318,610367,"SOLUTE CARRIER FAMILY 2 (FACILITATED GLUCOSE TRANSPORTER), MEMBER 11", SLC2A11
18319,610368,LEUCINE-RICH REPEATS- AND CALPONIN HOMOLOGY DOMAIN-CONTAINING PROTEIN 1, LRCH1
18320,610369,HEAT-SHOCK 70-KD PROTEIN 14, HSPA14
18321,610370,"DIARRHEA 4, MALABSORPTIVE, CONGENITAL", DIAR4
18322,610371,"SOLUTE CARRIER FAMILY 2 (FACILITATED GLUCOSE TRANSPORTER), MEMBER 7", SLC2A7
18323,610372,"SOLUTE CARRIER FAMILY 2 (FACILITATED GLUCOSE TRANSPORTER), MEMBER 12", SLC2A12
18324,610373,DExD-BOX HELICASE 50, DDX50
18325,610374,"DIABETES MELLITUS, TRANSIENT NEONATAL, 2", TNDM2
18326,610375,"CAPRIN FAMILY, MEMBER 2", CAPRIN2
18327,610376,ATYPICAL CHEMOKINE RECEPTOR 3, ACKR3
18328,610377,MEVALONIC ACIDURIA, MEVA
18329,610378,GLIS FAMILY ZINC FINGER PROTEIN 1, GLIS1
18330,610379,"WEST NILE VIRUS, SUSCEPTIBILITY TO",
18331,610380,LOEYS-DIETZ SYNDROME 2,
18332,610381,CONE-ROD DYSTROPHY 11, CORD11
18333,610382,"PROSOPAGNOSIA, HEREDITARY",
18334,610383,"RAS ASSOCIATION DOMAIN FAMILY, MEMBER 9", RASSF9
18335,610384,"HECT, C2, AND WW DOMAINS-CONTAINING E3 UBIQUITIN-PROTEIN LIGASE 1", HECW1
18336,610385,LR8 PROTEIN, LR8
18337,610386,BTB/POZ DOMAIN-CONTAINING PROTEIN 7, BTBD7
18338,610387,"SOLUTE CARRIER FAMILY 25 (MITOCHONDRIAL IRON CARRIER), MEMBER 37", SLC25A37
18339,610388,RRAD- AND GEM-LIKE GTPase 1, REM1
18340,610389,"LATE ENDOSOMAL/LYSOSOMAL ADAPTOR, MAPK AND MTOR ACTIVATOR 2", LAMTOR2
18341,610390,MACROPHAGE EXPRESSED GENE 1, MPEG1
18342,610391,PHOSPHOLIPID PHOSPHATASE-RELATED PROTEIN 3, PLPPR3
18343,610392,MYC-BINDING PROTEIN 2, MYCBP2
18344,610393,GON4-LIKE PROTEIN, GON4L
18345,610394,GLIPR1-LIKE PROTEIN 2, GLIPR1L2
18346,610395,GLIPR1-LIKE PROTEIN 1, GLIPR1L1
18347,610396,"TRAFFICKING PROTEIN PARTICLE COMPLEX, SUBUNIT 6A", TRAPPC6A
18348,610397,"TRAFFICKING PROTEIN PARTICLE COMPLEX, SUBUNIT 6B", TRAPPC6B
18349,610398,SAP30-LIKE PROTEIN, SAP30L
18350,610399,"TRANSMEMBRANE PROTEASE, SERINE 11E", TMPRSS11E
18351,610400,MONO-ADP RIBOSYLHYDROLASE 1, MACROD1
18352,610401,NETRIN 4, NTN4
18353,610402,"ANEURYSM, INTRACRANIAL BERRY, 3",
18354,610403,CULLIN-ASSOCIATED NEDDYLATION-DISSOCIATED 2, CAND2
18355,610404,RECQ-MEDIATED GENOME INSTABILITY 1, RMI1
18356,610405,CHONDROITIN POLYMERIZING FACTOR, CHPF
18357,610406,tRNA ARGININE (ANTICODON TCT) 2-1, TRR-TCT2-1
18358,610407,tRNA GLYCINE (ANTICODON GCC) 2-6, TRG-GCC2-6
18359,610408,"SOLUTE CARRIER FAMILY 15 (OLIGOPEPTIDE TRANSPORTER), MEMBER 3", SLC15A3
18360,610409,"SOLUTE CARRIER FAMILY 16 (MONOCARBOXYLIC ACID TRANSPORTER), MEMBER 8", SLC16A8
18361,610410,"SHORT-CHAIN DEHYDROGENASE/REDUCTASE FAMILY, MEMBER 1", DHRS1
18362,610411,IMPORTIN 13, IPO13
18363,610412,"SERINE PALMITOYLTRANSFERASE, SMALL SUBUNIT, B", SPTSSB
18364,610413,INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN-LIKE 1, IGFBPL1
18365,610414,"NEUROBLASTOMA BREAKPOINT FAMILY, MEMBER 15", NBPF15
18366,610415,SYNTAXIN-BINDING PROTEIN 4, STXBP4
18367,610416,SCAN DOMAIN-CONTAINING 1, SCAND1
18368,610417,SCAN DOMAIN-CONTAINING 2, SCAND2
18369,610418,WD REPEAT- AND FYVE DOMAIN-CONTAINING PROTEIN 2, WDFY2
18370,610419,"DEAFNESS, AUTOSOMAL RECESSIVE 68", DFNB68
18371,610420,"PREAURICULAR TAG, ISOLATED, AUTOSOMAL DOMINANT, 1",
18372,610421,"KH DOMAIN-CONTAINING, RNA-BINDING, SIGNAL TRANSDUCTION-ASSOCIATED PROTEIN 3", KHDRBS3
18373,610422,ALOPECIA-INTELLECTUAL DISABILITY SYNDROME 2, APMR2
18374,610423,PHOSPHOFURIN ACIDIC CLUSTER SORTING PROTEIN 2, PACS2
18375,610424,"HEPATITIS B VIRUS, SUSCEPTIBILITY TO",
18376,610425,"CATARACT 23, MULTIPLE TYPES", CTRCT23
18377,610426,"CATARACT 23, MULTIPLE TYPES",
18378,610427,"CONE-ROD SYNAPTIC DISORDER, CONGENITAL NONPROGRESSIVE", CRSD
18379,610428,CYTOCHROME c OXIDASE ASSEMBLY FACTOR COX18, COX18
18380,610429,CYTOCHROME c OXIDASE ASSEMBLY FACTOR COX19, COX19
18381,610430,"MACROGLOBULINEMIA, WALDENSTROM, SUSCEPTIBILITY TO, 2", WM2
18382,610431,RING FINGER PROTEIN 167, RNF167
18383,610432,RING FINGER PROTEIN 125, RNF125
18384,610433,"LYMPHOCYTE ANTIGEN 6 COMPLEX, LOCUS G5B", LY6G5B
18385,610434,"LYMPHOCYTE ANTIGEN 6 COMPLEX, LOCUS G5C", LY6G5C
18386,610435,"LYMPHOCYTE ANTIGEN 6 COMPLEX, LOCUS G6C", LY6G6C
18387,610436,ROTATIN, RTTN
18388,610437,"LYMPHOCYTE ANTIGEN 6 FAMILY, MEMBER G6E, PSEUDOGENE", LY6G6E
18389,610438,"RESTLESS LEGS SYNDROME, SUSCEPTIBILITY TO, 3", RLS3
18390,610439,"RESTLESS LEGS SYNDROME, SUSCEPTIBILITY TO, 4", RLS4
18391,610440,SMALL G PROTEIN SIGNALING MODULATOR 3, SGSM3
18392,610441,TESTICULAR MICROLITHIASIS,
18393,610442,"SPONDYLOEPIMETAPHYSEAL DYSPLASIA, GENEVIEVE TYPE", SEMDG
18394,610443,KOOLEN-DE VRIES SYNDROME, KDVS
18395,610444,"NIGHT BLINDNESS, CONGENITAL STATIONARY, AUTOSOMAL DOMINANT 3", CSNBAD3
18396,610445,"NIGHT BLINDNESS, CONGENITAL STATIONARY, AUTOSOMAL DOMINANT 1", CSNBAD1
18397,610446,"BURULI ULCER, SUSCEPTIBILITY TO",
18398,610447,SHADOW OF PRION PROTEIN, SPRN
18399,610448,CHILBLAIN LUPUS 1, CHBL1
18400,610449,MITOCHONDRIAL CARRIER HOMOLOG 1, MTCH1
18401,610450,LY6/PLAUR DOMAIN-CONTAINING PROTEIN 1, LYPD1
18402,610451,TUBULIN-SPECIFIC CHAPERONE E-LIKE, TBCEL
18403,610452,MUTAGEN SENSITIVITY,
18404,610453,HEPARAN-ALPHA-GLUCOSAMINIDE N-ACETYLTRANSFERASE, HGSNAT
18405,610454,"LEUCINE ZIPPER, PUTATIVE TUMOR SUPPRESSOR 2", LZTS2
18406,610455,"TUMORAL CALCINOSIS, NORMOPHOSPHATEMIC, FAMILIAL", NFTC
18407,610456,STERILE ALPHA MOTIF DOMAIN-CONTAINING PROTEIN 9, SAMD9
18408,610457,"SPHINGOMYELIN PHOSPHODIESTERASE 4, NEUTRAL MEMBRANE", SMPD4
18409,610458,LEUCINE ZIPPER AND CTNNBIP1 DOMAINS-CONTAINING PROTEIN, LZIC
18410,610459,PROLINE-RICH PROTEIN 13, PRR13
18411,610460,"THIOPURINES, POOR METABOLISM OF, 1", THPM1
18412,610461,RETICULON 4 RECEPTOR-LIKE 1, RTN4RL1
18413,610462,RETICULON 4 RECEPTOR-LIKE 2, RTN4RL2
18414,610463,NUS1 DEHYDRODOLICHYL DIPHOSPHATE SYNTHASE SUBUNIT, NUS1
18415,610464,G PROTEIN-COUPLED RECEPTOR 156, GPR156
18416,610465,"ACYL-CoA SYNTHETASE FAMILY, MEMBER 2", ACSF2
18417,610466,LIMB AND CNS EXPRESSED 1, LIX1
18418,610467,3-HYDROXYACYL-CoA DEHYDRATASE 1, HACD1
18419,610468,INTERFERON-INDUCED PROTEIN 44, IFI44
18420,610469,"ADAPTOR-RELATED PROTEIN COMPLEX 3, MU-2 SUBUNIT", AP3M2
18421,610470,TRANSFER RNA PHOSPHOTRANSFERASE 1, TRPT1
18422,610471,VASOHIBIN 2, VASH2
18423,610472,LPC ACYLTRANSFERASE 1, LPCAT1
18424,610473,LYSOPHOSPHATIDYLGLYCEROL ACYLTRANSFERASE 1, LPGAT1
18425,610474,"CAMPTODACTYLY, TALL STATURE, AND HEARING LOSS SYNDROME", CATSHLS
18426,610475,"PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 2", PPNAD2
18427,610476,"ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 11", ARVD11
18428,610477,"TRANSMEMBRANE PROTEASE, SERINE 9", TMPRSS9
18429,610478,RETINAL CONE DYSTROPHY 4, RCD4
18430,610479,SERUM RESPONSE FACTOR BINDING PROTEIN 1, SRFBP1
18431,610480,LEM DOMAIN-CONTAINING PROTEIN 1, LEMD1
18432,610481,SRC HOMOLOGY 2 DOMAIN-CONTAINING TRANSFORMING PROTEIN D, SHD
18433,610482,SH2 DOMAIN-CONTAINING PROTEIN E, SHE
18434,610483,"AGAMMAGLOBULINEMIA, MICROCEPHALY, AND SEVERE DERMATITIS",
18435,610484,PROLINE-RICH SYNAPSE-ASSOCIATED PROTEIN-INTERACTING PROTEIN 1,
18436,610485,LONG INTERGENIC NONCODING RNA 312, LINC00312
18437,610486,LEUCINE-RICH REPEAT-CONTAINING PROTEIN 4, LRRC4
18438,610487,"KH DOMAIN-CONTAINING, RNA-BINDING, SIGNAL TRANSDUCTION-ASSOCIATED PROTEIN 2", KHDRBS2
18439,610488,TETRATRICOPEPTIDE REPEAT DOMAIN-CONTAINING PROTEIN 9, TTC9
18440,610489,"PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 1", PPNAD1
18441,610490,"PURPLE ACID PHOSPHATASE, LONG FORM",
18442,610491,"SLAIN MOTIF FAMILY, MEMBER 1", SLAIN1
18443,610492,"SLAIN MOTIF FAMILY, MEMBER 2", SLAIN2
18444,610493,DIX DOMAIN-CONTAINING PROTEIN 1, DIXDC1
18445,610494,DDB1- AND CUL4-ASSOCIATED FACTOR 6, DCAF6
18446,610495,INTERMEDIATE FILAMENT FAMILY ORPHAN 1, IFFO1
18447,610496,RHO GTPase-ACTIVATING PROTEIN 29, ARHGAP29
18448,610497,BRISC AND BRCA1 A COMPLEX MEMBER 2, BABAM2
18449,610498,COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 2, COXPD2
18450,610499,RAP GUANINE NUCLEOTIDE EXCHANGE FACTOR 6, RAPGEF6
18451,610500,ANKYRIN REPEAT AND KH DOMAIN-CONTAINING PROTEIN 1, ANKHD1
18452,610501,"NEUROBLASTOMA BREAKPOINT FAMILY, MEMBER 1", NBPF1
18453,610502,RETICULON 4-INTERACTING PROTEIN 1, RTN4IP1
18454,610503,CELL DEATH-INDUCING p53 TARGET 1, CDIP1
18455,610504,PRETERM PREMATURE RUPTURE OF THE MEMBRANES, PPROM
18456,610505,COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 3, COXPD3
18457,610506,"PAF1 HOMOLOG, PAF1/RNA POLYMERASE II COMPLEX COMPONENT", PAF1
18458,610507,"LEO1 HOMOLOG, PAF1/RNA POLYMERASE II COMPLEX COMPONENT", LEO1
18459,610508,"MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 7", MODY7
18460,610509,RIC3 ACETYLCHOLINE RECEPTOR CHAPERONE, RIC3
18461,610510,AURORA BOREALIS, BORA
18462,610511,"SEC23 HOMOLOG A, COAT COMPLEX II COMPONENT", SEC23A
18463,610512,"SEC23 HOMOLOG B, COAT COMPLEX II COMPONENT", SEC23B
18464,610513,ATPase 13A2, ATP13A2
18465,610514,JADE FAMILY PHD FINGER 1, JADE1
18466,610515,JADE FAMILY PHD FINGER 2, JADE2
18467,610516,GLYCERATE KINASE, GLYCTK
18468,610517,CONTACTIN-ASSOCIATED PROTEIN-LIKE 3, CNTNAP3
18469,610518,CONTACTIN-ASSOCIATED PROTEIN-LIKE 4, CNTNAP4
18470,610519,CONTACTIN-ASSOCIATED PROTEIN-LIKE 5, CNTNAP5
18471,610520,"CD300 ANTIGEN-LIKE FAMILY, MEMBER G", CD300LG
18472,610521,POTASSIUM CHANNEL TETRAMERIZATION DOMAIN-CONTAINING PROTEIN 12, KCTD12
18473,610522,COORDINATED EXPRESSION TO IRXA2,
18474,610523,"CENTROSOMAL PROTEIN, 41-KD", CEP41
18475,610524,"ENDOGENOUS RETROVIRUS GROUP FRD, MEMBER 1", ERVFRD1
18476,610525,"5-PRIME-NUCLEOTIDASE, CYTOSOLIC, IA", NT5C1A
18477,610526,"5-PRIME-NUCLEOTIDASE, CYTOSOLIC, IB", NT5C1B
18478,610527,THIOREDOXIN-RELATED TRANSMEMBRANE PROTEIN 1, TMX1
18479,610528,CHROMODOMAIN HELICASE DNA-BINDING PROTEIN 8, CHD8
18480,610529,TUMOR SUPPRESSOR CANDIDATE 1, TUSC1
18481,610530,TRIPARTITE MOTIF-CONTAINING PROTEIN 41, TRIM41
18482,610531,"HYCCIN, PI4KA LIPID KINASE COMPLEX, SUBUNIT 1", HYCC1
18483,610532,"LEUKODYSTROPHY, HYPOMYELINATING, 5", HLD5
18484,610533,WW AND C2 DOMAINS-CONTAINING PROTEIN 1, WWC1
18485,610534,"DECAPPING ENZYME, SCAVENGER", DCPS
18486,610535,"GLAUCOMA 1, OPEN ANGLE, M", GLC1M
18487,610536,"MANDIBULOFACIAL DYSOSTOSIS, GUION-ALMEIDA TYPE", MFDGA
18488,610537,DIPEPTIDYL PEPTIDASE VII, DPP7
18489,610538,UBIQUITIN-CONJUGATING ENZYME E2 T, UBE2T
18490,610539,"GAUCHER DISEASE, ATYPICAL, DUE TO SAPOSIN C DEFICIENCY", GDSAPC
18491,610540,"GNAS COMPLEX LOCUS, ANTISENSE TRANSCRIPT 1", GNASAS1
18492,610541,"PROTEIN PHOSPHATASE 1, REGULATORY SUBUNIT 3B", PPP1R3B
18493,610542,"MYASTHENIC SYNDROME, CONGENITAL, 12", CMS12
18494,610543,"CHROMOSOME 16p13.3 DELETION SYNDROME, PROXIMAL",
18495,610544,IGF-LIKE FAMILY MEMBER 1, IGFL1
18496,610545,IGF-LIKE FAMILY MEMBER 2, IGFL2
18497,610546,IGF-LIKE FAMILY MEMBER 3, IGFL3
18498,610547,IGF-LIKE FAMILY MEMBER 4, IGFL4
18499,610548,AQUARIUS INTRON-BINDING SPLICEOSOMAL FACTOR, AQR
18500,610549,"DIABETES MELLITUS, INSULIN-RESISTANT, WITH ACANTHOSIS NIGRICANS",
18501,610550,"METHIONINE ADENOSYLTRANSFERASE I, ALPHA", MAT1A
18502,610551,"ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 1", IIAE1
18503,610552,UBIQUITIN-LIKE MODIFIER-ACTIVATING ENZYME 5, UBA5
18504,610553,UBIQUITIN-FOLD MODIFIER 1, UFM1
18505,610554,UBIQUITIN-FOLD MODIFIER-CONJUGATING ENZYME 1, UFC1
18506,610555,"CORE 1 SYNTHASE, GLYCOPROTEIN-N-ACETYLGALACTOSAMINE 3-BETA-GALACTOSYLTRANSFERASE, 1", C1GALT1
18507,610556,HIGHLY ACCELERATED REGION GENE 1A, HAR1A
18508,610557,HIGHLY ACCELERATED REGION GENE 1B, HAR1B
18509,610558,MITOGEN-ACTIVATED PROTEIN KINASE-ASSOCIATED PROTEIN 1, MAPKAP1
18510,610559,"RAS ASSOCIATION DOMAIN FAMILY, MEMBER 4", RASSF4
18511,610560,"PROTEASE, SERINE, 36", PRSS36
18512,610561,"PROTEASE, SERINE, 53", PRSS53
18513,610562,ZINC FINGER CCCH DOMAIN-CONTAINING PROTEIN 12A, ZC3H12A
18514,610563,KARYOPHERIN ALPHA-6, KPNA6
18515,610564,"PRENYL DIPHOSPHATE SYNTHASE, SUBUNIT 2", PDSS2
18516,610565,"DYNEIN, AXONEMAL, LIGHT CHAIN 4", DNAL4
18517,610566,MICRO RNA 146A, MIR146A
18518,610567,MICRO RNA 146B, MIR146B
18519,610568,ZINC FINGER PROTEIN 687, ZNF687
18520,610569,UBIQUITIN-SPECIFIC PROTEASE 24, USP24
18521,610570,UBIQUITIN-SPECIFIC PROTEASE 40, USP40
18522,610571,FK506-BINDING PROTEIN 11, FKBP11
18523,610572,MARVEL DOMAIN-CONTAINING PROTEIN 2, MARVELD2
18524,610573,R-SPONDIN 4, RSPO4
18525,610574,R-SPONDIN 3, RSPO3
18526,610575,R-SPONDIN 2, RSPO2
18527,610576,RHO GTPase-ACTIVATING PROTEIN 9, ARHGAP9
18528,610577,RHO GTPase-ACTIVATING PROTEIN 12, ARHGAP12
18529,610578,RHO GTPase-ACTIVATING PROTEIN 15, ARHGAP15
18530,610579,RCSD DOMAIN-CONTAINING PROTEIN 1, RCSD1
18531,610580,ONCOGENE PIM3, PIM3
18532,610581,"COATOMER PROTEIN COMPLEX, SUBUNIT GAMMA-2, INTRONIC TRANSCRIPT 1", COPG2IT1
18533,610582,"DIABETES MELLITUS, TRANSIENT NEONATAL, 3", TNDM3
18534,610583,ANKYRIN REPEAT DOMAIN-CONTAINING PROTEIN 6, ANKRD6
18535,610584,TRIPARTITE MOTIF-CONTAINING PROTEIN 67, TRIM67
18536,610585,RHO GTPase-ACTIVATING PROTEIN 22, ARHGAP22
18537,610586,RHO GTPase-ACTIVATING PROTEIN 24, ARHGAP24
18538,610587,RHO GTPase-ACTIVATING PROTEIN 25, ARHGAP25
18539,610588,DENDRIN, DDN
18540,610589,RHO GTPase-ACTIVATING PROTEIN 11A, ARHGAP11A
18541,610590,RHO GTPase-ACTIVATING PROTEIN 23, ARHGAP23
18542,610591,RHO GTPase-ACTIVATING PROTEIN 27, ARHGAP27
18543,610592,RHO GTPase-ACTIVATING PROTEIN 28, ARHGAP28
18544,610593,MAP6 DOMAIN-CONTAINING PROTEIN 1, MAP6D1
18545,610594,FOLLICULIN-INTERACTING PROTEIN 1, FNIP1
18546,610595,FLAVIN ADENINE DINUCLEOTIDE SYNTHETASE 1, FLAD1
18547,610596,BLOCK OF PROLIFERATION 1, BOP1
18548,610597,GLUTAMATE-RICH WD REPEAT-CONTAINING PROTEIN 1, GRWD1
18549,610598,PHOTORECEPTOR DISC COMPONENT, PRCD
18550,610599,RETINITIS PIGMENTOSA 36, RP36
18551,610600,CORTICOSTERONE METHYLOXIDASE TYPE II DEFICIENCY,
18552,610601,KALLIKREIN-RELATED PEPTIDASE 15, KLK15
18553,610602,"AlkB HOMOLOG 2, ALPHA-KETOGLUTARATE-DEPENDENT DIOXYGENASE", ALKBH2
18554,610603,"AlkB HOMOLOG 3, ALPHA-KETOGLUTARATE-DEPENDENT DIOXYGENASE", ALKBH3
18555,610604,"KILLER CELL IMMUNOGLOBULIN-LIKE RECEPTOR, THREE DOMAINS, PSEUDOGENE 1", KIR3DP1
18556,610605,CYTOPLASMIC POLYADENYLATION ELEMENT-BINDING PROTEIN 2, CPEB2
18557,610606,CYTOPLASMIC POLYADENYLATION ELEMENT-BINDING PROTEIN 3, CPEB3
18558,610607,CYTOPLASMIC POLYADENYLATION ELEMENT-BINDING PROTEIN 4, CPEB4
18559,610608,GINS COMPLEX SUBUNIT 1, GINS1
18560,610609,GINS COMPLEX SUBUNIT 2, GINS2
18561,610610,GINS COMPLEX SUBUNIT 3, GINS3
18562,610611,GINS COMPLEX SUBUNIT 4, GINS4
18563,610612,LEBER CONGENITAL AMAUROSIS 12, LCA12
18564,610613,"CYTOCHROME P450, SUBFAMILY XIB, POLYPEPTIDE 1", CYP11B1
18565,610614,TRANSFORMING GROWTH FACTOR-BETA REGULATOR 1, TBRG1
18566,610615,"RAB, MEMBER RAS ONCOGENE FAMILY-LIKE 6", RABL6
18567,610616,ANKYRIN REPEAT DOMAIN-CONTAINING PROTEIN 12, ANKRD12
18568,610617,DENTICLELESS E3 UBIQUITIN PROTEIN LIGASE HOMOLOG, DTL
18569,610618,"ANGIOEDEMA, HEREDITARY, 3", HAE3
18570,610619,COAGULATION FACTOR XII, F12
18571,610620,ADP-RIBOSYLHYDROLASE-LIKE 1, ADPRHL1
18572,610621,INTURNED PLANAR CELL POLARITY PROTEIN, INTU
18573,610622,FUZZY PLANAR CELL POLARITY PROTEIN, FUZ
18574,610623,"CATARACT 11, MULTIPLE TYPES", CTRCT11
18575,610624,ADP-RIBOSYLSERINE HYDROLASE, ADPRS
18576,610625,ADP-RIBOSYLTRANSFERASE 5, ART5
18577,610626,PHOSPHOLIPID PHOSPHATASE 5, PLPP5
18578,610627,ALPHA-2-MACROGLOBULIN-LIKE 1, A2ML1
18579,610628,HYPOGONADOTROPIC HYPOGONADISM 4 WITH OR WITHOUT ANOSMIA, HH4
18580,610629,DIAMOND-BLACKFAN ANEMIA 3, DBA3
18581,610630,"PROTEIN TYROSINE PHOSPHATASE, NONRECEPTOR-TYPE, 20", PTPN20
18582,610631,"PROTEIN TYROSINE PHOSPHATASE, NONRECEPTOR-TYPE, 20",
18583,610632,MITOCHONDRIAL CALCIUM UPTAKE PROTEIN 2, MICU2
18584,610633,MITOCHONDRIAL CALCIUM UPTAKE PROTEIN 3, MICU3
18585,610634,"CATARACT 32, MULTIPLE TYPES",
18586,610635,COLLAGEN TRIPLE-HELIX REPEAT-CONTAINING PROTEIN 1, CTHRC1
18587,610636,MICRO RNA 27B, MIR27B
18588,610637,MEMBRANE-ASSOCIATED RING-CH FINGER PROTEIN 5, MARCHF5
18589,610638,"IMMUNOGLOBULIN SUPERFAMILY, MEMBER 5", IGSF5
18590,610639,GRID2-INTERACTING PROTEIN 1, GRID2IP1
18591,610640,YTH N6-METHYLADENOSINE RNA-BINDING PROTEIN 2, YTHDF2
18592,610641,"TERMINAL URIDYLYL TRANSFERASE 1, U6 snRNA-SPECIFIC", TUT1
18593,610642,"ENDOPLASMIC RETICULUM PROTEIN, 27-KD", ERP27
18594,610643,CELL PROLIFERATION-REGULATING INHIBITOR OF PROTEIN PHOSPHATASE 2A, CIP2A
18595,610644,"PALMOPLANTAR HYPERKERATOSIS WITH SQUAMOUS CELL CARCINOMA OF SKIN AND 46,XX SEX REVERSAL",
18596,610645,CALCIUM- AND INTEGRIN-BINDING PROTEIN 3, CIB3
18597,610646,CALCIUM- AND INTEGRIN-BINDING PROTEIN 4, CIB4
18598,610647,N-ACETYLTRANSFERASE 8-LIKE, NAT8L
18599,610648,CUT-LIKE HOMEOBOX 2, CUX2
18600,610649,BONE SIZE QUANTITATIVE TRAIT LOCUS 3,
18601,610650,ADHESION-REGULATING MOLECULE 1, ADRM1
18602,610651,"XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP B", XPB
18603,610652,PHOSPHODIESTERASE 10A, PDE10A
18604,610653,RIBOSOMAL RNA-PROCESSING 1, RRP1
18605,610654,RIBOSOMAL RNA-PROCESSING 1B, RRP1B
18606,610655,"TELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 4", HHT4
18607,610656,CYSTEINE CONJUGATE BETA-LYASE 2, CCBL2
18608,610657,"WASH COMPLEX, SUBUNIT 5", WASHC5
18609,610658,TRIPARTITE MOTIF-CONTAINING PROTEIN 29, TRIM29
18610,610659,"GLUTAMATE RECEPTOR, IONOTROPIC, DELTA 1", GRID1
18611,610660,GLYOXYLATE REDUCTASE 1 HOMOLOG, GLYR1
18612,610661,N-GLYCANASE 1, NGLY1
18613,610662,PHOSPHATIDYLINOSITOL GLYCAN ANCHOR BIOSYNTHESIS CLASS Y PROTEIN, PIGY
18614,610663,SET AND MYND DOMAIN-CONTAINING PROTEIN 2, SMYD2
18615,610664,"BRIDGE-LIKE LIPID TRANSFER PROTEIN FAMILY, MEMBER 2", BLTP2
18616,610665,Fc FRAGMENT OF IgG RECEPTOR IIIb, FCGR3B
18617,610666,NEURENSIN 2, NRSN2
18618,610667,UBIQUITIN CARBOXYL-TERMINAL HYDROLASE L5, UCHL5
18619,610668,INSC SPINDLE ORIENTATION ADAPTOR PROTEIN, INSC
18620,610669,TNFAIP3-INTERACTING PROTEIN 2, TNIP2
18621,610670,"CYTOCHROME P450, FAMILY 2, SUBFAMILY U, POLYPEPTIDE 1", CYP2U1
18622,610671,ZINC FINGER PROTEIN 628, ZNF628
18623,610672,"NUCLEUS ACCUMBENS-ASSOCIATED PROTEIN 1, BEN AND BTB/POZ DOMAINS-CONTAINING", NACC1
18624,610673,NUCLEAR APOPTOSIS-INDUCING FACTOR 1, NAIF1
18625,610674,SPERM FLAGELLAR PROTEIN 1, SPEF1
18626,610675,UNCONVENTIONAL SNARE IN THE ER 1, USE1
18627,610676,"AUTISM, SUSCEPTIBILITY TO, 7", AUTS7
18628,610677,LSM14A mRNA PROCESSING BODY ASSEMBLY FACTOR, LSM14A
18629,610678,COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 4, COXPD4
18630,610679,CYCLIN-DEPENDENT KINASE 14, CDK14
18631,610680,"HOLOPROSENCEPHALY, RECURRENT INFECTIONS, AND MONOCYTOSIS",
18632,610681,"PHOSPHOFRUCTOKINASE, MUSCLE TYPE", PFKM
18633,610682,"OSTEOGENESIS IMPERFECTA, TYPE VII", OI7
18634,610683,BBS12 GENE, BBS12
18635,610684,C-TERMINAL DOMAIN NUCLEAR ENVELOPE PHOSPHATASE 1, CTDNEP1
18636,610685,SPLIT-HAND/FOOT MALFORMATION WITH LONG BONE DEFICIENCY 2, SHFLD2
18637,610686,UBX DOMAIN PROTEIN 2B, UBXN2B
18638,610687,NEMALINE MYOPATHY 7, NEM7
18639,610688,JOUBERT SYNDROME 6, JBTS6
18640,610689,"DIPLA1, ANTISENSE",
18641,610690,3-HYDROXYISOBUTYRYL-CoA HYDROLASE, HIBCH
18642,610691,PRUNE HOMOLOG 2 WITH BCH DOMAIN, PRUNE2
18643,610692,HEAT-SHOCK 27-KD PROTEIN 7, HSPB7
18644,610693,HYLS1 CENTRIOLAR AND CILIOGENESIS-ASSOCIATED PROTEIN, HYLS1
18645,610694,PYROGLUTAMYL PEPTIDASE I, PGPEP1
18646,610695,HEAT-SHOCK 27-KD PROTEIN 6, HSPB6
18647,610696,"PCNA-ASSOCIATED FACTOR, 15-KD",
18648,610697,PDZ DOMAIN-CONTAINING 2, PDZD2
18649,610698,"MACULAR DEGENERATION, AGE-RELATED, 4", ARMD4
18650,610699,ZINC FINGER AN1 DOMAIN-CONTAINING PROTEIN 2A, ZFAND2A
18651,610700,HTRA SERINE PEPTIDASE 4, HTRA4
18652,610701,HEAT-SHOCK 70-KD PROTEIN 12A, HSPA12A
18653,610702,HEAT-SHOCK 70-KD PROTEIN 12B, HSPA12B
18654,610703,HEAT-SHOCK 105/110-KD PROTEIN 1, HSPH1
18655,610704,PROHIBITIN 2, PHB2
18656,610705,"CD300 ANTIGEN-LIKE FAMILY, MEMBER B", CD300LB
18657,610706,"DEAFNESS, CONGENITAL, WITH INNER EAR AGENESIS, MICROTIA, AND MICRODONTIA",
18658,610707,"PSORIASIS 8, SUSCEPTIBILITY TO", PSORS8
18659,610708,OPTIC ATROPHY 5, OPA5
18660,610709,TESTIS-SPECIFIC SERINE/THREONINE KINASE 1, TSSK1
18661,610710,TESTIS-SPECIFIC SERINE/THREONINE KINASE 2, TSSK2
18662,610711,TESTIS-SPECIFIC SERINE/THREONINE KINASE 4, TSSK4
18663,610712,TESTIS-SPECIFIC SERINE/THREONINE KINASE 6, TSSK6
18664,610713,BRACHYDACTYLY-SYNDACTYLY SYNDROME, BDSD
18665,610714,PROTEIN KINASE N3, PKN3
18666,610715,HEMOGEN, HEMGN
18667,610716,TIMELESS-INTERACTING PROTEIN, TIPIN
18668,610717,NEUTRAL LIPID STORAGE DISEASE WITH MYOPATHY, NLSDM
18669,610718,MICRO RNA 195, MIR195
18670,610719,MICRO RNA 199A1, MIR199A1
18671,610720,MICRO RNA 199A2, MIR199A2
18672,610721,MICRO RNA 214, MIR214
18673,610722,MICRO RNA 23A,
18674,610723,MICRO RNA 23B, MIR23B
18675,610724,MICRO RNA 24-2, MIR24-2
18676,610725,"NEPHROTIC SYNDROME, TYPE 3", NPHS3
18677,610726,TRUB PSEUDOURIDINE SYNTHASE FAMILY MEMBER 1, TRUB1
18678,610727,TRUB PSEUDOURIDINE SYNTHASE FAMILY MEMBER 2, TRUB2
18679,610728,"SPHINGOMYELIN PHOSPHODIESTERASE, ACID-LIKE, 3A", SMPDL3A
18680,610729,"DYNEIN, AXONEMAL, ASSEMBLY FACTOR 10", DNAAF10
18681,610730,"CHAPERONIN-CONTAINING T-COMPLEX POLYPEPTIDE 1, SUBUNIT 6B", CCT6B
18682,610731,ANKYRIN REPEAT DOMAIN-CONTAINING PROTEIN 7, ANKRD7
18683,610732,TETRATRICOPEPTIDE REPEAT DOMAIN-CONTAINING PROTEIN 12, TTC12
18684,610733,NOONAN SYNDROME 4, NS4
18685,610734,ANKYRIN REPEAT DOMAIN-CONTAINING PROTEIN 2, ANKRD2
18686,610735,MYOZENIN 3, MYOZ3
18687,610736,ANKYRIN REPEAT DOMAIN-CONTAINING PROTEIN 23, ANKRD23
18688,610737,KINASE SUPPRESSOR OF RAS 2, KSR2
18689,610738,"NEUTROPENIA, SEVERE CONGENITAL, 3, AUTOSOMAL RECESSIVE", SCN3
18690,610739,TRINUCLEOTIDE REPEAT-CONTAINING GENE 6A, TNRC6A
18691,610740,TRINUCLEOTIDE REPEAT-CONTAINING GENE 6B, TNRC6B
18692,610741,TRINUCLEOTIDE REPEAT-CONTAINING GENE 6C, TNRC6C
18693,610742,MOV10 RISC COMPLEX RNA HELICASE , MOV10
18694,610743,"SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 8", SCAR8
18695,610744,IRIS PATTERN,
18696,610745,STIMULATED BY RETINOIC ACID 6, STRA6
18697,610746,DOLICHOL KINASE, DOLK
18698,610747,STERILE ALPHA MOTIF DOMAIN-CONTAINING PROTEIN 4A, SAMD4A
18699,610748,UBIQUITIN-SPECIFIC PROTEASE 28, USP28
18700,610749,KELCH-LIKE 31, KLHL31
18701,610750,ZINC FINGER CCHC DOMAIN- AND RNA-BINDING MOTIF-CONTAINING PROTEIN 1, ZCRB1
18702,610751,PHOSPHORIBOSYL TRANSFERASE DOMAIN-CONTAINING PROTEIN 1, PRTFDC1
18703,610752,URONYL 2-SULFOTRANSFERASE, UST
18704,610753,ALOPECIA AREATA 2, AA2
18705,610754,WAPL COHESIN RELEASE FACTOR, WAPL
18706,610755,"MULTIPLE ENDOCRINE NEOPLASIA, TYPE IV", MEN4
18707,610756,CEREBROOCULOFACIOSKELETAL SYNDROME 2, COFS2
18708,610757,"CHEMOKINE, CC MOTIF, LIGAND 4-LIKE 2", CCL4L2
18709,610758,CEREBROOCULOFACIOSKELETAL SYNDROME 4, COFS4
18710,610759,CORNELIA DE LANGE SYNDROME 3 WITH OR WITHOUT MIDLINE BRAIN DEFECTS, CDLS3
18711,610760,CHOLESTEROL LEVEL QUANTITATIVE TRAIT LOCUS 2,
18712,610761,HIGH DENSITY LIPOPROTEIN CHOLESTEROL LEVEL QUANTITATIVE TRAIT LOCUS 5,
18713,610762,HIGH DENSITY LIPOPROTEIN CHOLESTEROL LEVEL QUANTITATIVE TRAIT LOCUS 6, HDLCQ6
18714,610763,N-ACETYLNEURAMINIC ACID PHOSPHATASE, NANP
18715,610764,TSPO-ASSOCIATED PROTEIN 1, TSPOAP1
18716,610765,"ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 11",
18717,610766,MEIOSIS-SPECIFIC NUCLEAR STRUCTURAL PROTEIN 1, MNS1
18718,610767,AUTOPHAGY 16-LIKE 1, ATG16L1
18719,610768,"CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Im", CDG1M
18720,610769,NOC3-LIKE DNA REPLICATION REGULATOR, NOC3L
18721,610770,NOC2-LIKE NUCLEOLAR-ASSOCIATED TRANSCRIPTIONAL REPRESSOR, NOC2L
18722,610771,CHROMODOMAIN HELICASE DNA-BINDING PROTEIN 5, CHD5
18723,610772,NK6 HOMEOBOX 3, NKX6-3
18724,610773,MITOCHONDRIAL PHOSPHATE CARRIER DEFICIENCY, MPCD
18725,610774,CANOPY FGF SIGNALING REGULATOR 3, CNPY3
18726,610775,TP53-INDUCED GLYCOLYSIS AND APOPTOSIS REGULATOR, TIGAR
18727,610776,DAMAGE-REGULATED AUTOPHAGY MODULATOR 1, DRAM1
18728,610777,NEUROGUIDIN, NGDN
18729,610778,"GUANINE NUCLEOTIDE-BINDING PROTEIN, BETA-1-LIKE", GNB1L
18730,610779,NUCLEOTIDE-BINDING PROTEIN 2, NUBP2
18731,610780,LARGE 60S SUBUNIT NUCLEAR EXPORT GTPase 1, LSG1
18732,610781,GUANOSINE MONOPHOSPHATE REDUCTASE 2, GMPR2
18733,610782,MICRO RNA 29A, MIR29A
18734,610783,MICRO RNA 29B1, MIR29B1
18735,610784,MICRO RNA 29C, MIR29C
18736,610785,PDLIM1-INTERACTING KINASE 1-LIKE, PDIK1L
18737,610786,SRC KINASE SIGNALING INHIBITOR 1, SRCIN1
18738,610787,PRAC2 SMALL NUCLEAR PROTEIN, PRAC2
18739,610788,"SOLUTE CARRIER FAMILY 35 (3-PRIME-PHOSPHOADENOSINE 5-PRIME-PHOSPHOSULFATE TRANSPORTER), MEMBER B2", SLC35B2
18740,610789,p53 AND DNA DAMAGE-REGULATED 1, PDRG1
18741,610790,"SOLUTE CARRIER FAMILY 35, MEMBER B1", SLC35B1
18742,610791,"SOLUTE CARRIER FAMILY 43 (L-TYPE AMINO ACID TRANSPORTER), MEMBER 2", SLC43A2
18743,610792,"SOLUTE CARRIER FAMILY 22, MEMBER 25", SLC22A25
18744,610793,"SOLUTE CARRIER FAMILY 25 (MITOCHONDRIAL CARRIER, KIDNEY), MEMBER 30", SLC25A30
18745,610794,ZINC FINGER PROTEIN 323, ZNF323
18746,610795,SORBIN AND SH3 DOMAINS-CONTAINING PROTEIN 3, SORBS3
18747,610796,"SOLUTE CARRIER FAMILY 25 (MITOCHONDRIAL CARRIER, ADENINE NUCLEOTIDE TRANSLOCATOR), MEMBER 31", SLC25A31
18748,610797,"EPIPHYSEAL DYSPLASIA, BAUMANN TYPE",
18749,610798,IMMUNODEFICIENCY DUE TO DEFECT IN MAPBP-INTERACTING PROTEIN,
18750,610799,IMMUNODEFICIENCY 67,
18751,610800,AUTOPHAGY-RELATED 10, ATG10
18752,610801,"SOLUTE CARRIER FAMILY 41 (MAGNESIUM TRANSPORTER), MEMBER 1", SLC41A1
18753,610802,"SOLUTE CARRIER FAMILY 41, MEMBER 2", SLC41A2
18754,610803,"SOLUTE CARRIER FAMILY 41, MEMBER 3", SLC41A3
18755,610804,"SOLUTE CARRIER FAMILY 35 (UDP-GLUCURONIC ACID/UDP-N-ACETYLGALACTOSAMINE DUAL TRANSPORTER), MEMBER D1", SLC35D1
18756,610805,CONGENITAL ANOMALIES OF KIDNEY AND URINARY TRACT 1, CAKUT1
18757,610806,"TBC1 DOMAIN FAMILY, MEMBER 3C", TBC1D3C
18758,610807,"TBC1 DOMAIN FAMILY, MEMBER 3D", TBC1D3D
18759,610808,"TBC1 DOMAIN FAMILY, MEMBER 3E", TBC1D3E
18760,610809,"TBC1 DOMAIN FAMILY, MEMBER 3F", TBC1D3F
18761,610810,"TBC1 DOMAIN FAMILY, MEMBER 3G", TBC1D3G
18762,610811,"TBC1 DOMAIN FAMILY, MEMBER 3H", TBC1D3H
18763,610812,HYDIN AXONEMAL CENTRAL PAIR APPARATUS PROTEIN, HYDIN
18764,610813,HYDIN AXONEMAL CENTRAL PAIR APPARATUS PROTEIN 2, HYDIN2
18765,610814,"MICROPHTHALMIA, SYNDROMIC 9",
18766,610815,"SOLUTE CARRIER FAMILY 25 (MITOCHONDRIAL CARRIER, FOLATE), MEMBER 32",
18767,610816,"SOLUTE CARRIER FAMILY 25 (MITOCHONDRIAL CARRIER, PYRIMIDINE NUCLEOTIDE TRANSPORTER), MEMBER 33", SLC25A33
18768,610817,"SOLUTE CARRIER FAMILY 25, MEMBER 34", SLC25A34
18769,610818,"SOLUTE CARRIER FAMILY 25, MEMBER 35", SLC25A35
18770,610819,"SOLUTE CARRIER FAMILY 25, MEMBER 38", SLC25A38
18771,610820,"SOLUTE CARRIER FAMILY 25, MEMBER 39", SLC25A39
18772,610821,"SOLUTE CARRIER FAMILY 25, MEMBER 40", SLC25A40
18773,610822,"SOLUTE CARRIER FAMILY 25, MEMBER 41", SLC25A41
18774,610823,"SOLUTE CARRIER FAMILY 25, MEMBER 42", SLC25A42
18775,610824,"SOLUTE CARRIER FAMILY 25, MEMBER 44", SLC25A44
18776,610825,"SOLUTE CARRIER FAMILY 25, MEMBER 45", SLC25A45
18777,610826,"SOLUTE CARRIER FAMILY 25, MEMBER 46", SLC25A46
18778,610827,ZINC FINGER PROTEIN 335, ZNF335
18779,610828,HOLOPROSENCEPHALY 7, HPE7
18780,610829,HOLOPROSENCEPHALY 9, HPE9
18781,610830,POLYOSTEOLYSIS-HYPEROSTOSIS SYNDROME,
18782,610831,"TBC1 DOMAIN FAMILY, MEMBER 10C", TBC1D10C
18783,610832,"FANCONI ANEMIA, COMPLEMENTATION GROUP N", FANCN
18784,610833,"N-ALPHA-ACETYLTRANSFERASE 20, NatB CATALYTIC SUBUNIT", NAA20
18785,610834,"N-ALPHA-ACETYLTRANSFERASE 50, NatE CATALYTIC SUBUNIT", NAA50
18786,610835,NMDA RECEPTOR-REGULATED 2, NARG2
18787,610836,"AUTISM, SUSCEPTIBILITY TO, 11", AUTS11
18788,610837,BCL2-LIKE 12, BCL2L12
18789,610838,"AUTISM, SUSCEPTIBILITY TO, 12", AUTS12
18790,610839,OSTEOARTHRITIS SUSCEPTIBILITY 4, OS4
18791,610840,MITRAL VALVE PROLAPSE 3, MVP3
18792,610841,STROMAL INTERACTION MOLECULE 2, STIM2
18793,610842,PSEUDOXANTHOMA ELASTICUM-LIKE DISORDER WITH MULTIPLE COAGULATION FACTOR DEFICIENCY,
18794,610843,"UBIQUINOL-CYTOCHROME C REDUCTASE, COMPLEX III SUBUNIT X", UQCR10
18795,610844,"SPG11 VESICLE TRAFFICKING ASSOCIATED, SPATACSIN", SPG11
18796,610845,"SOLUTE CARRIER FAMILY 35 (3-PRIME-PHOSPHOADENOSINE 5-PRIME-PHOSPHOSULFATE TRANSPORTER), MEMBER B3", SLC35B3
18797,610846,LEUCINE-RICH REPEAT-CONTAINING PROTEIN 10, LRRC10
18798,610847,ZINC FINGER PROTEIN 322, ZNF322
18799,610848,RAB15 EFFECTOR PROTEIN, REP15
18800,610849,TUBULIN TYROSINE LIGASE-LIKE 6, TTLL6
18801,610850,XPA-BINDING PROTEIN 2, XAB2
18802,610851,ADAPTOR-RELATED PROTEIN COMPLEX 1-ASSOCIATED REGULATORY PROTEIN, AP1AR
18803,610852,"CILIARY DYSKINESIA, PRIMARY, 6", CILD6
18804,610853,AT-HOOK-CONTAINING TRANSCRIPTION FACTOR 1, AHCTF1
18805,610854,"OSTEOGENESIS IMPERFECTA, TYPE VII",
18806,610855,ANKYRIN REPEAT DOMAIN-CONTAINING PROTEIN 26, ANKRD26
18807,610856,ANKYRIN REPEAT DOMAIN-CONTAINING PROTEIN 30A, ANKRD30A
18808,610857,MUCIN-LIKE 1, MUCL1
18809,610858,"RNA TRANSCRIPTION, TRANSLATION, AND TRANSPORT FACTOR", RTRAF
18810,610859,CAPPING PROTEIN REGULATOR AND MYOSIN 1 LINKER 2, CARMIL2
18811,610860,"AMYLO-1,6-GLUCOSIDASE, 4-ALPHA-GLUCANOTRANSFERASE", AGL
18812,610861,SPECTRIN REPEAT-CONTAINING NUCLEAR ENVELOPE PROTEIN 3, SYNE3
18813,610862,"DELTA(4)-DESATURASE, SPHINGOLIPID, 2", DEGS2
18814,610863,"GUANINE NUCLEOTIDE-BINDING PROTEIN, BETA-4", GNB4
18815,610864,FLVCR1 DIVERGENT TRANSCRIPT, FLVCR1-DT
18816,610865,FLVCR HEME TRANSPORTER 2, FLVCR2
18817,610866,URIDINE/CYTIDINE KINASE-LIKE 1, UCKL1
18818,610867,LEUCINE-RICH REPEAT TRANSMEMBRANE PROTEIN 1: LRRTM1,
18819,610868,LEUCINE-RICH REPEAT TRANSMEMBRANE PROTEIN 2, LRRTM2
18820,610869,LEUCINE-RICH REPEAT TRANSMEMBRANE PROTEIN 3, LRRTM3
18821,610870,LEUCINE-RICH REPEAT TRANSMEMBRANE PROTEIN 4, LRRTM4
18822,610871,SAKODA COMPLEX,
18823,610872,IBR DOMAIN-CONTAINING PROTEIN 3, IBRDC3
18824,610873,"MENARCHE, AGE AT, QUANTITATIVE TRAIT LOCUS 1", MENAQ1
18825,610874,SPERMATOGENESIS AND CENTRIOLE-ASSOCIATED 1, SPATC1
18826,610875,"PROTEIN PHOSPHATASE 6, REGULATORY SUBUNIT 1", PPP6R1
18827,610876,HECT DOMAIN- AND ANKYRIN REPEAT-CONTAINING E3 UBIQUITIN PROTEIN LIGASE 1, HACE1
18828,610877,"PROTEIN PHOSPHATASE 6, REGULATORY SUBUNIT 2", PPP6R2
18829,610878,VESICOURETERAL REFLUX 2, VUR2
18830,610879,"PROTEIN PHOSPHATASE 6, REGULATORY SUBUNIT 3", PPP6R3
18831,610880,CHROMOSOME 11 OPEN READING FRAME 24, C11ORF24
18832,610881,LYSINE METHYLTRANSFERASE 5B, KMT5B
18833,610882,SJOGREN SYNDROME NUCLEAR AUTOANTIGEN 1, SSNA1
18834,610883,POTOCKI-LUPSKI SYNDROME, PTLS
18835,610884,FA CORE COMPLEX-ASSOCIATED PROTEIN 24, FAAP24
18836,610885,ESSENTIAL MEIOTIC STRUCTURE-SPECIFIC ENDONUCLEASE 1, EME1
18837,610886,ESSENTIAL MEIOTIC STRUCTURE-SPECIFIC ENDONUCLEASE 2, EME2
18838,610887,"POLYMERASE, DNA, NU", POLN
18839,610888,GASTRIC CANCER-RELATED GENE 224,
18840,610889,IMPORTIN 11, IPO11
18841,610890,REGULATOR OF G PROTEIN SIGNALING 7-BINDING PROTEIN, RGS7BP
18842,610891,"FAMILY WITH SEQUENCE SIMILARITY 102, MEMBER A", FAM102A
18843,610892,SYNAPTOTAGMIN 14-LIKE PROTEIN, SYT14L
18844,610893,CHARGED MULTIVESICULAR BODY PROTEIN 2A, CHMP2A
18845,610894,NEUREGULIN 4, NRG4
18846,610895,"WAP, FOLLISTATIN, IMMUNOGLOBULIN, KUNITZ, AND NTR DOMAINS-CONTAINING PROTEIN 2", WFIKKN2
18847,610896,BRANCHIOOTORENAL SYNDROME 2, BOR2
18848,610897,CHARGED MULTIVESICULAR BODY PROTEIN 4B, CHMP4B
18849,610898,"SUPRANUCLEAR PALSY, PROGRESSIVE, 3", PSNP3
18850,610899,CHARGED MULTIVESICULAR BODY PROTEIN 4C, CHMP4C
18851,610900,CHARGED MULTIVESICULAR BODY PROTEIN 5, CHMP5
18852,610901,CHARGED MULTIVESICULAR BODY PROTEIN 6, CHMP6
18853,610902,VESSICLE TRAFFICKING 1, VTA1
18854,610903,VACUOLAR PROTEIN SORTING 36 HOMOLOG, VPS36
18855,610904,SNF8 SUBUNIT OF ESCRIT-II, SNF8
18856,610905,AICARDI-GOUTIERES SYNDROME 1,
18857,610906,"ASTHMA-RELATED TRAITS, SUSCEPTIBILITY TO, 4",
18858,610907,VACUOLAR PROTEIN SORTING 25 HOMOLOG, VPS25
18859,610908,"AUTISM, SUSCEPTIBILITY TO, 13", AUTS13
18860,610909,MINICHROMOSOME MAINTENANCE COMPLEX-BINDING PROTEIN, MCMBP
18861,610910,"PULMONARY ALVEOLAR PROTEINOSIS, ACQUIRED",
18862,610911,RHO GTPase-ACTIVATING PROTEIN 31, ARHGAP31
18863,610912,AMELOTIN, AMTN
18864,610913,"SURFACTANT METABOLISM DYSFUNCTION, PULMONARY, 2", SMDP2
18865,610914,ECTO-NOX DISULFIDE-THIOL EXCHANGER 1, ENOX1
18866,610915,"OSTEOGENESIS IMPERFECTA, TYPE VIII", OI8
18867,610916,"NOP2/SUN RNA METHYLTRANSFERASE FAMILY, MEMBER 2", NSUN2
18868,610917,RAS-ASSOCIATED PROTEIN 34, RAB34
18869,610918,SELENOPROTEIN M, SELENOM
18870,610919,GTP-BINDING PROTEIN 5, GTPBP5
18871,610920,GTP-BINDING PROTEIN 10, GTPBP10
18872,610921,"SURFACTANT METABOLISM DYSFUNCTION, PULMONARY, 3", SMDP3
18873,610922,NUCLEAR PORE ASSOCIATED PROTEIN 1, NPAP1
18874,610923,"SOLUTE CARRIER FAMILY 35 (UDP-XYLOSE/UDP-N-ACETYLGLUCOSAMINE TRANSPORTER), MEMBER B4", SLC35B4
18875,610924,RANBP-TYPE AND C3HC4-TYPE ZINC FINGER-CONTAINING 1, RBCK1
18876,610925,INTERLEUKIN 17 RECEPTOR C, IL17RC
18877,610926,"TOOTH AGENESIS, SELECTIVE, 5", STHAG5
18878,610927,"SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 9", SLEB9
18879,610928,SRY-BOX 17, SOX17
18880,610929,ORAI CALCIUM RELEASE-ACTIVATED CALCIUM MODULATOR 2, ORAI2
18881,610930,ORAI CALCIUM RELEASE-ACTIVATED CALCIUM MODULATOR 3, ORAI3
18882,610931,ZINC FINGER GENE IN AUTOIMMUNE THYROID DISEASE 1, ZFAT1
18883,610932,TWINFILIN ACTIN-BINDING PROTEIN 1, TWF1
18884,610933,LEUCINE-RICH REPEAT- AND STERILE ALPHA MOTIF-CONTAINING 1, LRSAM1
18885,610934,NOBOX OOGENESIS HOMEOBOX, NOBOX
18886,610935,ZINC-ACTIVATED ION CHANNEL, ZACN
18887,610936,PHOSPHOSERINE AMINOTRANSFERASE 1, PSAT1
18888,610937,RPGRIP1-LIKE, RPGRIP1L
18889,610938,"CORONARY HEART DISEASE, SUSCEPTIBILITY TO, 7", CHDS7
18890,610939,MICRO RNA 192, MIR192
18891,610940,MICRO RNA 194-1, MIR194-1
18892,610941,MICRO RNA 194-2, MIR194-2
18893,610942,MICRO RNA 204, MIR204
18894,610943,MICRO RNA 215, MIR215
18895,610944,MICRO RNA 216, MIR216
18896,610945,MICRO RNA 296, MIR296
18897,610946,MICRO RNA 133B, MIR133B
18898,610947,"CORONARY ARTERY DISEASE, AUTOSOMAL DOMINANT 2", ADCAD2
18899,610948,"HYPERTENSION, ESSENTIAL, SUSCEPTIBILITY TO, 7",
18900,610949,SYNAPTOTAGMIN 14, SYT14
18901,610950,SYNAPTOTAGMIN 16, SYT16
18902,610951,"CEROID LIPOFUSCINOSIS, NEURONAL, 7", CLN7
18903,610952,CROOKED NECK PRE-mRNA SPLICING FACTOR-LIKE 1, CRNKL1
18904,610953,PIF1 5-PRIME-TO-3-PRIME DNA HELICASE, PIF1
18905,610954,PITT-HOPKINS SYNDROME, PTHS
18906,610955,"TRAFFICKING PROTEIN PARTICLE COMPLEX, SUBUNIT 3", TRAPPC3
18907,610956,ASPARTYL-tRNA SYNTHETASE 2, DARS2
18908,610957,TYROSYL-tRNA SYNTHETASE 2, YARS2
18909,610958,1-ACYLGLYCEROL-3-PHOSPHATE O-ACYLTRANSFERASE 9, AGPAT9
18910,610959,MICRO RNA 376A1, MIR376A1
18911,610960,MICRO RNA 376A2, MIR376A2
18912,610961,MICRO RNA 376B, MIR376B
18913,610962,SMG5 NONSENSE-MEDIATED mRNA DECAY FACTOR, SMG5
18914,610963,SMG6 NONSENSE-MEDIATED mRNA DECAY FACTOR, SMG6
18915,610964,SMG7 NONSENSE-MEDIATED mRNA DECAY FACTOR, SMG7
18916,610965,XFE PROGEROID SYNDROME, XFEPS
18917,610966,FTO ALPHA-KETOGLUTARATE-DEPENDENT DIOXYGENASE, FTO
18918,610967,"OSTEOGENESIS IMPERFECTA, TYPE V", OI5
18919,610968,"OSTEOGENESIS IMPERFECTA, TYPE XI", OI11
18920,610969,"TRAFFICKING PROTEIN PARTICLE COMPLEX, SUBUNIT 1", TRAPPC1
18921,610970,TRAFFICKING PROTEIN PARTICLE COMPLEX 2-LIKE, TRAPPC2L
18922,610971,"TRAFFICKING PROTEIN PARTICLE COMPLEX, SUBUNIT 4", TRAPPC4
18923,610972,ADHERENS JUNCTION-ASSOCIATED PROTEIN 1, AJAP1
18924,610973,"MEMBRANE PROTEIN, PALMITOYLATED 7", MPP7
18925,610974,ZINC FINGER PROTEIN 521, ZNF521
18926,610975,"SKIN-, EMBRYO-, BRAIN-, AND OOCYTE-SPECIFIC HOMEOBOX",
18927,610976,"APOLIPOPROTEIN B mRNA EDITING ENZYME, CATALYTIC POLYPEPTIDE-LIKE 3H", APOBEC3H
18928,610977,TETRACYCLINE TRANSPORTER-LIKE PROTEIN,
18929,610978,CHOREOATHETOSIS AND CONGENITAL HYPOTHYROIDISM WITH OR WITHOUT PULMONARY DYSFUNCTION, CAHTP
18930,610979,DIPHOSPHOINOSITOL PENTAKISPHOSPHATE KINASE 1, PPIP5K1
18931,610980,KCNQ1 DOWNSTREAM NEIGHBOR, KCNQ1DN
18932,610981,WWBP2 N-TERMINAL-LIKE PROTEIN, WBP2NL
18933,610982,INVERTED FORMIN 2, INF2
18934,610983,MICRO RNA 376C, MIR376C
18935,610984,COMPLEMENT FACTOR I DEFICIENCY, CFID
18936,610985,UBIQUITIN E2 VARIANT AND LACTATE/MALATE DEHYDROGENASE DOMAINS-CONTAINING PROTEIN, UEVLD
18937,610986,LEUCINE-RICH REPEAT KINASE 1, LRRK1
18938,610987,N-ACYLSPHINGOSINE AMIDOHYDROLASE 2B, ASAH2B
18939,610988,"LEPROSY, SUSCEPTIBILITY TO, 4", LPRS4
18940,610989,LEMUR TYROSINE KINASE 2, LMTK2
18941,610990,PROTEIN PHOSPHATASE 1 REGULATORY SUBUNIT 18, PPP1R18
18942,610991,OBSCURIN-LIKE 1, OBSL1
18943,610992,PHOSPHOSERINE AMINOTRANSFERASE DEFICIENCY, PSATD
18944,610993,UBIQUITIN-SPECIFIC PROTEASE 44, USP44
18945,610994,TRANSMEMBRANE PROTEIN 189, TMEM189
18946,610995,PRENYLCYSTEINE OXIDASE 1, PCYOX1
18947,610996,D-AMINOACYL-tRNA DEACYLASE 1, DTD1
18948,610997,"PROSTATE CANCER, HEREDITARY, 9", HPC9
18949,610998,METEORIN, METRN
18950,610999,ENHANCER OF POLYCOMB HOMOLOG 1, EPC1
18951,611000,ENHANCER OF POLYCOMB HOMOLOG 2, EPC2
18952,611001,MYST/ESA1-ASSOCIATED FACTOR 6, MEAF6
18953,611002,TRANSMEMBRANE PROTEIN 204, TMEM204
18954,611003,SMOKING AS A QUANTITATIVE TRAIT LOCUS 1, SQTL1
18955,611004,SMOKING AS A QUANTITATIVE TRAIT LOCUS 2, SQTL2
18956,611005,MEX3 RNA-BINDING FAMILY MEMBER C, MEX3C
18957,611006,IRON-SULFUR CLUSTER ASSEMBLY 1, ISCA1
18958,611007,MEX3 RNA-BINDING FAMILY MEMBER A, MEX3A
18959,611008,MEX3 RNA-BINDING FAMILY MEMBER B, MEX3B
18960,611009,MEX3 RNA-BINDING FAMILY MEMBER D, MEX3D
18961,611010,"FIBROMATOSIS, GINGIVAL, 4", GINGF4
18962,611011,TRANSMEMBRANE PROTEIN 259, TMEM259
18963,611012,REGULATOR OF G PROTEIN SIGNALING-LIKE 1, RGSL1
18964,611013,REGULATOR OF G PROTEIN SIGNALING-LIKE 2, RGSL2
18965,611014,"HYPERTENSION, ESSENTIAL, SUSCEPTIBILITY TO, 8", HYT8
18966,611015,"AUTISM, SUSCEPTIBILITY TO, 9", AUTS9
18967,611016,"AUTISM, SUSCEPTIBILITY TO, 10", AUTS10
18968,611017,TRYPSIN DOMAIN-CONTAINING PROTEIN 1, TYSND1
18969,611018,POLYADENYLATE-BINDING PROTEIN-INTERACTING PROTEIN 2B, PAIP2B
18970,611019,"ATPase, H+ TRANSPORTING, LYSOSOMAL, 9-KD, V0 SUBUNIT E2", ATP6V0E2
18971,611020,MICRO RNA 21, MIR21
18972,611021,NMD3 RIBOSOME EXPORT ADAPTOR, NMD3
18973,611022,"DEAFNESS, AUTOSOMAL RECESSIVE 24", DFNB24
18974,611023,tRNA METHYLTRANSFERASE 5, TRMT5
18975,611024,ZINC FINGER PROTEIN 667, ZNF667
18976,611025,"ENKURIN, TRPC CHANNEL-INTERACTING PROTEIN", ENKUR
18977,611026,FATTY ACID 2-HYDROXYLASE, FA2H
18978,611027,SHC-BINDING AND SPINDLE-ASSOCIATED PROTEIN 1, SHCBP1
18979,611028,TRANSMEMBRANE PROTEIN 30A, TMEM30A
18980,611029,TRANSMEMBRANE PROTEIN 30B, TMEM30B
18981,611030,TRANSMEMBRANE PROTEIN 30C, TMEM30C
18982,611031,EPISODIC KINESIGENIC DYSKINESIA 2, EKD2
18983,611032,SPERMATOGENESIS-ASSOCIATED PROTEIN 17, SPATA17
18984,611033,CHROMOSOME 11 OPEN READING FRAME 21, C11ORF21
18985,611034,"SOLUTE CARRIER FAMILY 17 (ORGANIC ANION TRANSPORTER), MEMBER 3", SLC17A3
18986,611035,APRATAXIN- AND PNKP-LIKE FACTOR, APLF
18987,611036,"SOLUTE CARRIER FAMILY 2 (FACILITATED GLUCOSE TRANSPORTER), MEMBER 13", SLC2A13
18988,611037,"SOLUTE CARRIER FAMILY 25 (MITOCHONDRIAL CARRIER, PHOSPHATE CARRIER), MEMBER 26", SLC25A26
18989,611038,"MICROPHTHALMIA, SYNDROMIC 16", MCOPS16
18990,611039,"SOLUTE CARRIER FAMILY 2 (FACILITATED GLUCOSE TRANSPORTER), MEMBER 14", SLC2A14
18991,611040,"MICROPHTHALMIA, ISOLATED 5", MCOP5
18992,611041,TRIPARTITE MOTIF-CONTAINING PROTEIN 47, TRIM47
18993,611042,LATE CORNIFIED ENVELOPE-LIKE PROLINE-RICH 1, LELP1
18994,611043,LIN28 HOMOLOG A, LIN28A
18995,611044,LIN28 HOMOLOG B, LIN28B
18996,611045,"GLUCOSE-6-PHOSPHATASE, CATALYTIC, 3", G6PC3
18997,611046,"MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO, 2",
18998,611047,RETINOIC ACID EARLY TRANSCRIPT 1L, RAET1L
18999,611048,"PROTEIN PHOSPHATASE 1, REGULATORY SUBUNIT 15A", PPP1R15A
19000,611049,"SOLUTE CARRIER FAMILY 17, MEMBER 2", SLC17A2
19001,611050,LEUCINE ZIPPER PROTEIN 6, LUZP6
19002,611051,COILED-COIL DOMAIN-CONTAINING PROTEIN 50, CCDC50
19003,611052,SET DOMAIN-CONTAINING PROTEIN 1A, SETD1A
19004,611053,RUN DOMAIN AND SH3 DOMAIN-CONTAINING PROTEIN 2, RUSC2
19005,611054,PTPRF-INTERACTING PROTEIN ALPHA-1, PPFIA1
19006,611055,SET DOMAIN-CONTAINING PROTEIN 1B, SETD1B
19007,611056,SELENOCYSTEINE LYASE, SCLY
19008,611057,ZINC FINGER PROTEIN 107,
19009,611058,PEROXISOME BIOGENESIS FACTOR 5-LIKE, PEX5L
19010,611059,WD REPEAT-CONTAINING PROTEIN 82, WDR82
19011,611060,SET-BINDING PROTEIN 1, SETBP1
19012,611061,"FAMILY WITH SEQUENCE SIMILARITY 20, MEMBER C", FAM20C
19013,611062,"FAMILY WITH SEQUENCE SIMILARITY 20, MEMBER A", FAM20A
19014,611063,FAM20B GLYCOSAMINOGLYCAN XYLOSYLKINASE, FAM20B
19015,611064,"ASTHMA-RELATED TRAITS, SUSCEPTIBILITY TO, 5",
19016,611065,"PROTEIN PHOSPHATASE, MAGNESIUM/MANGANESE-DEPENDENT, 1K", PPM1K
19017,611066,PH DOMAIN AND LEUCINE-RICH REPEAT PROTEIN PHOSPHATASE-LIKE, PHLPPL
19018,611067,"NEURONOPATHY, DISTAL HEREDITARY MOTOR, AUTOSOMAL RECESSIVE 4", HMNR4
19019,611068,"SMALL NUCLEOLAR RNA, C/D BOX, 43", SNORD43
19020,611069,"RNA, U86 SMALL NUCLEOLAR",
19021,611070,"SMALL NUCLEOLAR RNA, C/D BOX, 83A", SNORD83A
19022,611071,"SMALL NUCLEOLAR RNA, C/D BOX, 83B", SNORD83B
19023,611072,"DNAJ/HSP40 HOMOLOG, SUBFAMILY C, MEMBER 24", DNAJC24
19024,611073,ALZHEIMER DISEASE 12,
19025,611074,BRAIN-SPECIFIC HOMEOBOX, BSX
19026,611075,DIPHTHAMIDE BIOSYNTHESIS PROTEIN 5, DPH5
19027,611076,5-PRIME-NUCLEOTIDASE DOMAIN-CONTAINING PROTEIN 3, NT5DC3
19028,611077,COILED-COIL-HELIX-COILED-COIL-HELIX DOMAIN-CONTAINING PROTEIN 4, CHCHD4
19029,611078,COBALAMIN SYNTHETASE W DOMAIN-CONTAINING PROTEIN 1, CBWD1
19030,611079,COBALAMIN SYNTHETASE W DOMAIN-CONTAINING PROTEIN 2, CBWD2
19031,611080,COBALAMIN SYNTHETASE W DOMAIN-CONTAINING PROTEIN 3, CBWD3
19032,611081,INFLAMMATORY BOWEL DISEASE (CROHN DISEASE) 10, IBD10
19033,611082,MIAT GENE, MIAT
19034,611083,"ALCOHOL DEHYDROGENASE, IRON-CONTAINING, 1", ADHFE1
19035,611084,FORKHEAD BOX D4-LIKE 1, FOXD4L1
19036,611085,FORKHEAD BOX D4-LIKE 4, FOXD4L4
19037,611086,FORKHEAD BOX D4-LIKE 3, FOXD4L3
19038,611087,"POLYHYDRAMNIOS, MEGALENCEPHALY, AND SYMPTOMATIC EPILEPSY", PMSE
19039,611088,COILED-COIL DOMAIN-CONTAINING PROTEIN 65, CCDC65
19040,611089,MYOTUBULARIN-RELATED PROTEIN 14, MTMR14
19041,611090,"INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 12", MRT12
19042,611091,"INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 5", MRT5
19043,611092,"INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 6", MRT6
19044,611093,"INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 7", MRT7
19045,611094,HYPERMETHIONINEMIA DUE TO ADENOSINE KINASE DEFICIENCY,
19046,611095,"INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 9", MRT9
19047,611096,"INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 10", MRT10
19048,611097,"INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 11", MRT11
19049,611098,STEAP4 METALLOREDUCTASE, STEAP4
19050,611099,"PROTEIN DISULFIDE ISOMERASE, FAMILY A, MEMBER 6", PDIA6
19051,611100,"PROSTATE CANCER, HEREDITARY, 10", HPC10
19052,611101,PLECKSTRIN HOMOLOGY DOMAIN- AND RhoGEF DOMAIN-CONTAINING PROTEIN G5, PLEKHG5
19053,611102,DEAFNESS-INFERTILITY SYNDROME, DIS
19054,611103,"ACYL-CoA DEHYDROGENASE FAMILY, MEMBER 9", ACAD9
19055,611104,"FYVE, RhoGEF, AND PH DOMAIN-CONTAINING PROTEIN 4", FGD4
19056,611105,LEUKOENCEPHALOPATHY WITH BRAINSTEM AND SPINAL CORD INVOLVEMENT AND LACTATE ELEVATION, LBSL
19057,611106,ZINC FINGER CCCH DOMAIN-CONTAINING PROTEIN 12D, ZC3H12D
19058,611107,"INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 4", MRT4
19059,611108,VON WILLEBRAND FACTOR C DOMAIN-CONTAINING PROTEIN 2, VWC2
19060,611109,"CINNAMON ODOR, PLEASANTNESS OF",
19061,611110,MAP3K7 C-TERMINAL-LIKE PROTEIN, MAP3K7CL
19062,611111,DEVELOPMENTAL PLURIPOTENCY-ASSOCIATED GENE 5, DPPA5
19063,611112,"DAPPER, ANTAGONIST OF BETA-CATENIN, 3", DACT3
19064,611113,CEMENTUM PROTEIN 1, CEMP1
19065,611114,MICRO RNA 150, MIR150
19066,611115,VON WILLEBRAND FACTOR C AND EGF DOMAIN-CONTAINING PROTEIN, VWCE
19067,611116,MICRO RNA 208A, MIR208A
19068,611117,PROTEIN PHOSPHATASE METHYLESTERASE 1, PPME1
19069,611118,NUCLEAR PRELAMIN A RECOGNITION FACTOR-LIKE, NARFL
19070,611119,KELCH-LIKE 7, KLHL7
19071,611120,"SERINE PALMITOYLTRANSFERASE, LONG-CHAIN BASE SUBUNIT 3", SPTLC3
19072,611121,CALMIN, CLMN
19073,611122,ANKYRIN REPEAT DOMAIN-CONTAINING PROTEIN 28, ANKRD28
19074,611123,EPHRIN RECEPTOR EphA10, EPHA10
19075,611124,MAJOR FACILITATOR SUPERFAMILY DOMAIN-CONTAINING PROTEIN 8, MFSD8
19076,611125,DERMATAN SULFATE EPIMERASE-LIKE, DSEL
19077,611126,"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 20", MC1DN20
19078,611127,UBIQUITIN-LIKE 4B, UBL4B
19079,611128,MAM DOMAIN-CONTAINING GLYCOSYLPHOSPHATIDYLINOSITOL ANCHOR 2, MDGA2
19080,611129,WW DOMAIN-BINDING PROTEIN 1-LIKE, WBP1L
19081,611130,CHARGED MULTIVESICULAR BODY PROTEIN 7, CHMP7
19082,611131,RETINITIS PIGMENTOSA 37, RP37
19083,611132,RIBOKINASE, RBKS
19084,611133,"SMALL NUCLEOLAR RNA, C/D BOX, 82", SNORD82
19085,611134,"MECKEL SYNDROME, TYPE 4", MKS4
19086,611135,"KLOTHO, BETA", KLB
19087,611136,"EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 13", EIG13
19088,611137,"PROTEASOME SUBUNIT, BETA-TYPE, 11", PSMB11
19089,611138,SPERMATID PERINUCLEAR RNA-BINDING PROTEIN, STRBP
19090,611139,"CORONARY HEART DISEASE, SUSCEPTIBILITY TO, 8", CHDS8
19091,611140,TELOMERE MAINTENANCE 2, TELO2
19092,611141,MINDBOMB E3 UBIQUITIN PROTEIN LIGASE 2, MIB2
19093,611142,CYTOSKELETON-ASSOCIATED PROTEIN 5, CKAP5
19094,611143,"ABRAXAS 1, BRCA1 A COMPLEX SUBUNIT", ABRAXAS1
19095,611144,"ABRAXAS 2, BRISC COMPLEX SUBUNIT", ABRAXAS2
19096,611145,"SOLUTE CARRIER FAMILY 30 (ZINC TRANSPORTER), MEMBER 8", SLC30A8
19097,611146,"SOLUTE CARRIER FAMILY 30 (ZINC TRANSPORTER), MEMBER 10", SLC30A10
19098,611147,PAROXYSMAL NONKINESIGENIC DYSKINESIA 2, PNKD2
19099,611148,"SOLUTE CARRIER FAMILY 30 (ZINC TRANSPORTER), MEMBER 6", SLC30A6
19100,611149,"SOLUTE CARRIER FAMILY 30 (ZINC TRANSPORTER), MEMBER 7", SLC30A7
19101,611150,ATAXIN 10, ATXN10
19102,611151,tRNA METHYLTRANSFERASE 2 HOMOLOG A, TRMT2A
19103,611152,ALZHEIMER DISEASE 13, AD13
19104,611153,"XPA, DNA DAMAGE RECOGNITION AND REPAIR FACTOR", XPA
19105,611154,ALZHEIMER DISEASE 14, AD14
19106,611155,ALZHEIMER DISEASE 15,
19107,611156,ENDOPLASMIC RETICULUM METALLOPEPTIDASE 1, ERMP1
19108,611157,MRG/MORF4L-BINDING PROTEIN, MRGBP
19109,611158,"KERATIN 77, TYPE II", KRT77
19110,611159,"KERATIN 78, TYPE II", KRT78
19111,611160,"KERATIN 79, TYPE II", KRT79
19112,611161,"KERATIN 80, TYPE II", KRT80
19113,611162,"MALARIA, SUSCEPTIBILITY TO",
19114,611163,TOX HIGH MOBILITY GROUP BOX FAMILY MEMBER 2, TOX2
19115,611164,ARGININE-FIFTY HOMEOBOX, ARGFX
19116,611165,DIVERGENT-PAIRED RELATED HOMEOBOX, DPRX
19117,611166,TETRAPEPTIDE REPEAT HOMEOBOX 1, TPRX1
19118,611167,TETRAPEPTIDE REPEAT HOMEOBOX-LIKE, TPRXL
19119,611168,DOUBLE HOMEOBOX A, DUXA
19120,611169,"CATION CHANNEL, SPERM-ASSOCIATED, AUXILIARY SUBUNIT BETA", CATSPERB
19121,611170,STERILE ALPHA MOTIF DOMAIN-CONTAINING PROTEIN 9-LIKE, SAMD9L
19122,611171,SHOOTIN1, SHTN1
19123,611172,MICRO RNA 34A, MIR34A
19124,611173,MICRO RNA 375, MIR375
19125,611174,HAMAMY SYNDROME, HMMS
19126,611175,OBG-LIKE ATPase 1, OLA1
19127,611176,JNK/MAPK8-ASSOCIATED MEMBRANE PROTEIN, JKAMP
19128,611177,INTRAFLAGELLAR TRANSPORT 80, IFT80
19129,611178,GALANIN-LIKE PEPTIDE, GALP
19130,611179,SHROOM FAMILY MEMBER 1, SHROOM1
19131,611180,"NEGATIVE ELONGATION FACTOR COMPLEX, MEMBER B", NELFB
19132,611181,"ACYL-CoA DEHYDROGENASE FAMILY, MEMBER 10", ACAD10
19133,611182,"CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIh", CDG2H
19134,611183,"BRICK1, SCAR/WAVE ACTIN-NUCLEATING COMPLEX SUBUNIT", BRK1
19135,611184,PIEZO-TYPE MECHANOSENSITIVE ION CHANNEL COMPONENT 1, PIEZO1
19136,611185,"RESTLESS LEGS SYNDROME, SUSCEPTIBILITY TO, 6", RLS6
19137,611186,MICRO RNA 9-1, MIR9-1
19138,611187,MICRO RNA 9-2, MIR9-2
19139,611188,MICRO RNA 9-3, MIR9-3
19140,611189,MICRO RNA 197, MIR197
19141,611190,MICRO RNA 346, MIR346
19142,611191,MICRO RNA 125A, MIR125A
19143,611192,ANKYRIN REPEAT DOMAIN-CONTAINING PROTEIN 11, ANKRD11
19144,611193,RIBOSOMAL RNA-PROCESSING 15 HOMOLOG, RRP15
19145,611194,RUN AND FYVE DOMAINS-CONTAINING PROTEIN 3, RUFY3
19146,611195,JANUS KINASE AND MICROTUBULE-INTERACTING PROTEIN 1, JAKMIP1
19147,611196,ZINC FINGER MIZ-DOMAIN CONTAINING 2, ZMIZ2
19148,611197,JANUS KINASE AND MICROTUBULE-INTERACTING PROTEIN 2, JAKMIP2
19149,611198,JANUS KINASE AND MICROTUBULE-INTERACTING PROTEIN 3, JAKMIP3
19150,611199,DNTT-INTERACTING PROTEIN 2, DNTTIP2
19151,611200,TUDOR DOMAIN-CONTAINING PROTEIN 6, TDRD6
19152,611201,KELCH-LIKE 9, KLHL9
19153,611202,N-ACYLSPHINGOSINE AMIDOHYDROLASE 2, ASAH2
19154,611203,"DNAJ/HSP40 HOMOLOG, SUBFAMILY C, MEMBER 5", DNAJC5
19155,611204,COILED-COIL DOMAIN-CONTAINING PROTEIN 88C, CCDC88C
19156,611205,COILED-COIL DOMAIN-CONTAINING PROTEIN 88B, CCDC88B
19157,611206,"DNAJ/HSP40 HOMOLOG, SUBFAMILY C, MEMBER 9", DNAJC9
19158,611207,"DNAJ/HSP40 HOMOLOG, SUBFAMILY C, MEMBER 1", DNAJC1
19159,611208,HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN L-LIKE, HNRNPLL
19160,611209,"CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIg", CDG2G
19161,611210,PDZ-BINDING KINASE, PBK
19162,611211,RECEPTOR EXPRESSED IN LYMPHOID TISSUES, RELT
19163,611212,RELT-LIKE 1, RELL1
19164,611213,RELT-LIKE 2, RELL2
19165,611214,TSR1 RIBOSOME MATURATION FACTOR, TSR1
19166,611215,PRADER-WILLI REGION NONCODING RNA 1, PWRN1
19167,611216,UBX DOMAIN PROTEIN 4, UBXN4
19168,611217,PRADER-WILLI REGION NONCODING RNA 2, PWRN2
19169,611218,GASDERMIN A, GSDMA
19170,611219,UNC45 MYOSIN CHAPERONE A, UNC45A
19171,611220,UNC45 MYOSIN CHAPERONE B, UNC45B
19172,611221,GASDERMIN B, GSDMB
19173,611222,"MICROPHTHALMIA, SYNDROMIC 10", MCOPS10
19174,611223,AKT SERINE/THREONINE KINASE 3, AKT3
19175,611224,"SUCCINATE-CoA LIGASE, GDP/ADP-FORMING, SUBUNIT ALPHA", SUCLG1
19176,611225,"SPASTIC PARAPLEGIA 18B, AUTOSOMAL RECESSIVE", SPG18B
19177,611226,ARMADILLO REPEAT-CONTAINING PROTEIN 3, ARMC3
19178,611227,HYDROGEN VOLTAGE-GATED CHANNEL 1, HVCN1
19179,611228,"CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 4J", CMT4J
19180,611229,ENDOPLASMIC RETICULUM LECTIN 1, ERLEC1
19181,611230,NON-SMC CONDENSIN II COMPLEX SUBUNIT H2, NCAPH2
19182,611231,CLAUDIN 8, CLDN8
19183,611232,CLAUDIN 12, CLDN12
19184,611233,ARGININE-RICH PROTEIN MUTATED IN EARLY STAGE TUMORS-LIKE 1, ARMETL1
19185,611234,"FAMILY WITH SEQUENCE SIMILARITY 84, MEMBER A", FAM84A
19186,611235,TRANSMEMBRANE PROTEIN 38A, TMEM38A
19187,611236,TRANSMEMBRANE PROTEIN 38B, TMEM38B
19188,611237,BTB/POZ DOMAIN-CONTAINING PROTEIN 9, BTBD9
19189,611238,COILED-COIL-HELIX-COILED-COIL-HELIX DOMAIN-CONTAINING PROTEIN 7, CHCHD7
19190,611239,"GPRIN FAMILY, MEMBER 1", GPRIN1
19191,611240,"GPRIN FAMILY, MEMBER 2", GPRIN2
19192,611241,"GPRIN FAMILY, MEMBER 3", GPRIN3
19193,611242,"RESTLESS LEGS SYNDROME, SUSCEPTIBILITY TO, 5", RLS5
19194,611243,tRNA YW-SYNTHESIZING PROTEIN 1 HOMOLOG, TYW1
19195,611244,tRNA METHYLTRANSFERASE 12 HOMOLOG, TRMT12
19196,611245,tRNA YW-SYNTHESIZING PROTEIN 3 HOMOLOG, TYW3
19197,611246,LEUCINE CARBOXYL METHYLTRANSFERASE 2, LCMT2
19198,611247,MAJOR AFFECTIVE DISORDER 4, MAFD4
19199,611248,KELCH DOMAIN-CONTAINING PROTEIN 3, KLHDC3
19200,611249,MICRO RNA LET7B, MIRLET7B
19201,611250,MICRO RNA LET7E, MIRLET7E
19202,611251,"DISPATCHED RND TRANSPORTER FAMILY, MEMBER 3", DISP3
19203,611252,"SPASTIC PARAPLEGIA 32, AUTOSOMAL RECESSIVE", SPG32
19204,611253,KINESIN FAMILY MEMBER 27, KIF27
19205,611254,KINESIN FAMILY MEMBER 7, KIF7
19206,611255,NADPH OXIDASE ACTIVATOR 1, NOXA1
19207,611256,NADPH OXIDASE ORGANIZER 1, NOXO1
19208,611257,TRANSMEMBRANE PROTEIN 132D, TMEM132D
19209,611258,TUDOR DOMAIN-CONTAINING PROTEIN 7, TDRD7
19210,611259,CDK5 REGULATORY SUBUNIT-ASSOCIATED PROTEIN 1-LIKE 1, CDKAL1
19211,611260,THREONINE SYNTHASE-LIKE 1, THNSL1
19212,611261,THREONINE SYNTHASE-LIKE 2, THNSL2
19213,611262,DEOXYHYPUSINE HYDROXYLASE, DOHH
19214,611263,SHORT-RIB THORACIC DYSPLASIA 2 WITH OR WITHOUT POLYDACTYLY, SRTD2
19215,611264,CENTROMERIC PROTEIN W, CENPW
19216,611265,"PEROXISOMAL PROLIFERATOR-ACTIVATED RECEPTOR ALPHA-INTERACTING COFACTOR COMPLEX, 285-KD SUBUNIT",
19217,611266,"POTE ANKYRIN DOMAIN FAMILY, MEMBER K, PSEUDOGENE", POTEKP
19218,611267,"OLFACTORY RECEPTOR, FAMILY 51, SUBFAMILY E, MEMBER 1", OR51E1
19219,611268,"OLFACTORY RECEPTOR, FAMILY 51, SUBFAMILY E, MEMBER 2", OR51E2
19220,611269,NUCLEOLAR PROTEIN WITH MIF4G DOMAIN 1, NOM1
19221,611270,NSF ATTACHMENT PROTEIN BETA, NAPB
19222,611271,KINESIN FAMILY MEMBER 18A, KIF18A
19223,611272,ZINC FINGER PROTEIN WITH KRAB AND SCAN DOMAINS 5, ZKSCAN5
19224,611273,SKI FAMILY TRANSCRIPTIONAL COREPRESSOR 1, SKOR1
19225,611274,"GLAUCOMA 1, OPEN ANGLE, N", GLC1N
19226,611275,BCL2/ADENOVIRUS E1B 19-KD PROTEIN-INTERACTING PROTEIN 2-LIKE, BNIPL
19227,611276,"GLAUCOMA 1, OPEN ANGLE, H", GLC1H
19228,611277,"FEBRILE SEIZURES, FAMILIAL, 8",
19229,611278,KINESIN FAMILY MEMBER 12, KIF12
19230,611279,KINESIN FAMILY MEMBER 14, KIF14
19231,611280,KELCH DOMAIN-CONTAINING PROTEIN 2, KLHDC2
19232,611281,KELCH DOMAIN-CONTAINING PROTEIN 1, KLHDC1
19233,611282,DYNAMIN-BINDING PROTEIN, DNMBP
19234,611283,ISOBUTYRYL-CoA DEHYDROGENASE DEFICIENCY, IBDD
19235,611284,"DYSTONIA, FOCAL, TASK-SPECIFIC", FTSD
19236,611285,POTASSIUM CHANNEL TETRAMERIZATION DOMAIN-CONTAINING PROTEIN 5, KCTD5
19237,611286,RNA 3-PRIME-TERMINAL PHOSPHATE CYCLASE, RTCA
19238,611287,CORNICHON FAMILY AMPA RECEPTOR AUXILIARY PROTEIN 1, CNIH1
19239,611288,CORNICHON FAMILY AMPA RECEPTOR AUXILIARY PROTEIN 2, CNIH2
19240,611289,LEUCINE-RICH ALPHA-2-GLYCOPROTEIN 1, LRG1
19241,611290,NONHOMOLOGOUS END-JOINING FACTOR 1, NHEJ1
19242,611291,"IMMUNODEFICIENCY 124, SEVERE COMBINED", IMD124
19243,611292,CLAVESIN 1, CLVS1
19244,611293,COILED-COIL DOMAIN-CONTAINING PROTEIN 86, CCDC86
19245,611294,ONE CUT HOMEOBOX 3, ONECUT3
19246,611295,KELCH-LIKE 24, KLHL24
19247,611296,ANNEXIN A2 RECEPTOR, ANXA2R
19248,611297,ODD-SKIPPED-RELATED TRANSCRIPTION FACTOR 2, OSR2
19249,611298,ENDOSOME-LYSOSOME-ASSOCIATED APOPTOSIS AND AUTOPHAGY REGULATOR 1, ELAPOR1
19250,611299,G2/M PHASE-SPECIFIC E3 UBIQUITIN LIGASE, G2E3
19251,611300,"La RIBONUCLEOPROTEIN 6, TRANSLATIONAL REGULATOR", LARP6
19252,611301,"FANCONI ANEMIA-ASSOCIATED PROTEIN, 100-KD SUBUNIT", FAAP100
19253,611302,"SPASTIC ATAXIA 2, AUTOSOMAL RECESSIVE", SPAX2
19254,611303,"C-TYPE LECTIN DOMAIN FAMILY 16, MEMBER A", CLEC16A
19255,611304,LIPID DROPLET ASSEMBLY FACTOR 1, LDAF1
19256,611305,"ACTIN-BINDING LIM PROTEIN FAMILY, MEMBER 3", ABLIM3
19257,611306,"SCAVENGER RECEPTOR CLASS A, MEMBER 5", SCARA5
19258,611307,"MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 12", LGMDR12
19259,611308,"PERSISTENT HYPERPLASTIC PRIMARY VITREOUS, AUTOSOMAL DOMINANT", PHPVAD
19260,611309,DEPP1 AUTOPHAGY REGULATOR, DEPP1
19261,611310,PHOSPHOSERYL-tRNA KINASE, PSTK
19262,611311,"PERSISTENT HYPERPLASTIC PRIMARY VITREOUS, AUTOSOMAL RECESSIVE",
19263,611312,CORNULIN, CRNN
19264,611313,ARMS2 GENE, ARMS2
19265,611314,HIGH MOBILITY GROUP NUCLEOSOMAL BINDING PROTEIN 2 PSEUDOGENE 46, HMGN2P46
19266,611315,ZINC FINGER- AND SCAN DOMAIN-CONTAINING PROTEIN 20, ZSCAN20
19267,611316,"SOLUTE CARRIER FAMILY 12 (SODIUM/POTASSIUM/CHLORIDE TRANSPORTER), MEMBER 8", SLC12A8
19268,611317,"PHOSPHATIDYLINOSITOL 3-KINASE, REGULATORY SUBUNIT 5", PIK3R5
19269,611318,MEDIATOR COMPLEX SUBUNIT 12-LIKE, MED12L
19270,611319,INTERFERON-ALPHA-INDUCIBLE PROTEIN 27-LIKE 2, IFI27L2
19271,611320,INTERFERON-ALPHA-INDUCIBLE PROTEIN 27-LIKE 1, IFI27L1
19272,611321,CALSYNTENIN 1, CLSTN1
19273,611322,"DNAJ/HSP40 HOMOLOG, SUBFAMILY A, MEMBER 2", DNAJA2
19274,611323,CALSYNTENIN 2, CLSTN2
19275,611324,CALSYNTENIN 3, CLSTN3
19276,611325,TRANSFORMING GROWTH FACTOR-BETA REGULATOR 4, TBRG4
19277,611326,CELL CYCLE PROGRESSION 1, CCPG1
19278,611327,"DNAJ/HSP40 HOMOLOG, SUBFAMILY B, MEMBER 4", DNAJB4
19279,611328,"DNAJ/HSP40 HOMOLOG, SUBFAMILY B, MEMBER 5", DNAJB5
19280,611329,SMALL CAJAL BODY-SPECIFIC RNA 18, SCARNA18
19281,611330,"SMALL NUCLEOLAR RNA, H/ACA BOX, 12", SNORA12
19282,611331,"SMALL NUCLEOLAR RNA, H/ACA BOX, 74B", SNORA74B
19283,611332,"DNAJ/HSP40 HOMOLOG, SUBFAMILY B, MEMBER 6", DNAJB6
19284,611333,"SMALL NUCLEOLAR RNA, H/ACA BOX, 3B", SNORA3B
19285,611334,"SMALL NUCLEOLAR RNA, H/ACA BOX, 81", SNORA81
19286,611335,"SMALL NUCLEOLAR RNA, H/ACA BOX, 5C", SNORA5C
19287,611336,"DNAJ/HSP40 HOMOLOG, SUBFAMILY B, MEMBER 7", DNAJB7
19288,611337,"DNAJ/HSP40 HOMOLOG, SUBFAMILY B, MEMBER 8", DNAJB8
19289,611338,AUTOPHAGY-RELATED 4B CYSTEINE PEPTIDASE, ATG4B
19290,611339,AUTOPHAGY-RELATED 4C CYSTEINE PEPTIDASE, ATG4C
19291,611340,AUTOPHAGY-RELATED 4D CYSTEINE PEPTIDASE, ATG4D
19292,611341,"DNAJ/HSP40 HOMOLOG, SUBFAMILY B, MEMBER 11", DNAJB11
19293,611342,CHROMOSOME 9 OPEN READING FRAME 64, C9ORF64
19294,611343,IDNK GLUCONOKINASE, IDNK
19295,611344,RAS AND EF-HAND DOMAINS-CONTAINING PROTEIN, RASEF
19296,611345,INTEGRATOR COMPLEX SUBUNIT 1, INTS1
19297,611346,INTEGRATOR COMPLEX SUBUNIT 2, INTS2
19298,611347,INTEGRATOR COMPLEX SUBUNIT 3, INTS3
19299,611348,INTEGRATOR COMPLEX SUBUNIT 4, INTS4
19300,611349,INTEGRATOR COMPLEX SUBUNIT 5, INTS5
19301,611350,INTEGRATOR COMPLEX SUBUNIT 7, INTS7
19302,611351,INTEGRATOR COMPLEX SUBUNIT 8, INTS8
19303,611352,INTEGRATOR COMPLEX SUBUNIT 9, INTS9
19304,611353,INTEGRATOR COMPLEX SUBUNIT 10, INTS10
19305,611354,INTEGRATOR COMPLEX SUBUNIT 11, INTS11
19306,611355,INTEGRATOR COMPLEX SUBUNIT 12, INTS12
19307,611356,G KINASE-ANCHORING PROTEIN 1, GKAP1
19308,611357,TERMINAL NUCLEOTIDYLTRANSFERASE 5A, TENT5A
19309,611358,RING FINGER PROTEIN 135, RNF135
19310,611359,ACTIVATING MOLECULE IN BECLIN 1-REGULATED AUTOPHAGY, AMBRA1
19311,611360,FANCI GENE, FANCI
19312,611361,UBIQUITIN-LIKE MODIFIER-ACTIVATING ENZYME 6, UBA6
19313,611362,UBIQUITIN-CONJUGATING ENZYME E2 Z, UBE2Z
19314,611363,ATRIAL SEPTAL DEFECT 4, ASD4
19315,611364,"MYOCLONIC EPILEPSY, JUVENILE, SUSCEPTIBILITY TO, 4", EJM4
19316,611365,TRANSMEMBRANE PROTEIN 183B, TMEM183B
19317,611366,MYG1 EXONUCLEASE, MYG1
19318,611367,ASPARTYL AMINOPEPTIDASE, DNPEP
19319,611368,MAELSTROM SPERMATOGENIC TRANSPOSON SILENCER, MAEL
19320,611369,LETHAL CONGENITAL CONTRACTURE SYNDROME 3, LCCS3
19321,611370,FGGY CARBOHYDRATE KINASE DOMAIN-CONTAINING PROTEIN, FGGY
19322,611371,ZINC FINGER PROTEIN 653, ZNF653
19323,611372,SMALL ADP-RIBOSYLATION FACTOR GTPase-ACTIVATING PROTEIN 1, SMAP1
19324,611373,LIVER-EXPRESSED ANTIMICROBIAL PEPTIDE 2, LEAP2
19325,611374,MICRO RNA 34B, MIR34B
19326,611375,MICRO RNA 34C, MIR34C
19327,611376,MUNGAN SYNDROME, MGS
19328,611377,"BRACHYDACTYLY, TYPE B2", BDB2
19329,611378,"MACULAR DEGENERATION, AGE-RELATED, 9", ARMD9
19330,611379,DISCO-INTERACTING PROTEIN 2 HOMOLOG B, DIP2B
19331,611380,DISCO-INTERACTING PROTEIN 2 HOMOLOG C, DIP2C
19332,611381,"KALA-AZAR, SUSCEPTIBILITY TO, 2", KAZA2
19333,611382,"KALA-AZAR, SUSCEPTIBILITY TO, 3", KAZA3
19334,611383,"USHER SYNDROME, TYPE IID", USH2D
19335,611384,PLASMODIUM FALCIPARUM FEVER EPISODES QUANTITATIVE TRAIT LOCUS 1,
19336,611385,"PROTEASOME SUBUNIT, ALPHA-TYPE, 4",
19337,611386,ACTIVITY-DEPENDENT NEUROPROTECTOR HOMEOBOX, ADNP
19338,611387,CXC CHEMOKINE LIGAND 17, CXCL17
19339,611388,"DEOXYNUCLEOTIDYLTRANSFERASE, TERMINAL, INTERACTING PROTEIN 1", DNTTIP1
19340,611389,PRICKLE PLANAR CELL POLARITY PROTEIN 4, PRICKLE4
19341,611390,"SPASTIC ATAXIA 3, AUTOSOMAL RECESSIVE", SPAX3
19342,611391,"CATARACT 33, MULTIPLE TYPES", CTRCT33
19343,611392,2-AMINOETHANETHIOL DIOXYGENASE, ADO
19344,611393,"FAMILY WITH SEQUENCE SIMILARITY 110, MEMBER A", FAM110A
19345,611394,"FAMILY WITH SEQUENCE SIMILARITY 110, MEMBER B", FAM110B
19346,611395,"FAMILY WITH SEQUENCE SIMILARITY 110, MEMBER C", FAM110C
19347,611396,ADIPOGENIN, ADIG
19348,611397,"TETRATRICOPEPTIDE REPEAT-, ANKYRIN REPEAT-, AND COILED-COIL-CONTAINING PROTEIN 1", TANC1
19349,611398,GROWTH ARREST-SPECIFIC 2-LIKE 2, GAS2L2
19350,611399,SODIUM CHANNEL AND CLATHRIN LINKER 1, SCLT1
19351,611400,"HOX TRANSCRIPT ANTISENSE RNA, NONCODING", HOTAIR
19352,611401,CHROMOSOME 6 OPEN READING FRAME 15, C6ORF15
19353,611402,DOCKING PROTEIN 6, DOK6
19354,611403,"ASTHMA-RELATED TRAITS, SUSCEPTIBILITY TO, 6",
19355,611404,"LYMPHOCYTE ANTIGEN 6 FAMILY, MEMBER G6F", LY6G6F
19356,611405,RNA TERMINAL PHOSPHATE CYCLASE-LIKE 1, RCL1
19357,611406,"DYNEIN, CYTOPLASMIC 1, LIGHT INTERMEDIATE CHAIN 2", DYNC1LI2
19358,611407,"CARDIOMYOPATHY, DILATED, 1W", CMD1W
19359,611408,LEBERILIN LCA5, LCA5
19360,611409,OCA2 MELANOSOMAL TRANSMEMBRANE PROTEIN, OCA2
19361,611410,RHO FAMILY-INTERACTING CELL POLARIZATION REGULATOR 2, RIPOR2
19362,611411,"CALCIUM/CALMODULIN-DEPENDENT PROTEIN KINASE KINASE 1, ALPHA", CAMKK1
19363,611412,N-ACETYLNEURAMINATE PYRUVATE LYASE, NPL
19364,611413,DISCS LARGE-ASSOCIATED PROTEIN 3, DLGAP3
19365,611414,CALRETICULIN 3, CALR3
19366,611415,"POLYMERASE (DNA-DIRECTED), DELTA 3, ACCESSORY SUBUNIT", POLD3
19367,611416,TOX HIGH MOBILITY GROUP BOX FAMILY MEMBER 3, TOX3
19368,611417,SMALL G PROTEIN SIGNALING MODULATOR 1, SGSM1
19369,611418,SMALL G PROTEIN SIGNALING MODULATOR 2, SGSM2
19370,611419,SMALL INTEGRAL MEMBRANE PROTEIN 29, SMIM29
19371,611420,CDKN1A-INTERACTING ZINC FINGER PROTEIN 1, CIZ1
19372,611421,SNF2-RELATED CBP ACTIVATOR PROTEIN, SRCAP
19373,611422,MEIOTIC NUCLEAR DIVISIONS 1, MND1
19374,611423,"CENTROSOMAL PROTEIN, 135-KD", CEP135
19375,611424,ZINC FINGER MYND DOMAIN-CONTAINING PROTEIN 19, ZMYND19
19376,611425,"CENTROBIN, CENTRIOLE DUPLICATION AND SPINDLE ASSEMBLY PROTEIN", CNTROB
19377,611426,TENTED EYEBROWS,
19378,611427,"METHYLENETETRAHYDROFOLATE DEHYDROGENASE 1-LIKE, NADP(+)-DEPENDENT", MTHFD1L
19379,611428,DOWNSTREAM NEIGHBOR OF SON, DONSON
19380,611429,APRG1 TUMOR SUPPRESSOR CANDIDATE, APRG1
19381,611430,TETRATRICOPEPTIDE REPEAT DOMAIN-CONTAINING PROTEIN 21A, TTC21A
19382,611431,LEGIUS SYNDROME, LGSS
19383,611432,DEDICATOR OF CYTOKINESIS 8, DOCK8
19384,611433,SERINE/THREONINE/TYROSINE KINASE 1, STYK1
19385,611434,CYTOKINE-DEPENDENT HEMATOPOIETIC CELL LINKER, CLNK
19386,611435,DOCKING PROTEIN 3, DOK3
19387,611436,CARBONIC ANHYDRASE XIII, CA13
19388,611437,DUAL-SPECIFICITY PHOSPHATASE 19, DUSP19
19389,611438,"TAXILIN, BETA", TXLNB
19390,611439,ZINC FINGER- AND BTB DOMAIN-CONTAINING PROTEIN 22, ZBTB22
19391,611440,WD REPEAT-CONTAINING PROTEIN 46, WDR46
19392,611441,DOUBLE HOMEOBOX PROTEIN 1, DUX1
19393,611442,DOUBLE HOMEOBOX PROTEIN 2, DUX2
19394,611443,DOUBLE HOMEOBOX PROTEIN 3, DUX3
19395,611444,DOUBLE HOMEOBOX PROTEIN 5, DUX5
19396,611445,DYNAMIN 3, DNM3
19397,611446,DUAL-SPECIFICITY PHOSPHATASE 18, DUSP18
19398,611447,Y BOX-BINDING PROTEIN 2, YBX2
19399,611448,BMS1 RIBOSOME BIOGENESIS FACTOR, BMS1
19400,611449,EXPORTIN 4, XPO4
19401,611450,PXK DOMAIN-CONTAINING SERINE/THREONINE KINASE, PXK
19402,611451,"DEAFNESS, AUTOSOMAL RECESSIVE 63", DFNB63
19403,611452,HYPOTRICHOSIS 8,
19404,611453,DYSBINDIN DOMAIN-CONTAINING PROTEIN 2, DBNDD2
19405,611454,FRONTOTEMPORAL DEMENTIA AND/OR AMYOTROPHIC LATERAL SCLEROSIS 1,
19406,611455,KINOCILIN, KNCN
19407,611456,"TREMOR, HEREDITARY ESSENTIAL, 3", ETM3
19408,611457,FORKHEAD BOX O6, FOXO6
19409,611458,"GALACTOSIDASE, BETA-1", GLB1
19410,611459,"SOLUTE CARRIER FAMILY 10 (SODIUM/BILE ACID COTRANSPORTER FAMILY), MEMBER 7", SLC10A7
19411,611460,TUMOR PROTEIN p63-REGULATED PROTEIN 1-LIKE, TPRG1L
19412,611461,"SOLUTE CARRIER FAMILY 22 (ORGANIC CATION TRANSPORTER), MEMBER 17", SLC22A17
19413,611462,"PHOSPHATIDYLINOSITOL 3-KINASE, REGULATORY SUBUNIT 6", PIK3R6
19414,611463,SPERMIDINE/SPERMINE N1-ACETYLTRANSFERASE 2, SAT2
19415,611464,"MON1 HOMOLOG A, SECRETORY TRAFFICKING-ASSOCIATED", MON1A
19416,611465,GALLBLADDER DISEASE 4, GBD4
19417,611466,"PLECKSTRIN HOMOLOGY DOMAIN-CONTAINING PROTEIN, FAMILY M, MEMBER 1", PLEKHM1
19418,611467,GUANYLATE-BINDING PROTEIN 5: GBP5,
19419,611468,BDNF ANTISENSE RNA, BDNFAS
19420,611469,"COLORECTAL CANCER, SUSCEPTIBILITY TO, 2", CRCS2
19421,611470,GLUTAMATE-AMMONIA LIGASE (GLUTAMINE SYNTHETASE) DOMAIN-CONTAINING 1, GLULD1
19422,611471,"ACID PHOSPHATASE 6, LYSOPHOSPHATIDE", ACP6
19423,611472,METHYL-CpG-BINDING DOMAIN PROTEIN 5, MBD5
19424,611473,EMBRYONIC STEM CELL-RELATED PROTEIN, ESRG
19425,611474,PHOSPHOLIPASE A AND ACYLTRANSFERASE 5, PLAAT5
19426,611475,RNA POLYMERASE II-ASSOCIATED PROTEIN 1, RPAP1
19427,611476,RNA POLYMERASE II-ASSOCIATED PROTEIN 2, RPAP2
19428,611477,RNA POLYMERASE II-ASSOCIATED PROTEIN 3, RPAP3
19429,611478,METHYLPHOSPHATE CAPPING ENZYME, MEPCE
19430,611479,XPA-BINDING PROTEIN 1, XAB1
19431,611480,PIH1 DOMAIN-CONTAINING PROTEIN 1, PIH1D1
19432,611481,UFM1-SPECIFIC PEPTIDASE 1, UFSP1
19433,611482,UFM1-SPECIFIC PEPTIDASE 2, UFSP2
19434,611483,"YIP1 DOMAIN FAMILY, MEMBER 5", YIPF5
19435,611484,"YIP1-INTERACTING FACTOR HOMOLOG A, MEMBRANE-TRAFFICKING PROTEIN", YIF1A
19436,611485,"CYTOCHROME P450, FAMILY 4, SUBFAMILY F, POLYPEPTIDE 12", CYP4F12
19437,611486,SYNAPTONEMAL COMPLEX CENTRAL ELEMENT PROTEIN 1, SYCE1
19438,611487,SYNAPTONEMAL COMPLEX CENTRAL ELEMENT PROTEIN 2, SYCE2
19439,611488,"MACULAR DEGENERATION, AGE-RELATED, 10", ARMD10
19440,611489,CORTICOSTEROID-BINDING GLOBULIN DEFICIENCY,
19441,611490,"OSTEOPETROSIS,  AUTOSOMAL RECESSIVE 4", OPTB4
19442,611491,RAS ASSOCIATION AND DILUTE DOMAINS PROTEIN, RADIL
19443,611492,CARBONIC ANHYDRASE II, CA2
19444,611493,"ATRIAL FIBRILLATION, FAMILIAL, 4", ATFB4
19445,611494,"ATRIAL FIBRILLATION, FAMILIAL, 5", ATFB5
19446,611495,"CYTOCHROME P450, FAMILY 4, SUBFAMILY F, POLYPEPTIDE 22", CYP4F22
19447,611496,GATA-BINDING PROTEIN 5, GATA5
19448,611497,"OSTEOPETROSIS, AUTOSOMAL RECESSIVE 6", OPTB6
19449,611498,NEPHRONOPHTHISIS 7, NPHP7
19450,611499,BETA-GLUCURONIDASE, GUSB
19451,611500,MICRO RNA 219-1, MIR219-1
19452,611501,CALMODULIN-BINDING TRANSCRIPTION ACTIVATOR 1, CAMTA1
19453,611502,CENTROMERIC PROTEIN K, CENPK
19454,611503,CENTROMERIC PROTEIN L, CENPL
19455,611504,CENTROMERIC PROTEIN O, CENPO
19456,611505,CENTROMERIC PROTEIN P, CENPP
19457,611506,CENTROMERIC PROTEIN Q, CENPQ
19458,611507,CDGSH IRON SULFUR DOMAIN PROTEIN 2, CISD2
19459,611508,CALMODULIN-BINDING TRANSCRIPTION ACTIVATOR 2, CAMTA2
19460,611509,CENTROMERIC PROTEIN N, CENPN
19461,611510,CENTROMERIC PROTEIN T, CENPT
19462,611511,MLF1-INTERACTING PROTEIN, MLF1IP
19463,611512,LYSINE DEMETHYLASE 3A, KDM3A
19464,611513,NEUROGENIC DIFFERENTIATION 6, NEUROD6
19465,611514,WNT LIGAND SECRETION MEDIATOR, WLS
19466,611515,"FEBRILE SEIZURES, FAMILIAL, 7", FEB7
19467,611516,NICOLIN 1, NICN1
19468,611517,"CYTOCHROME P450, FAMILY 4, SUBFAMILY F, POLYPEPTIDE 11", CYP4F11
19469,611518,DEDICATOR OF CYTOKINESIS 10, DOCK10
19470,611519,POLYMERASE DELTA-INTERACTING PROTEIN 2, POLDIP2
19471,611520,POLYMERASE DELTA-INTERACTING PROTEIN 3, POLDIP3
19472,611521,IMMUNODEFICIENCY 35, IMD35
19473,611522,INTRAOCULAR PRESSURE QUANTITATIVE TRAIT LOCUS, IOPQTL
19474,611523,"PONTOCEREBELLAR HYPOPLASIA, TYPE 6", PCH6
19475,611524,ARGINYL-tRNA SYNTHETASE 2, RARS2
19476,611525,"POLYMERASE (DNA-DIRECTED), DELTA 4", POLD4
19477,611526,NOP14 NUCLEOLAR PROTEIN, NOP14
19478,611527,Na+/H+ EXCHANGER DOMAIN-CONTAINING PROTEIN 1, NHEDC1
19479,611528,"ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 12", ARVD12
19480,611529,"CYTOCHROME P450, FAMILY 2, SUBFAMILY S, POLYPEPTIDE 1", CYP2S1
19481,611530,NEUROLYSIN, NLN
19482,611531,EMG1 N1-SPECIFIC PSEUDOURIDINE METHYLTRANSFERASE, EMG1
19483,611532,NUCLEOLAR PROTEIN 6, NOL6
19484,611533,NUCLEOLAR PROTEIN 7, NOL7
19485,611534,NUCLEOLAR PROTEIN 8, NOL8
19486,611535,MAJOR AFFECTIVE DISORDER 5, MAFD5
19487,611536,MAJOR AFFECTIVE DISORDER 6, MAFD6
19488,611537,"CATENIN, BETA-LIKE, 1", CTNNBL1
19489,611538,"OLFACTORY RECEPTOR, FAMILY 7, SUBFAMILY D, MEMBER 4", OR7D4
19490,611539,FORKHEAD BOX D3, FOXD3
19491,611540,SH3-DOMAIN GRB2-LIKE (ENDOPHILIN)-INTERACTING PROTEIN 1, SGIP1
19492,611541,SORTING NEXIN 27, SNX27
19493,611542,ARYLSULFATASE B, ARSB
19494,611543,CAVITARY OPTIC DISC ANOMALIES, CODA
19495,611544,"CATARACT 17, MULTIPLE TYPES", CTRCT17
19496,611545,"CYTOCHROME P450, FAMILY 4, SUBFAMILY F, POLYPEPTIDE 8", CYP4F8
19497,611546,ELONGATION OF VERY LONG CHAIN FATTY ACIDS-LIKE 6, ELOVL6
19498,611547,STATURE QUANTITATIVE TRAIT LOCUS 9, STQTL9
19499,611548,PREMATURE OVARIAN FAILURE 5, POF5
19500,611549,"SODIUM LEAK CHANNEL, NONSELECTIVE", NALCN
19501,611550,NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 3, NCR3
19502,611551,FIBULIN 7, FBLN7
19503,611552,NICOTINATE PHOSPHORIBOSYLTRANSFERASE, NAPRT
19504,611553,NOONAN SYNDROME 5, NS5
19505,611554,LEOPARD SYNDROME 2, LPRD2
19506,611555,"RENAL TUBULAR ACIDOSIS, DISTAL, WITH NEPHROCALCINOSIS, SHORT STATURE, IMPAIRED INTELLECTUAL DEVELOPMENT, AND DISTINCTIVE FACIES",
19507,611556,"GLYCOGEN STORAGE DISEASE 0, MUSCLE", GSD0B
19508,611557,UROPLAKIN 1A, UPK1A
19509,611558,UROPLAKIN 2, UPK2
19510,611559,UROPLAKIN 3A, UPK3A
19511,611560,JOUBERT SYNDROME 7, JBTS7
19512,611561,"MECKEL SYNDROME, TYPE 5", MKS5
19513,611562,SEPTIN 12, SEPTIN12
19514,611563,SEPTIN 13, SEPT13
19515,611564,BTG3-ASSOCIATED NUCLEAR PROTEIN, BANP
19516,611565,"BRIDGE-LIKE LIPID TRANSFER PROTEIN FAMILY, MEMBER 1", BLTP1
19517,611566,PHOSPHORIBOSYLPYROPHOSPHATE SYNTHETASE 1-LIKE 1, PRPS1L1
19518,611567,MONO-ADP RIBOSYLHYDROLASE 2, MACROD2
19519,611568,SYNTABULIN, SYBU
19520,611569,CYTOSKELETON-ASSOCIATED PROTEIN 2, CKAP2
19521,611570,"FRUCTOSE-1,6-BISPHOSPHATASE 1", FBP1
19522,611571,OTOSCLEROSIS 4, OTSC4
19523,611572,OTOSCLEROSIS 7, OTSC7
19524,611573,SPHINGOMYELIN SYNTHASE 1, SGMS1
19525,611574,SPHINGOMYELIN SYNTHASE 2, SGMS2
19526,611575,STERILE ALPHA MOTIF DOMAIN-CONTAINING PROTEIN 8, SAMD8
19527,611576,MICRO RNA 10B, MIR10B
19528,611577,LYSINE DEMETHYLASE 6B, KDM6B
19529,611578,FERRIC CHELATE REDUCTASE 1, FRRS1
19530,611579,TRANSMEMBRANE PROTEIN 114, TMEM114
19531,611580,EPIDIDYMAL PROTEIN 3A, EDDM3A
19532,611581,"USHER SYNDROME, TYPE ID",
19533,611582,"FAMILY WITH SEQUENCE SIMILARITY 12, MEMBER B", FAM12B
19534,611583,AT-RICH INTERACTION DOMAIN-CONTAINING PROTEIN 5A, ARID5A
19535,611584,"WAARDENBURG SYNDROME, TYPE 2E", WS2E
19536,611585,TESCALCIN, TESC
19537,611586,"COMPLEMENT COMPONENT 1, q SUBCOMPONENT-LIKE 1", C1QL1
19538,611587,RHO GTPase-ACTIVATING PROTEIN 19, ARHGAP19
19539,611588,"MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 4", MDDGC4
19540,611589,PATATIN-LIKE PHOSPHOLIPASE DOMAIN-CONTAINING PROTEIN 5, PNPLA5
19541,611590,"RENAL TUBULAR ACIDOSIS, DISTAL, 4, WITH HEMOLYTIC ANEMIA", DRTA4
19542,611591,PRO-PLATELET BASIC PROTEIN PSEUDOGENE 2, PPBPP2
19543,611592,"PHENYLALANYL-tRNA SYNTHETASE 2, MITOCHONDRIAL", FARS2
19544,611593,SUBMAXILLARY GLAND ANDROGEN-REGULATED PROTEIN 3B, SMR3B
19545,611594,UBIQUITIN-SPECIFIC PROTEASE 39, USP39
19546,611595,THIOREDOXIN-LIKE 4A, TXNL4A
19547,611596,"SHORT-CHAIN DEHYDROGENASE/REDUCTASE FAMILY, MEMBER 4", DHRS4
19548,611597,"CATARACT 12, MULTIPLE TYPES", CTRCT12
19549,611598,"CELIAC DISEASE, SUSCEPTIBILITY TO, 6", CELIAC6
19550,611599,MICRO RNA 206, MIR206
19551,611600,PROTEIN REGULATING SYNAPTIC MEMBRANE EXOCYTOSIS 3, RIMS3
19552,611601,PROTEIN REGULATING SYNAPTIC MEMBRANE EXOCYTOSIS 4, RIMS4
19553,611602,RIMS-BINDING PROTEIN 2, RIMBP2
19554,611603,LISSENCEPHALY 3, LIS3
19555,611604,ENDOPLASMIC RETICULUM LIPID RAFT-ASSOCIATED PROTEIN 1, ERLIN1
19556,611605,ENDOPLASMIC RETICULUM LIPID RAFT-ASSOCIATED PROTEIN 2, ERLIN2
19557,611606,MICRO RNA 96, MIR96
19558,611607,MICRO RNA 182, MIR182
19559,611608,MICRO RNA 183, MIR183
19560,611609,SIPA1-LIKE PROTEIN 2, SIPA1L2
19561,611610,PHOSPHOGLUCOMUTASE 2-LIKE 1, PGM2L1
19562,611611,S-PHASE CYCLIN A-ASSOCIATED PROTEIN IN THE ENDOPLASMIC RETICULUM, SCAPER
19563,611612,THIAMINE TRIPHOSPHATASE, THTPA
19564,611613,PROTEIN O-GLUCOSYLTRANSFERASE 2, POGLUT2
19565,611614,UTP3 SMALL SUBUNIT PROCESSOME COMPONENT, UTP3
19566,611615,"CARDIOMYOPATHY, DILATED, 1X", CMD1X
19567,611616,NAD KINASE, NADK
19568,611617,"EF-HAND DOMAIN FAMILY, MEMBER D1", EFHD1
19569,611618,MANDIBULOACRAL DYSPLASIA WITH TYPE A LIPODYSTROPHY,
19570,611619,MICRO RNA 877, MIR877
19571,611620,MICRO RNA 1224, MIR1224
19572,611621,MICRO RNA 1225, MIR1225
19573,611622,IQ MOTIF-CONTAINING PROTEIN J, IQCJ
19574,611623,NECAP ENDOCYTOSIS-ASSOCIATED PROTEIN 1, NECAP1
19575,611624,NECAP ENDOCYTOSIS-ASSOCIATED PROTEIN 2, NECAP2
19576,611625,"GID COMPLEX, SUBUNIT 8", GID8
19577,611626,M-PHASE PHOSPHOPROTEIN 8, MPHOSPH8
19578,611627,TLC DOMAIN-CONTAINING PROTEIN 3A, TLCD3A
19579,611628,NEURON NAVIGATOR 1, NAV1
19580,611629,NEURON NAVIGATOR 3, NAV3
19581,611630,"EPILEPSY, FAMILIAL TEMPORAL LOBE, 3", ETL3
19582,611631,"EPILEPSY, FAMILIAL TEMPORAL LOBE, 4", ETL4
19583,611632,UbiA PRENYLTRANSFERASE DOMAIN-CONTAINING PROTEIN 1, UBIAD1
19584,611633,"RTF1 HOMOLOG, PAF1/RNA POLYMERASE II COMPLEX COMPONENT", RTF1
19585,611634,"FEBRILE SEIZURES, FAMILIAL, 9", FEB9
19586,611635,NEUROGENIC DIFFERENTIATION 4, NEUROD4
19587,611636,N-ACETYLATED ALPHA-LINKED ACIDIC DIPEPTIDASE 2, NAALAD2
19588,611637,"PRIMARY LATERAL SCLEROSIS, ADULT, 1", PLSA1
19589,611638,MICROPHTHALMIA/COLOBOMA 5, MCOPCB5
19590,611639,ZINC FINGER GATA-LIKE PROTEIN 1, ZGLP1
19591,611640,FIBRONECTIN TYPE III AND ANKYRIN REPEAT DOMAINS 1, FANK1
19592,611641,CANCER SUSCEPTIBILITY GENE HEPN1, HEPN1
19593,611642,HEPATOCYTE CELL ADHESION MOLECULE, HEPACAM
19594,611643,ZINC FINGER PROTEIN WITH KRAB AND SCAN DOMAINS 4, ZKSCAN4
19595,611644,"HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 9", HSCR9
19596,611645,CXXC FINGER PROTEIN 4, CXXC4
19597,611646,SPHK1-INTERACTING PROTEIN, SPHKAP
19598,611647,"ARV1 HOMOLOG, FATTY ACID HOMEOSTASIS MODULATOR", ARV1
19599,611648,DIPHOSPHOINOSITOL PENTAKISPHOSPHATE KINASE 2, PPIP5K2
19600,611649,MINDY LYSINE-48 DEUBIQUITINASE 3, MINDY3
19601,611650,"PERIPAPILLARY ATROPHY, BETA TYPE", PPAB
19602,611651,"PHOSPHOLIPASE A2, GROUP III", PLA2G3
19603,611652,"PHOSPHOLIPASE A2, GROUP XIIA", PLA2G12A
19604,611653,"PHOSPHOLIPASE A2, GROUP XIIB", PLA2G12B
19605,611654,CENTROSOME SPINDLE POLE-ASSOCIATED PROTEIN 1, CSPP1
19606,611655,POST-GPI ATTACHMENT TO PROTEINS 1, PGAP1
19607,611656,SUPPRESSOR OF IKBKE 1, SIKE1
19608,611657,SPRY DOMAIN- AND SOCS BOX-CONTAINING 1, SPSB1
19609,611658,SPRY DOMAIN- AND SOCS BOX-CONTAINING 2, SPSB2
19610,611659,SPRY DOMAIN- AND SOCS BOX-CONTAINING 3, SPSB3
19611,611660,SPRY DOMAIN- AND SOCS BOX-CONTAINING 4, SPSB4
19612,611661,DBF4 ZINC FINGER B, DBF4B
19613,611662,"EOSINOPHIL GRANULE ONTOGENY TRANSCRIPT, NONCODING", EGOT
19614,611663,"TBC1 DOMAIN FAMILY, MEMBER 20", TBC1D20
19615,611664,"SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 7", SHEP7
19616,611665,DEAD-BOX HELICASE 54, DDX54
19617,611666,PHOSPHOLIPID PHOSPHATASE 6, PLPP6
19618,611667,SPERMATOGENESIS-ASSOCIATED SERINE-RICH PROTEIN 2, SPATS2
19619,611668,CORONIN 7, CORO7
19620,611669,tRNA METHYLTRANSFERASE 1, TRMT1
19621,611670,INOSITOL-3-PHOSPHATE SYNTHASE 1, ISYNA1
19622,611671,PHOSPHATIDYLINOSITOL GLYCAN ANCHOR BIOSYNTHESIS CLASS Z PROTEIN, PIGZ
19623,611672,"SOLUTE CARRIER FAMILY 46 (FOLATE TRANSPORTER), MEMBER 1", SLC46A1
19624,611673,tRNA METHYLTRANSFERASE 1-LIKE, TRMT1L
19625,611674,"X KELL BLOOD GROUP PRECURSOR-RELATED FAMILY, MEMBER 3", XKR3
19626,611675,KIAA0513 GENE, KIAA0513
19627,611676,PHOSDUCIN-LIKE 2, PDCL2
19628,611677,"OLFACTORY RECEPTOR, FAMILY 13, SUBFAMILY G, MEMBER 1", OR13G1
19629,611678,PHOSDUCIN-LIKE 3, PDCL3
19630,611679,F-BOX AND WD40 DOMAIN PROTEIN 10, FBXW10
19631,611680,CHROMOSOME 1 OPEN READING FRAME 116, C1ORF116
19632,611681,"A DISINTEGRIN-LIKE AND METALLOPROTEINASE WITH THROMBOSPONDIN TYPE 1 MOTIF, 20", ADAMTS20
19633,611682,LIPOPROTEIN(a)-LIKE 2, LPAL2
19634,611683,FRUCTOSAMINE 3-KINASE-RELATED PROTEIN,
19635,611684,"SPLICEOSOME-ASSOCIATED FACTOR 3, U4/U6 RECYCLING PROTEIN", SART3
19636,611685,RING FINGER PROTEIN 8, RNF8
19637,611686,CAS1 DOMAIN-CONTAINING PROTEIN 1, CASD1
19638,611687,"KHDC3-LIKE PROTEIN, SUBCORTICAL MATERNAL COMPLEX MEMBER", KHDC3L
19639,611688,KH DOMAIN-CONTAINING PROTEIN 1, KHDC1
19640,611689,OOCYTE-EXPRESSED PROTEIN, OOEP
19641,611690,PROLINE-RICH GAMMA-CARBOXYGLUTAMIC ACID PROTEIN 4, PRRG4
19642,611691,"SUSHI, VON WILLEBRAND FACTOR TYPE A, EGF, AND PENTRAXIN DOMAINS-CONTAINING 1", SVEP1
19643,611692,ZINC FINGER- AND BTB DOMAIN-CONTAINING PROTEIN 34, ZBTB34
19644,611693,COXSACKIEVIRUS- AND ADENOVIRUS RECEPTOR-LIKE MEMBRANE PROTEIN, CLMP
19645,611694,DYSTONIA WITH CEREBELLAR ATROPHY, DYTCA
19646,611695,TAU TUBULIN KINASE 2, TTBK2
19647,611696,"SOLUTE CARRIER FAMILY 22, MEMBER 20", SLC22A20
19648,611697,"SOLUTE CARRIER FAMILY 22, MEMBER 23", SLC22A23
19649,611698,"SOLUTE CARRIER FAMILY 22, MEMBER 24", SLC22A24
19650,611699,SV2-RELATED PROTEIN, SVOP
19651,611700,SV2-RELATED PROTEIN-LIKE, SVOPL
19652,611701,SPHINGOLIPID TRANSPORTER 3, SPNS3
19653,611702,"SPONDYLOMETAPHYSEAL DYSPLASIA, EAST AFRICAN TYPE",
19654,611703,ZINC FINGER PROTEIN 436, ZNF436
19655,611704,"TRANSMEMBRANE PROTEASE, SERINE 11A", TMPRSS11A
19656,611705,CONGENITAL MYOPATHY 5 WITH CARDIOMYOPATHY, CMYO5
19657,611706,"MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 12", MGR12
19658,611707,MYELIN PROTEIN ZERO-LIKE 3, MPZL3
19659,611708,MICRO RNA 431, MIR431
19660,611709,MICRO RNA 127, MIR127
19661,611710,MICRO RNA 136, MIR136
19662,611711,MICRO RNA 433, MIR433
19663,611712,HOMEODOMAIN-INTERACTING PROTEIN KINASE 4, HIPK4
19664,611713,"DYNEIN, LIGHT CHAIN, TCTEX-TYPE 4", DYNLT4
19665,611714,GTPase-ACTIVATING PROTEIN AND VPS9 DOMAINS 1, GAPVD1
19666,611715,STEROID 5-ALPHA-REDUCTASE 3, SRD5A3
19667,611716,"ATPase, H+ TRANSPORTING, LYSOSOMAL, V0 SUBUNIT A2", ATP6V0A2
19668,611717,SPONDYLOEPIPHYSEAL DYSPLASIA-BRACHYDACTYLY AND DISTINCTIVE SPEECH,
19669,611718,"HYPOMAGNESEMIA 4, RENAL", HOMG4
19670,611719,COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 5, COXPD5
19671,611720,INTERFERON REGULATORY FACTOR 2-BINDING PROTEIN LIKE, IRF2BPL
19672,611721,COMBINED SAPOSIN DEFICIENCY, PSAPD
19673,611722,"KRABBE DISEASE, ATYPICAL, DUE TO SAPOSIN A DEFICIENCY", KRBSAPA
19674,611723,CHROMOSOME 21 OPEN READING FRAME 24, C21ORF24
19675,611724,"SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 8", SHEP8
19676,611725,POTASSIUM CHANNEL TETRAMERIZATION DOMAIN-CONTAINING PROTEIN 7, KCTD7
19677,611726,"EPILEPSY, PROGRESSIVE MYOCLONIC, 3, WITH OR WITHOUT INTRACELLULAR INCLUSIONS", EPM3
19678,611727,"FAMILY WITH SEQUENCE SIMILARITY 163, MEMBER A", FAM163A
19679,611728,PROLINE-RICH PROTEIN 5-LIKE, PRR5L
19680,611729,KINESIN LIGHT CHAIN 2, KLC2
19681,611730,ERYTHROCYTE MEMBRANE PROTEIN BAND 4.1-LIKE 5, EPB41L5
19682,611731,APC REGULATOR OF WNT SIGNALING PATHWAY, APC
19683,611732,MEMBRANE-BOUND O-ACETYLTRANSFERASE DOMAIN-CONTAINING PROTEIN 1, MBOAT1
19684,611733,DAUWERSE-PETERS SYNDROME,
19685,611734,WD REPEAT-CONTAINING PROTEIN 77, WDR77
19686,611735,CUB DOMAIN-CONTAINING PROTEIN 1, CDCP1
19687,611736,GREB1 PROTEIN,
19688,611737,SEPTIN 10, SEPTIN10
19689,611738,BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 7, BMND7
19690,611739,BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 8, BMND8
19691,611740,BETA-CAROTENE OXYGENASE 2, BCO2
19692,611741,"ACID-SENSING ION CHANNEL, SUBUNIT 3", ASIC3
19693,611742,"SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 9", SHEP9
19694,611743,PLECKSTRIN HOMOLOGY DOMAIN- AND RhoGEF DOMAIN-CONTAINING PROTEIN G6, PLEKHG6
19695,611744,OTU DOMAIN-CONTAINING PROTEIN 4, OTUD4
19696,611745,VCP/p47 COMPLEX-INTERACTING PROTEIN 1,   VCPIP1
19697,611746,"SIGNAL PEPTIDE-, CUB DOMAIN-, AND EGF-LIKE DOMAINS-CONTAINING PROTEIN 1", SCUBE1
19698,611747,"SIGNAL PEPTIDE-, CUB DOMAIN-, AND EGF-LIKE DOMAINS-CONTAINING PROTEIN 2", SCUBE2
19699,611748,OTU DOMAIN-CONTAINING PROTEIN 7B, OTUD7B
19700,611749,ZINC FINGER RANBP2-TYPE DOMAIN-CONTAINING PROTEIN 1, ZRANB1
19701,611750,SYNCOILIN 1, SYNC1
19702,611751,THUMP DOMAIN-CONTAINING PROTEIN 2, THUMPD2
19703,611752,ECRG4 AUGURIN PRECURSOR, ECRG4
19704,611753,VACUOLE MEMBRANE PROTEIN 1, VMP1
19705,611754,ALPHA-AMINOADIPATE AMINOTRANSFERASE, AADAT
19706,611755,LEBER CONGENITAL AMAUROSIS 10, LCA10
19707,611756,RHOPHILIN ASSOCIATED TAIL PROTEIN 1-LIKE, ROPN1L
19708,611757,RHOPHILIN-ASSOCIATED TAIL PROTEIN 1, ROPN1
19709,611758,OTU DOMAIN-CONTAINING PROTEIN 3, OTUD3
19710,611759,STARD3 N-TERMINAL-LIKE, STARD3NL
19711,611760,PROTOCADHERIN 17, PCDH17
19712,611761,LIPASE MATURATION FACTOR 1, LMF1
19713,611762,FAMILIAL COLD AUTOINFLAMMATORY SYNDROME 2, FCAS2
19714,611763,LBH REGULATOR OF WNT SIGNALING PATHWAY, LBH
19715,611764,CORNIFELIN, CNFN
19716,611765,"ASPARTIC PEPTIDASE, RETROVIRAL-LIKE 1", ASPRV1
19717,611766,MITOCHONDRIAL METHIONYL-tRNA FORMYLTRANSFERASE, MTFMT
19718,611767,MICRO RNA 126, MIR126
19719,611768,MICRO RNA 335, MIR335
19720,611769,MICRO RNA 128-2, MIR128-2
19721,611770,NK2 HOMEOBOX 6, NKX2-6
19722,611771,LIPOPROTEIN GLOMERULOPATHY, LPG
19723,611772,NUF2 COMPONENT OF NDC80 KINETOCHORE COMPLEX, NUF2
19724,611773,"ANGIOPATHY, HEREDITARY, WITH NEPHROPATHY, ANEURYSMS, AND MUSCLE CRAMPS", HANAC
19725,611774,MICRO RNA 128-1, MIR128-1
19726,611775,KAWASAKI DISEASE,
19727,611776,"NADH DEHYDROGENASE (UBIQUINONE) COMPLEX I, ASSEMBLY FACTOR 4", NDUFAF4
19728,611777,BRUGADA SYNDROME 2, BRGDA2
19729,611778,GLYCEROL-3-PHOSPHATE DEHYDROGENASE 1-LIKE, GPD1L
19730,611779,FIBROUS SHEATH CABYR-BINDING PROTEIN, FSCB
19731,611780,PHD AND RING FINGER DOMAIN-CONTAINING PROTEIN 1, PHRF1
19732,611781,PR DOMAIN-CONTAINING PROTEIN 14, PRDM14
19733,611782,DOWN SYNDROME CELL ADHESION MOLECULE-LIKE 1, DSCAML1
19734,611783,"ERYTHROCYTOSIS, FAMILIAL, 4", ECYT4
19735,611784,"GENERAL TRANSCRIPTION FACTOR 3C, POLYPEPTIDE 6", GTF3C6
19736,611785,"ATP-BINDING CASSETTE, SUBFAMILY B, MEMBER 5", ABCB5
19737,611786,MEDIATOR OF CELL MOTILITY 1, MEMO1
19738,611787,"CYTIDINE MONOPHOSPHATE (UMP-CMP) KINASE 2, MITOCHONDRIAL", CMPK2
19739,611788,"AORTIC ANEURYSM, FAMILIAL THORACIC 6", AAT6
19740,611789,NA+/H+ EXCHANGER DOMAIN-CONTAINING PROTEIN 2, NHEDC2
19741,611790,MYOSIN VIIA- AND RAB-INTERACTING PROTEIN, MYRIP
19742,611791,PATCHED DOMAIN-CONTAINING PROTEIN 3, PTCHD3
19743,611792,ZINC FINGER CCHC DOMAIN-CONTAINING PROTEIN 4, ZCCHC4
19744,611793,"LSM12, S. CEREVISIAE, HOMOLOG OF", LSM12
19745,611794,MICRO RNA 369, MIR369
19746,611795,MICRO RNA 145, MIR145
19747,611796,SECRETOGRANIN III, SCG3
19748,611797,UBIQUINOL-CYTOCHROME C REDUCTASE COMPLEX ASSEMBLY FACTOR 1, UQCC1
19749,611798,EFR3 HOMOLOG A, EFR3A
19750,611799,LIGAND-DEPENDENT NUCLEAR RECEPTOR COREPRESSOR-LIKE PROTEIN, LCORL
19751,611800,THADA ARMADILLO REPEAT-CONTAINING PROTEIN, THADA
19752,611801,POST-GPI ATTACHMENT TO PROTEINS 3, PGAP3
19753,611802,MIGRATION AND INVASION ENHANCER 1, MIEN1
19754,611803,INTEGRIN-ALPHA FG-GAP REPEAT-CONTAINING PROTEIN 1, ITFG1
19755,611804,ELLIPTOCYTOSIS 1, EL1
19756,611805,ELONGATION OF VERY LONG CHAIN FATTY ACIDS-LIKE 5, ELOVL5
19757,611806,ARSENIC (+3 OXIDATION STATE) METHYLTRANSFERASE, AS3MT
19758,611807,TIP41-LIKE PROTEIN, TIPRL
19759,611808,"TREMOR, HEREDITARY ESSENTIAL, AND IDIOPATHIC NORMAL PRESSURE HYDROCEPHALUS", ETINPH
19760,611809,"BESTROPHINOPATHY, AUTOSOMAL RECESSIVE", ARB
19761,611810,USH1C-BINDING PROTEIN 1, USHBP1
19762,611811,ZINC FINGER PROTEIN 333, ZNF333
19763,611812,"46,XX SEX REVERSAL WITH DYSGENESIS OF KIDNEYS, ADRENALS, AND LUNGS", SERKAL
19764,611813,ELONGATION OF VERY LONG CHAIN FATTY ACIDS-LIKE 1, ELOVL1
19765,611814,ELONGATION OF VERY LONG CHAIN FATTY ACIDS-LIKE 2, ELOVL2
19766,611815,ELONGATION OF VERY LONG CHAIN FATTY ACIDS-LIKE 3, ELOVL3
19767,611816,TEMPLE-BARAITSER SYNDROME, TMBTS
19768,611817,"KILLER CELL LECTIN-LIKE RECEPTOR, SUBFAMILY K, MEMBER 1", KLRK1
19769,611818,LONG QT SYNDROME 9, LQT9
19770,611819,LONG QT SYNDROME 10, LQT10
19771,611820,LONG QT SYNDROME 11, LQT11
19772,611821,MITOCHONDRIAL RIBOSOMAL PROTEIN L1, MRPL1
19773,611822,MITOCHONDRIAL RIBOSOMAL PROTEIN L2, MRPL2
19774,611823,MITOCHONDRIAL RIBOSOMAL PROTEIN L4, MRPL4
19775,611824,MITOCHONDRIAL RIBOSOMAL PROTEIN L9, MRPL9
19776,611825,MITOCHONDRIAL RIBOSOMAL PROTEIN L10, MRPL10
19777,611826,MITOCHONDRIAL RIBOSOMAL PROTEIN L11, MRPL11
19778,611827,MITOCHONDRIAL RIBOSOMAL PROTEIN L14, MRPL14
19779,611828,MITOCHONDRIAL RIBOSOMAL PROTEIN L15, MRPL15
19780,611829,MITOCHONDRIAL RIBOSOMAL PROTEIN L16, MRPL16
19781,611830,MITOCHONDRIAL RIBOSOMAL PROTEIN L17, MRPL17
19782,611831,MITOCHONDRIAL RIBOSOMAL PROTEIN L18, MRPL18
19783,611832,MITOCHONDRIAL RIBOSOMAL PROTEIN L19, MRPL19
19784,611833,MITOCHONDRIAL RIBOSOMAL PROTEIN L20, MRPL20
19785,611834,MITOCHONDRIAL RIBOSOMAL PROTEIN L21, MRPL21
19786,611835,MITOCHONDRIAL RIBOSOMAL PROTEIN L22, MRPL22
19787,611836,MITOCHONDRIAL RIBOSOMAL PROTEIN L24, MRPL24
19788,611837,MITOCHONDRIAL RIBOSOMAL PROTEIN L27, MRPL27
19789,611838,MITOCHONDRIAL RIBOSOMAL PROTEIN L30, MRPL30
19790,611839,MITOCHONDRIAL RIBOSOMAL PROTEIN L32, MRPL32
19791,611840,MITOCHONDRIAL RIBOSOMAL PROTEIN L34, MRPL34
19792,611841,MITOCHONDRIAL RIBOSOMAL PROTEIN L35, MRPL35
19793,611842,MITOCHONDRIAL RIBOSOMAL PROTEIN L36, MRPL36
19794,611843,MITOCHONDRIAL RIBOSOMAL PROTEIN L37, MRPL37
19795,611844,MITOCHONDRIAL RIBOSOMAL PROTEIN L38, MRPL38
19796,611845,MITOCHONDRIAL RIBOSOMAL PROTEIN L39, MRPL39
19797,611846,MITOCHONDRIAL RIBOSOMAL PROTEIN L41, MRPL41
19798,611847,MITOCHONDRIAL RIBOSOMAL PROTEIN L42, MRPL42
19799,611848,MITOCHONDRIAL RIBOSOMAL PROTEIN L43, MRPL43
19800,611849,MITOCHONDRIAL RIBOSOMAL PROTEIN L44, MRPL44
19801,611850,MITOCHONDRIAL RIBOSOMAL PROTEIN L45, MRPL45
19802,611851,MITOCHONDRIAL RIBOSOMAL PROTEIN L46, MRPL46
19803,611852,MITOCHONDRIAL RIBOSOMAL PROTEIN L47, MRPL47
19804,611853,MITOCHONDRIAL RIBOSOMAL PROTEIN L48, MRPL48
19805,611854,MITOCHONDRIAL RIBOSOMAL PROTEIN L50, MRPL50
19806,611855,MITOCHONDRIAL RIBOSOMAL PROTEIN L51, MRPL51
19807,611856,MITOCHONDRIAL RIBOSOMAL PROTEIN L52, MRPL52
19808,611857,MITOCHONDRIAL RIBOSOMAL PROTEIN L53, MRPL53
19809,611858,MITOCHONDRIAL RIBOSOMAL PROTEIN L54, MRPL54
19810,611859,MITOCHONDRIAL RIBOSOMAL PROTEIN L55, MRPL55
19811,611860,"MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE II",
19812,611861,ADP-DEPENDENT GLUCOKINASE, ADPGK
19813,611862,WHITE BLOOD CELL COUNT QUANTITATIVE TRAIT LOCUS 1, WBCQ1
19814,611863,MICROTIA WITH NASOLACRIMAL DUCT IMPERFORATION AND EYE COLOBOMA,
19815,611864,ARMADILLO REPEAT-CONTAINING 10, ARMC10
19816,611865,L3MBTL HISTONE METHYL-LYSINE-BINDING PROTEIN 2, L3MBTL2
19817,611866,RETINOL-BINDING PROTEIN 5, RBP5
19818,611867,"CHROMOSOME 22q11.2 DELETION SYNDROME, DISTAL",
19819,611868,"PROSTATE CANCER, HEREDITARY, 12", HPC12
19820,611869,"RABAPTIN, RAB GTPase-BINDING EFFECTOR PROTEIN 2", RABEP2
19821,611870,CENTLEIN, CNTLN
19822,611871,REGULATOR OF MICROTUBULE DYNAMICS 1, RMDN1
19823,611872,REGULATOR OF MICROTUBULE DYNAMICS 2, RMDN2
19824,611873,REGULATOR OF MICROTUBULE DYNAMICS 3, RMDN3
19825,611874,NEURON-DERIVED NEUROTROPHIC FACTOR, NENF
19826,611875,BRUGADA SYNDROME 3, BRGDA3
19827,611876,BRUGADA SYNDROME 4, BRGDA4
19828,611877,BAI1-ASSOCIATED PROTEIN 2-LIKE 1, BAIAP2L1
19829,611878,"CARDIOMYOPATHY, DILATED, 1Y", CMD1Y
19830,611879,"CARDIOMYOPATHY, DILATED, 1Z", CMD1Z
19831,611880,"CARDIOMYOPATHY, DILATED, 2A", CMD2A
19832,611881,GLYCOGEN STORAGE DISEASE XII, GSD12
19833,611882,PROLINE-RICH NUCLEAR RECEPTOR COACTIVATOR 2, PNRC2
19834,611883,BRCA2- AND CDKN1A-INTERACTING PROTEIN, BCCIP
19835,611884,"CILIARY DYSKINESIA, PRIMARY, 7", CILD7
19836,611885,SHANK-ASSOCIATED RH DOMAIN INTERACTOR, SHARPIN
19837,611886,"MESOMELIC DYSPLASIA, CAMERA TYPE",
19838,611887,UROPLAKIN 3B, UPK3B
19839,611888,ETS2 REPRESSOR FACTOR, ERF
19840,611889,S100P-BINDING PROTEIN, S100PBP
19841,611890,CONGENITAL ARTHROGRYPOSIS WITH ANTERIOR HORN CELL DISEASE, CAAHD
19842,611891,"AORTIC ANEURYSM, FAMILIAL ABDOMINAL, 3", AAA3
19843,611892,"ANEURYSM, INTRACRANIAL BERRY, 6", ANIB6
19844,611893,PLECKSTRIN HOMOLOGY DOMAIN- AND RhoGEF DOMAIN-CONTAINING PROTEIN G2, PLEKHG2
19845,611894,MICRO RNA 140, MIR140
19846,611895,AMYOTROPHIC LATERAL SCLEROSIS 9, ALS9
19847,611896,RETROTRANSPOSON-LIKE GENE 1, RTL1
19848,611897,NANOPHTHALMOS 3, NNO3
19849,611898,ENDO-BETA-N-ACETYLGLUCOSAMINIDASE, ENGASE
19850,611899,MICRO RNA 203A, MIR203A
19851,611900,METALLOPHOSPHOESTERASE 1, MPPE1
19852,611901,VON WILLEBRAND FACTOR A DOMAIN-CONTAINING PROTEIN 1, VWA1
19853,611902,COILED-COIL DOMAIN-CONTAINING PROTEIN 136, CCDC136
19854,611903,ZINC FINGER PROTEIN 649, ZNF649
19855,611904,PLACENTA-EXPRESSED TRANSCRIPT 1, PLET1
19856,611905,FIBRONECTIN TYPE III DOMAIN-CONTAINING PROTEIN 4, FNDC4
19857,611906,FIBRONECTIN TYPE III DOMAIN-CONTAINING PROTEIN 5, FNDC5
19858,611907,"EPISODIC ATAXIA, TYPE 7", EA7
19859,611908,RFT1 HOMOLOG, RFT1
19860,611909,FIBRONECTIN TYPE III DOMAIN-CONTAINING PROTEIN 3B, FNDC3B
19861,611910,"SOLUTE CARRIER FAMILY 16 (MONOCARBOXYLIC ACID TRANSPORTER), MEMBER 12", SLC16A12
19862,611911,IRON-SULFUR CLUSTER ASSEMBLY ENZYME, ISCU
19863,611912,NUCLEAR CASEIN KINASE AND CYCLIN-DEPENDENT KINASE SUBSTRATE 1, NUCKS1
19864,611913,"CHROMOSOME 16p11.2 DELETION SYNDROME, 593-KB",
19865,611914,"TSC22 DOMAIN FAMILY, MEMBER 4", TSC22D4
19866,611915,"VESICULAR, OVEREXPRESSED IN CANCER, PROSURVIVAL PROTEIN 1", VOPP1
19867,611916,"COLLAGEN, TYPE VI, ALPHA-5", COL6A5
19868,611917,LYSINE DEMETHYLASE 8, KDM8
19869,611918,"DEAFNESS, AUTOSOMAL RECESSIVE 15",
19870,611919,RIBOSOMAL OXYGENASE 1, RIOX1
19871,611920,"C-REACTIVE PROTEIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 1", CRPQTL1
19872,611921,"GAP JUNCTION PROTEIN, BETA-7", GJB7
19873,611922,"GAP JUNCTION PROTEIN, DELTA-4", GJD4
19874,611923,"GAP JUNCTION PROTEIN, ALPHA-9", GJA9
19875,611924,"GAP JUNCTION PROTEIN, ALPHA-10", GJA10
19876,611925,"GAP JUNCTION PROTEIN, GAMMA-3", GJC3
19877,611926,"IMMUNODEFICIENCY, OVARIAN DYSGENESIS, AND PULMONARY FIBROSIS",
19878,611927,"FAMILY WITH SEQUENCE SIMILARITY 83, MEMBER H", FAM83H
19879,611928,"PROSTATE CANCER, HEREDITARY, 13", HPC13
19880,611929,"CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE III",
19881,611930,INTERFERON-STIMULATED EXONUCLEASE GENE 20-KD-LIKE 2, ISG20L2
19882,611931,"PROTEIN PHOSPHATASE, MAGNESIUM/MANGANESE-DEPENDENT, 1L", PPM1L
19883,611932,CDGSH IRON SULFUR DOMAIN PROTEIN 1, CISD1
19884,611933,CDGSH IRON SULFUR DOMAIN PROTEIN 3, CISD3
19885,611934,"EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 5", EIG5
19886,611935,METABOLISM OF COBALAMIN ASSOCIATED D, MMADHC
19887,611936,CHROMOSOME 3q29 DUPLICATION SYNDROME,
19888,611937,IMMUNOGLOBULIN HEAVY CHAIN DIVERSITY GENE 3-3, IGHD3-3
19889,611938,"VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 2", CPVT2
19890,611939,IMMUNOGLOBULIN HEAVY CHAIN VARIABLE GENE 3-23, IGHV3-23
19891,611940,MEMBRANE-BOUND O-ACETYLTRANSFERASE DOMAIN-CONTAINING PROTEIN 4, MBOAT4
19892,611941,"ATPase FAMILY, AAA DOMAIN-CONTAINING, MEMBER 2", ATAD2
19893,611942,"EPILEPSY, CHILDHOOD ABSENCE, SUSCEPTIBILITY TO, 6", ECA6
19894,611943,RIDDLE SYNDROME, RIDL
19895,611944,LYMPHATIC MALFORMATION 2, LMPHM2
19896,611945,"SPASTIC PARAPLEGIA 37, AUTOSOMAL DOMINANT", SPG37
19897,611946,UBX DOMAIN PROTEIN 6, UBXN6
19898,611947,NLR FAMILY MEMBER X1, NLRX1
19899,611948,KNOBLOCH SYNDROME 1,
19900,611949,MEMBRANE-BOUND O-ACYLTRANSFERASE DOMAIN-CONTAINING PROTEIN 2, MBOAT2
19901,611950,LYSOPHOSPHATIDYLCHOLINE ACYLTRANSFERASE 3, LPCAT3
19902,611951,B9 DOMAIN-CONTAINING PROTEIN 2, B9D2
19903,611952,VPS28 SUBUNIT OF ESCRT-I, VPS28
19904,611953,"MACULAR DEGENERATION, AGE-RELATED, 11", ARMD11
19905,611954,MICRO RNA 373, MIR373
19906,611955,"PROSTATE CANCER, HEREDITARY, 11", HPC11
19907,611956,CHROMOSOME 3 OPEN READING FRAME 52, C3ORF52
19908,611957,MICRO RNA 378, MIRN378
19909,611958,"PROSTATE CANCER, HEREDITARY, 14", HPC14
19910,611959,"PROSTATE CANCER, HEREDITARY, 15", HPC15
19911,611960,"ASTHMA-RELATED TRAITS, SUSCEPTIBILITY TO, 7", ASRT7
19912,611961,STEVENSON-CAREY SYNDROME,
19913,611962,HUNTER-MACDONALD SYNDROME,
19914,611963,ACYL-CoA THIOESTERASE 7-LIKE,
19915,611964,"CYTOCHROME b5, TYPE B (OUTER MITOCHONDRIAL MEMBRANE)", CYB5B
19916,611965,"THO COMPLEX, SUBUNIT 7", THOC7
19917,611966,"TRAFFICKING PROTEIN PARTICLE COMPLEX, SUBUNIT 9", TRAPPC9
19918,611967,KELCH-LIKE 8, KLHL8
19919,611968,"CLEAVAGE STIMULATION FACTOR, 3-PRIME PRE-RNA, SUBUNIT 2, 64-KD, TAU VARIANT", CSTF2T
19920,611969,MOB KINASE ACTIVATOR 2, MOB2
19921,611970,NUCLEOLAR PROTEIN INTERACTING WITH THE FHA DOMAIN OF MKI67, NIFK
19922,611971,MITOCHONDRIAL RIBOSOMAL PROTEIN S2, MRPS2
19923,611972,MITOCHONDRIAL RIBOSOMAL PROTEIN S5, MRPS5
19924,611973,MITOCHONDRIAL RIBOSOMAL PROTEIN S6, MRPS6
19925,611974,MITOCHONDRIAL RIBOSOMAL PROTEIN S7, MRPS7
19926,611975,MITOCHONDRIAL RIBOSOMAL PROTEIN S9, MRPS9
19927,611976,MITOCHONDRIAL RIBOSOMAL PROTEIN S10, MRPS10
19928,611977,MITOCHONDRIAL RIBOSOMAL PROTEIN S11, MRPS11
19929,611978,MITOCHONDRIAL RIBOSOMAL PROTEIN S14, MRPS14
19930,611979,MITOCHONDRIAL RIBOSOMAL PROTEIN S15, MRPS15
19931,611980,MITOCHONDRIAL RIBOSOMAL PROTEIN S17, MRPS17
19932,611981,MITOCHONDRIAL RIBOSOMAL PROTEIN S18A, MRPS18A
19933,611982,MITOCHONDRIAL RIBOSOMAL PROTEIN S18B, MRPS18B
19934,611983,MITOCHONDRIAL RIBOSOMAL PROTEIN S18C, MRPS18C
19935,611984,MITOCHONDRIAL RIBOSOMAL PROTEIN S21, MRPS21
19936,611985,MITOCHONDRIAL RIBOSOMAL PROTEIN S23, MRPS23
19937,611986,MITOCHONDRIAL RIBOSOMAL PROTEIN S24, MRPS24
19938,611987,MITOCHONDRIAL RIBOSOMAL PROTEIN S25, MRPS25
19939,611988,MITOCHONDRIAL RIBOSOMAL PROTEIN S26, MRPS26
19940,611989,MITOCHONDRIAL RIBOSOMAL PROTEIN S27, MRPS27
19941,611990,MITOCHONDRIAL RIBOSOMAL PROTEIN S28, MRPS28
19942,611991,MITOCHONDRIAL RIBOSOMAL PROTEIN S30, MRPS30
19943,611992,MITOCHONDRIAL RIBOSOMAL PROTEIN S31, MRPS31
19944,611993,MITOCHONDRIAL RIBOSOMAL PROTEIN S33, MRPS33
19945,611994,MITOCHONDRIAL RIBOSOMAL PROTEIN S34, MRPS34
19946,611995,MITOCHONDRIAL RIBOSOMAL PROTEIN S35, MRPS35
19947,611996,MITOCHONDRIAL RIBOSOMAL PROTEIN S36, MRPS36
19948,611997,MITOCHONDRIAL RIBOSOMAL PROTEIN 63, MRP63
19949,611998,cAMP RESPONSE ELEMENT-BINDING PROTEIN 3-LIKE 3, CREB3L3
19950,611999,RAB11 FAMILY-INTERACTING PROTEIN 4, RAB11FIP4
19951,612000,TRIPARTITE MOTIF-CONTAINING PROTEIN 66, TRIM66
19952,612001,CHROMOSOME 15q13.3 DELETION SYNDROME,
19953,612002,DEP DOMAIN-CONTAINING PROTEIN 1, DEPDC1
19954,612003,GRB10-INTERACTING GYF PROTEIN 2, GIGYF2
19955,612004,THROMBOCYTOPENIA 4, THC4
19956,612005,"CELIAC DISEASE, SUSCEPTIBILITY TO, 7", CELIAC7
19957,612006,"CELIAC DISEASE, SUSCEPTIBILITY TO, 8", CELIAC8
19958,612007,"CELIAC DISEASE, SUSCEPTIBILITY TO, 9", CELIAC9
19959,612008,"CELIAC DISEASE, SUSCEPTIBILITY TO, 10", CELIAC10
19960,612009,"CELIAC DISEASE, SUSCEPTIBILITY TO, 11", CELIAC11
19961,612010,"CELIAC DISEASE, SUSCEPTIBILITY TO, 12", CELIAC12
19962,612011,"CELIAC DISEASE, SUSCEPTIBILITY TO, 13", CELIAC13
19963,612012,ZINC FINGER FYVE DOMAIN-CONTAINING PROTEIN 26, ZFYVE26
19964,612013,COILED-COIL AND C2 DOMAINS-CONTAINING PROTEIN 2A, CC2D2A
19965,612014,TETRATRICOPEPTIDE REPEAT DOMAIN-CONTAINING PROTEIN 21B, TTC21B
19966,612015,"CONGENITAL DISORDER OF GLYCOSYLATION, TYPE In", CDG1N
19967,612016,"COENZYME Q10 DEFICIENCY, PRIMARY, 4", COQ10D4
19968,612017,"PYLORIC STENOSIS, INFANTILE HYPERTROPHIC, 3", IHPS3
19969,612018,CATARACT 47, CTRCT47
19970,612019,INTESTINE-SPECIFIC HOMEOBOX, ISX
19971,612020,"SPASTIC PARAPLEGIA 39, AUTOSOMAL RECESSIVE", SPG39
19972,612021,OTU DOMAIN-CONTAINING PROTEIN 6B, OTUD6B
19973,612022,OTU DOMAIN-CONTAINING PROTEIN 1, OTUD1
19974,612023,YOD1 DEUBIQUITINASE, YOD1
19975,612024,OTU DOMAIN-CONTAINING PROTEIN 7A, OTUD7A
19976,612025,IODOTYROSINE DEIODINASE, IYD
19977,612026,"La RIBONUCLEOPROTEIN 7, TRANSCRIPTIONAL REGULATOR", LARP7
19978,612027,TRAFFICKING REGULATOR AND SCAFFOLD PROTEIN TAMALIN, TAMALIN
19979,612028,FAT STORAGE-INDUCING TRANSMEMBRANE PROTEIN 1, FITM1
19980,612029,FAT STORAGE-INDUCING TRANSMEMBRANE PROTEIN 2, FITM2
19981,612030,"CORONARY HEART DISEASE, SUSCEPTIBILITY TO, 9", CHDS9
19982,612031,"INHIBIN, BETA E", INHBE
19983,612032,DPY30 HISTONE METHYLTRANSFERASE COMPLEX REGULATORY SUBUNIT, DPY30
19984,612033,PAXIP1-ASSOCIATED GLUTAMATE-RICH PROTEIN 1, PAGR1
19985,612034,APC2 REGULATOR OF WNT SIGNALING PATHWAY 2, APC2
19986,612035,ALANYL-tRNA SYNTHETASE 2, AARS2
19987,612036,PROLYL-tRNA SYNTHETASE 2, PARS2
19988,612037,MITOCHONDRIAL UBIQUITIN LIGASE ACTIVATOR OF NFKB 1, MUL1
19989,612038,TRANSMEMBRANE p24 TRAFFICKING PROTEIN 4, TMED4
19990,612039,1-ACYLGLYCEROL-3-PHOSPHATE O-ACYLTRANSFERASE 7, AGPAT7
19991,612040,LYSOPHOSPHATIDYLCHOLINE ACYLTRANSFERASE 2, LPCAT2
19992,612041,RING FINGER PROTEIN 212, RNF212
19993,612042,RECOMBINATION RATE QUANTITATIVE TRAIT LOCUS 1, RRQTL1
19994,612043,MICRO RNA 371A, MIR371A
19995,612044,MICRO RNA 372, MIRN372
19996,612045,C1q- AND TUMOR NECROSIS FACTOR-RELATED PROTEIN 3, C1QTNF3
19997,612046,E2F TRANSCRIPTION FACTOR 7, E2F7
19998,612047,E2F TRANSCRIPTION FACTOR 8, E2F8
19999,612048,TRANSMEMBRANE PROTEIN 43, TMEM43
20000,612049,RIBOSOMAL OXYGENASE 2, RIOX2
20001,612050,NEDD4 FAMILY-INTERACTING PROTEIN 1, NDFIP1
20002,612051,"BRAIN-EXPRESSED, ASSOCIATED WITH NEDD4, 1", BEAN1
20003,612052,SMOKING AS A QUANTITATIVE TRAIT LOCUS 3, SQTL3
20004,612053,ZINC FINGER PROTEIN 36-LIKE 2, ZFP36L2
20005,612054,"CCR4-NOT TRANSCRIPTION COMPLEX, SUBUNIT 9", CNOT9
20006,612055,RIBOSOMAL PROTEIN S27-LIKE, RPS27L
20007,612056,GUIDED ENTRY OF TAIL-ANCHORED PROTEINS FACTOR 4, GET4
20008,612057,SUPPRESSOR APC DOMAIN-CONTAINING PROTEIN 2, SAPCD2
20009,612058,SAMM50 SORTING AND ASSEMBLY MACHINERY COMPONENT, SAMM50
20010,612059,"La RIBONUCLEOPROTEIN 1, TRANSLATIONAL REGULATOR", LARP1
20011,612060,ZINC FINGER AND RING FINGER PROTEIN 1, ZNRF1
20012,612061,ZINC FINGER AND RING FINGER PROTEIN 2, ZNRF2
20013,612062,ZINC FINGER AND RING FINGER PROTEIN 3, ZNRF3
20014,612063,ZINC FINGER AND RING FINGER PROTEIN 4, ZNRF4
20015,612064,GRB10-INTERACTING GYF PROTEIN 1, GIGYF1
20016,612065,"POLY(ADP-RIBOSE) POLYMERASE FAMILY, MEMBER 9", PARP9
20017,612066,"POLY(ADP-RIBOSE) POLYMERASE FAMILY, MEMBER 15", PARP15
20018,612067,DYSTONIA 16, DYT16
20019,612068,PHOSPHOINOSITIDE-INTERACTING REGULATOR OF TRANSIENT RECEPTOR POTENTIAL CHANNELS, PIRT
20020,612069,AMYOTROPHIC LATERAL SCLEROSIS 10 WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA, ALS10
20021,612070,MICRO RNA 144, MIRN144
20022,612071,MICRO RNA 451, MIRN451
20023,612072,MIF4G DOMAIN-CONTAINING PROTEIN, MIF4GD
20024,612073,MITOCHONDRIAL DNA DEPLETION SYNDROME 5 (ENCEPHALOMYOPATHIC WITH OR WITHOUT METHYLMALONIC ACIDURIA), MTDPS5
20025,612074,RNA-BINDING MOTIF PROTEIN 28, RBM28
20026,612075,MITOCHONDRIAL DNA DEPLETION SYNDROME 8A (ENCEPHALOMYOPATHIC TYPE WITH RENAL TUBULOPATHY), MTDPS8A
20027,612076,"HYPOURICEMIA, RENAL, 2", RHUC2
20028,612077,MICRO RNA 22, MIR22
20029,612078,ZINC FINGER PROTEIN 469, ZNF469
20030,612079,"ALOPECIA, NEUROLOGIC DEFECTS, AND ENDOCRINOPATHY SYNDROME", ANES
20031,612080,"UBIQUINOL-CYTOCHROME c REDUCTASE, COMPLEX III SUBUNIT VII", UQCRQ
20032,612081,INTERLEUKIN 34, IL34
20033,612082,CAPICUA TRANSCRIPTIONAL REPRESSOR, CIC
20034,612083,MUSCLE STRENGTH QUANTITATIVE TRAIT LOCUS 1,
20035,612084,"SOLUTE CARRIER FAMILY 51, SUBUNIT ALPHA", SLC51A
20036,612085,"SOLUTE CARRIER FAMILY 51, SUBUNIT BETA", SLC51B
20037,612086,"MINOR HISTOCOMPATIBILITY ANTIGEN, SERPIN DOMAIN-CONTAINING", HMSD
20038,612087,"C-TYPE LECTIN DOMAIN FAMILY 2, MEMBER A", CLEC2A
20039,612088,"C-TYPE LECTIN DOMAIN FAMILY 12, MEMBER A", CLEC12A
20040,612089,HYPOPHOSPHATEMIC RICKETS AND HYPERPARATHYROIDISM,
20041,612090,MICRO RNA 200A, MIR200A
20042,612091,MICRO RNA 200B, MIRN200B
20043,612092,MICRO RNA 200C, MIR200C
20044,612093,MICRO RNA 141, MIR141
20045,612094,MICRO RNA 429, MIRN429
20046,612095,RETINITIS PIGMENTOSA 41, RP41
20047,612096,OTOSCLEROSIS 8, OTSC8
20048,612097,"DEAFNESS, UNILATERAL, WITH DELAYED ENDOLYMPHATIC HYDROPS",
20049,612098,"CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 11", CMH11
20050,612099,"TRICHOEPITHELIOMA, MULTIPLE FAMILIAL, 2",
20051,612100,"AUTISM, SUSCEPTIBILITY TO, 15", AUTS15
20052,612101,"PHOSPHATIDYLINOSITOL 4-KINASE, TYPE 2, BETA", PI4K2B
20053,612102,MICRO RNA LET7G, MIRNLET7G
20054,612103,NUCLEIC ACID-BINDING PROTEIN 1, NABP1
20055,612104,NUCLEIC ACID-BINDING PROTEIN 2, NABP2
20056,612105,KILLIN, KLLN
20057,612106,ZINC FINGER- AND BTB DOMAIN-CONTAINING PROTEIN 40, ZBTB40
20058,612107,"SOLUTE CARRIER FAMILY 17 (VESICULAR NUCLEOTIDE TRANSPORTER), MEMBER 9", SLC17A9
20059,612108,FASTING PLASMA GLUCOSE LEVEL QUANTITATIVE TRAIT LOCUS 1, FGQTL1
20060,612109,OCULOAURICULAR SYNDROME, OCACS
20061,612110,BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 9, BMND9
20062,612111,TUMOR NECROSIS FACTOR-ALPHA-INDUCED PROTEIN 8, TNFAIP8
20063,612112,TUMOR NECROSIS FACTOR-ALPHA-INDUCED PROTEIN 8-LIKE 2, TNFAIP8L2
20064,612113,BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 10, BMND10
20065,612114,BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 11, BMND11
20066,612115,RHO GUANINE NUCLEOTIDE EXCHANGE FACTOR 3, ARHGEF3
20067,612116,UBIQUITIN-SPECIFIC PROTEASE 22, USP22
20068,612117,MICRO RNA 143, MIR143
20069,612118,IQ MOTIF- AND SEC7 DOMAIN-CONTAINING PROTEIN 3, IQSEC3
20070,612119,TREHALASE DEFICIENCY,
20071,612120,CELL DEATH-INDUCING DFFA-LIKE EFFECTOR C, CIDEC
20072,612121,PATATIN-LIKE PHOSPHOLIPASE DOMAIN-CONTAINING PROTEIN 1, PNPLA1
20073,612122,PATATIN-LIKE PHOSPHOLIPASE DOMAIN-CONTAINING PROTEIN 7, PNPLA7
20074,612123,PATATIN-LIKE PHOSPHOLIPASE DOMAIN-CONTAINING PROTEIN 8, PNPLA8
20075,612124,"CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 12", CMH12
20076,612125,SERTA DOMAIN-CONTAINING PROTEIN 3, SERTAD3
20077,612126,GLUT1 DEFICIENCY SYNDROME 2, GLUT1DS2
20078,612127,17-BETA-HYDROXYSTEROID DEHYDROGENASE XIII, HSD17B13
20079,612128,"RAS-LIKE, FAMILY 10, MEMBER B", RASL10B
20080,612129,"INDOLEAMINE 2,3-DIOXYGENASE 2", IDO2
20081,612130,GENE AMPLIFIED IN ESOPHAGEAL CANCER 1, GAEC1
20082,612131,"SHORT-CHAIN DEHYDROGENASE/REDUCTASE FAMILY, MEMBER 9", DHRS9
20083,612132,ECTODERMAL DYSPLASIA AND IMMUNODEFICIENCY 2, EDAID2
20084,612133,TRANSCRIPTION FACTOR NFE4, NFE4
20085,612134,GLUCURONIC ACID EPIMERASE, GLCE
20086,612135,CALCIUM-BINDING TYROSINE PHOSPHORYLATION-REGULATED PROTEIN, CABYR
20087,612136,ENOYL COENZYME A HYDRATASE DOMAIN-CONTAINING PROTEIN 1, ECHDC1
20088,612137,RING FINGER PROTEIN 146, RNF146
20089,612138,"EPIDERMOLYSIS BULLOSA SIMPLEX 5C, WITH PYLORIC ATRESIA", EBS5C
20090,612139,"PHOSPHATIDYLINOSITOL 3,4,5-TRISPHOSPHATE-DEPENDENT RAC EXCHANGER 2", PREX2
20091,612140,SEPTIN 14, SEPT14
20092,612141,ERYTHROCYTE MEMBRANE PROTEIN BAND 4.1-LIKE 4A, EPB41L4A
20093,612142,MICRO RNA LET7A2, MIRLET7A2
20094,612143,MICRO RNA LET7A3, MIRNLET7A3
20095,612144,MICRO RNA LET7C, MIRLET7C
20096,612145,MICRO RNA LET7D, MIRNLET7D
20097,612146,MICRO RNA LET7F1, MIRLET7F1
20098,612147,MYOSIN LIGHT CHAIN KINASE 3, MYLK3
20099,612148,MICRO RNA LET7I, MIRNLET7I
20100,612149,RNA-BINDING FOX1 HOMOLOG 2, RBFOX2
20101,612150,MICRO RNA 25, MIR25
20102,612151,MICRO RNA 26A1, MIR26A1
20103,612152,MICRO RNA 26B, MIR26B
20104,612153,MICRO RNA 27A, MIR27A
20105,612154,MICRO RNA 28, MIR28
20106,612155,MICRO RNA 31, MIR31
20107,612156,MICRO RNA 33A, MIR33A
20108,612157,"SENTRIN-SPECIFIC PROTEASE FAMILY, MEMBER 1", SENP1
20109,612158,"CARDIOMYOPATHY, DILATED, 1AA, WITH OR WITHOUT LEFT VENTRICULAR NONCOMPACTION", CMD1AA
20110,612159,RABPHILIN 3A, RPH3A
20111,612160,"HISTIOCYTOMA, ANGIOMATOID FIBROUS",
20112,612161,"ANEURYSM, INTRACRANIAL BERRY, 7", ANIB7
20113,612162,"ANEURYSM, INTRACRANIAL BERRY, 8", ANIB8
20114,612163,TWO-PORE SEGMENT CHANNEL 2, TPCN2
20115,612164,DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 4, DEE4
20116,612165,RETINITIS PIGMENTOSA 29, RP29
20117,612166,"SOLUTE CARRIER FAMILY 39 (ZINC TRANSPORTER), MEMBER 2", SLC39A2
20118,612167,WD REPEAT-CONTAINING PROTEIN 48, WDR48
20119,612168,"SOLUTE CARRIER FAMILY 39 (ZINC TRANSPORTER), MEMBER 3", SLC39A3
20120,612169,Fc FRAGMENT OF IgG RECEPTOR IIc, FCGR2C
20121,612170,"MUCIN 19, OLIGOMERIC", MUC19
20122,612171,REPRIMO, RPRM
20123,612172,DEAD-BOX HELICASE 23, DDX23
20124,612173,SPERM-ASSOCIATED ANTIGEN 16, SPAG16
20125,612174,CALCIUM-BINDING PROTEIN 39, CAB39
20126,612175,CALCIUM-BINDING PROTEIN 39-LIKE PROTEIN, CAB39L
20127,612176,"MYB-LIKE, SWIRM, AND MPN DOMAINS-CONTAINING PROTEIN 1", MYSM1
20128,612177,"RNA, 7SL, CYTOPLASMIC 1", RN7SL1
20129,612178,HEN METHYLTRANSFERASE 1, HENMT1
20130,612179,"RNA, 7SL, CYTOPLASMIC 2", RN7SL2
20131,612180,"RNA, 7SL, CYTOPLASMIC 3", RN7SL3
20132,612181,"MUCIN 13, CELL SURFACE-ASSOCIATED", MUC13
20133,612182,N-ACETYLTRANSFERASE 2, NAT2
20134,612183,G PROTEIN-COUPLED RECEPTOR 176, GPR176
20135,612184,CASK-INTERACTING PROTEIN 1, CASKIN1
20136,612185,CASK-INTERACTING PROTEIN 2, CASKIN2
20137,612186,DMX-LIKE 2, DMXL2
20138,612187,"SOLUTE CARRIER FAMILY 48 (HEME TRANSPORTER), MEMBER 1", SLC48A1
20139,612188,VPS39 SUBUNIT OF HOPS COMPLEX, VPS39
20140,612189,PHENAZINE BIOSYNTHESIS-LIKE PROTEIN DOMAIN-CONTAINING PROTEIN, PBLD
20141,612190,MTOR-ASSOCIATED PROTEIN LST8, MLST8
20142,612191,"MICROSEMINOPROTEIN, PROSTATE-ASSOCIATED", MSMP
20143,612192,ZFP57 ZINC FINGER PROTEIN, ZFP57
20144,612193,CARDIOMYOPATHY-ASSOCIATED PROTEIN 5, CMYA5
20145,612194,RAS-RELATED GTP-BINDING PROTEIN A, RRAGA
20146,612195,ABHYDROLASE DOMAIN-CONTAINING PROTEIN 1, ABHD1
20147,612196,"ABHYDROLASE DOMAIN-CONTAINING PROTEIN 2, ACYLGLYCEROL LIPASE", ABHD2
20148,612197,"ABHYDROLASE DOMAIN-CONTAINING PROTEIN 3, PHOSPHOLIPASE", ABHD3
20149,612198,DIASTASIS RECTI AND WEAKNESS OF THE LINEA ALBA,
20150,612199,CEREBRORETINAL MICROANGIOPATHY WITH CALCIFICATIONS AND CYSTS 1, CRMCC1
20151,612200,DIVERGENT PROTEIN KINASE DOMAIN 2A, DIPK2A
20152,612201,"ATRIAL FIBRILLATION, FAMILIAL, 6", ATFB6
20153,612202,SRY-BOX 7, SOX7
20154,612203,NUCLEOSOME ASSEMBLY PROTEIN 1-LIKE 5, NAP1L5
20155,612204,AUTOPHAGY-RELATED 9A, ATG9A
20156,612205,AUTOPHAGY-RELATED 9B, ATG9B
20157,612206,FOUR-JOINTED BOX KINASE 1, FJX1
20158,612207,GOLGI PHOSPHOPROTEIN 3, GOLPH3
20159,612208,GOLGI PHOSPHOPROTEIN 3-LIKE, GOLPH3L
20160,612209,MESOGENIN 1, MSGN1
20161,612210,HEPATOCELLULAR CARCINOMA-UPREGULATED LONG NONCODING RNA, HULC
20162,612211,TUMOR SUPPRESSOR CANDIDATE 5, TUSC5
20163,612212,PLASMINOGEN-LIKE A, PLGLA
20164,612213,BINDER OF SPERM PROTEIN HOMOLOG 1, BSPH1
20165,612214,RAL GUANINE NUCLEOTIDE DISSOCIATION STIMULATOR-LIKE 4, RGL4
20166,612215,SMALL NUCLEOLAR RNA HOST GENE 6, SNHG6
20167,612216,"SMALL NUCLEOLAR RNA, C/D BOX, 87", SNORD87
20168,612217,INFLAMMATION AND LIPID REGULATOR WITH UBA-LIKE AND NBR1-LIKE DOMAINS, ILRUN
20169,612218,ZINC FINGER- AND BTB DOMAIN-CONTAINING PROTEIN 38, ZBTB38
20170,612219,EWING SARCOMA, ES
20171,612220,"BETA-1,4-N-ACETYLGALACTOSAMINYLTRANSFERASE 3", B4GALNT3
20172,612221,STATURE QUANTITATIVE TRAIT LOCUS 10, STQTL10
20173,612222,GALACTOSAMINE-6-SULFATE SULFATASE, GALNS
20174,612223,STATURE QUANTITATIVE TRAIT LOCUS 11, STQTL11
20175,612224,STATURE QUANTITATIVE TRAIT LOCUS 12, STQTL12
20176,612225,"MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 9", MODY9
20177,612226,STATURE QUANTITATIVE TRAIT LOCUS 13, STQTL13
20178,612227,"DIABETES MELLITUS, KETOSIS-PRONE", KPD
20179,612228,STATURE QUANTITATIVE TRAIT LOCUS 14, STQTL14
20180,612229,"COLORECTAL CANCER, SUSCEPTIBILITY TO, 3", CRCS3
20181,612230,"COLORECTAL CANCER, SUSCEPTIBILITY TO, 5", CRCS5
20182,612231,"COLORECTAL CANCER, SUSCEPTIBILITY TO, 6", CRCS6
20183,612232,"COLORECTAL CANCER, SUSCEPTIBILITY TO, 7", CRCS7
20184,612233,"LEUKODYSTROPHY, HYPOMYELINATING, 4", HLD4
20185,612234,CALCIUM HOMEOSTASIS MODULATOR 1, CALHM1
20186,612235,CALCIUM HOMEOSTASIS MODULATOR 2, CALHM2
20187,612236,ENDOPLASMIC RETICULUM-GOLGI INTERMEDIATE COMPARTMENT PROTEIN 2, ERGIC2
20188,612237,"CHONDROSARCOMA, EXTRASKELETAL MYXOID",
20189,612238,"SCOLIOSIS, ISOLATED, SUSCEPTIBILITY TO, 4", IS4
20190,612239,"SCOLIOSIS, ISOLATED, SUSCEPTIBILITY TO, 5", IS5
20191,612240,"ATRIAL FIBRILLATION, FAMILIAL, 7", ATFB7
20192,612241,INFLAMMATORY BOWEL DISEASE 12, IBD12
20193,612242,CHROMOSOME 10q22.3-q23.2 DELETION SYNDROME,
20194,612243,ADHESION G PROTEIN-COUPLED RECEPTOR G6, ADGRG6
20195,612244,INFLAMMATORY BOWEL DISEASE 13, IBD13
20196,612245,INFLAMMATORY BOWEL DISEASE 14, IBD14
20197,612246,CD302 ANTIGEN, CD302
20198,612247,CROUZON SYNDROME WITH ACANTHOSIS NIGRICANS, CAN
20199,612248,ZINC FINGER PROTEIN 627, ZNF627
20200,612249,THROMBOSPONDIN TYPE-1 DOMAIN-CONTAINING PROTEIN 7A, THSD7A
20201,612250,G PROTEIN-COUPLED RECEPTOR 161: GPR161,
20202,612251,"SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 10", SLEB10
20203,612252,"C-TYPE LECTIN DOMAIN FAMILY 9, MEMBER A", CLEC9A
20204,612253,"SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 11", SLEB11
20205,612254,"SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 12", SLEB12
20206,612255,INFLAMMATORY BOWEL DISEASE 15, IBD15
20207,612256,MICROTUBULE-ASSOCIATED SERINE/THREONINE KINASE 1, MAST1
20208,612257,MICROTUBULE-ASSOCIATED SERINE/THREONINE KINASE 2, MAST2
20209,612258,MICROTUBULE-ASSOCIATED SERINE/THREONINE KINASE 3, MAST3
20210,612259,INFLAMMATORY BOWEL DISEASE 16, IBD16
20211,612260,IMMUNODEFICIENCY 68, IMD68
20212,612261,INFLAMMATORY BOWEL DISEASE 17, IBD17
20213,612262,INFLAMMATORY BOWEL DISEASE 18, IBD18
20214,612263,"MELANOMA, CUTANEOUS MALIGNANT, SUSCEPTIBILITY TO, 7", CMM7
20215,612264,"MANNOSE RECEPTOR, C-TYPE, 2", MRC2
20216,612265,"FAMILY WITH SEQUENCE SIMILARITY 120, MEMBER A", FAM120A
20217,612266,"FAMILY WITH SEQUENCE SIMILARITY 120, MEMBER B", FAM120B
20218,612267,"SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 10", SHEP10
20219,612268,TUBULIN TYROSINE LIGASE-LIKE 5, TTLL5
20220,612269,"EPILEPSY, CHILDHOOD ABSENCE, SUSCEPTIBILITY TO, 5", ECA5
20221,612270,CELL DIVISION CYCLE-ASSOCIATED PROTEIN 4, CDCA4
20222,612271,"SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 11", SHEP11
20223,612272,"CILIARY DYSKINESIA, PRIMARY, 3",
20224,612273,"CILIARY DYSKINESIA, PRIMARY, 7",
20225,612274,"CILIARY DYSKINESIA, PRIMARY, 8", CILD8
20226,612275,GAMETOGENETIN-BINDING PROTEIN 2, GGNBP2
20227,612276,YRDC DOMAIN-CONTAINING PROTEIN, YRDC
20228,612277,ADAMTS-LIKE PROTEIN 2, ADAMTSL2
20229,612278,INFLAMMATORY BOWEL DISEASE (CROHN DISEASE) 19, IBD19
20230,612279,"GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 6", GEFSP6
20231,612280,"FUCOSIDASE, ALPHA-L, 1", FUCA1
20232,612281,"ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 6", ARCI6
20233,612282,ZINC FINGER PROTEIN 804A, ZNF804A
20234,612283,PROTEIN C, PROC
20235,612284,"MECKEL SYNDROME, TYPE 6", MKS6
20236,612285,JOUBERT SYNDROME 9, JBTS9
20237,612286,"NEPHROLITHIASIS/OSTEOPOROSIS, HYPOPHOSPHATEMIC, 1", NPHLOP1
20238,612287,"NEPHROLITHIASIS/OSTEOPOROSIS, HYPOPHOSPHATEMIC, 2", NPHLOP2
20239,612288,INFLAMMATORY BOWEL DISEASE 20, IBD20
20240,612289,FONTAINE PROGEROID SYNDROME, FPS
20241,612290,"MICROTIA, HEARING IMPAIRMENT, AND CLEFT PALATE",
20242,612291,JOUBERT SYNDROME 8, JBTS8
20243,612292,BIRK-BAREL SYNDROME, BIBARS
20244,612293,"POROKERATOSIS 5, DISSEMINATED SUPERFICIAL ACTINIC TYPE", POROK5
20245,612294,DEP DOMAIN-CONTAINING PROTEIN 7, DEPDC7
20246,612295,ADP-RIBOSYLATION FACTOR-LIKE GTPase 14 EFFECTOR PROTEIN, ARL14EP
20247,612296,LONG INTERGENIC NONCODING RNA 294, LINC00294
20248,612297,CHROMOSOME 11 OPEN READING FRAME 41, C11ORF41
20249,612298,TRIPARTITE MOTIF-CONTAINING PROTEIN 44, TRIM44
20250,612299,COMM DOMAIN-CONTAINING PROTEIN 9, COMMD9
20251,612300,"HEMOLYTIC ANEMIA, CD59-MEDIATED, WITH OR WITHOUT IMMUNE-MEDIATED POLYNEUROPATHY", HACD59
20252,612301,"OSTEOPETROSIS, AUTOSOMAL RECESSIVE 7", OPTB7
20253,612302,ADHESION G PROTEIN-COUPLED RECEPTOR A1, ADGRA1
20254,612303,ADHESION G PROTEIN-COUPLED RECEPTOR A3, ADGRA3
20255,612304,"THROMBOPHILIA DUE TO PROTEIN C DEFICIENCY, AUTOSOMAL RECESSIVE", THPH4
20256,612305,"ADHESION G PROTEIN-COUPLED RECEPTOR E4, PSEUDOGENE", ADGRE4P
20257,612306,THYROID-STIMULATING HORMONE LEVEL QUANTITATIVE TRAIT LOCUS 1, TSHQTL1
20258,612307,ADHESION G PROTEIN-COUPLED RECEPTOR G7, ADGRG7
20259,612308,ZINC FINGER AND BTB DOMAIN-CONTAINING 4, ZBTB4
20260,612309,COAGULATION FACTOR V, F5
20261,612310,PREMATURE OVARIAN FAILURE 6, POF6
20262,612311,"ATTENTION DEFICIT-HYPERACTIVITY DISORDER, SUSCEPTIBILITY TO, 5",
20263,612312,"ATTENTION DEFICIT-HYPERACTIVITY DISORDER, SUSCEPTIBILITY TO, 6",
20264,612313,GLASS SYNDROME, GLASS
20265,612314,"GLUTATHIONE S-TRANSFERASE, OMEGA-2", GSTO2
20266,612315,"KERATIN 6C, TYPE II", KRT6C
20267,612316,"ATPase FAMILY, AAA DOMAIN-CONTAINING, MEMBER 3A", ATAD3A
20268,612317,"ATPase FAMILY, AAA DOMAIN-CONTAINING, MEMBER 3B", ATAD3B
20269,612318,PSEUDOFOLLICULITIS BARBAE,
20270,612319,"SPASTIC PARAPLEGIA 35, AUTOSOMAL RECESSIVE, WITH OR WITHOUT NEURODEGENERATION", SPG35
20271,612320,CUB DOMAIN-CONTAINING PROTEIN 2, CDCP2
20272,612321,DOUBLECORTIN DOMAIN-CONTAINING PROTEIN 1,
20273,612322,FAST KINASE DOMAINS 2, FASTKD2
20274,612323,"INNER MITOCHONDRIAL MEMBRANE PEPTIDASE, SUBUNIT 1", IMMP1L
20275,612324,COILED-COIL DOMAIN-CONTAINING PROTEIN 34, CCDC34
20276,612325,INTESTINAL CELL KINASE, ICK
20277,612326,TRANSCRIPTION FACTOR 25, TCF25
20278,612327,"MANNOSIDASE, ENDO-ALPHA", MANEA
20279,612328,COILED-COIL DOMAIN-CONTAINING PROTEIN 73: CCDC73,
20280,612329,MICRO RNA 30A, MIR30A
20281,612330,MICRO RNA 610, MIRN610
20282,612331,"LIN7 HOMOLOG B, CRUMBS CELL POLARITY COMPLEX COMPONENT", LIN7B
20283,612332,"LIN7 HOMOLOG C, CRUMBS CELL POLARITY COMPLEX COMPONENT", LIN7C
20284,612333,PROGRAMMED CELL DEATH 11, PDCD11
20285,612334,N-ACYL PHOSPHATIDYLETHANOLAMINE-HYDROLYZING PHOSPHOLIPASE D, NAPEPLD
20286,612335,"SPASTIC PARAPLEGIA 38, AUTOSOMAL DOMINANT", SPG38
20287,612336,"THROMBOPHILIA DUE TO PROTEIN S DEFICIENCY, AUTOSOMAL DOMINANT", THPH5
20288,612337,"INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 22", MRD22
20289,612338,"GAMMA-GLUTAMYLTRANSFERASE, LIGHT CHAIN 1", GGTLC1
20290,612339,"GAMMA-GLUTAMYLTRANSFERASE, LIGHT CHAIN 2", GGTLC2
20291,612340,"GAMMA-GLUTAMYLTRANSFERASE, LIGHT CHAIN 3", GGTLC3
20292,612341,GAMMA-GLUTAMYLTRANSFERASE 6, GGT6
20293,612342,GAMMA-GLUTAMYLTRANSFERASE 7, GGT7
20294,612343,MUSICAL APTITUDE QUANTITATIVE TRAIT LOCUS,
20295,612344,ZINC FINGER PROTEIN 385B, ZNF385B
20296,612345,CHROMOSOME 2q31.2 DELETION SYNDROME,
20297,612346,GAMMA-GLUTAMYLTRANSFERASE 1, GGT1
20298,612347,JERVELL AND LANGE-NIELSEN SYNDROME 2, JLNS2
20299,612348,"THROMBOPHILIA, FAMILIAL, DUE TO DECREASED RELEASE OF TISSUE PLASMINOGEN ACTIVATOR", THPH9
20300,612349,PHENYLALANINE HYDROXYLASE, PAH
20301,612350,"EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 3", EDSSPD3
20302,612351,FORKHEAD BOX I3, FOXI3
20303,612352,STAM-BINDING PROTEIN-LIKE 1, STAMBPL1
20304,612353,"POROKERATOSIS 6, MULTIPLE TYPES", POROK6
20305,612354,INFLAMMATORY BOWEL DISEASE 21, IBD21
20306,612355,"MICROTUBULE-ASSOCIATED MONOOXYGENASE, CALPONIN AND LIM DOMAINS-CONTAINING, 2",
20307,612356,HEPARIN COFACTOR II DEFICIENCY,
20308,612357,MAJOR AFFECTIVE DISORDER 8, MAFD8
20309,612358,KININOGEN 1, KNG1
20310,612359,COWDEN SYNDROME 1,
20311,612360,"NADH DEHYDROGENASE (UBIQUINONE) COMPLEX I, ASSEMBLY FACTOR 5", NDUFAF5
20312,612361,SCHIZOPHRENIA 14,
20313,612362,BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 12, BMIQ12
20314,612363,"ALANINE AMINOTRANSFERASE, PLASMA LEVEL OF, QUANTITATIVE TRAIT LOCUS 1",
20315,612364,"ALANINE AMINOTRANSFERASE, PLASMA LEVEL OF, QUANTITATIVE TRAIT LOCUS 2",
20316,612365,"GAMMA GLUTAMYLTRANSFERASE, PLASMA LEVEL OF, QUANTITATIVE TRAIT LOCUS 1",
20317,612366,"GAMMA GLUTAMYLTRANSFERASE, PLASMA LEVEL OF, QUANTITATIVE TRAIT LOCUS 2",
20318,612367,"ALKALINE PHOSPHATASE, PLASMA LEVEL OF, QUANTITATIVE TRAIT LOCUS 2",
20319,612368,"ALKALINE PHOSPHATASE, PLASMA LEVEL OF, QUANTITATIVE TRAIT LOCUS 3",
20320,612369,"ALKALINE PHOSPHATASE, PLASMA LEVEL OF, QUANTITATIVE TRAIT LOCUS 4",
20321,612370,HYPOGONADOTROPIC HYPOGONADISM 5 WITH OR WITHOUT ANOSMIA, HH5
20322,612371,MAJOR AFFECTIVE DISORDER 7, MAFD7
20323,612372,MAJOR AFFECTIVE DISORDER 9, MAFD9
20324,612373,"SOLUTE CARRIER FAMILY 29 (NUCLEOSIDE TRANSPORTER), MEMBER 3: SLC29A3",
20325,612374,STIMULATOR OF INTERFERON RESPONSE cGAMP INTERACTOR 1, STING1
20326,612375,"AXIN INTERACTOR, DORSALIZATION-ASSOCIATED", AIDA
20327,612376,ACUTE PROMYELOCYTIC LEUKEMIA, APL
20328,612377,COMM DOMAIN-CONTAINING PROTEIN 6, COMMD6
20329,612378,"SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 13", SLEB13
20330,612379,"CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Iq", CDG1Q
20331,612380,INFLAMMATORY BOWEL DISEASE 22, IBD22
20332,612381,INFLAMMATORY BOWEL DISEASE 23, IBD23
20333,612382,MEDIATOR COMPLEX SUBUNIT 10, MED10
20334,612383,MEDIATOR COMPLEX SUBUNIT 11, MED11
20335,612384,MEDIATOR COMPLEX SUBUNIT 18, MED18
20336,612385,MEDIATOR COMPLEX SUBUNIT 19, MED19
20337,612386,FERROCHELATASE, FECH
20338,612387,"SARCOIDOSIS, SUSCEPTIBILITY TO, 2", SS2
20339,612388,"SARCOIDOSIS, SUSCEPTIBILITY TO, 3", SS3
20340,612389,"PONTOCEREBELLAR HYPOPLASIA, TYPE 2B", PCH2B
20341,612390,"PONTOCEREBELLAR HYPOPLASIA, TYPE 2C", PCH2C
20342,612391,HISTIOCYTOSIS-LYMPHADENOPATHY PLUS SYNDROME,
20343,612392,"NADH DEHYDROGENASE (UBIQUINONE) COMPLEX I, ASSEMBLY FACTOR 6", NDUFAF6
20344,612393,"WAS PROTEIN HOMOLOG ASSOCIATED WITH ACTIN, GOLGI MEMBRANES, AND MICROTUBULES", WHAMM
20345,612394,BCARD SYNDROME, BCARD
20346,612395,"CHOLINE KINASE, BETA", CHKB
20347,612396,ALLANTOICASE, ALLC
20348,612397,"COLLAGEN, TYPE VI, ALPHA-4, PSEUDOGENE 1", COL6A4P1
20349,612398,RAB-ASSOCIATED PROTEIN RAB21, RAB21
20350,612399,"TLE FAMILY MEMBER 6, SUBCORTICAL MATERNAL COMPLEX MEMBER", TLE6
20351,612400,OSTEOARTHRITIS SUSCEPTIBILITY 5, OS5
20352,612401,OSTEOARTHRITIS SUSCEPTIBILITY 6, OS6
20353,612402,ALS2 C-TERMINAL-LIKE PROTEIN, ALS2CL
20354,612403,"RAS-LIKE, FAMILY 11, MEMBER A", RASL11A
20355,612404,"RAS-LIKE, FAMILY 11, MEMBER B", RASL11B
20356,612405,ADP-RIBOSYLATION FACTOR-LIKE GTPase 9, ARL9
20357,612406,"DYSTONIA 17, TORSION, AUTOSOMAL RECESSIVE", DYT17
20358,612407,REGULATOR OF G PROTEIN SIGNALING 21, RGS21
20359,612408,PARASPECKLE COMPONENT 1, PSPC1
20360,612409,RNA-BINDING MOTIF PROTEIN 14, RBM14
20361,612410,"PSORIASIS 10, SUSCEPTIBILITY TO", PSORS10
20362,612411,FAT ATYPICAL CADHERIN 4, FAT4
20363,612412,SPERMATOGENESIS AND CENTRIOLE-ASSOCIATED PROTEIN 1-LIKE, SPATC1L
20364,612413,RNA-BINDING MOTIF PROTEIN 7, RBM7
20365,612414,LEUCINE-RICH TRANSMEMBRANE O-METHYLTRANSFERASE, LRTOMT
20366,612415,RAS-ASSOCIATED PROTEIN 24, RAB24
20367,612416,FACTOR XI DEFICIENCY,
20368,612417,"NARCOLEPSY 4, SUSCEPTIBILITY TO", NRCLP4
20369,612418,TRANSMEMBRANE PROTEIN 70, TMEM70
20370,612419,CARTILAGE INTERMEDIATE LAYER PROTEIN 2, CILP2
20371,612420,ACTIN FILAMENT-ASSOCIATED PROTEIN 1-LIKE PROTEIN 2, AFAP1L2
20372,612421,"ALOPECIA, ANDROGENETIC, 3", AGA3
20373,612422,"CARDIOMYOPATHY, FAMILIAL RESTRICTIVE, 3", RCM3
20374,612423,PREKALLIKREIN DEFICIENCY, PKKD
20375,612424,EYES SHUT HOMOLOG, EYS
20376,612425,SHUGOSHIN-LIKE 2, SGOL2
20377,612426,RECQ-MEDIATED GENOME INSTABILITY 2, RMI2
20378,612427,RNA-BINDING MOTIF PROTEIN 25, RBM25
20379,612428,RNA-BINDING MOTIF PROTEIN 38, RBM38
20380,612429,ZINC FINGER PROTEIN 300, ZNF300
20381,612430,RNA-BINDING MOTIF PROTEIN 22, RBM22
20382,612431,"DEAFNESS, AUTOSOMAL DOMINANT 27", DFNA27
20383,612432,"WAS/WASL-INTERACTING PROTEIN FAMILY, MEMBER 3", WIPF3
20384,612433,"DEAFNESS, AUTOSOMAL RECESSIVE 45", DFNB45
20385,612434,"CYSTEINE-RICH SECRETORY PROTEIN, LCCL DOMAIN-CONTAINING, 2", CRISPLD2
20386,612435,"SOLUTE CARRIER ORGANIC ANION TRANSPORTER FAMILY, MEMBER 3A1", SLCO3A1
20387,612436,"SOLUTE CARRIER ORGANIC ANION TRANSPORTER FAMILY, MEMBER 4A1", SLCO4A1
20388,612437,"EPILEPSY, PROGRESSIVE MYOCLONIC, 1B", EPM1B
20389,612438,"LEUKODYSTROPHY, HYPOMYELINATING, 6", HLD6
20390,612439,ADP-RIBOSYLATION FACTOR GTPase-ACTIVATING PROTEIN 3, ARFGAP3
20391,612440,"LEUKODYSTROPHY, HYPOMYELINATING, 7, WITH OR WITHOUT OLIGODONTIA AND/OR HYPOGONADOTROPIC HYPOGONADISM",
20392,612441,"ALPHA-1,6-MANNOSYL-GLYCOPROTEIN BETA-1,6-N-ACETYLGLUCOSAMINYLTRANSFERASE, ISOZYME B", MGAT5B
20393,612442,"SEC22 HOMOLOG A, VESICLE TRAFFICKING PROTEIN", SEC22A
20394,612443,"SPASTIC PARAPLEGIA 35, AUTOSOMAL RECESSIVE, WITH OR WITHOUT NEURODEGENERATION",
20395,612444,"CILIARY DYSKINESIA, PRIMARY, 9", CILD9
20396,612445,"SCOLIOSIS, ARACHNODACTYLY, AND BLINDNESS",
20397,612446,COMPLEMENT COMPONENT 6 DEFICIENCY, C6D
20398,612447,"SKELETAL DEFECTS, GENITAL HYPOPLASIA, AND IMPAIRED INTELLECTUAL DEVELOPMENT",
20399,612448,AGE-RELATED HEARING IMPAIRMENT 1, ARHI1
20400,612449,GEN1 HOLLIDAY JUNCTION 5-PRIME FLAP ENDONUCLEASE, GEN1
20401,612450,HBS1-LIKE PROTEIN, HBS1L
20402,612451,RING FINGER PROTEIN 114, RNF114
20403,612452,"KAT8 REGULATORY NSL COMPLEX, SUBUNIT 1", KANSL1
20404,612453,MULTIPLE EPIDERMAL GROWTH FACTOR-LIKE DOMAINS 10, MEGF10
20405,612454,MULTIPLE EPIDERMAL GROWTH FACTOR-LIKE DOMAINS 11, MEGF11
20406,612455,"SOLUTE CARRIER FAMILY 5 (SODIUM/GLUCOSE COTRANSPORTER), MEMBER 12", SLC5A12
20407,612456,APOLIPOPROTEIN L DOMAIN-CONTAINING 1, APOLD1
20408,612457,AT-RICH INTERACTION DOMAIN-CONTAINING PROTEIN 3B, ARID3B
20409,612458,ACTIN-LIKE 6B, ACTL6B
20410,612459,BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 13, BMIQ13
20411,612460,BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 14, BMIQ14
20412,612461,ACTIVITY-REGULATED CYTOSKELETON-ASSOCIATED PROTEIN, ARC
20413,612462,"PSEUDOHYPOPARATHYROIDISM, TYPE IC", PHP1C
20414,612463,PSEUDOPSEUDOHYPOPARATHYROIDISM, PPHP
20415,612464,ARRESTIN DOMAIN-CONTAINING PROTEIN 3, ARRDC3
20416,612465,"TBC1 DOMAIN FAMILY, MEMBER 4", TBC1D4
20417,612466,GUANYLATE-BINDING PROTEIN 4, GBP4
20418,612467,GUANYLATE-BINDING PROTEIN 6, GBP6
20419,612468,GUANYLATE-BINDING PROTEIN 7, GBP7
20420,612469,WAGRO SYNDROME, WAGRO
20421,612470,"BASIC LEUCINE ZIPPER TRANSCRIPTION FACTOR, ATF-LIKE 3", BATF3
20422,612471,ALANINE-GLYOXYLATE AMINOTRANSFERASE 2, AGXT2
20423,612472,"METHYLTRANSFERASE 3, N6-ADENOSINE-METHYLTRANSFERASE COMPLEX CATALYTIC SUBUNIT", METTL3
20424,612473,PHOSPHATIDYLETHANOLAMINE-BINDING PROTEIN 4, PEBP4
20425,612474,"CHROMOSOME 1q21.1 DELETION SYNDROME, 1.35-MB",
20426,612475,CHROMOSOME 1q21.1 DUPLICATION SYNDROME,
20427,612476,"BASIC LEUCINE ZIPPER TRANSCRIPTION FACTOR, ATF-LIKE", BATF
20428,612477,IQ MOTIF-CONTAINING PROTEIN G, IQCG
20429,612478,N-TERMINAL EF-HAND CALCIUM-BINDING PROTEIN 3, NECAB3
20430,612479,"MACULAR DEGENERATION, AGE-RELATED, 1",
20431,612480,TCDD-INDUCIBLE POLY(ADP-RIBOSE) POLYMERASE, TIPARP
20432,612481,"POLY(ADP-RIBOSE) POLYMERASE FAMILY, MEMBER 12", PARP12
20433,612482,RING FINGER PROTEIN 43, RNF43
20434,612483,FAT ATYPICAL CADHERIN 3, FAT3
20435,612484,"RIBONUCLEASE A FAMILY, MEMBER 7", RNASE7
20436,612485,"RIBONUCLEASE A FAMILY, MEMBER 8", RNASE8
20437,612486,DACHSOUS CADHERIN-RELATED 2, DCHS2
20438,612487,RING FINGER PROTEIN 31, RNF31
20439,612488,RING FINGER PROTEIN 38, RNF38
20440,612489,RING FINGER PROTEIN 24, RNF24
20441,612490,RING FINGER PROTEIN 181, RNF181
20442,612491,APAF1-INTERACTING PROTEIN, APIP
20443,612492,UBIQUITIN-SPECIFIC PROTEASE 30, USP30
20444,612493,CANOPY FGF SIGNALING REGULATOR 1, CNPY1
20445,612494,RHO GUANINE NUCLEOTIDE EXCHANGE FACTOR 10-LIKE, ARHGEF10L
20446,612495,UBIQUITIN-PROTEIN LIGASE E3D, UBE3D
20447,612496,RHO GUANINE NUCLEOTIDE EXCHANGE FACTOR 19, ARHGEF19
20448,612497,TRANSFORMING GROWTH FACTOR-BETA-INDUCIBLE NUCLEAR PROTEIN 1,
20449,612498,ADENYLOSUCCINATE SYNTHASE 1, ADSS1
20450,612499,DIMT1 rRNA METHYLTRANSFERASE AND RIBOSOME MATURATION FACTOR, DIMT1
20451,612500,DExD-BOX HELICASE 52, DDX52
20452,612501,UBIQUITIN-CONJUGATING ENZYME E2 Q2, UBE2Q2
20453,612502,COLLECTIN 11, COLEC11
20454,612503,"ATP-BINDING CASSETTE, SUBFAMILY A, MEMBER 5", ABCA5
20455,612504,"ATP-BINDING CASSETTE, SUBFAMILY A, MEMBER 6", ABCA6
20456,612505,"ATP-BINDING CASSETTE, SUBFAMILY A, MEMBER 8", ABCA8
20457,612506,UBIQUITIN-CONJUGATING ENZYME E2 R2, UBE2R2
20458,612507,"ATP-BINDING CASSETTE, SUBFAMILY A, MEMBER 9", ABCA9
20459,612508,"ATP-BINDING CASSETTE, SUBFAMILY A, MEMBER 10", ABCA10
20460,612509,"ATP-BINDING CASSETTE, SUBFAMILY C, MEMBER 10", ABCC10
20461,612510,"ATP-BINDING CASSETTE, SUBFAMILY F, MEMBER 2", ABCF2
20462,612511,MICRO RNA 101-1, MIRN101-1
20463,612512,MICRO RNA 101-2, MIRN101-2
20464,612513,CHROMOSOME 2p16.1-p15 DELETION SYNDROME,
20465,612514,SPECIFIC LANGUAGE IMPAIRMENT 4, SLI4
20466,612515,DDB1- AND CUL4-ASSOCIATED FACTOR 17, DCAF17
20467,612516,UVEAL AUTOANTIGEN WITH COILED-COIL DOMAINS AND ANKYRIN REPEATS, UACA
20468,612517,"DYNEIN, AXONEMAL, ASSEMBLY FACTOR 2", DNAAF2
20469,612518,"CILIARY DYSKINESIA, PRIMARY, 10", CILD10
20470,612519,"SOLUTE CARRIER FAMILY 35, MEMBER D3", SLC35D3
20471,612520,TYPE 1 DIABETES MELLITUS 20, T1D20
20472,612521,TYPE 1 DIABETES MELLITUS 21, T1D21
20473,612522,TYPE 1 DIABETES MELLITUS 22, T1D22
20474,612523,IQ MOTIF-CONTAINING PROTEIN H: IQCH,
20475,612524,RIBONUCLEASE P/MRP SUBUNIT p21, RPP21
20476,612525,"PYLORIC STENOSIS, INFANTILE HYPERTROPHIC, 5", IHPS5
20477,612526,"LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 3", CGL3
20478,612527,DIAMOND-BLACKFAN ANEMIA 4, DBA4
20479,612528,DIAMOND-BLACKFAN ANEMIA 5, DBA5
20480,612529,"AMELOGENESIS IMPERFECTA, HYPOMATURATION TYPE, IIA2", AI2A2
20481,612530,CHROMOSOME 1q41-q42 DELETION SYNDROME,
20482,612531,THAP DOMAIN-CONTAINING PROTEIN 2, THAP2
20483,612532,THAP DOMAIN-CONTAINING PROTEIN 3, THAP3
20484,612533,THAP DOMAIN-CONTAINING PROTEIN 4, THAP4
20485,612534,THAP DOMAIN-CONTAINING PROTEIN 5, THAP5
20486,612535,THAP DOMAIN-CONTAINING PROTEIN 6, THAP6
20487,612536,THAP DOMAIN-CONTAINING PROTEIN 8, THAP8
20488,612537,THAP DOMAIN-CONTAINING PROTEIN 9, THAP9
20489,612538,THAP DOMAIN-CONTAINING PROTEIN 10, THAP10
20490,612539,"SPASTIC PARAPLEGIA 42, AUTOSOMAL DOMINANT", SPG42
20491,612540,CONGENITAL MYOPATHY 12, CMYO12
20492,612541,"NEUTROPENIA, SEVERE CONGENITAL, 4, AUTOSOMAL RECESSIVE", SCN4
20493,612542,VITAMIN B12 PLASMA LEVEL QUANTITATIVE TRAIT LOCUS 1, B12QTL1
20494,612543,UBIQUITIN-SPECIFIC PROTEASE 36, USP36
20495,612544,"ACTIN-BINDING LIM PROTEIN FAMILY, MEMBER 2", ABLIM2
20496,612545,WILLIAMS-BEUREN SYNDROME CHROMOSOME REGION 26, WBSCR26
20497,612546,METHYLTRANSFERASE-LIKE 27, METTL27
20498,612547,TRANSMEMBRANE PROTEIN 270, TMEM270
20499,612548,TRIPARTITE MOTIF-CONTAINING PROTEIN 50, TRIM50
20500,612549,TRIPARTITE MOTIF-CONTAINING PROTEIN 73, TRIM73
20501,612550,TRIPARTITE MOTIF-CONTAINING PROTEIN 74, TRIM74
20502,612551,"FOCAL SEGMENTAL GLOMERULOSCLEROSIS 4, SUSCEPTIBILITY TO", FSGS4
20503,612552,ZINC FINGER BED DOMAIN-CONTAINING PROTEIN 4, ZBED4
20504,612553,MICRO RNA 370, MIR370
20505,612554,"MYOPIA 16, AUTOSOMAL DOMINANT", MYP16
20506,612555,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2", BROVCA2
20507,612556,ADIPONECTIN DEFICIENCY, ADPOD
20508,612557,"LEUKEMIA, CHRONIC LYMPHOCYTIC, SUSCEPTIBILITY TO, 3",
20509,612558,"LEUKEMIA, CHRONIC LYMPHOCYTIC, SUSCEPTIBILITY TO, 4",
20510,612559,"LEUKEMIA, CHRONIC LYMPHOCYTIC, SUSCEPTIBILITY TO, 5",
20511,612560,BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 12, BMND12
20512,612561,DIAMOND-BLACKFAN ANEMIA 6, DBA6
20513,612562,DIAMOND-BLACKFAN ANEMIA 7, DBA7
20514,612563,DIAMOND-BLACKFAN ANEMIA 8, DBA8
20515,612564,THIOREDOXIN DOMAIN-CONTAINING PROTEIN 9, TXNDC9
20516,612565,RAS-ASSOCIATED PROTEIN RAB1B, RAB1B
20517,612566,INFLAMMATORY BOWEL DISEASE 24, IBD24
20518,612567,"INFLAMMATORY BOWEL DISEASE 25, AUTOSOMAL RECESSIVE", IBD25
20519,612568,SPIC TRANSCRIPTION FACTOR, SPIC
20520,612569,CELL DIVISION CYCLE AND APOPTOSIS REGULATOR 1, CCAR1
20521,612570,FIBRILLIN 2, FBN2
20522,612571,LUNG CANCER SUSCEPTIBILITY 3, LNCR3
20523,612572,RETINITIS PIGMENTOSA 46, RP46
20524,612573,MEAN PLATELET VOLUME/COUNT QUANTITATIVE TRAIT LOCUS 1, MPVCQTL1
20525,612574,MEAN PLATELET VOLUME/COUNT QUANTITATIVE TRAIT LOCUS 2, MPVCQTL2
20526,612575,MEAN PLATELET VOLUME/COUNT QUANTITATIVE TRAIT LOCUS 3, MPVCQTL3
20527,612576,"CHROMOSOME 17p13.3, TELOMERIC, DUPLICATION SYNDROME",
20528,612577,AMYOTROPHIC LATERAL SCLEROSIS 11, ALS11
20529,612578,STATURE QUANTITATIVE TRAIT LOCUS 15, STQTL15
20530,612579,STATURE QUANTITATIVE TRAIT LOCUS 16, STQTL16
20531,612580,"INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 3", MRD3
20532,612581,"INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 4", MRD4
20533,612582,CHROMOSOME 6pter-p24 DELETION SYNDROME,
20534,612583,SPHINGOLIPID TRANSPORTER 1, SPNS1
20535,612584,SPHINGOLIPID TRANSPORTER 2, SPNS2
20536,612585,CLPTM1-LIKE PROTEIN, CLPTM1L
20537,612586,"ANEURYSM, INTRACRANIAL BERRY, 9", ANIB9
20538,612587,"ANEURYSM, INTRACRANIAL BERRY, 10", ANIB10
20539,612588,BCL2-ASSOCIATED TRANSCRIPTION FACTOR 1, BCLAF1
20540,612589,"COLORECTAL CANCER, SUSCEPTIBILITY TO, 8", CRCS8
20541,612590,"COLORECTAL CANCER, SUSCEPTIBILITY TO, 9", CRCS9
20542,612591,"COLORECTAL CANCER, SUSCEPTIBILITY TO, 10", CRCS10
20543,612592,"COLORECTAL CANCER, SUSCEPTIBILITY TO, 11", CRCS11
20544,612593,LUNG CANCER SUSCEPTIBILITY 4, LNCR4
20545,612594,"MULTIPLE SCLEROSIS, SUSCEPTIBILITY TO, 2", MS2
20546,612595,"MULTIPLE SCLEROSIS, SUSCEPTIBILITY TO, 3", MS3
20547,612596,"MULTIPLE SCLEROSIS, SUSCEPTIBILITY TO, 4", MS4
20548,612597,CYTOTOXIC AND REGULATORY T-CELL MOLECULE, CRTAM
20549,612598,RING FINGER PROTEIN 11, RNF11
20550,612599,"PSORIASIS 11, SUSCEPTIBILITY TO", PSORS11
20551,612600,RNA METHYLTRANSFERASE-LIKE 1, RNMTL1
20552,612601,RET FINGER PROTEIN-LIKE 4A, RFPL4A
20553,612602,RNA-BINDING MOTIF PROTEIN 15B, RBM15B
20554,612603,LATE CORNIFIED ENVELOPE PROTEIN 1A, LCE1A
20555,612604,LATE CORNIFIED ENVELOPE PROTEIN 1B, LCE1B
20556,612605,LATE CORNIFIED ENVELOPE 1C, LCE1C
20557,612606,LATE CORNIFIED ENVELOPE PROTEIN 1D, LCE1D
20558,612607,LATE CORNIFIED ENVELOPE PROTEIN 1E, LCE1E
20559,612608,LATE CORNIFIED ENVELOPE PROTEIN 1F, LCE1F
20560,612609,LATE CORNIFIED ENVELOPE PROTEIN 2A, LCE2A
20561,612610,LATE CORNIFIED ENVELOPE PROTEIN 2B, LCE2B
20562,612611,LATE CORNIFIED ENVELOPE PROTEIN 2C, LCE2C
20563,612612,LATE CORNIFIED ENVELOPE PROTEIN 2D, LCE2D
20564,612613,LATE CORNIFIED ENVELOPE PROTEIN 3A, LCE3A
20565,612614,LATE CORNIFIED ENVELOPE PROTEIN 3B, LCE3B
20566,612615,LATE CORNIFIED ENVELOPE PROTEIN 3C, LCE3C
20567,612616,LATE CORNIFIED ENVELOPE PROTEIN 3D, LCE3D
20568,612617,LATE CORNIFIED ENVELOPE PROTEIN 3E, LCE3E
20569,612618,LATE CORNIFIED ENVELOPE PROTEIN 4A, LCE4A
20570,612619,LATE CORNIFIED ENVELOPE PROTEIN 5A, LCE5A
20571,612620,"RAS ASSOCIATION DOMAIN FAMILY, MEMBER 6", RASSF6
20572,612621,"INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 5", MRD5
20573,612622,TYPE 1 DIABETES MELLITUS 23, T1D23
20574,612623,"MICROVASCULAR COMPLICATIONS OF DIABETES, SUSCEPTIBILITY TO, 2", MVCD2
20575,612624,"MICROVASCULAR COMPLICATIONS OF DIABETES, SUSCEPTIBILITY TO, 3", MVCD3
20576,612625,LMBR1 DOMAIN-CONTAINING PROTEIN 1: LMBRD1,
20577,612626,CHROMOSOME 15q26-qter DELETION SYNDROME,
20578,612627,"SEIZURES, BENIGN FAMILIAL INFANTILE, 4", BFIS4
20579,612628,"MICROVASCULAR COMPLICATIONS OF DIABETES, SUSCEPTIBILITY TO, 4", MVCD4
20580,612629,"ADIPONECTIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 4", ADIPQTL4
20581,612630,HAIR MORPHOLOGY 1, HRM1
20582,612631,"ANEMIA, CONGENITAL, NONSPHEROCYTIC HEMOLYTIC, 3", CNSHA3
20583,612632,"USHER SYNDROME, TYPE IH", USH1H
20584,612633,"MICROVASCULAR COMPLICATIONS OF DIABETES, SUSCEPTIBILITY TO, 5", MVCD5
20585,612634,"MICROVASCULAR COMPLICATIONS OF DIABETES, SUSCEPTIBILITY TO, 6", MVCD6
20586,612635,"MICROVASCULAR COMPLICATIONS OF DIABETES, SUSCEPTIBILITY TO, 7", MVCD7
20587,612636,"UNC80 HOMOLOG, NALCN CHANNEL COMPLEX SUBUNIT", UNC80
20588,612637,"FEBRILE SEIZURES, FAMILIAL, 10", FEB10
20589,612638,NADH-UBIQUINONE OXIDOREDUCTASE SUBUNIT A11, NDUFA11
20590,612639,INFLAMMATORY BOWEL DISEASE 26, IBD26
20591,612640,"THYMUS, BRAIN, AND TESTES ASSOCIATED", TBATA
20592,612641,ANKYRIN 1, ANK1
20593,612642,"DEAFNESS, AUTOSOMAL DOMINANT 59", DFNA59
20594,612643,"DEAFNESS, AUTOSOMAL DOMINANT 3B", DFNA3B
20595,612644,"DEAFNESS, AUTOSOMAL DOMINANT 2B", DFNA2B
20596,612645,"DEAFNESS, AUTOSOMAL RECESSIVE 1B", DFNB1B
20597,612646,MET TRANSCRIPTIONAL REGULATOR MACC1, MACC1
20598,612647,RADIAL SPOKE HEAD COMPONENT 4A, RSPH4A
20599,612648,RADIAL SPOKE HEAD COMPONENT 9, RSPH9
20600,612649,"CILIARY DYSKINESIA, PRIMARY, 11", CILD11
20601,612650,"CILIARY DYSKINESIA, PRIMARY, 12", CILD12
20602,612651,ENDOCRINE-CEREBROOSTEODYSPLASIA, ECO
20603,612652,"CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIIA",
20604,612653,"SPHEROCYTOSIS, TYPE 4", SPH4
20605,612654,TRICHOPLEIN, TCHP
20606,612655,"TBC1 DOMAIN FAMILY, MEMBER 7", TBC1D7
20607,612656,"EPISODIC ATAXIA, TYPE 6", EA6
20608,612657,CONE-ROD DYSTROPHY 12, CORD12
20609,612658,TIGHT JUNCTION-ASSOCIATED PROTEIN 1, TJAP1
20610,612659,"REGULATORY FACTOR X, 6", RFX6
20611,612660,"REGULATORY FACTOR X, 7", RFX7
20612,612661,WD REPEAT-CONTAINING PROTEIN ANTISENSE TO TP53, WRAP53
20613,612662,"TBC1 DOMAIN FAMILY, MEMBER 15", TBC1D15
20614,612663,"TRAF-INTERACTING PROTEIN WITH FORKHEAD-ASSOCIATED DOMAIN, FAMILY MEMBER B", TIFAB
20615,612664,RAS-LIKE AND ESTROGEN-REGULATED GROWTH INHIBITOR, RERG
20616,612665,TESTIS-EXPRESSED GENE 101, TEX101
20617,612666,DUAL SERINE/THREONINE AND TYROSINE PROTEIN KINASE, DSTYK
20618,612667,HOLLIDAY JUNCTION RECOGNITION PROTEIN, HJURP
20619,612668,"TASTE RECEPTOR, TYPE 2, MEMBER 43", TAS2R43
20620,612669,"TASTE RECEPTOR, TYPE 2, MEMBER 31", TAS2R31
20621,612670,"URIC ACID CONCENTRATION, SERUM, QUANTITATIVE TRAIT LOCUS 1",
20622,612671,"URIC ACID CONCENTRATION, SERUM, QUANTITATIVE TRAIT LOCUS 4", UAQTL4
20623,612672,RAS-ASSOCIATED PROTEIN RAB10, RAB10
20624,612673,RAS-ASSOCIATED PROTEIN RAB14, RAB14
20625,612674,"POLYNEUROPATHY, HEARING LOSS, ATAXIA, RETINITIS PIGMENTOSA, AND CATARACT", PHARC
20626,612675,SMALL CAJAL BODY-SPECIFIC RNA 15, SCARNA15
20627,612676,QUINOID DIHYDROPTERIDINE REDUCTASE, QDPR
20628,612677,"PYRIN AND HIN DOMAIN FAMILY, MEMBER 1", PYHIN1
20629,612678,"CUGBP- AND ELAV-LIKE FAMILY, MEMBER 3", CELF3
20630,612679,"CUGBP- AND ELAV-LIKE FAMILY, MEMBER 4", CELF4
20631,612680,"CUGBP- AND ELAV-LIKE FAMILY, MEMBER 5", CELF5
20632,612681,"CUGBP- AND ELAV-LIKE FAMILY, MEMBER 6", CELF6
20633,612682,DORSAL INHIBITORY AXON GUIDANCE PROTEIN, DRAXIN
20634,612683,TEKTIN 3, TEKT3
20635,612684,ISTHMIN 2, ISM2
20636,612685,CALMODULIN-REGULATED SPECTRIN-ASSOCIATED PROTEIN 3, CAMSAP3
20637,612686,"PLECKSTRIN HOMOLOGY DOMAIN-CONTAINING PROTEIN, FAMILY A, MEMBER 7", PLEKHA7
20638,612687,"RGM DOMAIN FAMILY, MEMBER B", RGMB
20639,612688,RING FINGER PROTEIN 168, RNF168
20640,612689,TIGHT JUNCTION PROTEIN 3, TJP3
20641,612690,"SPHEROCYTOSIS, TYPE 5", SPH5
20642,612691,"POLYMICROGYRIA, BILATERAL TEMPOROOCCIPITAL", BTOP
20643,612692,"AGAMMAGLOBULINEMIA 6, AUTOSOMAL RECESSIVE", AGM6
20644,612693,UBIQUITIN-RELATED MODIFIER 1, URM1
20645,612694,"CYTOSOLIC THIOURIDYLASE, SUBUNIT 1", CTU1
20646,612695,VAULT RNA 1-1, VTRNA1-1
20647,612696,VAULT RNA 1-2, VTRNA1-2
20648,612697,VAULT RNA 1-3, VTRNA1-3
20649,612698,MICRO RNA 187, MIR187
20650,612699,RIMS-BINDING PROTEIN 3, RIMBP3
20651,612700,RIMS-BINDING PROTEIN 3B, RIMBP3B
20652,612701,RIMS-BINDING PROTEIN 3C, RIMBP3C
20653,612702,HYPOGONADOTROPIC HYPOGONADISM 6 WITH OR WITHOUT ANOSMIA, HH6
20654,612703,"MICROCEPHALY 7, PRIMARY, AUTOSOMAL RECESSIVE", MCPH7
20655,612704,RANBP2-LIKE AND GRIP DOMAIN-CONTAINING PROTEIN 1, RGPD1
20656,612705,RANBP2-LIKE AND GRIP DOMAIN-CONTAINING PROTEIN 2, RGPD2
20657,612706,RANBP2-LIKE AND GRIP DOMAIN-CONTAINING PROTEIN 3, RGPD3
20658,612707,RANBP2-LIKE AND GRIP DOMAIN-CONTAINING PROTEIN 4, RGPD4
20659,612708,RANBP2-LIKE AND GRIP DOMAIN-CONTAINING PROTEIN 5, RGPD5
20660,612709,RANBP2-LIKE AND GRIP DOMAIN-CONTAINING PROTEIN 6, RGPD6
20661,612710,RANBP2-LIKE AND GRIP DOMAIN-CONTAINING PROTEIN 7, RGPD7
20662,612711,GRIP AND COILED-COIL DOMAIN-CONTAINING PROTEIN 2, GCC2
20663,612712,LEBER CONGENITAL AMAUROSIS 13, LCA13
20664,612713,KAHRIZI SYNDROME, KHRZ
20665,612714,"EXOCRINE PANCREATIC INSUFFICIENCY, DYSERYTHROPOIETIC ANEMIA, AND CALVARIAL HYPEROSTOSIS",
20666,612715,DYSCHROMATOSIS UNIVERSALIS HEREDITARIA 2, DUH2
20667,612716,"DYSTONIA, DOPA-RESPONSIVE, DUE TO SEPIAPTERIN REDUCTASE DEFICIENCY",
20668,612717,"MYOPIA 15, AUTOSOMAL DOMINANT", MYP15
20669,612718,CEREBRAL CREATINE DEFICIENCY SYNDROME 3, CCDS3
20670,612719,6-PYRUVOYL-TETRAHYDROPTERIN SYNTHASE, PTS
20671,612720,DExH-BOX HELICASE, DHX29
20672,612721,REGULATED ENDOCRINE-SPECIFIC PROTEIN 18,
20673,612722,"ELONGATOR ACETYLTRANSFERASE COMPLEX, SUBUNIT 3", ELP3
20674,612723,"PLECKSTRIN HOMOLOGY DOMAIN-CONTAINING PROTEIN, FAMILY H, MEMBER 2", PLEKHH2
20675,612724,"ALDOLASE B, FRUCTOSE-BISPHOSPHATE", ALDOB
20676,612725,"PROTEIN PHOSPHATASE 6, CATALYTIC SUBUNIT", PPP6C
20677,612726,HARDIKAR SYNDROME,
20678,612727,BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 13, BMND13
20679,612728,BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 14, BMND14
20680,612729,LEAN BODY MASS QUANTITATIVE TRAIT LOCUS 1, LBMQTL1
20681,612730,"SOLUTE CARRIER FAMILY 9 (SODIUM/HYDROGEN EXCHANGER), MEMBER 8", SLC9A8
20682,612731,FACIOCARDIOMELIC SYNDROME,
20683,612732,COPROPORPHYRINOGEN OXIDASE, CPOX
20684,612733,"THO COMPLEX, SUBUNIT 5", THOC5
20685,612734,TLX1 NEIGHBOR, TLX1NB
20686,612735,"MAJOR HISTOCOMPATIBILITY COMPLEX, CLASS II, DR BETA-3", HLA-DRB3
20687,612736,CEREBRAL CREATINE DEFICIENCY SYNDROME 2, CCDS2
20688,612737,STATURE QUANTITATIVE TRAIT LOCUS 17, STQTL17
20689,612738,"SOLUTE CARRIER FAMILY 9, MEMBER 10", SLC9A10
20690,612739,SPERM ACROSOME-ASSOCIATED PROTEIN 1, SPACA1
20691,612740,"PORPHYRIA, ACUTE HEPATIC",
20692,612741,SNAIL FAMILY TRANSCRIPTIONAL REPRESSOR 3, SNAI3
20693,612742,MICRO RNA 181A1, MIR181A1
20694,612743,MICRO RNA 181A2, MIR181A2
20695,612744,MICRO RNA 181B1, MIR181B1
20696,612745,MICRO RNA 181B2, MIR181B2
20697,612746,MICRO RNA 181C, MIR181C
20698,612747,TUFTELIN-INTERACTING PROTEIN 11, TFIP11
20699,612748,LYSOZYME-LIKE 2, LYZL2
20700,612749,SPERM ACROSOME-ASSOCIATED PROTEIN 3, SPACA3
20701,612750,LYSOZYME-LIKE 4, LYZL4
20702,612751,LYSOZYME-LIKE 6, LYZL6
20703,612752,CXXC FINGER PROTEIN 5, CXXC5
20704,612753,COLLAGEN AND CALCIUM-BINDING EGF DOMAIN-CONTAINING PROTEIN 1, CCBE1
20705,612754,GLUTAREDOXIN 3, GLRX3
20706,612755,"N-ALPHA-ACETYLTRANSFERASE 25, NatB AUXILIARY SUBUNIT", NAA25
20707,612756,TESTICULAR CELL ADHESION MOLECULE 1, TCAM1
20708,612757,GLYCOSYLPHOSPHATIDYLINOSITOL-ANCHORED HIGH DENSITY LIPOPROTEIN-BINDING PROTEIN 1, GPIHBP1
20709,612758,TRANSMEMBRANE ANTERIOR POSTERIOR TRANSFORMATION 1, TAPT1
20710,612759,SYNESTHESIA,
20711,612760,SNF-RELATED KINASE, SNRK
20712,612761,"SWI/SNF-RELATED, MATRIX-ASSOCIATED ACTIN-DEPENDENT REGULATOR OF CHROMATIN, SUBFAMILY A, DEAD/H BOX-CONTAINING, 1", SMARCAD1
20713,612762,"SPTY7-LIKE, STAGA COMPLEX SUBUNIT GAMMA", SUPT7L
20714,612763,TRANSCRIPTIONAL ADAPTOR 1-LIKE, TADA1L
20715,612764,ISY1 SPLICING FACTOR HOMOLOG, ISY1
20716,612765,SFI1 CENTRIN-BINDING PROTEIN, SFI1
20717,612766,"BRISC AND BRCA1 A COMPLEX, MEMBER 1", BABAM1
20718,612767,DEAH-BOX HELICASE 36, DHX36
20719,612768,FOLLICULIN-INTERACTING PROTEIN 2, FNIP2
20720,612769,NONCODING NUCLEAR-ENRICHED ABUNDANT TRANSCRIPT 1, NEAT1
20721,612770,PHOSPHATIDYLSERINE DECARBOXYLASE, PISD
20722,612771,DUAL OXIDASE MATURATION FACTOR 1, DUOXA1
20723,612772,DUAL OXIDASE MATURATION FACTOR 2, DUOXA2
20724,612773,BASAL CELL ADHESION MOLECULE, BCAM
20725,612774,"TASTE RECEPTOR, TYPE 2, MEMBER 46", TAS2R46
20726,612775,CONE-ROD DYSTROPHY 9, CORD9
20727,612776,HYPOGLOSSIA WITH SITUS INVERSUS,
20728,612777,"HYPOTONIA, SEIZURES, AND PRECOCIOUS PUBERTY",
20729,612778,SET DOMAIN-CONTAINING PROTEIN 2, SETD2
20730,612779,DIHYDROPYRIMIDINE DEHYDROGENASE, DPYD
20731,612780,"SEIZURES, SENSORINEURAL DEAFNESS, ATAXIA, IMPAIRED INTELLECTUAL DEVELOPMENT, AND ELECTROLYTE IMBALANCE", SESAMES
20732,612781,"ISOLATED GROWTH HORMONE DEFICIENCY, TYPE IB", IGHD1B
20733,612782,IMMUNODEFICIENCY 9, IMD9
20734,612783,IMMUNODEFICIENCY 10, IMD10
20735,612784,HUNTINGTIN-INTERACTING PROTEIN K,
20736,612785,MEGARBANE-JALKH SYNDROME,
20737,612786,CYCLIN Y, CCNY
20738,612787,PSEUDOURIDYLATE SYNTHASE 10, PUS10
20739,612788,FORKHEAD BOX Q1, FOXQ1
20740,612789,"DEAFNESS, AUTOSOMAL RECESSIVE 71", DFNB71
20741,612790,RHO GUANINE NUCLEOTIDE EXCHANGE FACTOR 28, ARHGEF28
20742,612791,ZINC FINGER PROTEIN WITH KRAB AND SCAN DOMAINS 3, ZKSCAN3
20743,612792,PHOSPHATIDYLSERINE SYNTHASE 1, PTDSS1
20744,612793,PHOSPHATIDYLSERINE SYNTHASE 2, PTDSS2
20745,612794,ATRIAL SEPTAL DEFECT 5, ASD5
20746,612795,POLYUNSATURATED FATTY ACIDS PLASMA LEVEL QUANTITATIVE TRAIT LOCUS 1, PUFAQTL1
20747,612796,INFLAMMATORY BOWEL DISEASE 27, IBD27
20748,612797,HIGH DENSITY LIPOPROTEIN CHOLESTEROL LEVEL QUANTITATIVE TRAIT LOCUS 12, HDLCQ12
20749,612798,"QUESTION MARK EARS, ISOLATED", QME
20750,612799,"GLUTAMYL-tRNA SYNTHETASE 2, MITOCHONDRIAL", EARS2
20751,612800,CYSTEINYL-tRNA SYNTHETASE 2, CARS2
20752,612801,ISOLEUCYL-tRNA SYNTHETASE 2, IARS2
20753,612802,VALYL-tRNA SYNTHETASE 2, VARS2
20754,612803,ASPARAGINYL-tRNA SYNTHETASE 2, NARS2
20755,612804,SERYL-tRNA SYNTHETASE 2, SARS2
20756,612805,THREONYL-tRNA SYNTHETASE 2, TARS2
20757,612806,G PROTEIN-COUPLED RECEPTOR 89B, GPR89B
20758,612807,LEUCINE-RICH REPEAT AND FIBRONECTIN TYPE III DOMAIN-CONTAINING PROTEIN 1, LRFN1
20759,612808,LEUCINE-RICH REPEAT AND FIBRONECTIN TYPE III DOMAIN-CONTAINING PROTEIN 2, LRFN2
20760,612809,LEUCINE-RICH REPEAT AND FIBRONECTIN TYPE III DOMAIN-CONTAINING PROTEIN 3, LRFN3
20761,612810,LEUCINE-RICH REPEAT AND FIBRONECTIN TYPE III DOMAIN-CONTAINING PROTEIN 4, LRFN4
20762,612811,LEUCINE-RICH REPEAT AND FIBRONECTIN TYPE III DOMAIN-CONTAINING PROTEIN 5, LRFN5
20763,612812,PROFILIN 3, PFN3
20764,612813,"SPONDYLOEPIMETAPHYSEAL DYSPLASIA, AGGRECAN TYPE", SEMDAG
20765,612814,SPERMATOGENESIS-ASSOCIATED PROTEIN 18, SPATA18
20766,612815,ZINC FINGER DHHC DOMAIN-CONTAINING PROTEIN 13, ZDHHC13
20767,612816,UTP18 SMALL SUBUNIT PROCESSOME COMPONENT, UTP18
20768,612817,KRR1 SMALL SUBUNITPROCESSOME COMPONENT HOMOLOG, KRR1
20769,612818,NUCLEOLAR AND SPINDLE-ASSOCIATED PROTEIN 1, NUSAP1
20770,612819,NUCLEOLAR COMPLEX-ASSOCIATED PROTEIN 4 HOMOLOG, NOC4L
20771,612820,NEUROPLASTIN, NPTN
20772,612821,G PROTEIN-COUPLED RECEPTOR 89A, GPR89A
20773,612822,UTP20 SMALL SUBUNIT PROCESSOME COMPONENT, UTP20
20774,612823,TATA BOX-BINDING PROTEIN-ASSOCIATED FACTOR 1D, TAF1D
20775,612824,SEC14-LIKE LIPID-BINDING PROTEIN 3, SEC14L3
20776,612825,SEC14-LIKE LIPID-BINDING PROTEIN 4, SEC14L4
20777,612826,SPHINGOSINE-1-PHOSPHATE PHOSPHATASE 1, SGPP1
20778,612827,SPHINGOSINE-1-PHOSPHATE PHOSPHATASE 2, SGPP2
20779,612828,"CCAAT/ENHANCER-BINDING PROTEIN, ZETA", CEBPZ
20780,612829,RAS-ASSOCIATED PROTEIN RAB3C, RAB3C
20781,612830,"SHORT-CHAIN DEHYDROGENASE/REDUCTASE FAMILY, MEMBER 3", DHRS3
20782,612831,17-BETA-HYDROXYSTEROID DEHYDROGENASE XI, HSD17B11
20783,612832,17-BETA-HYDROXYSTEROID DEHYDROGENASE XIV, HSD17B14
20784,612833,"SHORT-CHAIN DEHYDROGENASE/REDUCTASE FAMILY, MEMBER 7", DHRS7
20785,612834,"PLECKSTRIN HOMOLOGY-LIKE DOMAIN, FAMILY B, MEMBER 1", PHLDB1
20786,612835,"PHOSPHOLIPASE C, ETA-1", PLCH1
20787,612836,"PHOSPHOLIPASE C, ETA-2", PLCH2
20788,612837,COENZYME 9, COQ9
20789,612838,BRUGADA SYNDROME 5, BRGDA5
20790,612839,TET METHYLCYTOSINE DIOXYGENASE 2, TET2
20791,612840,"LEUKOCYTE ADHESION DEFICIENCY, TYPE III", LAD3
20792,612841,HYPOTRICHOSIS 5, HYPT5
20793,612842,"RASD FAMILY, MEMBER 2", RASD2
20794,612843,"KERATOSIS FOLLICULARIS SPINULOSA DECALVANS, AUTOSOMAL DOMINANT", KFSD
20795,612844,"SENTRIN-SPECIFIC PROTEASE FAMILY, MEMBER 3", SENP3
20796,612845,"SENTRIN-SPECIFIC PROTEASE FAMILY, MEMBER 5", SENP5
20797,612846,"SENTRIN-SPECIFIC PROTEASE FAMILY, MEMBER 7", SENP7
20798,612847,BRACHYOLMIA TYPE 4 WITH MILD EPIPHYSEAL AND METAPHYSEAL CHANGES, BCYM4
20799,612848,SUCCINATE DEHYDROGENASE COMPLEX ASSEMBLY FACTOR 1, SDHAF1
20800,612849,UBIQUITIN-SPECIFIC PEPTIDASE 46, USP46
20801,612850,"TUBULIN, BETA-2B", TUBB2B
20802,612851,"NARCOLEPSY 5, SUSCEPTIBILITY TO", NRCLP5
20803,612852,"CHRONIC RECURRENT MULTIFOCAL OSTEOMYELITIS 2, WITH PERIOSTITIS AND PUSTULOSIS", CRMO2
20804,612853,"RESTLESS LEGS SYNDROME, SUSCEPTIBILITY TO, 7", RLS7
20805,612854,"SEC16 HOMOLOG A, ENDOPLASMIC RETICULUM EXPORT FACTOR", SEC16A
20806,612855,"SEC16 HOMOLOG B, ENDOPLASMIC RETICULUM EXPORT FACTOR", SEC16B
20807,612856,ASTROTACTIN 2, ASTN2
20808,612857,PLACENTA-SPECIFIC GENE 9, PLAC9
20809,612858,OROFACIAL CLEFT 12, OFC12
20810,612859,T-CELL IMMUNORECEPTOR WITH IMMUNOGLOBULIN AND ITIM DOMAINS, TIGIT
20811,612860,QUIESCIN Q6 SULFHYDRYL OXIDASE 2, QSOX2
20812,612861,NOP16 NUCLEOLAR PROTEIN, NOP16
20813,612862,"PULMONARY HYPERTENSION, CHRONIC THROMBOEMBOLIC, WITHOUT DEEP VEIN THROMBOSIS, SUSCEPTIBILITY TO",
20814,612863,CHROMOSOME 6q24-q25 DELETION SYNDROME,
20815,612864,"PHOSPHOLIPASE A2, GROUP IVD", PLA2G4D
20816,612865,PHOSPHATIDYLINOSITOL 4-PHOSPHATE-5-KINASE-LIKE 1, PIP5KL1
20817,612866,ALG14 UDP-N-ACETYLGLUCOSAMINYLTRANSFERASE SUBUNIT, ALG14
20818,612867,"CORNEAL DYSTROPHY, SUBEPITHELIAL MUCINOUS", SMCD
20819,612868,"CORNEAL DYSTROPHY, POSTERIOR AMORPHOUS", PACD
20820,612869,ATTRACTIN-LIKE 1, ATRNL1
20821,612870,PLECKSTRIN HOMOLOGY DOMAIN-INTERACTING PROTEIN, PHIP
20822,612871,Na+/K+ TRANSPORTING ATPase-INTERACTING 1, NKAIN1
20823,612872,Na+/K+ TRANSPORTING ATPase-INTERACTING 3, NKAIN3
20824,612873,Na+/K+ TRANSPORTING ATPase-INTERACTING 4, NKAIN4
20825,612874,ERYTHROCYTE AMP DEAMINASE DEFICIENCY,
20826,612875,GONADOTROPIN-RELEASING HORMONE RECEPTOR 2, GNRHR2
20827,612876,SPINOCEREBELLAR ATAXIA 9, SCA9
20828,612877,"CARDIOMYOPATHY, DILATED, 1BB", CMD1BB
20829,612878,EXOPHILIN 5, EXPH5
20830,612879,MAM DOMAIN-CONTAINING PROTEIN 2, MAMDC2
20831,612880,SYNAPTOTAGMIN-LIKE 2, SYTL2
20832,612881,"CHROMOSOME 5q14.3 DELETION SYNDROME, DISTAL",
20833,612882,"MENARCHE, AGE AT, QUANTITATIVE TRAIT LOCUS 2", MENAQ2
20834,612883,"MENARCHE, AGE AT, QUANTITATIVE TRAIT LOCUS 3", MENAQ3
20835,612884,"MENOPAUSE, NATURAL, AGE AT, QUANTITATIVE TRAIT LOCUS 2", MENOQ2
20836,612885,PREMATURE OVARIAN FAILURE 10, POF10
20837,612886,"MENOPAUSE, NATURAL, AGE AT, QUANTITATIVE TRAIT LOCUS 4", MENOQ4
20838,612887,SEPTIN 11, SEPT11
20839,612888,LEUCINE-RICH REPEAT-CONTAINING PROTEIN 8B, LRRC8B
20840,612889,LEUCINE-RICH REPEAT-CONTAINING PROTEIN 8C, LRRC8C
20841,612890,LEUCINE-RICH REPEAT-CONTAINING PROTEIN 8D, LRRC8D
20842,612891,LEUCINE-RICH REPEAT-CONTAINING PROTEIN 8E, LRRC8E
20843,612892,STATURE QUANTITATIVE TRAIT LOCUS 18, STQTL18
20844,612893,STATURE QUANTITATIVE TRAIT LOCUS 19, STQTL19
20845,612894,STATURE QUANTITATIVE TRAIT LOCUS 20, STQTL20
20846,612895,NUCLEOREDOXIN, NXN
20847,612896,RAD52 MOTIF-CONTAINING PROTEIN 1, RDM1
20848,612897,SEPTIN 1, SEPT1
20849,612898,COENZYME Q4, COQ4
20850,612899,"EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 8", EIG8
20851,612900,"CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 2", CPSQ2
20852,612901,"TUBULIN, BETA-1", TUBB1
20853,612902,LIPOCALIN 8, LCN8
20854,612903,LIPOCALIN 9, LCN9
20855,612904,LIPOCALIN 10, LCN10
20856,612905,LIPOCALIN 12, LCN12
20857,612906,RAS-ASSOCIATED PROTEIN RAB32, RAB32
20858,612907,"tRNA NUCLEOTIDYLTRANSFERASE, CCA-ADDING, 1", TRNT1
20859,612908,KERATOSIS PALMOPLANTARIS STRIATA II, PPKS2
20860,612909,RAS-ASSOCIATED PROTEIN RAB6C, RAB6C
20861,612910,PHD FINGER PROTEIN 23, PHF23
20862,612911,"NADH DEHYDROGENASE (UBIQUINONE) COMPLEX I, ASSEMBLY FACTOR 3", NDUFAF3
20863,612912,TRANSMEMBRANE PROTEIN 97, TMEM97
20864,612913,OROFACIODIGITAL SYNDROME XI, OFD11
20865,612914,MEDIATOR COMPLEX SUBUNIT 29, MED29
20866,612915,MEDIATOR COMPLEX SUBUNIT 20, MED20
20867,612916,ZECHI-CEIDE SYNDROME,
20868,612917,GIACHETI SYNDROME,
20869,612918,"CONGENITAL LIPOMATOUS OVERGROWTH, VASCULAR MALFORMATIONS, AND EPIDERMAL NEVI",
20870,612919,LanC-LIKE 2, LANCL2
20871,612920,THROMBOSPONDIN-TYPE LAMININ G DOMAIN AND EAR REPEATS, TSPEAR
20872,612921,THREE M SYNDROME 2, 3M2
20873,612922,"HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 2", AHUS2
20874,612923,"HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 3", AHUS3
20875,612924,"HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 4", AHUS4
20876,612925,"HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 5", AHUS5
20877,612926,"HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 6", AHUS6
20878,612927,AVL9 CELL MIGRATION-ASSOCIATED PROTEIN, AVL9
20879,612928,ISOCHORISMATASE DOMAIN-CONTAINING 2, ISOC2
20880,612929,"MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO, 3",
20881,612930,PHOSPHOTYROSINE INTERACTION DOMAIN-CONTAINING 1, PID1
20882,612931,PHOSPHOGLYCERATE MUTASE 2, PGAM2
20883,612932,GLYCOGEN STORAGE DISEASE XIII, GSD13
20884,612933,GLYCOGEN STORAGE DISEASE XI, GSD11
20885,612934,"CONGENITAL DISORDER OF GLYCOSYLATION, TYPE It",
20886,612935,MYOSIN PHOSPHATASE RHO-INTERACTING PROTEIN, MPRIP
20887,612936,"SPASTIC PARAPLEGIA 50, AUTOSOMAL RECESSIVE", SPG50
20888,612937,"MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 15", MDDGC15
20889,612938,"GROWTH RETARDATION, DEVELOPMENTAL DELAY, AND FACIAL DYSMORPHISM", GDFD
20890,612939,HEAT-SHOCK 70-KD PROTEIN-BINDING PROTEIN 1, HSPBP1
20891,612940,"CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIB", ARCL2B
20892,612941,PRE-mRNA-PROCESSING FACTOR 40 HOMOLOG A, PRPF40A
20893,612942,RAS-ASSOCIATED PROTEIN RAB25, RAB25
20894,612943,RETINITIS PIGMENTOSA 42, RP42
20895,612944,RIBONUCLEASE T2, RNASET2
20896,612945,RAS-ASSOCIATED PROTEIN RAB4B, RAB4B
20897,612946,HADZISELIMOVIC SYNDROME,
20898,612947,"MICROCEPHALY, GROWTH RETARDATION, CATARACT, HEARING LOSS, AND UNUSUAL APPEARANCE",
20899,612948,"STARGARDT MACULAR DEGENERATION, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM, IMPAIRED INTELLECTUAL DEVELOPMENT, AND DYSMORPHIC FACIAL FEATURES",
20900,612949,DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 39 WITH LEUKODYSTROPHY, DEE39
20901,612950,"PSORIASIS 12, SUSCEPTIBILITY TO", PSORS12
20902,612951,"LEUKOENCEPHALOPATHY, CYSTIC, WITHOUT MEGALENCEPHALY",
20903,612952,AICARDI-GOUTIERES SYNDROME 5, AGS5
20904,612953,"PARKINSON DISEASE 14, AUTOSOMAL RECESSIVE", PARK14
20905,612954,"MYOPATHY, MYOFIBRILLAR, 6", MFM6
20906,612955,LONG QT SYNDROME 12, LQT12
20907,612956,"VENTRICULAR FIBRILLATION, PAROXYSMAL FAMILIAL, 2", VF2
20908,612957,VITAMIN B6 PLASMA LEVEL QUANTITATIVE TRAIT LOCUS 1, B6QTL1
20909,612958,TRANSLATIONAL ACTIVATOR OF MITOCHONDRIALLY ENCODED CYTOCHROME c OXIDASE SUBUNIT I, TACO1
20910,612959,EPITHELIAL SPLICING REGULATORY PROTEIN 1, ESRP1
20911,612960,EPITHELIAL SPLICING REGULATORY PROTEIN 2, ESRP2
20912,612961,MULTIPLE SYNOSTOSES SYNDROME 3, SYNS3
20913,612962,DYNACTIN 5, DCTN5
20914,612963,DYNACTIN 6, DCTN6
20915,612964,PREMATURE OVARIAN FAILURE 7, POF7
20916,612965,"46,XY SEX REVERSAL 3", SRXY3
20917,612966,RAS-ASSOCIATED PROTEIN RAB22A, RAB22A
20918,612967,BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 15, BMIQ15
20919,612968,"CATARACT 34, MULTIPLE TYPES", CTRCT34
20920,612969,TIGGER TRANSPOSABLE ELEMENT-DERIVED GENE 7, TIGD7
20921,612970,"NEUROBLASTOMA BREAKPOINT FAMILY, MEMBER 17, PSEUDOGENE", NBPF17P
20922,612971,PDZ DOMAIN-CONTAINING 7, PDZD7
20923,612972,TIGGER TRANSPOSABLE ELEMENT-DERIVED GENE 1, TIGD1
20924,612973,TIGGER TRANSPOSABLE ELEMENT-DERIVED GENE 2, TIGD2
20925,612974,DEP DOMAIN-CONTAINING PROTEIN 6, DEPDC6
20926,612975,"SHORT SLEEP, FAMILIAL NATURAL, 1", FNSS1
20927,612976,AGE-RELATED HEARING IMPAIRMENT 2, ARHI2
20928,612977,DCN1 DOMAIN-CONTAINING PROTEIN 4, DCUN1D4
20929,612978,PRECEREBELLIN 3, CBLN3
20930,612979,SYS1 GOLGI TRAFFICKING PROTEIN, SYS1
20931,612980,IMP U3 SMALL NUCLEOLAR RIBONUCLEAR PROTEIN 3, IMP3
20932,612981,IMP U3 SMALL NUCLEOLAR RIBONUCLEAR PROTEIN 4, IMP4
20933,612982,MICRO RNA 210, MIR210
20934,612983,MICRO RNA 106B, MIR106B
20935,612984,MICRO RNA 93, MIR93
20936,612985,IROQUOIS HOMEOBOX PROTEIN 3, IRX3
20937,612986,EP300-INTERACTING INHIBITOR OF DIFFERENTIATION 3, EID3
20938,612987,"NSE4 HOMOLOG A, SMC5-SMC6 COMPLEX COMPONENT", NSMCE4A
20939,612988,TRANSMEMBRANE PROTEIN 126A, TMEM126A
20940,612989,OPTIC ATROPHY 7 WITH OR WITHOUT AUDITORY NEUROPATHY, OPA7
20941,612990,ASXL TRANSCRIPTIONAL REGULATOR 1, ASXL1
20942,612991,ASXL TRANSCRIPTIONAL REGULATOR 2, ASXL2
20943,612992,"NEUROBLASTOMA BREAKPOINT FAMILY, MEMBER 3", NBPF3
20944,612993,FILAMIN A-INTERACTING PROTEIN 1-LIKE, FILIP1L
20945,612994,RAS-ASSOCIATED PROTEIN 28, RAB28
20946,612995,tRNA VALINE (ANTICODON CAC) 1-2, TRV-CAC1-2
20947,612996,tRNA LYSINE (ANTICODON CTT) 2-3, TRK-CTT2-3
20948,612997,SPERMATOGENIC FAILURE 7, SPGF7
20949,612998,"EMERY-DREIFUSS MUSCULAR DYSTROPHY 4, AUTOSOMAL DOMINANT", EDMD4
20950,612999,"EMERY-DREIFUSS MUSCULAR DYSTROPHY 5, AUTOSOMAL DOMINANT", EDMD5
20951,613000,"PALMOPLANTAR KERATODERMA, NONEPIDERMOLYTIC, FOCAL 1", FNEPPK1
20952,613001,ENCEPHALOCRANIOCUTANEOUS LIPOMATOSIS, ECCL
20953,613002,"IMMUNODEFICIENCY 83, SUSCEPTIBILITY TO VIRAL INFECTIONS", IMD83
20954,613003,"ATTENTION DEFICIT-HYPERACTIVITY DISORDER, SUSCEPTIBILITY TO, 7", ADHD7
20955,613004,HUNTINGTIN, HTT
20956,613005,SANTOS SYNDROME,
20957,613006,TYPE 1 DIABETES MELLITUS 24, T1D24
20958,613007,"BILIARY CIRRHOSIS, PRIMARY, 2", PBC2
20959,613008,"BILIARY CIRRHOSIS, PRIMARY, 3", PBC3
20960,613009,O-PHOSPHOSERINE tRNA-SELENOCYSTEINE tRNA SYNTHASE, SEPSECS
20961,613010,RIBOFLAVIN KINASE, RFK
20962,613011,LYMPHOPROLIFERATIVE SYNDROME 1, LPFS1
20963,613012,UROCANASE DOMAIN-CONTAINING PROTEIN 1, UROC1
20964,613013,"NEUROBLASTOMA, SUSCEPTIBILITY TO, 2", NBLST2
20965,613014,"NEUROBLASTOMA, SUSCEPTIBILITY TO, 3", NBLST3
20966,613015,"NEUROBLASTOMA, SUSCEPTIBILITY TO, 4", NBLST4
20967,613016,"NEUROBLASTOMA, SUSCEPTIBILITY TO, 5", NBLST5
20968,613017,"NEUROBLASTOMA, SUSCEPTIBILITY TO, 6", NBLST6
20969,613018,TYROSINE AMINOTRANSFERASE, TAT
20970,613019,SUCCINATE DEHYDROGENASE COMPLEX ASSEMBLY FACTOR 2, SDHAF2
20971,613020,"CATARACT 6, MULTIPLE TYPES",
20972,613021,BRONCHIECTASIS WITH OR WITHOUT ELEVATED SWEAT CHLORIDE 2, BESC2
20973,613022,OXOGLUTARATE DEHYDROGENASE, OGDH
20974,613023,"CENTROSOMAL PROTEIN, 170-KD", CEP170
20975,613024,"FOLLICULAR LYMPHOMA, SUSCEPTIBILITY TO, 1", FL1
20976,613025,SCHIZOPHRENIA 13, SCZD13
20977,613026,"CHROMOSOME 19q13.11 DELETION SYNDROME, DISTAL",
20978,613027,GLYCOGEN STORAGE DISEASE IXc, GSD9C
20979,613028,GLIOMA SUSCEPTIBILITY 2, GLM2
20980,613029,GLIOMA SUSCEPTIBILITY 3, GLM3
20981,613030,GLIOMA SUSCEPTIBILITY 5, GLM5
20982,613031,GLIOMA SUSCEPTIBILITY 6, GLM6
20983,613032,GLIOMA SUSCEPTIBILITY 7, GLM7
20984,613033,GLIOMA SUSCEPTIBILITY 8, GLM8
20985,613034,"NEUTROPENIA, SEVERE CONGENITAL, 4, AUTOSOMAL RECESSIVE",
20986,613035,"HEARING LOSS, NOISE-INDUCED, SUSCEPTIBILITY TO", NIHL
20987,613036,"PEPTIDASE, MITOCHONDRIAL PROCESSING, ALPHA", PMPCA
20988,613037,"INOSITOL POLYPHOSPHATE-5-PHOSPHATASE, 72-KD", INPP5E
20989,613038,"PITUITARY HORMONE DEFICIENCY, COMBINED OR ISOLATED, 1", CPHD1
20990,613039,CHROMODOMAIN HELICASE DNA-BINDING PROTEIN 1-LIKE, CHD1L
20991,613040,CCDC26 LONG NONCODING RNA, CCDC26
20992,613041,"FAMILY WITH SEQUENCE SIMILARITY 90, MEMBER A1", FAM90A1
20993,613042,"FAMILY WITH SEQUENCE SIMILARITY 90, MEMBER A3", FAM90A3
20994,613043,"FAMILY WITH SEQUENCE SIMILARITY 90, MEMBER A5", FAM90A5
20995,613044,"FAMILY WITH SEQUENCE SIMILARITY 90, MEMBER A7", FAM90A7
20996,613045,"FAMILY WITH SEQUENCE SIMILARITY 90, MEMBER A8", FAM90A8
20997,613046,"FAMILY WITH SEQUENCE SIMILARITY 90, MEMBER A9", FAM90A9
20998,613047,"FAMILY WITH SEQUENCE SIMILARITY 90, MEMBER A10", FAM90A10
20999,613048,"FAMILY WITH SEQUENCE SIMILARITY 90, MEMBER A12", FAM90A12
21000,613049,"FAMILY WITH SEQUENCE SIMILARITY 90, MEMBER A13", FAM90A13
21001,613050,"FAMILY WITH SEQUENCE SIMILARITY 90, MEMBER A14", FAM90A14
21002,613051,"FAMILY WITH SEQUENCE SIMILARITY 90, MEMBER A15", FAM90A15
21003,613052,"FAMILY WITH SEQUENCE SIMILARITY 90, MEMBER A18", FAM90A18
21004,613053,"FAMILY WITH SEQUENCE SIMILARITY 90, MEMBER A19", FAM90A19
21005,613054,"FAMILY WITH SEQUENCE SIMILARITY 90, MEMBER A20", FAM90A20
21006,613055,"ATRIAL FIBRILLATION, FAMILIAL, 8", ATFB8
21007,613056,LUC7-LIKE 2 PRE-mRNA SPLICING FACTOR, LUC7L2
21008,613057,MICRO RNA 26A2, MIR26A2
21009,613058,"BASAL CELL CARCINOMA, SUSCEPTIBILITY TO, 2", BCC2
21010,613059,"BASAL CELL CARCINOMA, SUSCEPTIBILITY TO, 3", BCC3
21011,613060,"EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 10", EIG10
21012,613061,"BASAL CELL CARCINOMA, SUSCEPTIBILITY TO, 4", BCC4
21013,613062,"BASAL CELL CARCINOMA, SUSCEPTIBILITY TO, 5", BCC5
21014,613063,"BASAL CELL CARCINOMA, SUSCEPTIBILITY TO, 6", BCC6
21015,613064,"DERMATITIS, ATOPIC, 7", ATOD7
21016,613065,"LEUKEMIA, ACUTE LYMPHOBLASTIC", ALL
21017,613066,PBX/KNOTTED 1 HOMEOBOX 2, PKNOX2
21018,613067,"LEUKEMIA, ACUTE LYMPHOBLASTIC, SUSCEPTIBILITY TO, 2", ALL2
21019,613068,NEURODEGENERATION DUE TO CEREBRAL FOLATE TRANSPORT DEFICIENCY, NCFTD
21020,613069,PHD FINGER PROTEIN 10, PHF10
21021,613070,"LIVER FAILURE, INFANTILE, TRANSIENT", LFIT
21022,613071,BRONCHIECTASIS WITH OR WITHOUT ELEVATED SWEAT CHLORIDE 3, BESC3
21023,613072,LIPOXYGENASE HOMOLOGY DOMAIN-CONTAINING 1, LOXHD1
21024,613073,METAPHYSEAL ANADYSPLASIA 2, MANDP2
21025,613074,"DEAFNESS, AUTOSOMAL DOMINANT 50", DFNA50
21026,613075,MACS SYNDROME,
21027,613076,"MYOPATHY, MITOCHONDRIAL PROGRESSIVE, WITH CONGENITAL CATARACT AND DEVELOPMENTAL DELAY", MPMCD
21028,613077,"PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 5", PEOA5
21029,613078,NIJMEGEN BREAKAGE SYNDROME-LIKE DISORDER, NBSLD
21030,613079,"DEAFNESS, AUTOSOMAL RECESSIVE 77", DFNB77
21031,613080,"46,XY SEX REVERSAL 5", SRXY5
21032,613081,LYSINE DEMETHYLASE 1B, KDM1B
21033,613082,"ATPase, Ca(2+)-TRANSPORTING, TYPE 2C, MEMBER 2", ATP2C2
21034,613083,LISTERIN E3 UBIQUITIN PROTEIN LIGASE 1, LTN1
21035,613084,MYELIN TRANSCRIPTION FACTOR 1-LIKE, MYT1L
21036,613085,"GLAUCOMA 3, PRIMARY CONGENITAL, C", GLC3C
21037,613086,"GLAUCOMA 3, PRIMARY CONGENITAL, D", GLC3D
21038,613087,ATRIAL SEPTAL DEFECT 6, ASD6
21039,613088,"PELVIC ORGAN PROLAPSE, SUSCEPTIBILITY TO, 2",
21040,613089,"CAPILLARY MALFORMATION OF THE LOWER LIP, LYMPHATIC MALFORMATION OF FACE AND NECK, ASYMMETRY OF FACE AND LIMBS, AND PARTIAL/GENERALIZED OVERGROWTH",
21041,613090,"BARTTER SYNDROME, TYPE 4B, NEONATAL, WITH SENSORINEURAL DEAFNESS", BARTS4B
21042,613091,SHORT-RIB THORACIC DYSPLASIA 3 WITH OR WITHOUT POLYDACTYLY, SRTD3
21043,613092,"TUBULOINTERSTITIAL KIDNEY DISEASE, AUTOSOMAL DOMINANT 4", ADTKD4
21044,613093,CONE DYSTROPHY 4, COD4
21045,613094,"MICROPHTHALMIA, ISOLATED 4", MCOP4
21046,613095,POLYCYSTIC KIDNEY DISEASE 2 WITH OR WITHOUT POLYCYSTIC LIVER DISEASE, PKD2
21047,613096,"SPASTIC PARAPLEGIA 36, AUTOSOMAL DOMINANT", SPG36
21048,613097,DENTAL ANOMALIES AND SHORT STATURE,
21049,613098,"INCREASED ANALGESIA FROM KAPPA-OPIOID RECEPTOR AGONIST, FEMALE-SPECIFIC",
21050,613099,"MELANOMA, CUTANEOUS MALIGNANT, SUSCEPTIBILITY TO, 5", CMM5
21051,613100,"GLAUCOMA 1, OPEN ANGLE, O", GLC1O
21052,613101,"HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 5, WITH OR WITHOUT MICROVILLUS INCLUSION DISEASE", FHL5
21053,613102,HYPOTRICHOSIS AND RECURRENT SKIN VESICLES, HYPTSV
21054,613103,SERINE/ARGININE REPETITIVE MATRIX PROTEIN 4, SRRM4
21055,613104,CALCIUM CHANNEL FLOWER-DOMAIN CONTAINING PROTEIN 1, CACFD1
21056,613105,"CHOROIDAL DYSTROPHY, CENTRAL AREOLAR 2", CACD2
21057,613106,"VERTIGO, BENIGN RECURRENT, 2", BRV2
21058,613107,"NEUTROPENIA, SEVERE CONGENITAL, 2, AUTOSOMAL DOMINANT", SCN2
21059,613108,"CANDIDIASIS, FAMILIAL, 4", CANDF4
21060,613109,GM2 ACTIVATOR, GM2A
21061,613110,BLADDER CANCER-ASSOCIATED PROTEIN, BLCAP
21062,613111,CATHEPSIN A, CTSA
21063,613112,"MACROTHROMBOCYTOPENIA, ISOLATED, 1, AUTOSOMAL DOMINANT", MACTHC1
21064,613113,NEUROFIBROMIN 1, NF1
21065,613114,RETICULOPHAGY REGULATOR 1, RETREG1
21066,613115,"NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE IIB", HSAN2B
21067,613116,THROMBOPHILIA DUE TO HISTIDINE-RICH GLYCOPROTEIN DEFICIENCY, THPH11
21068,613117,"SMALL NUCLEOLAR RNA, C/D BOX, 50A", SNORD50A
21069,613118,ANTITHROMBIN III DEFICIENCY, AT3D
21070,613119,BRUGADA SYNDROME 6, BRGDA6
21071,613120,BRUGADA SYNDROME 7, BRGDA7
21072,613121,NEXILIN F-ACTIN-BINDING PROTEIN, NEXN
21073,613122,"CARDIOMYOPATHY, DILATED, 1CC", CMD1CC
21074,613123,BRUGADA SYNDROME 8, BRGDA8
21075,613124,"HYDROPS FETALIS, NONIMMUNE, WITH GRACILE BONES AND DYSMORPHISM",
21076,613125,NUCLEAR RECEPTOR-INTERACTING PROTEIN 3, NRIP3
21077,613126,PROLINE/SERINE-RICH COILED-COIL PROTEIN 1, PSRC1
21078,613127,CHORDIN-LIKE 2, CHRDL2
21079,613128,"STN1, CST COMPLEX SUBUNIT", STN1
21080,613129,CONSERVED TELOMERE MAINTENANCE COMPONENT 1, CTC1
21081,613130,"TEN1, CST COMPLEX SUBUNIT", TEN1
21082,613131,MICRO RNA 449A, MIR449A
21083,613132,MICRO RNA 449B, MIR449B
21084,613133,TETRASPANIN 2, TSPAN2
21085,613134,TETRASPANIN 3, TSPAN3
21086,613135,"PARKINSONISM-DYSTONIA 1, INFANTILE-ONSET", PKDYS1
21087,613136,TETRASPANIN 5, TSPAN5
21088,613137,TETRASPANIN 9, TSPAN9
21089,613138,TETRASPANIN 12, TSPAN12
21090,613139,TETRASPANIN 13, TSPAN13
21091,613140,TETRASPANIN 15, TSPAN15
21092,613141,DELTEX E3 UBIQUITIN LIGASE 2, DTX2
21093,613142,DELTEX E3 UBIQUITIN LIGASE 3, DTX3
21094,613143,DELTEX E3 UBIQUITIN LIGASE 3L, DTX3L
21095,613144,"CHOROIDAL DYSTROPHY, CENTRAL AREOLAR, 3", CACD3
21096,613145,"SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 14", SLEB14
21097,613146,MICRO RNA 184, MIR184
21098,613147,MICRO RNA 205, MIR205
21099,613148,"INFLAMMATORY BOWEL DISEASE 28, AUTOSOMAL RECESSIVE", IBD28
21100,613149,CDKN2B ANTISENSE RNA, CDKN2BAS
21101,613150,"MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 2", MDDGA2
21102,613151,"MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH IMPAIRED INTELLECTUAL DEVELOPMENT), TYPE B, 3", MDDGB3
21103,613152,"MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT), TYPE B, 4", MDDGB4
21104,613153,"MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 5", MDDGA5
21105,613154,"MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 6", MDDGA6
21106,613155,"MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH IMPAIRED INTELLECTUAL DEVELOPMENT), TYPE B, 1", MDDGB1
21107,613156,"MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH IMPAIRED INTELLECTUAL DEVELOPMENT), TYPE B, 2", MDDGB2
21108,613157,"MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 3", MDDGC3
21109,613158,"MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 2", MDDGC2
21110,613159,NEPHRONOPHTHISIS-LIKE NEPHROPATHY 1, NPHPL1
21111,613160,VON WILLEBRAND FACTOR, VWF
21112,613161,BETA-UREIDOPROPIONASE DEFICIENCY, UPB1D
21113,613162,"SPASTIC PARAPLEGIA 45, AUTOSOMAL RECESSIVE", SPG45
21114,613163,GABA-TRANSAMINASE DEFICIENCY, GABATD
21115,613164,PARKINSON DISEASE 16, PARK16
21116,613165,CALCIUM-ACTIVATED NUCLEOTIDASE 1, CANT1
21117,613166,DOUBLECORTIN-LIKE KINASE 2, DCLK2
21118,613167,DOUBLECORTIN-LIKE KINASE 3, DCLK3
21119,613168,"SERPIN PEPTIDASE INHIBITOR, CLADE F, MEMBER 2", SERPINF2
21120,613169,KELCH DOMAIN-CONTAINING PROTEIN 8B, KLHDC8B
21121,613170,TETRASPANIN 1, TSPAN1
21122,613171,RNA-BINDING MOTIF PROTEIN 20, RBM20
21123,613172,"CARDIOMYOPATHY, DILATED, 1DD", CMD1DD
21124,613173,NEURONAL GROWTH REGULATOR 1, NEGR1
21125,613174,CHROMOSOME 5p13 DUPLICATION SYNDROME,
21126,613175,SMG8 NONSENSE-MEDIATED mRNA DECAY FACTOR, SMG8
21127,613176,SMG9 NONSENSE-MEDIATED mRNA DECAY FACTOR, SMG9
21128,613177,"CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IC", ARCL1C
21129,613178,CAP-BINDING COMPLEX-DEPENDENT TRANSLATION INITIATION FACTOR, CTIF
21130,613179,PURINE NUCLEOSIDE PHOSPHORYLASE DEFICIENCY,
21131,613180,"CEREBRAL DYSGENESIS, NEUROPATHY, ICHTHYOSIS, AND PALMOPLANTAR KERATODERMA SYNDROME",
21132,613181,BOLA FAMILY MEMBER 1, BOLA1
21133,613182,BOLA FAMILY MEMBER 2, BOLA2
21134,613183,BOLA FAMILY MEMBER 3, BOLA3
21135,613184,TRIPARTITE MOTIF-CONTAINING PROTEIN 68, TRIM68
21136,613185,MICRO RNA 95, MIR95
21137,613186,MICRO RNA 100, MIR100
21138,613187,MICRO RNA 103-1, MIR103-1
21139,613188,MICRO RNA 103-2, MIR103-2
21140,613189,MICRO RNA 107, MIR107
21141,613190,"DYNEIN, AXONEMAL, ASSEMBLY FACTOR 1", DNAAF1
21142,613191,DUAL-SPECIFICITY PHOSPHATASE 13, DUSP13
21143,613192,"INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 13", MRT13
21144,613193,"CILIARY DYSKINESIA, PRIMARY, 13", CILD13
21145,613194,RETINITIS PIGMENTOSA 50, RP50
21146,613195,WEILL-MARCHESANI SYNDROME 4, WMS4
21147,613196,ETAA1 ACTIVATOR OF ATR KINASE, ETAA1
21148,613197,TRAF-TYPE ZINC FINGER DOMAIN-CONTAINING 1, TRAFD1
21149,613198,LYSINE METHYLTRANSFERASE 5C, KMT5C
21150,613199,TAO KINASE 2, TAOK2
21151,613200,PDS5 COHESIN-ASSOCIATED FACTOR A, PDS5A
21152,613201,CHROMOSOME TRANSMISSION FIDELITY FACTOR 18, CHTF18
21153,613202,CHROMOSOME TRANSMISSION FIDELITY FACTOR 8, CHTF8
21154,613203,DNA REPLICATION AND SISTER CHROMATID COHESION 1, DSCC1
21155,613204,"MUSCULAR DYSTROPHY, CONGENITAL, DUE TO INTEGRIN ALPHA-7 DEFICIENCY",
21156,613205,"MUSCULAR DYSTROPHY, CONGENITAL, LMNA-RELATED",
21157,613206,"SPASTIC PARAPLEGIA 44, AUTOSOMAL RECESSIVE", SPG44
21158,613207,"ASTHMA-RELATED TRAITS, SUSCEPTIBILITY TO, 8", ASRT8
21159,613208,"XPC COMPLEX SUBUNIT, DNA DAMAGE RECOGNITION AND REPAIR FACTOR", XPC
21160,613209,TRANSMEMBRANE PROTEIN 181, TMEM181
21161,613210,DIPHTHAMIDE BIOSYNTHESIS PROTEIN 7, DPH7
21162,613211,"AMELOGENESIS IMPERFECTA, HYPOMATURATION TYPE, IIA3", AI2A3
21163,613212,ALANYL-tRNA SYNTHETASE DOMAIN-CONTAINING 1, AARSD1
21164,613213,CYTOCHROME b5 REDUCTASE 3, CYB5R3
21165,613214,WD REPEAT-CONTAINING PROTEIN 72, WDR72
21166,613215,"CHROMOSOME 17p13.3, CENTROMERIC, DUPLICATION SYNDROME",
21167,613216,"NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1C", CSNB1C
21168,613217,"DIARRHEA 5, WITH TUFTING ENTEROPATHY, CONGENITAL", DIAR5
21169,613218,"CYTOCHROME b5, TYPE A (MICROSOMAL)", CYB5A
21170,613219,FASTING PLASMA GLUCOSE LEVEL QUANTITATIVE TRAIT LOCUS 2, FGQTL2
21171,613220,TRANSMEMBRANE PROTEIN 18, TMEM18
21172,613221,MITOCHONDRIAL CARRIER HOMOLOG 2, MTCH2
21173,613222,GLUCOSAMINE-6-PHOSPHATE DEAMINASE 2, GNPDA2
21174,613223,"LEPROSY, SUSCEPTIBILITY TO, 5", LPRS5
21175,613224,NOONAN SYNDROME 6, NS6
21176,613225,"FACTOR XIII, A SUBUNIT, DEFICIENCY OF",
21177,613226,ZINC FINGER PROTEIN 296, ZNF296
21178,613227,"SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 34", SCAR34
21179,613228,ASPARTYLGLUCOSAMINIDASE, AGA
21180,613229,TRICHOTILLOMANIA, TTM
21181,613230,PEPTIDASE D, PEPD
21182,613231,KINESIN FAMILY MEMBER 26A, KIF26A
21183,613232,RNA-BINDING MOTIF PROTEIN 42, RBM42
21184,613233,FASTING PLASMA GLUCOSE LEVEL QUANTITATIVE TRAIT LOCUS 3, FGQTL3
21185,613234,NEUTRAL CHOLESTEROL ESTER HYDROLASE 1, NCEH1
21186,613235,"FACTOR XIII, B SUBUNIT, DEFICIENCY OF",
21187,613236,"POTASSIUM CHANNEL, INWARDLY RECTIFYING, SUBFAMILY J, MEMBER 18", KCNJ18
21188,613237,FOCAL SEGMENTAL GLOMERULOSCLEROSIS 5, FSGS5
21189,613238,"SPONDYLOARTHROPATHY, SUSCEPTIBILITY TO, 3", SPDA3
21190,613239,"THYROTOXIC PERIODIC PARALYSIS, SUSCEPTIBILITY TO, 2", TTPP2
21191,613240,"PROTEIN PHOSPHATASE 1, REGULATORY SUBUNIT 1C", PPP1R1C
21192,613241,PSEUDOPILI ANNULATI,
21193,613242,"PROTEIN PHOSPHATASE 1, REGULATORY SUBUNIT 14C", PPP1R14C
21194,613243,"CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 13", CMH13
21195,613244,LYNCH SYNDROME 8, LYNCH8
21196,613245,"PROTEIN PHOSPHATASE 1, REGULATORY SUBUNIT 12C", PPP1R12C
21197,613246,"PROTEIN PHOSPHATASE 1, REGULATORY SUBUNIT 1A", PPP1R1A
21198,613247,PERILIPIN 4, PLIN4
21199,613248,PERILIPIN 5, PLIN5
21200,613249,ENDOGENOUS BORNA-LIKE N ELEMENT-CONTAINING PROTEIN 1, EBLN1
21201,613250,ENDOGENOUS BORNA-LIKE N ELEMENT-CONTAINING PROTEIN 2, EBLN2
21202,613251,"CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 14", CMH14
21203,613252,"CARDIOMYOPATHY, DILATED, 1EE", CMD1EE
21204,613253,RING FINGER PROTEIN 139,
21205,613254,TUBEROUS SCLEROSIS 2, TSC2
21206,613255,"CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 15", CMH15
21207,613256,"PROTEIN PHOSPHATASE 1, REGULATORY SUBUNIT 14D", PPP1R14D
21208,613257,"PROTEIN PHOSPHATASE 1, REGULATORY SUBUNIT 15B", PPP1R15B
21209,613258,CHROMOSOME 18 OPEN READING FRAME 54, C18ORF54
21210,613259,REPETIN, RPTN
21211,613260,KERATINOCYTE PROLINE-RICH PROTEIN, KPRP
21212,613261,PROTOGENIN, PRTG
21213,613262,RIBOSOMAL PROTEIN L24 DOMAIN-CONTAINING PROTEIN 1, RSL24D1
21214,613263,SMALL NUCLEOLAR RNA HOST GENE 5, SNHG5
21215,613264,"SMALL NUCLEOLAR RNA, C/D BOX", SNORD50B
21216,613265,"WAARDENBURG SYNDROME, TYPE 4B", WS4B
21217,613266,"WAARDENBURG SYNDROME, TYPE 4C", WS4C
21218,613267,"CORNEAL DYSTROPHY, FUCHS ENDOTHELIAL, 3", FECD3
21219,613268,"CORNEAL DYSTROPHY, FUCHS ENDOTHELIAL, 4", FECD4
21220,613269,"CORNEAL DYSTROPHY, FUCHS ENDOTHELIAL, 5", FECD5
21221,613270,"CORNEAL DYSTROPHY, FUCHS ENDOTHELIAL, 6", FECD6
21222,613271,"CORNEAL DYSTROPHY, FUCHS ENDOTHELIAL, 7", FECD7
21223,613272,POTASSIUM CHANNEL TETRAMERIZATION DOMAIN-CONTAINING PROTEIN 3, KCTD3
21224,613273,INST3- AND NABP-INTERACTING PROTEIN, INIP
21225,613274,MOLYBDENUM COFACTOR SULFURASE, MOCOS
21226,613275,"PROTEIN PHOSPHATASE 1, REGULATORY SUBUNIT 16B", PPP1R16B
21227,613276,U6 SMALL NUCLEAR RNA BIOGENESIS PHOSPHODIESTERASE 1, USB1
21228,613277,TRANSMEMBRANE PROTEIN 216, TMEM216
21229,613278,SLX4 STRUCTURE-SPECIFIC ENDONUCLEASE SUBUNIT, SLX4
21230,613279,ZINC FINGER CCCH DOMAIN-CONTAINING PROTEIN 14: ZC3H14,
21231,613280,HYPERMANGANESEMIA WITH DYSTONIA 1, HMNDYT1
21232,613281,SORTING NEXIN 20, SNX20
21233,613282,"FATTY LIVER DISEASE, SUSCEPTIBILITY TO, 1", FLD1
21234,613283,"GLUTAREDOXIN, CYSTEINE-RICH, 1", GRXCR1
21235,613284,HEMATOCRIT/HEMOGLOBIN QUANTITATIVE TRAIT LOCUS 3, HCHGQ3
21236,613285,"DEAFNESS, AUTOSOMAL RECESSIVE 25", DFNB25
21237,613286,"CARDIOMYOPATHY, DILATED, 1FF", CMD1FF
21238,613287,"CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2N", CMT2N
21239,613288,TRIPARTITE MOTIF-CONTAINING PROTEIN 72, TRIM72
21240,613289,ATAXIN 8, ATXN8
21241,613290,"HEARING LOSS, CISPLATIN-INDUCED, SUSCEPTIBILITY TO", CIHL
21242,613291,"BILE ACID MALABSORPTION, PRIMARY, 1", PBAM1
21243,613292,DENN/MADD DOMAIN-CONTAINING PROTEIN 1B, DENND1B
21244,613293,SH3 AND PX DOMAINS-CONTAINING PROTEIN 2B, SH3PXD2B
21245,613294,"SUMO1-ACTIVATING ENZYME, SUBUNIT 1", SAE1
21246,613295,UBIQUITIN-LIKE MODIFIER-ACTIVATING ENZYME 2, UBA2
21247,613296,"LYSOSOME-ASSOCIATED PROTEIN, TRANSMEMBRANE 4, BETA", LAPTM4B
21248,613297,MEMBRANE-ASSOCIATED RING-CH FINGER PROTEIN 6, MARCHF6
21249,613298,TOPBP1-INTERACTING CHECKPOINT AND REPLICATION REGULATOR, TICRR
21250,613299,"FAMILY WITH SEQUENCE SIMILARITY 13, MEMBER A", FAM13A
21251,613300,FAM13A OPPOSITE STRAND, FAM13AOS
21252,613301,FEZ FAMILY ZINC FINGER PROTEIN 1, FEZF1
21253,613302,"AlkB HOMOLOG 4, LYSINE DEMETHYLASE", ALKBH4
21254,613303,"AlkB HOMOLOG 5, RNA DEMETHYLASE", ALKBH5
21255,613304,AlkB HOMOLOG 6, ALKBH6
21256,613305,AlkB HOMOLOG 7, ALKBH7
21257,613306,"AlkB HOMOLOG 8, tRNA METHYLTRANSFERASE", ALKBH8
21258,613307,"DEAFNESS, AUTOSOMAL RECESSIVE 79", DFNB79
21259,613308,DIAMOND-BLACKFAN ANEMIA 9, DBA9
21260,613309,DIAMOND-BLACKFAN ANEMIA 10, DBA10
21261,613310,EXUDATIVE VITREORETINOPATHY 5, EVR5
21262,613311,LYR MOTIF-CONTAINING PROTEIN 4, LYRM4
21263,613312,"HYPOPHOSPHATEMIC RICKETS, AUTOSOMAL RECESSIVE, 2", ARHR2
21264,613313,"HEMOCHROMATOSIS, TYPE 2B", HFE2B
21265,613314,RIBOSOMAL PROTEIN L37A, RPL37A
21266,613315,RIBOSOMAL PROTEIN L41, RPL41
21267,613316,WD REPEAT- AND FYVE DOMAIN-CONTAINING PROTEIN 4, WDFY4
21268,613317,DDB1- AND CUL4-ASSOCIATED FACTOR 11, DCAF11
21269,613318,MIYOSHI MUSCULAR DYSTROPHY 2, MMD2
21270,613319,MIYOSHI MUSCULAR DYSTROPHY 3, MMD3
21271,613320,"SPONDYLOMETAPHYSEAL DYSPLASIA, MEGARBANE-DAGHER-MELKI TYPE", SMDMDM
21272,613321,GLUCOSIDE XYLOSYLTRANSFERASE 1, GXYLT1
21273,613322,GLUCOSIDE XYLOSYLTRANSFERASE 2, GXYLT2
21274,613323,FERM AND PDZ DOMAINS-CONTAINING PROTEIN 2, FRMPD2
21275,613324,SPERMATOGENESIS-ASSOCIATED PROTEIN 13, SPATA13
21276,613325,RHABDOID TUMOR PREDISPOSITION SYNDROME 2, RTPS2
21277,613326,DIHYDROPYRIMIDINASE, DPYS
21278,613327,"LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 4", CGL4
21279,613328,ROIFMAN-CHITAYAT SYNDROME, ROCHIS
21280,613329,PLASMINOGEN ACTIVATOR INHIBITOR-1 DEFICIENCY,
21281,613330,SPONDYLO-MEGAEPIPHYSEAL-METAPHYSEAL DYSPLASIA, SMMD
21282,613331,MEMBRANE-ASSOCIATED RING-CH FINGER PROTEIN 1, MARCHF1
21283,613332,MEMBRANE-ASSOCIATED RING-CH FINGER PROTEIN 2, MARCHF2
21284,613333,MEMBRANE-ASSOCIATED RING-CH FINGER PROTEIN 3, MARCHF3
21285,613334,MEMBRANE-ASSOCIATED RING-CH FINGER PROTEIN 7, MARCHF7
21286,613335,MEMBRANE-ASSOCIATED RING-CH FINGER PROTEIN 8, MARCHF8
21287,613336,MEMBRANE-ASSOCIATED RING-CH FINGER PROTEIN 9, MARCHF9
21288,613337,MEMBRANE-ASSOCIATED RING-CH FINGER PROTEIN 10, MARCHF10
21289,613338,MEMBRANE-ASSOCIATED RING-CH FINGER PROTEIN 11, MARCHF11
21290,613339,"EPILEPSY, HOT WATER, 1", HWE1
21291,613340,"EPILEPSY, HOT WATER, 2", HWE2
21292,613341,LEBER CONGENITAL AMAUROSIS 14, LCA14
21293,613342,MSELENI JOINT DISEASE,
21294,613343,HANDIGODU JOINT DISEASE,
21295,613344,KIAA1549 GENE, KIAA1549
21296,613345,"HYPOKALEMIC PERIODIC PARALYSIS, TYPE 2", HOKPP2
21297,613346,"SHISA FAMILY, MEMBER 9", SHISA9
21298,613347,"PANCREATIC CANCER, SUSCEPTIBILITY TO, 2",
21299,613348,"PANCREATIC CANCER, SUSCEPTIBILITY TO, 3",
21300,613349,ORNITHINE AMINOTRANSFERASE, OAT
21301,613350,"SOLUTE CARRIER FAMILY 52 (RIBOFLAVIN TRANSPORTER), MEMBER 3", SLC52A3
21302,613351,RHO GTPase-ACTIVATING PROTEIN 18, ARHGAP18
21303,613352,ARGININE/SERINE-RICH COILED-COIL PROTEIN 1, RSRC1
21304,613353,"MONONEUROPATHY OF THE MEDIAN NERVE, MILD", MNMN
21305,613354,TAPERIN, TPRN
21306,613355,CHROMOSOME 17q23.1-q23.2 DELETION SYNDROME,
21307,613356,TLR4 INTERACTOR WITH LEUCINE-RICH REPEATS, TRIL
21308,613357,FIBRINOGEN C DOMAIN-CONTAINING PROTEIN 1, FIBCD1
21309,613358,"ALDEHYDE DEHYDROGENASE 16 FAMILY, MEMBER A1", ALDH16A1
21310,613359,LY6/PLAUR DOMAIN-CONTAINING PROTEIN 6, LYPD6
21311,613360,DAMAGE-REGULATED AUTOPHAGY MODULATOR 2, DRAM2
21312,613361,"SOLUTE CARRIER FAMILY 18, MEMBER B1", SLC18B1
21313,613362,CDK2-INTERACTING PROTEIN, CINP
21314,613363,WD REPEAT-CONTAINING PROTEIN 34, WDR34
21315,613364,"SPASTIC PARAPLEGIA 41, AUTOSOMAL DOMINANT", SPG41
21316,613365,"SOLUTE CARRIER ORGANIC ANION TRANSPORTER FAMILY, MEMBER 6A1", SLCO6A1
21317,613366,"SOLUTE CARRIER FAMILY 10 (SODIUM/BILE ACID COTRANSPORTER FAMILY), MEMBER 6", SLC10A6
21318,613367,"LIN54, C. ELEGANS, HOMOLOG OF", LIN54
21319,613368,CARNOSINE SYNTHASE 1, CARNS1
21320,613369,DEAD-BOX HELICASE 42, DDX42
21321,613370,"MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 10", MODY10
21322,613371,SPINOCEREBELLAR ATAXIA 30, SCA30
21323,613372,UFM1-SPECIFIC LIGASE 1, UFL1
21324,613373,YEATS DOMAIN-CONTAINING PROTEIN 2, YEATS2
21325,613374,COILED-COIL DOMAIN-CONTAINING PROTEIN 101, CCDC101
21326,613375,"MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 11", MODY11
21327,613376,"NEURONOPATHY, DISTAL HEREDITARY MOTOR, AUTOSOMAL DOMINANT 4", HMND4
21328,613377,SH3 DOMAIN-CONTAINING RING FINGER PROTEIN 2, SH3RF2
21329,613378,AIG2-LIKE DOMAIN-CONTAINING PROTEIN 1, A2LD1
21330,613379,CARBOXYMETHYLENEBUTENOLIDASE-LIKE PROTEIN, CMBL
21331,613380,H6 FAMILY HOMEOBOX 3, HMX3
21332,613381,CYSTATHIONINE BETA-SYNTHASE, CBS
21333,613382,"BRACHYDACTYLY, TYPE E2", BDE2
21334,613383,ANKYRIN REPEAT DOMAIN-CONTAINING PROTEIN 54, ANKRD54
21335,613384,CYCLIN L1, CCNL1
21336,613385,"AUTOIMMUNE DISEASE, MULTISYSTEM, WITH FACIAL DYSMORPHISM", ADMFD
21337,613386,PROTEASOME MATURATION PROTEIN, POMP
21338,613387,"FATTY LIVER DISEASE, SUSCEPTIBILITY TO, 2", FLD2
21339,613388,FANCONI RENOTUBULAR SYNDROME 2, FRTS2
21340,613389,"SOLUTE CARRIER ORGANIC ANION TRANSPORTER FAMILY, MEMBER 1C1", SLCO1C1
21341,613390,"FANCONI ANEMIA, COMPLEMENTATION GROUP O", FANCO
21342,613391,"DEAFNESS, AUTOSOMAL RECESSIVE 84A", DFNB84A
21343,613392,"DEAFNESS, AUTOSOMAL RECESSIVE 85", DFNB85
21344,613393,BIRBECK GRANULE DEFICIENCY,
21345,613394,MICRO RNA 138-1, MIR138-1
21346,613395,MICRO RNA 138-2, MIR138-2
21347,613396,DOWN SYNDROME CRITICAL REGION GENE 8, DSCR8
21348,613397,ADVILLIN, AVIL
21349,613398,WARSAW BREAKAGE SYNDROME, WABS
21350,613399,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 3", BROVCA3
21351,613400,ACIREDUCTONE DIOXYGENASE 1, ADI1
21352,613401,"VPS33B-INTERACTING PROTEIN, APICAL-BASOLATERAL POLARITY REGULATOR, SPE39 HOMOLOG", VIPAS39
21353,613402,"MICROCEPHALY, SEIZURES, AND DEVELOPMENTAL DELAY", MCSZ
21354,613403,TRANSMEMBRANE PROTEIN 127, TMEM127
21355,613404,"ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 2", ARCS2
21356,613405,MICRO RNA 2861, MIR2861
21357,613406,WITTEVEEN-KOLK SYNDROME, WITKOS
21358,613407,"LEPROSY, SUSCEPTIBILITY TO, 6", LPRS6
21359,613408,COILED-COIL DOMAIN-CONTAINING PROTEIN 122, CCDC122
21360,613409,LACCASE (MULTICOPPER REDUCTASE) DOMAIN-CONTAINING PROTEIN 1, LACC1
21361,613410,"AUTISM, SUSCEPTIBILITY TO, 16", AUTS16
21362,613411,OGUCHI DISEASE 2,
21363,613412,"ESOPHAGITIS, EOSINOPHILIC, 2", EOE2
21364,613413,TRANSMEMBRANE PROTEIN 106B, TMEM106B
21365,613414,INTERLEUKIN 17 RECEPTOR E-LIKE, IL17REL
21366,613415,"CREATINE KINASE, MITOCHONDRIAL 1A", CKMT1A
21367,613416,SCINDERIN, SCIN
21368,613417,"FAMILY WITH SEQUENCE SIMILARITY 48, MEMBER A", FAM48A
21369,613418,BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 15, BMND15
21370,613419,ZINC FINGER- AND SCAN DOMAIN-CONTAINING PROTEIN 4, ZSCAN4
21371,613420,POTASSIUM CHANNEL TETRAMERIZATION DOMAIN-CONTAINING PROTEIN 1, KCTD1
21372,613421,POTASSIUM CHANNEL TETRAMERIZATION DOMAIN-CONTAINING PROTEIN 10, KCTD10
21373,613422,POTASSIUM CHANNEL TETRAMERIZATION DOMAIN-CONTAINING PROTEIN 2, KCTD2
21374,613423,POTASSIUM CHANNEL TETRAMERIZATION DOMAIN-CONTAINING PROTEIN 16, KCTD16
21375,613424,"CARDIOMYOPATHY, DILATED, 1R", CMD1R
21376,613425,PHOTORECEPTOR CILIUM ACTIN REGULATOR, PCARE
21377,613426,"CARDIOMYOPATHY, DILATED, 1S", CMD1S
21378,613427,"ANAPHASE-PROMOTING COMPLEX, SUBUNIT 16", ANAPC16
21379,613428,RETINITIS PIGMENTOSA 54, RP54
21380,613429,"HAUS AUGMIN-LIKE COMPLEX, SUBUNIT 2", HAUS2
21381,613430,"HAUS AUGMIN-LIKE COMPLEX, SUBUNIT 3", HAUS3
21382,613431,"HAUS AUGMIN-LIKE COMPLEX, SUBUNIT 4", HAUS4
21383,613432,"HAUS AUGMIN-LIKE COMPLEX, SUBUNIT 5", HAUS5
21384,613433,"HAUS AUGMIN-LIKE COMPLEX, SUBUNIT 6", HAUS6
21385,613434,"HAUS AUGMIN-LIKE COMPLEX, SUBUNIT 8", HAUS8
21386,613435,AMYOTROPHIC LATERAL SCLEROSIS 12 WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA, ALS12
21387,613436,"AUTISM, SUSCEPTIBILITY TO, 17", AUTS17
21388,613437,FCH DOMAIN ONLY PROTEIN 1, FCHO1
21389,613438,FCH DOMAIN ONLY PROTEIN 2, FCHO2
21390,613439,CONSORTIN, CNST
21391,613440,STATURE QUANTITATIVE TRAIT LOCUS 21, STQTL21
21392,613441,TRANSCOBALAMIN II, TCN2
21393,613442,PENTRAXIN 4, PTX4
21394,613443,"NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, STEREOTYPIC HAND MOVEMENTS, AND IMPAIRED LANGUAGE", NEDHSIL
21395,613444,"CHROMOSOME 16p11.2 DELETION SYNDROME, 220-KB",
21396,613445,MYOSIN IG,
21397,613446,"CENTROSOMAL PROTEIN, 120-KD", CEP120
21398,613447,SPINDLE- AND CENTRIOLE-ASSOCIATED PROTEIN 1, SPICE1
21399,613448,MITOTIC SPINDLE ORGANIZING PROTEIN 1, MZT1
21400,613449,"FAMILY WITH SEQUENCE SIMILARITY 128, MEMBER A", FAM128A
21401,613450,MITOTIC SPINDLE-ORGANIZING PROTEIN 2B, MZT2B
21402,613451,FRONTONASAL DYSPLASIA 2, FND2
21403,613452,"CATION CHANNEL, SPERM-ASSOCIATED, AUXILIARY SUBUNIT GAMMA", CATSPERG
21404,613453,"DEAFNESS, AUTOSOMAL RECESSIVE 91", DFNB91
21405,613454,"RETT SYNDROME, CONGENITAL VARIANT",
21406,613455,MIA SH3 DOMAIN ER EXPORT FACTOR 3, MIA3
21407,613456,FRONTONASAL DYSPLASIA 3, FND3
21408,613457,CHROMOSOME 14q11-q22 DELETION SYNDROME,
21409,613458,CHROMOSOME 16p13.3 DUPLICATION SYNDROME,
21410,613459,BIRTH WEIGHT QUANTITATIVE TRAIT LOCUS 2, BWQTL2
21411,613460,FASTING PLASMA GLUCOSE LEVEL QUANTITATIVE TRAIT LOCUS 6, FGQTL6
21412,613461,LEPTIN RECEPTOR OVERLAPPING TRANSCRIPT, LEPROT
21413,613462,FASTING PLASMA GLUCOSE LEVEL QUANTITATIVE TRAIT LOCUS 4, FGQTL4
21414,613463,FASTING PLASMA GLUCOSE LEVEL QUANTITATIVE TRAIT LOCUS 5, FGQTL5
21415,613464,RETINITIS PIGMENTOSA 51, RP51
21416,613465,"NME/NM23 FAMILY, MEMBER 7", NME7
21417,613466,PREFOLDIN 2, PFDN2
21418,613467,ZINC FINGER CCHC DOMAIN-CONTAINING PROTEIN 6, ZCCHC6
21419,613468,N-ACYLSPHINGOSINE AMIDOHYDROLASE 1, ASAH1
21420,613469,HEPARANASE 2, HPSE2
21421,613470,"ANEMIA, CONGENITAL, NONSPHEROCYTIC HEMOLYTIC, 4", CNSHA4
21422,613471,REYNOLDS SYNDROME,
21423,613472,UNC51-LIKE KINASE 3, ULK3
21424,613473,WD REPEAT-CONTAINING PROTEIN 7, WDR7
21425,613474,ZINC FINGER AN1 DOMAIN-CONTAINING PROTEIN 2B, ZFAND2B
21426,613475,RIBOSOMAL RNA-PROCESSING 36, RRP36
21427,613476,MAJOR FACILITATOR SUPERFAMILY DOMAIN-CONTAINING PROTEIN 6, MFSD6
21428,613477,DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 5, DEE5
21429,613478,COILED-COIL DOMAIN-CONTAINING PROTEIN 106, CCDC106
21430,613479,CENTROSOMAL PROTEIN 131, CEP131
21431,613480,LYMPHATIC MALFORMATION 3, LMPHM3
21432,613481,COILED-COIL DOMAIN-CONTAINING PROTEIN 62: CCDC62,
21433,613482,CYCLIN L2, CCNL2
21434,613483,"BASIC HELIX-LOOP-HELIX FAMILY, MEMBER E22", BHLHE22
21435,613484,SPEN FAMILY TRANSCRIPTIONAL REPRESSOR, SPEN
21436,613485,LONG QT SYNDROME 13, LQT13
21437,613486,MICRO RNA 33B, MIR33B
21438,613487,MICRO RNA 212, MIR212
21439,613488,MYXOID LIPOSARCOMA,
21440,613489,"CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIj", CDG2J
21441,613490,ALPHA-1-ANTITRYPSIN DEFICIENCY, A1ATD
21442,613491,ALKALINE CERAMIDASE 1, ACER1
21443,613492,ALKALINE CERAMIDASE 2, ACER2
21444,613493,"IMMUNODEFICIENCY, COMMON VARIABLE, 3", CVID3
21445,613494,"IMMUNODEFICIENCY, COMMON VARIABLE, 4", CVID4
21446,613495,"IMMUNODEFICIENCY, COMMON VARIABLE, 5", CVID5
21447,613496,"IMMUNODEFICIENCY, COMMON VARIABLE, 6", CVID6
21448,613497,"LIPASE A, LYSOSOMAL ACID", LIPA
21449,613498,SEX HORMONE-BINDING GLOBULIN CIRCULATING LEVEL QUANTITATIVE TRAIT LOCUS, SXGQTL1
21450,613499,"HISTONE GENE CLUSTER 1, H2A HISTONE FAMILY, MEMBER A", HIST1H2AA
21451,613500,"AGAMMAGLOBULINEMIA 2, AUTOSOMAL RECESSIVE", AGM2
21452,613501,"AGAMMAGLOBULINEMIA 3, AUTOSOMAL RECESSIVE", AGM3
21453,613502,"AGAMMAGLOBULINEMIA 4, AUTOSOMAL RECESSIVE", AGM4
21454,613503,"MAJOR HISTOCOMPATIBILITY COMPLEX, CLASS II, DQ ALPHA-2", HLA-DQA2
21455,613504,ZINC FINGER FYVE DOMAIN-CONTAINING PROTEIN 21, ZFYVE21
21456,613505,LEUCINE-RICH REPEAT-CONTAINING PROTEIN 26, LRRC26
21457,613506,"AGAMMAGLOBULINEMIA 5, AUTOSOMAL DOMINANT", AGM5
21458,613507,GLYCOGEN STORAGE DISEASE XV, GSD15
21459,613508,SODIUM SERUM LEVEL QUANTITATIVE TRAIT LOCUS 1, SSQTL1
21460,613509,CHROMOSOME 4q21 DELETION SYNDROME,
21461,613510,"LATE ENDOSOMAL/LYSOSOMAL ADAPTOR, MITOGEN-ACTIVATED PROTEIN KINASE AND MAMMALIAN TARGET OF RAPAMYCIN ACTIVATOR 1", LAMTOR1
21462,613511,"SERINE PROTEASE INHIBITOR, KAZAL-TYPE, 9", SPINK9
21463,613512,ZINC FINGER BED DOMAIN-CONTAINING PROTEIN 6, ZBED6
21464,613513,ZINC FINGER CCCH DOMAIN-CONTAINING PROTEIN 11A, ZC3H11A
21465,613514,ZONA PELLUCIDA GLYCOPROTEIN 4, ZP4
21466,613515,AUTOPHAGY-RELATED 14, ATG14
21467,613516,RUN DOMAIN- AND CYSTEINE-RICH DOMAIN-CONTAINING BECLIN-1-INTERACTING PROTEIN, RUBCN
21468,613517,"MICROPHTHALMIA, ISOLATED 6", MCOP6
21469,613518,"DERMATITIS, ATOPIC, 8", ATOD8
21470,613519,"DERMATITIS, ATOPIC, 9", ATOD9
21471,613520,"FYVE, RhoGEF, AND PH DOMAIN-CONTAINING PROTEIN 6", FGD6
21472,613521,UROPORPHYRINOGEN DECARBOXYLASE, UROD
21473,613522,"OPSIN 1, SHORT-WAVE-SENSITIVE", OPN1SW
21474,613523,CHROMOSOME 8p11 MYELOPROLIFERATIVE SYNDROME,
21475,613524,SHH SIGNALING AND CILIOGENESIS REGULATOR SDCCAG8, SDCCAG8
21476,613525,SEEK1 GENE,
21477,613526,SPR1 GENE,
21478,613527,"DNAJ/HSP40 HOMOLOG, SUBFAMILY C, MEMBER 27", DNAJC27
21479,613528,SYNAPTOTAGMIN 9, SYT9
21480,613529,"CENTROSOMAL PROTEIN, 152-KD", CEP152
21481,613530,"MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 1H", LGMD1H
21482,613531,PHOSPHATASE AND TENSIN HOMOLOG PSEUDOGENE, PTENP1
21483,613532,RAS-ASSOCIATED PROTEIN RAB8B, RAB8B
21484,613533,CHROMOSOME 17q21.31 DUPLICATION SYNDROME,
21485,613534,FANCD2/FANCI-ASSOCIATED NUCLEASE 1, FAN1
21486,613535,KIAA0319-LIKE, KIAA0319L
21487,613536,"LEUCINE-, GLUTAMATE-, AND LYSINE-RICH PROTEIN 1", LEKR1
21488,613537,"NLR FAMILY, CASPASE RECRUITMENT DOMAIN-CONTAINING 5", NLRC5
21489,613538,FEM1 HOMOLOG A, FEM1A
21490,613539,FEM1 HOMOLOG B, FEM1B
21491,613540,"SERINE PALMITOYLTRANSFERASE, SMALL SUBUNIT, A", SPTSSA
21492,613541,MITOCHONDRIAL TRANSLATION RELEASE FACTOR IN RESCUE, MTRFR
21493,613542,MITOCHONDRIAL TRANSLATIONAL RELEASE FACTOR 1-LIKE, MTRF1L
21494,613543,"SOLUTE CARRIER ORGANIC ANION TRANSPORTER FAMILY, MEMBER 5A1", SLCO5A1
21495,613544,CHROMOSOME 6q11-q14 DELETION SYNDROME,
21496,613545,"MACROSTOMIA, ISOLATED",
21497,613546,AROMATASE DEFICIENCY,
21498,613547,STATURE QUANTITATIVE TRAIT LOCUS 22, STQTL22
21499,613548,STATURE QUANTITATIVE TRAIT LOCUS 23, STQTL23
21500,613549,STATURE QUANTITATIVE TRAIT LOCUS 24, STQTL24
21501,613550,NEPHRONOPHTHISIS 11, NPHP11
21502,613551,"AUTOIMMUNE DISEASE, SUSCEPTIBILITY TO, 6", AIS6
21503,613552,GAMMA-SECRETASE-ACTIVATING PROTEIN, GSAP
21504,613553,X-PROLYL AMINOPEPTIDASE 3, XPNPEP3
21505,613554,"VON WILLEBRAND DISEASE, TYPE 2", VWD2
21506,613555,TET METHYLCYTOSINE DIOXYGENASE 3, TET3
21507,613556,MICRO RNA 659, MIR659
21508,613557,CHUDLEY-MCCULLOUGH SYNDROME,
21509,613558,"DEAFNESS, AUTOSOMAL DOMINANT 51", DFNA51
21510,613559,COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 7, COXPD7
21511,613560,N-TERMINAL X-PRO-LYS N-METHYLTRANSFERASE 1, NTMT1
21512,613561,"MYOPATHY, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA 2", MLASA2
21513,613562,Fc RECEPTOR-LIKE PROTEIN 6, FCRL6
21514,613563,NOONAN SYNDROME-LIKE DISORDER WITH OR WITHOUT JUVENILE MYELOMONOCYTIC LEUKEMIA, NSLL
21515,613564,CHROMOSOME 2p12-p11.2 DELETION SYNDROME,
21516,613565,UBIQUITINATION FACTOR E4B, UBE4B
21517,613566,FETAL HEMOGLOBIN QUANTITATIVE TRAIT LOCUS 6, HBFQTL6
21518,613567,"ZINC FINGER, MYM-TYPE 6", ZMYM6
21519,613568,"ZINC FINGER, MYM-TYPE 4", ZMYM4
21520,613569,SAD1 AND UNC84 DOMAIN-CONTAINING PROTEIN 2, SUN2
21521,613570,LIPID DROPLET ASSOCIATED HYDROLASE, LDAH
21522,613571,DISORDERED STEROIDOGENESIS DUE TO CYTOCHROME P450 OXIDOREDUCTASE DEFICIENCY,
21523,613572,"G PROTEIN-COUPLED RECEPTOR, FAMILY C, GROUP 6, MEMBER A", GPRC6A
21524,613573,ECTODERMAL DYSPLASIA-SYNDACTYLY SYNDROME 1, EDSS1
21525,613574,TETRATRICOPEPTIDE REPEAT DOMAIN-CONTAINING PROTEIN 39B, TTC39B
21526,613575,RETINITIS PIGMENTOSA 55, RP55
21527,613576,ECTODERMAL DYSPLASIA-SYNDACTYLY SYNDROME 2, EDSS2
21528,613577,"TBC1 DOMAIN FAMILY, MEMBER 24", TBC1D24
21529,613578,"PROTEASE, SERINE, 3", PRSS3
21530,613579,"C-TYPE LECTIN DOMAIN FAMILY 6, MEMBER A", CLEC6A
21531,613580,WD REPEAT-CONTAINING PLANAR CELL POLARITY EFFECTOR, WDPCP
21532,613581,RETINITIS PIGMENTOSA 56, RP56
21533,613582,RETINITIS PIGMENTOSA 57, RP57
21534,613583,WD REPEAT-CONTAINING PROTEIN 62, WDR62
21535,613584,"ALDEHYDE DEHYDROGENASE 1 FAMILY, MEMBER L2", ALDH1L2
21536,613585,TRANSMEMBRANE PROTEIN 147, TMEM147
21537,613586,NIN1-BINDING PROTEIN 1 HOMOLOG, NOB1
21538,613587,OCCULT MACULAR DYSTROPHY, OCMD
21539,613588,"C-TYPE LECTIN DOMAIN FAMILY 3, MEMBER A", CLEC3A
21540,613589,LOW DENSITY LIPOPROTEIN CHOLESTEROL LEVEL QUANTITATIVE TRAIT LOCUS 6, LDLCQ6
21541,613590,"BUTYROPHILIN, SUBFAMILY 2, MEMBER A1", BTN2A1
21542,613591,"BUTYROPHILIN, SUBFAMILY 2, MEMBER A2", BTN2A2
21543,613592,"BUTYROPHILIN, SUBFAMILY 2, MEMBER A3", BTN2A3
21544,613593,"BUTYROPHILIN, SUBFAMILY 3, MEMBER A1", BTN3A1
21545,613594,"BUTYROPHILIN, SUBFAMILY 3, MEMBER A2", BTN3A2
21546,613595,"BUTYROPHILIN, SUBFAMILY 3, MEMBER A3", BTN3A3
21547,613596,"FAMILY WITH SEQUENCE SIMILARITY 161, MEMBER A", FAM161A
21548,613597,4-HYDROXY-2-OXOGLUTARATE ALDOLASE 1, HOGA1
21549,613598,ZINC FINGER PROTEIN 513, ZNF513
21550,613599,"ABHYDROLASE DOMAIN-CONTAINING PROTEIN 12, LYSOPHOSPHOLIPASE", ABHD12
21551,613600,"TORSADE DE POINTES, SHORT-COUPLED VARIANT",
21552,613601,EARLY REPOLARIZATION ASSOCIATED WITH VENTRICULAR FIBRILLATION,
21553,613602,WD REPEAT-CONTAINING PROTEIN 35, WDR35
21554,613603,CHROMOSOME 4q32.1-q32.2 TRIPLICATION SYNDROME,
21555,613604,"CHROMOSOME 16p12.2-p11.2 DELETION SYNDROME, 7.1- TO 8.7-MB",
21556,613605,BBS PROTEIN COMPLEX-INTERACTING PROTEIN 1, BBIP1
21557,613606,FORSYTHE-WAKELING SYNDROME, FWS
21558,613607,THYMOCYTE SELECTION-ASSOCIATED PROTEIN, THEMIS
21559,613608,"EPILEPSY, FAMILIAL ADULT MYOCLONIC, 3", FAME3
21560,613609,HOMEOSTATIC IRON REGULATOR, HFE
21561,613610,CRANIOECTODERMAL DYSPLASIA 2, CED2
21562,613611,CHOANAL ATRESIA AND LYMPHEDEMA, CATLPH
21563,613612,"CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIi", CDG2I
21564,613613,MICRO RNA 208B, MIR208B
21565,613614,MICRO RNA 499, MIR499
21566,613615,SENIOR-LOKEN SYNDROME 7, SLSN7
21567,613616,"HYPEROXALURIA, PRIMARY, TYPE III", HP3
21568,613617,RETINITIS PIGMENTOSA 58, RP58
21569,613618,CHROMOSOME 17q23.1-q23.2 DUPLICATION SYNDROME,
21570,613619,"SCAVENGER RECEPTOR CLASS F, MEMBER 2", SCARF2
21571,613620,"TBC1 DOMAIN FAMILY, MEMBER 10B", TBC1D10B
21572,613621,NUCLEOTIDE-BINDING PROTEIN-LIKE PROTEIN, NUBPL
21573,613622,FAD-DEPENDENT OXIDOREDUCTASE DOMAIN-CONTAINING PROTEIN 1, FOXRED1
21574,613623,AGENESIS OF THE CORPUS CALLOSUM AND CONGENITAL LYMPHEDEMA,
21575,613624,ZINC FINGER PROTEIN 592, ZNF592
21576,613625,"FACTOR V AND FACTOR VIII, COMBINED DEFICIENCY OF, 2", F5F8D2
21577,613626,"MYOPIA 18, AUTOSOMAL RECESSIVE",
21578,613627,TSUKAHARA SYNDROME,
21579,613628,ODONTOID HYPOPLASIA,
21580,613629,PIEZO-TYPE MECHANOSENSITIVE ION CHANNEL COMPONENT 2, PIEZO2
21581,613630,FETAL ENCASEMENT SYNDROME,
21582,613631,"WASH COMPLEX, SUBUNIT 2C", WASHC2C
21583,613632,"WASH COMPLEX, SUBUNIT 1", WASHC1
21584,613633,DENN/MADD DOMAIN-CONTAINING PROTEIN 1A, DENND1A
21585,613634,DENN/MADD DOMAIN-CONTAINING PROTEIN 1C, DENND1C
21586,613635,EUKARYOTIC TRANSLATION INITIATION FACTOR 2-ALPHA KINASE 1, EIF2AK1
21587,613636,"TUBERCULIN SKIN TEST REACTIVITY, ABSENCE OF",
21588,613637,TUBERCULIN SKIN TEST REACTIVITY QUANTITATIVE TRAIT LOCUS,
21589,613638,CHROMOSOME 19p13.13 DELETION SYNDROME,
21590,613639,ADHESION G PROTEIN-COUPLED RECEPTOR D1, ADGRD1
21591,613640,"NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE IC", HSAN1C
21592,613641,"CHARCOT-MARIE-TOOTH DISEASE, RECESSIVE INTERMEDIATE B", CMTRIB
21593,613642,"CARDIOMYOPATHY, DILATED, 1GG", CMD1GG
21594,613643,"PARKINSON DISEASE 5, AUTOSOMAL DOMINANT, SUSCEPTIBILITY TO", PARK5
21595,613644,ACTIVATING TRANSCRIPTION FACTOR 7-INTERACTING PROTEIN, ATF7IP
21596,613645,ACTIVATING TRANSCRIPTION FACTOR 7-INTERACTING PROTEIN 2, ATF7IP2
21597,613646,"METHYLMALONIC ACIDURIA, TRANSIENT, DUE TO TRANSCOBALAMIN RECEPTOR DEFECT", MATR
21598,613647,"SPASTIC PARAPLEGIA 48, AUTOSOMAL RECESSIVE", SPG48
21599,613648,MATERNALLY EXPRESSED GENE 8, MEG8
21600,613649,"SMALL NUCLEOLAR RNA, C/D BOX, 112", SNORD112
21601,613650,"SMALL NUCLEOLAR RNA, C/D BOX, 113-1", SNORD113-1
21602,613651,"SMALL NUCLEOLAR RNA, C/D BOX, 114-1", SNORD114-1
21603,613652,C1q DEFICIENCY 1, C1QD1
21604,613653,"ADAPTOR-RELATED PROTEIN COMPLEX 5, ZETA-1 SUBUNIT", AP5Z1
21605,613654,MICRO RNA 380, MIR380
21606,613655,"POTASSIUM CHANNEL, SUBFAMILY K, MEMBER 18", KCNK18
21607,613656,"MIGRAINE WITH AURA, SUSCEPTIBILITY TO, 13", MGR13
21608,613657,D-2-HYDROXYGLUTARIC ACIDURIA 2, D2HGA2
21609,613658,RAJAB INTERSTITIAL LUNG DISEASE WITH BRAIN CALCIFICATIONS 1, RILDBC1
21610,613659,GASTRIC CANCER,
21611,613660,CONE-ROD DYSTROPHY 15, CORD15
21612,613661,"CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ip", CDG1P
21613,613662,MITOCHONDRIAL DNA DEPLETION SYNDROME 4B (MNGIE TYPE), MTDPS4B
21614,613663,"SHQ1, H/ACA RIBONUCLEOPROTEIN ASSEMBLY FACTOR", SHQ1
21615,613664,SMOOTHELIN-LIKE 1, SMTNL1
21616,613665,ATYPICAL CHEMOKINE RECEPTOR 1, ACKR1
21617,613666,"ALG11 ALPHA-1,2-MANNOSYLTRANSFERASE", ALG11
21618,613667,SINE OCULIS-BINDING PROTEIN HOMOLOG, SOBP
21619,613668,"MICROCEPHALY, POSTNATAL PROGRESSIVE, WITH SEIZURES AND BRAIN ATROPHY",
21620,613669,MITOCHONDRIAL POLY(A) POLYMERASE, MTPAP
21621,613670,INTELLECTUAL DEVELOPMENTAL DISORDER WITH LANGUAGE IMPAIRMENT AND WITH OR WITHOUT AUTISTIC FEATURES, IDDLA
21622,613671,"IMPAIRED INTELLECTUAL DEVELOPMENT, ANTERIOR MAXILLARY PROTRUSION, AND STRABISMUS", MRAMS
21623,613672,"SPASTIC ATAXIA 4, AUTOSOMAL RECESSIVE", SPAX4
21624,613673,"ANEMIA, CONGENITAL DYSERYTHROPOIETIC, TYPE IVa", CDAN4A
21625,613674,VESICOURETERAL REFLUX 3, VUR3
21626,613675,"CHROMOSOME 17q11.2 DELETION SYNDROME, 1.4-MB",
21627,613676,SECKEL SYNDROME 4, SCKL4
21628,613677,"HYPERALDOSTERONISM, FAMILIAL, TYPE III", HALD3
21629,613678,BRACHYOLMIA TYPE 2, BCYM2
21630,613679,"PROTHROMBIN DEFICIENCY, CONGENITAL",
21631,613680,BEAULIEU-BOYCOTT-INNES SYNDROME, BBIS
21632,613681,CHROMOSOME 2q31.1 DUPLICATION SYNDROME,
21633,613682,MICRO RNA 130B, MIR130B
21634,613683,"SOLUTE CARRIER FAMILY 50 (SUGAR TRANSPORTER), MEMBER 1", SLC50A1
21635,613684,RUBINSTEIN-TAYBI SYNDROME 2, RSTS2
21636,613685,"DEAFNESS, AUTOSOMAL RECESSIVE 83", DFNB83
21637,613686,"SPONDYLOCOSTAL DYSOSTOSIS 4, AUTOSOMAL RECESSIVE", SCDO4
21638,613687,PARP1-BINDING PROTEIN, PARPBP
21639,613688,LONG QT SYNDROME 2, LQT2
21640,613689,MAMMARY-DIGITAL-NAIL SYNDROME, MDNS
21641,613690,"CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 7", CMH7
21642,613691,GRAM DOMAIN-CONTAINING PROTEIN 4, GRAMD4
21643,613692,TERMINAL URIDYLYL TRANSFERASE 4, TUT4
21644,613693,LONG QT SYNDROME 6, LQT6
21645,613694,"CARDIOMYOPATHY, DILATED, 1U", CMD1U
21646,613695,LONG QT SYNDROME 5, LQT5
21647,613696,UPSTREAM BINDING TRANSCRIPTION FACTOR (RNA POLYMERASE I)-LIKE 1, UBTFL1
21648,613697,"CARDIOMYOPATHY, DILATED, 1V", CMD1V
21649,613698,"SOLUTE CARRIER FAMILY 25 (CARNITINE/ACYLCARNITINE TRANSLOCASE), MEMBER 20", SLC25A20
21650,613699,GLYCOSYLTRANSFERASE 6 DOMAIN-CONTAINING 1, GLT6D1
21651,613700,SUPERNUMERARY DER(22)t(8,22) SYNDROME
21652,613701,MICRO RNA 328, MIR328
21653,613702,"KLIPPEL-FEIL SYNDROME 3, AUTOSOMAL DOMINANT", KFS3
21654,613703,MICROPHTHALMIA/COLOBOMA 6, MCOPCB6
21655,613704,"MICROPHTHALMIA, ISOLATED 7", MCOP7
21656,613705,OROFACIAL CLEFT 10, OFC10
21657,613706,NOONAN SYNDROME 7, NS7
21658,613707,LEOPARD SYNDROME 3, LPRD3
21659,613708,"NEUROPATHY, HEREDITARY SENSORY, TYPE ID", HSN1D
21660,613709,EUKARYOTIC TRANSLATION INITIATION FACTOR 2D, EIF2D
21661,613710,THIAMINE METABOLISM DYSFUNCTION SYNDROME 4 (BILATERAL STRIATAL DEGENERATION AND PROGRESSIVE POLYNEUROPATHY TYPE), THMD4
21662,613711,"HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 3", HSCR3
21663,613712,"HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 4", HSCR4
21664,613713,PCI DOMAIN-CONTAINING PROTEIN 2, PCID2
21665,613714,NATURAL KILLER CELL CYTOTOXICITY RECEPTOR 3 LIGAND 1, NCR3LG1
21666,613715,"POLYMERASE I, RNA, SUBUNIT D", POLR1D
21667,613716,MICRO RNA 661, MIR661
21668,613717,TREACHER COLLINS SYNDROME 2, TCS2
21669,613718,"DEAFNESS, AUTOSOMAL RECESSIVE 74", DFNB74
21670,613719,METHIONINE SULFOXIDE REDUCTASE B3, MSRB3
21671,613720,DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 7, DEE7
21672,613721,DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 11, DEE11
21673,613722,DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 12, DEE12
21674,613723,"MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 17", LGMDR17
21675,613724,LEUKOENCEPHALOPATHY WITH DYSTONIA AND MOTOR NEUROPATHY, LKDMN
21676,613725,"SOLUTE CARRIER FAMILY 25, MEMBER 17", SLC25A27
21677,613726,ANOCTAMIN 10, ANO10
21678,613727,KELCH REPEAT- AND BTB/POZ DOMAIN-CONTAINING PROTEIN 13, KBTBD13
21679,613728,"SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 10", SCAR10
21680,613729,"CHROMOSOME 7q11.23 DELETION SYNDROME, DISTAL, 1.2-MB",
21681,613730,"HEMORRHAGIC DESTRUCTION OF THE BRAIN, SUBEPENDYMAL CALCIFICATION, AND CATARACTS", HDBSCC
21682,613731,RETINITIS PIGMENTOSA 4, RP4
21683,613732,PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 1,
21684,613733,MENIN 1 , MEN1
21685,613734,COILED-COIL DOMAIN-CONTAINING PROTEIN 115, CCDC115
21686,613735,BRAIN MALFORMATIONS WITH OR WITHOUT URINARY TRACT DEFECTS, BRMUTD
21687,613736,"ACNE INVERSA, FAMILIAL, 2, WITH OR WITHOUT DOWLING-DEGOS DISEASE", ACNINV2
21688,613737,"ACNE INVERSA, FAMILIAL, 3", ACNINV3
21689,613738,ALKYLGLYCEROL MONOOXYGENASE, AGMO
21690,613739,THYMOCYTE NUCLEAR PROTEIN 1, THYN1
21691,613740,"CARDIOMYOPATHY, DILATED, 1A",
21692,613741,"GLYCOGEN PHOSPHORYLASE, LIVER", PYGL
21693,613742,"GLUCOSE-6-PHOSPHATASE, CATALYTIC", G6PC
21694,613743,"ADRENAL INSUFFICIENCY, CONGENITAL, WITH 46,XY SEX REVERSAL, PARTIAL OR COMPLETE",
21695,613744,"SPASTIC PARAPLEGIA 51, AUTOSOMAL RECESSIVE", SPG51
21696,613745,"ANAPHASE-PROMOTING COMPLEX, SUBUNIT 10", ANAPC10
21697,613746,BREAST CANCER ANTIESTROGEN RESISTANCE 4, BCAR4
21698,613747,KINESIN FAMILY MEMBER 24, KIF24
21699,613748,COILED-COIL-HELIX-COILED-COIL-HELIX DOMAIN-CONTAINING PROTEIN 3, CHCHD3
21700,613749,ZINC FINGER PROTEIN 260, ZNF260
21701,613750,RETINITIS PIGMENTOSA 27, RP27
21702,613751,"HETEROTAXY, VISCERAL, 4, AUTOSOMAL", HTX4
21703,613752,HYPERMETHIONINEMIA WITH S-ADENOSYLHOMOCYSTEINE HYDROLASE DEFICIENCY,
21704,613753,MICRO RNA 211, MIR211
21705,613754,RING FINGER PROTEIN 187, RNF187
21706,613755,MICRO RNA 326, MIR326
21707,613756,RETINITIS PIGMENTOSA 49, RP49
21708,613757,"MACULAR DEGENERATION, AGE-RELATED, 6", ARMD6
21709,613758,RETINITIS PIGMENTOSA 47, RP47
21710,613759,"IMMUNODEFICIENCY 90 WITH ENCEPHALOPATHY, FUNCTIONAL HYPOSPLENIA, AND HEPATIC DYSFUNCTION", IMD90
21711,613760,"SOLUTE CARRIER FAMILY 36, MEMBER 4", SLC36A4
21712,613761,"MACULAR DEGENERATION, AGE-RELATED, 5", ARMD5
21713,613762,"46,XY SEX REVERSAL 6", SRXY6
21714,613763,"CATARACT 16, MULTIPLE TYPES", CTRCT16
21715,613764,SECRETORY CARRIER MEMBRANE PROTEIN 4, SCAMP4
21716,613765,"CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 9", CMH9
21717,613766,SECRETORY CARRIER MEMBRANE PROTEIN 5, SCAMP5
21718,613767,RETINITIS PIGMENTOSA 45, RP45
21719,613768,RING FINGER PROTEIN 213, RNF213
21720,613769,RETINITIS PIGMENTOSA 44, RP44
21721,613770,PLACENTA-SPECIFIC GENE 4, PLAC4
21722,613771,TRANSMEMBRANE PROTEIN 205, TMEM205
21723,613772,KELCH-LIKE 14, KLHL14
21724,613773,"IMMUNOGLOBULIN SUPERFAMILY, MEMBER 9B", IGSF9B
21725,613774,CALMODULIN-REGULATED SPECTRIN-ASSOCIATED PROTEIN 1, CAMSAP1
21726,613775,CALMODULIN-REGULATED SPECTRIN-ASSOCIATED PROTEIN 2, CAMSAP2
21727,613776,CHROMOSOME 17p13.1 DELETION SYNDROME,
21728,613777,FAD-DEPENDENT OXIDOREDUCTASE DOMAIN-CONTAINING PROTEIN 2, FOXRED2
21729,613778,"MACULAR DEGENERATION, AGE-RELATED, 8", ARMD8
21730,613779,"COMPLEMENT COMPONENT 3 DEFICIENCY, AUTOSOMAL RECESSIVE", C3D
21731,613780,"AORTIC ANEURYSM, FAMILIAL THORACIC 7", AAT7
21732,613781,COILED-COIL DOMAIN-CONTAINING PROTEIN 125, CCDC125
21733,613782,METHIONINE SULFOXIDE REDUCTASE B2, MSRB2
21734,613783,COMPLEMENT COMPONENT C1s DEFICIENCY, C1SD
21735,613784,"MACULAR DEGENERATION, AGE-RELATED, 12", ARMD12
21736,613785,"COMPLEMENT COMPONENT 1, r SUBCOMPONENT", C1R
21737,613786,MICRO RNA 148A, MIR148A
21738,613787,MICRO RNA 148B, MIR148B
21739,613788,MICRO RNA 152, MIR152
21740,613789,"COMPLEMENT COMPONENT 8 DEFICIENCY, TYPE II", C8D2
21741,613790,"COMPLEMENT COMPONENT 8 DEFICIENCY, TYPE I", C8D1
21742,613791,MASP2 DEFICIENCY,
21743,613792,CHROMOSOME 3pter-p25 DELETION SYNDROME,
21744,613793,"BLOOD GROUP, CROMER SYSTEM", CROM
21745,613794,RETINITIS PIGMENTOSA 20, RP20
21746,613795,LOEYS-DIETZ SYNDROME 3, LDS3
21747,613796,IMMUNODEFICIENCY 31B, IMD31B
21748,613797,"PROTEASE, SERINE, 33", PRSS33
21749,613798,COILED-COIL DOMAIN-CONTAINING PROTEIN 39, CCDC39
21750,613799,COILED-COIL DOMAIN-CONTAINING PROTEIN 40, CCDC40
21751,613800,MEIER-GORLIN SYNDROME 2, MGORS2
21752,613801,RETINITIS PIGMENTOSA 40, RP40
21753,613802,MALECTIN, MLEC
21754,613803,MEIER-GORLIN SYNDROME 3, MGORS3
21755,613804,MEIER-GORLIN SYNDROME 4, MGORS4
21756,613805,MEIER-GORLIN SYNDROME 5, MGORS5
21757,613806,"CHOLANGITIS, PRIMARY SCLEROSING", PSC
21758,613807,"CILIARY DYSKINESIA, PRIMARY, 14", CILD14
21759,613808,"CILIARY DYSKINESIA, PRIMARY, 15", CILD15
21760,613809,RETINITIS PIGMENTOSA 39, RP39
21761,613810,RETINITIS PIGMENTOSA 43, RP43
21762,613811,"PONTOCEREBELLAR HYPOPLASIA, TYPE 2D", PCH2D
21763,613812,"BILE ACID SYNTHESIS DEFECT, CONGENITAL, 3", CBAS3
21764,613813,MDM1 NUCLEAR PROTEIN, MDM1
21765,613814,TETRATRICOPEPTIDE REPEAT DOMAIN-CONTAINING PROTEIN 19, TTC19
21766,613815,"CYTOCHROME P450, FAMILY 21, SUBFAMILY A, POLYPEPTIDE 2", CYP21A2
21767,613816,UBIQUITIN PROTEIN LIGASE E3 COMPONENT N-RECOGNIN 7, UBR7
21768,613817,SPERMATOGENESIS-ASSOCIATED SERINE-RICH PROTEIN 2-LIKE, SPATS2L
21769,613818,"MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 9", MDDGC9
21770,613819,SHORT-RIB THORACIC DYSPLASIA 4 WITH OR WITHOUT POLYDACTYLY, SRTD4
21771,613820,NEPHRONOPHTHISIS 12, NPHP12
21772,613821,"PROTEIN PHOSPHATASE 3, REGULATORY SUBUNIT B, BETA", PPP3R2
21773,613822,"PROTEIN PHOSPHATASE 4, REGULATORY SUBUNIT 2", PPP4R2
21774,613823,SECKEL SYNDROME 5, SCKL5
21775,613824,NEPHRONOPHTHISIS 9, NPHP9
21776,613825,COMPLEMENT COMPONENT 9 DEFICIENCY, C9D
21777,613826,LEBER CONGENITAL AMAUROSIS 6, LCA6
21778,613827,RETINITIS PIGMENTOSA 48, RP48
21779,613828,"GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 8", GEFSP8
21780,613829,LEBER CONGENITAL AMAUROSIS 7, LCA7
21781,613830,"NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1D", CSNB1D
21782,613831,UBIQUITIN PROTEIN LIGASE E3 COMPONENT N-RECOGNIN 3, UBR3
21783,613832,"SENSORY ATAXIC NEUROPATHY, DYSARTHRIA, AND OPHTHALMOPARESIS",
21784,613833,KAT8 REGULATORY NSL COMPLEX SUBUNIT 1-LIKE PROTEIN, KANSL1L
21785,613834,SMOOTH MUSCLE DYSFUNCTION SYNDROME, SMDYS
21786,613835,LEBER CONGENITAL AMAUROSIS 8, LCA8
21787,613836,"ADIPONECTIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 5", ADIPQTL5
21788,613837,LEBER CONGENITAL AMAUROSIS 11, LCA11
21789,613838,"CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 16", CMH16
21790,613839,MEGALOBLASTIC ANEMIA DUE TO DIHYDROFOLATE REDUCTASE DEFICIENCY,
21791,613840,ZINC FINGER PROTEIN 304, ZNF304
21792,613841,UBINUCLEIN 2, UBN2
21793,613842,GDNF-INDUCIBLE ZINC FINGER PROTEIN 1, GZF1
21794,613843,LEBER CONGENITAL AMAUROSIS 15, LCA15
21795,613844,UBIQUINOL-CYTOCHROME C REDUCTASE HINGE PROTEIN, UQCRH
21796,613845,"HYPERURICEMIA, PULMONARY HYPERTENSION, RENAL FAILURE, AND ALKALOSIS SYNDROME", HUPRAS
21797,613846,"TECTONIC FAMILY, MEMBER 2", TCTN2
21798,613847,"TECTONIC FAMILY, MEMBER 3", TCTN3
21799,613848,"OSTEOGENESIS IMPERFECTA, TYPE X", OI10
21800,613849,"OSTEOGENESIS IMPERFECTA, TYPE XII", OI12
21801,613850,INOSINE TRIPHOSPHATASE DEFICIENCY,
21802,613851,PROLINE-RICH MEMBRANE ANCHOR 1, PRIMA1
21803,613852,FUCOSYLTRANSFERASE 6 DEFICIENCY,
21804,613853,"HETEROTAXY, VISCERAL, 2, AUTOSOMAL",
21805,613854,"CONGENITAL HEART DEFECTS, MULTIPLE TYPES, 6", CHTD6
21806,613855,"EPISODIC ATAXIA, TYPE 5", EA5
21807,613856,ACHROMATOPSIA 4, ACHM4
21808,613857,OROFACIAL CLEFT 13, OFC13
21809,613858,"PROTEASE, SERINE, 56", PRSS56
21810,613859,UROMODULIN-LIKE 1, UMODL1
21811,613860,FICOLIN 3 DEFICIENCY,
21812,613861,RETINITIS PIGMENTOSA 59, RP59
21813,613862,RETINITIS PIGMENTOSA 38, RP38
21814,613863,"GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 7", GEFSP7
21815,613864,ZINC FINGER PROTEIN 317, ZNF317
21816,613865,"DEAFNESS, AUTOSOMAL RECESSIVE 61", DFNB61
21817,613866,PHOSPHOLIPASE A AND ACYLTRANSFERASE 2, PLAAT2
21818,613867,PHOSPHOLIPASE A AND ACYLTRANSFERASE 3, PLAAT3
21819,613868,"SOLUTE CARRIER FAMILY 14 (UREA TRANSPORTER), MEMBER 1", SLC14A1
21820,613869,"MYOPATHY, MYOFIBRILLAR, FATAL INFANTILE HYPERTONIC, ALPHA-B CRYSTALLIN-RELATED",
21821,613870,"HIRSCHSPRUNG DISEASE, CARDIAC DEFECTS, AND AUTONOMIC DYSFUNCTION", HCAD
21822,613871,FUMARYLACETOACETATE HYDROLASE, FAH
21823,613872,COAGULATION FACTOR X, F10
21824,613873,"CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 17", CMH17
21825,613874,"CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 18", CMH18
21826,613875,"CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 1",
21827,613876,"CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 20", CMH20
21828,613877,"LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 4", FPLD4
21829,613878,COAGULATION FACTOR VII, F7
21830,613879,THYROTROPIN-RELEASING HORMONE, TRH
21831,613880,BROMO-ADJACENT HOMOLOGY DOMAIN-CONTAINING PROTEIN 1, BAHD1
21832,613881,"CARDIOMYOPATHY, DILATED, 1HH", CMD1HH
21833,613882,"HYPOMAGNESEMIA 6, RENAL", HOMG6
21834,613883,KELL BLOOD GROUP METALLOENDOPEPTIDASE, KEL
21835,613884,CHROMOSOME 13q14 DELETION SYNDROME,
21836,613885,"MECKEL SYNDROME, TYPE 8", MKS8
21837,613886,"OBESITY, HYPERPHAGIA, AND DEVELOPMENTAL DELAY", OBHD
21838,613887,CATARACT 36, CTRCT36
21839,613888,"RAS HOMOLOG GENE FAMILY, MEMBER T1", RHOT1
21840,613889,"RAS HOMOLOG GENE FAMILY, MEMBER T2", RHOT2
21841,613890,3-BETA-HYDROXYSTEROID DEHYDROGENASE 2, HSD3B2
21842,613891,URIDINE MONOPHOSPHATE SYNTHETASE, UMPS
21843,613892,DPY19-LIKE 1, DPY19L1
21844,613893,DPY19-LIKE 2, DPY19L2
21845,613894,DPY19-LIKE 3, DPY19L3
21846,613895,DPY19-LIKE 4, DPY19L4
21847,613896,BISPHOSPHOGLYCERATE MUTASE, BPGM
21848,613897,FANCF GENE, FANCF
21849,613898,3-HYDROXY-3-METHYLGLUTARYL-CoA LYASE, HMGCL
21850,613899,FANCC GENE, FANCC
21851,613900,TRANSGLUTAMINASE 6, TGM6
21852,613901,"RNA 2-PRIME,3-PRIME CYCLIC PHOSPHATE AND 5-PRIME-OH LIGASE", RTCB
21853,613902,ZINC FINGER PROTEIN 503, ZNF503
21854,613903,ZINC FINGER PROTEIN 540, ZNF540
21855,613904,ZINC FINGER PROTEIN 569, ZNF569
21856,613905,ZINC FINGER PROTEIN 606, ZNF606
21857,613906,ZINC FINGER PROTEIN 641, ZNF641
21858,613907,ZINC FINGER PROTEIN 652, ZNF652
21859,613908,SPINOCEREBELLAR ATAXIA 35, SCA35
21860,613909,SPINOCEREBELLAR ATAXIA 32, SCA32
21861,613910,ZINC FINGER PROTEIN 480, ZNF480
21862,613911,ZINC FINGER PROTEIN 496, ZNF496
21863,613912,COMPLEMENT FACTOR D DEFICIENCY, CFDD
21864,613913,"LIPODYSTROPHY, PARTIAL, ACQUIRED, WITH LOW COMPLEMENT COMPONENT C3, WITH OR WITHOUT GLOMERULONEPHRITIS", APLDC3
21865,613914,ZINC FINGER PROTEIN 746, ZNF746
21866,613915,ZINC FINGER- AND BTB DOMAIN-CONTAINING PROTEIN 42: ZBTB42,
21867,613916,"DEAFNESS, AUTOSOMAL RECESSIVE 89", DFNB89
21868,613917,MUCIN 22, MUC22
21869,613918,HLA COMPLEX GROUP 22, HCG22
21870,613919,KINESIN FAMILY MEMBER 6, KIF6
21871,613920,CYTOCHROME C OXIDASE ASSEMBLY FACTOR 5, COA5
21872,613921,"LIPASE FAMILY, MEMBER J", LIPJ
21873,613922,"LIPASE FAMILY, MEMBER K", LIPK
21874,613923,"LIPASE FAMILY, MEMBER M", LIPM
21875,613924,"LIPASE FAMILY, MEMBER N", LIPN
21876,613925,MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 2A, MLC2A
21877,613926,"MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 2B, REMITTING, WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT", MLC2B
21878,613927,COMPLEMENT COMPONENT 2, C2
21879,613928,MUCIN-LIKE 3, MUCL3
21880,613929,"SERINE PROTEASE INHIBITOR, KAZAL-TYPE, 4", SPINK4
21881,613930,ALOPECIA-INTELLECTUAL DISABILITY SYNDROME 3, APMR3
21882,613931,TARGET OF EGR1, TOE1
21883,613932,TNNI3-INTERACTING KINASE, TNNI3K
21884,613933,ACETYL-CoA CARBOXYLASE-ALPHA DEFICIENCY, ACACAD
21885,613934,TRANSMEMBRANE PROTEIN 25, TMEM25
21886,613935,TRANSMEMBRANE PROTEIN 74, TMEM74
21887,613936,TRANSMEMBRANE PROTEIN 102, TMEM102
21888,613937,TRANSMEMBRANE PROTEIN 184C, TMEM184C
21889,613938,"PARASOMNIA, SLEEPWALKING TYPE", PSMNSW
21890,613939,SPERMATOGENESIS-ASSOCIATED PROTEIN 20, SPATA20
21891,613940,AFG2 AAA ATPase HOMOLOG A, AFG2A
21892,613941,"SERINE PEPTIDASE INHIBITOR, KUNITZ-TYPE, 3", SPINT3
21893,613942,SAD1 AND UNC84 DOMAIN-CONTAINING PROTEIN 5, SUN5
21894,613943,"ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 8", ARCI8
21895,613944,"IgA NEPHROPATHY, SUSCEPTIBILITY TO, 2", IGAN2
21896,613945,"DNAJ/HSP40 HOMOLOG, SUBFAMILY C, MEMBER 5, BETA", DNAJC5B
21897,613946,"DNAJ/HSP40 HOMOLOG, SUBFAMILY C, MEMBER 5, GAMMA", DNAJC5G
21898,613947,SPERMATOGENESIS-ASSOCIATED PROTEIN 6, SPATA6
21899,613948,SPERMATOGENESIS-ASSOCIATED PROTEIN 8, SPATA8
21900,613949,OKT4 EPITOPE DEFICIENCY, OKT4D
21901,613950,SCHIZOPHRENIA 15, SCZD15
21902,613951,"FANCONI ANEMIA, COMPLEMENTATION GROUP P", FANCP
21903,613952,TERMINAL NUCLEOTIDYLTRANSFERASE 5C, TENT5C
21904,613953,IMMUNODEFICIENCY 51, IMD51
21905,613954,FRONTOTEMPORAL DEMENTIA AND/OR AMYOTROPHIC LATERAL SCLEROSIS 6, FTDALS6
21906,613955,"AMYLOIDOSIS, PRIMARY LOCALIZED CUTANEOUS, 2", PLCA2
21907,613956,"CANDIDIASIS, FAMILIAL, 6", CANDF6
21908,613957,SPERMATOGENIC FAILURE 8, SPGF8
21909,613958,SPERMATOGENIC FAILURE 9, SPGF9
21910,613959,SCHIZOPHRENIA 16, SCZD16
21911,613960,"GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, 3", CGD3
21912,613961,"TASTE RECEPTOR, TYPE 2, MEMBER 19", TAS2R19
21913,613962,"TASTE RECEPTOR, TYPE 2, MEMBER 20", TAS2R20
21914,613963,"TASTE RECEPTOR, TYPE 2, MEMBER 30", TAS2R30
21915,613964,"TASTE RECEPTOR, TYPE 2, MEMBER 40", TAS2R40
21916,613965,"TASTE RECEPTOR, TYPE 2, MEMBER 41", TAS2R41
21917,613966,"TASTE RECEPTOR, TYPE 2, MEMBER 42", TAS2R42
21918,613967,"TASTE RECEPTOR, TYPE 2, MEMBER 45", TAS2R45
21919,613968,"TASTE RECEPTOR, TYPE 2, MEMBER 60", TAS2R60
21920,613969,"MYOPIA 19, AUTOSOMAL DOMINANT", MYP19
21921,613970,"INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 6, WITH OR WITHOUT SEIZURES", MRD6
21922,613971,"EPILEPSY, FOCAL, WITH SPEECH DISORDER AND WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT",
21923,613972,"MELANOMA, CUTANEOUS MALIGNANT, SUSCEPTIBILITY TO, 6", CMM6
21924,613973,CYCLIC GMP-AMP SYNTHASE, CGAS
21925,613974,DExD/H-BOX HELICASE 60, DDX60
21926,613975,INTERFERON-INDUCED PROTEIN 44-LIKE, IFI44L
21927,613976,FANCE GENE, FANCE
21928,613977,"CYANOSIS, TRANSIENT NEONATAL", TNCY
21929,613978,HEMOGLOBIN H DISEASE, HBH
21930,613979,PRE-mRNA-PROCESSING FACTOR 6, PRPF6
21931,613980,"ATRIAL FIBRILLATION, FAMILIAL, 9", ATFB9
21932,613981,HYPOTRICHOSIS 3, HYPT3
21933,613982,"OSTEOGENESIS IMPERFECTA, TYPE VI", OI6
21934,613983,RETINITIS PIGMENTOSA 60, RP60
21935,613984,FANCD2 GENE, FANCD2
21936,613985,BETA-THALASSEMIA,
21937,613986,"PITUITARY HORMONE DEFICIENCY, COMBINED, 6", CPHD6
21938,613987,"DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 2", DKCB2
21939,613988,"DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 3", DKCB3
21940,613989,"DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 2", DKCA2
21941,613990,"DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 3", DKCA3
21942,613991,"CDC42-BINDING PROTEIN KINASE, GAMMA", CDC42BPG
21943,613992,"PROTEIN PHOSPHATASE 2, REGULATORY SUBUNIT B, DELTA", PPP2R2D
21944,613993,"MYOSIN, LIGHT CHAIN 7, REGULATORY", MYL7
21945,613994,"NEUROBLASTOMA BREAKPOINT FAMILY, MEMBER 4", NBPF4
21946,613995,"NEUROBLASTOMA BREAKPOINT FAMILY, MEMBER 5", NBPF5
21947,613996,"NEUROBLASTOMA BREAKPOINT FAMILY, MEMBER 6", NBPF6
21948,613997,"NEUROBLASTOMA BREAKPOINT FAMILY, MEMBER 7", NBPF7
21949,613998,"NEUROBLASTOMA BREAKPOINT FAMILY, MEMBER 8", NBPF8
21950,613999,"NEUROBLASTOMA BREAKPOINT FAMILY, MEMBER 9", NBPF9
21951,614000,"NEUROBLASTOMA BREAKPOINT FAMILY, MEMBER 10", NBPF10
21952,614001,"NEUROBLASTOMA BREAKPOINT FAMILY, MEMBER 11", NBPF11
21953,614002,"NEUROBLASTOMA BREAKPOINT FAMILY, MEMBER 12",
21954,614003,"NEUROBLASTOMA BREAKPOINT FAMILY, MEMBER 14", NBPF14
21955,614004,"NEUROBLASTOMA BREAKPOINT FAMILY, MEMBER 15",
21956,614005,"NEUROBLASTOMA BREAKPOINT FAMILY, MEMBER 15",
21957,614006,"NEUROBLASTOMA BREAKPOINT FAMILY, MEMBER 19", NBPF19
21958,614007,"NEUROBLASTOMA BREAKPOINT FAMILY, MEMBER 20", NBPF20
21959,614008,NESTOR-GUILLERMO PROGERIA SYNDROME, NGPS
21960,614009,"BLEEDING DISORDER, PLATELET-TYPE, 13, SUSCEPTIBILITY TO", BDPLT13
21961,614010,INOSITOL MONOPHOSPHATASE DOMAIN-CONTAINING PROTEIN 1, IMPAD1
21962,614011,"ENDOGENOUS RETROVIRUS GROUP K, MEMBER 4", ERVK-4
21963,614012,"ENDOGENOUS RETROVIRUS GROUP K, MEMBER 5", ERVK-5
21964,614013,"ENDOGENOUS RETROVIRUS GROUP K, MEMBER 7", ERVK-7
21965,614014,"RIBONUCLEASE A FAMILY, MEMBER 9, INACTIVE", RNASE9
21966,614015,"DIACYLGLYCEROL LIPASE, ALPHA", DAGLA
21967,614016,"DIACYLGLYCEROL LIPASE, BETA", DAGLB
21968,614017,"CILIARY DYSKINESIA, PRIMARY, 16", CILD16
21969,614018,"EPILEPSY, PROGRESSIVE MYOCLONIC, 6", EPM6
21970,614019,LISSENCEPHALY 4 WITH MICROCEPHALY, LIS4
21971,614020,"INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 14", MRT14
21972,614021,"VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 3", CPVT3
21973,614022,"ATRIAL FIBRILLATION, FAMILIAL, 10", ATFB10
21974,614023,PHOSPHOSERINE PHOSPHATASE DEFICIENCY, PSPHD
21975,614024,PROTEIN Z DEFICIENCY,
21976,614025,HEPATIC LIPASE DEFICIENCY,
21977,614026,KINESIN FAMILY MEMBER 26B, KIF26B
21978,614027,INSULINOMA-ASSOCIATED 2, INSM2
21979,614028,APOLIPOPROTEIN C-III DEFICIENCY,
21980,614029,"SPEEDY/RINGO CELL CYCLE REGULATOR FAMILY, MEMBER A", SPDYA
21981,614030,"SPEEDY/RINGO CELL CYCLE REGULATOR FAMILY, MEMBER C", SPDYC
21982,614031,RAN-BINDING PROTEIN 10, RANBP10
21983,614032,TOX HIGH MOBILITY GROUP BOX FAMILY MEMBER 4, TOX4
21984,614033,HYDROXYACYL GLUTATHIONE HYDROLASE DEFICIENCY,
21985,614034,HEME OXYGENASE 1 DEFICIENCY, HMOX1D
21986,614035,"DEAFNESS, AUTOSOMAL RECESSIVE 29", DFNB29
21987,614036,ALPHA-2-MACROGLOBULIN DEFICIENCY, A2MD
21988,614037,LEUKOTRIENE C4 SYNTHASE DEFICIENCY,
21989,614038,"LYMPHEDEMA, PRIMARY, WITH MYELODYSPLASIA",
21990,614039,"CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 1", CDCBM1
21991,614040,ZINC FINGER PROTEIN 467, ZNF467
21992,614041,RB TRANSCRIPTIONAL COREPRESSOR 1, RB1
21993,614042,MOYAMOYA DISEASE 5, MYMY5
21994,614043,LEUCINE-RICH REPEAT IN FLII-INTERACTING PROTEIN 2, LRRFIP2
21995,614044,TRYPSINOGEN DEFICIENCY,
21996,614045,"FAMILY WITH SEQUENCE SIMILARITY 129, MEMBER B", FAM129B
21997,614046,ARGININE- AND GLUTAMATE-RICH PROTEIN 1, ARGLU1
21998,614047,"METHYLENETETRAHYDROFOLATE DEHYDROGENASE 2-LIKE, NADP(+)-DEPENDENT", MTHFD2L
21999,614048,ENDOSOME-LYSOSOME-ASSOCIATED APOPTOSIS AND AUTOPHAGY REGULATOR 2, ELAPOR2
22000,614049,"ATRIAL FIBRILLATION, FAMILIAL, 11", ATFB11
22001,614050,"ATRIAL FIBRILLATION, FAMILIAL, 12", ATFB12
22002,614051,"CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIa",
22003,614052,"MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 2", MC5DN2
22004,614053,"MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 3", MC5DN3
22005,614054,"RIBOSOMAL MODIFICATION PROTEIN RimK-LIKE FAMILY, MEMBER B", RIMKLB
22006,614055,ACETYL-CoA ACETYLTRANSFERASE-2 DEFICIENCY, ACAT2D
22007,614056,"PROTEIN PHOSPHATASE 1, REGULATORY SUBUNIT 26", PPP1R26
22008,614057,MICRO RNA 409, MIR409
22009,614058,KETOHEXOKINASE, KHK
22010,614059,MICRO RNA 338, MIR338
22011,614060,HOXA DISTAL TRANSCRIPT ANTISENSE RNA, HOTTIP
22012,614061,OLFACTOMEDIN 4, OLFM4
22013,614062,"CDC42-BINDING PROTEIN KINASE, BETA", CDC42BPB
22014,614063,N-ACETYLASPARTATE DEFICIENCY, NACED
22015,614064,ZINC FINGER- AND BTB DOMAIN-CONTAINING PROTEIN 24, ZBTB24
22016,614065,"MYOPATHY, DISTAL, 4", MPD4
22017,614066,"SPASTIC PARAPLEGIA 47, AUTOSOMAL RECESSIVE", SPG47
22018,614067,"SPASTIC PARAPLEGIA 52, AUTOSOMAL RECESSIVE", SPG52
22019,614068,INTRAFLAGELLAR TRANSPORT 43, IFT43
22020,614069,IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 2, ICF2
22021,614070,"PSORIASIS 13, SUSCEPTIBILITY TO", PSORS13
22022,614071,MYOCARDIAL ZONULA ADHERENS PROTEIN, MYZAP
22023,614072,HERMANSKY-PUDLAK SYNDROME 3, HPS3
22024,614073,HERMANSKY-PUDLAK SYNDROME 4, HPS4
22025,614074,HERMANSKY-PUDLAK SYNDROME 5, HPS5
22026,614075,HERMANSKY-PUDLAK SYNDROME 6, HPS6
22027,614076,HERMANSKY-PUDLAK SYNDROME 7, HPS7
22028,614077,HERMANSKY-PUDLAK SYNDROME 8, HPS8
22029,614078,"CHONDRODYSPLASIA WITH JOINT DISLOCATIONS, GPAPP TYPE",
22030,614079,"ASPERGILLOSIS, SUSCEPTIBILITY TO",
22031,614080,MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 1, MCAHS1
22032,614081,ANHAPTOGLOBINEMIA, AHP
22033,614082,"FANCONI ANEMIA, COMPLEMENTATION GROUP G", FANCG
22034,614083,"FANCONI ANEMIA, COMPLEMENTATION GROUP L", FANCL
22035,614084,WEE1 HOMOLOG 2, WEE2
22036,614085,"RAD9-, RAD1-, AND HUS1-INTERACTING NUCLEAR ORPHAN 1", RHNO1
22037,614086,MULTICILIATE DIFFERENTIATION AND DNA SYNTHESIS-ASSOCIATED CELL CYCLE PROTEIN, MCIDAS
22038,614087,"FANCONI ANEMIA, COMPLEMENTATION GROUP A",
22039,614088,INTRACELLULAR ADHESION MOLECULE 4, ICAM4
22040,614089,ATRIAL SEPTAL DEFECT 3, ASD3
22041,614090,"SICK SINUS SYNDROME 3, SUSCEPTIBILITY TO", SSS3
22042,614091,SHORT-RIB THORACIC DYSPLASIA 7 WITH OR WITHOUT POLYDACTYLY, SRTD7
22043,614092,RAB-INTERACTING LYSOSOMAL PROTEIN-LIKE 1, RILPL1
22044,614093,RAB-INTERACTING LYSOSOMAL PROTEIN-LIKE 2, RILPL2
22045,614094,MARVEL DOMAIN-CONTAINING PROTEIN 3, MARVELD3
22046,614095,"PHOSPHOENOLPYRUVATE CARBOXYKINASE 2, MITOCHONDRIAL", PCK2
22047,614096,COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 8, COXPD8
22048,614097,ACATALASEMIA,
22049,614098,KEPPEN-LUBINSKY SYNDROME, KPLBS
22050,614099,CRANIOECTODERMAL DYSPLASIA 3, CED3
22051,614100,"CUTIS LAXA, NEONATAL, WITH MARFANOID PHENOTYPE",
22052,614101,PLASMA FIBRONECTIN DEFICIENCY,
22053,614102,IMMUNOGLOBULIN KAPPA LIGHT CHAIN DEFICIENCY, IGKCD
22054,614103,LIPEDEMA,
22055,614104,"INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 7", MRD7
22056,614105,METHYLMALONATE SEMIALDEHYDE DEHYDROGENASE DEFICIENCY, MMSDHD
22057,614106,MUSCULAR LMNA-INTERACTING PROTEIN, MLIP
22058,614107,KARYOPHERIN ALPHA-7, KPNA7
22059,614108,"BPI FOLD-CONTAINING PROTEIN, FAMILY B, MEMBER 2", BPIFB2
22060,614109,"BPI FOLD-CONTAINING PROTEIN, FAMILY C", BPIFC
22061,614110,"BPI FOLD-CONTAINING PROTEIN, FAMILY B, MEMBER 6", BPIFB6
22062,614111,PYRUVATE DEHYDROGENASE E1-BETA DEFICIENCY, PDHBD
22063,614112,MICRO RNA 320A, MIR320A
22064,614113,"INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 2", MRD2
22065,614114,MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 2, MVA2
22066,614115,"CORTICAL MALFORMATIONS, OCCIPITAL", OCCM
22067,614116,"NEUROPATHY, HEREDITARY SENSORY, TYPE IE", HSN1E
22068,614117,EXOCYST COMPLEX COMPONENT 3-LIKE 1, EXOC3L1
22069,614118,TEASHIRT ZINC FINGER HOMEOBOX 2, TSHZ2
22070,614119,TEASHIRT ZINC FINGER HOMEOBOX 3, TSHZ3
22071,614120,HYDROLETHALUS SYNDROME 2, HLS2
22072,614121,TERMINAL NUCLEOTIDYLTRANSFERASE 2, TENT2
22073,614122,CHITOTRIOSIDASE DEFICIENCY, CHITD
22074,614123,TRANSMEMBRANE AND COILED-COIL DOMAINS PROTEIN 1, TMCO1
22075,614124,GLYCEROPHOSPHOCHOLINE PHOSPHODIESTERASE 1, GPCPD1
22076,614125,DEVELOPMENTAL PLURIPOTENCY-ASSOCIATED GENE 4, DPPA4
22077,614126,MITOCHONDRIAL AMIDOXIME-REDUCING COMPONENT 1, MTARC1
22078,614127,MITOCHONDRIAL AMIDOXIME-REDUCING COMPONENT 2, MTARC2
22079,614128,LACTATE DEHYDROGENASE B DEFICIENCY, LDHBD
22080,614129,PERRAULT SYNDROME 3, PRLTS3
22081,614130,"ADENOSINE DEAMINASE DOMAIN-CONTAINING PROTEIN 1, TESTIS-SPECIFIC", ADAD1
22082,614131,FOCAL SEGMENTAL GLOMERULOSCLEROSIS 6, FSGS6
22083,614132,"CRANIOFACIAL DYSMORPHISM, SKELETAL ANOMALIES, AND IMPAIRED INTELLECTUAL DEVELOPMENT SYNDROME 1",
22084,614133,HEPACAM FAMILY MEMBER 2, HEPACAM2
22085,614134,"STICKLER SYNDROME, TYPE IV", STL4
22086,614135,"EPIPHYSEAL DYSPLASIA, MULTIPLE, 6", EDM6
22087,614136,"TRAFFICKING PROTEIN PARTICLE COMPLEX, SUBUNIT 8", TRAPPC8
22088,614137,"TRAFFICKING PROTEIN PARTICLE COMPLEX, SUBUNIT 3-LIKE", TRAPPC3L
22089,614138,"TRAFFICKING PROTEIN PARTICLE COMPLEX, SUBUNIT 11", TRAPPC11
22090,614139,"TRAFFICKING PROTEIN PARTICLE COMPLEX, SUBUNIT 12", TRAPPC12
22091,614140,SPERM ANTIGEN WITH CALPONIN HOMOLOGY AND COILED-COIL DOMAINS 1-LIKE, SPECC1L
22092,614141,TRIPARTITE MOTIF-CONTAINING PROTEIN 2, TRIM2
22093,614142,CUE DOMAIN-CONTAINING PROTEIN 2, CUEDC2
22094,614143,IGF-LIKE FAMILY RECEPTOR 1, IGFLR1
22095,614144,B9 DOMAIN-CONTAINING PROTEIN 1, B9D1
22096,614145,COILED-COIL DOMAIN-CONTAINING PROTEIN 8, CCDC8
22097,614146,"DYNEIN, AXONEMAL, ASSEMBLY FACTOR 9", DNAAF9
22098,614147,C1q- AND TUMOR NECROSIS FACTOR-RELATED PROTEIN 8, C1QTNF8
22099,614148,C1q- AND TUMOR NECROSIS FACTOR-RELATED PROTEIN 9B, C1QTNF9B
22100,614149,"NAIL DISORDER, NONSYNDROMIC CONGENITAL, 9", NDNC9
22101,614150,"PROTEIN KINASE DOMAIN-CONTAINING PROTEIN, CYTOPLASMIC", PKDCC
22102,614151,RING FINGER AND WD REPEAT DOMAINS-CONTAINING PROTEIN 3, RFWD3
22103,614152,"DEAFNESS, AUTOSOMAL DOMINANT 64", DFNA64
22104,614153,SPINOCEREBELLAR ATAXIA 36, SCA36
22105,614154,NOP56 RIBONUCLEAR PROTEIN, NOP56
22106,614155,MICRO RNA 1292, MIR1292
22107,614156,HYPERBILIVERDINEMIA, HBLVD
22108,614157,"NAIL DISORDER, NONSYNDROMIC CONGENITAL, 1",
22109,614158,"BLEEDING DISORDER, PLATELET-TYPE, 14", BDPLT14
22110,614159,ZINC FINGER PROTEIN 644, ZNF644
22111,614160,MUSCLE HYPERTROPHY, MSLHP
22112,614161,PR DOMAIN-CONTAINING PROTEIN 5, PRDM5
22113,614162,IMMUNODEFICIENCY 31C, IMD31C
22114,614163,"DELAYED SLEEP PHASE DISORDER, SUSCEPTIBILITY TO", DSPD
22115,614164,GLUTATHIONE PEROXIDASE DEFICIENCY, GPXD
22116,614165,PHEOCHROMOCYTOMA/PARAGANGLIOMA SYNDROME 5, PPGL5
22117,614166,"MYOPIA 20, AUTOSOMAL DOMINANT", MYP20
22118,614167,"MYOPIA 21, AUTOSOMAL DOMINANT", MYP21
22119,614168,"PHOSPHOENOLPYRUVATE CARBOXYKINASE 1, SOLUBLE", PCK1
22120,614169,NEUROBEACHIN-LIKE 2, NBEAL2
22121,614170,BRITTLE CORNEA SYNDROME 2, BCS2
22122,614171,HERMANSKY-PUDLAK SYNDROME 9, HPS9
22123,614172,IMMUNODEFICIENCY 21, IMD21
22124,614173,JOUBERT SYNDROME 13, JBTS13
22125,614174,MEIOSIS/SPERMIOGENESIS-ASSOCIATED PROTEIN 1, MEIG1
22126,614175,"MECKEL SYNDROME, TYPE 10", MKS10
22127,614176,ZINC FINGER FYVE DOMAIN-CONTAINING PROTEIN 28, ZFYVE28
22128,614177,EF-HAND CALCIUM-BINDING DOMAIN-CONTAINING PROTEIN 4A, EFCAB4A
22129,614178,CALCIUM RELEASE-ACTIVATED CALCIUM CHANNEL REGULATOR 2A, CRACR2A
22130,614179,IMMUNOGLOBULIN SUPERFAMILY CONTAINING LEUCINE-RICH REPEAT 2, ISLR2
22131,614180,RETINITIS PIGMENTOSA 61, RP61
22132,614181,RETINITIS PIGMENTOSA 62, RP62
22133,614182,HEART DEVELOPMENT PROTEIN WITH EGF-LIKE DOMAINS 1, HEG1
22134,614183,DIS3-LIKE EXOSOME 3-PRIME-5-PRIME EXORIBONUCLEASE, DIS3L
22135,614184,DIS3-LIKE 3-PRIME-5-PRIME EXORIBONUCLEASE 2, DIS3L2
22136,614185,GELEOPHYSIC DYSPLASIA 2, GPHYSD2
22137,614186,LEBER CONGENITAL AMAUROSIS 16, LCA16
22138,614187,"HYPERTELORISM, PREAURICULAR SINUS, PUNCTAL PITS, AND DEAFNESS", HPPD
22139,614188,CRANIOSYNOSTOSIS AND DENTAL ANOMALIES, CRSDA
22140,614189,"GOLGIN A7 FAMILY, MEMBER B", GOLGA7B
22141,614190,"PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 3", PPNAD3
22142,614191,DEP DOMAIN-CONTAINING PROTEIN 5, DEPDC5
22143,614192,"CHROMOSOME 17q11.2 DELETION SYNDROME, 1.4-MB",
22144,614193,TRANSFERRIN SERUM LEVEL QUANTITATIVE TRAIT LOCUS 2, TFQTL2
22145,614194,DEDICATOR OF CYTOKINESIS 6, DOCK6
22146,614195,CRANIOFACIAL ANOMALIES AND ANTERIOR SEGMENT DYSGENESIS SYNDROME, CAASDS
22147,614196,"NEPHROTIC SYNDROME, TYPE 6", NPHS6
22148,614197,MITOCHONDRIAL CALCIUM UNIPORTER, MCU
22149,614198,"MYASTHENIC SYNDROME, CONGENITAL, 16", CMS16
22150,614199,"NEPHROTIC SYNDROME, TYPE 5, WITH OR WITHOUT OCULAR ABNORMALITIES", NPHS5
22151,614200,"BLEEDING DISORDER, PLATELET-TYPE, 9", BDPLT9
22152,614201,"BLEEDING DISORDER, PLATELET-TYPE, 11", BDPLT11
22153,614202,RAFIQ SYNDROME, RAFQS
22154,614203,PARKINSON DISEASE 17, PARK17
22155,614204,"PSORIASIS 14, PUSTULAR", PSORS14
22156,614205,THREE M SYNDROME 3, 3M3
22157,614206,CHROMATIN TARGET OF PRMT1, CHTOP
22158,614207,HYPERPHOSPHATASIA WITH IMPAIRED INTELLECTUAL DEVELOPMENT SYNDROME 3, HPMRS3
22159,614208,"INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 16", MRT16
22160,614209,"MECKEL SYNDROME, TYPE 9", MKS9
22161,614210,LUNG CANCER SUSCEPTIBILITY 5, LNCR5
22162,614211,"DEAFNESS, AUTOSOMAL DOMINANT 33", DFNA33
22163,614212,"ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 4", IIAE4
22164,614213,"NEUROPATHY, HEREDITARY SENSORY, TYPE IIC", HSN2C
22165,614214,KELCH-LIKE 6, KLHL6
22166,614215,"ACTIVATING SIGNAL COINTEGRATOR 1 COMPLEX, SUBUNIT 1", ASCC1
22167,614216,"ACTIVATING SIGNAL COINTEGRATOR 1 COMPLEX, SUBUNIT 2", ASCC2
22168,614217,"ACTIVATING SIGNAL COINTEGRATOR 1 COMPLEX, SUBUNIT 3", ASCC3
22169,614218,WD REPEAT-CONTAINING PROTEIN 81, WDR81
22170,614219,ADAMS-OLIVER SYNDROME 2, AOS2
22171,614220,"BILIARY CIRRHOSIS, PRIMARY, 4", PBC4
22172,614221,"BILIARY CIRRHOSIS, PRIMARY, 5", PBC5
22173,614222,WARBURG MICRO SYNDROME 3, WARBM3
22174,614223,"NARCOLEPSY 6, SUSCEPTIBILITY TO", NRCLP6
22175,614224,RETINAL ARTERIAL MACROANEURYSM WITH SUPRAVALVULAR PULMONIC STENOSIS, RAMSVPS
22176,614225,WARBURG MICRO SYNDROME 2, WARBM2
22177,614226,HOLOPROSENCEPHALY 11, HPE11
22178,614227,"HYPERURICEMIC NEPHROPATHY, FAMILIAL JUVENILE, 3", HNFJ3
22179,614228,"CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2O", CMT2O
22180,614229,"SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 11", SCAR11
22181,614230,CHROMOSOME 8q21.11 DELETION SYNDROME,
22182,614231,"MICROCEPHALY, EPILEPSY, AND DIABETES SYNDROME 1", MEDS1
22183,614232,"11-BETA-HYDROXYSTEROID DEHYDROGENASE, TYPE II", HSD11B2
22184,614233,"HYPERPIGMENTATION, FAMILIAL PROGRESSIVE, 1", FPH1
22185,614234,PRIMARY CILIA FORMATION, PIFO
22186,614235,PDZ DOMAIN-CONTAINING PROTEIN 8, PDZD8
22187,614236,"SOLUTE CARRIER FAMILY 38 (AMINO ACID TRANSPORTER), MEMBER 7", SLC38A7
22188,614237,HYPOTRICHOSIS 9, HYPT9
22189,614238,HYPOTRICHOSIS 10, HYPT10
22190,614239,PH DOMAIN-CONTAINING ENDOCYTIC TRAFFICKING ADAPTOR 1, PHETA1
22191,614240,PH DOMAIN-CONTAINING ENDOCYTIC TRAFFICKING ADAPTOR 2, PHETA2
22192,614241,LYSOCARDIOLIPIN ACYLTRANSFERASE 1, LCLAT1
22193,614242,"SOLUTE CARRIER FAMILY 16 (MONOCARBOXYLIC ACID TRANSPORTER), MEMBER 9", SLC16A9
22194,614243,5-OXOPROLINASE (ATP-HYDROLYZING), OPLAH
22195,614244,PYRIDOXAL-DEPENDENT DECARBOXYLASE DOMAIN-CONTAINING PROTEIN 1, PDXDC1
22196,614245,"ACYL-CoA SYNTHETASE FAMILY, MEMBER 3", ACSF3
22197,614246,"N-ALPHA-ACETYLTRANSFERASE 60, NatF CATALYTIC SUBUNIT", NAA60
22198,614247,MICRO RNA 519D, MIR519D
22199,614248,PEAK FAMILY MEMBER 1, PEAK1
22200,614249,"INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 18, WITH OR WITHOUT EPILEPSY", MRT18
22201,614250,NARCOLEPSY 7, NRCLP7
22202,614251,"PARKINSON DISEASE 18, AUTOSOMAL DOMINANT, SUSCEPTIBILITY TO", PARK18
22203,614252,"ANEURYSM, INTRACRANIAL BERRY, 11", ANIB11
22204,614253,"AMELOGENESIS IMPERFECTA, TYPE IG",
22205,614254,"NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL DOMINANT", NDHMSD
22206,614255,NESCAV SYNDROME, NESCAVS
22207,614256,"INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 10", MRD10
22208,614257,CHROMOSOME 20q11-q12 DELETION SYNDROME,
22209,614258,"POLYMERASE III, RNA, SUBUNIT A", POLR3A
22210,614259,CILIA- AND FLAGELLA-ASSOCIATED PROTEIN 57, CFAP57
22211,614260,CHROMOSOME 9 OPEN READING FRAME 72, C9ORF72
22212,614261,MICROCEPHALY-CAPILLARY MALFORMATION SYNDROME, MICCAP
22213,614262,"ARTHROGRYPOSIS, PERTHES DISEASE, AND UPWARD GAZE PALSY", APUG
22214,614263,BACE1 ANTISENSE RNA: BACE1AS,
22215,614264,RHO GTPase-ACTIVATING PROTEIN 30, ARHGAP30
22216,614265,COMBINED MALONIC AND METHYLMALONIC ACIDURIA, CMAMMA
22217,614266,BARRETT ESOPHAGUS,
22218,614267,ACYL-CoA THIOESTERASE 6, ACOT6
22219,614268,ADHESION G PROTEIN-COUPLED RECEPTOR F4, ADGRF4
22220,614269,G PROTEIN-COUPLED RECEPTOR 153, GPR153
22221,614270,CILIA- AND FLAGELLA-ASSOCIATED PROTEIN 65, CFAP65
22222,614271,COILED-COIL DOMAIN-CONTAINING PROTEIN 137, CCDC137
22223,614272,FAST KINASE DOMAINS 5, FASTKD5
22224,614273,"OLFACTORY RECEPTOR, FAMILY 4, SUBFAMILY C, MEMBER 46", OR4C46
22225,614274,"STRAWBERRY NOTCH, DROSOPHILA, HOMOLOG OF, 1", SBNO1
22226,614275,ZINC FINGER PROTEIN 565, ZNF565
22227,614276,PHOSPHOLIPASE C-LIKE 2, PLCL2
22228,614277,UBIQUITIN-CONJUGATING ENZYME E2 W, UBE2W
22229,614278,PLATELET-ACTIVATING FACTOR ACETYLHYDROLASE DEFICIENCY, PAFAD
22230,614279,"46,XY SEX REVERSAL 8", SRXY8
22231,614280,"EPILEPSY, JUVENILE MYOCLONIC, SUSCEPTIBILITY TO, 9", EJM9
22232,614281,ENDOTHELIAL CELL ADHESION MOLECULE, ESAM
22233,614282,STROMAL CELL-DERIVED FACTOR 4, SDF4
22234,614283,GLUCOCORTICOID-INDUCED TRANSCRIPT 1, GLCCI1
22235,614284,"STICKLER SYNDROME, TYPE V", STL5
22236,614285,C1q- AND TUMOR NECROSIS FACTOR-RELATED PROTEIN 9, C1QTNF9
22237,614286,MYELODYSPLASTIC SYNDROME, MDS
22238,614287,OFC1 CANDIDATE GENE 1, OFCC1
22239,614288,"ACYL-CoA DEHYDROGENASE FAMILY, MEMBER 11", ACAD11
22240,614289,SUPPRESSOR OF LIN12-LIKE 2, SEL1L2
22241,614290,TETRASOMY 18p,
22242,614291,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 4", BROVCA4
22243,614292,"MYOPIA, HIGH, WITH CATARACT AND VITREORETINAL DEGENERATION", MCVD
22244,614293,"HYDATIDIFORM MOLE, RECURRENT, 2", HYDM2
22245,614294,CHROMOSOME 15q25 DELETION SYNDROME,
22246,614295,BICC FAMILY RNA-BINDING PROTEIN 1, BICC1
22247,614296,"WOLFRAM-LIKE SYNDROME, AUTOSOMAL DOMINANT", WFSL
22248,614297,CHROMOSOME 19 OPEN READING FRAME 12, C19ORF12
22249,614298,NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 4, NBIA4
22250,614299,MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 2 WITH HYPERGLYCINEMIA, MMDS2
22251,614300,HYPERMETHIONINEMIA DUE TO ADENOSINE KINASE DEFICIENCY,
22252,614301,ATAXIN 1-LIKE, ATXN1L
22253,614302,"EMERY-DREIFUSS MUSCULAR DYSTROPHY 7, AUTOSOMAL DOMINANT", EDMD7
22254,614303,EDICT SYNDROME, EDICT
22255,614304,MICRO RNA 137, MIR137
22256,614305,SCLEROSTEOSIS 2, SOST2
22257,614306,COGNITIVE IMPAIRMENT WITH OR WITHOUT CEREBELLAR ATAXIA, CIAT
22258,614307,ALPHA-METHYLACYL-CoA RACEMASE DEFICIENCY, AMACRD
22259,614308,FORMIMINOTRANSFERASE CYCLODEAMINASE N-TERMINAL-LIKE PROTEIN 1, FTCDNL1
22260,614309,tRNA METHYLTRANSFERASE 44 HOMOLOG, TRMT44
22261,614310,"CENTROSOMAL PROTEIN, 70-KD", CEP70
22262,614311,SYNAPSE DIFFERENTIATION-INDUCED GENE 1, SYNDIG1
22263,614312,ZINC FINGER MYND-CONTAINING PROTEIN 15, ZMYND15
22264,614313,ACYL-CoA THIOESTERASE 1, ACOT1
22265,614314,ACYL-CoA THIOESTERASE 4, ACOT4
22266,614315,ACYL-CoA THIOESTERASE 12, ACOT12
22267,614316,VESICLE TRANSPORT THROUGH INTERACTION WITH T-SNARES 1A, VTI1A
22268,614317,VESICOURETERAL REFLUX 4, VUR4
22269,614318,VESICOURETERAL REFLUX 5, VUR5
22270,614319,VESICOURETERAL REFLUX 6, VUR6
22271,614320,"PANCREATIC CANCER, SUSCEPTIBILITY TO, 4", PNCA4
22272,614321,"MYOPATHY, DISTAL, TATEYAMA TYPE", MPDT
22273,614322,"SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 12", SCAR12
22274,614323,"NEVOID HYPERMELANOSIS, LINEAR AND WHORLED", LWNH
22275,614324,OVARIAN DYSGENESIS 3, ODG3
22276,614325,PITT-HOPKINS-LIKE SYNDROME 2, PTHSL2
22277,614326,FEINGOLD SYNDROME 2, FGLDS2
22278,614327,TUMOR PREDISPOSITION SYNDROME 1, TPDS1
22279,614328,"INFLAMMATORY SKIN AND BOWEL DISEASE, NEONATAL, 1", NISBD1
22280,614329,"INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 31", MRT31
22281,614330,"COMPLEMENT COMPONENT 1, q SUBCOMPONENT-LIKE 2", C1QL2
22282,614331,"COLORECTAL CANCER, HEREDITARY NONPOLYPOSIS, TYPE 6", HNPCC6
22283,614332,CHROMOSOME 2p16.3 DELETION SYNDROME,
22284,614333,"INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 29", MRT29
22285,614334,"DNAJ/HSP40 HOMOLOG, SUBFAMILY C, MEMBER 13", DNAJC13
22286,614335,"ARTHROGRYPOSIS, DISTAL, TYPE 1B", DA1B
22287,614336,PRESEQUENCE TRANSLOCASE-ASSOCIATED MOTOR 16, PAM16
22288,614337,LYNCH SYNDROME 4, LYNCH4
22289,614338,PANCREATIC LIPASE DEFICIENCY, PNLIPD
22290,614339,"PONTOCEREBELLAR HYPOPLASIA, TYPE 1A",
22291,614340,"INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 27", MRT27
22292,614341,"INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 33", MRT33
22293,614342,"INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 30", MRT30
22294,614343,"INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 19", MRT19
22295,614344,"INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 23", MRT23
22296,614345,"INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 24", MRT24
22297,614346,"INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 25", MRT25
22298,614347,"INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 28", MRT28
22299,614348,ANDROGEN-DEPENDENT TFPI-REGULATING PROTEIN, ADTRP
22300,614349,ZINC FINGER PROTEIN 638, ZNF638
22301,614350,LYNCH SYNDROME 5, LYNCH5
22302,614351,"NUCLEOPORIN, 93-KD", NUP93
22303,614352,"NUCLEOPORIN, 205-KD", NUP205
22304,614353,HAS2 ANTISENSE RNA 1, HAS2AS1
22305,614354,PRO2268 GENE,
22306,614355,"ACYL-CoA SYNTHETASE SHORT CHAIN FAMILY, MEMBER 1", ACSS1
22307,614356,"ACYL-CoA SYNTHETASE SHORT CHAIN FAMILY, MEMBER 3", ACSS3
22308,614357,"ACYL-CoA SYNTHETASE MEDIUM CHAIN FAMILY, MEMBER 1", ACSM1
22309,614358,"ACYL-CoA SYNTHETASE MEDIUM CHAIN FAMILY, MEMBER 2A", ACSM2A
22310,614359,"ACYL-CoA SYNTHETASE MEDIUM CHAIN FAMILY, MEMBER 2B", ACSM2B
22311,614360,"ACYL-CoA SYNTHETASE MEDIUM CHAIN FAMILY, MEMBER 4", ACSM4
22312,614361,"ACYL-CoA SYNTHETASE MEDIUM CHAIN FAMILY, MEMBER 5", ACSM5
22313,614362,"ACYL-CoA SYNTHETASE, BUBBLEGUM FAMILY, MEMBER 1", ACSBG1
22314,614363,"ACYL-CoA SYNTHETASE, BUBBLEGUM FAMILY, MEMBER 2", ACSBG2
22315,614364,ACETOACETYL-CoA SYNTHETASE, AACS
22316,614365,AMINOADIPATE-SEMIALDEHYDE DEHYDROGENASE, AASDH
22317,614366,"POLYMERASE III, RNA, SUBUNIT B", POLR3B
22318,614367,"ADAPTOR-RELATED PROTEIN COMPLEX 5, BETA-1 SUBUNIT", AP5B1
22319,614368,"ADAPTOR-RELATED PROTEIN COMPLEX 5, MU-1 SUBUNIT", AP5M1
22320,614369,"PERIPHERAL NEUROPATHY, MYOPATHY, HOARSENESS, AND HEARING LOSS", PNMHH
22321,614370,"SURFACTANT METABOLISM DYSFUNCTION, PULMONARY, 5", SMDP5
22322,614371,"DENGUE VIRUS, SUSCEPTIBILITY TO",
22323,614372,MANNOSE-BINDING LECTIN DEFICIENCY, MBLD
22324,614373,"AMYOTROPHIC LATERAL SCLEROSIS 16, JUVENILE", ALS16
22325,614374,"BLOOD GROUP, CHIDO/RODGERS SYSTEM",
22326,614375,"AORTIC ANEURYSM, FAMILIAL ABDOMINAL, 4", AAA4
22327,614376,SHORT-RIB THORACIC DYSPLASIA 5 WITH OR WITHOUT POLYDACTYLY, SRTD5
22328,614377,NEPHRONOPHTHISIS 13, NPHP13
22329,614378,CRANIOECTODERMAL DYSPLASIA 4, CED4
22330,614379,COMPLEMENT COMPONENT 4B DEFICIENCY, C4BD
22331,614380,COMPLEMENT COMPONENT 4A DEFICIENCY, C4AD
22332,614381,"LEUKODYSTROPHY, HYPOMYELINATING, 8, WITH OR WITHOUT OLIGODONTIA AND/OR HYPOGONADOTROPIC HYPOGONADISM", HLD8
22333,614382,"BACTEREMIA, SUSCEPTIBILITY TO, 1", BACTS1
22334,614383,"BACTEREMIA, SUSCEPTIBILITY TO, 2", BACTS2
22335,614384,MICRO RNA 492, MIR492
22336,614385,"COLORECTAL CANCER, HEREDITARY NONPOLYPOSIS, TYPE 7", HNPCC7
22337,614386,PROLINE-RICH TRANSMEMBRANE PROTEIN 2, PRRT2
22338,614387,ZINC FINGER PROTEIN 526, ZNF526
22339,614388,ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 1, EMPF1
22340,614389,"PREGNANCY LOSS, RECURRENT, SUSCEPTIBILITY TO, 1", RPRGL1
22341,614390,"PREGNANCY LOSS, RECURRENT, SUSCEPTIBILITY TO, 2", RPRGL2
22342,614391,"PREGNANCY LOSS, RECURRENT, SUSCEPTIBILITY TO, 3", RPRGL3
22343,614392,TUDOR DOMAIN-CONTAINING PROTEIN 3, TDRD3
22344,614393,O-ACYL-ADP-RIBOSE DEACYLASE 1, OARD1
22345,614394,INTRAFLAGELLAR TRANSPORT 20, IFT20
22346,614395,"GRAFT-VERSUS-HOST DISEASE, SUSCEPTIBILITY TO", GVHDS
22347,614396,G-PATCH DOMAIN-CONTAINING PROTEIN 8, GPATCH8
22348,614397,MAJOR FACILITATOR SUPERFAMILY DOMAIN-CONTAINING PROTEIN 2A, MFSD2A
22349,614398,JUNCTIONAL CADHERIN 5-ASSOCIATED PROTEIN, JCAD
22350,614399,"CONGENITAL MYOPATHY 10A, SEVERE VARIANT", CMYO10A
22351,614400,"GLUCOCORTICOID THERAPY, RESPONSE TO", GCTR
22352,614401,"ACCELERATED TUMOR FORMATION, SUSCEPTIBILITY TO", ACTFS
22353,614402,"MICROPHTHALMIA, SYNDROMIC 11", MCOPS11
22354,614403,RHOMBOID 5 HOMOLOG 1, RHBDF1
22355,614404,RHOMBOID 5 HOMOLOG 2, RHBDF2
22356,614405,DEAH-BOX HELICASE 33, DHX33
22357,614406,SLP ADAPTOR- AND CSK-INTERACTING MEMBRANE PROTEIN, SCIMP
22358,614407,"MICROCEPHALY, CEREBELLAR HYPOPLASIA, AND CARDIAC CONDUCTION DEFECT SYNDROME", MCHCCD
22359,614408,"MYOPATHY, CENTRONUCLEAR, 1",
22360,614409,"SPASTIC PARAPLEGIA 46, AUTOSOMAL RECESSIVE", SPG46
22361,614410,ACTIN FILAMENT-ASSOCIATED PROTEIN 1-LIKE 1, AFAP1L1
22362,614411,GLYCEROL QUANTITATIVE TRAIT LOCUS, GLYCQTL
22363,614412,TESTIS- AND OVARY-SPECIFIC PAZ DOMAIN-CONTAINING PROTEIN 1, TOPAZ1
22364,614413,AMINOACYLASE 3, ACY3
22365,614414,"DEAFNESS, AUTOSOMAL RECESSIVE 96", DFNB96
22366,614415,CHILBLAIN LUPUS 2, CHBL2
22367,614416,RADIOHUMERAL FUSIONS WITH OTHER SKELETAL AND CRANIOFACIAL ANOMALIES, RHFCA
22368,614417,"EPILEPSY, FAMILIAL TEMPORAL LOBE, 5", ETL5
22369,614418,"FEBRILE SEIZURES, FAMILIAL, 11", FEB11
22370,614419,"ASPARTATE AMINOTRANSFERASE, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 1",
22371,614420,SYSTEMIC LUPUS ERYTHEMATOSUS 16, SLEB16
22372,614421,WEAVER SYNDROME,
22373,614422,CATARACT 37, CTRCT37
22374,614423,TRANSMEMBRANE PROTEIN 237, TMEM237
22375,614424,JOUBERT SYNDROME 14, JBTS14
22376,614425,TELO2-INTERACTING PROTEIN 1, TTI1
22377,614426,TELO2-INTERACTING PROTEIN 2, TTI2
22378,614427,TEASHIRT ZINC FINGER HOMEOBOX 1, TSHZ1
22379,614428,TRANSCRIPTION FACTOR AP2-EPSILON, TFAP2E
22380,614429,VENTRICULAR SEPTAL DEFECT 1, VSD1
22381,614430,ATRIOVENTRICULAR SEPTAL DEFECT 4, AVSD4
22382,614431,VENTRICULAR SEPTAL DEFECT 2, VSD2
22383,614432,VENTRICULAR SEPTAL DEFECT 3, VSD3
22384,614433,ATRIAL SEPTAL DEFECT 8, ASD8
22385,614434,"CUTIS LAXA, AUTOSOMAL DOMINANT 2", ADCL2
22386,614435,HYPOPLASTIC LEFT HEART SYNDROME 2, HLHS2
22387,614436,"CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2P", CMT2P
22388,614437,"CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IB", ARCL1B
22389,614438,"CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIIB", ARCL3B
22390,614439,ADP-RIBOSYLATION FACTOR-LIKE GTPase 14, ARL14
22391,614440,PLECKSTRIN AND SEC7 DOMAINS-CONTAINING PROTEIN 3, PSD3
22392,614441,PHOAR2-ENTEROPATHY SYNDROME, PHOAR2E
22393,614442,PLECKSTRIN AND SEC7 DOMAINS-CONTAINING PROTEIN 4, PSD4
22394,614443,EBNA1-BINDING PROTEIN 2, EBNA1BP2
22395,614444,RAL GUANINE NUCLEOTIDE EXCHANGE FACTOR WITH PH DOMAIN AND SH3 DOMAIN-BINDING MOTIF 1, RALGPS1
22396,614445,DEVELOPMENTAL PLURIPOTENCY-ASSOCIATED GENE 2, DPPA2
22397,614446,"ATPase, CLASS II, TYPE 9B", ATP9B
22398,614447,G0/G1 SWITCH GENE 2, G0S2
22399,614448,GEMININ COILED-COIL DOMAIN-CONTAINING PROTEIN, GMNC
22400,614449,PROTOCADHERIN 20, PCDH20
22401,614450,"HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 6", CHNG6
22402,614451,ELONGATION OF VERY LONG CHAIN FATTY ACIDS-LIKE 7, ELOVL7
22403,614452,"ATPase FAMILY, AAA DOMAIN-CONTAINING, MEMBER 1", ATAD1
22404,614453,LEUCINE-RICH REPEAT-CONTAINING PROTEIN 7, LRRC7
22405,614454,UBIQUITIN PROTEIN LIGASE E3C, UBE3C
22406,614455,"CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE E", CMTDIE
22407,614456,"MELANOMA, CUTANEOUS MALIGNANT, SUSCEPTIBILITY TO, 8", CMM8
22408,614457,"ICHTHYOSIS, SPASTIC QUADRIPLEGIA, AND IMPAIRED INTELLECTUAL DEVELOPMENT", ISQMR
22409,614458,THIAMINE METABOLISM DYSFUNCTION SYNDROME 5 (EPISODIC ENCEPHALOPATHY TYPE), THMD5
22410,614459,TRANSMEMBRANE PROTEIN 138, TMEM138
22411,614460,UBIQUITIN-SPECIFIC PROTEASE 47, USP47
22412,614461,UBIQUINOL-CYTOCHROME C REDUCTASE COMPLEX ASSEMBLY FACTOR 2, UQCC2
22413,614462,"HYPERGLYCINEMIA, LACTIC ACIDOSIS, AND SEIZURES", HGCLAS
22414,614463,NMYC DOWNSTREAM-REGULATED GENE 4, NDRG4
22415,614464,JOUBERT SYNDROME 15, JBTS15
22416,614465,JOUBERT SYNDROME 16, JBTS16
22417,614466,"CORONARY HEART DISEASE, SUSCEPTIBILITY TO, 6", CHDS6
22418,614467,SENGERS SYNDROME,
22419,614468,FAMILIAL COLD AUTOINFLAMMATORY SYNDROME 3, FCAS3
22420,614469,SERRATE RNA EFFECTOR MOLECULE, SRRT
22421,614470,RAS-ASSOCIATED AUTOIMMUNE LEUKOPROLIFERATIVE DISORDER, RALD
22422,614471,UBIQUITIN-SPECIFIC PROTEASE 19, USP19
22423,614472,RING FINGER PROTEIN 123, RNF123
22424,614473,"ARTERIAL CALCIFICATION, GENERALIZED, OF INFANCY, 2", GACI2
22425,614474,ATRIOVENTRICULAR SEPTAL DEFECT 5, AVSD5
22426,614475,ATRIAL SEPTAL DEFECT 9, ASD9
22427,614476,THROMBOSPONDIN TYPE-1 DOMAIN-CONTAINING PROTEIN 4, THSD4
22428,614477,CILIA- AND FLAGELLA-ASSOCIATED PROTEIN 418, CFAP418
22429,614478,CYTOCHROME c OXIDASE ASSEMBLY FACTOR COX14, COX14
22430,614479,"MALONYL CoA:ACP ACYLTRANSFERASE, MITOCHONDRIAL", MCAT
22431,614480,"HYPERTRIGLYCERIDEMIA, TRANSIENT INFANTILE", HTGTI
22432,614481,ATXN7 ANTISENSE RNA 1, ATXN7AS1
22433,614482,HUPPKE-BRENDEL SYNDROME, HPBDS
22434,614483,BRAIN SMALL VESSEL DISEASE 2, BSVD2
22435,614484,"ANAPHASE-PROMOTING COMPLEX, SUBUNIT 13", ANAPC13
22436,614485,TRIGONOCEPHALY 2, TRIGNO2
22437,614486,THROMBOPHILIA DUE TO THROMBOMODULIN DEFECT, THPH12
22438,614487,"SPASTIC ATAXIA 5, AUTOSOMAL RECESSIVE", SPAX5
22439,614488,MICRO RNA 1258, MIR1258
22440,614489,MICRO RNA 616, MIR616
22441,614490,"BLOOD GROUP, JUNIOR SYSTEM", JR
22442,614491,"PSEUDOHYPOALDOSTERONISM, TYPE IIB", PHA2B
22443,614492,"PSEUDOHYPOALDOSTERONISM, TYPE IIC", PHA2C
22444,614493,WISKOTT-ALDRICH SYNDROME 2, WAS2
22445,614494,RETINITIS PIGMENTOSA 63, RP63
22446,614495,"PSEUDOHYPOALDOSTERONISM, TYPE IID", PHA2D
22447,614496,"PSEUDOHYPOALDOSTERONISM, TYPE IIE", PHA2E
22448,614497,MICROPHTHALMIA/COLOBOMA 7, MCOPCB7
22449,614498,"RIGIDITY AND MULTIFOCAL SEIZURE SYNDROME, LETHAL NEONATAL", RMFSL
22450,614499,"INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 34, WITH VARIANT LISSENCEPHALY", MRT34
22451,614500,CONE-ROD DYSTROPHY 16, CORD16
22452,614501,"NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, CRANIOFACIAL ABNORMALITIES, AND SEIZURES", NEDHCS
22453,614502,PIERCER OF MICROTUBULE WALL 1, PIERCE1
22454,614503,KELCH DOMAIN-CONTAINING PROTEIN 8A, KLHDC8A
22455,614504,"USHER SYNDROME, TYPE IIIB", USH3B
22456,614505,FK506-BINDING PROTEIN 14, FKBP14
22457,614506,BRCA1-ASSOCIATED ATM ACTIVATOR 1, BRAT1
22458,614507,"CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ir", CDG1R
22459,614508,MIRROR MOVEMENTS 2, MRMV2
22460,614509,MICRO RNA 99A, MIR99A
22461,614510,MICRO RNA 99B, MIR99B
22462,614511,MYOD FAMILY INHIBITOR DOMAIN-CONTAINING PROTEIN, MDFIC
22463,614512,TORSIN 1A-INTERACTING PROTEIN 1, TOR1AIP1
22464,614513,TORSIN 1A-INTERACTING PROTEIN 2, TOR1AIP2
22465,614514,"THROMBOPHILIA DUE TO PROTEIN S DEFICIENCY, AUTOSOMAL RECESSIVE", THPH6
22466,614515,G PROTEIN-COUPLED RECEPTOR 179, GPR179
22467,614516,DOLICHYL PYROPHOSPHATE PHOSPHATASE 1, DOLPP1
22468,614517,BRAIN AND MUSCLE ARNT-LIKE PROTEIN 2, BMAL2
22469,614518,GATA ZINC FINGER DOMAIN-CONTAINING PROTEIN 1, GATAD1
22470,614519,"HEMORRHAGE, INTRACEREBRAL, SUSCEPTIBILITY TO", ICH
22471,614520,"ENCEPHALOMYOPATHY, MITOCHONDRIAL, DUE TO VOLTAGE-DEPENDENT ANION CHANNEL DEFICIENCY",
22472,614521,THROMBOCYTHEMIA 3, THCYT3
22473,614522,KELCH-LIKE 12, KLHL12
22474,614523,MICRO RNA 489, MIR489
22475,614524,FIBROCHONDROGENESIS 2, FBCG2
22476,614525,NFATC2-INTERACTING PROTEIN, NFATC2IP
22477,614526,CHROMOSOME 17q12 DUPLICATION SYNDROME,
22478,614527,CHROMOSOME 17q12 DELETION SYNDROME,
22479,614528,HIF1A ANTISENSE RNA 1, HIF1AAS1
22480,614529,HIF1A ANTISENSE RNA 2, HIF1AAS2
22481,614530,NADH-UBIQUINONE OXIDOREDUCTASE SUBUNIT A12, NDUFA12
22482,614531,"RASGEF DOMAIN FAMILY, MEMBER 1A", RASGEF1A
22483,614532,"RASGEF DOMAIN FAMILY, MEMBER 1B", RASGEF1B
22484,614533,CELL DIVISION CYCLE 26, CDC26
22485,614534,ANAPHASE-PROMOTING COMPLEX SUBUNIT 11, ANAPC11
22486,614535,ZINC FINGER SWIM DOMAIN-CONTAINING PROTEIN 7, ZSWIM7
22487,614536,SWIM-TYPE ZINC FINGER DOMAIN-CONTAINING PROTEIN 7-ASSOCIATED PROTEIN 1, SWSAP1
22488,614537,LEUCINE-RICH MELANOCYTE DIFFERENTIATION-ASSOCIATED PROTEIN, LRMDA
22489,614538,MICRO RNA 570, MIR570
22490,614539,"HELICASE, DNA, B", HELB
22491,614540,"BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 1",
22492,614541,CHROMOSOME 16q22 DELETION SYNDROME,
22493,614542,DIVERGENT PROTEIN KINASE DOMAIN 1A, DIPK1A
22494,614543,DIVERGENT PROTEIN KINASE DOMAIN 1B, DIPK1B
22495,614544,DIVERGENT PROTEIN KINASE DOMAIN 1C, DIPK1C
22496,614545,"ENDOPLASMIC RETICULUM MEMBRANE PROTEIN COMPLEX, SUBUNIT 10", EMC10
22497,614546,"EFAVIRENZ, POOR METABOLISM OF",
22498,614547,"FAMILY WITH SEQUENCE SIMILARITY 103, MEMBER A1", FAM103A1
22499,614548,SERINE INCORPORATOR 1, SERINC1
22500,614549,SERINE INCORPORATOR 2, SERINC2
22501,614550,SERINE INCORPORATOR 4, SERINC4
22502,614551,SERINE INCORPORATOR 5, SERINC5
22503,614552,XYLOSIDE XYLOSYLTRANSFERASE 1, XXYLT1
22504,614553,N6 ADENINE-SPECIFIC DNA METHYLTRANSFERASE 1, N6AMT1
22505,614554,"FAMILY WITH SEQUENCE SIMILARITY 32, MEMBER A", FAM32A
22506,614555,FERM DOMAIN-CONTAINING PROTEIN 6, FRMD6
22507,614556,AT-RICH INTERACTION DOMAIN-CONTAINING PROTEIN 1B, ARID1B
22508,614557,"EHLERS-DANLOS SYNDROME, KYPHOSCOLIOTIC TYPE, 2", EDSKSCL2
22509,614558,DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 13, DEE13
22510,614559,INFANTILE CEREBELLAR-RETINAL DEGENERATION, ICRD
22511,614560,MAU2 SISTER CHROMATID COHESION FACTOR, MAU2
22512,614561,"LEUKOENCEPHALOPATHY, BRAIN CALCIFICATIONS, AND CYSTS", LCC
22513,614562,COFFIN-SIRIS SYNDROME 1,
22514,614563,"CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 13", CDCBM13
22515,614564,"CUTANEOUS TELANGIECTASIA AND CANCER SYNDROME, FAMILIAL", FCTCS
22516,614565,"NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1E", CSNB1E
22517,614566,"DYNEIN, AXONEMAL, ASSEMBLY FACTOR 3", DNAAF3
22518,614567,DIAPHANOUS-RELATED FORMIN 3, DIAPH3
22519,614568,UNC13 HOMOLOG C, UNC13C
22520,614569,"MULTIPLE ENCHONDROMATOSIS, MAFFUCCI TYPE",
22521,614570,KINESIN FAMILY MEMBER 18B, KIF18B
22522,614571,"CILIOGENESIS AND PLANAR POLARITY EFFECTOR COMPLEX, SUBUNIT 1", CPLANE1
22523,614572,ZINC FINGER PROTEIN 42, ZFP42
22524,614573,G PROTEIN-COUPLED RECEPTOR 158, GPR158
22525,614574,ROGDI ATYPICAL LEUCINE ZIPPER, ROGDI
22526,614575,"CEREBELLAR ATAXIA, NEUROPATHY, AND VESTIBULAR AREFLEXIA SYNDROME", CANVAS
22527,614576,"CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIl", CDG2L
22528,614577,"PROGESTIN AND ADIPOQ RECEPTOR FAMILY, MEMBER 3", PAQR3
22529,614578,"PROGESTIN AND ADIPOQ RECEPTOR FAMILY, MEMBER 4", PAQR4
22530,614579,"PROGESTIN AND ADIPOQ RECEPTOR FAMILY, MEMBER 6", PAQR6
22531,614580,"PROGESTIN AND ADIPOQ RECEPTOR FAMILY, MEMBER 9", PAQR9
22532,614581,MONOCYTE-TO-MACROPHAGE DIFFERENTIATION-ASSOCIATED PROTEIN 2, MMD2
22533,614582,COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 9, COXPD9
22534,614583,BARAITSER-WINTER SYNDROME 2, BRWS2
22535,614584,"PROLYL 4-HYDROXYLASE, TRANSMEMBRANE", P4HTM
22536,614585,FERREDOXIN 2, FDX2
22537,614586,ZINC FINGER DHHC DOMAIN-CONTAINING PROTEIN 5, ZDHHC5
22538,614587,CHAC GLUTATHIONE-SPECIFIC GAMMA-GLUTAMYLCYCLOTRANSFERASE 1, CHAC1
22539,614588,DYSTONIA 21, DYT21
22540,614589,SKI3 SUBUNIT OF SUPERKILLER COMPLEX, SKIC3
22541,614590,"PODOCONIOSIS, SUSCEPTIBILITY TO", PDCOS
22542,614591,CEA CELL ADHESION MOLECULE 16, CEACAM16
22543,614592,BENT BONE DYSPLASIA SYNDROME 1, BBDS1
22544,614593,MEIOSIS REGULATOR AND mRNA STABILITY FACTOR 1, MARF1
22545,614594,OLMSTED SYNDROME 1, OLMS1
22546,614595,PREECLAMPSIA/ECLAMPSIA 5, PEE5
22547,614596,MICRO RNA 302A, MIR302A
22548,614597,MICRO RNA 302B, MIR302B
22549,614598,MICRO RNA 302C, MIR302C
22550,614599,MICRO RNA 302D, MIR302D
22551,614600,MICRO RNA 367, MIR367
22552,614601,ZINC FINGER PROTEIN 326, ZNF326
22553,614602,TRICHOHEPATOENTERIC SYNDROME 2, THES2
22554,614603,DDHD DOMAIN-CONTAINING PROTEIN 1, DDHD1
22555,614604,ZINC FINGER DHHC DOMAIN-CONTAINING PROTEIN 7, ZDHHC7
22556,614605,ZINC FINGER DHHC DOMAIN-CONTAINING PROTEIN 21, ZDHHC21
22557,614606,FOCADHESIN, FOCAD
22558,614607,COFFIN-SIRIS SYNDROME 2, CSS2
22559,614608,COFFIN-SIRIS SYNDROME 3, CSS3
22560,614609,COFFIN-SIRIS SYNDROME 4, CSS4
22561,614610,KN MOTIF- AND ANKYRIN REPEAT DOMAIN-CONTAINING PROTEIN 2, KANK2
22562,614611,KN MOTIF- AND ANKYRIN REPEAT DOMAIN-CONTAINING PROTEIN 3, KANK3
22563,614612,KN MOTIF- AND ANKYRIN REPEAT DOMAIN-CONTAINING PROTEIN 4, KANK4
22564,614613,ACRODYSOSTOSIS 2 WITH OR WITHOUT HORMONE RESISTANCE, ACRDYS2
22565,614614,"DEAFNESS, AUTOSOMAL DOMINANT 4B", DFNA4B
22566,614615,JOUBERT SYNDROME 17, JBTS17
22567,614616,DIARRHEA 6, DIAR6
22568,614617,"DEAFNESS, AUTOSOMAL RECESSIVE 86", DFNB86
22569,614618,HYPEREKPLEXIA 3, HKPX3
22570,614619,HYPEREKPLEXIA 2, HKPX2
22571,614620,INTRAFLAGELLAR TRANSPORT 140, IFT140
22572,614621,UV-SENSITIVE SYNDROME 2, UVSS2
22573,614622,KERATOCONUS 5, KTCN5
22574,614623,KERATOCONUS 6, KTCN6
22575,614624,MITOCHONDRIAL ASSEMBLY OF RIBOSOMAL LARGE SUBUNIT 1, MALSU1
22576,614625,DIFFERENTIATION-ANTAGONIZING NONCODING RNA, DANCR
22577,614626,"SMALL NUCLEOLAR RNA, H/ACA BOX, 26", SNORA26
22578,614627,MICRO RNA 4449, MIR4449
22579,614628,KERATOCONUS 8, KTCN8
22580,614629,KERATOCONUS 7, KTCN7
22581,614630,ANDROGLOBIN, ADGB
22582,614631,CDP-L-RIBITOL PYROPHOSPHORYLASE A, CRPPA
22583,614632,UV-STIMULATED SCAFFOLD PROTEIN A, UVSSA
22584,614633,VPS54 SUBUNIT OF GARP COMPLEX, VPS54
22585,614634,CENTROSOMAL PROTEIN 126, CEP126
22586,614635,LONG INTERGENIC NONCODING RNA 538, LINC00538
22587,614636,MYOSIN IH, MYO1H
22588,614637,DESUMOYLATING ISOPEPTIDASE 1, DESI1
22589,614638,DESUMOYLATING ISOPEPTIDASE 2, DESI2
22590,614639,ZINC FINGER- AND BTB DOMAIN-CONTAINING PROTEIN 46, ZBTB46
22591,614640,UV-SENSITIVE SYNDROME 3, UVSS3
22592,614641,LYSOSOME-ASSOCIATED MEMBRANE PROTEIN 5, LAMP5
22593,614642,START DOMAIN-CONTAINING PROTEIN 9, STARD9
22594,614643,"MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 7", MDDGA7
22595,614644,MEAN PLATELET VOLUME/COUNT QUANTITATIVE TRAIT LOCUS 4, MPVCQTL4
22596,614645,MEAN PLATELET VOLUME/COUNT QUANTITATIVE TRAIT LOCUS 5, MPVCQTL5
22597,614646,MEAN PLATELET VOLUME/COUNT QUANTITATIVE TRAIT LOCUS 6, MPVCQTL6
22598,614647,"COENZYME Q6, MONOOXYGENASE", COQ6
22599,614648,RALY-LIKE PROTEIN, RALYL
22600,614649,RING FINGER PROTEIN 170, RNF170
22601,614650,"COENZYME Q10 DEFICIENCY, PRIMARY, 6", COQ10D6
22602,614651,"COENZYME Q10 DEFICIENCY, PRIMARY, 2", COQ10D2
22603,614652,"COENZYME Q10 DEFICIENCY, PRIMARY, 3", COQ10D3
22604,614653,"NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE VI", HSAN6
22605,614654,"COENZYME Q10 DEFICIENCY, PRIMARY, 5", COQ10D5
22606,614655,"STUTTERING, FAMILIAL PERSISTENT, 3", STUT3
22607,614656,PALADIN1, PALD1
22608,614657,ANGIOMOTIN-LIKE 1, AMOTL1
22609,614658,ANGIOMOTIN-LIKE 2, AMOTL2
22610,614659,APC MEMBRANE RECRUITMENT PROTEIN 2, AMER2
22611,614660,"PAT1 HOMOLOG 1, PROCESSING BODY mRNA DECAY FACTOR", PATL1
22612,614661,PAT1 HOMOLOG 2, PATL2
22613,614662,CORTISONE REDUCTASE DEFICIENCY 2, CORTRD2
22614,614663,RALY HETEROGENEOUS NUCLEAR RIBONUCLEAR PROTEIN, RALY
22615,614664,TRIGGERING RECEPTOR EXPRESSED ON MYELOID CELLS-LIKE PROTEIN 4, TREML4
22616,614665,MECONIUM ILEUS,
22617,614666,COILED-COIL DOMAIN-CONTAINING PROTEIN 78, CCDC78
22618,614667,MITOCHONDRIAL tRNA TRANSLATION OPTIMIZATION 1, MTO1
22619,614668,"STUTTERING, FAMILIAL PERSISTENT, 4", STUT4
22620,614669,AURICULOCONDYLAR SYNDROME 2A, ARCND2A
22621,614670,"PERIPARTUM CARDIOMYOPATHY, SUSCEPTIBILITY TO", PPCM
22622,614671,CHROMOSOME 16p11.2 DUPLICATION SYNDROME,
22623,614672,"CARDIOMYOPATHY, DILATED, 2B", CMD2B
22624,614673,"MICROCEPHALY 8, PRIMARY, AUTOSOMAL RECESSIVE", MCPH8
22625,614674,"PERIODIC FEVER, MENSTRUAL CYCLE-DEPENDENT",
22626,614675,BONE MARROW FAILURE SYNDROME 1, BMFS1
22627,614676,"CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 21", CMH21
22628,614677,"DYNEIN, AXONEMAL, ASSEMBLY FACTOR 19", DNAAF19
22629,614678,"PONTOCEREBELLAR HYPOPLASIA, TYPE 1B", PCH1B
22630,614679,"CILIARY DYSKINESIA, PRIMARY, 17", CILD17
22631,614680,"INFLUENZA, SEVERE, SUSCEPTIBILITY TO",
22632,614681,AMINOGLYCOSIDE PHOSPHOTRANSFERASE DOMAIN-CONTAINING PROTEIN 1, AGPHD1
22633,614682,ALANINE-GLYOXYLATE AMINOTRANSFERASE 2-LIKE 1, AGXT2L1
22634,614683,5-PHOSPHOHYDROXY-L-LYSINE PHOSPHO-LYASE, PHYKPL
22635,614684,"HYPERTELORISM AND OTHER FACIAL DYSMORPHISM, BRACHYDACTYLY, GENITAL ABNORMALITIES, IMPAIRED INTELLECTUAL DEVELOPMENT, AND RECURRENT INFLAMMATORY EPISODES",
22636,614685,ZINC FINGER PROTEIN 597, ZNF597
22637,614686,"FAMILY WITH SEQUENCE SIMILARITY 50, MEMBER B", FAM50B
22638,614687,"ALAR CLEFT, ISOLATED",
22639,614688,PONTINE TEGMENTAL CAP DYSPLASIA, PTCD
22640,614689,"SOLUBLE INTERLEUKIN-6 RECEPTOR, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS",
22641,614690,CHROMOSOME 4 OPEN READING FRAME 48, C4ORF48
22642,614691,CATARACT 38, CTRCT38
22643,614692,"MEMBRANOUS NEPHROPATHY, SUSCEPTIBILITY TO", MBNP
22644,614693,ATM INTERACTOR, ATMIN
22645,614694,REGULATION OF NUCLEAR PRE-mRNA DOMAIN-CONTAINING PROTEIN 1B, RPRD1B
22646,614695,REGULATION OF NUCLEAR PRE-mRNA DOMAIN-CONTAINING 2, RPRD2
22647,614696,FRONTOTEMPORAL DEMENTIA AND/OR AMYOTROPHIC LATERAL SCLEROSIS 7,
22648,614697,"KATANIN, p60 SUBUNIT, A-LIKE PROTEIN 2", KATNAL2
22649,614698,CYTOCHROME c OXIDASE ASSEMBLY FACTOR COX20, COX20
22650,614699,"IMMUNODEFICIENCY, COMMON VARIABLE, 7", CVID7
22651,614700,"IMMUNODEFICIENCY, COMMON VARIABLE, 8, WITH AUTOIMMUNITY", CVID8
22652,614701,CORNELIA DE LANGE SYNDROME 4 WITH OR WITHOUT MIDLINE BRAIN DEFECTS, CDLS4
22653,614702,COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 10, COXPD10
22654,614703,SLIT-ROBO RHO GTPase-ACTIVATING PROTEIN 2B, SRGAP2B
22655,614704,SLIT-ROBO RHO GTPase-ACTIVATING PROTEIN 2C, SRGAP2C
22656,614705,SLIT-ROBO RHO GTPase-ACTIVATING PROTEIN 2D, SRGAP2D
22657,614706,"CEROID LIPOFUSCINOSIS, NEURONAL, 11", CLN11
22658,614707,BROWN-VIALETTO-VAN LAERE SYNDROME 2, BVVLS2
22659,614708,"SIGNAL PEPTIDE-, CUB DOMAIN-, AND EGF-LIKE DOMAINS-CONTAINING PROTEIN 3", SCUBE3
22660,614709,LYR MOTIF-CONTAINING PROTEIN 1, LYRM1
22661,614710,"FAMILY WITH SEQUENCE SIMILARITY 72, MEMBER A", FAM72A
22662,614711,"FAMILY WITH SEQUENCE SIMILARITY 72, MEMBER B", FAM72B
22663,614712,"FAMILY WITH SEQUENCE SIMILARITY 72, MEMBER D", FAM72D
22664,614713,"RAS ASSOCIATION DOMAIN FAMILY, MEMBER 10", RASSF10
22665,614714,"POROKERATOSIS 7, MULTIPLE TYPES", POROK7
22666,614715,TRANSMEMBRANE AND IMMUNOGLOBULIN DOMAINS-CONTAINING PROTEIN 2, TMIGD2
22667,614716,CAPPING PROTEIN REGULATOR AND MYOSIN 1 LINKER 3, CARMIL3
22668,614717,"ANAPHASE-PROMOTING COMPLEX, SUBUNIT 15", ANAPC15
22669,614718,KINETOCHORE-LOCALIZED ASTRIN/SPAG5-BINDING PROTEIN, KNSTRN
22670,614719,POTASSIUM CHANNEL MODULATORY FACTOR 1, KCMF1
22671,614720,CYCLIN-DEPENDENT KINASE 19, CDK19
22672,614721,TSPY-LIKE 5, TSPYL5
22673,614722,MICRO RNA 3120, MIR3120
22674,614723,ADENINE PHOSPHORIBOSYLTRANSFERASE DEFICIENCY, APRTD
22675,614724,"CENTROSOMAL PROTEIN, 63-KD", CEP63
22676,614725,SERINE ACTIVE SITE-CONTAINING PROTEIN 1, SERAC1
22677,614726,TRANSMEMBRANE PROTEIN 165, TMEM165
22678,614727,"CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIk", CDG2K
22679,614728,SECKEL SYNDROME 6, SCKL6
22680,614729,"COP9 SIGNALOSOME, SUBUNIT 6", COPS6
22681,614730,PHOSPHATIDYLINOSITOL GLYCAN ANCHOR BIOSYNTHESIS CLASS O PROTEIN, PIGO
22682,614731,"PROSTATE CANCER, HEREDITARY, 2", HPC2
22683,614732,"INTRAUTERINE GROWTH RETARDATION, METAPHYSEAL DYSPLASIA, ADRENAL HYPOPLASIA CONGENITA, AND GENITAL ANOMALIES", IMAGE
22684,614733,MICRO RNA 193A, MIR193A
22685,614734,MICRO RNA 193B, MIR193B
22686,614735,MICRO RNA 365A, MIR365A
22687,614736,GLUCOCORTICOID DEFICIENCY 4 WITH OR WITHOUT MINERALOCORTICOID DEFICIENCY, GCCD4
22688,614737,MITOCHONDRIAL PYRUVATE CARRIER 2, MPC2
22689,614738,MITOCHONDRIAL PYRUVATE CARRIER 1, MPC1
22690,614739,"3-METHYLGLUTACONIC ACIDURIA WITH DEAFNESS, ENCEPHALOPATHY, AND LEIGH-LIKE SYNDROME", MEGDEL
22691,614740,"BASAL CELL CARCINOMA, SUSCEPTIBILITY TO, 7", BCC7
22692,614741,MITOCHONDRIAL PYRUVATE CARRIER DEFICIENCY, MPYCD
22693,614742,"PULMONARY FIBROSIS AND/OR BONE MARROW FAILURE SYNDROME, TELOMERE-RELATED, 1", PFBMFT1
22694,614743,"PULMONARY FIBROSIS AND/OR BONE MARROW FAILURE SYNDROME, TELOMERE-RELATED, 2", PFBMFT2
22695,614744,"FACIAL PARESIS, HEREDITARY CONGENITAL, 3", HCFP3
22696,614745,"BLOOD GROUP, JOHN MILTON HAGEN SYSTEM", JMH
22697,614746,"URIC ACID CONCENTRATION, SERUM, QUANTITATIVE TRAIT LOCUS 5", UAQTL5
22698,614747,"URIC ACID CONCENTRATION, SERUM, QUANTITATIVE TRAIT LOCUS 6", UAQTL6
22699,614748,"EPIDERMOLYSIS BULLOSA, JUNCTIONAL 7, WITH INTERSTITIAL LUNG DISEASE AND NEPHROTIC SYNDROME", JEB7
22700,614749,HYPERPHOSPHATASIA WITH IMPAIRED INTELLECTUAL DEVELOPMENT SYNDROME 2, HPMRS2
22701,614750,"MYASTHENIC SYNDROME, CONGENITAL, 13", CMS13
22702,614751,"NEURONOPATHY, DISTAL HEREDITARY MOTOR, AUTOSOMAL DOMINANT 12", HMND12
22703,614752,"INTERLEUKIN 6, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS",
22704,614753,MALAN SYNDROME, MALNS
22705,614754,DOUBLESEX- AND MAB3-RELATED TRANSCRIPTION FACTOR 3, DMRT3
22706,614755,MICRO RNA 520H, MIR520H
22707,614756,CEREBELLAR DYSFUNCTION WITH VARIABLE COGNITIVE AND BEHAVIORAL ABNORMALITIES, CECBA
22708,614757,INTERFERON-INDUCED TRANSMEMBRANE PROTEIN 5, IFITM5
22709,614758,DYNACTIN 4, DCTN4
22710,614759,CILIA- AND FLAGELLA-ASSOCIATED PROTEIN 53, CFAP53
22711,614760,"SOLUTE CARRIER FAMILY 66, MEMBER 1", SLC66A1
22712,614761,GLYCINE N-ACYLTRANSFERASE-LIKE 1, GLYATL1
22713,614762,GLYCINE N-ACYLTRANSFERASE-LIKE 2, GLYATL2
22714,614763,GLYCINE N-ACYLTRANSFERASE-LIKE 3, GLYATL3
22715,614764,"KATANIN, p60 SUBUNIT, A-LIKE 1", KATNAL1
22716,614765,"STRIATIN, CALMODULIN-BINDING PROTEIN", STRN
22717,614766,"STRIATIN, CALMODULIN-BINDING PROTEIN 3", STRN3
22718,614767,"STRIATIN, CALMODULIN-BINDING PROTEIN 4", STRN4
22719,614768,TRANSMEMBRANE PROTEIN 66, TMEM66
22720,614769,CYTOCHROME c OXIDASE ASSEMBLY FACTOR 1 HOMOLOG, COA1
22721,614770,PET100 CYTOCHROME c OXIDASE CHAPERONE, PET100
22722,614771,PET117 CYTOCHROME c OXIDASE CHAPERONE, PET117
22723,614772,CYTOCHROME c OXIDASE ASSEMBLY FACTOR 6, COA6
22724,614773,MSS51 MITOCHONDRIAL TRANSLATIONAL ACTIVATOR, MSS51
22725,614774,PENTATRICOPEPTIDE REPEAT DOMAIN-CONTAINING PROTEIN 1, PTCD1
22726,614775,CYTOCHROME C OXIDASE ASSEMBLY FACTOR 3, COA3
22727,614776,SIK FAMILY KINASE 3, SIK3
22728,614777,"MMS19 HOMOLOG, CYTOSOLIC IRON-SULFUR ASSEMBLY COMPONENT", MMS19
22729,614778,CYTOSOLIC IRON-SULFUR ASSEMBLY COMPONENT 2B, CIAO2B
22730,614779,"HETEROTAXY, VISCERAL, 6, AUTOSOMAL", HTX6
22731,614780,SORTING NEXIN 10, SNX10
22732,614781,TECTONIN BETA-PROPELLER REPEAT-CONTAINING 1, TECPR1
22733,614782,"TREMOR, HEREDITARY ESSENTIAL, 4", ETM4
22734,614783,POC1 CENTRIOLAR PROTEIN A, POC1A
22735,614784,POC1 CENTRIOLAR PROTEIN B, POC1B
22736,614785,MITOCHONDRIAL FISSION FACTOR, MFF
22737,614786,TRANSMEMBRANE PROTEIN 207, TMEM207
22738,614787,POGO TRANSPOSABLE ELEMENT-DERIVED PROTEIN WITH ZNF DOMAIN, POGZ
22739,614788,"FYVE, RhoGEF, AND PH DOMAIN-CONTAINING PROTEIN 5", FGD5
22740,614789,EGF DOMAIN-SPECIFIC O-LINKED N-ACETYLGLUCOSAMINE TRANSFERASE, EOGT
22741,614790,WT1-INTERACTING PROTEIN, WTIP
22742,614791,MICRO RNA 199B, MIR199B
22743,614792,TRANSMEMBRANE AND UBIQUITIN-LIKE DOMAIN-CONTAINING PROTEIN 1, TMUB1
22744,614793,MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 21, MAP3K21
22745,614794,1-ACYLGLYCEROL-3-PHOSPHATE O-ACYLTRANSFERASE 3, AGPAT3
22746,614795,1-ACYLGLYCEROL-3-PHOSPHATE O-ACYLTRANSFERASE 4, AGPAT4
22747,614796,1-ACYLGLYCEROL-3-PHOSPHATE O-ACYLTRANSFERASE 5, AGPAT5
22748,614797,PELLINO E3 UBIQUITIN PROTEIN LIGASE 1, PELI1
22749,614798,PELLINO E3 UBIQUITIN PROTEIN LIGASE 2, PELI2
22750,614799,AFG2 INTERACTING RIBOSOME MATURATION FACTOR, AIRIM
22751,614800,"SHORT STATURE, OPTIC NERVE ATROPHY, AND PELGER-HUET ANOMALY", SOPH
22752,614801,MSL COMPLEX SUBUNIT 1, MSL1
22753,614802,MSL COMPLEX SUBUNIT 2, MSL2
22754,614803,DOUBLESEX- AND MAB3-RELATED TRANSCRIPTION FACTOR A1, DMRTA1
22755,614804,DOUBLESEX- AND MAB3-RELATED TRANSCRIPTION FACTOR A2, DMRTA2
22756,614805,DOUBLESEX- AND MAB3-RELATED TRANSCRIPTION FACTOR B1, DMRTB1
22757,614806,DOUBLESEX- AND MAB3-RELATED TRANSCRIPTION FACTOR C2, DMRTC2
22758,614807,"MYOPATHY, CENTRONUCLEAR, 4", CNM4
22759,614808,AMYOTROPHIC LATERAL SCLEROSIS 18, ALS18
22760,614809,C3 GLOMERULOPATHY 3, C3G3
22761,614810,"MULTIPLE SCLEROSIS, SUSCEPTIBILITY TO, 5", MS5
22762,614811,"L-3-HYDROXYPROLINE DEHYDRATASE, TRANS", L3HYPDH
22763,614812,"NUCLEAR PROTEIN, TRANSCRIPTIONAL REGULATOR, 1", NUPR1
22764,614813,"SHORT STATURE, ONYCHODYSPLASIA, FACIAL DYSMORPHISM, AND HYPOTRICHOSIS", SOFT
22765,614814,ADAMS-OLIVER SYNDROME 3, AOS3
22766,614815,JOUBERT SYNDROME 18, JBTS18
22767,614816,LOEYS-DIETZ SYNDROME 4, LDS4
22768,614817,"INTERSTITIAL NEPHRITIS, KARYOMEGALIC", KMIN
22769,614818,FRY MICROTUBULE-BINDING PROTEIN, FRY
22770,614819,WEILL-MARCHESANI SYNDROME 3, WMS3
22771,614820,ALTERNATING HEMIPLEGIA OF CHILDHOOD 2, AHC2
22772,614821,PTCSC3 GENE, PTCSC3
22773,614822,SPERMATOGENIC FAILURE 10, SPGF10
22774,614823,AORTIC VALVE DISEASE 2, AOVD2
22775,614824,"ADAPTOR-RELATED PROTEIN COMPLEX 5, SIGMA-1 SUBUNIT", AP5S1
22776,614825,RALBP1-ASSOCIATED EPS DOMAIN-CONTAINING PROTEIN 1, REPS1
22777,614826,"NYSTAGMUS 7, CONGENITAL, AUTOSOMAL DOMINANT", NYS7
22778,614827,"DNAJ/HSP40 HOMOLOG, SUBFAMILY C, MEMBER 11", DNAJC11
22779,614828,"PROTEIN O-MANNOSE BETA-1,4-N-ACETYLGLUCOSAMINYLTRANSFERASE 2", POMGNT2
22780,614829,ODONTOGENESIS-ASSOCIATED PHOSPHOPROTEIN, ODAPH
22781,614830,"MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 8", MDDGA8
22782,614831,"SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 13", SCAR13
22783,614832,"AMELOGENESIS IMPERFECTA, HYPOMATURATION TYPE, IIA4", AI2A4
22784,614833,"MICROCEPHALY, SHORT STATURE, AND POLYMICROGYRIA WITH OR WITHOUT SEIZURES", MSSP
22785,614834,"THYROTOXIC PERIODIC PARALYSIS, SUSCEPTIBILITY TO, 3", TTPP3
22786,614835,"ACTIN, BETA-LIKE, 2", ACTBL2
22787,614836,"HUMAN HERPESVIRUS 8, SUSCEPTIBILITY TO", HHV8S
22788,614837,HYPOGONADOTROPIC HYPOGONADISM 8 WITH OR WITHOUT ANOSMIA, HH8
22789,614838,HYPOGONADOTROPIC HYPOGONADISM 9 WITH OR WITHOUT ANOSMIA, HH9
22790,614839,HYPOGONADOTROPIC HYPOGONADISM 10 WITH OR WITHOUT ANOSMIA, HH10
22791,614840,HYPOGONADOTROPIC HYPOGONADISM 11 WITH OR WITHOUT ANOSMIA, HH11
22792,614841,HYPOGONADOTROPIC HYPOGONADISM 12 WITH OR WITHOUT ANOSMIA, HH12
22793,614842,HYPOGONADOTROPIC HYPOGONADISM 13 WITH OR WITHOUT ANOSMIA, HH13
22794,614843,ODONTOGENIC AMELOBLAST-ASSOCIATED PROTEIN, ODAM
22795,614844,NEPHRONOPHTHISIS 14, NPHP14
22796,614845,NEPHRONOPHTHISIS 15, NPHP15
22797,614846,TETRASOMY 15q26,
22798,614847,"EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 12", EIG12
22799,614848,"CENTROSOMAL PROTEIN, 164-KD", CEP164
22800,614849,IMMUNODEFICIENCY 132A, IMD132A
22801,614850,"ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 6", IIAE6
22802,614851,SECKEL SYNDROME 7, SCKL7
22803,614852,"MICROCEPHALY 9, PRIMARY, AUTOSOMAL RECESSIVE", MCPH9
22804,614853,CYTOKINE RECEPTOR-LIKE FACTOR 3, CRLF3
22805,614854,LEUCINE-RICH REPEAT-CONTAINING PROTEIN 59, LRRC59
22806,614855,"TBC1 DOMAIN FAMILY, MEMBER 14", TBC1D14
22807,614856,"OSTEOGENESIS IMPERFECTA, TYPE XIII", OI13
22808,614857,"METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, cblJ TYPE", MAHCJ
22809,614858,HYPOGONADOTROPIC HYPOGONADISM 14 WITH OR WITHOUT ANOSMIA, HH14
22810,614859,PEROXISOME BIOGENESIS DISORDER 3A (ZELLWEGER), PBD3A
22811,614860,DYSTONIA 23, DYT23
22812,614861,"DEAFNESS, AUTOSOMAL RECESSIVE 98", DFNB98
22813,614862,PEROXISOME BIOGENESIS DISORDER 4A (ZELLWEGER), PBD4A
22814,614863,PEROXISOME BIOGENESIS DISORDER 4B, PBD4B
22815,614864,"DYNEIN, AXONEMAL, ASSEMBLY FACTOR 5", DNAAF5
22816,614865,"D4Z4 BINDING ELEMENT TRANSCRIPT, NONCODING", DBET
22817,614866,PEROXISOME BIOGENESIS DISORDER 5A (ZELLWEGER), PBD5A
22818,614867,PEROXISOME BIOGENESIS DISORDER 5B, PBD5B
22819,614868,IMMUNODEFICIENCY 110 WITH LYMPHOPROLIFERATION, IMD110
22820,614869,"USHER SYNDROME, TYPE IJ", USH1J
22821,614870,PEROXISOME BIOGENESIS DISORDER 6A (ZELLWEGER), PBD6A
22822,614871,PEROXISOME BIOGENESIS DISORDER 6B, PBD6B
22823,614872,PEROXISOME BIOGENESIS DISORDER 7A (ZELLWEGER), PBD7A
22824,614873,PEROXISOME BIOGENESIS DISORDER 7B, PBD7B
22825,614874,"CILIARY DYSKINESIA, PRIMARY, 18", CILD18
22826,614875,METAPHYSEAL ENCHONDROMATOSIS WITH D-2-HYDROXYGLUTARIC ACIDURIA,
22827,614876,PEROXISOME BIOGENESIS DISORDER 8A (ZELLWEGER), PBD8A
22828,614877,PEROXISOME BIOGENESIS DISORDER 8B, PBD8B
22829,614878,"AUTOINFLAMMATION, ANTIBODY DEFICIENCY, AND IMMUNE DYSREGULATION", APLAID
22830,614879,PEROXISOME BIOGENESIS DISORDER 9B, PBD9B
22831,614880,HYPOGONADOTROPIC HYPOGONADISM 15 WITH OR WITHOUT ANOSMIA, HH15
22832,614881,"NEURONOPATHY, DISTAL HEREDITARY MOTOR, AUTOSOMAL RECESSIVE 5", HMNR5
22833,614882,PEROXISOME BIOGENESIS DISORDER 10A (ZELLWEGER), PBD10A
22834,614883,PEROXISOME BIOGENESIS DISORDER 11A (ZELLWEGER), PBD11A
22835,614884,VON WILLEBRAND FACTOR A DOMAIN-CONTAINING PROTEIN 3B, VWA3B
22836,614885,PEROXISOME BIOGENESIS DISORDER 11B, PBD11B
22837,614886,PEROXISOME BIOGENESIS DISORDER 12A (ZELLWEGER), PBD12A
22838,614887,PEROXISOME BIOGENESIS DISORDER 13A (ZELLWEGER), PBD13A
22839,614888,ALPHA- AND GAMMA-ADAPTIN-BINDING PROTEIN, AAGAB
22840,614889,IMMUNODEFICIENCY 28, IMD28
22841,614890,IMMUNODEFICIENCY 29, IMD29
22842,614891,IMMUNODEFICIENCY 30, IMD30
22843,614892,IMMUNODEFICIENCY 31A, IMD31A
22844,614893,IMMUNODEFICIENCY 32A, IMD32A
22845,614894,IMMUNODEFICIENCY 32B,
22846,614895,"CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 4F", CMT4F
22847,614896,SINOATRIAL NODE DYSFUNCTION AND DEAFNESS, SANDD
22848,614897,HYPOGONADOTROPIC HYPOGONADISM 16 WITH OR WITHOUT ANOSMIA, HH16
22849,614898,"SPASTIC PARAPLEGIA 53, AUTOSOMAL RECESSIVE", SPG53
22850,614899,"DEAFNESS, AUTOSOMAL RECESSIVE 93", DFNB93
22851,614900,DIAMOND-BLACKFAN ANEMIA 11, DBA11
22852,614901,BRANCHED-CHAIN ALPHA-KETO ACID DEHYDROGENASE KINASE, BCKDK
22853,614902,RHO GTPase-ACTIVATING PROTEIN 33, ARHGAP33
22854,614903,SORTING NEXIN 16, SNX16
22855,614904,SORTING NEXIN 7, SNX7
22856,614905,SORTING NEXIN 8, SNX8
22857,614906,SORTING NEXIN 11, SNX11
22858,614907,PRE-mRNA-PROCESSING FACTOR 39, PRPF39
22859,614908,HEAT SHOCK PROTEIN NUCLEAR IMPORT FACTOR HIKESHI, HIKESHI
22860,614909,TRANSMEMBRANE PROTEIN 174, TMEM174
22861,614910,C1q- AND TUMOR NECROSIS FACTOR-RELATED PROTEIN 6, C1QTNF6
22862,614911,C1q- AND TUMOR NECROSIS FACTOR-RELATED PROTEIN 4, C1QTNF4
22863,614912,TRAB DOMAIN-CONTAINING PROTEIN 2A, TRABD2A
22864,614913,TRAB DOMAIN-CONTAINING PROTEIN 2B, TRABD2B
22865,614914,MICRO RNA 298, MIR298
22866,614915,LETHAL CONGENITAL CONTRACTURE SYNDROME 4, LCCS4
22867,614916,"VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 4", CPVT4
22868,614917,REQUIRED FOR MEIOTIC NUCLEAR DIVISION 1 HOMOLOG, RMND1
22869,614918,PENTATRICOPEPTIDE REPEAT DOMAIN-CONTAINING PROTEIN 3, PTCD3
22870,614919,NITRIC OXIDE-ASSOCIATED PROTEIN 1, NOA1
22871,614920,PEROXISOME BIOGENESIS DISORDER 14B, PEX14B
22872,614921,"CONGENITAL DISORDER OF GLYCOSYLATION, TYPE It", CDG1T
22873,614922,COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 11, COXPD11
22874,614923,BRANCHED-CHAIN KETO ACID DEHYDROGENASE KINASE DEFICIENCY, BCKDKD
22875,614924,COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 12, COXPD12
22876,614925,OTOGELIN-LIKE PROTEIN, OTOGL
22877,614926,PERRAULT SYNDROME 2, PRLTS2
22878,614927,"ECTODERMAL DYSPLASIA 5, HAIR/NAIL TYPE", ECTD5
22879,614928,"ECTODERMAL DYSPLASIA 6, HAIR/NAIL TYPE", ECTD6
22880,614929,"ECTODERMAL DYSPLASIA 7, HAIR/NAIL TYPE", ECTD7
22881,614930,"DYNEIN, AXONEMAL, ASSEMBLY FACTOR 11", DNAAF11
22882,614931,"ECTODERMAL DYSPLASIA 9, HAIR/NAIL TYPE", ECTD9
22883,614932,COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 13, COXPD13
22884,614933,"LONG INTERGENIC NONCODING RNA, MUSCLE DIFFERENTIATION 1", LINCMD1
22885,614934,"DEAFNESS, AUTOSOMAL RECESSIVE 70, WITH OR WITHOUT ADULT-ONSET NEURODEGENERATION", DFNB70
22886,614935,"CILIARY DYSKINESIA, PRIMARY, 19", CILD19
22887,614936,"PALMOPLANTAR KERATODERMA, PUNCTATE TYPE IB", PPKP1B
22888,614937,"MYOCLONUS, FAMILIAL, 1", MYOCL1
22889,614938,VAULT RNA 2-1, VTRNA2-1
22890,614939,"PHOSPHOGLYCERATE MUTASE FAMILY, MEMBER 5", PGAM5
22891,614940,"ECTODERMAL DYSPLASIA 11A, HYPOHIDROTIC/HAIR/TOOTH TYPE, AUTOSOMAL DOMINANT", ECTD11A
22892,614941,"ECTODERMAL DYSPLASIA 11B, HYPOHIDROTIC/HAIR/TOOTH TYPE, AUTOSOMAL RECESSIVE", ECTD11B
22893,614942,PHOSPHATIDYLGLYCEROPHOSPHATE SYNTHASE 1, PGS1
22894,614943,TP53-REGULATED INHIBITOR OF APOPTOSIS 1, TRIAP1
22895,614944,"DEAFNESS, AUTOSOMAL RECESSIVE 84B", DFNB84B
22896,614945,"DEAFNESS, AUTOSOMAL RECESSIVE 18B", DFNB18B
22897,614946,COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 14, COXPD14
22898,614947,COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 15, COXPD15
22899,614948,TAM41 MITOCHONDRIAL TRANSLOCATOR ASSEMBLY AND MAINTENANCE HOMOLOG, TAMM41
22900,614949,TRANSMEMBRANE PROTEIN 231, TMEM231
22901,614950,TRANSMEMBRANE PROTEIN 17, TMEM17
22902,614951,HEAT REPEAT-CONTAINING PROTEIN 3, HEATR3
22903,614952,"SCHLAFEN FAMILY, MEMBER 5", SLFN5
22904,614953,"SCHLAFEN FAMILY, MEMBER 11", SLFN11
22905,614954,"CONGENITAL HEART DEFECTS, MULTIPLE TYPES, 3", CHTD3
22906,614955,"SCHLAFEN FAMILY, MEMBER 12", SLFN12
22907,614956,"SCHLAFEN FAMILY, MEMBER 12-LIKE", SLFN12L
22908,614957,"SCHLAFEN FAMILY, MEMBER 13", SLFN13
22909,614958,"SCHLAFEN FAMILY, MEMBER 14", SLFN14
22910,614959,DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 14, DEE14
22911,614960,"PHOSPHOLIPASE D FAMILY, MEMBER 6", PLD6
22912,614961,"PONTOCEREBELLAR HYPOPLASIA, TYPE 8", PCH8
22913,614962,LEPTIN DEFICIENCY OR DYSFUNCTION, LEPD
22914,614963,LEPTIN RECEPTOR DEFICIENCY, LEPRD
22915,614964,EXTRACELLULAR LEUCINE-RICH REPEAT AND FIBRONECTIN TYPE III DOMAIN-CONTAINING PROTEIN 1, ELFN1
22916,614965,SECERNIN 1, SCRN1
22917,614966,SECERNIN 2, SCRN2
22918,614967,SECERNIN 3, SCRN3
22919,614968,SH2 DOMAIN-CONTAINING PROTEIN 4A, SH2D4A
22920,614969,"PONTOCEREBELLAR HYPOPLASIA, TYPE 7", PCH7
22921,614970,JOUBERT SYNDROME 20, JBTS20
22922,614971,"TAURINE-UPREGULATED GENE 1, NONCODING", TUG1
22923,614972,"CHOLESTASIS, INTRAHEPATIC, OF PREGNANCY 3", ICP3
22924,614973,"FOCAL FACIAL DERMAL DYSPLASIA 2, BRAUER-SETLEIS TYPE", FFDD2
22925,614974,FOCAL FACIAL DERMAL DYSPLASIA 4, FFDD4
22926,614975,FOXF1 ADJACENT NONCODING DEVELOPMENTAL REGULATORY RNA, FENDRR
22927,614976,CARPENTER SYNDROME 2, CRPT2
22928,614977,LONG INTERGENIC NONCODING RNA 1081, LINC01081
22929,614978,LONG INTERGENIC NONCODING RNA 1082, LINC01082
22930,614979,"RETINAL DYSTROPHY, OPTIC NERVE EDEMA, SPLENOMEGALY, ANHIDROSIS, AND MIGRAINE HEADACHE SYNDROME", ROSAH
22931,614980,"CONGENITAL HEART DEFECTS, MULTIPLE TYPES, 2", CHTD2
22932,614981,ATPase INHIBITORY FACTOR 1, ATPIF1
22933,614982,STRUCTURAL MAINTENANCE OF CHROMOSOMES FLEXIBLE HINGE DOMAIN-CONTAINING PROTEIN 1, SMCHD1
22934,614983,"BASIC LEUCINE ZIPPER TRANSCRIPTION FACTOR, ATF-LIKE 2", BATF2
22935,614984,DEHYDROGENASE E1 AND TRANSKETOLASE DOMAINS-CONTAINING PROTEIN 1, DHTKD1
22936,614985,HELLP SYNDROME-ASSOCIATED LONG NONCODING RNA, HELLPAR
22937,614986,CALCIUM/CALMODULIN-DEPENDENT PROTEIN KINASE II INHIBITOR 1, CAMK2N1
22938,614987,EPS8-LIKE PROTEIN 1, EPS8L1
22939,614988,EPS8-LIKE PROTEIN 2, EPS8L2
22940,614989,EPS8-LIKE PROTEIN 3, EPS8L3
22941,614990,"USHER SYNDROME, TYPE IK", USH1K
22942,614991,"UBIQUITIN CARBOXYL-TERMINAL ESTERASE L1, ANTISENSE", UCH1LAS
22943,614992,LONG INTERGENIC NONCODING RNA 237, LINC00237
22944,614993,CAM KINASE-LIKE VESICLE-ASSOCIATED, CAMKV
22945,614994,CALCIUM/CALMODULIN-DEPENDENT PROTEIN KINASE IG, CAMK1G
22946,614995,INTERLEUKIN 17 RECEPTOR E, IL17RE
22947,614996,MYELINATING SCHWANN CELL ELEMENT, MSE
22948,614997,GATA ZINC FINGER DOMAIN-CONTAINING PROTEIN 2A, GATAD2A
22949,614998,GATA ZINC FINGER DOMAIN-CONTAINING PROTEIN 2B, GATAD2B
22950,614999,"CYTOCHROME P450, FAMILY 4, SUBFAMILY X, POLYPEPTIDE 1", CYP4X1
22951,615000,TECTONIN BETA-PROPELLER REPEAT-CONTAINING PROTEIN 2, TECPR2
22952,615001,ZINC FINGER CCCH DOMAIN-CONTAINING PROTEIN 12C, ZC3H12C
22953,615002,"CALCIUM/CALMODULIN-DEPENDENT PROTEIN KINASE KINASE 2, BETA", CAMKK2
22954,615003,DDHD DOMAIN-CONTAINING PROTEIN 2, DDHD2
22955,615004,"LEUCINE-RICH REPEAT, IMMUNOGLOBULIN-LIKE, AND TRANSMEMBRANE DOMAINS-CONTAINING PROTEIN 3", LRIT3
22956,615005,"EPILEPSY, NOCTURNAL FRONTAL LOBE, 5", ENFL5
22957,615006,DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 15, DEE15
22958,615007,"BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 4", IBGC4
22959,615008,"NEPHROTIC SYNDROME, TYPE 7", NPHS7
22960,615009,SCHUURS-HOEIJMAKERS SYNDROME, SHMS
22961,615010,AICARDI-GOUTIERES SYNDROME 6, AGS6
22962,615011,PHOSPHOHYDROXYLYSINURIA, PHLU
22963,615012,"HISTONE GENE CLUSTER 1, H2A HISTONE FAMILY, MEMBER G", HIST1H2AG
22964,615013,"HISTONE GENE CLUSTER 1, H2A HISTONE FAMILY, MEMBER H", HIST1H2AH
22965,615014,"HISTONE GENE CLUSTER 2, H2A HISTONE FAMILY, MEMBER B", HIST2H2AB
22966,615015,"HISTONE GENE CLUSTER 3, H2A HISTONE", HIST3H2A
22967,615016,"OLFACTORY RECEPTOR, FAMILY 2, SUBFAMILY J, MEMBER 3", OR2J3
22968,615017,MICRO RNA 139, MIR139
22969,615018,"BLOOD GROUP, SID SYSTEM", SID
22970,615019,"ELONGATOR ACETYLTRANSFERASE COMPLEX, SUBUNIT 5", ELP5
22971,615020,"ELONGATOR ACETYLTRANSFERASE COMPLEX, SUBUNIT 6", ELP6
22972,615021,"BLOOD GROUP, GLOBOSIDE SYSTEM", GLOB
22973,615022,"ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 7", ARCI7
22974,615023,"ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 9", ARCI9
22975,615024,"ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 10", ARCI10
22976,615025,"CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2Q", CMT2Q
22977,615026,RIBOFLAVIN DEFICIENCY, RBFVD
22978,615027,SIN3-HDAC COMPLEX ASSOCIATED FACTOR, SINHCAF
22979,615028,"EPIDERMOLYSIS BULLOSA SIMPLEX 4, LOCALIZED OR GENERALIZED INTERMEDIATE, AUTOSOMAL RECESSIVE", EBS4
22980,615029,PRECEREBELLIN 4, CBLN4
22981,615030,"SPASTIC PARAPLEGIA 56, AUTOSOMAL RECESSIVE, WITH OR WITHOUT PSEUDOXANTHOMA ELASTICUM", SPG56
22982,615031,"NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE IX, WITH DEVELOPMENTAL DELAY", HSAN9
22983,615032,INTELLECTUAL DEVELOPMENTAL DISORDER WITH AUTISM AND MACROCEPHALY, IDDAM
22984,615033,"SPASTIC PARAPLEGIA 54, AUTOSOMAL RECESSIVE", SPG54
22985,615034,DYSTONIA 24, DYT24
22986,615035,"SPASTIC PARAPLEGIA 55, AUTOSOMAL RECESSIVE", SPG55
22987,615036,MICRO RNA 410, MIR410
22988,615037,MICRO RNA 487B, MIR487B
22989,615038,OUTER DYNEIN ARM DOCKING COMPLEX SUBUNIT 1, ODAD1
22990,615039,N-DEACETYLASE/N-SULFOTRANSFERASE 4, NDST4
22991,615040,"EPISODIC PAIN SYNDROME, FAMILIAL, 1", FEPS1
22992,615041,"MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 10", MDDGA10
22993,615042,"CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Iu", CDG1U
22994,615043,"SPASTIC PARAPLEGIA 43, AUTOSOMAL RECESSIVE", SPG43
22995,615044,"HISTONE GENE CLUSTER 1, H2B HISTONE FAMILY, MEMBER J", HIST1H2BJ
22996,615045,"HISTONE GENE CLUSTER 1, H2B HISTONE FAMILY, MEMBER K", HIST1H2BK
22997,615046,"HISTONE GENE CLUSTER 3, H2B HISTONE FAMILY, MEMBER B", HIST3H2BB
22998,615047,"TETRATRICOPEPTIDE REPEAT-, ANKYRIN REPEAT-, AND COILED-COIL-CONTAINING PROTEIN 2", TANC2
22999,615048,"SPINAL MUSCULAR ATROPHY, JOKELA TYPE", SMAJ
23000,615049,WW DOMAIN-CONTAINING ADAPTOR WITH COILED-COIL REGION, WAC
23001,615050,ANKYRIN REPEAT- AND SOCS BOX-CONTAINING PROTEIN 5, ASB5
23002,615051,ANKYRIN REPEAT- AND SOCS BOX-CONTAINING PROTEIN 6, ASB6
23003,615052,ANKYRIN REPEAT- AND SOCS BOX-CONTAINING PROTEIN 7, ASB7
23004,615053,ANKYRIN REPEAT- AND SOCS BOX-CONTAINING PROTEIN 8, ASB8
23005,615054,ANKYRIN REPEAT- AND SOCS BOX-CONTAINING PROTEIN 10, ASB10
23006,615055,ANKYRIN REPEAT- AND SOCS BOX-CONTAINING PROTEIN 13, ASB13
23007,615056,ANKYRIN REPEAT- AND SOCS BOX-CONTAINING PROTEIN 16, ASB16
23008,615057,KAUFMAN OCULOCEREBROFACIAL SYNDROME,
23009,615058,"NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1F", CSNB1F
23010,615059,HYPOTRICHOSIS 11, HYPT11
23011,615060,"SECRETOGLOBIN, FAMILY 1D, MEMBER 1", SCGB1D1
23012,615061,"SECRETOGLOBIN, FAMILY 1D, MEMBER 2", SCGB1D2
23013,615062,"SECRETOGLOBIN, FAMILY 1D, MEMBER 4", SCGB1D4
23014,615063,"SECRETOGLOBIN, FAMILY 2B, MEMBER 2", SCGB2B2
23015,615064,"SOLUTE CARRIER FAMILY 25 (CARNITINE/ACYLCARNITINE TRANSLOCASE), MEMBER 29", SLC25A29
23016,615065,"ARTHROGRYPOSIS, DISTAL, TYPE 5D", DA5D
23017,615066,"OSTEOGENESIS IMPERFECTA, TYPE XIV", OI14
23018,615067,"CILIARY DYSKINESIA, PRIMARY, 20", CILD20
23019,615068,ECTOPIC P-GRANULES AUTOPHAGY PROTEIN 5 HOMOLOG, EPG5
23020,615069,H4 HISTONE 16, H4-16
23021,615070,MICRO RNA 590, MIR590
23022,615071,ALAZAMI SYNDROME, ALAZS
23023,615072,"BRACHYDACTYLY, TYPE A1, C", BDA1C
23024,615073,DYSTONIA 25, DYT25
23025,615074,GAND SYNDROME, GAND
23026,615075,NEURODEVELOPMENTAL DISORDER WITH SPASTIC DIPLEGIA AND VISUAL DEFECTS, NEDSDV
23027,615076,MITOCHONDRIAL GENOME MAINTENANCE EXONUCLEASE 1, MGME1
23028,615077,"TBC1 DOMAIN FAMILY, MEMBER 30", TBC1D30
23029,615078,GOLGI TRANSPORT 1B, GOLT1B
23030,615079,INTEGRATOR COMPLEX SUBUNIT 13, INTS13
23031,615080,ALZHEIMER DISEASE 17, AD17
23032,615081,SPERMATOGENIC FAILURE 11, SPGF11
23033,615082,"C3HEX, ABILITY TO SMELL",
23034,615083,"COLORECTAL CANCER, SUSCEPTIBILITY TO, 12", CRCS12
23035,615084,MITOCHONDRIAL DNA DEPLETION SYNDROME 11, MTDPS11
23036,615085,"OSTEOPETROSIS, AUTOSOMAL RECESSIVE 8", OPTB8
23037,615086,HARBINGER TRANSPOSASE-DERIVED GENE 1, HARBI1
23038,615087,SHORT-RIB THORACIC DYSPLASIA 3 WITH OR WITHOUT POLYDACTYLY,
23039,615088,AUTOPHAGY-RELATED 13, ATG13
23040,615089,AUTOPHAGY-RELATED PROTEIN 101, ATG101
23041,615090,"INTERFERON, LAMBDA-4", IFNL4
23042,615091,"AUTISM, SUSCEPTIBILITY TO, 19", AUTS19
23043,615092,LEFT VENTRICULAR NONCOMPACTION 7, LVNC7
23044,615093,"LYMPHOCYTE ANTIGEN 6 COMPLEX, LOCUS K", LY6K
23045,615094,PROSPERO-RELATED HOMEOBOX 2, PROX2
23046,615095,"MICROCEPHALY 10, PRIMARY, AUTOSOMAL RECESSIVE", MCPH10
23047,615096,MICRO RNA 217, MIR217
23048,615097,"SOLUTE CARRIER FAMILY 6 (NEUROTRANSMITTER TRANSPORTER, GABA), MEMBER 13", SLC6A13
23049,615098,TETRATRICOPEPTIDE REPEAT DOMAIN-CONTAINING PROTEIN 28, TTC28
23050,615099,ERYTHROFERRONE, ERFE
23051,615100,CTTNBP2 N TERMINUS-LIKE PROTEIN, CTTNBP2NL
23052,615101,"TUBULIN, BETA-2A", TUBB2A
23053,615102,TYSHCHENKO SYNDROME,
23054,615103,"TUBULIN, BETA-6", TUBB6
23055,615104,NCK-ASSOCIATED PROTEIN 5-LIKE, NCKAP5L
23056,615105,METHYLTHIORIBOSE-1-PHOSPHATE ISOMERASE 1, MRI1
23057,615106,COWDEN SYNDROME 1,
23058,615107,COWDEN SYNDROME 4, CWS4
23059,615108,COWDEN SYNDROME 5, CWS5
23060,615109,COWDEN SYNDROME 6, CWS6
23061,615110,WD REPEAT-CONTAINING PROTEIN 53, WDR53
23062,615111,DENN/MADD DOMAIN-CONTAINING PROTEIN 2D, DENND2D
23063,615112,UROFACIAL SYNDROME 2, UFS2
23064,615113,"MICROPHTHALMIA, ISOLATED 8", MCOP8
23065,615114,ZINC FINGER PROTEIN 516, ZNF516
23066,615115,ASXL TRANSCRIPTIONAL REGULATOR 3, ASXL3
23067,615116,SPERMATID MATURATION PROTEIN 1, SPEM1
23068,615117,CHROMOSOME 2 OPEN READING FRAME 88, C2ORF88
23069,615118,CRANIOMETADIAPHYSEAL DYSPLASIA,
23070,615119,"MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 6", MC4DN6
23071,615120,"MYASTHENIC SYNDROME, CONGENITAL, 8", CMS8
23072,615121,"STOMATIN-LIKE PROTEIN-2, HYPERPHOSPHORYLATION OF",
23073,615122,LYMPHOPROLIFERATIVE SYNDROME 2, LPFS2
23074,615123,ANKYRIN REPEAT DOMAIN-CONTAINING PROTEIN 13A, ANKRD13A
23075,615124,ANKYRIN REPEAT DOMAIN-CONTAINING PROTEIN 13B, ANKRD13B
23076,615125,ANKYRIN REPEAT DOMAIN-CONTAINING PROTEIN 13C, ANKRD13C
23077,615126,ANKYRIN REPEAT DOMAIN-CONTAINING PROTEIN 13D, ANKRD13D
23078,615127,"EPILEPSY, FAMILIAL ADULT MYOCLONIC, 4", FAME4
23079,615128,CENTROMERIC PROTEIN X, CENPX
23080,615129,UDP-N-ACETYL-ALPHA-D-GALACTOSAMINE:POLYPEPTIDE N-ACETYLGALACTOSAMINYLTRANSFERASE 5, GALNT5
23081,615130,UDP-N-ACETYL-ALPHA-D-GALACTOSAMINE:POLYPEPTIDE N-ACETYLGALACTOSAMINYLTRANSFERASE 11, GALNT11
23082,615131,UDP-N-ACETYL-ALPHA-D-GALACTOSAMINE:POLYPEPTIDE N-ACETYLGALACTOSAMINYLTRANSFERASE 15, GALNT15
23083,615132,UDP-N-ACETYL-ALPHA-D-GALACTOSAMINE:POLYPEPTIDE N-ACETYLGALACTOSAMINYLTRANSFERASE 16, GALNT16
23084,615133,UDP-N-ACETYL-ALPHA-D-GALACTOSAMINE:POLYPEPTIDE N-ACETYLGALACTOSAMINYLTRANSFERASE-LIKE 5, GALNTL5
23085,615134,"MELANOMA, CUTANEOUS MALIGNANT, SUSCEPTIBILITY TO, 9", CMM9
23086,615135,"MAPLE SYRUP URINE DISEASE, MILD VARIANT", MSUDMV
23087,615136,UDP-N-ACETYL-ALPHA-D-GALACTOSAMINE:POLYPEPTIDE N-ACETYLGALACTOSAMINYLTRANSFERASE 18, GALNT18
23088,615137,UDP-N-ACETYL-ALPHA-D-GALACTOSAMINE:POLYPEPTIDE N-ACETYLGALACTOSAMINYLTRANSFERASE 17, GALNT17
23089,615138,UDP-N-ACETYL-ALPHA-D-GALACTOSAMINE:POLYPEPTIDE N-ACETYLGALACTOSAMINYLTRANSFERASE-LIKE 6, GALNTL6
23090,615139,"FACIAL DYSMORPHISM, IMMUNODEFICIENCY, LIVEDO, AND SHORT STATURE", FILS
23091,615140,CHROMOSOME 12 OPEN READING FRAME 57, C12ORF57
23092,615141,"GLAUCOMA 1, OPEN ANGLE, P",
23093,615142,KINESIN FAMILY MEMBER 2B, KIF2B
23094,615143,UBIQUITIN-SPECIFIC PROTEASE 20, USP20
23095,615144,"PROTEASE, SERINE, 55", PRSS55
23096,615145,MICROPHTHALMIA/COLOBOMA 9, MCOPCB9
23097,615146,UBIQUITIN-SPECIFIC PROTEASE 33, USP33
23098,615147,"RETINAL DYSTROPHY, IRIS COLOBOMA, AND COMEDOGENIC ACNE SYNDROME", RDCCAS
23099,615148,MICRO RNA 551A, MIR551A
23100,615149,MICRO RNA 495, MIR495
23101,615150,MICRO RNA 191, MIR191
23102,615151,MICRO RNA 30C-1, MIR30C1
23103,615152,KELCH DOMAIN-CONTAINING PROTEIN 10, KLHDC10
23104,615153,MIXED LINEAGE KINASE DOMAIN-LIKE PROTEIN, MLKL
23105,615154,DPY30 DOMAIN-CONTAINING PROTEIN 1, DYDC1
23106,615155,STEEL SYNDROME, STLS
23107,615156,"PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 6", PEOA6
23108,615157,"MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 2", MC3DN2
23109,615158,"MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 3", MC3DN3
23110,615159,"MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 4", MC3DN4
23111,615160,"MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 5", MC3DN5
23112,615161,"MAJOR HISTOCOMPATIBILITY COMPLEX, CLASS II, DQ BETA-2", HLA-DQB2
23113,615162,"INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 35", MRT35
23114,615163,CONE-ROD DYSTROPHY 17, CORD17
23115,615164,AKIRIN 1, AKIRIN1
23116,615165,AKIRIN 2, AKIRIN2
23117,615166,C-X9-C MOTIF-CONTAINING 1, CMC1
23118,615167,LEUCINE-RICH REPEATS- AND WD REPEAT DOMAIN-CONTAINING PROTEIN 1, LRWD1
23119,615168,ARCHAELYSIN FAMILY METALLOPEPTIDASE 1, AMZ1
23120,615169,ARCHAELYSIN FAMILY METALLOPEPTIDASE 2, AMZ2
23121,615170,WAHAB SYNDROME,
23122,615171,LOC100134040 GENE,
23123,615172,"RING FINGER PROTEIN, TRANSMEMBRANE 1", RNFT1
23124,615173,"LONG INTERGENIC NONCODING RNA, REGULATOR OF REPROGRAMMING", LINC-ROR
23125,615174,"L-THREONINE DEHYDROGENASE, PSEUDOGENE", TDH
23126,615175,TLC DOMAIN-CONTAINING PROTEIN 3B, TLCD3B
23127,615176,"NPTN INTRONIC TRANSCRIPT 1, NONCODING", NPTNIT1
23128,615177,RING FINGER PROTEIN 126, RNF126
23129,615178,KXDL MOTIF-CONTAINING PROTEIN 1, KXD1
23130,615179,"ALBINISM, OCULOCUTANEOUS, TYPE VII", OCA7
23131,615180,TRANSLOCASE OF INNER MITOCHONDRIAL MEMBRANE 21, TIMM21
23132,615181,"MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 11", MDDGA11
23133,615182,COMBINED D-2- AND L-2-HYDROXYGLUTARIC ACIDURIA, D2L2AD
23134,615183,FA CORE COMPLEX-ASSOCIATED PROTEIN 20, FAAP20
23135,615184,"CARDIOMYOPATHY, DILATED, 1II", CMD1II
23136,615185,"CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE F", CMTDIF
23137,615186,CWC22 SPLICEOSOME-ASSOCIATED PROTEIN HOMOLOG, CWC22
23138,615187,POST-GPI ATTACHMENT TO PROTEINS 2, PGAP2
23139,615188,"CATARACT 39, MULTIPLE TYPES", CTRCT39
23140,615189,ANKYRIN REPEAT DOMAIN-CONTAINING PROTEIN 55, ANKRD55
23141,615190,"DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 5", DKCB5
23142,615191,LISSENCEPHALY 5, LIS5
23143,615192,BIRTH WEIGHT QUANTITATIVE TRAIT LOCUS 4, BWQTL4
23144,615193,"BLEEDING DISORDER, PLATELET-TYPE, 15", BDPLT15
23145,615194,"SHORT-CHAIN DEHYDROGENASE/REDUCTASE FAMILY, MEMBER 2", DHRS2
23146,615195,"SHORT-CHAIN DEHYDROGENASE/REDUCTASE FAMILY, MEMBER 4-LIKE 1", DHRS4L1
23147,615196,"SHORT-CHAIN DEHYDROGENASE/REDUCTASE FAMILY, MEMBER 4-LIKE 2", DHRS4L2
23148,615197,"RESTLESS LEGS SYNDROME, SUSCEPTIBILITY TO, 8", RLS8
23149,615198,OSTEOSCLEROTIC METAPHYSEAL DYSPLASIA, OSMD
23150,615199,"SOLUTE CARRIER FAMILY 35, MEMBER G5", SLC35G5
23151,615200,"PLECKSTRIN HOMOLOGY DOMAIN-CONTAINING PROTEIN, FAMILY F, MEMBER 1", PLEKHF1
23152,615201,MICRO RNA 1909, MIR1909
23153,615202,MICRO RNA 1915, MIR1915
23154,615203,RHOMBOID DOMAIN-CONTAINING PROTEIN 2, RHBDD2
23155,615204,ATP SYNTHASE MEMBRANE SUBUNIT DAPIT, ATP5MD
23156,615205,"SERINE PROTEASE INHIBITOR, KAZAL-TYPE, 13", SPINK13
23157,615206,IMMUNODEFICIENCY 11A, IMD11A
23158,615207,IMMUNODEFICIENCY 56, IMD56
23159,615208,"PLECKSTRIN HOMOLOGY DOMAIN-CONTAINING PROTEIN, FAMILY F, MEMBER 2", PLEKHF2
23160,615209,MICRO RNA 149, MIR149
23161,615210,PEST-CONTAINING NUCLEAR PROTEIN, PCNP
23162,615211,"UBIQUITIN-LIKE PROTEIN CONTAINING PHD AND RING FINGER DOMAINS 2, E3 UBIQUITIN PROTEIN LIGASE", UHRF2
23163,615212,LEUCINE-RICH REPEAT-CONTAINING PROTEIN 38, LRRC38
23164,615213,LEUCINE-RICH REPEAT-CONTAINING PROTEIN 55, LRRC55
23165,615214,"AGAMMAGLOBULINEMIA 7, AUTOSOMAL RECESSIVE", AGM7
23166,615215,"POTASSIUM CHANNEL, SUBFAMILY U, MEMBER 1", KCNU1
23167,615216,KINESIN FAMILY MEMBER C2, KIFC2
23168,615217,ATAXIA-OCULOMOTOR APRAXIA 3, AOA3
23169,615218,LEUCINE-RICH REPEAT-CONTAINING PROTEIN 52, LRRC52
23170,615219,"HYDROCEPHALUS, CONGENITAL, 2, WITH OR WITHOUT BRAIN OR EYE ANOMALIES", HYC2
23171,615220,"OSTEOGENESIS IMPERFECTA, TYPE XV", OI15
23172,615221,BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 16, BMND16
23173,615222,SMITH-MCCORT DYSPLASIA 2, SMC2
23174,615223,"INTERFERON, EPSILON", IFNE
23175,615224,"ADVANCED SLEEP PHASE SYNDROME, FAMILIAL, 2", FASPS2
23176,615225,"PALMOPLANTAR CARCINOMA, MULTIPLE SELF-HEALING", MSPC
23177,615226,"POLYDACTYLY, POSTAXIAL, TYPE A6", PAPA6
23178,615227,"COMPLEMENT COMPONENT 1, q SUBCOMPONENT-LIKE 3", C1QL3
23179,615228,"MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 4B", MC5DN4B
23180,615229,"COMPLEMENT COMPONENT 1, q SUBCOMPONENT-LIKE 4", C1QL4
23181,615230,LONG INTERGENIC NONCODING RNA 1080, LINC01080
23182,615231,RING FINGER AND CCCH-TYPE ZINC FINGER DOMAINS-CONTAINING PROTEIN 2, RC3H2
23183,615232,SCHIZOPHRENIA 18, SCZD18
23184,615233,RETINITIS PIGMENTOSA 66, RP66
23185,615234,"ANEMIA, HYPOCHROMIC MICROCYTIC, WITH IRON OVERLOAD 2", AHMIO2
23186,615235,"CARDIOMYOPATHY, DILATED, 1JJ", CMD1JJ
23187,615236,WOODS SYNDROME,
23188,615237,CONGENITAL SHORT BOWEL SYNDROME, CSBS
23189,615238,"LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 5", FPLD5
23190,615239,MICRO RNA 7-1, MIR7-1
23191,615240,POTASSIUM CHANNEL TETRAMERIZATION DOMAIN-CONTAINING PROTEIN 15, KCTD15
23192,615241,TERMINAL DIFFERENTIATION-INDUCED NONCODING RNA, TINCR
23193,615242,SMALL INTEGRAL MEMBRANE PROTEIN 1, SMIM1
23194,615243,"DEFENSIN, BETA, 114", DEFB114
23195,615244,"NEPHROTIC SYNDROME, TYPE 8", NPHS8
23196,615245,MICRO RNA 671, MIR671
23197,615246,ZINC FINGER BED DOMAIN-CONTAINING PROTEIN 2, ZBED2
23198,615247,PROTEIN-O-MANNOSE KINASE, POMK
23199,615248,"CARDIOMYOPATHY, DILATED, 1KK", CMD1KK
23200,615249,"MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 12", MDDGA12
23201,615250,ZINC FINGER BED DOMAIN-CONTAINING PROTEIN 3, ZBED3
23202,615251,ZINC FINGER BED DOMAIN-CONTAINING PROTEIN 5, ZBED5
23203,615252,ZBED6 C TERMINUS-LIKE PROTEIN, ZBED6CL
23204,615253,ZINC FINGER BED DOMAIN-CONTAINING PROTEIN 8, ZBED8
23205,615254,SCAN DOMAIN-CONTAINING PROTEIN 3, SCAND3
23206,615255,METHYLTRANSFERASE-LIKE 18, METTL18
23207,615256,ELECTRON TRANSFER FLAVOPROTEIN BETA-SUBUNIT LYSINE METHYLTRANSFERASE, ETFBKMT
23208,615257,"METHYLTRANSFERASE 21A, HSPA LYSINE", METTL21A
23209,615258,EEF1A LYSINE METHYLTRANSFERASE 3, EEF1AKMT3
23210,615259,"METHYLTRANSFERASE 21C, AARS1 LYSINE", METTL21C
23211,615260,VALOSIN-CONTAINING PROTEIN LYSINE METHYLTRANSFERASE, VCPKMT
23212,615261,"METHYLTRANSFERASE 22, KIN27 LYSINE", METTL22
23213,615262,METHYLTRANSFERASE-LIKE 23, METTL23
23214,615263,EUKARYOTIC ELONGATION FACTOR 2 LYSINE METHYLTRANSFERASE, EEF2KMT
23215,615264,"BLOOD GROUP, VEL SYSTEM", VEL
23216,615265,FORMIN-BINDING PROTEIN 4, FNBP4
23217,615266,HYPOGONADOTROPIC HYPOGONADISM 17 WITH OR WITHOUT ANOSMIA, HH17
23218,615267,HYPOGONADOTROPIC HYPOGONADISM 18 WITH OR WITHOUT ANOSMIA, HH18
23219,615268,"CEREBELLAR ATAXIA, IMPAIRED INTELLECTUAL DEVELOPMENT, AND DYSEQUILIBRIUM SYNDROME 4", CAMRQ4
23220,615269,HYPOGONADOTROPIC HYPOGONADISM 19 WITH OR WITHOUT ANOSMIA, HH19
23221,615270,HYPOGONADOTROPIC HYPOGONADISM 20 WITH OR WITHOUT ANOSMIA, HH20
23222,615271,HYPOGONADOTROPIC HYPOGONADISM 21 WITH OR WITHOUT ANOSMIA, HH21
23223,615272,"FANCONI ANEMIA, COMPLEMENTATION GROUP Q", FANCQ
23224,615273,CONGENITAL DISORDER OF DEGLYCOSYLATION 1, CDDG1
23225,615274,"CATARACT 15, MULTIPLE TYPES", CTRCT15
23226,615275,ACONITATE DECARBOXYLASE 1, ACOD1
23227,615276,CERAMIDE SYNTHASE 3, CERS3
23228,615277,"CATARACT 19, MULTIPLE TYPES", CTRCT19
23229,615278,CARDIOFACIOCUTANEOUS SYNDROME 2, CFC2
23230,615279,CARDIOFACIOCUTANEOUS SYNDROME 3, CFC3
23231,615280,CARDIOFACIOCUTANEOUS SYNDROME 4, CFC4
23232,615281,HYPOMYELINATION WITH BRAINSTEM AND SPINAL CORD INVOLVEMENT AND LEG SPASTICITY, HBSL
23233,615282,"CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 2", CDCBM2
23234,615283,EXOCYST COMPLEX COMPONENT 8, EXOC8
23235,615284,"CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 4B3", CMT4B3
23236,615285,"NEUTROPENIA, SEVERE CONGENITAL, 5, AUTOSOMAL RECESSIVE", SCN5
23237,615286,"NEURODEVELOPMENTAL DISORDER WITH BRAIN ABNORMALITIES, POOR GROWTH, AND DYSMORPHIC FACIES", NEDBGF
23238,615287,"MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 13", MDDGA13
23239,615288,"DYNEIN REGULATORY COMPLEX, SUBUNIT 1", DRC1
23240,615289,MITOTIC SPINDLE-POSITIONING PROTEIN, MISP
23241,615290,"SPINAL MUSCULAR ATROPHY, LOWER EXTREMITY-PREDOMINANT, 2A, CHILDHOOD ONSET, AUTOSOMAL DOMINANT", SMALED2A
23242,615291,"BETA-1,3-GALACTOSYLTRANSFERASE 6", B3GALT6
23243,615292,"FAMILY WITH SEQUENCE SIMILARITY 111, MEMBER A", FAM111A
23244,615293,"MYOFIBROMATOSIS, INFANTILE, 2", IMF2
23245,615294,"CILIARY DYSKINESIA, PRIMARY, 21", CILD21
23246,615295,UBIQUITIN-SPECIFIC PROTEASE 34, USP34
23247,615296,"INTERLEUKIN 1 FAMILY, MEMBER 10", IL1F10
23248,615297,ADAMS-OLIVER SYNDROME 4, AOS4
23249,615298,"SYMPHALANGISM, PROXIMAL, 1B", SYM1B
23250,615299,NUCLEOREDOXIN-LIKE PROTEIN 2, NXNL2
23251,615300,PERRAULT SYNDROME 4, PRLTS4
23252,615301,TRANSMEMBRANE PROTEIN 214, TMEM214
23253,615302,"ADENOSINE DEAMINASE, tRNA-SPECIFIC, 3", ADAT3
23254,615303,tRNA GLYCINE (ANTICODON TCC) 1-1, TRG-TCC1-1
23255,615304,tRNA VALINE (ANTICODON CAC) 3-1, TRV-CAC3-1
23256,615305,tRNA ARGININE (ANTICODON ACG) 1-2, TRR-ACG1-2
23257,615306,tRNA VALINE (ANTICODON CAC) 1-6, TRV-CAC1-6
23258,615307,tRNA VALINE (ANTICODON AAC) 5-1, TRV-AAC5-1
23259,615308,tRNA VALINE (ANTICODON AAC) 4-1, TRV-AAC4-1
23260,615309,tRNA THREONINE (ANTICODON AGT) 2-2, TRT-AGT2-2
23261,615310,tRNA VALINE (ANTICODON AAC) 1-1, TRV-AAC1-1
23262,615311,BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 17, BMND17
23263,615312,"ALBINISM, OCULOCUTANEOUS, TYPE V", OCA5
23264,615313,"BETA-1,3-N-ACETYLGLUCOSAMINYLTRANSFERASE 7", B3GNT7
23265,615314,CRANIOSYNOSTOSIS 3, CRS3
23266,615315,"BETA-1,3-N-ACETYLGLUCOSAMINYLTRANSFERASE 6", B3GNT6
23267,615316,IRON-SULFUR CLUSTER ASSEMBLY FACTOR IBA57, IBA57
23268,615317,IRON-SULFUR CLUSTER ASSEMBLY 2, ISCA2
23269,615318,TRANSMEMBRANE PROTEIN 14C, TMEM14C
23270,615319,IMPACT RWD DOMAIN PROTEIN, IMPACT
23271,615320,GDP-MANNOSE PYROPHOSPHORYLASE B, GMPPB
23272,615321,CHLORIDE INTRACELLULAR CHANNEL 6, CLIC6
23273,615322,NEGATIVE REGULATOR OF REACTIVE OXYGEN SPECIES, NRROS
23274,615323,JOSEPHIN DOMAIN-CONTAINING PROTEIN 1, JOSD1
23275,615324,JOSEPHIN DOMAIN-CONTAINING PROTEIN 2, JOSD2
23276,615325,"MYOPATHY, MYOFIBRILLAR, 1",
23277,615326,"INTERFERON, KAPPA", IFNK
23278,615327,DOWLING-DEGOS DISEASE 2, DDD2
23279,615328,SHAHEEN SYNDROME, SHNS
23280,615329,EXOCYST COMPLEX COMPONENT 2, EXOC2
23281,615330,MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 3, MMDS3
23282,615331,INTERFERON REGULATORY FACTOR 2-BINDING PROTEIN 1, IRF2BP1
23283,615332,INTERFERON REGULATORY FACTOR 2-BINDING PROTEIN 2, IRF2BP2
23284,615333,"BETA-1,3-N-ACETYLGLUCOSAMINYLTRANSFERASE 5", B3GNT5
23285,615334,CERAMIDE SYNTHASE 4, CERS4
23286,615335,CERAMIDE SYNTHASE 5, CERS5
23287,615336,CERAMIDE SYNTHASE 6, CERS6
23288,615337,"BETA-1,3-N-ACETYLGLUCOSAMINYLTRANSFERASE-LIKE 1", B3GNTL1
23289,615338,DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 16, DEE16
23290,615339,"DNAJ/HSP40 HOMOLOG, SUBFAMILY C, MEMBER 15", DNAJC15
23291,615340,KELCH-LIKE 40: KLHL40,
23292,615341,"CYTOCHROME P450, FAMILY 4, SUBFAMILY A, POLYPEPTIDE 22", CYP4A22
23293,615342,"PULMONARY HYPERTENSION, PRIMARY, 2", PPH2
23294,615343,"PULMONARY HYPERTENSION, PRIMARY, 3", PPH3
23295,615344,"PULMONARY HYPERTENSION, PRIMARY, 4", PPH4
23296,615345,MYOMAKER, MYMK
23297,615346,"PRECOCIOUS PUBERTY, CENTRAL, 2", CPPB2
23298,615347,"ATPase FAMILY, AAA DOMAIN-CONTAINING, MEMBER 2B", ATAD2B
23299,615348,NEMALINE MYOPATHY 8, NEM8
23300,615349,"EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 2", EDSSPD2
23301,615350,"MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 14", MDDGA14
23302,615351,"MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH IMPAIRED INTELLECTUAL DEVELOPMENT), TYPE B, 14", MDDGB14
23303,615352,"MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 14", MDDGC14
23304,615353,COILED-COIL DOMAIN-CONTAINING PROTEIN 28A, CCDC28A
23305,615354,LIGAND-DEPENDENT NUCLEAR RECEPTOR-INTERACTING FACTOR 1, LRIF1
23306,615355,NOONAN SYNDROME 8, NS8
23307,615356,"MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 18", LGMDR18
23308,615357,"BETA-1,3-GALACTOSYLTRANSFERASE 8", B3GNT8
23309,615358,ADENYLATE KINASE 9, AK9
23310,615359,MEIOSIS REGULATOR FOR OOCYTE DEVELOPMENT, MIOS
23311,615360,LEBER CONGENITAL AMAUROSIS 17, LCA17
23312,615361,"HYPOCALCEMIA, AUTOSOMAL DOMINANT 2", HYPOC2
23313,615362,"CEROID LIPOFUSCINOSIS, NEURONAL, 13 (KUFS TYPE)", CLN13
23314,615363,ESTROGEN RESISTANCE, ESTRR
23315,615364,ADENYLATE KINASE 7, AK7
23316,615365,ADENYLATE KINASE 8, AK8
23317,615366,NUCLEOLAR PROTEIN 11, NOL11
23318,615367,N-TERMINAL ASPARAGINE AMIDASE, NTAN1
23319,615368,LETHAL CONGENITAL CONTRACTURE SYNDROME 5, LCCS5
23320,615369,DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 94, DEE94
23321,615370,ANKYRIN REPEAT AND STERILE ALPHA MOTIF DOMAINS-CONTAINING PROTEIN 6, ANKS6
23322,615371,"PULMONARY HYPERTENSION, NEONATAL, SUSCEPTIBILITY TO", PHN
23323,615372,MICRO RNA 1260B, MIR1260B
23324,615373,LEFT VENTRICULAR NONCOMPACTION 8, LVNC8
23325,615374,CONE-ROD DYSTROPHY 18, CORD18
23326,615375,INTERLEUKIN 1 RECEPTOR-ASSOCIATED KINASE 1-BINDING PROTEIN 1, IRAK1BP1
23327,615376,"CHARCOT-MARIE-TOOTH DISEASE, RECESSIVE INTERMEDIATE C", CMTRIC
23328,615377,"ATRIAL FIBRILLATION, FAMILIAL, 13", ATFB13
23329,615378,"ATRIAL FIBRILLATION, FAMILIAL, 14", ATFB14
23330,615379,MICRO RNA 650, MIR650
23331,615380,APOPTOSIS-RESISTANT E3 UBIQUITIN PROTEIN LIGASE 1, AREL1
23332,615381,"MANDIBULAR HYPOPLASIA, DEAFNESS, PROGEROID FEATURES, AND LIPODYSTROPHY SYNDROME", MDPL
23333,615382,NEPHRONOPHTHISIS 16, NPHP16
23334,615383,FIDGETIN-LIKE PROTEIN 1, FIGNL1
23335,615384,SCAFFOLDING PROTEIN INVOLVED IN DNA REPAIR, SPIDR
23336,615385,MICRO RNA 485, MIR485
23337,615386,"SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 14", SCAR14
23338,615387,IMMUNODEFICIENCY 7, IMD7
23339,615388,"ADENOSINE DEAMINASE, tRNA-SPECIFIC, 2", ADAT2
23340,615389,ISOPENTENYL-DIPHOSPHATE DELTA ISOMERASE 2, IDI2
23341,615390,VESICOURETERAL REFLUX 7, VUR7
23342,615391,"IDI2 ANTISENSE RNA 1, NONCODING", IDI2AS1
23343,615392,SCM-LIKE PROTEIN WITH 4 MBT DOMAINS 2, SFMBT2
23344,615393,MITOCHONDRIAL TRANSCRIPTION TERMINATION FACTOR 4, MTERF4
23345,615394,"NOP2/SUN RNA METHYLTRANSFERASE FAMILY, MEMBER 4", NSUN4
23346,615395,COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 16, COXPD16
23347,615396,LEFT VENTRICULAR NONCOMPACTION 10, LVNC10
23348,615397,"MECKEL SYNDROME, TYPE 11", MKS11
23349,615398,MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 3, MCAHS3
23350,615399,PAROXYSMAL NOCTURNAL HEMOGLOBINURIA 2, PNH2
23351,615400,"EPILEPSY, EARLY-ONSET, 5, WITH OR WITHOUT DEVELOPMENTAL DELAY", EPEO5
23352,615401,IMMUNODEFICIENCY 8 WITH LYMPHOPROLIFERATION, IMD8
23353,615402,DYSCHROMATOSIS UNIVERSALIS HEREDITARIA 3, DUH3
23354,615403,"THO COMPLEX, SUBUNIT 6", THOC6
23355,615404,"TRANSMEMBRANE 4 L6 FAMILY, MEMBER 20", TM4SF20
23356,615405,"GUANINE NUCLEOTIDE-BINDING PROTEIN, GAMMA-12", GNG12
23357,615406,"GNG12 ANTISENSE RNA 1, NONCODING", GNG12AS1
23358,615407,ADP-RIBOSYLATION FACTOR-LIKE GTPase 2-BINDING PROTEIN, ARL2BP
23359,615408,OUTER DYNEIN ARM DOCKING COMPLEX SUBUNIT 2, ODAD2
23360,615409,SPERMATOGENESIS-ASSOCIATED PROTEIN 33, SPATA33
23361,615410,MELANOCORTIN 2 RECEPTOR ACCESSORY PROTEIN 2, MRAP2
23362,615411,"CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 3", CDCBM3
23363,615412,"CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 4", CDCBM4
23364,615413,SPERMATOGENIC FAILURE 12, SPGF12
23365,615414,"MICROCEPHALY 11, PRIMARY, AUTOSOMAL RECESSIVE", MCPH11
23366,615415,RENAL-HEPATIC-PANCREATIC DYSPLASIA 2, RHPD2
23367,615416,"BASIC HELIX-LOOP-HELIX FAMILY, MEMBER A9", BHLHA9
23368,615417,BET1-LIKE PROTEIN, BET1L
23369,615418,"MITOCHONDRIAL DNA DEPLETION SYNDROME 12B (CARDIOMYOPATHIC TYPE), AUTOSOMAL RECESSIVE", MTDPS12B
23370,615419,"HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 1", IHPRF1
23371,615420,"MYOPIA 22, AUTOSOMAL DOMINANT", MYP22
23372,615421,COILED-COIL DOMAIN-CONTAINING 111, CCDC111
23373,615422,INCLUSION BODY MYOPATHY WITH EARLY-ONSET PAGET DISEASE WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA 2, IBMPFD2
23374,615423,"tRNA METHYLTRANSFERASE 10C, MITOCHONDRIAL RNAse P SUBUNIT", TRMT10C
23375,615424,INCLUSION BODY MYOPATHY WITH EARLY-ONSET PAGET DISEASE WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA 3, IBMPFD3
23376,615425,"EPIDERMOLYSIS BULLOSA SIMPLEX 3, LOCALIZED OR GENERALIZED INTERMEDIATE, WITH BP230 DEFICIENCY", EBS3
23377,615426,AMYOTROPHIC LATERAL SCLEROSIS 20, ALS20
23378,615427,ELMO/CED12 DOMAIN-CONTAINING PROTEIN 3, ELMOD3
23379,615428,DEAD-BOX HELICASE 47, DDX47
23380,615429,"DEAFNESS, AUTOSOMAL RECESSIVE 88", DFNB88
23381,615430,TRANSMEMBRANE PROTEIN 241, TMEM241
23382,615431,"MYOPIA 23, AUTOSOMAL RECESSIVE", MYP23
23383,615432,SPECIFIC LANGUAGE IMPAIRMENT 5, SLI5
23384,615433,CHROMOSOME 3q13.31 DELETION SYNDROME,
23385,615434,RETINITIS PIGMENTOSA 82 WITH OR WITHOUT SITUS INVERSUS, RP82
23386,615435,ENDOPLASMIC RETICULUM OXIDOREDUCTIN 1-LIKE, ERO1L
23387,615436,"AORTIC ANEURYSM, FAMILIAL THORACIC 8", AAT8
23388,615437,"ENDOPLASMIC RETICULUM OXIDOREDUCTIN 1-LIKE, BETA", ERO1LB
23389,615438,INFANTILE LIVER FAILURE SYNDROME 1, ILFS1
23390,615439,"MACULAR DEGENERATION, AGE-RELATED, 13", ARMD13
23391,615440,COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 17, COXPD17
23392,615441,"CARDIAC ARRHYTHMIA SYNDROME, WITH OR WITHOUT SKELETAL MUSCLE WEAKNESS", CARDAR
23393,615442,T-CELL RECEPTOR ALPHA CHAIN VARIABLE GENE CLUSTER, TRAV@
23394,615443,T-CELL RECEPTOR ALPHA CHAIN JOINING GENE CLUSTER, TRAJ@
23395,615444,"CILIARY DYSKINESIA, PRIMARY, 22", CILD22
23396,615445,T-CELL RECEPTOR BETA CHAIN CONSTANT REGION 2, TRBC2
23397,615446,T-CELL RECEPTOR BETA CHAIN VARIABLE GENE CLUSTER, TRBV@
23398,615447,T-CELL RECEPTOR BETA CHAIN DIVERSITY GENE 1, TRBD1
23399,615448,T-CELL RECEPTOR BETA CHAIN DIVERSITY GENE 2, TRBD2
23400,615449,T-CELL RECEPTOR BETA CHAIN JOINING GENE CLUSTER, TRBJ@
23401,615450,T-CELL RECEPTOR GAMMA CHAIN CONSTANT REGION 2, TRGC2
23402,615451,"CILIARY DYSKINESIA, PRIMARY, 23", CILD23
23403,615452,PROSTATE CANCER-ASSOCIATED NONCODING RNA 1, PRNCR1
23404,615453,"MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 6", MC3DN6
23405,615454,T-CELL RECEPTOR GAMMA CHAIN VARIABLE GENE CLUSTER, TRGV@
23406,615455,T-CELL RECEPTOR GAMMA CHAIN JOINING GENE CLUSTER, TRGJ@
23407,615456,ELMO/CED12 DOMAIN-CONTAINING PROTEIN 1, ELMOD1
23408,615457,BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 18, BMIQ18
23409,615458,"MICROCORNEA, MYOPIC CHORIORETINAL ATROPHY, AND TELECANTHUS", MMCAT
23410,615459,T-CELL RECEPTOR DELTA CHAIN VARIABLE GENE CLUSTER, TRDV@
23411,615460,T-CELL RECEPTOR DELTA CHAIN DIVERSITY GENE CLUSTER, TRDD@
23412,615461,T-CELL RECEPTOR DELTA CHAIN JOINING GENE CLUSTER, TRDJ@
23413,615462,WD REPEAT-CONTAINING PROTEIN 60, WDR60
23414,615463,SZT2 SUBUNIT OF KICSTOR COMPLEX, SZT2
23415,615464,DEAD-BOX HELICASE 59, DDX59
23416,615465,HARTSFIELD SYNDROME, HRTFDS
23417,615466,TALIN ROD DOMAIN-CONTAINING PROTEIN 1, TLNRD1
23418,615467,GLYCOLIPID TRANSFER PROTEIN DOMAIN-CONTAINING PROTEIN 1, GLTPD1
23419,615468,IMMUNODEFICIENCY 12, IMD12
23420,615469,MICRO RNA 574, MIR574
23421,615470,"CENTROSOMAL PROTEIN, 89-KD", CEP89
23422,615471,MITOCHONDRIAL DNA DEPLETION SYNDROME 13 (ENCEPHALOMYOPATHIC TYPE), MTDPS13
23423,615472,"COATOMER PROTEIN COMPLEX, SUBUNIT ZETA-1", COPZ1
23424,615473,DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 17, DEE17
23425,615474,"PRIMARY ALDOSTERONISM, SEIZURES, AND NEUROLOGIC ABNORMALITIES", PASNA
23426,615475,DExH-BOX HELICASE 34, DHX34
23427,615476,DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 18, DEE18
23428,615477,NEURONAL TYROSINE-PHOSPHORYLATED PHOSPHOINOSITIDE 3-KINASE ADAPTOR 1, NYAP1
23429,615478,NEURONAL TYROSINE-PHOSPHORYLATED PHOSPHOINOSITIDE 3-KINASE ADAPTOR 2, NYAP2
23430,615479,MYOSIN XVI, MYO16
23431,615480,"BLADDER CANCER-ASSOCIATED TRANSCRIPT 1, NONCODING", BLACAT1
23432,615481,"CILIARY DYSKINESIA, PRIMARY, 24", CILD24
23433,615482,"CILIARY DYSKINESIA, PRIMARY, 25", CILD25
23434,615483,"BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 5", IBGC5
23435,615484,PENTATRICOPEPTIDE REPEAT DOMAIN-CONTAINING PROTEIN 2, PTCD2
23436,615485,BAINBRIDGE-ROPERS SYNDROME, BRPS
23437,615486,INTERSTITIAL LUNG AND LIVER DISEASE, ILLD
23438,615487,"SMALL NUCLEOLAR RNA, H/ACA BOX, 2C", SNORA2C
23439,615488,"KAT8 REGULATORY NSL COMPLEX, SUBUNIT 2", KANSL2
23440,615489,"MACULAR DEGENERATION, AGE-RELATED, 14", ARMD14
23441,615490,"CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2R", CMT2R
23442,615491,"SPASTIC PARAPLEGIA 79B, AUTOSOMAL RECESSIVE", SPG79B
23443,615492,LONG INTERGENIC NONCODING RNA COX2,
23444,615493,"INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 37", MRT37
23445,615494,CILIA- AND FLAGELLA-ASSOCIATED PROTEIN 298, CFAP298
23446,615495,GDP-MANNOSE PYROPHOSPHORYLASE A, GMPPA
23447,615496,ATP/GTP-BINDING PROTEIN-LIKE 1, AGBL1
23448,615497,MITOCHONDRIAL ELONGATION FACTOR 1, MIEF1
23449,615498,MITOCHONDRIAL ELONGATION FACTOR 2, MIEF2
23450,615499,PYRUVATE DEHYDROGENASE PHOSPHATASE CATALYTIC SUBUNIT 2, PDP2
23451,615500,"CILIARY DYSKINESIA, PRIMARY, 26", CILD26
23452,615501,"MOLYBDENUM COFACTOR DEFICIENCY, TYPE C", MOCODC
23453,615502,"INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 21", MRD21
23454,615503,SHORT-RIB THORACIC DYSPLASIA 8 WITH OR WITHOUT POLYDACTYLY, SRTD8
23455,615504,"CILIARY DYSKINESIA, PRIMARY, 27", CILD27
23456,615505,"CILIARY DYSKINESIA, PRIMARY, 28", CILD28
23457,615506,"TELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 5", HHT5
23458,615507,NISCHARIN, NISCH
23459,615508,"ERYTHRODERMA, CONGENITAL, WITH PALMOPLANTAR KERATODERMA, HYPOTRICHOSIS, AND HYPER-IgE", EPKHE
23460,615509,MICRO RNA 675, MIR675
23461,615510,"ALACRIMA, ACHALASIA, AND IMPAIRED INTELLECTUAL DEVELOPMENT SYNDROME", AAMR
23462,615511,MYOPATHY DUE TO MYOADENYLATE DEAMINASE DEFICIENCY, MMDD
23463,615512,TRIOSEPHOSPHATE ISOMERASE DEFICIENCY, TPID
23464,615513,"IMMUNODEFICIENCY 14A WITH LYMPHOPROLIFERATION, AUTOSOMAL DOMINANT", IMD14A
23465,615514,CYCLIN-DEPENDENT KINASE 12, CDK12
23466,615515,AMYOTROPHIC LATERAL SCLEROSIS 19, ALS19
23467,615516,"INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 38", MRT38
23468,615517,"HEMOCHROMATOSIS, TYPE 5", HFE5
23469,615518,IMMUNODEFICIENCY 13, IMD13
23470,615519,TARGET OF MYB1-LIKE 2 MEMBRANE TRAFFICKING PROTEIN, TOM1L2
23471,615520,MICRO RNA 297, MIR297
23472,615521,SH3 AND CYSTEINE-RICH DOMAINS 3, STAC3
23473,615522,COLE DISEASE, COLED
23474,615523,"CORNEAL DYSTROPHY, FUCHS ENDOTHELIAL, 8", FECD8
23475,615524,"MICROPHTHALMIA, SYNDROMIC 12", MCOPS12
23476,615525,"COATOMER PROTEIN COMPLEX, SUBUNIT GAMMA-1", COPG1
23477,615526,"COATOMER PROTEIN COMPLEX, SUBUNIT ZETA-2", COPZ2
23478,615527,"CANDIDIASIS, FAMILIAL, 8", CANDF8
23479,615528,"PARKINSON DISEASE 19A, JUVENILE-ONSET", PARK19A
23480,615529,"CRANIOSYNOSTOSIS 5, SUSCEPTIBILITY TO", CRS5
23481,615530,"PARKINSON DISEASE 20, EARLY-ONSET", PARK20
23482,615531,TRANSMEMBRANE PROTEIN 79, TMEM79
23483,615532,ENDOPLASMIC RETICULUM MEMBRANE-ASSOCIATED RNA DEGRADATION PROTEIN, ERMARD
23484,615533,TRANSMEMBRANE PROTEIN 126B, TMEM126B
23485,615534,TRANSLOCASE OF INNER MITOCHONDRIAL MEMBRANE DOMAIN-CONTAINING PROTEIN 1, TIMMDC1
23486,615535,SPECTRIN REPEAT-CONTAINING NUCLEAR ENVELOPE PROTEIN 4, SYNE4
23487,615536,CHROMOSOME 2 OPEN READING FRAME 80, C2ORF80
23488,615537,RETICULATE ACROPIGMENTATION OF KITAMURA, RAK
23489,615538,CHROMOSOME 22q13 DUPLICATION SYNDROME,
23490,615539,"EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE, 2", EDSMC2
23491,615540,"DEAFNESS, AUTOSOMAL RECESSIVE 76", DFNB76
23492,615541,"INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 39", MRT39
23493,615542,TESTICULAR ANOMALIES WITH OR WITHOUT CONGENITAL HEART DISEASE, TACHD
23494,615543,ACTIN-RELATED PROTEIN 2/3 COMPLEX INHIBITOR, ARPIN
23495,615544,PERIVENTRICULAR NODULAR HETEROTOPIA 6, PVNH6
23496,615545,"LEUKEMIA, ACUTE LYMPHOBLASTIC, SUSCEPTIBILITY TO, 3", ALL3
23497,615546,VAN MALDERGEM SYNDROME 2, VMLDS2
23498,615547,SCHAAF-YANG SYNDROME, SHFYNG
23499,615548,"NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE VII", HSAN7
23500,615549,ARMADILLO REPEAT-CONTAINING PROTEIN 5, ARMC5
23501,615550,DIAMOND-BLACKFAN ANEMIA 12, DBA12
23502,615551,"EPISODIC PAIN SYNDROME, FAMILIAL, 2", FEPS2
23503,615552,"EPISODIC PAIN SYNDROME, FAMILIAL, 3", FEPS3
23504,615553,"ARTHROGRYPOSIS, IMPAIRED INTELLECTUAL DEVELOPMENT, AND SEIZURES", AMRS
23505,615554,MULTIPLE FIBROADENOMAS OF THE BREAST, MFAB
23506,615555,HYPERPROLACTINEMIA, HPRL
23507,615556,ALPHA-TUBULIN ACETYLTRANSFERASE 1, ATAT1
23508,615557,"MELIOIDOSIS, SUSCEPTIBILITY TO",
23509,615558,"HYPOBETALIPOPROTEINEMIA, FAMILIAL, 1", FHBL1
23510,615559,"AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME, TYPE III", ALPS3
23511,615560,"OTOFACIOCERVICAL SYNDROME 2, WITH T-CELL DEFICIENCY", OTFCS2
23512,615561,COMPLEMENT FACTOR B DEFICIENCY, CFBD
23513,615562,SPERM-ASSOCIATED ANTIGEN 5, SPAG5
23514,615563,NUCLEAR RECEPTOR-BINDING PROTEIN 2, NRBP2
23515,615564,SIDEROFLEXIN 4, SFXN4
23516,615565,RETINITIS PIGMENTOSA 67, RP67
23517,615566,BTB/POZ DOMAIN-CONTAINING PROTEIN 3, BTBD3
23518,615567,COENZYME Q8B, COQ8B
23519,615568,"SWI/SNF COMPLEX ANTAGONIST ASSOCIATED WITH PROSTATE CANCER 1, NONCODING", SCHLAP1
23520,615569,SIDEROFLEXIN 1, SFXN1
23521,615570,SIDEROFLEXIN 2, SFXN2
23522,615571,SIDEROFLEXIN 3, SFXN3
23523,615572,SIDEROFLEXIN 5, SFXN5
23524,615573,"NEPHROTIC SYNDROME, TYPE 9", NPHS9
23525,615574,ASPARAGINE SYNTHETASE DEFICIENCY, ASNSD
23526,615575,"NEURONOPATHY, DISTAL HEREDITARY MOTOR, AUTOSOMAL DOMINANT 6", HMND6
23527,615576,MICRO RNA 185, MIR185
23528,615577,"IMMUNODEFICIENCY, COMMON VARIABLE, 10", CVID10
23529,615578,COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 18, COXPD18
23530,615579,ATAXIN 7-LIKE 3B, ATXN7L3B
23531,615580,ZINC FINGER PROTEIN 528, ZNF528
23532,615581,DOUBLE HOMEOBOX 4-LIKE 9, DUX4L9
23533,615582,LOEYS-DIETZ SYNDROME 5, LDS5
23534,615583,VERHEIJ SYNDROME, VRJS
23535,615584,"FAMILY WITH SEQUENCE SIMILARITY 111, MEMBER B", FAM111B
23536,615585,"SOLUTE CARRIER FAMILY 38 (AMINO ACID TRANSPORTER), MEMBER 8", SLC38A8
23537,615586,"CENTROSOMAL PROTEIN, 19-KD", CEP19
23538,615587,"NUCLEOPORIN, 188-KD", NUP188
23539,615588,SINGLE-PASS MEMBRANE PROTEIN WITH ASPARTATE-RICH TAIL 1, SMDT1
23540,615589,OTOSCLEROSIS 10, OTSC10
23541,615590,ALZHEIMER DISEASE 18, AD18
23542,615591,"MACULAR DEGENERATION, AGE-RELATED, 15", ARMD15
23543,615592,IMMUNODEFICIENCY 15B, IMD15B
23544,615593,IMMUNODEFICIENCY 16, IMD16
23545,615594,APELIN RECEPTOR EARLY ENDOGENOUS LIGAND, APELA
23546,615595,COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 19, COXPD19
23547,615596,"CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Iw, AUTOSOMAL RECESSIVE", CDG1WAR
23548,615597,"CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ix", CDG1X
23549,615598,"PALMOPLANTAR KERATODERMA, NAGASHIMA TYPE", PPKN
23550,615599,"NEURODEVELOPMENTAL DISORDER WITH FEEDING DIFFICULTIES, THIN CORPUS CALLOSUM, AND FOOT DEFORMITY", NEDFCF
23551,615600,ZINC FINGER PROTEIN 582, ZNF582
23552,615601,GLUTAMATE DECARBOXYLASE-LIKE 1, GADL1
23553,615602,MEMORY QUANTITATIVE TRAIT LOCUS, MEMRYQTL
23554,615603,CALCINEURIN-LIKE PHOSPHOESTERASE DOMAIN-CONTAINING PROTEIN 1, CPPED1
23555,615604,L-FERRITIN DEFICIENCY, LFTD
23556,615605,FANCONI RENOTUBULAR SYNDROME 3, FRTS3
23557,615606,BUTYROPHILIN-LIKE PROTEIN 8, BTNL8
23558,615607,IMMUNODEFICIENCY 17, IMD17
23559,615608,V-SET IMMUNOREGULATORY RECEPTOR, VSIR
23560,615609,"SIAH E3 UBIQUITIN PROTEIN LIGASE FAMILY, MEMBER 3", SIAH3
23561,615610,"CADHERIN-RELATED FAMILY, MEMBER 3", CDHR3
23562,615611,CASEINOLYTIC MITOCHONDRIAL MATRIX PEPTIDASE CHAPERONE SUBUNIT, CLPX
23563,615612,DEVELOPMENTAL DYSPLASIA OF THE HIP 2, DDH2
23564,615613,HEPATOCELLULAR CARCINOMA-ASSOCIATED TRANSCRIPT 5, HCCAT5
23565,615614,MMS22-LIKE PROTEIN, MMS22L
23566,615615,IMMUNODEFICIENCY 18, IMD18
23567,615616,"ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 13", ARVD13
23568,615617,"IMMUNODEFICIENCY 19, SEVERE COMBINED", IMD19
23569,615618,PROTEIN O-GLUCOSYLTRANSFERASE 1, POGLUT1
23570,615619,"CHOLANGIOCARCINOMA, SUSCEPTIBILITY TO",
23571,615620,KAPTIN, KPTN
23572,615621,RETROELEMENT SILENCING FACTOR 1, RESF1
23573,615622,TNF- AND HNRNPL-RELATED IMMUNOREGULATORY LONG NONCODING RNA, THRIL
23574,615623,CYTOCHROME C OXIDASE ASSEMBLY FACTOR 7, COA7
23575,615624,"COLORECTAL NEOPLASIA DIFFERENTIALLY EXPRESSED GENE, NONCODING", CRNDE
23576,615625,"SPASTIC PARAPLEGIA 72A, AUTOSOMAL DOMINANT", SPG72A
23577,615626,CDAN1-INTERACTING NUCLEASE 1, CDIN1
23578,615627,BRI3-BINDING PROTEIN, BRI3BP
23579,615628,BRAIN PROTEIN I3, BRI3
23580,615629,"DEAFNESS, AUTOSOMAL DOMINANT 56", DFNA56
23581,615630,SHORT-RIB THORACIC DYSPLASIA 10 WITH OR WITHOUT POLYDACTYLY, SRTD10
23582,615631,"ANEMIA, CONGENITAL DYSERYTHROPOIETIC, TYPE Ib", CDAN1B
23583,615632,"NEUROPATHY, HEREDITARY SENSORY, TYPE IF", HSN1F
23584,615633,SHORT-RIB THORACIC DYSPLASIA 11 WITH OR WITHOUT POLYDACTYLY, SRTD11
23585,615634,COILED-COIL-HELIX-COILED-COIL-HELIX DOMAIN-CONTAINING PROTEIN 6, CHCHD6
23586,615635,ZINC FINGER RNA-BINDING PROTEIN, ZFR
23587,615636,JOUBERT SYNDROME 21, JBTS21
23588,615637,"INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 41", MRT41
23589,615638,NON-SMC CONDENSIN I COMPLEX SUBUNIT D2, NCAPD2
23590,615639,SMALL CAJAL BODY-SPECIFIC RNA 10, SCARNA10
23591,615640,SMALL CAJAL BODY-SPECIFIC RNA 5, SCARNA5
23592,615641,SMALL CAJAL BODY-SPECIFIC RNA 6, SCARNA6
23593,615642,SMALL CAJAL BODY-SPECIFIC RNA 12, SCARNA12
23594,615643,NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 6, NBIA6
23595,615644,SMALL CAJAL BODY-SPECIFIC RNA 7, SCARNA7
23596,615645,SMALL CAJAL BODY-SPECIFIC RNA 17, SCARNA17
23597,615646,SMALL CAJAL BODY-SPECIFIC RNA 8, SCARNA8
23598,615647,TESTIS-EXPRESSED GENE 19, TEX19
23599,615648,"NLR FAMILY, CASPASE RECRUITMENT DOMAIN-CONTAINING 3", NLRC3
23600,615649,"DEAFNESS, AUTOSOMAL DOMINANT 54", DFNA54
23601,615650,REGULATOR OF G PROTEIN SIGNALING 22, RGS22
23602,615651,LEUKOENCEPHALOPATHY WITH ATAXIA, LKPAT
23603,615652,ACYL-CoA THIOESTERASE 13, ACOT13
23604,615653,THIOESTERASE SUPERFAMILY MEMBER 5, THEM5
23605,615654,"DEAFNESS, AUTOSOMAL DOMINANT 58", DFNA58
23606,615655,ZINC FINGER RANBP2-TYPE DOMAIN-CONTAINING PROTEIN 3, ZRANB3
23607,615656,CHROMOSOME 15q11.2 DELETION SYNDROME,
23608,615657,MICRO RNA 142, MIR142
23609,615658,"SPASTIC PARAPLEGIA 57, AUTOSOMAL RECESSIVE", SPG57
23610,615659,TRANSMEMBRANE PROTEIN 131, TMEM131
23611,615660,RIBOSOMAL PROTEIN L10A, RPL10A
23612,615661,PROGRAMMED CELL DEATH 2-LIKE PROTEIN, PDCD2L
23613,615662,"SERPIN PEPTIDASE INHIBITOR, CLADE B (OVALBUMIN), MEMBER 12", SERPINB12
23614,615663,WARBURG MICRO SYNDROME 4, WARBM4
23615,615664,THYMOCYTE-EXPRESSED POSITIVE SELECTION-ASSOCIATED PROTEIN 1, TESPA1
23616,615665,JOUBERT SYNDROME 22, JBTS22
23617,615666,PUTATIVE tRNA METHYLTRANSFERASE 9B, TRMT9B
23618,615667,ERCC EXCISION REPAIR 6-LIKE 2, ERCC6L2
23619,615668,CHROMOSOME 5q12 DELETION SYNDROME,
23620,615669,EMBIGIN, EMB
23621,615670,SCHWANNOMATOSIS 2, SWN2
23622,615671,SET DOMAIN-CONTAINING PROTEIN 3, SETD3
23623,615672,MICRO RNA 497, MIR497
23624,615673,MYOPATHY WITH EXTRAPYRAMIDAL SIGNS, MPXPS
23625,615674,DOWLING-DEGOS DISEASE 3, DDD3
23626,615675,MICRO RNA 301A, MIR301A
23627,615676,"TESTIS DEVELOPMENT-RELATED GENE 1, NONCODING", TDRG1
23628,615677,"SERPIN PEPTIDASE INHIBITOR, CLADE A, MEMBER 9", SERPINA9
23629,615678,SH3 DOMAIN-BINDING GLUTAMIC ACID-RICH PROTEIN-LIKE PROTEIN 2, SH3BGRL2
23630,615679,SH3 DOMAIN-BINDING GLUTAMIC ACID-RICH PROTEIN-LIKE PROTEIN 3, SH3BGRL3
23631,615680,CASPASE RECRUITMENT DOMAIN-CONTAINING PROTEIN 16, CARD16
23632,615681,"SPASTIC PARAPLEGIA 62, AUTOSOMAL RECESSIVE", SPG62
23633,615682,"SERPIN PEPTIDASE INHIBITOR, CLADE B (OVALBUMIN), MEMBER 11", SERPINB11
23634,615683,"SPASTIC PARAPLEGIA 64, AUTOSOMAL RECESSIVE", SPG64
23635,615684,HELICASE FOR MEIOSIS 1, HFM1
23636,615685,"SPASTIC PARAPLEGIA 61, AUTOSOMAL RECESSIVE", SPG61
23637,615686,"SPASTIC PARAPLEGIA 63, AUTOSOMAL RECESSIVE", SPG63
23638,615687,BECLIN 2, BECN2
23639,615688,"VASCULITIS, AUTOINFLAMMATION, IMMUNODEFICIENCY, AND HEMATOLOGIC DEFECTS SYNDROME", VAIHS
23640,615689,ADHESION MOLECULE WITH Ig-LIKE DOMAIN 1, AMIGO1
23641,615690,ADHESION MOLECULE WITH Ig-LIKE DOMAIN 2, AMIGO2
23642,615691,ADHESION MOLECULE WITH Ig-LIKE DOMAIN 3, AMIGO3
23643,615692,CHITINASE DOMAIN-CONTAINING PROTEIN 1, CHID1
23644,615693,COLCA1 GENE, COLCA1
23645,615694,POU CLASS 2 HOMEOBOX-ASSOCIATING FACTOR 3, POU2AF3
23646,615695,HEXAMETHYLENE BIS ACETAMIDE-INDUCIBLE PROTEIN 2, HEXIM2
23647,615696,DOWLING-DEGOS DISEASE 4, DDD4
23648,615697,"EPILEPSY, FAMILIAL TEMPORAL LOBE, 6", ETL6
23649,615698,"PHOSPHOLIPASE D FAMILY, MEMBER 3", PLD3
23650,615699,ZINC FINGER TRANSLOCATION-ASSOCIATED PROTEIN, ZFTA
23651,615700,PYRIN DOMAIN-CONTAINING PROTEIN 1, PYDC1
23652,615701,PYRIN DOMAIN-CONTAINING PROTEIN 2, PYDC2
23653,615702,"OLFACTORY RECEPTOR, FAMILY 5, SUBFAMILY AN, MEMBER 1", OR5AN1
23654,615703,MORBID OBESITY AND SPERMATOGENIC FAILURE, MOSPGF
23655,615704,"POIKILODERMA, HEREDITARY FIBROSING, WITH TENDON CONTRACTURES, MYOPATHY, AND PULMONARY FIBROSIS", POIKTMP
23656,615705,"SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 15", SCAR15
23657,615706,AURICULOCONDYLAR SYNDROME 3, ARCND3
23658,615707,IMMUNODEFICIENCY 20, IMD20
23659,615708,ZINC FINGER PROTEIN 451, ZNF451
23660,615709,SACRAL AGENESIS WITH VERTEBRAL ANOMALIES, SAVA
23661,615710,MITCHELL-RILEY SYNDROME, MTCHRS
23662,615711,ALZHEIMER DISEASE 19, AD19
23663,615712,OTU DEUBIQUITINASE WITH LINEAR LINKAGE SPECIFICITY, OTULIN
23664,615713,ZINC FINGER MYND DOMAIN-CONTAINING PROTEIN 8, ZMYND8
23665,615714,"POLR1H ANTISENSE, PSEUDOGENE", POLR1HASP
23666,615715,BONE MARROW FAILURE SYNDROME 2, BMFS2
23667,615716,HYPERPHOSPHATASIA WITH IMPAIRED INTELLECTUAL DEVELOPMENT SYNDROME 4, HPMRS4
23668,615717,"BPI FOLD-CONTAINING PROTEIN, FAMILY B, MEMBER 3", BPIFB3
23669,615718,"BPI FOLD-CONTAINING PROTEIN, FAMILY B, MEMBER 4", BPIFB4
23670,615719,TCL1 UPSTREAM NEURAL DIFFERENTIATION-ASSOCIATED RNA, TUNAR
23671,615720,"SOLUTE CARRIER FAMILY 7, MEMBER 14", SLC7A14
23672,615721,RENAL HYPODYSPLASIA/APLASIA 2, RHDA2
23673,615722,BOSCH-BOONSTRA-SCHAAF OPTIC ATROPHY SYNDROME, BBSOAS
23674,615723,PREMATURE OVARIAN FAILURE 8, POF8
23675,615724,PREMATURE OVARIAN FAILURE 9, POF9
23676,615725,RETINITIS PIGMENTOSA 68, RP68
23677,615726,PACHYONYCHIA CONGENITA 3, PC3
23678,615727,"KILLER CELL IMMUNOGLOBULIN-LIKE RECEPTOR, TWO DOMAINS, LONG CYTOPLASMIC TAIL, 5B", KIR2DL5B
23679,615728,PACHYONYCHIA CONGENITA 4, PC4
23680,615729,"STRAWBERRY NOTCH, DROSOPHILA, HOMOLOG OF, 2", SBNO2
23681,615730,DEDICATOR OF CYTOKINESIS 7, DOCK7
23682,615731,NEMALINE MYOPATHY 9, NEM9
23683,615732,"NOP2/SUN RNA METHYLTRANSFERASE FAMILY, MEMBER 5", NSUN5
23684,615733,rRNA METHYLTRANSFERASE AND RIBOSOME MATURATION FACTOR BUD23, BUD23
23685,615734,WD REPEAT-CONTAINING PROTEIN 47, WDR47
23686,615735,"PALMOPLANTAR KERATODERMA, NONEPIDERMOLYTIC, FOCAL OR DIFFUSE", PPKNEFD
23687,615736,ENDOTHELIAL CELL SURFACE-EXPRESSED CHEMOTAXIS AND APOPTOSIS REGULATOR, ECSCR
23688,615737,"IZUMO1 RECEPTOR, JUNO", IZUMO1R
23689,615738,VPS51 SUBUNIT OF GARP COMPLEX, VPS51
23690,615739,"POU DOMAIN, CLASS 5, TRANSCRIPTION FACTOR 1B", POU5F1B
23691,615740,"TBC1 DOMAIN FAMILY, MEMBER 5", TBC1D5
23692,615741,DAP3-BINDING CELL DEATH ENHANCER 1, DELE1
23693,615742,"RGP1 HOMOLOG, RAB6A GEF COMPLEX PARTNER 1", RGP1
23694,615743,SET DOMAIN-CONTAINING PROTEIN 5, SETD5
23695,615744,DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 19, DEE19
23696,615745,ATRIAL STANDSTILL 2, ATRST2
23697,615746,ZXD FAMILY ZINC FINGER PROTEIN C, ZXDC
23698,615747,CEA CELL ADHESION MOLECULE 8, CEACAM8
23699,615748,"WASH COMPLEX, SUBUNIT 4", WASHC4
23700,615749,"ECULIZUMAB, POOR RESPONSE TO",
23701,615750,MOYAMOYA DISEASE 6 WITH OR WITHOUT ACHALASIA, MYMY6
23702,615751,"CARBONIC ANHYDRASE VA DEFICIENCY, HYPERAMMONEMIA DUE TO", CA5AD
23703,615752,"CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 14B (BILATERAL PERISYLVIAN)", CDCBM14B
23704,615753,POM121 TRANSMEMBRANE NUCLEOPORIN, POM121
23705,615754,POM121 TRANSMEMBRANE NUCLEOPORIN C, POM121C
23706,615755,FORKHEAD BOX R1, FOXR1
23707,615756,SELENOCYSTEINE INSERTION SEQUENCE-BINDING PROTEIN 2-LIKE, SECISBP2L
23708,615757,KIZUNA CENTROSOMAL PROTEIN, KIZ
23709,615758,IMMUNODEFICIENCY 22, IMD22
23710,615759,"KINASE D-INTERACTING SUBSTRATE, 220-KD", KIDINS220
23711,615760,"MICROCEPHALY, PROGRESSIVE, WITH SEIZURES AND CEREBRAL AND CEREBELLAR ATROPHY", MSCCA
23712,615761,"INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 23", MRD23
23713,615762,"GLUTAREDOXIN, CYSTEINE-RICH, 2", GRXCR2
23714,615763,"CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 5", CDCBM5
23715,615764,LONG STRESS-INDUCED NONCODING TRANSCRIPT 5, LSINCT5
23716,615765,"SOLUTE CARRIER FAMILY 16, MEMBER 11", SLC16A11
23717,615766,MICROTUBULE CROSSLINKING FACTOR 1, MTCL1
23718,615767,"IMMUNODEFICIENCY, COMMON VARIABLE, 11", CVID11
23719,615768,"SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 16", SCAR16
23720,615769,"FAMILY WITH SEQUENCE SIMILARITY 169, MEMBER A", FAM169A
23721,615770,"ATRIAL FIBRILLATION, FAMILIAL, 15", ATFB15
23722,615771,"CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 6", CDCBM6
23723,615772,"WAP FOUR-DISULFIDE CORE DOMAIN 21, PSEUDOGENE", WFDC21P
23724,615773,SUCCINATE DEHYDROGENASE COMPLEX ASSEMBLY FACTOR 3, SDHAF3
23725,615774,OOCYTE/ZYGOTE/EMBRYO MATURATION ARREST 1, OZEMA1
23726,615775,SYNAPTONEMAL COMPLEX CENTRAL ELEMENT PROTEIN 3, SYCE3
23727,615776,CILIARY ROOTLET COILED-COIL PROTEIN, CROCC
23728,615777,DESBUQUOIS DYSPLASIA 2, DBQD2
23729,615778,CLAUDIN 15, CLDN15
23730,615779,"CONGENITAL HEART DEFECTS, MULTIPLE TYPES, 4", CHTD4
23731,615780,RETINITIS PIGMENTOSA 69, RP69
23732,615781,"ADAPTOR-RELATED PROTEIN COMPLEX 1, SIGMA-3 SUBUNIT", AP1S3
23733,615782,CIRCADIAN-ASSOCIATED REPRESSOR OF TRANSCRIPTION, CIART
23734,615783,N-ACETYLTRANSFERASE 16, NAT16
23735,615784,GLUTATHIONE PEROXIDASE 7, GPX7
23736,615785,WHITE SPONGE NEVUS 2, WSN2
23737,615786,"NACC FAMILY, MEMBER 2, BEN AND BTB/POZ DOMAINS-CONTAINING", NACC2
23738,615787,"NAD KINASE 2, MITOCHONDRIAL", NADK2
23739,615788,NEDD4-BINDING PROTEIN 2-LIKE 2, N4BP2L2
23740,615789,"ROTHMUND-THOMSON SYNDROME, TYPE 3", RTS3
23741,615790,AT-HOOK DNA-BINDING MOTIF-CONTAINING PROTEIN 1, AHDC1
23742,615791,NUDIX HYDROLASE 18, NUDT18
23743,615792,NUDIX HYDROLASE 15, NUDT15
23744,615793,ISTHMIN 1, ISM1
23745,615794,FIBRONECTIN TYPE III DOMAIN-CONTAINING PROTEIN 3A, FNDC3A
23746,615795,FIBROUS SHEATH-INTERACTING PROTEIN 1, FSIP1
23747,615796,FIBROUS SHEATH-INTERACTING PROTEIN 2, FSIP2
23748,615797,"HLA COMPLEX GROUP 9, NONCODING", HCG9
23749,615798,CLAUDIN 6, CLDN6
23750,615799,CLAUDIN 9, CLDN9
23751,615800,"FASCIN ACTIN-BUNDLING PROTEIN 3, TESTICULAR", FSCN3
23752,615801,"POLR1H ANTISENSE, PSEUDOGENE",
23753,615802,"NEURODEVELOPMENTAL DISORDER WITH DYSMORPHIC FEATURES, SPASTICITY, AND BRAIN ABNORMALITIES", NEDDSBA
23754,615803,"PONTOCEREBELLAR HYPOPLASIA, TYPE 10", PCH10
23755,615804,UREIDOIMIDAZOLINE (2-OXO-4-HYDROXY-4-CARBOXY-5-) DECARBOXYLASE, URAD
23756,615805,"URATE (HYDROXYISO-) HYDROLASE, PSEUDOGENE", URAHP
23757,615806,"SOLUTE CARRIER FAMILY 15 (OLIGOPEPTIDE TRANSPORTER), MEMBER 4", SLC15A4
23758,615807,SECKEL SYNDROME 8, SCKL8
23759,615808,"TRANSLATION MACHINERY-ASSOCIATED 7, S. CEREVISIAE, HOMOLOG OF", TMA7
23760,615809,"PONTOCEREBELLAR HYPOPLASIA, TYPE 9", PCH9
23761,615810,CHROMOSOME 11 OPEN READING FRAME 54, C11ORF54
23762,615811,PEPTIDYL-PROLYL ISOMERASE-LIKE 3, PPIL3
23763,615812,ABDOMINAL OBESITY-METABOLIC SYNDROME 3, AOMS3
23764,615813,"FAMILY WITH SEQUENCE SIMILARITY 193, MEMBER B", FAM193B
23765,615814,SERINE/THREONINE/TYROSINE-INTERACTING PROTEIN, STYX
23766,615815,SMOOTH MUSCLE- AND ENDOTHELIAL CELL-ENRICHED MIGRATION/DIFFERENTIATION-ASSOCIATED LONG NONCODING RNA, SENCR
23767,615816,IMMUNODEFICIENCY 23, IMD23
23768,615817,"INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 43", MRT43
23769,615818,RIBOSOMAL RNA PROCESSING 8, RRP8
23770,615819,"SULFOTRANSFERASE FAMILY 1A, CYTOSOLIC, PHENOL-PREFERRING, MEMBER 4", SULT1A4
23771,615820,DDB1- AND CUL4-ASSOCIATED FACTOR 8, DCAF8
23772,615821,"CARDIOMYOPATHY, DILATED, WITH WOOLLY HAIR, KERATODERMA, AND TOOTH AGENESIS", DCWHKTA
23773,615822,"SLX1 HOMOLOG A, STRUCTURE-SPECIFIC ENDONUCLEASE SUBUNIT", SLX1A
23774,615823,"SLX1 HOMOLOG B, STRUCTURE-SPECIFIC ENDONUCLEASE SUBUNIT", SLX1B
23775,615824,"MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 7", MC3DN7
23776,615825,SUSHI DOMAIN-CONTAINING PROTEIN 2, SUSD2
23777,615826,SPERM-TAIL PG-RICH REPEAT-CONTAINING PROTEIN 1, STPG1
23778,615827,SUSHI DOMAIN-CONTAINING PROTEIN 4, SUSD4
23779,615828,VULTO-VAN SILFHOUT-DE VRIES SYNDROME, VSVS
23780,615829,XIA-GIBBS SYNDROME, XIGIS
23781,615830,"PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 4", PPNAD4
23782,615831,LYR MOTIF-CONTAINING PROTEIN 7, LYRM7
23783,615832,UBIQUITIN-CONJUGATING ENZYME E2 Q FAMILY-LIKE PROTEIN 1, UBE2QL1
23784,615833,DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 21, DEE21
23785,615834,"INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 26", MRD26
23786,615835,"CHROMOSOME 16 INVERSION, 0.45-MB",
23787,615836,SERINE/THREONINE PROTEIN KINASE 38-LIKE PROTEIN, STK38L
23788,615837,"DEAFNESS, AUTOSOMAL RECESSIVE 101", DFNB101
23789,615838,"MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 8", MC3DN8
23790,615839,"2,4-DIENOYL-CoA REDUCTASE 2, PEROXISOMAL", DECR2
23791,615840,dCTP PYROPHOSPHATASE 1, DCTPP1
23792,615841,SPERMATOGENIC FAILURE 13, SPGF13
23793,615842,SPERMATOGENIC FAILURE 14, SPGF14
23794,615843,"DELTA(4)-DESATURASE, SPHINGOLIPID, 1", DEGS1
23795,615844,TRIOKINASE AND FMN CYCLASE, TKFC
23796,615845,MICRO RNA 190A, MIR190A
23797,615846,AICARDI-GOUTIERES SYNDROME 7, AGS7
23798,615847,"CENTROSOMAL PROTEIN, 83-KD", CEP83
23799,615848,TUMOR PREDISPOSITION SYNDROME 3, TPDS3
23800,615849,CULLER-JONES SYNDROME, CJS
23801,615850,VPS53 SUBUNIT OF GARP COMPLEX, VPS53
23802,615851,"PONTOCEREBELLAR HYPOPLASIA, TYPE 2E", PCH2E
23803,615852,RAS-ASSOCIATED PROTEIN RAB6B, RAB6B
23804,615853,POLYAMINE OXIDASE, PAOX
23805,615854,SPERMINE OXIDASE, SMOX
23806,615855,TRANSMEMBRANE AND TETRATRICOPEPTIDE REPEAT DOMAINS-CONTAINING PROTEIN 1, TMTC1
23807,615856,TRANSMEMBRANE AND TETRATRICOPEPTIDE REPEAT DOMAINS-CONTAINING PROTEIN 2, TMTC2
23808,615857,2-OXOGLUTARATE- AND IRON-DEPENDENT OXYGENASE DOMAIN-CONTAINING PROTEIN 1, OGFOD1
23809,615858,ROUND SPERMATID BASIC PROTEIN 1, RSBN1
23810,615859,DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 23, DEE23
23811,615860,CONE-ROD DYSTROPHY 19, CORD19
23812,615861,"NEPHROTIC SYNDROME, TYPE 10", NPHS10
23813,615862,NEPHRONOPHTHISIS 18, NPHP18
23814,615863,"DIARRHEA 7, PROTEIN-LOSING ENTEROPATHY TYPE", DIAR7
23815,615864,"CENTROSOMAL PROTEIN, 97-KD", CEP97
23816,615865,NEURALIZED E3 UBIQUITIN PROTEIN LIGASE 4, NEURL4
23817,615866,INTELLECTUAL DEVELOPMENTAL DISORDER WITH MICROCEPHALY AND WITH OR WITHOUT OCULAR MALFORMATIONS OR HYPOGONADOTROPIC HYPOGONADISM, IDDMOH
23818,615867,"TBC1 DOMAIN FAMILY, MEMBER 32", TBC1D32
23819,615868,"SERINE PEPTIDASE INHIBITOR, KAZAL-TYPE, 6", SPINK6
23820,615869,TUMOR NECROSIS FACTOR-ALPHA-INDUCED PROTEIN 8-LIKE 1, TNFAIP8L1
23821,615870,INTRAFLAGELLAR TRANSPORT 27, IFT27
23822,615871,DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 24, DEE24
23823,615872,"CILIARY DYSKINESIA, PRIMARY, 29", CILD29
23824,615873,HELSMOORTEL-VAN DER AA SYNDROME, HVDAS
23825,615874,RIBOSOMAL L1 DOMAIN-CONTAINING PROTEIN 1, RSL1D1
23826,615875,RWD DOMAIN-CONTAINING PROTEIN 3, RWDD3
23827,615876,RADIAL SPOKE HEAD 3, RSPH3
23828,615877,MICROPHTHALMIA/COLOBOMA AND SKELETAL DYSPLASIA SYNDROME, MCSKS
23829,615878,"CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC, 4", PFIC4
23830,615879,TATTON-BROWN-RAHMAN SYNDROME, TBRS
23831,615880,RHO GTPase-ACTIVATING PROTEIN 39, ARHGAP39
23832,615881,PLASMA TRIGLYCERIDE LEVEL QUANTITATIVE TRAIT LOCUS, TGQTL
23833,615882,RAB GTPase-ACTIVATING PROTEIN 1, RABGAP1
23834,615883,"MYOPATHY, TUBULAR AGGREGATE, 2", TAM2
23835,615884,ADIPOCYTE PLASMA MEMBRANE-ASSOCIATED PROTEIN, APMAP
23836,615885,HYPOTRICHOSIS 12, HYPT12
23837,615886,"FAMILY WITH SEQUENCE SIMILARITY 83, MEMBER G", FAM83G
23838,615887,"AMELOGENESIS IMPERFECTA, HYPOMATURATION TYPE, IIA5", AI2A5
23839,615888,"BLEEDING DISORDER, PLATELET-TYPE, 18", BDPLT18
23840,615889,"LEUKOENCEPHALOPATHY, PROGRESSIVE, WITH OVARIAN FAILURE", LKENP
23841,615890,"DYNEIN, CYTOPLASMIC 1, LIGHT INTERMEDIATE CHAIN 1", DYNC1LI1
23842,615891,"ZINC FINGER- AND BTB DOMAIN-CONTAINING PROTEIN 8, OPPOSITE STRAND", ZBTB8OS
23843,615892,OROFACIAL CLEFT 14, OFC14
23844,615893,NEURALIZED E3 UBIQUITIN PROTEIN LIGASE 1B, NEURL1B
23845,615894,ZINC FINGER PROTEIN 407, ZNF407
23846,615895,POLYGLUCOSAN BODY MYOPATHY 1 WITH OR WITHOUT IMMUNODEFICIENCY, PGBM1
23847,615896,HYPOTRICHOSIS 13, HYPT13
23848,615897,IMMUNODEFICIENCY 24, IMD24
23849,615898,"NADH DEHYDROGENASE (UBIQUINONE) COMPLEX I, ASSEMBLY FACTOR 7", NDUFAF7
23850,615899,OLFACTOMEDIN-LIKE 2A, OLFML2A
23851,615900,AATP/GTP-BINDING PROTEIN-LIKE 5, AGBL5
23852,615901,"NCCRP1, F-BOX-ASSOCIATED DOMAIN CONTAINING", NCCRP1
23853,615902,"PROTEIN PHOSPHATASE 2, REGULATORY SUBUNIT B-DOUBLE PRIME, GAMMA", PPP2R3C
23854,615903,COILED-COIL-HELIX-COILED-COIL-HELIX DOMAIN-CONTAINING PROTEIN 10, CHCHD10
23855,615904,PEROXIDASIN-LIKE PROTEIN, PXDNL
23856,615905,DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 25 WITH AMELOGENESIS IMPERFECTA, DEE25
23857,615906,ORC UBIQUITIN LIGASE 1, OBI1
23858,615907,LYMPHATIC MALFORMATION 4, LMPHM4
23859,615908,MICRO RNA 520C, MIR520C
23860,615909,DIAMOND-BLACKFAN ANEMIA 13, DBA13
23861,615910,NAD(P)HX DEHYDRATASE, NAXD
23862,615911,FRONTOTEMPORAL DEMENTIA AND/OR AMYOTROPHIC LATERAL SCLEROSIS 2, FTDALS2
23863,615912,GLUTATHIONE S-TRANSFERASE C-TERMINAL DOMAIN-CONTAINING PROTEIN, GSTCD
23864,615913,PEPTIDASE M20 DOMAIN-CONTAINING PROTEIN 2, PM20D2
23865,615914,CYCLIN-DEPENDENT KINASE INHIBITOR 2A-INTERACTING PROTEIN, CDKN2AIP
23866,615915,ZONA PELLUCIDA-LIKE DOMAIN-CONTAINING PROTEIN 1, ZPLD1
23867,615916,"CARDIOMYOPATHY, DILATED, 1NN", CMD1NN
23868,615917,COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 20, COXPD20
23869,615918,COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 21, COXPD21
23870,615919,ATAXIA-TELANGIECTASIA-LIKE DISORDER 2, ATLD2
23871,615920,PROLINE-RICH PROTEIN 11, PRR11
23872,615921,"PPARGC1- AND ESRR-INDUCED REGULATOR, MUSCLE, 1", PERM1
23873,615922,RETINITIS PIGMENTOSA 70, RP70
23874,615923,"EPIPHYSEAL CHONDRODYSPLASIA, MIURA TYPE", ECDM
23875,615924,"ENCEPHALOPATHY, PROGRESSIVE, WITH OR WITHOUT LIPODYSTROPHY", PELD
23876,615925,"GROWTH HORMONE DEFICIENCY, ISOLATED PARTIAL", GHDP
23877,615926,WEBB-DATTANI SYNDROME, WEDAS
23878,615927,REFILIN A, RFLNA
23879,615928,REFILIN B, RFLNB
23880,615929,ANKYRIN REPEAT DOMAIN-CONTAINING PROTEIN 17, ANKRD17
23881,615930,"COLORECTAL ADENOCARCINOMA HYPERMETHYLATED GENE, NONCODING", CAHM
23882,615931,PROLINE-RICH PROTEIN 16, PRR16
23883,615932,POTASSIUM CHANNEL TETRAMERIZATION DOMAIN-CONTAINING PROTEIN 20, KCTD20
23884,615933,BTB/POZ DOMAIN-CONTAINING PROTEIN 10, BTBD10
23885,615934,"STING-ASSOCIATED VASCULOPATHY, INFANTILE-ONSET", SAVI
23886,615935,PANCREATIC AGENESIS 2, PAGEN2
23887,615936,RHO GTPase-ACTIVATING PROTEIN 42, ARHGAP42
23888,615937,MEGALENCEPHALY-POLYMICROGYRIA-POLYDACTYLY-HYDROCEPHALUS SYNDROME 2, MPPH2
23889,615938,MEGALENCEPHALY-POLYMICROGYRIA-POLYDACTYLY-HYDROCEPHALUS SYNDROME 3, MPPH3
23890,615939,"PROTEIN TYROSINE PHOSPHATASE-LIKE (PROLINE INSTEAD OF CATALYTIC ARGININE), MEMBER B", PTPLB
23891,615940,PROTEIN TYROSINE PHOSPHATASE-LIKE A DOMAIN-CONTAINING PROTEIN 1, PTPLAD1
23892,615941,PROTEIN TYROSINE PHOSPHATASE-LIKE A DOMAIN-CONTAINING PROTEIN 2, PTPLAD2
23893,615942,"INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 44", MRT44
23894,615943,"MEMBRANE-ASSOCIATED GUANYLATE KINASE, WW AND PDZ DOMAINS-CONTAINING, 3", MAGI3
23895,615944,C2 CALCIUM-DEPENDENT DOMAIN-CONTAINING PROTEIN 3, C2CD3
23896,615945,SPINOCEREBELLAR ATAXIA 37, SCA37
23897,615946,"MYOPIA 24, AUTOSOMAL DOMINANT", MYP24
23898,615947,"HYPERLIPOPROTEINEMIA, TYPE ID",
23899,615948,OROFACIODIGITAL SYNDROME XIV, OFD14
23900,615949,TRANSMEMBRANE PROTEIN 98, TMEM98
23901,615950,SPEG COMPLEX LOCUS, SPEG
23902,615951,ZINC FINGER SWIM DOMAIN-CONTAINING PROTEIN 6, ZSWIM6
23903,615952,"AUTOIMMUNE DISEASE, MULTISYSTEM, INFANTILE-ONSET, 1", ADMIO1
23904,615953,"KALLIKREIN, DECREASED URINARY ACTIVITY OF",
23905,615954,ACTH-INDEPENDENT MACRONODULAR ADRENAL HYPERPLASIA 2, AIMAH2
23906,615955,COILED-COIL DOMAIN-CONTAINING PROTEIN 183, CCDC183
23907,615956,OUTER DYNEIN ARM DOCKING COMPLEX SUBUNIT 3, ODAD3
23908,615957,SPINOCEREBELLAR ATAXIA 38, SCA38
23909,615958,SLX4-INTERACTING PROTEIN, SLX4IP
23910,615959,"MYOPATHY, CENTRONUCLEAR, 5", CNM5
23911,615960,PORETTI-BOLTSHAUSER SYNDROME, PTBHS
23912,615961,ACID-LABILE SUBUNIT DEFICIENCY, ACLSD
23913,615962,"GLUCOCORTICOID RESISTANCE, GENERALIZED", GCCR
23914,615963,VESICOURETERAL REFLUX 8, VUR8
23915,615964,"MIR99A-LET7C CLUSTER HOST GENE, NONCODING", MIR99AHG
23916,615965,"MIR100-LET7A2 CLUSTER HOST GENE, NONCODING", MIR100HG
23917,615966,IMMUNODEFICIENCY 26 WITH OR WITHOUT NEUROLOGIC ABNORMALITIES, IMD26
23918,615967,"CYTOCHROME P450, FAMILY 2, SUBFAMILY W, POLYPEPTIDE 1", CYP2W1
23919,615968,"MYCN UPSTREAM TRANSCRIPT, NONCODING", MYCNUT
23920,615969,ALPHA-FETOPROTEIN DEFICIENCY, AFPD
23921,615970,"ALPHA-FETOPROTEIN, HEREDITARY PERSISTENCE OF", HPAFP
23922,615971,TITLE NOT AVAILABLE AT THIS MOMENT,
23923,615972,NANOPHTHALMOS 4, NNO4
23924,615973,CONE-ROD DYSTROPHY 20, CORD20
23925,615974,"DEAFNESS, AUTOSOMAL RECESSIVE 102", DFNB102
23926,615975,TRANSMEMBRANE PROTEIN 129, TMEM129
23927,615976,"FOXC1 UPSTREAM TRANSCRIPT, NONCODING", FOXCUT
23928,615977,MICRO RNA 339, MIR339
23929,615978,IMMUNODEFICIENCY 27B, IMD27B
23930,615979,"INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 45", MRT45
23931,615980,"LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 6", FPLD6
23932,615981,BARDET-BIEDL SYNDROME 2, BBS2
23933,615982,BARDET-BIEDL SYNDROME 4, BBS4
23934,615983,BARDET-BIEDL SYNDROME 5, BBS5
23935,615984,BARDET-BIEDL SYNDROME 7, BBS7
23936,615985,BARDET-BIEDL SYNDROME 8, BBS8
23937,615986,BARDET-BIEDL SYNDROME 9, BBS9
23938,615987,BARDET-BIEDL SYNDROME 10, BBS10
23939,615988,BARDET-BIEDL SYNDROME 11, BBS11
23940,615989,BARDET-BIEDL SYNDROME 12, BBS12
23941,615990,BARDET-BIEDL SYNDROME 13, BBS13
23942,615991,BARDET-BIEDL SYNDROME 14, BBS14
23943,615992,BARDET-BIEDL SYNDROME 15, BBS15
23944,615993,BARDET-BIEDL SYNDROME 16, BBS16
23945,615994,BARDET-BIEDL SYNDROME 17, BBS17
23946,615995,BARDET-BIEDL SYNDROME 18, BBS18
23947,615996,BARDET-BIEDL SYNDROME 19, BBS19
23948,615997,"DEFENSIN, BETA, 119", DEFB119
23949,615998,RING FINGER PROTEIN 10, RNF10
23950,615999,"HYPERTHYROXINEMIA, FAMILIAL DYSALBUMINEMIC", FDAH
23951,616000,ANALBUMINEMIA, ANALBA
23952,616001,"BREASTS AND/OR NIPPLES, APLASIA OR HYPOPLASIA OF, 2", BNAH2
23953,616002,FOCAL SEGMENTAL GLOMERULOSCLEROSIS 7, FSGS7
23954,616003,"APOPTOGENIC PROTEIN 1, MITOCHONDRIAL", APOPT1
23955,616004,"DYSFIBRINOGENEMIA, CONGENITAL",
23956,616005,IMMUNODEFICIENCY 36 WITH LYMPHOPROLIFERATION, IMD36
23957,616006,HENNEKAM LYMPHANGIECTASIA-LYMPHEDEMA SYNDROME 2, HKLLS2
23958,616007,"CATARACTS, GROWTH HORMONE DEFICIENCY, SENSORY NEUROPATHY, SENSORINEURAL HEARING LOSS, AND SKELETAL DYSPLASIA", CAGSSS
23959,616008,"COP9 SIGNALOSOME, SUBUNIT 4", COPS4
23960,616009,"COP9 SIGNALOSOME, SUBUNIT 7A", COPS7A
23961,616010,"COP9 SIGNALOSOME, SUBUNIT 7B", COPS7B
23962,616011,"COP9 SIGNALOSOME, SUBUNIT 8", COPS8
23963,616012,JAGUNAL HOMOLOG 1, JAGN1
23964,616013,tRNA METHYLTRANSFERASE 10A, TRMT10A
23965,616014,RING FINGER PROTEIN 25, RNF25
23966,616015,RING FINGER PROTEIN 180, RNF180
23967,616016,"PROTEIN PHOSPHATASE, MAGNESIUM/MANGANESE-DEPENDENT, 1H", PPM1H
23968,616017,TRIPARTITE MOTIF-CONTAINING PROTEIN 69, TRIM69
23969,616018,TITLE NOT AVAILABLE AT THIS MOMENT,
23970,616019,REST COREPRESSOR 2, RCOR2
23971,616020,CYSTEINE/TYROSINE-RICH PROTEIN 1, CYYR1
23972,616021,CYYR1 ANTISENSE RNA 1, CYYR1AS1
23973,616022,"NEUTROPENIA, SEVERE CONGENITAL, 6, AUTOSOMAL RECESSIVE", SCN6
23974,616023,SR-RELATED C-TERMINAL DOMAIN-ASSOCIATED FACTOR 4, SCAF4
23975,616024,SR-RELATED C-TERMINAL DOMAIN-ASSOCIATED FACTOR 8, SCAF8
23976,616025,GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 11, GPIBD11
23977,616026,FANCONI RENOTUBULAR SYNDROME 4 WITH MATURITY-ONSET DIABETES OF THE YOUNG, FRTS4
23978,616027,ACTIN-BINDING PROTEIN ANILLIN, ANLN
23979,616028,ADAMS-OLIVER SYNDROME 5, AOS5
23980,616029,ECTODERMAL DYSPLASIA/SHORT STATURE SYNDROME, ECTDS
23981,616030,HYPOGONADOTROPIC HYPOGONADISM 22 WITH OR WITHOUT ANOSMIA, HH22
23982,616031,COILED-COIL DOMAIN-CONTAINING PROTEIN 141, CCDC141
23983,616032,FOCAL SEGMENTAL GLOMERULOSCLEROSIS 8, FSGS8
23984,616033,"MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 1", MSSGM1
23985,616034,"2,4-DIENOYL-CoA REDUCTASE DEFICIENCY", DECRD
23986,616035,FORKHEAD BOX J3, FOXJ3
23987,616036,MICRO RNA 494, MIR494
23988,616037,"CILIARY DYSKINESIA, PRIMARY, 30", CILD30
23989,616038,NEU-LAXOVA SYNDROME 2, NLS2
23990,616039,"CHARCOT-MARIE-TOOTH DISEASE, RECESSIVE INTERMEDIATE D", CMTRID
23991,616040,"MYASTHENIC SYNDROME, CONGENITAL, 7A, PRESYNAPTIC, AND DISTAL MOTOR NEUROPATHY, AUTOSOMAL DOMINANT", CMS7A
23992,616041,THIOSULFATE SULFURTRANSFERASE (RHODANESE)-LIKE DOMAIN-CONTAINING PROTEIN 1, TSTD1
23993,616042,"DEAFNESS, AUTOSOMAL RECESSIVE 103", DFNB103
23994,616043,"PROSTATE CANCER-ASSOCIATED TRANSCRIPT 1, NONCODING", PCAT1
23995,616044,"DEAFNESS, AUTOSOMAL DOMINANT 65", DFNA65
23996,616045,COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 22, COXPD22
23997,616046,PROLINE/SERINE/THREONINE PHOSPHATASE-INTERACTING PROTEIN 2, PSTPIP2
23998,616047,CILIA- AND FLAGELLA-ASSOCIATED PROTEIN 97, CFAP97
23999,616048,"ALU-MEDIATED CDKN1A/p21 TRANSCRIPTIONAL REGULATOR, NONCODING", APTR
24000,616049,TRANSLOCASE OF OUTER MITOCHONDRIAL MEMBRANE 34, TOMM34
24001,616050,AUTOINFLAMMATION WITH INFANTILE ENTEROCOLITIS, AIFEC
24002,616051,"MICROCEPHALY 13, PRIMARY, AUTOSOMAL RECESSIVE", MCPH13
24003,616052,"MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 7", MDDGC7
24004,616053,SPINOCEREBELLAR ATAXIA 40, SCA40
24005,616054,"ELONGATOR ACETYLTRANSFERASE COMPLEX, SUBUNIT 2", ELP2
24006,616055,"EPISODIC ATAXIA, TYPE 8", EA8
24007,616056,DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 26, DEE26
24008,616057,"TUMOR SUPPRESSOR CANDIDATE 7, NONCODING", TUSC7
24009,616058,TCF21 ANTISENSE RNA INDUCING PROMOTER DEMETHYLATION, TARID
24010,616059,MIRROR MOVEMENTS 3, MRMV3
24011,616060,"BLOOD GROUP, DOMBROCK SYSTEM", DO
24012,616061,MAX DIMERIZATION PROTEIN MGA, MGA
24013,616062,ANKYRIN REPEAT- AND LEM DOMAIN-CONTAINING PROTEIN 2, ANKLE2
24014,616063,"POROKERATOSIS 8, DISSEMINATED SUPERFICIAL ACTINIC TYPE", POROK8
24015,616064,TUBULOINTERSTITIAL NEPHRITIS ANTIGEN-LIKE PROTEIN 1, TINAGL1
24016,616065,PILR-ALPHA-ASSOCIATED NEURAL PROTEIN, PIANP
24017,616066,SPERMATOGENESIS- AND OOGENESIS-SPECIFIC BASIC HELIX-LOOP-HELIX PROTEIN 2, SOHLH2
24018,616067,"46,XY SEX REVERSAL 9", SRXY9
24019,616068,"HOXA CLUSTER ANTISENSE RNA 2, NONCODING", HOXAAS2
24020,616069,NEONATAL NEPHROCUTANEOUS INFLAMMATORY SYNDROME, NNCIS
24021,616070,COILED-COIL DOMAIN-CONTAINING PROTEIN 113, CCDC113
24022,616071,SPERM MICROTUBULE INNER PROTEIN 4, SPMIP4
24023,616072,HETEROCHROMATIN PROTEIN 1-BINDING PROTEIN 3, HP1BP3
24024,616073,DEP DOMAIN-CONTAINING PROTEIN 1B, DEPDC1B
24025,616074,CHEMOKINE-LIKE FACTOR, CKLF
24026,616075,"DEFENSIN, BETA, 121", DEFB121
24027,616076,"DEFENSIN, BETA, 123", DEFB123
24028,616077,"DEFENSIN, BETA, 122, PSEUDOGENE", DEFB122
24029,616078,"INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 29", MRD29
24030,616079,RETINAL DYSTROPHY WITH INNER RETINAL DYSFUNCTION AND GANGLION CELL ABNORMALITIES, RDGCA
24031,616080,"MICROCEPHALY 12, PRIMARY, AUTOSOMAL RECESSIVE", MCPH12
24032,616081,"PONTOCEREBELLAR HYPOPLASIA, TYPE 1C", PCH1C
24033,616082,CHROMOSOME 12 OPEN READING FRAME 4, C12ORF4
24034,616083,"INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 30, WITH SPEECH DELAY AND BEHAVIORAL ABNORMALITIES", MRD30
24035,616084,"SIDEROBLASTIC ANEMIA WITH B-CELL IMMUNODEFICIENCY, PERIODIC FEVERS, AND DEVELOPMENTAL DELAY", SIFD
24036,616085,ZINC FINGER PROTEIN 37A, ZNF37A
24037,616086,SprT-LIKE N-TERMINAL DOMAIN PROTEIN, SPRTN
24038,616087,TYPE 2 DIABETES 5, T2D5
24039,616088,REGULATOR OF HEMOGLOBINIZATION AND ERYTHROID CELL EXPANSION, RHEX
24040,616089,"BLOOD GROUP, GERBICH SYSTEM", GE
24041,616090,MICRO RNA 802, MIR802
24042,616091,METHYLTRANSFERASE-LIKE 17, METTL17
24043,616092,FOCALLY AMPLIFIED LONG NONCODING RNA IN EPITHELIAL CANCER, FALEC
24044,616093,"BLOOD GROUP, ABO SYSTEM",
24045,616094,"MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 12", MDDGC12
24046,616095,MONOCARBOXYLATE TRANSPORTER 1 DEFICIENCY, MCT1D
24047,616096,"MYOSIN HEAVY CHAIN-ASSOCIATED RNA TRANSCRIPT, NONCODING", MHRT
24048,616097,UBIQUINOL-CYTOCHROME C REDUCTASE COMPLEX ASSEMBLY FACTOR 3, UQCC3
24049,616098,IMMUNODEFICIENCY 37, IMD37
24050,616099,PALMOPLANTAR KERATODERMA AND WOOLLY HAIR, PPKWH
24051,616100,"IMMUNE DYSREGULATION WITH AUTOIMMUNITY, IMMUNODEFICIENCY, AND LYMPHOPROLIFERATION", IDAIL
24052,616101,TRANSMEMBRANE PROTEIN 240, TMEM240
24053,616102,THIOREDOXIN-RELATED TRANSMEMBRANE PROTEIN 3, TMX3
24054,616103,"LEUCINE-RICH REPEAT, IMMUNOGLOBULIN-LIKE, AND TRANSMEMBRANE DOMAINS-CONTAINING PROTEIN 1", LRIT1
24055,616104,RBPJ-LIKE PROTEIN, RBPJL
24056,616105,SORTING NEXIN 14, SNX14
24057,616106,"PSORIASIS 15, PUSTULAR, SUSCEPTIBILITY TO", PSORS15
24058,616107,FATTY ACYL CoA REDUCTASE 1, FAR1
24059,616108,"RETINAL DYSTROPHY, JUVENILE CATARACTS, AND SHORT STATURE SYNDROME", RDJCSS
24060,616109,TOP6B-LIKE INITIATOR OF MEIOTIC DOUBLE STRAND BREAKS, TOP6BL
24061,616110,DELTEX E3 UBIQUITIN LIGASE 4, DTX4
24062,616111,"MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 9", MC3DN9
24063,616112,LEIOMODIN 3, LMOD3
24064,616113,POLYENDOCRINE-POLYNEUROPATHY SYNDROME, PEPNS
24065,616114,CHROMODOMAIN HELICASE DNA-BINDING PROTEIN 6, CHD6
24066,616115,FAMILIAL COLD AUTOINFLAMMATORY SYNDROME 4, FCAS4
24067,616116,"INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 46", MRT46
24068,616117,CARDIAC CONDUCTION DISEASE WITH OR WITHOUT DILATED CARDIOMYOPATHY, CCDD
24069,616118,"MACULAR DEGENERATION, EARLY-ONSET", EOMD
24070,616119,CILIA- AND FLAGELLA-ASSOCIATED PROTEIN 126, CFAP126
24071,616120,CWF19-LIKE CELL CYCLE CONTROL FACTOR 1, CWF19L1
24072,616121,"GTPase, VERY LARGE INTERFERON-INDUCIBLE, PSEUDOGENE 1", GVINP1
24073,616122,"FAMILY WITH SEQUENCE SIMILARITY 86, MEMBER B1", FAM86B1
24074,616123,"FAMILY WITH SEQUENCE SIMILARITY 86, MEMBER B2", FAM86B2
24075,616124,"FAMILY WITH SEQUENCE SIMILARITY 86, MEMBER C1, PSEUDOGENE", FAM86C1P
24076,616125,PROTEIN ARGININE METHYLTRANSFERASE 9, PRMT9
24077,616126,IMMUNODEFICIENCY 38 WITH BASAL GANGLIA CALCIFICATION, IMD38
24078,616127,"SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 17", SCAR17
24079,616128,"FAMILY WITH SEQUENCE SIMILARITY 89, MEMBER B", FAM89B
24080,616129,LEUCINE-RICH ADAPTOR PROTEIN 1, LURAP1
24081,616130,LEUCINE-RICH ADAPTOR PROTEIN 1-LIKE, LURAP1L
24082,616131,"GASTRIC CANCER-ASSOCIATED TRANSCRIPT 2, NONCODING", GACAT2
24083,616132,"GASTRIC CANCER-ASSOCIATED TRANSCRIPT 3, NONCODING", GACAT3
24084,616133,MPV17 MITOCHONDRIAL INNER MEMBRANE PROTEIN-LIKE 2, MPV17L2
24085,616134,"H3 HISTONE, FAMILY 3C", H3F3C
24086,616135,INTERFERON-INDUCED PROTEIN WITH TETRATRICOPEPTIDE REPEATS 5, IFIT5
24087,616136,RING FINGER PROTEIN 220, RNF220
24088,616137,MICRO RNA 873, MIR873
24089,616138,PERRAULT SYNDROME 5, PRLTS5
24090,616139,DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 27, DEE27
24091,616140,"LEUKODYSTROPHY, HYPOMYELINATING, 9", HLD9
24092,616141,MACRO H2A.2 HISTONE, MACROH2A2
24093,616142,"FAMILY WITH SEQUENCE SIMILARITY 98, MEMBER B", FAM98B
24094,616143,LYSOPHOSPHOLIPASE II, LYPLA2
24095,616144,WD REPEAT-CONTAINING PROTEIN 73, WDR73
24096,616145,CATEL-MANZKE SYNDROME, CATMANS
24097,616146,"TDP-GLUCOSE 4,6-DEHYDRATASE", TGDS
24098,616147,CYCLIN-DEPENDENT KINASE 15, CDK15
24099,616148,TRIPARTITE MOTIF-CONTAINING PROTEIN 59, TRIM59
24100,616149,"SOLUTE CARRIER FAMILY 25 (MITOCHONDRIAL CARRIER, PYRIMIDINE NUCLEOTIDE TRANSPORTER), MEMBER 36", SLC25A36
24101,616150,"SOLUTE CARRIER FAMILY 25, MEMBER 48", SLC25A48
24102,616151,"MACULAR DYSTROPHY, VITELLIFORM, 4", VMD4
24103,616152,"MACULAR DYSTROPHY, VITELLIFORM, 5", VMD5
24104,616153,"SOLUTE CARRIER FAMILY 25, MEMBER 52", SLC25A52
24105,616154,PEROXISOMAL FATTY ACYL-CoA REDUCTASE 1 DISORDER, PFCRD
24106,616155,"CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2S", CMT2S
24107,616156,FATTY ACYL CoA REDUCTASE 2, FAR2
24108,616157,"SHORT-CHAIN DEHYDROGENASE/REDUCTASE FAMILY, MEMBER 13", DHRS13
24109,616158,"NEURODEVELOPMENTAL DISORDER WITH NEONATAL RESPIRATORY INSUFFICIENCY, HYPOTONIA, AND FEEDING DIFFICULTIES", NEDRIHF
24110,616159,"SHORT-CHAIN DEHYDROGENASE/REDUCTASE FAMILY, MEMBER 11", DHRS11
24111,616160,"SHORT-CHAIN DEHYDROGENASE/REDUCTASE FAMILY, MEMBER 7B", DHRS7B
24112,616161,"SHORT-CHAIN DEHYDROGENASE/REDUCTASE FAMILY, MEMBER 7C", DHRS7C
24113,616162,"SHORT-CHAIN DEHYDROGENASE/REDUCTASE FAMILY 39U, MEMBER 1", SDR39U1
24114,616163,"SHORT-CHAIN DEHYDROGENASE/REDUCTASE FAMILY, MEMBER 12", DHRS12
24115,616164,"SHORT-CHAIN DEHYDROGENASE/REDUCTASE FAMILY 42E, MEMBER 1", SDR42E1
24116,616165,NEMALINE MYOPATHY 10, NEM10
24117,616166,"AORTIC ANEURYSM, FAMILIAL THORACIC 9", AAT9
24118,616167,DCN1 DOMAIN-CONTAINING PROTEIN 3, DCUN1D3
24119,616168,TRANSLOCASE OF OUTER MITOCHONDRIAL MEMBRANE 6, TOMM6
24120,616169,TRANSLOCASE OF OUTER MITOCHONDRIAL MEMBRANE 5, TOMM5
24121,616170,MACULAR DYSTROPHY WITH CENTRAL CONE INVOLVEMENT, CCMD
24122,616171,"MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 2", MCCRP2
24123,616172,"GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 9", GEFSP9
24124,616173,NUCLEAR SPECKLE SPLICING REGULATORY PROTEIN 1, NSRP1
24125,616174,CYTOSKELETON-ASSOCIATED PROTEIN 2-LIKE, CKAP2L
24126,616175,UBIQUITIN-CONJUGATING ENZYME E2 J1, UBE2J1
24127,616176,"BLEEDING DISORDER, PLATELET-TYPE, 19", BDPLT19
24128,616177,DDRGK DOMAIN-CONTAINING PROTEIN 1, DDRGK1
24129,616178,TRANSMEMBRANE PROTEIN 132E, TMEM132E
24130,616179,THIOREDOXIN DOMAIN-CONTAINING PROTEIN 16, TXNDC16
24131,616180,"GOLGIN A8 FAMILY, MEMBER A", GOLGA8A
24132,616181,ZINC FINGER PROTEIN 713, ZNF713
24133,616182,"CHRONIC MOUNTAIN SICKNESS, SUSCEPTIBILITY TO",
24134,616183,TRANSMEMBRANE PROTEIN 107, TMEM107
24135,616184,"CLUSTERED MITOCHONDRIA, D. DISCOIDEUM, HOMOLOG OF", CLUH
24136,616185,OVARIAN DYSGENESIS 4, ODG4
24137,616186,H19/IGF2-IMPRINTING CONTROL REGION,
24138,616187,"EPILEPSY, PROGRESSIVE MYOCLONIC 7", EPM7
24139,616188,RETINAL DYSTROPHY AND OBESITY, RDOB
24140,616189,CAP METHYLTRANSFERASE 1, CMTR1
24141,616190,CAP METHYLTRANSFERASE 2, CMTR2
24142,616191,DISCS LARGE-ASSOCIATED PROTEIN 4, DLGAP4
24143,616192,"ATAXIA, COMBINED CEREBELLAR AND PERIPHERAL, WITH HEARING LOSS AND DIABETES MELLITUS", ACPHD
24144,616193,"INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 47", MRT47
24145,616194,UTP15 SMALL SUBUNIT PROCESSOME COMPONENT, UTP15
24146,616195,WD REPEAT-CONTAINING PROTEIN 43, WDR43
24147,616196,DDB1- AND CUL4-ASSOCIATED FACTOR 13, DCAF13
24148,616197,NUCLEOLAR PROTEIN 10, NOL10
24149,616198,COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 23, COXPD23
24150,616199,POLYGLUCOSAN BODY MYOPATHY 2, PGBM2
24151,616200,RUIJS-AALFS SYNDROME, RJALS
24152,616201,CHRONIC ATRIAL AND INTESTINAL DYSRHYTHMIA, CAID
24153,616202,CEREBELLOFACIODENTAL SYNDROME, CFDS
24154,616203,"SOLUTE CARRIER FAMILY 38, MEMBER 9", SLC38A9
24155,616204,"SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 18", SCAR18
24156,616205,MICRO RNA 648, MIR648
24157,616206,"NEUROBLASTOMA-ASSOCIATED TRANSCRIPT 1, NONCODING", NBAT1
24158,616207,"NEGATIVE REGULATOR OF ANTIVIRAL RESPONSE, NONCODING", NRAV
24159,616208,AMYOTROPHIC LATERAL SCLEROSIS 22 WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA, ALS22
24160,616209,"MYOPATHY, ISOLATED MITOCHONDRIAL, AUTOSOMAL DOMINANT", IMMD
24161,616210,CHROMOSOME 4 OPEN READING FRAME 46, C4ORF46
24162,616211,DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 28, DEE28
24163,616212,LISSENCEPHALY 6 WITH MICROCEPHALY, LIS6
24164,616213,ZINC FINGER PROTEIN 292, ZNF292
24165,616214,HYPERPROINSULINEMIA,
24166,616215,cAMP RESPONSE ELEMENT-BINDING PROTEIN 3-LIKE 1, CREB3L1
24167,616216,THROMBOCYTOPENIA 5, THC5
24168,616217,NEPHRONOPHTHISIS 19, NPHP19
24169,616218,"TBC1 DOMAIN FAMILY, MEMBER 13", TBC1D13
24170,616219,"FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, 5", CFEOM5
24171,616220,FOCAL SEGMENTAL GLOMERULOSCLEROSIS 9, FSGS9
24172,616221,"AMELOGENESIS IMPERFECTA, TYPE IH", AI1H
24173,616222,TEMPLE SYNDROME,
24174,616223,ANGIOPOIETIN-LIKE 8, ANGPTL8
24175,616224,"MYASTHENIC SYNDROME, CONGENITAL, 22", CMS22
24176,616225,AUTOPHAGY-RELATED 2A, ATG2A
24177,616226,AUTOPHAGY-RELATED 2B, ATG2B
24178,616227,"MYASTHENIC SYNDROME, CONGENITAL, 15", CMS15
24179,616228,"MYASTHENIC SYNDROME, CONGENITAL, 14", CMS14
24180,616229,"OSTEOGENESIS IMPERFECTA, TYPE XVI", OI16
24181,616230,"EPILEPSY, PROGRESSIVE MYOCLONIC, 8", EPM8
24182,616231,"MYOPATHY, VACUOLAR, WITH CASQ1 AGGREGATES", VMCQA
24183,616232,MEIOTIC KINETOCHORE FACTOR, MEIKIN
24184,616233,"NEURONOPATHY, DISTAL HEREDITARY MOTOR, AUTOSOMAL RECESSIVE 5",
24185,616234,WD REPEAT- AND COILED-COIL-CONTAINING PROTEIN, WDCP
24186,616235,"KATANIN, p80 SUBUNIT, B-LIKE 1", KATNBL1
24187,616236,CHONDROADHERIN-LIKE, CHADL
24188,616237,KINASE NONCATALYTIC C-LOBE DOMAIN-CONTAINING PROTEIN 1, KNDC1
24189,616238,ZINC FINGER- AND BTB DOMAIN-CONTAINING PROTEIN 49, ZBTB49
24190,616239,COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 24, COXPD24
24191,616240,OLIGODENDROCYTE MATURATION-ASSOCIATED LONG INTERGENIC NONCODING RNA, OLMALINC
24192,616241,METEORIN-LIKE PROTEIN, METRNL
24193,616242,"TRANSMEMBRANE AND COILED-COIL DOMAIN FAMILY, MEMBER 1", TMCC1
24194,616243,TRANSMEMBRANE PROTEIN 131-LIKE, TMEM131L
24195,616244,COILED-COIL-HELIX-COILED-COIL-HELIX DOMAIN-CONTAINING PROTEIN 2, CHCHD2
24196,616245,"ENDOPLASMIC RETICULUM MEMBRANE PROTEIN COMPLEX, SUBUNIT 4", EMC4
24197,616246,MYOREGULIN, MRLN
24198,616247,LONG QT SYNDROME 14, LQT14
24199,616248,LETHAL CONGENITAL CONTRACTURE SYNDROME 6, LCCS6
24200,616249,LONG QT SYNDROME 15, LQT15
24201,616250,NACHT DOMAIN- AND WD REPEAT-CONTAINING PROTEIN 1, NWD1
24202,616251,TRPM8 CHANNEL-ASSOCIATED FACTOR 1, TCAF1
24203,616252,TRPM8 CHANNEL-ASSOCIATED FACTOR 2, TCAF2
24204,616253,GS HOMEOBOX 2, GSX2
24205,616254,CASEINOLYTIC PEPTIDASE B, CLPB
24206,616255,SHORT STATURE WITH NONSPECIFIC SKELETAL ABNORMALITIES 1, SNSK1
24207,616256,"C-TYPE LECTIN DOMAIN FAMILY 4, MEMBER G", CLEC4G
24208,616257,FK506-BINDING PROTEIN 9, FKBP9
24209,616258,MECKEL SYNDROME 12, MKS12
24210,616259,SMALL NUCLEOLAR RNA HOST GENE 14, SNHG14
24211,616260,TENORIO SYNDROME, TNORS
24212,616261,"PSEUDOURIDYLATE SYNTHASE 7, PUTATIVE", PUS7
24213,616262,KELCH-LIKE 21, KLHL21
24214,616263,"NEUROLOGIC, ENDOCRINE, AND PANCREATIC DISEASE, MULTISYSTEM, INFANTILE-ONSET 1", IMNEPD1
24215,616264,"MAF TRANSCRIPTIONAL REGULATOR RNA, NONCODING", MAFTRR
24216,616265,PEELING SKIN SYNDROME 3, PSS3
24217,616266,"CONGENITAL CONTRACTURES OF THE LIMBS AND FACE, HYPOTONIA, AND DEVELOPMENTAL DELAY", CLIFAHDD
24218,616267,ATAXIA-OCULOMOTOR APRAXIA 4, AOA4
24219,616268,ARBOLEDA-THAM SYNDROME, ARTHS
24220,616269,"INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 48", MRT48
24221,616270,"AMELOGENESIS IMPERFECTA, TYPE IF", AI1F
24222,616271,"3-METHYLGLUTACONIC ACIDURIA, TYPE VIIB", MGCA7B
24223,616272,MICRO RNA 520G, MIR520G
24224,616273,"PROSTATE CANCER-ASSOCIATED TRANSCRIPT 29, NONCODING", PCAT29
24225,616274,MICRO RNA 4276, MIR4276
24226,616275,"FAMILY WITH SEQUENCE SIMILARITY 136, MEMBER A", FAM136A
24227,616276,"COENZYME Q10 DEFICIENCY, PRIMARY, 7", COQ10D7
24228,616277,MITOCHONDRIAL SHORT-CHAIN ENOYL-CoA HYDRATASE 1 DEFICIENCY, ECHS1D
24229,616278,"BILE ACID SYNTHESIS DEFECT, CONGENITAL, 5", CBAS5
24230,616279,CATARACT 43, CTRCT43
24231,616280,"CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2U", CMT2U
24232,616281,NEURODEVELOPMENTAL DISORDER WITH SPASTIC PARAPLEGIA AND MICROCEPHALY, NEDSPM
24233,616282,"SPASTIC PARAPLEGIA 73, AUTOSOMAL DOMINANT", SPG73
24234,616283,PSEUDOURIDYLATE SYNTHASE 3, PUS3
24235,616284,FILAGGRIN FAMILY MEMBER 2, FLG2
24236,616285,FORMIN-LIKE 2, FMNL2
24237,616286,LETHAL CONGENITAL CONTRACTURE SYNDROME 7, LCCS7
24238,616287,LETHAL CONGENITAL CONTRACTURE SYNDROME 8, LCCS8
24239,616288,FORMIN-LIKE 3, FMNL3
24240,616289,OPTIC ATROPHY 9, OPA9
24241,616290,ZINC FINGER PROTEIN 658, ZNF658
24242,616291,LICHTENSTEIN-KNORR SYNDROME, LIKNS
24243,616292,STABILIZER OF AXONEMAL MICROTUBULES 1, SAXO1
24244,616293,HORNERIN, HRNR
24245,616294,COLE-CARPENTER SYNDROME 2, CLCRP2
24246,616295,"PEELING SKIN WITH LEUKONYCHIA, ACRAL PUNCTATE KERATOSES, CHEILITIS, AND KNUCKLE PADS", PLACK
24247,616296,MULTIPLE C2 DOMAINS-CONTAINING TRANSMEMBRANE PROTEIN 1, MCTP1
24248,616297,MULTIPLE C2 DOMAINS-CONTAINING TRANSMEMBRANE PROTEIN 2, MCTP2
24249,616298,SINGLETON-MERTEN SYNDROME 2, SGMRT2
24250,616299,LIPOYLTRANSFERASE 1 DEFICIENCY, LIPT1D
24251,616300,SHORT-RIB THORACIC DYSPLASIA 13 WITH OR WITHOUT POLYDACTYLY, SRTD13
24252,616301,"CD300 ANTIGEN-LIKE FAMILY, MEMBER D", CD300LD
24253,616302,FORKHEAD BOX K1, FOXK1
24254,616303,WD REPEAT-CONTAINING PROTEIN 91, WDR91
24255,616304,"MYASTHENIC SYNDROME, CONGENITAL, 17", CMS17
24256,616305,FERM DOMAIN-CONTAINING PROTEIN 4A, FRMD4A
24257,616306,FIBRINOGEN SILENCER-BINDING PROTEIN, FSBP
24258,616307,SENIOR-LOKEN SYNDROME 8, SLSN8
24259,616308,"BETA-GLOBIN LOCUS TRANSCRIPT 3, NONCODING", BGLT3
24260,616309,FERM DOMAIN-CONTAINING PROTEIN 5, FRMD5
24261,616310,RHO GTPase-ACTIVATING PROTEIN 11B, ARHGAP11B
24262,616311,"INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 33", MRD33
24263,616312,LEM DOMAIN-CONTAINING PROTEIN 2, LEMD2
24264,616313,"MYASTHENIC SYNDROME, CONGENITAL, 2A, SLOW-CHANNEL", CMS2A
24265,616314,"MYASTHENIC SYNDROME, CONGENITAL, 2C, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY", CMS2C
24266,616315,PAXX NONHOMOLOGOUS END JOINING FACTOR, PAXX
24267,616316,"FAMILY WITH SEQUENCE SIMILARITY 168, MEMBER A", FAM168A
24268,616317,GLYCEROPHOSPHODIESTER PHOSPHODIESTERASE DOMAIN-CONTAINING PROTEIN 1, GDPD1
24269,616318,GLYCEROPHOSPHODIESTER PHOSPHODIESTERASE DOMAIN-CONTAINING PROTEIN 3, GDPD3
24270,616319,RING FINGER PROTEIN 138, RNF138
24271,616320,FUMARYLACETOACETATE HYDROLASE DOMAIN-CONTAINING PROTEIN 1, FAHD1
24272,616321,"MYASTHENIC SYNDROME, CONGENITAL, 3A, SLOW-CHANNEL", CMS3A
24273,616322,"MYASTHENIC SYNDROME, CONGENITAL, 3B, FAST-CHANNEL", CMS3B
24274,616323,"MYASTHENIC SYNDROME, CONGENITAL, 3C, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY", CMS3C
24275,616324,"MYASTHENIC SYNDROME, CONGENITAL, 4B, FAST-CHANNEL", CMS4B
24276,616325,"MYASTHENIC SYNDROME, CONGENITAL, 9, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY", CMS9
24277,616326,"MYASTHENIC SYNDROME, CONGENITAL, 11, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY", CMS11
24278,616327,CHROMOSOME ALIGNMENT-MAINTAINING PHOSPHOPROTEIN 1, CHAMP1
24279,616328,LONG INTERGENIC NONCODING RNA PINKY,
24280,616329,"MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 13", MODY13
24281,616330,"MYASTHENIC SYNDROME, CONGENITAL, 18", CMS18
24282,616331,"ROBINOW SYNDROME, AUTOSOMAL DOMINANT 2", DRS2
24283,616332,ACIDIC RESIDUE METHYLTRANSFERASE 1, ARMT1
24284,616333,WNT SIGNALING PATHWAY ACTIVATING NONCODING RNA, WSPAR
24285,616334,TRANSMEMBRANE PROTEIN 100, TMEM100
24286,616335,"MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 3", MCCRP3
24287,616336,"ALDO-KETO REDUCTASE FAMILY 1, MEMBER B15", AKR1B15
24288,616337,SUPPRESSOR OF CYTOKINE SIGNALING 4, SOCS4
24289,616338,"SOX2 OVERLAPPING TRANSCRIPT, NONCODING", SOX2OT
24290,616339,DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 29, DEE29
24291,616340,"DEAFNESS, AUTOSOMAL DOMINANT 67", DFNA67
24292,616341,DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 30, DEE30
24293,616342,LISSENCEPHALY 7 WITH CEREBELLAR HYPOPLASIA, LIS7
24294,616343,"TUMOR PROTEIN p53 PATHWAY COREPRESSOR 1, NONCODING", TP53COR1
24295,616344,TETRATRICOPEPTIDE REPEAT DOMAIN-CONTAINING PROTEIN 23-LIKE, TTC23L
24296,616345,IMMUNODEFICIENCY 39, IMD39
24297,616346,DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 31A, DEE31A
24298,616347,PR DOMAIN-CONTAINING PROTEIN 11, PRDM11
24299,616348,ZINC FINGER PROTEIN 695, ZNF695
24300,616349,SORBIN AND SH3 DOMAINS-CONTAINING PROTEIN 2, SORBS2
24301,616350,PROMOTER OF MAT2A ANTISENSE RADIATION-INDUCED CIRCULATING LONG NONCODING RNA, PARTICL
24302,616351,"NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, SPEECH DELAY, AND DYSMORPHIC FACIES", NEDHSF
24303,616352,ACYL-CoA-BINDING DOMAIN-CONTAINING PROTEIN 6, ACBD6
24304,616353,"DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 6", DKCB6
24305,616354,"SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 20", SCAR20
24306,616355,HOUGE-JANSSENS SYNDROME 1, HJS1
24307,616356,"MICRO RNA 31 HOST GENE, NONCODING", MIR31HG
24308,616357,"DEAFNESS, AUTOSOMAL DOMINANT 40", DFNA40
24309,616358,MICRO RNA 379, MIR379
24310,616359,"COENZYME Q5, METHYLTRANSFERASE", COQ5
24311,616360,TRANSMEMBRANE PROTEIN 135, TMEM135
24312,616361,PARKINSON DISEASE 21, PARK21
24313,616362,HOUGE-JANSSENS SYNDROME 2, HJS2
24314,616363,SMALL PROLINE-RICH PROTEIN 4, SPRR4
24315,616364,WHITE-SUTTON SYNDROME, WHSUS
24316,616365,SCY1-LIKE PROTEIN 2, SCYL2
24317,616366,DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 32, DEE32
24318,616367,MANDIBULOFACIAL DYSOSTOSIS WITH ALOPECIA, MFDA
24319,616368,CHOPS SYNDROME, CHOPS
24320,616369,STROMME SYNDROME,
24321,616370,MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 4, MMDS4
24322,616371,"PULMONARY FIBROSIS AND/OR BONE MARROW FAILURE SYNDROME, TELOMERE-RELATED, 4", PFBMFT4
24323,616372,DDB1- AND CUL4-ASSOCIATED FACTOR 4, DCAF4
24324,616373,"PULMONARY FIBROSIS AND/OR BONE MARROW FAILURE SYNDROME, TELOMERE-RELATED, 3", PFBMFT3
24325,616374,BEN DOMAIN-CONTAINING PROTEIN 3, BEND3
24326,616375,UNKEMPT FAMILY ZINC FINGER PROTEIN, UNK
24327,616376,MICRO RNA 656, MIR656
24328,616377,PROLINE DEHYDROGENASE (OXIDASE) 2, PRODH2
24329,616378,UBX DOMAIN PROTEIN 1, UBXN1
24330,616379,UBX DOMAIN PROTEIN 7, UBXN7
24331,616380,"LAMININ, BETA-4", LAMB4
24332,616381,ZINC FINGER CCHC DOMAIN-CONTAINING PROTEIN 8, ZCCHC8
24333,616382,"UDP GLUCURONOSYLTRANSFERASE FAMILY 2, MEMBER A3", UGT2A3
24334,616383,"URIDINE DIPHOSPHATE GLUCURONOSYLTRANSFERASE 3 FAMILY, MEMBER A1", UGT3A1
24335,616384,"URIDINE DIPHOSPHATE GLUCURONOSYLTRANSFERASE 3 FAMILY, MEMBER A2", UGT3A2
24336,616385,LONG INTERGENIC NONCODING RNA 1018, LINC01018
24337,616386,POTASSIUM CHANNEL TETRAMERIZATION DOMAIN-CONTAINING PROTEIN 17, KCTD17
24338,616387,"DOWNREGULATED RNA IN ANDROGEN-INDEPENDENT CELLS, NONCODING", DRAIC
24339,616388,UBIQUITIN DOMAIN-CONTAINING PROTEIN 1, UBTD1
24340,616389,"NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1G", CSNB1G
24341,616390,"TRICHOTHIODYSTROPHY 2, PHOTOSENSITIVE", TTD2
24342,616391,RAN-BINDING PROTEIN 3-LIKE, RANBP3L
24343,616392,SKINT1-LIKE PSEUDOGENE, SKINTL
24344,616393,"INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 38", MRD38
24345,616394,RETINITIS PIGMENTOSA 71, RP71
24346,616395,"TRICHOTHIODYSTROPHY 3, PHOTOSENSITIVE", TTD3
24347,616396,SCM POLYCOMB GROUP PROTEIN HOMOLOG 1, SCMH1
24348,616397,PEROXISOMAL MEMBRANE PROTEIN 4, PXMP4
24349,616398,"DYSTONIA 26, MYOCLONIC", DYT26
24350,616399,BRUGADA SYNDROME 9, BRGDA9
24351,616400,"PALMOPLANTAR KERATODERMA, NONEPIDERMOLYTIC, FOCAL 2", FNEPPK2
24352,616401,SPINDLE APPARATUS COILED-COIL PROTEIN 1, SPDL1
24353,616402,"MICROCEPHALY 14, PRIMARY, AUTOSOMAL RECESSIVE", MCPH14
24354,616403,TP53 TARGET GENE 1, TP53TG1
24355,616404,"POLYMERASE I, RNA, SUBUNIT A", POLR1A
24356,616405,ADAPTOR PROTEIN 2-ASSOCIATED KINASE 1, AAK1
24357,616406,PYRROLINE-5-CARBOXYLATE REDUCTASE 2, PYCR2
24358,616407,BROWN SYNDROME, BRWNS
24359,616408,PYRROLINE-5-CARBOXYLATE REDUCTASE-LIKE, PYCRL
24360,616409,DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 33, DEE33
24361,616410,SPINOCEREBELLAR ATAXIA 41, SCA41
24362,616411,DYSTONIA 27, DYT27
24363,616412,THIOREDOXIN DOMAIN-CONTAINING PROTEIN 5, TXNDC5
24364,616413,"BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 6", IBGC6
24365,616414,"AUTOINFLAMMATION AND AUTOIMMUNITY, SYSTEMIC, WITH IMMUNE DYSREGULATION", AIAISD
24366,616415,FAMILIAL ADENOMATOUS POLYPOSIS 3, FAP3
24367,616416,ADHESION G PROTEIN-COUPLED RECEPTOR L1, ADGRL1
24368,616417,ADHESION G PROTEIN-COUPLED RECEPTOR L3, ADGRL3
24369,616418,"HYPOMAGNESEMIA, SEIZURES, AND IMPAIRED INTELLECTUAL DEVELOPMENT 1", HOMGSMR1
24370,616419,ADHESION G PROTEIN-COUPLED RECEPTOR L4, ADGRL4
24371,616420,"LEUKODYSTROPHY, HYPOMYELINATING, 10", HLD10
24372,616421,MYOCLONIC-ATONIC EPILEPSY, MAE
24373,616422,"TRANSCRIPTION ELONGATION FACTOR, MITOCHONDRIAL", TEFM
24374,616423,DExH-BOX HELICASE 30, DHX30
24375,616424,SET DOMAIN-CONTAINING PROTEIN 6, SETD6
24376,616425,"46,XY SEX REVERSAL 10", SRXY10
24377,616426,"CENTROSOMAL PROTEIN, 192-KD", CEP192
24378,616427,A-KINASE ANCHOR INHIBITOR 1, AKAIN1
24379,616428,MICROPHTHALMIA/COLOBOMA 10, MCOPCB10
24380,616429,SUSHI DOMAIN-CONTAINING PROTEIN 3, SUSD3
24381,616430,COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 25, COXPD25
24382,616431,"GLYCEROL-3-PHOSPHATE ACYLTRANSFERASE 2, MITOCHONDRIAL", GPAT2
24383,616432,RHO GUANINE NUCLEOTIDE EXCHANGE FACTOR 18, ARHGEF18
24384,616433,IMMUNODEFICIENCY 40, IMD40
24385,616434,IST1 FACTOR ASSOCIATED WITH ESCRT-III, IST1
24386,616435,"FANCONI ANEMIA, COMPLEMENTATION GROUP T", FANCT
24387,616436,"EPILEPSY, FAMILIAL TEMPORAL LOBE, 7", ETL7
24388,616437,FRONTOTEMPORAL DEMENTIA AND/OR AMYOTROPHIC LATERAL SCLEROSIS 3, FTDALS3
24389,616438,TUMOR NECROSIS FACTOR-ALPHA-INDUCED PROTEIN 8-LIKE 3, TNFAIP8L3
24390,616439,FRONTOTEMPORAL DEMENTIA AND/OR AMYOTROPHIC LATERAL SCLEROSIS 4, FTDALS4
24391,616440,"SOLUTE CARRIER FAMILY 32 (GABA VESICULAR TRANSPORTER), MEMBER 1", SLC32A1
24392,616441,OVO-LIKE 2, OVOL2
24393,616442,OVO-LIKE 3, OVOL3
24394,616443,"ZINC FINGER, MYM-TYPE 5", ZMYM5
24395,616444,RNA-BINDING MOTIF PROTEIN 19, RBM19
24396,616445,"CANDIDIASIS, FAMILIAL, 9", CANDF9
24397,616446,LYMPHOCYTE EXPANSION MOLECULE, LEXM
24398,616447,VIR-LIKE M6A METHYLTRANSFERASE-ASSOCIATED PROTEIN, VIRMA
24399,616448,RAS-ASSOCIATED PROTEIN RAB12, RAB12
24400,616449,BASEL-VANAGAITE-SMIRIN-YOSEF SYNDROME, BVSYS
24401,616450,"EF-HAND DOMAIN FAMILY, MEMBER D2", EFHD2
24402,616451,"SPASTIC PARAPLEGIA 74, AUTOSOMAL RECESSIVE", SPG74
24403,616452,B-CELL EXPANSION WITH NFKB AND T-CELL ANERGY, BENTA
24404,616453,ZINC FINGER CCCH DOMAIN-CONTAINING PROTEIN 13, ZC3H13
24405,616454,ZINC FINGER PROTEIN 408, ZNF408
24406,616455,ZIMMERMANN-LABAND SYNDROME 2, ZLS2
24407,616456,"INO80 COMPLEX, SUBUNIT B", INO80B
24408,616457,DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 50, DEE50
24409,616458,PR DOMAIN-CONTAINING PROTEIN 12, PRDM12
24410,616459,AL-RAQAD SYNDROME, ARS
24411,616460,"INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 50", MRT50
24412,616461,"EPILEPSY, FAMILIAL TEMPORAL LOBE, 8", ETL8
24413,616462,"ACROFACIAL DYSOSTOSIS, CINCINNATI TYPE", AFDCIN
24414,616463,ZINC FINGER PROTEIN 232, ZNF232
24415,616464,ECDYSONELESS CELL CYCLE REGULATOR, ECD
24416,616465,"VPS50, EARP/GARPII COMPLEX SUBUNIT", VPS50
24417,616466,UNC5 NETRIN RECEPTOR D, UNC5D
24418,616467,"DELETED IN PRIMARY CILIARY DYSKINESIA, MOUSE, HOMOLOG OF", DPCD
24419,616468,EXUDATIVE VITREORETINOPATHY 6, EVR6
24420,616469,RETINITIS PIGMENTOSA 72, RP72
24421,616470,ULLRICH CONGENITAL MUSCULAR DYSTROPHY 2, UCMD2
24422,616471,BETHLEM MYOPATHY 2, BTHLM2
24423,616472,UBIQUITIN-ASSOCIATED PROTEIN 2-LIKE, UBAP2L
24424,616473,MICRO RNA 558, MIR558
24425,616474,ZINC FINGER- AND SCAN DOMAIN-CONTAINING PROTEIN 26, ZSCAN26
24426,616475,"CENTROSOMAL PROTEIN, 72-KD", CEP72
24427,616476,ATP/GTP-BINDING PROTEIN-LIKE 4, AGBL4
24428,616477,NUCLEAR RECEPTOR-BINDING FACTOR 2, NRBF2
24429,616478,LEUCINE-RICH REPEATS- AND GUANYLATE KINASE DOMAIN-CONTAINING PROTEIN, LRGUK
24430,616479,"PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 2", PEOB2
24431,616480,KIAA1328 GENE, KIAA1328
24432,616481,"CILIARY DYSKINESIA, PRIMARY, 32", CILD32
24433,616482,"ACHONDROPLASIA, SEVERE, WITH DEVELOPMENTAL DELAY AND ACANTHOSIS NIGRICANS", SADDAN
24434,616483,INFANTILE LIVER FAILURE SYNDROME 2, ILFS2
24435,616484,TAX1-BINDING PROTEIN 3, TAX1BP3
24436,616485,ZINC FINGER- AND BTB DOMAIN-CONTAINING PROTEIN 21, ZBTB21
24437,616486,"NEURODEVELOPMENTAL DISORDER WITH PROGRESSIVE MICROCEPHALY, SPASTICITY, AND BRAIN IMAGING ABNORMALITIES", NEDMISBA
24438,616487,"EPIDERMOLYSIS BULLOSA SIMPLEX 5D, GENERALIZED INTERMEDIATE, AUTOSOMAL RECESSIVE", EBS5D
24439,616488,"NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE VIII", HSAN8
24440,616489,SILVER-RUSSELL SYNDROME 3, SRS3
24441,616490,JOUBERT SYNDROME 23, JBTS23
24442,616491,"CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2V", CMT2V
24443,616492,"EWING SARCOMA-ASSOCIATED TRANSCRIPT 1, NONCODING", EWSAT1
24444,616493,TRANSCRIPTION ACTIVATION REPRESSOR, TASOR
24445,616494,"LEUKODYSTROPHY, HYPOMYELINATING, 11", HLD11
24446,616495,ADP-RIBOSYLATION FACTOR-LIKE GTPase 6-INTERACTING PROTEIN 6, ARL6IP6
24447,616496,NUCLEAR ENVELOPE INTEGRAL MEMBRANE PROTEIN 1, NEMP1
24448,616497,NUCLEAR ENVELOPE INTEGRAL MEMBRANE PROTEIN 2, NEMP2
24449,616498,RETICULOPHAGY REGULATOR 3, RETREG3
24450,616499,TRANSMEMBRANE PROTEIN 203, TMEM203
24451,616500,"MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 9", MC4DN9
24452,616501,"MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 13", MC4DN13
24453,616502,CONE-ROD DYSTROPHY 21, CORD21
24454,616503,LETHAL CONGENITAL CONTRACTURE SYNDROME 9, LCCS9
24455,616504,"METHYLTRANSFERASE 14, N6-ADENOSINE-METHYLTRANSFERASE SUBUNIT", METTL14
24456,616505,"NEUROPATHY, HEREDITARY MOTOR AND SENSORY, TYPE VIB, WITH OPTIC ATROPHY", HMSN6B
24457,616506,NEURON-DERIVED NEUROTROPHIC FACTOR, NDNF
24458,616507,"OSTEOGENESIS IMPERFECTA, TYPE XVII", OI17
24459,616508,"SOLUTE CARRIER FAMILY 39 (ZINC TRANSPORTER), MEMBER 11", SLC39A11
24460,616509,CATARACT 44, CTRCT44
24461,616510,GLUCOSAMINE-PHOSPHATE N-ACETYLTRANSFERASE 1, GNPNAT1
24462,616511,"MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 14", MODY14
24463,616512,RING FINGER PROTEIN 152, RNF152
24464,616513,La RIBONUCLEOPROTEIN 4B, LARP4B
24465,616514,"FAMILY WITH SEQUENCE SIMILARITY 195, MEMBER B", FAM195B
24466,616515,"DEAFNESS, AUTOSOMAL RECESSIVE 104", DFNB104
24467,616516,"EMERY-DREIFUSS MUSCULAR DYSTROPHY 3, AUTOSOMAL RECESSIVE", EDMD3
24468,616517,ACHROMATOPSIA 7, ACHM7
24469,616518,"SOLUTE CARRIER FAMILY 38 (AMINO ACID TRANSPORTER), MEMBER 6", SLC38A6
24470,616519,PHOSPHODIESTERASE 12, PDE12
24471,616520,ADENOSYLHOMOCYSTEINASE-LIKE 2, AHCYL2
24472,616521,"INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 39", MRD39
24473,616522,DCN1 DOMAIN-CONTAINING PROTEIN 5, DCUN1D5
24474,616523,MICROFIBRILLAR-ASSOCIATED PROTEIN 3-LIKE, MFAP3L
24475,616524,TRANSMEMBRANE PROTEIN 139, TMEM139
24476,616525,"SOLUTE CARRIER FAMILY 38 (AMINO ACID TRANSPORTER), MEMBER 10", SLC38A10
24477,616526,"SOLUTE CARRIER FAMILY 38 (AMINO ACID TRANSPORTER), MEMBER 11", SLC38A11
24478,616527,SWI5-DEPENDENT HOMOLOGOUS RECOMBINATION REPAIR PROTEIN 1, SFR1
24479,616528,SWI5 HOMOLOGOUS RECOMBINATION REPAIR PROTEIN, SWI5
24480,616529,YTH N6-METHYLADENOSINE RNA-BINDING PROTEIN 1, YTHDF1
24481,616530,YTH DOMAIN-CONTAINING PROTEIN 2, YTHDC2
24482,616531,"NEURODEVELOPMENTAL DISORDER WITH SPASTICITY, HYPOMYELINATING LEUKODYSTROPHY, AND BRAIN ABNORMALITIES", NEDSPLB
24483,616532,"ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 7", IIAE7
24484,616533,DEAD-BOX HELICASE 31, DDX31
24485,616534,"THYROID CANCER, NONMEDULLARY, 4", NMTC4
24486,616535,"THYROID CANCER, NONMEDULLARY, 5", NMTC5
24487,616536,CYSTATIN 9-LIKE, CST9L
24488,616537,V-SET AND TRANSMEMBRANE DOMAINS-CONTAINING PROTEIN 2-LIKE, VSTM2L
24489,616538,"MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 9", MDDGA9
24490,616539,"PERIPHERAL NEUROPATHY WITH VARIABLE SPASTICITY, EXERCISE INTOLERANCE, AND DEVELOPMENTAL DELAY", PNSED
24491,616540,"EPILEPSY, PROGRESSIVE MYOCLONIC, 9", EPM9
24492,616541,"SHORT STATURE, MICROCEPHALY, AND ENDOCRINE DYSFUNCTION", SSMED
24493,616542,GS HOMEOBOX 1, GSX1
24494,616543,CYSTATIN 9, CST9
24495,616544,RETINITIS PIGMENTOSA 73, RP73
24496,616545,PRELI DOMAIN-CONTAINING PROTEIN 3A, PRELID3A
24497,616546,SHORT-RIB THORACIC DYSPLASIA 14 WITH POLYDACTYLY, SRTD14
24498,616547,LYSOZYME G2, LYG2
24499,616548,LYSOPHOSPHOLIPASE-LIKE 1, LYPLAL1
24500,616549,"KLIPPEL-FEIL SYNDROME 4, AUTOSOMAL RECESSIVE, WITH NEMALINE MYOPATHY AND FACIAL DYSMORPHISM", KFS4
24501,616550,TRANSMEMBRANE PROTEIN 120A, TMEM120A
24502,616551,TRANSMEMBRANE PROTEIN 120B, TMEM120B
24503,616552,CARNOSINE N-METHYLTRANSFERASE 1, CARNMT1
24504,616553,"DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 6", DKCA6
24505,616554,SPERM-ASSOCIATED ANTIGEN 17, SPAG17
24506,616555,LEUCINE-RICH REPEAT-CONTAINING PROTEIN 37A, LRRC37A
24507,616556,LEUCINE-RICH REPEAT-CONTAINING PROTEIN 37A2, LRRC37A2
24508,616557,LEUCINE-RICH REPEAT-CONTAINING PROTEIN 37A3, LRRC37A3
24509,616558,LEUCINE-RICH REPEAT-CONTAINING PROTEIN 37B, LRRC37B
24510,616559,NOONAN SYNDROME 9, NS9
24511,616560,CD300H ANTIGEN,
24512,616561,RAS PROTEIN ACTIVATOR-LIKE 3, RASAL3
24513,616562,RETINITIS PIGMENTOSA 74, RP74
24514,616563,STE20-LIKE PROTEIN KINASE, SLK
24515,616564,NOONAN SYNDROME 10, NS10
24516,616565,ANKYRIN REPEAT DOMAIN-CONTAINING PROTEIN 30B, ANKRD30B
24517,616566,"SPONDYLOCOSTAL DYSOSTOSIS 6, AUTOSOMAL RECESSIVE", SCDO6
24518,616567,DEATH-ASSOCIATED PROTEIN KINASE 2, DAPK2
24519,616568,TUMOR PREDISPOSITION SYNDROME 3,
24520,616569,CYSTEINE SULFINIC ACID DECARBOXYLASE, CSAD
24521,616570,CEREBROOCULOFACIOSKELETAL SYNDROME 3, COFS3
24522,616571,"C-TYPE LECTIN DOMAIN FAMILY 18, MEMBER A", CLEC18A
24523,616572,"C-TYPE LECTIN DOMAIN FAMILY 18, MEMBER B", CLEC18B
24524,616573,"C-TYPE LECTIN DOMAIN FAMILY 18, MEMBER C", CLEC18C
24525,616574,"MITOCHONDRIAL CONTACT SITE AND CRISTAE ORGANIZING SYSTEM, 10-KD SUBUNIT", MICOS10
24526,616575,LEUKOCYTE RECEPTOR CLUSTER GENE 8, LENG8
24527,616576,"IMMUNODEFICIENCY, COMMON VARIABLE, 12, WITH AUTOIMMUNITY", CVID12
24528,616577,"NEURODEVELOPMENTAL DISORDER WITH HEARING LOSS, SEIZURES, AND BRAIN ABNORMALITIES", NEDHSB
24529,616578,ZINC FINGER- AND BTB DOMAIN-CONTAINING PROTEIN 1, ZBTB1
24530,616579,"NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, IMPAIRED LANGUAGE, AND DYSMORPHIC FEATURES", NEDHILD
24531,616580,AU-KLINE SYNDROME, AUKS
24532,616581,LYSINE DEMETHYLASE 4E, KDM4E
24533,616582,LIPOLYSIS-STIMULATED LIPOPROTEIN RECEPTOR, LSR
24534,616583,"SPONDYLOEPIPHYSEAL DYSPLASIA, STANESCU TYPE", SEDSTN
24535,616584,"SPERMATOGENESIS-ASSOCIATED PROTEIN 31, SUBFAMILY A, MEMBER 7", SPATA31A7
24536,616585,RING FINGER- AND SPRY DOMAIN-CONTAINING PROTEIN 1, RSPRY1
24537,616586,"SPASTIC PARAPLEGIA 9B, AUTOSOMAL RECESSIVE", SPG9B
24538,616587,"FAMILY WITH SEQUENCE SIMILARITY 118, MEMBER B", FAM118B
24539,616588,DIHYDROFOLATE REDUCTASE-LIKE 1, DHFRL1
24540,616589,ADAMS-OLIVER SYNDROME 6, AOS6
24541,616590,ZINC FINGER- AND BTB DOMAIN-CONTAINING PROTEIN 5, ZBTB5
24542,616591,ZINC FINGER- AND BTB DOMAIN-CONTAINING PROTEIN 7C, ZBTB7C
24543,616592,KOSAKI OVERGROWTH SYNDROME, KOGS
24544,616593,C1q- AND TUMOR NECROSIS FACTOR-RELATED PROTEIN 12, C1QTNF12
24545,616594,"ARF GTPase-ACTIVATING PROTEIN WITH SH3 DOMAIN, ANKYRIN REPEAT, AND PH DOMAIN 3", ASAP3
24546,616595,ZINC FINGER- AND BTB DOMAIN-CONTAINING PROTEIN 2, ZBTB2
24547,616596,ADP-RIBOSYLATION FACTOR-LIKE GTPase 8B, ARL8B
24548,616597,ADP-RIBOSYLATION FACTOR-LIKE GTPase 8A, ARL8A
24549,616598,"BLOC1-RELATED COMPLEX, SUBUNIT 5", BORCS5
24550,616599,"BLOC1-RELATED COMPLEX, SUBUNIT 6", BORCS6
24551,616600,"BLOC1-RELATED COMPLEX, SUBUNIT 7", BORCS7
24552,616601,"BLOC1-RELATED COMPLEX, SUBUNIT 8", BORCS8
24553,616602,CRANIOSYNOSTOSIS 6, CRS6
24554,616603,"CUTIS LAXA, AUTOSOMAL DOMINANT 3", ADCL3
24555,616604,"CHROMOSOME 14q32 DUPLICATION SYNDROME, 700-KB",
24556,616605,GSK3B-INTERACTING PROTEIN, GSKIP
24557,616606,RING CHROMOSOME 14 SYNDROME,
24558,616607,KELCH REPEAT- AND BTB/POZ DOMAIN-CONTAINING PROTEIN 8, KBTBD8
24559,616608,MACROPHAGE IMMUNOMETABOLISM REGULATOR, MACIR
24560,616609,TRANSMEMBRANE PROTEIN 65, TMEM65
24561,616610,"CANCER SUSCEPTIBILITY CANDIDATE 15, NONCODING", CASC15
24562,616611,LONG INTERGENIC NONCODING RNA 461, LINC00461
24563,616612,"COLLAGEN, TYPE VI, ALPHA-4, PSEUDOGENE 2", COL6A4P2
24564,616613,"COLLAGEN, TYPE VI, ALPHA-6", COL6A6
24565,616614,HISTONE PARYLATION FACTOR 1, HPF1
24566,616615,CHONDROITIN SULFATE N-ACETYLGALACTOSAMINYLTRANSFERASE 1, CSGALNACT1
24567,616616,CHONDROITIN SULFATE N-ACETYLGALACTOSAMINYLTRANSFERASE 2, CSGALNACT2
24568,616617,HEIMLER SYNDROME 2, HMLR2
24569,616618,ACYL-CoA-BINDING DOMAIN-CONTAINING PROTEIN 5, ACBD5
24570,616619,"DPPA2 UPSTREAM-BINDING RNA, NONCODING", DUBR
24571,616620,WD REPEAT-CONTAINING PROTEIN 12, WDR12
24572,616621,DEAD-BOX HELICASE 27, DDX27
24573,616622,IMMUNODEFICIENCY 42, IMD42
24574,616623,"FAMILY WITH SEQUENCE SIMILARITY 30, MEMBER A", FAM30A
24575,616624,NUCLEAR CAP-BINDING PROTEIN 3, NCBP3
24576,616625,"CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2W", CMT2W
24577,616626,CEREBRAL ENDOTHELIAL CELL ADHESION MOLECULE, CERCAM
24578,616627,PODOCALYXIN-LIKE 2, PODXL2
24579,616628,"FAMILY WITH SEQUENCE SIMILARITY 220, MEMBER A", FAM220A
24580,616629,SENIOR-LOKEN SYNDROME 9, SLSN9
24581,616630,NEURENSIN 1, NRSN1
24582,616631,"POROKERATOSIS 9, MULTIPLE TYPES", POROK9
24583,616632,"SEIZURES, CORTICAL BLINDNESS, AND MICROCEPHALY SYNDROME", SCBMS
24584,616633,PROLINE-RICH PROTEIN 12, PRR12
24585,616634,"SUSHI, NIDOGEN, AND EGF-LIKE DOMAINS PROTEIN 1", SNED1
24586,616635,CYSTEINE- AND HISTIDINE-RICH PROTEIN 1, CYHR1
24587,616636,IMMUNODEFICIENCY 44, IMD44
24588,616637,"TBC1 DOMAIN FAMILY, MEMBER 16", TBC1D16
24589,616638,SMITH-KINGSMORE SYNDROME, SKS
24590,616639,PR DOMAIN-CONTAINING PROTEIN 8, PRDM8
24591,616640,"EPILEPSY, PROGRESSIVE MYOCLONIC, 10", EPM10
24592,616641,RING FINGER PROTEIN 141, RNF141
24593,616642,C6ORF89 GENE, C6ORF89
24594,616643,HEPATOMA-DERIVED GROWTH FACTOR-RELATED PROTEIN 3,
24595,616644,CUB AND ZONA PELLUCIDA-LIKE DOMAINS 1, CUZD1
24596,616645,DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 34, DEE34
24597,616646,"KERATIN 25, TYPE I", KRT25
24598,616647,DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 35, DEE35
24599,616648,OPTIC ATROPHY 8, OPA8
24600,616649,"SPHEROCYTOSIS, TYPE 2", SPH2
24601,616650,KATANIN-INTERACTING PROTEIN, KATNIP
24602,616651,ROIFMAN SYNDROME, RFMN
24603,616652,YUAN-HAREL-LUPSKI SYNDROME, YUHAL
24604,616653,PNN-INTERACTING SERINE/ARGININE-RICH PROTEIN, PNISR
24605,616654,JOUBERT SYNDROME 24, JBTS24
24606,616655,SIPA1-LIKE PROTEIN 3, SIPA1L3
24607,616656,COMM DOMAIN-CONTAINING PROTEIN 8, COMMD8
24608,616657,"SPASTIC TETRAPLEGIA, THIN CORPUS CALLOSUM, AND PROGRESSIVE MICROCEPHALY", SPATCCM
24609,616658,"MITOCHONDRIAL CONTACT SITE AND CRISTAE ORGANIZING SYSTEM, 13-KD SUBUNIT", MICOS13
24610,616659,"TBC1 DOMAIN FAMILY, MEMBER 17", TBC1D17
24611,616660,TRANSMEMBRANE PROTEIN 175: TMEM175,
24612,616661,MORC FAMILY CW-TYPE ZINC FINGER PROTEIN 2, MORC2
24613,616662,THUMP DOMAIN-CONTAINING PROTEIN 1, THUMPD1
24614,616663,"SMALL NUCLEOLAR RNA, C/D BOX, 118", SNORD118
24615,616664,"SMALL NUCLEOLAR RNA, C/D BOX, 13", SNORD13
24616,616665,SYNAPTOPHYSIN-LIKE 1, SYPL1
24617,616666,"SEIZURE-RELATED 6, MOUSE, HOMOLOG OF", SEZ6
24618,616667,SEZ6-LIKE PROTEIN 2, SEZ6L2
24619,616668,"CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2X", CMT2X
24620,616669,IMMUNODEFICIENCY 45, IMD45
24621,616670,EXTENDED SYNAPTOTAGMIN-LIKE PROTEIN 1, ESYT1
24622,616671,"KERATIN 76, TYPE II", KRT76
24623,616672,COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 27, COXPD27
24624,616673,"SPINDLE- AND KINETOCHORE-ASSOCIATED COMPLEX, SUBUNIT 1", SKA1
24625,616674,"SPINDLE- AND KINETOCHORE-ASSOCIATED COMPLEX, SUBUNIT 2", SKA2
24626,616675,"KERATIN 26, TYPE I", KRT26
24627,616676,"KERATIN 27, TYPE I", KRT27
24628,616677,"KERATIN 28, TYPE I", KRT28
24629,616678,"KERATIN 39, TYPE I", KRT39
24630,616679,"KERATIN 40, TYPE I", KRT40
24631,616680,"SPASTIC PARAPLEGIA 75, AUTOSOMAL RECESSIVE", SPG75
24632,616681,"MICROCEPHALY 16, PRIMARY, AUTOSOMAL RECESSIVE", MCPH16
24633,616682,"SEIZURES, SCOLIOSIS, AND MACROCEPHALY/MICROCEPHALY SYNDROME", SSMS
24634,616683,"LEUKODYSTROPHY, HYPOMYELINATING, 12", HLD12
24635,616684,"CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 4K", CMT4K
24636,616685,"EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 14", EIG14
24637,616686,SYNAPTOTAGMIN-BINDING CYTOPLASMIC RNA-INTERACTING PROTEIN, SYNCRIP
24638,616687,"CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2Y", CMT2Y
24639,616688,"CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2Z", CMT2Z
24640,616689,DEHYDRATED HEREDITARY STOMATOCYTOSIS 2, DHS2
24641,616690,"CENTROSOMAL PROTEIN, 104-KD", CEP104
24642,616691,EXTENDED SYNAPTOTAGMIN-LIKE PROTEIN 2, ESYT2
24643,616692,EXTENDED SYNAPTOTAGMIN-LIKE PROTEIN 3, ESYT3
24644,616693,"ACID-SENSING ION CHANNEL, SUBUNIT 5", ASIC5
24645,616694,ECM29 PROTEASOME ADAPTOR AND SCAFFOLD PROTEIN, ECPAS
24646,616695,SERINE/THREONINE/TYROSINE-INTERACTING PROTEIN-LIKE 1, STYXL1
24647,616696,KIAA0040 GENE, KIAA0040
24648,616697,"DEAFNESS, AUTOSOMAL DOMINANT 69", DFNA69
24649,616698,ZINC FINGER PROTEIN 593, ZNF593
24650,616699,COMM DOMAIN-CONTAINING PROTEIN 2, COMMD2
24651,616700,COMM DOMAIN-CONTAINING PROTEIN 3, COMMD3
24652,616701,COMM DOMAIN-CONTAINING PROTEIN 4, COMMD4
24653,616702,ZINC FINGER PROTEIN 589, ZNF589
24654,616703,COMM DOMAIN-CONTAINING PROTEIN 7, COMMD7
24655,616704,COMM DOMAIN-CONTAINING PROTEIN 10, COMMD10
24656,616705,"DEAFNESS, AUTOSOMAL RECESSIVE 97", DFNB97
24657,616706,"POLY(ADP-RIBOSE) POLYMERASE FAMILY, MEMBER 11", PARP11
24658,616707,"DEAFNESS, AUTOSOMAL DOMINANT 68", DFNA68
24659,616708,DESANTO-SHINAWI SYNDROME, DESSH
24660,616709,"ALPHA-1,4-N-ACETYLGLUCOSAMINYLTRANSFERASE", A4GNT
24661,616710,"PARKINSON DISEASE 22, AUTOSOMAL DOMINANT", PARK22
24662,616711,TAO KINASE 3, TAOK3
24663,616712,START DOMAIN-CONTAINING PROTEIN 7, STARD7
24664,616713,PIPECOLIC ACID OXIDASE, PIPOX
24665,616714,HMG-BOX TRANSCRIPTION FACTOR 1, HBP1
24666,616715,THIOREDOXIN-RELATED TRANSMEMBRANE PROTEIN 2, TMX2
24667,616716,"RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 5", RCDP5
24668,616717,TESTIS-EXPRESSED GENE 10, TEX10
24669,616718,NEURITE OUTGROWTH-ASSOCIATED PROTEIN, NGRN
24670,616719,"SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 21", SCAR21
24671,616720,"MYASTHENIC SYNDROME, CONGENITAL, 19", CMS19
24672,616721,"CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIn", CDG2N
24673,616722,RETINAL DYSTROPHY AND IRIS COLOBOMA WITH OR WITHOUT CATARACT, RDICC
24674,616723,"SPONDYLOEPIMETAPHYSEAL DYSPLASIA, FADEN-ALKURAYA TYPE", SEMDFA
24675,616724,"TOOTH AGENESIS, SELECTIVE, 7", STHAG7
24676,616725,DExD/H-BOX HELICASE 60-LIKE PROTEIN, DDX60L
24677,616726,"CILIARY DYSKINESIA, PRIMARY, 33", CILD33
24678,616727,PHD FINGER PROTEIN 21B, PHF21B
24679,616728,"CLEFT PALATE, PSYCHOMOTOR RETARDATION, AND DISTINCTIVE FACIAL FEATURES", CPRF
24680,616729,"OLFACTORY RECEPTOR, FAMILY 2, SUBFAMILY W, MEMBER 3", OR2W3
24681,616730,"NEPHROTIC SYNDROME, TYPE 11", NPHS11
24682,616731,NIMA-RELATED KINASE 5, NEK5
24683,616732,"OPTIC ATROPHY 10 WITH OR WITHOUT ATAXIA, IMPAIRED INTELLECTUAL DEVELOPMENT, AND SEIZURES", OPA10
24684,616733,"COENZYME Q10 DEFICIENCY, PRIMARY, 8", COQ10D8
24685,616734,"SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 2", CSCSC2
24686,616735,COILED-COIL DOMAIN-CONTAINING PROTEIN 174: CCDC174,
24687,616736,"TREMOR, HEREDITARY ESSENTIAL, 5", ETM5
24688,616737,TAKENOUCHI-KOSAKI SYNDROME, TKS
24689,616738,RADIOULNAR SYNOSTOSIS WITH AMEGAKARYOCYTIC THROMBOCYTOPENIA 2, RUSAT2
24690,616739,"INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 51", MRT51
24691,616740,IMMUNODEFICIENCY 46, IMD46
24692,616741,PR DOMAIN-CONTAINING PROTEIN 13, PRDM13
24693,616742,NOP58 RIBONUCLEOPROTEIN, NOP58
24694,616743,RAL GUANINE NUCLEOTIDE DISSOCIATION STIMULATOR-LIKE 3, RGL3
24695,616744,"AUTOINFLAMMATORY SYNDROME, FAMILIAL, BEHCET-LIKE 1", AIFBL1
24696,616745,BIORIENTATION OF CHROMOSOMES IN CELL DIVISION 1, BOD1
24697,616746,BOD1-LIKE PROTEIN 1, BOD1L1
24698,616747,CHOLINE PHOSPHOTRANSFERASE 1, CHPT1
24699,616748,ECTONUCLEOSIDE TRIPHOSPHATE DIPHOSPHOHYDROLASE 8, ENTPD8
24700,616749,"HETEROTAXY, VISCERAL, 7, AUTOSOMAL", HTX7
24701,616750,ZINC FINGER DHHC DOMAIN-CONTAINING PROTEIN 16, ZDHHC16
24702,616751,CHOLINE/ETHANOLAMINE PHOSPHOTRANSFERASE 1, CEPT1
24703,616752,NEURONAL VESICLE TRAFFICKING-ASSOCIATED PROTEIN 2, NSG2
24704,616753,ECTONUCLEOSIDE TRIPHOSPHATE DIPHOSPHOHYDROLASE 7, ENTPD7
24705,616754,BOMBAY PHENOTYPE,
24706,616755,TRIPARTITE MOTIF-CONTAINING PROTEIN 62, TRIM62
24707,616756,SPASTIC PARAPLEGIA AND PSYCHOMOTOR RETARDATION WITH OR WITHOUT SEIZURES, SPPRS
24708,616757,TRANSMEMBRANE PROTEIN 150A, TMEM150A
24709,616758,KERATINOCYTE DIFFERENTIATION FACTOR 1, KDF1
24710,616759,NITRIC OXIDE SYNTHASE-INTERACTING PROTEIN, NOSIP
24711,616760,"WOOLLY HAIR, AUTOSOMAL RECESSIVE 3", ARWH3
24712,616761,SUSHI DOMAIN-CONTAINING PROTEIN 6, SUSD6
24713,616762,"CENTRIOLE-, CILIA-, AND SPINDLE-ASSOCIATED PROTEIN", CCSAP
24714,616763,LEUKODYSTROPHY AND ACQUIRED MICROCEPHALY WITH OR WITHOUT DYSTONIA, LDAMD
24715,616764,"SOLUTE CARRIER FAMILY 46, MEMBER 3", SLC46A3
24716,616765,STERILE ALPHA MOTIF DOMAIN-CONTAINING PROTEIN 11, SAMD11
24717,616766,THIOREDOXIN-RELATED TRANSMEMBRANE PROTEIN 4, TMX4
24718,616767,"CALPAIN, SMALL SUBUNIT 2", CAPNS2
24719,616768,"TUBULIN, BETA-8", TUBB8
24720,616769,NITRILASE FAMILY MEMBER 2, NIT2
24721,616770,MICRO RNA 218-1, MIR218-1
24722,616771,MICRO RNA 218-2, MIR218-2
24723,616772,"MANNOSIDASE, ALPHA, CLASS 1C, MEMBER 1", MAN1C1
24724,616773,MITOGUARDIN 1, MIGA1
24725,616774,MITOGUARDIN 2, MIGA2
24726,616775,ZINC FINGER PROTEIN 683, ZNF683
24727,616776,DUAL-SPECIFICITY PHOSPHATASE 15, DUSP15
24728,616777,SECKEL SYNDROME 9, SCKL9
24729,616778,DUAL-SPECIFICITY PHOSPHATASE 22, DUSP22
24730,616779,"CEREBRAL ARTERIOPATHY, AUTOSOMAL DOMINANT, WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY, TYPE 2", CADASIL2
24731,616780,OOCYTE/ZYGOTE/EMBRYO MATURATION ARREST 2, OZEMA2
24732,616781,JOUBERT SYNDROME 25, JBTS25
24733,616782,GLUCOSAMINYL (N-ACETYL) TRANSFERASE 4, GCNT4
24734,616783,UBX DOMAIN PROTEIN 10, UBXN10
24735,616784,JOUBERT SYNDROME 26, JBTS26
24736,616785,PUTATIVE HOMEODOMAIN TRANSCRIPTION FACTOR 2, PHTF2
24737,616786,MITOGEN-ACTIVATED PROTEIN KINASE-BINDING PROTEIN 1, MAPKBP1
24738,616787,CLUSTERIN-ASSOCIATED PROTEIN 1, CLUAP1
24739,616788,OROFACIAL CLEFT 15, OFC15
24740,616789,IMPAIRED INTELLECTUAL DEVELOPMENT AND DISTINCTIVE FACIAL FEATURES WITH OR WITHOUT CARDIAC DEFECTS, MRFACD
24741,616790,"PROTEIN PHOSPHATASE 4, REGULATORY SUBUNIT 4", PPP4R4
24742,616791,PIGGYBAC TRANSPOSABLE ELEMENT-DERIVED GENE 5, PGBD5
24743,616792,"NEUROBLASTOMA, SUSCEPTIBILITY TO, 7", NBLST7
24744,616793,"PHOSPHOLIPASE A2, GROUP IIF", PLA2G2F
24745,616794,COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 28, COXPD28
24746,616795,SPINOCEREBELLAR ATAXIA 42, SCA42
24747,616796,RETINOL DEHYDROGENASE 14, RDH14
24748,616797,EFR3 HOMOLOG B, EFR3B
24749,616798,ZINC FINGER PROTEIN 28, ZFP28
24750,616799,SYNAPTONEMAL COMPLEX PROTEIN 2-LIKE, SYCP2L
24751,616800,"LOXL1 ANTISENSE RNA 1, NONCODING", LOXL1AS1
24752,616801,"HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 2", IHPRF2
24753,616802,T CELL-INTERACTING ACTIVATING RECEPTOR ON MYELOID CELLS 1, TARM1
24754,616803,LAMB-SHAFFER SYNDROME, LAMSHF
24755,616804,V-SET AND TRANSMEMBRANE DOMAINS-CONTAINING PROTEIN 1, VSTM1
24756,616805,MYC TARGET IN MYELOID CELLS 1, MYCT1
24757,616806,WILMS TUMOR 6, WT6
24758,616807,FAS-BINDING FACTOR 1, FBF1
24759,616808,SHIFTLESS ANTIVIRAL INHIBITOR OF RIBOSOMAL FRAMESHIFTING, SHFL
24760,616809,HYPERPHOSPHATASIA WITH IMPAIRED INTELLECTUAL DEVELOPMENT SYNDROME 6, HPMRS6
24761,616810,"IMMUNOGLOBULIN SUPERFAMILY, DCC SUBCLASS, MEMBER 4", IGDCC4
24762,616811,COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 29, COXPD29
24763,616812,"MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 25", LGMDR25
24764,616813,"ARF GTPase-ACTIVATING PROTEIN WITH GTPase DOMAIN, ANKYRIN REPEAT, AND PLECKSTRIN HOMOLOGY DOMAIN 3", AGAP3
24765,616814,OOCYTE/ZYGOTE/EMBRYO MATURATION ARREST 15, OZEMA15
24766,616815,TRANSMEMBRANE PROTEIN 199, TMEM199
24767,616816,"HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION", IHPMR
24768,616817,"MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 2", MSSGM2
24769,616818,"IgA NEPHROPATHY, SUSCEPTIBILITY TO, 3", IGAN3
24770,616819,"CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND CEREBELLAR ATAXIA", CCAFCA
24771,616820,METHENYLTETRAHYDROFOLATE SYNTHETASE DOMAIN-CONTAINING PROTEIN, MTHFSD
24772,616821,THROMBOSPONDIN TYPE 1 DOMAIN-CONTAINING PROTEIN 1, THSD1
24773,616822,"MON2, REGULATOR OF ENDOSOME-TO-GOLGI TRAFFICKING", MON2
24774,616823,DOP1 LEUCINE ZIPPER-LIKE PROTEIN A, DOP1A
24775,616824,TMF1-REGULATED NUCLEAR PROTEIN 1, TRNP1
24776,616825,NUCLEAR RECEPTOR COACTIVATOR 5, NCOA5
24777,616826,EPS15-LIKE PROTEIN 1, EPS15L1
24778,616827,"MUSCULAR DYSTROPHY, AUTOSOMAL RECESSIVE, WITH CARDIOMYOPATHY AND TRIANGULAR TONGUE", MDRCMTT
24779,616828,"CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIo", CDG2O
24780,616829,"CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIp", CDG2P
24781,616830,TRANSPORT AND GOLGI ORGANIZATION 2 HOMOLOG, TANGO2
24782,616831,LUSCAN-LUMISH SYNDROME, LLS
24783,616832,MYOMESIN 3, MYOM3
24784,616833,PAGET DISEASE OF BONE 6, PDB6
24785,616834,"MICROCEPHALY, CONGENITAL CATARACT, AND PSORIASIFORM DERMATITIS", MCCPD
24786,616835,MEIER-GORLIN SYNDROME 6, MGORS6
24787,616836,G-PATCH DOMAIN-CONTAINING PROTEIN 2, GPATCH2
24788,616837,"HUMAN PLURIPOTENCY-ASSOCIATED TRANSCRIPT 5, NONCODING",
24789,616838,"C-TYPE LECTIN DOMAIN FAMILY 17, MEMBER A", CLEC17A
24790,616839,"EXERCISE INTOLERANCE, RIBOFLAVIN-RESPONSIVE", RREI
24791,616840,"PARKINSON DISEASE 23, AUTOSOMAL RECESSIVE EARLY-ONSET", PARK23
24792,616841,ZINC FINGER PROTEIN 468, ZNF468
24793,616842,"DNase1 HYPERSENSITIVITY, CHROMOSOME 6, SITE 1", DHS6S1
24794,616843,LYMPHATIC MALFORMATION 6, LMPHM6
24795,616844,"DNAJ/HSP40 HOMOLOG, SUBFAMILY C, MEMBER 17", DNAJC17
24796,616845,"C-TYPE LECTIN DOMAIN FAMILY 14, MEMBER A", CLEC14A
24797,616846,"ENDOPLASMIC RETICULUM MEMBRANE PROTEIN COMPLEX, SUBUNIT 1", EMC1
24798,616847,ZINC FINGER PROTEIN 543, ZNF543
24799,616848,MIER1 TRANSCRIPTIONAL REGULATOR, MIER1
24800,616849,"BRACHYDACTYLY, TYPE A1, D", BDA1D
24801,616850,WD REPEAT-CONTAINING PROTEIN 83, WDR83
24802,616851,CATARACT 45, CTRCT45
24803,616852,"MYOPATHY, SCAPULOHUMEROPERONEAL", SHPM
24804,616853,"FAMILY WITH SEQUENCE SIMILARITY 72, MEMBER C: FAM72C",
24805,616854,EVEN-PLUS SYNDROME, EVPLS
24806,616855,"CYTOCHROME c OXIDASE, SUBUNIT 8C", COX8C
24807,616856,BROMODOMAIN- AND PHD FINGER-CONTAINING PROTEIN 3, BRPF3
24808,616857,CHLORIDE CHANNEL ACCESSORY 4, CLCA4
24809,616858,COWDEN SYNDROME 7, CWS7
24810,616859,"SPASTICITY, CHILDHOOD-ONSET, WITH HYPERGLYCINEMIA", SPAHGC
24811,616860,"ANEMIA, SIDEROBLASTIC, 3, PYRIDOXINE-REFRACTORY", SIDBA3
24812,616861,"SOLUTE CARRIER FAMILY 12 (POTASSIUM/CHLORIDE TRANSPORTER), MEMBER 9", SLC12A9
24813,616862,RIBOSOMAL PROTEIN L34, RPL34
24814,616863,HAO-FOUNTAIN SYNDROME, HAFOUS
24815,616864,HEXOSAMINIDASE D, HEXD
24816,616865,"POLY(A) POLYMERASE, GAMMA", PAPOLG
24817,616866,SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 1, SMABF1
24818,616867,SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 2, SMABF2
24819,616868,"DIARRHEA 8, SECRETORY SODIUM, CONGENITAL", DIAR8
24820,616869,C-TERMINAL DOMAIN NUCLEAR ENVELOPE PHOSPHATASE 1 REGULATORY SUBUNIT 1, CNEP1R1
24821,616870,TRANSMEMBRANE PROTEIN 14A, TMEM14A
24822,616871,"MYELOPROLIFERATIVE/LYMPHOPROLIFERATIVE NEOPLASMS, FAMILIAL (MULTIPLE TYPES), SUSCEPTIBILITY TO", MPLPF
24823,616872,"TRANSMEMBRANE 9 SUPERFAMILY, MEMBER 3", TM9SF3
24824,616873,"IMMUNODEFICIENCY, COMMON VARIABLE, 13", CVID13
24825,616874,TRANSMEMBRANE BAX INHIBITOR MOTIF-CONTAINING PROTEIN 4, TMBIM4
24826,616875,"CEREBELLAR ATROPHY, VISUAL IMPAIRMENT, AND PSYCHOMOTOR RETARDATION", CAVIPMR
24827,616876,TRANSMEMBRANE p24 TRAFFICKING PROTEIN 5, TMED5
24828,616877,TRANSMEMBRANE PROTEIN 9, TMEM9
24829,616878,"METABOLIC CRISES, RECURRENT, WITH RHABDOMYOLYSIS, CARDIAC ARRHYTHMIAS, AND NEURODEGENERATION", MECRCN
24830,616879,"TBC1 DOMAIN FAMILY, MEMBER 22A", TBC1D22A
24831,616880,"TBC1 DOMAIN FAMILY, MEMBER 22B", TBC1D22B
24832,616881,"LEUKODYSTROPHY, HYPOMYELINATING, 13", HLD13
24833,616882,"ADVANCED SLEEP PHASE SYNDROME, FAMILIAL, 3", FASPS3
24834,616883,"SRP RECEPTOR SUBUNIT, BETA", SRPRB
24835,616884,"UNC79 HOMOLOG, NALCN CHANNEL COMPLEX SUBUNIT", UNC79
24836,616885,CALCIUM-REGULATED HEAT-STABLE PROTEIN 1, CARHSP1
24837,616886,GSE1 COILED-COIL PROTEIN, GSE1
24838,616887,"INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 52", MRT52
24839,616888,TRANSMEMBRANE PROTEIN 8B, TMEM8B
24840,616889,"CENTROSOMAL PROTEIN, 68-KD", CEP68
24841,616890,SPLIT-FOOT MALFORMATION WITH MESOAXIAL POLYDACTYLY, SFMMP
24842,616891,SMALL TRANSMEMBRANE REGULATOR OF ION TRANSPORT 1, STRIT1
24843,616892,"NEPHROTIC SYNDROME, TYPE 12", NPHS12
24844,616893,"NEPHROTIC SYNDROME, TYPE 13", NPHS13
24845,616894,"ROBINOW SYNDROME, AUTOSOMAL DOMINANT 3", DRS3
24846,616895,SURVIVAL-ASSOCIATED MITOCHONDRIAL MELANOMA-SPECIFIC ONCOGENIC NONCODING RNA, SAMMSON
24847,616896,MITOCHONDRIAL DNA DEPLETION SYNDROME 14 (CARDIOENCEPHALOMYOPATHIC TYPE), MTDPS14
24848,616897,"OSTEOCHONDRODYSPLASIA, COMPLEX LETHAL, SYMOENS-BARNES-GISTELINCK TYPE", OCLSBG
24849,616898,CHROMOSOME 15q14 DELETION SYNDROME,
24850,616899,TBC1 DOMAIN-CONTAINING KINASE, TBCK
24851,616900,"HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 3", IHPRF3
24852,616901,"DEVELOPMENTAL DELAY WITH SHORT STATURE, DYSMORPHIC FACIAL FEATURES, AND SPARSE HAIR 1", DEDSSH1
24853,616902,"CHROMOSOME 11p13 DELETION SYNDROME, DISTAL",
24854,616903,"THIOPURINES, POOR METABOLISM OF, 2", THPM2
24855,616904,DEDICATOR OF CYTOKINESIS 5, DOCK5
24856,616905,MORF4 FAMILY-ASSOCIATED PROTEIN 1, MRFAP1
24857,616906,CANCER SUSCEPTIBILITY CANDIDATE 1, CASC1
24858,616907,"SPASTIC PARAPLEGIA 76, AUTOSOMAL RECESSIVE", SPG76
24859,616908,PATCHED DOMAIN-CONTAINING PROTEIN 4, PTCHD4
24860,616909,COILED-COIL DOMAIN-CONTAINING PROTEIN 68, CCDC68
24861,616910,IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 3, ICF3
24862,616911,IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 4, ICF4
24863,616912,ENAH/VASP-LIKE PROTEIN, EVL
24864,616913,"BLEEDING DISORDER, PLATELET-TYPE, 20", BDPLT20
24865,616914,MARFANOID-PROGEROID-LIPODYSTROPHY SYNDROME, MFLS
24866,616915,TITLE NOT AVAILABLE AT THIS MOMENT,
24867,616916,SMALL ADP-RIBOSYLATION FACTOR GTPase-ACTIVATING PROTEIN 2, SMAP2
24868,616917,"NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPOTONIA, SEIZURES, AND CEREBELLAR ATROPHY", NEDHSCA
24869,616918,PHOSPHATIDYLINOSITOL GLYCAN ANCHOR BIOSYNTHESIS CLASS G PROTEIN, PIGG
24870,616919,FERM AND PDZ DOMAINS-CONTAINING PROTEIN 1, FRMPD1
24871,616920,HEART AND BRAIN MALFORMATION SYNDROME, HBMS
24872,616921,"DYSKINESIA, LIMB AND OROFACIAL, INFANTILE-ONSET", IOLOD
24873,616922,"STRIATAL DEGENERATION, AUTOSOMAL DOMINANT 2", ADSD2
24874,616923,RING FINGER PROTEIN 207, RNF207
24875,616924,"CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2CC", CMT2CC
24876,616925,"DDHRS4 ANTISENSE RNA 1, NONCODING", DHRS4AS1
24877,616926,FXYD DOMAIN-CONTAINING ION TRANSPORT REGULATOR 4, FXYD4
24878,616927,EXOCYST COMPLEX COMPONENT 3-LIKE 2, EXOC3L2
24879,616928,TRANSMEMBRANE PROTEIN 45A, TMEM45A
24880,616929,"TRANSCRIPTION TERMINATION FACTOR 2, MITOCHONDRIAL", MTERF2
24881,616930,"TRANSCRIPTION TERMINATION FACTOR 3, MITOCHONDRIAL", MTERF3
24882,616931,FUCOSYLTRANSFERASE 10, FUT10
24883,616932,FUCOSYLTRANSFERASE 11, FUT11
24884,616933,FORTY-TWO-THREE DOMAIN-CONTAINING PROTEIN 1, FYTTD1
24885,616934,MEIOSIS-SPECIFIC PROTEIN WITH COILED-COIL DOMAIN, MEIOC
24886,616935,"FAS-ASSOCIATED FACTOR FAMILY, MEMBER 2", FAF2
24887,616936,CHROMODOMAIN HELICASE DNA-BINDING PROTEIN 9, CHD9
24888,616937,THROMBOCYTOPENIA 6, THC6
24889,616938,COFFIN-SIRIS SYNDROME 5, CSS5
24890,616939,"CHOREA, CHILDHOOD-ONSET, WITH PSYCHOMOTOR RETARDATION", COCPMR
24891,616940,EXONUCLEASE 3-PRIME-TO-5-PRIME DOMAIN-CONTAINING PROTEIN 2, EXD2
24892,616941,"AGAMMAGLOBULINEMIA 8A, AUTOSOMAL DOMINANT", AGM8A
24893,616942,"PROTEIN DISULFIDE ISOMERASE, FAMILY A, MEMBER 5", PDIA5
24894,616943,"TRICHOTHIODYSTROPHY 6, NONPHOTOSENSITIVE", TTD6
24895,616944,"INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 41", MRD41
24896,616945,CLAVESIN 2, CLVS2
24897,616946,PREMATURE OVARIAN FAILURE 11, POF11
24898,616947,PREMATURE OVARIAN FAILURE 12, POF12
24899,616948,"SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 22", SCAR22
24900,616949,"SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 23", SCAR23
24901,616950,SPERMATOGENIC FAILURE 15, SPGF15
24902,616951,MTSS I-BAR DOMAIN-CONTAINING PROTEIN 2, MTSS2
24903,616952,MITOCHONDRIAL CALCIUM UNIPORTER REGULATOR 1, MCUR1
24904,616953,CUTA DIVALENT CATION TOLERANCE HOMOLOG, CUTA
24905,616954,YOU-HOOVER-FONG SYNDROME, YHFS
24906,616955,RRAD- AND GEM-LIKE GTPase 2, REM2
24907,616956,"TUBULIN POLYMERIZATION-PROMOTING PROTEIN FAMILY, MEMBER 2", TPPP2
24908,616957,"TUBULIN POLYMERIZATION-PROMOTING PROTEIN FAMILY, MEMBER 3", TPPP3
24909,616958,"DEAFNESS, AUTOSOMAL RECESSIVE 32, WITH OR WITHOUT IMMOTILE SPERM",
24910,616959,RETINITIS PIGMENTOSA AND ERYTHROCYTIC MICROCYTOSIS, RPEM
24911,616960,"GTPase, IMAP FAMILY, MEMBER 6", GIMAP6
24912,616961,"GTPase, IMAP FAMILY, MEMBER 7", GIMAP7
24913,616962,"GTPase, IMAP FAMILY, MEMBER 8", GIMAP8
24914,616963,"HYPERCALCEMIA, INFANTILE, 2", HCINF2
24915,616964,"PALMOPLANTAR CARCINOMA, MULTIPLE SELF-HEALING",
24916,616965,ADHESION G PROTEIN-COUPLED RECEPTOR G5, ADGRG5
24917,616966,"ABHYDROLASE DOMAIN-CONTAINING PROTEIN 6, ACYLGLYCEROL LIPASE", ABHD6
24918,616967,THIOREDOXIN DOMAIN-CONTAINING PROTEIN 17, TXNDC17
24919,616968,"DEAFNESS, AUTOSOMAL DOMINANT 70", DFNA70
24920,616969,"DEAFNESS, AUTOSOMAL DOMINANT 66", DFNA66
24921,616970,MARVEL DOMAIN-CONTAINING PROTEIN 1, MARVELD1
24922,616971,ENDOPLASMIC RETICULUM-GOLGI INTERMEDIATE COMPARTMENT PROTEIN 3, ERGIC3
24923,616972,MICRO RNA 490, MIR490
24924,616973,"INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 42", MRD42
24925,616974,COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 30, COXPD30
24926,616975,"NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT ANOMALIES OF THE BRAIN, EYE, OR HEART", NEDBEH
24927,616976,TRIPARTITE MOTIF-CONTAINING PROTEIN 40, TRIM40
24928,616977,"INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 43", MRD43
24929,616978,COILED COIL-HELIX-COILED COIL-HELIX DOMAIN-CONTAINING PROTEIN 5, CHCHD5
24930,616979,DEATH DOMAIN-CONTAINING PROTEIN 1, DTHD1
24931,616980,CELL CYCLE REGULATOR OF NONHOMOLOGOUS END JOINING, CYREN
24932,616981,DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 37, DEE37
24933,616982,PR DOMAIN-CONTAINING PROTEIN 6, PRDM6
24934,616983,ECTONUCLEOTIDE PYROPHOSPHATASE/PHOSPHODIESTERASE 6, ENPP6
24935,616984,NEUROPEPTIDE VF PRECURSOR, NPVF
24936,616985,MTRNR2-LIKE 1, MTRNR2L1
24937,616986,LONG INTERGENIC NONCODING RNA AC011288.2,
24938,616987,CHROMOSOME 6 OPEN READING FRAME 120, C6ORF120
24939,616988,CHRONIC LYMPHOCYTIC LEUKEMIA UPREGULATED GENE 1, CLLU1
24940,616989,"CHRONIC LYMPHOCYTIC LEUKEMIA UPREGULATED 1, OPPOSITE STRAND", CLLU1OS
24941,616990,CLUSTERIN-LIKE PROTEIN 1, CLUL1
24942,616991,"MUCIN 21, CELL SURFACE-ASSOCIATED", MUC21
24943,616992,CHROMOSOME 8 OPEN READING FRAME 17, C8ORF17
24944,616993,TRANSMEMBRANE PROTEIN 243, TMEM243
24945,616994,"CRANIOFACIAL DYSMORPHISM, SKELETAL ANOMALIES, AND IMPAIRED INTELLECTUAL DEVELOPMENT SYNDROME 2", CFSMR2
24946,616995,CLOCK-INTERACTING PACEMAKER, CIPC
24947,616996,TRIPARTITE MOTIF-CONTAINING PROTEIN 56, TRIM56
24948,616997,ECTONUCLEOTIDE PYROPHOSPHATASE/PHOSPHODIESTERASE 7, ENPP7
24949,616998,"LLP HOMOLOG, LONG-TERM SYNAPTIC FACILITATION FACTOR", LLPH
24950,616999,RNA-BINDING FOX1 HOMOLOG 3, RBFOX3
24951,617000,ECTONUCLEOTIDE PYROPHOSPHATASE/PHOSPHODIESTERASE 4, ENPP4
24952,617001,ECTONUCLEOTIDE PYROPHOSPHATASE/PHOSPHODIESTERASE 5, ENPP5
24953,617002,BICD FAMILY-LIKE CARGO ADAPTOR 1, BICDL1
24954,617003,BICD FAMILY-LIKE CARGO ADAPTOR 2, BICDL2
24955,617004,POLYCYSTIC LIVER DISEASE 2 WITH OR WITHOUT KIDNEY CYSTS, PCLD2
24956,617005,CLAUDIN 17, CLDN17
24957,617006,"AUTOIMMUNE DISEASE, MULTISYSTEM, INFANTILE-ONSET, 2", ADMIO2
24958,617007,TRIPARTITE MOTIF-CONTAINING PROTEIN 35, TRIM35
24959,617008,"CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 3", CPSQ3
24960,617009,ANKYRIN REPEAT DOMAIN-CONTAINING PROTEIN 53, ANKRD53
24961,617010,UNC51-LIKE KINASE 4, ULK4
24962,617011,"MACROCEPHALY, DYSMORPHIC FACIES, AND PSYCHOMOTOR RETARDATION", MDFPMR
24963,617012,POLIOVIRUS RECEPTOR-RELATED IMMUNOGLOBULIN DOMAIN-CONTAINING PROTEIN, PVRIG
24964,617013,HYPERMANGANESEMIA WITH DYSTONIA 2, HMNDYT2
24965,617014,"NEUTROPENIA, SEVERE CONGENITAL, 7, AUTOSOMAL RECESSIVE", SCN7
24966,617015,"PHOSPHOLIPASE C, PHOSPHATIDYLINOSITOL-SPECIFIC, X DOMAIN-CONTAINING PROTEIN 2", PLCXD2
24967,617016,"PHOSPHOLIPASE C, PHOSPHATIDYLINOSITOL-SPECIFIC, X DOMAIN-CONTAINING PROTEIN 3", PLCXD3
24968,617017,"CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2T", CMT2T
24969,617018,SPINOCEREBELLAR ATAXIA 43, SCA43
24970,617019,TRANSMEMBRANE PROTEIN 230, TMEM230
24971,617020,DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 38, DEE38
24972,617021,"HYDROPS, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA", HLASA
24973,617022,LETHAL CONGENITAL CONTRACTURE SYNDROME 10, LCCS10
24974,617023,RETINITIS PIGMENTOSA 75, RP75
24975,617024,"NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1H", CSNB1H
24976,617025,NEVUS COMEDONICUS, NC
24977,617026,"PONTOCEREBELLAR HYPOPLASIA, TYPE 2F", PCH2F
24978,617027,"HYPERALDOSTERONISM, FAMILIAL, TYPE IV", HALD4
24979,617028,"INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 54", MRT54
24980,617029,SEMAPHORIN 4B, SEMA4B
24981,617030,"MYOPATHY, DISTAL, 5", MPD5
24982,617031,PRE-mRNA-PROCESSING FACTOR 38A, PRPF38A
24983,617032,PROTEIN-GLUCOSYLGALACTOSYLHYDROXYLYSINE GLUCOSIDASE, PGGHG
24984,617033,CELLULAR ARGININE SENSOR FOR MTORC1 PROTEIN 2, CASTOR2
24985,617034,CELLULAR ARGININE SENSOR FOR MTORC1 PROTEIN 1, CASTOR1
24986,617035,PATENT DUCTUS ARTERIOSUS 2, PDA2
24987,617036,ALKALINE CERAMIDASE 3, ACER3
24988,617037,NONCODING RNA ACTIVATED BY DNA DAMAGE, NORAD
24989,617038,LONG INTERGENIC NONCODING RNA 1370, LINC01370
24990,617039,PATENT DUCTUS ARTERIOSUS 3, PDA3
24991,617040,MICRO RNA 1231, MIR1231
24992,617041,DUANE RETRACTION SYNDROME 3 WITH OR WITHOUT DEAFNESS, DURS3
24993,617042,GASDERMIN D, GSDMD
24994,617043,RHO GUANINE NUCLEOTIDE EXCHANGE FACTOR 17, ARHGEF17
24995,617044,"SHORT STATURE, DEVELOPMENTAL DELAY, AND CONGENITAL HEART DEFECTS", SDDHD
24996,617045,ZINC FINGER PROTEIN 703, ZNF703
24997,617046,"SPASTIC PARAPLEGIA 77, AUTOSOMAL RECESSIVE", SPG77
24998,617047,"CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 26", CMH26
24999,617048,"DNAJ/HSP40 HOMOLOG, SUBFAMILY C, MEMBER 21", DNAJC21
25000,617049,"CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC, 5", PFIC5
25001,617050,HERMANSKY-PUDLAK SYNDROME 10, HPS10
25002,617051,NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY AND GRAY SCLERAE, NEDMIGS
25003,617052,BONE MARROW FAILURE SYNDROME 3, BMFS3
25004,617053,MIRAGE SYNDROME, MIRAGE
25005,617054,"STRIATONIGRAL DEGENERATION, CHILDHOOD-ONSET", SNDC
25006,617055,PERCHING SYNDROME, PERCHING
25007,617056,"TUBULOINTERSTITIAL KIDNEY DISEASE, AUTOSOMAL DOMINANT 5", ADTKD5
25008,617057,"CYTOSOLIC THIOURIDYLASE, SUBUNIT 2", CTU2
25009,617058,TSR3 RIBOSOME MATURATION FACTOR, TSR3
25010,617059,ZINC FINGER DBF DOMAIN-CONTAINING PROTEIN 2, ZDBF2
25011,617060,LACTASE-LIKE PROTEIN, LCTL
25012,617061,"INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 44, WITH MICROCEPHALY", MRD44
25013,617062,OKUR-CHUNG NEURODEVELOPMENTAL SYNDROME, OCNDS
25014,617063,MEIER-GORLIN SYNDROME 7, MGORS7
25015,617064,GTP-BINDING ELONGATION FACTOR GUF1, GUF1
25016,617065,DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 40, DEE40
25017,617066,"MUSCULAR DYSTROPHY, CONGENITAL, DAVIGNON-CHAUVEAU TYPE", MDCDC
25018,617067,LY6/PLAUR DOMAIN-CONTAINING PROTEIN 8, LYPD8
25019,617068,"PORTAL HYPERTENSION, NONCIRRHOTIC, 1", NCPH1
25020,617069,"PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 3", PEOB3
25021,617070,"PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 4", PEOB4
25022,617071,LONG NONCODING RNA 13,
25023,617072,"MYOPATHY, AUTOSOMAL RECESSIVE, WITH RIGID SPINE AND DISTAL JOINT CONTRACTURES", MRRSDC
25024,617073,"TOOTH AGENESIS, SELECTIVE, 8", STHAG8
25025,617074,"SMITH-MAGENIS SYNDROME CHROMOSOME REGION, CANDIDATE GENE 8", SMCR8
25026,617075,"NASOPHARYNGEAL CARCINOMA, SUSCEPTIBILITY TO, 3", NPCA3
25027,617076,FK506-BINDING PROTEIN-LIKE, FKBPL
25028,617077,ZINC FINGER PROTEIN 618, ZNF618
25029,617078,DEATH EFFECTOR DOMAIN-CONTAINING PROTEIN 2, DEDD2
25030,617079,LONG INTERGENIC NONCODING RNA 673, LINC00673
25031,617080,"SEIZURES, BENIGN FAMILIAL INFANTILE, 5", BFIS5
25032,617081,OMA1 ZINC METALLOPEPTIDASE, OMA1
25033,617082,"CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Iaa", CDG1AA
25034,617083,"DYNEIN, CYTOPLASMIC 2, LIGHT INTERMEDIATE CHAIN 1", DYNC2LI1
25035,617084,TRANSMEMBRANE PROTEIN 59, TMEM59
25036,617085,"FIN BUD INITIATION FACTOR, ZEBRAFISH, HOMOLOG OF", FIBIN
25037,617086,ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 2, EMPF2
25038,617087,"CHARCOT-MARIE-TOOTH DISEASE, AXONAL, AUTOSOMAL RECESSIVE, TYPE 2A2B", CMT2A2B
25039,617088,SHORT-RIB THORACIC DYSPLASIA 15 WITH POLYDACTYLY, SRTD15
25040,617089,NUCLEOLUS AND NEURAL PROGENITOR PROTEIN, NEPRO
25041,617090,"MICROCEPHALY 17, PRIMARY, AUTOSOMAL RECESSIVE", MCPH17
25042,617091,"CILIARY DYSKINESIA, PRIMARY, 34", CILD34
25043,617092,"CILIARY DYSKINESIA, PRIMARY, 35", CILD35
25044,617093,"GROWTH RETARDATION, IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND HEPATOPATHY", GRIDHH
25045,617094,INTRAFLAGELLAR TRANSPORT 52, IFT52
25046,617095,OUTER DYNEIN ARM DOCKING COMPLEX SUBUNIT 4, ODAD4
25047,617096,TRANSMEMBRANE PROTEIN 59-LIKE, TMEM59L
25048,617097,LONG INTERGENIC NONCODING RNA 1194, LINC01194
25049,617098,RIBONUCLEASE K, RNASEK
25050,617099,"AUTOINFLAMMATION, PANNICULITIS, AND DERMATOSIS SYNDROME, AUTOSOMAL RECESSIVE", AIPDSB
25051,617100,FAMILIAL ADENOMATOUS POLYPOSIS 4, FAP4
25052,617101,INTELLECTUAL DEVELOPMENTAL DISORDER WITH PERSISTENCE OF FETAL HEMOGLOBIN,
25053,617102,SHORT-RIB THORACIC DYSPLASIA 16 WITH OR WITHOUT POLYDACTYLY, SRTD16
25054,617103,ZINC FINGER PROTEIN 668, ZNF668
25055,617104,"PHOSPHATIDYLINOSITOL 5-PHOSPHATE 4-KINASE, TYPE II, GAMMA", PIP4K2C
25056,617105,DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 41, DEE41
25057,617106,DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 42, DEE42
25058,617107,THAUVIN-ROBINET-FAIVRE SYNDROME, TROFAS
25059,617108,SESSILE SERRATED POLYPOSIS CANCER SYNDROME, SSPCS
25060,617109,CREB3 RECRUITMENT FACTOR, CREBRF
25061,617110,"CENTROSOMAL PROTEIN, 78-KD", CEP78
25062,617111,"MACULAR DYSTROPHY, PATTERNED, 3", MDPT3
25063,617112,KIAA0753 GENE, KIAA0753
25064,617113,DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 43, DEE43
25065,617114,"MYOPATHY, MYOFIBRILLAR, 7", MFM7
25066,617115,PEELING SKIN SYNDROME 5, PSS5
25067,617116,"EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 2", FFEVF2
25068,617117,LONG INTERGENIC NONCODING RNA 663, LINC00663
25069,617118,"EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 3", FFEVF3
25070,617119,BARDET-BIEDL SYNDROME 22, BBS22
25071,617120,JOUBERT SYNDROME 27, JBTS27
25072,617121,JOUBERT SYNDROME 28, JBTS28
25073,617122,C1QTNF9B ANTISENSE RNA 1, C1QTNF9BAS1
25074,617123,RETINITIS PIGMENTOSA 76, RP76
25075,617124,PEPTIDASE M20 DOMAIN-CONTAINING PROTEIN 1, PM20D1
25076,617125,"INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 56", MRT56
25077,617126,ALAZAMI-YUAN SYNDROME, ALYUS
25078,617127,OROFACIODIGITAL SYNDROME XV, OFD15
25079,617128,INHIBITORY SYNAPTIC FACTOR 1, INSYN1
25080,617129,INHIBITORY SYNAPTIC FACTOR 2A, INSYN2A
25081,617130,MEMBRANE-ANCHORED JUNCTION PROTEIN, MAJIN
25082,617131,TELOMERE REPEAT-BINDING BOUQUET FORMATION PROTEIN 2, TERB2
25083,617132,DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 44, DEE44
25084,617133,"SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 24", SCAR24
25085,617134,TRANSMEMBRANE AND COILED-COIL DOMAINS PROTEIN 3, TMCO3
25086,617135,L3MBTL HISTONE METHYL-LYSINE-BINDING PROTEIN 4, L3MBTL4
25087,617136,TFAP2A ANTISENSE RNA 2, TFAP2AAS2
25088,617137,FRONTOMETAPHYSEAL DYSPLASIA 2, FMD2
25089,617138,SKI FAMILY TRANSCRIPTIONAL COREPRESSOR 2, SKOR2
25090,617139,"LECTIN, GALACTOSIDE-BINDING, SOLUBLE, 7B", LGALS7B
25091,617140,ZTTK SYNDROME, ZTTKS
25092,617141,ANIRIDIA 2, AN2
25093,617142,ANIRIDIA 3, AN3
25094,617143,"MYASTHENIC SYNDROME, CONGENITAL, 20, PRESYNAPTIC", CMS20
25095,617144,"MICRO RNA 4435-2 HOST GENE, NONCODING", MIR4435-2HG
25096,617145,"NEURODEGENERATION WITH ATAXIA, DYSTONIA, AND GAZE PALSY, CHILDHOOD-ONSET", NADGP
25097,617146,"ARTHROGRYPOSIS, DISTAL, WITH IMPAIRED PROPRIOCEPTION AND TOUCH", DAIPT
25098,617147,COILED-COIL DOMAIN-CONTAINING PROTEIN 14, CCDC14
25099,617148,DEUTEROSOME ASSEMBLY PROTEIN 1, DEUP1
25100,617149,CENTROSOMAL PROTEIN 20, CEP20
25101,617150,ZINC FINGER DHHC DOMAIN-CONTAINING PROTEIN 3, ZDHHC3
25102,617151,"SULFOTRANSFERASE FAMILY 1C, MEMBER 3", SULT1C3
25103,617152,"SULFOTRANSFERASE FAMILY 6B, MEMBER 1", SULT6B1
25104,617153,DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 45, DEE45
25105,617154,MRN COMPLEX-INTERACTING PROTEIN, MRNIP
25106,617155,SUPPRESSION OF TUMORIGENICITY 18, ST18
25107,617156,MITOCHONDRIAL DNA DEPLETION SYNDROME 15 (HEPATOCEREBRAL TYPE), MTDPS15
25108,617157,"SHORT STATURE, BRACHYDACTYLY, IMPAIRED INTELLECTUAL DEVELOPMENT, AND SEIZURES", SBIDDS
25109,617158,"MYOPATHY, DISTAL, WITH RIMMED VACUOLES", DMRV
25110,617159,SIFRIM-HITZ-WEISS SYNDROME, SIHIWES
25111,617160,PROMININ 2, PROM2
25112,617161,GSG1-LIKE PROTEIN, GSG1L
25113,617162,DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 46, DEE46
25114,617163,RING FINGER PROTEIN 186, RNF186
25115,617164,SHORT STATURE-MICROGNATHIA SYNDROME, SSMG
25116,617165,"FAMILY WITH SEQUENCE SIMILARITY 213, MEMBER A", FAM213A
25117,617166,DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 47, DEE47
25118,617167,"SOLUTE CARRIER FAMILY 35, MEMBER G1", SLC35G1
25119,617168,"AORTIC ANEURYSM, FAMILIAL THORACIC 10", AAT10
25120,617169,"INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 74", MRT74
25121,617170,CWC27 SPLICEOSOME-ASSOCIATED CYCLOPHILIN, CWC27
25122,617171,NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA AND IMPAIRED EXPRESSIVE LANGUAGE AND WITH OR WITHOUT SEIZURES, NEDHELS
25123,617172,GLUTATHIONE PEROXIDASE 8, GPX8
25124,617173,"LODDER-MERLA SYNDROME, TYPE 1, WITH IMPAIRED INTELLECTUAL DEVELOPMENT AND CARDIAC ARRHYTHMIA", LDMLS1
25125,617174,"EHLERS-DANLOS SYNDROME, PERIODONTAL TYPE, 2", EDSPD2
25126,617175,RETINAL DYSTROPHY WITH OR WITHOUT EXTRAOCULAR ANOMALIES, RDEOA
25127,617176,MICRO RNA 4271, MIR4271
25128,617177,MYOSIN LIGHT CHAIN 10, MYL10
25129,617178,RING FINGER PROTEIN 166, RNF166
25130,617179,PROMOTER OF CDKN1A ANTISENSE DNA DAMAGE-ACTIVATED RNA, PANDAR
25131,617180,CHITAYAT SYNDROME, CHYTS
25132,617181,TRANSMEMBRANE CHANNEL-LIKE PROTEIN 4, TMC4
25133,617182,"LODDER-MERLA SYNDROME, TYPE 2, WITH DEVELOPMENTAL DELAY AND WITH OR WITHOUT CARDIAC ARRHYTHMIA", LDMLS2
25134,617183,HAREL-YOON SYNDROME, HAYOS
25135,617184,"MITOCHONDRIAL DNA DEPLETION SYNDROME 12A (CARDIOMYOPATHIC TYPE), AUTOSOMAL DOMINANT", MTDPS12A
25136,617185,"NOP2/SUN RNA METHYLTRANSFERASE FAMILY, MEMBER 7", NSUN7
25137,617186,"ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 1", PEBEL1
25138,617187,SPERMATOGENIC FAILURE 16, SPGF16
25139,617188,"INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 57", MRT57
25140,617189,TRANSMEMBRANE PROTEIN 110, TMEM110
25141,617190,SHASHI-PENA SYNDROME, SHAPNS
25142,617191,p38-INHIBITED CUTANEOUS SQUAMOUS CELL CARCINOMA-ASSOCIATED LONG INTERGENIC NONCODING RNA, PICSAR
25143,617192,ENDONUCLEASE/EXONUCLEASE/PHOSPHATASE FAMILY DOMAIN-CONTAINING PROTEIN 1, EEPD1
25144,617193,"ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND THIN CORPUS CALLOSUM", PEBAT
25145,617194,LETHAL CONGENITAL CONTRACTURE SYNDROME 11, LCCS11
25146,617195,MUSCULOSKELETAL EMBRYONIC NUCLEAR PROTEIN 1, MUSTN1
25147,617196,TRANSMEMBRANE CHANNEL-LIKE PROTEIN 3, TMC3
25148,617197,TRANSMEMBRANE CHANNEL-LIKE PROTEIN 5, TMC5
25149,617198,TRANSMEMBRANE CHANNEL-LIKE PROTEIN 7, TMC7
25150,617199,"NOP2/SUN RNA METHYLTRANSFERASE FAMILY, MEMBER 6", NSUN6
25151,617200,OLIGODENDROCYTIC MYELIN PARANODAL AND INNER LOOP PROTEIN, OPALIN
25152,617201,PERIVENTRICULAR NODULAR HETEROTOPIA 7, PVNH7
25153,617202,FORKHEAD BOX I2, FOXI2
25154,617203,TRANSMEMBRANE PROTEIN 87B, TMEM87B
25155,617204,VIMENTIN-TYPE INTERMEDIATE FILAMENT-ASSOCIATED COILED-COIL PROTEIN, VMAC
25156,617205,"HETEROTAXY, VISCERAL, 8, AUTOSOMAL", HTX8
25157,617206,NEURALIZED E3 UBIQUITIN PROTEIN LIGASE 3, NEURL3
25158,617207,"ENCEPHALOPATHY, PROGRESSIVE, WITH AMYOTROPHY AND OPTIC ATROPHY", PEAMO
25159,617208,MAM DOMAIN-CONTAINING PROTEIN 4, MAMDC4
25160,617209,GLUTAMINYL-tRNA AMIDOTRANSFERASE SUBUNIT QRSL1, QRSL1
25161,617210,"GLUTAMYL-tRNA AMIDOTRANSFERASE, SUBUNIT C", GATC
25162,617211,DERMOKINE, DMKN
25163,617212,KERATINOCYTE DIFFERENTIATION-ASSOCIATED PROTEIN, KRTDAP
25164,617213,SEDOHEPTULOKINASE DEFICIENCY, SHPKD
25165,617214,SPERMATOGENIC FAILURE 17, SPGF17
25166,617215,CHROMOSOME 17 OPEN READING FRAME 49, C17ORF49
25167,617216,ZINC FINGER PROTEIN 420, ZNF420
25168,617217,"AMELOGENESIS IMPERFECTA, HYPOMATURATION TYPE, IIA6", AI2A6
25169,617218,TRANSMEMBRANE AND TETRATRICOPEPTIDE REPEAT DOMAINS-CONTAINING PROTEIN 3, TMTC3
25170,617219,"CHROMOSOME 19q13.11 DELETION SYNDROME, PROXIMAL",
25171,617220,PYRIDINE NUCLEOTIDE-DISULFIDE OXIDOREDUCTASE DOMAIN-CONTAINING PROTEIN 1, PYROXD1
25172,617221,HEXOKINASE DOMAIN-CONTAINING PROTEIN 1, HKDC1
25173,617222,"SUDDEN CARDIAC FAILURE, INFANTILE", SCFI
25174,617223,"SUDDEN CARDIAC FAILURE, ALCOHOL-INDUCED", SCFAI
25175,617224,GROWTH ARREST-SPECIFIC 2-LIKE 3, GAS2L3
25176,617225,"SPASTIC PARAPLEGIA 78, AUTOSOMAL RECESSIVE", SPG78
25177,617226,MITOGEN-ACTIVATED PROTEIN KINASE 1-INTERACTING PROTEIN 1-LIKE PROTEIN, MAPK1IP1L
25178,617227,"ATPase FAMILY, AAA DOMAIN-CONTAINING, MEMBER 3C", ATAD3C
25179,617228,COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 31, COXPD31
25180,617229,"FAMILY WITH SEQUENCE SIMILARITY 53, MEMBER A", FAM53A
25181,617230,ZFP1 ZINC FINGER PROTEIN, ZFP1
25182,617231,PHOSPHOLYSINE PHOSPHOHISTIDINE INORGANIC PYROPHOSPHATE PHOSPHATASE, LHPP
25183,617232,"MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 21", LGMDR21
25184,617233,WD REPEAT-CONTAINING PROTEIN 70, WDR70
25185,617234,OOCYTE/ZYGOTE/EMBRYO MATURATION ARREST 16, OZEMA16
25186,617235,"MYOCLONUS, INTRACTABLE, NEONATAL", NEIMY
25187,617236,CONE-ROD DYSTROPHY AND HEARING LOSS 1, CRDHL1
25188,617237,"IMMUNODEFICIENCY 49, SEVERE COMBINED", IMD49
25189,617238,"MYOPIA 25, AUTOSOMAL DOMINANT", MYP25
25190,617239,"MYASTHENIC SYNDROME, CONGENITAL, 21, PRESYNAPTIC", CMS21
25191,617240,"HAND2 ANTISENSE RNA 1, NONCODING", HAND2AS1
25192,617241,"LUNG DISEASE, IMMUNODEFICIENCY, AND CHROMOSOME BREAKAGE SYNDROME", LICS
25193,617242,"TRANS-2,3-ENOYL-CoA REDUCTASE-LIKE PROTEIN", TECRL
25194,617243,"FANCONI ANEMIA, COMPLEMENTATION GROUP V", FANCV
25195,617244,"FANCONI ANEMIA, COMPLEMENTATION GROUP R", FANCR
25196,617245,"HECT, C2, AND WW DOMAINS-CONTAINING E3 UBIQUITIN-PROTEIN LIGASE 2", HECW2
25197,617246,"NSE2 (MMS21) HOMOLOG, SMC5-SMC6 COMPLEX SUMO LIGASE", NSMCE2
25198,617247,"FANCONI ANEMIA, COMPLEMENTATION GROUP U", FANCU
25199,617248,"3-METHYLGLUTACONIC ACIDURIA, TYPE VIII", MGCA8
25200,617249,"FAMILY WITH SEQUENCE SIMILARITY 122, MEMBER A", FAM122A
25201,617250,"ELKS/RAB6-INTERACTING/CAST FAMILY, MEMBER 2", ERC2
25202,617251,UNCOMBABLE HAIR SYNDROME 2, UHS2
25203,617252,UNCOMBABLE HAIR SYNDROME 3, UHS3
25204,617253,SECKEL SYNDROME 10, SCKL10
25205,617254,LAMIN TAIL DOMAIN-CONTAINING PROTEIN 1, LMNTD1
25206,617255,LISSENCEPHALY 8, LIS8
25207,617256,"SOLUTE CARRIER FAMILY 7, MEMBER 13", SLC7A13
25208,617257,SPERMATOGENESIS-ASSOCIATED PROTEIN 46, SPATA46
25209,617258,"MYOPATHY, MYOFIBRILLAR, 8", MFM8
25210,617259,DDB1- AND CUL4-ASSOCIATED FACTOR 1, DCAF1
25211,617260,"GLOBAL DEVELOPMENTAL DELAY, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM, AND DYSMORPHIC FACIES", GDACCF
25212,617261,TRANSMEMBRANE PROTEIN 261, TMEM261
25213,617262,ATP5S-LIKE PROTEIN, ATP5SL
25214,617263,"NSE1 HOMOLOG, SMC5-SMC6 COMPLEX COMPONENT", NSMCE1
25215,617264,SR-RELATED C-TERMINAL DOMAIN-ASSOCIATED FACTOR 1, SCAF1
25216,617265,POTASSIUM CHANNEL TETRAMERIZATION DOMAIN-CONTAINING PROTEIN 9, KCTD9
25217,617266,KIAA0825 GENE, KIAA0825
25218,617267,MATRIX AAA PEPTIDASE-INTERACTING PROTEIN 1, MAIP1
25219,617268,"NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, SEIZURES, AND ABSENT LANGUAGE", NDHSAL
25220,617269,"SOCS2 ANTISENSE RNA 1, NONCODING", SOCS2AS1
25221,617270,"INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 58", MRT58
25222,617271,NEPHRONOPHTHISIS 20, NPHP20
25223,617272,"GLAUCOMA 3, PRIMARY CONGENITAL, E", GLC3E
25224,617273,CBY1-INTERACTING BAR DOMAIN-CONTAINING PROTEIN 1, CIBAR1
25225,617274,CBY1-INTERACTING BAR DOMAIN-CONTAINING PROTEIN 2, CIBAR2
25226,617275,"TOOTH AGENESIS, SELECTIVE, 9", STHAG9
25227,617276,DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 48, DEE48
25228,617277,DYNEIN HEAVY CHAIN DOMAIN 1, DNHD1
25229,617278,DENN DOMAIN-CONTAINING PROTEIN 5A, DENND5A
25230,617279,DENN DOMAIN-CONTAINING PROTEIN 5B, DENND5B
25231,617280,"ATRIAL FIBRILLATION, FAMILIAL, 18", ATFB18
25232,617281,DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 49, DEE49
25233,617282,"DYSTONIA, CHILDHOOD-ONSET, WITH OPTIC ATROPHY AND BASAL GANGLIA ABNORMALITIES", DYTOABG
25234,617283,YTH DOMAIN-CONTAINING PROTEIN 1, YTHDC1
25235,617284,"DYSTONIA 28, CHILDHOOD-ONSET", DYT28
25236,617285,HIGH MOBILITY GROUP BOX 4, HMGB4
25237,617286,PITX2 ADJACENT NONCODING RNA, PANCR
25238,617287,PHOSPHOLIPID PHOSPHATASE-RELATED PROTEIN 5, PLPPR5
25239,617288,"SERINE PEPTIDASE INHIBITOR, KAZAL-TYPE, 7", SPINK7
25240,617289,"FAMILY WITH SEQUENCE SIMILARITY 53, MEMBER B", FAM53B
25241,617290,"EPILEPSY, EARLY-ONSET, 1, VITAMIN B6-DEPENDENT", EPEO1
25242,617291,TRANSMEMBRANE PROTEIN 150B, TMEM150B
25243,617292,TRANSMEMBRANE PROTEIN 150C, TMEM150C
25244,617293,MATRIX REMODELING-ASSOCIATED PROTEIN 8, MXRA8
25245,617294,"EPIDERMOLYSIS BULLOSA SIMPLEX 6, GENERALIZED INTERMEDIATE, WITH OR WITHOUT CARDIOMYOPATHY", EBS6
25246,617295,RUN DOMAIN-CONTAINING PROTEIN 3B, RUNDC3B
25247,617296,"SPASTIC PARAPLEGIA, INTELLECTUAL DISABILITY, NYSTAGMUS, AND OBESITY", SINO
25248,617297,"AMELOGENESIS IMPERFECTA, TYPE IJ", AI1J
25249,617298,"APOPTOSIS-INDUCING FACTOR, MITOCHONDRIA-ASSOCIATED, 3", AIFM3
25250,617299,RPA-INTERACTING PROTEIN, RPAIN
25251,617300,LYMPHATIC MALFORMATION 7, LMPHM7
25252,617301,GLYCINE ENCEPHALOPATHY WITH NORMAL SERUM GLYCINE,
25253,617302,OPTIC ATROPHY 11, OPA11
25254,617303,MUCOPOLYSACCHARIDOSIS-PLUS SYNDROME, MPSPS
25255,617304,RETINITIS PIGMENTOSA 77, RP77
25256,617305,"FAMILY WITH SEQUENCE SIMILARITY 26, MEMBER F", FAM26F
25257,617306,"COLOBOMA, OSTEOPETROSIS, MICROPHTHALMIA, MACROCEPHALY, ALBINISM, AND DEAFNESS", COMMAD
25258,617307,CHROMOSOME 14 OPEN READING FRAME 39, C14ORF39
25259,617308,"BILE ACID SYNTHESIS DEFECT, CONGENITAL, 6", CBAS6
25260,617309,IMMUNOGLOBULIN-LIKE AND FIBRONECTIN TYPE III DOMAINS-CONTAINING PROTEIN 1, IGFN1
25261,617310,ANKYRIN REPEAT AND STERILE ALPHA MOTIF DOMAINS-CONTAINING PROTEIN 3, ANKS3
25262,617311,"ZYMOGEN GRANULE PROTEIN, 16-KD", ZG16
25263,617312,FHF COMPLEX SUBUNIT HOOK-INTERACTING PROTEIN 2A, FHIP2A
25264,617313,SH2 DOMAIN-CONTAINING ADAPTOR PROTEIN F, SHF
25265,617314,SH3 DOMAIN- AND SYLF DOMAIN-CONTAINING PROTEIN 1, SH3YL1
25266,617315,ANTERIOR SEGMENT DYSGENESIS 6, ASGD6
25267,617316,TP53 TARGET GENE 5, TP53TG5
25268,617317,ZFP30 ZINC FINGER PROTEIN, ZFP30
25269,617318,RUN DOMAIN- AND SH3 DOMAIN-CONTAINING PROTEIN 1, RUSC1
25270,617319,ANTERIOR SEGMENT DYSGENESIS 8, ASGD8
25271,617320,"ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 12", ARCI12
25272,617321,YAO SYNDROME, YAOS
25273,617322,SH3KBP1-BINDING PROTEIN 1, SHKBP1
25274,617323,"INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 59", MRT59
25275,617324,"SHISA FAMILY, MEMBER 2", SHISA2
25276,617325,"SHISA FAMILY, MEMBER 3", SHISA3
25277,617326,"SHISA FAMILY, MEMBER 4", SHISA4
25278,617327,"SHISA FAMILY, MEMBER 6", SHISA6
25279,617328,"SHISA FAMILY, MEMBER 7", SHISA7
25280,617329,"SHISA FAMILY, MEMBER 8", SHISA8
25281,617330,"HYPOTONIA, ATAXIA, AND DELAYED DEVELOPMENT SYNDROME", HADDS
25282,617331,MAJOR FACILITATOR SUPERFAMILY DOMAIN-CONTAINING PROTEIN 4B, MFSD4B
25283,617332,TELOMERE REPEAT-BINDING BOUQUET FORMATION PROTEIN 1, TERB1
25284,617333,INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND PTOSIS, IDDDFP
25285,617334,ZINC FINGER DHHC-TYPE CONTAINING 23, ZDHHC23
25286,617335,EMOPAMIL-BINDING PROTEIN-LIKE, EBPL
25287,617336,CONGENITAL MYOPATHY 24, CMYO24
25288,617337,"ECTODERMAL DYSPLASIA 12, HYPOHIDROTIC/HAIR/TOOTH/NAIL TYPE", ECTD12
25289,617338,NUDIX HYDROLASE 16-LIKE 1, NUDT16L1
25290,617339,DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 51, DEE51
25291,617340,URIDINE PHOSPHORYLASE 2, UPP2
25292,617341,CEREBRORETINAL MICROANGIOPATHY WITH CALCIFICATIONS AND CYSTS 2, CRMCC2
25293,617342,PEPTIDYL-tRNA HYDROLASE DOMAIN-CONTAINING 1, PTRHD1
25294,617343,HYPERPARATHYROIDISM 4, HRPT4
25295,617344,PEAK1-RELATED KINASE-ACTIVATING PSEUDOKINASE 1, PRAG1
25296,617345,ATP/GTP-BINDING PROTEIN-LIKE 2, AGBL2
25297,617346,ATP/GTP-BINDING PROTEIN-LIKE 3, AGBL3
25298,617347,"HYPERLIPOPROTEINEMIA, TYPE III",
25299,617348,"CARBOXYPEPTIDASE X, M14 FAMILY, MEMBER 2", CPXM2
25300,617349,"AORTIC ANEURYSM, FAMILIAL THORACIC 11, SUSCEPTIBILITY TO", AAT11
25301,617350,DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 52, DEE52
25302,617351,"IMMUNOGLOBULIN SUPERFAMILY, MEMBER 10", IGSF10
25303,617352,MULCHANDANI-BHOJ-CONLIN SYNDROME, MBCS
25304,617353,"DYNEIN, LIGHT CHAIN, TCTEX-TYPE, 2B", DYNLT2B
25305,617354,CHROMOBOX 8, CBX8
25306,617355,EP300-INTERACTING INHIBITOR OF DIFFERENTIATION 2B, EID2B
25307,617356,SUBCOMMISSURAL ORGAN SPONDIN, SSPO
25308,617357,ZINC FINGER PROTEIN 222, ZNF222
25309,617358,SYNDECAN-BINDING PROTEIN 2, SDCBP2
25310,617359,STORKHEAD BOX 2, STOX2
25311,617360,"CONGENITAL HEART DEFECTS, DYSMORPHIC FACIAL FEATURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER", CHDFIDD
25312,617361,TRANSMEMBRANE PROTEIN 108, TMEM108
25313,617362,DEAH-BOX HELICASE 37, DHX37
25314,617363,TRANSMEMBRANE PROTEIN 132A, TMEM132A
25315,617364,CONGENITAL HEART DEFECTS AND ECTODERMAL DYSPLASIA, CHDED
25316,617365,AAR2 SPLICING FACTOR, AAR2
25317,617366,COILED-COIL DOMAIN-CONTAINING PROTEIN 91, CCDC91
25318,617367,KIAA1217 GENE, KIAA1217
25319,617368,SH3 DOMAIN-BINDING PROTEIN 1, SH3BP1
25320,617369,HYALURONAN-BINDING PROTEIN 4, HABP4
25321,617370,PEROXISOME BIOGENESIS DISORDER 10B, PBD10B
25322,617371,ZINC FINGER PROTEIN 462, ZNF462
25323,617372,SHC TRANSFORMING PROTEIN 4, SHC4
25324,617373,PROLINE-RICH COILED-COIL PROTEIN 2C, PRRC2C
25325,617374,"INHIBITOR OF CDK, CYCLIN A1-INTERACTING PROTEIN 1", INCA1
25326,617375,KELCH DOMAIN-CONTAINING PROTEIN 9, KLHDC9
25327,617376,PROLINE-RICH CYCLIN A1-INTERACTING PROTEIN, PROCA1
25328,617377,SYNAPSE DEFECTIVE RHO GTPase HOMOLOG 1, SYDE1
25329,617378,MYOSIN LIGHT CHAIN 11, MYL11
25330,617379,MYOSIN XIX, MYO19
25331,617380,TRANSLOCASE OF INNER MITOCHONDRIAL MEMBRANE 29, TIMM29
25332,617381,NUDIX HYDROLASE 16, NUDT16
25333,617382,START DOMAIN-CONTAINING PROTEIN 10, STARD10
25334,617383,"AVASCULAR NECROSIS OF FEMORAL HEAD, PRIMARY, 2", ANFH2
25335,617384,"HYPERPHENYLALANINEMIA, MILD, NON-BH4-DEFICIENT", HPANBH4
25336,617385,"ATPase, H+ TRANSPORTING, LYSOSOMAL, 31-KD, V1 SUBUNIT E, ISOFORM 1", ATP6V1E2
25337,617386,"NUCLEAR RECEPTOR SUBFAMILY 1, GROUP H, MEMBER 5, PSEUDOGENE", NR1H5P
25338,617387,GLUTAMINE-RICH PROTEIN 1, QRICH1
25339,617388,AUTOINFLAMMATION WITH ARTHRITIS AND DYSKERATOSIS, AIADK
25340,617389,DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 53, DEE53
25341,617390,KIAA1958 GENE, KIAA1958
25342,617391,DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 54, DEE54
25343,617392,"ECTODERMAL DYSPLASIA 13, HAIR/TOOTH TYPE", ECTD13
25344,617393,"NEURODEVELOPMENTAL DISORDER WITH EPILEPSY, CATARACTS, FEEDING DIFFICULTIES, AND DELAYED BRAIN MYELINATION", NECFM
25345,617394,"SCLEROSING CHOLANGITIS, NEONATAL", NSC
25346,617395,"CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIq", CDG2Q
25347,617396,ANAUXETIC DYSPLASIA 2, ANXD2
25348,617397,PSEUDO-TORCH SYNDROME 2, PTORCH2
25349,617398,FK506-BINDING PROTEIN 15, FKBP15
25350,617399,PEROXISOMAL MEMBRANE PROTEIN 2, PXMP2
25351,617400,EPOXIDE HYDROLASE 3, EPHX3
25352,617401,EPOXIDE HYDROLASE 4, EPHX4
25353,617402,"CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIC", ARCL2C
25354,617403,"CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IID", ARCL2D
25355,617404,"MUSCULAR DYSTROPHY, CONGENITAL, WITH CATARACTS AND IMPAIRED INTELLECTUAL DEVELOPMENT", MDCCAID
25356,617405,SHORT-RIB THORACIC DYSPLASIA 17 WITH OR WITHOUT POLYDACTYLY, SRTD17
25357,617406,BARDET-BIEDL SYNDROME 21, BBS21
25358,617407,POLYCOMB GROUP RING FINGER PROTEIN 5, PCGF5
25359,617408,DIAMOND-BLACKFAN ANEMIA 16, DBA16
25360,617409,DIAMOND-BLACKFAN ANEMIA 17, DBA17
25361,617410,ZINC FINGER PROTEIN 419, ZNF419
25362,617411,ADP-RIBOSYLATION FACTOR GUANINE NUCLEOTIDE EXCHANGE FACTOR 3, ARFGEF3
25363,617412,"BRACHYCEPHALY, TRICHOMEGALY, AND DEVELOPMENTAL DELAY", BTDD
25364,617413,PRUNE EXOPOLYPHOSPHATASE 1, PRUNE1
25365,617414,RIBOSOMAL PROTEIN L14, RPL14
25366,617415,RIBOSOMAL PROTEIN L31, RPL31
25367,617416,RIBOSOMAL PROTEIN L3-LIKE, RPL3L
25368,617417,RIBOSOMAL PROTEIN L7-LIKE 1, RPL7L1
25369,617418,WD REPEAT-CONTAINING PROTEIN 59, WDR59
25370,617419,PROLYL 3-HYDROXYLASE 4, P3H4
25371,617420,KICSTOR SUBUNIT 2, KICS2
25372,617421,INTEGRIN-ALPHA FG-GAP REPEAT-CONTAINING PROTEIN 2, ITFG2
25373,617422,ACTIVITY-DEPENDENT NEUROPROTECTOR HOMEOBOX 2, ADNP2
25374,617423,PROLINE-RICH PROTEIN 14, PRR14
25375,617424,WD REPEAT-CONTAINING PROTEIN 26, WDR26
25376,617425,IMMUNOSKELETAL DYSPLASIA WITH NEURODEVELOPMENTAL ABNORMALITIES, ISDNA
25377,617426,CYSTEINE-RICH C-TERMINAL 1, CRCT1
25378,617427,S100 CALCIUM-BINDING PROTEIN A7A, S100A7A
25379,617428,CHROMOSOME 1 OPEN READING FRAME 43, C1ORF43
25380,617429,UBIQUITIN-CONJUGATING ENZYME E2 Q1, UBE2Q1
25381,617430,ADHESION G PROTEIN-COUPLED RECEPTOR F1, ADGRF1
25382,617431,UBIQUITIN-SPECIFIC PEPTIDASE 53, USP53
25383,617432,"INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 60", MRT60
25384,617433,RETINITIS PIGMENTOSA 78, RP78
25385,617434,LONG NONCODING RNA HOST2,
25386,617435,LOPES-MACIEL-RODAN SYNDROME, LOMARS
25387,617436,GON7 SUBUNIT OF KEOPS COMPLEX, GON7
25388,617437,S100 CALCIUM-BINDING PROTEIN A16, S100A16
25389,617438,CHROMOBOX 6, CBX6
25390,617439,CRANIOSYNOSTOSIS 7, CRS7
25391,617440,PAPILLARY THYROID CARCINOMA SUSCEPTIBILITY CANDIDATE 1 GENE, PTCSC1
25392,617441,"THROMBOCYTOPENIA, ANEMIA, AND MYELOFIBROSIS", THAMY
25393,617442,PREMATURE OVARIAN FAILURE 13, POF13
25394,617443,"BLEEDING DISORDER, PLATELET-TYPE, 21", BDPLT21
25395,617444,ZINC FINGER PROTEIN 479, ZNF479
25396,617445,UBIQUITIN-SPECIFIC PEPTIDASE 48, USP48
25397,617446,CHAC CATION TRANSPORT REGULATOR HOMOLOG 2, CHAC2
25398,617447,PABP-DEPENDENT POLY(A) NUCLEASE 2, PAN2
25399,617448,PABP-DEPENDENT POLY(A) NUCLEASE 3, PAN3
25400,617449,TRANSMEMBRANE PROTEIN 260, TMEM260
25401,617450,JANSEN-DE VRIES SYNDROME, JDVS
25402,617451,"ALDO-KETO REDUCTASE FAMILY 1, MEMBER E2", AKR1E2
25403,617452,"INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES, SEIZURES, AND DISTAL LIMB ANOMALIES", IDDFSDA
25404,617453,TETRATRICOPEPTIDE REPEAT DOMAIN-CONTAINING PROTEIN 26, TTC26
25405,617454,"POLYMERASE III, RNA, SUBUNIT C", POLR3C
25406,617455,"POLYMERASE III, RNA, SUBUNIT F", POLR3F
25407,617456,"POLYMERASE III, RNA, SUBUNIT G", POLR3G
25408,617457,"POLYMERASE III, RNA, SUBUNIT G-LIKE", POLR3GL
25409,617458,"PRKR-INTERACTING PROTEIN 1, IL11-INDUCIBLE", PRKRIP1
25410,617459,"TRANSMEMBRANE AND COILED-COIL DOMAIN FAMILY, MEMBER 3", TMCC3
25411,617460,RETINITIS PIGMENTOSA 79, RP79
25412,617461,YBEY METALLOPEPTIDASE, YBEY
25413,617462,"PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR-GAMMA, COACTIVATOR-RELATED PROTEIN 1", PPRC1
25414,617463,UNKEMPT FAMILY-LIKE ZINC FINGER, UNKL
25415,617464,UNC5 FAMILY C-TERMINAL-LIKE PROTEIN, UNC5CL
25416,617465,SMALL INTEGRAL MEMBRANE PROTEIN 20, SMIM20
25417,617466,TOWNES-BROCKS SYNDROME 2, TBS2
25418,617467,FERM DOMAIN-CONTAINING PROTEIN 4B, FRMD4B
25419,617468,"ARTHROGRYPOSIS MULTIPLEX CONGENITA 1, NEUROGENIC, WITH MYELIN DEFECT", AMC1
25420,617469,AFG1-LIKE ATPase, AFG1L
25421,617470,UBIQUITIN-SPECIFIC PEPTIDASE-LIKE 1, USPL1
25422,617471,"SERPIN PEPTIDASE INHIBITOR, CLADE A, MEMBER 12", SERPINA12
25423,617472,TENASCIN N, TNN
25424,617473,"ATP SYNTHASE, H+ TRANSPORTING, MITOCHONDRIAL F0 COMPLEX, SUBUNIT G", ATP5L
25425,617474,ZINC FINGER PROTEIN 609, ZNF609
25426,617475,SPECIFIC GRANULE DEFICIENCY 2, SGD2
25427,617476,"CNKSR FAMILY, MEMBER 3", CNKSR3
25428,617477,ZINC FINGER PROTEIN 324, ZNF324
25429,617478,STRUCTURAL HEART DEFECTS AND RENAL ANOMALIES SYNDROME, SHDRA
25430,617479,SSU2 HOMOLOG, SSUH2
25431,617480,"46,XX SEX REVERSAL 4", SRXX4
25432,617481,"NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, HYPOTONIA, AND VARIABLE BRAIN ANOMALIES", NMIHBA
25433,617482,TP53 TARGET GENE 3, TP53TG3
25434,617483,CORNICHON FAMILY AMPA RECEPTOR AUXILIARY PROTEIN 4, CNIH4
25435,617484,GAMETOCYTE-SPECIFIC FACTOR 1, GTSF1
25436,617485,WD REPEAT- AND FYVE DOMAIN-CONTAINING PROTEIN 3, WDFY3
25437,617486,G-PATCH DOMAIN-CONTAINING PROTEIN 3, GPATCH3
25438,617487,"DNAJ/HSP40 HOMOLOG, SUBFAMILY B, MEMBER 14", DNAJB14
25439,617488,RNA PSEUDOURIDYLATE SYNTHASE DOMAIN-CONTAINING PROTEIN 4, RPUSD4
25440,617489,LONG INTERGENIC NONCODING RNA 305, LINC00305
25441,617490,"CATION CHANNEL, SPERM-ASSOCIATED, AUXILIARY SUBUNIT DELTA", CATSPERD
25442,617491,"NOP2/SUN RNA METHYLTRANSFERASE FAMILY, MEMBER 3", NSUN3
25443,617492,OLFACTOMEDIN 2, OLFM2
25444,617493,NEURODEVELOPMENTAL DISORDER WITH INVOLUNTARY MOVEMENTS, NEDIM
25445,617494,ECHINODERM MICROTUBULE-ASSOCIATED PROTEIN-LIKE 2, EML2
25446,617495,TAFA CHEMOKINE-LIKE FAMILY MEMBER 1, TAFA1
25447,617496,"FAMILY WITH SEQUENCE SIMILARITY 19, MEMBER A2, CC MOTIF CHEMOKINE-LIKE", FAM19A2
25448,617497,"FAMILY WITH SEQUENCE SIMILARITY 19, MEMBER A3, CC MOTIF CHEMOKINE-LIKE", FAM19A3
25449,617498,"FAMILY WITH SEQUENCE SIMILARITY 19, MEMBER A4, CC MOTIF CHEMOKINE-LIKE", FAM19A4
25450,617499,"FAMILY WITH SEQUENCE SIMILARITY 19, MEMBER A5, CC MOTIF CHEMOKINE-LIKE", FAM19A5
25451,617500,UROTHELIAL CANCER-ASSOCIATED GENE 1, UCA1
25452,617501,LYSINE ACETYLTRANSFERASE 14, KAT14
25453,617502,WD REPEAT-CONTAINING PROTEIN 41, WDR41
25454,617503,DENN DOMAIN-CONTAINING PROTEIN 3, DENND3
25455,617504,SIPA1-LIKE PROTEIN 1, SIPA1L1
25456,617505,TRANSLOCATION-ASSOCIATED MEMBRANE PROTEIN 1-LIKE 1, TRAM1L1
25457,617506,NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 2, NSLH2
25458,617507,PEHO-LIKE SYNDROME, PEHOL
25459,617508,ZINC FINGER PROTEIN 598, ZNF598
25460,617509,VON WILLEBRAND FACTOR A DOMAIN-CONTAINING PROTEIN 8, VWA8
25461,617510,"CATION CHANNEL, SPERM-ASSOCIATED, AUXILIARY SUBUNIT EPSILON", CATSPERE
25462,617511,"CATION CHANNEL, SPERM-ASSOCIATED, AUXILIARY SUBUNIT ZETA", CATSPERZ
25463,617512,ZINC FINGER PROTEIN 318, ZNF318
25464,617513,OXOGLUTARATE DEHYDROGENASE-LIKE PROTEIN, OGDHL
25465,617514,IMMUNODEFICIENCY 52, IMD52
25466,617515,RHOMBOID DOMAIN-CONTAINING 1, RHBDD1
25467,617516,STANKIEWICZ-ISIDOR SYNDROME, STISS
25468,617517,RIBOSOMAL PROTEIN S6 KINASE C1, RPS6KC1
25469,617518,BSD DOMAIN-CONTAINING PROTEIN 1, BSDC1
25470,617519,"NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, NEUROPATHY, AND DEAFNESS", NEDHND
25471,617520,"MICROCEPHALY 18, PRIMARY, AUTOSOMAL DOMINANT", MCPH18
25472,617521,"YIP1 DOMAIN FAMILY, MEMBER 1", YIPF1
25473,617522,"YIP1 DOMAIN FAMILY, MEMBER 2", YIPF2
25474,617523,NEURODEVELOPMENTAL DISORDER WITH MIDBRAIN AND HINDBRAIN MALFORMATIONS, NEDMHM
25475,617524,ERYTHROKERATODERMIA VARIABILIS ET PROGRESSIVA 2, EKVP2
25476,617525,ERYTHROKERATODERMIA VARIABILIS ET PROGRESSIVA 3, EKVP3
25477,617526,ERYTHROKERATODERMIA VARIABILIS ET PROGRESSIVA 4, EKVP4
25478,617527,"NEURODEVELOPMENTAL DISORDER WITH PROGRESSIVE MICROCEPHALY, SPASTICITY, AND BRAIN ANOMALIES", NDMSBA
25479,617528,PROTEASOME ASSEMBLY CHAPERONE 3, PSMG3
25480,617529,FAST KINASE DOMAINS 1, FASTKD1
25481,617530,FAST KINASE DOMAINS 3, FASTKD3
25482,617531,COLLAGEN BETA(1-O)GALACTOSYLTRANSFERASE 1, COLGALT1
25483,617532,INTELLECTUAL DEVELOPMENTAL DISORDER WITH NEUROPSYCHIATRIC FEATURES, IDDNPF
25484,617533,COLLAGEN BETA(1-O)GALACTOSYLTRANSFERASE 2, COLGALT2
25485,617534,"YIP1 DOMAIN FAMILY, MEMBER 4", YIPF4
25486,617535,FAS APOPTOTIC INHIBITORY MOLECULE, FAIM
25487,617536,BAI1-ASSOCIATED PROTEIN 2-LIKE 2, BAIAP2L2
25488,617537,RAHMAN SYNDROME, RMNS
25489,617538,ELONGATION FACTOR-LIKE GTPase 1, EFL1
25490,617539,CHLORIDE CHANNEL CLIC-LIKE 1, CLCC1
25491,617540,"PITUITARY ADENOMA 5, MULTIPLE TYPES", PITA5
25492,617541,ANKYRIN REPEAT- AND ZINC FINGER DOMAIN-CONTAINING 1, ANKZF1
25493,617542,"GAZE PALSY, FAMILIAL HORIZONTAL, WITH PROGRESSIVE SCOLIOSIS 2, WITH IMPAIRED INTELLECTUAL DEVELOPMENT", HGPPS2
25494,617543,POLYCOMB GROUP RING FINGER PROTEIN 3, PCGF3
25495,617544,LONG INTERGENIC NONCODING RNA 672, LINC00672
25496,617545,MINICHROMOSOME MAINTENANCE DOMAIN-CONTAINING PROTEIN 2, MCMDC2
25497,617546,HELT bHLH TRANSCRIPTION FACTOR, HELT
25498,617547,RETINAL DYSTROPHY WITH OR WITHOUT MACULAR STAPHYLOMA, RDMS
25499,617548,WAP 4-DISULFIDE CORE DOMAIN 2, WFDC2
25500,617549,TUMOR PROTEIN p53-INDUCIBLE NUCLEAR PROTEIN 2, TP53INP2
25501,617550,PROTEASOME ASSEMBLY CHAPERONE 4, PSMG4
25502,617551,"SID1 TRANSMEMBRANE FAMILY, MEMBER 2", SIDT2
25503,617552,RHO GUANINE NUCLEOTIDE EXCHANGE FACTOR 26, ARHGEF26
25504,617553,Fc FRAGMENT OF IgG-BINDING PROTEIN, FCGBP
25505,617554,"FYVE, RhoGEF, AND PH DOMAIN-CONTAINING PROTEIN 3", FGD3
25506,617555,FCH AND DOUBLE SH3 DOMAINS PROTEIN 1, FCHSD1
25507,617556,FCH AND DOUBLE SH3 DOMAINS PROTEIN 2, FCHSD2
25508,617557,GABRIELE-DE VRIES SYNDROME, GADEVS
25509,617558,CILIA- AND FLAGELLA-ASSOCIATED PROTEIN 43, CFAP43
25510,617559,CILIA- AND FLAGELLA-ASSOCIATED PROTEIN 44, CFAP44
25511,617560,"SPASTIC ATAXIA 8, AUTOSOMAL RECESSIVE, WITH HYPOMYELINATING LEUKODYSTROPHY", SPAX8
25512,617561,COHEN-GIBSON SYNDROME, COGIS
25513,617562,MECKEL SYNDROME 13, MKS13
25514,617563,OROFACIODIGITAL SYNDROME XVI, OFD16
25515,617564,MEIER-GORLIN SYNDROME 8, MGORS8
25516,617565,PERRAULT SYNDROME 6, PRLTS6
25517,617566,ZINC FINGER PROTEIN 568, ZNF568
25518,617567,TUMOR PROTEIN D52-LIKE 3, TPD52L3
25519,617568,"UPSTREAM TRANSCRIPTION FACTOR FAMILY, MEMBER 3", USF3
25520,617569,"KINESIN FAMILY, MEMBER 15", KIF15
25521,617570,DAZ-INTERACTING ZINC FINGER PROTEIN 1-LIKE, DZIP1L
25522,617571,"ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 14", ARCI14
25523,617572,EXUDATIVE VITREORETINOPATHY 7, EVR7
25524,617573,"C-TYPE LECTIN DOMAIN FAMILY 12, MEMBER B", CLEC12B
25525,617574,"ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 13", ARCI13
25526,617575,RENI SYNDROME, RENI
25527,617576,SPERMATOGENIC FAILURE 18, SPGF18
25528,617577,"CILIARY DYSKINESIA, PRIMARY, 37", CILD37
25529,617578,FER3-LIKE bHLH TRANSCRIPTION FACTOR, FERD3L
25530,617579,CLAUDIN 10, CLDN10
25531,617580,TETRASPANIN 16, TSPAN16
25532,617581,C2 CALCIUM-DEPENDENT DOMAIN-CONTAINING PROTEIN 2, C2CD2
25533,617582,C2 CALCIUM-DEPENDENT DOMAIN-CONTAINING PROTEIN 2-LIKE, C2CD2L
25534,617583,SULFIREDOXIN 1, SRXN1
25535,617584,"SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 25", SCAR25
25536,617585,IMMUNODEFICIENCY 53, IMD53
25537,617586,"FERM, ARHGEF, AND PLECKSTRIN DOMAINS-CONTAINING PROTEIN 2", FARP2
25538,617587,SMALL PROLINE-RICH PROTEIN 2D, SPRR2D
25539,617588,SMALL PROLINE-RICH PROTEIN 2E, SPRR2E
25540,617589,SMALL PROLINE-RICH PROTEIN 2F, SPRR2F
25541,617590,SMALL PROLINE-RICH PROTEIN 2G, SPRR2G
25542,617591,PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 3, PRAAS3
25543,617592,SPERMATOGENIC FAILURE 19, SPGF19
25544,617593,SPERMATOGENIC FAILURE 20, SPGF20
25545,617594,JUNCTIONAL CADHERIN COMPLEX REGULATOR, JHY
25546,617595,BIRK-LANDAU-PEREZ SYNDROME, BILAPES
25547,617596,MALEYLACETOACETATE ISOMERASE DEFICIENCY, MAAID
25548,617597,RETINOL SATURASE, RETSAT
25549,617598,MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 3, MVA3
25550,617599,DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 55, DEE55
25551,617600,"INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 45", MRD45
25552,617601,"INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 46", MRD46
25553,617602,CONGENITAL HEART DEFECTS AND SKELETAL MALFORMATIONS SYNDROME, CHDSKM
25554,617603,RNA-BINDING MOTIF PROTEIN 24, RBM24
25555,617604,"MICROCEPHALY, SHORT STATURE, AND LIMB ABNORMALITIES", MISSLA
25556,617605,"DEAFNESS, AUTOSOMAL DOMINANT 71", DFNA71
25557,617606,"DEAFNESS, AUTOSOMAL DOMINANT 72", DFNA72
25558,617607,"AMELOGENESIS IMPERFECTA, TYPE IIIB", AI3B
25559,617608,ALPHA KINASE 3, ALPK3
25560,617609,"NEPHROTIC SYNDROME, TYPE 15", NPHS15
25561,617610,POLYCYSTIC KIDNEY DISEASE 5, PKD5
25562,617611,PICALM-INTERACTING MITOTIC REGULATOR, PIMREG
25563,617612,ARMADILLO REPEAT-CONTAINING PROTEIN 9, ARMC9
25564,617613,MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 5, MMDS5
25565,617614,SPOUT DOMAIN-CONTAINING METHYLTRANSFERASE 1, SPOUT1
25566,617615,TRANSMEMBRANE PROTEIN 258, TMEM258
25567,617616,SKRABAN-DEARDORFF SYNDROME, SKDEAS
25568,617617,"SPRY4 INTRONIC TRANSCRIPT 1, NONCODING", SPRY4IT1
25569,617618,TOG ARRAY REGULATOR OF AXONEMAL MICROTUBULES 1, TOGARAM1
25570,617619,MISATO MITOCHONDRIAL DISTRIBUTION AND MORPHOLOGY REGULATOR 1, MSTO1
25571,617620,LEUCINE-RICH REPEAT-CONTAINING PROTEIN 3, LRRC3
25572,617621,PAX3- AND PAX7-BINDING PROTEIN 1, PAXBP1
25573,617622,JOUBERT SYNDROME 30, JBTS30
25574,617623,"SPEEDY/RINGO CELL CYCLE REGULATOR FAMILY, MEMBER E1", SPDYE1
25575,617624,"SPEEDY/RINGO CELL CYCLE REGULATOR FAMILY, MEMBER E2", SPDYE2
25576,617625,"SPEEDY/RINGO CELL CYCLE REGULATOR FAMILY, MEMBER E3", SPDYE3
25577,617626,"FIBROMATOSIS, GINGIVAL, 5", GINGF5
25578,617627,SMALL REGULATORY POLYPEPTIDE OF AMINO ACID RESPONSE, SPAAR
25579,617628,"SPEEDY/RINGO CELL CYCLE REGULATOR FAMILY, MEMBER E4", SPDYE4
25580,617629,SCHIZOPHRENIA 19, SCZD19
25581,617630,G PROTEIN-COUPLED RECEPTOR 37-LIKE 1, GPR37L1
25582,617631,IQ DOMAIN-CONTAINING PROTEIN E, IQCE
25583,617632,EF-HAND CALCIUM-BINDING DOMAIN-CONTAINING PROTEIN 7, EFCAB7
25584,617633,"SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 26", SCAR26
25585,617634,COILED-COIL GLUTAMATE-RICH PROTEIN 2, CCER2
25586,617635,"INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 47", MRD47
25587,617636,CMKLR2 ANTISENSE RNA, CMKLR2AS
25588,617637,"DEAFNESS, AUTOSOMAL RECESSIVE 106", DFNB106
25589,617638,IMMUNODEFICIENCY 11B WITH ATOPIC DERMATITIS, IMD11B
25590,617639,"DEAFNESS, AUTOSOMAL RECESSIVE 107", DFNB107
25591,617640,SUPPRESSOR OF TUMORIGENICITY 7-LIKE PROTEIN, ST7L
25592,617641,"CONGENITAL ANOMALIES OF KIDNEY AND URINARY TRACT SYNDROME WITH OR WITHOUT HEARING LOSS, ABNORMAL EARS, OR DEVELOPMENTAL DELAY", CAKUTHED
25593,617642,"POLYDACTYLY, POSTAXIAL, TYPE A7", PAPA7
25594,617643,"CEREBELLAR ATROPHY, DEVELOPMENTAL DELAY, AND SEIZURES", CADEDS
25595,617644,SPERMATOGENIC FAILURE 21, SPGF21
25596,617645,KELCH REPEAT- AND BTB/POZ DOMAIN-CONTAINING PROTEIN 4, KBTBD4
25597,617646,BAH DOMAIN- AND COILED-COIL DOMAIN-CONTAINING PROTEIN 1, BAHCC1
25598,617647,"PROSTATE CANCER-ASSOCIATED TRANSCRIPT 18, NONCODING", PCAT18
25599,617648,BMP2-INDUCIBLE KINASE, BMP2K
25600,617649,UBIQUITIN-CONJUGATING ENZYME E2 O, UBE2O
25601,617650,"PTGS2 ANTISENSE NFKB1 COMPLEX-MEDIATED EXPRESSION REGULATOR RNA, NONCODING", PACERR
25602,617651,"EQTN, MOB3B, IFNK, AND C9ORF72 ENHANCER RNA I, NONCODING",
25603,617652,MOB KINASE ACTIVATOR 3B, MOB3B
25604,617653,EQUATORIN, EQTN
25605,617654,"DEAFNESS, AUTOSOMAL RECESSIVE 108", DFNB108
25606,617655,PECANEX 1, PCNX1
25607,617656,PECANEX 2, PCNX2
25608,617657,PECANEX 3, PCNX3
25609,617658,SULFIDE:QUINONE OXIDOREDUCTASE, SQOR
25610,617659,LIPOYL(OCTANOYL) TRANSFERASE 2, LIPT2
25611,617660,"VERTEBRAL, CARDIAC, RENAL, AND LIMB DEFECTS SYNDROME 1", VCRL1
25612,617661,"VERTEBRAL, CARDIAC, RENAL, AND LIMB DEFECTS SYNDROME 2", VCRL2
25613,617662,"JOINT LAXITY, SHORT STATURE, AND MYOPIA", JLSM
25614,617663,"DEAFNESS, AUTOSOMAL DOMINANT 73", DFNA73
25615,617664,COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 32, COXPD32
25616,617665,DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 56, DEE56
25617,617666,FRASER SYNDROME 2, FRASRS2
25618,617667,FRASER SYNDROME 3, FRASRS3
25619,617668,"ENCEPHALOPATHY, NEONATAL SEVERE, WITH LACTIC ACIDOSIS AND BRAIN ABNORMALITIES", NELABA
25620,617669,"ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND SPASTICITY", PEBAS
25621,617670,MEIOSIS-SPECIFIC PROTEIN WITH OB DOMAINS, MEIOB
25622,617671,HELIX SYNDROME, HELIX
25623,617672,"NEURODEGENERATION, CHILDHOOD-ONSET, WITH BRAIN ATROPHY", CONDBA
25624,617673,SPERMATOGENESIS-ASSOCIATED PROTEIN 22, SPATA22
25625,617674,STRESS-ASSOCIATED ENDOPLASMIC RETICULUM PROTEIN 1, SERP1
25626,617675,"MYOPATHY, MITOCHONDRIAL, AND ATAXIA", MMYAT
25627,617676,"PROTEASOME 26S SUBUNIT, NON-ATPase, 3", PSMD3
25628,617677,ZO2-ASSOCIATED SPECKLE PROTEIN,
25629,617678,"PROSTATE CANCER-ASSOCIATED TRANSCRIPT 2, NONCODING", PCAT2
25630,617679,KELCH-LIKE 20, KLHL20
25631,617680,"SSU72 HOMOLOG, RNA POLYMERASE II CTD PHOSPHATASE", SSU72
25632,617681,BLEPHAROCHEILODONTIC SYNDROME 2, BCDS2
25633,617682,PILAROWSKI-BJORNSSON SYNDROME, PILBOS
25634,617683,"EGF-LIKE, FIBRONECTIN TYPE III, AND LAMININ G DOMAINS-CONTAINING PROTEIN", EGFLAM
25635,617684,Ly1 ANTIBODY-REACTIVE PROTEIN, LYAR
25636,617685,CADHERIN 26, CDH26
25637,617686,"PITUITARY ADENOMA 3, MULTIPLE TYPES", PITA3
25638,617687,"TBC1 DOMAIN FAMILY, MEMBER 23", TBC1D23
25639,617688,PROSTATE ANDROGEN-REGULATED MUCIN-LIKE PROTEIN 1, PARM1
25640,617689,COLD-SHOCK DOMAIN-CONTAINING PROTEIN C2, CSDC2
25641,617690,OVARIAN DYSGENESIS 5, ODG5
25642,617691,SPINOCEREBELLAR ATAXIA 44, SCA44
25643,617692,PR DOMAIN-CONTAINING PROTEIN 15, PRDM15
25644,617693,VITRIN, VIT
25645,617694,AL KAISSI SYNDROME, ALKAS
25646,617695,"PONTOCEREBELLAR HYPOPLASIA, TYPE 11", PCH11
25647,617696,LONG INTERGENIC NONCODING RNA 1488, LINC01488
25648,617697,LONG INTERGENIC NONCODING RNA 2757, LINC02747
25649,617698,"3-METHYLGLUTACONIC ACIDURIA, TYPE IX", MGCA9
25650,617699,"GID COMPLEX, SUBUNIT 4", GID4
25651,617700,UBIQUITIN-CONJUGATING ENZYME E2 F, UBE2F
25652,617701,"CANCER SUSCEPTIBILITY CANDIDATE 8, NONCODING", CASC8
25653,617702,"CANCER SUSCEPTIBILITY CANDIDATE 21, NONCODING", CASC21
25654,617703,"CANCER SUSCEPTIBILITY CANDIDATE 19, NONCODING", CASC19
25655,617704,"CANCER SUSCEPTIBILITY CANDIDATE 11, NONCODING", CASC11
25656,617705,"COLON CANCER-ASSOCIATED TRANSCRIPT 1, NONCODING", CCAT1
25657,617706,SPERMATOGENIC FAILURE 22, SPGF22
25658,617707,SPERMATOGENIC FAILURE 23, SPGF23
25659,617708,CELL DIVISION CYCLE 123, CDC123
25660,617709,"NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, ATAXIA, AND SEIZURES", NEDMAS
25661,617710,"NEURODEVELOPMENTAL DISORDER, MITOCHONDRIAL, WITH ABNORMAL MOVEMENTS AND LACTIC ACIDOSIS, WITH OR WITHOUT SEIZURES", NEMMLAS
25662,617711,DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 91, DEE91
25663,617712,OOCYTE/ZYGOTE/EMBRYO MATURATION ARREST 3, OZEMA3
25664,617713,COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 33, COXPD33
25665,617714,CAVEOLAE-ASSOCIATED PROTEIN 4, CAVIN4
25666,617715,MAM AND LDL RECEPTOR CLASS A DOMAIN-CONTAINING PROTEIN 1, MALRD1
25667,617716,RHO GTPase-ACTIVATING PROTEIN 44, ARHGAP44
25668,617717,AUDITORY NEUROPATHY AND OPTIC ATROPHY, ANOA
25669,617718,IMMUNODEFICIENCY 71 WITH INFLAMMATORY DISEASE AND CONGENITAL THROMBOCYTOPENIA, IMD71
25670,617719,"EPIPHYSEAL DYSPLASIA, MULTIPLE, 7", EDM7
25671,617720,"PROTEIN PHOSPHATASE 1, REGULATORY SUBUNIT 42", PPP1R42
25672,617721,"NEURONOPATHY, DISTAL HEREDITARY MOTOR, AUTOSOMAL DOMINANT 9", HMND9
25673,617722,THIOREDOXIN-LIKE 4B, TXNL4B
25674,617723,RIBOSOMAL RNA-PROCESSING 12, RRP12
25675,617724,"TSC22 DOMAIN FAMILY, MEMBER 2", TSC22D2
25676,617725,FUCOSE MUTAROTASE, FUOM
25677,617726,CASPASE RECRUITMENT DOMAIN-CONTAINING PROTEIN 19, CARD19
25678,617727,"TRANSMEMBRANE 9 SUPERFAMILY, MEMBER 4", TM9SF4
25679,617728,"CENTROSOMAL PROTEIN, 295-KD", CEP295
25680,617729,GALLOWAY-MOWAT SYNDROME 3, GAMOS3
25681,617730,GALLOWAY-MOWAT SYNDROME 4, GAMOS4
25682,617731,GALLOWAY-MOWAT SYNDROME 5, GAMOS5
25683,617732,"FACIAL PALSY, CONGENITAL, WITH PTOSIS AND VELOPHARYNGEAL DYSFUNCTION", FPVEPD
25684,617733,ZINC FINGER PROTEIN 518A, ZNF518A
25685,617734,ZINC FINGER PROTEIN 518B, ZNF518B
25686,617735,CHROMOSOME 10 OPEN READING FRAME 90, C10ORF90
25687,617736,MORN REPEAT-CONTAINING PROTEIN 4, MORN4
25688,617737,"SPHINGOMYELIN PHOSPHODIESTERASE, ACID-LIKE, 3B", SMPDL3B
25689,617738,KELCH REPEAT- AND BTB DOMAIN-CONTAINING PROTEIN 6, KBTBD6
25690,617739,KELCH REPEAT- AND BTB DOMAIN-CONTAINING PROTEIN 7, KBTBD7
25691,617740,V-SET AND IMMUNOGLOBULIN DOMAINS-CONTAINING PROTEIN 10-LIKE, VSIG10L
25692,617741,WD REPEAT-CONTAINING PROTEIN 20, WDR20
25693,617742,"KAT8 REGULATORY NSL COMPLEX, SUBUNIT 3", KANSL3
25694,617743,OOCYTE/ZYGOTE/EMBRYO MATURATION ARREST 4, OZEMA4
25695,617744,"IMMUNODEFICIENCY, DEVELOPMENTAL DELAY, AND HYPOHOMOCYSTEINEMIA", IMDDHH
25696,617745,MAJOR FACILITATOR SUPERFAMILY DOMAIN-CONTAINING PROTEIN 12, MFSD12
25697,617746,SWEENEY-COX SYNDROME, SWCOS
25698,617747,NUCLEAR BODY PROTEIN SP140-LIKE, SP140L
25699,617748,TUDOR DOMAIN-CONTAINING PROTEIN 5, TDRD5
25700,617749,ACTN3 DEFICIENCY,
25701,617750,LIM AND CALPONIN HOMOLOGY DOMAINS-CONTAINING PROTEIN 1, LIMCH1
25702,617751,"INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 48", MRD48
25703,617752,CLARK-BARAITSER SYNDROME, CLABARS
25704,617753,RIO KINASE 1, RIOK1
25705,617754,RIO KINASE 2, RIOK2
25706,617755,NEURODEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND DISTAL LIMB ANOMALIES, NEDDFL
25707,617756,ERYTHROKERATODERMIA VARIABILIS ET PROGRESSIVA 5, EKVP5
25708,617757,JOUBERT SYNDROME 32, JBTS32
25709,617758,ZINC FINGER PROTEIN 692, ZNF692
25710,617759,RNA PSEUDOURIDYLATE SYNTHASE DOMAIN-CONTAINING PROTEIN 3, RPUSD3
25711,617760,"MYOPATHY, CENTRONUCLEAR, 6, WITH FIBER-TYPE DISPROPORTION", CNM6
25712,617761,JOUBERT SYNDROME 31, JBTS31
25713,617762,"LEUKODYSTROPHY, PROGRESSIVE, EARLY CHILDHOOD-ONSET", PLDECO
25714,617763,"SHORT STATURE, HEARING LOSS, RETINITIS PIGMENTOSA, AND DISTINCTIVE FACIES", SHRF
25715,617764,ZYG11-RELATED CELL CYCLE REGULATOR, ZER1
25716,617765,"IMMUNODEFICIENCY, COMMON VARIABLE, 14", CVID14
25717,617766,"FAMILY WITH SEQUENCE SIMILARITY 192, MEMBER A", FAM192A
25718,617767,JOUBERT SYNDROME 33, JBTS33
25719,617768,KLEEFSTRA SYNDROME 2, KLEFS2
25720,617769,SPINOCEREBELLAR ATAXIA 45, SCA45
25721,617770,SPINOCEREBELLAR ATAXIA 46, SCA46
25722,617771,DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 57, DEE57
25723,617772,"DEAFNESS, AUTOSOMAL DOMINANT 34, WITH OR WITHOUT INFLAMMATION", DFNA34
25724,617773,"INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 61", MRT61
25725,617774,"LON PEPTIDASE 2, PEROXISOMAL", LONP2
25726,617775,CHROMOSOME 10 OPEN READING FRAME 99, C10ORF99
25727,617776,"BAGE FAMILY, MEMBER 2", BAGE2
25728,617777,"BAGE FAMILY, MEMBER 3", BAGE3
25729,617778,THIOREDOXIN DOMAIN-CONTAINING PROTEIN 15, TXNDC15
25730,617779,TRANSMEMBRANE PROTEIN 256, TMEM256
25731,617780,COMBINED IMMUNODEFICIENCY AND MEGALOBLASTIC ANEMIA WITH OR WITHOUT HYPERHOMOCYSTEINEMIA, CIMAH
25732,617781,RETINITIS PIGMENTOSA 80, RP80
25733,617782,GREB1-LIKE RETINOIC ACID RECEPTOR COACTIVATOR, GREB1L
25734,617783,"NEPHROTIC SYNDROME, TYPE 16", NPHS16
25735,617784,"FANCONI ANEMIA, COMPLEMENTATION GROUP W", FANCW
25736,617785,"PAPILIN, PROTEOGLYCAN-LIKE SULFATED GLYCOPROTEIN", PAPLN
25737,617786,"CHAPERONIN CONTAINING T-COMPLEX POLYPEPTIDE 1, SUBUNIT 8", CCT8
25738,617787,"INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 50, WITH BEHAVIORAL ABNORMALITIES", MRD50
25739,617788,"INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 51", MRD51
25740,617789,THIOREDOXIN DOMAIN-CONTAINING PROTEIN 8, TXNDC8
25741,617790,THIOREDOXIN DOMAIN-CONTAINING PROTEIN 2, TXNDC2
25742,617791,LEUCINE-RICH REPEAT- AND COILED-COIL DOMAIN-CONTAINING CENTROSOMAL PROTEIN 1, LRRCC1
25743,617792,THIOREDOXIN DOMAIN-CONTAINING PROTEIN 11, TXNDC11
25744,617793,EEF1A LYSINE METHYLTRANSFERASE 1, EEF1AKMT1
25745,617794,EEF1A LYSINE METHYLTRANSFERASE 2, EEF1AKMT2
25746,617795,ELONGIN BC- AND POLYCOMB REPRESSIVE COMPLEX 2-ASSOCIATED PROTEIN, EPOP
25747,617796,"INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 52", MRD52
25748,617797,SRC-RELATED KINASE LACKING C-TERMINAL REGULATORY TYROSINE AND N-TERMINAL MYRISTYLATION SITES, SRMS
25749,617798,"INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 53", MRD53
25750,617799,"INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 54", MRD54
25751,617800,"MICROCEPHALY 19, PRIMARY, AUTOSOMAL RECESSIVE", MCPH19
25752,617801,CYCLASE-ASSOCIATED ACTIN CYTOSKELETON REGULATORY PROTEIN 1, CAP1
25753,617802,"NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, SEIZURES, AND CORTICAL ATROPHY", NDMSCA
25754,617803,TRANSMEMBRANE PROTEIN 26, TMEM26
25755,617804,NEURODEVELOPMENTAL DISORDER WITH VARIABLE MOTOR AND LANGUAGE IMPAIRMENT, NEDMIAL
25756,617805,RENAL HYPODYSPLASIA/APLASIA 3, RHDA3
25757,617806,TRANSMEMBRANE PROTEIN 86B, TMEM86B
25758,617807,"NEURODEVELOPMENTAL DISORDER WITH ATAXIC GAIT, ABSENT SPEECH, AND DECREASED CORTICAL WHITE MATTER", NDAGSCW
25759,617808,COFFIN-SIRIS SYNDROME 6, CSS6
25760,617809,GELEOPHYSIC DYSPLASIA 3, GPHYSD3
25761,617810,GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 15, GPIBD15
25762,617811,DNA REPLICATION REGULATOR AND SPLICEOSOMAL FACTOR SMU1, SMU1
25763,617812,"SOLUTE CARRIER FAMILY 35, MEMBER G2", SLC35G2
25764,617813,TRANSMEMBRANE PROTEIN 88, TMEM88
25765,617814,TRANSMEMBRANE PROTEIN 95, TMEM95
25766,617815,"POLYMERASE III, RNA, SUBUNIT E", POLR3E
25767,617816,GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 16, GPIBD16
25768,617817,TUBULIN-GAMMA COMPLEX-ASSOCIATED PROTEIN 2, TUBGCP2
25769,617818,TUBULIN-GAMMA COMPLEX-ASSOCIATED PROTEIN 3, TUBGCP3
25770,617819,RAL GUANINE NUCLEOTIDE EXCHANGE FACTOR WITH PH DOMAIN AND SH3 DOMAIN-BINDING MOTIF 2, RALGPS2
25771,617820,"NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL RECESSIVE", NDHMSR
25772,617821,"EHLERS-DANLOS SYNDROME, ARTHROCHALASIA TYPE, 2", EDSARTH2
25773,617822,ALKURAYA-KUCINSKAS SYNDROME, ALKKUCS
25774,617823,PWWP DOMAIN-CONTAINING PROTEIN 2A, PWWP2A
25775,617824,BROMODOMAIN AND WD REPEAT DOMAIN-CONTAINING PROTEIN 1, BRWD1
25776,617825,GLUCOCORTICOID DEFICIENCY 5, GCCD5
25777,617826,"UNC50, INNER NUCLEAR MEMBRANE RNA-BINDING PROTEIN", UNC50
25778,617827,IMMUNODEFICIENCY 55, IMD55
25779,617828,ZINC FINGER HOMEOBOX 2, ZFHX2
25780,617829,DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 92, DEE92
25781,617830,DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 58, DEE58
25782,617831,"INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 55, WITH SEIZURES", MRD55
25783,617832,"SENTAN, CILIA APICAL STRUCTURAL PROTEIN", SNTN
25784,617833,"ZFHX2 ANTISENSE RNA 1, NONCODING", ZFHX2AS1
25785,617834,"PLECKSTRIN HOMOLOGY DOMAIN-CONTAINING PROTEIN, FAMILY J, MEMBER 1", PLEKHJ1
25786,617835,PYRUVATE DEHYDROGENASE PHOSPHATASE REGULATORY SUBUNIT, PDPR
25787,617836,DEVELOPMENTAL DELAY AND SEIZURES WITH OR WITHOUT MOVEMENT ABNORMALITIES, DEDSM
25788,617837,GDNF FAMILY RECEPTOR ALPHA-LIKE PROTEIN, GFRAL
25789,617838,"FAMILY WITH SEQUENCE SIMILARITY 234, MEMBER B", FAM234B
25790,617839,AMYOTROPHIC LATERAL SCLEROSIS 23, ALS23
25791,617840,tRNA ISOPENTENYLTRANSFERASE 1, TRIT1
25792,617841,"PROTEASOME SUBUNIT, ALPHA-TYPE, 8", PSMA8
25793,617842,"PROTEASOME 26S SUBUNIT, NON-ATPase, 1", PSMD1
25794,617843,RWD DOMAIN-CONTAINING PROTEIN 2B, RWDD2B
25795,617844,"PROTEASOME 26S SUBUNIT, NON-ATPase, 8", PSMD8
25796,617845,MAJOR FACILITATOR SUPERFAMILY DOMAIN-CONTAINING PROTEIN 2B, MFSD2B
25797,617846,PHD FINGER PROTEIN 5A, PHF5A
25798,617847,"SPLICING FACTOR 3B, SUBUNIT 5", SF3B5
25799,617848,DEAD-BOX HELICASE 46, DDX46
25800,617849,U2 SMALL NUCLEAR RIBONUCLEOPROTEIN-ASSOCIATED SURP DOMAIN-CONTAINING PROTEIN, U2SURP
25801,617850,SERTA DOMAIN-CONTAINING PROTEIN 1, SERTAD1
25802,617851,SERTA DOMAIN-CONTAINING PROTEIN 2, SERTAD2
25803,617852,SEC23-INTERACTING PROTEIN, SEC23IP
25804,617853,SMALL VASOHIBIN-BINDING PROTEIN, SVBP
25805,617854,"INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 56", MRD56
25806,617855,BASE METHYLTRANSFERASE OF 25S rRNA 2 HOMOLOG, BMT2
25807,617856,"THYMOCYTE SELECTION-ASSOCIATED PROTEIN FAMILY, MEMBER 2", THEMIS2
25808,617857,"PROTEASOME 26S SUBUNIT, NON-ATPase, 6", PSMD6
25809,617858,PROTEASOME INHIBITOR SUBUNIT 1, PSMF1
25810,617859,DISCS LARGE-ASSOCIATED PROTEIN 5, DLGAP5
25811,617860,SURFACTANT-ASSOCIATED PROTEIN 3, SFTA3
25812,617861,"MYB-RELATED TRANSCRIPTION FACTOR, PARTNER OF PROFILIN", MYPOP
25813,617862,"NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND BRAIN ATROPHY", NEDMEBA
25814,617863,"INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 69", MRD69
25815,617864,NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT SEIZURES AND GAIT ABNORMALITIES, NEDSGA
25816,617865,"NEURODEVELOPMENTAL DISORDER WITH MOVEMENT ABNORMALITIES, ABNORMAL GAIT, AND AUTISTIC FEATURES", NEDMAGA
25817,617866,SHORT-RIB THORACIC DYSPLASIA 18 WITH POLYDACTYLY, SRTD18
25818,617867,TUMOR PROTEIN p53-INDUCIBLE PROTEIN 11, TP53I11
25819,617868,NUCLEAR ASSEMBLY FACTOR 1 RIBONUCLEOPROTEIN, NAF1
25820,617869,NK1 HOMEOBOX 1, NKX1-1
25821,617870,CENTROSOMAL PROTEIN 350, CEP350
25822,617871,RETINITIS PIGMENTOSA 81, RP81
25823,617872,COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 34, COXPD34
25824,617873,COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 35, COXPD35
25825,617874,POLYCYSTIC LIVER DISEASE 3 WITH OR WITHOUT KIDNEY CYSTS, PCLD3
25826,617875,POLYCYSTIC LIVER DISEASE 4 WITH OR WITHOUT KIDNEY CYSTS, PCLD4
25827,617876,"RNA, U7 SMALL NUCLEAR, 1", RNU7-1
25828,617877,"SHORT STATURE, FACIAL DYSMORPHISM, AND SKELETAL ANOMALIES WITH OR WITHOUT CARDIAC ANOMALIES 1", SSFSC1
25829,617878,"TUBULIN, ALPHA-3D", TUBA3D
25830,617879,LEBER CONGENITAL AMAUROSIS WITH EARLY-ONSET DEAFNESS, LCAEOD
25831,617880,POC5 CENTRIOLAR PROTEIN, POC5
25832,617881,CHROMOSOME 4 OPEN READING FRAME 54, C4ORF54
25833,617882,"CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE G", CMTDIG
25834,617883,"FANCONI ANEMIA, COMPLEMENTATION GROUP S", FANCS
25835,617884,HEPATOMA-DERIVED GROWTH FACTOR-LIKE PROTEIN 2, HDGFL2
25836,617885,BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 19, BMIQ19
25837,617886,ZINC FINGER PROTEIN 512B, ZNF512B
25838,617887,AGMATINASE, AGMAT
25839,617888,ZINC FINGER PROTEIN 580, ZNF580
25840,617889,PYRIDINE NUCLEOTIDE-DISULPHIDE OXIDOREDUCTASE DOMAIN-CONTAINING PROTEIN 2, PYROXD2
25841,617890,ZINC FINGER PROTEIN 664, ZNF664
25842,617891,ZINC FINGER PROTEIN 655, ZNF655
25843,617892,"AMYOTROPHIC LATERAL SCLEROSIS, SUSCEPTIBILITY TO, 24", ALS24
25844,617893,RIBOSOMAL PROTEIN L36, RPL36
25845,617894,TRANSMEMBRANE PROTEIN 50B, TMEM50B
25846,617895,SHORT-RIB THORACIC DYSPLASIA 19 WITH OR WITHOUT POLYDACTYLY, SRTD19
25847,617896,"ZIC FAMILY, MEMBER 5", ZIC5
25848,617897,CITRATE SYNTHASE LYSINE METHYLTRANSFERASE, CSKMT
25849,617898,MULTIPLE SYNOSTOSES SYNDROME 4, SYNS4
25850,617899,"LEUKODYSTROPHY, HYPOMYELINATING, 14", HLD14
25851,617900,"ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 8", IIAE8
25852,617901,DEXAMETHASONE-INDUCED GENE, DEXI
25853,617902,GALECTIN-LIKE PROTEIN, LGALSL
25854,617903,NEURODEVELOPMENTAL DISORDER WITH POOR LANGUAGE AND LOSS OF HAND SKILLS, NDPLHS
25855,617904,DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 59, DEE59
25856,617905,HYPOXIA-INDUCIBLE LIPID DROPLET-ASSOCIATED PROTEIN, HILPDA
25857,617906,CILIA- AND FLAGELLA-ASSOCIATED PROTEIN 20, CFAP20
25858,617907,"ERYTHROCYTOSIS, FAMILIAL, 5", ECYT5
25859,617908,ZINC FINGER PROTEIN 473, ZNF473
25860,617909,"LSM10, U7 SMALL NUCLEAR RNA-ASSOCIATED PROTEIN", LSM10
25861,617910,"LSM11, U7 SMALL NUCLEAR RNA-ASSOCIATED PROTEIN", LSM11
25862,617911,DIAMOND-BLACKFAN ANEMIA-LIKE, DBAL
25863,617912,"CONGENITAL HEART DEFECTS, MULTIPLE TYPES, 5", CHTD5
25864,617913,"NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, CATARACTS, AND RENAL ABNORMALITIES", NEDMCR
25865,617914,"MICROCEPHALY 20, PRIMARY, AUTOSOMAL RECESSIVE", MCPH20
25866,617915,"HYPOTONIA, ATAXIA, DEVELOPMENTAL DELAY, AND TOOTH ENAMEL DEFECT SYNDROME", HADDTS
25867,617916,NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 7, NBIA7
25868,617917,NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 8, NBIA8
25869,617918,STRIATIN-INTERACTING PROTEIN 1, STRIP1
25870,617919,STRIATIN-INTERACTING PROTEIN 2, STRIP2
25871,617920,"AMYLOIDOSIS, PRIMARY LOCALIZED CUTANEOUS, 3", PLCA3
25872,617921,"AMYOTROPHIC LATERAL SCLEROSIS, SUSCEPTIBILITY TO, 25", ALS25
25873,617922,GLYCOPHORIN A, GYPA
25874,617923,GLYCOPHORIN B, GYPB
25875,617924,"EPILEPSY, JUVENILE MYOCLONIC, SUSCEPTIBILITY TO, 10", EJM10
25876,617925,SHORT-RIB THORACIC DYSPLASIA 20 WITH POLYDACTYLY, SRTD20
25877,617926,OROFACIODIGITAL SYNDROME XVII, OFD17
25878,617927,OROFACIODIGITAL SYNDROME XVIII, OFD18
25879,617928,KERATOCONUS 9, KTCN9
25880,617929,DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 60, DEE60
25881,617930,CHROMOSOME 1p35 DELETION SYNDROME,
25882,617931,SPINOCEREBELLAR ATAXIA 47, SCA47
25883,617932,RHOPHILIN 2, RHPN2
25884,617933,DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 61, DEE61
25885,617934,AE-BINDING PROTEIN 2, AEBP2
25886,617935,"EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 4", FFEVF4
25887,617936,BUTYRYLCHOLINESTERASE DEFICIENCY, BCHED
25888,617937,RNA-BINDING MOTIF PROTEIN 11, RBM11
25889,617938,DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 62, DEE62
25890,617939,ZINC FINGER PROTEIN 69, ZFP69
25891,617940,PLECKSTRIN HOMOLOGY DOMAIN- AND RhoGEF DOMAIN-CONTAINING PROTEIN G3, PLEKHG3
25892,617941,SHWACHMAN-DIAMOND SYNDROME 2, SDS2
25893,617942,"ABHYDROLASE DOMAIN-CONTAINING PROTEIN 17A, DEPALMITOYLASE", ABHD17A
25894,617943,"ABHYDROLASE DOMAIN-CONTAINING PROTEIN 17B, DEPALMITOYLASE", ABHD17B
25895,617944,"ABHYDROLASE DOMAIN-CONTAINING PROTEIN 17C, DEPALMITOYLASE", ABHD17C
25896,617945,BTB DOMAIN-CONTAINING PROTEIN 8, BTBD8
25897,617946,ENDOPLASMIC RETICULUM-GOLGI INTERMEDIATE COMPARTMENT PROTEIN 1, ERGIC1
25898,617947,WD REPEAT-CONTAINING PROTEIN 74, WDR74
25899,617948,ELLIPTOCYTOSIS 3, EL3
25900,617949,CILIA- AND FLAGELLA-ASSOCIATED PROTEIN 69, CFAP69
25901,617950,COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 36, COXPD36
25902,617951,"LEUKODYSTROPHY, HYPOMYELINATING, 15", HLD15
25903,617952,"OSTEOGENESIS IMPERFECTA, TYPE XVIII", OI18
25904,617953,"HYPERTHYROXINEMIA, EUTHYROID, CAUSED BY GENERALIZED 5-PRIME-DEIODINASE DEFICIENCY",
25905,617954,MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 6, MMDS6
25906,617955,PHENYTOIN TOXICITY,
25907,617956,BETA-GLUCOPYRANOSIDE TASTING, BGLPT
25908,617957,LEUCINE RICH REPEATS- AND IQ MOTIF-CONTAINING PROTEIN 3, LRRIQ3
25909,617958,INTERACTOR OF LITTLE ELONGATION COMPLEX ELL SUBUNIT 1, ICE1
25910,617959,SPERMATOGENIC FAILURE 24, SPGF24
25911,617960,SPERMATOGENIC FAILURE 25, SPGF25
25912,617961,SPERMATOGENIC FAILURE 26, SPGF26
25913,617962,ZINC FINGER PROTEIN 827, ZNF827
25914,617963,TUDOR DOMAIN-CONTAINING PROTEIN 9, TDRD9
25915,617964,"LEUKODYSTROPHY, HYPOMYELINATING, 16", HLD16
25916,617965,SPERMATOGENIC FAILURE 27, SPGF27
25917,617966,LOW DENSITY LIPOPROTEIN CHOLESTEROL LEVEL QUANTITATIVE TRAIT LOCUS 7, LDLCQ7
25918,617967,"HYDROCEPHALUS, CONGENITAL, 3, WITH BRAIN ANOMALIES", HYC3
25919,617968,WD REPEAT-CONTAINING PROTEIN 63, WDR63
25920,617969,COILED-COIL DOMAIN-CONTAINING PROTEIN 63, CCDC63
25921,617970,"RH-NULL, AMORPH TYPE", RHNA
25922,617971,"METHEMOGLOBINEMIA, BETA TYPE",
25923,617972,ZINC FINGER DHHC DOMAIN-CONTAINING PROTEIN 20, ZDHHC20
25924,617973,"METHEMOGLOBINEMIA, ALPHA TYPE",
25925,617974,"SPONDYLOEPIMETAPHYSEAL DYSPLASIA, DI ROCCO TYPE", SEMDDR
25926,617975,"FAMILY WITH SEQUENCE SIMILARITY 210, MEMBER A", FAM210A
25927,617976,DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 63, DEE63
25928,617977,NEURODEVELOPMENTAL DISORDER WITH SPASTIC QUADRIPLEGIA AND BRAIN ABNORMALITIES WITH OR WITHOUT SEIZURES, NEDSBAS
25929,617978,CYFIP-RELATED RAC1 INTERACTOR B, CYRIB
25930,617979,LONG NONCODING RNA NEAR ACOD1,
25931,617980,"ERYTHROCYTOSIS, FAMILIAL, 6", ECYT6
25932,617981,"ERYTHROCYTOSIS, FAMILIAL, 7", ECYT7
25933,617982,VERVERI-BRADY SYNDROME, VERBRAS
25934,617983,"MICROCEPHALY 21, PRIMARY, AUTOSOMAL RECESSIVE", MCPH21
25935,617984,"MICROCEPHALY 22, PRIMARY, AUTOSOMAL RECESSIVE", MCPH22
25936,617985,"MICROCEPHALY 23, PRIMARY, AUTOSOMAL RECESSIVE", MCPH23
25937,617986,LOW DENSITY LIPOPROTEIN RECEPTOR CLASS A DOMAIN-CONTAINING PROTEIN 3, LDLRAD3
25938,617987,"METHYLTRANSFERASE 13, EEF1A LYSINE AND N-TERMINAL METHYLTRANSFERASE", METTL13
25939,617988,JABERI-ELAHI SYNDROME, JABELS
25940,617989,"N-ALPHA-ACETYLTRANSFERASE 30, NatC CATALYTIC SUBUNIT", NAA30
25941,617990,"N-ALPHA-ACETYLTRANSFERASE 38, NatC AUXILIARY SUBUNIT", NAA38
25942,617991,CHUNG-JANSEN SYNDROME, CHUJANS
25943,617992,"DEAFNESS, CONGENITAL HEART DEFECTS, AND POSTERIOR EMBRYOTOXON", DCHE
25944,617993,"TUMORAL CALCINOSIS, HYPERPHOSPHATEMIC, FAMILIAL, 2", HFTC2
25945,617994,"TUMORAL CALCINOSIS, HYPERPHOSPHATEMIC, FAMILIAL, 3", HFTC3
25946,617995,"IMPDH2 ENZYME ACTIVITY, VARIATION IN", IMPDH2V
25947,617996,OOCYTE/ZYGOTE/EMBRYO MATURATION ARREST 5, OZEMA5
25948,617997,RCC1 DOMAIN-CONTAINING PROTEIN 1, RCCD1
25949,617998,"GRB2-ASSOCIATED REGULATOR OF MAPK1, SUBTYPE 1", GAREM1
25950,617999,"GRB2-ASSOCIATED REGULATOR OF MAPK1, SUBTYPE 2", GAREM2
25951,618000,"EHLERS-DANLOS SYNDROME, CLASSIC-LIKE, 2", EDSCLL2
25952,618001,"RAB11 EFFECTOR CONTAINING LIS1 HOMOLOGY DOMAIN, COILED-COIL DOMAINS, AND HEAT REPEATS", RELCH
25953,618002,MICROTUBULE-ASSOCIATED SERINE/THREONINE KINASE 4, MAST4
25954,618003,"DEAFNESS, AUTOSOMAL RECESSIVE 57", DFNB57
25955,618004,DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 64, DEE64
25956,618005,CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 1, CDGF1
25957,618006,"LEUKODYSTROPHY, HYPOMYELINATING, 17", HLD17
25958,618007,RAJAB INTERSTITIAL LUNG DISEASE WITH BRAIN CALCIFICATIONS 1,
25959,618008,DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 65, DEE65
25960,618009,"INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 61", MRD61
25961,618010,GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 17, GPIBD17
25962,618011,HYPEREKPLEXIA 4, HKPX4
25963,618012,DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 93, DEE93
25964,618013,"DEAFNESS, AUTOSOMAL RECESSIVE 109", DFNB109
25965,618014,PREMATURE OVARIAN FAILURE 14, POF14
25966,618015,"PROTOPORPHYRIA, ERYTHROPOIETIC, 2", EPP2
25967,618016,RNA-BINDING REGION-CONTAINING PROTEIN 3, RNPC3
25968,618017,ANKYRIN REPEAT DOMAIN-CONTAINING PROTEIN 16, ANKRD16
25969,618018,"DRUG METABOLISM, ALTERED, CYP2C8-RELATED",
25970,618019,RHIZOMELIC SKELETAL DYSPLASIA WITH OR WITHOUT PELGER-HUET ANOMALY, SKPHA
25971,618020,KELCH-LIKE 22, KLHL22
25972,618021,TETRAAMELIA SYNDROME 2, TETAMS2
25973,618022,HUMEROFEMORAL HYPOPLASIA WITH RADIOTIBIAL RAY DEFICIENCY, HHRRD
25974,618023,NOTCH2 N-TERMINAL-LIKE A, NOTCH2NLA
25975,618024,NOTCH2 N-TERMINAL-LIKE B, NOTCH2NLB
25976,618025,NOTCH2 N-TERMINAL-LIKE C, NOTCH2NLC
25977,618026,NOTCH2 N-TERMINAL-LIKE R, NOTCH2NLR
25978,618027,COFFIN-SIRIS SYNDROME 7, CSS7
25979,618028,"SHIELD COMPLEX, SUBUNIT 1", SHLD1
25980,618029,"SHIELD COMPLEX, SUBUNIT 2", SHLD2
25981,618030,"SHIELD COMPLEX, SUBUNIT 3", SHLD3
25982,618031,"CORNEAL DYSTROPHY, POSTERIOR POLYMORPHOUS, 4", PPCD4
25983,618032,ZINC FINGER PROTEIN 768, ZNF768
25984,618033,ZINC FINGER PROTEIN 689, ZNF689
25985,618034,"SOLUTE CARRIER FAMILY 43, MEMBER 3", SLC43A3
25986,618035,"TBC1 DOMAIN FAMILY, MEMBER 9", TBC1D9
25987,618036,"CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2DD", CMT2DD
25988,618037,ZINC FINGER PROTEIN 536, ZNF536
25989,618038,SHORTAGE IN CHIASMATA 1, SHOC1
25990,618039,"TBC1 DOMAIN FAMILY, MEMBER 9B", TBC1D9B
25991,618040,DIGEORGE SYNDROME CRITICAL REGION GENE 5, DGCR5
25992,618041,PURINE-RICH ELEMENT-BINDING PROTEIN G, PURG
25993,618042,IMMUNODEFICIENCY 100 WITH PULMONARY ALVEOLAR PROTEINOSIS AND HYPOGAMMAGLOBULINEMIA, IMD100
25994,618043,"POU DOMAIN, CLASS 6, TRANSCRIPTION FACTOR 1", POU6F1
25995,618044,C2 CALCIUM-DEPENDENT DOMAIN-CONTAINING PROTEIN 5, C2CD5
25996,618045,DNA DAMAGE-INDUCED APOPTOSIS SUPPRESSOR, DDIAS
25997,618046,"OLFACTORY RECEPTOR, FAMILY 1, SUBFAMILY A, MEMBER 1", OR1A1
25998,618047,"OLFACTORY RECEPTOR, FAMILY 1, SUBFAMILY A, MEMBER 2", OR1A2
25999,618048,PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 2, PRAAS2
26000,618049,"PARKINSONISM-DYSTONIA 2, INFANTILE-ONSET", PKDYS2
26001,618050,"INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 57", MRD57
26002,618051,INNATE IMMUNITY ACTIVATOR, INAVA
26003,618052,"CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 27", CMH27
26004,618053,ANDROGEN RECEPTOR-REGULATED LONG NONCODING RNA 1, ARLNC1
26005,618054,MEMBRANE INTEGRAL NOTCH2-ASSOCIATED RECEPTOR 1, MINAR1
26006,618055,CELLULAR REPRESSOR OF E1A-STIMULATED GENES 1, CREG1
26007,618056,NEURODEVELOPMENTAL DISORDER WITH CEREBELLAR ATROPHY AND WITH OR WITHOUT SEIZURES, NEDCAS
26008,618057,"DRUG METABOLISM, ALTERED, CES1-RELATED",
26009,618058,CILIA- AND FLAGELLA-ASSOCIATED PROTEIN 300, CFAP300
26010,618059,WD REPEAT-CONTAINING PROTEIN 25, WDR25
26011,618060,INTELLECTUAL DEVELOPMENTAL DISORDER WITH OR WITHOUT EPILEPSY OR CEREBELLAR ATAXIA, IDDECA
26012,618061,POLYCYSTIC KIDNEY DISEASE 6 WITH OR WITHOUT POLYCYSTIC LIVER DISEASE, PKD6
26013,618062,CYSTEINE-RICH SECRETORY PROTEIN 3, CRISP3
26014,618063,"CILIARY DYSKINESIA, PRIMARY, 38", CILD38
26015,618064,CYTOCHROME c OXIDASE ASSEMBLY FACTOR 16, COX16
26016,618065,"PONTOCEREBELLAR HYPOPLASIA, TYPE 1D", PCH1D
26017,618066,"HOMEOBOX B CLUSTER ANTISENSE RNA 1, NONCODING", HOXBAS1
26018,618067,DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 66, DEE66
26019,618068,SPERMATOGENIC LEUCINE ZIPPER PROTEIN 1, SPZ1
26020,618069,"CCR4-NOT TRANSCRIPTION COMPLEX, SUBUNIT 6-LIKE", CNOT6L
26021,618070,"ATPase, H+ TRANSPORTING, LYSOSOMAL, 42-KD, V1 SUBUNIT C, ISOFORM 2", ATP6V1C2
26022,618071,"ATPase, H+ TRANSPORTING, LYSOSOMAL, 13-KD, V1 SUBUNIT G, ISOFORM 3", ATP6V1G3
26023,618072,"ATPase, H+ TRANSPORTING, LYSOSOMAL, 38-KD, V0 SUBUNIT D, ISOFORM 2", ATP6V0D2
26024,618073,STERILE ALPHA MOTIF DOMAIN-CONTAINING PROTEIN 12, SAMD12
26025,618074,"EPILEPSY, FAMILIAL ADULT MYOCLONIC, 6", FAME6
26026,618075,"EPILEPSY, FAMILIAL ADULT MYOCLONIC, 7", FAME7
26027,618076,NEURODEVELOPMENTAL DISORDER WITH SPASTICITY AND POOR GROWTH, NEDSG
26028,618077,INFLAMMATORY BOWEL DISEASE 29, IBD29
26029,618078,OVARIAN DYSGENESIS 6, ODG6
26030,618079,LOW DENSITY LIPOPROTEIN CHOLESTEROL LEVEL QUANTITATIVE TRAIT LOCUS 8, LDLCQ8
26031,618080,WD REPEAT-AND FYVE DOMAIN-CONTAINING PROTEIN 1, WDFY1
26032,618081,IMMUNOGLOBULIN-LIKE DOMAIN-CONTAINING RECEPTOR 2, ILDR2
26033,618082,WD REPEAT-CONTAINING PROTEIN 33, WDR33
26034,618083,WW-BINDING PROTEIN 11, WBP11
26035,618084,PEELING SKIN SYNDROME 6, PSS6
26036,618085,POLYAMINE-MODULATED FACTOR 1-BINDING PROTEIN 1, PMFBP1
26037,618086,SPERMATOGENIC FAILURE 28, SPGF28
26038,618087,"SPINOCEREBELLAR ATAXIA 42, EARLY-ONSET, SEVERE, WITH NEURODEVELOPMENTAL DEFICITS", SCA42ND
26039,618088,"NEURODEVELOPMENTAL DISORDER WITH REGRESSION, ABNORMAL MOVEMENTS, LOSS OF SPEECH, AND SEIZURES", NEDAMSS
26040,618089,INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND BEHAVIORAL ABNORMALITIES, IDDFBA
26041,618090,NEURODEVELOPMENTAL DISORDER WITH EPILEPSY AND HYPOPLASIA OF THE CORPUS CALLOSUM, NEDEHCC
26042,618091,SPERMATOGENIC FAILURE 29, SPGF29
26043,618092,"INTELLECTUAL DEVELOPMENTAL DISORDER WITH SPEECH DELAY, DYSMORPHIC FACIES, AND T-CELL ABNORMALITIES", IDDSFTA
26044,618093,SPINOCEREBELLAR ATAXIA 48, SCA48
26045,618094,"DEAFNESS, AUTOSOMAL RECESSIVE 110", DFNB110
26046,618095,"INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 63", MRT63
26047,618096,PREMATURE OVARIAN FAILURE 15, POF15
26048,618097,"MICROCEPHALY, GROWTH RESTRICTION, AND INCREASED SISTER CHROMATID EXCHANGE 2", MGRISCE2
26049,618098,"PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 5", PEOB5
26050,618099,MITOCHONDRIAL RIBOSOMAL RNA METHYLTRANSFERASE 1, MRM1
26051,618100,MPV17 MITOCHONDRIAL INNER MEMBRANE PROTEIN-LIKE, MPV17L
26052,618101,MATRIX METALLOPROTEINASE 27, MMP27
26053,618102,SUMO-INTERACTING MOTIFS-CONTAINING PROTEIN 1, SIMC1
26054,618103,"INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 64", MRT64
26055,618104,MEMBRANE METALLOENDOPEPTIDASE-LIKE 1, MMEL1
26056,618105,SIALIC ACID-BINDING IMMUNOGLOBULIN-LIKE LECTIN 15, SIGLEC15
26057,618106,"INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 58", MRD58
26058,618107,"OSTEOPETROSIS, AUTOSOMAL DOMINANT 3", OPTA3
26059,618108,IMMUNODEFICIENCY 57 WITH AUTOINFLAMMATION, IMD57
26060,618109,"INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 65", MRT65
26061,618110,SPERMATOGENIC FAILURE 30, SPGF30
26062,618111,ZINC FINGER PROTEIN 64, ZFP64
26063,618112,SPERMATOGENIC FAILURE 31, SPGF31
26064,618113,"ENCEPHALITIS/ENCEPHALOPATHY, MILD, WITH REVERSIBLE MYELIN VACUOLIZATION", MMERV
26065,618114,LIDDLE SYNDROME 2, LIDLS2
26066,618115,SPERMATOGENIC FAILURE 32, SPGF32
26067,618116,BONE MARROW FAILURE SYNDROME 4, BMFS4
26068,618117,OVARIAN DYSGENESIS 7, ODG7
26069,618118,ECHINODERM MICROTUBULE-ASSOCIATED PROTEIN-LIKE 3, EML3
26070,618119,ECHINODERM MICROTUBULE-ASSOCIATED PROTEIN-LIKE 5, EML5
26071,618120,"MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 5", MC5DN5
26072,618121,"ATP SYNTHASE PERIPHERAL STALK, SUBUNIT D", ATP5PD
26073,618122,MTR4 EXOSOME RNA HELICASE, MTREX
26074,618123,"POLYDACTYLY, POSTAXIAL, TYPE A8", PAPA8
26075,618124,"PERIPHERAL NEUROPATHY, AUTOSOMAL RECESSIVE, WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT", PNRIID
26076,618125,KASH DOMAIN-CONTAINING PROTEIN 5, KASH5
26077,618126,LIDDLE SYNDROME 3, LIDLS3
26078,618127,"CYTOCHROME C OXIDASE, SUBUNIT 6B2", COX6B2
26079,618128,GANGLIOSIDE-INDUCED DIFFERENTIATION-ASSOCIATED PROTEIN 2, GDAP2
26080,618129,"MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL DOMINANT 4", LGMDD4
26081,618130,N-TERMINAL EF-HAND CALCIUM-BINDING PROTEIN 2, NECAB2
26082,618131,IMMUNODEFICIENCY 58, IMD58
26083,618132,SIALIC ACID-BINDING IMMUNOGLOBULIN-LIKE LECTIN 14, SIGLEC14
26084,618133,"NEUREXOPHILIN AND PC-ESTERASE DOMAIN FAMILY, MEMBER 4", NXPE4
26085,618134,UROTENSIN 2B, UTS2B
26086,618135,"MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 8", MDDGC8
26087,618136,MAD2L1-BINDING PROTEIN, MAD2L1BP
26088,618137,MIS18 KINETOCHORE PROTEIN A: MIS18A,
26089,618138,"MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 23", LGMDR23
26090,618139,MIS18-BINDING PROTEIN 1, MIS18BP1
26091,618140,"DEAFNESS, AUTOSOMAL DOMINANT 74", DFNA74
26092,618141,DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 67, DEE67
26093,618142,"MICROCEPHALY, FACIAL DYSMORPHISM, RENAL AGENESIS, AND AMBIGUOUS GENITALIA SYNDROME", MFRG
26094,618143,DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 95, DEE95
26095,618144,"USHER SYNDROME, TYPE IV", USH4
26096,618145,"DEAFNESS, AUTOSOMAL RECESSIVE 111", DFNB111
26097,618146,CILIA- AND FLAGELLA-ASSOCIATED PROTEIN 251, CFAP251
26098,618147,INTELLECTUAL DEVELOPMENTAL DISORDER WITH HYPERTELORISM AND DISTINCTIVE FACIES, IDDHDF
26099,618148,EXTRAORAL HALITOSIS DUE TO METHANETHIOL OXIDASE DEFICIENCY, EHMTO
26100,618149,OROFACIAL CLEFT 8, OFC8
26101,618150,SAUL-WILSON SYNDROME, SWILS
26102,618151,TESTIS-EXPRESSED BASIC PROTEIN 1, TSBP1
26103,618152,SPERMATOGENIC FAILURE 33, SPGF33
26104,618153,SPERMATOGENIC FAILURE 34, SPGF34
26105,618154,HENNEKAM LYMPHANGIECTASIA-LYMPHEDEMA SYNDROME 3, HKLLS3
26106,618155,"OPHTHALMOPLEGIA, EXTERNAL, WITH RIB AND VERTEBRAL ANOMALIES", EORVA
26107,618156,SQUALENE SYNTHASE DEFICIENCY, SQSD
26108,618157,"ISOLATED GROWTH HORMONE DEFICIENCY, TYPE IV", IGHD4
26109,618158,"INTELLECTUAL DEVELOPMENTAL DISORDER WITH MACROCEPHALY, SEIZURES, AND SPEECH DELAY", IDDMSSD
26110,618159,"PROTEIN PHOSPHATASE 1, REGULATORY SUBUNIT 21", PPP1R21
26111,618160,"PITUITARY HORMONE DEFICIENCY, COMBINED OR ISOLATED, 7", CPHD7
26112,618161,JOUBERT SYNDROME 35, JBTS35
26113,618162,"SPONDYLOEPIMETAPHYSEAL DYSPLASIA, KRAKOW TYPE", SEMDK
26114,618163,TRANSMEMBRANE PROTEIN 94, TMEM94
26115,618164,"CARDIAC, FACIAL, AND DIGITAL ANOMALIES WITH DEVELOPMENTAL DELAY", CAFDADD
26116,618165,BONE MARROW FAILURE SYNDROME 5, BMFS5
26117,618166,CYCLIN N-TERMINAL DOMAIN-CONTAINING PROTEIN 1, CNTD1
26118,618167,"OSTEOCHONDRODYSPLASIA, BRACHYDACTYLY, AND OVERLAPPING MALFORMED DIGITS", OCBMD
26119,618168,DIARRHEA 9, DIAR9
26120,618169,POU3F3-ADJACENT NONCODING TRANSCRIPT 1, PANTR1
26121,618170,"NEURODEGENERATION, CHILDHOOD-ONSET, STRESS-INDUCED, WITH VARIABLE ATAXIA AND SEIZURES", CONDSIAS
26122,618171,KINESIN FAMILY MEMBER 16B, KIF16B
26123,618172,LONG NONCODING RNA UPREGULATOR OF ANTIVIRAL RESPONSE INTERFERON SIGNALING, LUARIS
26124,618173,RETINITIS PIGMENTOSA 83, RP83
26125,618174,"CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 9", CDCBM9
26126,618175,WARBURG-CINOTTI SYNDROME, WRCN
26127,618176,"NEPHROTIC SYNDROME, TYPE 17", NPHS17
26128,618177,"NEPHROTIC SYNDROME, TYPE 18", NPHS18
26129,618178,"NEPHROTIC SYNDROME, TYPE 19", NPHS19
26130,618179,"MICROCEPHALY 24, PRIMARY, AUTOSOMAL RECESSIVE", MCPH24
26131,618180,"ECTODERMAL DYSPLASIA 14, HAIR/TOOTH TYPE, WITH OR WITHOUT HYPOHIDROSIS", ECTD14
26132,618181,ZINC FINGER- AND BTB DOMAIN-CONTAINING PROTEIN 11, ZBTB11
26133,618182,ORTHOSTATIC HYPOTENSION 2, ORTHYP2
26134,618183,"DIARRHEA 10, PROTEIN-LOSING ENTEROPATHY TYPE", DIAR10
26135,618184,"NEUROPATHY, CONGENITAL HYPOMYELINATING, 2", CHN2
26136,618185,PERIVENTRICULAR NODULAR HETEROTOPIA 8, PVNH8
26137,618186,"NEUROPATHY, CONGENITAL HYPOMYELINATING, 3", CHN3
26138,618187,OVARIAN DYSGENESIS 8, ODG8
26139,618188,"HYPERPARATHYROIDISM, TRANSIENT NEONATAL", HRPTTN
26140,618189,"CARDIOMYOPATHY, DILATED, 2C", CMD2C
26141,618190,"LUNG CANCER-ASSOCIATED TRANSCRIPT 1, NONCODING", LUCAT1
26142,618191,CEA CELL ADHESION MOLECULE 21, CEACAM21
26143,618192,"PROSTATE CANCER-ASSOCIATED TRANSCRIPT 19, NONCODING", PCAT19
26144,618193,POLYCYSTIC LIPOMEMBRANOUS OSTEODYSPLASIA WITH SCLEROSING LEUKOENCEPHALOPATHY 2, PLOSL2
26145,618194,SCAVENGER RECEPTOR CYSTEINE-RICH FAMILY MEMBER WITH 5 DOMAINS, SSC5D
26146,618195,INTELLECTUAL DEVELOPMENTAL DISORDER AND RETINITIS PIGMENTOSA, IDDRP
26147,618196,CAPILLARY MALFORMATION-ARTERIOVENOUS MALFORMATION 2, CMAVM2
26148,618197,"MYASTHENIC SYNDROME, CONGENITAL, 23, PRESYNAPTIC", CMS23
26149,618198,"MYASTHENIC SYNDROME, CONGENITAL, 24, PRESYNAPTIC", CMS24
26150,618199,APOBEC1 COMPLEMENTATION FACTOR, A1CF
26151,618200,MIDASIN AAA ATPase 1, MDN1
26152,618201,DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 68, DEE68
26153,618202,"DNAJ/HSP40 HOMOLOG, SUBFAMILY C, MEMBER 30", DNAJC30
26154,618203,TRANSMEMBRANE AND TETRATRICOPEPTIDE REPEAT DOMAINS-CONTAINING PROTEIN 4, TMTC4
26155,618204,IMMUNODEFICIENCY 15A, IMD15A
26156,618205,SNIJDERS BLOK-CAMPEAU SYNDROME, SNIBCPS
26157,618206,ZINC FINGER CCCH DOMAIN-CONTAINING PROTEIN 7B, ZC3H7B
26158,618207,SEC1 FAMILY DOMAIN-CONTAINING PROTEIN 1, SCFD1
26159,618208,LONG INTERGENIC NONCODING RNA 1159, LINC01159
26160,618209,HOXD ANTISENSE GROWTH-ASSOCIATED LONG NONCODING RNA, HAGLR
26161,618210,LIPID RAFT LINKING PROTEIN 1, RFTN1
26162,618211,PITRILYSIN METALLOPEPTIDASE 1, PITRM1
26163,618212,"LONG INTERGENIC NONCODING RNA, p53-INDUCED TRANSCRIPT", LINC-PINT
26164,618213,"INFLAMMATORY BOWEL DISEASE, IMMUNODEFICIENCY, AND ENCEPHALOPATHY", IBDIMDE
26165,618214,LONG INTERGENIC NONCODING RNA 1157, LINC01157
26166,618215,LIPID RAFT LINKING PROTEIN 2, RFTN2
26167,618216,"MIRLET7B HOST GENE, NONCODING", MIRLET7BHG
26168,618217,EGFR LONG NONCODING DOWNSTREAM RNA, ELDR
26169,618218,BAKER-GORDON SYNDROME, BAGOS
26170,618219,"POLYDACTYLY, POSTAXIAL, TYPE A9", PAPA9
26171,618220,RETINITIS PIGMENTOSA 84, RP84
26172,618221,"INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 66", MRT66
26173,618222,"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 2", MC1DN2
26174,618223,VERTEBRAL ANOMALIES AND VARIABLE ENDOCRINE AND T-CELL DYSFUNCTION, VETD
26175,618224,"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 3", MC1DN3
26176,618225,"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 4", MC1DN4
26177,618226,"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 5", MC1DN5
26178,618227,LEUCINE-RICH REPEAT-CONTAINING PROTEIN 56, LRRC56
26179,618228,"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 6", MC1DN6
26180,618229,"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 7", MC1DN7
26181,618230,"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 8", MC1DN8
26182,618231,"EPIDERMODYSPLASIA VERRUCIFORMIS, SUSCEPTIBILITY TO, 2", EV2
26183,618232,"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 9", MC1DN9
26184,618233,"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 10", MC1DN10
26185,618234,"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 11", MC1DN11
26186,618235,"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 13", MC1DN13
26187,618236,"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 14", MC1DN14
26188,618237,"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 15", MC1DN15
26189,618238,"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 16", MC1DN16
26190,618239,"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 17", MC1DN17
26191,618240,"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 18", MC1DN18
26192,618241,"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 19", MC1DN19
26193,618242,"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 21", MC1DN21
26194,618243,"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 22", MC1DN22
26195,618244,"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 23", MC1DN23
26196,618245,"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 24", MC1DN24
26197,618246,"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 25", MC1DN25
26198,618247,"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 26", MC1DN26
26199,618248,"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 27", MC1DN27
26200,618249,"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 28", MC1DN28
26201,618250,"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 29", MC1DN29
26202,618251,"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 31", MC1DN31
26203,618252,"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 32", MC1DN32
26204,618253,"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 33", MC1DN33
26205,618254,"CILIARY DYSKINESIA, PRIMARY, 39", CILD39
26206,618255,MYOGENESIS-REGULATING GLYCOSIDASE, MYORG
26207,618256,BIPARENTAL MITOCHONDRIAL DNA TRANSMISSION,
26208,618257,"DEAFNESS, AUTOSOMAL RECESSIVE 112", DFNB112
26209,618258,"SEC11 HOMOLOG A, SIGNAL PEPTIDASE COMPLEX SUBUNIT", SEC11A
26210,618259,LONG INTERGENIC NONCODING RNA 1565, LINC01565
26211,618260,COILED-COIL DOMAIN-CONTAINING PROTEIN 47, CCDC47
26212,618261,LYMPHOPROLIFERATIVE SYNDROME 3, LPFS3
26213,618262,cAMP RESPONSE ELEMENT-BINDING PROTEIN 5, CREB5
26214,618263,CALCIUM HOMEOSTASIS MODULATOR 3, CALHM3
26215,618264,MIRROR MOVEMENTS 4, MRMV4
26216,618265,"ARTHROGRYPOSIS, CLEFT PALATE, CRANIOSYNOSTOSIS, AND IMPAIRED INTELLECTUAL DEVELOPMENT", ACCIID
26217,618266,"PONTOCEREBELLAR HYPOPLASIA, TYPE 12", PCH12
26218,618267,"EPIDERMODYSPLASIA VERRUCIFORMIS, SUSCEPTIBILITY TO, 3", EV3
26219,618268,TRICHOHEPATONEURODEVELOPMENTAL SYNDROME, THNS
26220,618269,ZINC FINGER PROTEIN 341, ZNF341
26221,618270,CONGENITAL ANOMALIES OF KIDNEY AND URINARY TRACT 3, CAKUT3
26222,618271,"SEC61 TRANSLOCON, ALPHA-2 SUBUNIT", SEC61A2
26223,618272,"GLOBAL DEVELOPMENTAL DELAY, LUNG CYSTS, OVERGROWTH, AND WILMS TUMOR", GLOW
26224,618273,MEGA-CORPUS-CALLOSUM SYNDROME WITH CEREBELLAR HYPOPLASIA AND CORTICAL MALFORMATIONS, MCCCHCM
26225,618274,PEPTIDYLPROLYL ISOMERASE DOMAIN- AND WD40 REPEAT-CONTAINING PROTEIN 1, PPWD1
26226,618275,HYPOTRICHOSIS 14, HYPT14
26227,618276,"NEURODEGENERATION, CHILDHOOD-ONSET, WITH CEREBELLAR ATROPHY", CONDCA
26228,618277,NHL REPEAT-CONTAINING PROTEIN 2, NHLRC2
26229,618278,"FIBROSIS, NEURODEGENERATION, AND CEREBRAL ANGIOMATOSIS", FINCA
26230,618279,"CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1G", CMT1G
26231,618280,CARDIAC-UROGENITAL SYNDROME, CUGS
26232,618281,VON WILLEBRAND FACTOR A DOMAIN-CONTAINING PROTEIN 2, VWA2
26233,618282,"HYPER-IgE SYNDROME 3, AUTOSOMAL RECESSIVE, WITH RECURRENT INFECTIONS", HIES3
26234,618283,VISUAL IMPAIRMENT AND PROGRESSIVE PHTHISIS BULBI, VIPB
26235,618284,"MICROCEPHALY, CATARACTS, IMPAIRED INTELLECTUAL DEVELOPMENT, AND DYSTONIA WITH ABNORMAL STRIATUM", MCIDDS
26236,618285,DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 69, DEE69
26237,618286,"MACROCEPHALY, ACQUIRED, WITH IMPAIRED INTELLECTUAL DEVELOPMENT", MACID
26238,618287,"AUTOINFLAMMATORY DISEASE, FAMILIAL, BEHCET-LIKE 3", AIFBL3
26239,618288,"5-HYDROXYMETHYLCYTOSINE-BINDING PROTEIN, EMBRYONIC STEM CELL-SPECIFIC", HMCES
26240,618289,ENDOSOME-ASSOCIATED TRAFFICKING REGULATOR 1, ENTR1
26241,618290,WD REPEAT-CONTAINING PROTEIN 90, WDR90
26242,618291,"SPINAL MUSCULAR ATROPHY, LOWER EXTREMITY-PREDOMINANT, 2B, PRENATAL ONSET, AUTOSOMAL DOMINANT", SMALED2B
26243,618292,"NEURODEVELOPMENTAL DISORDER WITH IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND ATAXIA", NEDIDHA
26244,618293,INTERFERON-INDUCED TRANSMEMBRANE PROTEIN 10, IFITM10
26245,618294,TRANSMEMBRANE PROTEIN 91, TMEM91
26246,618295,"INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 67", MRT67
26247,618296,TRANSMEMBRANE PROTEIN 233, TMEM233
26248,618297,PROLINE-RICH TRANSMEMBRANE PROTEIN 1, PRRT1
26249,618298,DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 70, DEE70
26250,618299,LOW DENSITY LIPOPROTEIN RECEPTOR-RELATED PROTEIN 12, LRP12
26251,618300,"CILIARY DYSKINESIA, PRIMARY, 40", CILD40
26252,618301,"KAZRIN, PERIPLAKIN-INTERACTING PROTEIN", KAZN
26253,618302,"INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 68", MRT68
26254,618303,CAVEOLAE-ASSOCIATED PROTEIN 3, CAVIN3
26255,618304,GLUTAMINE-RICH PROTEIN 2, QRICH2
26256,618305,"ATP1A1 ANTISENSE RNA 1, NONCODING", ATP1A1AS1
26257,618306,PROLINE-RICH PROTEIN 7, PRR7
26258,618307,IMMUNODEFICIENCY 129, IMD129
26259,618308,NOP9 NUCLEOLAR PROTEIN, NOP9
26260,618309,IMMUNODEFICIENCY 130 WITH HPV-RELATED VERRUCOSIS, IMD130
26261,618310,DIAMOND-BLACKFAN ANEMIA 18, DBA18
26262,618311,RIBOSOME BIOGENESIS REGULATOR 1 HOMOLOG, RRS1
26263,618312,DIAMOND-BLACKFAN ANEMIA 19, DBA19
26264,618313,DIAMOND-BLACKFAN ANEMIA 20, DBA20
26265,618314,"HYPOMAGNESEMIA, SEIZURES, AND IMPAIRED INTELLECTUAL DEVELOPMENT 2", HOMGSMR2
26266,618315,RIBOSOMAL PROTEIN L35, RPL35
26267,618316,INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC DEFECTS AND DYSMORPHIC FACIES, IDDCDF
26268,618317,"BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 7, AUTOSOMAL RECESSIVE", IBGC7
26269,618318,CILIA- AND FLAGELLA-ASSOCIATED PROTEIN 119, CFAP119
26270,618319,PR DOMAIN-CONTAINING PROTEIN 10, PRDM10
26271,618320,"SECRETORY PHOSPHOLIPASE A2, GROUP IIE", PLA2G2E
26272,618321,"ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 2", PEBEL2
26273,618322,UBIQUITIN-SPECIFIC PROTEASE 38, USP38
26274,618323,"MYASTHENIC SYNDROME, CONGENITAL, 25, PRESYNAPTIC", CMS25
26275,618324,CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 2, CDGF2
26276,618325,LISSENCEPHALY 9 WITH COMPLEX BRAINSTEM MALFORMATION, LIS9
26277,618326,ZINC FINGER CCHC DOMAIN-CONTAINING PROTEIN 3, ZCCHC3
26278,618327,CAPPING PROTEIN INHIBITING REGULATOR OF ACTIN DYNAMICS, CRACD
26279,618328,DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 71, DEE71
26280,618329,COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 37, COXPD37
26281,618330,GLOBAL DEVELOPMENTAL DELAY WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT, GDDI
26282,618331,"ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH EPISODIC RHABDOMYOLYSIS", PEERB
26283,618332,MENKE-HENNEKAM SYNDROME 1, MKHK1
26284,618333,MENKE-HENNEKAM SYNDROME 2, MKHK2
26285,618334,CYTOCHROME b(-254) CHAPERONE 1, CYBC1
26286,618335,LONG INTERGENIC NONCODING RNA 958, LINC00958
26287,618336,"INTRAUTERINE GROWTH RETARDATION, METAPHYSEAL DYSPLASIA, ADRENAL HYPOPLASIA CONGENITA, GENITAL ANOMALIES, AND IMMUNODEFICIENCY", IMAGEI
26288,618337,FERM DOMAIN-CONTAINING PROTEIN 8, FRMD8
26289,618338,THIOL METHYLTRANSFERASE 1A, TMT1A
26290,618339,CASGID SYNDROME, CASGID
26291,618340,SUBMAXILLARY GLAND ANDROGEN-REGULATED PROTEIN 3A, SMR3A
26292,618341,SPERMATOGENIC FAILURE 35, SPGF35
26293,618342,"INTELLECTUAL DEVELOPMENTAL DISORDER WITH ABNORMAL BEHAVIOR, MICROCEPHALY, AND SHORT STATURE", IDDABS
26294,618343,POLYMICROGYRIA WITH OR WITHOUT VASCULAR-TYPE EHLERS-DANLOS SYNDROME, PMGEDSV
26295,618344,PROLINE-RICH PROTEIN 15, PRR15
26296,618345,RETINITIS PIGMENTOSA 85, RP85
26297,618346,"MICROCEPHALY, GROWTH DEFICIENCY, SEIZURES, AND BRAIN MALFORMATIONS", MIGSB
26298,618347,GALLOWAY-MOWAT SYNDROME 6, GAMOS6
26299,618348,GALLOWAY-MOWAT SYNDROME 7, GAMOS7
26300,618349,GALLOWAY-MOWAT SYNDROME 8, GAMOS8
26301,618350,MICROTUBULE-ASSOCIATED PROTEIN 11, MAP11
26302,618351,"MICROCEPHALY 25, PRIMARY, AUTOSOMAL RECESSIVE", MCPH25
26303,618352,CENTRAL CENTRIFUGAL CICATRICIAL ALOPECIA, CCCA
26304,618353,OOCYTE/ZYGOTE/EMBRYO MATURATION ARREST 6, OZEMA6
26305,618354,HOUGE-JANSSENS SYNDROME 3, HJS3
26306,618355,"ALG10 ALPHA-1,2-GLUCOSYLTRANSFERASE", ALG10
26307,618356,NEURODEVELOPMENTAL DISORDER WITH CENTRAL AND PERIPHERAL MOTOR DYSFUNCTION, NEDCPMD
26308,618357,"EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 15", EIG15
26309,618358,CONE-ROD DYSTROPHY AND HEARING LOSS 2, CRDHL2
26310,618359,ZINC FINGER PROTEIN 197, ZNF197
26311,618360,BRAIN SMALL VESSEL DISEASE 3, BSVD3
26312,618361,DUAL-SPECIFICITY PHOSPHATASE 23, DUSP23
26313,618362,COFFIN-SIRIS SYNDROME 8, CSS8
26314,618363,"SHORT STATURE, AMELOGENESIS IMPERFECTA, AND SKELETAL DYSPLASIA WITH SCOLIOSIS", SSASKS
26315,618364,"MYOCLONUS, FAMILIAL, 2", MYOCL2
26316,618365,ZINC FINGER- AND SCAN DOMAIN-CONTAINING PROTEIN 10, ZSCAN10
26317,618366,VPS8 CORVET COMPLEX SUBUNIT, VPS8
26318,618367,"NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND HYPOMYELINATION", NEDMEHM
26319,618368,DUAL-SPECIFICITY PHOSPHATASE 26, DUSP26
26320,618369,"SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 27", SCAR27
26321,618370,"NEXN ANTISENSE RNA 1, NONCODING", NEXNAS1
26322,618371,TURNPENNY-FRY SYNDROME, TPFS
26323,618372,"GASTROINTESTINAL ULCERATION, RECURRENT, WITH DYSFUNCTIONAL PLATELETS", GURDP
26324,618373,"CANCER, ALOPECIA, PIGMENT DYSCRASIA, ONYCHODYSTROPHY, AND KERATODERMA", CAPOK
26325,618374,DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 72, DEE72
26326,618375,FATTY ACID AMIDE HYDROLASE PSEUDOGENE 1, FAAHP1
26327,618376,"PROTEASE, SERINE, 23", PRSS23
26328,618377,PAIN SENSITIVITY QUANTITATIVE TRAIT LOCUS 1, PAINQTL1
26329,618378,COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 38, COXPD38
26330,618379,DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 73, DEE73
26331,618380,"FAMILY WITH SEQUENCE SIMILARITY 83, MEMBER D", FAM83D
26332,618381,"FACIAL DYSMORPHISM, HYPERTRICHOSIS, EPILEPSY, INTELLECTUAL/DEVELOPMENTAL DELAY, AND GINGIVAL OVERGROWTH SYNDROME", FHEIG
26333,618382,CYTOSOLIC IRON-SULFUR ASSEMBLY COMPONENT 2A, CIAO2A
26334,618383,"NEURODEVELOPMENTAL DISORDER WITH PROGRESSIVE MOVEMENT ABNORMALITIES, COGNITIVE DECLINE, AND BRAIN ABNORMALITIES", NEDMCB
26335,618384,"LEUKOENCEPHALOPATHY, ACUTE REVERSIBLE, WITH INCREASED URINARY ALPHA-KETOGLUTARATE", ARLIAK
26336,618385,CYCLASE-ASSOCIATED ACTIN CYTOSKELETON REGULATORY PROTEIN 2, CAP2
26337,618386,"AMELOGENESIS IMPERFECTA, TYPE IIIC", AI3C
26338,618387,"SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE, WITH AXONAL NEUROPATHY 3", SCAN3
26339,618388,FETAL AKINESIA DEFORMATION SEQUENCE 2, FADS2
26340,618389,FETAL AKINESIA DEFORMATION SEQUENCE 3, FADS3
26341,618390,BONE MORPHOGENETIC PROTEIN/RETINOIC ACID-INDUCIBLE NEURAL-SPECIFIC PROTEIN 3, BRINP3
26342,618391,DIPHTHAMIDE BIOSYNTHESIS PROTEIN 6, DPH6
26343,618392,"SPONDYLOEPIPHYSEAL DYSPLASIA, KONDO-FU TYPE", SEDKF
26344,618393,FETAL AKINESIA DEFORMATION SEQUENCE 4, FADS4
26345,618394,IMMUNODEFICIENCY 60 AND AUTOIMMUNITY, IMD60
26346,618395,"SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY, TYPE 3", SEMDJL3
26347,618396,DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 74, DEE74
26348,618397,COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 39, COXPD39
26349,618398,"T-CELL LYMPHOMA, SUBCUTANEOUS PANNICULITIS-LIKE", SPTCL
26350,618399,GLYCOSYLTRANSFERASE 8 DOMAIN-CONTAINING PROTEIN 1, GLT8D1
26351,618400,"CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2EE", CMT2EE
26352,618401,"FAMILY WITH SEQUENCE SIMILARITY 170, MEMBER A", FAM170A
26353,618402,"INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 70", MRT70
26354,618403,"FAMILY WITH SEQUENCE SIMILARITY 124, MEMBER B", FAM124B
26355,618404,"LEUKODYSTROPHY, HYPOMYELINATING, 18", HLD18
26356,618405,ZINC FINGER PROTEIN 717, ZNF717
26357,618406,BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 20, BMIQ20
26358,618407,MINDY LYSINE-48 DEUBIQUITINASE 1, MINDY1
26359,618408,MINDY LYSINE-48 DEUBIQUITINASE 2, MINDY2
26360,618409,"FAMILY WITH SEQUENCE SIMILARITY 8, MEMBER A1", FAM8A1
26361,618410,"DEAFNESS, AUTOSOMAL RECESSIVE 113", DFNB113
26362,618411,FTSJ RNA 2-PRIME-O-METHYLTRANSFERASE 3, FTSJ3
26363,618412,"GLOBAL DEVELOPMENTAL DELAY, PROGRESSIVE ATAXIA, AND ELEVATED GLUTAMINE", GDPAG
26364,618413,"FAMILY WITH SEQUENCE SIMILARITY 149, MEMBER B1", FAM149B1
26365,618414,CONGENITAL MYOPATHY 14, CMYO14
26366,618415,CATARACT 48, CTRCT48
26367,618416,"METABOLIC CRISES, RECURRENT, WITH VARIABLE ENCEPHALOMYOPATHIC FEATURES AND NEUROLOGIC REGRESSION", MECREN
26368,618417,MEIOTIC DOUBLE-STRANDED BREAK FORMATION PROTEIN 4, MEI4
26369,618418,"SPASTIC PARAPLEGIA 80, AUTOSOMAL DOMINANT", SPG80
26370,618419,MYOECTODERMAL GONADAL DYSGENESIS SYNDROME, MEGD
26371,618420,SPERMATOGENIC FAILURE 36, SPGF36
26372,618421,REC114 MEIOTIC RECOMBINATION PROTEIN, REC114
26373,618422,"DEAFNESS, AUTOSOMAL RECESSIVE 100", DFNB100
26374,618423,ANKYRIN REPEAT DOMAIN-CONTAINING PROTEIN 31, ANKRD31
26375,618424,ARMADILLO REPEAT-CONTAINING PROTEIN 2, ARMC2
26376,618425,NEURODEVELOPMENTAL DISORDER WITH IMPAIRED SPEECH AND HYPERKINETIC MOVEMENTS, NEDISHM
26377,618426,"ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 9", IIAE9
26378,618427,PROTON-ACTIVATED CHLORIDE CHANNEL 1, PACC1
26379,618428,TITLE NOT AVAILABLE AT THIS MOMENT,
26380,618429,SPERMATOGENIC FAILURE 37, SPGF37
26381,618430,DEVELOPMENTAL DELAY WITH VARIABLE INTELLECTUAL IMPAIRMENT AND BEHAVIORAL ABNORMALITIES, DDVIBA
26382,618431,"HYDATIDIFORM MOLE, RECURRENT, 3", HYDM3
26383,618432,"HYDATIDIFORM MOLE, RECURRENT, 4", HYDM4
26384,618433,SPERMATOGENIC FAILURE 38, SPGF38
26385,618434,"DEAFNESS, AUTOSOMAL RECESSIVE 94", DFNB94
26386,618435,"ARTHROGRYPOSIS, DISTAL, TYPE 2B2", DA2B2
26387,618436,"ARTHROGRYPOSIS, DISTAL, TYPE 2B3", DA2B3
26388,618437,DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 75, DEE75
26389,618438,"SPASTIC ATAXIA 9, AUTOSOMAL RECESSIVE", SPAX9
26390,618439,UBIQUITIN-SPECIFIC PROTEASE 45, USP45
26391,618440,OCULOSKELETODENTAL SYNDROME, OCSKD
26392,618441,ADHESION G PROTEIN-COUPLED RECEPTOR G3, ADGRG3
26393,618442,POTASSIUM CHANNEL TETRAMERIZATION DOMAIN-CONTAINING PROTEIN 8, KCTD8
26394,618443,NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT VARIABLE BRAIN ABNORMALITIES, NEDBA
26395,618444,PLASMINOGEN RECEPTOR WITH C-TERMINAL LYSINE, PLGRKT
26396,618445,"GHRELIN OPPOSITE STRAND, NONCODING", GHRLOS
26397,618446,GLYPICAN 2, GPC2
26398,618447,LONG QT SYNDROME 8, LQT8
26399,618448,G PROTEIN-COUPLED RECEPTOR 139, GPR139
26400,618449,"CILIARY DYSKINESIA, PRIMARY, 41", CILD41
26401,618450,RHOTEKIN 2, RTKN2
26402,618451,"NEURODEGENERATION, EARLY-ONSET, WITH CHOREOATHETOID MOVEMENTS AND MICROCYTIC ANEMIA", NDCAMA
26403,618452,"PLECKSTRIN HOMOLOGY DOMAIN-CONTAINING PROTEIN, FAMILY B, MEMBER 2", PLEKHB2
26404,618453,INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE AND VARIABLE SKELETAL ANOMALIES, IDDSSA
26405,618454,DEVELOPMENTAL DELAY WITH OR WITHOUT DYSMORPHIC FACIES AND AUTISM, DEDDFA
26406,618455,HEPHAESTIN-LIKE PROTEIN 1, HEPHL1
26407,618456,"DEAFNESS, AUTOSOMAL RECESSIVE 114", DFNB114
26408,618457,"DEAFNESS, AUTOSOMAL RECESSIVE 115", DFNB115
26409,618458,KNOBLOCH SYNDROME 2, KNO2
26410,618459,IMMUNODEFICIENCY 62, IMD62
26411,618460,KHAN-KHAN-KATSANIS SYNDROME, 3KS
26412,618461,"NADH DEHYDROGENASE (UBIQUINONE) COMPLEX I, ASSEMBLY FACTOR 8", NDUFAF8
26413,618462,"BLEEDING DISORDER, PLATELET-TYPE, 22", BDPLT22
26414,618463,"HYPOALPHALIPOPROTEINEMIA, PRIMARY, 2",
26415,618464,PHEOCHROMOCYTOMA/PARAGANGLIOMA SYNDROME 6, PPGL6
26416,618465,BROMODOMAIN-CONTAINING PROTEIN 9, BRD9
26417,618466,BIOGENESIS OF RIBOSOMES BRIX1, BRIX1
26418,618467,SMC5-SMC6 COMPLEX LOCALIZATION FACTOR 1, SLF1
26419,618468,DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 76, DEE76
26420,618469,"CONTRACTURES, PTERYGIA, AND SPONDYLOCARPOTARSAL FUSION SYNDROME 1B", CPSFS1B
26421,618470,INTELLECTUAL DEVELOPMENTAL DISORDER WITH SEVERE SPEECH AND AMBULATION DEFECTS, IDDSSAD
26422,618471,RIBOSOME PRODUCTION FACTOR 2 HOMOLOG, RPF2
26423,618472,ASPARAGINASE, ASPG
26424,618473,EUKARYOTIC TRANSLATION INITIATION FACTOR 1A DOMAIN-CONTAINING PROTEIN, EIF1AD
26425,618474,WDR83 OPPOSITE STRAND, WDR83OS
26426,618475,PHEOCHROMOCYTOMA/PARAGANGLIOMA SYNDROME 7, PPGL7
26427,618476,"BRAIN ABNORMALITIES, NEURODEGENERATION, AND DYSOSTEOSCLEROSIS", BANDDOS
26428,618477,URIDINE-CYTIDINEURIA, URCTU
26429,618478,FYN-BINDING PROTEIN 2, FYB2
26430,618479,"CEREBELLAR, OCULAR, CRANIOFACIAL, AND GENITAL SYNDROME", COFG
26431,618480,NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND SPEECH AND WALKING IMPAIRMENT, NEDSSWI
26432,618481,"DEAFNESS, AUTOSOMAL RECESSIVE 99", DFNB99
26433,618482,"GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 10", GEFSP10
26434,618483,LLGL SCRIBBLE CELL POLARITY COMPLEX COMPONENT 2, LLGL2
26435,618484,"ARTHROGRYPOSIS MULTIPLEX CONGENITA 3, MYOGENIC TYPE", AMC3
26436,618485,"ZBTB40 INTRONIC TRANSCRIPT 1, NONCODING", ZBTB40IT1
26437,618486,PHOSPHOLIPASE B DOMAIN-CONTAINING PROTEIN 1, PLBD1
26438,618487,G PROTEIN-COUPLED RECEPTOR 151, GPR151
26439,618488,"PHOSPHOLIPASE D FAMILY, MEMBER 4", PLD4
26440,618489,BROMODOMAIN-CONTAINING PROTEIN 7, BRD7
26441,618490,G PROTEIN-COUPLED RECEPTOR 107, GPR107
26442,618491,G PROTEIN-COUPLED RECEPTOR 108, GPR108
26443,618492,NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY AND STRUCTURAL BRAIN ANOMALIES, NEDMIBA
26444,618493,"HYPOTONIA, HYPOVENTILATION, IMPAIRED INTELLECTUAL DEVELOPMENT, DYSAUTONOMIA, EPILEPSY, AND EYE ABNORMALITIES", HIDEA
26445,618494,"CONGENITAL HYPOTONIA, EPILEPSY, DEVELOPMENTAL DELAY, AND DIGITAL ANOMALIES", CHEDDA
26446,618495,IMMUNODEFICIENCY 63 WITH LYMPHOPROLIFERATION AND AUTOIMMUNITY, IMD63
26447,618496,AORTIC VALVE DISEASE 3, AOVD3
26448,618497,NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND NONEPILEPTIC HYPERKINETIC MOVEMENTS, NEDNEH
26449,618498,"POLYDACTYLY, POSTAXIAL, TYPE A10", PAPA10
26450,618499,NOONAN SYNDROME 11, NS11
26451,618500,HOLOPROSENCEPHALY 12 WITH OR WITHOUT PANCREATIC AGENESIS, HPE12
26452,618501,CEREBELLAR ATROPHY WITH SEIZURES AND VARIABLE DEVELOPMENTAL DELAY, CASVDD
26453,618502,BRD4-INTERACTING CHROMATIN REMODELING COMPLEX-ASSOCIATED PROTEIN-LIKE, BICRAL
26454,618503,PROTEIN O-GLUCOSYLTRANSFERASE 3, POGLUT3
26455,618504,"INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 71", MRT71
26456,618505,STOLERMAN NEURODEVELOPMENTAL SYNDROME, NEDSST
26457,618506,INTELLECTUAL DEVELOPMENTAL DISORDER WITH SPEECH DELAY AND DYSMORPHIC FACIES, IDDSDF
26458,618507,WOUND- AND KERATINOCYTE MIGRATION-ASSOCIATED LONG NONCODING RNA 1, WAKMAR1
26459,618508,WOUND- AND KERATINOCYTE MIGRATION-ASSOCIATED LONG NONCODING RNA 2, WAKMAR2
26460,618509,"OLFACTORY RECEPTOR, FAMILY 2, SUBFAMILY M, MEMBER 7", OR2M7
26461,618510,DYSTROTELIN, DYTN
26462,618511,"NEUROPATHY, HEREDITARY MOTOR AND SENSORY, TYPE VIC, WITH OPTIC ATROPHY", HMSN6C
26463,618512,O'DONNELL-LURIA-RODAN SYNDROME, ODLURO
26464,618513,LEBER CONGENITAL AMAUROSIS 19, LCA19
26465,618514,BRMS1-LIKE TRANSCRIPTIONAL REPRESSOR, BRMS1L
26466,618515,TRANSMEMBRANE PROTEIN 33, TMEM33
26467,618516,"OLFACTORY RECEPTOR, FAMILY 14, SUBFAMILY I, MEMBER 1", OR14I1
26468,618517,ANGIOPOIETIN-LIKE 7, ANGPTL7
26469,618518,LONG INTERGENIC NONCODING RNA 261, LINC00261
26470,618519,CHROMOSOME 2 OPEN READING FRAME 68, C2ORF68
26471,618520,EF-HAND CALCIUM-BINDING DOMAIN-CONTAINING PROTEIN 9, EFCAB9
26472,618521,ARMADILLO REPEAT-CONTAINING PROTEIN 8, ARMC8
26473,618522,"INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 59", MRD59
26474,618523,"HYPER-IgE SYNDROME 4B, AUTOSOMAL RECESSIVE, WITH RECURRENT INFECTIONS", HIES4B
26475,618524,CONGENITAL MYOPATHY 16, CMYO16
26476,618525,COILED-COIL DOMAIN-CONTAINING PROTEIN 33, CCDC33
26477,618526,PEAK FAMILY MEMBER 3, PEAK3
26478,618527,"ICHTHYOTIC KERATODERMA, SPASTICITY, HYPOMYELINATION, AND DYSMORPHIC FACIAL FEATURES", IKSHD
26479,618528,MITOCHONDRIAL DNA DEPLETION SYNDROME 16 (HEPATIC TYPE), MTDPS16
26480,618529,"ROBINOW SYNDROME, AUTOSOMAL RECESSIVE 2", RRS2
26481,618530,SERINE/THREONINE KINASE-LIKE DOMAIN-CONTAINING PROTEIN 1, STKLD1
26482,618531,ERYTHROKERATODERMIA VARIABILIS ET PROGRESSIVA 6, EKVP6
26483,618532,CLK4-ASSOCIATING SERINE/ARGININE-RICH PROTEIN, CLASRP
26484,618533,"DEAFNESS, AUTOSOMAL DOMINANT 37", DFNA37
26485,618534,IMMUNODEFICIENCY 64 WITH LYMPHOPROLIFERATION, IMD64
26486,618535,"ECTODERMAL DYSPLASIA 15, HYPOHIDROTIC/HAIR TYPE", ECTD15
26487,618536,"CACTIN, SPLICEOSOME C COMPLEX SUBUNIT", CACTIN
26488,618537,ARGININE VASOPRESSIN-INDUCED PROTEIN 1, AVPI1
26489,618538,CANNABINOID RECEPTOR-INTERACTING PROTEIN 1, CNRIP1
26490,618539,CALCIUM HOMEOSTASIS ENDOPLASMIC RETICULUM PROTEIN, CHERP
26491,618540,CELLULAR REPRESSOR OF E1A-STIMULATED GENES 2, CREG2
26492,618541,"HYPOPIGMENTATION, ORGANOMEGALY, AND DELAYED MYELINATION AND DEVELOPMENT", HOD
26493,618542,"RAB, MEMBER OF RAS ONCOGENE FAMILY-LIKE 3", RABL3
26494,618543,CILIA- AND FLAGELLA-ASSOCIATED PROTEIN 46, CFAP46
26495,618544,ZINC FINGER- AND SCAN DOMAIN-CONTAINING PROTEIN 16, ZSCAN16
26496,618545,"GRPE-LIKE 2, MITOCHONDRIAL", GRPEL2
26497,618546,"TRICHOTHIODYSTROPHY 7, NONPHOTOSENSITIVE", TTD7
26498,618547,NEURODEVELOPMENTAL DISORDER WITH VISUAL DEFECTS AND BRAIN ANOMALIES, NEDVIBA
26499,618548,MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 4, MCAHS4
26500,618549,"HEPATITIS, FULMINANT VIRAL, SUSCEPTIBILITY TO", FVH
26501,618550,OOCYTE/ZYGOTE/EMBRYO MATURATION ARREST 7, OZEMA7
26502,618551,MICROTUBULE-ASSOCIATED PROTEIN 10, MAP10
26503,618552,SPERM ACROSOME-ASSOCIATED PROTEIN 9, SPACA9
26504,618553,BONE MARROW-ASSOCIATED LONG NONCODING RNA, BMNCR
26505,618554,ZINC FINGER PROTEIN 84, ZNF84
26506,618555,"NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE1I", CSNB1I
26507,618556,ENERGY HOMEOSTASIS-ASSOCIATED PROTEIN, ENHO
26508,618557,DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 78, DEE78
26509,618558,G PROTEIN SIGNALING MODULATOR 3, GPSM3
26510,618559,DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 79, DEE79
26511,618560,"BETA-1,4-N-ACETYL-GALACTOSAMINYLTRANSFERASE 4", B4GALNT4
26512,618561,CELL WALL BIOGENESIS PROTEIN 43 C-TERMINAL HOMOLOG, CWH43
26513,618562,TESTIS-EXPRESSED GENE 261, TEX261
26514,618563,"SOLUTE CARRIER FAMILY 10 (SODIUM/BILE ACID COTRANSPORTER FAMILY), MEMBER 4", SLC10A4
26515,618564,"MICROANGIOPATHY AND LEUKOENCEPHALOPATHY, PONTINE, AUTOSOMAL DOMINANT", PADMAL
26516,618565,H1.7 LINKER HISTONE, H1-7
26517,618566,ADENINE NUCLEOTIDE TRANSLOCASE LYSINE METHYLTRANSFERASE, ANTKMT
26518,618567,MITOCHONDRIAL DNA DEPLETION SYNDROME 17, MTDPS17
26519,618568,ATP SYNTHASE C SUBUNIT LYSINE N-METHYLTRANSFERASE, ATPSCKMT
26520,618569,"NEURODEVELOPMENTAL DISORDER WITH ATAXIA, HYPOTONIA, AND MICROCEPHALY", NEDAHM
26521,618570,TRIPARTITE MOTIF-CONTAINING PROTEIN 71, TRIM71
26522,618571,"NEURODEVELOPMENTAL DISORDER WITH CATARACTS, POOR GROWTH, AND DYSMORPHIC FACIES", NDCAGF
26523,618572,NEURODEVELOPMENTAL DISORDER WITH CEREBELLAR HYPOPLASIA AND SPASTICITY, NEDCHS
26524,618573,"HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 7", CHNG7
26525,618574,DUAL-SPECIFICITY PHOSPHATASE DOMAIN- AND PROLINE ISOMERASE DOMAIN-CONTAINING PROTEIN 1, DUPD1
26526,618575,E2F1 mRNA STABILIZING LONG NONCODING RNA, EMSLR
26527,618576,ZINC FINGER- AND BTB DOMAIN-CONTAINING PROTEIN 10, ZBTB10
26528,618577,NEURODEVELOPMENTAL DISORDER WITH STRUCTURAL BRAIN ANOMALIES AND DYSMORPHIC FACIES, NEDBAF
26529,618578,CONGENITAL MYOPATHY 19, CMYO19
26530,618579,DISTAL MEMBRANE ARM ASSEMBLY COMPLEX 2-LIKE PROTEIN, DMAC2L
26531,618580,DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 80, DEE80
26532,618581,ANKYRIN REPEAT DOMAIN-CONTAINING PROTEIN 34B, ANKRD34B
26533,618582,"SOLUTE CARRIER FAMILY 10 (SODIUM/BILE ACID COTRANSPORTER FAMILY), MEMBER A5", SLC10A5
26534,618583,MITOCHONDRIAL TRANSCRIPTION RESCUE FACTOR 1, MTRES1
26535,618584,"NME/NM23 FAMILY, MEMBER 9", NME9
26536,618585,COILED-COIL DOMAIN-CONTAINING PROTEIN 51, CCDC51
26537,618586,WD REPEAT-CONTAINING PROTEIN 37, WDR37
26538,618587,"INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 60, WITH SEIZURES", MRD60
26539,618588,"PROTEIN DISULFIDE ISOMERASE-LIKE PROTEIN, TESTIS-EXPRESSED", PDILT
26540,618589,GASTROKINE 2, GKN2
26541,618590,"NEURODEVELOPMENTAL DISORDER WITH BRAIN ANOMALIES, SEIZURES, AND SCOLIOSIS", NEDBSS
26542,618591,"SHORT SLEEP, FAMILIAL NATURAL, 2", FNSS2
26543,618592,RING FINGER PROTEIN 217, RNF217
26544,618593,ZINC FINGER PROTEIN 398, ZNF398
26545,618594,"NEPHROTIC SYNDROME, TYPE 21", NPHS21
26546,618595,CYTOSKELETON-ASSOCIATED PROTEIN 4, CKAP4
26547,618596,"EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 16", EIG16
26548,618597,BRAIN-ENRICHED GUANYLATE KINASE-ASSOCIATED PROTEIN, BEGAIN
26549,618598,"SPASTIC TETRAPLEGIA AND AXIAL HYPOTONIA, PROGRESSIVE", STAHP
26550,618599,CADHERIN 24, CDH24
26551,618600,"CALCIUM-BINDING PROTEIN, SPERMATID-ASSOCIATED 1", CABS1
26552,618601,EXONUCLEASE 5, EXO5
26553,618602,ADAM METALLOPEPTIDASE DOMAIN-CONTAINING PROTEIN 32, ADAM32
26554,618603,NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA AND VARIABLE INTELLECTUAL AND BEHAVIORAL ABNORMALITIES, NEDHIB
26555,618604,SNIJDERS BLOK-FISHER SYNDROME, SNIBFIS
26556,618605,ANKYRIN REPEAT DOMAIN-CONTAINING PROTEIN 9, ANKRD9
26557,618606,"PONTOCEREBELLAR HYPOPLASIA, TYPE 13", PCH13
26558,618607,Yjef N-TERMINAL DOMAIN-CONTAINING PROTEIN 3, YJEFN3
26559,618608,"INTELLECTUAL DEVELOPMENTAL DISORDER WITH NASAL SPEECH, DYSMORPHIC FACIES, AND VARIABLE SKELETAL ANOMALIES", IDNADFS
26560,618609,"HemK METHYLTRANSFERASE FAMILY, MEMBER 1", HEMK1
26561,618610,HOMEOBOX-CONTAINING PROTEIN 1, HMBOX1
26562,618611,HOMOLOGOUS RECOMBINATION FACTOR WITH OB-FOLD, HROB
26563,618612,"LOWER URINARY TRACT OBSTRUCTION, CONGENITAL", LUTO
26564,618613,RETINITIS PIGMENTOSA 86, RP86
26565,618614,"CHIBBY FAMILY, MEMBER 2", CBY2
26566,618615,HEPATOCELLULAR CARCINOMA-UPREGULATED EZH2-ASSOCIATED LONG NONCODING RNA, HEIH
26567,618616,MITOGEN-ACTIVATED PROTEIN KINASE 15, MAPK15
26568,618617,ZINC FINGER HIT DOMAIN-CONTAINING PROTEIN 1, ZNHIT1
26569,618618,"SPONDYLOEPIPHYSEAL DYSPLASIA, NISHIMURA TYPE", SEDN
26570,618619,WEISS-KRUSZKA SYNDROME, WSKA
26571,618620,ABDOMINAL OBESITY-METABOLIC SYNDROME 4, AOMS4
26572,618621,ZINC FINGER DHHC-TYPE PALMITOYLTRANSFERASE 2, ZDHHC2
26573,618622,"NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, ARTHROGRYPOSIS, AND STRUCTURAL BRAIN ANOMALIES", NEDMABA
26574,618623,"HIG1 HYPOXIA-INDUCIBLE DOMAIN FAMILY, MEMBER 1A", HIGD1A
26575,618624,NOONAN SYNDROME 12, NS12
26576,618625,"ROTHMUND-THOMSON SYNDROME, TYPE 1", RTS1
26577,618626,PHOSPHORYLATED C-TERMINAL DOMAIN-INTERACTING FACTOR 1, PCIF1
26578,618627,"GERM CELL-LESS 1, SPERMATOGENESIS-ASSOCIATED", GMCL1
26579,618628,"METHYLTRANSFERASE 5, N6-ADENOSINE", METTL5
26580,618629,"GERM CELL-LESS 2, SPERMATOGENESIS ASSOCIATED", GMCL2
26581,618630,tRNA METHYLTRANSFERASE SUBUNIT 11-2, TRMT112
26582,618631,"NRDE2, NECESSARY FOR RNA INTERFERENCE, DOMAIN CONTAINING", NRDE2
26583,618632,"USHER SYNDROME, TYPE 1M", USH1M
26584,618633,"SOLUTE CARRIER FAMILY 5 (LOW-AFFINITY GLUCOSE COTRANSPORTER), MEMBER 4", SLC5A4
26585,618634,DELETED IN LYMPHOCYTIC LEUKEMIA 7, DLEU7
26586,618635,SIDDIQI SYNDROME, SIDDIS
26587,618636,"SOLUTE CARRIER FAMILY 5 (SODIUM/GLUCOSE COTRANSPORTER), MEMBER 10", SLC5A10
26588,618637,OCULOPHARYNGEAL MYOPATHY WITH LEUKOENCEPHALOPATHY 1, OPML1
26589,618638,HECT DOMAIN E3 UBIQUITIN PROTEIN LIGASE 3, HECTD3
26590,618639,NUTM2B ANTISENSE RNA 1, NUTM2BAS1
26591,618640,ZINC FINGER CCCH DOMAIN-CONTAINING PROTEIN 3, ZC3H3
26592,618641,INFANTILE LIVER FAILURE SYNDROME 3, ILFS3
26593,618642,SH3 DOMAIN-CONTAINING RING FINGER PROTEIN 1, SH3RF1
26594,618643,SPERMATOGENIC FAILURE 39, SPGF39
26595,618644,"OSTEOGENESIS IMPERFECTA, TYPE XX", OI20
26596,618645,PHD FINGER PROTEIN 12, PHF12
26597,618646,DIENCEPHALIC-MESENCEPHALIC JUNCTION DYSPLASIA SYNDROME 2, DMJDS2
26598,618647,C1q- AND TNF-RELATED PROTEIN 2, C1QTNF2
26599,618648,"IMMUNODEFICIENCY 65, SUSCEPTIBILITY TO VIRAL INFECTIONS", IMD65
26600,618649,HECT DOMAIN E3 UBIQUITIN PROTEIN LIGASE 1, HECTD1
26601,618650,RING FINGER PROTEIN 169, RNF169
26602,618651,HALPERIN-BIRK SYNDROME, HLBKS
26603,618652,NEUROOCULOCARDIOGENITOURINARY SYNDROME, NOCGUS
26604,618653,INTELLECTUAL DEVELOPMENTAL DISORDER WITH IMPAIRED LANGUAGE AND DYSMORPHIC FACIES, IDDILF
26605,618654,CONGENITAL MYOPATHY 8, CMYO8
26606,618655,"MYOPATHY, DISTAL, 6, ADULT-ONSET, AUTOSOMAL DOMINANT", MPD6
26607,618656,PROLINE- AND GLUTAMATE-RICH PROTEIN WITH COILED-COIL DOMAIN 1, PERCC1
26608,618657,La RIBONUCLEOPROTEIN 4, LARP4
26609,618658,ZIMMERMANN-LABAND SYNDROME 3, ZLS3
26610,618659,NEURODEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND DISTAL SKELETAL ANOMALIES, NEDDFSA
26611,618660,"ANEMIA, CONGENITAL, NONSPHEROCYTIC HEMOLYTIC, 10", CNSHA10
26612,618661,CILIA- AND FLAGELLA-ASSOCIATED PROTEIN 70, CFAP70
26613,618662,"DIARRHEA 11, MALABSORPTIVE, CONGENITAL", DIAR11
26614,618663,DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 81, DEE81
26615,618664,SPERMATOGENIC FAILURE 40, SPGF40
26616,618665,"INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 72", MRT72
26617,618666,SITOSTEROLEMIA 2, STSL2
26618,618667,"HYDROCEPHALUS, CONGENITAL, 4", HYC4
26619,618668,"GAMMA-AMINOBUTYRIC ACID RECEPTOR, RH0-3", GABRR3
26620,618669,YTH N6-METHYLADENOSINE RNA-BINDING PROTEIN 3, YTHDF3
26621,618670,SPERMATOGENIC FAILURE 41, SPGF41
26622,618671,ZINC FINGER DHHC DOMAIN-CONTAINING PALMITOYLTRANSFERASE 19, ZDHHC19
26623,618672,"INTELLECTUAL DEVELOPMENTAL DISORDER WITH SPEECH DELAY, AUTISM, AND DYSMORPHIC FACIES", IDDSADF
26624,618673,"ZYG11 FAMILY, MEMBER B, CELL CYCLE REGULATOR", ZYG11B
26625,618674,"PULMONARY FIBROSIS AND/OR BONE MARROW FAILURE SYNDROME, TELOMERE-RELATED, 5", PFBMFT5
26626,618675,"ZYG11 FAMILY, MEMBER A, CELL CYCLE REGULATOR", ZYG11A
26627,618676,ZINC FINGER- AND BTB DOMAIN-CONTAINING PROTEIN 43, ZBTB43
26628,618677,"CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 10", CDCBM10
26629,618678,CARBOXYLESTERASE 5A, CES5A
26630,618679,GDNF FAMILY RECEPTOR ALPHA-4, GFRA4
26631,618680,"PANCREATIC CANCER, SUSCEPTIBILITY TO, 5", PNCA5
26632,618681,LESSEL-KUBISCH SYNDROME, LSKB
26633,618682,CILIA- AND FLAGELLA-ASSOCIATED PROTEIN 276, CFAP276
26634,618683,"MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 6", MC5DN6
26635,618685,TRANSMEMBRANE PROTEIN 63A, TMEM63A
26636,618686,TEKTIN 5, TEKT5
26637,618687,INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE AND BEHAVIORAL ABNORMALITIES, IDDSSBA
26638,618688,"LEUKODYSTROPHY, HYPOMYELINATING, 19, TRANSIENT INFANTILE", HLD19
26639,618689,NETRIN G2, NTNG2
26640,618690,"PSORIASIS SUSCEPTIBILITY 1 CANDIDATE GENE 3, NONCODING", PSORS1C3
26641,618691,TRANSMEMBRANE PROTEIN 266, TMEM266
26642,618692,VESTIGIAL-LIKE FAMILY MEMBER 4, VGLL4
26643,618693,CHYMOTRYPSIN-LIKE ELASTASE 3A, CELA3A
26644,618694,CHYMOTRYPSIN-LIKE ELASTASE 3A, CELA3B
26645,618695,"CILIARY DYSKINESIA, PRIMARY, 42", CILD42
26646,618696,GOLGI-ASSOCIATED OLFACTORY SIGNALING REGULATOR, GFY
26647,618697,RETINITIS PIGMENTOSA 87 WITH CHOROIDAL INVOLVEMENT, RP87
26648,618698,DOUBLE HOMEOBOX B, DUXB
26649,618699,"CILIARY DYSKINESIA, PRIMARY, 43", CILD43
26650,618700,CYTOPLASMIC POLYADENYLATED HOMEOBOX-LIKE, CPHXL
26651,618701,LEUCINE TWENTY HOMEOBOX, LEUTX
26652,618702,SHORT STATURE AND MICROCEPHALY WITH GENITAL ANOMALIES, SSMGA
26653,618703,ZINC FINGER PROTEIN 281, ZNF281
26654,618704,CILIA- AND FLAGELLA-ASSOCIATED PROTEIN 221, CFAP221
26655,618705,MBT DOMAIN-CONTAINING PROTEIN 1, MBTD1
26656,618706,"HOXA CLUSTER ANTISENSE RNA 3, NONCODING", HOXAAS3
26657,618707,NEURODEVELOPMENTAL DISORDER WITH ABSENT LANGUAGE AND VARIABLE SEIZURES, NEDALVS
26658,618708,"NEIGHBOR OF BRCA1 GENE 2, NONCODING", NBR2
26659,618709,NEURODEVELOPMENTAL DISORDER WITH NONSPECIFIC BRAIN ABNORMALITIES AND WITH OR WITHOUT SEIZURES, NEDBAS
26660,618710,PARTNER OF NOB1, PNO1
26661,618711,METHYLTRANSFERASE-LIKE 15, METTL15
26662,618712,ANKYRIN REPEAT DOMAIN-CONTAINING PROTEIN 45, ANKRD45
26663,618713,CYSTIN 1, CYS1
26664,618714,RAP1 GTPase-ACTIVATING PROTEIN 2, RAP1GAP2
26665,618715,ZINC FINGER DHHC-TYPE PALMITOYLTRANSFERASE 6, ZDHHC6
26666,618716,AUTOPHAGY 16-LIKE 2, ATG16L2
26667,618717,EPITHELIAL MITOGEN, EPGN
26668,618718,"NEURODEVELOPMENTAL DISORDER WITH BEHAVIORAL ABNORMALITIES, ABSENT SPEECH, AND HYPOTONIA", NEDBASH
26669,618719,"MEGABLADDER, CONGENITAL", MGBL
26670,618720,"PEPTIDE DEFORMYLASE, MITOCHONDRIAL", PDF
26671,618721,DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 82, DEE82
26672,618722,"FAMILY WITH SEQUENCE SIMILARITY 210, MEMBER B", FAM210B
26673,618723,PREMATURE OVARIAN FAILURE 16, POF16
26674,618724,HEYN-SPROUL-JACKSON SYNDROME, HESJAS
26675,618725,INTELLECTUAL DEVELOPMENTAL DISORDER WITH BEHAVIORAL ABNORMALITIES AND CRANIOFACIAL DYSMORPHISM WITH OR WITHOUT SEIZURES, IDDBCS
26676,618726,NIMA-RELATED KINASE 10, NEK10
26677,618727,"ECTODERMAL DYSPLASIA WITH FACIAL DYSMORPHISM AND ACRAL, OCULAR, AND BRAIN ANOMALIES", EDFAOB
26678,618728,"SPONDYLOEPIMETAPHYSEAL DYSPLASIA, ISIDOR-TOUTAIN TYPE", SEMDIST
26679,618729,LIANG-WANG SYNDROME, LIWAS
26680,618730,"NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, CORTICAL MALFORMATIONS, AND SPASTICITY", NEDMCMS
26681,618731,NEURODEVELOPMENTAL DISORDER WITH BRAIN ANOMALIES AND WITH OR WITHOUT VERTEBRAL OR CARDIAC ANOMALIES, NEDBAVC
26682,618732,POIRIER-BIENVENU NEURODEVELOPMENTAL SYNDROME, POBINDS
26683,618733,NEUROMUSCULAR OCULOAUDITORY SYNDROME, NMOAS
26684,618734,"ANEURYSM, INTRACRANIAL BERRY, 12", ANIB12
26685,618735,TETRATRICOPEPTIDE REPEAT DOMAIN-CONTAINING PROTEIN 29, TTC29
26686,618736,STRUCTURAL BRAIN ANOMALIES WITH IMPAIRED INTELLECTUAL DEVELOPMENT AND CRANIOSYNOSTOSIS, BAIDCS
26687,618737,"CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 15", CDCBM15
26688,618738,TUBULIN TYROSINE LIGASE-LIKE 4, TTLL4
26689,618739,CTD SMALL PHOSPHATASE-LIKE PROTEIN 2, CTDSPL2
26690,618740,COILED-COIL DOMAIN-CONTAINING PROTEIN 154, CCDC154
26691,618741,"NEURODEVELOPMENTAL DISORDER WITH EPILEPSY, SPASTICITY, AND BRAIN ATROPHY", NEDESBA
26692,618742,ZINC FINGER- AND BTB DOMAIN-CONTAINING PROTEIN 8A, ZBTB8A
26693,618743,PHOSPHOLIPID PHOSPHATASE 7, PLPP7
26694,618744,DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 83, DEE83
26695,618745,SPERMATOGENIC FAILURE 42, SPGF42
26696,618746,CORTEXIN 3, CTXN3
26697,618747,CHROMOSOME 1 OPEN READING FRAME 61, C1ORF61
26698,618748,INTELLECTUAL DEVELOPMENTAL DISORDER WITH HYPOTONIA AND BEHAVIORAL ABNORMALITIES, IDDHBA
26699,618749,LEUCINE-RICH REPEAT-CONTAINING PROTEIN 17, LRRC17
26700,618750,ACTIVATOR OF BASAL TRANSCRIPTION 1, ABT1
26701,618751,SPERMATOGENIC FAILURE 43, SPGF43
26702,618752,"NEUTROPENIA, SEVERE CONGENITAL, 8, AUTOSOMAL DOMINANT", SCN8
26703,618753,LEUCINE-RICH REPEAT-CONTAINING PROTEIN 41, LRRC41
26704,618754,CARBOXYPEPTIDASE Q, CPQ
26705,618755,SHORT TRANSMEMBRANE MITOCHONDRIAL PROTEIN 1, STMP1
26706,618756,"ABHYDROLASE DOMAIN-CONTAINING PROTEIN 10, DEPALMITOYLASE", ABHD10
26707,618757,"CYTOCHROME b561 FAMILY, MEMBER A3", CYB561A3
26708,618758,DYNEIN REGULATORY COMPLEX SUBUNIT 3, DRC3
26709,618759,CALCIUM-BINDING PROTEIN 7, CABP7
26710,618760,NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA AND AUTISTIC FEATURES WITH OR WITHOUT HYPERKINETIC MOVEMENTS, NEDHAHM
26711,618761,CATIFA SYNDROME, CATIFA
26712,618762,2-PRIME-DEOXYNUCLEOSIDE 5-PRIME-PHOSPHATE N-HYDROLASE 1, DNPH1
26713,618763,JOUBERT SYNDROME 36, JBTS36
26714,618764,CDK2-ASSOCIATED CULLIN DOMAIN-CONTAINING PROTEIN 1, CACUL1
26715,618765,ESF1 NUCLEOLAR PRE-rRNA-PROCESSING PROTEIN, ESF1
26716,618766,"ARTHROGRYPOSIS MULTIPLEX CONGENITA 4, NEUROGENIC, WITH AGENESIS OF THE CORPUS CALLOSUM", AMC4
26717,618767,"CORNEAL DYSTROPHY, MEESMANN, 2", MECD2
26718,618768,"SPASTIC PARAPLEGIA 81, AUTOSOMAL RECESSIVE", SPG81
26719,618769,DYNEIN REGULATORY COMPLEX SUBUNIT 7, DRC7
26720,618770,"SPASTIC PARAPLEGIA 82, AUTOSOMAL RECESSIVE", SPG82
26721,618771,ABHYDROLASE DOMAIN-CONTAINING PROTEIN 14A, ABHD14A
26722,618772,CDK5 AND ABL ENZYME SUBSTRATE 2, CABLES2
26723,618773,LYMPHATIC MALFORMATION 8, LMPHM8
26724,618774,CEBALID SYNDROME, CEBALID
26725,618775,"MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 10", MC3DN10
26726,618776,"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 34", MC1DN34
26727,618777,CALPAIN 8, CAPN8
26728,618778,"DEAFNESS, AUTOSOMAL DOMINANT 75", DFNA75
26729,618779,COFFIN-SIRIS SYNDROME 11, CSS11
26730,618780,"CONGENITAL HEART DEFECTS, MULTIPLE TYPES, 7", CHTD7
26731,618781,"CILIARY DYSKINESIA, PRIMARY, 44", CILD44
26732,618782,LONG QT SYNDROME 16, LQT16
26733,618783,CYCLIN I, CCNI
26734,618784,PITH DOMAIN-CONTAINING PROTEIN 1, PITHD1
26735,618785,CELL DIVISION CYCLE-ASSOCIATED PROTEIN 2, CDCA2
26736,618786,IMAGAWA-MATSUMOTO SYNDROME, IMMAS
26737,618787,"DEAFNESS, AUTOSOMAL DOMINANT 76", DFNA76
26738,618788,COILED-COIL DOMAIN-CONTAINING PROTEIN 134, CCDC134
26739,618789,CDV3 HOMOLOG, CDV3
26740,618790,POTASSIUM CHANNEL TETRAMERIZATION DOMAIN-CONTAINING PROTEIN 21, KCTD21
26741,618791,POTASSIUM CHANNEL TETRAMERIZATION DOMAIN-CONTAINING PROTEIN 6, KCTD6
26742,618792,DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 84, DEE84
26743,618793,"INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 62", MRD62
26744,618794,KELCH REPEAT- AND BTB/POZ DOMAIN-CONTAINING PROTEIN 11, KBTBD11
26745,618795,JUVENILE ARTHRITIS, JUVAR
26746,618796,SAC3 DOMAIN-CONTAINING PROTEIN 1, SAC3D1
26747,618797,"NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, NEONATAL RESPIRATORY INSUFFICIENCY, AND THERMODYSREGULATION", NEDHRIT
26748,618798,BECK-FAHRNER SYNDROME, BEFAHRS
26749,618799,CALCYPHOSINE-LIKE PROTEIN, CAPSL
26750,618800,"SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 28", SCAR28
26751,618801,"CILIARY DYSKINESIA, PRIMARY, 45", CILD45
26752,618802,tRNA-HISTIDINE GUANYLYLTRANSFERASE 1-LIKE PROTEIN, THG1L
26753,618803,"RESPIRATORY PAPILLOMATOSIS, JUVENILE RECURRENT, CONGENITAL", JRRP
26754,618804,SANDESTIG-STEFANOVA SYNDROME, SANDSTEF
26755,618805,TRIOKINASE AND FMN CYCLASE DEFICIENCY SYNDROME, TKFCD
26756,618806,"T-CELL LYMPHOPENIA, INFANTILE, WITH OR WITHOUT NAIL DYSTROPHY, AUTOSOMAL DOMINANT", TLIND
26757,618807,LIPOPROTEIN(a) QUANTITATIVE TRAIT LOCUS, LPAQTL
26758,618808,INTELLECTUAL DEVELOPMENTAL DISORDER WITH POOR GROWTH AND WITH OR WITHOUT SEIZURES OR ATAXIA, IDPOGSA
26759,618809,PIGB OPPOSITE STRAND 1, PIGBOS1
26760,618810,"PONTOCEREBELLAR HYPOPLASIA, HYPOTONIA, AND RESPIRATORY INSUFFICIENCY SYNDROME, NEONATAL LETHAL", PHRINL
26761,618811,MITOCHONDRIAL DNA DEPLETION SYNDROME 18, MTDPS18
26762,618812,UBIQUINOL-CYTOCHROME C REDUCTASE COMPLEX ASSEMBLY FACTOR 6, UQCC6
26763,618813,TUBULIN TYROSINE LIGASE-LIKE 7, TTLL7
26764,618814,KILLER CELL LECTIN-LIKE RECEPTOR F2, KLRF2
26765,618815,"CHROMOSOME 1p36.33 DUPLICATION SYNDROME, ATAD3 GENE CLUSTER, AUTOSOMAL DOMINANT",
26766,618816,CDY-LIKE PROTEIN 2, CDYL2
26767,618817,TRANSMEMBRANE PROTEIN 11, TMEM11
26768,618818,HOST CELL FACTOR C1 REGULATOR 1, HCFC1R1
26769,618819,PBX HOMEOBOX-INTERACTING PROTEIN 1, PBXIP1
26770,618820,GENITOURINARY AND/OR BRAIN MALFORMATION SYNDROME, GUBS
26771,618821,RHIZOMELIC LIMB SHORTENING WITH DYSMORPHIC FEATURES, RLSDF
26772,618822,CONGENITAL MYOPATHY 9A, CMYO9A
26773,618823,"CONGENITAL MYOPATHY 9B, PROXIMAL, WITH MINICORE LESIONS", CMYO9B
26774,618824,"BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 8, AUTOSOMAL RECESSIVE", IBGC8
26775,618825,"INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 63, WITH MACROCEPHALY", MRD63
26776,618826,RETINITIS PIGMENTOSA 88, RP88
26777,618827,"MYOPIA 27, AUTOSOMAL DOMINANT", MYP27
26778,618828,"NABAIS SA-DE VRIES SYNDROME, TYPE 1", NSDVS1
26779,618829,"NABAIS SA-DE VRIES SYNDROME, TYPE 2", NSDVS2
26780,618830,"AUTISM, SUSCEPTIBILITY TO, 20", AUTS20
26781,618831,TRANSMEMBRANE PROTEIN 37, TMEM37
26782,618832,"EPILEPSY, EARLY-ONSET, 2, WITH OR WITHOUT DEVELOPMENTAL DELAY", EPEO2
26783,618833,"RAL GTPase-ACTIVATING PROTEIN, NONCATALYTIC SUBUNIT BETA", RALGAPB
26784,618834,"LATE ENDOSOMAL/LYSOSOMAL ADAPTOR, MITOGEN-ACTIVATED PROTEIN KINASE AND MAMMALIAN TARGET OF RAPAMYCIN ACTIVATOR 4", LAMTOR4
26785,618835,COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 40, COXPD40
26786,618836,"RAL GTPase-ACTIVATING PROTEIN, CATALYTIC SUBUNIT ALPHA-2", RALGAPA2
26787,618837,"LYSOSOME-ASSOCIATED PROTEIN, TRANSMEMBRANE 4, ALPHA", LAPTM4A
26788,618838,COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 41, COXPD41
26789,618839,COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 42, COXPD42
26790,618840,ALOPECIA-INTELLECTUAL DISABILITY SYNDROME 4, APMR4
26791,618841,HYPOGONADOTROPIC HYPOGONADISM 25 WITH ANOSMIA, HH25
26792,618842,HORMA DOMAIN-CONTAINING PROTEIN 2, HORMAD2
26793,618843,LAYILIN, LAYN
26794,618844,L3MBTL HISTONE METHYL-LYSINE-BINDING PROTEIN 3, L3MBTL3
26795,618845,"VERTEBRAL, CARDIAC, RENAL, AND LIMB DEFECTS SYNDROME 3", VCRL3
26796,618846,DIETS-JONGMANS SYNDROME, DIJOS
26797,618847,IMMUNODEFICIENCY 66, IMD66
26798,618848,"MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 26", LGMDR26
26799,618849,BONE MARROW FAILURE SYNDROME 6, BMFS6
26800,618850,HYPERVALINEMIA AND HYPERLEUCINE-ISOLEUCINEMIA, HVLI
26801,618851,COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 43, COXPD43
26802,618852,AUTOINFLAMMATION WITH EPISODIC FEVER AND LYMPHADENOPATHY, AIEFL
26803,618853,ANAUXETIC DYSPLASIA 3, ANXD3
26804,618854,"SIGNAL PEPTIDASE COMPLEX, SUBUNIT 3", SPCS3
26805,618855,COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 44, COXPD44
26806,618856,"DIABETES MELLITUS, PERMANENT NEONATAL, 2", PNDM2
26807,618857,"DIABETES MELLITUS, PERMANENT NEONATAL, 3", PNDM3
26808,618858,"DIABETES MELLITUS, PERMANENT NEONATAL, 4", PNDM4
26809,618859,NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT AUTISTIC FEATURES AND/OR STRUCTURAL BRAIN ABNORMALITIES, NEDASB
26810,618860,CHROMOSOME 1 OPEN READING FRAME 87, C1ORF87
26811,618861,"IGLON FAMILY, MEMBER 5", IGLON5
26812,618862,"NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, MICROCEPHALY, AND SEIZURES", NEDHYMS
26813,618863,RETINAL DYSTROPHY WITH LEUKODYSTROPHY, RDLKD
26814,618864,"CHROMOSOME 19 OPEN READING FRAME 48, PSEUDOGENE", C19ORF48P
26815,618865,CEP85-LIKE PROTEIN, CEP85L
26816,618866,"TREMOR, HEREDITARY ESSENTIAL, 6", ETM6
26817,618867,"RAS HOMOLOG GENE FAMILY, MEMBER F, FILOPODIA-ASSOCIATED", RHOF
26818,618868,"NEURODEGENERATION, CHILDHOOD-ONSET, WITH ATAXIA, TREMOR, OPTIC ATROPHY, AND COGNITIVE DECLINE", CONATOC
26819,618869,RING FINGER PROTEIN 144B, RNF144B
26820,618870,"SKELETAL DYSPLASIA, MILD, WITH JOINT LAXITY AND ADVANCED BONE AGE", SDJLABA
26821,618871,RHO GUANINE NUCLEOTIDE EXCHANGE FACTOR 16, ARHGEF16
26822,618872,NIZON-ISIDOR SYNDROME, NIZIDS
26823,618873,LISSENCEPHALY 10, LIS10
26824,618874,"CHROMOSOME 17q11.2 DUPLICATION SYNDROME, 1.4-MB",
26825,618875,"SEIZURES, EARLY-ONSET, WITH NEURODEGENERATION AND BRAIN CALCIFICATIONS", SENEBAC
26826,618876,"EPILEPSY, PROGRESSIVE MYOCLONIC, 11", EPM11
26827,618877,"LEUKOENCEPHALOPATHY, DEVELOPMENTAL DELAY, AND EPISODIC NEUROLOGIC REGRESSION SYNDROME", LEUDEN
26828,618878,"LEUKOENCEPHALOPATHY, MOTOR DELAY, SPASTICITY, AND DYSARTHRIA SYNDROME", LEMSPAD
26829,618879,"NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA AND CEREBELLAR ATROPHY, WITH OR WITHOUT SEIZURES", NEDHCAS
26830,618880,"GLAUCOMA, PRIMARY CLOSED-ANGLE", GLCC
26831,618881,GALACTOSEMIA IV, GALAC4
26832,618882,IMERSLUND-GRASBECK SYNDROME 2, IGS2
26833,618883,"HYPOPARATHYROIDISM, FAMILIAL ISOLATED, 2", FIH2
26834,618884,"PROTEINURIA, CHRONIC BENIGN", PROCHOB
26835,618885,"CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIt", CDG2T
26836,618886,PSEUDO-TORCH SYNDROME 3, PTORCH3
26837,618887,"NUCLEAR FACTOR KAPPA-B INHIBITOR, DELTA", NFKBID
26838,618888,"CAS SCAFFOLD PROTEIN FAMILY, MEMBER 4", CASS4
26839,618889,LIBERFARB SYNDROME, LIBF
26840,618890,NEURODEVELOPMENTAL DISORDER AND STRUCTURAL BRAIN ANOMALIES WITH OR WITHOUT SEIZURES AND SPASTICITY, NEDBASS
26841,618891,"MICROCEPHALY, DEVELOPMENTAL DELAY, AND BRITTLE HAIR SYNDROME", MDBH
26842,618892,HARDEROPORPHYRIA, HARPO
26843,618893,NUCLEOLAR PROTEIN 4-LIKE, NOL4L
26844,618894,REACTIVE OXYGEN SPECIES MODULATOR 1, ROMO1
26845,618895,"IZUMO FAMILY, MEMBER 2", IZUMO2
26846,618896,"IZUMO FAMILY, MEMBER 3", IZUMO3
26847,618897,"IZUMO FAMILY, MEMBER 4", IZUMO4
26848,618898,"CENTROSOMAL PROTEIN, 85-KD", CEP85
26849,618899,"MANNOSIDASE, ALPHA, CLASS 2B, MEMBER 2", MAN2B2
26850,618900,ZINC FINGER CW-TYPE DOMAIN- AND PWWP DOMAIN-CONTAINING PROTEIN 1, ZCWPW1
26851,618901,"46,XX SEX REVERSAL 5", SRXX5
26852,618902,"METHYLTRANSFERASE 2A, METHYLCYTIDINE", METTL2A
26853,618903,"METHYLTRANSFERASE 6, METHYLCYTIDINE", METTL6
26854,618904,DALR ANTICODON-BINDING DOMAIN-CONTAINING PROTEIN 3, DALRD3
26855,618905,SILVER-RUSSELL SYNDROME 2, SRS2
26856,618906,"INTELLECTUAL DEVELOPMENTAL DISORDER WITH AUTISTIC FEATURES AND LANGUAGE DELAY, WITH OR WITHOUT SEIZURES", IDDALDS
26857,618907,SILVER-RUSSELL SYNDROME 4, SRS4
26858,618908,SILVER-RUSSELL SYNDROME 5, SRS5
26859,618909,ILK-ASSOCIATED SERINE/THREONINE PHOSPHATASE, ILKAP
26860,618910,DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 86, DEE86
26861,618911,CHROMOSOME 16 OPEN READING FRAME 92, C16ORF92
26862,618912,"NEURONOPATHY, DISTAL HEREDITARY MOTOR, AUTOSOMAL RECESSIVE 8", HMNR8
26863,618913,FANCONI RENOTUBULAR SYNDROME 5, FRTS5
26864,618914,"NEURODEVELOPMENTAL, JAW, EYE, AND DIGITAL SYNDROME", NEDJED
26865,618915,"DEAFNESS, AUTOSOMAL DOMINANT 77", DFNA77
26866,618916,DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 87, DEE87
26867,618917,NEURODEVELOPMENTAL DISORDER WITH LANGUAGE IMPAIRMENT AND BEHAVIORAL ABNORMALITIES, NEDLIB
26868,618918,PERIVENTRICULAR NODULAR HETEROTOPIA 9, PVNH9
26869,618919,"KELCH-LIKE FAMILY, MEMBER 42", KLHL42
26870,618920,"ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 14", ARVD14
26871,618921,"LACTAMASE, BETA-2", LACTB2
26872,618922,"NEURODEVELOPMENTAL DISORDER WITH SEIZURES, HYPOTONIA, AND BRAIN IMAGING ABNORMALITIES", NEDSHBA
26873,618923,FATTY ACID-BINDING PROTEIN 12, FABP12
26874,618924,"EPISODIC ATAXIA, TYPE 9", EA9
26875,618925,G PROTEIN-COUPLED RECEPTOR 171, GPR171
26876,618926,OSTEOMODULIN, OMD
26877,618927,KERATIN-ASSOCIATED PROTEIN 24-1, KRTAP24-1
26878,618928,LACTATE DEHYDROGENASE A-LIKE PROTEIN 6A, LDHAL6A
26879,618929,"AGENESIS OF CORPUS CALLOSUM, CARDIAC, OCULAR, AND GENITAL SYNDROME", ACOGS
26880,618930,ANKYRIN REPEAT DOMAIN-CONTAINING PROTEIN 18B, ANKRD18B
26881,618931,ZINC FINGER NFX1-TYPE DOMAIN-CONTAINING PROTEIN 1, ZNFX1
26882,618932,"OLIGOSACCHARYLTRANSFERASE COMPLEX, SUBUNIT 4, NONCATALYTIC", OST4
26883,618933,SH3 DOMAIN-CONTAINING RING FINGER PROTEIN 3, SH3RF3
26884,618934,COILED-COIL SERINE-RICH PROTEIN 1, CCSER1
26885,618935,"GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, 5", CGD5
26886,618936,SPERMATOGENESIS-ASSOCIATED PROTEIN 25, SPATA25
26887,618937,"PROTEIN PHOSPHATASE 1, REGULATORY SUBUNIT 35", PPP1R35
26888,618938,LONG NONCODING RNA ASSOCIATED WITH SART3 REGULATION OF SPLICING, LASTR
26889,618939,TREACHER COLLINS SYNDROME 4, TCS4
26890,618940,OCULOPHARYNGODISTAL MYOPATHY 2, OPDM2
26891,618941,COILED-COIL DOMAIN-CONTAINING PROTEIN 32, CCDC32
26892,618942,IQ MOTIF- AND ANKYRIN REPEAT-CONTAINING PROTEIN 1, IQANK1
26893,618943,"SMALL NUCLEOLAR RNA, C/D BOX, 8", SNORD8
26894,618944,"HYPER-IgE SYNDROME 5, AUTOSOMAL RECESSIVE, WITH RECURRENT INFECTIONS", HIES5
26895,618945,SPERM ACROSOME-ASSOCIATED PROTEIN 6, SPACA6
26896,618946,LLLL MOTIF- AND CFNLAS MOTIF-CONTAINING PROTEIN 1, LLCFC1
26897,618947,ARTHROGRYPOSIS MULTIPLEX CONGENITA 5, AMC5
26898,618948,"HETEROTAXY, VISCERAL, 9, AUTOSOMAL, WITH MALE INFERTILITY", HTX9
26899,618949,"RIBOSOMAL MODIFICATION PROTEIN RimK-LIKE FAMILY, MEMBER A", RIMKLA
26900,618950,SULEIMAN-EL-HATTAB SYNDROME, SULEHS
26901,618951,COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 45, COXPD45
26902,618952,COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 46, COXPD46
26903,618953,"CYTOCHROME P450, FAMILY 4, SUBFAMILY Z, MEMBER 1", CYP4Z1
26904,618954,"CYTOCHROME P450, FAMILY 4, SUBFAMILY Z, MEMBER 2, PSEUDOGENE", CYP4Z2P
26905,618955,RETINITIS PIGMENTOSA 89, RP89
26906,618956,RHEB-LIKE PROTEIN 1, RHEBL1
26907,618957,ANKYRIN REPEAT DOMAIN-CONTAINING PROTEIN 27, ANKRD27
26908,618958,COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 47, COXPD47
26909,618959,DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 88, DEE88
26910,618960,MITCHELL SYNDROME, MITCH
26911,618961,SPONDYLOMETAPHYSEAL DYSPLASIA WITH CORNEAL DYSTROPHY, SMDCD
26912,618962,OVOCHYMASE 2, OVCH2
26913,618963,IMMUNODEFICIENCY 69, IMD69
26914,618964,REQUIRED FOR MEIOTIC NUCLEAR DIVISION 5 HOMOLOG A, RMND5A
26915,618965,"TRANSMEMBRANE PROTEIN 9 SUPERFAMILY, MEMBER 1", TM9SF1
26916,618966,TRANSMEMBRANE PROTEIN 161A, TMEM161A
26917,618967,"ATP-BINDING CASSETTE, SUBFAMILY F, MEMBER 3", ABCF3
26918,618968,CHROMOSOME 1 OPEN READING FRAME 146, C1ORF146
26919,618969,IMMUNODEFICIENCY 70, IMD70
26920,618970,"CONE-ROD SYNAPTIC DISORDER SYNDROME, CONGENITAL NONPROGRESSIVE", CRSDS
26921,618971,TOLCHIN-LE CAIGNEC SYNDROME, TOLCAS
26922,618972,MITOCHONDRIAL DNA DEPLETION SYNDROME 19, MTDPS19
26923,618973,SODIUM-DEPENDENT MULTIVITAMIN TRANSPORTER DEFICIENCY, SMVTD
26924,618974,LI-GHORBANI-WEISZ-HUBSHMAN SYNDROME, LIGOWS
26925,618975,CONGENITAL MYOPATHY 17, CMYO17
26926,618976,"MYOCARDIN-INDUCED SMOOTH MUSCLE LONG NONCODING RNA, INDUCER OF DIFFERENTIATION", MYOSLID
26927,618977,OPTIC ATROPHY 12, OPA12
26928,618978,TRANSMEMBRANE PROTEIN 163, TMEM163
26929,618979,HIGH DENSITY LIPOPROTEIN CHOLESTEROL LEVEL QUANTITATIVE TRAIT LOCUS 7, HDLCQ7
26930,618980,"CENTROSOMAL PROTEIN, 112-KD", CEP112
26931,618981,VPS35 ENDOSOMAL PROTEIN-SORTING FACTOR-LIKE, VPS35L
26932,618982,IMMUNODEFICIENCY 72 WITH AUTOINFLAMMATION AND LYMPHOPROLIFERATION, IMD72
26933,618983,"BLOOD GROUP, LEWIS SYSTEM", LE
26934,618984,SAD1 AND UNC84 DOMAIN-CONTAINING PROTEIN 3, SUN3
26935,618985,"GROWTH HORMONE INSENSITIVITY SYNDROME WITH IMMUNE DYSREGULATION 2, AUTOSOMAL DOMINANT", GHISID2
26936,618986,IMMUNODEFICIENCY 73B WITH DEFECTIVE NEUTROPHIL CHEMOTAXIS AND LYMPHOPENIA, IMD73B
26937,618987,IMMUNODEFICIENCY 73C WITH DEFECTIVE NEUTROPHIL CHEMOTAXIS AND HYPOGAMMAGLOBULINEMIA, IMD73C
26938,618988,CLARIN 2, CLRN2
26939,618989,TRANSMEMBRANE PROTEIN 119, TMEM119
26940,618990,"EVA1 HOMOLOG A, REGULATOR OF PROGRAMMED CELL DEATH", EVA1A
26941,618991,SEMAPHORIN 4G, SEMA4G
26942,618992,"MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH IMPAIRED INTELLECTUAL DEVELOPMENT), TYPE B, 15", MDDGB15
26943,618993,RING FINGER PROTEIN 208, RNF208
26944,618994,4-HYDROXYPHENYLPYRUVATE DIOXYGENASE-LIKE, HPDL
26945,618995,BPES CANDIDATE GENE 1, BPESC1
26946,618996,LEUCINE-RICH REPEAT-CONTAINING PROTEIN 3B, LRRC3B
26947,618997,CYTIDINE AND DEOXYCYTIDYLATE DEAMINASE DOMAIN-CONTAINING PROTEIN 1, CDADC1
26948,618998,IMMUNE DYSREGULATION AND SYSTEMIC HYPERINFLAMMATION SYNDROME, IMDYSHI
26949,618999,"AUTOINFLAMMATION, IMMUNE DYSREGULATION, AND EOSINOPHILIA", AIIDE
26950,619000,INTELLECTUAL DEVELOPMENTAL DISORDER WITH SEIZURES AND LANGUAGE DELAY, IDDSELD
26951,619001,ANGEL HOMOLOG 2, ANGEL2
26952,619002,LEUCINE-RICH REPEAT-CONTAINING PROTEIN 18, LRRC18
26953,619003,"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 35", MC1DN35
26954,619004,DEEAH SYNDROME, DEEAH
26955,619005,"NEURODEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES, IMPAIRED SPEECH, AND HYPOTONIA", NEDDISH
26956,619006,BASIC IMMUNOGLOBULIN-LIKE VARIABLE MOTIF-CONTAINING PROTEIN, BIVM
26957,619007,RETINITIS PIGMENTOSA 90, RP90
26958,619008,LONG INTERGENIC NONCODING RNA 598, LINC00598
26959,619009,OOCYTE/ZYGOTE/EMBRYO MATURATION ARREST 8, OZEMA8
26960,619010,ATXN7-LIKE 3, ATXN7L3
26961,619011,OOCYTE/ZYGOTE/EMBRYO MATURATION ARREST 9, OZEMA9
26962,619012,COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 48, COXPD48
26963,619013,RAJAB INTERSTITIAL LUNG DISEASE WITH BRAIN CALCIFICATIONS 2, RILDBC2
26964,619014,TETRATRICOPEPTIDE REPEAT DOMAIN-CONTAINING PROTEIN 5, TTC5
26965,619015,ENY2 TRANSCRIPTION AND EXPORT COMPLEX 2 SUBUNIT, ENY2
26966,619016,IFAP SYNDROME 2, IFAP2
26967,619017,RHOMBOID-LIKE 3, RHBDL3
26968,619018,MICRO RNA 30B, MIR30B
26969,619019,MICRO RNA 30D, MIR30D
26970,619020,LRP2-BINDING PROTEIN, LRP2BP
26971,619021,ANKYRIN REPEAT DOMAIN-CONTAINING PROTEIN 37, ANKRD37
26972,619022,TRANSMEMBRANE PROTEIN 229B, TMEM229B
26973,619023,"OLIGOSACCHARYLTRANSFERASE COMPLEX, NONCATALYTIC SUBUNIT", OSTC
26974,619024,COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 49, COXPD49
26975,619025,COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 50, COXPD50
26976,619026,NEURODEVELOPMENTAL DISORDER WITH PROGRESSIVE SPASTICITY AND BRAIN WHITE MATTER ABNORMALITIES, NEDSWMA
26977,619027,"SPASTIC PARAPLEGIA 83, AUTOSOMAL RECESSIVE", SPG83
26978,619028,"COENZYME Q10 DEFICIENCY, PRIMARY, 9", COQ10D9
26979,619029,KERATINOCYTE-ASSOCIATED PROTEIN 2, KRTCAP2
26980,619030,SKELETAL MUSCLE GLYCOGEN CONTENT AND METABOLISM QUANTITATIVE TRAIT LOCUS, SMGMQTL
26981,619031,"INTELLECTUAL DEVELOPMENTAL DISORDER WITH EPILEPSY, BEHAVIORAL ABNORMALITIES, AND COARSE FACIES", IDDEBF
26982,619032,RETICULOCALBIN 3, RCN3
26983,619033,VISSERS-BODMER SYNDROME, VIBOS
26984,619034,"RNA-BINDING PROTEIN, mRNA-PROCESSING FACTOR, 2", RBPMS2
26985,619035,MICRO RNA 29B2, MIR29B2
26986,619036,"MYOPATHY, EPILEPSY, AND PROGRESSIVE CEREBRAL ATROPHY", MEPCA
26987,619037,LEUCINE-RICH REPEAT-CONTAINING PROTEIN 34, LRRC34
26988,619038,SPOC DOMAIN-CONTAINING PROTEIN 1, SPOCD1
26989,619039,REPLICATION INITIATOR 1, REPIN1
26990,619040,MYOFIBRILLAR MYOPATHY 10, MFM10
26991,619041,MONOSOMY 7 MYELODYSPLASIA AND LEUKEMIA SYNDROME 2, M7MLS2
26992,619042,"SPINAL MUSCULAR ATROPHY, INFANTILE, JAMES TYPE", SMAJI
26993,619043,INOSITOL-PENTAKISPHOSPHATE 2-KINASE, IPPK
26994,619044,SPERMATOGENIC FAILURE 44, SPGF44
26995,619045,SERINE HYDROLASE-LIKE 2, SERHL2
26996,619046,"MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 3", MC4DN3
26997,619047,"PROTEIN PHOSPHATASE 1, REGULATORY SUBUNIT 32", PPP1R32
26998,619048,"MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 4", MC4DN4
26999,619049,TESTIS DEVELOPMENT-RELATED PROTEIN, TDRP
27000,619050,3-HYDROXY-3-METHYLGLUTARYL-CoA LYASE-LIKE PROTEIN 1, HMGCLL1
27001,619051,"MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 7", MC4DN7
27002,619052,"MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 8", MC4DN8
27003,619053,"MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 10", MC4DN10
27004,619054,"MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 11", MC4DN11
27005,619055,"MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 12", MC4DN12
27006,619056,NEURODEVELOPMENTAL DISORDER WITH SPEECH IMPAIRMENT AND DYSMORPHIC FACIES, NEDSID
27007,619057,COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 51, COXPD51
27008,619058,"MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 14", MC4DN14
27009,619059,"MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 15", MC4DN15
27010,619060,"MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 16", MC4DN16
27011,619061,"MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 17", MC4DN17
27012,619062,"MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 18", MC4DN18
27013,619063,"MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 19", MC4DN19
27014,619064,"MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 20", MC4DN20
27015,619065,"MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 21", MC4DN21
27016,619066,ZINC FINGER PROTEIN 532, ZNF532
27017,619067,HYDROXYSTEROID DEHYDROGENASE-LIKE PROTEIN 1, HSDL1
27018,619068,LEUCINE-RICH REPEAT-CONTAINING PROTEIN 19, LRRC19
27019,619069,TERMINAL NUCLEOTIDYLTRANSFERASE 5B, TENT5B
27020,619070,LETM1 DOMAIN-CONTAINING PROTEIN 1, LETMD1
27021,619071,"LEUKODYSTROPHY, HYPOMYELINATING, 20", HLD20
27022,619072,NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND BRAIN ATROPHY, NEDSEBA
27023,619073,"VITAMIN D-DEPENDENT RICKETS, TYPE 3", VDDR3
27024,619074,"CLEFT PALATE, PROLIFERATIVE RETINOPATHY, AND DEVELOPMENTAL DELAY", CPPRDD
27025,619075,BACHMANN-BUPP SYNDROME, BABS
27026,619076,"NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, SEIZURES, AND BRAIN ATROPHY", NEDMISB
27027,619077,HEAT-SHOCK PROTEIN FAMILY A (HSP70) MEMBER 4-LIKE PROTEIN, HSPA4L
27028,619078,"KELCH-LIKE FAMILY, MEMBER 11", KLHL11
27029,619079,INFLAMMATORY BOWEL DISEASE (CROHN DISEASE) 30, IBD30
27030,619080,KILQUIST SYNDROME, KILQS
27031,619081,"DEAFNESS, AUTOSOMAL DOMINANT 78", DFNA78
27032,619082,"MICROCORNEA, ROD-CONE DYSTROPHY, CATARACT, AND POSTERIOR STAPHYLOMA 1", MRCS1
27033,619083,DELPIRE-MCNEILL SYNDROME, DELMNES
27034,619084,TIGGER TRANSPOSABLE ELEMENT-DERIVED GENE 3, TIGD3
27035,619085,PROGENITOR RENEWAL-ASSOCIATED NONCODING RNA, PRANCR
27036,619086,"DEAFNESS, AUTOSOMAL DOMINANT 79", DFNA79
27037,619087,NOONAN SYNDROME 13, NS13
27038,619088,"NUCLEAR GTPase, GERMINAL CENTER-ASSOCIATED", NUGGC
27039,619089,"GIPC PDZ DOMAIN-CONTAINING FAMILY, MEMBER 2", GIPC2
27040,619090,"DEVELOPMENTAL DELAY, IMPAIRED GROWTH, DYSMORPHIC FACIES, AND AXONAL NEUROPATHY", DIGFAN
27041,619091,"NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, IMPAIRED LANGUAGE, AND GAIT ABNORMALITIES", NEDMILG
27042,619092,"NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, IMPAIRED LANGUAGE, EPILEPSY, AND GAIT ABNORMALITIES", NEDMILEG
27043,619093,"DEAFNESS, AUTOSOMAL RECESSIVE 116", DFNB116
27044,619094,SPERMATOGENIC FAILURE 45, SPGF45
27045,619095,SPERMATOGENIC FAILURE 46, SPGF46
27046,619096,MISMATCH REPAIR CANCER SYNDROME 2, MMRCS2
27047,619097,MISMATCH REPAIR CANCER SYNDROME 3, MMRCS3
27048,619098,MEIOSIS 1-ASSOCIATED PROTEIN, M1AP
27049,619099,INTELLECTUAL DEVELOPMENTAL DISORDER WITH SPEECH DELAY AND AXONAL PERIPHERAL NEUROPATHY, IDDSAPN
27050,619100,COILED-COIL DOMAIN-CONTAINING PROTEIN 25, CCDC25
27051,619101,MISMATCH REPAIR CANCER SYNDROME 4, MMRCS4
27052,619102,SPERMATOGENIC FAILURE 47, SPGF47
27053,619103,"NEURODEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES, SLEEP DISTURBANCE, AND BRAIN ABNORMALITIES", NEDFASB
27054,619104,RNA-BINDING MOTIF PROTEIN 47, RBM47
27055,619105,MICRO RNA 30E, MIR30E
27056,619106,"PRRT3 ANTISENSE RNA 1, NONCODING", PRRT3AS1
27057,619107,SORTING NEXIN 33, SNX33
27058,619108,SPERMATOGENIC FAILURE 48, SPGF48
27059,619109,"YIP1-INTERACTING FACTOR HOMOLOG B, MEMBRANE-TRAFFICKING PROTEIN", YIF1B
27060,619110,"ARTHROGRYPOSIS, DISTAL, TYPE 1C", DA1C
27061,619111,COACH SYNDROME 2, COACH2
27062,619112,"NEURONOPATHY, DISTAL HEREDITARY MOTOR, AUTOSOMAL DOMINANT 13", HMND13
27063,619113,COACH SYNDROME 3, COACH3
27064,619114,SET AND MYND DOMAIN-CONTAINING PROTEIN 5, SMYD5
27065,619115,COMBINED OSTEOGENESIS IMPERFECTA AND EHLERS-DANLOS SYNDROME 1, OIEDS1
27066,619116,"SOLUTE CARRIER FAMILY 39 (ZINC TRANSPORTER), MEMBER 9", SLC39A9
27067,619117,ADP-RIBOSYLATION FACTOR-LIKE GTPase 16, ARL16
27068,619118,ATPase 13A1, ATP13A1
27069,619119,ATPase 13A5, ATP13A5
27070,619120,COMBINED OSTEOGENESIS IMPERFECTA AND EHLERS-DANLOS SYNDROME 2, OIEDS2
27071,619121,"NEURODEVELOPMENTAL DISORDER WITH CARDIOMYOPATHY, SPASTICITY, AND BRAIN ABNORMALITIES", NEDCASB
27072,619122,VERTEBRAL HYPERSEGMENTATION AND OROFACIAL ANOMALIES, VHO
27073,619123,CARDIOFACIONEURODEVELOPMENTAL SYNDROME, CFNDS
27074,619124,DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 89, DEE89
27075,619125,KAYA-BARAKAT-MASSON SYNDROME, KABAMAS
27076,619126,IMMUNODEFICIENCY 75 WITH LYMPHOPROLIFERATION, IMD75
27077,619127,MANDIBULOACRAL DYSPLASIA PROGEROID SYNDROME, MDPS
27078,619128,HYDROXYPYRUVATE ISOMERASE, HYI
27079,619129,CILIA- AND FLAGELLA-ASSOCIATED PROTEIN 58, CFAP58
27080,619130,THROMBOCYTOPENIA 7, THC7
27081,619131,"OSTEOGENESIS IMPERFECTA, TYPE XXI", OI21
27082,619132,FRONTOTEMPORAL DEMENTIA AND/OR AMYOTROPHIC LATERAL SCLEROSIS 8, FTDALS8
27083,619133,AMYOTROPHIC LATERAL SCLEROSIS 26 WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA, ALS26
27084,619134,SET AND MYND DOMAIN-CONTAINING PROTEIN 4, SMYD4
27085,619135,RITSCHER-SCHINZEL SYNDROME 3, RTSC3
27086,619136,"SOLUTE CARRIER FAMILY 37 (GLUCOSE-6-PHOSPHATE TRANSPORTER), MEMBER A2", SLC37A2
27087,619137,"SOLUTE CARRIER FAMILY 37, MEMBER A3", SLC37A3
27088,619138,NEDD4-BINDING PROTEIN 1, N4BP1
27089,619139,NEDD4-BINDING PROTEIN 2, N4BP2
27090,619140,NEDD4-BINDING PROTEIN 3, N4BP3
27091,619141,FRONTOTEMPORAL DEMENTIA AND/OR AMYOTROPHIC LATERAL SCLEROSIS 5, FTDALS5
27092,619142,CARDIOACROFACIAL DYSPLASIA 1, CAFD1
27093,619143,CARDIOACROFACIAL DYSPLASIA 2, CAFD2
27094,619144,SPERMATOGENIC FAILURE 49, SPGF49
27095,619145,SPERMATOGENIC FAILURE 50, SPGF50
27096,619146,PREMATURE OVARIAN FAILURE 17, POF17
27097,619147,"LEUKOENCEPHALOPATHY, PROGRESSIVE, INFANTILE-ONSET, WITH OR WITHOUT DEAFNESS", LEPID
27098,619148,CHROMOSOME 13q33-q34 DELETION SYNDROME,
27099,619149,LESSEL-KREIENKAMP SYNDROME, LESKRES
27100,619150,INTELLECTUAL DEVELOPMENTAL DISORDER WITH PAROXYSMAL DYSKINESIA OR SEIZURES, IDDPADS
27101,619151,"AMED SYNDROME, DIGENIC", AMEDS
27102,619152,"TBC1 DOMAIN FAMILY, MEMBER 2B", TBC1D2B
27103,619153,"SOLUTE CARRIER FAMILY 25 (MITOCHONDRIAL CARRIER, NAD+ TRANSPORTER), MEMBER 51", SLC25A51
27104,619154,LEUCINE-RICH REPEAT-CONTAINING PROTEIN 47, LRRC47
27105,619155,"NEPHROTIC SYNDROME, TYPE 22", NPHS22
27106,619156,"DYNEIN, AXONEMAL, INTERMEDIATE CHAIN 4", DNAI4
27107,619157,NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT EARLY-ONSET GENERALIZED EPILEPSY, NEDEGE
27108,619158,PHOSPHATIDYLINOSITOL 3-KINASE-INTERACTING PROTEIN 1, PIK3IP1
27109,619159,CEA CELL ADHESION MOLECULE 4, CEACAM4
27110,619160,CEA CELL ADHESION MOLECULE 7, CEACAM7
27111,619161,CARPAL TUNNEL SYNDROME 2, CTS2
27112,619162,FORKHEAD BOX J2, FOXJ2
27113,619163,RING FINGER PROTEIN 130, RNF130
27114,619164,IMMUNODEFICIENCY 76, IMD76
27115,619165,"OCULOCUTANEOUS ALBINISM, TYPE VIII", OCA8
27116,619166,"MITOCHONDRIAL COMPLEX II DEFICIENCY, NUCLEAR TYPE 2", MC2DN2
27117,619167,"MITOCHONDRIAL COMPLEX II DEFICIENCY, NUCLEAR TYPE 3", MC2DN3
27118,619168,TRANSMEMBRANE PROTEIN 109, TMEM109
27119,619169,GTP-BINDING PROTEIN 4, GTPBP4
27120,619170,"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 36", MC1DN36
27121,619171,GUANYLYL CYCLASE DOMAIN-CONTAINING PROTEIN 1, GUCD1
27122,619172,HERMANSKY-PUDLAK SYNDROME 11, HPS11
27123,619173,"CEROID LIPOFUSCINOSIS, NEURONAL, 15", CLN15
27124,619174,"DEAFNESS, AUTOSOMAL RECESSIVE 117", DFNB117
27125,619175,PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 5, PRAAS5
27126,619176,OOCYTE/ZYGOTE/EMBRYO MATURATION ARREST 10, OZEMA10
27127,619177,SPERMATOGENIC FAILURE 51, SPGF51
27128,619178,MYOFIBRILLAR MYOPATHY 11, MFM11
27129,619179,"MICROCEPHALY 26, PRIMARY, AUTOSOMAL DOMINANT", MCPH26
27130,619180,"MICROCEPHALY 27, PRIMARY, AUTOSOMAL DOMINANT", MCPH27
27131,619181,"FAMILY WITH SEQUENCE SIMILARITY 177, MEMBER A1", FAM177A1
27132,619182,GASTRIC ADENOCARCINOMA AND PROXIMAL POLYPOSIS OF THE STOMACH, GAPPS
27133,619183,PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 4, PRAAS4
27134,619184,"SHORT STATURE, FACIAL DYSMORPHISM, AND SKELETAL ANOMALIES WITH OR WITHOUT CARDIAC ANOMALIES 2", SSFSC2
27135,619185,JOUBERT SYNDROME 37, JBTS37
27136,619186,"PLECKSTRIN HOMOLOGY DOMAIN-CONTAINING PROTEIN, FAMILY M, MEMBER 3", PLEKHM3
27137,619187,GALECTIN-RELATED INTERFIBER PROTEIN, GRIFIN
27138,619188,"INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 64", MRD64
27139,619189,LI-CAMPEAU SYNDROME, LICAS
27140,619190,INTERACTOR OF HORMAD1 1, IHO1
27141,619191,"EPILEPSY, PROGRESSIVE MYOCLONIC, 12", EPM12
27142,619192,"SOLUTE CARRIER FAMILY 7, MEMBER 6 OPPOSITE STRAND", SLC7A6OS
27143,619193,TUBULIN TYROSINE LIGASE-LIKE 8, TTLL8
27144,619194,NEUROFACIOSKELETAL SYNDROME WITH OR WITHOUT RENAL AGENESIS, NFSRA
27145,619195,TUBULIN TYROSINE LIGASE-LIKE 3, TTLL3
27146,619196,"DEAFNESS, CONGENITAL, AND ADULT-ONSET PROGRESSIVE LEUKOENCEPHALOPATHY", DEAPLE
27147,619197,"EUKARYOTIC TRANSLATION INITIATION FACTOR 3, SUBUNIT L", EIF3L
27148,619198,SUCCINATE DEHYDROGENASE COMPLEX ASSEMBLY FACTOR 4, SDHAF4
27149,619199,6-PHOSPHOGLUCONATE DEHYDROGENASE DEFICIENCY, PGDD
27150,619200,"SORTING NEXIN FAMILY, MEMBER 21", SNX21
27151,619201,"NEPHROTIC SYNDROME, TYPE 23", NPHS23
27152,619202,SPERMATOGENIC FAILURE 52, SPGF52
27153,619203,PREMATURE OVARIAN FAILURE 18, POF18
27154,619204,NUCLEOLAR PRE-rRNA-PROCESSING PROTEIN NIP7, NIP7
27155,619205,GROWTH HORMONE-INDUCIBLE TRANSMEMBRANE PROTEIN, GHITM
27156,619206,SCHWANNOMIN-INTERACTING PROTEIN 1, SCHIP1
27157,619207,"INO80 COMPLEX, SUBUNIT D", INO80D
27158,619208,OLMSTED SYNDROME 2, OLMS2
27159,619209,ERYTHROKERATODERMIA VARIABILIS ET PROGRESSIVA 7, EKVP7
27160,619210,HEPARAN SULFATE-GLUCOSAMINE 3-SULFOTRANSFERASE 6, HS3ST6
27161,619211,HIPPOCALCIN-LIKE 4, HPCAL4
27162,619212,IGF1R ANTISENSE IMPRINTED NONCODING RNA, IRAIN
27163,619213,ZINC FINGER SWIM DOMAIN-CONTAINING PROTEIN 8, ZSWIM8
27164,619214,ZINC FINGER PROTEIN 639, ZNF639
27165,619215,OCULOMOTOR-ABDUCENS SYNKINESIS, OCABSN
27166,619216,"NEURONOPATHY, DISTAL HEREDITARY MOTOR, AUTOSOMAL RECESSIVE 7", HMNR7
27167,619217,"ENDOVE SYNDROME, LIMB-ONLY TYPE", ENDOVESL
27168,619218,"ENDOVE SYNDROME, LIMB-BRAIN TYPE", ENDOVESLB
27169,619219,CHROMOSOME 2 OPEN READING FRAME 69, C2ORF69
27170,619220,IMMUNODEFICIENCY 78 WITH AUTOIMMUNITY AND DEVELOPMENTAL DELAY, IMD78
27171,619221,SULFIDE:QUINONE OXIDOREDUCTASE DEFICIENCY, SQORD
27172,619222,SUPPRESSOR OF CANCER CELL INVASION, SCAI
27173,619223,IMMUNODEFICIENCY 77, IMD77
27174,619224,"MITOCHONDRIAL COMPLEX II DEFICIENCY, NUCLEAR TYPE 4", MC2DN4
27175,619225,RIBOSOMAL PROTEIN L13A, RPL13A
27176,619226,"BLISTERING, ACANTHOLYTIC, OF ORAL AND LARYNGEAL MUCOSA", ABOLM
27177,619227,"VERTEBRAL, CARDIAC, TRACHEOESOPHAGEAL, RENAL, AND LIMB DEFECTS", VCTERL
27178,619228,DEVELOPMENTAL DELAY WITH DYSMORPHIC FACIES AND DENTAL ANOMALIES, DEFDA
27179,619229,DEN HOED-DE BOER-VOISIN SYNDROME, DHDBV
27180,619230,"SIN3A-ASSOCIATED PROTEIN, 25-KD", SAP25
27181,619231,STERILE ALPHA MOTIF DOMAIN-CONTAINING PROTEIN 4B, SAMD4B
27182,619232,"HYPERCHOLANEMIA, FAMILIAL 3", FHCA3
27183,619233,STERILE ALPHA MOTIF DOMAIN-CONTAINING PROTEIN 14, SAMD14
27184,619234,"SHORT STATURE, OLIGODONTIA, DYSMORPHIC FACIES, AND MOTOR DELAY", SOFM
27185,619235,RIBONUCLEASE P/MRP SUBUNIT p25, RPP25
27186,619236,KIAA0408 GENE, KIAA0408
27187,619237,KIAA0232 GENE, KIAA0232
27188,619238,IMMUNODEFICIENCY 79, IMD79
27189,619239,NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT AUTISM OR SEIZURES, NEDAUS
27190,619240,GDP-D-GLUCOSE PHOSPHORYLASE 1, GDPGP1
27191,619241,JUPITER MICROTUBULE-ASSOCIATED HOMOLOG 2, JPT2
27192,619242,JUPITER MICROTUBULE-ASSOCIATED HOMOLOG 1, JPT1
27193,619243,GLOBAL DEVELOPMENTAL DELAY WITH SPEECH AND BEHAVIORAL ABNORMALITIES, GDSBA
27194,619244,NEURODEVELOPMENTAL DISORDER WITH CEREBRAL ATROPHY AND VARIABLE FACIAL DYSMORPHISM, NEDCAFD
27195,619245,PREMATURE OVARIAN FAILURE 19, POF19
27196,619246,SPEXIN HORMONE, SPX
27197,619247,"SPINDLE- AND KINETOCHORE-ASSOCIATED COMPLEX, SUBUNIT 3", SKA3
27198,619248,VITREORETINOPATHY WITH PHALANGEAL EPIPHYSEAL DYSPLASIA, VPED
27199,619249,COILED-COIL DOMAIN-CONTAINING PROTEIN 186, CCDC186
27200,619250,RUN DOMAIN-CONTAINING PROTEIN 1, RUNDC1
27201,619251,ACTIN-LIKE 9, ACTL9
27202,619252,BASIC LEUCINE ZIPPER DOMAIN- AND W2 DOMAIN-CONTAINING PROTEIN 1, BZW1
27203,619253,WSC DOMAIN-CONTAINING PROTEIN 2, WSCD2
27204,619254,ZINC FINGER PROTEIN 17, ZNF17
27205,619255,BARALLE-MACKEN SYNDROME, BARMACS
27206,619256,"HYPERCHOLANEMIA, FAMILIAL, 2", FHCA2
27207,619257,HR UPSTREAM OPEN READING FRAME, HRURF
27208,619258,SPERMATOGENIC FAILURE 53, SPGF53
27209,619259,NEURODEGENERATION WITH ATAXIA AND LATE-ONSET OPTIC ATROPHY, NDAXOA
27210,619260,"SPONDYLOEPIPHYSEAL DYSPLASIA, SENSORINEURAL HEARING LOSS, IMPAIRED INTELLECTUAL DEVELOPMENT, AND LEBER CONGENITAL AMAUROSIS", SHILCA
27211,619261,KERATINOCYTE-ASSOCIATED PROTEIN 3, KRTCAP3
27212,619262,KELCH-LIKE 17, KLHL17
27213,619263,"NEPHROTIC SYNDROME, TYPE 24", NPHS24
27214,619264,NEURODEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND VARIABLE SEIZURES, NEDDFAS
27215,619265,TRIPARTITE MOTIF-CONTAINING PROTEIN 52, TRIM52
27216,619266,"TRIM52 ANTISENSE RNA 1, NONCODING", TRIM52AS1
27217,619267,GLANZMANN THROMBASTHENIA 2, GT2
27218,619268,ALZAHRANI-KUWAHARA SYNDROME, ALKUS
27219,619269,ODONTOCHONDRODYSPLASIA 2 WITH HEARING LOSS AND DIABETES, ODCD2
27220,619270,INTRAFLAGELLAR TRANSPORT-ASSOCIATED PROTEIN, IFTAP
27221,619271,"BLEEDING DISORDER, PLATELET-TYPE, 24", BDPLT24
27222,619272,"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 37", MC1DN37
27223,619273,CIMDAG SYNDROME, CIMDAG
27224,619274,"DEAFNESS, AUTOSOMAL DOMINANT 80", DFNA80
27225,619275,BASIC LEUCINE ZIPPER DOMAIN- AND W2 DOMAIN-CONTAINING PROTEIN 2, BZW2
27226,619276,BREAK REPAIR MEIOTIC RECOMBINASE RECRUITMENT FACTOR 1, BRME1
27227,619277,CILIARY MICROTUBULE INNER PROTEIN 1, CIMIP1
27228,619278,"MICROCEPHALY, EPILEPSY, AND DIABETES SYNDROME 2", MEDS2
27229,619279,PARKINSONISM WITH POLYNEUROPATHY, PKNPY
27230,619280,COILED-COIL DOMAIN-CONTAINING PROTEIN 59, CCDC59
27231,619281,"IMMUNODEFICIENCY 14B, AUTOSOMAL RECESSIVE", IMD14B
27232,619282,"FAMILY WITH SEQUENCE SIMILARITY 131, MEMBER B", FAM131B
27233,619283,RING FINGER PROTEIN 44, RNF44
27234,619284,ZINC FINGER RNA-BINDING PROTEIN 2, ZFR2
27235,619285,TRANSMEMBRANE PROTEIN 218, TMEM218
27236,619286,"NEURODEVELOPMENTAL DISORDER WITH SPASTICITY, CATARACTS, AND CEREBELLAR HYPOPLASIA", NEDSCAC
27237,619287,COILED-COIL DOMAIN-CONTAINING PROTEIN 66, CCDC66
27238,619288,COILED-COIL DOMAIN-CONTAINING PROTEIN 69, CCDC69
27239,619289,"ZINC FINGER PROTEIN 91, ATYPICAL E3 UBIQUITIN LIGASE", ZFP91
27240,619290,MAHVASH DISEASE, MVAH
27241,619291,DYSTONIA 30, DYT30
27242,619292,VPS9 DOMAIN-CONTAINING PROTEIN 1, VPS9D1
27243,619293,BLEPHAROPHIMOSIS-IMPAIRED INTELLECTUAL DEVELOPMENT SYNDROME, BIS
27244,619294,NIBAN APOPTOSIS REGULATOR 1, NIBAN1
27245,619295,ZINC FINGER DHHC-TYPE PALMITOYLTRANSFERASE 14, ZDHHC14
27246,619296,TESTIS-ASSOCIATED ONCOGENIC LONG NONCODING RNA, THORLNC
27247,619297,KINSSHIP SYNDROME, KINS
27248,619298,ZINC FINGER PROTEIN 777, ZNF777
27249,619299,ZINC FINGER PROTEIN 646, ZNF646
27250,619300,ZINC FINGER PROTEIN 394, ZNF394
27251,619301,"PONTOCEREBELLAR HYPOPLASIA, TYPE 14", PCH14
27252,619302,"PONTOCEREBELLAR HYPOPLASIA, TYPE 15", PCH15
27253,619303,"PONTOCEREBELLAR HYPOPLASIA, TYPE 1E", PCH1E
27254,619304,"PONTOCEREBELLAR HYPOPLASIA, TYPE 1F", PCH1F
27255,619305,"TANDEM C2 DOMAINS PROTEIN, NUCLEAR", TC2N
27256,619306,NEURODEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND CEREBELLAR HYPOPLASIA, NEDFACH
27257,619307,MAGNESIUM TRANSPORTER MRS2, MRS2
27258,619308,"PROTEIN PHOSPHATASE, MAGNESIUM/MANGANESE-DEPENDENT, 1E", PPM1E
27259,619309,"PROTEIN PHOSPHATASE, MAGNESIUM/MANGANESE-DEPENDENT, 1F", PPM1F
27260,619310,"LEUKODYSTROPHY, HYPOMYELINATING, 21", HLD21
27261,619311,HIATT-NEU-COOPER NEURODEVELOPMENTAL SYNDROME, HINCONS
27262,619312,RADIO-TARTAGLIA SYNDROME, RATARS
27263,619313,IMMUNODEFICIENCY 80 WITH OR WITHOUT CONGENITAL CARDIOMYOPATHY, IMD80
27264,619314,BURATTI-HAREL SYNDROME, BURHAS
27265,619315,"SOLUTE CARRIER FAMILY 35, MEMBER E2B", SLC35E2B
27266,619316,TETRATRICOPEPTIDE REPEAT- AND ANKYRIN REPEAT-CONTAINING PROTEIN 1, TRANK1
27267,619317,DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 6B, DEE6B
27268,619318,OCULOGASTROINTESTINAL NEURODEVELOPMENTAL SYNDROME, OGIN
27269,619319,LYMPHATIC MALFORMATION 9, LMPHM9
27270,619320,"INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 65", MRD65
27271,619321,"GROWTH RESTRICTION, HYPOPLASTIC KIDNEYS, ALOPECIA, AND DISTINCTIVE FACIES", GKAF
27272,619322,MARBACH-RUSTAD PROGEROID SYNDROME, MARUPS
27273,619323,NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND GINGIVAL OVERGROWTH, NEDSGO
27274,619324,HYPERTRIGLYCERIDEMIA 2, HYTG2
27275,619325,COFFIN-SIRIS SYNDROME 12, CSS12
27276,619326,BDV SYNDROME, BDVS
27277,619327,LEUCINE-RICH REPEAT-CONTAINING PROTEIN 15, LRRC15
27278,619328,"LEUKODYSTROPHY, HYPOMYELINATING, 22", HLD22
27279,619329,"FIBROMUSCULAR DYSPLASIA, MULTIFOCAL", FMDMF
27280,619330,TatD DNase DOMAIN-CONTAINING PROTEIN 2, TATDN2
27281,619331,"MTOR-ASSOCIATED PROTEIN, EAK7 HOMOLOG", MEAK7
27282,619332,LYSOSOMAL ENZYME TRAFFICKING FACTOR, LYSET
27283,619333,NEURODEVELOPMENTAL DISORDER WITH CEREBELLAR ATROPHY AND MOTOR DYSFUNCTION, NEDCAM
27284,619334,ARTHROGRYPOSIS MULTIPLEX CONGENITA 6, AMC6
27285,619335,GRANULE-ASSOCIATED RAC AND RHOG EFFECTOR 1, GARRE1
27286,619336,METAXIN 3, MTX3
27287,619337,NEUROMEDIN S, NMS
27288,619338,"CATARACTS, SPASTIC PARAPARESIS, AND SPEECH DELAY", CSPSD
27289,619339,BARTSOCAS-PAPAS SYNDROME 2, BPS2
27290,619340,DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 96, DEE96
27291,619341,PRAJA RING FINGER UBIQUITIN LIGASE 2, PJA2
27292,619342,POST-GPI ATTACHMENT TO PROTEINS 6, PGAP6
27293,619343,"CHROMOSOME 1p36 DELETION SYNDROME, PROXIMAL",
27294,619344,PURKINJE CELL PROTEIN 2, PCP2
27295,619345,"DYSOSTOSIS MULTIPLEX, AIN-NAZ TYPE", DMAN
27296,619346,ADENOSINE DEAMINASE-LIKE PROTEIN, ADAL
27297,619347,COILED-COIL DOMAIN-CONTAINING PROTEIN 96, CCDC96
27298,619348,ANKYRIN REPEAT- AND LEM DOMAIN-CONTAINING PROTEIN 1, ANKLE1
27299,619349,"COP9 SIGNALOSOME, SUBUNIT 9", COPS9
27300,619350,VISCERAL MYOPATHY 2, VSCM2
27301,619351,MEGACYSTIS-MICROCOLON-INTESTINAL HYPOPERISTALSIS SYNDROME 2, MMIHS2
27302,619352,"ATAXIA, INTENTION TREMOR, AND HYPOTONIA SYNDROME, CHILDHOOD-ONSET", ATITHS
27303,619353,"PAR3 FAMILY CELL POLARITY REGULATOR, BETA", PARD3B
27304,619354,"DEAFNESS, CATARACT, IMPAIRED INTELLECTUAL DEVELOPMENT, AND POLYNEUROPATHY", DCIDP
27305,619355,"MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 22", MC4DN22
27306,619356,"ONYCHODYSTROPHY, OSTEODYSTROPHY, IMPAIRED INTELLECTUAL DEVELOPMENT, AND SEIZURES SYNDROME", OORS
27307,619357,ADENYLATE KINASE 6, AK6
27308,619358,MICROTUBULE-ASSOCIATED SCAFFOLD PROTEIN 2, MTUS2
27309,619359,BONE MORPHOGENETIC PROTEIN/RETINOIC ACID-INDUCIBLE NEURAL-SPECIFIC PROTEIN 2, BRINP2
27310,619360,"ANGIOEDEMA, HEREDITARY, 4", HAE4
27311,619361,"ANGIOEDEMA, HEREDITARY, 5", HAE5
27312,619362,MEGACYSTIS-MICROCOLON-INTESTINAL HYPOPERISTALSIS SYNDROME 3, MMIHS3
27313,619363,"ANGIOEDEMA, HEREDITARY, 6", HAE6
27314,619364,TatD DNase DOMAIN-CONTAINING PROTEIN 1, TATDN1
27315,619365,MEGACYSTIS-MICROCOLON-INTESTINAL HYPOPERISTALSIS SYNDROME 4, MMIHS4
27316,619366,"ANGIOEDEMA, HEREDITARY, 7", HAE7
27317,619367,"ANGIOEDEMA, HEREDITARY, 8", HAE8
27318,619368,LEUCINE-RICH REPEAT-CONTAINING PROTEIN 14, LRRC14
27319,619369,LYMPHATIC MALFORMATION 10, LMPHM10
27320,619370,"KH DOMAIN-CONTAINING PROTEIN 4, PRE-mRNA SPLICING FACTOR", KHDC4
27321,619371,"CARDIOMYOPATHY, DILATED, 2D", CMD2D
27322,619372,URB2 RIBOSOME BIOGENESIS HOMOLOG, URB2
27323,619373,NEURODEVELOPMENTAL DISORDER WITH INFANTILE EPILEPTIC SPASMS, NEDIES
27324,619374,IMMUNODEFICIENCY 81, IMD81
27325,619375,"AUTOINFLAMMATORY SYNDROME, FAMILIAL, WITH OR WITHOUT IMMUNODEFICIENCY", AISIMD
27326,619376,FAUNDES-BANKA SYNDROME, FABAS
27327,619377,OSTEOOTOHEPATOENTERIC SYNDROME, OOHE
27328,619378,"SMALL NUCLEOLAR RNA, H/ACA BOX, 31", SNORA31
27329,619379,SPERMATOGENIC FAILURE 54, SPGF54
27330,619380,SPERMATOGENIC FAILURE 55, SPGF55
27331,619381,IMMUNODEFICIENCY 82 WITH SYSTEMIC INFLAMMATION, IMD82
27332,619382,"LEBER-LIKE HEREDITARY OPTIC NEUROPATHY, AUTOSOMAL RECESSIVE 1", LHONAR1
27333,619383,"NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, FACIAL DYSMORPHISM, AND BRAIN ABNORMALITIES", NEDHFBA
27334,619384,ZINC FINGER- AND BTB DOMAIN-CONTAINING PROTEIN 39, ZBTB39
27335,619385,ZINC FINGER PROTEIN 510, ZNF510
27336,619386,COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 52, COXPD52
27337,619387,CILIOGENESIS-ASSOCIATED TTC17-INTERACTING PROTEIN, CATIP
27338,619388,TETRATRICOPEPTIDE REPEAT DOMAIN-CONTAINING PROTEIN 17, TTC17
27339,619389,"SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 29", SCAR29
27340,619390,"COLLAGEN, TYPE XX, ALPHA-1", COL20A1
27341,619391,COILED-COIL DOMAIN-CONTAINING PROTEIN 157, CCDC157
27342,619392,CHROMOSOME 14 OPEN READING FRAME 180, C14ORF180
27343,619393,KELCH REPEAT- AND BTB DOMAIN-CONTAINING PROTEIN 2, KBTBD2
27344,619394,CARBONYL REDUCTASE 4, CBR4
27345,619395,MYELIN EXPRESSION FACTOR 2, MYEF2
27346,619396,"ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 10", IIAE10
27347,619397,ZINC FINGER PROTEIN-LIKE 1, ZFPL1
27348,619398,"INFLAMMATORY BOWEL DISEASE (INFANTILE ULCERATIVE COLITIS) 31, AUTOSOMAL RECESSIVE", IBD31
27349,619399,TETRASPANIN 18, TSPAN18
27350,619400,"VISCERAL LEIOMYOPATHY, AFRICAN DEGENERATIVE", ADL
27351,619401,LYMPHATIC MALFORMATION 11, LMPHM11
27352,619402,"CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 28", CMH28
27353,619403,"COLON CANCER-ASSOCIATED TRANSCRIPT 2, NONCODING", CCAT2
27354,619404,tRNA METHYLTRANSFERASE 61B, TRMT61B
27355,619405,"SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 30", SCAR30
27356,619406,HYPOKALEMIC TUBULOPATHY AND DEAFNESS, HKTD
27357,619407,WHIM SYNDROME 2, WHIMS2
27358,619408,TRIPARTITE MOTIF-CONTAINING PROTEIN 65, TRIM65
27359,619409,TRANSLOCATOR PROTEIN 2, TSPO2
27360,619410,TUBULIN TYROSINE LIGASE-LIKE 12, TTLL12
27361,619411,"SIGNAL PEPTIDASE COMPLEX, SUBUNIT 2", SPCS2
27362,619412,SEC14-LIKE LIPID-BINDING PROTEIN 5, SEC14L5
27363,619413,COILED-COIL DOMAIN-CONTAINING PROTEIN 144A, CCDC144A
27364,619414,MITOCHONDRIAL FISSION REGULATOR 1, MTFR1
27365,619415,TAU TUBULIN KINASE 1, TTBK1
27366,619416,TRIPARTITE MOTIF-CONTAINING PROTEIN 60, TRIM60
27367,619417,TRIPARTITE MOTIF-CONTAINING PROTEIN 61, TRIM61
27368,619418,"NEUROLOGIC, ENDOCRINE, AND PANCREATIC DISEASE, MULTISYSTEM, INFANTILE-ONSET 2", IMNEPD2
27369,619419,NAC-ALPHA DOMAIN-CONTAINING PROTEIN, NACAD
27370,619420,MARTSOLF SYNDROME 2, MARTS2
27371,619421,DYNACTIN-ASSOCIATED PROTEIN, DYNAP
27372,619422,"SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 31", SCAR31
27373,619423,COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 53, COXPD53
27374,619424,"MYOPATHY, MYOFIBRILLAR, 12, INFANTILE-ONSET, WITH CARDIOMYOPATHY", MFM12
27375,619425,MITOCHONDRIAL DNA DEPLETION SYNDROME 16B (NEUROOPHTHALMIC TYPE), MTDPS16B
27376,619426,WHITE-KERNOHAN SYNDROME, WHIKERS
27377,619427,ZINC FINGER PROTEIN 410, ZNF410
27378,619428,FOCAL SEGMENTAL GLOMERULOSCLEROSIS AND NEURODEVELOPMENTAL SYNDROME, FSGSNEDS
27379,619429,"TRANSMEMBRANE AND COILED-COIL DOMAIN FAMILY, MEMBER 2", TMCC2
27380,619430,"SERINE PEPTIDASE INHIBITOR, KUNITZ-TYPE, 4", SPINT4
27381,619431,MEGACYSTIS-MICROCOLON-INTESTINAL HYPOPERISTALSIS SYNDROME 5, MMIHS5
27382,619432,"N-ALPHA-ACETYLTRANSFERASE 11, NatA CATALYTIC SUBUNIT", NAA11
27383,619433,"CARDIOMYOPATHY, FAMILIAL RESTRICTIVE, 6", RCM6
27384,619434,SUN DOMAIN-CONTAINING OSSIFICATION FACTOR, SUCO
27385,619435,RITSCHER-SCHINZEL SYNDROME 4, RTSC4
27386,619436,"CILIARY DYSKINESIA, PRIMARY, 46", CILD46
27387,619437,IMMUNODEFICIENCY 84, IMD84
27388,619438,"N-ALPHA-ACETYLTRANSFERASE 35, NatC AUXILIARY SUBUNIT", NAA35
27389,619439,"POLY(ADP-RIBOSE) POLYMERASE FAMILY, MEMBER 6", PARP6
27390,619440,GLUTAMINE- AND SERINE-RICH PROTEIN 1, QSER1
27391,619441,"ENCEPHALITIS, ACUTE, INFECTION (VIRAL)-INDUCED, SUSCEPTIBILITY TO, 11", IIAE11
27392,619442,TUB-LIKE PROTEIN 4, TULP4
27393,619443,MEIS HOMEOBOX 3, MEIS3
27394,619444,COILED-COIL DOMAIN-CONTAINING PROTEIN 7, CCDC7
27395,619445,"DIARRHEA 12, WITH MICROVILLUS ATROPHY", DIAR12
27396,619446,RETINAL DYSTROPHY AND MICROVILLUS INCLUSION DISEASE, RDMVID
27397,619447,"FAMILY WITH SEQUENCE SIMILARITY 189, MEMBER B", FAM189B
27398,619448,STEROID RECEPTOR-ASSOCIATED AND -REGULATED PROTEIN, SRARP
27399,619449,RIBOSOMAL RNA-PROCESSING PROTEIN 7 HOMOLOG A, RRP7A
27400,619450,MICRO RNA 874, MIR874
27401,619451,"CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIE", ARCL2E
27402,619452,ANENCEPHALY 2, ANPH2
27403,619453,"MICROCEPHALY 28, PRIMARY, AUTOSOMAL RECESSIVE", MCPH28
27404,619454,RING FINGER PROTEIN 144A, RNF144A
27405,619455,SH3 AND PX DOMAINS-CONTAINING PROTEIN 2A, SH3PXD2A
27406,619456,CDC42 SMALL EFFECTOR 1, CDC42SE1
27407,619457,CDC42 SMALL EFFECTOR 2, CDC42SE2
27408,619458,METHYL-CpG-BINDING DOMAIN PROTEIN 6, MBD6
27409,619459,ZINC FINGER ZZ-TYPE DOMAIN- AND EF-HAND DOMAIN-CONTAINING PROTEIN 1, ZZEF1
27410,619460,LUO-SCHOCH-YAMAMOTO SYNDROME, LUSYAM
27411,619461,"MYASTHENIC SYNDROME, CONGENITAL, 7B, PRESYNAPTIC, AUTOSOMAL RECESSIVE", CMS7B
27412,619462,"HEMOLYTIC DISEASE OF FETUS AND NEWBORN, RH-INDUCED", HDFNRH
27413,619463,"PORTAL HYPERTENSION, NONCIRRHOTIC, 2", NCPH2
27414,619464,SICK SINUS SYNDROME 4, SSS4
27415,619465,"VISCERAL NEUROPATHY, FAMILIAL, 2, AUTOSOMAL RECESSIVE", VSCN2
27416,619466,"CILIARY DYSKINESIA, PRIMARY, 47, AND LISSENCEPHALY", CILD47
27417,619467,"USMANI-RIAZUDDIN SYNDROME, AUTOSOMAL DOMINANT", USRISD
27418,619468,NEPHRONOPHTHISIS-LIKE NEPHROPATHY 2, NPHPL2
27419,619469,TRANSMEMBRANE PROTEIN 222, TMEM222
27420,619470,NEURODEVELOPMENTAL DISORDER WITH MOTOR AND SPEECH DELAY AND BEHAVIORAL ABNORMALITIES, NEDMOSBA
27421,619471,BARDET-BIEDL SYNDROME 20, BBS20
27422,619472,VISS SYNDROME, VISS
27423,619473,OCULOPHARYNGODISTAL MYOPATHY 3, OPDM3
27424,619474,R3H DOMAIN-CONTAINING PROTEIN 1, R3HDM1
27425,619475,"DEVELOPMENTAL DELAY, IMPAIRED SPEECH, AND BEHAVIORAL ABNORMALITIES", DDISBA
27426,619476,JOUBERT SYNDROME 38, JBTS38
27427,619477,"FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY 3, DIGENIC", FSHD3
27428,619478,"FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY 4, DIGENIC", FSHD4
27429,619479,SHORT-RIB THORACIC DYSPLASIA 21 WITHOUT POLYDACTYLY, SRTD21
27430,619480,NEURODEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND THIN CORPUS CALLOSUM, NEDDFAC
27431,619481,"BILE ACID MALABSORPTION, PRIMARY, 2", PBAM2
27432,619482,"CENTRAL HYPOVENTILATION SYNDROME, CONGENITAL, 2, AND AUTONOMIC DYSFUNCTION", CCHS2
27433,619483,"CENTRAL HYPOVENTILATION SYNDROME, CONGENITAL, 3", CCHS3
27434,619484,"CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC, 6", PFIC6
27435,619485,PAPPALYSIN 2, PAPPA2
27436,619486,AICARDI-GOUTIERES SYNDROME 8, AGS8
27437,619487,AICARDI-GOUTIERES SYNDROME 9, AGS9
27438,619488,DEGCAGS SYNDROME, DEGCAGS
27439,619489,"SHORT STATURE, DAUBER-ARGENTE TYPE", SSDA
27440,619490,LMBR1 DOMAIN-CONTAINING PROTEIN 2, LMBRD2
27441,619491,"PARKINSON DISEASE 24, AUTOSOMAL DOMINANT, SUSCEPTIBILITY TO", PARK24
27442,619492,"CARDIOMYOPATHY, DILATED, 2E", CMD2E
27443,619493,"CONGENITAL DISORDER OF GLYCOSYLATION, TYPE 2v", CDG2V
27444,619494,"SMALL NUCLEOLAR RNA HOST GENE 11, NONCODING", SNHG11
27445,619495,ADAM METALLOPEPTIDASE DOMAIN-CONTAINING PROTEIN 18, ADAM18
27446,619496,ZINC FINGER PROTEIN 358, ZNF358
27447,619497,"N-ALPHA-ACETYLTRANSFERASE 16, NatA AUXILIARY SUBUNIT", NAA16
27448,619498,ZINC FINGER CCCH DOMAIN-CONTAINING PROTEIN 4, ZC3H4
27449,619499,ZINC FINGER PROTEIN 383, ZNF383
27450,619500,"DEAFNESS, AUTOSOMAL DOMINANT 81", DFNA81
27451,619501,VENTRICULOMEGALY AND ARTHROGRYPOSIS, VENARG
27452,619502,SPERM MICROTUBULE INNER PROTEIN 6, SPMIP6
27453,619503,NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA AND DYSMORPHIC FACIES, NEDHYDF
27454,619504,CHOPRA-AMIEL-GORDON SYNDROME, CAGS
27455,619505,ZINC FINGER PROTEIN 431, ZNF431
27456,619506,ZINC FINGER PROTEIN 415, ZNF415
27457,619507,ZINC FINGER PROTEIN 425, ZNF425
27458,619508,ZINC FINGER PROTEIN 445, ZNF445
27459,619509,ZINC FINGER PROTEIN 418, ZNF418
27460,619510,IMMUNODEFICIENCY 85 AND AUTOIMMUNITY, IMD85
27461,619511,ZINC FINGER PROTEIN 354C, ZNF354C
27462,619512,NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA AND BRAIN ABNORMALITIES, NEDHYBA
27463,619513,SWT1 RNA ENDORIBONUCLEASE HOMOLOG, SWT1
27464,619514,SHC-BINDING AND SPINDLE-ASSOCIATED PROTEIN 1-LIKE PROTEIN, SHCBP1L
27465,619515,SPERMATOGENIC FAILURE 56, SPGF56
27466,619516,BIFUNCTIONAL APOPTOSIS REGULATOR, BFAR
27467,619517,NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND BRAIN ABNORMALITIES, NEDSBA
27468,619518,"MUSCULAR DYSTROPHY, CONGENITAL HEARING LOSS, AND OVARIAN INSUFFICIENCY SYNDROME", MDHLO
27469,619519,"CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2FF", CMT2FF
27470,619520,BOX H/ACA SMALL NUCLEOLAR RNA-ENDED LONG NONCODING RNA THAT ENHANCES PRE-rRNA TRANSCRIPTION, SLERT
27471,619521,"EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 18", EIG18
27472,619522,NEURODEVELOPMENTAL-CRANIOFACIAL SYNDROME WITH VARIABLE RENAL AND CARDIAC ABNORMALITIES, NECRC
27473,619523,"ANEMIA, SIDEROBLASTIC, 5", SIDBA5
27474,619524,ZINC FINGER PROTEIN 764, ZNF764
27475,619525,"CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIw", CDG2W
27476,619526,ZINC FINGER PROTEIN 706, ZNF706
27477,619527,"PONTOCEREBELLAR HYPOPLASIA, TYPE 16", PCH16
27478,619528,SPERMATOGENIC FAILURE 57, SPGF57
27479,619529,PARN-LIKE RIBONUCLEASE DOMAIN-CONTAINING EXONUCLEASE 1, PNLDC1
27480,619530,"SOLUTE CARRIER FAMILY 35, MEMBER C2", SLC35C2
27481,619531,CONE-ROD DYSTROPHY 22, CORD22
27482,619532,ADENOSINE DEAMINASE DOMAIN-CONTAINING PROTEIN 2, ADAD2
27483,619533,RAD21 COHESIN COMPLEX COMPONENT-LIKE 1, RAD21L1
27484,619534,"BILIARY, RENAL, NEUROLOGIC, AND SKELETAL SYNDROME", BRENS
27485,619535,RING FINGER PROTEIN 115, RNF115
27486,619536,UBIQUITIN-SPECIFIC PEPTIDASE 31, USP31
27487,619537,ANGEL HOMOLOG 1, ANGEL1
27488,619538,CEREBRAL CAVERNOUS MALFORMATIONS 4, CCM4
27489,619539,NEUROOCULAR SYNDROME 1, NOC1
27490,619540,"PROTEIN PHOSPHATASE 1, REGULATORY SUBUNIT 3E", PPP1R3E
27491,619541,"PROTEIN PHOSPHATASE 1, REGULATORY SUBUNIT 3G", PPP1R3G
27492,619542,KING-DENBOROUGH SYNDROME, KDS
27493,619543,BOUDIN-MORTIER SYNDROME, BOMOS
27494,619544,PROLINE-RICH COILED-COIL PROTEIN 2B, PRRC2B
27495,619545,HYPOPLASTIC FEMURS AND PELVIS, HYPOFP
27496,619546,"OLFACTORY RECEPTOR, FAMILY 10, SUBFAMILY J, MEMBER 5", OR10J5
27497,619547,"RAB15, MEMBER RAS ONCOGENE FAMILY", RAB15
27498,619548,"USMANI-RIAZUDDIN SYNDROME, AUTOSOMAL RECESSIVE", USRISR
27499,619549,IMMUNODEFICIENCY 86, IMD86
27500,619550,"RAB40B, MEMBER RAS ONCOGENE FAMILY", RAB40B
27501,619551,"RAB40C, MEMBER RAS ONCOGENE FAMILY", RAB40C
27502,619552,"MAGO HOMOLOG B, EXON JUNCTION COMPLEX SUBUNIT", MAGOHB
27503,619553,"DEAFNESS, AUTOSOMAL RECESSIVE 118, WITH COCHLEAR APLASIA", DFNB118
27504,619554,MITOCHONDRIAL TRANSLATIONAL INITIATION FACTOR 3, MTIF3
27505,619555,"EPIDERMOLYSIS BULLOSA SIMPLEX 2A, GENERALIZED SEVERE", EBS2A
27506,619556,"INTELLECTUAL DEVELOPMENTAL DISORDER WITH HYPOTONIA, IMPAIRED SPEECH, AND DYSMORPHIC FACIES", IDDHISD
27507,619557,"SHORT STATURE, IMPAIRED INTELLECTUAL DEVELOPMENT, MICROCEPHALY, HYPOTONIA, AND OCULAR ANOMALIES", SIMHA
27508,619558,"RAB39A, MEMBER RAS ONCOGENE FAMILY", RAB39A
27509,619559,EF-HAND CALCIUM-BINDING DOMAIN-CONTAINING PROTEIN 14, EFCAB14
27510,619560,MICRO RNA 135B, MIR135B
27511,619561,DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 97, DEE97
27512,619562,JOUBERT SYNDROME 39, JBTS39
27513,619563,MICAL-LIKE PROTEIN 1, MICALL1
27514,619564,CALAXIN, CLXN
27515,619565,DYSTONIA 31, DYT31
27516,619566,"MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 27", LGMDR27
27517,619567,EF-HAND CALCIUM-BINDING DOMAIN-CONTAINING PROTEIN 3, EFCAB3
27518,619568,ENDONUCLEASE DOMAIN-CONTAINING PROTEIN 1, ENDOD1
27519,619569,CHROMOSOME 9 OPEN READING FRAME 78, C9ORF78
27520,619570,UHRF1-BINDING PROTEIN 1, UHRF1BP1
27521,619571,ANKYRIN REPEAT DOMAIN-CONTAINING PROTEIN 49, ANKRD49
27522,619572,MICRO RNA 15B, MIR15B
27523,619573,IMMUNODEFICIENCY 87 AND AUTOIMMUNITY, IMD87
27524,619574,"CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2HH", CMT2HH
27525,619575,DEVELOPMENTAL DELAY WITH OR WITHOUT INTELLECTUAL IMPAIRMENT OR BEHAVIORAL ABNORMALITIES, DDIB
27526,619576,"CEREBELLAR ATAXIA, BRAIN ABNORMALITIES, AND CARDIAC CONDUCTION DEFECTS", CABAC
27527,619577,ZINC FINGER CCCH DOMAIN- AND G-PATCH DOMAIN-CONTAINING PROTEIN, ZGPAT
27528,619578,AFG2 AAA ATPase HOMOLOG B, AFG2B
27529,619579,KH DOMAIN- AND NYN DOMAIN-CONTAINING PROTEIN, KHNYN
27530,619580,NEURODEVELOPMENTAL DISORDER WITH IMPAIRED LANGUAGE AND ATAXIA AND WITH OR WITHOUT SEIZURES, NEDLAS
27531,619581,"SOLUTE CARRIER FAMILY 45, MEMBER 4", SLC45A4
27532,619582,JOUBERT SYNDROME 40, JBTS40
27533,619583,EH DOMAIN-BINDING PROTEIN 1-LIKE 1, EHBP1L1
27534,619584,WSC DOMAIN-CONTAINING PROTEIN 1, WSCD1
27535,619585,SPERMATOGENIC FAILURE 58, SPGF58
27536,619586,TSPY-LIKE 4, TSPYL4
27537,619587,ZINC FINGER PROTEIN 629, ZNF629
27538,619588,"EPIDERMOLYSIS BULLOSA SIMPLEX 2B, GENERALIZED INTERMEDIATE", EBS2B
27539,619589,BRAF-ACTIVATED NONCODING RNA, BANCR
27540,619590,PHOSPHOLIPID PHOSPHATASE-RELATED PROTEIN 1, PLPPR1
27541,619591,PHOSPHOLIPID PHOSPHATASE-RELATED PROTEIN 2, PLPPR2
27542,619593,CATARACT 49, CTRCT49
27543,619594,"EPIDERMOLYSIS BULLOSA SIMPLEX 2C, LOCALIZED", EBS2C
27544,619595,"DEVELOPMENTAL DELAY, HYPOTONIA, MUSCULOSKELETAL DEFECTS, AND BEHAVIORAL ABNORMALITIES", DEHMBA
27545,619596,OCIA DOMAIN-CONTAINING PROTEIN 1, OCIAD1
27546,619597,tRNA SELENOCYSTEINE 1-ASSOCIATED PROTEIN 1, TRNAU1AP
27547,619598,"RHIZOMELIC DYSPLASIA, AIN-NAZ TYPE", RHZDAN
27548,619599,"EPIDERMOLYSIS BULLOSA SIMPLEX 2D, GENERALIZED, INTERMEDIATE OR SEVERE, AUTOSOMAL RECESSIVE", EBS2D
27549,619600,AMINOPEPTIDASE O, AOPEP
27550,619601,BCDIN3 DOMAIN-CONTAINING RNA METHYLTRANSFERASE, BCDIN3D
27551,619602,"FETAL AKINESIA, RESPIRATORY INSUFFICIENCY, MICROCEPHALY, POLYMICROGYRIA, AND DYSMORPHIC FACIES", FARIMPD
27552,619603,GALLOWAY-MOWAT SYNDROME 9, GAMOS9
27553,619604,TRANSMEMBRANE PROTEIN 92, TMEM92
27554,619605,DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 98, DEE98
27555,619606,DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 99, DEE99
27556,619607,"HETEROTAXY, VISCERAL, 10, AUTOSOMAL, WITH MALE INFERTILITY", HTX10
27557,619608,"HETEROTAXY, VISCERAL, 11, AUTOSOMAL, WITH MALE INFERTILITY", HTX11
27558,619609,GALLOWAY-MOWAT SYNDROME 10, GAMOS10
27559,619610,KINESIN FAMILY MEMBER 19, KIF19
27560,619611,INTERSTITIAL LUNG DISEASE 1, ILD1
27561,619612,B-CELL RECEPTOR-ASSOCIATED PROTEIN 29, BCAP29
27562,619613,"DELAYED PUBERTY, SELF-LIMITED", DPSL
27563,619614,RETINITIS PIGMENTOSA 92, RP92
27564,619615,"DEAFNESS, AUTOSOMAL RECESSIVE 119", DFNB119
27565,619616,NEURODEVELOPMENTAL DISORDER WITH HEARING LOSS AND SPASTICITY, NEDHLS
27566,619617,EF-HAND CALCIUM-BINDING DOMAIN-CONTAINING PROTEIN 2, EFCAB2
27567,619618,LY6/PLAUR DOMAIN-CONTAINING PROTEIN 5, LYPD5
27568,619619,"SERPIN FAMILY A, MEMBER 11", SERPINA11
27569,619620,CHYMOTRYPSINOGEN B2, CTRB2
27570,619621,"SPASTIC PARAPLEGIA 84, AUTOSOMAL RECESSIVE", SPG84
27571,619622,LYMPHOCYTE TRANSMEMBRANE ADAPTOR 1, LAX1
27572,619623,LEUCINE-RICH REPEAT NEURONAL PROTEIN 1, LRRN1
27573,619624,LEMUR TYROSINE KINASE 3, LMTK3
27574,619625,CHROMOSOME 11 OPEN READING FRAME 58, C11ORF58
27575,619626,"METHYLTRANSFERASE 4, N6-ADENOSINE", METTL4
27576,619627,HEAT REPEAT-CONTAINING PROTEIN 5B, HEATR5B
27577,619628,AFTIPHILIN, AFTPH
27578,619629,"SMALL NUCLEAR RIBONUCLEOPROTEIN U4/U6.U5, SUBUNIT 27", SNRNP27
27579,619630,IMMUNODEFICIENCY 88, IMD88
27580,619631,"SMALL NUCLEAR RIBONUCLEOPROTEIN U11/U12, SUBUNIT 35", SNRNP35
27581,619632,IMMUNODEFICIENCY 89 AND AUTOIMMUNITY, IMD89
27582,619633,OCIA DOMAIN-CONTAINING PROTEIN 2, OCIAD2
27583,619634,O-SIALOGLYCOPROTEIN ENDOPEPTIDASE-LIKE 1, OSGEPL1
27584,619635,ZINC FINGER FYVE DOMAIN-CONTAINING PROTEIN 19, ZFYVE19
27585,619636,ACROMESOMELIC DYSPLASIA 4, AMD4
27586,619637,DYSTONIA 32, DYT32
27587,619638,"SPONDYLOMETAPHYSEAL DYSPLASIA, PAGNAMENTA TYPE", SMDP
27588,619639,NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA AND GROSS MOTOR AND SPEECH DELAY, NEDHMS
27589,619640,LYSINE DEMETHYLASE 7A, KDM7A
27590,619641,HENGEL-MAROOFIAN-SCHOLS SYNDROME, HEMARS
27591,619642,TRANSMEMBRANE p24 TRAFFICKING PROTEIN 2, TMED2
27592,619643,OOCYTE/ZYGOTE/EMBRYO MATURATION ARREST 11, OZEMA11
27593,619644,IMMUNODEFICIENCY 91 AND HYPERINFLAMMATION, IMD91
27594,619645,SPERMATOGENIC FAILURE 59, SPGF59
27595,619646,SPERMATOGENIC FAILURE 60, SPGF60
27596,619647,"DYSKINESIA WITH OROFACIAL INVOLVEMENT, AUTOSOMAL RECESSIVE", DSKOR
27597,619648,ZAKI SYNDROME, ZKS
27598,619649,CHROMOSOME 16q12 DUPLICATION SYNDROME,
27599,619650,VHL-LIKE PROTEIN, VHLL
27600,619651,NEURODEVELOPMENTAL DISORDER WITH HYPERKINETIC MOVEMENTS AND DYSKINESIA, NEDHYD
27601,619652,IMMUNODEFICIENCY 92, IMD92
27602,619653,"NEURODEVELOPMENTAL DISORDER, NONPROGRESSIVE, WITH SPASTICITY AND TRANSIENT OPISTHOTONUS", NEDSTO
27603,619654,CHROMOSOME 3 OPEN READING FRAME 33, C3ORF33
27604,619655,RIBOSOMAL PROTEIN L10-LIKE, RPL10L
27605,619656,LOEYS-DIETZ SYNDROME 6, LDS6
27606,619657,"CONGENITAL HEART DEFECTS, MULTIPLE TYPES, 8, WITH OR WITHOUT HETEROTAXY", CHTD8
27607,619658,"CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC, 7, WITH OR WITHOUT HEARING LOSS", PFIC7
27608,619659,SYNAPTOSOME-ASSOCIATED PROTEIN 47, SNAP47
27609,619660,BCL2-LIKE 15, BCL2L15
27610,619661,"LEUKOENCEPHALOPATHY, HEREDITARY DIFFUSE, WITH SPHEROIDS 2", HDLS2
27611,619662,"CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC, 8", PFIC8
27612,619663,UTP25 SMALL SUBUNIT PROCESSOR COMPONENT, UTP25
27613,619664,EF-HAND CALCIUM-BINDING DOMAIN-CONTAINING PROTEIN 6, EFCAB6
27614,619665,OVARIAN DYSGENESIS 9, ODG9
27615,619666,VILLIN-LIKE PROTEIN, VILL
27616,619667,"SOLUTE CARRIER FAMILY 35, MEMBER F6", SLC35F6
27617,619668,DEOXYRIBOSE-PHOSPHATE ALDOLASE, DERA
27618,619669,PIERCER OF MICROTUBULE WALL 2, PIERCE2
27619,619670,ALK AND LTK LIGAND 1, ALKAL1
27620,619671,ALK AND LTK LIGAND 2, ALKAL2
27621,619672,SPERMATOGENIC FAILURE 61, SPGF61
27622,619673,SPERMATOGENIC FAILURE 62, SPGF62
27623,619674,PROTEASE-ASSOCIATED DOMAIN-CONTAINING PROTEIN 1, PRADC1
27624,619675,U-BOX DOMAIN-CONTAINING PROTEIN 5, UBOX5
27625,619676,SPERM MICROTUBULE INNER PROTEIN 9, SPMIP9
27626,619677,CLAUDIN DOMAIN-CONTAINING PROTEIN 1, CLDND1
27627,619678,CHROMOSOME 22 OPEN READING FRAME 23, C22ORF23
27628,619679,TSSK6-ACTIVATING COCHAPERONE, TSACC
27629,619680,MARBACH-SCHAAF NEURODEVELOPMENTAL SYNDROME, MASNS
27630,619681,"DYSTONIA, EARLY-ONSET, AND/OR SPASTIC PARAPLEGIA", DYTSPG
27631,619682,ALL-TRANS RETINOIC ACID-INDUCED DIFFERENTIATION FACTOR, ATRAID
27632,619683,B-BOX- AND SPRY DOMAIN-CONTAINING PROTEIN, BSPRY
27633,619684,MITOCHONDRIA-LOCALIZED GLUTAMIC ACID-RICH PROTEIN, MGARP
27634,619685,"NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, SEIZURES, AND NEONATAL CHOLESTASIS", NEDMSC
27635,619686,"SPASTIC PARAPLEGIA 85, AUTOSOMAL RECESSIVE", SPG85
27636,619687,DYSTONIA 33, DYT33
27637,619688,"LEUKODYSTROPHY, HYPOMYELINATING, 23, WITH ATAXIA, DEAFNESS, LIVER DYSFUNCTION, AND DILATED CARDIOMYOPATHY", HLD23
27638,619689,SPERMATOGENIC FAILURE 63, SPGF63
27639,619690,BRUNET-WAGNER NEURODEVELOPMENTAL SYNDROME, BRUWAG
27640,619691,"TRICHOTHIODYSTROPHY 8, NONPHOTOSENSITIVE", TTD8
27641,619692,"TRICHOTHIODYSTROPHY 9, NONPHOTOSENSITIVE", TTD9
27642,619693,"AGAMMAGLOBULINEMIA 9, AUTOSOMAL RECESSIVE", AGM9
27643,619694,DEVELOPMENTAL DELAY WITH VARIABLE NEUROLOGIC AND BRAIN ABNORMALITIES, DENBA
27644,619695,RAUCH-STEINDL SYNDROME, RAUST
27645,619696,SPERMATOGENIC FAILURE 64, SPGF64
27646,619697,OOCYTE/ZYGOTE/EMBRYO MATURATION ARREST 12, OZEMA12
27647,619698,"MUCOPOLYSACCHARIDOSIS, TYPE X", MPS10
27648,619699,FERGUSON-BONNI NEURODEVELOPMENTAL SYNDROME, FERBON
27649,619700,CILIATED LEFT-RIGHT ORGANIZER PROTEIN CONTAINING ZP-N DOMAINS, CIROZ
27650,619701,YOON-BELLEN NEURODEVELOPMENTAL SYNDROME, YOBELN
27651,619702,"HETEROTAXY, VISCERAL, 12, AUTOSOMAL", HTX12
27652,619703,CILIATED LEFT-RIGHT ORGANIZER METALLOPEPTIDASE, CIROP
27653,619704,ZINC FINGER CCCH DOMAIN-CONTAINING PROTEIN 15, ZC3H15
27654,619705,IMMUNODEFICIENCY 93 AND HYPERTROPHIC CARDIOMYOPATHY, IMD93
27655,619706,LEUCINE-RICH REPEAT NEURONAL PROTEIN 4, LRRN4
27656,619707,"AGAMMAGLOBULINEMIA 10, AUTOSOMAL DOMINANT", AGM10
27657,619708,GASTROINTESTINAL DEFECTS AND IMMUNODEFICIENCY SYNDROME 2, GIDID2
27658,619709,KIAA0930 GENE, KIAA0930
27659,619710,HYALURONAN AND PROTEOGLYCAN LINK PROTEIN 4, HAPLN4
27660,619711,CHROMOSOME 19 OPEN READING FRAME 33, C19ORF33
27661,619712,SPERMATOGENIC FAILURE 65, SPGF65
27662,619713,"CADHERIN-RELATED FAMILY, MEMBER 2", CDHR2
27663,619714,"CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Iw, AUTOSOMAL DOMINANT", CDG1WAD
27664,619715,WIZ ZINC FINGER PROTEIN, WIZ
27665,619716,ACTIN-RELATED PROTEIN 8, ACTR8
27666,619717,"INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 73", MRT73
27667,619718,HYPOGONADOTROPIC HYPOGONADISM 26 WITH OR WITHOUT ANOSMIA, HH26
27668,619719,INTELLECTUAL DISABILITY AND MYOPATHY SYNDROME, IDMYS
27669,619720,BRYANT-LI-BHOJ NEURODEVELOPMENTAL SYNDROME 1, BRYLIB1
27670,619721,BRYANT-LI-BHOJ NEURODEVELOPMENTAL SYNDROME 2, BRYLIB2
27671,619722,TRANSMEMBRANE PROTEIN 53, TMEM53
27672,619723,SERINE CARBOXYPEPTIDASE 1, SCPEP1
27673,619724,"DYSTONIA 34, MYOCLONIC", DYT34
27674,619725,NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT VARIABLE MOVEMENT OR BEHAVIORAL ABNORMALITIES, NEDMAB
27675,619726,HYALURONAN AND PROTEOGLYCAN LINK PROTEIN 2, HAPLN2
27676,619727,"CRANIOTUBULAR DYSPLASIA, IKEGAWA TYPE", CTDI
27677,619728,"ABHYDROLASE DOMAIN-CONTAINING PROTEIN 4, N-ACYL PHOSPHOLIPASE B", ABHD4
27678,619729,ACTIN-RELATED PROTEIN 6, ACTR6
27679,619730,ACTIN-RELATED PROTEIN 5, ACTR5
27680,619731,ACTIN-RELATED PROTEIN 10, ACTR10
27681,619732,2-PHOSPHOXYLOSE PHOSPHATASE 1, PXYLP1
27682,619733,INCLUSION BODY MYOPATHY AND BRAIN WHITE MATTER ABNORMALITIES, IBMWMA
27683,619734,EPENDYMIN-RELATED PROTEIN 1, EPDR1
27684,619735,"SPASTIC PARAPLEGIA 86, AUTOSOMAL RECESSIVE", SPG86
27685,619736,TEEBI HYPERTELORISM SYNDROME 2, TBHS2
27686,619737,COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 54, COXPD54
27687,619738,"PARKINSONISM-DYSTONIA 3, CHILDHOOD-ONSET", PKDYS3
27688,619739,ASPARAGINE SYNTHETASE DOMAIN-CONTAINING PROTEIN 1, ASNSD1
27689,619740,ASNSD1 UPSTREAM OPEN READING FRAME, ASDURF
27690,619741,"ZINC FINGER, MATRIN-TYPE 5", ZMAT5
27691,619742,"CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1I", CMT1I
27692,619743,COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 55, COXPD55
27693,619744,ZINC FINGER CCHC DOMAIN-CONTAINING PROTEIN 17, ZCCHC17
27694,619745,NOONAN SYNDROME 14, NS14
27695,619746,ZINC FINGER C3HC-TYPE DOMAIN-CONTAINING PROTEIN 1, ZC3HC1
27696,619747,"CARDIOMYOPATHY, DILATED, 2F", CMD2F
27697,619748,LEUCINE-RICH REPEAT NEURONAL PROTEIN 3, LRRN3
27698,619749,"VEZATIN, ADHERENS JUNCTIONS TRANSMEMBRANE PROTEIN", VEZT
27699,619750,IMMUNODEFICIENCY 94 WITH AUTOINFLAMMATION AND DYSMORPHIC FACIES, IMD94
27700,619751,STUVE-WIEDEMANN SYNDROME 2, STWS2
27701,619752,"HYPER-IgE SYNDROME 4A, AUTOSOMAL DOMINANT, WITH RECURRENT INFECTIONS", HIES4A
27702,619753,"PYM HOMOLOG 1, EXON JUNCTION COMPLEX-ASSOCIATED FACTOR", PYM1
27703,619754,"YIP1 DOMAIN FAMILY, MEMBER 7", YIPF7
27704,619755,HYPOGONADOTROPIC HYPOGONADISM 27 WITHOUT ANOSMIA, HH27
27705,619756,UBIQUITIN-CONJUGATING ENZYME E2 J2, UBE2J2
27706,619757,ANKYRIN REPEAT- AND SOCS BOX-CONTAINING PROTEIN 15, ASB15
27707,619758,TESSADORI-BICKNELL-VAN HAAFTEN NEURODEVELOPMENTAL SYNDROME 1, TEBIVANED1
27708,619759,TESSADORI-BICKNELL-VAN HAAFTEN NEURODEVELOPMENTAL SYNDROME 2, TEBIVANED2
27709,619760,ATP23 METALLOPEPTIDASE AND ATP SYNTHASE ASSEMBLY FACTOR HOMOLOG, ATP23
27710,619761,"CEREBELLAR DYSFUNCTION, IMPAIRED INTELLECTUAL DEVELOPMENT, AND HYPOGONADOTROPIC HYPOGONADISM", CDIDHH
27711,619762,KURY-ISIDOR SYNDROME, KURIS
27712,619763,WD AND TETRATRICOPEPTIDE REPEATS PROTEIN 1, WDTC1
27713,619764,"CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1H", CMT1H
27714,619765,CRYSTALLIN BETA-GAMMA DOMAIN-CONTAINING PROTEIN 2, CRYBG2
27715,619766,YLP MOTIF-CONTAINING PROTEIN 1, YLPM1
27716,619767,"PULMONARY FIBROSIS AND/OR BONE MARROW FAILURE SYNDROME, TELOMERE-RELATED, 6", PFBMFT6
27717,619768,ARRESTIN DOMAIN-CONTAINING PROTEIN 1, ARRDC1
27718,619769,"MACROCEPHALY, NEURODEVELOPMENTAL DELAY, LYMPHOID HYPERPLASIA, AND PERSISTENT FETAL HEMOGLOBIN", MNDLFH
27719,619770,YDJC CHITOOLIGOSACCHARIDE DEACETYLASE HOMOLOG, YDJC
27720,619771,VRK SERINE/THREONINE KINASE 3, VRK3
27721,619772,PROTEASOMAL ATPase-ASSOCIATED FACTOR 1, PAAF1
27722,619773,IMMUNODEFICIENCY 95, IMD95
27723,619774,IMMUNODEFICIENCY 96, IMD96
27724,619775,CONGENITAL DISORDER OF DEGLYCOSYLATION 2, CDDG2
27725,619776,C2 CALCIUM-DEPENDENT DOMAIN-CONTAINING PROTEIN 6, C2CD6
27726,619777,DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 100, DEE100
27727,619778,ANKYRIN REPEAT DOMAIN-CONTAINING PROTEIN 42, ANKRD42
27728,619779,"AFAP1 ANTISENSE RNA 1, NONCODING", AFAP1AS1
27729,619780,MITOCHONDRIAL DNA DEPLETION SYNDROME 20 (MNGIE TYPE), MTDPS20
27730,619781,"MYOPIA 28, AUTOSOMAL RECESSIVE", MYP28
27731,619782,SPERM ACROSOME DEVELOPMENTAL REGULATOR, SPACDR
27732,619783,"EPIDERMOLYSIS BULLOSA, JUNCTIONAL 2A, INTERMEDIATE", JEB2A
27733,619784,"EPIDERMOLYSIS BULLOSA, JUNCTIONAL 2B, SEVERE", JEB2B
27734,619785,"EPIDERMOLYSIS BULLOSA, JUNCTIONAL 3A, INTERMEDIATE", JEB3A
27735,619786,"EPIDERMOLYSIS BULLOSA, JUNCTIONAL 3B, SEVERE", JEB3B
27736,619787,"EPIDERMOLYSIS BULLOSA, JUNCTIONAL 4, INTERMEDIATE", JEB4
27737,619788,ARRESTIN DOMAIN-CONTAINING PROTEIN 4, ARRDC4
27738,619789,"ANEMIA, CONGENITAL DYSERYTHROPOIETIC, TYPE IIIb, AUTOSOMAL RECESSIVE", CDAN3B
27739,619790,OCULOPHARYNGODISTAL MYOPATHY 4, OPDM4
27740,619791,"ATPase, PHOSPHOLIPID-TRANSPORTING, 10B", ATP10B
27741,619792,ATP SYNTHASE MEMBRANE SUBUNIT F, ATP5MF
27742,619793,RESTRICTIVE DERMOPATHY 2, RSDM2
27743,619794,VON WILLEBRAND FACTOR C DOMAIN-CONTAINING PROTEIN 2-LIKE, VWC2L
27744,619795,"OSTEOGENESIS IMPERFECTA, TYPE XXII", OI22
27745,619796,FLAGELLUM-ASSOCIATED PROTEIN CONTAINING COILED-COIL DOMAINS 1, FLACC1
27746,619797,NEURODEVELOPMENTAL DISORDER WITH CENTRAL HYPOTONIA AND DYSMORPHIC FACIES, NEDCHF
27747,619798,E74-LIKE ETS TRANSCRIPTION FACTOR 2, ELF2
27748,619799,SPERMATOGENIC FAILURE 66, SPGF66
27749,619800,HMG BOX-CONTAINING PROTEIN 3, HMGXB3
27750,619801,"RNA POLYMERASE III, SUBUNIT H", POLR3H
27751,619802,IMMUNODEFICIENCY 97 WITH AUTOINFLAMMATION, IMD97
27752,619803,SPERMATOGENIC FAILURE 67, SPGF67
27753,619804,"DEAFNESS, AUTOSOMAL DOMINANT 82", DFNA82
27754,619805,SPERMATOGENIC FAILURE 68, SPGF68
27755,619806,SPINOCEREBELLAR ATAXIA 49, SCA49
27756,619807,MYOSIN-BINDING PROTEIN H-LIKE, MYBPHL
27757,619808,"DEAFNESS, AUTOSOMAL DOMINANT 83", DFNA83
27758,619809,"UDP GLUCURONOSYLTRANSFERASE FAMILY 2, MEMBER A2", UGT2A2
27759,619810,"DEAFNESS, AUTOSOMAL DOMINANT 84", DFNA84
27760,619811,UHRF1-BINDING PROTEIN 1-LIKE, UHRF1BP1L
27761,619812,"BLOOD GROUP, EMM SYSTEM", EMM
27762,619813,"NEUTROPENIA, SEVERE CONGENITAL, 9, AUTOSOMAL DOMINANT", SCN9
27763,619814,DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 101, DEE101
27764,619815,"ATPase, PHOSPHOLIPID-TRANSPORTING, 10D", ATP10D
27765,619816,"EPIDERMOLYSIS BULLOSA, JUNCTIONAL 5A, INTERMEDIATE", JEB5A
27766,619817,"EPIDERMOLYSIS BULLOSA, JUNCTIONAL 6, WITH PYLORIC ATRESIA", JEB6
27767,619818,ELONGATION FACTOR 1, ELOF1
27768,619819,ZINC FINGER CCCH DOMAIN-CONTAINING PROTEIN 7A, ZC3H7A
27769,619820,ATONAL bHLH TRANSCRIPTION FACTOR 8, ATOH8
27770,619821,ENDONUCLEASE V, ENDOV
27771,619822,BCL2-LIKE 13, BCL2L13
27772,619823,"ACIDIC NUCLEAR PHOSPHOPROTEIN 32 FAMILY, MEMBER B", ANP32B
27773,619824,"AGAMMAGLOBULINEMIA 8B, AUTOSOMAL RECESSIVE", AGM8B
27774,619825,"AORTIC ANEURYSM, FAMILIAL THORACIC 12", AAT12
27775,619826,SPERMATOGENIC FAILURE 69, SPGF69
27776,619827,"INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 75, WITH NEUROPSYCHIATRIC FEATURES AND VARIANT LISSENCEPHALY", MRT75
27777,619828,SPERMATOGENIC FAILURE 70, SPGF70
27778,619829,COILED-COIL DOMAIN-CONTAINING PROTEIN 146, CCDC146
27779,619830,DEVELOPING BRAIN HOMEOBOX 1, DBX1
27780,619831,SPERMATOGENIC FAILURE 71, SPGF71
27781,619832,"AUDITORY NEUROPATHY, AUTOSOMAL DOMINANT 3", AUNA3
27782,619833,NEURODEVELOPMENTAL DISORDER WITH NEUROMUSCULAR AND SKELETAL ABNORMALITIES, NEDNMS
27783,619834,OVARIAN DYSGENESIS 10, ODG10
27784,619835,"3-METHYLGLUTACONIC ACIDURIA, TYPE VIIA", MGCA7A
27785,619836,"HYPOALPHALIPOPROTEINEMIA, PRIMARY, 2, INTERMEDIATE",
27786,619837,MORN REPEAT-CONTAINING PROTEIN 5, MORN5
27787,619838,TUBULIN TYROSINE LIGASE-LIKE 9, TTLL9
27788,619839,SORTING NEXIN 31, SNX31
27789,619840,"MACROTHROMBOCYTOPENIA, ISOLATED, 2, AUTOSOMAL DOMINANT", MACTHC2
27790,619841,CHILTON-OKUR-CHUNG NEURODEVELOPMENTAL SYNDROME, CHOCNS
27791,619842,RHO FAMILY-INTERACTING CELL POLARIZATION REGULATOR 1, RIPOR1
27792,619843,DENN DOMAIN-CONTAINING PROTEIN 4B, DENND4B
27793,619844,INTELLECTUAL DEVELOPMENTAL DISORDER WITH OR WITHOUT PERIPHERAL NEUROPATHY, IDDPN
27794,619845,RETINITIS PIGMENTOSA 93, RP93
27795,619846,IMMUNODEFICIENCY 99 WITH HYPOGAMMAGLOBULINEMIA AND AUTOIMMUNE CYTOPENIAS, IMD99
27796,619847,"NEURODEGENERATION, CHILDHOOD-ONSET, WITH PROGRESSIVE MICROCEPHALY", CONPM
27797,619848,TBCC DOMAIN-CONTAINING PROTEIN 1, TBCCD1
27798,619849,"CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC, 9", PFIC9
27799,619850,"ALPHA-1,3-GALACTOSYLTRANSFERASE 2", A3GALT2
27800,619851,"LEUKODYSTROPHY, HYPOMYELINATING, 24", HLD24
27801,619852,"GOLGI-ASSOCIATED RAB2 INTERACTOR FAMILY, MEMBER 4", GARIN4
27802,619853,FATTY ACID HYDROXYLASE DOMAIN-CONTAINING PROTEIN 2, FAXDC2
27803,619854,"NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, IMPAIRED SPEECH, AND BEHAVIORAL ABNORMALITIES", NEDHISB
27804,619855,"THYROID HORMONE METABOLISM, ABNORMAL, 2", THMA2
27805,619856,ANKYRIN REPEAT DOMAIN-CONTAINING PROTEIN 50, ANKRD50
27806,619857,SPERMATOGENESIS-ASSOCIATED PROTEIN 3, SPATA3
27807,619858,AUTOINFLAMMATORY-PANCYTOPENIA SYNDROME, AIPCS
27808,619859,PHOSPHORIBOSYLAMINOIMIDAZOLE CARBOXYLASE DEFICIENCY, PAICSD
27809,619860,DCSTAMP DOMAIN-CONTAINING PROTEIN 1, DCST1
27810,619861,DCSTAMP DOMAIN-CONTAINING PROTEIN 1, DCST2
27811,619862,"SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 32", SCAR32
27812,619863,JUNCTOPHILIN 4, JPH4
27813,619864,"LEUKODYSTROPHY, CHILDHOOD-ONSET, REMITTING", CORLK
27814,619865,TRANSMEMBRANE PROTEIN 14B, TMEM14B
27815,619866,CFAP97 DOMAIN-CONTAINING PROTEIN 1, CFAP97D1
27816,619867,SPERMATOGENIC FAILURE 72, SPGF72
27817,619868,"CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC, 10", PFIC10
27818,619869,NEUROCARDIOFACIODIGITAL SYNDROME, NCFD
27819,619870,COILED-COIL DOMAIN-CONTAINING PROTEIN 82, CCDC82
27820,619871,"CORNEAL DYSTROPHY, PUNCTIFORM AND POLYCHROMATIC PRE-DESCEMET", PPPCD
27821,619872,IMMUNODEFICIENCY 101 (VARICELLA ZOSTER VIRUS-SPECIFIC), IMD101
27822,619873,PARENTI-MIGNOT NEURODEVELOPMENTAL SYNDROME, PMNDS
27823,619874,"CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC, 11", PFIC11
27824,619875,"SOLUTE CARRIER ORGANIC ANION TRANSPORTER FAMILY, MEMBER 1B7", SLCO1B7
27825,619876,"NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, HYPOTONIA, NYSTAGMUS, AND SEIZURES", NEDMHS
27826,619877,DENTICI-NOVELLI NEURODEVELOPMENTAL SYNDROME, DENNED
27827,619878,SPERMATOGENIC FAILURE 73, SPGF73
27828,619879,MECKEL SYNDROME 14, MKS14
27829,619880,NEURODEVELOPMENTAL DISORDER WITH POOR GROWTH AND SKELETAL ANOMALIES, NEDGS
27830,619881,DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 102, DEE102
27831,619882,tRNA YW-SYNTHESIZING PROTEIN 5, TYW5
27832,619883,"GOLGI-ASSOCIATED RAB2B INTERACTOR FAMILY, MEMBER 3", GARIN3
27833,619884,"OSTEOPOROSIS, CHILDHOOD- OR JUVENILE-ONSET, WITH DEVELOPMENTAL DELAY", OPDD
27834,619885,TETRATRICOPEPTIDE REPEAT DOMAIN-CONTAINING PROTEIN 39A, TTC39A
27835,619886,R3H DOMAIN-CONTAINING PROTEIN 2, R3HDM2
27836,619887,RENAL HYPODYSPLASIA/APLASIA 4, RHDA4
27837,619888,"GASTRIC CARCINOMA PROLIFERATION-ENHANCING TRANSCRIPT 1, NONCODING", GHET1
27838,619889,T-COMPLEX PROTEIN 11-LIKE 2, TCP11L2
27839,619890,GOLGI-ASSOCIATED RAB2 INTERACTOR 5A, GARIN5A
27840,619891,WD REPEAT-CONTAINING PROTEIN 93, WDR93
27841,619892,ZINC FINGER ZZ-TYPE DOMAIN-CONTAINING PROTEIN 3, ZZZ3
27842,619893,"KELCH-LIKE FAMILY, MEMBER 25", KLHL25
27843,619894,ABHYDROLASE DOMAIN-CONTAINING PROTEIN 15, ABHD15
27844,619895,HOLOPROSENCEPHALY 14, HPE14
27845,619896,MICROTUBULE-ASSOCIATED TYROSINE CARBOXYPEPTIDASE 2, MATCAP2
27846,619897,"CARDIOMYOPATHY, DILATED, 2G", CMD2G
27847,619898,"GOLGI-ASSOCIATED RAB2 INTERACTOR FAMILY, MEMBER 2", GARIN2
27848,619899,NALCN CHANNEL AUXILIARY FACTOR 1, NALF1
27849,619900,KDEL ENDOPLASMIC RETICULUM PROTEIN RETENTION RECEPTOR 3, KDELR3
27850,619901,EUKARYOTIC TRANSLATION INITIATION FACTOR 1, EIF1
27851,619902,HEPATORENOCARDIAC DEGENERATIVE FIBROSIS, HRCDF
27852,619903,"PERIPHERAL MOTOR NEUROPATHY, CHILDHOOD-ONSET, BIOTIN-RESPONSIVE", COMNB
27853,619904,GOLGI-ASSOCIATED RAB2 INTERACTOR 1A, GARIN1A
27854,619905,GOLGI-ASSOCIATED RAB2 INTERACTOR 1B, GARIN1B
27855,619906,DExD-BOX HELICASE 39A, DDX39A
27856,619907,PHD FINGER PROTEIN 14, PHF14
27857,619908,NEURODEVELOPMENTAL DISORDER WITH LANGUAGE DELAY AND SEIZURES, NEDLDS
27858,619909,"PONTOCEREBELLAR HYPOPLASIA, TYPE 17", PCH17
27859,619910,"INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 66", MRD66
27860,619911,INTELLECTUAL DEVELOPMENTAL DISORDER WITH LANGUAGE IMPAIRMENT AND EARLY-ONSET DOPA-RESPONSIVE DYSTONIA-PARKINSONISM, IDLDP
27861,619912,MYOMIXER, MYMX
27862,619913,DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 103, DEE103
27863,619914,"SEL1L FAMILY, MEMBER 3", SEL1L3
27864,619915,RNA-BINDING MOTIF PROTEIN 34, RBM34
27865,619916,ZINC FINGER PROTEIN 799, ZNF799
27866,619917,SUSHI DOMAIN-CONTAINING PROTEIN 5, SUSD5
27867,619918,"TUBULIN, ALPHA-3E", TUBA3E
27868,619919,RHO GUANINE NUCLEOTIDE EXCHANGE FACTOR 38, ARHGEF38
27869,619920,ANKYRIN REPEAT- AND DEATH DOMAIN-CONTAINING PROTEIN 1B, ANKDD1B
27870,619921,"DYSTONIA 35, CHILDHOOD-ONSET", DYT35
27871,619922,NEURODEVELOPMENTAL DISORDER WITH DYSTONIA AND SEIZURES, NEDDS
27872,619923,"PROTEIN PHOSPHATASE 1, REGULATORY SUBUNIT 36", PPP1R36
27873,619924,"IMMUNODEFICIENCY 105, SEVERE COMBINED", IMD105
27874,619925,"WASH COMPLEX, SUBUNIT 3", WASHC3
27875,619926,"KELCH-LIKE FAMILY, MEMBER 18", KLHL18
27876,619927,"INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 67", MRD67
27877,619928,PHD FINGER PROTEIN 24, PHF24
27878,619929,TESTIS-EXPRESSED GENE 2, TEX2
27879,619930,"ZINC FINGER, MATRIN-TYPE 2", ZMAT2
27880,619931,"INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 76", MRT76
27881,619932,GLUCOSE-FRUCTOSE OXIDOREDUCTASE DOMAIN-CONTAINING PROTEIN 1, GFOD1
27882,619933,GLUCOSE-FRUCTOSE OXIDOREDUCTASE DOMAIN-CONTAINING PROTEIN 2, GFOD2
27883,619934,"INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 68", MRD68
27884,619935,"IMMUNODEFICIENCY 106, SUSCEPTIBILITY TO VIRAL INFECTIONS", IMD106
27885,619936,ANKYRIN REPEAT- AND SOCS BOX-CONTAINING PROTEIN 17, ASB17
27886,619937,SPERMATOGENIC FAILURE 74, SPGF74
27887,619938,PREMATURE OVARIAN FAILURE 20, POF20
27888,619939,"OLFACTORY RECEPTOR, FAMILY 4, SUBFAMILY M, MEMBER 1", OR4M1
27889,619940,XK-RELATED PROTEIN 8, XKR8
27890,619941,CAREY-FINEMAN-ZITER SYNDROME 2, CFZS2
27891,619942,ZINC FINGER PROTEIN 541, ZNF541
27892,619943,POTASSIUM CHANNEL TETRAMERIZATION DOMAIN-CONTAINING PROTEIN 19, KCTD19
27893,619944,COILED-COIL SERINE-RICH PROTEIN 2, CCSER2
27894,619945,"FAMILY WITH SEQUENCE SIMILARITY 184, MEMBER B", FAM184B
27895,619946,MCF.2 CELL LINE-DERIVED TRANSFORMING SEQUENCE-LIKE 2, MCF2L2
27896,619947,"WAARDENBURG SYNDROME, TYPE 2F", WS2F
27897,619948,INTERACTION PROTEIN FOR CYTOHESIN EXCHANGE FACTORS 1, IPCEF1
27898,619949,SPERMATOGENIC FAILURE 75, SPGF75
27899,619950,TESSADORI-BICKNELL-VAN HAAFTEN NEURODEVELOPMENTAL SYNDROME 3, TEBIVANED3
27900,619951,TESSADORI-BICKNELL-VAN HAAFTEN NEURODEVELOPMENTAL SYNDROME 4, TEBIVANED4
27901,619952,TRANSMEMBRANE PROTEIN 63B, TMEM63B
27902,619953,TRANSMEMBRANE PROTEIN 63C, TMEM63C
27903,619954,SYNAPTONEMAL COMPLEX CENTRAL ELEMENT PROTEIN 1-LIKE, SYCE1L
27904,619955,DWORSCHAK-PUNETHA NEURODEVELOPMENTAL SYNDROME, DWOPNED
27905,619956,PIGY UPSTREAM OPEN READING FRAME, PYURF
27906,619957,ATTENTION DEFICIT-HYPERACTIVITY DISORDER 8, ADHD8
27907,619958,GLYCOSYLATED LYSOSOMAL MEMBRANE PROTEIN, GLMP
27908,619959,ACCES SYNDROME, ACCES
27909,619960,RAB5-INTERACTING FACTOR, RAB5IF
27910,619961,FORKHEAD BOX B1, FOXB1
27911,619962,FORKHEAD BOX B2, FOXB2
27912,619963,ANOCTAMIN 9, ANO9
27913,619964,"DEVELOPMENTAL DELAY, IMPAIRED SPEECH, AND BEHAVIORAL ABNORMALITIES, WITH OR WITHOUT SEIZURES", DEDISB
27914,619965,ALPHA KINASE 2, ALPK2
27915,619966,"SPASTIC PARAPLEGIA 87, AUTOSOMAL RECESSIVE", SPG87
27916,619967,CONGENITAL MYOPATHY 11, CMYO11
27917,619968,ACYL-CoA-BINDING DOMAIN-CONTAINING PROTEIN 4, ACBD4
27918,619969,ZINC FINGER- AND BTB DOMAIN-CONTAINING PROTEIN 47, ZBTB47
27919,619970,DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 104, DEE104
27920,619971,NEURODEVELOPMENTAL DISORDER WITH EPILEPSY AND BRAIN ATROPHY, NEDEBA
27921,619972,"NEURODEVELOPMENTAL DISORDER WITH SEVERE MOTOR IMPAIRMENT, ABSENT LANGUAGE, CEREBRAL HYPOMYELINATION, AND BRAIN ATROPHY", NEDMLHB
27922,619973,"DNAJ/HSP40 HEAT-SHOCK PROTEIN FAMILY, MEMBER C16", DNAJC16
27923,619974,ESPIN-LIKE PROTEIN, ESPNL
27924,619975,TUMOR PREDISPOSITION SYNDROME 2, TPDS2
27925,619976,MAJOR FACILITATOR SUPERFAMILY DOMAIN-CONTAINING PROTEIN 1, MFSD1
27926,619977,"MACULAR DYSTROPHY, RETINAL, 4", MCDR4
27927,619978,MICROTUBULE-ASSOCIATED TYROSINE CARBOXYPEPTIDASE 1, MATCAP1
27928,619979,CHROMOSOME 18 OPEN READING FRAME 32, C18ORF32
27929,619980,BRADDOCK-CAREY SYNDROME 1, BRDCS1
27930,619981,BRADDOCK-CAREY SYNDROME 2, BRDCS2
27931,619982,VIM ANTISENSE RNA 1, VIMAS1
27932,619983,DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 105 WITH HYPOPITUITARISM, DEE105
27933,619984,"NUCLEAR PORE COMPLEX-INTERACTING PROTEIN FAMILY, MEMBER B3", NPIPB3
27934,619985,GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 25, GPIBD25
27935,619986,"IMMUNODEFICIENCY 107, SUSCEPTIBILITY TO INVASIVE STAPHYLOCOCCUS AUREUS INFECTION", IMD107
27936,619987,NOTCH-REGULATED ANKYRIN REPEAT-CONTAINING PROTEIN, NRARP
27937,619988,"INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 77", MRT77
27938,619989,NEURODEVELOPMENTAL DISORDER WITH SPEECH DELAY AND VARIABLE OCULAR ANOMALIES, NEDSOA
27939,619990,TRANSMEMBRANE p24 TRAFFICKING PROTEIN 7, TMED7
27940,619991,"LIVER DISEASE, SEVERE CONGENITAL", SCOLIV
27941,619992,CHROMOSOME 3 OPEN READING FRAME 20, C3ORF20
27942,619993,PROLINE-RICH TRANSMEMBRANE PROTEIN 3, PRRT3
27943,619994,"DYNEIN LIGHT CHAIN, TCTEX-TYPE FAMILY, MEMBER 5", DYNLT5
27944,619995,"NEURODEVELOPMENTAL DISORDER WITH INTENTION TREMOR, PYRAMIDAL SIGNS, DYSPRAXIA, AND OCULAR ANOMALIES", NEDITPO
27945,619996,ARGININE- AND SERINE-RICH COILED-COIL PROTEIN 2, RSRC2
27946,619997,"SOLUTE CARRIER FAMILY 35, MEMBER F5", SLC35F5
27947,619998,NUCLEOPORIN 42, NUP42
27948,619999,"N-ALPHA-ACETYLTRANSFERASE 40, NatD CATALYTIC SUBUNIT", NAA40
27949,620000,TRANSMEMBRANE PROTEIN 167A, TMEM167A
27950,620001,"NEURODEVELOPMENTAL DISORDER WITH SPASTICITY, SEIZURES, AND BRAIN ABNORMALITIES", NEDSSBA
27951,620002,CHROMOSOME 5 OPEN READING FRAME 47, C5ORF47
27952,620003,"TBC1 DOMAIN FAMILY, MEMBER 12", TBC1D12
27953,620004,NMRA-LIKE REDOX SENSOR 1, NMRAL1
27954,620005,PRIMORDIAL DWARFISM-IMMUNODEFICIENCY-LIPODYSTROPHY SYNDROME, PDIL
27955,620006,RAD54-LIKE 2, RAD54L2
27956,620007,INTELLECTUAL DEVELOPMENTAL DISORDER WITH MUSCLE TONE ABNORMALITIES AND DISTAL SKELETAL DEFECTS, IDDMDS
27957,620008,H2A.Z VARIANT HISTONE 2, H2AZ2
27958,620009,"KERATODERMA-ICHTHYOSIS-DEAFNESS SYNDROME, AUTOSOMAL RECESSIVE", KDIDAR
27959,620010,"CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC, 12", PFIC12
27960,620011,"NEURONOPATHY, DISTAL HEREDITARY MOTOR, AUTOSOMAL RECESSIVE 6", HMNR6
27961,620012,"DEVELOPMENTAL DELAY, HYPOTONIA, AND IMPAIRED LANGUAGE", DEDHIL
27962,620013,"RIBOSOMAL RNA-PROCESSING 9, U3 SMALL NUCLEOLAR RNA-BINDING PROTEIN", RRP9
27963,620014,LYMPHATIC MALFORMATION 12, LMPHM12
27964,620015,"ADVANCE SLEEP PHASE SYNDROME, FAMILIAL, 4", FASPS4
27965,620016,MAX DIMERIZATION PROTEIN 4, MXD4
27966,620017,NURIM, NRM
27967,620018,"PROTEIN DISULFIDE ISOMERASE, FAMILY A, MEMBER 4", PDIA4
27968,620019,"ARTHROGRYPOSIS, DISTAL, TYPE 11", DA11
27969,620020,G3BP STRESS GRANULE ASSEMBLY FACTOR 2, G3BP2
27970,620021,INTELLECTUAL DEVELOPMENTAL DISORDER WITH AUTISM AND DYSMORPHIC FACIES, IDDADF
27971,620022,"STICKLER SYNDROME, TYPE VI", STL6
27972,620023,"NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, MOVEMENT ABNORMALITIES, AND SEIZURES", NEDMIMS
27973,620024,"NEURODEVELOPMENTAL DISORDER WITH SEIZURES, MICROCEPHALY, AND BRAIN ABNORMALITIES", NEDSMBA
27974,620025,"DIAPHRAGMATIC HERNIA 4, WITH CARDIOVASCULAR DEFECTS", DIH4
27975,620026,ZINC FINGER- AND SCAN DOMAIN-CONTAINING PROTEIN 1, ZSCAN1
27976,620027,"NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, SHORT STATURE, AND SPEECH DELAY", NEDMISS
27977,620028,DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 106, DEE106
27978,620029,"NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, LANGUAGE DELAY, AND SKELETAL DEFECTS WITH OR WITHOUT SEIZURES", NEDHLSS
27979,620030,ARGININE- AND SERINE-RICH PROTEIN 1, RSRP1
27980,620031,POLYHOMEOTIC HOMOLOG 3, PHC3
27981,620032,"CILIARY DYSKINESIA, PRIMARY, 48, WITHOUT SITUS INVERSUS", CILD48
27982,620033,DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 107, DEE107
27983,620034,NIPA-LIKE DOMAIN-CONTAINING PROTEIN 3, NIPAL3
27984,620035,"SMAD5 ANTISENSE RNA 1, NONCODING", SMAD5AS1
27985,620036,IMMEDIATE-EARLY RESPONSE GENE 2, IER2
27986,620037,"FAMILY WITH SEQUENCE SIMILARITY 193, MEMBER A", FAM193A
27987,620038,"NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, HYPOTONIA, AND ABSENT LANGUAGE", NEDMHAL
27988,620039,POGO TRANSPOSABLE ELEMENT-DERIVED PROTEIN WITH KRAB DOMAIN, POGK
27989,620040,"DYSKERATOSIS CONGENITA, DIGENIC", DKCD
27990,620041,"5-PRIME-NUCLEOTIDASE, CYTOSOLIC IIIB", NT5C3B
27991,620042,PHYTANOYL-CoA DIOXYGENASE DOMAIN-CONTAINING PROTEIN 1, PHYHD1
27992,620043,RETINOL DEHYDROGENASE 16, RDH16
27993,620044,BONE MARROW FAILURE AND DIABETES MELLITUS SYNDROME, BMFDMS
27994,620045,INTESTINAL DYSMOTILITY SYNDROME, IDMTS
27995,620046,"PROFILIN FAMILY, MEMBER 4", PFN4
27996,620047,"MICROCEPHALY 29, PRIMARY, AUTOSOMAL RECESSIVE", MCPH29
27997,620048,RETENTION IN ENDOPLASMIC RETICULUM SORTING RECEPTOR 1, RER1
27998,620049,"NEPHROTIC SYNDROME, TYPE 26", NPHS26
27999,620050,PHD FINGER PROTEIN 20-LIKE 1, PHF20L1
28000,620051,"RING FINGER PROTEIN 41, E3 UBIQUITIN PROTEIN LIGASE", RNF41
28001,620052,ENDOSOMAL TRANSMEMBRANE EPSIN INTERACTOR 2, ENTREP2
28002,620053,LONG INTERGENIC NONCODING RNA 974, LINC00974
28003,620054,PHD FINGER PROTEIN 13, PHF13
28004,620055,"PWP1 HOMOLOG, ENDONUCLEIN", PWP1
28005,620056,POLYCYSTIC KIDNEY DISEASE 7, PKD7
28006,620057,PHD FINGER PROTEIN 7, PHF7
28007,620058,FAMILIAL APOLIPOPROTEIN GENE CLUSTER DELETION SYNDROME,
28008,620059,LONG INTERGENIC NONCODING RNA 472, LINC00472
28009,620060,TETRATRICOPEPTIDE REPEAT DOMAIN-CONTAINING PROTEIN 7B, TTC7B
28010,620061,CDK2-ASSOCIATED PROTEIN 2, CDK2AP2
28011,620062,"DEVELOPMENTAL DELAY WITH SHORT STATURE, DYSMORPHIC FACIAL FEATURES, AND SPARSE HAIR 2", DEDSSH2
28012,620063,"DNA POLYMERASE ALPHA-2, ACCESSORY SUBUNIT", POLA2
28013,620064,OXOEICOSANOID RECEPTOR 1, OXER1
28014,620065,"DEVELOPMENTAL DELAY, BEHAVIORAL ABNORMALITIES, AND NEUROPSYCHIATRIC DISORDERS", DEDBANP
28015,620066,"NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, CEREBRAL ATROPHY, AND VISUAL IMPAIRMENT", NEDMVIC
28016,620067,CARDIAC VALVULAR DYSPLASIA 2, CVDP2
28017,620068,"CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2II", CMT2II
28018,620069,ANKYRIN REPEAT- AND IBR DOMAIN-CONTAINING PROTEIN 1, ANKIB1
28019,620070,"NEURODEVELOPMENTAL DISORDER WITH SHORT STATURE, PROMINENT FOREHEAD, AND FEEDING DIFFICULTIES", NEDSFF
28020,620071,BIRK-AHARONI SYNDROME, BKAH
28021,620072,DIAMOND-BLACKFAN ANEMIA 21, DBA21
28022,620073,NEURODEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND SKELETAL AND BRAIN ABNORMALITIES, NEDDFSB
28023,620074,LTV1 RIBOSOME BIOGENESIS FACTOR, LTV1
28024,620075,"NEURODEVELOPMENTAL DISORDER WITH FACIAL DYSMORPHISM, ABSENT LANGUAGE, AND PSEUDO-PELGER-HUET ANOMALY", NEDFLPH
28025,620076,BENT BONE DYSPLASIA SYNDROME 2, BBDS2
28026,620077,PROTEIN-L-ISOASPARTATE (D-ASPARTATE) O-METHYLTRANSFERASE DOMAIN-CONTAINING PROTEIN 2, PCMTD2
28027,620078,"FAMILY WITH SEQUENCE SIMILARITY 168, MEMBER B", FAM168B
28028,620079,LONG INTERGENIC NONCODING RNA 467, LINC00467
28029,620080,"NEURONOPATHY, DISTAL HEREDITARY MOTOR, AUTOSOMAL DOMINANT 10", HMND10
28030,620081,RNA-BINDING MOTIF PROTEIN 26, RBM26
28031,620082,RNA-BINDING MOTIF PROTEIN 27, RBM27
28032,620083,NEURODEVELOPMENTAL DISORDER WITH CRANIOFACIAL DYSMORPHISM AND SKELETAL DEFECTS, NEDCDS
28033,620084,SPERMATOGENIC FAILURE 76, SPGF76
28034,620085,HYPERMETABOLISM DUE TO UNCOUPLED MITOCHONDRIAL OXIDATIVE PHOSPHORYLATION 2, HUMOP2
28035,620086,INTELLECTUAL DEVELOPMENTAL DISORDER WITH OCULAR ANOMALIES AND DISTINCTIVE FACIAL FEATURES, IDDOF
28036,620087,DDB1- AND CUL4-ASSOCIATED FACTOR 12, DCAF12
28037,620088,"WWC2 ANTISENSE RNA 1, NONCODING", WWC2AS1
28038,620089,"NEURODEGENERATION, CHILDHOOD-ONSET, WITH MULTISYSTEM INVOLVEMENT DUE TO MITOCHONDRIAL DYSFUNCTION", CONDMIM
28039,620090,ZINC FINGER PROTEIN 675, ZNF675
28040,620091,PROTEIN-L-ISOASPARTATE (D-ASPARTATE) O-METHYLTRANSFERASE DOMAIN-CONTAINING PROTEIN 1, PCMTD1
28041,620092,"MIER FAMILY, MEMBER 2", MIER2
28042,620093,ACTIN MATURATION PROTEASE, ACTMAP
28043,620094,NEURODEVELOPMENTAL DISORDER WITH EYE MOVEMENT ABNORMALITIES AND ATAXIA, NEDEMA
28044,620095,ZINC FINGER CCHC DOMAIN-CONTAINING PROTEIN 2, ZCCHC2
28045,620096,RING FINGER PROTEIN 185, RNF185
28046,620097,PHOSPHOLIPASE B DOMAIN CONTAINING 2, PLBD2
28047,620098,DEVELOPMENTAL DELAY WITH VARIABLE INTELLECTUAL DISABILITY AND DYSMORPHIC FACIES, DIDDF
28048,620099,CLEIDOCRANIAL DYSPLASIA 2, CLCD2
28049,620100,"MIER FAMILY, MEMBER 3", MIER3
28050,620101,"RAS HOMOLOG FAMILY, MEMBER V", RHOV
28051,620102,RETINITIS PIGMENTOSA 95, RP95
28052,620103,SPERMATOGENIC FAILURE 77, SPGF77
28053,620104,"AMELOGENESIS IMPERFECTA, TYPE IK", AI1K
28054,620105,"C-TYPE LECTIN DOMAIN FAMILY 4, MEMBER F", CLEC4F
28055,620106,"SPASTIC PARAPLEGIA 88, AUTOSOMAL DOMINANT", SPG88
28056,620107,OROFACIODIGITAL SYNDROME XIX, OFD19
28057,620108,TRANSMEMBRANE PROTEIN 151A, TMEM151A
28058,620109,DDB1- AND CUL4-ASSOCIATED FACTOR 15, DCAF15
28059,620110,WW AND C2 DOMAINS-CONTAINING PROTEIN 2, WWC2
28060,620111,"CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1J", CMT1J
28061,620112,"APOA1 ANTISENSE RNA, NONCODING", APOA1AS
28062,620113,"NEURODEVELOPMENTAL DISORDER WITH GROWTH RETARDATION, DYSMORPHIC FACIES, AND CORPUS CALLOSUM ABNORMALITIES", NEDGFC
28063,620114,NEURODEVELOPMENTAL DISORDER WITH SPEECH IMPAIRMENT AND WITH OR WITHOUT SEIZURES, NEDSIS
28064,620115,DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 108, DEE108
28065,620116,"FATTY LIVER DISEASE, PROTECTION FROM", FLDP
28066,620117,MICRO RNA 887, MIR887
28067,620118,ZINC FINGER PROTEIN 490, ZNF490
28068,620119,LONG NONCODING RNA CRYBG3,
28069,620120,DENN DOMAIN-CONTAINING PROTEIN 2A, DENND2A
28070,620121,"IRON OVERLOAD, SUSCEPTIBILITY TO", IO
28071,620122,DENN DOMAIN-CONTAINING PROTEIN 11, DENND11
28072,620123,FIBROSIN-LIKE 1, FBRSL1
28073,620124,ZINC FINGER PROTEIN 492, ZNF492
28074,620125,"PSEUDOHYPOALDOSTERONISM, TYPE IB2, AUTOSOMAL RECESSIVE", PHA1B2
28075,620126,"PSEUDOHYPOALDOSTERONISM, TYPE IB3, AUTOSOMAL RECESSIVE", PHA1B3
28076,620127,MICRO RNA 151A, MIR151A
28077,620128,FOLLISTATIN-LIKE 5, FSTL5
28078,620129,NYN DOMAIN- AND RETROVIRAL INTEGRASE-CONTAINING PROTEIN, NYNRIN
28079,620130,OUTER DENSE FIBER OF SPERM TAILS 2-LIKE PROTEIN, ODF2L
28080,620131,"DEFENSIN, BETA, 126", DEFB126
28081,620132,ZINC FINGER SWIM DOMAIN-CONTAINING PROTEIN 5, ZSWIM5
28082,620133,"DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 8", DKCB8
28083,620134,PLECKSTRIN HOMOLOGY DOMAIN- AND RhoGEF DOMAIN-CONTAINING PROTEIN G1, PLEKHG1
28084,620135,"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 39", MC1DN39
28085,620136,NUDC DOMAIN-CONTAINING PROTEIN 2, NUDCD2
28086,620137,"MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 11", MC3DN11
28087,620138,"MYOPATHY WITH MYALGIA, INCREASED SERUM CREATINE KINASE, AND WITH OR WITHOUT EPISODIC RHABDOMYOLYSIS 1", MMCKR1
28088,620139,COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 56, COXPD56
28089,620140,SYNCOLLIN, SYCN
28090,620141,"DEVELOPMENTAL DELAY, LANGUAGE IMPAIRMENT, AND OCULAR ABNORMALITIES", DEVLO
28091,620142,CENTROSOMAL AT-AC SPLICING FACTOR, CENATAC
28092,620143,TRANSMEMBRANE PROTEIN 232, TMEM232
28093,620144,CACHE DOMAIN-CONTAINING PROTEIN 1, CACHD1
28094,620145,DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 109, DEE109
28095,620146,CRYSTALLIN BETA-GAMMA DOMAIN-CONTAINING PROTEIN 3, CRYBG3
28096,620147,RNA-BINDING MOTIF PROTEIN 46, RBM46
28097,620148,"ICHTHYOSIS, ANNULAR EPIDERMOLYTIC, 2", AEI2
28098,620149,DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 110, DEE110
28099,620150,"EPIDERMOLYTIC HYPERKERATOSIS 2A, AUTOSOMAL DOMINANT", EHK2A
28100,620151,WOLMAN DISEASE, WOLD
28101,620152,"HYPOMAGNESEMIA 7, RENAL, WITH OR WITHOUT DILATED CARDIOMYOPATHY", HOMG7
28102,620153,MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 4, MVA4
28103,620154,OOCYTE/ZYGOTE/EMBRYO MATURATION ARREST 13, OZEMA13
28104,620155,RABIN-PAPPAS SYNDROME, RAPAS
28105,620156,"CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 11", CDCBM11
28106,620157,"INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 70", MRD70
28107,620158,SPINOCEREBELLAR ATAXIA 50, SCA50
28108,620159,"PNMA FAMILY, MEMBER 8B", PNMA8B
28109,620160,IQ MOTIF-CONTAINING PROTEIN N, IQCN
28110,620161,CONGENITAL MYOPATHY 15, CMYO15
28111,620162,ZINC FINGER PROTEIN 471, ZNF471
28112,620163,ZFP14 ZINC FINGER PROTEIN, ZFP14
28113,620164,ZINC FINGER- AND BTB DOMAIN-CONTAINING PROTEIN 26, ZBTB26
28114,620165,LEUCINE-RICH REPEATS- AND CALPONIN HOMOLOGY DOMAIN-CONTAINING PROTEIN 4, LRCH4
28115,620166,"MUSCULAR DYSTROPHY, CONGENITAL, WITH OR WITHOUT SEIZURES", MYOS
28116,620167,COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 57, COXPD57
28117,620168,ATOS HOMOLOG A, ATOSA
28118,620169,ATOS HOMOLOG B, ATOSB
28119,620170,SPERMATOGENIC FAILURE 78, SPGF78
28120,620171,NHS-LIKE PROTEIN 1, NHSL1
28121,620172,NACHT DOMAIN- AND WD REPEAT-CONTAINING PROTEIN 2, NWD2
28122,620173,"TOOTH AGENESIS, SELECTIVE, 10", STHAG10
28123,620174,"SPINOCEREBELLAR ATAXIA 27B, LATE-ONSET", SCA27B
28124,620175,RUBICON-LIKE AUTOPHAGY ENHANCER, RUBCNL
28125,620176,DEAD-BOX HELICASE 55, DDX55
28126,620177,HYPOTRICHOSIS 15, HYPT15
28127,620178,GRAM DOMAIN-CONTAINING PROTEIN 1A, GRAMD1A
28128,620179,GRAM DOMAIN-CONTAINING PROTEIN 1B, GRAMD1B
28129,620180,GRAM DOMAIN-CONTAINING PROTEIN 1C, GRAMD1C
28130,620181,GRAM DOMAIN-CONTAINING PROTEIN 2A, GRAMD2A
28131,620182,GRAM DOMAIN-CONTAINING PROTEIN 2B, GRAMD2B
28132,620183,"MICROCEPHALY 30, PRIMARY, AUTOSOMAL RECESSIVE", MCPH30
28133,620184,ATELIS SYNDROME 1, ATELS1
28134,620185,ATELIS SYNDROME 2, ATELS2
28135,620186,"BRANCHIAL ARCH ABNORMALITIES, CHOANAL ATRESIA, ATHELIA, HEARING LOSS, AND HYPOTHYROIDISM SYNDROME", BCAHH
28136,620187,CILIA- AND FLAGELLA-ASSOCIATED PROTEIN 74, CFAP74
28137,620188,TRANSPORT AND GOLGI ORGANIZATION 6 HOMOLOG, TANGO6
28138,620189,MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 7 WITH INFLAMMATION AND TUMOR PREDISPOSITION, MVA7
28139,620190,ABHYDROLASE DOMAIN-CONTAINING PROTEIN 16B, ABHD16B
28140,620191,"NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, DYSMORPHIC FACIES, AND SKIN ABNORMALITIES", NEDHFS
28141,620192,LACRIMOAURICULODENTODIGITAL SYNDROME 2, LADD2
28142,620193,LACRIMOAURICULODENTODIGITAL SYNDROME 3, LADD3
28143,620194,"NEURODEVELOPMENTAL DISORDER WITH POOR GROWTH, LARGE EARS, AND DYSMORPHIC FACIES", NEDGEF
28144,620195,OBESITY AND HYPOPIGMENTATION, OBHP
28145,620196,SPERMATOGENIC FAILURE 79, SPGF79
28146,620197,"CILIARY DYSKINESIA, PRIMARY, 49, WITHOUT SITUS INVERSUS", CILD49
28147,620198,"THYROID HORMONE METABOLISM, ABNORMAL, 3", THMA3
28148,620199,INFLAMMATORY POIKILODERMA WITH HAIR ABNORMALITIES AND ACRAL KERATOSES, IPHAK
28149,620200,"CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIy", CDG2Y
28150,620201,"CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIz", CDG2Z
28151,620202,VESICLE AMINE TRANSPORT PROTEIN 1-LIKE, VAT1L
28152,620203,"CARDIOMYOPATHY, DILATED, 2H", CMD2H
28153,620204,"RNA, U12 SMALL NUCLEAR", RNU12
28154,620205,"INOSITOL 1,4,5-TRISPHOSPHATE RECEPTOR-INTERACTING PROTEIN", ITPRIP
28155,620206,STERILE ALPHA MOTIF-DOMAIN CONTAINING PROTEIN 1, SAMD1
28156,620207,"BLOOD GROUP, ER", ER
28157,620208,"SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 33", SCAR33
28158,620209,HECT DOMAIN E3 UBIQUITIN PROTEIN LIGASE 4, HECTD4
28159,620210,NEURODEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND ISCHIOPUBIC HYPOPLASIA, NEDFIH
28160,620211,"HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 8", HHF8
28161,620212,SH3 DOMAIN-BINDING KINASE 1, SBK1
28162,620213,SANT AND BTB DOMAIN REGULATOR OF CSR, SANBR
28163,620214,HHIP-LIKE 2, HHIPL2
28164,620215,MEMBRANE INTEGRAL NOTCH2-ASSOCIATED RECEPTOR 2, MINAR2
28165,620216,"SOLUTE CARRIER FAMILY 5 (SODIUM/GLUCOSE COTRANSPORTER), MEMBER 9", SLC5A9
28166,620217,"CENTROSOMAL PROTEIN, 44-KD", CEP44
28167,620218,SHISA-LIKE 2A, SHISAL2A
28168,620219,SHISA-LIKE 2B, SHISAL2B
28169,620220,SHISA-LIKE 1, SHISAL1
28170,620221,"SPASTIC PARAPLEGIA 79A, AUTOSOMAL DOMINANT, WITH ATAXIA", SPG79A
28171,620222,SPERMATOGENIC FAILURE 80, SPGF80
28172,620223,EXTRACELLULAR LEUCINE-RICH REPEAT AND FIBRONECTIN TYPE III DOMAIN-CONTAINING PROTEIN 2, ELFN2
28173,620224,"NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, DYSMORPHIC FACIES, AND SKELETAL ANOMALIES, WITH OR WITHOUT SEIZURES", NEDFSS
28174,620225,"SUPPRESSOR OF GLUCOSE, AUTOPHAGY-ASSOCIATED PROTEIN 1", SOGA1
28175,620226,UBIQUITIN-SPECIFIC PEPTIDASE 37, USP37
28176,620227,"DEAFNESS, AUTOSOMAL DOMINANT 85", DFNA85
28177,620228,RETINITIS PIGMENTOSA 96, RP96
28178,620229,FHF COMPLEX SUBUNIT HOOK-INTERACTING PROTEIN 1B, FHIP1B
28179,620230,FHF COMPLEX SUBUNIT HOOK-INTERACTING PROTEIN 2B, FHIP2B
28180,620231,SHORT QT SYNDROME 7, SQT7
28181,620232,"JOINT CONTRACTURES, OSTEOCHONDROMAS, AND B-CELL LYMPHOMA", JCOSL
28182,620233,"RESPIRATORY INFECTIONS, RECURRENT, AND FAILURE TO THRIVE WITH OR WITHOUT DIARRHEA", RIFTD
28183,620234,ANKYRIN REPEAT DOMAIN-CONTAINING PROTEIN 24, ANKRD24
28184,620235,"RHABDOMYOLYSIS, SUSCEPTIBILITY TO, 1", RHABDO1
28185,620236,"CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 29, WITH POLYGLUCOSAN BODIES", CMH29
28186,620237,"INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 78", MRT78
28187,620238,"DEAFNESS, AUTOSOMAL RECESSIVE 120", DFNB120
28188,620239,"BETA-1,3-GALACTOSYLTRANSFERASE 9", B3GALT9
28189,620240,"DEVELOPMENTAL DELAY WITH HYPOTONIA, MYOPATHY, AND BRAIN ABNORMALITIES", DEDHMB
28190,620241,"HYDROCEPHALUS, CONGENITAL, 5, SUSCEPTIBILITY TO", HYC5
28191,620242,NEURODEVELOPMENTAL DISORDER WITH POOR GROWTH AND BEHAVIORAL ABNORMALITIES, NEDGBA
28192,620243,"LEUKODYSTROPHY, HYPOMYELINATING, 25", HLD25
28193,620244,LYMPHATIC MALFORMATION 13, LMPHM13
28194,620245,EPISODIC KINESIGENIC DYSKINESIA 3, EKD3
28195,620246,CONGENITAL MYOPATHY 18, CMYO18
28196,620247,"CARDIOMYOPATHY, DILATED, 1OO", CMD1OO
28197,620248,TRANSMEMBRANE PROTEIN 80, TMEM80
28198,620249,"CONGENITAL MYOPATHY 10B, MILD VARIANT", CMYO10B
28199,620250,"NEURODEVELOPMENTAL DISORDER WITH SEIZURES, SPASTICITY, AND COMPLETE OR PARTIAL AGENESIS OF THE CORPUS CALLOSUM", NEDSSCC
28200,620251,CENTROSOMAL PROTEIN 170B, CEP170B
28201,620252,TRANSMEMBRANE PROTEIN 245, TMEM245
28202,620253,CATARACT 50 WITH OR WITHOUT GLAUCOMA, CTRCT50
28203,620254,"RING FINGER PROTEIN, TRANSMEMBRANE 2", RNFT2
28204,620255,MAJOR FACILITATOR SUPERFAMILY DOMAIN-CONTAINING PROTEIN 13A, MFSD13A
28205,620256,CLARIN 3, CLRN3
28206,620257,TRANSMEMBRANE PROTEIN 158, TMEM158
28207,620258,TRANSMEMBRANE PROTEIN 160, TMEM160
28208,620259,ANKYRIN REPEAT DOMAIN-CONTAINING PROTEIN 18A, ANKRD18A
28209,620260,TRANSMEMBRANE PROTEIN 132B, TMEM132B
28210,620261,"ENDOPLASMIC RETICULUM MEMBRANE PROTEIN COMPLEX, SUBUNIT 6", EMC6
28211,620262,ANKYRIN REPEAT DOMAIN-CONTAINING PROTEIN 36, ANKRD36
28212,620263,OOCYTE-SECRETED PROTEIN 2, OOSP2
28213,620264,"POST-GPI ATTACHMENT TO PROTEINS, GalNAc TRANSFERASE, 4", PGAP4
28214,620265,"CONGENITAL MYOPATHY 2B, SEVERE INFANTILE, AUTOSOMAL RECESSIVE", CMYO2B
28215,620266,RAB7A-INTERACTING MON1-CCZ1 COMPLEX SUBUNIT 1, RIMOC1
28216,620267,REGULATOR OF MON1-CCZ1, RMC1
28217,620268,FH2 DOMAIN-CONTAINING PROTEIN 1, FHDC1
28218,620269,"LEUKODYSTROPHY, HYPOMYELINATING, 26, WITH CHONDRODYSPLASIA", HLD26
28219,620270,NEURODEVELOPMENTAL DISORDER WITH ABSENT SPEECH AND MOVEMENT AND BEHAVIORAL ABNORMALITIES, NEDSMB
28220,620271,TRANSMEMBRANE PROTEIN 41B, TMEM41B
28221,620272,TRANSMEMBRANE PROTEIN 235, TMEM235
28222,620273,"ENDOPLASMIC RETICULUM MEMBRANE PROTEIN COMPLEX, SUBUNIT 3", EMC3
28223,620274,WD REPEAT-CONTAINING PROTEIN 87, WDR87
28224,620275,"MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 23", MC4DN23
28225,620276,OOCYTE/ZYGOTE/EMBRYO MATURATION ARREST 14, OZEMA14
28226,620277,SPERMATOGENIC FAILURE 81, SPGF81
28227,620278,"CONGENITAL MYOPATHY 2C, SEVERE INFANTILE, AUTOSOMAL DOMINANT", CMYO2C
28228,620279,DYNEIN ASSEMBLY FACTOR WITH WD REPEATS 1, DAW1
28229,620280,"DEAFNESS, AUTOSOMAL DOMINANT 86", DFNA86
28230,620281,"DEAFNESS, AUTOSOMAL DOMINANT 87", DFNA87
28231,620282,IMMUNODEFICIENCY 109 WITH LYMPHOPROLIFERATION, IMD109
28232,620283,"DEAFNESS, AUTOSOMAL DOMINANT 88", DFNA88
28233,620284,"DEAFNESS, AUTOSOMAL DOMINANT 89", DFNA89
28234,620285,"AMYOTROPHIC LATERAL SCLEROSIS 27, JUVENILE", ALS27
28235,620286,"MYOPATHY, SARCOPLASMIC BODY", MYOSB
28236,620287,TRANSMEMBRANE PROTEIN 71, TMEM71
28237,620288,TRANSMEMBRANE EPIDIDYMAL PROTEIN 1, TEDDM1
28238,620289,TRANSMEMBRANE PROTEIN 234, TMEM234
28239,620290,TRANSMEMBRANE PROTEIN 219, TMEM219
28240,620291,WD REPEAT-CONTAINING PROTEIN 18, WDR18
28241,620292,"NEURODEVELOPMENTAL DISORDER WITH LANGUAGE DELAY AND BEHAVIORAL ABNORMALITIES, WITH OR WITHOUT SEIZURES", NEDLBAS
28242,620293,"TMEM9 DOMAIN FAMILY, MEMBER B", TMEM9B
28243,620294,"CONGENITAL HEART DEFECTS, MULTIPLE TYPES, 9", CHTD9
28244,620295,DDB1- AND CUL4-ASSOCIATED FACTOR 10, DCAF10
28245,620296,AUTOINFLAMMATION WITH PULMONARY AND CUTANEOUS VASCULITIS, AIPCV
28246,620297,"SOLUTE CARRIER FAMILY 35, MEMBER A4", SLC35A4
28247,620298,"SOLUTE CARRIER FAMILY 35, MEMBER A5", SLC35A5
28248,620299,MAJOR FACILITATOR SUPERFAMILY DOMAIN-CONTAINING PROTEIN 4A, MFSD4A
28249,620300,MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFICIENCY 2, MTPD2
28250,620301,MAJOR FACILITATOR SUPERFAMILY DOMAIN-CONTAINING PROTEIN 9, MFSD9
28251,620302,WD REPEAT-CONTAINING PROTEIN 76, WDR76
28252,620303,"PITUITARY HORMONE DEFICIENCY, COMBINED OR ISOLATED, 8", CPHD8
28253,620304,NUCLEOLAR PROTEIN 9, NOL9
28254,620305,NEUROOCULORENAL SYNDROME, NORS
28255,620306,NEURODEGENERATION AND SEIZURES DUE TO COPPER TRANSPORT DEFECT, NSCT
28256,620307,WD REPEAT-CONTAINING PROTEIN 24, WDR24
28257,620308,MAJOR FACILITATOR SUPERFAMILY DOMAIN-CONTAINING PROTEIN 3, MFSD3
28258,620309,"FAMILY WITH SEQUENCE SIMILARITY 171, MEMBER B", FAM171B
28259,620310,CONGENITAL MYOPATHY 20, CMYO20
28260,620311,PREMATURE OVARIAN FAILURE 21, POF21
28261,620312,LEUKOENCEPHALOPATHY WITH VANISHING WHITE MATTER 2, VWM2
28262,620313,LEUKOENCEPHALOPATHY WITH VANISHING WHITE MATTER 3, VWM3
28263,620314,LEUKOENCEPHALOPATHY WITH VANISHING WHITE MATTER 4, VWM4
28264,620315,LEUKOENCEPHALOPATHY WITH VANISHING WHITE MATTER 5, VWM5
28265,620316,"CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 12", CDCBM12
28266,620317,"NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY AND SPEECH DELAY, WITH OR WITHOUT BRAIN ABNORMALITIES", NEDMSBA
28267,620318,"SOLUTE CARRIER FAMILY 49, MEMBER 3", SLC49A3
28268,620319,OOCYTE/ZYGOTE/EMBRYO MATURATION ARREST 17, OZEMA17
28269,620320,"HEMATURIA, BENIGN FAMILIAL, 2", BFH2
28270,620321,C1q DEFICIENCY 2, C1QD2
28271,620322,C1q DEFICIENCY 3, C1QD3
28272,620323,"SPASTIC PARAPLEGIA 70, AUTOSOMAL RECESSIVE", SPG70
28273,620324,"SOLUTE CARRIER FAMILY 15, MEMBER 5", SLC15A5
28274,620325,TRANSMEMBRANE PROTEIN 144, TMEM144
28275,620326,CONGENITAL MYOPATHY 21 WITH EARLY RESPIRATORY FAILURE, CMYO21
28276,620327,"NEURODEGENERATION WITH DEVELOPMENTAL DELAY, EARLY RESPIRATORY FAILURE, MYOCLONIC SEIZURES, AND BRAIN ABNORMALITIES", NDDRSB
28277,620328,"SOLUTE CARRIER FAMILY 44, MEMBER 3", SLC44A3
28278,620329,"SOLUTE CARRIER FAMILY 44, MEMBER 5", SLC44A5
28279,620330,"INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 71, WITH BEHAVIORAL ABNORMALITIES", MRD71
28280,620331,HATIPOGLU IMMUNODEFICIENCY SYNDROME, HATIS
28281,620332,OOCYTE/ZYGOTE/EMBRYO MATURATION ARREST 18, OZEMA18
28282,620333,OOCYTE/ZYGOTE/EMBRYO MATURATION ARREST 19, OZEMA19
28283,620334,TRIPARTITE MOTIF-CONTAINING PROTEIN 42, TRIM42
28284,620335,CELL DIVISION CYCLE 20B, CDC20B
28285,620336,ZINC FINGER SWIM DOMAIN-CONTAINING PROTEIN 3, ZSWIM3
28286,620337,"SOLUTE CARRIER FAMILY 35, MEMBER E1", SLC35E1
28287,620338,"SOLUTE CARRIER FAMILY 9, MEMBER C2", SLC9C2
28288,620339,"SOLUTE CARRIER FAMILY 23, MEMBER 3", SLC23A3
28289,620340,NIPA-LIKE DOMAIN-CONTAINING PROTEIN 1, NIPAL1
28290,620341,WD REPEAT-CONTAINING PROTEIN 75, WDR75
28291,620342,CONE-ROD DYSTROPHY 24, CORD24
28292,620343,BASAL CELL NEVUS SYNDROME 2, BCNS2
28293,620344,PROLONGED ELECTRORETINAL RESPONSE SUPPRESSION 2, PERRS2
28294,620345,MAJOR FACILITATOR SUPERFAMILY DOMAIN-CONTAINING PROTEIN 5, MFSD5
28295,620346,MAJOR FACILITATOR SUPERFAMILY DOMAIN-CONTAINING PROTEIN 11, MFSD11
28296,620347,MAJOR FACILITATOR SUPERFAMILY DOMAIN-CONTAINING PROTEIN 14A, MFSD14A
28297,620348,MAJOR FACILITATOR SUPERFAMILY DOMAIN-CONTAINING PROTEIN 14B, MFSD14B
28298,620349,"SOLUTE CARRIER FAMILY 35, MEMBER F1", SLC35F1
28299,620350,"SOLUTE CARRIER FAMILY 35, MEMBER F2", SLC35F2
28300,620351,"CONGENITAL MYOPATHY 22A, CLASSIC", CMYO22A
28301,620352,DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 31B, DEE31B
28302,620353,SPERMATOGENIC FAILURE 82, SPGF82
28303,620354,SPERMATOGENIC FAILURE 83, SPGF83
28304,620355,"SOLUTE CARRIER FAMILY 35, MEMBER E3", SLC35E3
28305,620356,"CILIARY DYSKINESIA, PRIMARY, 50", CILD50
28306,620357,DIARRHEA 13, DIAR13
28307,620358,"MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 4A", MC5DN4A
28308,620359,"MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 7", MC5DN7
28309,620360,TETRAPEPTIDE REPEAT HOMEOBOX 2, TPRX2
28310,620361,"RNA, U5D SMALL NUCLEAR 1", RNU5D-1
28311,620362,"RNA, U5E SMALL NUCLEAR 1", RNU5E-1
28312,620363,"RNA, U5F SMALL NUCLEAR 1", RNU5F-1
28313,620364,COMBINED LOW LDL AND FIBRINOGEN, CLDLFIB
28314,620365,"PULMONARY FIBROSIS AND/OR BONE MARROW FAILURE SYNDROME, TELOMERE-RELATED, 7", PFBMFT7
28315,620366,"OSTEOPETROSIS, AUTOSOMAL RECESSIVE 9", OPTB9
28316,620367,"PULMONARY FIBROSIS AND/OR BONE MARROW FAILURE SYNDROME, TELOMERE-RELATED, 8", PFBMFT8
28317,620368,CEREBRORETINAL MICROANGIOPATHY WITH CALCIFICATIONS AND CYSTS 3, CRMCC3
28318,620369,"CONGENITAL MYOPATHY 22B, SEVERE FETAL", CMYO22B
28319,620370,RECON PROGEROID SYNDROME, RECON
28320,620371,"NEURODEVELOPMENTAL DISORDER WITH INTRACRANIAL HEMORRHAGE, SEIZURES, AND SPASTICITY", NEDIHSS
28321,620372,HYPERSULFATURIA, HYSULF
28322,620373,ADIPOSE-SECRETED SIGNALING PROTEIN, ADISSP
28323,620374,"NEPHROLITHIASIS, CALCIUM OXALATE, 2, WITH OR WITHOUT NEPHROCALCINOSIS", CAON2
28324,620375,"MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 28", LGMDR28
28325,620376,"AUTOINFLAMMATORY DISEASE, SYSTEMIC, WITH VASCULITIS", SAIDV
28326,620377,ARMADILLO REPEAT-CONTAINING PROTEIN 12, ARMC12
28327,620378,"CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE A", CMTDIA
28328,620379,"SPASTIC PARAPLEGIA 89, AUTOSOMAL RECESSIVE", SPG89
28329,620380,LEUCINE ZIPPER/EF-HAND-CONTAINING TRANSMEMBRANE PROTEIN 2, LETM2
28330,620381,CILIA- AND FLAGELLA-ASSOCIATED PROTEIN 61, CFAP61
28331,620382,ZINC FINGER CCHC DOMAIN-CONTAINING PROTEIN 9, ZCCHC9
28332,620383,OOCYTE/ZYGOTE/EMBRYO MATURATION ARREST 20, OZEMA20
28333,620384,"AUDITORY NEUROPATHY, AUTOSOMAL DOMINANT 2", AUNA2
28334,620385,ARMADILLO REPEAT-CONTAINING PROTEIN 1, ARMC1
28335,620386,"NEMALINE MYOPATHY 5B, AUTOSOMAL RECESSIVE, CHILDHOOD-ONSET", NEM5B
28336,620387,"TBC1 DOMAIN FAMILY, MEMBER 21", TBC1D21
28337,620388,DYSBINDIN DOMAIN-CONTAINING PROTEIN 1, DBNDD1
28338,620389,"NEMALINE MYOPATHY 5C, AUTOSOMAL DOMINANT", NEM5C
28339,620390,HEAT REPEAT-CONTAINING PROTEIN 1, HEATR1
28340,620391,"POLY(ADP-RIBOSE) POLYMERASE FAMILY, MEMBER 16", PARP16
28341,620392,ACTIN-BINDING TRANSCRIPTION MODULATOR, ABITRAM
28342,620393,"INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 79", MRT79
28343,620394,PROTEIN SERINE KINASE H2, PSKH2
28344,620395,CYCLIN J, CCNJ
28345,620396,CYCLIN P, CCNP
28346,620397,AURORA KINASE A- AND NINEIN-INTERACTING PROTEIN, AUNIP
28347,620398,GLYCINE ENCEPHALOPATHY 2, GCE2
28348,620399,AARF DOMAIN-CONTAINING KINASE 1, ADCK1
28349,620400,"PULMONARY FIBROSIS AND/OR BONE MARROW FAILURE SYNDROME, TELOMERE-RELATED, 9", PFBMFT9
28350,620402,"NEURONOPATHY, DISTAL HEREDITARY MOTOR, AUTOSOMAL RECESSIVE 9", HMNR9
28351,620403,INKA-BOX ACTIN REGULATOR 2, INKA2
28352,620404,CYSTEINE- AND SERINE-RICH NUCLEAR PROTEIN 2, CSRNP2
28353,620405,CYSTEINE- AND SERINE-RICH NUCLEAR PROTEIN 3, CSRNP3
28354,620406,"MCTS FAMILY, MEMBER 2", MCTS2
28355,620407,"MER1 REPEAT-CONTAINING IMPRINTED TRANSCRIPT 1, NONCODING", MIMT1
28356,620408,MICRO RNA 337, MIR337
28357,620409,SPERMATOGENIC FAILURE 84, SPGF84
28358,620410,LOW DENSITY LIPOPROTEIN CHOLESTEROL LEVEL QUANTITATIVE TRAIT LOCUS 3, LDLCQ3
28359,620411,"PALMOPLANTAR KERATODERMA, EPIDERMOLYTIC, 2", EPPK2
28360,620412,NONCODING RNA ASSOCIATED WITH MAP KINASE PATHWAY AND GROWTH ARREST, NAMA
28361,620413,GOLGI-ASSOCIATED KINASE 1A, GASK1A
28362,620414,"SH3 DOMAIN-BINDING KINASE FAMILY, MEMBER 2", SBK2
28363,620415,WOOLLY HAIR-SKIN FRAGILITY SYNDROME, WHSF
28364,620416,"SPASTIC PARAPLEGIA 90A, AUTOSOMAL DOMINANT", SPG90A
28365,620417,"SPASTIC PARAPLEGIA 90B, AUTOSOMAL RECESSIVE", SPG90B
28366,620418,"NEGATIVE REGULATOR OF INTERFERON RESPONSE, NONCODING", NRIR
28367,620419,"CYCLIN I FAMILY, MEMBER 2", CCNI2
28368,620420,"HIG1 HYPOXIA-INDUCIBLE DOMAIN FAMILY, MEMBER 1B", HIGD1B
28369,620421,DDB1- AND CUL4-ASSOCIATED FACTOR 4-LIKE 2, DCAF4L2
28370,620422,RETINITIS PIGMENTOSA 97, RP97
28371,620423,MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 7, MMDS7
28372,620424,ZYGOTE ARREST 1-LIKE, ZAR1L
28373,620425,"CATARACTS, HEARING IMPAIRMENT, NEPHROTIC SYNDROME, AND ENTEROCOLITIS 2", CHINE2
28374,620426,INKA BOX ACTIN REGULATOR 1, INKA1
28375,620427,"DYSTONIA 37, EARLY-ONSET, WITH STRIATAL LESIONS", DYT37
28376,620428,"NEURODEVELOPMENTAL DISORDER WITH MOTOR AND LANGUAGE DELAY, OCULAR DEFECTS, AND BRAIN ABNORMALITIES", NEDMLOB
28377,620429,TRANSMEMBRANE PROTEIN 64, TMEM64
28378,620430,"AUTOIMMUNE DISEASE, MULTISYSTEM, INFANTILE-ONSET, 3", ADMIO3
28379,620431,FLYWCH-TYPE ZINC FINGER PROTEIN 1, FLYWCH1
28380,620432,OSTEOCLAST STIMULATORY TRANSMEMBRANE PROTEIN, OCSTAMP
28381,620433,TRANSMEMBRANE PROTEIN 186, TMEM186
28382,620434,TRANSMEMBRANE PROTEIN 223, TMEM223
28383,620435,UBIQUINOL-CYTOCHROME C REDUCTASE COMPLEX ASSEMBLY FACTOR 5, UQCC5
28384,620436,TRANSMEMBRANE p24 TRAFFICKING PROTEIN 9, TMED9
28385,620437,TRANSMEMBRANE p24 TRAFFICKING PROTEIN 3, TMED3
28386,620438,"CILIARY DYSKINESIA, PRIMARY, 51", CILD51
28387,620439,"INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 72", MRD72
28388,620440,"GRB2-BINDING ADAPTOR PROTEIN, TRANSMEMBRANE", GAPT
28389,620441,ZINC FINGER PROTEIN 470, ZNF470
28390,620442,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 5", BROVCA5
28391,620443,DISABLING PANSCLEROTIC MORPHEA OF CHILDHOOD, DPMC
28392,620444,CRANIOFACIAL MICROSOMIA 2, CFM2
28393,620445,NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY AND MOVEMENT ABNORMALITIES, NEDMIM
28394,620446,TETRASPANIN 17, TSPAN17
28395,620447,MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 3, MLC3
28396,620448,"MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 4, REMITTING", MLC4
28397,620449,IMMUNODEFICIENCY 112, IMD112
28398,620450,"INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 73", MRD73
28399,620451,COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 58, COXPD58
28400,620452,AMYOTROPHIC LATERAL SCLEROSIS 28, ALS28
28401,620453,"DYSTONIA 22, JUVENILE-ONSET", DYT22JO
28402,620454,"CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIaa", CDG2AA
28403,620455,"NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA AND SPEECH DELAY, WITH OR WITHOUT SEIZURES", NEDHSS
28404,620456,"DYSTONIA 22, ADULT-ONSET", DYT22AO
28405,620457,AURICULOCONDYLAR SYNDROME 4, ARCND4
28406,620458,AURICULOCONDYLAR SYNDROME 2B, ARCND2B
28407,620459,BIRT-HOGG-DUBE SYNDROME 2, BHD2
28408,620460,OCULOPHARYNGEAL MUSCULAR DYSTROPHY 2, OPMD2
28409,620461,"ENCEPHALITIS, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 12", IIAE12
28410,620462,"CARDIOMYOPATHY, DILATED, 2I", CMD2I
28411,620463,ERYTHROID DIFFERENTIATION REGULATORY FACTOR 1, EDRF1
28412,620464,REST COREPRESSOR 3, RCOR3
28413,620465,"EPILEPSY, EARLY-ONSET, 3, WITH OR WITHOUT DEVELOPMENTAL DELAY", EPEO3
28414,620466,ZINC FINGER PROTEIN 28, ZNF28
28415,620467,La RIBONUCLEOPROTEIN 1B, LARP1B
28416,620468,VERTEBRAE DEVELOPMENT-ASSOCIATED GENE, VRTN
28417,620469,"CRANIAL DYSINNERVATION DISORDER, CONGENITAL, WITH ABSENT CORNEAL REFLEX AND DEVELOPMENTAL DELAY", CCDDRD
28418,620470,"CONGENITAL SMOOTH MUSCLE HAMARTOMA, WITH OR WITHOUT HEMIHYPERTROPHY", CSMH
28419,620471,FORKHEAD BOX O3B, FOXO3B
28420,620472,"TRAFFICKING PROTEIN PARTICLE COMPLEX, SUBUNIT 2B", TRAPPC2B
28421,620473,ZINC FINGER HIT DOMAIN-CONTAINING PROTEIN 6, ZNHIT6
28422,620474,ADIPOGENESIS-ASSOCIATED MTH938 DOMAIN-CONTAINING PROTEIN, AAMDC
28423,620475,"THROMBOCYTOPENIA 8, WITH DYSMORPHIC FEATURES AND DEVELOPMENTAL DELAY", THC8
28424,620476,"MRT4 HOMOLOG, RIBOSOME MATURATION FACTOR", MRTO4
28425,620477,ZYMOGEN GRANULE PROTEIN 16B, ZG16B
28426,620478,THROMBOCYTOPENIA 9, THC9
28427,620479,CENTRIOLAR SATELLITE-ASSOCIATED TUBULIN POLYGLUTAMYLASE COMPLEX REGULATOR 1, CSTPP1
28428,620480,TRIPARTITE MOTIF FAMILY-LIKE PROTEIN 2, TRIML2
28429,620481,"AMEGAKARYOCYTIC THROMBOCYTOPENIA, CONGENITAL, 2", CAMT2
28430,620482,"PARKINSON DISEASE 25, AUTOSOMAL RECESSIVE EARLY-ONSET, WITH IMPAIRED INTELLECTUAL DEVELOPMENT", PARK25
28431,620483,"VARIEGATE PORPHYRIA, CHILDHOOD-ONSET", VPCO
28432,620484,THROMBOCYTOPENIA 10, THC10
28433,620485,TUBULIN TYROSINE LIGASE-LIKE 13, TTLL13
28434,620486,"BLEEDING DISORDER, PLATELET-TYPE, 25", BDPLT25
28435,620487,"CILIOGENESIS AND PLANAR POLARITY EFFECTOR COMPLEX, SUBUNIT 2", CPLANE2
28436,620488,"NUCLEAR TRANSCRIPTION FACTOR, X BOX-BINDING-LIKE 1", NFXL1
28437,620489,NEURODEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND BEHAVIORAL ABNORMALITIES, NEDFBA
28438,620490,SPERMATOGENIC FAILURE 85, SPGF85
28439,620491,"MATURIN, NEURAL PROGENITOR DIFFERENTIATION REGULATOR HOMOLOG", MTURN
28440,620492,MEDIATOR COMPLEX SUBUNIT 31, MED31
28441,620493,STERILE ALPHA MOTIF DOMAIN-CONTAINING PROTEIN 7, SAMD7
28442,620494,"NEURODEVELOPMENTAL DISORDER WITH IMPAIRED LANGUAGE, BEHAVIORAL ABNORMALITIES, AND DYSMORPHIC FACIES", NEDLBF
28443,620495,REGULATOR OF DNA CLASS I CROSSOVER INTERMEDIATES 1, REDIC1
28444,620496,BASAL BODY ORIENTATION FACTOR 1, BBOF1
28445,620497,LEUCINE-RICH REPEAT-CONTAINING PROTEIN 49, LRRC49
28446,620498,TRANSCRIPTION ELONGATION REGULATOR 1-LIKE, TCERG1L
28447,620499,SPERMATOGENIC FAILURE 86, SPGF86
28448,620500,SPERMATOGENIC FAILURE 87, SPGF87
28449,620501,ZIEGLER-HUANG SYNDROME, ZHS
28450,620502,NEURODEVELOPMENTAL DISORDER WITH LANGUAGE DELAY AND VARIABLE COGNITIVE ABNORMALITIES, NEDLC
28451,620503,FIDGETIN-LIKE PROTEIN 2, FIGNL2
28452,620504,DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 111, DEE111
28453,620505,INTRAFLAGELLAR TRANSPORT 22, IFT22
28454,620506,INTRAFLAGELLAR TRANSPORT 46, IFT46
28455,620507,ICHTHYOSIS WITH ERYTHROKERATODERMA, IEKD
28456,620508,"CCR4-NOT TRANSCRIPTION COMPLEX, SUBUNIT 10", CNOT10
28457,620509,"CCR4-NOT TRANSCRIPTION COMPLEX, SUBUNIT 11", CNOT11
28458,620510,XEROSIS AND GROWTH FAILURE WITH IMMUNE AND PULMONARY DYSFUNCTION SYNDROME, XGIP
28459,620511,FLIEDNER-ZWEIER SYNDROME, FZS
28460,620512,"SPASTIC PARAPLEGIA 18A, AUTOSOMAL DOMINANT", SPG18A
28461,620513,UNC119 LIPID-BINDING CHAPERONE B, UNC119B
28462,620514,"IMMUNE DYSREGULATION, AUTOIMMUNITY, AND AUTOINFLAMMATION", IDAA
28463,620515,"NEURODEVELOPMENTAL DISORDER WITH MOTOR REGRESSION, PROGRESSIVE SPASTIC PARAPLEGIA, AND OROMOTOR DYSFUNCTION", NEDRSO
28464,620516,STERILE ALPHA MOTIF DOMAIN-CONTAINING PROTEIN 3, SAMD3
28465,620517,STERILE ALPHA MOTIF DOMAIN-CONTAINING PROTEIN 5, SAMD5
28466,620518,KELCH DOMAIN-CONTAINING PROTEIN 4, KLHDC4
28467,620519,ARRHYTHMOGENIC CARDIOMYOPATHY WITH VARIABLE ECTODERMAL ABNORMALITIES, ARCME
28468,620520,CALMODULIN-LIKE 4, CALML4
28469,620521,KELCH DOMAIN-CONTAINING PROTEIN 7B, KLHDC7B
28470,620522,ONCOMODULIN 2, OCM2
28471,620523,RING FINGER PROTEIN 122, RNF122
28472,620524,DDB1- AND CUL4-ASSOCIATED FACTOR 16, DCAF16
28473,620525,LONG INTERGENIC NONCODING RNA 2228, LINC02228
28474,620526,"SMALL GLUTAMINE-RICH TETRATRICOPEPTIDE REPEAT COCHAPERONE, BETA", SGTB
28475,620527,TRIPARTITE MOTIF-CONTAINING PROTEIN 58, TRIM58
28476,620528,"NEURONOPATHY, DISTAL HEREDITARY MOTOR, AUTOSOMAL DOMINANT 11", HMND11
28477,620529,RING FINGER PROTEIN 121, RNF121
28478,620530,CHROMOSOME 4 OPEN READING FRAME 3, C4ORF3
28479,620531,SMALL INTEGRAL MEMBRANE PROTEIN 6, SMIM6
28480,620532,"HYPER-IgE SYNDROME 6, AUTOSOMAL DOMINANT, WITH RECURRENT INFECTIONS", HIES6
28481,620533,LONG INTERGENIC NONCODING RNA 520, LINC00520
28482,620534,"NEUTROPENIA, SEVERE CONGENITAL, 10, AUTOSOMAL RECESSIVE", SCN10
28483,620535,"DEVELOPMENTAL DELAY, DYSMORPHIC FACIES, AND BRAIN ANOMALIES", DEVDFB
28484,620536,"ALPORT SYNDROME 3B, AUTOSOMAL RECESSIVE", ATS3B
28485,620537,DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 112, DEE112
28486,620538,"SPASTIC PARAPLEGIA 91, AUTOSOMAL DOMINANT, WITH OR WITHOUT CEREBELLAR ATAXIA", SPG91
28487,620539,ZINC FINGER SWIM DOMAIN-CONTAINING PROTEIN 4, ZSWIM4
28488,620540,DEVELOPMENTAL DELAY WITH OR WITHOUT EPILEPSY, DEVEP
28489,620541,PROAPOPTOTIC NUCLEOLAR PROTEIN 1, PANO1
28490,620542,"NEURONOPATHY, DISTAL HEREDITARY MOTOR, AUTOSOMAL RECESSIVE 10", HMNR10
28491,620543,ZINC FINGER CONTAINING UBIQUITIN PEPTIDASE 1, ZUP1
28492,620544,"PPP1R13B DIVERGENT TRANSCRIPT, NONCODING", PPP1R13BDT
28493,620545,"ARTHROGRYPOSIS, DISTAL, TYPE 12", DA12
28494,620546,"CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIbb", CDG2BB
28495,620547,SPERMATOGENIC FAILURE 88, SPGF88
28496,620548,PREMATURE OVARIAN FAILURE 22, POF22
28497,620549,F-BOX PROTEIN 48, FBXO48
28498,620550,OPTIC ATROPHY 14, OPA14
28499,620551,"DEAFNESS, AUTOSOMAL RECESSIVE 121", DFNB121
28500,620552,CUE DOMAIN-CONTAINING PROTEIN 1, CUEDC1
28501,620553,COILED-COIL DOMAIN-CONTAINING PROTEIN 93, CCDC93
28502,620554,ZINC FINGER PROTEIN 432, ZNF432
28503,620555,SMALL NUCLEOLAR RNA HOST GENE 20, SNHG20
28504,620556,RING FINGER PROTEIN 133, RNF133
28505,620557,IQ MOTIF- AND UBIQUITIN DOMAIN-CONTAINING PROTEIN, IQUB
28506,620558,CRANIOMETADIAPHYSEAL OSTEOSCLEROSIS WITH HIP DYSPLASIA, CMDOH
28507,620559,CYCLIN Y-LIKE 1, CCNYL1
28508,620560,CEBPA DIVERGENT TRANSCRIPT, CEBPA-DT
28509,620561,DENN DOMAIN-CONTAINING PROTEIN 6A, DENND6A
28510,620562,DENN DOMAIN-CONTAINING PROTEIN 6B, DENND6B
28511,620563,UBIQUITIN-SPECIFIC PEPTIDASE 50, USP50
28512,620564,ANTAGONIST OF MITOTIC EXIT NETWORK 1 HOMOLOG, AMN1
28513,620565,IMMUNODEFICIENCY 113 WITH AUTOIMMUNITY AND AUTOINFLAMMATION, IMD113
28514,620566,CLAUDIN 22, CLDN22
28515,620567,ZINC FINGER PROTEIN 507, ZNF507
28516,620568,CORNELIA DE LANGE SYNDROME 6, CDLS6
28517,620569,"LEBER-LIKE HEREDITARY OPTIC NEUROPATHY, AUTOSOMAL RECESSIVE 2", LHONAR2
28518,620570,"CILIARY DYSKINESIA, PRIMARY, 52", CILD52
28519,620571,MICRO RNA 512-1, MIR512-1
28520,620572,MICRO RNA 512-2, MIR512-2
28521,620573,MICRO RNA 520E, MIR520E
28522,620574,MICRO RNA 515-1, MIR515-1
28523,620575,MICRO RNA 519E, MIR519E
28524,620576,OTOSCLEROSIS 11, OTSC11
28525,620577,FATTY ACID DESATURASE 6, FADS6
28526,620578,UBIQUINOL-CYTOCHROME C REDUCTASE COMPLEX ASSEMBLY FACTOR 4, UQCC4
28527,620579,COILED-COIL DOMAIN-CONTAINING PROTEIN 3, CCDC3
28528,620580,DEAQ-BOX RNA-DEPENDENT ATPase 1, DQX1
28529,620581,OXIDOREDUCTASE NAD-BINDING DOMAIN-CONTAINING PROTEIN 1, OXNAD1
28530,620582,CHROMOSOME 1 OPEN READING FRAME 210, C1ORF210
28531,620583,OPTIC ATROPHY 15, OPA15
28532,620584,MICRO RNA 498, MIR498
28533,620585,MICRO RNA 520F, MIR520F
28534,620586,MICRO RNA 515-2, MIR515-2
28535,620587,MICRO RNA 519C, MIR519C
28536,620588,MICRO RNA 520A, MIR520A
28537,620589,MICRO RNA 526B, MIR526B
28538,620590,RADICAL S-ADENOSYL METHIONINE DOMAIN-CONTAINING PROTEIN 1, RSAD1
28539,620591,MICRO RNA 519B, MIR519B
28540,620592,MICRO RNA 525, MIR525
28541,620593,MICRO RNA 523, MIR523
28542,620594,MICRO RNA 518F, MIR518F
28543,620595,MICRO RNA 520B, MIR520B
28544,620596,MICRO RNA 518B, MIR518B
28545,620597,MICRO RNA 526A1, MIR526A1
28546,620598,MICRO RNA 518C, MIR518C
28547,620599,MICRO RNA 524, MIR524
28548,620600,MICRO RNA 517A, MIR517A
28549,620601,GARG-MISHRA PROGEROID SYNDROME, GMPGS
28550,620602,LYMPHATIC MALFORMATION 14, LMPHM14
28551,620603,"IMMUNODEFICIENCY 114, FOLATE-RESPONSIVE", IMD114
28552,620604,PROSTAGLANDIN REDUCTASE 3, PTGR3
28553,620605,"CYTOCHROME P450, FAMILY 27, SUBFAMILY C, MEMBER 1", CYP27C1
28554,620606,"SPASTIC PARAPLEGIA 72B, AUTOSOMAL RECESSIVE", SPG72B
28555,620607,"SPASTIC PARAPLEGIA 30B, AUTOSOMAL RECESSIVE", SPG30B
28556,620608,TESTIS-EXPRESSED GENE 264, TEX264
28557,620609,LONG-OLSEN-DISTELMAIER SYNDROME, LNGODS
28558,620610,OOCYTE/ZYGOTE/EMBRYO MATURATION ARREST 21, OZEMA21
28559,620611,MICRO RNA 521-2, MIR521-2
28560,620612,MICRO RNA 520D, MIR520D
28561,620613,MICRO RNA 517B, MIR517B
28562,620614,MICRO RNA 516B2, MIR516B2
28563,620615,MICRO RNA 526A2, MIR526A2
28564,620616,MICRO RNA 518E, MIR518E
28565,620617,MICRO RNA 518A1, MIR518A1
28566,620618,MICRO RNA 518D, MIR518D
28567,620619,MICRO RNA 516B1, MIR516B1
28568,620620,MICRO RNA 518A2, MIR518A2
28569,620621,MICRO RNA 517C, MIR517C
28570,620622,MICRO RNA 521-1, MIR521-1
28571,620623,MICRO RNA 522, MIR522
28572,620624,MICRO RNA 519A1, MIR519A1
28573,620625,MICRO RNA 527, MIR527
28574,620626,MICRO RNA 516A1, MIR516A1
28575,620627,MICRO RNA 516A2, MIR516A2
28576,620628,MICRO RNA 519A2, MIR519A2
28577,620629,OPTIC ATROPHY 16, OPA16
28578,620630,TRANSMEMBRANE PROTEIN 170A, TMEM170A
28579,620631,"ENDOPLASMIC RETICULUM MEMBRANE PROTEIN COMPLEX, SUBUNIT 7", EMC7
28580,620632,IMMUNODEFICIENCY 115 WITH AUTOINFLAMMATION, IMD115
28581,620633,GOLGI TRANSPORT 1A, GOLT1A
28582,620634,IMMUNITY-RELATED GTPase CINEMA, IRGC
28583,620635,"CARDIOMYOPATHY, DILATED, 2J", CMD2J
28584,620636,"NEURODEGENERATION, CHILDHOOD-ONSET, WITH CEREBELLAR ATAXIA AND COGNITIVE DECLINE", CONDCAC
28585,620637,CADHERIN-LIKE DOMAIN- AND PC-ESTERASE DOMAIN-CONTAINING PROTEIN 1, CPED1
28586,620638,POTASSIUM CHANNEL TETRAMERIZATION DOMAIN-CONTAINING PROTEIN 4, KCTD4
28587,620639,"OSTEOGENESIS IMPERFECTA, TYPE XXIII", OI23
28588,620640,RING FINGER PROTEIN 145, RNF145
28589,620641,TAN-ALMURSHEDI SYNDROME, TANALS
28590,620642,"CILIARY DYSKINESIA, PRIMARY, 53", CILD53
28591,620643,MICRO RNA 1323, MIR1323
28592,620644,MICRO RNA 1283-1, MIR1283-1
28593,620645,MICRO RNA 1283-2, MIR283-2
28594,620646,COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 59, COXPD59
28595,620647,"PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 6", PEOB6
28596,620648,BUTYROPHILIN-LIKE PROTEIN 9, BTNL9
28597,620649,"PHOSPHOLIPASE A2, GROUP IVE", PLA2G4E
28598,620650,GLYOXALASE DOMAIN-CONTAINING PROTEIN 4, GLOD4
28599,620651,"DIABETES, DEAFNESS, DEVELOPMENTAL DELAY, AND SHORT STATURE SYNDROME", DDDS
28600,620652,SH3 DOMAIN-BINDING PROTEIN 5-LIKE, SH3BP5L
28601,620653,"INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 80, WITH VARIANT LISSENCEPHALY", MRT80
28602,620654,THROMBOCYTOPENIA 11 WITH MULTIPLE CONGENITAL ANOMALIES AND DYSMORPHIC FACIES, THC11
28603,620655,ALFADHEL SYNDROME, AFDL
28604,620656,PLECKSTRIN AND SEC7 DOMAINS-CONTAINING PROTEIN 2, PSD2
28605,620657,"AMYLOIDOSIS, HEREDITARY SYSTEMIC 3", AMYLD3
28606,620658,"AMYLOIDOSIS, HEREDITARY SYSTEMIC 5", AMYLD5
28607,620659,"AMYLOIDOSIS, HEREDITARY SYSTEMIC 6", AMYLD6
28608,620660,"CCZ1 HOMOLOG, VACUOLAR PROTEIN TRAFFICKING- AND BIOGENESIS-ASSOCIATED PROTEIN", CCZ1
28609,620661,CHROMOSOME 10 OPEN READING FRAME 88, C10ORF88
28610,620662,HOXHA-ALIU SYNDROME, HXAL
28611,620663,"SPONDYLOEPIMETAPHYSEAL DYSPLASIA, GUO-CAMPEAU TYPE", SEMDGC
28612,620664,RHO GUANINE NUCLEOTIDE EXCHANGE FACTOR 37, ARHGEF37
28613,620665,PLECKSTRIN HOMOLOGY DOMAIN- AND RhoGEF DOMAIN-CONTAINING PROTEIN G4B, PLEKHG4B
28614,620666,"SPASTIC ATAXIA 10, AUTOSOMAL RECESSIVE", SPAX10
28615,620667,"CENTROSOMAL PROTEIN, 128-KD", CEP128
28616,620668,IMMUNODEFICIENCY 117, IMD117
28617,620669,NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 9, NBIA9
28618,620670,"IMMUNODEFICIENCY, COMMON VARIABLE, 15", CVID15
28619,620671,POU CLASS 2 HOMEOBOX-ASSOCIATING FACTOR 2, POU2AF2
28620,620672,LEUCINE-RICH REPEAT-CONTAINING PROTEIN 24, LRRC24
28621,620673,"MICROTUBULE-ASSOCIATED PROTEIN 1, LIGHT CHAIN 3, BETA-2", MAP1LC3B2
28622,620674,"NEUTROPENIA, SEVERE CONGENITAL, 11, AUTOSOMAL DOMINANT", SCN11
28623,620675,"LEUKODYSTROPHY, HYPOMYELINATING, 27", HLD27
28624,620676,COILED-COIL DOMAIN-CONTAINING PROTEIN 61, CCDC61
28625,620677,TRANSMEMBRANE PROTEIN 192, TMEM192
28626,620678,RAS AND RAB INTERACTOR-LIKE PROTEIN, RINL
28627,620679,"LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 8", FPLD8
28628,620680,"LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 5", CGL5
28629,620681,MYOCLONIC EPILEPSY OF LAFORA 2, MELF2
28630,620682,SUZ RNA-BINDING DOMAIN-CONTAINING PROTEIN 1, SZRD1
28631,620683,"LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 9", FPLD9
28632,620684,HGH1 HOMOLOG, HGH1
28633,620685,CHROMOSOME 19 OPEN READING FRAME 53, C19ORF53
28634,620686,PREMATURE OVARIAN FAILURE 23, POF23
28635,620687,MOYAMOYA DISEASE 7, MYMY7
28636,620688,"INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 74", MRD74
28637,620689,"LSM FAMILY, MEMBER 14B", LSM14B
28638,620690,DEVELOPMENTAL DYSPLASIA OF THE HIP 3, DDH3
28639,620691,BUD13 HOMOLOG, BUD13
28640,620692,NANOG NEIGHBOR HOMEOBOX, NANOGNB
28641,620693,ASTEROID HOMOLOG 1, ASTE1
28642,620694,TUBULIN TYROSINE LIGASE-LIKE 11, TTLL11
28643,620695,NOTOCHORD HOMEOBOX, NOTO
28644,620696,RBPJ-INTERACTING AND TUBULIN-ASSOCIATED PROTEIN 1, RITA1
28645,620697,ZINC FINGER CCHC DOMAIN-CONTAINING PROTEIN 14, ZCCHC14
28646,620698,"MAPLE SYRUP URINE DISEASE, TYPE IB", MSUD1B
28647,620699,"MAPLE SYRUP URINE DISEASE, TYPE II", MSUD2
28648,620700,"INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 81", MRT81
28649,620701,TETRATRICOPEPTIDE REPEAT DOMAIN 36, TTC36
28650,620702,"MITOCHONDRIAL CALCIUM UNIPORTER, DOMINANT-NEGATIVE SUBUNIT BETA", MCUB
28651,620703,YUKSEL-VOGEL-BAUER SYNDROME, YUVOB
28652,620704,"ENCEPHALOPATHY, PORPHYRIA-RELATED", ENCEP
28653,620705,SPERMATOGENIC FAILURE 89, SPGF89
28654,620706,DEVELOPING BRAIN HOMEOBOX 2, DBX2
28655,620707,"EPIDERMOLYTIC HYPERKERATOSIS 2B, AUTOSOMAL RECESSIVE", EHK2B
28656,620708,LEUCINE-RICH REPEAT-CONTAINING PROTEIN 23, LRRC23
28657,620709,"TUBULIN POLYGLUTAMYLASE COMPLEX, SUBUNIT 1", TPGS1
28658,620710,"TUBULIN POLYGLUTAMYLASE COMPLEX, SUBUNIT 2", TPGS2
28659,620711,"LEUKOENCEPHALOPATHY, PORPHYRIA-RELATED", LENCEP
28660,620712,POLYDACTYLY-MACROCEPHALY SYNDROME, PDMCS
28661,620713,MITOCHONDRIAL MATRIX IMPORT FACTOR 23, MIX23
28662,620714,"DEAFNESS, AUTOSOMAL RECESSIVE 122", DFNB122
28663,620715,"BLEEDING DISORDER, VASCULAR-TYPE", BDVAS
28664,620716,D-GLUTAMATE CYCLASE, DGLUCY
28665,620717,MITOCHONDRIAL NUCLEOID-ASSOCIATED PROTEIN 1, MTNAP1
28666,620718,OROFACIODIGITAL SYNDROME XX, OFD20
28667,620719,"NEURODEVELOPMENTAL DISORDER WITH MOTOR ABNORMALITIES, SEIZURES, AND FACIAL DYSMORPHISM", NEDMSF
28668,620720,ZINC FINGER PROTEIN 549, ZNF549
28669,620721,TRANSMEMBRANE PROTEIN 242, TMEM242
28670,620722,"DEAFNESS, AUTOSOMAL DOMINANT 90", DFNA90
28671,620723,LONG INTERGENIC NONCODING RNA 2381, LINC02381
28672,620724,ENOYL COENZYME A HYDRATASE DOMAIN-CONTAINING PROTEIN 2, ECHDC2
28673,620725,BETHLEM MYOPATHY 1B, BTHLM1B
28674,620726,BETHLEM MYOPATHY 1C, BTHLM1C
28675,620727,ULLRICH CONGENITAL MUSCULAR DYSTROPHY 1B, UCMD1B
28676,620728,ULLRICH CONGENITAL MUSCULAR DYSTROPHY 1C, UCMD1C
28677,620729,HYPERFERRITINEMIA, HRFT
28678,620730,"HYPEREMESIS GRAVIDARUM, SUSCEPTIBILITY TO", HG
28679,620731,MICROPHTHALMIA/COLOBOMA 11, MCOPCB11
28680,620732,"NEURODEVELOPMENTAL DISORDER WITH HYPERKINETIC MOVEMENTS, SEIZURES, AND STRUCTURAL BRAIN ABNORMALITIES", NEDMSB
28681,620733,MICRO RNA 708, MIR708
28682,620734,"CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 30, ATRIAL", CMH30
28683,620735,SERINE DEHYDRATASE-LIKE PROTEIN, SDSL
28684,620736,COENZYME Q10A, COQ10A
28685,620737,COENZYME Q10B, COQ10B
28686,620738,ZONE OF POLARIZING ACTIVITY REGULATORY SEQUENCE, ZRS
28687,620739,RCC1-LIKE PROTEIN, RCC1L
28688,620740,STATHMIN 4, STMN4
28689,620741,INTRAFLAGELLAR TRANSPORT 70A, IFT70A
28690,620742,INTRAFLAGELLAR TRANSPORT 70B, IFT70B
28691,620743,SDE2 TELOMERE MAINTENANCE HOMOLOG, SDE2
28692,620744,SPERMATOGENIC FAILURE 90, SPGF90
28693,620745,"DEAFNESS, AUTOSOMAL RECESSIVE 123", DFNB123
28694,620746,NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA AND CHARACTERISTIC BRAIN ABNORMALITIES, NEDHBA
28695,620747,NEURODEVELOPMENTAL DISORDER WITH EARLY-ONSET PARKINSONISM AND BEHAVIORAL ABNORMALITIES, NEDPBA
28696,620748,MEGALENCEPHALY-POLYDACTYLY SYNDROME, MPAPA
28697,620749,ZINC FINGER PROTEIN 438, ZNF438
28698,620750,PRELI DOMAIN-CONTAINING PROTEIN 2, PRELID2
28699,620751,RETROTRANSPOSON GAG-LIKE 10, RTL10
28700,620752,TRANSMEMBRANE PROTEIN 177, TMEM177
28701,620753,COILED-COIL DOMAIN-CONTAINING PROTEIN 90B, CCDC90B
28702,620754,PRELI DOMAIN-CONTAINING PROTEIN 3B, PRELID3B
28703,620755,"GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 12", GEFSP12
28704,620756,ENOYL COENZYME A HYDRATASE DOMAIN-CONTAINING PROTEIN 3, ECHDC3
28705,620757,THROMBOCYTOPENIA 12 WITH OR WITHOUT MYOPATHY, THC12
28706,620758,TRANSLOCASE OF INNER MITOCHONDRIAL MEMBRANE 23B, TIMM23B
28707,620759,POLG ALTERNATIVE READING FRAME, POLGARF
28708,620760,MITOCHONDRIAL LACTATE DEHYDROGENASE REGULATOR, MLDHR
28709,620761,CHROMOSOME 9 OPEN READING FRAME 85, C9ORF85
28710,620762,MACULAR DYSTROPHY WITH OR WITHOUT CONE DYSFUNCTION, MDCD
28711,620763,"CORNEAL DYSTROPHY, LISCH EPITHELIAL", LECD
28712,620764,MITOCHONDRIAL SHEATH FORMATION-ASSOCIATED, MISFA
28713,620765,MITOCHONDRIAL FISSION REGULATOR 1-LIKE PROTEIN, MTFR1L
28714,620766,FORMATION OF MITOCHONDRIAL COMPLEX V ASSEMBLY FACTOR 1 HOMOLOG, FMC1
28715,620767,SECKEL SYNDROME 11, SCKL11
28716,620768,RIBOSOME-BINDING FACTOR A, RBFA
28717,620769,"HYDROXYACYL-THIOESTER DEHYDRATASE, TYPE 2", HTD2
28718,620770,MITOREGULIN, MTLN
28719,620771,JEFFRIES-LAKHANI NEURODEVELOPMENTAL SYNDROME, JELANS
28720,620772,DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 113, DEE113
28721,620773,PROLINE- AND SERINE-RICH PROTEIN 1, PROSER1
28722,620774,DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 114, DEE114
28723,620775,"NEUROMUSCULAR DISORDER, CONGENITAL, WITH DYSMORPHIC FACIES", NMDF
28724,620776,"THROMBOCYTOPENIA 13, SYNDROMIC", THC13
28725,620777,"PULMONARY HYPERTENSION, PRIMARY, 6", PPH6
28726,620778,"KILLER CELL IMMUNOGLOBULIN-LIKE RECEPTOR, THREE DOMAINS, SHORT CYTOPLASMIC TAIL, 1", KIR3DS1
28727,620779,"INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 82", MRT82
28728,620780,"CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE ID", ARCL1D
28729,620781,TRANSMEMBRANE PROTEIN 208, TMEM208
28730,620782,"NEURODEVELOPMENTAL DISORDER WITH LANGUAGE IMPAIRMENT, AUTISM, AND ATTENTION DEFICIT-HYPERACTIVITY DISORDER", NEDLAAD
28731,620783,DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 115, DEE115
28732,620784,NEURODEVELOPMENTAL DISORDER PLUS OPTIC ATROPHY, NEDOA
28733,620785,NEURODEVELOPMENTAL DISORDER WITH PROGRESSIVE MOVEMENT ABNORMALITIES, NEDPM
28734,620786,"BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 9, AUTOSOMAL RECESSIVE", IBGC9
28735,620787,"T-CELL ACTIVATION INHIBITOR, MITOCHONDRIAL", TCAIM
28736,620788,"HIG1 HYPOXIA-INDUCIBLE DOMAIN FAMILY, MEMBER 2A", HIGD2A
28737,620789,APLASIA CUTIS-ENAMEL DYSPLASIA SYNDROME, ACED
28738,620790,NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA AND SEIZURES, NEDHS
28739,620791,"CENTROSOMAL PROTEIN, 76-KD", CEP76
28740,620792,OTOSCLEROSIS 12, OTSC12
28741,620793,"MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 29", LGMDR29
28742,620794,"DEAFNESS, AUTOSOMAL RECESSIVE 124", DFNB124
28743,620795,AUTOINFLAMMATION WITH EPISODIC FEVER AND IMMUNE DYSREGULATION, AIFID
28744,620796,PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 6, PRAAS6
28745,620797,DNL-TYPE ZINC FINGER PROTEIN, DNLZ
28746,620798,FRY-LIKE TRANSCRIPTION COACTIVATOR, FRYL
28747,620799,LONG INTERGENIC NONCODING RNA 941, LINC00941
28748,620800,STERILE ALPHA MOTIF DOMAIN-CONTAINING PROTEIN 13, SAMD13
28749,620801,GLYCEROL KINASE 5, GK5
28750,620802,"WD REPEAT-, STERILE ALPHA MOTIF-, AND U-BOX DOMAIN-CONTAINING PROTEIN 1", WDSUB1
28751,620803,"HIG1 HYPOXIA-INDUCIBLE DOMAIN FAMILY, MEMBER 1C", HIGD1C
28752,620804,MOB KINASE ACTIVATOR 3C, MOB3C
28753,620805,ISOCHORISMATASE DOMAIN-CONTAINING PROTEIN 1, ISOC1
28754,620806,DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 116, DEE116
28755,620807,IMMUNODEFICIENCY 121 WITH AUTOINFLAMMATION, IMD121
28756,620808,SMALL NUCLEOLAR RNA HOST GENE 17, SNHG17
28757,620809,ACHAETE-SCUTE FAMILY bHLH TRANSCRIPTION FACTOR 5, ASCL5
28758,620810,"SMALL NUCLEOLAR RNA, C/D BOX, 94", SNORD94
28759,620811,SMALL CAJAL BODY-SPECIFIC RNA 1, SCARNA1
28760,620812,CLAUDIN 25, CLDN25
28761,620813,MHC CLASS I DEFICIENCY 2, MHC1D2
28762,620814,MHC CLASS I DEFICIENCY 3, MHC1D3
28763,620815,MHC CLASS II DEFICIENCY 2, MHC2D2
28764,620816,MHC CLASS II DEFICIENCY 3, MHC2D3
28765,620817,MHC CLASS II DEFICIENCY 4, MHC2D4
28766,620818,MHC CLASS II DEFICIENCY 5, MHC2D5
28767,620819,"ROTHMUND-THOMSON SYNDROME, TYPE 4", RTS4
28768,620820,EL HAYEK-CHAHROUR NEURODEVELOPMENTAL SYNDROME, NEDEHC
28769,620821,ITPRIPL1-LIKE PROTEIN 1, ITPRIPL1
28770,620822,"RNA, U4 SMALL NUCLEAR 1", RNU4-1
28771,620823,"RNA, U4 SMALL NUCLEAR 2", RNU4-2
28772,620824,GLYCOLIPID TRANSFER PROTEIN DOMAIN-CONTAINING PROTEIN 2, GLTPD2
28773,620825,IMMUNODEFICIENCY 119, IMD119
28774,620826,WD REPEAT-CONTAINING PROTEIN 54, WDR54
28775,620827,ZINC FINGER PROTEIN 229, ZNF229
28776,620828,"OLFACTORY RECEPTOR, FAMILY 9, SUBFAMILY I, MEMBER 1", OR9I1
28777,620829,"HERPUD FAMILY, MEMBER 2", HERPUD2
28778,620830,AURONEURODENTAL SYNDROME, ANDS
28779,620831,"SACCHAROPINE DEHYDROGENASE, PUTATIVE", SCCPDH
28780,620832,WD REPEAT-CONTAINING PROTEIN 55, WDR55
28781,620833,RNA-BINDING MOTIF PROTEIN 33, RBM33
28782,620834,SYNAPSE DEFECTIVE RHO GTPase HOMOLOG 2, SYDE2
28783,620835,"TUBULIN, ALPHA-LIKE 3", TUBAL3
28784,620836,IMMUNODEFICIENCY 120, IMD120
28785,620837,ADHESION G PROTEIN-COUPLED RECEPTOR D2, ADGRD2
28786,620838,SPERMATOGENIC FAILURE 91, SPGF91
28787,620839,CHROMOSOME 6 OPEN READING FRAME 132, C6ORF132
28788,620840,PREMATURE OVARIAN FAILURE 24, POF24
28789,620841,INTRAFLAGELLAR TRANSPORT 25, IFT25
28790,620842,ANKYRIN REPEAT- AND MYND DOMAIN-CONTAINING PROTEIN 1, ANKMY1
28791,620843,HEAT-SHOCK TRANSCRIPTION FACTOR 5, HSF5
28792,620844,RWD DOMAIN-CONTAINING PROTEIN 1, RWDD1
28793,620845,"TRANSMEMBRANE 4 L6 FAMILY, MEMBER 19", TM4SF19
28794,620846,N-TERMINAL GLUTAMINE AMIDASE 1, NTAQ1
28795,620847,BONE MORPHOGENETIC PROTEIN 8A, BMP8A
28796,620848,SPERMATOGENIC FAILURE 92, SPGF92
28797,620849,SPERMATOGENIC FAILURE 93, SPGF93
28798,620850,SPERMATOGENIC FAILURE 94, SPGF94
28799,620851,ReNU SYNDROME, RENU
28800,620852,"NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, FEEDING DIFFICULTIES, FACIAL DYSMORPHISM, AND BRAIN ABNORMALITIES", NEDHFDB
28801,620853,ANKYRIN REPEAT- AND FIBRONECTIN TYPE III DOMAIN-CONTAINING PROTEIN 1, ANKFN1
28802,620854,"NEURONOPATHY, DISTAL HEREDITARY MOTOR, AUTOSOMAL RECESSIVE 11, WITH SPASTICITY", HMNR11
28803,620855,G PROTEIN-COUPLED RECEPTOR 155, GPR155
28804,620856,FATTY ACID-BINDING PROTEIN 9, FABP9
28805,620857,ANKYRIN REPEAT DOMAIN-CONTAINING PROTEIN 33, ANKRD33
28806,620858,GLUTAMATE-RICH PROTEIN 2, ERICH2
28807,620859,EXONUCLEASE 3-PRIME-TO-5-PRIME DOMAIN-CONTAINING PROTEIN 3, EXD3
28808,620860,G PROTEIN-COUPLED RECEPTOR 157, GPR157
28809,620861,ANKYRIN REPEAT DOMAIN-CONTAINING PROTEIN 44, ANKRD44
28810,620862,ANKYRIN REPEAT DOMAIN-CONTAINING PROTEIN 52, ANKRD52
28811,620863,AMIDOHYDROLASE DOMAIN-CONTAINING PROTEIN 1, AMDHD1
28812,620864,AMIDOHYDROLASE DOMAIN-CONTAINING PROTEIN 2, AMDHD2
28813,620865,"EHLERS-DANLOS SYNDROME, CLASSIC-LIKE, 3", EDSCLL3
28814,620866,GLUTAMATE-RICH PROTEIN 3, ERICH3
28815,620867,ARMADILLO-LIKE HELICAL DOMAIN-CONTAINING PROTEIN 3, ARMH3
28816,620868,AT-RICH INTERACTION DOMAIN-CONTAINING PROTEIN 3C, ARID3C
28817,620869,IMMUNODEFICIENCY 122, IMD122
28818,620870,DNA DAMAGE-INDUCIBLE 1 HOMOLOG 1, DDI1
28819,620871,DNA DAMAGE-INDUCIBLE 1 HOMOLOG 2, DDI2
28820,620872,ADHESION G PROTEIN-COUPLED RECEPTOR F2, ADGRF2
28821,620873,ADHESION G PROTEIN-COUPLED RECEPTOR F3, ADGRF3
28822,620874,ADHESION G PROTEIN-COUPLED RECEPTOR F5, ADGRF5
28823,620875,FIC DOMAIN-CONTAINING PROTEIN ADENYLYLTRANSFERASE, FICD
28824,620876,HECT DOMAIN E3 UBIQUITIN PROTEIN LIGASE 2, HECTD2
28825,620877,"DEAFNESS, AUTOSOMAL RECESSIVE 125", DFNB125
28826,620878,INTEGRATOR COMPLEX SUBUNIT 14, INTS14
28827,620879,FIBROBLAST GROWTH FACTOR-BINDING PROTEIN 3, FGFBP3
28828,620880,AUTOINFLAMMATION WITH ARTHRITIS AND VASCULITIS, AIARV
28829,620881,COILED-COIL GLUTAMATE-RICH PROTEIN 1, CCER1
28830,620882,SECONDARY OSSIFICATION CENTER-ASSOCIATED REGULATOR OF CHONDROCYTE MATURATION, SNORC
28831,620883,"FER1-LIKE FAMILY, MEMBER 5", FER1L5
28832,620884,"FER1-LIKE FAMILY, MEMBER 6", FER1L6
28833,620885,tRNA METHYLTRANSFERASE 61A, TRMT61A
28834,620886,"tRNA METHYLTRANSFERASE 6, NONCATALYTIC SUBUNIT", TRMT6
28835,620887,MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 9B, MMDS9B
28836,620888,NEURODEVELOPMENTAL DISORDER WITH CHARACTERISTIC FACIAL AND ECTODERMAL FEATURES AND TETRAPARESIS 1, NEDFET1
28837,620889,FORKHEAD-ASSOCIATED PHOSPHOPEPTIDE-BINDING DOMAIN-CONTAINING PROTEIN 1, FHAD1
28838,620890,GROWTH HORMONE-REGULATED TBC PROTEIN 1, GRTP1
28839,620891,COILED-COIL DOMAIN-CONTAINING PROTEIN 181, CCDC181
28840,620892,"CHIBBY FAMILY, MEMBER 3", CBY3
28841,620893,IMPORTIN 9, IPO9
28842,620894,"CARDIOMYOPATHY, DILATED, 2K", CMD2K
28843,620895,GLUTAMATE-RICH PROTEIN 5, ERICH5
28844,620896,LEUCINE-RICH REPEAT-CONTAINING PROTEIN 42, LRRC42
28845,620897,OVARIAN DYSGENESIS 11, ODG11
28846,620898,MICRO RNA 7-2, MIR7-2
28847,620899,MICRO RNA 1179, MIR1179
28848,620900,"SHORT TANDEM REPEAT, TTTG(4), THYROID-SPECIFIC", STRTS
28849,620901,IMMUNODEFICIENCY 123 WITH HPV-RELATED VERRUCOSIS, IMD123
28850,620902,TRINUCLEOTIDE REPEAT-CONTAINING GENE 18, TNRC18
28851,620903,POLYCYSTIC KIDNEY DISEASE 8, PKD8
28852,620904,"FAMILY WITH SEQUENCE SIMILARITY 98, MEMBER A", FAM98A
28853,620905,DOUBLE ZINC RIBBON AND ANKYRIN REPEAT DOMAINS 1, DZANK1
28854,620906,METALLO-BETA-LACTAMASE DOMAIN-CONTAINING PROTEIN 1, MBLAC1
28855,620907,METALLO-BETA-LACTAMASE DOMAIN-CONTAINING PROTEIN 2, MBLAC2
28856,620908,ARTERIAL TORTUOSITY-BONE FRAGILITY SYNDROME, ATBFS
28857,620909,KINESIN LIGHT CHAIN 4, KLC4
28858,620910,OTOFACIAL NEURODEVELOPMENTAL SYNDROME, OFNS
28859,620911,"SPASTIC PARAPLEGIA 92, AUTOSOMAL RECESSIVE", SPG92
28860,620912,MICAL-LIKE PROTEIN 2, MICALL2
28861,620913,N-ACETYLTRANSFERASE 9, NAT9
28862,620914,MAB21 DOMAIN-CONTAINING PROTEIN 2, MB21D2
28863,620915,MYOSIN XVB, MYO15B
28864,620916,ZINC FINGER- AND SCAN DOMAIN-CONTAINING PROTEIN 5A, ZSCAN5A
28865,620917,SPERMATOGENIC FAILURE 95, SPGF95
28866,620918,ZINC FINGER- AND SCAN DOMAIN-CONTAINING PROTEIN 5B, ZSCAN5B
28867,620919,"MANNOSIDASE, ENDO-ALPHA-LIKE", MANEAL
28868,620920,KRAB-A DOMAIN-CONTAINING PROTEIN 2, KRBA2
28869,620921,ZINC FINGER PROTEIN 512, ZNF512
28870,620922,LEUCINE-RICH REPEATS- AND IQ MOTIF-CONTAINING PROTEIN 1, LRRIQ1
28871,620923,"PARKINSON DISEASE 26, AUTOSOMAL DOMINANT, SUSCEPTIBILITY TO", PARK26
28872,620924,NOTCHLESS HOMOLOG 1, NLE1
28873,620925,LEUCINE-RICH REPEAT-CONTAINING PROTEIN 31, LRRC31
28874,620926,IMMUNODEFICIENCY 125, IMD125
28875,620927,LEUCINE-RICH REPEAT-CONTAINING PROTEIN 46, LRRC46
28876,620928,JUMONJI DOMAIN-CONTAINING PROTEIN 4, JMJD4
28877,620929,MOB KINASE ACTIVATOR 3A, MOB3A
28878,620930,"MAESTRO HEAT-LIKE REPEAT FAMILY, MEMBER 2B", MROH2B
28879,620931,"IMMUNODEFICIENCY 126, SUSCEPTIBILITY TO", IMD126
28880,620932,ZINC FINGER- AND SCAN DOMAIN-CONTAINING PROTEIN 29, ZSCAN29
28881,620933,"PNMA FAMILY, MEMBER 8A", PNMA8A
28882,620934,"PNMA FAMILY, MEMBER 8C", PNMA8C
28883,620935,TESTIS-EXPRESSED GENE 9, TEX9
28884,620936,WD REPEAT-CONTAINING PROTEIN 27, WDR27
28885,620937,KARIMINEJAD NEURODEVELOPMENTAL SYNDROME, KAREVS
28886,620938,"SPASTIC PARAPLEGIA 93, AUTOSOMAL RECESSIVE", SPG93
28887,620939,"MYELOFIBROSIS, CONGENITAL, WITH ANEMIA, NEUTROPENIA, DEVELOPMENTAL DELAY, AND OCULAR ABNORMALITIES", MFANDO
28888,620940,"METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, cblL TYPE", MAHCL
28889,620941,SYNAPTOPODIN 2, SYNPO2
28890,620942,SYNPO2 INTRON SENSE-OVERLAPPING LONG NONCODING RNA,
28891,620943,BRAIN MALFORMATION RENAL SYNDROME, BMRS
28892,620944,ARRESTIN DOMAIN-CONTAINING PROTEIN 5, ARRDC5
28893,620945,CILIARY MICROTUBULE INNER PROTEIN 4, CIMIP4
28894,620946,UBIQUITIN-SPECIFIC PEPTIDASE 42, USP42
28895,620947,SPINOCEREBELLAR ATAXIA 51, SCA51
28896,620948,UTP6 SMALL SUBUNIT PROCESSOME COMPONENT, UTP6
28897,620949,TOG ARRAY REGULATOR OF AXONEMAL MICROTUBULES 2, TOGARAM2
28898,620950,"ENCEPHALOPATHY, ACUTE TRANSIENT", ENPAT
28899,620951,WD REPEAT-CONTAINING PROTEIN 31, WDR31
28900,620952,"HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, cblD TYPE", HMAD
28901,620953,"METHYLMALONIC ACIDURIA, cblD TYPE", MACD
28902,620954,TETRATRICOPEPTIDE REPEAT DOMAIN-CONTAINING PROTEIN 6, TTC6
28903,620955,SORTING NEXIN 30, SNX30
28904,620956,ZINC FINGER C3H1 DOMAIN-CONTAINING PROTEIN, ZFC3H1
28905,620957,tRNA METHYLTRANSFERASE 10B, TRMT10B
28906,620958,FOVEAL HYPOPLASIA 3, FVH3
28907,620959,UBIQUITIN-SPECIFIC PEPTIDASE 35, USP35
28908,620960,MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 10, MMDS10
28909,620961,SORTING NEXIN 25, SNX25
28910,620962,"CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC, 13", PFIC13
28911,620963,ZINC FINGER DHHC-TYPE PALMITOYLTRANSFERASE 18, ZDHHC18
28912,620964,CONGENITAL MYOPATHY 25, CMYO25
28913,620965,SMALL VCP-INTERACTING PROTEIN, SVIP
28914,620966,TLC DOMAIN-CONTAINING PROTEIN 1, TLCD1
28915,620967,TLC DOMAIN-CONTAINING PROTEIN 2, TLCD2
28916,620968,MICROPHTHALMIA/COLOBOMA 13, MCOPCB13
28917,620969,"ANEMIA, CONGENITAL DYSERYTHROPOIETIC, TYPE IVb", CDAN4B
28918,620970,ZINC FINGER PROTEIN 808, ZNF808
28919,620971,"MYOPATHY WITH MYALGIA, INCREASED SERUM CREATINE KINASE, AND WITH OR WITHOUT EPISODIC RHABDOMYOLYSIS 2", MMCKR2
28920,620972,ZINC FINGER PROTEIN 608, ZNF608
28921,620973,SYNAPTOTAGMIN-LIKE 3, SYTL3
28922,620974,ZINC FINGER PROTEIN 862, ZNF862
28923,620975,"BLOOD GROUP, ANTON SYSTEM",
28924,620976,ZINC FINGER PROTEIN 740, ZNF740
28925,620977,IMMUNODEFICIENCY 127, IMD127
28926,620978,"LEUKODYSTROPHY, HYPOMYELINATING, 28", HLD28
28927,620979,TRIPARTITE MOTIF FAMILY-LIKE PROTEIN 1, TRIML1
28928,620980,ZINC FINGER PROTEIN 414, ZNF414
28929,620981,ZINC FINGER PROTEIN 697, ZNF697
28930,620982,ZINC FINGER PROTEIN 385C, ZNF385C
28931,620983,IMMUNODEFICIENCY 128, IMD128
28932,620984,BRONCHIECTASIS AND NASAL POLYPOSIS, BENP
28933,620985,KARAYOL-BORROTO-HAGHSHENAS NEURODEVELOPMENTAL SYNDROME, KBHS
28934,620986,T-SNARE DOMAIN-CONTAINING PROTEIN 1, TSNARE1
28935,620987,"NEURODEGENERATION, INFANTILE-ONSET, WITH OPTIC ATROPHY AND BRAIN ABNORMALITIES", NDOABA
28936,620988,"INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 75", MRD75
28937,620989,"SERPIN FAMILY E, MEMBER 3", SERPINE3
28938,620990,ACTH-INDEPENDENT MACRONODULAR ADRENAL HYPERPLASIA 3, AIMAH3
28939,620991,PANCREATIC AGENESIS 3, PAGEN3
28940,620992,SAFB-LIKE TRANSCRIPTION MODULATOR, SLTM
28941,620993,CHD2-ADJACENT SUPPRESSIVE REGULATORY RNA, CHASERR
28942,620994,RUN AND FYVE DOMAINS-CONTAINING PROTEIN 4, RUFY4
28943,620995,SET DOMAIN-CONTAINING PROTEIN 4, SETD4
28944,620996,RETINITIS PIGMENTOSA 98, RP98
28945,620997,SEMAPHORIN 3G, SEMA3G
28946,620998,ZINC FINGER PROTEIN 230, ZNF230
28947,620999,"FIBROMATOSIS, GINGIVAL, 6", GINGF6
28948,621000,SORTING NEXIN 18, SNX18
28949,621001,SPERMATOGENIC FAILURE 96, SPGF96
28950,621002,PREMATURE OVARIAN FAILURE 25, POF25
28951,621003,TRANSCRIPTION FACTOR Sp9, SP9
28952,621004,AUTOIMMUNE DISEASE WITH SUSCEPTIBILITY TO MYCOBACTERIUM TUBERCULOSIS, AIMTBS
28953,621005,SOMATOMEDIN B AND THROMBOSPONDIN TYPE 1 DOMAIN-CONTAINING PROTEIN, SBSPON
28954,621006,RETROTRANSPOSON GAG-LIKE PROTEIN 6, RTL6
28955,621007,ZINC FINGER PROTEIN 800, ZNF800
28956,621009,KLF TRANSCRIPTION FACTOR 18, KLF18
28957,621010,MORIMOTO-RYU-MALICDAN NEUROMUSCULAR SYNDROME, MRMNS
28958,621011,SEC14 AND SPECTRIN DOMAINS-CONTAINING PROTEIN 1, SESTD1
28959,621012,"NEURODEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES, ABSENT SPEECH AND AMBULATION, AND BRAIN ABNORMALITIES", NEDFSAB
28960,621013,TETRASPANIN 11, TSPAN11
28961,621014,ANKYRIN REPEAT- AND BTB DOMAIN-CONTAINING PROTEIN 2, ABTB2
28962,621015,RNA-BINDING MOTIF PROTEIN 48, RBM48
28963,621016,NEURODEVELOPMENTAL DISORDER WITH VARIABLE FAMILIAL HYPERCHOLANEMIA, NEDFHCA
28964,621017,ZINC FINGER PROTEIN 334, ZNF334
28965,621018,"BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 10, AUTOSOMAL RECESSIVE", IBGC10
28966,621019,PRE-mRNA-PROCESSING FACTOR 40 HOMOLOG B, PRPF40B
28967,621020,RING FINGER PROTEIN 212B, RNF212B
28968,621021,INTELLECTUAL DEVELOPMENTAL DISORDER WITH POLYMICROGYRIA AND SEIZURES, IDDPMGS
28969,621022,"FAMILY WITH SEQUENCE SIMILARITY 83, MEMBER A", FAM83A
28970,621023,RNA-BINDING MOTIF PROTEIN 23, RBM23
28971,621024,PROTEIN PRENYLTRANSFERASE ALPHA SUBUNIT REPEAT-CONTAINING PROTEIN 1, PTAR1
28972,621025,RAB3A-INTERACTING PROTEIN-LIKE 1, RAB3IL1
28973,621026,RING FINGER PROTEIN 182, RNF182
28974,621027,"CHOLESTEROL-INDUCED REGULATOR OF METABOLISM RNA, NONCODING", CHROMR
28975,621028,ANKYRIN REPEAT- AND BTB DOMAIN-CONTAINING PROTEIN 3, ABTB3
28976,621029,RING FINGER PROTEIN 183, RNF183
28977,621030,"AUTOINFLAMMATION, PANNICULITIS, AND DERMATOSIS SYNDROME, AUTOSOMAL DOMINANT", AIPDSA
28978,621031,"POLYMERASE I, RNA, SUBUNIT E", POLR1E
28979,621032,CEREBRAL CAVERNOUS MALFORMATIONS 5, CCM5
28980,621033,NUP210-LIKE PROTEIN, NUP210L
28981,621034,NEURODEVELOPMENTAL DISORDER WITH SPEECH OR VISUAL IMPAIRMENT AND BRAIN HYPOMYELINATION, NEDSVH
28982,621035,PROLINE-RICH PROTEIN 14-LIKE PROTEIN, PRR14L
28983,621036,ABHYDROLASE DOMAIN-CONTAINING PROTEIN 8, ABHD8
28984,621037,PROTEIN PHOSPHATASE 2C-LIKE DOMAIN-CONTAINING PROTEIN 1, PP2D1
28985,621038,RNA-BINDING MOTIF PROTEIN 44, RBM44
28986,621039,ABHYDROLASE DOMAIN-CONTAINING PROTEIN 13, ABHD13
28987,621040,ABHYDROLASE DOMAIN-CONTAINING PROTEIN 14B, ABHD14B
28988,621041,"PLECKSTRIN HOMOLOGY-LIKE DOMAIN, FAMILY B, MEMBER 3", PHLDB3
28989,621042,ALANINE- AND ARGININE-RICH DOMAIN-CONTAINING PROTEIN, AARD
28990,621043,PODOCAN-LIKE 1, PODNL1
28991,621044,RING FINGER PROTEIN 157, RNF157
28992,621045,RNA-BINDING MOTIF PROTEIN 4B, RBM4B
28993,621046,"RIBONUCLEASE A FAMILY, MEMBER 10, INACTIVE", RNASE10
28994,621047,PEPTIDYL-tRNA HYDROLASE 1, PTRH1
28995,621048,"POLO-LIKE KINASE 5, INACTIVE", PLK5
28996,621049,PAN-CHUNG-BELLEN SYNDROME, PCBS
28997,621050,ABHYDROLASE DOMAIN-CONTAINING PROTEIN 11, ABHD11
28998,621051,PARALEMMIN 3, PALM3
28999,621052,PLECKSTRIN HOMOLOGY DOMAIN-CONTAINING PROTEIN N1, PLEKHN1
29000,621053,NEDD4-BINDING PROTEIN 2-LIKE 1, N4BP2L1
29001,621054,NUCLEAR RECEPTOR-INTERACTING PROTEIN 2, NRIP2
29002,621055,"POLYADENYLATE-BINDING PROTEIN, CYTOPLASMIC, 1-LIKE", PABPC1L
29003,621056,"TELANGIECTASIA, IMPAIRED INTELLECTUAL DEVELOPMENT, MICROCEPHALY, METAPHYSEAL DYSPLASIA, EYE ABNORMALITIES, AND SHORT STATURE", TIMES
29004,621057,SPERMATOGENIC FAILURE 97, SPGF97
29005,621058,NK1 HOMEOBOX 2, NKX1-2
29006,621059,UBIQUITIN FAMILY DOMAIN-CONTAINING PROTEIN 1, UBFD1
29007,621060,"NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, ABSENT SPEECH, AND HYPOTONIA", NEDMISH
29008,621061,"LEUKODYSTROPHY, DEMYELINATING, ADULT-ONSET, AUTOSOMAL DOMINANT, ATYPICAL", ADLDAT
29009,621062,NPAS4 LONG NONCODING ENHANCER RNA,
29010,621063,MUGGENTHALER-CHOWDHURY-CHIOZA SYNDROME, MCCS
29011,621064,"EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 19", EIG19
29012,621065,PREMATURE OVARIAN FAILURE 26, POF26
29013,621066,LYSOZYME G1, LYG1
29014,621067,"NEURODEVELOPMENTAL DISORDER WITH POOR GROWTH, ABSENT SPEECH, PROGRESSIVE ATAXIA, AND DYSMORPHIC FACIES", NEDGSAF
29015,621068,"NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, POOR GROWTH, DYSMORPHIC FACIES, AND AGAMMAGLOBULINEMIA", NEDHGFA
29016,621069,OVOCHYMASE 1, OVCH1
29017,621070,"OUT AT FIRST, DROSOPHILA, HOMOLOG OF", OAF
29018,621071,MITOCHONDRIAL DNA DEPLETION SYNDROME 21, MTDPS21
29019,621072,BACULOVIRAL IAP REPEAT-CONTAINING PROTEIN 8, BIRC8
29020,621073,SORTING NEXIN 32, SNX32
29021,621074,MITOTIC DEACETYLASE-ASSOCIATED SANT DOMAIN PROTEIN, MIDEAS
29022,621075,TRANSMEMBRANE PROTEIN 45B, TMEM45B
29023,621076,5-PRIME-NUCLEOTIDASE DOMAIN-CONTAINING PROTEIN 2, NT5DC1
29024,621077,5-PRIME-NUCLEOTIDASE DOMAIN-CONTAINING PROTEIN 2, NT5DC2
29025,621078,"MYOPATHY, MYOFIBRILLAR, 13, WITH RIMMED VACUOLES", MFM13
29026,621079,"HETEROTAXY, VISCERAL, 13, AUTOSOMAL",
29027,621080,"HETEROTAXY, VISCERAL, 14, AUTOSOMAL", HTX14
29028,621081,IMMUNITY-RELATED GTPase Q, IRGQ
29029,621082,FANCD2 OPPOSITE STRAND, FANCD2OS
29030,621083,ISLET CELL AUTOANTIGEN 1-LIKE PROTEIN, ICA1L
29031,621084,ECHINODERM MICROTUBULE-ASSOCIATED PROTEIN-LIKE 6, EML6
29032,621085,EXOCYST COMPLEX COMPONENT 3-LIKE 4, EXOC3L4
29033,621086,SPERMATOGENESIS-ASSOCIATED PROTEIN 24, SPATA24
29034,621087,DIHYDROURIDINE SYNTHASE 1-LIKE PROTEIN, DUS1L
29035,621088,SMALL NUCLEOLAR RNA HOST GENE 4, SNHG4
29036,621089,"SMALL NUCLEOLAR RNA, H/ACA BOX, 74A", SNORA74A
29037,621090,"RNA, U5B SMALL NUCLEAR 1", RNU5B-1
29038,621091,OCULAR PTERYGIUM-DIGITAL KELOID DYSPLASIA SYNDROME, OPDKD
29039,621092,IQ MOTIF-CONTAINING GTPase-ACTIVATING PROTEIN 3, IQGAP3
29040,621093,OOCYTE/ZYGOTE/EMBRYO MATURATION ARREST 22, OZEMA22
29041,621094,"NEURONOPATHY, DISTAL HEREDITARY MOTOR, AUTOSOMAL DOMINANT 15", HMND15
29042,621095,"CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2JJ", CMT2JJ
29043,621096,IMMUNODEFICIENCY 132B, IMD132B
29044,621097,IMMUNODEFICIENCY 131, IMD131
29045,621098,V-SET AND IMMUNOGLOBULIN DOMAINS-CONTAINING PROTEIN 8, VSIG8
29046,621099,"SPONDYLOEPIMETAPHYSEAL DYSPLASIA, LI-SHAO-LI TYPE", SEMDLSL
29047,621100,"INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 83", MRT83
29048,621101,PERRAULT SYNDROME 7, PRLTS7
29049,621102,NEURODEVELOPMENTAL DISORDER WITH PROGRESSIVE SPASTICITY AND BRAIN ABNORMALITIES, NEDPSB
29050,621103,"GOLGI-ASSOCIATED RAB2 INTERACTOR FAMILY, MEMBER 5B", GARIN5B
29051,621104,DIHYDROURIDINE SYNTHASE 3-LIKE PROTEIN, DUS3L
29052,621105,ETS VARIANT TRANSCRIPTION FACTOR 3-LIKE, ETV3L
29053,621106,"TUBULOINTERSTITIAL KIDNEY DISEASE, AUTOSOMAL DOMINANT 6", ADTKD6
29054,621107,HEMICENTIN 2, HMCN2
29055,621108,"DNAJ/HSP40 HOMOLOG, SUBFAMILY C, MEMBER 18", DNAJC2
29056,621109,"VCP NUCLEAR COFACTOR FAMILY, MEMBER 1", VCF1
29057,621110,VITELLINE MEMBRANE OUTER LAYER PROTEIN 1 HOMOLOG, VMO1
29058,621111,OOCYTE-SECRETED PROTEIN 1, OOSP1
29059,621112,OOCYTE-SECRETED PROTEIN 3, OOSP3
29060,621113,VON WILLEBRAND FACTOR A DOMAIN-CONTAINING PROTEIN 3A, VWA3A
29061,621114,CILIA- AND FLAGELLA-ASSOCIATED PROTEIN 144, CFAP144
29062,621115,RIB43A DOMAIN WITH COILED-COILS PROTEIN 2, RIBC2
29063,621116,DTW DOMAIN-CONTAINING PROTEIN 1, DTWD1
29064,621117,DTW DOMAIN-CONTAINING PROTEIN 2, DTWD2
29065,621118,V-SET AND TRANSMEMBRANE DOMAINS-CONTAINING PROTEIN 5, VSTM5
29066,621119,ENKURIN DOMAIN-CONTAINING PROTEIN 1, ENKD1
29067,621120,DELTA-LIKE NONCANONICAL NOTCH LIGAND 2, DLK2
